COMPOUND_NAME,CHEMBL_ID,INCHI,SMILES,PARENT_CHEMBL_ID,PARENT_INCHI,PARENT_SMILES,ASSAY_CHEMBL_ID,ASSAY,ENDPOINT,RELATION,VALUE,UNITS,ASSAY_COMMENTS,TARGET_CHEMBL_ID,TARGET,SPECIES,UNIPROT_ID,REF_CHEMBL_ID,REFERENCE,PUBMED_ID,SOURCE
14c,CHEMBL266707,"InChI=1S/C16H12FN3S/c17-13-3-1-12(2-4-13)15-14(11-5-7-18-8-6-11)19-16-20(15)9-10-21-16/h1-8H,9-10H2",Fc1ccc(cc1)c2c(nc3SCCn23)c4ccncc4,CHEMBL266707,"InChI=1S/C16H12FN3S/c17-13-3-1-12(2-4-13)15-14(11-5-7-18-8-6-11)19-16-20(15)9-10-21-16/h1-8H,9-10H2",Fc1ccc(cc1)c2c(nc3SCCn23)c4ccncc4,CHEMBL788399,Adjuvant arthritic activity in rat injected leg on day 16 tested at 50 mg/kg perorally,Inhibition,=,4,%,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1122599,"J. Med. Chem., 27, p. 72 (1984)",6690686,Scientific Literature
13c,CHEMBL313417,"InChI=1S/C16H12FN3S/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14/h1-8H,9-10H2",Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL313417,"InChI=1S/C16H12FN3S/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14/h1-8H,9-10H2",Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL788400,Adjuvant arthritic activity in rat injected leg on day 16 tested at 50 mg/kg perorally.,Inhibition,=,38,%,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1122599,"J. Med. Chem., 27, p. 72 (1984)",6690686,Scientific Literature
13c,CHEMBL313417,"InChI=1S/C16H12FN3S/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14/h1-8H,9-10H2",Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL313417,"InChI=1S/C16H12FN3S/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14/h1-8H,9-10H2",Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL788401,Adjuvant arthritic activity in rat injected leg on day 3 tested at 50 mg/kg perorally,Inhibition,=,27,%,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1122599,"J. Med. Chem., 27, p. 72 (1984)",6690686,Scientific Literature
14c,CHEMBL266707,"InChI=1S/C16H12FN3S/c17-13-3-1-12(2-4-13)15-14(11-5-7-18-8-6-11)19-16-20(15)9-10-21-16/h1-8H,9-10H2",Fc1ccc(cc1)c2c(nc3SCCn23)c4ccncc4,CHEMBL266707,"InChI=1S/C16H12FN3S/c17-13-3-1-12(2-4-13)15-14(11-5-7-18-8-6-11)19-16-20(15)9-10-21-16/h1-8H,9-10H2",Fc1ccc(cc1)c2c(nc3SCCn23)c4ccncc4,CHEMBL788401,Adjuvant arthritic activity in rat injected leg on day 3 tested at 50 mg/kg perorally,Inhibition,=,2,%,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1122599,"J. Med. Chem., 27, p. 72 (1984)",6690686,Scientific Literature
14c,CHEMBL266707,"InChI=1S/C16H12FN3S/c17-13-3-1-12(2-4-13)15-14(11-5-7-18-8-6-11)19-16-20(15)9-10-21-16/h1-8H,9-10H2",Fc1ccc(cc1)c2c(nc3SCCn23)c4ccncc4,CHEMBL266707,"InChI=1S/C16H12FN3S/c17-13-3-1-12(2-4-13)15-14(11-5-7-18-8-6-11)19-16-20(15)9-10-21-16/h1-8H,9-10H2",Fc1ccc(cc1)c2c(nc3SCCn23)c4ccncc4,CHEMBL785838,Adjuvant arthritic activity in rat uninjected leg on day 16 tested at 50 mg/kg perorally,Inhibition,=,9,%,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1122599,"J. Med. Chem., 27, p. 72 (1984)",6690686,Scientific Literature
13c,CHEMBL313417,"InChI=1S/C16H12FN3S/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14/h1-8H,9-10H2",Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL313417,"InChI=1S/C16H12FN3S/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14/h1-8H,9-10H2",Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL785839,Adjuvant arthritic activity in rat uninjected leg on day 16 tested at 50 mg/kg perorally.,Inhibition,=,44,%,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1122599,"J. Med. Chem., 27, p. 72 (1984)",6690686,Scientific Literature
14c,CHEMBL266707,"InChI=1S/C16H12FN3S/c17-13-3-1-12(2-4-13)15-14(11-5-7-18-8-6-11)19-16-20(15)9-10-21-16/h1-8H,9-10H2",Fc1ccc(cc1)c2c(nc3SCCn23)c4ccncc4,CHEMBL266707,"InChI=1S/C16H12FN3S/c17-13-3-1-12(2-4-13)15-14(11-5-7-18-8-6-11)19-16-20(15)9-10-21-16/h1-8H,9-10H2",Fc1ccc(cc1)c2c(nc3SCCn23)c4ccncc4,CHEMBL794022,Cutaneous oxazolone induced contact sensitivity in mouse and percent stimulation in right hind paw was determined at a dose 25 mg/kg perorally,Stimulation,=,15,%,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1122599,"J. Med. Chem., 27, p. 72 (1984)",6690686,Scientific Literature
13c,CHEMBL313417,"InChI=1S/C16H12FN3S/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14/h1-8H,9-10H2",Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL313417,"InChI=1S/C16H12FN3S/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14/h1-8H,9-10H2",Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL794023,Cutaneous oxazolone induced contact sensitivity in mouse and percent stimulation in right hind paw was determined at a dose 25 mg/kg perorally.,Stimulation,=,69,%,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1122599,"J. Med. Chem., 27, p. 72 (1984)",6690686,Scientific Literature
"9, SB-210313",CHEMBL14112,"InChI=1S/C21H23FN4O/c22-19-4-2-17(3-5-19)20-21(18-6-8-23-9-7-18)26(16-24-20)11-1-10-25-12-14-27-15-13-25/h2-9,16H,1,10-15H2",Fc1ccc(cc1)c2ncn(CCCN3CCOCC3)c2c4ccncc4,CHEMBL14112,"InChI=1S/C21H23FN4O/c22-19-4-2-17(3-5-19)20-21(18-6-8-23-9-7-18)26(16-24-20)11-1-10-25-12-14-27-15-13-25/h2-9,16H,1,10-15H2",Fc1ccc(cc1)c2ncn(CCCN3CCOCC3)c2c4ccncc4,CHEMBL717406,In vivo inhibition of LPS-induced TNF production in mice 50 mg/Kg.,Change,=,-55,%,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1129676,"J. Med. Chem., 39, p. 3929 (1996)",8831759,Scientific Literature
"9, SB-210313",CHEMBL14112,"InChI=1S/C21H23FN4O/c22-19-4-2-17(3-5-19)20-21(18-6-8-23-9-7-18)26(16-24-20)11-1-10-25-12-14-27-15-13-25/h2-9,16H,1,10-15H2",Fc1ccc(cc1)c2ncn(CCCN3CCOCC3)c2c4ccncc4,CHEMBL14112,"InChI=1S/C21H23FN4O/c22-19-4-2-17(3-5-19)20-21(18-6-8-23-9-7-18)26(16-24-20)11-1-10-25-12-14-27-15-13-25/h2-9,16H,1,10-15H2",Fc1ccc(cc1)c2ncn(CCCN3CCOCC3)c2c4ccncc4,CHEMBL619237,Inhibitory concentration against 5-lipoxygenase in rat RBL-1 cells,IC50,>,100000,nM,,CHEMBL312,Arachidonate 5-lipoxygenase,Rattus norvegicus,P12527,CHEMBL1129676,"J. Med. Chem., 39, p. 3929 (1996)",8831759,Scientific Literature
SKF-86002,CHEMBL313417,"InChI=1S/C16H12FN3S/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14/h1-8H,9-10H2",Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL313417,"InChI=1S/C16H12FN3S/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14/h1-8H,9-10H2",Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL619237,Inhibitory concentration against 5-lipoxygenase in rat RBL-1 cells,IC50,=,10000,nM,,CHEMBL312,Arachidonate 5-lipoxygenase,Rattus norvegicus,P12527,CHEMBL1129676,"J. Med. Chem., 39, p. 3929 (1996)",8831759,Scientific Literature
"9, SB-210313",CHEMBL14112,"InChI=1S/C21H23FN4O/c22-19-4-2-17(3-5-19)20-21(18-6-8-23-9-7-18)26(16-24-20)11-1-10-25-12-14-27-15-13-25/h2-9,16H,1,10-15H2",Fc1ccc(cc1)c2ncn(CCCN3CCOCC3)c2c4ccncc4,CHEMBL14112,"InChI=1S/C21H23FN4O/c22-19-4-2-17(3-5-19)20-21(18-6-8-23-9-7-18)26(16-24-20)11-1-10-25-12-14-27-15-13-25/h2-9,16H,1,10-15H2",Fc1ccc(cc1)c2ncn(CCCN3CCOCC3)c2c4ccncc4,CHEMBL768431,Inhibitory concentration against Prostaglandin H2 synthase 1 (PGHS-1) from ram seminal vesicle,IC50,>,100000,nM,,CHEMBL221,Cyclooxygenase-1,Homo sapiens,P23219,CHEMBL1129676,"J. Med. Chem., 39, p. 3929 (1996)",8831759,Scientific Literature
SKF-86002,CHEMBL313417,"InChI=1S/C16H12FN3S/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14/h1-8H,9-10H2",Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL313417,"InChI=1S/C16H12FN3S/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14/h1-8H,9-10H2",Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL768431,Inhibitory concentration against Prostaglandin H2 synthase 1 (PGHS-1) from ram seminal vesicle,IC50,=,5400,nM,,CHEMBL221,Cyclooxygenase-1,Homo sapiens,P23219,CHEMBL1129676,"J. Med. Chem., 39, p. 3929 (1996)",8831759,Scientific Literature
"1a, SB-210313",CHEMBL14112,"InChI=1S/C21H23FN4O/c22-19-4-2-17(3-5-19)20-21(18-6-8-23-9-7-18)26(16-24-20)11-1-10-25-12-14-27-15-13-25/h2-9,16H,1,10-15H2",Fc1ccc(cc1)c2ncn(CCCN3CCOCC3)c2c4ccncc4,CHEMBL14112,"InChI=1S/C21H23FN4O/c22-19-4-2-17(3-5-19)20-21(18-6-8-23-9-7-18)26(16-24-20)11-1-10-25-12-14-27-15-13-25/h2-9,16H,1,10-15H2",Fc1ccc(cc1)c2ncn(CCCN3CCOCC3)c2c4ccncc4,CHEMBL735879,Effective dose required to determine the oral activity in the mouse LPS-induced TNF alpha assay,ED50,=,42,mg.kg-1,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1130658,"Bioorg. Med. Chem. Lett., 8, p. 3111 (1998)",9873686,Scientific Literature
4b,CHEMBL274863,"InChI=1S/C20H23FN6O/c21-16-4-2-15(3-5-16)18-19(17-6-7-23-20(22)25-17)27(14-24-18)9-1-8-26-10-12-28-13-11-26/h2-7,14H,1,8-13H2,(H2,22,23,25)",Nc1nccc(n1)c2c(ncn2CCCN3CCOCC3)c4ccc(F)cc4,CHEMBL274863,"InChI=1S/C20H23FN6O/c21-16-4-2-15(3-5-16)18-19(17-6-7-23-20(22)25-17)27(14-24-18)9-1-8-26-10-12-28-13-11-26/h2-7,14H,1,8-13H2,(H2,22,23,25)",Nc1nccc(n1)c2c(ncn2CCCN3CCOCC3)c4ccc(F)cc4,CHEMBL735879,Effective dose required to determine the oral activity in the mouse LPS-induced TNF alpha assay,ED50,=,5.2,mg.kg-1,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1130658,"Bioorg. Med. Chem. Lett., 8, p. 3111 (1998)",9873686,Scientific Literature
"1a, SB-210313",CHEMBL14112,"InChI=1S/C21H23FN4O/c22-19-4-2-17(3-5-19)20-21(18-6-8-23-9-7-18)26(16-24-20)11-1-10-25-12-14-27-15-13-25/h2-9,16H,1,10-15H2",Fc1ccc(cc1)c2ncn(CCCN3CCOCC3)c2c4ccncc4,CHEMBL14112,"InChI=1S/C21H23FN4O/c22-19-4-2-17(3-5-19)20-21(18-6-8-23-9-7-18)26(16-24-20)11-1-10-25-12-14-27-15-13-25/h2-9,16H,1,10-15H2",Fc1ccc(cc1)c2ncn(CCCN3CCOCC3)c2c4ccncc4,CHEMBL665883,Percent inhibition of human hepatic cytochrome P450 2D6 at 10 uM,Inhibition,=,86,%,,CHEMBL289,Cytochrome P450 2D6,Homo sapiens,P10635,CHEMBL1130658,"Bioorg. Med. Chem. Lett., 8, p. 3111 (1998)",9873686,Scientific Literature
4b,CHEMBL274863,"InChI=1S/C20H23FN6O/c21-16-4-2-15(3-5-16)18-19(17-6-7-23-20(22)25-17)27(14-24-18)9-1-8-26-10-12-28-13-11-26/h2-7,14H,1,8-13H2,(H2,22,23,25)",Nc1nccc(n1)c2c(ncn2CCCN3CCOCC3)c4ccc(F)cc4,CHEMBL274863,"InChI=1S/C20H23FN6O/c21-16-4-2-15(3-5-16)18-19(17-6-7-23-20(22)25-17)27(14-24-18)9-1-8-26-10-12-28-13-11-26/h2-7,14H,1,8-13H2,(H2,22,23,25)",Nc1nccc(n1)c2c(ncn2CCCN3CCOCC3)c4ccc(F)cc4,CHEMBL665883,Percent inhibition of human hepatic cytochrome P450 2D6 at 10 uM,Inhibition,=,47,%,,CHEMBL289,Cytochrome P450 2D6,Homo sapiens,P10635,CHEMBL1130658,"Bioorg. Med. Chem. Lett., 8, p. 3111 (1998)",9873686,Scientific Literature
3k,CHEMBL304624,"InChI=1S/C20H15N3O/c24-17-8-4-7-16(13-17)19-18(14-9-11-21-12-10-14)22-20(23-19)15-5-2-1-3-6-15/h1-13,24H,(H,22,23)",Oc1cccc(c1)c2nc([nH]c2c3ccncc3)c4ccccc4,CHEMBL304624,"InChI=1S/C20H15N3O/c24-17-8-4-7-16(13-17)19-18(14-9-11-21-12-10-14)22-20(23-19)15-5-2-1-3-6-15/h1-13,24H,(H,22,23)",Oc1cccc(c1)c2nc([nH]c2c3ccncc3)c4ccccc4,CHEMBL765226,Inhibitory activity against recombinant human RAF proto-oncogene serine/threonine-protein kinase,IC50,=,23,nM,,CHEMBL1906,Serine/threonine-protein kinase RAF,Homo sapiens,P04049,CHEMBL1132637,"J. Med. Chem., 42, p. 2180 (1999)",10377223,Scientific Literature
3,CHEMBL1789963,"InChI=1S/C20H11Cl2NO4/c21-14-7-10(8-15(22)19(14)25)6-13-12-9-11(3-4-16(12)23-20(13)26)18(24)17-2-1-5-27-17/h1-9,25H,(H,23,26)",Oc1c(Cl)cc(C=C2C(=O)Nc3ccc(cc23)C(=O)c4occc4)cc1Cl,CHEMBL1789963,"InChI=1S/C20H11Cl2NO4/c21-14-7-10(8-15(22)19(14)25)6-13-12-9-11(3-4-16(12)23-20(13)26)18(24)17-2-1-5-27-17/h1-9,25H,(H,23,26)",Oc1c(Cl)cc(C=C2C(=O)Nc3ccc(cc23)C(=O)c4occc4)cc1Cl,CHEMBL820190,Inhibition of cRaf1 kinase in cascade assay,IC50,=,46,nM,,CHEMBL1906,Serine/threonine-protein kinase RAF,Homo sapiens,P04049,CHEMBL1133034,"Bioorg. Med. Chem. Lett., 10, p. 223 (2000)",10698440,Scientific Literature
4,CHEMBL1794050,"InChI=1S/C20H12Br2N2O2.ClH/c21-16-7-11(8-17(22)19(16)25)6-15-14-9-12(13-2-1-5-23-10-13)3-4-18(14)24-20(15)26;/h1-10,25H,(H,24,26);1H",Cl.Oc1c(Br)cc(C=C2C(=O)Nc3ccc(cc23)c4cccnc4)cc1Br,CHEMBL1851668,"InChI=1S/C20H12Br2N2O2/c21-16-7-11(8-17(22)19(16)25)6-15-14-9-12(13-2-1-5-23-10-13)3-4-18(14)24-20(15)26/h1-10,25H,(H,24,26)",Oc1c(Br)cc(C=C2C(=O)Nc3ccc(cc23)c4cccnc4)cc1Br,CHEMBL820190,Inhibition of cRaf1 kinase in cascade assay,IC50,=,11,nM,,CHEMBL1906,Serine/threonine-protein kinase RAF,Homo sapiens,P04049,CHEMBL1133034,"Bioorg. Med. Chem. Lett., 10, p. 223 (2000)",10698440,Scientific Literature
8,CHEMBL1794052,"InChI=1S/C17H11Br2NO4/c1-24-17(23)9-2-3-14-10(7-9)11(16(22)20-14)4-8-5-12(18)15(21)13(19)6-8/h2-7,21H,1H3,(H,20,22)",COC(=O)c1ccc2NC(=O)C(=Cc3cc(Br)c(O)c(Br)c3)c2c1,CHEMBL1794052,"InChI=1S/C17H11Br2NO4/c1-24-17(23)9-2-3-14-10(7-9)11(16(22)20-14)4-8-5-12(18)15(21)13(19)6-8/h2-7,21H,1H3,(H,20,22)",COC(=O)c1ccc2NC(=O)C(=Cc3cc(Br)c(O)c(Br)c3)c2c1,CHEMBL820190,Inhibition of cRaf1 kinase in cascade assay,IC50,=,13,nM,,CHEMBL1906,Serine/threonine-protein kinase RAF,Homo sapiens,P04049,CHEMBL1133034,"Bioorg. Med. Chem. Lett., 10, p. 223 (2000)",10698440,Scientific Literature
3B,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL621682,Bioavailability in dog,F,=,82,%,,CHEMBL373,Canis familiaris,Canis lupus familiaris,,CHEMBL1134080,"Bioorg. Med. Chem. Lett., 11, p. 1401 (2001)",11378364,Scientific Literature
3B,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL624339,Bioavailability was measured in mouse,F,>,23,%,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1134080,"Bioorg. Med. Chem. Lett., 11, p. 1401 (2001)",11378364,Scientific Literature
3B,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL622007,Bioavailability was measured in rat,F,=,24,%,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1134080,"Bioorg. Med. Chem. Lett., 11, p. 1401 (2001)",11378364,Scientific Literature
3B,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL624496,Half-life was measured in dog,T1/2,=,0.733333333333,hr,,CHEMBL373,Canis familiaris,Canis lupus familiaris,,CHEMBL1134080,"Bioorg. Med. Chem. Lett., 11, p. 1401 (2001)",11378364,Scientific Literature
3B,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL620266,Half-life was measured in mouse,T1/2,=,0.333333333333,hr,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1134080,"Bioorg. Med. Chem. Lett., 11, p. 1401 (2001)",11378364,Scientific Literature
3B,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL876603,Half-life was measured in rat,T1/2,=,0.3,hr,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1134080,"Bioorg. Med. Chem. Lett., 11, p. 1401 (2001)",11378364,Scientific Literature
3B,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL660799,Inhibition of Cyclin-dependent kinase 1,IC50,>,8000,nM,,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1134080,"Bioorg. Med. Chem. Lett., 11, p. 1401 (2001)",11378364,Scientific Literature
3B,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL662522,Inhibition of Cyclin-dependent kinase 2,IC50,>,8000,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1134080,"Bioorg. Med. Chem. Lett., 11, p. 1401 (2001)",11378364,Scientific Literature
3B,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL675238,Inhibition of EGF receptor,IC50,=,1,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1134080,"Bioorg. Med. Chem. Lett., 11, p. 1401 (2001)",11378364,Scientific Literature
3B,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL714276,Inhibition of MRC5 cell proliferation,IC50,>,50000,nM,,CHEMBL614181,MRC5 (Embryonic lung fibroblast cells),Homo sapiens,,CHEMBL1134080,"Bioorg. Med. Chem. Lett., 11, p. 1401 (2001)",11378364,Scientific Literature
3B,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL691457,Inhibition of RAS overexpressing HB4a.R4.2 cell proliferation,IC50,=,30000,nM,,CHEMBL614786,HB4a,,,CHEMBL1134080,"Bioorg. Med. Chem. Lett., 11, p. 1401 (2001)",11378364,Scientific Literature
3B,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL769163,Inhibition of Raf kinase,IC50,=,49000,nM,,CHEMBL1906,Serine/threonine-protein kinase RAF,Homo sapiens,P04049,CHEMBL1134080,"Bioorg. Med. Chem. Lett., 11, p. 1401 (2001)",11378364,Scientific Literature
3B,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL806423,Inhibition of Src kinase,IC50,>,50000,nM,,CHEMBL267,Tyrosine-protein kinase SRC,Homo sapiens,P12931,CHEMBL1134080,"Bioorg. Med. Chem. Lett., 11, p. 1401 (2001)",11378364,Scientific Literature
3B,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL795907,Inhibition of erbB4 receptor,IC50,=,20,nM,,CHEMBL3009,Receptor protein-tyrosine kinase erbB-4,Homo sapiens,Q15303,CHEMBL1134080,"Bioorg. Med. Chem. Lett., 11, p. 1401 (2001)",11378364,Scientific Literature
3B,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL795906,Inhibition of rat Receptor protein-tyrosine kinase erbB2,IC50,=,18,nM,,CHEMBL3848,Receptor protein-tyrosine kinase erbB-2,Rattus norvegicus,P06494,CHEMBL1134080,"Bioorg. Med. Chem. Lett., 11, p. 1401 (2001)",11378364,Scientific Literature
B2,CHEMBL416031,"InChI=1S/C24H21N5O2/c1-30-22-11-19-20(12-23(22)31-2)25-15-26-24(19)28-18-8-9-21-17(10-18)13-27-29(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",COc1cc2ncnc(Nc3ccc4c(cnn4Cc5ccccc5)c3)c2cc1OC,CHEMBL416031,"InChI=1S/C24H21N5O2/c1-30-22-11-19-20(12-23(22)31-2)25-15-26-24(19)28-18-8-9-21-17(10-18)13-27-29(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",COc1cc2ncnc(Nc3ccc4c(cnn4Cc5ccccc5)c3)c2cc1OC,CHEMBL795906,Inhibition of rat Receptor protein-tyrosine kinase erbB2,IC50,=,1,nM,,CHEMBL3848,Receptor protein-tyrosine kinase erbB-2,Rattus norvegicus,P06494,CHEMBL1134080,"Bioorg. Med. Chem. Lett., 11, p. 1401 (2001)",11378364,Scientific Literature
E1,CHEMBL32464,"InChI=1S/C22H17N5/c1-2-6-15(7-3-1)12-21-26-19-11-10-16(13-20(19)27-21)25-22-17-8-4-5-9-18(17)23-14-24-22/h1-11,13-14H,12H2,(H,26,27)(H,23,24,25)",C(c1ccccc1)c2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2,CHEMBL32464,"InChI=1S/C22H17N5/c1-2-6-15(7-3-1)12-21-26-19-11-10-16(13-20(19)27-21)25-22-17-8-4-5-9-18(17)23-14-24-22/h1-11,13-14H,12H2,(H,26,27)(H,23,24,25)",C(c1ccccc1)c2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2,CHEMBL795906,Inhibition of rat Receptor protein-tyrosine kinase erbB2,IC50,=,560,nM,,CHEMBL3848,Receptor protein-tyrosine kinase erbB-2,Rattus norvegicus,P06494,CHEMBL1134080,"Bioorg. Med. Chem. Lett., 11, p. 1401 (2001)",11378364,Scientific Literature
3B,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL622784,Pharmacokinetic property (Plasma clearance) was measured in dog,CL,=,34,mL.min-1.kg-1,,CHEMBL373,Canis familiaris,Canis lupus familiaris,,CHEMBL1134080,"Bioorg. Med. Chem. Lett., 11, p. 1401 (2001)",11378364,Scientific Literature
3B,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL623491,Pharmacokinetic property (Plasma clearance) was measured in mouse,CL,>,27,mL.min-1.kg-1,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1134080,"Bioorg. Med. Chem. Lett., 11, p. 1401 (2001)",11378364,Scientific Literature
3B,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL621798,Pharmacokinetic property (Plasma clearance) was measured in rat,CL,=,19,mL.min-1.kg-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1134080,"Bioorg. Med. Chem. Lett., 11, p. 1401 (2001)",11378364,Scientific Literature
3B,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL624233,Pharmacokinetic property (vdss) was measured in dog,Vdss,=,0.87,,,CHEMBL373,Canis familiaris,Canis lupus familiaris,,CHEMBL1134080,"Bioorg. Med. Chem. Lett., 11, p. 1401 (2001)",11378364,Scientific Literature
3B,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL618981,Pharmacokinetic property (vdss) was measured in mouse,Vdss,>,0.15,,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1134080,"Bioorg. Med. Chem. Lett., 11, p. 1401 (2001)",11378364,Scientific Literature
3B,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL618529,Pharmacokinetic property (vdss) was measured in rat,Vdss,=,0.19,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1134080,"Bioorg. Med. Chem. Lett., 11, p. 1401 (2001)",11378364,Scientific Literature
6,CHEMBL352222,"InChI=1S/C16H9Cl2N3O5/c17-10-5-8(6-11(18)14(10)22)19-13-12(15(23)20-16(13)24)7-2-1-3-9(4-7)21(25)26/h1-6,22H,(H2,19,20,23,24)",Oc1c(Cl)cc(NC2=C(C(=O)NC2=O)c3cccc(c3)N(=O)=O)cc1Cl,CHEMBL352222,"InChI=1S/C16H9Cl2N3O5/c17-10-5-8(6-11(18)14(10)22)19-13-12(15(23)20-16(13)24)7-2-1-3-9(4-7)21(25)26/h1-6,22H,(H2,19,20,23,24)",Oc1c(Cl)cc(NC2=C(C(=O)NC2=O)c3cccc(c3)N(=O)=O)cc1Cl,CHEMBL686311,Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha,IC50,=,20000,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1134212,"Bioorg. Med. Chem. Lett., 11, p. 635 (2001)",11266159,Scientific Literature
6,CHEMBL156263,"InChI=1S/C17H14N2O3/c1-22-13-10-6-5-9-12(13)14-15(17(21)19-16(14)20)18-11-7-3-2-4-8-11/h2-10H,1H3,(H2,18,19,20,21)",COc1ccccc1C2=C(Nc3ccccc3)C(=O)NC2=O,CHEMBL156263,"InChI=1S/C17H14N2O3/c1-22-13-10-6-5-9-12(13)14-15(17(21)19-16(14)20)18-11-7-3-2-4-8-11/h2-10H,1H3,(H2,18,19,20,21)",COc1ccccc1C2=C(Nc3ccccc3)C(=O)NC2=O,CHEMBL686311,Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha,IC50,=,216000,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1134212,"Bioorg. Med. Chem. Lett., 11, p. 635 (2001)",11266159,Scientific Literature
6,CHEMBL160937,"InChI=1S/C16H11ClN2O3/c17-12-7-2-1-6-11(12)13-14(16(22)19-15(13)21)18-9-4-3-5-10(20)8-9/h1-8,20H,(H2,18,19,21,22)",Oc1cccc(NC2=C(C(=O)NC2=O)c3ccccc3Cl)c1,CHEMBL160937,"InChI=1S/C16H11ClN2O3/c17-12-7-2-1-6-11(12)13-14(16(22)19-15(13)21)18-9-4-3-5-10(20)8-9/h1-8,20H,(H2,18,19,21,22)",Oc1cccc(NC2=C(C(=O)NC2=O)c3ccccc3Cl)c1,CHEMBL686311,Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha,IC50,=,374000.0,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1134212,"Bioorg. Med. Chem. Lett., 11, p. 635 (2001)",11266159,Scientific Literature
6,CHEMBL160876,"InChI=1S/C17H10Cl2N2O4/c18-9-3-1-8(2-4-9)13-14(16(23)21-15(13)22)20-10-5-6-12(19)11(7-10)17(24)25/h1-7H,(H,24,25)(H2,20,21,22,23)",OC(=O)c1cc(NC2=C(C(=O)NC2=O)c3ccc(Cl)cc3)ccc1Cl,CHEMBL160876,"InChI=1S/C17H10Cl2N2O4/c18-9-3-1-8(2-4-9)13-14(16(23)21-15(13)22)20-10-5-6-12(19)11(7-10)17(24)25/h1-7H,(H,24,25)(H2,20,21,22,23)",OC(=O)c1cc(NC2=C(C(=O)NC2=O)c3ccc(Cl)cc3)ccc1Cl,CHEMBL686311,Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha,IC50,=,109000,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1134212,"Bioorg. Med. Chem. Lett., 11, p. 635 (2001)",11266159,Scientific Literature
6,CHEMBL346551,"InChI=1S/C16H12N2O2/c19-15-13(11-7-3-1-4-8-11)14(16(20)18-15)17-12-9-5-2-6-10-12/h1-10H,(H2,17,18,19,20)",O=C1NC(=O)C(=C1Nc2ccccc2)c3ccccc3,CHEMBL346551,"InChI=1S/C16H12N2O2/c19-15-13(11-7-3-1-4-8-11)14(16(20)18-15)17-12-9-5-2-6-10-12/h1-10H,(H2,17,18,19,20)",O=C1NC(=O)C(=C1Nc2ccccc2)c3ccccc3,CHEMBL686311,Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha,IC50,=,529000,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1134212,"Bioorg. Med. Chem. Lett., 11, p. 635 (2001)",11266159,Scientific Literature
6,CHEMBL160333,"InChI=1S/C16H10Cl2N2O3/c17-9-3-1-2-8(6-9)13-14(16(23)20-15(13)22)19-10-4-5-12(21)11(18)7-10/h1-7,21H,(H2,19,20,22,23)",Oc1ccc(NC2=C(C(=O)NC2=O)c3cccc(Cl)c3)cc1Cl,CHEMBL160333,"InChI=1S/C16H10Cl2N2O3/c17-9-3-1-2-8(6-9)13-14(16(23)20-15(13)22)19-10-4-5-12(21)11(18)7-10/h1-7,21H,(H2,19,20,22,23)",Oc1ccc(NC2=C(C(=O)NC2=O)c3cccc(Cl)c3)cc1Cl,CHEMBL686311,Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha,IC50,=,94000,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1134212,"Bioorg. Med. Chem. Lett., 11, p. 635 (2001)",11266159,Scientific Literature
6,CHEMBL156987,"InChI=1S/C17H10Cl2N2O4/c18-9-3-1-2-8(6-9)13-14(16(23)21-15(13)22)20-10-4-5-12(19)11(7-10)17(24)25/h1-7H,(H,24,25)(H2,20,21,22,23)",OC(=O)c1cc(NC2=C(C(=O)NC2=O)c3cccc(Cl)c3)ccc1Cl,CHEMBL156987,"InChI=1S/C17H10Cl2N2O4/c18-9-3-1-2-8(6-9)13-14(16(23)21-15(13)22)20-10-4-5-12(19)11(7-10)17(24)25/h1-7H,(H,24,25)(H2,20,21,22,23)",OC(=O)c1cc(NC2=C(C(=O)NC2=O)c3cccc(Cl)c3)ccc1Cl,CHEMBL686311,Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha,IC50,=,76000,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1134212,"Bioorg. Med. Chem. Lett., 11, p. 635 (2001)",11266159,Scientific Literature
6,CHEMBL157258,"InChI=1S/C16H9Cl3N2O3/c17-9-4-2-1-3-8(9)12-13(16(24)21-15(12)23)20-7-5-10(18)14(22)11(19)6-7/h1-6,22H,(H2,20,21,23,24)",Oc1c(Cl)cc(NC2=C(C(=O)NC2=O)c3ccccc3Cl)cc1Cl,CHEMBL157258,"InChI=1S/C16H9Cl3N2O3/c17-9-4-2-1-3-8(9)12-13(16(24)21-15(12)23)20-7-5-10(18)14(22)11(19)6-7/h1-6,22H,(H2,20,21,23,24)",Oc1c(Cl)cc(NC2=C(C(=O)NC2=O)c3ccccc3Cl)cc1Cl,CHEMBL686311,Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha,IC50,=,93000,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1134212,"Bioorg. Med. Chem. Lett., 11, p. 635 (2001)",11266159,Scientific Literature
8,CHEMBL347580,"InChI=1S/C19H16N2O3/c1-24-14-8-6-13(7-9-14)16-17(19(23)20-18(16)22)21-11-10-12-4-2-3-5-15(12)21/h2-9H,10-11H2,1H3,(H,20,22,23)",COc1ccc(cc1)C2=C(N3CCc4ccccc34)C(=O)NC2=O,CHEMBL347580,"InChI=1S/C19H16N2O3/c1-24-14-8-6-13(7-9-14)16-17(19(23)20-18(16)22)21-11-10-12-4-2-3-5-15(12)21/h2-9H,10-11H2,1H3,(H,20,22,23)",COc1ccc(cc1)C2=C(N3CCc4ccccc34)C(=O)NC2=O,CHEMBL686311,Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha,IC50,=,694000,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1134212,"Bioorg. Med. Chem. Lett., 11, p. 635 (2001)",11266159,Scientific Literature
8,CHEMBL156524,"InChI=1S/C18H13ClN2O2/c19-13-7-5-12(6-8-13)15-16(18(23)20-17(15)22)21-10-9-11-3-1-2-4-14(11)21/h1-8H,9-10H2,(H,20,22,23)",Clc1ccc(cc1)C2=C(N3CCc4ccccc34)C(=O)NC2=O,CHEMBL156524,"InChI=1S/C18H13ClN2O2/c19-13-7-5-12(6-8-13)15-16(18(23)20-17(15)22)21-10-9-11-3-1-2-4-14(11)21/h1-8H,9-10H2,(H,20,22,23)",Clc1ccc(cc1)C2=C(N3CCc4ccccc34)C(=O)NC2=O,CHEMBL686311,Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha,IC50,=,1412000,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1134212,"Bioorg. Med. Chem. Lett., 11, p. 635 (2001)",11266159,Scientific Literature
54,CHEMBL269883,"InChI=1S/C20H21N3O5S/c1-12(2)11-28-20(25)13-3-8-18-16(9-13)17(19(24)23-18)10-22-14-4-6-15(7-5-14)29(21,26)27/h3-10,12,22H,11H2,1-2H3,(H,23,24)(H2,21,26,27)/b17-10-",CC(C)COC(=O)c1ccc2NC(=O)\C(=C/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL269883,"InChI=1S/C20H21N3O5S/c1-12(2)11-28-20(25)13-3-8-18-16(9-13)17(19(24)23-18)10-22-14-4-6-15(7-5-14)29(21,26)27/h3-10,12,22H,11H2,1-2H3,(H,23,24)(H2,21,26,27)/b17-10-",CC(C)COC(=O)c1ccc2NC(=O)\C(=C/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL687685,Inhibition of HT-29 tumor cell proliferation,IC50,=,2000,nM,,CHEMBL384,HT-29 (Colon adenocarcinoma cells),Homo sapiens,,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
81,CHEMBL409892,"InChI=1S/C17H13N5O3S/c18-26(24,25)11-5-3-10(4-6-11)21-22-16-15-12-2-1-9-19-13(12)7-8-14(15)20-17(16)23/h1-9,21H,(H2,18,24,25)(H,20,22,23)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc4ncccc4c23)cc1,CHEMBL409892,"InChI=1S/C17H13N5O3S/c18-26(24,25)11-5-3-10(4-6-11)21-22-16-15-12-2-1-9-19-13(12)7-8-14(15)20-17(16)23/h1-9,21H,(H2,18,24,25)(H,20,22,23)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc4ncccc4c23)cc1,CHEMBL687685,Inhibition of HT-29 tumor cell proliferation,IC50,=,3100,nM,,CHEMBL384,HT-29 (Colon adenocarcinoma cells),Homo sapiens,,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
54,CHEMBL269883,"InChI=1S/C20H21N3O5S/c1-12(2)11-28-20(25)13-3-8-18-16(9-13)17(19(24)23-18)10-22-14-4-6-15(7-5-14)29(21,26)27/h3-10,12,22H,11H2,1-2H3,(H,23,24)(H2,21,26,27)/b17-10-",CC(C)COC(=O)c1ccc2NC(=O)\C(=C/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL269883,"InChI=1S/C20H21N3O5S/c1-12(2)11-28-20(25)13-3-8-18-16(9-13)17(19(24)23-18)10-22-14-4-6-15(7-5-14)29(21,26)27/h3-10,12,22H,11H2,1-2H3,(H,23,24)(H2,21,26,27)/b17-10-",CC(C)COC(=O)c1ccc2NC(=O)\C(=C/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL713367,Inhibition of MDA-MB468 tumor cell proliferation,IC50,=,2000,nM,,CHEMBL614335,MDA-MB-468 (Breast adenocarcinoma),Homo sapiens,,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
81,CHEMBL409892,"InChI=1S/C17H13N5O3S/c18-26(24,25)11-5-3-10(4-6-11)21-22-16-15-12-2-1-9-19-13(12)7-8-14(15)20-17(16)23/h1-9,21H,(H2,18,24,25)(H,20,22,23)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc4ncccc4c23)cc1,CHEMBL409892,"InChI=1S/C17H13N5O3S/c18-26(24,25)11-5-3-10(4-6-11)21-22-16-15-12-2-1-9-19-13(12)7-8-14(15)20-17(16)23/h1-9,21H,(H2,18,24,25)(H,20,22,23)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc4ncccc4c23)cc1,CHEMBL713367,Inhibition of MDA-MB468 tumor cell proliferation,IC50,=,810.0,nM,,CHEMBL614335,MDA-MB-468 (Breast adenocarcinoma),Homo sapiens,,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
54,CHEMBL269883,"InChI=1S/C20H21N3O5S/c1-12(2)11-28-20(25)13-3-8-18-16(9-13)17(19(24)23-18)10-22-14-4-6-15(7-5-14)29(21,26)27/h3-10,12,22H,11H2,1-2H3,(H,23,24)(H2,21,26,27)/b17-10-",CC(C)COC(=O)c1ccc2NC(=O)\C(=C/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL269883,"InChI=1S/C20H21N3O5S/c1-12(2)11-28-20(25)13-3-8-18-16(9-13)17(19(24)23-18)10-22-14-4-6-15(7-5-14)29(21,26)27/h3-10,12,22H,11H2,1-2H3,(H,23,24)(H2,21,26,27)/b17-10-",CC(C)COC(=O)c1ccc2NC(=O)\C(=C/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL768216,Inhibition of RKO tumor cell proliferation,IC50,=,890,nM,,CHEMBL614879,RKO (Colon carcinoma),Homo sapiens,,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
81,CHEMBL409892,"InChI=1S/C17H13N5O3S/c18-26(24,25)11-5-3-10(4-6-11)21-22-16-15-12-2-1-9-19-13(12)7-8-14(15)20-17(16)23/h1-9,21H,(H2,18,24,25)(H,20,22,23)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc4ncccc4c23)cc1,CHEMBL409892,"InChI=1S/C17H13N5O3S/c18-26(24,25)11-5-3-10(4-6-11)21-22-16-15-12-2-1-9-19-13(12)7-8-14(15)20-17(16)23/h1-9,21H,(H2,18,24,25)(H,20,22,23)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc4ncccc4c23)cc1,CHEMBL768216,Inhibition of RKO tumor cell proliferation,IC50,=,390,nM,,CHEMBL614879,RKO (Colon carcinoma),Homo sapiens,,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
54,CHEMBL269883,"InChI=1S/C20H21N3O5S/c1-12(2)11-28-20(25)13-3-8-18-16(9-13)17(19(24)23-18)10-22-14-4-6-15(7-5-14)29(21,26)27/h3-10,12,22H,11H2,1-2H3,(H,23,24)(H2,21,26,27)/b17-10-",CC(C)COC(=O)c1ccc2NC(=O)\C(=C/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL269883,"InChI=1S/C20H21N3O5S/c1-12(2)11-28-20(25)13-3-8-18-16(9-13)17(19(24)23-18)10-22-14-4-6-15(7-5-14)29(21,26)27/h3-10,12,22H,11H2,1-2H3,(H,23,24)(H2,21,26,27)/b17-10-",CC(C)COC(=O)c1ccc2NC(=O)\C(=C/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL805739,Inhibition of SW620 tumor cell proliferation,IC50,=,1400,nM,,CHEMBL612262,SW-620 (Colon adenocarcinoma cells),Homo sapiens,,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
81,CHEMBL409892,"InChI=1S/C17H13N5O3S/c18-26(24,25)11-5-3-10(4-6-11)21-22-16-15-12-2-1-9-19-13(12)7-8-14(15)20-17(16)23/h1-9,21H,(H2,18,24,25)(H,20,22,23)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc4ncccc4c23)cc1,CHEMBL409892,"InChI=1S/C17H13N5O3S/c18-26(24,25)11-5-3-10(4-6-11)21-22-16-15-12-2-1-9-19-13(12)7-8-14(15)20-17(16)23/h1-9,21H,(H2,18,24,25)(H,20,22,23)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc4ncccc4c23)cc1,CHEMBL805739,Inhibition of SW620 tumor cell proliferation,IC50,=,870.0,nM,,CHEMBL612262,SW-620 (Colon adenocarcinoma cells),Homo sapiens,,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
54,CHEMBL269883,"InChI=1S/C20H21N3O5S/c1-12(2)11-28-20(25)13-3-8-18-16(9-13)17(19(24)23-18)10-22-14-4-6-15(7-5-14)29(21,26)27/h3-10,12,22H,11H2,1-2H3,(H,23,24)(H2,21,26,27)/b17-10-",CC(C)COC(=O)c1ccc2NC(=O)\C(=C/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL269883,"InChI=1S/C20H21N3O5S/c1-12(2)11-28-20(25)13-3-8-18-16(9-13)17(19(24)23-18)10-22-14-4-6-15(7-5-14)29(21,26)27/h3-10,12,22H,11H2,1-2H3,(H,23,24)(H2,21,26,27)/b17-10-",CC(C)COC(=O)c1ccc2NC(=O)\C(=C/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL692152,Inhibition of human foreskin fibroblasts (HFF) proliferation,IC50,=,3600,nM,,CHEMBL614071,HFF (Foreskin fibroblasts),Homo sapiens,,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
81,CHEMBL409892,"InChI=1S/C17H13N5O3S/c18-26(24,25)11-5-3-10(4-6-11)21-22-16-15-12-2-1-9-19-13(12)7-8-14(15)20-17(16)23/h1-9,21H,(H2,18,24,25)(H,20,22,23)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc4ncccc4c23)cc1,CHEMBL409892,"InChI=1S/C17H13N5O3S/c18-26(24,25)11-5-3-10(4-6-11)21-22-16-15-12-2-1-9-19-13(12)7-8-14(15)20-17(16)23/h1-9,21H,(H2,18,24,25)(H,20,22,23)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc4ncccc4c23)cc1,CHEMBL692152,Inhibition of human foreskin fibroblasts (HFF) proliferation,IC50,=,1900,nM,,CHEMBL614071,HFF (Foreskin fibroblasts),Homo sapiens,,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
54,CHEMBL269883,"InChI=1S/C20H21N3O5S/c1-12(2)11-28-20(25)13-3-8-18-16(9-13)17(19(24)23-18)10-22-14-4-6-15(7-5-14)29(21,26)27/h3-10,12,22H,11H2,1-2H3,(H,23,24)(H2,21,26,27)/b17-10-",CC(C)COC(=O)c1ccc2NC(=O)\C(=C/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL269883,"InChI=1S/C20H21N3O5S/c1-12(2)11-28-20(25)13-3-8-18-16(9-13)17(19(24)23-18)10-22-14-4-6-15(7-5-14)29(21,26)27/h3-10,12,22H,11H2,1-2H3,(H,23,24)(H2,21,26,27)/b17-10-",CC(C)COC(=O)c1ccc2NC(=O)\C(=C/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL845182,Inhibition of progression of cells from G1 into S-phase by BrdU incorporation assay,IC50,=,2300,nM,,CHEMBL612545,,,,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
81,CHEMBL409892,"InChI=1S/C17H13N5O3S/c18-26(24,25)11-5-3-10(4-6-11)21-22-16-15-12-2-1-9-19-13(12)7-8-14(15)20-17(16)23/h1-9,21H,(H2,18,24,25)(H,20,22,23)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc4ncccc4c23)cc1,CHEMBL409892,"InChI=1S/C17H13N5O3S/c18-26(24,25)11-5-3-10(4-6-11)21-22-16-15-12-2-1-9-19-13(12)7-8-14(15)20-17(16)23/h1-9,21H,(H2,18,24,25)(H,20,22,23)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc4ncccc4c23)cc1,CHEMBL845182,Inhibition of progression of cells from G1 into S-phase by BrdU incorporation assay,IC50,=,290,nM,,CHEMBL612545,,,,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
19,CHEMBL405042,"InChI=1S/C16H15N3O3S/c1-10(15-13-4-2-3-5-14(13)19-16(15)20)18-11-6-8-12(9-7-11)23(17,21)22/h2-9,18H,1H3,(H,19,20)(H2,17,21,22)/b15-10-",C\C(=C/1\C(=O)Nc2ccccc12)\Nc3ccc(cc3)S(=O)(=O)N,CHEMBL405042,"InChI=1S/C16H15N3O3S/c1-10(15-13-4-2-3-5-14(13)19-16(15)20)18-11-6-8-12(9-7-11)23(17,21)22/h2-9,18H,1H3,(H,19,20)(H2,17,21,22)/b15-10-",C\C(=C/1\C(=O)Nc2ccccc12)\Nc3ccc(cc3)S(=O)(=O)N,CHEMBL666140,Inhibitory activity against human cyclin-dependent kinase 1 (CDK1),IC50,=,2300,nM,,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
20,CHEMBL270054,"InChI=1S/C14H11ClN4O3S/c15-8-1-6-12-11(7-8)13(14(20)17-12)19-18-9-2-4-10(5-3-9)23(16,21)22/h1-7,18H,(H2,16,21,22)(H,17,19,20)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(Cl)cc23)cc1,CHEMBL270054,"InChI=1S/C14H11ClN4O3S/c15-8-1-6-12-11(7-8)13(14(20)17-12)19-18-9-2-4-10(5-3-9)23(16,21)22/h1-7,18H,(H2,16,21,22)(H,17,19,20)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(Cl)cc23)cc1,CHEMBL666140,Inhibitory activity against human cyclin-dependent kinase 1 (CDK1),IC50,=,300,nM,,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
22,CHEMBL269827,"InChI=1S/C17H13N5O4S/c18-27(24,25)12-4-2-11(3-5-12)21-22-16-13-7-10(15-8-19-9-26-15)1-6-14(13)20-17(16)23/h1-9,21H,(H2,18,24,25)(H,20,22,23)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)c4ocnc4)cc1,CHEMBL269827,"InChI=1S/C17H13N5O4S/c18-27(24,25)12-4-2-11(3-5-12)21-22-16-13-7-10(15-8-19-9-26-15)1-6-14(13)20-17(16)23/h1-9,21H,(H2,18,24,25)(H,20,22,23)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)c4ocnc4)cc1,CHEMBL666140,Inhibitory activity against human cyclin-dependent kinase 1 (CDK1),IC50,=,10,nM,,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
29,CHEMBL270544,"InChI=1S/C18H18N4O3S/c1-11(2)10-12-4-3-5-15-16(12)17(18(23)20-15)22-21-13-6-8-14(9-7-13)26(19,24)25/h3-10,21H,1-2H3,(H2,19,24,25)(H,20,22,23)",CC(=Cc1cccc2NC(=O)\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\c12)C,CHEMBL270544,"InChI=1S/C18H18N4O3S/c1-11(2)10-12-4-3-5-15-16(12)17(18(23)20-15)22-21-13-6-8-14(9-7-13)26(19,24)25/h3-10,21H,1-2H3,(H2,19,24,25)(H,20,22,23)",CC(=Cc1cccc2NC(=O)\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\c12)C,CHEMBL666140,Inhibitory activity against human cyclin-dependent kinase 1 (CDK1),IC50,=,15,nM,,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
33,CHEMBL1794054,"InChI=1S/C21H19N5O3S/c22-30(28,29)17-8-6-16(7-9-17)25-26-20-19-15(2-1-3-18(19)24-21(20)27)5-4-14-10-12-23-13-11-14/h1-3,6-13,25H,4-5H2,(H2,22,28,29)(H,24,26,27)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3cccc(CCc4ccncc4)c23)cc1,CHEMBL1794054,"InChI=1S/C21H19N5O3S/c22-30(28,29)17-8-6-16(7-9-17)25-26-20-19-15(2-1-3-18(19)24-21(20)27)5-4-14-10-12-23-13-11-14/h1-3,6-13,25H,4-5H2,(H2,22,28,29)(H,24,26,27)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3cccc(CCc4ccncc4)c23)cc1,CHEMBL666140,Inhibitory activity against human cyclin-dependent kinase 1 (CDK1),IC50,=,290,nM,,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
43,CHEMBL271843,"InChI=1S/C15H14N4O3S/c1-9-2-7-13-12(8-9)14(15(20)17-13)19-18-10-3-5-11(6-4-10)23(16,21)22/h2-8,18H,1H3,(H2,16,21,22)(H,17,19,20)",Cc1ccc2NC(=O)\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL271843,"InChI=1S/C15H14N4O3S/c1-9-2-7-13-12(8-9)14(15(20)17-13)19-18-10-3-5-11(6-4-10)23(16,21)22/h2-8,18H,1H3,(H2,16,21,22)(H,17,19,20)",Cc1ccc2NC(=O)\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL666140,Inhibitory activity against human cyclin-dependent kinase 1 (CDK1),IC50,=,330,nM,,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
48,CHEMBL272414,"InChI=1S/C17H18N4O3S/c1-21(2)12-5-8-16-14(9-12)15(17(22)20-16)10-19-11-3-6-13(7-4-11)25(18,23)24/h3-10,19H,1-2H3,(H,20,22)(H2,18,23,24)/b15-10-",CN(C)c1ccc2NC(=O)\C(=C/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL272414,"InChI=1S/C17H18N4O3S/c1-21(2)12-5-8-16-14(9-12)15(17(22)20-16)10-19-11-3-6-13(7-4-11)25(18,23)24/h3-10,19H,1-2H3,(H,20,22)(H2,18,23,24)/b15-10-",CN(C)c1ccc2NC(=O)\C(=C/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL666140,Inhibitory activity against human cyclin-dependent kinase 1 (CDK1),IC50,=,2800,nM,,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
54,CHEMBL269883,"InChI=1S/C20H21N3O5S/c1-12(2)11-28-20(25)13-3-8-18-16(9-13)17(19(24)23-18)10-22-14-4-6-15(7-5-14)29(21,26)27/h3-10,12,22H,11H2,1-2H3,(H,23,24)(H2,21,26,27)/b17-10-",CC(C)COC(=O)c1ccc2NC(=O)\C(=C/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL269883,"InChI=1S/C20H21N3O5S/c1-12(2)11-28-20(25)13-3-8-18-16(9-13)17(19(24)23-18)10-22-14-4-6-15(7-5-14)29(21,26)27/h3-10,12,22H,11H2,1-2H3,(H,23,24)(H2,21,26,27)/b17-10-",CC(C)COC(=O)c1ccc2NC(=O)\C(=C/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL666140,Inhibitory activity against human cyclin-dependent kinase 1 (CDK1),IC50,=,19,nM,,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
58,CHEMBL272028,"InChI=1S/C20H19N7O4S/c21-32(30,31)15-4-2-13(3-5-15)26-27-18-16-9-12(1-6-17(16)25-20(18)29)19(28)23-8-7-14-10-22-11-24-14/h1-6,9-11,26H,7-8H2,(H,22,24)(H,23,28)(H2,21,30,31)(H,25,27,29)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)C(=O)NCCc4c[nH]cn4)cc1,CHEMBL272028,"InChI=1S/C20H19N7O4S/c21-32(30,31)15-4-2-13(3-5-15)26-27-18-16-9-12(1-6-17(16)25-20(18)29)19(28)23-8-7-14-10-22-11-24-14/h1-6,9-11,26H,7-8H2,(H,22,24)(H,23,28)(H2,21,30,31)(H,25,27,29)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)C(=O)NCCc4c[nH]cn4)cc1,CHEMBL666140,Inhibitory activity against human cyclin-dependent kinase 1 (CDK1),IC50,=,69,nM,,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
59,CHEMBL272026,"InChI=1S/C21H21N7O4S/c22-33(31,32)16-5-3-15(4-6-16)26-27-19-17-12-14(2-7-18(17)25-21(19)30)20(29)24-8-1-10-28-11-9-23-13-28/h2-7,9,11-13,26H,1,8,10H2,(H,24,29)(H2,22,31,32)(H,25,27,30)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)C(=O)NCCCn4ccnc4)cc1,CHEMBL272026,"InChI=1S/C21H21N7O4S/c22-33(31,32)16-5-3-15(4-6-16)26-27-19-17-12-14(2-7-18(17)25-21(19)30)20(29)24-8-1-10-28-11-9-23-13-28/h2-7,9,11-13,26H,1,8,10H2,(H,24,29)(H2,22,31,32)(H,25,27,30)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)C(=O)NCCCn4ccnc4)cc1,CHEMBL666140,Inhibitory activity against human cyclin-dependent kinase 1 (CDK1),IC50,=,230,nM,,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
60,CHEMBL272165,"InChI=1S/C21H18N6O4S/c22-32(30,31)16-4-2-15(3-5-16)26-27-19-17-11-14(1-6-18(17)25-21(19)29)20(28)24-12-13-7-9-23-10-8-13/h1-11,26H,12H2,(H,24,28)(H2,22,30,31)(H,25,27,29)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)C(=O)NCc4ccncc4)cc1,CHEMBL272165,"InChI=1S/C21H18N6O4S/c22-32(30,31)16-4-2-15(3-5-16)26-27-19-17-11-14(1-6-18(17)25-21(19)29)20(28)24-12-13-7-9-23-10-8-13/h1-11,26H,12H2,(H,24,28)(H2,22,30,31)(H,25,27,29)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)C(=O)NCc4ccncc4)cc1,CHEMBL666140,Inhibitory activity against human cyclin-dependent kinase 1 (CDK1),IC50,=,74,nM,,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
62,CHEMBL410072,"InChI=1S/C20H23N5O5S/c1-20(2,11-26)10-22-18(27)12-3-8-16-15(9-12)17(19(28)23-16)25-24-13-4-6-14(7-5-13)31(21,29)30/h3-9,24,26H,10-11H2,1-2H3,(H,22,27)(H2,21,29,30)(H,23,25,28)",CC(C)(CO)CNC(=O)c1ccc2NC(=O)\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL410072,"InChI=1S/C20H23N5O5S/c1-20(2,11-26)10-22-18(27)12-3-8-16-15(9-12)17(19(28)23-16)25-24-13-4-6-14(7-5-13)31(21,29)30/h3-9,24,26H,10-11H2,1-2H3,(H,22,27)(H2,21,29,30)(H,23,25,28)",CC(C)(CO)CNC(=O)c1ccc2NC(=O)\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL666140,Inhibitory activity against human cyclin-dependent kinase 1 (CDK1),IC50,=,60,nM,,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
66,CHEMBL271594,"InChI=1S/C17H18N4O3S/c1-10(2)11-3-8-14-15(9-11)19-17(22)16(14)21-20-12-4-6-13(7-5-12)25(18,23)24/h3-10,20H,1-2H3,(H2,18,23,24)(H,19,21,22)",CC(C)c1ccc2\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\C(=O)Nc2c1,CHEMBL271594,"InChI=1S/C17H18N4O3S/c1-10(2)11-3-8-14-15(9-11)19-17(22)16(14)21-20-12-4-6-13(7-5-12)25(18,23)24/h3-10,20H,1-2H3,(H2,18,23,24)(H,19,21,22)",CC(C)c1ccc2\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\C(=O)Nc2c1,CHEMBL666140,Inhibitory activity against human cyclin-dependent kinase 1 (CDK1),IC50,=,790,nM,,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
80,CHEMBL1794055,"InChI=1S/C16H12N4O3S2/c17-25(22,23)10-3-1-9(2-4-10)18-7-11-14-12(20-16(11)21)5-6-13-15(14)24-8-19-13/h1-8,18H,(H,20,21)(H2,17,22,23)",NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c23)cc1,CHEMBL1794055,"InChI=1S/C16H12N4O3S2/c17-25(22,23)10-3-1-9(2-4-10)18-7-11-14-12(20-16(11)21)5-6-13-15(14)24-8-19-13/h1-8,18H,(H,20,21)(H2,17,22,23)",NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c23)cc1,CHEMBL666140,Inhibitory activity against human cyclin-dependent kinase 1 (CDK1),IC50,=,29,nM,,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
81,CHEMBL409892,"InChI=1S/C17H13N5O3S/c18-26(24,25)11-5-3-10(4-6-11)21-22-16-15-12-2-1-9-19-13(12)7-8-14(15)20-17(16)23/h1-9,21H,(H2,18,24,25)(H,20,22,23)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc4ncccc4c23)cc1,CHEMBL409892,"InChI=1S/C17H13N5O3S/c18-26(24,25)11-5-3-10(4-6-11)21-22-16-15-12-2-1-9-19-13(12)7-8-14(15)20-17(16)23/h1-9,21H,(H2,18,24,25)(H,20,22,23)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc4ncccc4c23)cc1,CHEMBL666140,Inhibitory activity against human cyclin-dependent kinase 1 (CDK1),IC50,=,12,nM,,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
19,CHEMBL405042,"InChI=1S/C16H15N3O3S/c1-10(15-13-4-2-3-5-14(13)19-16(15)20)18-11-6-8-12(9-7-11)23(17,21)22/h2-9,18H,1H3,(H,19,20)(H2,17,21,22)/b15-10-",C\C(=C/1\C(=O)Nc2ccccc12)\Nc3ccc(cc3)S(=O)(=O)N,CHEMBL405042,"InChI=1S/C16H15N3O3S/c1-10(15-13-4-2-3-5-14(13)19-16(15)20)18-11-6-8-12(9-7-11)23(17,21)22/h2-9,18H,1H3,(H,19,20)(H2,17,21,22)/b15-10-",C\C(=C/1\C(=O)Nc2ccccc12)\Nc3ccc(cc3)S(=O)(=O)N,CHEMBL661125,Inhibitory activity against human cyclin-dependent kinase 2 (CDK2),IC50,=,360,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
20,CHEMBL270054,"InChI=1S/C14H11ClN4O3S/c15-8-1-6-12-11(7-8)13(14(20)17-12)19-18-9-2-4-10(5-3-9)23(16,21)22/h1-7,18H,(H2,16,21,22)(H,17,19,20)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(Cl)cc23)cc1,CHEMBL270054,"InChI=1S/C14H11ClN4O3S/c15-8-1-6-12-11(7-8)13(14(20)17-12)19-18-9-2-4-10(5-3-9)23(16,21)22/h1-7,18H,(H2,16,21,22)(H,17,19,20)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(Cl)cc23)cc1,CHEMBL661125,Inhibitory activity against human cyclin-dependent kinase 2 (CDK2),IC50,=,43,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
22,CHEMBL269827,"InChI=1S/C17H13N5O4S/c18-27(24,25)12-4-2-11(3-5-12)21-22-16-13-7-10(15-8-19-9-26-15)1-6-14(13)20-17(16)23/h1-9,21H,(H2,18,24,25)(H,20,22,23)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)c4ocnc4)cc1,CHEMBL269827,"InChI=1S/C17H13N5O4S/c18-27(24,25)12-4-2-11(3-5-12)21-22-16-13-7-10(15-8-19-9-26-15)1-6-14(13)20-17(16)23/h1-9,21H,(H2,18,24,25)(H,20,22,23)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)c4ocnc4)cc1,CHEMBL661125,Inhibitory activity against human cyclin-dependent kinase 2 (CDK2),IC50,=,2.3,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
29,CHEMBL270544,"InChI=1S/C18H18N4O3S/c1-11(2)10-12-4-3-5-15-16(12)17(18(23)20-15)22-21-13-6-8-14(9-7-13)26(19,24)25/h3-10,21H,1-2H3,(H2,19,24,25)(H,20,22,23)",CC(=Cc1cccc2NC(=O)\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\c12)C,CHEMBL270544,"InChI=1S/C18H18N4O3S/c1-11(2)10-12-4-3-5-15-16(12)17(18(23)20-15)22-21-13-6-8-14(9-7-13)26(19,24)25/h3-10,21H,1-2H3,(H2,19,24,25)(H,20,22,23)",CC(=Cc1cccc2NC(=O)\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\c12)C,CHEMBL661125,Inhibitory activity against human cyclin-dependent kinase 2 (CDK2),IC50,=,1.5,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
33,CHEMBL1794054,"InChI=1S/C21H19N5O3S/c22-30(28,29)17-8-6-16(7-9-17)25-26-20-19-15(2-1-3-18(19)24-21(20)27)5-4-14-10-12-23-13-11-14/h1-3,6-13,25H,4-5H2,(H2,22,28,29)(H,24,26,27)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3cccc(CCc4ccncc4)c23)cc1,CHEMBL1794054,"InChI=1S/C21H19N5O3S/c22-30(28,29)17-8-6-16(7-9-17)25-26-20-19-15(2-1-3-18(19)24-21(20)27)5-4-14-10-12-23-13-11-14/h1-3,6-13,25H,4-5H2,(H2,22,28,29)(H,24,26,27)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3cccc(CCc4ccncc4)c23)cc1,CHEMBL661125,Inhibitory activity against human cyclin-dependent kinase 2 (CDK2),IC50,=,21,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
43,CHEMBL271843,"InChI=1S/C15H14N4O3S/c1-9-2-7-13-12(8-9)14(15(20)17-13)19-18-10-3-5-11(6-4-10)23(16,21)22/h2-8,18H,1H3,(H2,16,21,22)(H,17,19,20)",Cc1ccc2NC(=O)\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL271843,"InChI=1S/C15H14N4O3S/c1-9-2-7-13-12(8-9)14(15(20)17-13)19-18-10-3-5-11(6-4-10)23(16,21)22/h2-8,18H,1H3,(H2,16,21,22)(H,17,19,20)",Cc1ccc2NC(=O)\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL661125,Inhibitory activity against human cyclin-dependent kinase 2 (CDK2),IC50,=,46,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
48,CHEMBL272414,"InChI=1S/C17H18N4O3S/c1-21(2)12-5-8-16-14(9-12)15(17(22)20-16)10-19-11-3-6-13(7-4-11)25(18,23)24/h3-10,19H,1-2H3,(H,20,22)(H2,18,23,24)/b15-10-",CN(C)c1ccc2NC(=O)\C(=C/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL272414,"InChI=1S/C17H18N4O3S/c1-21(2)12-5-8-16-14(9-12)15(17(22)20-16)10-19-11-3-6-13(7-4-11)25(18,23)24/h3-10,19H,1-2H3,(H,20,22)(H2,18,23,24)/b15-10-",CN(C)c1ccc2NC(=O)\C(=C/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL661125,Inhibitory activity against human cyclin-dependent kinase 2 (CDK2),IC50,=,310,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
54,CHEMBL269883,"InChI=1S/C20H21N3O5S/c1-12(2)11-28-20(25)13-3-8-18-16(9-13)17(19(24)23-18)10-22-14-4-6-15(7-5-14)29(21,26)27/h3-10,12,22H,11H2,1-2H3,(H,23,24)(H2,21,26,27)/b17-10-",CC(C)COC(=O)c1ccc2NC(=O)\C(=C/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL269883,"InChI=1S/C20H21N3O5S/c1-12(2)11-28-20(25)13-3-8-18-16(9-13)17(19(24)23-18)10-22-14-4-6-15(7-5-14)29(21,26)27/h3-10,12,22H,11H2,1-2H3,(H,23,24)(H2,21,26,27)/b17-10-",CC(C)COC(=O)c1ccc2NC(=O)\C(=C/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL661125,Inhibitory activity against human cyclin-dependent kinase 2 (CDK2),IC50,=,3,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
58,CHEMBL272028,"InChI=1S/C20H19N7O4S/c21-32(30,31)15-4-2-13(3-5-15)26-27-18-16-9-12(1-6-17(16)25-20(18)29)19(28)23-8-7-14-10-22-11-24-14/h1-6,9-11,26H,7-8H2,(H,22,24)(H,23,28)(H2,21,30,31)(H,25,27,29)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)C(=O)NCCc4c[nH]cn4)cc1,CHEMBL272028,"InChI=1S/C20H19N7O4S/c21-32(30,31)15-4-2-13(3-5-15)26-27-18-16-9-12(1-6-17(16)25-20(18)29)19(28)23-8-7-14-10-22-11-24-14/h1-6,9-11,26H,7-8H2,(H,22,24)(H,23,28)(H2,21,30,31)(H,25,27,29)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)C(=O)NCCc4c[nH]cn4)cc1,CHEMBL661125,Inhibitory activity against human cyclin-dependent kinase 2 (CDK2),IC50,=,12,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
59,CHEMBL272026,"InChI=1S/C21H21N7O4S/c22-33(31,32)16-5-3-15(4-6-16)26-27-19-17-12-14(2-7-18(17)25-21(19)30)20(29)24-8-1-10-28-11-9-23-13-28/h2-7,9,11-13,26H,1,8,10H2,(H,24,29)(H2,22,31,32)(H,25,27,30)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)C(=O)NCCCn4ccnc4)cc1,CHEMBL272026,"InChI=1S/C21H21N7O4S/c22-33(31,32)16-5-3-15(4-6-16)26-27-19-17-12-14(2-7-18(17)25-21(19)30)20(29)24-8-1-10-28-11-9-23-13-28/h2-7,9,11-13,26H,1,8,10H2,(H,24,29)(H2,22,31,32)(H,25,27,30)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)C(=O)NCCCn4ccnc4)cc1,CHEMBL661125,Inhibitory activity against human cyclin-dependent kinase 2 (CDK2),IC50,=,25,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
60,CHEMBL272165,"InChI=1S/C21H18N6O4S/c22-32(30,31)16-4-2-15(3-5-16)26-27-19-17-11-14(1-6-18(17)25-21(19)29)20(28)24-12-13-7-9-23-10-8-13/h1-11,26H,12H2,(H,24,28)(H2,22,30,31)(H,25,27,29)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)C(=O)NCc4ccncc4)cc1,CHEMBL272165,"InChI=1S/C21H18N6O4S/c22-32(30,31)16-4-2-15(3-5-16)26-27-19-17-11-14(1-6-18(17)25-21(19)29)20(28)24-12-13-7-9-23-10-8-13/h1-11,26H,12H2,(H,24,28)(H2,22,30,31)(H,25,27,29)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)C(=O)NCc4ccncc4)cc1,CHEMBL661125,Inhibitory activity against human cyclin-dependent kinase 2 (CDK2),IC50,=,8.9,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
62,CHEMBL410072,"InChI=1S/C20H23N5O5S/c1-20(2,11-26)10-22-18(27)12-3-8-16-15(9-12)17(19(28)23-16)25-24-13-4-6-14(7-5-13)31(21,29)30/h3-9,24,26H,10-11H2,1-2H3,(H,22,27)(H2,21,29,30)(H,23,25,28)",CC(C)(CO)CNC(=O)c1ccc2NC(=O)\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL410072,"InChI=1S/C20H23N5O5S/c1-20(2,11-26)10-22-18(27)12-3-8-16-15(9-12)17(19(28)23-16)25-24-13-4-6-14(7-5-13)31(21,29)30/h3-9,24,26H,10-11H2,1-2H3,(H,22,27)(H2,21,29,30)(H,23,25,28)",CC(C)(CO)CNC(=O)c1ccc2NC(=O)\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL661125,Inhibitory activity against human cyclin-dependent kinase 2 (CDK2),IC50,=,6.8,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
66,CHEMBL271594,"InChI=1S/C17H18N4O3S/c1-10(2)11-3-8-14-15(9-11)19-17(22)16(14)21-20-12-4-6-13(7-5-12)25(18,23)24/h3-10,20H,1-2H3,(H2,18,23,24)(H,19,21,22)",CC(C)c1ccc2\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\C(=O)Nc2c1,CHEMBL271594,"InChI=1S/C17H18N4O3S/c1-10(2)11-3-8-14-15(9-11)19-17(22)16(14)21-20-12-4-6-13(7-5-12)25(18,23)24/h3-10,20H,1-2H3,(H2,18,23,24)(H,19,21,22)",CC(C)c1ccc2\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\C(=O)Nc2c1,CHEMBL661125,Inhibitory activity against human cyclin-dependent kinase 2 (CDK2),IC50,=,75,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
80,CHEMBL1794055,"InChI=1S/C16H12N4O3S2/c17-25(22,23)10-3-1-9(2-4-10)18-7-11-14-12(20-16(11)21)5-6-13-15(14)24-8-19-13/h1-8,18H,(H,20,21)(H2,17,22,23)",NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c23)cc1,CHEMBL1794055,"InChI=1S/C16H12N4O3S2/c17-25(22,23)10-3-1-9(2-4-10)18-7-11-14-12(20-16(11)21)5-6-13-15(14)24-8-19-13/h1-8,18H,(H,20,21)(H2,17,22,23)",NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c23)cc1,CHEMBL661125,Inhibitory activity against human cyclin-dependent kinase 2 (CDK2),IC50,=,2.8,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
81,CHEMBL409892,"InChI=1S/C17H13N5O3S/c18-26(24,25)11-5-3-10(4-6-11)21-22-16-15-12-2-1-9-19-13(12)7-8-14(15)20-17(16)23/h1-9,21H,(H2,18,24,25)(H,20,22,23)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc4ncccc4c23)cc1,CHEMBL409892,"InChI=1S/C17H13N5O3S/c18-26(24,25)11-5-3-10(4-6-11)21-22-16-15-12-2-1-9-19-13(12)7-8-14(15)20-17(16)23/h1-9,21H,(H2,18,24,25)(H,20,22,23)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc4ncccc4c23)cc1,CHEMBL661125,Inhibitory activity against human cyclin-dependent kinase 2 (CDK2),IC50,=,1.6,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1134300,"J. Med. Chem., 44, p. 4339 (2001)",11728181,Scientific Literature
1,CHEMBL274863,"InChI=1S/C20H23FN6O/c21-16-4-2-15(3-5-16)18-19(17-6-7-23-20(22)25-17)27(14-24-18)9-1-8-26-10-12-28-13-11-26/h2-7,14H,1,8-13H2,(H2,22,23,25)",Nc1nccc(n1)c2c(ncn2CCCN3CCOCC3)c4ccc(F)cc4,CHEMBL274863,"InChI=1S/C20H23FN6O/c21-16-4-2-15(3-5-16)18-19(17-6-7-23-20(22)25-17)27(14-24-18)9-1-8-26-10-12-28-13-11-26/h2-7,14H,1,8-13H2,(H2,22,23,25)",Nc1nccc(n1)c2c(ncn2CCCN3CCOCC3)c4ccc(F)cc4,CHEMBL735050,Inhibition against Mitogen-activated protein kinase p38 alpha,IC50,=,480,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1134743,"Bioorg. Med. Chem. Lett., 11, p. 2867 (2001)",11597418,Scientific Literature
16,CHEMBL330422,"InChI=1S/C21H25FN6O/c1-27-11-7-17(8-12-27)28-14-25-19(15-2-4-16(22)5-3-15)20(28)18-6-9-23-21(26-18)24-10-13-29/h2-6,9,14,17,29H,7-8,10-13H2,1H3,(H,23,24,26)",CN1CCC(CC1)n2cnc(c3ccc(F)cc3)c2c4ccnc(NCCO)n4,CHEMBL330422,"InChI=1S/C21H25FN6O/c1-27-11-7-17(8-12-27)28-14-25-19(15-2-4-16(22)5-3-15)20(28)18-6-9-23-21(26-18)24-10-13-29/h2-6,9,14,17,29H,7-8,10-13H2,1H3,(H,23,24,26)",CN1CCC(CC1)n2cnc(c3ccc(F)cc3)c2c4ccnc(NCCO)n4,CHEMBL735050,Inhibition against Mitogen-activated protein kinase p38 alpha,IC50,=,53,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1134743,"Bioorg. Med. Chem. Lett., 11, p. 2867 (2001)",11597418,Scientific Literature
17,CHEMBL318892,"InChI=1S/C25H25FN6/c1-31-15-12-21(13-16-31)32-17-28-23(18-7-9-19(26)10-8-18)24(32)22-11-14-27-25(30-22)29-20-5-3-2-4-6-20/h2-11,14,17,21H,12-13,15-16H2,1H3,(H,27,29,30)",CN1CCC(CC1)n2cnc(c3ccc(F)cc3)c2c4ccnc(Nc5ccccc5)n4,CHEMBL318892,"InChI=1S/C25H25FN6/c1-31-15-12-21(13-16-31)32-17-28-23(18-7-9-19(26)10-8-18)24(32)22-11-14-27-25(30-22)29-20-5-3-2-4-6-20/h2-11,14,17,21H,12-13,15-16H2,1H3,(H,27,29,30)",CN1CCC(CC1)n2cnc(c3ccc(F)cc3)c2c4ccnc(Nc5ccccc5)n4,CHEMBL735050,Inhibition against Mitogen-activated protein kinase p38 alpha,IC50,=,3,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1134743,"Bioorg. Med. Chem. Lett., 11, p. 2867 (2001)",11597418,Scientific Literature
23,CHEMBL275798,"InChI=1S/C24H22FN5O/c25-18-8-6-17(7-9-18)22-23(30(16-28-22)19-10-13-26-14-11-19)21-12-15-27-24(29-21)31-20-4-2-1-3-5-20/h1-9,12,15-16,19,26H,10-11,13-14H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccccc5)n4,CHEMBL275798,"InChI=1S/C24H22FN5O/c25-18-8-6-17(7-9-18)22-23(30(16-28-22)19-10-13-26-14-11-19)21-12-15-27-24(29-21)31-20-4-2-1-3-5-20/h1-9,12,15-16,19,26H,10-11,13-14H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccccc5)n4,CHEMBL735050,Inhibition against Mitogen-activated protein kinase p38 alpha,IC50,=,20,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1134743,"Bioorg. Med. Chem. Lett., 11, p. 2867 (2001)",11597418,Scientific Literature
3,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL735050,Inhibition against Mitogen-activated protein kinase p38 alpha,IC50,=,20,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1134743,"Bioorg. Med. Chem. Lett., 11, p. 2867 (2001)",11597418,Scientific Literature
4,CHEMBL95502,"InChI=1S/C22H27FN6/c1-21(2)11-16(12-22(3,4)28-21)29-13-26-18(14-5-7-15(23)8-6-14)19(29)17-9-10-25-20(24)27-17/h5-10,13,16,28H,11-12H2,1-4H3,(H2,24,25,27)",CC1(C)CC(CC(C)(C)N1)n2cnc(c3ccc(F)cc3)c2c4ccnc(N)n4,CHEMBL95502,"InChI=1S/C22H27FN6/c1-21(2)11-16(12-22(3,4)28-21)29-13-26-18(14-5-7-15(23)8-6-14)19(29)17-9-10-25-20(24)27-17/h5-10,13,16,28H,11-12H2,1-4H3,(H2,24,25,27)",CC1(C)CC(CC(C)(C)N1)n2cnc(c3ccc(F)cc3)c2c4ccnc(N)n4,CHEMBL735050,Inhibition against Mitogen-activated protein kinase p38 alpha,IC50,=,58,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1134743,"Bioorg. Med. Chem. Lett., 11, p. 2867 (2001)",11597418,Scientific Literature
9,CHEMBL95207,"InChI=1S/C19H21FN6/c1-25-10-7-15(8-11-25)26-12-23-17(13-2-4-14(20)5-3-13)18(26)16-6-9-22-19(21)24-16/h2-6,9,12,15H,7-8,10-11H2,1H3,(H2,21,22,24)",CN1CCC(CC1)n2cnc(c3ccc(F)cc3)c2c4ccnc(N)n4,CHEMBL95207,"InChI=1S/C19H21FN6/c1-25-10-7-15(8-11-25)26-12-23-17(13-2-4-14(20)5-3-13)18(26)16-6-9-22-19(21)24-16/h2-6,9,12,15H,7-8,10-11H2,1H3,(H2,21,22,24)",CN1CCC(CC1)n2cnc(c3ccc(F)cc3)c2c4ccnc(N)n4,CHEMBL735050,Inhibition against Mitogen-activated protein kinase p38 alpha,IC50,=,86,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1134743,"Bioorg. Med. Chem. Lett., 11, p. 2867 (2001)",11597418,Scientific Literature
1,CHEMBL274863,"InChI=1S/C20H23FN6O/c21-16-4-2-15(3-5-16)18-19(17-6-7-23-20(22)25-17)27(14-24-18)9-1-8-26-10-12-28-13-11-26/h2-7,14H,1,8-13H2,(H2,22,23,25)",Nc1nccc(n1)c2c(ncn2CCCN3CCOCC3)c4ccc(F)cc4,CHEMBL274863,"InChI=1S/C20H23FN6O/c21-16-4-2-15(3-5-16)18-19(17-6-7-23-20(22)25-17)27(14-24-18)9-1-8-26-10-12-28-13-11-26/h2-7,14H,1,8-13H2,(H2,22,23,25)",Nc1nccc(n1)c2c(ncn2CCCN3CCOCC3)c4ccc(F)cc4,CHEMBL736654,Inhibition against murine TNF synthesis induced by lipopolysaccharide (LPS),ED50,=,5.2,mg.kg-1,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1134743,"Bioorg. Med. Chem. Lett., 11, p. 2867 (2001)",11597418,Scientific Literature
16,CHEMBL330422,"InChI=1S/C21H25FN6O/c1-27-11-7-17(8-12-27)28-14-25-19(15-2-4-16(22)5-3-15)20(28)18-6-9-23-21(26-18)24-10-13-29/h2-6,9,14,17,29H,7-8,10-13H2,1H3,(H,23,24,26)",CN1CCC(CC1)n2cnc(c3ccc(F)cc3)c2c4ccnc(NCCO)n4,CHEMBL330422,"InChI=1S/C21H25FN6O/c1-27-11-7-17(8-12-27)28-14-25-19(15-2-4-16(22)5-3-15)20(28)18-6-9-23-21(26-18)24-10-13-29/h2-6,9,14,17,29H,7-8,10-13H2,1H3,(H,23,24,26)",CN1CCC(CC1)n2cnc(c3ccc(F)cc3)c2c4ccnc(NCCO)n4,CHEMBL736654,Inhibition against murine TNF synthesis induced by lipopolysaccharide (LPS),ED50,=,16,mg.kg-1,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1134743,"Bioorg. Med. Chem. Lett., 11, p. 2867 (2001)",11597418,Scientific Literature
17,CHEMBL318892,"InChI=1S/C25H25FN6/c1-31-15-12-21(13-16-31)32-17-28-23(18-7-9-19(26)10-8-18)24(32)22-11-14-27-25(30-22)29-20-5-3-2-4-6-20/h2-11,14,17,21H,12-13,15-16H2,1H3,(H,27,29,30)",CN1CCC(CC1)n2cnc(c3ccc(F)cc3)c2c4ccnc(Nc5ccccc5)n4,CHEMBL318892,"InChI=1S/C25H25FN6/c1-31-15-12-21(13-16-31)32-17-28-23(18-7-9-19(26)10-8-18)24(32)22-11-14-27-25(30-22)29-20-5-3-2-4-6-20/h2-11,14,17,21H,12-13,15-16H2,1H3,(H,27,29,30)",CN1CCC(CC1)n2cnc(c3ccc(F)cc3)c2c4ccnc(Nc5ccccc5)n4,CHEMBL736654,Inhibition against murine TNF synthesis induced by lipopolysaccharide (LPS),ED50,=,0.42,mg.kg-1,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1134743,"Bioorg. Med. Chem. Lett., 11, p. 2867 (2001)",11597418,Scientific Literature
23,CHEMBL275798,"InChI=1S/C24H22FN5O/c25-18-8-6-17(7-9-18)22-23(30(16-28-22)19-10-13-26-14-11-19)21-12-15-27-24(29-21)31-20-4-2-1-3-5-20/h1-9,12,15-16,19,26H,10-11,13-14H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccccc5)n4,CHEMBL275798,"InChI=1S/C24H22FN5O/c25-18-8-6-17(7-9-18)22-23(30(16-28-22)19-10-13-26-14-11-19)21-12-15-27-24(29-21)31-20-4-2-1-3-5-20/h1-9,12,15-16,19,26H,10-11,13-14H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccccc5)n4,CHEMBL736654,Inhibition against murine TNF synthesis induced by lipopolysaccharide (LPS),ED50,=,0.84,mg.kg-1,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1134743,"Bioorg. Med. Chem. Lett., 11, p. 2867 (2001)",11597418,Scientific Literature
3,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL736654,Inhibition against murine TNF synthesis induced by lipopolysaccharide (LPS),ED50,=,8,mg.kg-1,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1134743,"Bioorg. Med. Chem. Lett., 11, p. 2867 (2001)",11597418,Scientific Literature
4,CHEMBL95502,"InChI=1S/C22H27FN6/c1-21(2)11-16(12-22(3,4)28-21)29-13-26-18(14-5-7-15(23)8-6-14)19(29)17-9-10-25-20(24)27-17/h5-10,13,16,28H,11-12H2,1-4H3,(H2,24,25,27)",CC1(C)CC(CC(C)(C)N1)n2cnc(c3ccc(F)cc3)c2c4ccnc(N)n4,CHEMBL95502,"InChI=1S/C22H27FN6/c1-21(2)11-16(12-22(3,4)28-21)29-13-26-18(14-5-7-15(23)8-6-14)19(29)17-9-10-25-20(24)27-17/h5-10,13,16,28H,11-12H2,1-4H3,(H2,24,25,27)",CC1(C)CC(CC(C)(C)N1)n2cnc(c3ccc(F)cc3)c2c4ccnc(N)n4,CHEMBL736654,Inhibition against murine TNF synthesis induced by lipopolysaccharide (LPS),ED50,=,9,mg.kg-1,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1134743,"Bioorg. Med. Chem. Lett., 11, p. 2867 (2001)",11597418,Scientific Literature
9,CHEMBL95207,"InChI=1S/C19H21FN6/c1-25-10-7-15(8-11-25)26-12-23-17(13-2-4-14(20)5-3-13)18(26)16-6-9-22-19(21)24-16/h2-6,9,12,15H,7-8,10-11H2,1H3,(H2,21,22,24)",CN1CCC(CC1)n2cnc(c3ccc(F)cc3)c2c4ccnc(N)n4,CHEMBL95207,"InChI=1S/C19H21FN6/c1-25-10-7-15(8-11-25)26-12-23-17(13-2-4-14(20)5-3-13)18(26)16-6-9-22-19(21)24-16/h2-6,9,12,15H,7-8,10-11H2,1H3,(H2,21,22,24)",CN1CCC(CC1)n2cnc(c3ccc(F)cc3)c2c4ccnc(N)n4,CHEMBL736654,Inhibition against murine TNF synthesis induced by lipopolysaccharide (LPS),ED50,=,4.4,mg.kg-1,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1134743,"Bioorg. Med. Chem. Lett., 11, p. 2867 (2001)",11597418,Scientific Literature
3,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL783148,Inhibition of LPS-induced TNF synthesis in the rat,ED50,=,20,mg.kg-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1134743,"Bioorg. Med. Chem. Lett., 11, p. 2867 (2001)",11597418,Scientific Literature
9,CHEMBL95207,"InChI=1S/C19H21FN6/c1-25-10-7-15(8-11-25)26-12-23-17(13-2-4-14(20)5-3-13)18(26)16-6-9-22-19(21)24-16/h2-6,9,12,15H,7-8,10-11H2,1H3,(H2,21,22,24)",CN1CCC(CC1)n2cnc(c3ccc(F)cc3)c2c4ccnc(N)n4,CHEMBL95207,"InChI=1S/C19H21FN6/c1-25-10-7-15(8-11-25)26-12-23-17(13-2-4-14(20)5-3-13)18(26)16-6-9-22-19(21)24-16/h2-6,9,12,15H,7-8,10-11H2,1H3,(H2,21,22,24)",CN1CCC(CC1)n2cnc(c3ccc(F)cc3)c2c4ccnc(N)n4,CHEMBL783148,Inhibition of LPS-induced TNF synthesis in the rat,ED50,=,4,mg.kg-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1134743,"Bioorg. Med. Chem. Lett., 11, p. 2867 (2001)",11597418,Scientific Literature
3,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL842192,Inhibition of p38 alpha kinase,IC50,=,19,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1134743,"Bioorg. Med. Chem. Lett., 11, p. 2867 (2001)",11597418,Scientific Literature
1,CHEMBL14112,"InChI=1S/C21H23FN4O/c22-19-4-2-17(3-5-19)20-21(18-6-8-23-9-7-18)26(16-24-20)11-1-10-25-12-14-27-15-13-25/h2-9,16H,1,10-15H2",Fc1ccc(cc1)c2ncn(CCCN3CCOCC3)c2c4ccncc4,CHEMBL14112,"InChI=1S/C21H23FN4O/c22-19-4-2-17(3-5-19)20-21(18-6-8-23-9-7-18)26(16-24-20)11-1-10-25-12-14-27-15-13-25/h2-9,16H,1,10-15H2",Fc1ccc(cc1)c2ncn(CCCN3CCOCC3)c2c4ccncc4,CHEMBL874040,Inhibitory concentration against mitogen-activated protein kinase p38 alpha,IC50,=,1300,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1134753,"Bioorg. Med. Chem. Lett., 11, p. 1123 (2001)",11354358,Scientific Literature
15aa,CHEMBL275168,"InChI=1S/C24H21ClFN5O/c25-17-3-7-20(8-4-17)32-24-28-14-11-21(30-24)23-22(16-1-5-18(26)6-2-16)29-15-31(23)19-9-12-27-13-10-19/h1-8,11,14-15,19,27H,9-10,12-13H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc(Cl)cc5)n4,CHEMBL275168,"InChI=1S/C24H21ClFN5O/c25-17-3-7-20(8-4-17)32-24-28-14-11-21(30-24)23-22(16-1-5-18(26)6-2-16)29-15-31(23)19-9-12-27-13-10-19/h1-8,11,14-15,19,27H,9-10,12-13H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc(Cl)cc5)n4,CHEMBL874040,Inhibitory concentration against mitogen-activated protein kinase p38 alpha,IC50,=,114,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1134753,"Bioorg. Med. Chem. Lett., 11, p. 1123 (2001)",11354358,Scientific Literature
15ac,CHEMBL13868,"InChI=1S/C30H26FN5O2/c31-22-8-6-21(7-9-22)28-29(36(20-34-28)23-14-17-32-18-15-23)27-16-19-33-30(35-27)38-26-12-10-25(11-13-26)37-24-4-2-1-3-5-24/h1-13,16,19-20,23,32H,14-15,17-18H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc(Oc6ccccc6)cc5)n4,CHEMBL13868,"InChI=1S/C30H26FN5O2/c31-22-8-6-21(7-9-22)28-29(36(20-34-28)23-14-17-32-18-15-23)27-16-19-33-30(35-27)38-26-12-10-25(11-13-26)37-24-4-2-1-3-5-24/h1-13,16,19-20,23,32H,14-15,17-18H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc(Oc6ccccc6)cc5)n4,CHEMBL874040,Inhibitory concentration against mitogen-activated protein kinase p38 alpha,IC50,=,130,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1134753,"Bioorg. Med. Chem. Lett., 11, p. 1123 (2001)",11354358,Scientific Literature
15ad,CHEMBL275666,"InChI=1S/C25H21F4N5O/c26-18-6-4-16(5-7-18)22-23(34(15-32-22)19-8-11-30-12-9-19)21-10-13-31-24(33-21)35-20-3-1-2-17(14-20)25(27,28)29/h1-7,10,13-15,19,30H,8-9,11-12H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5cccc(c5)C(F)(F)F)n4,CHEMBL275666,"InChI=1S/C25H21F4N5O/c26-18-6-4-16(5-7-18)22-23(34(15-32-22)19-8-11-30-12-9-19)21-10-13-31-24(33-21)35-20-3-1-2-17(14-20)25(27,28)29/h1-7,10,13-15,19,30H,8-9,11-12H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5cccc(c5)C(F)(F)F)n4,CHEMBL874040,Inhibitory concentration against mitogen-activated protein kinase p38 alpha,IC50,=,132,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1134753,"Bioorg. Med. Chem. Lett., 11, p. 1123 (2001)",11354358,Scientific Literature
15ai,CHEMBL13972,"InChI=1S/C25H21FN6O/c26-19-5-3-18(4-6-19)23-24(32(16-30-23)20-9-12-28-13-10-20)22-11-14-29-25(31-22)33-21-7-1-17(15-27)2-8-21/h1-8,11,14,16,20,28H,9-10,12-13H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc(cc5)C#N)n4,CHEMBL13972,"InChI=1S/C25H21FN6O/c26-19-5-3-18(4-6-19)23-24(32(16-30-23)20-9-12-28-13-10-20)22-11-14-29-25(31-22)33-21-7-1-17(15-27)2-8-21/h1-8,11,14,16,20,28H,9-10,12-13H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc(cc5)C#N)n4,CHEMBL874040,Inhibitory concentration against mitogen-activated protein kinase p38 alpha,IC50,=,177,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1134753,"Bioorg. Med. Chem. Lett., 11, p. 1123 (2001)",11354358,Scientific Literature
15am,CHEMBL269450,"InChI=1S/C24H21F2N5O/c25-17-3-1-16(2-4-17)22-23(31(15-29-22)19-9-12-27-13-10-19)21-11-14-28-24(30-21)32-20-7-5-18(26)6-8-20/h1-8,11,14-15,19,27H,9-10,12-13H2",Fc1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL269450,"InChI=1S/C24H21F2N5O/c25-17-3-1-16(2-4-17)22-23(31(15-29-22)19-9-12-27-13-10-19)21-11-14-28-24(30-21)32-20-7-5-18(26)6-8-20/h1-8,11,14-15,19,27H,9-10,12-13H2",Fc1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL874040,Inhibitory concentration against mitogen-activated protein kinase p38 alpha,IC50,=,300,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1134753,"Bioorg. Med. Chem. Lett., 11, p. 1123 (2001)",11354358,Scientific Literature
15as,CHEMBL418348,"InChI=1S/C25H24FN5O3S/c1-35(32,33)21-8-6-20(7-9-21)34-25-28-15-12-22(30-25)24-23(17-2-4-18(26)5-3-17)29-16-31(24)19-10-13-27-14-11-19/h2-9,12,15-16,19,27H,10-11,13-14H2,1H3",CS(=O)(=O)c1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL418348,"InChI=1S/C25H24FN5O3S/c1-35(32,33)21-8-6-20(7-9-21)34-25-28-15-12-22(30-25)24-23(17-2-4-18(26)5-3-17)29-16-31(24)19-10-13-27-14-11-19/h2-9,12,15-16,19,27H,10-11,13-14H2,1H3",CS(=O)(=O)c1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL874040,Inhibitory concentration against mitogen-activated protein kinase p38 alpha,IC50,=,650,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1134753,"Bioorg. Med. Chem. Lett., 11, p. 1123 (2001)",11354358,Scientific Literature
15c,CHEMBL428877,"InChI=1S/C26H26FN5O/c1-2-18-3-9-22(10-4-18)33-26-29-16-13-23(31-26)25-24(19-5-7-20(27)8-6-19)30-17-32(25)21-11-14-28-15-12-21/h3-10,13,16-17,21,28H,2,11-12,14-15H2,1H3",CCc1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL428877,"InChI=1S/C26H26FN5O/c1-2-18-3-9-22(10-4-18)33-26-29-16-13-23(31-26)25-24(19-5-7-20(27)8-6-19)30-17-32(25)21-11-14-28-15-12-21/h3-10,13,16-17,21,28H,2,11-12,14-15H2,1H3",CCc1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL874040,Inhibitory concentration against mitogen-activated protein kinase p38 alpha,IC50,=,7.4,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1134753,"Bioorg. Med. Chem. Lett., 11, p. 1123 (2001)",11354358,Scientific Literature
15h,CHEMBL14212,"InChI=1S/C26H26FN5O/c1-17-4-3-5-23(18(17)2)33-26-29-15-12-22(31-26)25-24(19-6-8-20(27)9-7-19)30-16-32(25)21-10-13-28-14-11-21/h3-9,12,15-16,21,28H,10-11,13-14H2,1-2H3",Cc1cccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)c1C,CHEMBL14212,"InChI=1S/C26H26FN5O/c1-17-4-3-5-23(18(17)2)33-26-29-15-12-22(31-26)25-24(19-6-8-20(27)9-7-19)30-16-32(25)21-10-13-28-14-11-21/h3-9,12,15-16,21,28H,10-11,13-14H2,1-2H3",Cc1cccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)c1C,CHEMBL874040,Inhibitory concentration against mitogen-activated protein kinase p38 alpha,IC50,=,15.2,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1134753,"Bioorg. Med. Chem. Lett., 11, p. 1123 (2001)",11354358,Scientific Literature
15n,CHEMBL273611,"InChI=1S/C25H22FN5O3/c26-17-3-1-16(2-4-17)23-24(31(14-29-23)18-7-10-27-11-8-18)20-9-12-28-25(30-20)34-19-5-6-21-22(13-19)33-15-32-21/h1-6,9,12-14,18,27H,7-8,10-11,15H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc6OCOc6c5)n4,CHEMBL273611,"InChI=1S/C25H22FN5O3/c26-17-3-1-16(2-4-17)23-24(31(14-29-23)18-7-10-27-11-8-18)20-9-12-28-25(30-20)34-19-5-6-21-22(13-19)33-15-32-21/h1-6,9,12-14,18,27H,7-8,10-11,15H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc6OCOc6c5)n4,CHEMBL874040,Inhibitory concentration against mitogen-activated protein kinase p38 alpha,IC50,=,23,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1134753,"Bioorg. Med. Chem. Lett., 11, p. 1123 (2001)",11354358,Scientific Literature
15o,CHEMBL417804,"InChI=1S/C25H24FN5O2/c1-32-21-4-2-3-5-22(21)33-25-28-15-12-20(30-25)24-23(17-6-8-18(26)9-7-17)29-16-31(24)19-10-13-27-14-11-19/h2-9,12,15-16,19,27H,10-11,13-14H2,1H3",COc1ccccc1Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5,CHEMBL417804,"InChI=1S/C25H24FN5O2/c1-32-21-4-2-3-5-22(21)33-25-28-15-12-20(30-25)24-23(17-6-8-18(26)9-7-17)29-16-31(24)19-10-13-27-14-11-19/h2-9,12,15-16,19,27H,10-11,13-14H2,1H3",COc1ccccc1Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5,CHEMBL874040,Inhibitory concentration against mitogen-activated protein kinase p38 alpha,IC50,=,25,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1134753,"Bioorg. Med. Chem. Lett., 11, p. 1123 (2001)",11354358,Scientific Literature
15v,CHEMBL275200,"InChI=1S/C28H30FN5O/c1-28(2,3)20-6-10-23(11-7-20)35-27-31-17-14-24(33-27)26-25(19-4-8-21(29)9-5-19)32-18-34(26)22-12-15-30-16-13-22/h4-11,14,17-18,22,30H,12-13,15-16H2,1-3H3",CC(C)(C)c1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL275200,"InChI=1S/C28H30FN5O/c1-28(2,3)20-6-10-23(11-7-20)35-27-31-17-14-24(33-27)26-25(19-4-8-21(29)9-5-19)32-18-34(26)22-12-15-30-16-13-22/h4-11,14,17-18,22,30H,12-13,15-16H2,1-3H3",CC(C)(C)c1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL874040,Inhibitory concentration against mitogen-activated protein kinase p38 alpha,IC50,=,79,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1134753,"Bioorg. Med. Chem. Lett., 11, p. 1123 (2001)",11354358,Scientific Literature
15w,CHEMBL14233,"InChI=1S/C25H22FN5O3/c26-18-5-1-16(2-6-18)22-23(31(15-29-22)19-9-12-27-13-10-19)21-11-14-28-25(30-21)34-20-7-3-17(4-8-20)24(32)33/h1-8,11,14-15,19,27H,9-10,12-13H2,(H,32,33)",OC(=O)c1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL14233,"InChI=1S/C25H22FN5O3/c26-18-5-1-16(2-6-18)22-23(31(15-29-22)19-9-12-27-13-10-19)21-11-14-28-25(30-21)34-20-7-3-17(4-8-20)24(32)33/h1-8,11,14-15,19,27H,9-10,12-13H2,(H,32,33)",OC(=O)c1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL874040,Inhibitory concentration against mitogen-activated protein kinase p38 alpha,IC50,=,82,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1134753,"Bioorg. Med. Chem. Lett., 11, p. 1123 (2001)",11354358,Scientific Literature
15y,CHEMBL275724,"InChI=1S/C25H23FN6O2/c26-18-5-1-16(2-6-18)22-23(32(15-30-22)19-9-12-28-13-10-19)21-11-14-29-25(31-21)34-20-7-3-17(4-8-20)24(27)33/h1-8,11,14-15,19,28H,9-10,12-13H2,(H2,27,33)",NC(=O)c1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL275724,"InChI=1S/C25H23FN6O2/c26-18-5-1-16(2-6-18)22-23(32(15-30-22)19-9-12-28-13-10-19)21-11-14-29-25(31-21)34-20-7-3-17(4-8-20)24(27)33/h1-8,11,14-15,19,28H,9-10,12-13H2,(H2,27,33)",NC(=O)c1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL874040,Inhibitory concentration against mitogen-activated protein kinase p38 alpha,IC50,=,89.7,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1134753,"Bioorg. Med. Chem. Lett., 11, p. 1123 (2001)",11354358,Scientific Literature
15z,CHEMBL14014,"InChI=1S/C24H21F2N5O/c25-17-6-4-16(5-7-17)22-23(31(15-29-22)19-8-11-27-12-9-19)21-10-13-28-24(30-21)32-20-3-1-2-18(26)14-20/h1-7,10,13-15,19,27H,8-9,11-12H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5cccc(F)c5)n4,CHEMBL14014,"InChI=1S/C24H21F2N5O/c25-17-6-4-16(5-7-17)22-23(31(15-29-22)19-8-11-27-12-9-19)21-10-13-28-24(30-21)32-20-3-1-2-18(26)14-20/h1-7,10,13-15,19,27H,8-9,11-12H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5cccc(F)c5)n4,CHEMBL874040,Inhibitory concentration against mitogen-activated protein kinase p38 alpha,IC50,=,95,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1134753,"Bioorg. Med. Chem. Lett., 11, p. 1123 (2001)",11354358,Scientific Literature
3,CHEMBL274863,"InChI=1S/C20H23FN6O/c21-16-4-2-15(3-5-16)18-19(17-6-7-23-20(22)25-17)27(14-24-18)9-1-8-26-10-12-28-13-11-26/h2-7,14H,1,8-13H2,(H2,22,23,25)",Nc1nccc(n1)c2c(ncn2CCCN3CCOCC3)c4ccc(F)cc4,CHEMBL274863,"InChI=1S/C20H23FN6O/c21-16-4-2-15(3-5-16)18-19(17-6-7-23-20(22)25-17)27(14-24-18)9-1-8-26-10-12-28-13-11-26/h2-7,14H,1,8-13H2,(H2,22,23,25)",Nc1nccc(n1)c2c(ncn2CCCN3CCOCC3)c4ccc(F)cc4,CHEMBL874040,Inhibitory concentration against mitogen-activated protein kinase p38 alpha,IC50,=,480,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1134753,"Bioorg. Med. Chem. Lett., 11, p. 1123 (2001)",11354358,Scientific Literature
6,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL874040,Inhibitory concentration against mitogen-activated protein kinase p38 alpha,IC50,=,20,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1134753,"Bioorg. Med. Chem. Lett., 11, p. 1123 (2001)",11354358,Scientific Literature
7,CHEMBL275798,"InChI=1S/C24H22FN5O/c25-18-8-6-17(7-9-18)22-23(30(16-28-22)19-10-13-26-14-11-19)21-12-15-27-24(29-21)31-20-4-2-1-3-5-20/h1-9,12,15-16,19,26H,10-11,13-14H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccccc5)n4,CHEMBL275798,"InChI=1S/C24H22FN5O/c25-18-8-6-17(7-9-18)22-23(30(16-28-22)19-10-13-26-14-11-19)21-12-15-27-24(29-21)31-20-4-2-1-3-5-20/h1-9,12,15-16,19,26H,10-11,13-14H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccccc5)n4,CHEMBL874040,Inhibitory concentration against mitogen-activated protein kinase p38 alpha,IC50,=,19,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1134753,"Bioorg. Med. Chem. Lett., 11, p. 1123 (2001)",11354358,Scientific Literature
12c,CHEMBL1794053,"InChI=1S/C18H11Br2N3O2S.ClH/c19-12-4-8(5-13(20)16(12)24)3-11-10-6-9(15-7-26-18(21)23-15)1-2-14(10)22-17(11)25;/h1-7,24H,(H2,21,23)(H,22,25);1H",Cl.Nc1nc(cs1)c2ccc3NC(=O)C(=Cc4cc(Br)c(O)c(Br)c4)c3c2,CHEMBL1852697,"InChI=1S/C18H11Br2N3O2S/c19-12-4-8(5-13(20)16(12)24)3-11-10-6-9(15-7-26-18(21)23-15)1-2-14(10)22-17(11)25/h1-7,24H,(H2,21,23)(H,22,25)",Nc1nc(cs1)c2ccc3NC(=O)C(=Cc4cc(Br)c(O)c(Br)c4)c3c2,CHEMBL815443,Evaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligand,Ki,=,78.6,nM,,CHEMBL2868,Vasopressin V1a receptor,Rattus norvegicus,P30560,CHEMBL1135377,"Bioorg. Med. Chem. Lett., 12, p. 229 (2002)",11755361,Scientific Literature
12c,CHEMBL1794053,"InChI=1S/C18H11Br2N3O2S.ClH/c19-12-4-8(5-13(20)16(12)24)3-11-10-6-9(15-7-26-18(21)23-15)1-2-14(10)22-17(11)25;/h1-7,24H,(H2,21,23)(H,22,25);1H",Cl.Nc1nc(cs1)c2ccc3NC(=O)C(=Cc4cc(Br)c(O)c(Br)c4)c3c2,CHEMBL1852697,"InChI=1S/C18H11Br2N3O2S/c19-12-4-8(5-13(20)16(12)24)3-11-10-6-9(15-7-26-18(21)23-15)1-2-14(10)22-17(11)25/h1-7,24H,(H2,21,23)(H,22,25)",Nc1nc(cs1)c2ccc3NC(=O)C(=Cc4cc(Br)c(O)c(Br)c4)c3c2,CHEMBL885387,Evaluated for the binding affinity towards vasopressin (V2) receptor in rat kidney membrane using [3H]AVP as radioligand,Ki,=,168,nM,,CHEMBL3766,Vasopressin V2 receptor,Rattus norvegicus,Q00788,CHEMBL1135377,"Bioorg. Med. Chem. Lett., 12, p. 229 (2002)",11755361,Scientific Literature
13,CHEMBL267228,"InChI=1S/C22H17N3O3/c26-12-14-4-6-15(7-5-14)22-24-20(21(25-22)17-3-1-2-10-23-17)16-8-9-18-19(11-16)28-13-27-18/h1-11,26H,12-13H2,(H,24,25)",OCc1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL267228,"InChI=1S/C22H17N3O3/c26-12-14-4-6-15(7-5-14)22-24-20(21(25-22)17-3-1-2-10-23-17)16-8-9-18-19(11-16)28-13-27-18/h1-11,26H,12-13H2,(H,24,25)",OCc1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL642728,"Inhibition of Activin like receptor kinase 5, TGF beta type I receptor",IC50,=,260,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1135833,"J. Med. Chem., 45, p. 999 (2002)",11855979,Scientific Literature
14,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL642728,"Inhibition of Activin like receptor kinase 5, TGF beta type I receptor",IC50,=,94,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1135833,"J. Med. Chem., 45, p. 999 (2002)",11855979,Scientific Literature
4,CHEMBL266707,"InChI=1S/C16H12FN3S/c17-13-3-1-12(2-4-13)15-14(11-5-7-18-8-6-11)19-16-20(15)9-10-21-16/h1-8H,9-10H2",Fc1ccc(cc1)c2c(nc3SCCn23)c4ccncc4,CHEMBL266707,"InChI=1S/C16H12FN3S/c17-13-3-1-12(2-4-13)15-14(11-5-7-18-8-6-11)19-16-20(15)9-10-21-16/h1-8H,9-10H2",Fc1ccc(cc1)c2c(nc3SCCn23)c4ccncc4,CHEMBL642728,"Inhibition of Activin like receptor kinase 5, TGF beta type I receptor",IC50,>,50000,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1135833,"J. Med. Chem., 45, p. 999 (2002)",11855979,Scientific Literature
7,CHEMBL268889,"InChI=1S/C18H15N3O2/c1-2-8-19-13(4-1)17-18(21-9-3-5-16(21)20-17)12-6-7-14-15(10-12)23-11-22-14/h1-2,4,6-8,10H,3,5,9,11H2",C1Cc2nc(c3ccccn3)c(c4ccc5OCOc5c4)n2C1,CHEMBL268889,"InChI=1S/C18H15N3O2/c1-2-8-19-13(4-1)17-18(21-9-3-5-16(21)20-17)12-6-7-14-15(10-12)23-11-22-14/h1-2,4,6-8,10H,3,5,9,11H2",C1Cc2nc(c3ccccn3)c(c4ccc5OCOc5c4)n2C1,CHEMBL642728,"Inhibition of Activin like receptor kinase 5, TGF beta type I receptor",IC50,=,460,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1135833,"J. Med. Chem., 45, p. 999 (2002)",11855979,Scientific Literature
1f,CHEMBL103115,"InChI=1S/C15H13FN4O3S/c16-12-7-9(1-6-14(12)21)13-8-15(20-19-13)18-10-2-4-11(5-3-10)24(17,22)23/h1-8,21H,(H2,17,22,23)(H2,18,19,20)",NS(=O)(=O)c1ccc(Nc2cc(n[nH]2)c3ccc(O)c(F)c3)cc1,CHEMBL103115,"InChI=1S/C15H13FN4O3S/c16-12-7-9(1-6-14(12)21)13-8-15(20-19-13)18-10-2-4-11(5-3-10)24(17,22)23/h1-8,21H,(H2,17,22,23)(H2,18,19,20)",NS(=O)(=O)c1ccc(Nc2cc(n[nH]2)c3ccc(O)c(F)c3)cc1,CHEMBL661129,In vitro inhibition of Cyclin-dependent kinase 2 was determined.,IC50,=,12.6,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1136197,"Bioorg. Med. Chem. Lett., 13, p. 2985 (2003)",12941317,Scientific Literature
1k,CHEMBL103104,"InChI=1S/C15H14N4O3S/c16-23(21,22)13-6-4-11(5-7-13)17-15-9-14(18-19-15)10-2-1-3-12(20)8-10/h1-9,20H,(H2,16,21,22)(H2,17,18,19)",NS(=O)(=O)c1ccc(Nc2cc(n[nH]2)c3cccc(O)c3)cc1,CHEMBL103104,"InChI=1S/C15H14N4O3S/c16-23(21,22)13-6-4-11(5-7-13)17-15-9-14(18-19-15)10-2-1-3-12(20)8-10/h1-9,20H,(H2,16,21,22)(H2,17,18,19)",NS(=O)(=O)c1ccc(Nc2cc(n[nH]2)c3cccc(O)c3)cc1,CHEMBL661129,In vitro inhibition of Cyclin-dependent kinase 2 was determined.,IC50,=,9.1,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1136197,"Bioorg. Med. Chem. Lett., 13, p. 2985 (2003)",12941317,Scientific Literature
3,CHEMBL329040,"InChI=1S/C15H13FN4O2S/c16-11-6-4-10(5-7-11)14-9-15(20-19-14)18-12-2-1-3-13(8-12)23(17,21)22/h1-9H,(H2,17,21,22)(H2,18,19,20)",NS(=O)(=O)c1cccc(Nc2cc(n[nH]2)c3ccc(F)cc3)c1,CHEMBL329040,"InChI=1S/C15H13FN4O2S/c16-11-6-4-10(5-7-11)14-9-15(20-19-14)18-12-2-1-3-13(8-12)23(17,21)22/h1-9H,(H2,17,21,22)(H2,18,19,20)",NS(=O)(=O)c1cccc(Nc2cc(n[nH]2)c3ccc(F)cc3)c1,CHEMBL661129,In vitro inhibition of Cyclin-dependent kinase 2 was determined.,IC50,=,871,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1136197,"Bioorg. Med. Chem. Lett., 13, p. 2985 (2003)",12941317,Scientific Literature
1f,CHEMBL103115,"InChI=1S/C15H13FN4O3S/c16-12-7-9(1-6-14(12)21)13-8-15(20-19-13)18-10-2-4-11(5-3-10)24(17,22)23/h1-8,21H,(H2,17,22,23)(H2,18,19,20)",NS(=O)(=O)c1ccc(Nc2cc(n[nH]2)c3ccc(O)c(F)c3)cc1,CHEMBL103115,"InChI=1S/C15H13FN4O3S/c16-12-7-9(1-6-14(12)21)13-8-15(20-19-13)18-10-2-4-11(5-3-10)24(17,22)23/h1-8,21H,(H2,17,22,23)(H2,18,19,20)",NS(=O)(=O)c1ccc(Nc2cc(n[nH]2)c3ccc(O)c(F)c3)cc1,CHEMBL666144,Inhibition of Cyclin-dependent kinase 1,IC50,=,200,nM,,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1136197,"Bioorg. Med. Chem. Lett., 13, p. 2985 (2003)",12941317,Scientific Literature
1k,CHEMBL103104,"InChI=1S/C15H14N4O3S/c16-23(21,22)13-6-4-11(5-7-13)17-15-9-14(18-19-15)10-2-1-3-12(20)8-10/h1-9,20H,(H2,16,21,22)(H2,17,18,19)",NS(=O)(=O)c1ccc(Nc2cc(n[nH]2)c3cccc(O)c3)cc1,CHEMBL103104,"InChI=1S/C15H14N4O3S/c16-23(21,22)13-6-4-11(5-7-13)17-15-9-14(18-19-15)10-2-1-3-12(20)8-10/h1-9,20H,(H2,16,21,22)(H2,17,18,19)",NS(=O)(=O)c1ccc(Nc2cc(n[nH]2)c3cccc(O)c3)cc1,CHEMBL666144,Inhibition of Cyclin-dependent kinase 1,IC50,=,398,nM,,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1136197,"Bioorg. Med. Chem. Lett., 13, p. 2985 (2003)",12941317,Scientific Literature
3,CHEMBL329040,"InChI=1S/C15H13FN4O2S/c16-11-6-4-10(5-7-11)14-9-15(20-19-14)18-12-2-1-3-13(8-12)23(17,21)22/h1-9H,(H2,17,21,22)(H2,18,19,20)",NS(=O)(=O)c1cccc(Nc2cc(n[nH]2)c3ccc(F)cc3)c1,CHEMBL329040,"InChI=1S/C15H13FN4O2S/c16-11-6-4-10(5-7-11)14-9-15(20-19-14)18-12-2-1-3-13(8-12)23(17,21)22/h1-9H,(H2,17,21,22)(H2,18,19,20)",NS(=O)(=O)c1cccc(Nc2cc(n[nH]2)c3ccc(F)cc3)c1,CHEMBL661617,Inhibition of Cyclin-dependent kinase 1 (not determined),IC50,,,,Not Determined,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1136197,"Bioorg. Med. Chem. Lett., 13, p. 2985 (2003)",12941317,Scientific Literature
13,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL686308,Inhibitory activity to human glycogen synthase kinase-3 alpha (GSK-3alpha) was determined,IC50,=,0.8,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1136206,"Bioorg. Med. Chem. Lett., 13, p. 3055 (2003)",12941332,Scientific Literature
23,CHEMBL261129,"InChI=1S/C19H20BrN5O2/c1-25-8-6-12(7-9-25)19(27)22-18-14-10-15(20)16(21-17(14)23-24-18)11-2-4-13(26)5-3-11/h2-5,10,12,26H,6-9H2,1H3,(H2,21,22,23,24,27)",CN1CCC(CC1)C(=O)Nc2n[nH]c3nc(c(Br)cc23)c4ccc(O)cc4,CHEMBL261129,"InChI=1S/C19H20BrN5O2/c1-25-8-6-12(7-9-25)19(27)22-18-14-10-15(20)16(21-17(14)23-24-18)11-2-4-13(26)5-3-11/h2-5,10,12,26H,6-9H2,1H3,(H2,21,22,23,24,27)",CN1CCC(CC1)C(=O)Nc2n[nH]c3nc(c(Br)cc23)c4ccc(O)cc4,CHEMBL686308,Inhibitory activity to human glycogen synthase kinase-3 alpha (GSK-3alpha) was determined,IC50,=,1,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1136206,"Bioorg. Med. Chem. Lett., 13, p. 3055 (2003)",12941332,Scientific Literature
6,CHEMBL408732,"InChI=1S/C17H16N4O2/c1-23-12-6-4-10(5-7-12)14-9-8-13-15(18-14)20-21-16(13)19-17(22)11-2-3-11/h4-9,11H,2-3H2,1H3,(H2,18,19,20,21,22)",COc1ccc(cc1)c2ccc3c(NC(=O)C4CC4)n[nH]c3n2,CHEMBL408732,"InChI=1S/C17H16N4O2/c1-23-12-6-4-10(5-7-12)14-9-8-13-15(18-14)20-21-16(13)19-17(22)11-2-3-11/h4-9,11H,2-3H2,1H3,(H2,18,19,20,21,22)",COc1ccc(cc1)c2ccc3c(NC(=O)C4CC4)n[nH]c3n2,CHEMBL686308,Inhibitory activity to human glycogen synthase kinase-3 alpha (GSK-3alpha) was determined,IC50,>,5000,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1136206,"Bioorg. Med. Chem. Lett., 13, p. 3055 (2003)",12941332,Scientific Literature
4,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL686313,Inhibition of 10 uM Glycogen synthase kinase-3 alpha at 10 uM,Inhibition,=,100,%,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
34,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL673366,Inhibition of Dual-specificity tyrosine-phosphorylation regulated kinase 1A at 10 uM,Inhibition,=,23,%,,CHEMBL2292,Dual-specificity tyrosine-phosphorylation regulated kinase 1A,Homo sapiens,Q13627,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
4,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL673367,Inhibition of Dual-specificity tyrosine-phosphorylation regulated kinase 1A at 10 uM,Inhibition,=,80,%,,CHEMBL2292,Dual-specificity tyrosine-phosphorylation regulated kinase 1A,Homo sapiens,Q13627,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
34,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL711115,Inhibition of MAP kinase-activated protein kinase 2 at 10 uM,Inhibition,=,2,%,,CHEMBL2208,MAP kinase-activated protein kinase 2,Homo sapiens,P49137,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
4,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL711115,Inhibition of MAP kinase-activated protein kinase 2 at 10 uM,Inhibition,=,19,%,,CHEMBL2208,MAP kinase-activated protein kinase 2,Homo sapiens,P49137,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
34,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL714975,Inhibition of MSK-1 kinase at 10 uM,Inhibition,=,3,%,,CHEMBL4237,Ribosomal protein S6 kinase alpha 5,Homo sapiens,O75582,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
4,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL714975,Inhibition of MSK-1 kinase at 10 uM,Inhibition,=,58,%,,CHEMBL4237,Ribosomal protein S6 kinase alpha 5,Homo sapiens,O75582,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
34,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL731421,Inhibition of Mitogen activated protein kinase kinase 1 at 10 uM,Inhibition,=,19,%,,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,Homo sapiens,Q02750,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
4,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL731421,Inhibition of Mitogen activated protein kinase kinase 1 at 10 uM,Inhibition,=,5,%,,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,Homo sapiens,Q02750,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
34,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL737104,Inhibition of Mitogen-activated protein kinase at 10 uM,Inhibition,=,6,%,,CHEMBL1907606,Mitogen-activated protein kinase; ERK1/ERK2,Homo sapiens,,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
4,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL728623,Inhibition of Mitogen-activated protein kinase at 10 uM,Inhibition,=,45,%,,CHEMBL1907606,Mitogen-activated protein kinase; ERK1/ERK2,Homo sapiens,,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
34,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL761537,Inhibition of PDK1 at 10 uM,Inhibition,=,8,%,,CHEMBL2534,3-phosphoinositide dependent protein kinase-1,Homo sapiens,O15530,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
4,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL761450,Inhibition of PDK1 at 10 uM,Inhibition,=,59,%,,CHEMBL2534,3-phosphoinositide dependent protein kinase-1,Homo sapiens,O15530,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
34,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL760348,Inhibition of PKBa at 10 uM,Inhibition,=,1,%,,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,P31749,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
4,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL760347,Inhibition of PKBa at 10 uM,Inhibition,=,17,%,,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,P31749,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
34,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL769588,Inhibition of Protein kinase C alpha at 10 uM,Inhibition,=,0,%,,CHEMBL299,Protein kinase C alpha ,Homo sapiens,P17252,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
4,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL769588,Inhibition of Protein kinase C alpha at 10 uM,Inhibition,=,62,%,,CHEMBL299,Protein kinase C alpha ,Homo sapiens,P17252,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
34,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL769154,Inhibition of Protein kinase PRAK at 10 uM,Inhibition,=,18,%,,CHEMBL3094,MAP kinase-activated protein kinase 5,Homo sapiens,Q8IW41,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
4,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL769154,Inhibition of Protein kinase PRAK at 10 uM,Inhibition,=,1,%,,CHEMBL3094,MAP kinase-activated protein kinase 5,Homo sapiens,Q8IW41,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
34,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL770790,"Inhibition of ROKa, ROCK II at 10 uM",Inhibition,=,13,%,,CHEMBL2973,Rho-associated protein kinase 2,Homo sapiens,O75116,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
4,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL770790,"Inhibition of ROKa, ROCK II at 10 uM",Inhibition,=,4,%,,CHEMBL2973,Rho-associated protein kinase 2,Homo sapiens,O75116,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
34,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL798339,Inhibition of Serine/threonine-protein kinase Chk1 at 10 uM,Inhibition,=,8,%,,CHEMBL4630,Serine/threonine-protein kinase Chk1 ,Homo sapiens,O14757,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
4,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL798338,Inhibition of Serine/threonine-protein kinase Chk1 at 10 uM,Inhibition,=,66,%,,CHEMBL4630,Serine/threonine-protein kinase Chk1 ,Homo sapiens,O14757,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
34,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL811036,Inhibition of Stress activated protein kinase 2a at 10 uM,Inhibition,=,9,%,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
4,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL811036,Inhibition of Stress activated protein kinase 2a at 10 uM,Inhibition,=,41,%,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
34,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL811043,Inhibition of Stress activated protein kinase 2b at 10 uM,Inhibition,=,4,%,,CHEMBL3961,MAP kinase p38 beta,Homo sapiens,Q15759,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
4,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL811043,Inhibition of Stress activated protein kinase 2b at 10 uM,Inhibition,=,59,%,,CHEMBL3961,MAP kinase p38 beta,Homo sapiens,Q15759,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
34,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL811049,Inhibition of Stress activated protein kinase 3 at 10 uM,Inhibition,=,7,%,,CHEMBL4674,MAP kinase p38 gamma,Homo sapiens,P53778,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
4,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL811049,Inhibition of Stress activated protein kinase 3 at 10 uM,Inhibition,=,62,%,,CHEMBL4674,MAP kinase p38 gamma,Homo sapiens,P53778,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
34,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL810203,Inhibition of Stress activated protein kinase 4 at 10 uM,Inhibition,=,10,%,,CHEMBL2939,MAP kinase p38 delta,Homo sapiens,O15264,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
4,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL810203,Inhibition of Stress activated protein kinase 4 at 10 uM,Inhibition,=,61,%,,CHEMBL2939,MAP kinase p38 delta,Homo sapiens,O15264,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
34,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL818503,Inhibition of c-Jun N-terminal kinase 1 at 10 uM,Inhibition,=,2,%,,CHEMBL2276,c-Jun N-terminal kinase 1,Homo sapiens,P45983,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
4,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL818503,Inhibition of c-Jun N-terminal kinase 1 at 10 uM,Inhibition,=,15,%,,CHEMBL2276,c-Jun N-terminal kinase 1,Homo sapiens,P45983,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
34,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL842644,Inhibition of p56 Lck tyrosine kinase at 10 uM,Inhibition,=,8,%,,CHEMBL258,Tyrosine-protein kinase LCK,Homo sapiens,P06239,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
4,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL842644,Inhibition of p56 Lck tyrosine kinase at 10 uM,Inhibition,=,89,%,,CHEMBL258,Tyrosine-protein kinase LCK,Homo sapiens,P06239,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
11,CHEMBL405021,"InChI=1S/C17H15N3O/c21-17(12-6-7-12)18-16-14-9-8-13(10-15(14)19-20-16)11-4-2-1-3-5-11/h1-5,8-10,12H,6-7H2,(H2,18,19,20,21)",O=C(Nc1n[nH]c2cc(ccc12)c3ccccc3)C4CC4,CHEMBL405021,"InChI=1S/C17H15N3O/c21-17(12-6-7-12)18-16-14-9-8-13(10-15(14)19-20-16)11-4-2-1-3-5-11/h1-5,8-10,12H,6-7H2,(H2,18,19,20,21)",O=C(Nc1n[nH]c2cc(ccc12)c3ccccc3)C4CC4,CHEMBL661128,Inhibitory concentration against cyclin-dependent kinase 2,IC50,>,1000,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
15,CHEMBL103098,"InChI=1S/C17H16N4O3S/c18-25(23,24)13-6-3-10(4-7-13)12-5-8-14-15(9-12)20-21-16(14)19-17(22)11-1-2-11/h3-9,11H,1-2H2,(H2,18,23,24)(H2,19,20,21,22)",NS(=O)(=O)c1ccc(cc1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL103098,"InChI=1S/C17H16N4O3S/c18-25(23,24)13-6-3-10(4-7-13)12-5-8-14-15(9-12)20-21-16(14)19-17(22)11-1-2-11/h3-9,11H,1-2H2,(H2,18,23,24)(H2,19,20,21,22)",NS(=O)(=O)c1ccc(cc1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL661128,Inhibitory concentration against cyclin-dependent kinase 2,IC50,>,1000,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
16,CHEMBL407113,"InChI=1S/C17H16N4O3S/c18-25(23,24)13-3-1-2-11(8-13)12-6-7-14-15(9-12)20-21-16(14)19-17(22)10-4-5-10/h1-3,6-10H,4-5H2,(H2,18,23,24)(H2,19,20,21,22)",NS(=O)(=O)c1cccc(c1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL407113,"InChI=1S/C17H16N4O3S/c18-25(23,24)13-3-1-2-11(8-13)12-6-7-14-15(9-12)20-21-16(14)19-17(22)10-4-5-10/h1-3,6-10H,4-5H2,(H2,18,23,24)(H2,19,20,21,22)",NS(=O)(=O)c1cccc(c1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL661128,Inhibitory concentration against cyclin-dependent kinase 2,IC50,>,1000,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
17,CHEMBL103080,"InChI=1S/C18H18N4O3S/c1-26(24,25)22-14-4-2-3-12(9-14)13-7-8-15-16(10-13)20-21-17(15)19-18(23)11-5-6-11/h2-4,7-11,22H,5-6H2,1H3,(H2,19,20,21,23)",CS(=O)(=O)Nc1cccc(c1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL103080,"InChI=1S/C18H18N4O3S/c1-26(24,25)22-14-4-2-3-12(9-14)13-7-8-15-16(10-13)20-21-17(15)19-18(23)11-5-6-11/h2-4,7-11,22H,5-6H2,1H3,(H2,19,20,21,23)",CS(=O)(=O)Nc1cccc(c1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL661128,Inhibitory concentration against cyclin-dependent kinase 2,IC50,>,1000,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
18,CHEMBL102936,"InChI=1S/C18H18N4O3S/c1-26(24,25)22-14-7-4-11(5-8-14)13-6-9-15-16(10-13)20-21-17(15)19-18(23)12-2-3-12/h4-10,12,22H,2-3H2,1H3,(H2,19,20,21,23)",CS(=O)(=O)Nc1ccc(cc1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL102936,"InChI=1S/C18H18N4O3S/c1-26(24,25)22-14-7-4-11(5-8-14)13-6-9-15-16(10-13)20-21-17(15)19-18(23)12-2-3-12/h4-10,12,22H,2-3H2,1H3,(H2,19,20,21,23)",CS(=O)(=O)Nc1ccc(cc1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL661128,Inhibitory concentration against cyclin-dependent kinase 2,IC50,>,1000,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
21,CHEMBL261440,"InChI=1S/C17H13F2N3O/c18-11-4-6-14(19)13(8-11)10-3-5-12-15(7-10)21-22-16(12)20-17(23)9-1-2-9/h3-9H,1-2H2,(H2,20,21,22,23)",Fc1ccc(F)c(c1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL261440,"InChI=1S/C17H13F2N3O/c18-11-4-6-14(19)13(8-11)10-3-5-12-15(7-10)21-22-16(12)20-17(23)9-1-2-9/h3-9H,1-2H2,(H2,20,21,22,23)",Fc1ccc(F)c(c1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL661128,Inhibitory concentration against cyclin-dependent kinase 2,IC50,>,1000,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
25,CHEMBL419903,"InChI=1S/C17H14FN3O/c18-13-6-3-10(4-7-13)12-5-8-14-15(9-12)20-21-16(14)19-17(22)11-1-2-11/h3-9,11H,1-2H2,(H2,19,20,21,22)",Fc1ccc(cc1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL419903,"InChI=1S/C17H14FN3O/c18-13-6-3-10(4-7-13)12-5-8-14-15(9-12)20-21-16(14)19-17(22)11-1-2-11/h3-9,11H,1-2H2,(H2,19,20,21,22)",Fc1ccc(cc1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL661128,Inhibitory concentration against cyclin-dependent kinase 2,IC50,>,1000,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
33,CHEMBL101804,"InChI=1S/C14H12N4O2/c19-14(8-3-4-8)16-13-9-5-6-10(11-2-1-7-20-11)15-12(9)17-18-13/h1-2,5-8H,3-4H2,(H2,15,16,17,18,19)",O=C(Nc1n[nH]c2nc(ccc12)c3occc3)C4CC4,CHEMBL101804,"InChI=1S/C14H12N4O2/c19-14(8-3-4-8)16-13-9-5-6-10(11-2-1-7-20-11)15-12(9)17-18-13/h1-2,5-8H,3-4H2,(H2,15,16,17,18,19)",O=C(Nc1n[nH]c2nc(ccc12)c3occc3)C4CC4,CHEMBL661128,Inhibitory concentration against cyclin-dependent kinase 2,IC50,>,1000,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
34,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL661128,Inhibitory concentration against cyclin-dependent kinase 2,IC50,>,1000,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
37,CHEMBL101747,"InChI=1S/C19H22BrN5OS/c1-2-25-7-5-12(6-8-25)10-16(26)21-18-13-11-14(20)17(15-4-3-9-27-15)22-19(13)24-23-18/h3-4,9,11-12H,2,5-8,10H2,1H3,(H2,21,22,23,24,26)",CCN1CCC(CC(=O)Nc2n[nH]c3nc(c(Br)cc23)c4cccs4)CC1,CHEMBL101747,"InChI=1S/C19H22BrN5OS/c1-2-25-7-5-12(6-8-25)10-16(26)21-18-13-11-14(20)17(15-4-3-9-27-15)22-19(13)24-23-18/h3-4,9,11-12H,2,5-8,10H2,1H3,(H2,21,22,23,24,26)",CCN1CCC(CC(=O)Nc2n[nH]c3nc(c(Br)cc23)c4cccs4)CC1,CHEMBL661128,Inhibitory concentration against cyclin-dependent kinase 2,IC50,>,1000,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
4,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL661128,Inhibitory concentration against cyclin-dependent kinase 2,IC50,=,5,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
11,CHEMBL405021,"InChI=1S/C17H15N3O/c21-17(12-6-7-12)18-16-14-9-8-13(10-15(14)19-20-16)11-4-2-1-3-5-11/h1-5,8-10,12H,6-7H2,(H2,18,19,20,21)",O=C(Nc1n[nH]c2cc(ccc12)c3ccccc3)C4CC4,CHEMBL405021,"InChI=1S/C17H15N3O/c21-17(12-6-7-12)18-16-14-9-8-13(10-15(14)19-20-16)11-4-2-1-3-5-11/h1-5,8-10,12H,6-7H2,(H2,18,19,20,21)",O=C(Nc1n[nH]c2cc(ccc12)c3ccccc3)C4CC4,CHEMBL686309,Inhibitory concentration against glycogen synthase kinase-3 alpha,IC50,=,498.0,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
15,CHEMBL103098,"InChI=1S/C17H16N4O3S/c18-25(23,24)13-6-3-10(4-7-13)12-5-8-14-15(9-12)20-21-16(14)19-17(22)11-1-2-11/h3-9,11H,1-2H2,(H2,18,23,24)(H2,19,20,21,22)",NS(=O)(=O)c1ccc(cc1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL103098,"InChI=1S/C17H16N4O3S/c18-25(23,24)13-6-3-10(4-7-13)12-5-8-14-15(9-12)20-21-16(14)19-17(22)11-1-2-11/h3-9,11H,1-2H2,(H2,18,23,24)(H2,19,20,21,22)",NS(=O)(=O)c1ccc(cc1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL686309,Inhibitory concentration against glycogen synthase kinase-3 alpha,IC50,>,1000,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
16,CHEMBL407113,"InChI=1S/C17H16N4O3S/c18-25(23,24)13-3-1-2-11(8-13)12-6-7-14-15(9-12)20-21-16(14)19-17(22)10-4-5-10/h1-3,6-10H,4-5H2,(H2,18,23,24)(H2,19,20,21,22)",NS(=O)(=O)c1cccc(c1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL407113,"InChI=1S/C17H16N4O3S/c18-25(23,24)13-3-1-2-11(8-13)12-6-7-14-15(9-12)20-21-16(14)19-17(22)10-4-5-10/h1-3,6-10H,4-5H2,(H2,18,23,24)(H2,19,20,21,22)",NS(=O)(=O)c1cccc(c1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL686309,Inhibitory concentration against glycogen synthase kinase-3 alpha,IC50,=,481.0,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
17,CHEMBL103080,"InChI=1S/C18H18N4O3S/c1-26(24,25)22-14-4-2-3-12(9-14)13-7-8-15-16(10-13)20-21-17(15)19-18(23)11-5-6-11/h2-4,7-11,22H,5-6H2,1H3,(H2,19,20,21,23)",CS(=O)(=O)Nc1cccc(c1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL103080,"InChI=1S/C18H18N4O3S/c1-26(24,25)22-14-4-2-3-12(9-14)13-7-8-15-16(10-13)20-21-17(15)19-18(23)11-5-6-11/h2-4,7-11,22H,5-6H2,1H3,(H2,19,20,21,23)",CS(=O)(=O)Nc1cccc(c1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL686309,Inhibitory concentration against glycogen synthase kinase-3 alpha,IC50,>,1000,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
18,CHEMBL102936,"InChI=1S/C18H18N4O3S/c1-26(24,25)22-14-7-4-11(5-8-14)13-6-9-15-16(10-13)20-21-17(15)19-18(23)12-2-3-12/h4-10,12,22H,2-3H2,1H3,(H2,19,20,21,23)",CS(=O)(=O)Nc1ccc(cc1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL102936,"InChI=1S/C18H18N4O3S/c1-26(24,25)22-14-7-4-11(5-8-14)13-6-9-15-16(10-13)20-21-17(15)19-18(23)12-2-3-12/h4-10,12,22H,2-3H2,1H3,(H2,19,20,21,23)",CS(=O)(=O)Nc1ccc(cc1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL686309,Inhibitory concentration against glycogen synthase kinase-3 alpha,IC50,>,1000,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
21,CHEMBL261440,"InChI=1S/C17H13F2N3O/c18-11-4-6-14(19)13(8-11)10-3-5-12-15(7-10)21-22-16(12)20-17(23)9-1-2-9/h3-9H,1-2H2,(H2,20,21,22,23)",Fc1ccc(F)c(c1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL261440,"InChI=1S/C17H13F2N3O/c18-11-4-6-14(19)13(8-11)10-3-5-12-15(7-10)21-22-16(12)20-17(23)9-1-2-9/h3-9H,1-2H2,(H2,20,21,22,23)",Fc1ccc(F)c(c1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL686309,Inhibitory concentration against glycogen synthase kinase-3 alpha,IC50,>,1000,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
25,CHEMBL419903,"InChI=1S/C17H14FN3O/c18-13-6-3-10(4-7-13)12-5-8-14-15(9-12)20-21-16(14)19-17(22)11-1-2-11/h3-9,11H,1-2H2,(H2,19,20,21,22)",Fc1ccc(cc1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL419903,"InChI=1S/C17H14FN3O/c18-13-6-3-10(4-7-13)12-5-8-14-15(9-12)20-21-16(14)19-17(22)11-1-2-11/h3-9,11H,1-2H2,(H2,19,20,21,22)",Fc1ccc(cc1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL686309,Inhibitory concentration against glycogen synthase kinase-3 alpha,IC50,>,1000,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
33,CHEMBL101804,"InChI=1S/C14H12N4O2/c19-14(8-3-4-8)16-13-9-5-6-10(11-2-1-7-20-11)15-12(9)17-18-13/h1-2,5-8H,3-4H2,(H2,15,16,17,18,19)",O=C(Nc1n[nH]c2nc(ccc12)c3occc3)C4CC4,CHEMBL101804,"InChI=1S/C14H12N4O2/c19-14(8-3-4-8)16-13-9-5-6-10(11-2-1-7-20-11)15-12(9)17-18-13/h1-2,5-8H,3-4H2,(H2,15,16,17,18,19)",O=C(Nc1n[nH]c2nc(ccc12)c3occc3)C4CC4,CHEMBL686309,Inhibitory concentration against glycogen synthase kinase-3 alpha,IC50,=,141,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
34,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL686309,Inhibitory concentration against glycogen synthase kinase-3 alpha,IC50,=,7,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
37,CHEMBL101747,"InChI=1S/C19H22BrN5OS/c1-2-25-7-5-12(6-8-25)10-16(26)21-18-13-11-14(20)17(15-4-3-9-27-15)22-19(13)24-23-18/h3-4,9,11-12H,2,5-8,10H2,1H3,(H2,21,22,23,24,26)",CCN1CCC(CC(=O)Nc2n[nH]c3nc(c(Br)cc23)c4cccs4)CC1,CHEMBL101747,"InChI=1S/C19H22BrN5OS/c1-2-25-7-5-12(6-8-25)10-16(26)21-18-13-11-14(20)17(15-4-3-9-27-15)22-19(13)24-23-18/h3-4,9,11-12H,2,5-8,10H2,1H3,(H2,21,22,23,24,26)",CCN1CCC(CC(=O)Nc2n[nH]c3nc(c(Br)cc23)c4cccs4)CC1,CHEMBL686309,Inhibitory concentration against glycogen synthase kinase-3 alpha,IC50,=,18,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
4,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL686309,Inhibitory concentration against glycogen synthase kinase-3 alpha,IC50,=,0.8,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1136207,"Bioorg. Med. Chem. Lett., 13, p. 3059 (2003)",12941333,Scientific Literature
16,CHEMBL35785,"InChI=1S/C14H12N6O/c21-14(8-3-4-8)16-12-10-6-11(9-2-1-5-15-7-9)17-19-13(10)20-18-12/h1-2,5-8H,3-4H2,(H2,16,18,19,20,21)",O=C(Nc1n[nH]c2nnc(cc12)c3cccnc3)C4CC4,CHEMBL35785,"InChI=1S/C14H12N6O/c21-14(8-3-4-8)16-12-10-6-11(9-2-1-5-15-7-9)17-19-13(10)20-18-12/h1-2,5-8H,3-4H2,(H2,16,18,19,20,21)",O=C(Nc1n[nH]c2nnc(cc12)c3cccnc3)C4CC4,CHEMBL658108,Binding affinity towards cyclin dependent kinase-2 was determined,cKi,=,5,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1136434,"Bioorg. Med. Chem. Lett., 13, p. 1581 (2003)",12699760,Scientific Literature
18,CHEMBL39300,"InChI=1S/C19H20F2N6O/c1-2-27-8-6-11(7-9-27)19(28)22-17-13-10-15(23-25-18(13)26-24-17)12-4-3-5-14(20)16(12)21/h3-5,10-11H,2,6-9H2,1H3,(H2,22,24,25,26,28)",CCN1CCC(CC1)C(=O)Nc2n[nH]c3nnc(cc23)c4cccc(F)c4F,CHEMBL39300,"InChI=1S/C19H20F2N6O/c1-2-27-8-6-11(7-9-27)19(28)22-17-13-10-15(23-25-18(13)26-24-17)12-4-3-5-14(20)16(12)21/h3-5,10-11H,2,6-9H2,1H3,(H2,22,24,25,26,28)",CCN1CCC(CC1)C(=O)Nc2n[nH]c3nnc(cc23)c4cccc(F)c4F,CHEMBL658108,Binding affinity towards cyclin dependent kinase-2 was determined,cKi,=,450,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1136434,"Bioorg. Med. Chem. Lett., 13, p. 1581 (2003)",12699760,Scientific Literature
19,CHEMBL38425,"InChI=1S/C20H22F2N6O/c1-2-28-8-6-12(7-9-28)10-17(29)23-19-14-11-16(24-26-20(14)27-25-19)13-4-3-5-15(21)18(13)22/h3-5,11-12H,2,6-10H2,1H3,(H2,23,25,26,27,29)",CCN1CCC(CC(=O)Nc2n[nH]c3nnc(cc23)c4cccc(F)c4F)CC1,CHEMBL38425,"InChI=1S/C20H22F2N6O/c1-2-28-8-6-12(7-9-28)10-17(29)23-19-14-11-16(24-26-20(14)27-25-19)13-4-3-5-15(21)18(13)22/h3-5,11-12H,2,6-10H2,1H3,(H2,23,25,26,27,29)",CCN1CCC(CC(=O)Nc2n[nH]c3nnc(cc23)c4cccc(F)c4F)CC1,CHEMBL658108,Binding affinity towards cyclin dependent kinase-2 was determined,cKi,=,540,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1136434,"Bioorg. Med. Chem. Lett., 13, p. 1581 (2003)",12699760,Scientific Literature
16,CHEMBL35785,"InChI=1S/C14H12N6O/c21-14(8-3-4-8)16-12-10-6-11(9-2-1-5-15-7-9)17-19-13(10)20-18-12/h1-2,5-8H,3-4H2,(H2,16,18,19,20,21)",O=C(Nc1n[nH]c2nnc(cc12)c3cccnc3)C4CC4,CHEMBL35785,"InChI=1S/C14H12N6O/c21-14(8-3-4-8)16-12-10-6-11(9-2-1-5-15-7-9)17-19-13(10)20-18-12/h1-2,5-8H,3-4H2,(H2,16,18,19,20,21)",O=C(Nc1n[nH]c2nnc(cc12)c3cccnc3)C4CC4,CHEMBL686314,Binding affinity towards glycogen synthase kinase-3 alpha (GSK-3alpha) was determined,cKi,=,0.08,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1136434,"Bioorg. Med. Chem. Lett., 13, p. 1581 (2003)",12699760,Scientific Literature
18,CHEMBL39300,"InChI=1S/C19H20F2N6O/c1-2-27-8-6-11(7-9-27)19(28)22-17-13-10-15(23-25-18(13)26-24-17)12-4-3-5-14(20)16(12)21/h3-5,10-11H,2,6-9H2,1H3,(H2,22,24,25,26,28)",CCN1CCC(CC1)C(=O)Nc2n[nH]c3nnc(cc23)c4cccc(F)c4F,CHEMBL39300,"InChI=1S/C19H20F2N6O/c1-2-27-8-6-11(7-9-27)19(28)22-17-13-10-15(23-25-18(13)26-24-17)12-4-3-5-14(20)16(12)21/h3-5,10-11H,2,6-9H2,1H3,(H2,22,24,25,26,28)",CCN1CCC(CC1)C(=O)Nc2n[nH]c3nnc(cc23)c4cccc(F)c4F,CHEMBL686314,Binding affinity towards glycogen synthase kinase-3 alpha (GSK-3alpha) was determined,cKi,=,0.95,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1136434,"Bioorg. Med. Chem. Lett., 13, p. 1581 (2003)",12699760,Scientific Literature
19,CHEMBL38425,"InChI=1S/C20H22F2N6O/c1-2-28-8-6-12(7-9-28)10-17(29)23-19-14-11-16(24-26-20(14)27-25-19)13-4-3-5-15(21)18(13)22/h3-5,11-12H,2,6-10H2,1H3,(H2,23,25,26,27,29)",CCN1CCC(CC(=O)Nc2n[nH]c3nnc(cc23)c4cccc(F)c4F)CC1,CHEMBL38425,"InChI=1S/C20H22F2N6O/c1-2-28-8-6-12(7-9-28)10-17(29)23-19-14-11-16(24-26-20(14)27-25-19)13-4-3-5-15(21)18(13)22/h3-5,11-12H,2,6-10H2,1H3,(H2,23,25,26,27,29)",CCN1CCC(CC(=O)Nc2n[nH]c3nnc(cc23)c4cccc(F)c4F)CC1,CHEMBL686314,Binding affinity towards glycogen synthase kinase-3 alpha (GSK-3alpha) was determined,cKi,=,0.19,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1136434,"Bioorg. Med. Chem. Lett., 13, p. 1581 (2003)",12699760,Scientific Literature
13,CHEMBL406125,"InChI=1S/C18H20N6O/c1-24-9-7-13(8-10-24)18(25)19-16-14-11-15(12-5-3-2-4-6-12)20-22-17(14)23-21-16/h2-6,11,13H,7-10H2,1H3,(H2,19,21,22,23,25)",CN1CCC(CC1)C(=O)Nc2n[nH]c3nnc(cc23)c4ccccc4,CHEMBL406125,"InChI=1S/C18H20N6O/c1-24-9-7-13(8-10-24)18(25)19-16-14-11-15(12-5-3-2-4-6-12)20-22-17(14)23-21-16/h2-6,11,13H,7-10H2,1H3,(H2,19,21,22,23,25)",CN1CCC(CC1)C(=O)Nc2n[nH]c3nnc(cc23)c4ccccc4,CHEMBL686307,Inhibition of human glycogen synthase kinase-3alpha (hGSK-3),IC50,=,9,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1136434,"Bioorg. Med. Chem. Lett., 13, p. 1581 (2003)",12699760,Scientific Literature
16,CHEMBL35785,"InChI=1S/C14H12N6O/c21-14(8-3-4-8)16-12-10-6-11(9-2-1-5-15-7-9)17-19-13(10)20-18-12/h1-2,5-8H,3-4H2,(H2,16,18,19,20,21)",O=C(Nc1n[nH]c2nnc(cc12)c3cccnc3)C4CC4,CHEMBL35785,"InChI=1S/C14H12N6O/c21-14(8-3-4-8)16-12-10-6-11(9-2-1-5-15-7-9)17-19-13(10)20-18-12/h1-2,5-8H,3-4H2,(H2,16,18,19,20,21)",O=C(Nc1n[nH]c2nnc(cc12)c3cccnc3)C4CC4,CHEMBL843755,Selectivity ratio between CDK-2 to GSK-3,Ratio,=,62,,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1136434,"Bioorg. Med. Chem. Lett., 13, p. 1581 (2003)",12699760,Scientific Literature
18,CHEMBL39300,"InChI=1S/C19H20F2N6O/c1-2-27-8-6-11(7-9-27)19(28)22-17-13-10-15(23-25-18(13)26-24-17)12-4-3-5-14(20)16(12)21/h3-5,10-11H,2,6-9H2,1H3,(H2,22,24,25,26,28)",CCN1CCC(CC1)C(=O)Nc2n[nH]c3nnc(cc23)c4cccc(F)c4F,CHEMBL39300,"InChI=1S/C19H20F2N6O/c1-2-27-8-6-11(7-9-27)19(28)22-17-13-10-15(23-25-18(13)26-24-17)12-4-3-5-14(20)16(12)21/h3-5,10-11H,2,6-9H2,1H3,(H2,22,24,25,26,28)",CCN1CCC(CC1)C(=O)Nc2n[nH]c3nnc(cc23)c4cccc(F)c4F,CHEMBL843755,Selectivity ratio between CDK-2 to GSK-3,Ratio,=,474.0,,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1136434,"Bioorg. Med. Chem. Lett., 13, p. 1581 (2003)",12699760,Scientific Literature
19,CHEMBL38425,"InChI=1S/C20H22F2N6O/c1-2-28-8-6-12(7-9-28)10-17(29)23-19-14-11-16(24-26-20(14)27-25-19)13-4-3-5-15(21)18(13)22/h3-5,11-12H,2,6-10H2,1H3,(H2,23,25,26,27,29)",CCN1CCC(CC(=O)Nc2n[nH]c3nnc(cc23)c4cccc(F)c4F)CC1,CHEMBL38425,"InChI=1S/C20H22F2N6O/c1-2-28-8-6-12(7-9-28)10-17(29)23-19-14-11-16(24-26-20(14)27-25-19)13-4-3-5-15(21)18(13)22/h3-5,11-12H,2,6-10H2,1H3,(H2,23,25,26,27,29)",CCN1CCC(CC(=O)Nc2n[nH]c3nnc(cc23)c4cccc(F)c4F)CC1,CHEMBL843755,Selectivity ratio between CDK-2 to GSK-3,Ratio,=,2842.0,,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1136434,"Bioorg. Med. Chem. Lett., 13, p. 1581 (2003)",12699760,Scientific Literature
C10,CHEMBL1794054,"InChI=1S/C21H19N5O3S/c22-30(28,29)17-8-6-16(7-9-17)25-26-20-19-15(2-1-3-18(19)24-21(20)27)5-4-14-10-12-23-13-11-14/h1-3,6-13,25H,4-5H2,(H2,22,28,29)(H,24,26,27)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3cccc(CCc4ccncc4)c23)cc1,CHEMBL1794054,"InChI=1S/C21H19N5O3S/c22-30(28,29)17-8-6-16(7-9-17)25-26-20-19-15(2-1-3-18(19)24-21(20)27)5-4-14-10-12-23-13-11-14/h1-3,6-13,25H,4-5H2,(H2,22,28,29)(H,24,26,27)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3cccc(CCc4ccncc4)c23)cc1,CHEMBL661123,Evaluated for inhibition of human cyclin dependent kinase 2,IC50,=,21,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1137075,"J. Med. Chem., 47, p. 2534 (2004)",15115396,Scientific Literature
C16,CHEMBL270054,"InChI=1S/C14H11ClN4O3S/c15-8-1-6-12-11(7-8)13(14(20)17-12)19-18-9-2-4-10(5-3-9)23(16,21)22/h1-7,18H,(H2,16,21,22)(H,17,19,20)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(Cl)cc23)cc1,CHEMBL270054,"InChI=1S/C14H11ClN4O3S/c15-8-1-6-12-11(7-8)13(14(20)17-12)19-18-9-2-4-10(5-3-9)23(16,21)22/h1-7,18H,(H2,16,21,22)(H,17,19,20)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(Cl)cc23)cc1,CHEMBL661123,Evaluated for inhibition of human cyclin dependent kinase 2,IC50,=,43,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1137075,"J. Med. Chem., 47, p. 2534 (2004)",15115396,Scientific Literature
C19,CHEMBL271843,"InChI=1S/C15H14N4O3S/c1-9-2-7-13-12(8-9)14(15(20)17-13)19-18-10-3-5-11(6-4-10)23(16,21)22/h2-8,18H,1H3,(H2,16,21,22)(H,17,19,20)",Cc1ccc2NC(=O)\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL271843,"InChI=1S/C15H14N4O3S/c1-9-2-7-13-12(8-9)14(15(20)17-13)19-18-10-3-5-11(6-4-10)23(16,21)22/h2-8,18H,1H3,(H2,16,21,22)(H,17,19,20)",Cc1ccc2NC(=O)\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL661123,Evaluated for inhibition of human cyclin dependent kinase 2,IC50,=,46,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1137075,"J. Med. Chem., 47, p. 2534 (2004)",15115396,Scientific Literature
C28,CHEMBL272165,"InChI=1S/C21H18N6O4S/c22-32(30,31)16-4-2-15(3-5-16)26-27-19-17-11-14(1-6-18(17)25-21(19)29)20(28)24-12-13-7-9-23-10-8-13/h1-11,26H,12H2,(H,24,28)(H2,22,30,31)(H,25,27,29)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)C(=O)NCc4ccncc4)cc1,CHEMBL272165,"InChI=1S/C21H18N6O4S/c22-32(30,31)16-4-2-15(3-5-16)26-27-19-17-11-14(1-6-18(17)25-21(19)29)20(28)24-12-13-7-9-23-10-8-13/h1-11,26H,12H2,(H,24,28)(H2,22,30,31)(H,25,27,29)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)C(=O)NCc4ccncc4)cc1,CHEMBL661123,Evaluated for inhibition of human cyclin dependent kinase 2,IC50,=,8.9,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1137075,"J. Med. Chem., 47, p. 2534 (2004)",15115396,Scientific Literature
C30,CHEMBL269827,"InChI=1S/C17H13N5O4S/c18-27(24,25)12-4-2-11(3-5-12)21-22-16-13-7-10(15-8-19-9-26-15)1-6-14(13)20-17(16)23/h1-9,21H,(H2,18,24,25)(H,20,22,23)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)c4ocnc4)cc1,CHEMBL269827,"InChI=1S/C17H13N5O4S/c18-27(24,25)12-4-2-11(3-5-12)21-22-16-13-7-10(15-8-19-9-26-15)1-6-14(13)20-17(16)23/h1-9,21H,(H2,18,24,25)(H,20,22,23)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)c4ocnc4)cc1,CHEMBL661123,Evaluated for inhibition of human cyclin dependent kinase 2,IC50,=,2.3,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1137075,"J. Med. Chem., 47, p. 2534 (2004)",15115396,Scientific Literature
C33,CHEMBL271594,"InChI=1S/C17H18N4O3S/c1-10(2)11-3-8-14-15(9-11)19-17(22)16(14)21-20-12-4-6-13(7-5-12)25(18,23)24/h3-10,20H,1-2H3,(H2,18,23,24)(H,19,21,22)",CC(C)c1ccc2\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\C(=O)Nc2c1,CHEMBL271594,"InChI=1S/C17H18N4O3S/c1-10(2)11-3-8-14-15(9-11)19-17(22)16(14)21-20-12-4-6-13(7-5-12)25(18,23)24/h3-10,20H,1-2H3,(H2,18,23,24)(H,19,21,22)",CC(C)c1ccc2\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\C(=O)Nc2c1,CHEMBL661123,Evaluated for inhibition of human cyclin dependent kinase 2,IC50,=,75,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1137075,"J. Med. Chem., 47, p. 2534 (2004)",15115396,Scientific Literature
C6,CHEMBL270544,"InChI=1S/C18H18N4O3S/c1-11(2)10-12-4-3-5-15-16(12)17(18(23)20-15)22-21-13-6-8-14(9-7-13)26(19,24)25/h3-10,21H,1-2H3,(H2,19,24,25)(H,20,22,23)",CC(=Cc1cccc2NC(=O)\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\c12)C,CHEMBL270544,"InChI=1S/C18H18N4O3S/c1-11(2)10-12-4-3-5-15-16(12)17(18(23)20-15)22-21-13-6-8-14(9-7-13)26(19,24)25/h3-10,21H,1-2H3,(H2,19,24,25)(H,20,22,23)",CC(=Cc1cccc2NC(=O)\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\c12)C,CHEMBL661123,Evaluated for inhibition of human cyclin dependent kinase 2,IC50,=,1.5,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1137075,"J. Med. Chem., 47, p. 2534 (2004)",15115396,Scientific Literature
C42,CHEMBL405042,"InChI=1S/C16H15N3O3S/c1-10(15-13-4-2-3-5-14(13)19-16(15)20)18-11-6-8-12(9-7-11)23(17,21)22/h2-9,18H,1H3,(H,19,20)(H2,17,21,22)/b15-10-",C\C(=C/1\C(=O)Nc2ccccc12)\Nc3ccc(cc3)S(=O)(=O)N,CHEMBL405042,"InChI=1S/C16H15N3O3S/c1-10(15-13-4-2-3-5-14(13)19-16(15)20)18-11-6-8-12(9-7-11)23(17,21)22/h2-9,18H,1H3,(H,19,20)(H2,17,21,22)/b15-10-",C\C(=C/1\C(=O)Nc2ccccc12)\Nc3ccc(cc3)S(=O)(=O)N,CHEMBL661124,Evaluated for inhibition of human cyclin dependent kinase 2 (CDK2),IC50,=,360,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1137075,"J. Med. Chem., 47, p. 2534 (2004)",15115396,Scientific Literature
C45,CHEMBL272414,"InChI=1S/C17H18N4O3S/c1-21(2)12-5-8-16-14(9-12)15(17(22)20-16)10-19-11-3-6-13(7-4-11)25(18,23)24/h3-10,19H,1-2H3,(H,20,22)(H2,18,23,24)/b15-10-",CN(C)c1ccc2NC(=O)\C(=C/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL272414,"InChI=1S/C17H18N4O3S/c1-21(2)12-5-8-16-14(9-12)15(17(22)20-16)10-19-11-3-6-13(7-4-11)25(18,23)24/h3-10,19H,1-2H3,(H,20,22)(H2,18,23,24)/b15-10-",CN(C)c1ccc2NC(=O)\C(=C/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL661124,Evaluated for inhibition of human cyclin dependent kinase 2 (CDK2),IC50,=,310,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1137075,"J. Med. Chem., 47, p. 2534 (2004)",15115396,Scientific Literature
C50,CHEMBL1794055,"InChI=1S/C16H12N4O3S2/c17-25(22,23)10-3-1-9(2-4-10)18-7-11-14-12(20-16(11)21)5-6-13-15(14)24-8-19-13/h1-8,18H,(H,20,21)(H2,17,22,23)",NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c23)cc1,CHEMBL1794055,"InChI=1S/C16H12N4O3S2/c17-25(22,23)10-3-1-9(2-4-10)18-7-11-14-12(20-16(11)21)5-6-13-15(14)24-8-19-13/h1-8,18H,(H,20,21)(H2,17,22,23)",NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c23)cc1,CHEMBL661124,Evaluated for inhibition of human cyclin dependent kinase 2 (CDK2),IC50,=,2.8,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1137075,"J. Med. Chem., 47, p. 2534 (2004)",15115396,Scientific Literature
17,CHEMBL182283,"InChI=1S/C17H15N3O2/c1-10-2-4-11(5-3-10)14-8-13-15(18-9-19-17(13)22-14)20-16(21)12-6-7-12/h2-5,8-9,12H,6-7H2,1H3,(H,18,19,20,21)",Cc1ccc(cc1)c2oc3ncnc(NC(=O)C4CC4)c3c2,CHEMBL182283,"InChI=1S/C17H15N3O2/c1-10-2-4-11(5-3-10)14-8-13-15(18-9-19-17(13)22-14)20-16(21)12-6-7-12/h2-5,8-9,12H,6-7H2,1H3,(H,18,19,20,21)",Cc1ccc(cc1)c2oc3ncnc(NC(=O)C4CC4)c3c2,CHEMBL828499,Inhibition of cyclin-dependent kinase 2,IC50,>,21000,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1137112,"Bioorg. Med. Chem. Lett., 14, p. 3907 (2004)",15225695,Scientific Literature
17,CHEMBL182283,"InChI=1S/C17H15N3O2/c1-10-2-4-11(5-3-10)14-8-13-15(18-9-19-17(13)22-14)20-16(21)12-6-7-12/h2-5,8-9,12H,6-7H2,1H3,(H,18,19,20,21)",Cc1ccc(cc1)c2oc3ncnc(NC(=O)C4CC4)c3c2,CHEMBL182283,"InChI=1S/C17H15N3O2/c1-10-2-4-11(5-3-10)14-8-13-15(18-9-19-17(13)22-14)20-16(21)12-6-7-12/h2-5,8-9,12H,6-7H2,1H3,(H,18,19,20,21)",Cc1ccc(cc1)c2oc3ncnc(NC(=O)C4CC4)c3c2,CHEMBL827786,Inhibition of human Glycogen synthase kinase-3 beta,IC50,=,610,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1137112,"Bioorg. Med. Chem. Lett., 14, p. 3907 (2004)",15225695,Scientific Literature
30,CHEMBL374680,"InChI=1S/C21H18N6/c1-14-9-17(20-5-3-4-8-23-20)10-15(2)19(14)7-6-16-11-18(13-22-12-16)21-24-26-27-25-21/h3-13H,1-2H3,(H,24,25,26,27)/b7-6+",Cc1cc(cc(C)c1\C=C\c2cncc(c2)c3nn[nH]n3)c4ccccn4,CHEMBL374680,"InChI=1S/C21H18N6/c1-14-9-17(20-5-3-4-8-23-20)10-15(2)19(14)7-6-16-11-18(13-22-12-16)21-24-26-27-25-21/h3-13H,1-2H3,(H,24,25,26,27)/b7-6+",Cc1cc(cc(C)c1\C=C\c2cncc(c2)c3nn[nH]n3)c4ccccn4,CHEMBL907114,Inhibition of JNK3,Activity,,,,Not Active,CHEMBL2637,c-Jun N-terminal kinase 3,Homo sapiens,P53779,CHEMBL1137278,"Bioorg. Med. Chem. Lett., 16, p. 5378 (2006)",16890436,Scientific Literature
8,CHEMBL218791,"InChI=1S/C16H15N5O/c1-10-5-14(22)6-11(2)15(10)4-3-12-7-13(9-17-8-12)16-18-20-21-19-16/h3-9,22H,1-2H3,(H,18,19,20,21)/b4-3+",Cc1cc(O)cc(C)c1\C=C\c2cncc(c2)c3nn[nH]n3,CHEMBL218791,"InChI=1S/C16H15N5O/c1-10-5-14(22)6-11(2)15(10)4-3-12-7-13(9-17-8-12)16-18-20-21-19-16/h3-9,22H,1-2H3,(H,18,19,20,21)/b4-3+",Cc1cc(O)cc(C)c1\C=C\c2cncc(c2)c3nn[nH]n3,CHEMBL907114,Inhibition of JNK3,Activity,,,,Not Active,CHEMBL2637,c-Jun N-terminal kinase 3,Homo sapiens,P53779,CHEMBL1137278,"Bioorg. Med. Chem. Lett., 16, p. 5378 (2006)",16890436,Scientific Literature
30,CHEMBL374680,"InChI=1S/C21H18N6/c1-14-9-17(20-5-3-4-8-23-20)10-15(2)19(14)7-6-16-11-18(13-22-12-16)21-24-26-27-25-21/h3-13H,1-2H3,(H,24,25,26,27)/b7-6+",Cc1cc(cc(C)c1\C=C\c2cncc(c2)c3nn[nH]n3)c4ccccn4,CHEMBL374680,"InChI=1S/C21H18N6/c1-14-9-17(20-5-3-4-8-23-20)10-15(2)19(14)7-6-16-11-18(13-22-12-16)21-24-26-27-25-21/h3-13H,1-2H3,(H,24,25,26,27)/b7-6+",Cc1cc(cc(C)c1\C=C\c2cncc(c2)c3nn[nH]n3)c4ccccn4,CHEMBL856503,Inhibition of LYN at 10 uM,Activity,,,,Active,CHEMBL3905,Tyrosine-protein kinase Lyn ,Homo sapiens,P07948,CHEMBL1137278,"Bioorg. Med. Chem. Lett., 16, p. 5378 (2006)",16890436,Scientific Literature
30,CHEMBL374680,"InChI=1S/C21H18N6/c1-14-9-17(20-5-3-4-8-23-20)10-15(2)19(14)7-6-16-11-18(13-22-12-16)21-24-26-27-25-21/h3-13H,1-2H3,(H,24,25,26,27)/b7-6+",Cc1cc(cc(C)c1\C=C\c2cncc(c2)c3nn[nH]n3)c4ccccn4,CHEMBL374680,"InChI=1S/C21H18N6/c1-14-9-17(20-5-3-4-8-23-20)10-15(2)19(14)7-6-16-11-18(13-22-12-16)21-24-26-27-25-21/h3-13H,1-2H3,(H,24,25,26,27)/b7-6+",Cc1cc(cc(C)c1\C=C\c2cncc(c2)c3nn[nH]n3)c4ccccn4,CHEMBL856504,Inhibition of SRC kinase at 10 uM,Activity,,,,Active,CHEMBL267,Tyrosine-protein kinase SRC,Homo sapiens,P12931,CHEMBL1137278,"Bioorg. Med. Chem. Lett., 16, p. 5378 (2006)",16890436,Scientific Literature
8,CHEMBL218791,"InChI=1S/C16H15N5O/c1-10-5-14(22)6-11(2)15(10)4-3-12-7-13(9-17-8-12)16-18-20-21-19-16/h3-9,22H,1-2H3,(H,18,19,20,21)/b4-3+",Cc1cc(O)cc(C)c1\C=C\c2cncc(c2)c3nn[nH]n3,CHEMBL218791,"InChI=1S/C16H15N5O/c1-10-5-14(22)6-11(2)15(10)4-3-12-7-13(9-17-8-12)16-18-20-21-19-16/h3-9,22H,1-2H3,(H,18,19,20,21)/b4-3+",Cc1cc(O)cc(C)c1\C=C\c2cncc(c2)c3nn[nH]n3,CHEMBL856507,Inhibition of c-RAF,IC50,=,4,nM,,CHEMBL1906,Serine/threonine-protein kinase RAF,Homo sapiens,P04049,CHEMBL1137278,"Bioorg. Med. Chem. Lett., 16, p. 5378 (2006)",16890436,Scientific Literature
8,CHEMBL218791,"InChI=1S/C16H15N5O/c1-10-5-14(22)6-11(2)15(10)4-3-12-7-13(9-17-8-12)16-18-20-21-19-16/h3-9,22H,1-2H3,(H,18,19,20,21)/b4-3+",Cc1cc(O)cc(C)c1\C=C\c2cncc(c2)c3nn[nH]n3,CHEMBL218791,"InChI=1S/C16H15N5O/c1-10-5-14(22)6-11(2)15(10)4-3-12-7-13(9-17-8-12)16-18-20-21-19-16/h3-9,22H,1-2H3,(H,18,19,20,21)/b4-3+",Cc1cc(O)cc(C)c1\C=C\c2cncc(c2)c3nn[nH]n3,CHEMBL856508,Inhibition of mouse FYN,IC50,=,40,nM,,CHEMBL4517,Tyrosine-protein kinase FYN,Mus musculus,P39688,CHEMBL1137278,"Bioorg. Med. Chem. Lett., 16, p. 5378 (2006)",16890436,Scientific Literature
30,CHEMBL374680,"InChI=1S/C21H18N6/c1-14-9-17(20-5-3-4-8-23-20)10-15(2)19(14)7-6-16-11-18(13-22-12-16)21-24-26-27-25-21/h3-13H,1-2H3,(H,24,25,26,27)/b7-6+",Cc1cc(cc(C)c1\C=C\c2cncc(c2)c3nn[nH]n3)c4ccccn4,CHEMBL374680,"InChI=1S/C21H18N6/c1-14-9-17(20-5-3-4-8-23-20)10-15(2)19(14)7-6-16-11-18(13-22-12-16)21-24-26-27-25-21/h3-13H,1-2H3,(H,24,25,26,27)/b7-6+",Cc1cc(cc(C)c1\C=C\c2cncc(c2)c3nn[nH]n3)c4ccccn4,CHEMBL856501,Inhibition of mouse FYN at 10 uM,Activity,,,,Active,CHEMBL4517,Tyrosine-protein kinase FYN,Mus musculus,P39688,CHEMBL1137278,"Bioorg. Med. Chem. Lett., 16, p. 5378 (2006)",16890436,Scientific Literature
30,CHEMBL374680,"InChI=1S/C21H18N6/c1-14-9-17(20-5-3-4-8-23-20)10-15(2)19(14)7-6-16-11-18(13-22-12-16)21-24-26-27-25-21/h3-13H,1-2H3,(H,24,25,26,27)/b7-6+",Cc1cc(cc(C)c1\C=C\c2cncc(c2)c3nn[nH]n3)c4ccccn4,CHEMBL374680,"InChI=1S/C21H18N6/c1-14-9-17(20-5-3-4-8-23-20)10-15(2)19(14)7-6-16-11-18(13-22-12-16)21-24-26-27-25-21/h3-13H,1-2H3,(H,24,25,26,27)/b7-6+",Cc1cc(cc(C)c1\C=C\c2cncc(c2)c3nn[nH]n3)c4ccccn4,CHEMBL856502,Inhibition of mouse LCK at 10 uM,Activity,,,,Active,CHEMBL2480,Tyrosine-protein kinase LCK,Mus musculus,P06240,CHEMBL1137278,"Bioorg. Med. Chem. Lett., 16, p. 5378 (2006)",16890436,Scientific Literature
23,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL899824,Inhibition of AKT1,IC50,>,30000,nM,,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,P31749,CHEMBL1137478,"Bioorg. Med. Chem. Lett., 17, p. 5514 (2007)",17826092,Scientific Literature
23,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL899823,Inhibition of ALK5,IC50,=,296,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1137478,"Bioorg. Med. Chem. Lett., 17, p. 5514 (2007)",17826092,Scientific Literature
23,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL899836,Inhibition of Abl kinase,IC50,>,30000,nM,,CHEMBL1862,Tyrosine-protein kinase ABL,Homo sapiens,P00519,CHEMBL1137478,"Bioorg. Med. Chem. Lett., 17, p. 5514 (2007)",17826092,Scientific Literature
23,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL899840,Inhibition of CDK2,IC50,>,30000,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1137478,"Bioorg. Med. Chem. Lett., 17, p. 5514 (2007)",17826092,Scientific Literature
23,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL899834,Inhibition of FGFR1,IC50,=,9700,nM,,CHEMBL3650,Fibroblast growth factor receptor 1,Homo sapiens,P11362,CHEMBL1137478,"Bioorg. Med. Chem. Lett., 17, p. 5514 (2007)",17826092,Scientific Literature
23,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL899829,Inhibition of FLT3,IC50,>,30000,nM,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,Homo sapiens,P36888,CHEMBL1137478,"Bioorg. Med. Chem. Lett., 17, p. 5514 (2007)",17826092,Scientific Literature
23,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL899821,Inhibition of GSK3,IC50,>,30000,nM,,CHEMBL612545,,,,CHEMBL1137478,"Bioorg. Med. Chem. Lett., 17, p. 5514 (2007)",17826092,Scientific Literature
23,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL899827,Inhibition of IGFR1,IC50,>,30000,nM,,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1137478,"Bioorg. Med. Chem. Lett., 17, p. 5514 (2007)",17826092,Scientific Literature
23,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL899828,Inhibition of INSR,IC50,>,30000,nM,,CHEMBL1981,Insulin receptor,Homo sapiens,P06213,CHEMBL1137478,"Bioorg. Med. Chem. Lett., 17, p. 5514 (2007)",17826092,Scientific Literature
23,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL899830,Inhibition of KIT,IC50,>,30000,nM,,CHEMBL1936,Stem cell growth factor receptor,Homo sapiens,P10721,CHEMBL1137478,"Bioorg. Med. Chem. Lett., 17, p. 5514 (2007)",17826092,Scientific Literature
23,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL899835,Inhibition of MET,IC50,>,30000,nM,,CHEMBL3717,Hepatocyte growth factor receptor,Homo sapiens,P08581,CHEMBL1137478,"Bioorg. Med. Chem. Lett., 17, p. 5514 (2007)",17826092,Scientific Literature
23,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL899831,Inhibition of PDGFRalpha,IC50,>,30000,nM,,CHEMBL2007,Platelet-derived growth factor receptor alpha ,Homo sapiens,P16234,CHEMBL1137478,"Bioorg. Med. Chem. Lett., 17, p. 5514 (2007)",17826092,Scientific Literature
23,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL899832,Inhibition of PDGFRbeta,IC50,>,30000,nM,,CHEMBL1913,Platelet-derived growth factor receptor beta,Homo sapiens,P09619,CHEMBL1137478,"Bioorg. Med. Chem. Lett., 17, p. 5514 (2007)",17826092,Scientific Literature
23,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL899837,Inhibition of PKCbeta1,IC50,>,30000,nM,,CHEMBL3045,Protein kinase C beta,Homo sapiens,P05771,CHEMBL1137478,"Bioorg. Med. Chem. Lett., 17, p. 5514 (2007)",17826092,Scientific Literature
2,CHEMBL399410,"InChI=1S/C27H23N3O2S/c1-30-26(22-5-4-21-17-23(32-2)9-6-20(21)16-22)25(18-12-14-28-15-13-18)29-27(30)19-7-10-24(11-8-19)33(3)31/h4-17H,1-3H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4)S(=O)C)n3C)c5ccncc5,CHEMBL399410,"InChI=1S/C27H23N3O2S/c1-30-26(22-5-4-21-17-23(32-2)9-6-20(21)16-22)25(18-12-14-28-15-13-18)29-27(30)19-7-10-24(11-8-19)33(3)31/h4-17H,1-3H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4)S(=O)C)n3C)c5ccncc5,CHEMBL899826,Inhibition of Tie2,IC50,=,60,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1137478,"Bioorg. Med. Chem. Lett., 17, p. 5514 (2007)",17826092,Scientific Literature
23,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL899826,Inhibition of Tie2,IC50,=,12,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1137478,"Bioorg. Med. Chem. Lett., 17, p. 5514 (2007)",17826092,Scientific Literature
24,CHEMBL237571,"InChI=1S/C28H25N3O3S/c1-18-15-24(35(4,32)33)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(34-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)(=O)C)n3C)c5ccncc5,CHEMBL237571,"InChI=1S/C28H25N3O3S/c1-18-15-24(35(4,32)33)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(34-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)(=O)C)n3C)c5ccncc5,CHEMBL899826,Inhibition of Tie2,IC50,=,114,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1137478,"Bioorg. Med. Chem. Lett., 17, p. 5514 (2007)",17826092,Scientific Literature
23,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL899833,Inhibition of VEGFR2,IC50,=,1500,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1137478,"Bioorg. Med. Chem. Lett., 17, p. 5514 (2007)",17826092,Scientific Literature
23,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL897616,"Inhibition of bFGF-stimulated angiogenesis in Matrigel mouse model at 25 mg/kg, po after 6 days",Inhibition,=,35,%,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1137478,"Bioorg. Med. Chem. Lett., 17, p. 5514 (2007)",17826092,Scientific Literature
23,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL897617,"Inhibition of bFGF-stimulated angiogenesis in Matrigel mouse model at 50 mg/kg, po after 6 days",Inhibition,=,80,%,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1137478,"Bioorg. Med. Chem. Lett., 17, p. 5514 (2007)",17826092,Scientific Literature
23,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL899839,Inhibition of cFMS,IC50,=,550,nM,,CHEMBL1844,Macrophage colony stimulating factor  receptor ,Homo sapiens,P07333,CHEMBL1137478,"Bioorg. Med. Chem. Lett., 17, p. 5514 (2007)",17826092,Scientific Literature
23,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL899838,Inhibition of mitogen-activated protein kinase p38,IC50,=,4100,nM,,CHEMBL612545,,,,CHEMBL1137478,"Bioorg. Med. Chem. Lett., 17, p. 5514 (2007)",17826092,Scientific Literature
23,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL899822,Selectivity for Tie2 over ALK5,Selectivity ratio,=,25,,,CHEMBL612545,,,,CHEMBL1137478,"Bioorg. Med. Chem. Lett., 17, p. 5514 (2007)",17826092,Scientific Literature
23,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL897618,Selectivity for Tie2 over cfms,Selectivity ratio,=,50,,,CHEMBL612545,,,,CHEMBL1137478,"Bioorg. Med. Chem. Lett., 17, p. 5514 (2007)",17826092,Scientific Literature
33,CHEMBL395358,"InChI=1S/C21H17N3O/c1-14-5-7-16(25)13-20(14)24-19-9-11-23-21-12-15(6-8-17(19)21)18-4-2-3-10-22-18/h2-13,25H,1H3,(H,23,24)",Cc1ccc(O)cc1Nc2ccnc3cc(ccc23)c4ccccn4,CHEMBL395358,"InChI=1S/C21H17N3O/c1-14-5-7-16(25)13-20(14)24-19-9-11-23-21-12-15(6-8-17(19)21)18-4-2-3-10-22-18/h2-13,25H,1H3,(H,23,24)",Cc1ccc(O)cc1Nc2ccnc3cc(ccc23)c4ccccn4,CHEMBL899077,Inhibition of RET kinase in Sf9 cells,IC50,=,75,nM,,CHEMBL2041,Tyrosine-protein kinase receptor RET,Homo sapiens,P07949,CHEMBL1137530,"Bioorg. Med. Chem. Lett., 17, p. 5886 (2007)",17884497,Scientific Literature
38,CHEMBL237347,"InChI=1S/C17H16N2O3S/c1-11-3-4-12(20)9-17(11)19-16-7-8-18-15-6-5-13(10-14(15)16)23(2,21)22/h3-10,20H,1-2H3,(H,18,19)",Cc1ccc(O)cc1Nc2ccnc3ccc(cc23)S(=O)(=O)C,CHEMBL237347,"InChI=1S/C17H16N2O3S/c1-11-3-4-12(20)9-17(11)19-16-7-8-18-15-6-5-13(10-14(15)16)23(2,21)22/h3-10,20H,1-2H3,(H,18,19)",Cc1ccc(O)cc1Nc2ccnc3ccc(cc23)S(=O)(=O)C,CHEMBL899077,Inhibition of RET kinase in Sf9 cells,IC50,=,3,nM,,CHEMBL2041,Tyrosine-protein kinase receptor RET,Homo sapiens,P07949,CHEMBL1137530,"Bioorg. Med. Chem. Lett., 17, p. 5886 (2007)",17884497,Scientific Literature
38,CHEMBL237347,"InChI=1S/C17H16N2O3S/c1-11-3-4-12(20)9-17(11)19-16-7-8-18-15-6-5-13(10-14(15)16)23(2,21)22/h3-10,20H,1-2H3,(H,18,19)",Cc1ccc(O)cc1Nc2ccnc3ccc(cc23)S(=O)(=O)C,CHEMBL237347,"InChI=1S/C17H16N2O3S/c1-11-3-4-12(20)9-17(11)19-16-7-8-18-15-6-5-13(10-14(15)16)23(2,21)22/h3-10,20H,1-2H3,(H,18,19)",Cc1ccc(O)cc1Nc2ccnc3ccc(cc23)S(=O)(=O)C,CHEMBL899078,Inhibition of chimeric human EGFR/RET kinase expressed in SK-N-MC cells after 1 hr by western blotting,ED50,=,45,nM,,CHEMBL612545,,,,CHEMBL1137530,"Bioorg. Med. Chem. Lett., 17, p. 5886 (2007)",17884497,Scientific Literature
38,CHEMBL237347,"InChI=1S/C17H16N2O3S/c1-11-3-4-12(20)9-17(11)19-16-7-8-18-15-6-5-13(10-14(15)16)23(2,21)22/h3-10,20H,1-2H3,(H,18,19)",Cc1ccc(O)cc1Nc2ccnc3ccc(cc23)S(=O)(=O)C,CHEMBL237347,"InChI=1S/C17H16N2O3S/c1-11-3-4-12(20)9-17(11)19-16-7-8-18-15-6-5-13(10-14(15)16)23(2,21)22/h3-10,20H,1-2H3,(H,18,19)",Cc1ccc(O)cc1Nc2ccnc3ccc(cc23)S(=O)(=O)C,CHEMBL899082,Inhibitory of TIE2,Activity,,,,Active,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1137530,"Bioorg. Med. Chem. Lett., 17, p. 5886 (2007)",17884497,Scientific Literature
38,CHEMBL237347,"InChI=1S/C17H16N2O3S/c1-11-3-4-12(20)9-17(11)19-16-7-8-18-15-6-5-13(10-14(15)16)23(2,21)22/h3-10,20H,1-2H3,(H,18,19)",Cc1ccc(O)cc1Nc2ccnc3ccc(cc23)S(=O)(=O)C,CHEMBL237347,"InChI=1S/C17H16N2O3S/c1-11-3-4-12(20)9-17(11)19-16-7-8-18-15-6-5-13(10-14(15)16)23(2,21)22/h3-10,20H,1-2H3,(H,18,19)",Cc1ccc(O)cc1Nc2ccnc3ccc(cc23)S(=O)(=O)C,CHEMBL899081,Inhibitory of VEGFR2,Activity,,,,Active,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1137530,"Bioorg. Med. Chem. Lett., 17, p. 5886 (2007)",17884497,Scientific Literature
38,CHEMBL237347,"InChI=1S/C17H16N2O3S/c1-11-3-4-12(20)9-17(11)19-16-7-8-18-15-6-5-13(10-14(15)16)23(2,21)22/h3-10,20H,1-2H3,(H,18,19)",Cc1ccc(O)cc1Nc2ccnc3ccc(cc23)S(=O)(=O)C,CHEMBL237347,"InChI=1S/C17H16N2O3S/c1-11-3-4-12(20)9-17(11)19-16-7-8-18-15-6-5-13(10-14(15)16)23(2,21)22/h3-10,20H,1-2H3,(H,18,19)",Cc1ccc(O)cc1Nc2ccnc3ccc(cc23)S(=O)(=O)C,CHEMBL899079,Inhibitory of c-SRC,Activity,,,,Active,CHEMBL267,Tyrosine-protein kinase SRC,Homo sapiens,P12931,CHEMBL1137530,"Bioorg. Med. Chem. Lett., 17, p. 5886 (2007)",17884497,Scientific Literature
38,CHEMBL237347,"InChI=1S/C17H16N2O3S/c1-11-3-4-12(20)9-17(11)19-16-7-8-18-15-6-5-13(10-14(15)16)23(2,21)22/h3-10,20H,1-2H3,(H,18,19)",Cc1ccc(O)cc1Nc2ccnc3ccc(cc23)S(=O)(=O)C,CHEMBL237347,"InChI=1S/C17H16N2O3S/c1-11-3-4-12(20)9-17(11)19-16-7-8-18-15-6-5-13(10-14(15)16)23(2,21)22/h3-10,20H,1-2H3,(H,18,19)",Cc1ccc(O)cc1Nc2ccnc3ccc(cc23)S(=O)(=O)C,CHEMBL899080,Inhibitory of lyn,Activity,,,,Active,CHEMBL3905,Tyrosine-protein kinase Lyn ,Homo sapiens,P07948,CHEMBL1137530,"Bioorg. Med. Chem. Lett., 17, p. 5886 (2007)",17884497,Scientific Literature
"22, SB-220025",CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL900179,Inhibition of p38 MAPK activity assessed as EGFR phosphorylation,IC50,=,19,nM,,CHEMBL612545,,,,CHEMBL1138242,"J. Med. Chem., 50, p. 5712 (2007)",17948975,Scientific Literature
9f,CHEMBL241517,"InChI=1S/C19H13ClFN3O2S2/c20-15-7-11(4-5-16(15)21)14-9-27-18-13(8-24-19(22)17(14)18)10-2-1-3-12(6-10)28(23,25)26/h1-9H,(H2,22,24)(H2,23,25,26)",Nc1ncc(c2cccc(c2)S(=O)(=O)N)c3scc(c4ccc(F)c(Cl)c4)c13,CHEMBL241517,"InChI=1S/C19H13ClFN3O2S2/c20-15-7-11(4-5-16(15)21)14-9-27-18-13(8-24-19(22)17(14)18)10-2-1-3-12(6-10)28(23,25)26/h1-9H,(H2,22,24)(H2,23,25,26)",Nc1ncc(c2cccc(c2)S(=O)(=O)N)c3scc(c4ccc(F)c(Cl)c4)c13,CHEMBL902107,Inhibition of Akt3,IC50,>,10000,nM,,CHEMBL4816,Serine/threonine-protein kinase AKT3,Homo sapiens,Q9Y243,CHEMBL1138370,"Bioorg. Med. Chem. Lett., 17, p. 250 (2007)",17027260,Scientific Literature
9f,CHEMBL241517,"InChI=1S/C19H13ClFN3O2S2/c20-15-7-11(4-5-16(15)21)14-9-27-18-13(8-24-19(22)17(14)18)10-2-1-3-12(6-10)28(23,25)26/h1-9H,(H2,22,24)(H2,23,25,26)",Nc1ncc(c2cccc(c2)S(=O)(=O)N)c3scc(c4ccc(F)c(Cl)c4)c13,CHEMBL241517,"InChI=1S/C19H13ClFN3O2S2/c20-15-7-11(4-5-16(15)21)14-9-27-18-13(8-24-19(22)17(14)18)10-2-1-3-12(6-10)28(23,25)26/h1-9H,(H2,22,24)(H2,23,25,26)",Nc1ncc(c2cccc(c2)S(=O)(=O)N)c3scc(c4ccc(F)c(Cl)c4)c13,CHEMBL902108,Inhibition of CDK2,IC50,>,10000,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1138370,"Bioorg. Med. Chem. Lett., 17, p. 250 (2007)",17027260,Scientific Literature
9f,CHEMBL241517,"InChI=1S/C19H13ClFN3O2S2/c20-15-7-11(4-5-16(15)21)14-9-27-18-13(8-24-19(22)17(14)18)10-2-1-3-12(6-10)28(23,25)26/h1-9H,(H2,22,24)(H2,23,25,26)",Nc1ncc(c2cccc(c2)S(=O)(=O)N)c3scc(c4ccc(F)c(Cl)c4)c13,CHEMBL241517,"InChI=1S/C19H13ClFN3O2S2/c20-15-7-11(4-5-16(15)21)14-9-27-18-13(8-24-19(22)17(14)18)10-2-1-3-12(6-10)28(23,25)26/h1-9H,(H2,22,24)(H2,23,25,26)",Nc1ncc(c2cccc(c2)S(=O)(=O)N)c3scc(c4ccc(F)c(Cl)c4)c13,CHEMBL902109,Inhibition of ErbB2,IC50,>,10000,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1138370,"Bioorg. Med. Chem. Lett., 17, p. 250 (2007)",17027260,Scientific Literature
9f,CHEMBL241517,"InChI=1S/C19H13ClFN3O2S2/c20-15-7-11(4-5-16(15)21)14-9-27-18-13(8-24-19(22)17(14)18)10-2-1-3-12(6-10)28(23,25)26/h1-9H,(H2,22,24)(H2,23,25,26)",Nc1ncc(c2cccc(c2)S(=O)(=O)N)c3scc(c4ccc(F)c(Cl)c4)c13,CHEMBL241517,"InChI=1S/C19H13ClFN3O2S2/c20-15-7-11(4-5-16(15)21)14-9-27-18-13(8-24-19(22)17(14)18)10-2-1-3-12(6-10)28(23,25)26/h1-9H,(H2,22,24)(H2,23,25,26)",Nc1ncc(c2cccc(c2)S(=O)(=O)N)c3scc(c4ccc(F)c(Cl)c4)c13,CHEMBL902110,Inhibition of GSK3b,IC50,>,10000,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1138370,"Bioorg. Med. Chem. Lett., 17, p. 250 (2007)",17027260,Scientific Literature
9f,CHEMBL241517,"InChI=1S/C19H13ClFN3O2S2/c20-15-7-11(4-5-16(15)21)14-9-27-18-13(8-24-19(22)17(14)18)10-2-1-3-12(6-10)28(23,25)26/h1-9H,(H2,22,24)(H2,23,25,26)",Nc1ncc(c2cccc(c2)S(=O)(=O)N)c3scc(c4ccc(F)c(Cl)c4)c13,CHEMBL241517,"InChI=1S/C19H13ClFN3O2S2/c20-15-7-11(4-5-16(15)21)14-9-27-18-13(8-24-19(22)17(14)18)10-2-1-3-12(6-10)28(23,25)26/h1-9H,(H2,22,24)(H2,23,25,26)",Nc1ncc(c2cccc(c2)S(=O)(=O)N)c3scc(c4ccc(F)c(Cl)c4)c13,CHEMBL902111,Inhibition of IKK2,IC50,>,10000,nM,,CHEMBL1991,Inhibitor of nuclear factor kappa B kinase beta subunit,Homo sapiens,O14920,CHEMBL1138370,"Bioorg. Med. Chem. Lett., 17, p. 250 (2007)",17027260,Scientific Literature
9f,CHEMBL241517,"InChI=1S/C19H13ClFN3O2S2/c20-15-7-11(4-5-16(15)21)14-9-27-18-13(8-24-19(22)17(14)18)10-2-1-3-12(6-10)28(23,25)26/h1-9H,(H2,22,24)(H2,23,25,26)",Nc1ncc(c2cccc(c2)S(=O)(=O)N)c3scc(c4ccc(F)c(Cl)c4)c13,CHEMBL241517,"InChI=1S/C19H13ClFN3O2S2/c20-15-7-11(4-5-16(15)21)14-9-27-18-13(8-24-19(22)17(14)18)10-2-1-3-12(6-10)28(23,25)26/h1-9H,(H2,22,24)(H2,23,25,26)",Nc1ncc(c2cccc(c2)S(=O)(=O)N)c3scc(c4ccc(F)c(Cl)c4)c13,CHEMBL902112,Inhibition of MAPKAPK2,IC50,>,10000,nM,,CHEMBL2208,MAP kinase-activated protein kinase 2,Homo sapiens,P49137,CHEMBL1138370,"Bioorg. Med. Chem. Lett., 17, p. 250 (2007)",17027260,Scientific Literature
9f,CHEMBL241517,"InChI=1S/C19H13ClFN3O2S2/c20-15-7-11(4-5-16(15)21)14-9-27-18-13(8-24-19(22)17(14)18)10-2-1-3-12(6-10)28(23,25)26/h1-9H,(H2,22,24)(H2,23,25,26)",Nc1ncc(c2cccc(c2)S(=O)(=O)N)c3scc(c4ccc(F)c(Cl)c4)c13,CHEMBL241517,"InChI=1S/C19H13ClFN3O2S2/c20-15-7-11(4-5-16(15)21)14-9-27-18-13(8-24-19(22)17(14)18)10-2-1-3-12(6-10)28(23,25)26/h1-9H,(H2,22,24)(H2,23,25,26)",Nc1ncc(c2cccc(c2)S(=O)(=O)N)c3scc(c4ccc(F)c(Cl)c4)c13,CHEMBL902113,Inhibition of PLK1,IC50,>,10000,nM,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1138370,"Bioorg. Med. Chem. Lett., 17, p. 250 (2007)",17027260,Scientific Literature
9f,CHEMBL241517,"InChI=1S/C19H13ClFN3O2S2/c20-15-7-11(4-5-16(15)21)14-9-27-18-13(8-24-19(22)17(14)18)10-2-1-3-12(6-10)28(23,25)26/h1-9H,(H2,22,24)(H2,23,25,26)",Nc1ncc(c2cccc(c2)S(=O)(=O)N)c3scc(c4ccc(F)c(Cl)c4)c13,CHEMBL241517,"InChI=1S/C19H13ClFN3O2S2/c20-15-7-11(4-5-16(15)21)14-9-27-18-13(8-24-19(22)17(14)18)10-2-1-3-12(6-10)28(23,25)26/h1-9H,(H2,22,24)(H2,23,25,26)",Nc1ncc(c2cccc(c2)S(=O)(=O)N)c3scc(c4ccc(F)c(Cl)c4)c13,CHEMBL902105,Inhibition of human EphB4 by scintillation proximity method,IC50,=,21,nM,,CHEMBL5147,Ephrin type-B receptor 4,Homo sapiens,P54760,CHEMBL1138370,"Bioorg. Med. Chem. Lett., 17, p. 250 (2007)",17027260,Scientific Literature
9f,CHEMBL241517,"InChI=1S/C19H13ClFN3O2S2/c20-15-7-11(4-5-16(15)21)14-9-27-18-13(8-24-19(22)17(14)18)10-2-1-3-12(6-10)28(23,25)26/h1-9H,(H2,22,24)(H2,23,25,26)",Nc1ncc(c2cccc(c2)S(=O)(=O)N)c3scc(c4ccc(F)c(Cl)c4)c13,CHEMBL241517,"InChI=1S/C19H13ClFN3O2S2/c20-15-7-11(4-5-16(15)21)14-9-27-18-13(8-24-19(22)17(14)18)10-2-1-3-12(6-10)28(23,25)26/h1-9H,(H2,22,24)(H2,23,25,26)",Nc1ncc(c2cccc(c2)S(=O)(=O)N)c3scc(c4ccc(F)c(Cl)c4)c13,CHEMBL902104,Inhibition of human recombinant GST-6XHis-VEGFR2 by HTRF method,IC50,=,1900,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1138370,"Bioorg. Med. Chem. Lett., 17, p. 250 (2007)",17027260,Scientific Literature
9f,CHEMBL241517,"InChI=1S/C19H13ClFN3O2S2/c20-15-7-11(4-5-16(15)21)14-9-27-18-13(8-24-19(22)17(14)18)10-2-1-3-12(6-10)28(23,25)26/h1-9H,(H2,22,24)(H2,23,25,26)",Nc1ncc(c2cccc(c2)S(=O)(=O)N)c3scc(c4ccc(F)c(Cl)c4)c13,CHEMBL241517,"InChI=1S/C19H13ClFN3O2S2/c20-15-7-11(4-5-16(15)21)14-9-27-18-13(8-24-19(22)17(14)18)10-2-1-3-12(6-10)28(23,25)26/h1-9H,(H2,22,24)(H2,23,25,26)",Nc1ncc(c2cccc(c2)S(=O)(=O)N)c3scc(c4ccc(F)c(Cl)c4)c13,CHEMBL902103,Inhibition of human recombinant GST-Tie2 by HTRF method,IC50,>,20000,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1138370,"Bioorg. Med. Chem. Lett., 17, p. 250 (2007)",17027260,Scientific Literature
6,CHEMBL483747,"InChI=1S/C22H18N2O3S/c23-28(25,26)20-8-4-7-18(11-20)21-12-17-9-10-24-14-19(17)13-22(21)27-15-16-5-2-1-3-6-16/h1-14H,15H2,(H2,23,25,26)",NS(=O)(=O)c1cccc(c1)c2cc3ccncc3cc2OCc4ccccc4,CHEMBL483747,"InChI=1S/C22H18N2O3S/c23-28(25,26)20-8-4-7-18(11-20)21-12-17-9-10-24-14-19(17)13-22(21)27-15-16-5-2-1-3-6-16/h1-14H,15H2,(H2,23,25,26)",NS(=O)(=O)c1cccc(c1)c2cc3ccncc3cc2OCc4ccccc4,CHEMBL985016,Inhibition if human recombinant GST-tagged IKK-beta (1 to 737),pIC50,=,5.1,,,CHEMBL1991,Inhibitor of nuclear factor kappa B kinase beta subunit,Homo sapiens,O14920,CHEMBL1138455,"J. Med. Chem., 52, p. 3098 (2009)",19348415,Scientific Literature
7,CHEMBL483748,"InChI=1S/C22H18N2O3S/c23-28(25,26)20-8-6-17(7-9-20)21-12-18-10-11-24-14-19(18)13-22(21)27-15-16-4-2-1-3-5-16/h1-14H,15H2,(H2,23,25,26)",NS(=O)(=O)c1ccc(cc1)c2cc3ccncc3cc2OCc4ccccc4,CHEMBL483748,"InChI=1S/C22H18N2O3S/c23-28(25,26)20-8-6-17(7-9-20)21-12-18-10-11-24-14-19(18)13-22(21)27-15-16-4-2-1-3-5-16/h1-14H,15H2,(H2,23,25,26)",NS(=O)(=O)c1ccc(cc1)c2cc3ccncc3cc2OCc4ccccc4,CHEMBL985016,Inhibition if human recombinant GST-tagged IKK-beta (1 to 737),pIC50,=,5.5,,,CHEMBL1991,Inhibitor of nuclear factor kappa B kinase beta subunit,Homo sapiens,O14920,CHEMBL1138455,"J. Med. Chem., 52, p. 3098 (2009)",19348415,Scientific Literature
6,CHEMBL483747,"InChI=1S/C22H18N2O3S/c23-28(25,26)20-8-4-7-18(11-20)21-12-17-9-10-24-14-19(17)13-22(21)27-15-16-5-2-1-3-6-16/h1-14H,15H2,(H2,23,25,26)",NS(=O)(=O)c1cccc(c1)c2cc3ccncc3cc2OCc4ccccc4,CHEMBL483747,"InChI=1S/C22H18N2O3S/c23-28(25,26)20-8-4-7-18(11-20)21-12-17-9-10-24-14-19(17)13-22(21)27-15-16-5-2-1-3-6-16/h1-14H,15H2,(H2,23,25,26)",NS(=O)(=O)c1cccc(c1)c2cc3ccncc3cc2OCc4ccccc4,CHEMBL985015,Inhibition of His-tagged IKKalpha,pIC50,<,4.6,,,CHEMBL3476,Inhibitor of nuclear factor kappa B kinase alpha subunit,Homo sapiens,O15111,CHEMBL1138455,"J. Med. Chem., 52, p. 3098 (2009)",19348415,Scientific Literature
7,CHEMBL483748,"InChI=1S/C22H18N2O3S/c23-28(25,26)20-8-6-17(7-9-20)21-12-18-10-11-24-14-19(18)13-22(21)27-15-16-4-2-1-3-5-16/h1-14H,15H2,(H2,23,25,26)",NS(=O)(=O)c1ccc(cc1)c2cc3ccncc3cc2OCc4ccccc4,CHEMBL483748,"InChI=1S/C22H18N2O3S/c23-28(25,26)20-8-6-17(7-9-20)21-12-18-10-11-24-14-19(18)13-22(21)27-15-16-4-2-1-3-5-16/h1-14H,15H2,(H2,23,25,26)",NS(=O)(=O)c1ccc(cc1)c2cc3ccncc3cc2OCc4ccccc4,CHEMBL985015,Inhibition of His-tagged IKKalpha,pIC50,<,4.6,,,CHEMBL3476,Inhibitor of nuclear factor kappa B kinase alpha subunit,Homo sapiens,O15111,CHEMBL1138455,"J. Med. Chem., 52, p. 3098 (2009)",19348415,Scientific Literature
6,CHEMBL483747,"InChI=1S/C22H18N2O3S/c23-28(25,26)20-8-4-7-18(11-20)21-12-17-9-10-24-14-19(17)13-22(21)27-15-16-5-2-1-3-6-16/h1-14H,15H2,(H2,23,25,26)",NS(=O)(=O)c1cccc(c1)c2cc3ccncc3cc2OCc4ccccc4,CHEMBL483747,"InChI=1S/C22H18N2O3S/c23-28(25,26)20-8-4-7-18(11-20)21-12-17-9-10-24-14-19(17)13-22(21)27-15-16-5-2-1-3-6-16/h1-14H,15H2,(H2,23,25,26)",NS(=O)(=O)c1cccc(c1)c2cc3ccncc3cc2OCc4ccccc4,CHEMBL985028,Selectivity for human recombinant IKK-beta over IKKalpha,Ratio,=,10,,,CHEMBL612545,,,,CHEMBL1138455,"J. Med. Chem., 52, p. 3098 (2009)",19348415,Scientific Literature
7,CHEMBL483748,"InChI=1S/C22H18N2O3S/c23-28(25,26)20-8-6-17(7-9-20)21-12-18-10-11-24-14-19(18)13-22(21)27-15-16-4-2-1-3-5-16/h1-14H,15H2,(H2,23,25,26)",NS(=O)(=O)c1ccc(cc1)c2cc3ccncc3cc2OCc4ccccc4,CHEMBL483748,"InChI=1S/C22H18N2O3S/c23-28(25,26)20-8-6-17(7-9-20)21-12-18-10-11-24-14-19(18)13-22(21)27-15-16-4-2-1-3-5-16/h1-14H,15H2,(H2,23,25,26)",NS(=O)(=O)c1ccc(cc1)c2cc3ccncc3cc2OCc4ccccc4,CHEMBL985028,Selectivity for human recombinant IKK-beta over IKKalpha,Ratio,=,10,,,CHEMBL612545,,,,CHEMBL1138455,"J. Med. Chem., 52, p. 3098 (2009)",19348415,Scientific Literature
17,CHEMBL365663,"InChI=1S/C17H11ClN4S/c18-11-4-1-3-10(9-11)15-16(23-17(19)22-15)14-7-6-12-13(21-14)5-2-8-20-12/h1-9H,(H2,19,22)",Nc1nc(c2cccc(Cl)c2)c(s1)c3ccc4ncccc4n3,CHEMBL365663,"InChI=1S/C17H11ClN4S/c18-11-4-1-3-10(9-11)15-16(23-17(19)22-15)14-7-6-12-13(21-14)5-2-8-20-12/h1-9H,(H2,19,22)",Nc1nc(c2cccc(Cl)c2)c(s1)c3ccc4ncccc4n3,CHEMBL831710,Binding affinity to Activin A receptor type II-like kinase (ALK5) in fluorescence polarization binding assay; Range is (0.020-0.026),IC50,=,20,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1138735,"J. Med. Chem., 47, p. 4494 (2004)",15317461,Scientific Literature
19,CHEMBL185238,"InChI=1S/C17H13N5/c1-11-4-2-5-16(20-11)17-12(10-19-22-17)13-7-8-14-15(21-13)6-3-9-18-14/h2-10H,1H3,(H,19,22)",Cc1cccc(n1)c2n[nH]cc2c3ccc4ncccc4n3,CHEMBL185238,"InChI=1S/C17H13N5/c1-11-4-2-5-16(20-11)17-12(10-19-22-17)13-7-8-14-15(21-13)6-3-9-18-14/h2-10H,1H3,(H,19,22)",Cc1cccc(n1)c2n[nH]cc2c3ccc4ncccc4n3,CHEMBL831710,Binding affinity to Activin A receptor type II-like kinase (ALK5) in fluorescence polarization binding assay; Range is (0.020-0.026),IC50,=,20,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1138735,"J. Med. Chem., 47, p. 4494 (2004)",15317461,Scientific Literature
11,CHEMBL181361,"InChI=1S/C16H11N5S/c17-16-21-14(12-4-1-2-8-19-12)15(22-16)13-7-6-10-11(20-13)5-3-9-18-10/h1-9H,(H2,17,21)",Nc1nc(c2ccccn2)c(s1)c3ccc4ncccc4n3,CHEMBL181361,"InChI=1S/C16H11N5S/c17-16-21-14(12-4-1-2-8-19-12)15(22-16)13-7-6-10-11(20-13)5-3-9-18-10/h1-9H,(H2,17,21)",Nc1nc(c2ccccn2)c(s1)c3ccc4ncccc4n3,CHEMBL831713,Binding affinity to Activin A receptor type II-like kinase (ALK5) in fluorescence polarization binding assay; Range is (0.038-0.042),IC50,=,40,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1138735,"J. Med. Chem., 47, p. 4494 (2004)",15317461,Scientific Literature
16,CHEMBL361237,"InChI=1S/C17H11FN4S/c18-11-5-3-10(4-6-11)15-16(23-17(19)22-15)14-8-7-12-13(21-14)2-1-9-20-12/h1-9H,(H2,19,22)",Nc1nc(c2ccc(F)cc2)c(s1)c3ccc4ncccc4n3,CHEMBL361237,"InChI=1S/C17H11FN4S/c18-11-5-3-10(4-6-11)15-16(23-17(19)22-15)14-8-7-12-13(21-14)2-1-9-20-12/h1-9H,(H2,19,22)",Nc1nc(c2ccc(F)cc2)c(s1)c3ccc4ncccc4n3,CHEMBL832529,Binding affinity to Activin A receptor type II-like kinase (ALK5) in fluorescence polarization binding assay; Range is (0.040-0.044),IC50,=,40,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1138735,"J. Med. Chem., 47, p. 4494 (2004)",15317461,Scientific Literature
19,CHEMBL185238,"InChI=1S/C17H13N5/c1-11-4-2-5-16(20-11)17-12(10-19-22-17)13-7-8-14-15(21-13)6-3-9-18-14/h2-10H,1H3,(H,19,22)",Cc1cccc(n1)c2n[nH]cc2c3ccc4ncccc4n3,CHEMBL185238,"InChI=1S/C17H13N5/c1-11-4-2-5-16(20-11)17-12(10-19-22-17)13-7-8-14-15(21-13)6-3-9-18-14/h2-10H,1H3,(H,19,22)",Cc1cccc(n1)c2n[nH]cc2c3ccc4ncccc4n3,CHEMBL830961,Inhibition of IL-2-inducible T-cell kinase binding in HTRF assay,IC50,>,16000,nM,,CHEMBL2959,Tyrosine-protein kinase ITK/TSK ,Homo sapiens,Q08881,CHEMBL1138735,"J. Med. Chem., 47, p. 4494 (2004)",15317461,Scientific Literature
19,CHEMBL185238,"InChI=1S/C17H13N5/c1-11-4-2-5-16(20-11)17-12(10-19-22-17)13-7-8-14-15(21-13)6-3-9-18-14/h2-10H,1H3,(H,19,22)",Cc1cccc(n1)c2n[nH]cc2c3ccc4ncccc4n3,CHEMBL185238,"InChI=1S/C17H13N5/c1-11-4-2-5-16(20-11)17-12(10-19-22-17)13-7-8-14-15(21-13)6-3-9-18-14/h2-10H,1H3,(H,19,22)",Cc1cccc(n1)c2n[nH]cc2c3ccc4ncccc4n3,CHEMBL828396,Inhibition of MLK3 kinase binding in fluorescence polarization assay,IC50,>,16000,nM,,CHEMBL2708,Mitogen-activated protein kinase kinase kinase 11,Homo sapiens,Q16584,CHEMBL1138735,"J. Med. Chem., 47, p. 4494 (2004)",15317461,Scientific Literature
19,CHEMBL185238,"InChI=1S/C17H13N5/c1-11-4-2-5-16(20-11)17-12(10-19-22-17)13-7-8-14-15(21-13)6-3-9-18-14/h2-10H,1H3,(H,19,22)",Cc1cccc(n1)c2n[nH]cc2c3ccc4ncccc4n3,CHEMBL185238,"InChI=1S/C17H13N5/c1-11-4-2-5-16(20-11)17-12(10-19-22-17)13-7-8-14-15(21-13)6-3-9-18-14/h2-10H,1H3,(H,19,22)",Cc1cccc(n1)c2n[nH]cc2c3ccc4ncccc4n3,CHEMBL828433,Inhibition of MSK-1 kinase binding in fluorescence polarization assay,IC50,>,16000,nM,,CHEMBL4237,Ribosomal protein S6 kinase alpha 5,Homo sapiens,O75582,CHEMBL1138735,"J. Med. Chem., 47, p. 4494 (2004)",15317461,Scientific Literature
19,CHEMBL185238,"InChI=1S/C17H13N5/c1-11-4-2-5-16(20-11)17-12(10-19-22-17)13-7-8-14-15(21-13)6-3-9-18-14/h2-10H,1H3,(H,19,22)",Cc1cccc(n1)c2n[nH]cc2c3ccc4ncccc4n3,CHEMBL185238,"InChI=1S/C17H13N5/c1-11-4-2-5-16(20-11)17-12(10-19-22-17)13-7-8-14-15(21-13)6-3-9-18-14/h2-10H,1H3,(H,19,22)",Cc1cccc(n1)c2n[nH]cc2c3ccc4ncccc4n3,CHEMBL829087,Inhibition of Protein kinase Raf-B binding in fluorescence polarization assay,IC50,>,16000,nM,,CHEMBL5145,Serine/threonine-protein kinase B-raf,Homo sapiens,P15056,CHEMBL1138735,"J. Med. Chem., 47, p. 4494 (2004)",15317461,Scientific Literature
19,CHEMBL185238,"InChI=1S/C17H13N5/c1-11-4-2-5-16(20-11)17-12(10-19-22-17)13-7-8-14-15(21-13)6-3-9-18-14/h2-10H,1H3,(H,19,22)",Cc1cccc(n1)c2n[nH]cc2c3ccc4ncccc4n3,CHEMBL185238,"InChI=1S/C17H13N5/c1-11-4-2-5-16(20-11)17-12(10-19-22-17)13-7-8-14-15(21-13)6-3-9-18-14/h2-10H,1H3,(H,19,22)",Cc1cccc(n1)c2n[nH]cc2c3ccc4ncccc4n3,CHEMBL832978,Inhibition of c-Jun N-terminal kinase 1-alpha 1 binding in fluorescence polarization assay,IC50,>,16000,nM,,CHEMBL2276,c-Jun N-terminal kinase 1,Homo sapiens,P45983,CHEMBL1138735,"J. Med. Chem., 47, p. 4494 (2004)",15317461,Scientific Literature
19,CHEMBL185238,"InChI=1S/C17H13N5/c1-11-4-2-5-16(20-11)17-12(10-19-22-17)13-7-8-14-15(21-13)6-3-9-18-14/h2-10H,1H3,(H,19,22)",Cc1cccc(n1)c2n[nH]cc2c3ccc4ncccc4n3,CHEMBL185238,"InChI=1S/C17H13N5/c1-11-4-2-5-16(20-11)17-12(10-19-22-17)13-7-8-14-15(21-13)6-3-9-18-14/h2-10H,1H3,(H,19,22)",Cc1cccc(n1)c2n[nH]cc2c3ccc4ncccc4n3,CHEMBL831152,Inhibition of c-Jun N-terminal kinase 3-alpha binding in HTRF assay,IC50,>,16000,nM,,CHEMBL2637,c-Jun N-terminal kinase 3,Homo sapiens,P53779,CHEMBL1138735,"J. Med. Chem., 47, p. 4494 (2004)",15317461,Scientific Literature
19,CHEMBL185238,"InChI=1S/C17H13N5/c1-11-4-2-5-16(20-11)17-12(10-19-22-17)13-7-8-14-15(21-13)6-3-9-18-14/h2-10H,1H3,(H,19,22)",Cc1cccc(n1)c2n[nH]cc2c3ccc4ncccc4n3,CHEMBL185238,"InChI=1S/C17H13N5/c1-11-4-2-5-16(20-11)17-12(10-19-22-17)13-7-8-14-15(21-13)6-3-9-18-14/h2-10H,1H3,(H,19,22)",Cc1cccc(n1)c2n[nH]cc2c3ccc4ncccc4n3,CHEMBL833024,Inhibition of p56 Lck tyrosine kinase binding in HTRF assay,IC50,>,16000,nM,,CHEMBL2480,Tyrosine-protein kinase LCK,Mus musculus,P06240,CHEMBL1138735,"J. Med. Chem., 47, p. 4494 (2004)",15317461,Scientific Literature
11,CHEMBL181361,"InChI=1S/C16H11N5S/c17-16-21-14(12-4-1-2-8-19-12)15(22-16)13-7-6-10-11(20-13)5-3-9-18-10/h1-9H,(H2,17,21)",Nc1nc(c2ccccn2)c(s1)c3ccc4ncccc4n3,CHEMBL181361,"InChI=1S/C16H11N5S/c17-16-21-14(12-4-1-2-8-19-12)15(22-16)13-7-6-10-11(20-13)5-3-9-18-10/h1-9H,(H2,17,21)",Nc1nc(c2ccccn2)c(s1)c3ccc4ncccc4n3,CHEMBL831120,Inhibition of recombinant Activin A receptor type II-like kinase (ALK5) expressed in baculovirus/Sf9 cells,IC50,=,20,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1138735,"J. Med. Chem., 47, p. 4494 (2004)",15317461,Scientific Literature
16,CHEMBL361237,"InChI=1S/C17H11FN4S/c18-11-5-3-10(4-6-11)15-16(23-17(19)22-15)14-8-7-12-13(21-14)2-1-9-20-12/h1-9H,(H2,19,22)",Nc1nc(c2ccc(F)cc2)c(s1)c3ccc4ncccc4n3,CHEMBL361237,"InChI=1S/C17H11FN4S/c18-11-5-3-10(4-6-11)15-16(23-17(19)22-15)14-8-7-12-13(21-14)2-1-9-20-12/h1-9H,(H2,19,22)",Nc1nc(c2ccc(F)cc2)c(s1)c3ccc4ncccc4n3,CHEMBL831120,Inhibition of recombinant Activin A receptor type II-like kinase (ALK5) expressed in baculovirus/Sf9 cells,IC50,=,10,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1138735,"J. Med. Chem., 47, p. 4494 (2004)",15317461,Scientific Literature
17,CHEMBL365663,"InChI=1S/C17H11ClN4S/c18-11-4-1-3-10(9-11)15-16(23-17(19)22-15)14-7-6-12-13(21-14)5-2-8-20-12/h1-9H,(H2,19,22)",Nc1nc(c2cccc(Cl)c2)c(s1)c3ccc4ncccc4n3,CHEMBL365663,"InChI=1S/C17H11ClN4S/c18-11-4-1-3-10(9-11)15-16(23-17(19)22-15)14-7-6-12-13(21-14)5-2-8-20-12/h1-9H,(H2,19,22)",Nc1nc(c2cccc(Cl)c2)c(s1)c3ccc4ncccc4n3,CHEMBL831120,Inhibition of recombinant Activin A receptor type II-like kinase (ALK5) expressed in baculovirus/Sf9 cells,IC50,=,10,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1138735,"J. Med. Chem., 47, p. 4494 (2004)",15317461,Scientific Literature
19,CHEMBL185238,"InChI=1S/C17H13N5/c1-11-4-2-5-16(20-11)17-12(10-19-22-17)13-7-8-14-15(21-13)6-3-9-18-14/h2-10H,1H3,(H,19,22)",Cc1cccc(n1)c2n[nH]cc2c3ccc4ncccc4n3,CHEMBL185238,"InChI=1S/C17H13N5/c1-11-4-2-5-16(20-11)17-12(10-19-22-17)13-7-8-14-15(21-13)6-3-9-18-14/h2-10H,1H3,(H,19,22)",Cc1cccc(n1)c2n[nH]cc2c3ccc4ncccc4n3,CHEMBL831120,Inhibition of recombinant Activin A receptor type II-like kinase (ALK5) expressed in baculovirus/Sf9 cells,IC50,=,4,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1138735,"J. Med. Chem., 47, p. 4494 (2004)",15317461,Scientific Literature
11,CHEMBL181361,"InChI=1S/C16H11N5S/c17-16-21-14(12-4-1-2-8-19-12)15(22-16)13-7-6-10-11(20-13)5-3-9-18-10/h1-9H,(H2,17,21)",Nc1nc(c2ccccn2)c(s1)c3ccc4ncccc4n3,CHEMBL181361,"InChI=1S/C16H11N5S/c17-16-21-14(12-4-1-2-8-19-12)15(22-16)13-7-6-10-11(20-13)5-3-9-18-10/h1-9H,(H2,17,21)",Nc1nc(c2ccccn2)c(s1)c3ccc4ncccc4n3,CHEMBL829583,Stimulation of Transforming growth factor beta receptor I kinase in HepG2 cells,IC50,=,120,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1138735,"J. Med. Chem., 47, p. 4494 (2004)",15317461,Scientific Literature
16,CHEMBL361237,"InChI=1S/C17H11FN4S/c18-11-5-3-10(4-6-11)15-16(23-17(19)22-15)14-8-7-12-13(21-14)2-1-9-20-12/h1-9H,(H2,19,22)",Nc1nc(c2ccc(F)cc2)c(s1)c3ccc4ncccc4n3,CHEMBL361237,"InChI=1S/C17H11FN4S/c18-11-5-3-10(4-6-11)15-16(23-17(19)22-15)14-8-7-12-13(21-14)2-1-9-20-12/h1-9H,(H2,19,22)",Nc1nc(c2ccc(F)cc2)c(s1)c3ccc4ncccc4n3,CHEMBL829583,Stimulation of Transforming growth factor beta receptor I kinase in HepG2 cells,IC50,=,30,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1138735,"J. Med. Chem., 47, p. 4494 (2004)",15317461,Scientific Literature
17,CHEMBL365663,"InChI=1S/C17H11ClN4S/c18-11-4-1-3-10(9-11)15-16(23-17(19)22-15)14-7-6-12-13(21-14)5-2-8-20-12/h1-9H,(H2,19,22)",Nc1nc(c2cccc(Cl)c2)c(s1)c3ccc4ncccc4n3,CHEMBL365663,"InChI=1S/C17H11ClN4S/c18-11-4-1-3-10(9-11)15-16(23-17(19)22-15)14-7-6-12-13(21-14)5-2-8-20-12/h1-9H,(H2,19,22)",Nc1nc(c2cccc(Cl)c2)c(s1)c3ccc4ncccc4n3,CHEMBL829583,Stimulation of Transforming growth factor beta receptor I kinase in HepG2 cells,IC50,=,10,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1138735,"J. Med. Chem., 47, p. 4494 (2004)",15317461,Scientific Literature
19,CHEMBL185238,"InChI=1S/C17H13N5/c1-11-4-2-5-16(20-11)17-12(10-19-22-17)13-7-8-14-15(21-13)6-3-9-18-14/h2-10H,1H3,(H,19,22)",Cc1cccc(n1)c2n[nH]cc2c3ccc4ncccc4n3,CHEMBL185238,"InChI=1S/C17H13N5/c1-11-4-2-5-16(20-11)17-12(10-19-22-17)13-7-8-14-15(21-13)6-3-9-18-14/h2-10H,1H3,(H,19,22)",Cc1cccc(n1)c2n[nH]cc2c3ccc4ncccc4n3,CHEMBL829583,Stimulation of Transforming growth factor beta receptor I kinase in HepG2 cells,IC50,=,10,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1138735,"J. Med. Chem., 47, p. 4494 (2004)",15317461,Scientific Literature
19,CHEMBL187081,"InChI=1S/C17H14N6O/c1-24-13-5-2-4-12(10-13)21-17-18-9-7-15(22-17)14-11-20-23-16(14)6-3-8-19-23/h2-11H,1H3,(H,18,21,22)",COc1cccc(Nc2nccc(n2)c3cnn4ncccc34)c1,CHEMBL187081,"InChI=1S/C17H14N6O/c1-24-13-5-2-4-12(10-13)21-17-18-9-7-15(22-17)14-11-20-23-16(14)6-3-8-19-23/h2-11H,1H3,(H,18,21,22)",COc1cccc(Nc2nccc(n2)c3cnn4ncccc34)c1,CHEMBL827377,Binding affinity for human cyclin-dependent kinase 2,Ki,=,2,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
22,CHEMBL359963,"InChI=1S/C19H18N6/c1-13(2)14-5-7-15(8-6-14)23-19-20-11-9-17(24-19)16-12-22-25-18(16)4-3-10-21-25/h3-13H,1-2H3,(H,20,23,24)",CC(C)c1ccc(Nc2nccc(n2)c3cnn4ncccc34)cc1,CHEMBL359963,"InChI=1S/C19H18N6/c1-13(2)14-5-7-15(8-6-14)23-19-20-11-9-17(24-19)16-12-22-25-18(16)4-3-10-21-25/h3-13H,1-2H3,(H,20,23,24)",CC(C)c1ccc(Nc2nccc(n2)c3cnn4ncccc34)cc1,CHEMBL827377,Binding affinity for human cyclin-dependent kinase 2,Ki,=,10,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
27,CHEMBL361894,"InChI=1S/C18H14N6O2/c1-2-15-13(11-21-24(15)20-6-1)14-5-7-19-18(23-14)22-12-3-4-16-17(10-12)26-9-8-25-16/h1-7,10-11H,8-9H2,(H,19,22,23)",C1COc2cc(Nc3nccc(n3)c4cnn5ncccc45)ccc2O1,CHEMBL361894,"InChI=1S/C18H14N6O2/c1-2-15-13(11-21-24(15)20-6-1)14-5-7-19-18(23-14)22-12-3-4-16-17(10-12)26-9-8-25-16/h1-7,10-11H,8-9H2,(H,19,22,23)",C1COc2cc(Nc3nccc(n3)c4cnn5ncccc45)ccc2O1,CHEMBL827377,Binding affinity for human cyclin-dependent kinase 2,Ki,=,6,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
32,CHEMBL359999,"InChI=1S/C18H16N6O2/c1-25-13-8-12(9-14(10-13)26-2)22-18-19-7-5-16(23-18)15-11-21-24-17(15)4-3-6-20-24/h3-11H,1-2H3,(H,19,22,23)",COc1cc(Nc2nccc(n2)c3cnn4ncccc34)cc(OC)c1,CHEMBL359999,"InChI=1S/C18H16N6O2/c1-25-13-8-12(9-14(10-13)26-2)22-18-19-7-5-16(23-18)15-11-21-24-17(15)4-3-6-20-24/h3-11H,1-2H3,(H,19,22,23)",COc1cc(Nc2nccc(n2)c3cnn4ncccc34)cc(OC)c1,CHEMBL827377,Binding affinity for human cyclin-dependent kinase 2,Ki,=,10,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
40,CHEMBL183993,"InChI=1S/C19H15F3N6O/c1-2-29-17-7-6-16-14(11-24-28(16)27-17)15-8-9-23-18(26-15)25-13-5-3-4-12(10-13)19(20,21)22/h3-11H,2H2,1H3,(H,23,25,26)",CCOc1ccc2c(cnn2n1)c3ccnc(Nc4cccc(c4)C(F)(F)F)n3,CHEMBL183993,"InChI=1S/C19H15F3N6O/c1-2-29-17-7-6-16-14(11-24-28(16)27-17)15-8-9-23-18(26-15)25-13-5-3-4-12(10-13)19(20,21)22/h3-11H,2H2,1H3,(H,23,25,26)",CCOc1ccc2c(cnn2n1)c3ccnc(Nc4cccc(c4)C(F)(F)F)n3,CHEMBL827377,Binding affinity for human cyclin-dependent kinase 2,Ki,=,1990,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
43,CHEMBL365248,"InChI=1S/C18H13F3N6O2/c1-28-16-6-5-15-13(10-23-27(15)26-16)14-7-8-22-17(25-14)24-11-3-2-4-12(9-11)29-18(19,20)21/h2-10H,1H3,(H,22,24,25)",COc1ccc2c(cnn2n1)c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3,CHEMBL365248,"InChI=1S/C18H13F3N6O2/c1-28-16-6-5-15-13(10-23-27(15)26-16)14-7-8-22-17(25-14)24-11-3-2-4-12(9-11)29-18(19,20)21/h2-10H,1H3,(H,22,24,25)",COc1ccc2c(cnn2n1)c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3,CHEMBL827377,Binding affinity for human cyclin-dependent kinase 2,Ki,=,190,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
48,CHEMBL188426,"InChI=1S/C20H17F3N6O2/c1-3-31-18-5-4-17-15(11-25-29(17)28-18)16-6-7-24-19(27-16)26-13-8-12(20(21,22)23)9-14(10-13)30-2/h4-11H,3H2,1-2H3,(H,24,26,27)",CCOc1ccc2c(cnn2n1)c3ccnc(Nc4cc(OC)cc(c4)C(F)(F)F)n3,CHEMBL188426,"InChI=1S/C20H17F3N6O2/c1-3-31-18-5-4-17-15(11-25-29(17)28-18)16-6-7-24-19(27-16)26-13-8-12(20(21,22)23)9-14(10-13)30-2/h4-11H,3H2,1-2H3,(H,24,26,27)",CCOc1ccc2c(cnn2n1)c3ccnc(Nc4cc(OC)cc(c4)C(F)(F)F)n3,CHEMBL827377,Binding affinity for human cyclin-dependent kinase 2,Ki,>,19950,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
55,CHEMBL189415,"InChI=1S/C23H15F3N6/c24-23(25,26)16-7-4-8-17(13-16)29-22-27-12-11-20(30-22)18-14-28-32-21(18)10-9-19(31-32)15-5-2-1-3-6-15/h1-14H,(H,27,29,30)",FC(F)(F)c1cccc(Nc2nccc(n2)c3cnn4nc(ccc34)c5ccccc5)c1,CHEMBL189415,"InChI=1S/C23H15F3N6/c24-23(25,26)16-7-4-8-17(13-16)29-22-27-12-11-20(30-22)18-14-28-32-21(18)10-9-19(31-32)15-5-2-1-3-6-15/h1-14H,(H,27,29,30)",FC(F)(F)c1cccc(Nc2nccc(n2)c3cnn4nc(ccc34)c5ccccc5)c1,CHEMBL827377,Binding affinity for human cyclin-dependent kinase 2,Ki,=,2500,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
67,CHEMBL365297,"InChI=1S/C24H17FN6O2/c25-16-5-3-15(4-6-16)23-22(19-2-1-10-27-31(19)30-23)18-9-11-26-24(29-18)28-17-7-8-20-21(14-17)33-13-12-32-20/h1-11,14H,12-13H2,(H,26,28,29)",Fc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccc6OCCOc6c5)n4,CHEMBL365297,"InChI=1S/C24H17FN6O2/c25-16-5-3-15(4-6-16)23-22(19-2-1-10-27-31(19)30-23)18-9-11-26-24(29-18)28-17-7-8-20-21(14-17)33-13-12-32-20/h1-11,14H,12-13H2,(H,26,28,29)",Fc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccc6OCCOc6c5)n4,CHEMBL827377,Binding affinity for human cyclin-dependent kinase 2,Ki,>,19950,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
69,CHEMBL186213,"InChI=1S/C24H17F3N6O/c1-34-18-9-7-15(8-10-18)22-21(20-6-3-12-29-33(20)32-22)19-11-13-28-23(31-19)30-17-5-2-4-16(14-17)24(25,26)27/h2-14H,1H3,(H,28,30,31)",COc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5cccc(c5)C(F)(F)F)n4,CHEMBL186213,"InChI=1S/C24H17F3N6O/c1-34-18-9-7-15(8-10-18)22-21(20-6-3-12-29-33(20)32-22)19-11-13-28-23(31-19)30-17-5-2-4-16(14-17)24(25,26)27/h2-14H,1H3,(H,28,30,31)",COc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5cccc(c5)C(F)(F)F)n4,CHEMBL827377,Binding affinity for human cyclin-dependent kinase 2,Ki,>,19950,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
70,CHEMBL427159,"InChI=1S/C23H16F2N6O/c1-32-16-7-4-14(5-8-16)22-21(20-3-2-11-27-31(20)30-22)19-10-12-26-23(29-19)28-15-6-9-17(24)18(25)13-15/h2-13H,1H3,(H,26,28,29)",COc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccc(F)c(F)c5)n4,CHEMBL427159,"InChI=1S/C23H16F2N6O/c1-32-16-7-4-14(5-8-16)22-21(20-3-2-11-27-31(20)30-22)19-10-12-26-23(29-19)28-15-6-9-17(24)18(25)13-15/h2-13H,1H3,(H,26,28,29)",COc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccc(F)c(F)c5)n4,CHEMBL827377,Binding affinity for human cyclin-dependent kinase 2,Ki,>,19950,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
71,CHEMBL188794,"InChI=1S/C24H16ClF3N6O/c1-35-16-7-4-14(5-8-16)22-21(20-3-2-11-30-34(20)33-22)19-10-12-29-23(32-19)31-15-6-9-18(25)17(13-15)24(26,27)28/h2-13H,1H3,(H,29,31,32)",COc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccc(Cl)c(c5)C(F)(F)F)n4,CHEMBL188794,"InChI=1S/C24H16ClF3N6O/c1-35-16-7-4-14(5-8-16)22-21(20-3-2-11-30-34(20)33-22)19-10-12-29-23(32-19)31-15-6-9-18(25)17(13-15)24(26,27)28/h2-13H,1H3,(H,29,31,32)",COc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccc(Cl)c(c5)C(F)(F)F)n4,CHEMBL827377,Binding affinity for human cyclin-dependent kinase 2,Ki,>,19950,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
72,CHEMBL188257,"InChI=1S/C25H20N6O3/c1-32-18-7-4-16(5-8-18)24-23(20-3-2-11-27-31(20)30-24)19-10-12-26-25(29-19)28-17-6-9-21-22(15-17)34-14-13-33-21/h2-12,15H,13-14H2,1H3,(H,26,28,29)",COc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccc6OCCOc6c5)n4,CHEMBL188257,"InChI=1S/C25H20N6O3/c1-32-18-7-4-16(5-8-18)24-23(20-3-2-11-27-31(20)30-24)19-10-12-26-25(29-19)28-17-6-9-21-22(15-17)34-14-13-33-21/h2-12,15H,13-14H2,1H3,(H,26,28,29)",COc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccc6OCCOc6c5)n4,CHEMBL827377,Binding affinity for human cyclin-dependent kinase 2,Ki,>,19950,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
75,CHEMBL188784,"InChI=1S/C23H13F5N6/c24-16-8-7-15(12-17(16)25)31-22-29-11-9-18(32-22)20-19-2-1-10-30-34(19)33-21(20)13-3-5-14(6-4-13)23(26,27)28/h1-12H,(H,29,31,32)",Fc1ccc(Nc2nccc(n2)c3c(nn4ncccc34)c5ccc(cc5)C(F)(F)F)cc1F,CHEMBL188784,"InChI=1S/C23H13F5N6/c24-16-8-7-15(12-17(16)25)31-22-29-11-9-18(32-22)20-19-2-1-10-30-34(19)33-21(20)13-3-5-14(6-4-13)23(26,27)28/h1-12H,(H,29,31,32)",Fc1ccc(Nc2nccc(n2)c3c(nn4ncccc34)c5ccc(cc5)C(F)(F)F)cc1F,CHEMBL827377,Binding affinity for human cyclin-dependent kinase 2,Ki,>,19950,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
76,CHEMBL185939,"InChI=1S/C25H17F3N6O2/c26-25(27,28)16-5-3-15(4-6-16)23-22(19-2-1-10-30-34(19)33-23)18-9-11-29-24(32-18)31-17-7-8-20-21(14-17)36-13-12-35-20/h1-11,14H,12-13H2,(H,29,31,32)",FC(F)(F)c1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccc6OCCOc6c5)n4,CHEMBL185939,"InChI=1S/C25H17F3N6O2/c26-25(27,28)16-5-3-15(4-6-16)23-22(19-2-1-10-30-34(19)33-23)18-9-11-29-24(32-18)31-17-7-8-20-21(14-17)36-13-12-35-20/h1-11,14H,12-13H2,(H,29,31,32)",FC(F)(F)c1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccc6OCCOc6c5)n4,CHEMBL827377,Binding affinity for human cyclin-dependent kinase 2,Ki,>,19950,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
80,CHEMBL362155,"InChI=1S/C25H17F3N6O2/c26-25(27,28)16-4-1-3-15(13-16)23-22(19-5-2-9-30-34(19)33-23)18-8-10-29-24(32-18)31-17-6-7-20-21(14-17)36-12-11-35-20/h1-10,13-14H,11-12H2,(H,29,31,32)",FC(F)(F)c1cccc(c1)c2nn3ncccc3c2c4ccnc(Nc5ccc6OCCOc6c5)n4,CHEMBL362155,"InChI=1S/C25H17F3N6O2/c26-25(27,28)16-4-1-3-15(13-16)23-22(19-5-2-9-30-34(19)33-23)18-8-10-29-24(32-18)31-17-6-7-20-21(14-17)36-12-11-35-20/h1-10,13-14H,11-12H2,(H,29,31,32)",FC(F)(F)c1cccc(c1)c2nn3ncccc3c2c4ccnc(Nc5ccc6OCCOc6c5)n4,CHEMBL827377,Binding affinity for human cyclin-dependent kinase 2,Ki,>,19950,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
82,CHEMBL189148,"InChI=1S/C22H15ClN6/c23-16-10-8-15(9-11-16)21-20(19-7-4-13-25-29(19)28-21)18-12-14-24-22(27-18)26-17-5-2-1-3-6-17/h1-14H,(H,24,26,27)",Clc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccccc5)n4,CHEMBL189148,"InChI=1S/C22H15ClN6/c23-16-10-8-15(9-11-16)21-20(19-7-4-13-25-29(19)28-21)18-12-14-24-22(27-18)26-17-5-2-1-3-6-17/h1-14H,(H,24,26,27)",Clc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccccc5)n4,CHEMBL827377,Binding affinity for human cyclin-dependent kinase 2,Ki,>,19950,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
88,CHEMBL434729,"InChI=1S/C24H17F3N6/c1-15-10-11-20-21(22(32-33(20)31-15)16-6-3-2-4-7-16)19-12-13-28-23(30-19)29-18-9-5-8-17(14-18)24(25,26)27/h2-14H,1H3,(H,28,29,30)",Cc1ccc2c(c3ccnc(Nc4cccc(c4)C(F)(F)F)n3)c(nn2n1)c5ccccc5,CHEMBL434729,"InChI=1S/C24H17F3N6/c1-15-10-11-20-21(22(32-33(20)31-15)16-6-3-2-4-7-16)19-12-13-28-23(30-19)29-18-9-5-8-17(14-18)24(25,26)27/h2-14H,1H3,(H,28,29,30)",Cc1ccc2c(c3ccnc(Nc4cccc(c4)C(F)(F)F)n3)c(nn2n1)c5ccccc5,CHEMBL827377,Binding affinity for human cyclin-dependent kinase 2,Ki,>,19950,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
97,CHEMBL188247,"InChI=1S/C26H19F3N6O2/c1-15-2-8-20-23(24(34-35(20)33-15)16-3-5-17(6-4-16)26(27,28)29)19-10-11-30-25(32-19)31-18-7-9-21-22(14-18)37-13-12-36-21/h2-11,14H,12-13H2,1H3,(H,30,31,32)",Cc1ccc2c(c3ccnc(Nc4ccc5OCCOc5c4)n3)c(nn2n1)c6ccc(cc6)C(F)(F)F,CHEMBL188247,"InChI=1S/C26H19F3N6O2/c1-15-2-8-20-23(24(34-35(20)33-15)16-3-5-17(6-4-16)26(27,28)29)19-10-11-30-25(32-19)31-18-7-9-21-22(14-18)37-13-12-36-21/h2-11,14H,12-13H2,1H3,(H,30,31,32)",Cc1ccc2c(c3ccnc(Nc4ccc5OCCOc5c4)n3)c(nn2n1)c6ccc(cc6)C(F)(F)F,CHEMBL827377,Binding affinity for human cyclin-dependent kinase 2,Ki,>,19950,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
98,CHEMBL189459,"InChI=1S/C23H17FN6/c1-15-7-12-20-21(22(29-30(20)28-15)16-8-10-17(24)11-9-16)19-13-14-25-23(27-19)26-18-5-3-2-4-6-18/h2-14H,1H3,(H,25,26,27)",Cc1ccc2c(c3ccnc(Nc4ccccc4)n3)c(nn2n1)c5ccc(F)cc5,CHEMBL189459,"InChI=1S/C23H17FN6/c1-15-7-12-20-21(22(29-30(20)28-15)16-8-10-17(24)11-9-16)19-13-14-25-23(27-19)26-18-5-3-2-4-6-18/h2-14H,1H3,(H,25,26,27)",Cc1ccc2c(c3ccnc(Nc4ccccc4)n3)c(nn2n1)c5ccc(F)cc5,CHEMBL827377,Binding affinity for human cyclin-dependent kinase 2,Ki,>,19950,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
19,CHEMBL187081,"InChI=1S/C17H14N6O/c1-24-13-5-2-4-12(10-13)21-17-18-9-7-15(22-17)14-11-20-23-16(14)6-3-8-19-23/h2-11H,1H3,(H,18,21,22)",COc1cccc(Nc2nccc(n2)c3cnn4ncccc34)c1,CHEMBL187081,"InChI=1S/C17H14N6O/c1-24-13-5-2-4-12(10-13)21-17-18-9-7-15(22-17)14-11-20-23-16(14)6-3-8-19-23/h2-11H,1H3,(H,18,21,22)",COc1cccc(Nc2nccc(n2)c3cnn4ncccc34)c1,CHEMBL827378,Binding affinity for human cyclin-dependent kinase 4,Ki,=,60,nM,,CHEMBL331,Cyclin-dependent kinase 4,Homo sapiens,P11802,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
22,CHEMBL359963,"InChI=1S/C19H18N6/c1-13(2)14-5-7-15(8-6-14)23-19-20-11-9-17(24-19)16-12-22-25-18(16)4-3-10-21-25/h3-13H,1-2H3,(H,20,23,24)",CC(C)c1ccc(Nc2nccc(n2)c3cnn4ncccc34)cc1,CHEMBL359963,"InChI=1S/C19H18N6/c1-13(2)14-5-7-15(8-6-14)23-19-20-11-9-17(24-19)16-12-22-25-18(16)4-3-10-21-25/h3-13H,1-2H3,(H,20,23,24)",CC(C)c1ccc(Nc2nccc(n2)c3cnn4ncccc34)cc1,CHEMBL827378,Binding affinity for human cyclin-dependent kinase 4,Ki,=,1990,nM,,CHEMBL331,Cyclin-dependent kinase 4,Homo sapiens,P11802,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
27,CHEMBL361894,"InChI=1S/C18H14N6O2/c1-2-15-13(11-21-24(15)20-6-1)14-5-7-19-18(23-14)22-12-3-4-16-17(10-12)26-9-8-25-16/h1-7,10-11H,8-9H2,(H,19,22,23)",C1COc2cc(Nc3nccc(n3)c4cnn5ncccc45)ccc2O1,CHEMBL361894,"InChI=1S/C18H14N6O2/c1-2-15-13(11-21-24(15)20-6-1)14-5-7-19-18(23-14)22-12-3-4-16-17(10-12)26-9-8-25-16/h1-7,10-11H,8-9H2,(H,19,22,23)",C1COc2cc(Nc3nccc(n3)c4cnn5ncccc45)ccc2O1,CHEMBL827378,Binding affinity for human cyclin-dependent kinase 4,Ki,=,10,nM,,CHEMBL331,Cyclin-dependent kinase 4,Homo sapiens,P11802,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
32,CHEMBL359999,"InChI=1S/C18H16N6O2/c1-25-13-8-12(9-14(10-13)26-2)22-18-19-7-5-16(23-18)15-11-21-24-17(15)4-3-6-20-24/h3-11H,1-2H3,(H,19,22,23)",COc1cc(Nc2nccc(n2)c3cnn4ncccc34)cc(OC)c1,CHEMBL359999,"InChI=1S/C18H16N6O2/c1-25-13-8-12(9-14(10-13)26-2)22-18-19-7-5-16(23-18)15-11-21-24-17(15)4-3-6-20-24/h3-11H,1-2H3,(H,19,22,23)",COc1cc(Nc2nccc(n2)c3cnn4ncccc34)cc(OC)c1,CHEMBL827378,Binding affinity for human cyclin-dependent kinase 4,Ki,=,10,nM,,CHEMBL331,Cyclin-dependent kinase 4,Homo sapiens,P11802,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
43,CHEMBL365248,"InChI=1S/C18H13F3N6O2/c1-28-16-6-5-15-13(10-23-27(15)26-16)14-7-8-22-17(25-14)24-11-3-2-4-12(9-11)29-18(19,20)21/h2-10H,1H3,(H,22,24,25)",COc1ccc2c(cnn2n1)c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3,CHEMBL365248,"InChI=1S/C18H13F3N6O2/c1-28-16-6-5-15-13(10-23-27(15)26-16)14-7-8-22-17(25-14)24-11-3-2-4-12(9-11)29-18(19,20)21/h2-10H,1H3,(H,22,24,25)",COc1ccc2c(cnn2n1)c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3,CHEMBL827378,Binding affinity for human cyclin-dependent kinase 4,Ki,>,19950,nM,,CHEMBL331,Cyclin-dependent kinase 4,Homo sapiens,P11802,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
40,CHEMBL183993,"InChI=1S/C19H15F3N6O/c1-2-29-17-7-6-16-14(11-24-28(16)27-17)15-8-9-23-18(26-15)25-13-5-3-4-12(10-13)19(20,21)22/h3-11H,2H2,1H3,(H,23,25,26)",CCOc1ccc2c(cnn2n1)c3ccnc(Nc4cccc(c4)C(F)(F)F)n3,CHEMBL183993,"InChI=1S/C19H15F3N6O/c1-2-29-17-7-6-16-14(11-24-28(16)27-17)15-8-9-23-18(26-15)25-13-5-3-4-12(10-13)19(20,21)22/h3-11H,2H2,1H3,(H,23,25,26)",CCOc1ccc2c(cnn2n1)c3ccnc(Nc4cccc(c4)C(F)(F)F)n3,CHEMBL830206,Binding affinity for human cyclin-dependent kinase 4; ND= Not determined,Ki,,,,Not Determined,CHEMBL331,Cyclin-dependent kinase 4,Homo sapiens,P11802,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
48,CHEMBL188426,"InChI=1S/C20H17F3N6O2/c1-3-31-18-5-4-17-15(11-25-29(17)28-18)16-6-7-24-19(27-16)26-13-8-12(20(21,22)23)9-14(10-13)30-2/h4-11H,3H2,1-2H3,(H,24,26,27)",CCOc1ccc2c(cnn2n1)c3ccnc(Nc4cc(OC)cc(c4)C(F)(F)F)n3,CHEMBL188426,"InChI=1S/C20H17F3N6O2/c1-3-31-18-5-4-17-15(11-25-29(17)28-18)16-6-7-24-19(27-16)26-13-8-12(20(21,22)23)9-14(10-13)30-2/h4-11H,3H2,1-2H3,(H,24,26,27)",CCOc1ccc2c(cnn2n1)c3ccnc(Nc4cc(OC)cc(c4)C(F)(F)F)n3,CHEMBL830206,Binding affinity for human cyclin-dependent kinase 4; ND= Not determined,Ki,,,,Not Determined,CHEMBL331,Cyclin-dependent kinase 4,Homo sapiens,P11802,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
55,CHEMBL189415,"InChI=1S/C23H15F3N6/c24-23(25,26)16-7-4-8-17(13-16)29-22-27-12-11-20(30-22)18-14-28-32-21(18)10-9-19(31-32)15-5-2-1-3-6-15/h1-14H,(H,27,29,30)",FC(F)(F)c1cccc(Nc2nccc(n2)c3cnn4nc(ccc34)c5ccccc5)c1,CHEMBL189415,"InChI=1S/C23H15F3N6/c24-23(25,26)16-7-4-8-17(13-16)29-22-27-12-11-20(30-22)18-14-28-32-21(18)10-9-19(31-32)15-5-2-1-3-6-15/h1-14H,(H,27,29,30)",FC(F)(F)c1cccc(Nc2nccc(n2)c3cnn4nc(ccc34)c5ccccc5)c1,CHEMBL830206,Binding affinity for human cyclin-dependent kinase 4; ND= Not determined,Ki,,,,Not Determined,CHEMBL331,Cyclin-dependent kinase 4,Homo sapiens,P11802,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
19,CHEMBL187081,"InChI=1S/C17H14N6O/c1-24-13-5-2-4-12(10-13)21-17-18-9-7-15(22-17)14-11-20-23-16(14)6-3-8-19-23/h2-11H,1H3,(H,18,21,22)",COc1cccc(Nc2nccc(n2)c3cnn4ncccc34)c1,CHEMBL187081,"InChI=1S/C17H14N6O/c1-24-13-5-2-4-12(10-13)21-17-18-9-7-15(22-17)14-11-20-23-16(14)6-3-8-19-23/h2-11H,1H3,(H,18,21,22)",COc1cccc(Nc2nccc(n2)c3cnn4ncccc34)c1,CHEMBL839940,Binding affinity for human glycogen synthase kinase 3 beta,Ki,=,10,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
22,CHEMBL359963,"InChI=1S/C19H18N6/c1-13(2)14-5-7-15(8-6-14)23-19-20-11-9-17(24-19)16-12-22-25-18(16)4-3-10-21-25/h3-13H,1-2H3,(H,20,23,24)",CC(C)c1ccc(Nc2nccc(n2)c3cnn4ncccc34)cc1,CHEMBL359963,"InChI=1S/C19H18N6/c1-13(2)14-5-7-15(8-6-14)23-19-20-11-9-17(24-19)16-12-22-25-18(16)4-3-10-21-25/h3-13H,1-2H3,(H,20,23,24)",CC(C)c1ccc(Nc2nccc(n2)c3cnn4ncccc34)cc1,CHEMBL839940,Binding affinity for human glycogen synthase kinase 3 beta,Ki,=,30,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
27,CHEMBL361894,"InChI=1S/C18H14N6O2/c1-2-15-13(11-21-24(15)20-6-1)14-5-7-19-18(23-14)22-12-3-4-16-17(10-12)26-9-8-25-16/h1-7,10-11H,8-9H2,(H,19,22,23)",C1COc2cc(Nc3nccc(n3)c4cnn5ncccc45)ccc2O1,CHEMBL361894,"InChI=1S/C18H14N6O2/c1-2-15-13(11-21-24(15)20-6-1)14-5-7-19-18(23-14)22-12-3-4-16-17(10-12)26-9-8-25-16/h1-7,10-11H,8-9H2,(H,19,22,23)",C1COc2cc(Nc3nccc(n3)c4cnn5ncccc45)ccc2O1,CHEMBL839940,Binding affinity for human glycogen synthase kinase 3 beta,Ki,<,10,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
32,CHEMBL359999,"InChI=1S/C18H16N6O2/c1-25-13-8-12(9-14(10-13)26-2)22-18-19-7-5-16(23-18)15-11-21-24-17(15)4-3-6-20-24/h3-11H,1-2H3,(H,19,22,23)",COc1cc(Nc2nccc(n2)c3cnn4ncccc34)cc(OC)c1,CHEMBL359999,"InChI=1S/C18H16N6O2/c1-25-13-8-12(9-14(10-13)26-2)22-18-19-7-5-16(23-18)15-11-21-24-17(15)4-3-6-20-24/h3-11H,1-2H3,(H,19,22,23)",COc1cc(Nc2nccc(n2)c3cnn4ncccc34)cc(OC)c1,CHEMBL839940,Binding affinity for human glycogen synthase kinase 3 beta,Ki,=,10,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
40,CHEMBL183993,"InChI=1S/C19H15F3N6O/c1-2-29-17-7-6-16-14(11-24-28(16)27-17)15-8-9-23-18(26-15)25-13-5-3-4-12(10-13)19(20,21)22/h3-11H,2H2,1H3,(H,23,25,26)",CCOc1ccc2c(cnn2n1)c3ccnc(Nc4cccc(c4)C(F)(F)F)n3,CHEMBL183993,"InChI=1S/C19H15F3N6O/c1-2-29-17-7-6-16-14(11-24-28(16)27-17)15-8-9-23-18(26-15)25-13-5-3-4-12(10-13)19(20,21)22/h3-11H,2H2,1H3,(H,23,25,26)",CCOc1ccc2c(cnn2n1)c3ccnc(Nc4cccc(c4)C(F)(F)F)n3,CHEMBL839940,Binding affinity for human glycogen synthase kinase 3 beta,Ki,=,190,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
43,CHEMBL365248,"InChI=1S/C18H13F3N6O2/c1-28-16-6-5-15-13(10-23-27(15)26-16)14-7-8-22-17(25-14)24-11-3-2-4-12(9-11)29-18(19,20)21/h2-10H,1H3,(H,22,24,25)",COc1ccc2c(cnn2n1)c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3,CHEMBL365248,"InChI=1S/C18H13F3N6O2/c1-28-16-6-5-15-13(10-23-27(15)26-16)14-7-8-22-17(25-14)24-11-3-2-4-12(9-11)29-18(19,20)21/h2-10H,1H3,(H,22,24,25)",COc1ccc2c(cnn2n1)c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3,CHEMBL839940,Binding affinity for human glycogen synthase kinase 3 beta,Ki,=,50,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
48,CHEMBL188426,"InChI=1S/C20H17F3N6O2/c1-3-31-18-5-4-17-15(11-25-29(17)28-18)16-6-7-24-19(27-16)26-13-8-12(20(21,22)23)9-14(10-13)30-2/h4-11H,3H2,1-2H3,(H,24,26,27)",CCOc1ccc2c(cnn2n1)c3ccnc(Nc4cc(OC)cc(c4)C(F)(F)F)n3,CHEMBL188426,"InChI=1S/C20H17F3N6O2/c1-3-31-18-5-4-17-15(11-25-29(17)28-18)16-6-7-24-19(27-16)26-13-8-12(20(21,22)23)9-14(10-13)30-2/h4-11H,3H2,1-2H3,(H,24,26,27)",CCOc1ccc2c(cnn2n1)c3ccnc(Nc4cc(OC)cc(c4)C(F)(F)F)n3,CHEMBL839940,Binding affinity for human glycogen synthase kinase 3 beta,Ki,=,3160,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
55,CHEMBL189415,"InChI=1S/C23H15F3N6/c24-23(25,26)16-7-4-8-17(13-16)29-22-27-12-11-20(30-22)18-14-28-32-21(18)10-9-19(31-32)15-5-2-1-3-6-15/h1-14H,(H,27,29,30)",FC(F)(F)c1cccc(Nc2nccc(n2)c3cnn4nc(ccc34)c5ccccc5)c1,CHEMBL189415,"InChI=1S/C23H15F3N6/c24-23(25,26)16-7-4-8-17(13-16)29-22-27-12-11-20(30-22)18-14-28-32-21(18)10-9-19(31-32)15-5-2-1-3-6-15/h1-14H,(H,27,29,30)",FC(F)(F)c1cccc(Nc2nccc(n2)c3cnn4nc(ccc34)c5ccccc5)c1,CHEMBL839940,Binding affinity for human glycogen synthase kinase 3 beta,Ki,=,150,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
67,CHEMBL365297,"InChI=1S/C24H17FN6O2/c25-16-5-3-15(4-6-16)23-22(19-2-1-10-27-31(19)30-23)18-9-11-26-24(29-18)28-17-7-8-20-21(14-17)33-13-12-32-20/h1-11,14H,12-13H2,(H,26,28,29)",Fc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccc6OCCOc6c5)n4,CHEMBL365297,"InChI=1S/C24H17FN6O2/c25-16-5-3-15(4-6-16)23-22(19-2-1-10-27-31(19)30-23)18-9-11-26-24(29-18)28-17-7-8-20-21(14-17)33-13-12-32-20/h1-11,14H,12-13H2,(H,26,28,29)",Fc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccc6OCCOc6c5)n4,CHEMBL839940,Binding affinity for human glycogen synthase kinase 3 beta,Ki,=,10,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
69,CHEMBL186213,"InChI=1S/C24H17F3N6O/c1-34-18-9-7-15(8-10-18)22-21(20-6-3-12-29-33(20)32-22)19-11-13-28-23(31-19)30-17-5-2-4-16(14-17)24(25,26)27/h2-14H,1H3,(H,28,30,31)",COc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5cccc(c5)C(F)(F)F)n4,CHEMBL186213,"InChI=1S/C24H17F3N6O/c1-34-18-9-7-15(8-10-18)22-21(20-6-3-12-29-33(20)32-22)19-11-13-28-23(31-19)30-17-5-2-4-16(14-17)24(25,26)27/h2-14H,1H3,(H,28,30,31)",COc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5cccc(c5)C(F)(F)F)n4,CHEMBL839940,Binding affinity for human glycogen synthase kinase 3 beta,Ki,=,31600,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
70,CHEMBL427159,"InChI=1S/C23H16F2N6O/c1-32-16-7-4-14(5-8-16)22-21(20-3-2-11-27-31(20)30-22)19-10-12-26-23(29-19)28-15-6-9-17(24)18(25)13-15/h2-13H,1H3,(H,26,28,29)",COc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccc(F)c(F)c5)n4,CHEMBL427159,"InChI=1S/C23H16F2N6O/c1-32-16-7-4-14(5-8-16)22-21(20-3-2-11-27-31(20)30-22)19-10-12-26-23(29-19)28-15-6-9-17(24)18(25)13-15/h2-13H,1H3,(H,26,28,29)",COc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccc(F)c(F)c5)n4,CHEMBL839940,Binding affinity for human glycogen synthase kinase 3 beta,Ki,=,7940,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
71,CHEMBL188794,"InChI=1S/C24H16ClF3N6O/c1-35-16-7-4-14(5-8-16)22-21(20-3-2-11-30-34(20)33-22)19-10-12-29-23(32-19)31-15-6-9-18(25)17(13-15)24(26,27)28/h2-13H,1H3,(H,29,31,32)",COc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccc(Cl)c(c5)C(F)(F)F)n4,CHEMBL188794,"InChI=1S/C24H16ClF3N6O/c1-35-16-7-4-14(5-8-16)22-21(20-3-2-11-30-34(20)33-22)19-10-12-29-23(32-19)31-15-6-9-18(25)17(13-15)24(26,27)28/h2-13H,1H3,(H,29,31,32)",COc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccc(Cl)c(c5)C(F)(F)F)n4,CHEMBL839940,Binding affinity for human glycogen synthase kinase 3 beta,Ki,=,31000,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
72,CHEMBL188257,"InChI=1S/C25H20N6O3/c1-32-18-7-4-16(5-8-18)24-23(20-3-2-11-27-31(20)30-24)19-10-12-26-25(29-19)28-17-6-9-21-22(15-17)34-14-13-33-21/h2-12,15H,13-14H2,1H3,(H,26,28,29)",COc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccc6OCCOc6c5)n4,CHEMBL188257,"InChI=1S/C25H20N6O3/c1-32-18-7-4-16(5-8-18)24-23(20-3-2-11-27-31(20)30-24)19-10-12-26-25(29-19)28-17-6-9-21-22(15-17)34-14-13-33-21/h2-12,15H,13-14H2,1H3,(H,26,28,29)",COc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccc6OCCOc6c5)n4,CHEMBL839940,Binding affinity for human glycogen synthase kinase 3 beta,Ki,=,5010,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
75,CHEMBL188784,"InChI=1S/C23H13F5N6/c24-16-8-7-15(12-17(16)25)31-22-29-11-9-18(32-22)20-19-2-1-10-30-34(19)33-21(20)13-3-5-14(6-4-13)23(26,27)28/h1-12H,(H,29,31,32)",Fc1ccc(Nc2nccc(n2)c3c(nn4ncccc34)c5ccc(cc5)C(F)(F)F)cc1F,CHEMBL188784,"InChI=1S/C23H13F5N6/c24-16-8-7-15(12-17(16)25)31-22-29-11-9-18(32-22)20-19-2-1-10-30-34(19)33-21(20)13-3-5-14(6-4-13)23(26,27)28/h1-12H,(H,29,31,32)",Fc1ccc(Nc2nccc(n2)c3c(nn4ncccc34)c5ccc(cc5)C(F)(F)F)cc1F,CHEMBL839940,Binding affinity for human glycogen synthase kinase 3 beta,Ki,>,31600,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
76,CHEMBL185939,"InChI=1S/C25H17F3N6O2/c26-25(27,28)16-5-3-15(4-6-16)23-22(19-2-1-10-30-34(19)33-23)18-9-11-29-24(32-18)31-17-7-8-20-21(14-17)36-13-12-35-20/h1-11,14H,12-13H2,(H,29,31,32)",FC(F)(F)c1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccc6OCCOc6c5)n4,CHEMBL185939,"InChI=1S/C25H17F3N6O2/c26-25(27,28)16-5-3-15(4-6-16)23-22(19-2-1-10-30-34(19)33-23)18-9-11-29-24(32-18)31-17-7-8-20-21(14-17)36-13-12-35-20/h1-11,14H,12-13H2,(H,29,31,32)",FC(F)(F)c1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccc6OCCOc6c5)n4,CHEMBL839940,Binding affinity for human glycogen synthase kinase 3 beta,Ki,>,31600,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
80,CHEMBL362155,"InChI=1S/C25H17F3N6O2/c26-25(27,28)16-4-1-3-15(13-16)23-22(19-5-2-9-30-34(19)33-23)18-8-10-29-24(32-18)31-17-6-7-20-21(14-17)36-12-11-35-20/h1-10,13-14H,11-12H2,(H,29,31,32)",FC(F)(F)c1cccc(c1)c2nn3ncccc3c2c4ccnc(Nc5ccc6OCCOc6c5)n4,CHEMBL362155,"InChI=1S/C25H17F3N6O2/c26-25(27,28)16-4-1-3-15(13-16)23-22(19-5-2-9-30-34(19)33-23)18-8-10-29-24(32-18)31-17-6-7-20-21(14-17)36-12-11-35-20/h1-10,13-14H,11-12H2,(H,29,31,32)",FC(F)(F)c1cccc(c1)c2nn3ncccc3c2c4ccnc(Nc5ccc6OCCOc6c5)n4,CHEMBL839940,Binding affinity for human glycogen synthase kinase 3 beta,Ki,=,50,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
82,CHEMBL189148,"InChI=1S/C22H15ClN6/c23-16-10-8-15(9-11-16)21-20(19-7-4-13-25-29(19)28-21)18-12-14-24-22(27-18)26-17-5-2-1-3-6-17/h1-14H,(H,24,26,27)",Clc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccccc5)n4,CHEMBL189148,"InChI=1S/C22H15ClN6/c23-16-10-8-15(9-11-16)21-20(19-7-4-13-25-29(19)28-21)18-12-14-24-22(27-18)26-17-5-2-1-3-6-17/h1-14H,(H,24,26,27)",Clc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccccc5)n4,CHEMBL839940,Binding affinity for human glycogen synthase kinase 3 beta,Ki,=,1250,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
88,CHEMBL434729,"InChI=1S/C24H17F3N6/c1-15-10-11-20-21(22(32-33(20)31-15)16-6-3-2-4-7-16)19-12-13-28-23(30-19)29-18-9-5-8-17(14-18)24(25,26)27/h2-14H,1H3,(H,28,29,30)",Cc1ccc2c(c3ccnc(Nc4cccc(c4)C(F)(F)F)n3)c(nn2n1)c5ccccc5,CHEMBL434729,"InChI=1S/C24H17F3N6/c1-15-10-11-20-21(22(32-33(20)31-15)16-6-3-2-4-7-16)19-12-13-28-23(30-19)29-18-9-5-8-17(14-18)24(25,26)27/h2-14H,1H3,(H,28,29,30)",Cc1ccc2c(c3ccnc(Nc4cccc(c4)C(F)(F)F)n3)c(nn2n1)c5ccccc5,CHEMBL839940,Binding affinity for human glycogen synthase kinase 3 beta,Ki,=,40,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
97,CHEMBL188247,"InChI=1S/C26H19F3N6O2/c1-15-2-8-20-23(24(34-35(20)33-15)16-3-5-17(6-4-16)26(27,28)29)19-10-11-30-25(32-19)31-18-7-9-21-22(14-18)37-13-12-36-21/h2-11,14H,12-13H2,1H3,(H,30,31,32)",Cc1ccc2c(c3ccnc(Nc4ccc5OCCOc5c4)n3)c(nn2n1)c6ccc(cc6)C(F)(F)F,CHEMBL188247,"InChI=1S/C26H19F3N6O2/c1-15-2-8-20-23(24(34-35(20)33-15)16-3-5-17(6-4-16)26(27,28)29)19-10-11-30-25(32-19)31-18-7-9-21-22(14-18)37-13-12-36-21/h2-11,14H,12-13H2,1H3,(H,30,31,32)",Cc1ccc2c(c3ccnc(Nc4ccc5OCCOc5c4)n3)c(nn2n1)c6ccc(cc6)C(F)(F)F,CHEMBL839940,Binding affinity for human glycogen synthase kinase 3 beta,Ki,>,31600,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
98,CHEMBL189459,"InChI=1S/C23H17FN6/c1-15-7-12-20-21(22(29-30(20)28-15)16-8-10-17(24)11-9-16)19-13-14-25-23(27-19)26-18-5-3-2-4-6-18/h2-14H,1H3,(H,25,26,27)",Cc1ccc2c(c3ccnc(Nc4ccccc4)n3)c(nn2n1)c5ccc(F)cc5,CHEMBL189459,"InChI=1S/C23H17FN6/c1-15-7-12-20-21(22(29-30(20)28-15)16-8-10-17(24)11-9-16)19-13-14-25-23(27-19)26-18-5-3-2-4-6-18/h2-14H,1H3,(H,25,26,27)",Cc1ccc2c(c3ccnc(Nc4ccccc4)n3)c(nn2n1)c5ccc(F)cc5,CHEMBL839940,Binding affinity for human glycogen synthase kinase 3 beta,Ki,=,20,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
19,CHEMBL187081,"InChI=1S/C17H14N6O/c1-24-13-5-2-4-12(10-13)21-17-18-9-7-15(22-17)14-11-20-23-16(14)6-3-8-19-23/h2-11H,1H3,(H,18,21,22)",COc1cccc(Nc2nccc(n2)c3cnn4ncccc34)c1,CHEMBL187081,"InChI=1S/C17H14N6O/c1-24-13-5-2-4-12(10-13)21-17-18-9-7-15(22-17)14-11-20-23-16(14)6-3-8-19-23/h2-11H,1H3,(H,18,21,22)",COc1cccc(Nc2nccc(n2)c3cnn4ncccc34)c1,CHEMBL840825,Effective concentration to increase glycogen deposition in rat skeletal muscle L6 myoblast cells,EC50,=,1300,nM,,CHEMBL3669,Glycogen synthase kinase-3 beta,Rattus norvegicus,P18266,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
27,CHEMBL361894,"InChI=1S/C18H14N6O2/c1-2-15-13(11-21-24(15)20-6-1)14-5-7-19-18(23-14)22-12-3-4-16-17(10-12)26-9-8-25-16/h1-7,10-11H,8-9H2,(H,19,22,23)",C1COc2cc(Nc3nccc(n3)c4cnn5ncccc45)ccc2O1,CHEMBL361894,"InChI=1S/C18H14N6O2/c1-2-15-13(11-21-24(15)20-6-1)14-5-7-19-18(23-14)22-12-3-4-16-17(10-12)26-9-8-25-16/h1-7,10-11H,8-9H2,(H,19,22,23)",C1COc2cc(Nc3nccc(n3)c4cnn5ncccc45)ccc2O1,CHEMBL840825,Effective concentration to increase glycogen deposition in rat skeletal muscle L6 myoblast cells,EC50,=,800,nM,,CHEMBL3669,Glycogen synthase kinase-3 beta,Rattus norvegicus,P18266,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
19,CHEMBL187081,"InChI=1S/C17H14N6O/c1-24-13-5-2-4-12(10-13)21-17-18-9-7-15(22-17)14-11-20-23-16(14)6-3-8-19-23/h2-11H,1H3,(H,18,21,22)",COc1cccc(Nc2nccc(n2)c3cnn4ncccc34)c1,CHEMBL187081,"InChI=1S/C17H14N6O/c1-24-13-5-2-4-12(10-13)21-17-18-9-7-15(22-17)14-11-20-23-16(14)6-3-8-19-23/h2-11H,1H3,(H,18,21,22)",COc1cccc(Nc2nccc(n2)c3cnn4ncccc34)c1,CHEMBL876278,Maximal effect as percent response in glycogen accumulation compared to insulin,Response,=,56,%,,CHEMBL3669,Glycogen synthase kinase-3 beta,Rattus norvegicus,P18266,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
27,CHEMBL361894,"InChI=1S/C18H14N6O2/c1-2-15-13(11-21-24(15)20-6-1)14-5-7-19-18(23-14)22-12-3-4-16-17(10-12)26-9-8-25-16/h1-7,10-11H,8-9H2,(H,19,22,23)",C1COc2cc(Nc3nccc(n3)c4cnn5ncccc45)ccc2O1,CHEMBL361894,"InChI=1S/C18H14N6O2/c1-2-15-13(11-21-24(15)20-6-1)14-5-7-19-18(23-14)22-12-3-4-16-17(10-12)26-9-8-25-16/h1-7,10-11H,8-9H2,(H,19,22,23)",C1COc2cc(Nc3nccc(n3)c4cnn5ncccc45)ccc2O1,CHEMBL876278,Maximal effect as percent response in glycogen accumulation compared to insulin,Response,=,27,%,,CHEMBL3669,Glycogen synthase kinase-3 beta,Rattus norvegicus,P18266,CHEMBL1138749,"J. Med. Chem., 47, p. 4716 (2004)",15341487,Scientific Literature
8a,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL903557,"AUC (0 to t) in CD1 mouse at 10.7 mg/kg, po",AUC,=,1201,ug min ml-1,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1139135,"Bioorg. Med. Chem. Lett., 17, p. 1773 (2007)",17276055,Scientific Literature
8a,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL903559,Antiangiogenic activity against human HT29 cells xenografted in nude CD1 mouse,Activity,,,,Active,CHEMBL384,HT-29 (Colon adenocarcinoma cells),Homo sapiens,,CHEMBL1139135,"Bioorg. Med. Chem. Lett., 17, p. 1773 (2007)",17276055,Scientific Literature
8a,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL903562,"Antiangiogenic activity against human HT29 cells xenografted in nude CD1 mouse assessed as decrease in blood vessel density at 10 mg/kg, po",Activity,=,35.6,%,,CHEMBL384,HT-29 (Colon adenocarcinoma cells),Homo sapiens,,CHEMBL1139135,"Bioorg. Med. Chem. Lett., 17, p. 1773 (2007)",17276055,Scientific Literature
8a,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL903561,"Antiangiogenic activity against human HT29 cells xenografted in nude CD1 mouse assessed as decrease in blood vessel density at 3 mg/kg, po",Activity,=,24.3,%,,CHEMBL384,HT-29 (Colon adenocarcinoma cells),Homo sapiens,,CHEMBL1139135,"Bioorg. Med. Chem. Lett., 17, p. 1773 (2007)",17276055,Scientific Literature
8a,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL903563,"Antiangiogenic activity against human HT29 cells xenografted in nude CD1 mouse assessed as decrease in blood vessel density at 30 mg/kg, po",Activity,=,62.9,%,,CHEMBL384,HT-29 (Colon adenocarcinoma cells),Homo sapiens,,CHEMBL1139135,"Bioorg. Med. Chem. Lett., 17, p. 1773 (2007)",17276055,Scientific Literature
8a,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL903555,"Cmax in CD1 mouse at 10.7 mg/kg, po",Cmax,=,2.724,ug.mL-1,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1139135,"Bioorg. Med. Chem. Lett., 17, p. 1773 (2007)",17276055,Scientific Literature
8a,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL903553,Cytotoxicity against human HFF cells after 3 days,IC50,=,2506,nM,,CHEMBL614071,HFF (Foreskin fibroblasts),Homo sapiens,,CHEMBL1139135,"Bioorg. Med. Chem. Lett., 17, p. 1773 (2007)",17276055,Scientific Literature
8a,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL903554,Cytotoxicity against human HT29 cells after 3 days,IC50,=,5084,nM,,CHEMBL384,HT-29 (Colon adenocarcinoma cells),Homo sapiens,,CHEMBL1139135,"Bioorg. Med. Chem. Lett., 17, p. 1773 (2007)",17276055,Scientific Literature
8a,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL902487,Growth inhibition of VEGF-stimulated human HUVEC cells,IC50,=,2.6,nM,,CHEMBL613979,HUVEC (Umbilical vein endothelial cells),Homo sapiens,,CHEMBL1139135,"Bioorg. Med. Chem. Lett., 17, p. 1773 (2007)",17276055,Scientific Literature
8a,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL903552,Inhibition of c-fms/Tie2 chimeric receptor transfected in 3T3 cell assessed as autophosphorylation activity,IC50,=,18.3,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1139135,"Bioorg. Med. Chem. Lett., 17, p. 1773 (2007)",17276055,Scientific Literature
8a,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL903564,Inhibition of human Akt3,Log IC50,=,4.76,,,CHEMBL4816,Serine/threonine-protein kinase AKT3,Homo sapiens,Q9Y243,CHEMBL1139135,"Bioorg. Med. Chem. Lett., 17, p. 1773 (2007)",17276055,Scientific Literature
8a,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL903565,Inhibition of human CDK2,Log IC50,=,4.75,,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1139135,"Bioorg. Med. Chem. Lett., 17, p. 1773 (2007)",17276055,Scientific Literature
8a,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL903566,Inhibition of human EGFR,Log IC50,=,5,,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1139135,"Bioorg. Med. Chem. Lett., 17, p. 1773 (2007)",17276055,Scientific Literature
8a,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL903567,Inhibition of human GSK3,Log IC50,=,5.66,,,CHEMBL612545,,,,CHEMBL1139135,"Bioorg. Med. Chem. Lett., 17, p. 1773 (2007)",17276055,Scientific Literature
8a,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL903570,Inhibition of human PDGFR,Log IC50,=,7.56,,,CHEMBL612545,,,,CHEMBL1139135,"Bioorg. Med. Chem. Lett., 17, p. 1773 (2007)",17276055,Scientific Literature
8a,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL903568,Inhibition of human SRC,Log IC50,=,6.27,,,CHEMBL267,Tyrosine-protein kinase SRC,Homo sapiens,P12931,CHEMBL1139135,"Bioorg. Med. Chem. Lett., 17, p. 1773 (2007)",17276055,Scientific Literature
2,CHEMBL194911,"InChI=1S/C27H19F4N5O3/c1-38-18-9-4-15(5-10-18)23-21(22-24(32)33-13-34-25(22)39-23)14-2-7-17(8-3-14)35-26(37)36-20-12-16(27(29,30)31)6-11-19(20)28/h2-13H,1H3,(H2,32,33,34)(H2,35,36,37)",COc1ccc(cc1)c2oc3ncnc(N)c3c2c4ccc(NC(=O)Nc5cc(ccc5F)C(F)(F)F)cc4,CHEMBL194911,"InChI=1S/C27H19F4N5O3/c1-38-18-9-4-15(5-10-18)23-21(22-24(32)33-13-34-25(22)39-23)14-2-7-17(8-3-14)35-26(37)36-20-12-16(27(29,30)31)6-11-19(20)28/h2-13H,1H3,(H2,32,33,34)(H2,35,36,37)",COc1ccc(cc1)c2oc3ncnc(N)c3c2c4ccc(NC(=O)Nc5cc(ccc5F)C(F)(F)F)cc4,CHEMBL902485,Inhibition of human Tie2 by HTRF method,Log IC50,,,,Not Determined,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1139135,"Bioorg. Med. Chem. Lett., 17, p. 1773 (2007)",17276055,Scientific Literature
8a,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL902485,Inhibition of human Tie2 by HTRF method,Log IC50,=,7.87,,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1139135,"Bioorg. Med. Chem. Lett., 17, p. 1773 (2007)",17276055,Scientific Literature
8b,CHEMBL396107,"InChI=1S/C21H13F6N5O2/c22-20(23,24)11-5-12(21(25,26)27)7-14(6-11)32-19(33)31-13-3-1-10(2-4-13)15-8-34-18-16(15)17(28)29-9-30-18/h1-9H,(H2,28,29,30)(H2,31,32,33)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(cc(c4)C(F)(F)F)C(F)(F)F)cc3)c12,CHEMBL396107,"InChI=1S/C21H13F6N5O2/c22-20(23,24)11-5-12(21(25,26)27)7-14(6-11)32-19(33)31-13-3-1-10(2-4-13)15-8-34-18-16(15)17(28)29-9-30-18/h1-9H,(H2,28,29,30)(H2,31,32,33)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(cc(c4)C(F)(F)F)C(F)(F)F)cc3)c12,CHEMBL902485,Inhibition of human Tie2 by HTRF method,Log IC50,=,6.42,,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1139135,"Bioorg. Med. Chem. Lett., 17, p. 1773 (2007)",17276055,Scientific Literature
8d,CHEMBL273564,"InChI=1S/C20H14F3N5O2/c21-20(22,23)12-2-1-3-14(8-12)28-19(29)27-13-6-4-11(5-7-13)15-9-30-18-16(15)17(24)25-10-26-18/h1-10H,(H2,24,25,26)(H2,27,28,29)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cccc(c4)C(F)(F)F)cc3)c12,CHEMBL273564,"InChI=1S/C20H14F3N5O2/c21-20(22,23)12-2-1-3-14(8-12)28-19(29)27-13-6-4-11(5-7-13)15-9-30-18-16(15)17(24)25-10-26-18/h1-10H,(H2,24,25,26)(H2,27,28,29)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cccc(c4)C(F)(F)F)cc3)c12,CHEMBL902485,Inhibition of human Tie2 by HTRF method,Log IC50,=,7.99,,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1139135,"Bioorg. Med. Chem. Lett., 17, p. 1773 (2007)",17276055,Scientific Literature
8a,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL903571,Inhibition of human VEGFR1,Log IC50,=,8.07,,,CHEMBL1868,Vascular endothelial growth factor receptor 1,Homo sapiens,P17948,CHEMBL1139135,"Bioorg. Med. Chem. Lett., 17, p. 1773 (2007)",17276055,Scientific Literature
2,CHEMBL194911,"InChI=1S/C27H19F4N5O3/c1-38-18-9-4-15(5-10-18)23-21(22-24(32)33-13-34-25(22)39-23)14-2-7-17(8-3-14)35-26(37)36-20-12-16(27(29,30)31)6-11-19(20)28/h2-13H,1H3,(H2,32,33,34)(H2,35,36,37)",COc1ccc(cc1)c2oc3ncnc(N)c3c2c4ccc(NC(=O)Nc5cc(ccc5F)C(F)(F)F)cc4,CHEMBL194911,"InChI=1S/C27H19F4N5O3/c1-38-18-9-4-15(5-10-18)23-21(22-24(32)33-13-34-25(22)39-23)14-2-7-17(8-3-14)35-26(37)36-20-12-16(27(29,30)31)6-11-19(20)28/h2-13H,1H3,(H2,32,33,34)(H2,35,36,37)",COc1ccc(cc1)c2oc3ncnc(N)c3c2c4ccc(NC(=O)Nc5cc(ccc5F)C(F)(F)F)cc4,CHEMBL902486,Inhibition of human VEGFR2 by HTRF method,Log IC50,=,7.81,,,CHEMBL1868,Vascular endothelial growth factor receptor 1,Homo sapiens,P17948,CHEMBL1139135,"Bioorg. Med. Chem. Lett., 17, p. 1773 (2007)",17276055,Scientific Literature
8a,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL902486,Inhibition of human VEGFR2 by HTRF method,Log IC50,=,8.11,,,CHEMBL1868,Vascular endothelial growth factor receptor 1,Homo sapiens,P17948,CHEMBL1139135,"Bioorg. Med. Chem. Lett., 17, p. 1773 (2007)",17276055,Scientific Literature
8b,CHEMBL396107,"InChI=1S/C21H13F6N5O2/c22-20(23,24)11-5-12(21(25,26)27)7-14(6-11)32-19(33)31-13-3-1-10(2-4-13)15-8-34-18-16(15)17(28)29-9-30-18/h1-9H,(H2,28,29,30)(H2,31,32,33)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(cc(c4)C(F)(F)F)C(F)(F)F)cc3)c12,CHEMBL396107,"InChI=1S/C21H13F6N5O2/c22-20(23,24)11-5-12(21(25,26)27)7-14(6-11)32-19(33)31-13-3-1-10(2-4-13)15-8-34-18-16(15)17(28)29-9-30-18/h1-9H,(H2,28,29,30)(H2,31,32,33)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(cc(c4)C(F)(F)F)C(F)(F)F)cc3)c12,CHEMBL902486,Inhibition of human VEGFR2 by HTRF method,Log IC50,=,6.86,,,CHEMBL1868,Vascular endothelial growth factor receptor 1,Homo sapiens,P17948,CHEMBL1139135,"Bioorg. Med. Chem. Lett., 17, p. 1773 (2007)",17276055,Scientific Literature
8d,CHEMBL273564,"InChI=1S/C20H14F3N5O2/c21-20(22,23)12-2-1-3-14(8-12)28-19(29)27-13-6-4-11(5-7-13)15-9-30-18-16(15)17(24)25-10-26-18/h1-10H,(H2,24,25,26)(H2,27,28,29)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cccc(c4)C(F)(F)F)cc3)c12,CHEMBL273564,"InChI=1S/C20H14F3N5O2/c21-20(22,23)12-2-1-3-14(8-12)28-19(29)27-13-6-4-11(5-7-13)15-9-30-18-16(15)17(24)25-10-26-18/h1-10H,(H2,24,25,26)(H2,27,28,29)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cccc(c4)C(F)(F)F)cc3)c12,CHEMBL902486,Inhibition of human VEGFR2 by HTRF method,Log IC50,=,8.15,,,CHEMBL1868,Vascular endothelial growth factor receptor 1,Homo sapiens,P17948,CHEMBL1139135,"Bioorg. Med. Chem. Lett., 17, p. 1773 (2007)",17276055,Scientific Literature
8a,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL903572,Inhibition of human VGFR3,Log IC50,=,8.12,,,CHEMBL1955,Vascular endothelial growth factor receptor 3,Homo sapiens,P35916,CHEMBL1139135,"Bioorg. Med. Chem. Lett., 17, p. 1773 (2007)",17276055,Scientific Literature
8a,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL903569,Inhibition of human cFMS,Log IC50,=,7.41,,,CHEMBL1844,Macrophage colony stimulating factor  receptor ,Homo sapiens,P07333,CHEMBL1139135,"Bioorg. Med. Chem. Lett., 17, p. 1773 (2007)",17276055,Scientific Literature
8a,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL903560,Inhibition of tumor growth in human HT29 cells xenografted in orally dosed nude CD1 mouse,Activity,,,,Dose-dependent effect,CHEMBL384,HT-29 (Colon adenocarcinoma cells),Homo sapiens,,CHEMBL1139135,"Bioorg. Med. Chem. Lett., 17, p. 1773 (2007)",17276055,Scientific Literature
8a,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL903558,"Normalized AUC (0 to t) in CD1 mouse at 10.7 mg/kg, po",AUC,=,112,min kg L-1,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1139135,"Bioorg. Med. Chem. Lett., 17, p. 1773 (2007)",17276055,Scientific Literature
8a,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL903556,"Tmax in CD1 mouse at 10.7 mg/kg, po",Tmax,=,2,hr,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1139135,"Bioorg. Med. Chem. Lett., 17, p. 1773 (2007)",17276055,Scientific Literature
6h,CHEMBL220465,"InChI=1S/C25H24N8O3/c1-4-33-20-13-21(27-14-19(20)29-24(33)22-23(26)31-36-30-22)35-18-7-5-6-16(12-18)28-25(34)15-8-10-17(11-9-15)32(2)3/h5-14H,4H2,1-3H3,(H2,26,31)(H,28,34)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(cc4)N(C)C)c3)cc12)c5nonc5N,CHEMBL220465,"InChI=1S/C25H24N8O3/c1-4-33-20-13-21(27-14-19(20)29-24(33)22-23(26)31-36-30-22)35-18-7-5-6-16(12-18)28-25(34)15-8-10-17(11-9-15)32(2)3/h5-14H,4H2,1-3H3,(H2,26,31)(H,28,34)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(cc4)N(C)C)c3)cc12)c5nonc5N,CHEMBL912839,"Clearance in Sprague-Dawley rat at 0.85 mg/kg, iv",CL,=,0.14,mL.min-1.kg-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139215,"J. Med. Chem., 50, p. 2 (2007)",17201404,Scientific Literature
6n,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL912864,"Clearance in Sprague-Dawley rat at 1.6 mg/kg, iv",CL,=,7.6,mL.min-1.kg-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139215,"J. Med. Chem., 50, p. 2 (2007)",17201404,Scientific Literature
6h,CHEMBL220465,"InChI=1S/C25H24N8O3/c1-4-33-20-13-21(27-14-19(20)29-24(33)22-23(26)31-36-30-22)35-18-7-5-6-16(12-18)28-25(34)15-8-10-17(11-9-15)32(2)3/h5-14H,4H2,1-3H3,(H2,26,31)(H,28,34)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(cc4)N(C)C)c3)cc12)c5nonc5N,CHEMBL220465,"InChI=1S/C25H24N8O3/c1-4-33-20-13-21(27-14-19(20)29-24(33)22-23(26)31-36-30-22)35-18-7-5-6-16(12-18)28-25(34)15-8-10-17(11-9-15)32(2)3/h5-14H,4H2,1-3H3,(H2,26,31)(H,28,34)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(cc4)N(C)C)c3)cc12)c5nonc5N,CHEMBL912836,"Cmax in Sprague-Dawley rat at 0.85 mg/kg, iv",Cmax,=,18.6,ug.mL-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139215,"J. Med. Chem., 50, p. 2 (2007)",17201404,Scientific Literature
6n,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL912853,"Cmax in Sprague-Dawley rat at 1.6 mg/kg, iv",Cmax,=,1.27,ug.mL-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139215,"J. Med. Chem., 50, p. 2 (2007)",17201404,Scientific Literature
6h,CHEMBL220465,"InChI=1S/C25H24N8O3/c1-4-33-20-13-21(27-14-19(20)29-24(33)22-23(26)31-36-30-22)35-18-7-5-6-16(12-18)28-25(34)15-8-10-17(11-9-15)32(2)3/h5-14H,4H2,1-3H3,(H2,26,31)(H,28,34)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(cc4)N(C)C)c3)cc12)c5nonc5N,CHEMBL220465,"InChI=1S/C25H24N8O3/c1-4-33-20-13-21(27-14-19(20)29-24(33)22-23(26)31-36-30-22)35-18-7-5-6-16(12-18)28-25(34)15-8-10-17(11-9-15)32(2)3/h5-14H,4H2,1-3H3,(H2,26,31)(H,28,34)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(cc4)N(C)C)c3)cc12)c5nonc5N,CHEMBL912837,"Cmax in Sprague-Dawley rat at 2 mg/kg, po",Cmax,=,3.62,ug.mL-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139215,"J. Med. Chem., 50, p. 2 (2007)",17201404,Scientific Literature
6n,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL912855,"Cmax in Sprague-Dawley rat at 3.3 mg/kg, po",Cmax,=,0.8,ug.mL-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139215,"J. Med. Chem., 50, p. 2 (2007)",17201404,Scientific Literature
6h,CHEMBL220465,"InChI=1S/C25H24N8O3/c1-4-33-20-13-21(27-14-19(20)29-24(33)22-23(26)31-36-30-22)35-18-7-5-6-16(12-18)28-25(34)15-8-10-17(11-9-15)32(2)3/h5-14H,4H2,1-3H3,(H2,26,31)(H,28,34)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(cc4)N(C)C)c3)cc12)c5nonc5N,CHEMBL220465,"InChI=1S/C25H24N8O3/c1-4-33-20-13-21(27-14-19(20)29-24(33)22-23(26)31-36-30-22)35-18-7-5-6-16(12-18)28-25(34)15-8-10-17(11-9-15)32(2)3/h5-14H,4H2,1-3H3,(H2,26,31)(H,28,34)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(cc4)N(C)C)c3)cc12)c5nonc5N,CHEMBL912838,"Half life in Sprague-Dawley rat at 0.85 mg/kg, iv",T1/2,=,8.6,hr,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139215,"J. Med. Chem., 50, p. 2 (2007)",17201404,Scientific Literature
6n,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL912860,"Half life in Sprague-Dawley rat at 1.6 mg/kg, iv",T1/2,=,2.2,hr,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139215,"J. Med. Chem., 50, p. 2 (2007)",17201404,Scientific Literature
6h,CHEMBL220465,"InChI=1S/C25H24N8O3/c1-4-33-20-13-21(27-14-19(20)29-24(33)22-23(26)31-36-30-22)35-18-7-5-6-16(12-18)28-25(34)15-8-10-17(11-9-15)32(2)3/h5-14H,4H2,1-3H3,(H2,26,31)(H,28,34)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(cc4)N(C)C)c3)cc12)c5nonc5N,CHEMBL220465,"InChI=1S/C25H24N8O3/c1-4-33-20-13-21(27-14-19(20)29-24(33)22-23(26)31-36-30-22)35-18-7-5-6-16(12-18)28-25(34)15-8-10-17(11-9-15)32(2)3/h5-14H,4H2,1-3H3,(H2,26,31)(H,28,34)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(cc4)N(C)C)c3)cc12)c5nonc5N,CHEMBL912268,Inhibition of human ROCK1 in Sf9 cells,IC50,=,2,nM,,CHEMBL3231,Rho-associated protein kinase 1 ,Homo sapiens,Q13464,CHEMBL1139215,"J. Med. Chem., 50, p. 2 (2007)",17201404,Scientific Literature
6n,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL912268,Inhibition of human ROCK1 in Sf9 cells,IC50,=,1.8,nM,,CHEMBL3231,Rho-associated protein kinase 1 ,Homo sapiens,Q13464,CHEMBL1139215,"J. Med. Chem., 50, p. 2 (2007)",17201404,Scientific Literature
6h,CHEMBL220465,"InChI=1S/C25H24N8O3/c1-4-33-20-13-21(27-14-19(20)29-24(33)22-23(26)31-36-30-22)35-18-7-5-6-16(12-18)28-25(34)15-8-10-17(11-9-15)32(2)3/h5-14H,4H2,1-3H3,(H2,26,31)(H,28,34)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(cc4)N(C)C)c3)cc12)c5nonc5N,CHEMBL220465,"InChI=1S/C25H24N8O3/c1-4-33-20-13-21(27-14-19(20)29-24(33)22-23(26)31-36-30-22)35-18-7-5-6-16(12-18)28-25(34)15-8-10-17(11-9-15)32(2)3/h5-14H,4H2,1-3H3,(H2,26,31)(H,28,34)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(cc4)N(C)C)c3)cc12)c5nonc5N,CHEMBL912841,"Oral bioavailability in Sprague-Dawley rat at 2 mg/kg, po",F,=,11,%,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139215,"J. Med. Chem., 50, p. 2 (2007)",17201404,Scientific Literature
6n,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL912871,"Oral bioavailability in Sprague-Dawley rat at 3.3 mg/kg, po",F,=,78,%,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139215,"J. Med. Chem., 50, p. 2 (2007)",17201404,Scientific Literature
6n,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL911685,"Plasma concentration in spotaneously hypertensive rat at 3 mg/kg, po after 0.5 hrs",Cp,=,280,ng ml-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139215,"J. Med. Chem., 50, p. 2 (2007)",17201404,Scientific Literature
6n,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL911686,"Plasma concentration in spotaneously hypertensive rat at 3 mg/kg, po after 1 hr",Cp,=,330,ng ml-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139215,"J. Med. Chem., 50, p. 2 (2007)",17201404,Scientific Literature
6n,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL911687,"Plasma concentration in spotaneously hypertensive rat at 3 mg/kg, po after 2 hrs",Cp,=,290,ng ml-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139215,"J. Med. Chem., 50, p. 2 (2007)",17201404,Scientific Literature
6n,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL913364,"Plasma concentration in spotaneously hypertensive rat at 3 mg/kg, po after 4 hrs",Cp,=,150,ng ml-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139215,"J. Med. Chem., 50, p. 2 (2007)",17201404,Scientific Literature
6n,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL913365,"Plasma concentration in spotaneously hypertensive rat at 3 mg/kg, po after 8 hrs",Cp,=,88,ng ml-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139215,"J. Med. Chem., 50, p. 2 (2007)",17201404,Scientific Literature
6n,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL911682,"Reduction of mean arterial blood pressure in spontaneous hypertensive rat at 0.3 mg/kg, po",Activity,,,,Active,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139215,"J. Med. Chem., 50, p. 2 (2007)",17201404,Scientific Literature
6n,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL911683,"Reduction of mean arterial blood pressure in spontaneous hypertensive rat at 1 mg/kg, po",Activity,,,,Active,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139215,"J. Med. Chem., 50, p. 2 (2007)",17201404,Scientific Literature
6n,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL911684,"Reduction of mean arterial blood pressure in spontaneous hypertensive rat at 3 mg/kg, po",Activity,,,,Active,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139215,"J. Med. Chem., 50, p. 2 (2007)",17201404,Scientific Literature
6h,CHEMBL220465,"InChI=1S/C25H24N8O3/c1-4-33-20-13-21(27-14-19(20)29-24(33)22-23(26)31-36-30-22)35-18-7-5-6-16(12-18)28-25(34)15-8-10-17(11-9-15)32(2)3/h5-14H,4H2,1-3H3,(H2,26,31)(H,28,34)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(cc4)N(C)C)c3)cc12)c5nonc5N,CHEMBL220465,"InChI=1S/C25H24N8O3/c1-4-33-20-13-21(27-14-19(20)29-24(33)22-23(26)31-36-30-22)35-18-7-5-6-16(12-18)28-25(34)15-8-10-17(11-9-15)32(2)3/h5-14H,4H2,1-3H3,(H2,26,31)(H,28,34)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(cc4)N(C)C)c3)cc12)c5nonc5N,CHEMBL912259,Relaxation of phenylephrine contracted Sprague-Dawley rat aortic rings,IC50,=,106,nM,,CHEMBL613606,Aorta,Rattus norvegicus,,CHEMBL1139215,"J. Med. Chem., 50, p. 2 (2007)",17201404,Scientific Literature
6n,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL912259,Relaxation of phenylephrine contracted Sprague-Dawley rat aortic rings,IC50,=,35,nM,,CHEMBL613606,Aorta,Rattus norvegicus,,CHEMBL1139215,"J. Med. Chem., 50, p. 2 (2007)",17201404,Scientific Literature
6h,CHEMBL220465,"InChI=1S/C25H24N8O3/c1-4-33-20-13-21(27-14-19(20)29-24(33)22-23(26)31-36-30-22)35-18-7-5-6-16(12-18)28-25(34)15-8-10-17(11-9-15)32(2)3/h5-14H,4H2,1-3H3,(H2,26,31)(H,28,34)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(cc4)N(C)C)c3)cc12)c5nonc5N,CHEMBL220465,"InChI=1S/C25H24N8O3/c1-4-33-20-13-21(27-14-19(20)29-24(33)22-23(26)31-36-30-22)35-18-7-5-6-16(12-18)28-25(34)15-8-10-17(11-9-15)32(2)3/h5-14H,4H2,1-3H3,(H2,26,31)(H,28,34)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(cc4)N(C)C)c3)cc12)c5nonc5N,CHEMBL912840,Volume of distribution in Sprague-Dawley rat at 0.85 mg/kg,Vdss,=,0.09,L.kg-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139215,"J. Med. Chem., 50, p. 2 (2007)",17201404,Scientific Literature
6n,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL912869,"Volume of distribution in Sprague-Dawley rat at 1.6 mg/kg, iv",Vdss,=,1.3,L.kg-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139215,"J. Med. Chem., 50, p. 2 (2007)",17201404,Scientific Literature
3,CHEMBL384073,"InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)",CC1=C(C(NC(=O)N1)c2ccc(F)cc2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL384073,"InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)",CC1=C(C(NC(=O)N1)c2ccc(F)cc2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL913380,Clearance in Sprague-Dawley rat,CL,=,50,mL.min-1.kg-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
11,CHEMBL374453,"InChI=1S/C20H16Cl2N4O2/c1-10-19(20(28)25-13-3-5-17-12(6-13)9-23-26-17)14(8-18(27)24-10)11-2-4-15(21)16(22)7-11/h2-7,9,14H,8H2,1H3,(H,23,26)(H,24,27)(H,25,28)",CC1=C(C(CC(=O)N1)c2ccc(Cl)c(Cl)c2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL374453,"InChI=1S/C20H16Cl2N4O2/c1-10-19(20(28)25-13-3-5-17-12(6-13)9-23-26-17)14(8-18(27)24-10)11-2-4-15(21)16(22)7-11/h2-7,9,14H,8H2,1H3,(H,23,26)(H,24,27)(H,25,28)",CC1=C(C(CC(=O)N1)c2ccc(Cl)c(Cl)c2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL853720,Clearance in Sprague-Dawley rat at 0.9 mg/kg,CL,=,57,mL.min-1.kg-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
16,CHEMBL427058,"InChI=1S/C21H16ClF3N4O2/c1-10-18(20(31)28-14-6-12-9-26-29-19(12)16(22)7-14)15(8-17(30)27-10)11-2-4-13(5-3-11)21(23,24)25/h2-7,9,15H,8H2,1H3,(H,26,29)(H,27,30)(H,28,31)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3cc(Cl)c4[nH]ncc4c3,CHEMBL427058,"InChI=1S/C21H16ClF3N4O2/c1-10-18(20(31)28-14-6-12-9-26-29-19(12)16(22)7-14)15(8-17(30)27-10)11-2-4-13(5-3-11)21(23,24)25/h2-7,9,15H,8H2,1H3,(H,26,29)(H,27,30)(H,28,31)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3cc(Cl)c4[nH]ncc4c3,CHEMBL853720,Clearance in Sprague-Dawley rat at 0.9 mg/kg,CL,=,81,mL.min-1.kg-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
13,CHEMBL218720,"InChI=1S/C22H19F3N4O2/c1-11-16-9-15(7-8-18(16)29-28-11)27-21(31)20-12(2)26-19(30)10-17(20)13-3-5-14(6-4-13)22(23,24)25/h3-9,17H,10H2,1-2H3,(H,26,30)(H,27,31)(H,28,29)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3ccc4[nH]nc(C)c4c3,CHEMBL218720,"InChI=1S/C22H19F3N4O2/c1-11-16-9-15(7-8-18(16)29-28-11)27-21(31)20-12(2)26-19(30)10-17(20)13-3-5-14(6-4-13)22(23,24)25/h3-9,17H,10H2,1-2H3,(H,26,30)(H,27,31)(H,28,29)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3ccc4[nH]nc(C)c4c3,CHEMBL913383,Clearance in Sprague-Dawley rat at 1.3 mg/kg,CL,=,24,mL.min-1.kg-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
3,CHEMBL384073,"InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)",CC1=C(C(NC(=O)N1)c2ccc(F)cc2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL384073,"InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)",CC1=C(C(NC(=O)N1)c2ccc(F)cc2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL913383,Clearance in Sprague-Dawley rat at 1.3 mg/kg,CL,=,49,mL.min-1.kg-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
12,CHEMBL441702,"InChI=1S/C24H20N4O2/c1-14-23(24(30)27-19-8-9-21-18(11-19)13-25-28-21)20(12-22(29)26-14)17-7-6-15-4-2-3-5-16(15)10-17/h2-11,13,20H,12H2,1H3,(H,25,28)(H,26,29)(H,27,30)",CC1=C(C(CC(=O)N1)c2ccc3ccccc3c2)C(=O)Nc4ccc5[nH]ncc5c4,CHEMBL441702,"InChI=1S/C24H20N4O2/c1-14-23(24(30)27-19-8-9-21-18(11-19)13-25-28-21)20(12-22(29)26-14)17-7-6-15-4-2-3-5-16(15)10-17/h2-11,13,20H,12H2,1H3,(H,25,28)(H,26,29)(H,27,30)",CC1=C(C(CC(=O)N1)c2ccc3ccccc3c2)C(=O)Nc4ccc5[nH]ncc5c4,CHEMBL853721,Clearance in Sprague-Dawley rat at 1.7 mg/kg,CL,=,45,mL.min-1.kg-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
11,CHEMBL374453,"InChI=1S/C20H16Cl2N4O2/c1-10-19(20(28)25-13-3-5-17-12(6-13)9-23-26-17)14(8-18(27)24-10)11-2-4-15(21)16(22)7-11/h2-7,9,14H,8H2,1H3,(H,23,26)(H,24,27)(H,25,28)",CC1=C(C(CC(=O)N1)c2ccc(Cl)c(Cl)c2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL374453,"InChI=1S/C20H16Cl2N4O2/c1-10-19(20(28)25-13-3-5-17-12(6-13)9-23-26-17)14(8-18(27)24-10)11-2-4-15(21)16(22)7-11/h2-7,9,14H,8H2,1H3,(H,23,26)(H,24,27)(H,25,28)",CC1=C(C(CC(=O)N1)c2ccc(Cl)c(Cl)c2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL853716,"Cmax in Sprague-Dawley rat at 0.9 mg/kg, iv",Cmax,=,0.334,ug.mL-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
16,CHEMBL427058,"InChI=1S/C21H16ClF3N4O2/c1-10-18(20(31)28-14-6-12-9-26-29-19(12)16(22)7-14)15(8-17(30)27-10)11-2-4-13(5-3-11)21(23,24)25/h2-7,9,15H,8H2,1H3,(H,26,29)(H,27,30)(H,28,31)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3cc(Cl)c4[nH]ncc4c3,CHEMBL427058,"InChI=1S/C21H16ClF3N4O2/c1-10-18(20(31)28-14-6-12-9-26-29-19(12)16(22)7-14)15(8-17(30)27-10)11-2-4-13(5-3-11)21(23,24)25/h2-7,9,15H,8H2,1H3,(H,26,29)(H,27,30)(H,28,31)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3cc(Cl)c4[nH]ncc4c3,CHEMBL853716,"Cmax in Sprague-Dawley rat at 0.9 mg/kg, iv",Cmax,=,0.424,ug.mL-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
13,CHEMBL218720,"InChI=1S/C22H19F3N4O2/c1-11-16-9-15(7-8-18(16)29-28-11)27-21(31)20-12(2)26-19(30)10-17(20)13-3-5-14(6-4-13)22(23,24)25/h3-9,17H,10H2,1-2H3,(H,26,30)(H,27,31)(H,28,29)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3ccc4[nH]nc(C)c4c3,CHEMBL218720,"InChI=1S/C22H19F3N4O2/c1-11-16-9-15(7-8-18(16)29-28-11)27-21(31)20-12(2)26-19(30)10-17(20)13-3-5-14(6-4-13)22(23,24)25/h3-9,17H,10H2,1-2H3,(H,26,30)(H,27,31)(H,28,29)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3ccc4[nH]nc(C)c4c3,CHEMBL913381,"Cmax in Sprague-Dawley rat at 1.3 mg/kg, iv",Cmax,=,0.672,ug.mL-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
3,CHEMBL384073,"InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)",CC1=C(C(NC(=O)N1)c2ccc(F)cc2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL384073,"InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)",CC1=C(C(NC(=O)N1)c2ccc(F)cc2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL913381,"Cmax in Sprague-Dawley rat at 1.3 mg/kg, iv",Cmax,=,0.567,ug.mL-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
12,CHEMBL441702,"InChI=1S/C24H20N4O2/c1-14-23(24(30)27-19-8-9-21-18(11-19)13-25-28-21)20(12-22(29)26-14)17-7-6-15-4-2-3-5-16(15)10-17/h2-11,13,20H,12H2,1H3,(H,25,28)(H,26,29)(H,27,30)",CC1=C(C(CC(=O)N1)c2ccc3ccccc3c2)C(=O)Nc4ccc5[nH]ncc5c4,CHEMBL441702,"InChI=1S/C24H20N4O2/c1-14-23(24(30)27-19-8-9-21-18(11-19)13-25-28-21)20(12-22(29)26-14)17-7-6-15-4-2-3-5-16(15)10-17/h2-11,13,20H,12H2,1H3,(H,25,28)(H,26,29)(H,27,30)",CC1=C(C(CC(=O)N1)c2ccc3ccccc3c2)C(=O)Nc4ccc5[nH]ncc5c4,CHEMBL853717,"Cmax in Sprague-Dawley rat at 1.7 mg/kg, iv",Cmax,=,0.7,ug.mL-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
11,CHEMBL374453,"InChI=1S/C20H16Cl2N4O2/c1-10-19(20(28)25-13-3-5-17-12(6-13)9-23-26-17)14(8-18(27)24-10)11-2-4-15(21)16(22)7-11/h2-7,9,14H,8H2,1H3,(H,23,26)(H,24,27)(H,25,28)",CC1=C(C(CC(=O)N1)c2ccc(Cl)c(Cl)c2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL374453,"InChI=1S/C20H16Cl2N4O2/c1-10-19(20(28)25-13-3-5-17-12(6-13)9-23-26-17)14(8-18(27)24-10)11-2-4-15(21)16(22)7-11/h2-7,9,14H,8H2,1H3,(H,23,26)(H,24,27)(H,25,28)",CC1=C(C(CC(=O)N1)c2ccc(Cl)c(Cl)c2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL912246,Dilatory activity against phenylephrine-induced contraction of Sprague-Dawley rat thoracic aorta,IC50,,,,Not Determined,CHEMBL612545,,,,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
12,CHEMBL441702,"InChI=1S/C24H20N4O2/c1-14-23(24(30)27-19-8-9-21-18(11-19)13-25-28-21)20(12-22(29)26-14)17-7-6-15-4-2-3-5-16(15)10-17/h2-11,13,20H,12H2,1H3,(H,25,28)(H,26,29)(H,27,30)",CC1=C(C(CC(=O)N1)c2ccc3ccccc3c2)C(=O)Nc4ccc5[nH]ncc5c4,CHEMBL441702,"InChI=1S/C24H20N4O2/c1-14-23(24(30)27-19-8-9-21-18(11-19)13-25-28-21)20(12-22(29)26-14)17-7-6-15-4-2-3-5-16(15)10-17/h2-11,13,20H,12H2,1H3,(H,25,28)(H,26,29)(H,27,30)",CC1=C(C(CC(=O)N1)c2ccc3ccccc3c2)C(=O)Nc4ccc5[nH]ncc5c4,CHEMBL912246,Dilatory activity against phenylephrine-induced contraction of Sprague-Dawley rat thoracic aorta,IC50,=,76,nM,,CHEMBL612545,,,,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
13,CHEMBL218720,"InChI=1S/C22H19F3N4O2/c1-11-16-9-15(7-8-18(16)29-28-11)27-21(31)20-12(2)26-19(30)10-17(20)13-3-5-14(6-4-13)22(23,24)25/h3-9,17H,10H2,1-2H3,(H,26,30)(H,27,31)(H,28,29)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3ccc4[nH]nc(C)c4c3,CHEMBL218720,"InChI=1S/C22H19F3N4O2/c1-11-16-9-15(7-8-18(16)29-28-11)27-21(31)20-12(2)26-19(30)10-17(20)13-3-5-14(6-4-13)22(23,24)25/h3-9,17H,10H2,1-2H3,(H,26,30)(H,27,31)(H,28,29)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3ccc4[nH]nc(C)c4c3,CHEMBL912246,Dilatory activity against phenylephrine-induced contraction of Sprague-Dawley rat thoracic aorta,IC50,=,130,nM,,CHEMBL612545,,,,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
16,CHEMBL427058,"InChI=1S/C21H16ClF3N4O2/c1-10-18(20(31)28-14-6-12-9-26-29-19(12)16(22)7-14)15(8-17(30)27-10)11-2-4-13(5-3-11)21(23,24)25/h2-7,9,15H,8H2,1H3,(H,26,29)(H,27,30)(H,28,31)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3cc(Cl)c4[nH]ncc4c3,CHEMBL427058,"InChI=1S/C21H16ClF3N4O2/c1-10-18(20(31)28-14-6-12-9-26-29-19(12)16(22)7-14)15(8-17(30)27-10)11-2-4-13(5-3-11)21(23,24)25/h2-7,9,15H,8H2,1H3,(H,26,29)(H,27,30)(H,28,31)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3cc(Cl)c4[nH]ncc4c3,CHEMBL912246,Dilatory activity against phenylephrine-induced contraction of Sprague-Dawley rat thoracic aorta,IC50,,,,Not Determined,CHEMBL612545,,,,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
3,CHEMBL384073,"InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)",CC1=C(C(NC(=O)N1)c2ccc(F)cc2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL384073,"InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)",CC1=C(C(NC(=O)N1)c2ccc(F)cc2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL912246,Dilatory activity against phenylephrine-induced contraction of Sprague-Dawley rat thoracic aorta,IC50,=,760,nM,,CHEMBL612545,,,,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
11,CHEMBL374453,"InChI=1S/C20H16Cl2N4O2/c1-10-19(20(28)25-13-3-5-17-12(6-13)9-23-26-17)14(8-18(27)24-10)11-2-4-15(21)16(22)7-11/h2-7,9,14H,8H2,1H3,(H,23,26)(H,24,27)(H,25,28)",CC1=C(C(CC(=O)N1)c2ccc(Cl)c(Cl)c2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL374453,"InChI=1S/C20H16Cl2N4O2/c1-10-19(20(28)25-13-3-5-17-12(6-13)9-23-26-17)14(8-18(27)24-10)11-2-4-15(21)16(22)7-11/h2-7,9,14H,8H2,1H3,(H,23,26)(H,24,27)(H,25,28)",CC1=C(C(CC(=O)N1)c2ccc(Cl)c(Cl)c2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL853718,Half life in Sprague-Dawley rat at 0.9 mg/kg,T1/2,=,0.8,hr,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
16,CHEMBL427058,"InChI=1S/C21H16ClF3N4O2/c1-10-18(20(31)28-14-6-12-9-26-29-19(12)16(22)7-14)15(8-17(30)27-10)11-2-4-13(5-3-11)21(23,24)25/h2-7,9,15H,8H2,1H3,(H,26,29)(H,27,30)(H,28,31)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3cc(Cl)c4[nH]ncc4c3,CHEMBL427058,"InChI=1S/C21H16ClF3N4O2/c1-10-18(20(31)28-14-6-12-9-26-29-19(12)16(22)7-14)15(8-17(30)27-10)11-2-4-13(5-3-11)21(23,24)25/h2-7,9,15H,8H2,1H3,(H,26,29)(H,27,30)(H,28,31)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3cc(Cl)c4[nH]ncc4c3,CHEMBL853718,Half life in Sprague-Dawley rat at 0.9 mg/kg,T1/2,=,1.2,hr,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
13,CHEMBL218720,"InChI=1S/C22H19F3N4O2/c1-11-16-9-15(7-8-18(16)29-28-11)27-21(31)20-12(2)26-19(30)10-17(20)13-3-5-14(6-4-13)22(23,24)25/h3-9,17H,10H2,1-2H3,(H,26,30)(H,27,31)(H,28,29)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3ccc4[nH]nc(C)c4c3,CHEMBL218720,"InChI=1S/C22H19F3N4O2/c1-11-16-9-15(7-8-18(16)29-28-11)27-21(31)20-12(2)26-19(30)10-17(20)13-3-5-14(6-4-13)22(23,24)25/h3-9,17H,10H2,1-2H3,(H,26,30)(H,27,31)(H,28,29)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3ccc4[nH]nc(C)c4c3,CHEMBL913382,Half life in Sprague-Dawley rat at 1.3 mg/kg,T1/2,=,2,hr,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
3,CHEMBL384073,"InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)",CC1=C(C(NC(=O)N1)c2ccc(F)cc2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL384073,"InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)",CC1=C(C(NC(=O)N1)c2ccc(F)cc2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL913382,Half life in Sprague-Dawley rat at 1.3 mg/kg,T1/2,=,0.7,hr,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
12,CHEMBL441702,"InChI=1S/C24H20N4O2/c1-14-23(24(30)27-19-8-9-21-18(11-19)13-25-28-21)20(12-22(29)26-14)17-7-6-15-4-2-3-5-16(15)10-17/h2-11,13,20H,12H2,1H3,(H,25,28)(H,26,29)(H,27,30)",CC1=C(C(CC(=O)N1)c2ccc3ccccc3c2)C(=O)Nc4ccc5[nH]ncc5c4,CHEMBL441702,"InChI=1S/C24H20N4O2/c1-14-23(24(30)27-19-8-9-21-18(11-19)13-25-28-21)20(12-22(29)26-14)17-7-6-15-4-2-3-5-16(15)10-17/h2-11,13,20H,12H2,1H3,(H,25,28)(H,26,29)(H,27,30)",CC1=C(C(CC(=O)N1)c2ccc3ccccc3c2)C(=O)Nc4ccc5[nH]ncc5c4,CHEMBL853719,Half life in Sprague-Dawley rat at 1.7 mg/kg,T1/2,=,0.9,hr,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
11,CHEMBL374453,"InChI=1S/C20H16Cl2N4O2/c1-10-19(20(28)25-13-3-5-17-12(6-13)9-23-26-17)14(8-18(27)24-10)11-2-4-15(21)16(22)7-11/h2-7,9,14H,8H2,1H3,(H,23,26)(H,24,27)(H,25,28)",CC1=C(C(CC(=O)N1)c2ccc(Cl)c(Cl)c2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL374453,"InChI=1S/C20H16Cl2N4O2/c1-10-19(20(28)25-13-3-5-17-12(6-13)9-23-26-17)14(8-18(27)24-10)11-2-4-15(21)16(22)7-11/h2-7,9,14H,8H2,1H3,(H,23,26)(H,24,27)(H,25,28)",CC1=C(C(CC(=O)N1)c2ccc(Cl)c(Cl)c2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL911039,Inhibition of RSK1,IC50,=,620,nM,,CHEMBL2553,Ribosomal protein S6 kinase alpha 1,Homo sapiens,Q15418,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
12,CHEMBL441702,"InChI=1S/C24H20N4O2/c1-14-23(24(30)27-19-8-9-21-18(11-19)13-25-28-21)20(12-22(29)26-14)17-7-6-15-4-2-3-5-16(15)10-17/h2-11,13,20H,12H2,1H3,(H,25,28)(H,26,29)(H,27,30)",CC1=C(C(CC(=O)N1)c2ccc3ccccc3c2)C(=O)Nc4ccc5[nH]ncc5c4,CHEMBL441702,"InChI=1S/C24H20N4O2/c1-14-23(24(30)27-19-8-9-21-18(11-19)13-25-28-21)20(12-22(29)26-14)17-7-6-15-4-2-3-5-16(15)10-17/h2-11,13,20H,12H2,1H3,(H,25,28)(H,26,29)(H,27,30)",CC1=C(C(CC(=O)N1)c2ccc3ccccc3c2)C(=O)Nc4ccc5[nH]ncc5c4,CHEMBL911039,Inhibition of RSK1,IC50,=,1100,nM,,CHEMBL2553,Ribosomal protein S6 kinase alpha 1,Homo sapiens,Q15418,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
13,CHEMBL218720,"InChI=1S/C22H19F3N4O2/c1-11-16-9-15(7-8-18(16)29-28-11)27-21(31)20-12(2)26-19(30)10-17(20)13-3-5-14(6-4-13)22(23,24)25/h3-9,17H,10H2,1-2H3,(H,26,30)(H,27,31)(H,28,29)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3ccc4[nH]nc(C)c4c3,CHEMBL218720,"InChI=1S/C22H19F3N4O2/c1-11-16-9-15(7-8-18(16)29-28-11)27-21(31)20-12(2)26-19(30)10-17(20)13-3-5-14(6-4-13)22(23,24)25/h3-9,17H,10H2,1-2H3,(H,26,30)(H,27,31)(H,28,29)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3ccc4[nH]nc(C)c4c3,CHEMBL911039,Inhibition of RSK1,IC50,=,1950,nM,,CHEMBL2553,Ribosomal protein S6 kinase alpha 1,Homo sapiens,Q15418,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
16,CHEMBL427058,"InChI=1S/C21H16ClF3N4O2/c1-10-18(20(31)28-14-6-12-9-26-29-19(12)16(22)7-14)15(8-17(30)27-10)11-2-4-13(5-3-11)21(23,24)25/h2-7,9,15H,8H2,1H3,(H,26,29)(H,27,30)(H,28,31)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3cc(Cl)c4[nH]ncc4c3,CHEMBL427058,"InChI=1S/C21H16ClF3N4O2/c1-10-18(20(31)28-14-6-12-9-26-29-19(12)16(22)7-14)15(8-17(30)27-10)11-2-4-13(5-3-11)21(23,24)25/h2-7,9,15H,8H2,1H3,(H,26,29)(H,27,30)(H,28,31)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3cc(Cl)c4[nH]ncc4c3,CHEMBL911039,Inhibition of RSK1,IC50,=,90,nM,,CHEMBL2553,Ribosomal protein S6 kinase alpha 1,Homo sapiens,Q15418,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
3,CHEMBL384073,"InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)",CC1=C(C(NC(=O)N1)c2ccc(F)cc2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL384073,"InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)",CC1=C(C(NC(=O)N1)c2ccc(F)cc2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL911039,Inhibition of RSK1,IC50,=,3100,nM,,CHEMBL2553,Ribosomal protein S6 kinase alpha 1,Homo sapiens,Q15418,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
11,CHEMBL374453,"InChI=1S/C20H16Cl2N4O2/c1-10-19(20(28)25-13-3-5-17-12(6-13)9-23-26-17)14(8-18(27)24-10)11-2-4-15(21)16(22)7-11/h2-7,9,14H,8H2,1H3,(H,23,26)(H,24,27)(H,25,28)",CC1=C(C(CC(=O)N1)c2ccc(Cl)c(Cl)c2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL374453,"InChI=1S/C20H16Cl2N4O2/c1-10-19(20(28)25-13-3-5-17-12(6-13)9-23-26-17)14(8-18(27)24-10)11-2-4-15(21)16(22)7-11/h2-7,9,14H,8H2,1H3,(H,23,26)(H,24,27)(H,25,28)",CC1=C(C(CC(=O)N1)c2ccc(Cl)c(Cl)c2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL912250,Inhibition of human recombinant ROCK1 expressed in Sf9 cells at 10 mM,IC50,=,8,nM,,CHEMBL3231,Rho-associated protein kinase 1 ,Homo sapiens,Q13464,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
12,CHEMBL441702,"InChI=1S/C24H20N4O2/c1-14-23(24(30)27-19-8-9-21-18(11-19)13-25-28-21)20(12-22(29)26-14)17-7-6-15-4-2-3-5-16(15)10-17/h2-11,13,20H,12H2,1H3,(H,25,28)(H,26,29)(H,27,30)",CC1=C(C(CC(=O)N1)c2ccc3ccccc3c2)C(=O)Nc4ccc5[nH]ncc5c4,CHEMBL441702,"InChI=1S/C24H20N4O2/c1-14-23(24(30)27-19-8-9-21-18(11-19)13-25-28-21)20(12-22(29)26-14)17-7-6-15-4-2-3-5-16(15)10-17/h2-11,13,20H,12H2,1H3,(H,25,28)(H,26,29)(H,27,30)",CC1=C(C(CC(=O)N1)c2ccc3ccccc3c2)C(=O)Nc4ccc5[nH]ncc5c4,CHEMBL912250,Inhibition of human recombinant ROCK1 expressed in Sf9 cells at 10 mM,IC50,=,9,nM,,CHEMBL3231,Rho-associated protein kinase 1 ,Homo sapiens,Q13464,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
13,CHEMBL218720,"InChI=1S/C22H19F3N4O2/c1-11-16-9-15(7-8-18(16)29-28-11)27-21(31)20-12(2)26-19(30)10-17(20)13-3-5-14(6-4-13)22(23,24)25/h3-9,17H,10H2,1-2H3,(H,26,30)(H,27,31)(H,28,29)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3ccc4[nH]nc(C)c4c3,CHEMBL218720,"InChI=1S/C22H19F3N4O2/c1-11-16-9-15(7-8-18(16)29-28-11)27-21(31)20-12(2)26-19(30)10-17(20)13-3-5-14(6-4-13)22(23,24)25/h3-9,17H,10H2,1-2H3,(H,26,30)(H,27,31)(H,28,29)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3ccc4[nH]nc(C)c4c3,CHEMBL912250,Inhibition of human recombinant ROCK1 expressed in Sf9 cells at 10 mM,IC50,=,9,nM,,CHEMBL3231,Rho-associated protein kinase 1 ,Homo sapiens,Q13464,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
16,CHEMBL427058,"InChI=1S/C21H16ClF3N4O2/c1-10-18(20(31)28-14-6-12-9-26-29-19(12)16(22)7-14)15(8-17(30)27-10)11-2-4-13(5-3-11)21(23,24)25/h2-7,9,15H,8H2,1H3,(H,26,29)(H,27,30)(H,28,31)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3cc(Cl)c4[nH]ncc4c3,CHEMBL427058,"InChI=1S/C21H16ClF3N4O2/c1-10-18(20(31)28-14-6-12-9-26-29-19(12)16(22)7-14)15(8-17(30)27-10)11-2-4-13(5-3-11)21(23,24)25/h2-7,9,15H,8H2,1H3,(H,26,29)(H,27,30)(H,28,31)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3cc(Cl)c4[nH]ncc4c3,CHEMBL912250,Inhibition of human recombinant ROCK1 expressed in Sf9 cells at 10 mM,IC50,=,8,nM,,CHEMBL3231,Rho-associated protein kinase 1 ,Homo sapiens,Q13464,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
3,CHEMBL384073,"InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)",CC1=C(C(NC(=O)N1)c2ccc(F)cc2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL384073,"InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)",CC1=C(C(NC(=O)N1)c2ccc(F)cc2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL912250,Inhibition of human recombinant ROCK1 expressed in Sf9 cells at 10 mM,IC50,=,14,nM,,CHEMBL3231,Rho-associated protein kinase 1 ,Homo sapiens,Q13464,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
11,CHEMBL374453,"InChI=1S/C20H16Cl2N4O2/c1-10-19(20(28)25-13-3-5-17-12(6-13)9-23-26-17)14(8-18(27)24-10)11-2-4-15(21)16(22)7-11/h2-7,9,14H,8H2,1H3,(H,23,26)(H,24,27)(H,25,28)",CC1=C(C(CC(=O)N1)c2ccc(Cl)c(Cl)c2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL374453,"InChI=1S/C20H16Cl2N4O2/c1-10-19(20(28)25-13-3-5-17-12(6-13)9-23-26-17)14(8-18(27)24-10)11-2-4-15(21)16(22)7-11/h2-7,9,14H,8H2,1H3,(H,23,26)(H,24,27)(H,25,28)",CC1=C(C(CC(=O)N1)c2ccc(Cl)c(Cl)c2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL913368,Inhibition of p70S6K,IC50,=,560,nM,,CHEMBL4501,Ribosomal protein S6 kinase 1,Homo sapiens,P23443,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
12,CHEMBL441702,"InChI=1S/C24H20N4O2/c1-14-23(24(30)27-19-8-9-21-18(11-19)13-25-28-21)20(12-22(29)26-14)17-7-6-15-4-2-3-5-16(15)10-17/h2-11,13,20H,12H2,1H3,(H,25,28)(H,26,29)(H,27,30)",CC1=C(C(CC(=O)N1)c2ccc3ccccc3c2)C(=O)Nc4ccc5[nH]ncc5c4,CHEMBL441702,"InChI=1S/C24H20N4O2/c1-14-23(24(30)27-19-8-9-21-18(11-19)13-25-28-21)20(12-22(29)26-14)17-7-6-15-4-2-3-5-16(15)10-17/h2-11,13,20H,12H2,1H3,(H,25,28)(H,26,29)(H,27,30)",CC1=C(C(CC(=O)N1)c2ccc3ccccc3c2)C(=O)Nc4ccc5[nH]ncc5c4,CHEMBL913368,Inhibition of p70S6K,IC50,=,1550,nM,,CHEMBL4501,Ribosomal protein S6 kinase 1,Homo sapiens,P23443,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
13,CHEMBL218720,"InChI=1S/C22H19F3N4O2/c1-11-16-9-15(7-8-18(16)29-28-11)27-21(31)20-12(2)26-19(30)10-17(20)13-3-5-14(6-4-13)22(23,24)25/h3-9,17H,10H2,1-2H3,(H,26,30)(H,27,31)(H,28,29)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3ccc4[nH]nc(C)c4c3,CHEMBL218720,"InChI=1S/C22H19F3N4O2/c1-11-16-9-15(7-8-18(16)29-28-11)27-21(31)20-12(2)26-19(30)10-17(20)13-3-5-14(6-4-13)22(23,24)25/h3-9,17H,10H2,1-2H3,(H,26,30)(H,27,31)(H,28,29)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3ccc4[nH]nc(C)c4c3,CHEMBL913368,Inhibition of p70S6K,IC50,=,4790,nM,,CHEMBL4501,Ribosomal protein S6 kinase 1,Homo sapiens,P23443,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
16,CHEMBL427058,"InChI=1S/C21H16ClF3N4O2/c1-10-18(20(31)28-14-6-12-9-26-29-19(12)16(22)7-14)15(8-17(30)27-10)11-2-4-13(5-3-11)21(23,24)25/h2-7,9,15H,8H2,1H3,(H,26,29)(H,27,30)(H,28,31)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3cc(Cl)c4[nH]ncc4c3,CHEMBL427058,"InChI=1S/C21H16ClF3N4O2/c1-10-18(20(31)28-14-6-12-9-26-29-19(12)16(22)7-14)15(8-17(30)27-10)11-2-4-13(5-3-11)21(23,24)25/h2-7,9,15H,8H2,1H3,(H,26,29)(H,27,30)(H,28,31)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3cc(Cl)c4[nH]ncc4c3,CHEMBL913368,Inhibition of p70S6K,IC50,=,590,nM,,CHEMBL4501,Ribosomal protein S6 kinase 1,Homo sapiens,P23443,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
3,CHEMBL384073,"InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)",CC1=C(C(NC(=O)N1)c2ccc(F)cc2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL384073,"InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)",CC1=C(C(NC(=O)N1)c2ccc(F)cc2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL913368,Inhibition of p70S6K,IC50,=,2850,nM,,CHEMBL4501,Ribosomal protein S6 kinase 1,Homo sapiens,P23443,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
11,CHEMBL374453,"InChI=1S/C20H16Cl2N4O2/c1-10-19(20(28)25-13-3-5-17-12(6-13)9-23-26-17)14(8-18(27)24-10)11-2-4-15(21)16(22)7-11/h2-7,9,14H,8H2,1H3,(H,23,26)(H,24,27)(H,25,28)",CC1=C(C(CC(=O)N1)c2ccc(Cl)c(Cl)c2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL374453,"InChI=1S/C20H16Cl2N4O2/c1-10-19(20(28)25-13-3-5-17-12(6-13)9-23-26-17)14(8-18(27)24-10)11-2-4-15(21)16(22)7-11/h2-7,9,14H,8H2,1H3,(H,23,26)(H,24,27)(H,25,28)",CC1=C(C(CC(=O)N1)c2ccc(Cl)c(Cl)c2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL853724,"Oral bioavailability in Sprague-Dawley rat at 0.9 mg/kg, po",F,=,1,%,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
16,CHEMBL427058,"InChI=1S/C21H16ClF3N4O2/c1-10-18(20(31)28-14-6-12-9-26-29-19(12)16(22)7-14)15(8-17(30)27-10)11-2-4-13(5-3-11)21(23,24)25/h2-7,9,15H,8H2,1H3,(H,26,29)(H,27,30)(H,28,31)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3cc(Cl)c4[nH]ncc4c3,CHEMBL427058,"InChI=1S/C21H16ClF3N4O2/c1-10-18(20(31)28-14-6-12-9-26-29-19(12)16(22)7-14)15(8-17(30)27-10)11-2-4-13(5-3-11)21(23,24)25/h2-7,9,15H,8H2,1H3,(H,26,29)(H,27,30)(H,28,31)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3cc(Cl)c4[nH]ncc4c3,CHEMBL853724,"Oral bioavailability in Sprague-Dawley rat at 0.9 mg/kg, po",F,=,29,%,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
13,CHEMBL218720,"InChI=1S/C22H19F3N4O2/c1-11-16-9-15(7-8-18(16)29-28-11)27-21(31)20-12(2)26-19(30)10-17(20)13-3-5-14(6-4-13)22(23,24)25/h3-9,17H,10H2,1-2H3,(H,26,30)(H,27,31)(H,28,29)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3ccc4[nH]nc(C)c4c3,CHEMBL218720,"InChI=1S/C22H19F3N4O2/c1-11-16-9-15(7-8-18(16)29-28-11)27-21(31)20-12(2)26-19(30)10-17(20)13-3-5-14(6-4-13)22(23,24)25/h3-9,17H,10H2,1-2H3,(H,26,30)(H,27,31)(H,28,29)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3ccc4[nH]nc(C)c4c3,CHEMBL913378,"Oral bioavailability in Sprague-Dawley rat at 1.3 mg/kg, po",F,=,18,%,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
3,CHEMBL384073,"InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)",CC1=C(C(NC(=O)N1)c2ccc(F)cc2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL384073,"InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)",CC1=C(C(NC(=O)N1)c2ccc(F)cc2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL913378,"Oral bioavailability in Sprague-Dawley rat at 1.3 mg/kg, po",F,,,,Not Determined,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
12,CHEMBL441702,"InChI=1S/C24H20N4O2/c1-14-23(24(30)27-19-8-9-21-18(11-19)13-25-28-21)20(12-22(29)26-14)17-7-6-15-4-2-3-5-16(15)10-17/h2-11,13,20H,12H2,1H3,(H,25,28)(H,26,29)(H,27,30)",CC1=C(C(CC(=O)N1)c2ccc3ccccc3c2)C(=O)Nc4ccc5[nH]ncc5c4,CHEMBL441702,"InChI=1S/C24H20N4O2/c1-14-23(24(30)27-19-8-9-21-18(11-19)13-25-28-21)20(12-22(29)26-14)17-7-6-15-4-2-3-5-16(15)10-17/h2-11,13,20H,12H2,1H3,(H,25,28)(H,26,29)(H,27,30)",CC1=C(C(CC(=O)N1)c2ccc3ccccc3c2)C(=O)Nc4ccc5[nH]ncc5c4,CHEMBL853725,"Oral bioavailability in Sprague-Dawley rat at 1.7 mg/kg, po",F,=,13,%,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
11,CHEMBL374453,"InChI=1S/C20H16Cl2N4O2/c1-10-19(20(28)25-13-3-5-17-12(6-13)9-23-26-17)14(8-18(27)24-10)11-2-4-15(21)16(22)7-11/h2-7,9,14H,8H2,1H3,(H,23,26)(H,24,27)(H,25,28)",CC1=C(C(CC(=O)N1)c2ccc(Cl)c(Cl)c2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL374453,"InChI=1S/C20H16Cl2N4O2/c1-10-19(20(28)25-13-3-5-17-12(6-13)9-23-26-17)14(8-18(27)24-10)11-2-4-15(21)16(22)7-11/h2-7,9,14H,8H2,1H3,(H,23,26)(H,24,27)(H,25,28)",CC1=C(C(CC(=O)N1)c2ccc(Cl)c(Cl)c2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL853722,Volume of distribution in Sprague-Dawley rat at 0.9 mg/kg,Vdss,=,2.4,L.kg-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
16,CHEMBL427058,"InChI=1S/C21H16ClF3N4O2/c1-10-18(20(31)28-14-6-12-9-26-29-19(12)16(22)7-14)15(8-17(30)27-10)11-2-4-13(5-3-11)21(23,24)25/h2-7,9,15H,8H2,1H3,(H,26,29)(H,27,30)(H,28,31)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3cc(Cl)c4[nH]ncc4c3,CHEMBL427058,"InChI=1S/C21H16ClF3N4O2/c1-10-18(20(31)28-14-6-12-9-26-29-19(12)16(22)7-14)15(8-17(30)27-10)11-2-4-13(5-3-11)21(23,24)25/h2-7,9,15H,8H2,1H3,(H,26,29)(H,27,30)(H,28,31)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3cc(Cl)c4[nH]ncc4c3,CHEMBL853722,Volume of distribution in Sprague-Dawley rat at 0.9 mg/kg,Vdss,=,3.9,L.kg-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
13,CHEMBL218720,"InChI=1S/C22H19F3N4O2/c1-11-16-9-15(7-8-18(16)29-28-11)27-21(31)20-12(2)26-19(30)10-17(20)13-3-5-14(6-4-13)22(23,24)25/h3-9,17H,10H2,1-2H3,(H,26,30)(H,27,31)(H,28,29)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3ccc4[nH]nc(C)c4c3,CHEMBL218720,"InChI=1S/C22H19F3N4O2/c1-11-16-9-15(7-8-18(16)29-28-11)27-21(31)20-12(2)26-19(30)10-17(20)13-3-5-14(6-4-13)22(23,24)25/h3-9,17H,10H2,1-2H3,(H,26,30)(H,27,31)(H,28,29)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3ccc4[nH]nc(C)c4c3,CHEMBL913384,Volume of distribution in Sprague-Dawley rat at 1.3 mg/kg,Vdss,=,2.8,L.kg-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
3,CHEMBL384073,"InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)",CC1=C(C(NC(=O)N1)c2ccc(F)cc2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL384073,"InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)",CC1=C(C(NC(=O)N1)c2ccc(F)cc2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL913384,Volume of distribution in Sprague-Dawley rat at 1.3 mg/kg,Vdss,=,2.2,L.kg-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
12,CHEMBL441702,"InChI=1S/C24H20N4O2/c1-14-23(24(30)27-19-8-9-21-18(11-19)13-25-28-21)20(12-22(29)26-14)17-7-6-15-4-2-3-5-16(15)10-17/h2-11,13,20H,12H2,1H3,(H,25,28)(H,26,29)(H,27,30)",CC1=C(C(CC(=O)N1)c2ccc3ccccc3c2)C(=O)Nc4ccc5[nH]ncc5c4,CHEMBL441702,"InChI=1S/C24H20N4O2/c1-14-23(24(30)27-19-8-9-21-18(11-19)13-25-28-21)20(12-22(29)26-14)17-7-6-15-4-2-3-5-16(15)10-17/h2-11,13,20H,12H2,1H3,(H,25,28)(H,26,29)(H,27,30)",CC1=C(C(CC(=O)N1)c2ccc3ccccc3c2)C(=O)Nc4ccc5[nH]ncc5c4,CHEMBL853723,Volume of distribution in Sprague-Dawley rat at 1.7 mg/kg,Vdss,=,1.8,L.kg-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1139217,"J. Med. Chem., 50, p. 6 (2007)",17201405,Scientific Literature
15,CHEMBL466412,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m0/s1",CN(C)C(=O)O[C@@H]1CN[C@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL466412,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m0/s1",CN(C)C(=O)O[C@@H]1CN[C@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL1009321,Antiproliferative activity against human BT474 cells overexpressing ERBb2 after 3 days by methylene blue staining,EC50,=,30,nM,,CHEMBL612545,,,,CHEMBL1139297,"Bioorg. Med. Chem. Lett., 19, p. 21 (2009)",19028424,Scientific Literature
6c,CHEMBL512076,"InChI=1S/C28H25ClFN5O3S/c1-2-31-28(36)38-21-11-19(32-14-21)6-8-22-13-24-26(39-22)27(34-16-33-24)35-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,32H,2,11,14-15H2,1H3,(H,31,36)(H,33,34,35)/t19-,21-/m1/s1",CCNC(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL512076,"InChI=1S/C28H25ClFN5O3S/c1-2-31-28(36)38-21-11-19(32-14-21)6-8-22-13-24-26(39-22)27(34-16-33-24)35-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,32H,2,11,14-15H2,1H3,(H,31,36)(H,33,34,35)/t19-,21-/m1/s1",CCNC(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL1009321,Antiproliferative activity against human BT474 cells overexpressing ERBb2 after 3 days by methylene blue staining,EC50,=,30,nM,,CHEMBL612545,,,,CHEMBL1139297,"Bioorg. Med. Chem. Lett., 19, p. 21 (2009)",19028424,Scientific Literature
6d,CHEMBL517123,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m1/s1",CN(C)C(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL517123,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m1/s1",CN(C)C(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL1009321,Antiproliferative activity against human BT474 cells overexpressing ERBb2 after 3 days by methylene blue staining,EC50,=,30,nM,,CHEMBL612545,,,,CHEMBL1139297,"Bioorg. Med. Chem. Lett., 19, p. 21 (2009)",19028424,Scientific Literature
6h,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL1009321,Antiproliferative activity against human BT474 cells overexpressing ERBb2 after 3 days by methylene blue staining,EC50,=,30,nM,,CHEMBL612545,,,,CHEMBL1139297,"Bioorg. Med. Chem. Lett., 19, p. 21 (2009)",19028424,Scientific Literature
6c,CHEMBL512076,"InChI=1S/C28H25ClFN5O3S/c1-2-31-28(36)38-21-11-19(32-14-21)6-8-22-13-24-26(39-22)27(34-16-33-24)35-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,32H,2,11,14-15H2,1H3,(H,31,36)(H,33,34,35)/t19-,21-/m1/s1",CCNC(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL512076,"InChI=1S/C28H25ClFN5O3S/c1-2-31-28(36)38-21-11-19(32-14-21)6-8-22-13-24-26(39-22)27(34-16-33-24)35-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,32H,2,11,14-15H2,1H3,(H,31,36)(H,33,34,35)/t19-,21-/m1/s1",CCNC(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL1009322,Antiproliferative activity against human HFF cells after 3 days by methylene blue staining,EC50,=,4200,nM,,CHEMBL614071,HFF (Foreskin fibroblasts),Homo sapiens,,CHEMBL1139297,"Bioorg. Med. Chem. Lett., 19, p. 21 (2009)",19028424,Scientific Literature
6d,CHEMBL517123,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m1/s1",CN(C)C(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL517123,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m1/s1",CN(C)C(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL1009322,Antiproliferative activity against human HFF cells after 3 days by methylene blue staining,EC50,=,2800,nM,,CHEMBL614071,HFF (Foreskin fibroblasts),Homo sapiens,,CHEMBL1139297,"Bioorg. Med. Chem. Lett., 19, p. 21 (2009)",19028424,Scientific Literature
6h,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL1009322,Antiproliferative activity against human HFF cells after 3 days by methylene blue staining,EC50,=,4900,nM,,CHEMBL614071,HFF (Foreskin fibroblasts),Homo sapiens,,CHEMBL1139297,"Bioorg. Med. Chem. Lett., 19, p. 21 (2009)",19028424,Scientific Literature
6c,CHEMBL512076,"InChI=1S/C28H25ClFN5O3S/c1-2-31-28(36)38-21-11-19(32-14-21)6-8-22-13-24-26(39-22)27(34-16-33-24)35-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,32H,2,11,14-15H2,1H3,(H,31,36)(H,33,34,35)/t19-,21-/m1/s1",CCNC(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL512076,"InChI=1S/C28H25ClFN5O3S/c1-2-31-28(36)38-21-11-19(32-14-21)6-8-22-13-24-26(39-22)27(34-16-33-24)35-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,32H,2,11,14-15H2,1H3,(H,31,36)(H,33,34,35)/t19-,21-/m1/s1",CCNC(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL1009320,Antiproliferative activity against human HN5 cells overexpressing EGFR after 3 days by methylene blue staining,EC50,=,95,nM,,CHEMBL614828,HN5 (Squamous cell carcinoma),Homo sapiens,,CHEMBL1139297,"Bioorg. Med. Chem. Lett., 19, p. 21 (2009)",19028424,Scientific Literature
6d,CHEMBL517123,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m1/s1",CN(C)C(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL517123,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m1/s1",CN(C)C(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL1009320,Antiproliferative activity against human HN5 cells overexpressing EGFR after 3 days by methylene blue staining,EC50,=,100,nM,,CHEMBL614828,HN5 (Squamous cell carcinoma),Homo sapiens,,CHEMBL1139297,"Bioorg. Med. Chem. Lett., 19, p. 21 (2009)",19028424,Scientific Literature
6h,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL1009320,Antiproliferative activity against human HN5 cells overexpressing EGFR after 3 days by methylene blue staining,EC50,=,160,nM,,CHEMBL614828,HN5 (Squamous cell carcinoma),Homo sapiens,,CHEMBL1139297,"Bioorg. Med. Chem. Lett., 19, p. 21 (2009)",19028424,Scientific Literature
6c,CHEMBL512076,"InChI=1S/C28H25ClFN5O3S/c1-2-31-28(36)38-21-11-19(32-14-21)6-8-22-13-24-26(39-22)27(34-16-33-24)35-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,32H,2,11,14-15H2,1H3,(H,31,36)(H,33,34,35)/t19-,21-/m1/s1",CCNC(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL512076,"InChI=1S/C28H25ClFN5O3S/c1-2-31-28(36)38-21-11-19(32-14-21)6-8-22-13-24-26(39-22)27(34-16-33-24)35-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,32H,2,11,14-15H2,1H3,(H,31,36)(H,33,34,35)/t19-,21-/m1/s1",CCNC(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL1009323,Induction of EGFR covalent modification assessed as alkylation at 0.002 mM after 3 hrs,Activity,=,24,%,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1139297,"Bioorg. Med. Chem. Lett., 19, p. 21 (2009)",19028424,Scientific Literature
6d,CHEMBL517123,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m1/s1",CN(C)C(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL517123,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m1/s1",CN(C)C(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL1009323,Induction of EGFR covalent modification assessed as alkylation at 0.002 mM after 3 hrs,Activity,=,11,%,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1139297,"Bioorg. Med. Chem. Lett., 19, p. 21 (2009)",19028424,Scientific Literature
6h,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL1009328,Induction of EGFR covalent modification assessed as alkylation at 0.006 mM after 3 hrs,Activity,=,5,%,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1139297,"Bioorg. Med. Chem. Lett., 19, p. 21 (2009)",19028424,Scientific Literature
15,CHEMBL466412,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m0/s1",CN(C)C(=O)O[C@@H]1CN[C@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL466412,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m0/s1",CN(C)C(=O)O[C@@H]1CN[C@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL1009318,Inhibition of EGFR by HTRF assay,IC50,=,40,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1139297,"Bioorg. Med. Chem. Lett., 19, p. 21 (2009)",19028424,Scientific Literature
6c,CHEMBL512076,"InChI=1S/C28H25ClFN5O3S/c1-2-31-28(36)38-21-11-19(32-14-21)6-8-22-13-24-26(39-22)27(34-16-33-24)35-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,32H,2,11,14-15H2,1H3,(H,31,36)(H,33,34,35)/t19-,21-/m1/s1",CCNC(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL512076,"InChI=1S/C28H25ClFN5O3S/c1-2-31-28(36)38-21-11-19(32-14-21)6-8-22-13-24-26(39-22)27(34-16-33-24)35-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,32H,2,11,14-15H2,1H3,(H,31,36)(H,33,34,35)/t19-,21-/m1/s1",CCNC(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL1009318,Inhibition of EGFR by HTRF assay,IC50,=,32,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1139297,"Bioorg. Med. Chem. Lett., 19, p. 21 (2009)",19028424,Scientific Literature
6d,CHEMBL517123,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m1/s1",CN(C)C(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL517123,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m1/s1",CN(C)C(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL1009318,Inhibition of EGFR by HTRF assay,IC50,=,28,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1139297,"Bioorg. Med. Chem. Lett., 19, p. 21 (2009)",19028424,Scientific Literature
6h,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL1009318,Inhibition of EGFR by HTRF assay,IC50,=,65,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1139297,"Bioorg. Med. Chem. Lett., 19, p. 21 (2009)",19028424,Scientific Literature
15,CHEMBL466412,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m0/s1",CN(C)C(=O)O[C@@H]1CN[C@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL466412,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m0/s1",CN(C)C(=O)O[C@@H]1CN[C@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL1009324,Inhibition of ERBb2 by DELFIA assay,EC50,=,30,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1139297,"Bioorg. Med. Chem. Lett., 19, p. 21 (2009)",19028424,Scientific Literature
6c,CHEMBL512076,"InChI=1S/C28H25ClFN5O3S/c1-2-31-28(36)38-21-11-19(32-14-21)6-8-22-13-24-26(39-22)27(34-16-33-24)35-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,32H,2,11,14-15H2,1H3,(H,31,36)(H,33,34,35)/t19-,21-/m1/s1",CCNC(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL512076,"InChI=1S/C28H25ClFN5O3S/c1-2-31-28(36)38-21-11-19(32-14-21)6-8-22-13-24-26(39-22)27(34-16-33-24)35-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,32H,2,11,14-15H2,1H3,(H,31,36)(H,33,34,35)/t19-,21-/m1/s1",CCNC(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL1009324,Inhibition of ERBb2 by DELFIA assay,IC50,=,10,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1139297,"Bioorg. Med. Chem. Lett., 19, p. 21 (2009)",19028424,Scientific Literature
6d,CHEMBL517123,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m1/s1",CN(C)C(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL517123,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m1/s1",CN(C)C(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL1009324,Inhibition of ERBb2 by DELFIA assay,IC50,=,10,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1139297,"Bioorg. Med. Chem. Lett., 19, p. 21 (2009)",19028424,Scientific Literature
6h,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL1009324,Inhibition of ERBb2 by DELFIA assay,IC50,=,50,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1139297,"Bioorg. Med. Chem. Lett., 19, p. 21 (2009)",19028424,Scientific Literature
15,CHEMBL466412,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m0/s1",CN(C)C(=O)O[C@@H]1CN[C@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL466412,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m0/s1",CN(C)C(=O)O[C@@H]1CN[C@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL1009319,Inhibition of ERBb2 by HTRF assay,IC50,=,40,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1139297,"Bioorg. Med. Chem. Lett., 19, p. 21 (2009)",19028424,Scientific Literature
6c,CHEMBL512076,"InChI=1S/C28H25ClFN5O3S/c1-2-31-28(36)38-21-11-19(32-14-21)6-8-22-13-24-26(39-22)27(34-16-33-24)35-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,32H,2,11,14-15H2,1H3,(H,31,36)(H,33,34,35)/t19-,21-/m1/s1",CCNC(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL512076,"InChI=1S/C28H25ClFN5O3S/c1-2-31-28(36)38-21-11-19(32-14-21)6-8-22-13-24-26(39-22)27(34-16-33-24)35-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,32H,2,11,14-15H2,1H3,(H,31,36)(H,33,34,35)/t19-,21-/m1/s1",CCNC(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL1009319,Inhibition of ERBb2 by HTRF assay,IC50,=,43,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1139297,"Bioorg. Med. Chem. Lett., 19, p. 21 (2009)",19028424,Scientific Literature
6d,CHEMBL517123,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m1/s1",CN(C)C(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL517123,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m1/s1",CN(C)C(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL1009319,Inhibition of ERBb2 by HTRF assay,IC50,=,68,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1139297,"Bioorg. Med. Chem. Lett., 19, p. 21 (2009)",19028424,Scientific Literature
6h,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL1009319,Inhibition of ERBb2 by HTRF assay,IC50,=,84,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1139297,"Bioorg. Med. Chem. Lett., 19, p. 21 (2009)",19028424,Scientific Literature
6c,CHEMBL512076,"InChI=1S/C28H25ClFN5O3S/c1-2-31-28(36)38-21-11-19(32-14-21)6-8-22-13-24-26(39-22)27(34-16-33-24)35-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,32H,2,11,14-15H2,1H3,(H,31,36)(H,33,34,35)/t19-,21-/m1/s1",CCNC(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL512076,"InChI=1S/C28H25ClFN5O3S/c1-2-31-28(36)38-21-11-19(32-14-21)6-8-22-13-24-26(39-22)27(34-16-33-24)35-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,32H,2,11,14-15H2,1H3,(H,31,36)(H,33,34,35)/t19-,21-/m1/s1",CCNC(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL1009325,"Normalized AUC in mouse at 10 mg/kg, po in methanesulfonic acid:hydroxypropyl-beta-cyclodextrin",AUC,=,61,ng hr kg mg-1 ml-1,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1139297,"Bioorg. Med. Chem. Lett., 19, p. 21 (2009)",19028424,Scientific Literature
6d,CHEMBL517123,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m1/s1",CN(C)C(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL517123,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m1/s1",CN(C)C(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL1009325,"Normalized AUC in mouse at 10 mg/kg, po in methanesulfonic acid:hydroxypropyl-beta-cyclodextrin",AUC,=,93,ng hr kg mg-1 ml-1,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1139297,"Bioorg. Med. Chem. Lett., 19, p. 21 (2009)",19028424,Scientific Literature
6h,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL1009325,"Normalized AUC in mouse at 10 mg/kg, po in methanesulfonic acid:hydroxypropyl-beta-cyclodextrin",AUC,=,91,ng hr kg mg-1 ml-1,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1139297,"Bioorg. Med. Chem. Lett., 19, p. 21 (2009)",19028424,Scientific Literature
11,CHEMBL189231,"InChI=1S/C14H16N6O/c15-13-12(18-21-19-13)14-17-10-8-16-7-6-11(10)20(14)9-4-2-1-3-5-9/h6-9H,1-5H2,(H2,15,19)",Nc1nonc1c2nc3cnccc3n2C4CCCCC4,CHEMBL189231,"InChI=1S/C14H16N6O/c15-13-12(18-21-19-13)14-17-10-8-16-7-6-11(10)20(14)9-4-2-1-3-5-9/h6-9H,1-5H2,(H2,15,19)",Nc1nonc1c2nc3cnccc3n2C4CCCCC4,CHEMBL877123,Inhibitory concentration against MSK-1,IC50,=,3,nM,,CHEMBL4237,Ribosomal protein S6 kinase alpha 5,Homo sapiens,O75582,CHEMBL1139578,"Bioorg. Med. Chem. Lett., 15, p. 3407 (2005)",15955699,Scientific Literature
12,CHEMBL185962,"InChI=1S/C11H10N6O/c12-10-9(15-18-16-10)11-14-7-5-13-4-3-8(7)17(11)6-1-2-6/h3-6H,1-2H2,(H2,12,16)",Nc1nonc1c2nc3cnccc3n2C4CC4,CHEMBL185962,"InChI=1S/C11H10N6O/c12-10-9(15-18-16-10)11-14-7-5-13-4-3-8(7)17(11)6-1-2-6/h3-6H,1-2H2,(H2,12,16)",Nc1nonc1c2nc3cnccc3n2C4CC4,CHEMBL877123,Inhibitory concentration against MSK-1,IC50,=,1.5,nM,,CHEMBL4237,Ribosomal protein S6 kinase alpha 5,Homo sapiens,O75582,CHEMBL1139578,"Bioorg. Med. Chem. Lett., 15, p. 3407 (2005)",15955699,Scientific Literature
16,CHEMBL191105,"InChI=1S/C13H17N7O/c1-19(2)6-3-7-20-10-4-5-15-8-9(10)16-13(20)11-12(14)18-21-17-11/h4-5,8H,3,6-7H2,1-2H3,(H2,14,18)",CN(C)CCCn1c(nc2cnccc12)c3nonc3N,CHEMBL191105,"InChI=1S/C13H17N7O/c1-19(2)6-3-7-20-10-4-5-15-8-9(10)16-13(20)11-12(14)18-21-17-11/h4-5,8H,3,6-7H2,1-2H3,(H2,14,18)",CN(C)CCCn1c(nc2cnccc12)c3nonc3N,CHEMBL877123,Inhibitory concentration against MSK-1,IC50,=,617,nM,,CHEMBL4237,Ribosomal protein S6 kinase alpha 5,Homo sapiens,O75582,CHEMBL1139578,"Bioorg. Med. Chem. Lett., 15, p. 3407 (2005)",15955699,Scientific Literature
21,CHEMBL188268,"InChI=1S/C15H13N7O/c16-7-9-1-3-10(4-2-9)22-12-5-6-18-8-11(12)19-15(22)13-14(17)21-23-20-13/h1-6,8H,7,16H2,(H2,17,21)",NCc1ccc(cc1)n2c(nc3cnccc23)c4nonc4N,CHEMBL188268,"InChI=1S/C15H13N7O/c16-7-9-1-3-10(4-2-9)22-12-5-6-18-8-11(12)19-15(22)13-14(17)21-23-20-13/h1-6,8H,7,16H2,(H2,17,21)",NCc1ccc(cc1)n2c(nc3cnccc23)c4nonc4N,CHEMBL877123,Inhibitory concentration against MSK-1,IC50,=,4,nM,,CHEMBL4237,Ribosomal protein S6 kinase alpha 5,Homo sapiens,O75582,CHEMBL1139578,"Bioorg. Med. Chem. Lett., 15, p. 3407 (2005)",15955699,Scientific Literature
5,CHEMBL365072,"InChI=1S/C12H14N6O/c1-3-7-9-8(5-6-14-7)18(4-2)12(15-9)10-11(13)17-19-16-10/h5-6H,3-4H2,1-2H3,(H2,13,17)",CCc1nccc2c1nc(c3nonc3N)n2CC,CHEMBL365072,"InChI=1S/C12H14N6O/c1-3-7-9-8(5-6-14-7)18(4-2)12(15-9)10-11(13)17-19-16-10/h5-6H,3-4H2,1-2H3,(H2,13,17)",CCc1nccc2c1nc(c3nonc3N)n2CC,CHEMBL877123,Inhibitory concentration against MSK-1,IC50,=,229,nM,,CHEMBL4237,Ribosomal protein S6 kinase alpha 5,Homo sapiens,O75582,CHEMBL1139578,"Bioorg. Med. Chem. Lett., 15, p. 3407 (2005)",15955699,Scientific Literature
7,CHEMBL188240,"InChI=1S/C12H14N6O2/c1-3-18-7-5-6-14-12(19-4-2)8(7)15-11(18)9-10(13)17-20-16-9/h5-6H,3-4H2,1-2H3,(H2,13,17)",CCOc1nccc2c1nc(c3nonc3N)n2CC,CHEMBL188240,"InChI=1S/C12H14N6O2/c1-3-18-7-5-6-14-12(19-4-2)8(7)15-11(18)9-10(13)17-20-16-9/h5-6H,3-4H2,1-2H3,(H2,13,17)",CCOc1nccc2c1nc(c3nonc3N)n2CC,CHEMBL877123,Inhibitory concentration against MSK-1,IC50,=,174,nM,,CHEMBL4237,Ribosomal protein S6 kinase alpha 5,Homo sapiens,O75582,CHEMBL1139578,"Bioorg. Med. Chem. Lett., 15, p. 3407 (2005)",15955699,Scientific Literature
9,CHEMBL187985,"InChI=1S/C14H17N7O/c1-2-21-9-5-6-16-13(20-7-3-4-8-20)10(9)17-14(21)11-12(15)19-22-18-11/h5-6H,2-4,7-8H2,1H3,(H2,15,19)",CCn1c(nc2c(nccc12)N3CCCC3)c4nonc4N,CHEMBL187985,"InChI=1S/C14H17N7O/c1-2-21-9-5-6-16-13(20-7-3-4-8-20)10(9)17-14(21)11-12(15)19-22-18-11/h5-6H,2-4,7-8H2,1H3,(H2,15,19)",CCn1c(nc2c(nccc12)N3CCCC3)c4nonc4N,CHEMBL877123,Inhibitory concentration against MSK-1,IC50,=,2240.0,nM,,CHEMBL4237,Ribosomal protein S6 kinase alpha 5,Homo sapiens,O75582,CHEMBL1139578,"Bioorg. Med. Chem. Lett., 15, p. 3407 (2005)",15955699,Scientific Literature
SB-590885,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL1025605,Inhibition of C-RAF,Ki,=,1.72,nM,,CHEMBL1906,Serine/threonine-protein kinase RAF,Homo sapiens,P04049,CHEMBL1140099,"J. Med. Chem., 51, p. 6121 (2008)",18783202,Scientific Literature
SB-590885,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL1035690,Inhibition of human cloned wild type BRAF by ELISA-based MEK phosphorylation assay,Ki,=,0.16,nM,,CHEMBL5145,Serine/threonine-protein kinase B-raf,Homo sapiens,P15056,CHEMBL1140099,"J. Med. Chem., 51, p. 6121 (2008)",18783202,Scientific Literature
3b,CHEMBL1794065,"InChI=1S/C21H27N7O3.C2HF3O2/c1-4-28-18-15(30-12-13-6-9-23-10-7-13)11-24-14(5-8-21(2,3)29)16(18)25-20(28)17-19(22)27-31-26-17;3-2(4,5)1(6)7/h11,13,23,29H,4,6-7,9-10,12H2,1-3H3,(H2,22,27);(H,6,7)",CCn1c(nc2c(ncc(OCC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N.OC(=O)C(F)(F)F,CHEMBL521658,"InChI=1S/C21H27N7O3/c1-4-28-18-15(30-12-13-6-9-23-10-7-13)11-24-14(5-8-21(2,3)29)16(18)25-20(28)17-19(22)27-31-26-17/h11,13,23,29H,4,6-7,9-10,12H2,1-3H3,(H2,22,27)",CCn1c(nc2c(ncc(OCC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N,CHEMBL1028099,Antiproliferative activity against human BT474 cells,IC50,=,380,nM,,CHEMBL612545,,,,CHEMBL1140130,"J. Med. Chem., 51, p. 5663 (2008)",18800763,Scientific Literature
3f,CHEMBL1794066,"InChI=1S/C20H25N7O3.C2HF3O2/c1-4-27-17-14(29-12-6-9-22-10-7-12)11-23-13(5-8-20(2,3)28)15(17)24-19(27)16-18(21)26-30-25-16;3-2(4,5)1(6)7/h11-12,22,28H,4,6-7,9-10H2,1-3H3,(H2,21,26);(H,6,7)",CCn1c(nc2c(ncc(OC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N.OC(=O)C(F)(F)F,CHEMBL522857,"InChI=1S/C20H25N7O3/c1-4-27-17-14(29-12-6-9-22-10-7-12)11-23-13(5-8-20(2,3)28)15(17)24-19(27)16-18(21)26-30-25-16/h11-12,22,28H,4,6-7,9-10H2,1-3H3,(H2,21,26)",CCn1c(nc2c(ncc(OC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N,CHEMBL1028099,Antiproliferative activity against human BT474 cells,IC50,=,1280,nM,,CHEMBL612545,,,,CHEMBL1140130,"J. Med. Chem., 51, p. 5663 (2008)",18800763,Scientific Literature
3b,CHEMBL1794065,"InChI=1S/C21H27N7O3.C2HF3O2/c1-4-28-18-15(30-12-13-6-9-23-10-7-13)11-24-14(5-8-21(2,3)29)16(18)25-20(28)17-19(22)27-31-26-17;3-2(4,5)1(6)7/h11,13,23,29H,4,6-7,9-10,12H2,1-3H3,(H2,22,27);(H,6,7)",CCn1c(nc2c(ncc(OCC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N.OC(=O)C(F)(F)F,CHEMBL521658,"InChI=1S/C21H27N7O3/c1-4-28-18-15(30-12-13-6-9-23-10-7-13)11-24-14(5-8-21(2,3)29)16(18)25-20(28)17-19(22)27-31-26-17/h11,13,23,29H,4,6-7,9-10,12H2,1-3H3,(H2,22,27)",CCn1c(nc2c(ncc(OCC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N,CHEMBL1028100,Antiproliferative activity against human LNCaP cells,IC50,=,220,nM,,CHEMBL612518,LNCaP (Prostate carcinoma),Homo sapiens,,CHEMBL1140130,"J. Med. Chem., 51, p. 5663 (2008)",18800763,Scientific Literature
3f,CHEMBL1794066,"InChI=1S/C20H25N7O3.C2HF3O2/c1-4-27-17-14(29-12-6-9-22-10-7-12)11-23-13(5-8-20(2,3)28)15(17)24-19(27)16-18(21)26-30-25-16;3-2(4,5)1(6)7/h11-12,22,28H,4,6-7,9-10H2,1-3H3,(H2,21,26);(H,6,7)",CCn1c(nc2c(ncc(OC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N.OC(=O)C(F)(F)F,CHEMBL522857,"InChI=1S/C20H25N7O3/c1-4-27-17-14(29-12-6-9-22-10-7-12)11-23-13(5-8-20(2,3)28)15(17)24-19(27)16-18(21)26-30-25-16/h11-12,22,28H,4,6-7,9-10H2,1-3H3,(H2,21,26)",CCn1c(nc2c(ncc(OC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N,CHEMBL1028100,Antiproliferative activity against human LNCaP cells,IC50,=,180,nM,,CHEMBL612518,LNCaP (Prostate carcinoma),Homo sapiens,,CHEMBL1140130,"J. Med. Chem., 51, p. 5663 (2008)",18800763,Scientific Literature
3b,CHEMBL1794065,"InChI=1S/C21H27N7O3.C2HF3O2/c1-4-28-18-15(30-12-13-6-9-23-10-7-13)11-24-14(5-8-21(2,3)29)16(18)25-20(28)17-19(22)27-31-26-17;3-2(4,5)1(6)7/h11,13,23,29H,4,6-7,9-10,12H2,1-3H3,(H2,22,27);(H,6,7)",CCn1c(nc2c(ncc(OCC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N.OC(=O)C(F)(F)F,CHEMBL521658,"InChI=1S/C21H27N7O3/c1-4-28-18-15(30-12-13-6-9-23-10-7-13)11-24-14(5-8-21(2,3)29)16(18)25-20(28)17-19(22)27-31-26-17/h11,13,23,29H,4,6-7,9-10,12H2,1-3H3,(H2,22,27)",CCn1c(nc2c(ncc(OCC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N,CHEMBL1028101,Cytotoxicity against HFF cells,IC50,>,30000,nM,,CHEMBL614071,HFF (Foreskin fibroblasts),Homo sapiens,,CHEMBL1140130,"J. Med. Chem., 51, p. 5663 (2008)",18800763,Scientific Literature
3f,CHEMBL1794066,"InChI=1S/C20H25N7O3.C2HF3O2/c1-4-27-17-14(29-12-6-9-22-10-7-12)11-23-13(5-8-20(2,3)28)15(17)24-19(27)16-18(21)26-30-25-16;3-2(4,5)1(6)7/h11-12,22,28H,4,6-7,9-10H2,1-3H3,(H2,21,26);(H,6,7)",CCn1c(nc2c(ncc(OC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N.OC(=O)C(F)(F)F,CHEMBL522857,"InChI=1S/C20H25N7O3/c1-4-27-17-14(29-12-6-9-22-10-7-12)11-23-13(5-8-20(2,3)28)15(17)24-19(27)16-18(21)26-30-25-16/h11-12,22,28H,4,6-7,9-10H2,1-3H3,(H2,21,26)",CCn1c(nc2c(ncc(OC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N,CHEMBL1028101,Cytotoxicity against HFF cells,IC50,=,18100,nM,,CHEMBL614071,HFF (Foreskin fibroblasts),Homo sapiens,,CHEMBL1140130,"J. Med. Chem., 51, p. 5663 (2008)",18800763,Scientific Literature
13,CHEMBL1794064,"InChI=1S/C16H20N8O2.C2HF3O2/c1-2-24-14-11(25-8-4-7-18)9-20-10(5-3-6-17)12(14)21-16(24)13-15(19)23-26-22-13;3-2(4,5)1(6)7/h9H,2,4,6-8,17-18H2,1H3,(H2,19,23);(H,6,7)",CCn1c(nc2c(ncc(OCCCN)c12)C#CCN)c3nonc3N.OC(=O)C(F)(F)F,CHEMBL494280,"InChI=1S/C16H20N8O2/c1-2-24-14-11(25-8-4-7-18)9-20-10(5-3-6-17)12(14)21-16(24)13-15(19)23-26-22-13/h9H,2,4,6-8,17-18H2,1H3,(H2,19,23)",CCn1c(nc2c(ncc(OCCCN)c12)C#CCN)c3nonc3N,CHEMBL1028096,Inhibition of AKT-mediated GSK3-beta phosphorylation in human BT474 cells,IC50,,,,Not Determined,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,P31749,CHEMBL1140130,"J. Med. Chem., 51, p. 5663 (2008)",18800763,Scientific Literature
3b,CHEMBL1794065,"InChI=1S/C21H27N7O3.C2HF3O2/c1-4-28-18-15(30-12-13-6-9-23-10-7-13)11-24-14(5-8-21(2,3)29)16(18)25-20(28)17-19(22)27-31-26-17;3-2(4,5)1(6)7/h11,13,23,29H,4,6-7,9-10,12H2,1-3H3,(H2,22,27);(H,6,7)",CCn1c(nc2c(ncc(OCC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N.OC(=O)C(F)(F)F,CHEMBL521658,"InChI=1S/C21H27N7O3/c1-4-28-18-15(30-12-13-6-9-23-10-7-13)11-24-14(5-8-21(2,3)29)16(18)25-20(28)17-19(22)27-31-26-17/h11,13,23,29H,4,6-7,9-10,12H2,1-3H3,(H2,22,27)",CCn1c(nc2c(ncc(OCC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N,CHEMBL1028096,Inhibition of AKT-mediated GSK3-beta phosphorylation in human BT474 cells,IC50,=,2100,nM,,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,P31749,CHEMBL1140130,"J. Med. Chem., 51, p. 5663 (2008)",18800763,Scientific Literature
3f,CHEMBL1794066,"InChI=1S/C20H25N7O3.C2HF3O2/c1-4-27-17-14(29-12-6-9-22-10-7-12)11-23-13(5-8-20(2,3)28)15(17)24-19(27)16-18(21)26-30-25-16;3-2(4,5)1(6)7/h11-12,22,28H,4,6-7,9-10H2,1-3H3,(H2,21,26);(H,6,7)",CCn1c(nc2c(ncc(OC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N.OC(=O)C(F)(F)F,CHEMBL522857,"InChI=1S/C20H25N7O3/c1-4-27-17-14(29-12-6-9-22-10-7-12)11-23-13(5-8-20(2,3)28)15(17)24-19(27)16-18(21)26-30-25-16/h11-12,22,28H,4,6-7,9-10H2,1-3H3,(H2,21,26)",CCn1c(nc2c(ncc(OC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N,CHEMBL1028096,Inhibition of AKT-mediated GSK3-beta phosphorylation in human BT474 cells,IC50,=,560,nM,,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,P31749,CHEMBL1140130,"J. Med. Chem., 51, p. 5663 (2008)",18800763,Scientific Literature
13,CHEMBL1794064,"InChI=1S/C16H20N8O2.C2HF3O2/c1-2-24-14-11(25-8-4-7-18)9-20-10(5-3-6-17)12(14)21-16(24)13-15(19)23-26-22-13;3-2(4,5)1(6)7/h9H,2,4,6-8,17-18H2,1H3,(H2,19,23);(H,6,7)",CCn1c(nc2c(ncc(OCCCN)c12)C#CCN)c3nonc3N.OC(=O)C(F)(F)F,CHEMBL494280,"InChI=1S/C16H20N8O2/c1-2-24-14-11(25-8-4-7-18)9-20-10(5-3-6-17)12(14)21-16(24)13-15(19)23-26-22-13/h9H,2,4,6-8,17-18H2,1H3,(H2,19,23)",CCn1c(nc2c(ncc(OCCCN)c12)C#CCN)c3nonc3N,CHEMBL1028091,Inhibition of MSK1,IC50,,,,Not Determined,CHEMBL4237,Ribosomal protein S6 kinase alpha 5,Homo sapiens,O75582,CHEMBL1140130,"J. Med. Chem., 51, p. 5663 (2008)",18800763,Scientific Literature
2,CHEMBL506153,"InChI=1S/C14H18N8O2/c1-3-22-11-8(14(23)18-5-4-16-2)6-17-7-9(11)19-13(22)10-12(15)21-24-20-10/h6-7,16H,3-5H2,1-2H3,(H2,15,21)(H,18,23)",CCn1c(nc2cncc(C(=O)NCCNC)c12)c3nonc3N,CHEMBL506153,"InChI=1S/C14H18N8O2/c1-3-22-11-8(14(23)18-5-4-16-2)6-17-7-9(11)19-13(22)10-12(15)21-24-20-10/h6-7,16H,3-5H2,1-2H3,(H2,15,21)(H,18,23)",CCn1c(nc2cncc(C(=O)NCCNC)c12)c3nonc3N,CHEMBL1028091,Inhibition of MSK1,IC50,=,15,nM,,CHEMBL4237,Ribosomal protein S6 kinase alpha 5,Homo sapiens,O75582,CHEMBL1140130,"J. Med. Chem., 51, p. 5663 (2008)",18800763,Scientific Literature
5,CHEMBL493066,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-5-3-17-4-6-22)7-18-8-10(12)19-14(23)11-13(16)21-25-20-11/h7-8,17H,2-6H2,1H3,(H2,16,21)",CCn1c(nc2cncc(C(=O)N3CCNCC3)c12)c4nonc4N,CHEMBL493066,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-5-3-17-4-6-22)7-18-8-10(12)19-14(23)11-13(16)21-25-20-11/h7-8,17H,2-6H2,1H3,(H2,16,21)",CCn1c(nc2cncc(C(=O)N3CCNCC3)c12)c4nonc4N,CHEMBL1028091,Inhibition of MSK1,IC50,=,47,nM,,CHEMBL4237,Ribosomal protein S6 kinase alpha 5,Homo sapiens,O75582,CHEMBL1140130,"J. Med. Chem., 51, p. 5663 (2008)",18800763,Scientific Literature
13,CHEMBL1794064,"InChI=1S/C16H20N8O2.C2HF3O2/c1-2-24-14-11(25-8-4-7-18)9-20-10(5-3-6-17)12(14)21-16(24)13-15(19)23-26-22-13;3-2(4,5)1(6)7/h9H,2,4,6-8,17-18H2,1H3,(H2,19,23);(H,6,7)",CCn1c(nc2c(ncc(OCCCN)c12)C#CCN)c3nonc3N.OC(=O)C(F)(F)F,CHEMBL494280,"InChI=1S/C16H20N8O2/c1-2-24-14-11(25-8-4-7-18)9-20-10(5-3-6-17)12(14)21-16(24)13-15(19)23-26-22-13/h9H,2,4,6-8,17-18H2,1H3,(H2,19,23)",CCn1c(nc2c(ncc(OCCCN)c12)C#CCN)c3nonc3N,CHEMBL1028103,Inhibition of RSK1,IC50,=,251,nM,,CHEMBL2553,Ribosomal protein S6 kinase alpha 1,Homo sapiens,Q15418,CHEMBL1140130,"J. Med. Chem., 51, p. 5663 (2008)",18800763,Scientific Literature
3b,CHEMBL1794065,"InChI=1S/C21H27N7O3.C2HF3O2/c1-4-28-18-15(30-12-13-6-9-23-10-7-13)11-24-14(5-8-21(2,3)29)16(18)25-20(28)17-19(22)27-31-26-17;3-2(4,5)1(6)7/h11,13,23,29H,4,6-7,9-10,12H2,1-3H3,(H2,22,27);(H,6,7)",CCn1c(nc2c(ncc(OCC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N.OC(=O)C(F)(F)F,CHEMBL521658,"InChI=1S/C21H27N7O3/c1-4-28-18-15(30-12-13-6-9-23-10-7-13)11-24-14(5-8-21(2,3)29)16(18)25-20(28)17-19(22)27-31-26-17/h11,13,23,29H,4,6-7,9-10,12H2,1-3H3,(H2,22,27)",CCn1c(nc2c(ncc(OCC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N,CHEMBL1028103,Inhibition of RSK1,IC50,=,2510,nM,,CHEMBL2553,Ribosomal protein S6 kinase alpha 1,Homo sapiens,Q15418,CHEMBL1140130,"J. Med. Chem., 51, p. 5663 (2008)",18800763,Scientific Literature
3f,CHEMBL1794066,"InChI=1S/C20H25N7O3.C2HF3O2/c1-4-27-17-14(29-12-6-9-22-10-7-12)11-23-13(5-8-20(2,3)28)15(17)24-19(27)16-18(21)26-30-25-16;3-2(4,5)1(6)7/h11-12,22,28H,4,6-7,9-10H2,1-3H3,(H2,21,26);(H,6,7)",CCn1c(nc2c(ncc(OC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N.OC(=O)C(F)(F)F,CHEMBL522857,"InChI=1S/C20H25N7O3/c1-4-27-17-14(29-12-6-9-22-10-7-12)11-23-13(5-8-20(2,3)28)15(17)24-19(27)16-18(21)26-30-25-16/h11-12,22,28H,4,6-7,9-10H2,1-3H3,(H2,21,26)",CCn1c(nc2c(ncc(OC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N,CHEMBL1028103,Inhibition of RSK1,IC50,=,3980,nM,,CHEMBL2553,Ribosomal protein S6 kinase alpha 1,Homo sapiens,Q15418,CHEMBL1140130,"J. Med. Chem., 51, p. 5663 (2008)",18800763,Scientific Literature
13,CHEMBL1794064,"InChI=1S/C16H20N8O2.C2HF3O2/c1-2-24-14-11(25-8-4-7-18)9-20-10(5-3-6-17)12(14)21-16(24)13-15(19)23-26-22-13;3-2(4,5)1(6)7/h9H,2,4,6-8,17-18H2,1H3,(H2,19,23);(H,6,7)",CCn1c(nc2c(ncc(OCCCN)c12)C#CCN)c3nonc3N.OC(=O)C(F)(F)F,CHEMBL494280,"InChI=1S/C16H20N8O2/c1-2-24-14-11(25-8-4-7-18)9-20-10(5-3-6-17)12(14)21-16(24)13-15(19)23-26-22-13/h9H,2,4,6-8,17-18H2,1H3,(H2,19,23)",CCn1c(nc2c(ncc(OCCCN)c12)C#CCN)c3nonc3N,CHEMBL1028090,Inhibition of human AKT1,IC50,=,794,nM,,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,P31749,CHEMBL1140130,"J. Med. Chem., 51, p. 5663 (2008)",18800763,Scientific Literature
2,CHEMBL506153,"InChI=1S/C14H18N8O2/c1-3-22-11-8(14(23)18-5-4-16-2)6-17-7-9(11)19-13(22)10-12(15)21-24-20-10/h6-7,16H,3-5H2,1-2H3,(H2,15,21)(H,18,23)",CCn1c(nc2cncc(C(=O)NCCNC)c12)c3nonc3N,CHEMBL506153,"InChI=1S/C14H18N8O2/c1-3-22-11-8(14(23)18-5-4-16-2)6-17-7-9(11)19-13(22)10-12(15)21-24-20-10/h6-7,16H,3-5H2,1-2H3,(H2,15,21)(H,18,23)",CCn1c(nc2cncc(C(=O)NCCNC)c12)c3nonc3N,CHEMBL1028090,Inhibition of human AKT1,IC50,=,126,nM,,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,P31749,CHEMBL1140130,"J. Med. Chem., 51, p. 5663 (2008)",18800763,Scientific Literature
3b,CHEMBL1794065,"InChI=1S/C21H27N7O3.C2HF3O2/c1-4-28-18-15(30-12-13-6-9-23-10-7-13)11-24-14(5-8-21(2,3)29)16(18)25-20(28)17-19(22)27-31-26-17;3-2(4,5)1(6)7/h11,13,23,29H,4,6-7,9-10,12H2,1-3H3,(H2,22,27);(H,6,7)",CCn1c(nc2c(ncc(OCC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N.OC(=O)C(F)(F)F,CHEMBL521658,"InChI=1S/C21H27N7O3/c1-4-28-18-15(30-12-13-6-9-23-10-7-13)11-24-14(5-8-21(2,3)29)16(18)25-20(28)17-19(22)27-31-26-17/h11,13,23,29H,4,6-7,9-10,12H2,1-3H3,(H2,22,27)",CCn1c(nc2c(ncc(OCC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N,CHEMBL1028090,Inhibition of human AKT1,IC50,=,10,nM,,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,P31749,CHEMBL1140130,"J. Med. Chem., 51, p. 5663 (2008)",18800763,Scientific Literature
3f,CHEMBL1794066,"InChI=1S/C20H25N7O3.C2HF3O2/c1-4-27-17-14(29-12-6-9-22-10-7-12)11-23-13(5-8-20(2,3)28)15(17)24-19(27)16-18(21)26-30-25-16;3-2(4,5)1(6)7/h11-12,22,28H,4,6-7,9-10H2,1-3H3,(H2,21,26);(H,6,7)",CCn1c(nc2c(ncc(OC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N.OC(=O)C(F)(F)F,CHEMBL522857,"InChI=1S/C20H25N7O3/c1-4-27-17-14(29-12-6-9-22-10-7-12)11-23-13(5-8-20(2,3)28)15(17)24-19(27)16-18(21)26-30-25-16/h11-12,22,28H,4,6-7,9-10H2,1-3H3,(H2,21,26)",CCn1c(nc2c(ncc(OC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N,CHEMBL1028090,Inhibition of human AKT1,IC50,=,8,nM,,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,P31749,CHEMBL1140130,"J. Med. Chem., 51, p. 5663 (2008)",18800763,Scientific Literature
5,CHEMBL493066,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-5-3-17-4-6-22)7-18-8-10(12)19-14(23)11-13(16)21-25-20-11/h7-8,17H,2-6H2,1H3,(H2,16,21)",CCn1c(nc2cncc(C(=O)N3CCNCC3)c12)c4nonc4N,CHEMBL493066,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-5-3-17-4-6-22)7-18-8-10(12)19-14(23)11-13(16)21-25-20-11/h7-8,17H,2-6H2,1H3,(H2,16,21)",CCn1c(nc2cncc(C(=O)N3CCNCC3)c12)c4nonc4N,CHEMBL1028090,Inhibition of human AKT1,IC50,=,501,nM,,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,P31749,CHEMBL1140130,"J. Med. Chem., 51, p. 5663 (2008)",18800763,Scientific Literature
2,CHEMBL506153,"InChI=1S/C14H18N8O2/c1-3-22-11-8(14(23)18-5-4-16-2)6-17-7-9(11)19-13(22)10-12(15)21-24-20-10/h6-7,16H,3-5H2,1-2H3,(H2,15,21)(H,18,23)",CCn1c(nc2cncc(C(=O)NCCNC)c12)c3nonc3N,CHEMBL506153,"InChI=1S/C14H18N8O2/c1-3-22-11-8(14(23)18-5-4-16-2)6-17-7-9(11)19-13(22)10-12(15)21-24-20-10/h6-7,16H,3-5H2,1-2H3,(H2,15,21)(H,18,23)",CCn1c(nc2cncc(C(=O)NCCNC)c12)c3nonc3N,CHEMBL1028093,Inhibition of human AKT2,IC50,=,3980,nM,,CHEMBL2431,Serine/threonine-protein kinase AKT2,Homo sapiens,P31751,CHEMBL1140130,"J. Med. Chem., 51, p. 5663 (2008)",18800763,Scientific Literature
3b,CHEMBL1794065,"InChI=1S/C21H27N7O3.C2HF3O2/c1-4-28-18-15(30-12-13-6-9-23-10-7-13)11-24-14(5-8-21(2,3)29)16(18)25-20(28)17-19(22)27-31-26-17;3-2(4,5)1(6)7/h11,13,23,29H,4,6-7,9-10,12H2,1-3H3,(H2,22,27);(H,6,7)",CCn1c(nc2c(ncc(OCC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N.OC(=O)C(F)(F)F,CHEMBL521658,"InChI=1S/C21H27N7O3/c1-4-28-18-15(30-12-13-6-9-23-10-7-13)11-24-14(5-8-21(2,3)29)16(18)25-20(28)17-19(22)27-31-26-17/h11,13,23,29H,4,6-7,9-10,12H2,1-3H3,(H2,22,27)",CCn1c(nc2c(ncc(OCC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N,CHEMBL1028093,Inhibition of human AKT2,IC50,=,8,nM,,CHEMBL2431,Serine/threonine-protein kinase AKT2,Homo sapiens,P31751,CHEMBL1140130,"J. Med. Chem., 51, p. 5663 (2008)",18800763,Scientific Literature
3f,CHEMBL1794066,"InChI=1S/C20H25N7O3.C2HF3O2/c1-4-27-17-14(29-12-6-9-22-10-7-12)11-23-13(5-8-20(2,3)28)15(17)24-19(27)16-18(21)26-30-25-16;3-2(4,5)1(6)7/h11-12,22,28H,4,6-7,9-10H2,1-3H3,(H2,21,26);(H,6,7)",CCn1c(nc2c(ncc(OC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N.OC(=O)C(F)(F)F,CHEMBL522857,"InChI=1S/C20H25N7O3/c1-4-27-17-14(29-12-6-9-22-10-7-12)11-23-13(5-8-20(2,3)28)15(17)24-19(27)16-18(21)26-30-25-16/h11-12,22,28H,4,6-7,9-10H2,1-3H3,(H2,21,26)",CCn1c(nc2c(ncc(OC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N,CHEMBL1028093,Inhibition of human AKT2,IC50,=,8,nM,,CHEMBL2431,Serine/threonine-protein kinase AKT2,Homo sapiens,P31751,CHEMBL1140130,"J. Med. Chem., 51, p. 5663 (2008)",18800763,Scientific Literature
5,CHEMBL493066,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-5-3-17-4-6-22)7-18-8-10(12)19-14(23)11-13(16)21-25-20-11/h7-8,17H,2-6H2,1H3,(H2,16,21)",CCn1c(nc2cncc(C(=O)N3CCNCC3)c12)c4nonc4N,CHEMBL493066,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-5-3-17-4-6-22)7-18-8-10(12)19-14(23)11-13(16)21-25-20-11/h7-8,17H,2-6H2,1H3,(H2,16,21)",CCn1c(nc2cncc(C(=O)N3CCNCC3)c12)c4nonc4N,CHEMBL1028093,Inhibition of human AKT2,IC50,=,2510,nM,,CHEMBL2431,Serine/threonine-protein kinase AKT2,Homo sapiens,P31751,CHEMBL1140130,"J. Med. Chem., 51, p. 5663 (2008)",18800763,Scientific Literature
2,CHEMBL506153,"InChI=1S/C14H18N8O2/c1-3-22-11-8(14(23)18-5-4-16-2)6-17-7-9(11)19-13(22)10-12(15)21-24-20-10/h6-7,16H,3-5H2,1-2H3,(H2,15,21)(H,18,23)",CCn1c(nc2cncc(C(=O)NCCNC)c12)c3nonc3N,CHEMBL506153,"InChI=1S/C14H18N8O2/c1-3-22-11-8(14(23)18-5-4-16-2)6-17-7-9(11)19-13(22)10-12(15)21-24-20-10/h6-7,16H,3-5H2,1-2H3,(H2,15,21)(H,18,23)",CCn1c(nc2cncc(C(=O)NCCNC)c12)c3nonc3N,CHEMBL1028094,Inhibition of human AKT3,IC50,=,1410,nM,,CHEMBL4816,Serine/threonine-protein kinase AKT3,Homo sapiens,Q9Y243,CHEMBL1140130,"J. Med. Chem., 51, p. 5663 (2008)",18800763,Scientific Literature
3b,CHEMBL1794065,"InChI=1S/C21H27N7O3.C2HF3O2/c1-4-28-18-15(30-12-13-6-9-23-10-7-13)11-24-14(5-8-21(2,3)29)16(18)25-20(28)17-19(22)27-31-26-17;3-2(4,5)1(6)7/h11,13,23,29H,4,6-7,9-10,12H2,1-3H3,(H2,22,27);(H,6,7)",CCn1c(nc2c(ncc(OCC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N.OC(=O)C(F)(F)F,CHEMBL521658,"InChI=1S/C21H27N7O3/c1-4-28-18-15(30-12-13-6-9-23-10-7-13)11-24-14(5-8-21(2,3)29)16(18)25-20(28)17-19(22)27-31-26-17/h11,13,23,29H,4,6-7,9-10,12H2,1-3H3,(H2,22,27)",CCn1c(nc2c(ncc(OCC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N,CHEMBL1028094,Inhibition of human AKT3,IC50,=,40,nM,,CHEMBL4816,Serine/threonine-protein kinase AKT3,Homo sapiens,Q9Y243,CHEMBL1140130,"J. Med. Chem., 51, p. 5663 (2008)",18800763,Scientific Literature
3f,CHEMBL1794066,"InChI=1S/C20H25N7O3.C2HF3O2/c1-4-27-17-14(29-12-6-9-22-10-7-12)11-23-13(5-8-20(2,3)28)15(17)24-19(27)16-18(21)26-30-25-16;3-2(4,5)1(6)7/h11-12,22,28H,4,6-7,9-10H2,1-3H3,(H2,21,26);(H,6,7)",CCn1c(nc2c(ncc(OC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N.OC(=O)C(F)(F)F,CHEMBL522857,"InChI=1S/C20H25N7O3/c1-4-27-17-14(29-12-6-9-22-10-7-12)11-23-13(5-8-20(2,3)28)15(17)24-19(27)16-18(21)26-30-25-16/h11-12,22,28H,4,6-7,9-10H2,1-3H3,(H2,21,26)",CCn1c(nc2c(ncc(OC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N,CHEMBL1028094,Inhibition of human AKT3,IC50,,,,Not Determined,CHEMBL4816,Serine/threonine-protein kinase AKT3,Homo sapiens,Q9Y243,CHEMBL1140130,"J. Med. Chem., 51, p. 5663 (2008)",18800763,Scientific Literature
5,CHEMBL493066,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-5-3-17-4-6-22)7-18-8-10(12)19-14(23)11-13(16)21-25-20-11/h7-8,17H,2-6H2,1H3,(H2,16,21)",CCn1c(nc2cncc(C(=O)N3CCNCC3)c12)c4nonc4N,CHEMBL493066,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-5-3-17-4-6-22)7-18-8-10(12)19-14(23)11-13(16)21-25-20-11/h7-8,17H,2-6H2,1H3,(H2,16,21)",CCn1c(nc2cncc(C(=O)N3CCNCC3)c12)c4nonc4N,CHEMBL1028094,Inhibition of human AKT3,IC50,=,1549,nM,,CHEMBL4816,Serine/threonine-protein kinase AKT3,Homo sapiens,Q9Y243,CHEMBL1140130,"J. Med. Chem., 51, p. 5663 (2008)",18800763,Scientific Literature
13,CHEMBL1794064,"InChI=1S/C16H20N8O2.C2HF3O2/c1-2-24-14-11(25-8-4-7-18)9-20-10(5-3-6-17)12(14)21-16(24)13-15(19)23-26-22-13;3-2(4,5)1(6)7/h9H,2,4,6-8,17-18H2,1H3,(H2,19,23);(H,6,7)",CCn1c(nc2c(ncc(OCCCN)c12)C#CCN)c3nonc3N.OC(=O)C(F)(F)F,CHEMBL494280,"InChI=1S/C16H20N8O2/c1-2-24-14-11(25-8-4-7-18)9-20-10(5-3-6-17)12(14)21-16(24)13-15(19)23-26-22-13/h9H,2,4,6-8,17-18H2,1H3,(H2,19,23)",CCn1c(nc2c(ncc(OCCCN)c12)C#CCN)c3nonc3N,CHEMBL1028092,Inhibition of human recombinant ROCK1 expressed in Sf9 cells,IC50,=,200,nM,,CHEMBL3231,Rho-associated protein kinase 1 ,Homo sapiens,Q13464,CHEMBL1140130,"J. Med. Chem., 51, p. 5663 (2008)",18800763,Scientific Literature
2,CHEMBL506153,"InChI=1S/C14H18N8O2/c1-3-22-11-8(14(23)18-5-4-16-2)6-17-7-9(11)19-13(22)10-12(15)21-24-20-10/h6-7,16H,3-5H2,1-2H3,(H2,15,21)(H,18,23)",CCn1c(nc2cncc(C(=O)NCCNC)c12)c3nonc3N,CHEMBL506153,"InChI=1S/C14H18N8O2/c1-3-22-11-8(14(23)18-5-4-16-2)6-17-7-9(11)19-13(22)10-12(15)21-24-20-10/h6-7,16H,3-5H2,1-2H3,(H2,15,21)(H,18,23)",CCn1c(nc2cncc(C(=O)NCCNC)c12)c3nonc3N,CHEMBL1028092,Inhibition of human recombinant ROCK1 expressed in Sf9 cells,IC50,=,5,nM,,CHEMBL3231,Rho-associated protein kinase 1 ,Homo sapiens,Q13464,CHEMBL1140130,"J. Med. Chem., 51, p. 5663 (2008)",18800763,Scientific Literature
3b,CHEMBL1794065,"InChI=1S/C21H27N7O3.C2HF3O2/c1-4-28-18-15(30-12-13-6-9-23-10-7-13)11-24-14(5-8-21(2,3)29)16(18)25-20(28)17-19(22)27-31-26-17;3-2(4,5)1(6)7/h11,13,23,29H,4,6-7,9-10,12H2,1-3H3,(H2,22,27);(H,6,7)",CCn1c(nc2c(ncc(OCC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N.OC(=O)C(F)(F)F,CHEMBL521658,"InChI=1S/C21H27N7O3/c1-4-28-18-15(30-12-13-6-9-23-10-7-13)11-24-14(5-8-21(2,3)29)16(18)25-20(28)17-19(22)27-31-26-17/h11,13,23,29H,4,6-7,9-10,12H2,1-3H3,(H2,22,27)",CCn1c(nc2c(ncc(OCC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N,CHEMBL1028092,Inhibition of human recombinant ROCK1 expressed in Sf9 cells,IC50,=,2510,nM,,CHEMBL3231,Rho-associated protein kinase 1 ,Homo sapiens,Q13464,CHEMBL1140130,"J. Med. Chem., 51, p. 5663 (2008)",18800763,Scientific Literature
3f,CHEMBL1794066,"InChI=1S/C20H25N7O3.C2HF3O2/c1-4-27-17-14(29-12-6-9-22-10-7-12)11-23-13(5-8-20(2,3)28)15(17)24-19(27)16-18(21)26-30-25-16;3-2(4,5)1(6)7/h11-12,22,28H,4,6-7,9-10H2,1-3H3,(H2,21,26);(H,6,7)",CCn1c(nc2c(ncc(OC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N.OC(=O)C(F)(F)F,CHEMBL522857,"InChI=1S/C20H25N7O3/c1-4-27-17-14(29-12-6-9-22-10-7-12)11-23-13(5-8-20(2,3)28)15(17)24-19(27)16-18(21)26-30-25-16/h11-12,22,28H,4,6-7,9-10H2,1-3H3,(H2,21,26)",CCn1c(nc2c(ncc(OC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N,CHEMBL1028092,Inhibition of human recombinant ROCK1 expressed in Sf9 cells,IC50,=,1000,nM,,CHEMBL3231,Rho-associated protein kinase 1 ,Homo sapiens,Q13464,CHEMBL1140130,"J. Med. Chem., 51, p. 5663 (2008)",18800763,Scientific Literature
5,CHEMBL493066,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-5-3-17-4-6-22)7-18-8-10(12)19-14(23)11-13(16)21-25-20-11/h7-8,17H,2-6H2,1H3,(H2,16,21)",CCn1c(nc2cncc(C(=O)N3CCNCC3)c12)c4nonc4N,CHEMBL493066,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-5-3-17-4-6-22)7-18-8-10(12)19-14(23)11-13(16)21-25-20-11/h7-8,17H,2-6H2,1H3,(H2,16,21)",CCn1c(nc2cncc(C(=O)N3CCNCC3)c12)c4nonc4N,CHEMBL1028092,Inhibition of human recombinant ROCK1 expressed in Sf9 cells,IC50,=,20,nM,,CHEMBL3231,Rho-associated protein kinase 1 ,Homo sapiens,Q13464,CHEMBL1140130,"J. Med. Chem., 51, p. 5663 (2008)",18800763,Scientific Literature
1,CHEMBL365286,"InChI=1S/C11H11N5O/c1-2-16-8-6-4-3-5-7(8)13-11(16)9-10(12)15-17-14-9/h3-6H,2H2,1H3,(H2,12,15)",CCn1c(nc2ccccc12)c3nonc3N,CHEMBL365286,"InChI=1S/C11H11N5O/c1-2-16-8-6-4-3-5-7(8)13-11(16)9-10(12)15-17-14-9/h3-6H,2H2,1H3,(H2,12,15)",CCn1c(nc2ccccc12)c3nonc3N,CHEMBL828472,Inhibitory concentration exhibited towards MSK-1,IC50,=,140,nM,,CHEMBL4237,Ribosomal protein S6 kinase alpha 5,Homo sapiens,O75582,CHEMBL1140255,"Bioorg. Med. Chem. Lett., 15, p. 3402 (2005)",15950465,Scientific Literature
10,CHEMBL185710,"InChI=1S/C10H10N6O/c1-2-16-7-5-12-4-3-6(7)13-10(16)8-9(11)15-17-14-8/h3-5H,2H2,1H3,(H2,11,15)",CCn1c(nc2ccncc12)c3nonc3N,CHEMBL185710,"InChI=1S/C10H10N6O/c1-2-16-7-5-12-4-3-6(7)13-10(16)8-9(11)15-17-14-8/h3-5H,2H2,1H3,(H2,11,15)",CCn1c(nc2ccncc12)c3nonc3N,CHEMBL828472,Inhibitory concentration exhibited towards MSK-1,IC50,=,1540,nM,,CHEMBL4237,Ribosomal protein S6 kinase alpha 5,Homo sapiens,O75582,CHEMBL1140255,"Bioorg. Med. Chem. Lett., 15, p. 3402 (2005)",15950465,Scientific Literature
26,CHEMBL188048,"InChI=1S/C9H8N6O/c1-15-6-2-3-11-4-5(6)12-9(15)7-8(10)14-16-13-7/h2-4H,1H3,(H2,10,14)",Cn1c(nc2cnccc12)c3nonc3N,CHEMBL188048,"InChI=1S/C9H8N6O/c1-15-6-2-3-11-4-5(6)12-9(15)7-8(10)14-16-13-7/h2-4H,1H3,(H2,10,14)",Cn1c(nc2cnccc12)c3nonc3N,CHEMBL828472,Inhibitory concentration exhibited towards MSK-1,IC50,=,126,nM,,CHEMBL4237,Ribosomal protein S6 kinase alpha 5,Homo sapiens,O75582,CHEMBL1140255,"Bioorg. Med. Chem. Lett., 15, p. 3402 (2005)",15950465,Scientific Literature
27,CHEMBL185962,"InChI=1S/C11H10N6O/c12-10-9(15-18-16-10)11-14-7-5-13-4-3-8(7)17(11)6-1-2-6/h3-6H,1-2H2,(H2,12,16)",Nc1nonc1c2nc3cnccc3n2C4CC4,CHEMBL185962,"InChI=1S/C11H10N6O/c12-10-9(15-18-16-10)11-14-7-5-13-4-3-8(7)17(11)6-1-2-6/h3-6H,1-2H2,(H2,12,16)",Nc1nonc1c2nc3cnccc3n2C4CC4,CHEMBL828472,Inhibitory concentration exhibited towards MSK-1,IC50,=,1.8,nM,,CHEMBL4237,Ribosomal protein S6 kinase alpha 5,Homo sapiens,O75582,CHEMBL1140255,"Bioorg. Med. Chem. Lett., 15, p. 3402 (2005)",15950465,Scientific Literature
28,CHEMBL189231,"InChI=1S/C14H16N6O/c15-13-12(18-21-19-13)14-17-10-8-16-7-6-11(10)20(14)9-4-2-1-3-5-9/h6-9H,1-5H2,(H2,15,19)",Nc1nonc1c2nc3cnccc3n2C4CCCCC4,CHEMBL189231,"InChI=1S/C14H16N6O/c15-13-12(18-21-19-13)14-17-10-8-16-7-6-11(10)20(14)9-4-2-1-3-5-9/h6-9H,1-5H2,(H2,15,19)",Nc1nonc1c2nc3cnccc3n2C4CCCCC4,CHEMBL828472,Inhibitory concentration exhibited towards MSK-1,IC50,=,3,nM,,CHEMBL4237,Ribosomal protein S6 kinase alpha 5,Homo sapiens,O75582,CHEMBL1140255,"Bioorg. Med. Chem. Lett., 15, p. 3402 (2005)",15950465,Scientific Literature
7,CHEMBL426800,"InChI=1S/C11H10FN5O/c1-2-17-8-5-6(12)3-4-7(8)14-11(17)9-10(13)16-18-15-9/h3-5H,2H2,1H3,(H2,13,16)",CCn1c(nc2ccc(F)cc12)c3nonc3N,CHEMBL426800,"InChI=1S/C11H10FN5O/c1-2-17-8-5-6(12)3-4-7(8)14-11(17)9-10(13)16-18-15-9/h3-5H,2H2,1H3,(H2,13,16)",CCn1c(nc2ccc(F)cc12)c3nonc3N,CHEMBL828472,Inhibitory concentration exhibited towards MSK-1,IC50,=,2120.0,nM,,CHEMBL4237,Ribosomal protein S6 kinase alpha 5,Homo sapiens,O75582,CHEMBL1140255,"Bioorg. Med. Chem. Lett., 15, p. 3402 (2005)",15950465,Scientific Literature
23,CHEMBL188381,"InChI=1S/C25H22F3N7O4S/c1-35(22-13-14-30-23(34-22)31-18-3-2-4-21(15-18)40(29,37)38)19-9-5-16(6-10-19)32-24(36)33-17-7-11-20(12-8-17)39-25(26,27)28/h2-15H,1H3,(H2,29,37,38)(H,30,31,34)(H2,32,33,36)",CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c3ccnc(Nc4cccc(c4)S(=O)(=O)N)n3,CHEMBL188381,"InChI=1S/C25H22F3N7O4S/c1-35(22-13-14-30-23(34-22)31-18-3-2-4-21(15-18)40(29,37)38)19-9-5-16(6-10-19)32-24(36)33-17-7-11-20(12-8-17)39-25(26,27)28/h2-15H,1H3,(H2,29,37,38)(H,30,31,34)(H2,32,33,36)",CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c3ccnc(Nc4cccc(c4)S(=O)(=O)N)n3,CHEMBL828488,Inhibitory concentration against human VEGFR2 kinase,IC50,=,2,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1140275,"Bioorg. Med. Chem. Lett., 15, p. 3519 (2005)",15990302,Scientific Literature
25,CHEMBL189353,"InChI=1S/C26H24Cl2N6O3S/c1-34(20-11-9-18(10-12-20)31-26(35)33-24-21(27)7-4-8-22(24)28)23-13-14-29-25(32-23)30-19-6-3-5-17(15-19)16-38(2,36)37/h3-15H,16H2,1-2H3,(H,29,30,32)(H2,31,33,35)",CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c3ccnc(Nc4cccc(CS(=O)(=O)C)c4)n3,CHEMBL189353,"InChI=1S/C26H24Cl2N6O3S/c1-34(20-11-9-18(10-12-20)31-26(35)33-24-21(27)7-4-8-22(24)28)23-13-14-29-25(32-23)30-19-6-3-5-17(15-19)16-38(2,36)37/h3-15H,16H2,1-2H3,(H,29,30,32)(H2,31,33,35)",CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c3ccnc(Nc4cccc(CS(=O)(=O)C)c4)n3,CHEMBL828488,Inhibitory concentration against human VEGFR2 kinase,IC50,=,65,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1140275,"Bioorg. Med. Chem. Lett., 15, p. 3519 (2005)",15990302,Scientific Literature
32,CHEMBL187930,"InChI=1S/C24H31N7O3S/c1-30(2)16-15-26-24(32)28-20-9-11-21(12-10-20)31(3)22-13-14-25-23(29-22)27-19-7-5-18(6-8-19)17-35(4,33)34/h5-14H,15-17H2,1-4H3,(H,25,27,29)(H2,26,28,32)",CN(C)CCNC(=O)Nc1ccc(cc1)N(C)c2ccnc(Nc3ccc(CS(=O)(=O)C)cc3)n2,CHEMBL187930,"InChI=1S/C24H31N7O3S/c1-30(2)16-15-26-24(32)28-20-9-11-21(12-10-20)31(3)22-13-14-25-23(29-22)27-19-7-5-18(6-8-19)17-35(4,33)34/h5-14H,15-17H2,1-4H3,(H,25,27,29)(H2,26,28,32)",CN(C)CCNC(=O)Nc1ccc(cc1)N(C)c2ccnc(Nc3ccc(CS(=O)(=O)C)cc3)n2,CHEMBL828488,Inhibitory concentration against human VEGFR2 kinase,IC50,=,3114,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1140275,"Bioorg. Med. Chem. Lett., 15, p. 3519 (2005)",15990302,Scientific Literature
33,CHEMBL363316,"InChI=1S/C26H33N7O4S/c1-32(23-9-7-22(8-10-23)30-26(34)28-13-14-33-15-17-37-18-16-33)24-11-12-27-25(31-24)29-21-5-3-20(4-6-21)19-38(2,35)36/h3-12H,13-19H2,1-2H3,(H,27,29,31)(H2,28,30,34)",CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c3ccnc(Nc4ccc(CS(=O)(=O)C)cc4)n3,CHEMBL363316,"InChI=1S/C26H33N7O4S/c1-32(23-9-7-22(8-10-23)30-26(34)28-13-14-33-15-17-37-18-16-33)24-11-12-27-25(31-24)29-21-5-3-20(4-6-21)19-38(2,35)36/h3-12H,13-19H2,1-2H3,(H,27,29,31)(H2,28,30,34)",CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c3ccnc(Nc4ccc(CS(=O)(=O)C)cc4)n3,CHEMBL828488,Inhibitory concentration against human VEGFR2 kinase,IC50,=,990,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1140275,"Bioorg. Med. Chem. Lett., 15, p. 3519 (2005)",15990302,Scientific Literature
36,CHEMBL187494,"InChI=1S/C32H36N8O4S/c1-38-18-20-40(21-19-38)30(41)24-6-10-26(11-7-24)35-32(42)36-27-12-14-28(15-13-27)39(2)29-16-17-33-31(37-29)34-25-8-4-23(5-9-25)22-45(3,43)44/h4-17H,18-22H2,1-3H3,(H,33,34,37)(H2,35,36,42)",CN(c1ccc(NC(=O)Nc2ccc(cc2)C(=O)N3CCN(C)CC3)cc1)c4ccnc(Nc5ccc(CS(=O)(=O)C)cc5)n4,CHEMBL187494,"InChI=1S/C32H36N8O4S/c1-38-18-20-40(21-19-38)30(41)24-6-10-26(11-7-24)35-32(42)36-27-12-14-28(15-13-27)39(2)29-16-17-33-31(37-29)34-25-8-4-23(5-9-25)22-45(3,43)44/h4-17H,18-22H2,1-3H3,(H,33,34,37)(H2,35,36,42)",CN(c1ccc(NC(=O)Nc2ccc(cc2)C(=O)N3CCN(C)CC3)cc1)c4ccnc(Nc5ccc(CS(=O)(=O)C)cc5)n4,CHEMBL828488,Inhibitory concentration against human VEGFR2 kinase,IC50,=,150,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1140275,"Bioorg. Med. Chem. Lett., 15, p. 3519 (2005)",15990302,Scientific Literature
23,CHEMBL188381,"InChI=1S/C25H22F3N7O4S/c1-35(22-13-14-30-23(34-22)31-18-3-2-4-21(15-18)40(29,37)38)19-9-5-16(6-10-19)32-24(36)33-17-7-11-20(12-8-17)39-25(26,27)28/h2-15H,1H3,(H2,29,37,38)(H,30,31,34)(H2,32,33,36)",CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c3ccnc(Nc4cccc(c4)S(=O)(=O)N)n3,CHEMBL188381,"InChI=1S/C25H22F3N7O4S/c1-35(22-13-14-30-23(34-22)31-18-3-2-4-21(15-18)40(29,37)38)19-9-5-16(6-10-19)32-24(36)33-17-7-11-20(12-8-17)39-25(26,27)28/h2-15H,1H3,(H2,29,37,38)(H,30,31,34)(H2,32,33,36)",CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c3ccnc(Nc4cccc(c4)S(=O)(=O)N)n3,CHEMBL837260,Inhibitory concentration against human umbilical vein endothelial cells (HUVECs) induced by VEGF,IC50,=,5,nM,,CHEMBL613979,HUVEC (Umbilical vein endothelial cells),Homo sapiens,,CHEMBL1140275,"Bioorg. Med. Chem. Lett., 15, p. 3519 (2005)",15990302,Scientific Literature
25,CHEMBL189353,"InChI=1S/C26H24Cl2N6O3S/c1-34(20-11-9-18(10-12-20)31-26(35)33-24-21(27)7-4-8-22(24)28)23-13-14-29-25(32-23)30-19-6-3-5-17(15-19)16-38(2,36)37/h3-15H,16H2,1-2H3,(H,29,30,32)(H2,31,33,35)",CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c3ccnc(Nc4cccc(CS(=O)(=O)C)c4)n3,CHEMBL189353,"InChI=1S/C26H24Cl2N6O3S/c1-34(20-11-9-18(10-12-20)31-26(35)33-24-21(27)7-4-8-22(24)28)23-13-14-29-25(32-23)30-19-6-3-5-17(15-19)16-38(2,36)37/h3-15H,16H2,1-2H3,(H,29,30,32)(H2,31,33,35)",CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c3ccnc(Nc4cccc(CS(=O)(=O)C)c4)n3,CHEMBL837260,Inhibitory concentration against human umbilical vein endothelial cells (HUVECs) induced by VEGF,IC50,=,29,nM,,CHEMBL613979,HUVEC (Umbilical vein endothelial cells),Homo sapiens,,CHEMBL1140275,"Bioorg. Med. Chem. Lett., 15, p. 3519 (2005)",15990302,Scientific Literature
32,CHEMBL187930,"InChI=1S/C24H31N7O3S/c1-30(2)16-15-26-24(32)28-20-9-11-21(12-10-20)31(3)22-13-14-25-23(29-22)27-19-7-5-18(6-8-19)17-35(4,33)34/h5-14H,15-17H2,1-4H3,(H,25,27,29)(H2,26,28,32)",CN(C)CCNC(=O)Nc1ccc(cc1)N(C)c2ccnc(Nc3ccc(CS(=O)(=O)C)cc3)n2,CHEMBL187930,"InChI=1S/C24H31N7O3S/c1-30(2)16-15-26-24(32)28-20-9-11-21(12-10-20)31(3)22-13-14-25-23(29-22)27-19-7-5-18(6-8-19)17-35(4,33)34/h5-14H,15-17H2,1-4H3,(H,25,27,29)(H2,26,28,32)",CN(C)CCNC(=O)Nc1ccc(cc1)N(C)c2ccnc(Nc3ccc(CS(=O)(=O)C)cc3)n2,CHEMBL837260,Inhibitory concentration against human umbilical vein endothelial cells (HUVECs) induced by VEGF,IC50,=,2982,nM,,CHEMBL613979,HUVEC (Umbilical vein endothelial cells),Homo sapiens,,CHEMBL1140275,"Bioorg. Med. Chem. Lett., 15, p. 3519 (2005)",15990302,Scientific Literature
33,CHEMBL363316,"InChI=1S/C26H33N7O4S/c1-32(23-9-7-22(8-10-23)30-26(34)28-13-14-33-15-17-37-18-16-33)24-11-12-27-25(31-24)29-21-5-3-20(4-6-21)19-38(2,35)36/h3-12H,13-19H2,1-2H3,(H,27,29,31)(H2,28,30,34)",CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c3ccnc(Nc4ccc(CS(=O)(=O)C)cc4)n3,CHEMBL363316,"InChI=1S/C26H33N7O4S/c1-32(23-9-7-22(8-10-23)30-26(34)28-13-14-33-15-17-37-18-16-33)24-11-12-27-25(31-24)29-21-5-3-20(4-6-21)19-38(2,35)36/h3-12H,13-19H2,1-2H3,(H,27,29,31)(H2,28,30,34)",CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c3ccnc(Nc4ccc(CS(=O)(=O)C)cc4)n3,CHEMBL837260,Inhibitory concentration against human umbilical vein endothelial cells (HUVECs) induced by VEGF,IC50,=,471,nM,,CHEMBL613979,HUVEC (Umbilical vein endothelial cells),Homo sapiens,,CHEMBL1140275,"Bioorg. Med. Chem. Lett., 15, p. 3519 (2005)",15990302,Scientific Literature
36,CHEMBL187494,"InChI=1S/C32H36N8O4S/c1-38-18-20-40(21-19-38)30(41)24-6-10-26(11-7-24)35-32(42)36-27-12-14-28(15-13-27)39(2)29-16-17-33-31(37-29)34-25-8-4-23(5-9-25)22-45(3,43)44/h4-17H,18-22H2,1-3H3,(H,33,34,37)(H2,35,36,42)",CN(c1ccc(NC(=O)Nc2ccc(cc2)C(=O)N3CCN(C)CC3)cc1)c4ccnc(Nc5ccc(CS(=O)(=O)C)cc5)n4,CHEMBL187494,"InChI=1S/C32H36N8O4S/c1-38-18-20-40(21-19-38)30(41)24-6-10-26(11-7-24)35-32(42)36-27-12-14-28(15-13-27)39(2)29-16-17-33-31(37-29)34-25-8-4-23(5-9-25)22-45(3,43)44/h4-17H,18-22H2,1-3H3,(H,33,34,37)(H2,35,36,42)",CN(c1ccc(NC(=O)Nc2ccc(cc2)C(=O)N3CCN(C)CC3)cc1)c4ccnc(Nc5ccc(CS(=O)(=O)C)cc5)n4,CHEMBL837260,Inhibitory concentration against human umbilical vein endothelial cells (HUVECs) induced by VEGF,IC50,=,516,nM,,CHEMBL613979,HUVEC (Umbilical vein endothelial cells),Homo sapiens,,CHEMBL1140275,"Bioorg. Med. Chem. Lett., 15, p. 3519 (2005)",15990302,Scientific Literature
"9, Pyrazolopyridazine 1",CHEMBL187081,"InChI=1S/C17H14N6O/c1-24-13-5-2-4-12(10-13)21-17-18-9-7-15(22-17)14-11-20-23-16(14)6-3-8-19-23/h2-11H,1H3,(H,18,21,22)",COc1cccc(Nc2nccc(n2)c3cnn4ncccc34)c1,CHEMBL187081,"InChI=1S/C17H14N6O/c1-24-13-5-2-4-12(10-13)21-17-18-9-7-15(22-17)14-11-20-23-16(14)6-3-8-19-23/h2-11H,1H3,(H,18,21,22)",COc1cccc(Nc2nccc(n2)c3cnn4ncccc34)c1,CHEMBL925067,Inhibition of GSK3,IC50,=,10,nM,,CHEMBL612545,,,,CHEMBL1140622,"Bioorg. Med. Chem., 15, p. 3728 (2007)",17399989,Scientific Literature
"14, Pyrazolopyrimidine 1",CHEMBL66292,"InChI=1S/C20H18N6O3S/c1-29-16-5-3-4-15(10-16)26-20-18(12-24-26)19(21-13-22-20)25-23-11-14-6-8-17(9-7-14)30(2,27)28/h3-13H,1-2H3,(H,21,22,25)/b23-11+",COc1cccc(c1)n2ncc3c(N\N=C\c4ccc(cc4)S(=O)(=O)C)ncnc23,CHEMBL66292,"InChI=1S/C20H18N6O3S/c1-29-16-5-3-4-15(10-16)26-20-18(12-24-26)19(21-13-22-20)25-23-11-14-6-8-17(9-7-14)30(2,27)28/h3-13H,1-2H3,(H,21,22,25)/b23-11+",COc1cccc(c1)n2ncc3c(N\N=C\c4ccc(cc4)S(=O)(=O)C)ncnc23,CHEMBL925067,Inhibition of GSK3,Log IC50,=,8.6,,,CHEMBL612545,,,,CHEMBL1140622,"Bioorg. Med. Chem., 15, p. 3728 (2007)",17399989,Scientific Literature
20,CHEMBL400388,"InChI=1S/C17H14FN5O/c18-12-4-2-6-14(10-12)21-15-7-8-20-17(23-15)22-13-5-1-3-11(9-13)16(19)24/h1-10H,(H2,19,24)(H2,20,21,22,23)",NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1,CHEMBL400388,"InChI=1S/C17H14FN5O/c18-12-4-2-6-14(10-12)21-15-7-8-20-17(23-15)22-13-5-1-3-11(9-13)16(19)24/h1-10H,(H2,19,24)(H2,20,21,22,23)",NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1,CHEMBL923137,Inhibition of murine Lck by TR-FRET assay,IC50,=,3300,nM,,CHEMBL2480,Tyrosine-protein kinase LCK,Mus musculus,P06240,CHEMBL1140683,"Bioorg. Med. Chem. Lett., 17, p. 4363 (2007)",17600705,Scientific Literature
36,CHEMBL251549,"InChI=1S/C18H15N7O/c19-17(26)11-3-1-4-12(9-11)22-18-20-8-7-16(24-18)23-14-5-2-6-15-13(14)10-21-25-15/h1-10H,(H2,19,26)(H,21,25)(H2,20,22,23,24)",NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1,CHEMBL251549,"InChI=1S/C18H15N7O/c19-17(26)11-3-1-4-12(9-11)22-18-20-8-7-16(24-18)23-14-5-2-6-15-13(14)10-21-25-15/h1-10H,(H2,19,26)(H,21,25)(H2,20,22,23,24)",NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1,CHEMBL923137,Inhibition of murine Lck by TR-FRET assay,IC50,=,100,nM,,CHEMBL2480,Tyrosine-protein kinase LCK,Mus musculus,P06240,CHEMBL1140683,"Bioorg. Med. Chem. Lett., 17, p. 4363 (2007)",17600705,Scientific Literature
5,CHEMBL250322,"InChI=1S/C18H17N5O2/c1-11-5-6-14(10-15(11)24)21-16-7-8-20-18(23-16)22-13-4-2-3-12(9-13)17(19)25/h2-10,24H,1H3,(H2,19,25)(H2,20,21,22,23)",Cc1ccc(Nc2ccnc(Nc3cccc(c3)C(=O)N)n2)cc1O,CHEMBL250322,"InChI=1S/C18H17N5O2/c1-11-5-6-14(10-15(11)24)21-16-7-8-20-18(23-16)22-13-4-2-3-12(9-13)17(19)25/h2-10,24H,1H3,(H2,19,25)(H2,20,21,22,23)",Cc1ccc(Nc2ccnc(Nc3cccc(c3)C(=O)N)n2)cc1O,CHEMBL923137,Inhibition of murine Lck by TR-FRET assay,IC50,=,190,nM,,CHEMBL2480,Tyrosine-protein kinase LCK,Mus musculus,P06240,CHEMBL1140683,"Bioorg. Med. Chem. Lett., 17, p. 4363 (2007)",17600705,Scientific Literature
"1, SI,Table 1",CHEMBL516375,"InChI=1S/C21H19ClFN5O2S2/c1-32(29,30)7-6-24-10-20-28-19(11-31-20)13-2-5-18-15(8-13)21(26-12-25-18)27-14-3-4-17(23)16(22)9-14/h2-5,8-9,11-12,24H,6-7,10H2,1H3,(H,25,26,27)",CS(=O)(=O)CCNCc1nc(cs1)c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2,CHEMBL516375,"InChI=1S/C21H19ClFN5O2S2/c1-32(29,30)7-6-24-10-20-28-19(11-31-20)13-2-5-18-15(8-13)21(26-12-25-18)27-14-3-4-17(23)16(22)9-14/h2-5,8-9,11-12,24H,6-7,10H2,1H3,(H,25,26,27)",CS(=O)(=O)CCNCc1nc(cs1)c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2,CHEMBL944276,Inhibition of human recombinant EGFR,pIC50,=,7.46,,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1140899,"J. Med. Chem., 52, p. 964 (2009)",19170633,Scientific Literature
"10, SI,Table 1",CHEMBL15202,"InChI=1S/C22H19N3O2/c1-26-19-11-12-21-20(13-19)22(24-15-23-21)25-17-7-9-18(10-8-17)27-14-16-5-3-2-4-6-16/h2-13,15H,14H2,1H3,(H,23,24,25)",COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1,CHEMBL15202,"InChI=1S/C22H19N3O2/c1-26-19-11-12-21-20(13-19)22(24-15-23-21)25-17-7-9-18(10-8-17)27-14-16-5-3-2-4-6-16/h2-13,15H,14H2,1H3,(H,23,24,25)",COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1,CHEMBL944276,Inhibition of human recombinant EGFR,pIC50,=,7.17,,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1140899,"J. Med. Chem., 52, p. 964 (2009)",19170633,Scientific Literature
"15, SI,Table 1",CHEMBL517907,"InChI=1S/C23H26N4O3S/c1-3-18-7-6-8-19(15-18)27-23-21-16-20(9-10-22(21)25-17-26-23)30-13-5-4-11-24-12-14-31(2,28)29/h1,6-10,15-17,24H,4-5,11-14H2,2H3,(H,25,26,27)",CS(=O)(=O)CCNCCCCOc1ccc2ncnc(Nc3cccc(c3)C#C)c2c1,CHEMBL517907,"InChI=1S/C23H26N4O3S/c1-3-18-7-6-8-19(15-18)27-23-21-16-20(9-10-22(21)25-17-26-23)30-13-5-4-11-24-12-14-31(2,28)29/h1,6-10,15-17,24H,4-5,11-14H2,2H3,(H,25,26,27)",CS(=O)(=O)CCNCCCCOc1ccc2ncnc(Nc3cccc(c3)C#C)c2c1,CHEMBL944276,Inhibition of human recombinant EGFR,pIC50,=,7.96,,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1140899,"J. Med. Chem., 52, p. 964 (2009)",19170633,Scientific Literature
"4, SI,Table 1",CHEMBL505970,"InChI=1S/C29H26F3N5O3S2/c1-42(38,39)12-11-33-15-27-37-26(17-41-27)20-5-10-25-24(14-20)28(35-18-34-25)36-22-6-8-23(9-7-22)40-16-19-3-2-4-21(13-19)29(30,31)32/h2-10,13-14,17-18,33H,11-12,15-16H2,1H3,(H,34,35,36)",CS(=O)(=O)CCNCc1nc(cs1)c2ccc3ncnc(Nc4ccc(OCc5cccc(c5)C(F)(F)F)cc4)c3c2,CHEMBL505970,"InChI=1S/C29H26F3N5O3S2/c1-42(38,39)12-11-33-15-27-37-26(17-41-27)20-5-10-25-24(14-20)28(35-18-34-25)36-22-6-8-23(9-7-22)40-16-19-3-2-4-21(13-19)29(30,31)32/h2-10,13-14,17-18,33H,11-12,15-16H2,1H3,(H,34,35,36)",CS(=O)(=O)CCNCc1nc(cs1)c2ccc3ncnc(Nc4ccc(OCc5cccc(c5)C(F)(F)F)cc4)c3c2,CHEMBL944276,Inhibition of human recombinant EGFR,pIC50,=,6.27,,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1140899,"J. Med. Chem., 52, p. 964 (2009)",19170633,Scientific Literature
3,CHEMBL270164,"InChI=1S/C24H18N4O2/c1-15-6-7-20(24-28-27-16(2)30-24)13-22(15)18-8-10-19(11-9-18)23(29)26-21-5-3-4-17(12-21)14-25/h3-13H,1-2H3,(H,26,29)",Cc1oc(nn1)c2ccc(C)c(c2)c3ccc(cc3)C(=O)Nc4cccc(c4)C#N,CHEMBL270164,"InChI=1S/C24H18N4O2/c1-15-6-7-20(24-28-27-16(2)30-24)13-22(15)18-8-10-19(11-9-18)23(29)26-21-5-3-4-17(12-21)14-25/h3-13H,1-2H3,(H,26,29)",Cc1oc(nn1)c2ccc(C)c(c2)c3ccc(cc3)C(=O)Nc4cccc(c4)C#N,CHEMBL929905,Inhibition of JNK,Ki,>,4000,nM,,CHEMBL612545,,,,CHEMBL1141605,"Bioorg. Med. Chem. Lett., 18, p. 318 (2008)",18006306,Scientific Literature
3,CHEMBL270164,"InChI=1S/C24H18N4O2/c1-15-6-7-20(24-28-27-16(2)30-24)13-22(15)18-8-10-19(11-9-18)23(29)26-21-5-3-4-17(12-21)14-25/h3-13H,1-2H3,(H,26,29)",Cc1oc(nn1)c2ccc(C)c(c2)c3ccc(cc3)C(=O)Nc4cccc(c4)C#N,CHEMBL270164,"InChI=1S/C24H18N4O2/c1-15-6-7-20(24-28-27-16(2)30-24)13-22(15)18-8-10-19(11-9-18)23(29)26-21-5-3-4-17(12-21)14-25/h3-13H,1-2H3,(H,26,29)",Cc1oc(nn1)c2ccc(C)c(c2)c3ccc(cc3)C(=O)Nc4cccc(c4)C#N,CHEMBL929904,Inhibition of JNK3,IC50,>,16000,nM,,CHEMBL2637,c-Jun N-terminal kinase 3,Homo sapiens,P53779,CHEMBL1141605,"Bioorg. Med. Chem. Lett., 18, p. 318 (2008)",18006306,Scientific Literature
3,CHEMBL270164,"InChI=1S/C24H18N4O2/c1-15-6-7-20(24-28-27-16(2)30-24)13-22(15)18-8-10-19(11-9-18)23(29)26-21-5-3-4-17(12-21)14-25/h3-13H,1-2H3,(H,26,29)",Cc1oc(nn1)c2ccc(C)c(c2)c3ccc(cc3)C(=O)Nc4cccc(c4)C#N,CHEMBL270164,"InChI=1S/C24H18N4O2/c1-15-6-7-20(24-28-27-16(2)30-24)13-22(15)18-8-10-19(11-9-18)23(29)26-21-5-3-4-17(12-21)14-25/h3-13H,1-2H3,(H,26,29)",Cc1oc(nn1)c2ccc(C)c(c2)c3ccc(cc3)C(=O)Nc4cccc(c4)C#N,CHEMBL929904,Inhibition of JNK3,Ki,>,4000,nM,,CHEMBL2637,c-Jun N-terminal kinase 3,Homo sapiens,P53779,CHEMBL1141605,"Bioorg. Med. Chem. Lett., 18, p. 318 (2008)",18006306,Scientific Literature
3,CHEMBL270164,"InChI=1S/C24H18N4O2/c1-15-6-7-20(24-28-27-16(2)30-24)13-22(15)18-8-10-19(11-9-18)23(29)26-21-5-3-4-17(12-21)14-25/h3-13H,1-2H3,(H,26,29)",Cc1oc(nn1)c2ccc(C)c(c2)c3ccc(cc3)C(=O)Nc4cccc(c4)C#N,CHEMBL270164,"InChI=1S/C24H18N4O2/c1-15-6-7-20(24-28-27-16(2)30-24)13-22(15)18-8-10-19(11-9-18)23(29)26-21-5-3-4-17(12-21)14-25/h3-13H,1-2H3,(H,26,29)",Cc1oc(nn1)c2ccc(C)c(c2)c3ccc(cc3)C(=O)Nc4cccc(c4)C#N,CHEMBL929903,Inhibition of Lck,IC50,>,16000,nM,,CHEMBL258,Tyrosine-protein kinase LCK,Homo sapiens,P06239,CHEMBL1141605,"Bioorg. Med. Chem. Lett., 18, p. 318 (2008)",18006306,Scientific Literature
3,CHEMBL270164,"InChI=1S/C24H18N4O2/c1-15-6-7-20(24-28-27-16(2)30-24)13-22(15)18-8-10-19(11-9-18)23(29)26-21-5-3-4-17(12-21)14-25/h3-13H,1-2H3,(H,26,29)",Cc1oc(nn1)c2ccc(C)c(c2)c3ccc(cc3)C(=O)Nc4cccc(c4)C#N,CHEMBL270164,"InChI=1S/C24H18N4O2/c1-15-6-7-20(24-28-27-16(2)30-24)13-22(15)18-8-10-19(11-9-18)23(29)26-21-5-3-4-17(12-21)14-25/h3-13H,1-2H3,(H,26,29)",Cc1oc(nn1)c2ccc(C)c(c2)c3ccc(cc3)C(=O)Nc4cccc(c4)C#N,CHEMBL929903,Inhibition of Lck,Ki,>,5400,nM,,CHEMBL258,Tyrosine-protein kinase LCK,Homo sapiens,P06239,CHEMBL1141605,"Bioorg. Med. Chem. Lett., 18, p. 318 (2008)",18006306,Scientific Literature
3,CHEMBL270164,"InChI=1S/C24H18N4O2/c1-15-6-7-20(24-28-27-16(2)30-24)13-22(15)18-8-10-19(11-9-18)23(29)26-21-5-3-4-17(12-21)14-25/h3-13H,1-2H3,(H,26,29)",Cc1oc(nn1)c2ccc(C)c(c2)c3ccc(cc3)C(=O)Nc4cccc(c4)C#N,CHEMBL270164,"InChI=1S/C24H18N4O2/c1-15-6-7-20(24-28-27-16(2)30-24)13-22(15)18-8-10-19(11-9-18)23(29)26-21-5-3-4-17(12-21)14-25/h3-13H,1-2H3,(H,26,29)",Cc1oc(nn1)c2ccc(C)c(c2)c3ccc(cc3)C(=O)Nc4cccc(c4)C#N,CHEMBL929902,Inhibition of purified human p38alpha,IC50,=,1500,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1141605,"Bioorg. Med. Chem. Lett., 18, p. 318 (2008)",18006306,Scientific Literature
3,CHEMBL270164,"InChI=1S/C24H18N4O2/c1-15-6-7-20(24-28-27-16(2)30-24)13-22(15)18-8-10-19(11-9-18)23(29)26-21-5-3-4-17(12-21)14-25/h3-13H,1-2H3,(H,26,29)",Cc1oc(nn1)c2ccc(C)c(c2)c3ccc(cc3)C(=O)Nc4cccc(c4)C#N,CHEMBL270164,"InChI=1S/C24H18N4O2/c1-15-6-7-20(24-28-27-16(2)30-24)13-22(15)18-8-10-19(11-9-18)23(29)26-21-5-3-4-17(12-21)14-25/h3-13H,1-2H3,(H,26,29)",Cc1oc(nn1)c2ccc(C)c(c2)c3ccc(cc3)C(=O)Nc4cccc(c4)C#N,CHEMBL929902,Inhibition of purified human p38alpha,Ki,=,240,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1141605,"Bioorg. Med. Chem. Lett., 18, p. 318 (2008)",18006306,Scientific Literature
5,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL929988,Inhibition of human GSK3-beta,IC50,=,7,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1141635,"Bioorg. Med. Chem., 16, p. 636 (2008)",18006321,Scientific Literature
6,CHEMBL156987,"InChI=1S/C17H10Cl2N2O4/c18-9-3-1-2-8(6-9)13-14(16(23)21-15(13)22)20-10-4-5-12(19)11(7-10)17(24)25/h1-7H,(H,24,25)(H2,20,21,22,23)",OC(=O)c1cc(NC2=C(C(=O)NC2=O)c3cccc(Cl)c3)ccc1Cl,CHEMBL156987,"InChI=1S/C17H10Cl2N2O4/c18-9-3-1-2-8(6-9)13-14(16(23)21-15(13)22)20-10-4-5-12(19)11(7-10)17(24)25/h1-7H,(H,24,25)(H2,20,21,22,23)",OC(=O)c1cc(NC2=C(C(=O)NC2=O)c3cccc(Cl)c3)ccc1Cl,CHEMBL929988,Inhibition of human GSK3-beta,IC50,=,76,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1141635,"Bioorg. Med. Chem., 16, p. 636 (2008)",18006321,Scientific Literature
"Table 3, Ref",CHEMBL346551,"InChI=1S/C16H12N2O2/c19-15-13(11-7-3-1-4-8-11)14(16(20)18-15)17-12-9-5-2-6-10-12/h1-10H,(H2,17,18,19,20)",O=C1NC(=O)C(=C1Nc2ccccc2)c3ccccc3,CHEMBL346551,"InChI=1S/C16H12N2O2/c19-15-13(11-7-3-1-4-8-11)14(16(20)18-15)17-12-9-5-2-6-10-12/h1-10H,(H2,17,18,19,20)",O=C1NC(=O)C(=C1Nc2ccccc2)c3ccccc3,CHEMBL929988,Inhibition of human GSK3-beta,IC50,=,520,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1141635,"Bioorg. Med. Chem., 16, p. 636 (2008)",18006321,Scientific Literature
17a,CHEMBL495902,"InChI=1S/C18H17N3O/c1-11-2-3-13(18(22)20-15-5-6-15)9-16(11)12-4-7-17-14(8-12)10-19-21-17/h2-4,7-10,15H,5-6H2,1H3,(H,19,21)(H,20,22)",Cc1ccc(cc1c2ccc3[nH]ncc3c2)C(=O)NC4CC4,CHEMBL495902,"InChI=1S/C18H17N3O/c1-11-2-3-13(18(22)20-15-5-6-15)9-16(11)12-4-7-17-14(8-12)10-19-21-17/h2-4,7-10,15H,5-6H2,1H3,(H,19,21)(H,20,22)",Cc1ccc(cc1c2ccc3[nH]ncc3c2)C(=O)NC4CC4,CHEMBL997720,Displacement of fluorescent ATP competitive ligand from p38alpha,Ki,=,87,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1141712,"Bioorg. Med. Chem. Lett., 18, p. 5285 (2008)",18789685,Scientific Literature
1,CHEMBL346551,"InChI=1S/C16H12N2O2/c19-15-13(11-7-3-1-4-8-11)14(16(20)18-15)17-12-9-5-2-6-10-12/h1-10H,(H2,17,18,19,20)",O=C1NC(=O)C(=C1Nc2ccccc2)c3ccccc3,CHEMBL346551,"InChI=1S/C16H12N2O2/c19-15-13(11-7-3-1-4-8-11)14(16(20)18-15)17-12-9-5-2-6-10-12/h1-10H,(H2,17,18,19,20)",O=C1NC(=O)C(=C1Nc2ccccc2)c3ccccc3,CHEMBL930273,Inhibition of recombinant GSK3-beta,IC50,=,590,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1142395,"J. Med. Chem., 51, p. 2062 (2008)",18324764,Scientific Literature
10,CHEMBL160937,"InChI=1S/C16H11ClN2O3/c17-12-7-2-1-6-11(12)13-14(16(22)19-15(13)21)18-9-4-3-5-10(20)8-9/h1-8,20H,(H2,18,19,21,22)",Oc1cccc(NC2=C(C(=O)NC2=O)c3ccccc3Cl)c1,CHEMBL160937,"InChI=1S/C16H11ClN2O3/c17-12-7-2-1-6-11(12)13-14(16(22)19-15(13)21)18-9-4-3-5-10(20)8-9/h1-8,20H,(H2,18,19,21,22)",Oc1cccc(NC2=C(C(=O)NC2=O)c3ccccc3Cl)c1,CHEMBL930273,Inhibition of recombinant GSK3-beta,IC50,=,374,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1142395,"J. Med. Chem., 51, p. 2062 (2008)",18324764,Scientific Literature
12,CHEMBL157258,"InChI=1S/C16H9Cl3N2O3/c17-9-4-2-1-3-8(9)12-13(16(24)21-15(12)23)20-7-5-10(18)14(22)11(19)6-7/h1-6,22H,(H2,20,21,23,24)",Oc1c(Cl)cc(NC2=C(C(=O)NC2=O)c3ccccc3Cl)cc1Cl,CHEMBL157258,"InChI=1S/C16H9Cl3N2O3/c17-9-4-2-1-3-8(9)12-13(16(24)21-15(12)23)20-7-5-10(18)14(22)11(19)6-7/h1-6,22H,(H2,20,21,23,24)",Oc1c(Cl)cc(NC2=C(C(=O)NC2=O)c3ccccc3Cl)cc1Cl,CHEMBL930273,Inhibition of recombinant GSK3-beta,IC50,=,93,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1142395,"J. Med. Chem., 51, p. 2062 (2008)",18324764,Scientific Literature
131,CHEMBL261129,"InChI=1S/C19H20BrN5O2/c1-25-8-6-12(7-9-25)19(27)22-18-14-10-15(20)16(21-17(14)23-24-18)11-2-4-13(26)5-3-11/h2-5,10,12,26H,6-9H2,1H3,(H2,21,22,23,24,27)",CN1CCC(CC1)C(=O)Nc2n[nH]c3nc(c(Br)cc23)c4ccc(O)cc4,CHEMBL261129,"InChI=1S/C19H20BrN5O2/c1-25-8-6-12(7-9-25)19(27)22-18-14-10-15(20)16(21-17(14)23-24-18)11-2-4-13(26)5-3-11/h2-5,10,12,26H,6-9H2,1H3,(H2,21,22,23,24,27)",CN1CCC(CC1)C(=O)Nc2n[nH]c3nc(c(Br)cc23)c4ccc(O)cc4,CHEMBL930273,Inhibition of recombinant GSK3-beta,IC50,=,1,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1142395,"J. Med. Chem., 51, p. 2062 (2008)",18324764,Scientific Literature
133,CHEMBL408732,"InChI=1S/C17H16N4O2/c1-23-12-6-4-10(5-7-12)14-9-8-13-15(18-14)20-21-16(13)19-17(22)11-2-3-11/h4-9,11H,2-3H2,1H3,(H2,18,19,20,21,22)",COc1ccc(cc1)c2ccc3c(NC(=O)C4CC4)n[nH]c3n2,CHEMBL408732,"InChI=1S/C17H16N4O2/c1-23-12-6-4-10(5-7-12)14-9-8-13-15(18-14)20-21-16(13)19-17(22)11-2-3-11/h4-9,11H,2-3H2,1H3,(H2,18,19,20,21,22)",COc1ccc(cc1)c2ccc3c(NC(=O)C4CC4)n[nH]c3n2,CHEMBL930273,Inhibition of recombinant GSK3-beta,IC50,=,23000,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1142395,"J. Med. Chem., 51, p. 2062 (2008)",18324764,Scientific Literature
134,CHEMBL405021,"InChI=1S/C17H15N3O/c21-17(12-6-7-12)18-16-14-9-8-13(10-15(14)19-20-16)11-4-2-1-3-5-11/h1-5,8-10,12H,6-7H2,(H2,18,19,20,21)",O=C(Nc1n[nH]c2cc(ccc12)c3ccccc3)C4CC4,CHEMBL405021,"InChI=1S/C17H15N3O/c21-17(12-6-7-12)18-16-14-9-8-13(10-15(14)19-20-16)11-4-2-1-3-5-11/h1-5,8-10,12H,6-7H2,(H2,18,19,20,21)",O=C(Nc1n[nH]c2cc(ccc12)c3ccccc3)C4CC4,CHEMBL930273,Inhibition of recombinant GSK3-beta,IC50,=,498,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1142395,"J. Med. Chem., 51, p. 2062 (2008)",18324764,Scientific Literature
137,CHEMBL407113,"InChI=1S/C17H16N4O3S/c18-25(23,24)13-3-1-2-11(8-13)12-6-7-14-15(9-12)20-21-16(14)19-17(22)10-4-5-10/h1-3,6-10H,4-5H2,(H2,18,23,24)(H2,19,20,21,22)",NS(=O)(=O)c1cccc(c1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL407113,"InChI=1S/C17H16N4O3S/c18-25(23,24)13-3-1-2-11(8-13)12-6-7-14-15(9-12)20-21-16(14)19-17(22)10-4-5-10/h1-3,6-10H,4-5H2,(H2,18,23,24)(H2,19,20,21,22)",NS(=O)(=O)c1cccc(c1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL930273,Inhibition of recombinant GSK3-beta,IC50,=,481,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1142395,"J. Med. Chem., 51, p. 2062 (2008)",18324764,Scientific Literature
143,CHEMBL261440,"InChI=1S/C17H13F2N3O/c18-11-4-6-14(19)13(8-11)10-3-5-12-15(7-10)21-22-16(12)20-17(23)9-1-2-9/h3-9H,1-2H2,(H2,20,21,22,23)",Fc1ccc(F)c(c1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL261440,"InChI=1S/C17H13F2N3O/c18-11-4-6-14(19)13(8-11)10-3-5-12-15(7-10)21-22-16(12)20-17(23)9-1-2-9/h3-9H,1-2H2,(H2,20,21,22,23)",Fc1ccc(F)c(c1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL930273,Inhibition of recombinant GSK3-beta,IC50,=,1000,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1142395,"J. Med. Chem., 51, p. 2062 (2008)",18324764,Scientific Literature
16,CHEMBL156263,"InChI=1S/C17H14N2O3/c1-22-13-10-6-5-9-12(13)14-15(17(21)19-16(14)20)18-11-7-3-2-4-8-11/h2-10H,1H3,(H2,18,19,20,21)",COc1ccccc1C2=C(Nc3ccccc3)C(=O)NC2=O,CHEMBL156263,"InChI=1S/C17H14N2O3/c1-22-13-10-6-5-9-12(13)14-15(17(21)19-16(14)20)18-11-7-3-2-4-8-11/h2-10H,1H3,(H2,18,19,20,21)",COc1ccccc1C2=C(Nc3ccccc3)C(=O)NC2=O,CHEMBL930273,Inhibition of recombinant GSK3-beta,IC50,=,216,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1142395,"J. Med. Chem., 51, p. 2062 (2008)",18324764,Scientific Literature
28,CHEMBL160333,"InChI=1S/C16H10Cl2N2O3/c17-9-3-1-2-8(6-9)13-14(16(23)20-15(13)22)19-10-4-5-12(21)11(18)7-10/h1-7,21H,(H2,19,20,22,23)",Oc1ccc(NC2=C(C(=O)NC2=O)c3cccc(Cl)c3)cc1Cl,CHEMBL160333,"InChI=1S/C16H10Cl2N2O3/c17-9-3-1-2-8(6-9)13-14(16(23)20-15(13)22)19-10-4-5-12(21)11(18)7-10/h1-7,21H,(H2,19,20,22,23)",Oc1ccc(NC2=C(C(=O)NC2=O)c3cccc(Cl)c3)cc1Cl,CHEMBL930273,Inhibition of recombinant GSK3-beta,IC50,=,94,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1142395,"J. Med. Chem., 51, p. 2062 (2008)",18324764,Scientific Literature
31,CHEMBL156987,"InChI=1S/C17H10Cl2N2O4/c18-9-3-1-2-8(6-9)13-14(16(23)21-15(13)22)20-10-4-5-12(19)11(7-10)17(24)25/h1-7H,(H,24,25)(H2,20,21,22,23)",OC(=O)c1cc(NC2=C(C(=O)NC2=O)c3cccc(Cl)c3)ccc1Cl,CHEMBL156987,"InChI=1S/C17H10Cl2N2O4/c18-9-3-1-2-8(6-9)13-14(16(23)21-15(13)22)20-10-4-5-12(19)11(7-10)17(24)25/h1-7H,(H,24,25)(H2,20,21,22,23)",OC(=O)c1cc(NC2=C(C(=O)NC2=O)c3cccc(Cl)c3)ccc1Cl,CHEMBL930273,Inhibition of recombinant GSK3-beta,IC50,=,76,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1142395,"J. Med. Chem., 51, p. 2062 (2008)",18324764,Scientific Literature
44,CHEMBL352222,"InChI=1S/C16H9Cl2N3O5/c17-10-5-8(6-11(18)14(10)22)19-13-12(15(23)20-16(13)24)7-2-1-3-9(4-7)21(25)26/h1-6,22H,(H2,19,20,23,24)",Oc1c(Cl)cc(NC2=C(C(=O)NC2=O)c3cccc(c3)N(=O)=O)cc1Cl,CHEMBL352222,"InChI=1S/C16H9Cl2N3O5/c17-10-5-8(6-11(18)14(10)22)19-13-12(15(23)20-16(13)24)7-2-1-3-9(4-7)21(25)26/h1-6,22H,(H2,19,20,23,24)",Oc1c(Cl)cc(NC2=C(C(=O)NC2=O)c3cccc(c3)N(=O)=O)cc1Cl,CHEMBL930273,Inhibition of recombinant GSK3-beta,IC50,=,20,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1142395,"J. Med. Chem., 51, p. 2062 (2008)",18324764,Scientific Literature
55,CHEMBL160876,"InChI=1S/C17H10Cl2N2O4/c18-9-3-1-8(2-4-9)13-14(16(23)21-15(13)22)20-10-5-6-12(19)11(7-10)17(24)25/h1-7H,(H,24,25)(H2,20,21,22,23)",OC(=O)c1cc(NC2=C(C(=O)NC2=O)c3ccc(Cl)cc3)ccc1Cl,CHEMBL160876,"InChI=1S/C17H10Cl2N2O4/c18-9-3-1-8(2-4-9)13-14(16(23)21-15(13)22)20-10-5-6-12(19)11(7-10)17(24)25/h1-7H,(H,24,25)(H2,20,21,22,23)",OC(=O)c1cc(NC2=C(C(=O)NC2=O)c3ccc(Cl)cc3)ccc1Cl,CHEMBL930273,Inhibition of recombinant GSK3-beta,IC50,=,109,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1142395,"J. Med. Chem., 51, p. 2062 (2008)",18324764,Scientific Literature
73,CHEMBL156524,"InChI=1S/C18H13ClN2O2/c19-13-7-5-12(6-8-13)15-16(18(23)20-17(15)22)21-10-9-11-3-1-2-4-14(11)21/h1-8H,9-10H2,(H,20,22,23)",Clc1ccc(cc1)C2=C(N3CCc4ccccc34)C(=O)NC2=O,CHEMBL156524,"InChI=1S/C18H13ClN2O2/c19-13-7-5-12(6-8-13)15-16(18(23)20-17(15)22)21-10-9-11-3-1-2-4-14(11)21/h1-8H,9-10H2,(H,20,22,23)",Clc1ccc(cc1)C2=C(N3CCc4ccccc34)C(=O)NC2=O,CHEMBL930273,Inhibition of recombinant GSK3-beta,IC50,=,1412,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1142395,"J. Med. Chem., 51, p. 2062 (2008)",18324764,Scientific Literature
74,CHEMBL347580,"InChI=1S/C19H16N2O3/c1-24-14-8-6-13(7-9-14)16-17(19(23)20-18(16)22)21-11-10-12-4-2-3-5-15(12)21/h2-9H,10-11H2,1H3,(H,20,22,23)",COc1ccc(cc1)C2=C(N3CCc4ccccc34)C(=O)NC2=O,CHEMBL347580,"InChI=1S/C19H16N2O3/c1-24-14-8-6-13(7-9-14)16-17(19(23)20-18(16)22)21-11-10-12-4-2-3-5-15(12)21/h2-9H,10-11H2,1H3,(H,20,22,23)",COc1ccc(cc1)C2=C(N3CCc4ccccc34)C(=O)NC2=O,CHEMBL930273,Inhibition of recombinant GSK3-beta,IC50,=,694,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1142395,"J. Med. Chem., 51, p. 2062 (2008)",18324764,Scientific Literature
83,CHEMBL406125,"InChI=1S/C18H20N6O/c1-24-9-7-13(8-10-24)18(25)19-16-14-11-15(12-5-3-2-4-6-12)20-22-17(14)23-21-16/h2-6,11,13H,7-10H2,1H3,(H2,19,21,22,23,25)",CN1CCC(CC1)C(=O)Nc2n[nH]c3nnc(cc23)c4ccccc4,CHEMBL406125,"InChI=1S/C18H20N6O/c1-24-9-7-13(8-10-24)18(25)19-16-14-11-15(12-5-3-2-4-6-12)20-22-17(14)23-21-16/h2-6,11,13H,7-10H2,1H3,(H2,19,21,22,23,25)",CN1CCC(CC1)C(=O)Nc2n[nH]c3nnc(cc23)c4ccccc4,CHEMBL930273,Inhibition of recombinant GSK3-beta,IC50,=,9,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1142395,"J. Med. Chem., 51, p. 2062 (2008)",18324764,Scientific Literature
87,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL930273,Inhibition of recombinant GSK3-beta,IC50,=,0.8,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1142395,"J. Med. Chem., 51, p. 2062 (2008)",18324764,Scientific Literature
96,CHEMBL101804,"InChI=1S/C14H12N4O2/c19-14(8-3-4-8)16-13-9-5-6-10(11-2-1-7-20-11)15-12(9)17-18-13/h1-2,5-8H,3-4H2,(H2,15,16,17,18,19)",O=C(Nc1n[nH]c2nc(ccc12)c3occc3)C4CC4,CHEMBL101804,"InChI=1S/C14H12N4O2/c19-14(8-3-4-8)16-13-9-5-6-10(11-2-1-7-20-11)15-12(9)17-18-13/h1-2,5-8H,3-4H2,(H2,15,16,17,18,19)",O=C(Nc1n[nH]c2nc(ccc12)c3occc3)C4CC4,CHEMBL930273,Inhibition of recombinant GSK3-beta,IC50,=,141,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1142395,"J. Med. Chem., 51, p. 2062 (2008)",18324764,Scientific Literature
97,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL930273,Inhibition of recombinant GSK3-beta,IC50,=,7,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1142395,"J. Med. Chem., 51, p. 2062 (2008)",18324764,Scientific Literature
1,CHEMBL384073,"InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)",CC1=C(C(NC(=O)N1)c2ccc(F)cc2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL384073,"InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)",CC1=C(C(NC(=O)N1)c2ccc(F)cc2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL986244,"Clearance in Sprague-Dawley rat at 1.3 mg/kg, iv",CL,=,49,mL.min-1.kg-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1142520,"J. Med. Chem., 51, p. 6631 (2008)",18842034,Scientific Literature
1,CHEMBL384073,"InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)",CC1=C(C(NC(=O)N1)c2ccc(F)cc2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL384073,"InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)",CC1=C(C(NC(=O)N1)c2ccc(F)cc2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL986245,"Half life in Sprague-Dawley rat at 1.3 mg/kg, iv",T1/2,=,0.7,hr,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1142520,"J. Med. Chem., 51, p. 6631 (2008)",18842034,Scientific Literature
1,CHEMBL384073,"InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)",CC1=C(C(NC(=O)N1)c2ccc(F)cc2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL384073,"InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)",CC1=C(C(NC(=O)N1)c2ccc(F)cc2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL987091,Inhibition of RSK1,IC50,=,3100,nM,,CHEMBL2553,Ribosomal protein S6 kinase alpha 1,Homo sapiens,Q15418,CHEMBL1142520,"J. Med. Chem., 51, p. 6631 (2008)",18842034,Scientific Literature
1,CHEMBL384073,"InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)",CC1=C(C(NC(=O)N1)c2ccc(F)cc2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL384073,"InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)",CC1=C(C(NC(=O)N1)c2ccc(F)cc2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL987092,Inhibition of human recombinant ROCK1 kinase expressed in insect Sf9 cells by SPA,IC50,=,14,nM,,CHEMBL3231,Rho-associated protein kinase 1 ,Homo sapiens,Q13464,CHEMBL1142520,"J. Med. Chem., 51, p. 6631 (2008)",18842034,Scientific Literature
16,CHEMBL485598,"InChI=1S/C25H18F4N6O/c1-13-21(24(36)33-18-7-8-19-16(10-18)12-31-35-19)22(14-2-5-17(26)6-3-14)34-23(32-13)15-4-9-20(30-11-15)25(27,28)29/h2-12,22H,1H3,(H,31,35)(H,32,34)(H,33,36)",CC1=C(C(N=C(N1)c2ccc(nc2)C(F)(F)F)c3ccc(F)cc3)C(=O)Nc4ccc5[nH]ncc5c4,CHEMBL485598,"InChI=1S/C25H18F4N6O/c1-13-21(24(36)33-18-7-8-19-16(10-18)12-31-35-19)22(14-2-5-17(26)6-3-14)34-23(32-13)15-4-9-20(30-11-15)25(27,28)29/h2-12,22H,1H3,(H,31,35)(H,32,34)(H,33,36)",CC1=C(C(N=C(N1)c2ccc(nc2)C(F)(F)F)c3ccc(F)cc3)C(=O)Nc4ccc5[nH]ncc5c4,CHEMBL987092,Inhibition of human recombinant ROCK1 kinase expressed in insect Sf9 cells by SPA,IC50,=,75,nM,,CHEMBL3231,Rho-associated protein kinase 1 ,Homo sapiens,Q13464,CHEMBL1142520,"J. Med. Chem., 51, p. 6631 (2008)",18842034,Scientific Literature
1,CHEMBL384073,"InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)",CC1=C(C(NC(=O)N1)c2ccc(F)cc2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL384073,"InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)",CC1=C(C(NC(=O)N1)c2ccc(F)cc2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL987090,Inhibition of p70S6K,IC50,=,2850,nM,,CHEMBL4501,Ribosomal protein S6 kinase 1,Homo sapiens,P23443,CHEMBL1142520,"J. Med. Chem., 51, p. 6631 (2008)",18842034,Scientific Literature
1,CHEMBL384073,"InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)",CC1=C(C(NC(=O)N1)c2ccc(F)cc2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL384073,"InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)",CC1=C(C(NC(=O)N1)c2ccc(F)cc2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL986250,Inhibition of phenylephrine-induced aortic ring contraction in Sprague-Dawley rat,IC50,=,760,nM,,CHEMBL613606,Aorta,Rattus norvegicus,,CHEMBL1142520,"J. Med. Chem., 51, p. 6631 (2008)",18842034,Scientific Literature
1,CHEMBL384073,"InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)",CC1=C(C(NC(=O)N1)c2ccc(F)cc2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL384073,"InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)",CC1=C(C(NC(=O)N1)c2ccc(F)cc2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL986243,"Volume of distribution at steady state in Sprague-Dawley rat at 1.3 mg/kg, iv",Vdss,=,2.2,L.kg-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1142520,"J. Med. Chem., 51, p. 6631 (2008)",18842034,Scientific Literature
10,CHEMBL1794061,"InChI=1S/C16H11N3O.ClH/c17-10-12-5-4-8-14(9-12)19-16-18-11-15(20-16)13-6-2-1-3-7-13;/h1-9,11H,(H,18,19);1H",Cl.N#Cc1cccc(Nc2oc(cn2)c3ccccc3)c1,CHEMBL192413,"InChI=1S/C16H11N3O/c17-10-12-5-4-8-14(9-12)19-16-18-11-15(20-16)13-6-2-1-3-7-13/h1-9,11H,(H,18,19)",N#Cc1cccc(Nc2oc(cn2)c3ccccc3)c1,CHEMBL829592,Inhibition of human Vascular endothelial growth factor receptor 2,IC50,=,930.0,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1142709,"J. Med. Chem., 48, p. 1610 (2005)",15743202,Scientific Literature
14,CHEMBL192417,"InChI=1S/C16H14N2O/c1-12-6-5-9-14(10-12)18-16-17-11-15(19-16)13-7-3-2-4-8-13/h2-11H,1H3,(H,17,18)",Cc1cccc(Nc2oc(cn2)c3ccccc3)c1,CHEMBL192417,"InChI=1S/C16H14N2O/c1-12-6-5-9-14(10-12)18-16-17-11-15(19-16)13-7-3-2-4-8-13/h2-11H,1H3,(H,17,18)",Cc1cccc(Nc2oc(cn2)c3ccccc3)c1,CHEMBL829592,Inhibition of human Vascular endothelial growth factor receptor 2,IC50,=,870.0,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1142709,"J. Med. Chem., 48, p. 1610 (2005)",15743202,Scientific Literature
15,CHEMBL194062,"InChI=1S/C15H13N3O3S/c16-22(19,20)13-8-6-12(7-9-13)18-15-17-10-14(21-15)11-4-2-1-3-5-11/h1-10H,(H,17,18)(H2,16,19,20)",NS(=O)(=O)c1ccc(Nc2oc(cn2)c3ccccc3)cc1,CHEMBL194062,"InChI=1S/C15H13N3O3S/c16-22(19,20)13-8-6-12(7-9-13)18-15-17-10-14(21-15)11-4-2-1-3-5-11/h1-10H,(H,17,18)(H2,16,19,20)",NS(=O)(=O)c1ccc(Nc2oc(cn2)c3ccccc3)cc1,CHEMBL829592,Inhibition of human Vascular endothelial growth factor receptor 2,IC50,=,500,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1142709,"J. Med. Chem., 48, p. 1610 (2005)",15743202,Scientific Literature
16,CHEMBL194117,"InChI=1S/C21H16N2O2/c1-3-7-16(8-4-1)20-15-22-21(25-20)23-17-11-13-19(14-12-17)24-18-9-5-2-6-10-18/h1-15H,(H,22,23)",N(c1ccc(Oc2ccccc2)cc1)c3oc(cn3)c4ccccc4,CHEMBL194117,"InChI=1S/C21H16N2O2/c1-3-7-16(8-4-1)20-15-22-21(25-20)23-17-11-13-19(14-12-17)24-18-9-5-2-6-10-18/h1-15H,(H,22,23)",N(c1ccc(Oc2ccccc2)cc1)c3oc(cn3)c4ccccc4,CHEMBL829592,Inhibition of human Vascular endothelial growth factor receptor 2,IC50,>,10000,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1142709,"J. Med. Chem., 48, p. 1610 (2005)",15743202,Scientific Literature
17,CHEMBL1794060,"InChI=1S/C17H16N2O3.ClH/c1-20-14-9-8-13(10-15(14)21-2)19-17-18-11-16(22-17)12-6-4-3-5-7-12;/h3-11H,1-2H3,(H,18,19);1H",Cl.COc1ccc(Nc2oc(cn2)c3ccccc3)cc1OC,CHEMBL360561,"InChI=1S/C17H16N2O3/c1-20-14-9-8-13(10-15(14)21-2)19-17-18-11-16(22-17)12-6-4-3-5-7-12/h3-11H,1-2H3,(H,18,19)",COc1ccc(Nc2oc(cn2)c3ccccc3)cc1OC,CHEMBL829592,Inhibition of human Vascular endothelial growth factor receptor 2,IC50,=,140,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1142709,"J. Med. Chem., 48, p. 1610 (2005)",15743202,Scientific Literature
18,CHEMBL176553,"InChI=1S/C17H16N2O3/c1-20-14-8-13(9-15(10-14)21-2)19-17-18-11-16(22-17)12-6-4-3-5-7-12/h3-11H,1-2H3,(H,18,19)",COc1cc(Nc2oc(cn2)c3ccccc3)cc(OC)c1,CHEMBL176553,"InChI=1S/C17H16N2O3/c1-20-14-8-13(9-15(10-14)21-2)19-17-18-11-16(22-17)12-6-4-3-5-7-12/h3-11H,1-2H3,(H,18,19)",COc1cc(Nc2oc(cn2)c3ccccc3)cc(OC)c1,CHEMBL829592,Inhibition of human Vascular endothelial growth factor receptor 2,IC50,=,170,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1142709,"J. Med. Chem., 48, p. 1610 (2005)",15743202,Scientific Literature
19,CHEMBL443563,"InChI=1S/C18H18N2O4/c1-21-14-9-13(10-15(22-2)17(14)23-3)20-18-19-11-16(24-18)12-7-5-4-6-8-12/h4-11H,1-3H3,(H,19,20)",COc1cc(Nc2oc(cn2)c3ccccc3)cc(OC)c1OC,CHEMBL443563,"InChI=1S/C18H18N2O4/c1-21-14-9-13(10-15(22-2)17(14)23-3)20-18-19-11-16(24-18)12-7-5-4-6-8-12/h4-11H,1-3H3,(H,19,20)",COc1cc(Nc2oc(cn2)c3ccccc3)cc(OC)c1OC,CHEMBL829592,Inhibition of human Vascular endothelial growth factor receptor 2,IC50,=,100,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1142709,"J. Med. Chem., 48, p. 1610 (2005)",15743202,Scientific Literature
20,CHEMBL275473,"InChI=1S/C20H23N3O4S/c1-4-23(5-2)28(24,25)16-11-12-18(26-3)17(13-16)22-20-21-14-19(27-20)15-9-7-6-8-10-15/h6-14H,4-5H2,1-3H3,(H,21,22)",CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3ccccc3)c1,CHEMBL275473,"InChI=1S/C20H23N3O4S/c1-4-23(5-2)28(24,25)16-11-12-18(26-3)17(13-16)22-20-21-14-19(27-20)15-9-7-6-8-10-15/h6-14H,4-5H2,1-3H3,(H,21,22)",CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3ccccc3)c1,CHEMBL829592,Inhibition of human Vascular endothelial growth factor receptor 2,IC50,=,23,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1142709,"J. Med. Chem., 48, p. 1610 (2005)",15743202,Scientific Literature
24,CHEMBL179453,"InChI=1S/C18H17ClN2O4S/c1-3-26(22,23)12-8-9-16(24-2)15(10-12)21-18-20-11-17(25-18)13-6-4-5-7-14(13)19/h4-11H,3H2,1-2H3,(H,20,21)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3ccccc3Cl)c1,CHEMBL179453,"InChI=1S/C18H17ClN2O4S/c1-3-26(22,23)12-8-9-16(24-2)15(10-12)21-18-20-11-17(25-18)13-6-4-5-7-14(13)19/h4-11H,3H2,1-2H3,(H,20,21)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3ccccc3Cl)c1,CHEMBL829592,Inhibition of human Vascular endothelial growth factor receptor 2,IC50,=,360,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1142709,"J. Med. Chem., 48, p. 1610 (2005)",15743202,Scientific Literature
27,CHEMBL179311,"InChI=1S/C19H20N2O5S/c1-4-27(22,23)15-8-9-17(25-3)16(11-15)21-19-20-12-18(26-19)13-6-5-7-14(10-13)24-2/h5-12H,4H2,1-3H3,(H,20,21)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(OC)c3)c1,CHEMBL179311,"InChI=1S/C19H20N2O5S/c1-4-27(22,23)15-8-9-17(25-3)16(11-15)21-19-20-12-18(26-19)13-6-5-7-14(10-13)24-2/h5-12H,4H2,1-3H3,(H,20,21)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(OC)c3)c1,CHEMBL829592,Inhibition of human Vascular endothelial growth factor receptor 2,IC50,=,360,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1142709,"J. Med. Chem., 48, p. 1610 (2005)",15743202,Scientific Literature
28,CHEMBL179465,"InChI=1S/C18H17FN2O4S/c1-3-26(22,23)14-7-8-16(24-2)15(10-14)21-18-20-11-17(25-18)12-5-4-6-13(19)9-12/h4-11H,3H2,1-2H3,(H,20,21)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(F)c3)c1,CHEMBL179465,"InChI=1S/C18H17FN2O4S/c1-3-26(22,23)14-7-8-16(24-2)15(10-14)21-18-20-11-17(25-18)12-5-4-6-13(19)9-12/h4-11H,3H2,1-2H3,(H,20,21)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(F)c3)c1,CHEMBL829592,Inhibition of human Vascular endothelial growth factor receptor 2,IC50,=,93,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1142709,"J. Med. Chem., 48, p. 1610 (2005)",15743202,Scientific Literature
36,CHEMBL191705,"InChI=1S/C20H20N2O5S/c1-4-28(24,25)16-8-9-18(26-3)17(11-16)22-20-21-12-19(27-20)15-7-5-6-14(10-15)13(2)23/h5-12H,4H2,1-3H3,(H,21,22)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(c3)C(=O)C)c1,CHEMBL191705,"InChI=1S/C20H20N2O5S/c1-4-28(24,25)16-8-9-18(26-3)17(11-16)22-20-21-12-19(27-20)15-7-5-6-14(10-15)13(2)23/h5-12H,4H2,1-3H3,(H,21,22)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(c3)C(=O)C)c1,CHEMBL829592,Inhibition of human Vascular endothelial growth factor receptor 2,IC50,=,91,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1142709,"J. Med. Chem., 48, p. 1610 (2005)",15743202,Scientific Literature
44,CHEMBL372474,"InChI=1S/C24H21FN2O4S/c1-3-32(28,29)18-11-12-22(30-2)21(14-18)27-24-26-15-23(31-24)17-8-6-7-16(13-17)19-9-4-5-10-20(19)25/h4-15H,3H2,1-2H3,(H,26,27)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(c3)c4ccccc4F)c1,CHEMBL372474,"InChI=1S/C24H21FN2O4S/c1-3-32(28,29)18-11-12-22(30-2)21(14-18)27-24-26-15-23(31-24)17-8-6-7-16(13-17)19-9-4-5-10-20(19)25/h4-15H,3H2,1-2H3,(H,26,27)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(c3)c4ccccc4F)c1,CHEMBL829592,Inhibition of human Vascular endothelial growth factor receptor 2,IC50,=,89,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1142709,"J. Med. Chem., 48, p. 1610 (2005)",15743202,Scientific Literature
5,CHEMBL318728,"InChI=1S/C15H12N2O/c1-3-7-12(8-4-1)14-11-16-15(18-14)17-13-9-5-2-6-10-13/h1-11H,(H,16,17)",N(c1ccccc1)c2oc(cn2)c3ccccc3,CHEMBL318728,"InChI=1S/C15H12N2O/c1-3-7-12(8-4-1)14-11-16-15(18-14)17-13-9-5-2-6-10-13/h1-11H,(H,16,17)",N(c1ccccc1)c2oc(cn2)c3ccccc3,CHEMBL829592,Inhibition of human Vascular endothelial growth factor receptor 2,IC50,=,1200,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1142709,"J. Med. Chem., 48, p. 1610 (2005)",15743202,Scientific Literature
9,CHEMBL1794062,"InChI=1S/C16H14N2O2.ClH/c1-19-14-10-6-5-9-13(14)18-16-17-11-15(20-16)12-7-3-2-4-8-12;/h2-11H,1H3,(H,17,18);1H",Cl.COc1ccccc1Nc2oc(cn2)c3ccccc3,CHEMBL194027,"InChI=1S/C16H14N2O2/c1-19-14-10-6-5-9-13(14)18-16-17-11-15(20-16)12-7-3-2-4-8-12/h2-11H,1H3,(H,17,18)",COc1ccccc1Nc2oc(cn2)c3ccccc3,CHEMBL829592,Inhibition of human Vascular endothelial growth factor receptor 2,IC50,=,380,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1142709,"J. Med. Chem., 48, p. 1610 (2005)",15743202,Scientific Literature
44,CHEMBL372474,"InChI=1S/C24H21FN2O4S/c1-3-32(28,29)18-11-12-22(30-2)21(14-18)27-24-26-15-23(31-24)17-8-6-7-16(13-17)19-9-4-5-10-20(19)25/h4-15H,3H2,1-2H3,(H,26,27)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(c3)c4ccccc4F)c1,CHEMBL372474,"InChI=1S/C24H21FN2O4S/c1-3-32(28,29)18-11-12-22(30-2)21(14-18)27-24-26-15-23(31-24)17-8-6-7-16(13-17)19-9-4-5-10-20(19)25/h4-15H,3H2,1-2H3,(H,26,27)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(c3)c4ccccc4F)c1,CHEMBL832131,Selectivity for Cyclin-dependent kinase 2 by scintillation proximity assay; No data,Selectivity,,,,Not Determined,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1142709,"J. Med. Chem., 48, p. 1610 (2005)",15743202,Scientific Literature
44,CHEMBL372474,"InChI=1S/C24H21FN2O4S/c1-3-32(28,29)18-11-12-22(30-2)21(14-18)27-24-26-15-23(31-24)17-8-6-7-16(13-17)19-9-4-5-10-20(19)25/h4-15H,3H2,1-2H3,(H,26,27)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(c3)c4ccccc4F)c1,CHEMBL372474,"InChI=1S/C24H21FN2O4S/c1-3-32(28,29)18-11-12-22(30-2)21(14-18)27-24-26-15-23(31-24)17-8-6-7-16(13-17)19-9-4-5-10-20(19)25/h4-15H,3H2,1-2H3,(H,26,27)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(c3)c4ccccc4F)c1,CHEMBL832138,Selectivity for Cyclin-dependent kinase 4 by plate capture and filtration binding assay,Selectivity,>,10000,nM,,CHEMBL331,Cyclin-dependent kinase 4,Homo sapiens,P11802,CHEMBL1142709,"J. Med. Chem., 48, p. 1610 (2005)",15743202,Scientific Literature
44,CHEMBL372474,"InChI=1S/C24H21FN2O4S/c1-3-32(28,29)18-11-12-22(30-2)21(14-18)27-24-26-15-23(31-24)17-8-6-7-16(13-17)19-9-4-5-10-20(19)25/h4-15H,3H2,1-2H3,(H,26,27)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(c3)c4ccccc4F)c1,CHEMBL372474,"InChI=1S/C24H21FN2O4S/c1-3-32(28,29)18-11-12-22(30-2)21(14-18)27-24-26-15-23(31-24)17-8-6-7-16(13-17)19-9-4-5-10-20(19)25/h4-15H,3H2,1-2H3,(H,26,27)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(c3)c4ccccc4F)c1,CHEMBL830756,Selectivity for EPH receptor B4 by scintillation proximity assay; No data,Selectivity,,,,Not Determined,CHEMBL5147,Ephrin type-B receptor 4,Homo sapiens,P54760,CHEMBL1142709,"J. Med. Chem., 48, p. 1610 (2005)",15743202,Scientific Literature
44,CHEMBL372474,"InChI=1S/C24H21FN2O4S/c1-3-32(28,29)18-11-12-22(30-2)21(14-18)27-24-26-15-23(31-24)17-8-6-7-16(13-17)19-9-4-5-10-20(19)25/h4-15H,3H2,1-2H3,(H,26,27)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(c3)c4ccccc4F)c1,CHEMBL372474,"InChI=1S/C24H21FN2O4S/c1-3-32(28,29)18-11-12-22(30-2)21(14-18)27-24-26-15-23(31-24)17-8-6-7-16(13-17)19-9-4-5-10-20(19)25/h4-15H,3H2,1-2H3,(H,26,27)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(c3)c4ccccc4F)c1,CHEMBL830751,Selectivity for ERBB2 receptor kinase by scintillation proximity assay,Selectivity,>,10000,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1142709,"J. Med. Chem., 48, p. 1610 (2005)",15743202,Scientific Literature
44,CHEMBL372474,"InChI=1S/C24H21FN2O4S/c1-3-32(28,29)18-11-12-22(30-2)21(14-18)27-24-26-15-23(31-24)17-8-6-7-16(13-17)19-9-4-5-10-20(19)25/h4-15H,3H2,1-2H3,(H,26,27)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(c3)c4ccccc4F)c1,CHEMBL372474,"InChI=1S/C24H21FN2O4S/c1-3-32(28,29)18-11-12-22(30-2)21(14-18)27-24-26-15-23(31-24)17-8-6-7-16(13-17)19-9-4-5-10-20(19)25/h4-15H,3H2,1-2H3,(H,26,27)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(c3)c4ccccc4F)c1,CHEMBL831726,Selectivity for Epidermal growth factor receptor by scintillation proximity assay,Selectivity,>,10000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1142709,"J. Med. Chem., 48, p. 1610 (2005)",15743202,Scientific Literature
44,CHEMBL372474,"InChI=1S/C24H21FN2O4S/c1-3-32(28,29)18-11-12-22(30-2)21(14-18)27-24-26-15-23(31-24)17-8-6-7-16(13-17)19-9-4-5-10-20(19)25/h4-15H,3H2,1-2H3,(H,26,27)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(c3)c4ccccc4F)c1,CHEMBL372474,"InChI=1S/C24H21FN2O4S/c1-3-32(28,29)18-11-12-22(30-2)21(14-18)27-24-26-15-23(31-24)17-8-6-7-16(13-17)19-9-4-5-10-20(19)25/h4-15H,3H2,1-2H3,(H,26,27)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(c3)c4ccccc4F)c1,CHEMBL832136,Selectivity for IL-2-inducible T-cell kinase by fluorescence polarization binding assay,Selectivity,=,43,nM,,CHEMBL2959,Tyrosine-protein kinase ITK/TSK ,Homo sapiens,Q08881,CHEMBL1142709,"J. Med. Chem., 48, p. 1610 (2005)",15743202,Scientific Literature
44,CHEMBL372474,"InChI=1S/C24H21FN2O4S/c1-3-32(28,29)18-11-12-22(30-2)21(14-18)27-24-26-15-23(31-24)17-8-6-7-16(13-17)19-9-4-5-10-20(19)25/h4-15H,3H2,1-2H3,(H,26,27)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(c3)c4ccccc4F)c1,CHEMBL372474,"InChI=1S/C24H21FN2O4S/c1-3-32(28,29)18-11-12-22(30-2)21(14-18)27-24-26-15-23(31-24)17-8-6-7-16(13-17)19-9-4-5-10-20(19)25/h4-15H,3H2,1-2H3,(H,26,27)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(c3)c4ccccc4F)c1,CHEMBL830765,Selectivity for Platelet-derived growth factor receptor beta by homologous time-resolved fluorescence assay,Selectivity,=,420,nM,,CHEMBL1913,Platelet-derived growth factor receptor beta,Homo sapiens,P09619,CHEMBL1142709,"J. Med. Chem., 48, p. 1610 (2005)",15743202,Scientific Literature
44,CHEMBL372474,"InChI=1S/C24H21FN2O4S/c1-3-32(28,29)18-11-12-22(30-2)21(14-18)27-24-26-15-23(31-24)17-8-6-7-16(13-17)19-9-4-5-10-20(19)25/h4-15H,3H2,1-2H3,(H,26,27)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(c3)c4ccccc4F)c1,CHEMBL372474,"InChI=1S/C24H21FN2O4S/c1-3-32(28,29)18-11-12-22(30-2)21(14-18)27-24-26-15-23(31-24)17-8-6-7-16(13-17)19-9-4-5-10-20(19)25/h4-15H,3H2,1-2H3,(H,26,27)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(c3)c4ccccc4F)c1,CHEMBL832158,Selectivity for Src protein tryrosine kinase by homologous time-resolved fluorescence assay,Selectivity,=,260,nM,,CHEMBL267,Tyrosine-protein kinase SRC,Homo sapiens,P12931,CHEMBL1142709,"J. Med. Chem., 48, p. 1610 (2005)",15743202,Scientific Literature
44,CHEMBL372474,"InChI=1S/C24H21FN2O4S/c1-3-32(28,29)18-11-12-22(30-2)21(14-18)27-24-26-15-23(31-24)17-8-6-7-16(13-17)19-9-4-5-10-20(19)25/h4-15H,3H2,1-2H3,(H,26,27)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(c3)c4ccccc4F)c1,CHEMBL372474,"InChI=1S/C24H21FN2O4S/c1-3-32(28,29)18-11-12-22(30-2)21(14-18)27-24-26-15-23(31-24)17-8-6-7-16(13-17)19-9-4-5-10-20(19)25/h4-15H,3H2,1-2H3,(H,26,27)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(c3)c4ccccc4F)c1,CHEMBL832166,Selectivity for Tyrosine protein kinase receptor TIE-2 by homologous time-resolved fluorescence assay,Selectivity,=,1400,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1142709,"J. Med. Chem., 48, p. 1610 (2005)",15743202,Scientific Literature
44,CHEMBL372474,"InChI=1S/C24H21FN2O4S/c1-3-32(28,29)18-11-12-22(30-2)21(14-18)27-24-26-15-23(31-24)17-8-6-7-16(13-17)19-9-4-5-10-20(19)25/h4-15H,3H2,1-2H3,(H,26,27)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(c3)c4ccccc4F)c1,CHEMBL372474,"InChI=1S/C24H21FN2O4S/c1-3-32(28,29)18-11-12-22(30-2)21(14-18)27-24-26-15-23(31-24)17-8-6-7-16(13-17)19-9-4-5-10-20(19)25/h4-15H,3H2,1-2H3,(H,26,27)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(c3)c4ccccc4F)c1,CHEMBL830766,Selectivity for Vascular endothelial growth factor receptor 1 by homologous time-resolved fluorescence assay,Selectivity,=,400,nM,,CHEMBL1868,Vascular endothelial growth factor receptor 1,Homo sapiens,P17948,CHEMBL1142709,"J. Med. Chem., 48, p. 1610 (2005)",15743202,Scientific Literature
44,CHEMBL372474,"InChI=1S/C24H21FN2O4S/c1-3-32(28,29)18-11-12-22(30-2)21(14-18)27-24-26-15-23(31-24)17-8-6-7-16(13-17)19-9-4-5-10-20(19)25/h4-15H,3H2,1-2H3,(H,26,27)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(c3)c4ccccc4F)c1,CHEMBL372474,"InChI=1S/C24H21FN2O4S/c1-3-32(28,29)18-11-12-22(30-2)21(14-18)27-24-26-15-23(31-24)17-8-6-7-16(13-17)19-9-4-5-10-20(19)25/h4-15H,3H2,1-2H3,(H,26,27)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(c3)c4ccccc4F)c1,CHEMBL830767,Selectivity for Vascular endothelial growth factor receptor 3 by homologous time-resolved fluorescence assay,Selectivity,=,55,nM,,CHEMBL1955,Vascular endothelial growth factor receptor 3,Homo sapiens,P35916,CHEMBL1142709,"J. Med. Chem., 48, p. 1610 (2005)",15743202,Scientific Literature
44,CHEMBL372474,"InChI=1S/C24H21FN2O4S/c1-3-32(28,29)18-11-12-22(30-2)21(14-18)27-24-26-15-23(31-24)17-8-6-7-16(13-17)19-9-4-5-10-20(19)25/h4-15H,3H2,1-2H3,(H,26,27)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(c3)c4ccccc4F)c1,CHEMBL372474,"InChI=1S/C24H21FN2O4S/c1-3-32(28,29)18-11-12-22(30-2)21(14-18)27-24-26-15-23(31-24)17-8-6-7-16(13-17)19-9-4-5-10-20(19)25/h4-15H,3H2,1-2H3,(H,26,27)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(c3)c4ccccc4F)c1,CHEMBL832164,Selectivity for colony stimulating factor 1 receptor by plate capture and filtration binding assay,Selectivity,=,380,nM,,CHEMBL1844,Macrophage colony stimulating factor  receptor ,Homo sapiens,P07333,CHEMBL1142709,"J. Med. Chem., 48, p. 1610 (2005)",15743202,Scientific Literature
44,CHEMBL372474,"InChI=1S/C24H21FN2O4S/c1-3-32(28,29)18-11-12-22(30-2)21(14-18)27-24-26-15-23(31-24)17-8-6-7-16(13-17)19-9-4-5-10-20(19)25/h4-15H,3H2,1-2H3,(H,26,27)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(c3)c4ccccc4F)c1,CHEMBL372474,"InChI=1S/C24H21FN2O4S/c1-3-32(28,29)18-11-12-22(30-2)21(14-18)27-24-26-15-23(31-24)17-8-6-7-16(13-17)19-9-4-5-10-20(19)25/h4-15H,3H2,1-2H3,(H,26,27)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(c3)c4ccccc4F)c1,CHEMBL830769,Selectivity for human Vascular endothelial growth factor receptor 2 by homologous time-resolved fluorescence assay,Selectivity,=,89,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1142709,"J. Med. Chem., 48, p. 1610 (2005)",15743202,Scientific Literature
44,CHEMBL372474,"InChI=1S/C24H21FN2O4S/c1-3-32(28,29)18-11-12-22(30-2)21(14-18)27-24-26-15-23(31-24)17-8-6-7-16(13-17)19-9-4-5-10-20(19)25/h4-15H,3H2,1-2H3,(H,26,27)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(c3)c4ccccc4F)c1,CHEMBL372474,"InChI=1S/C24H21FN2O4S/c1-3-32(28,29)18-11-12-22(30-2)21(14-18)27-24-26-15-23(31-24)17-8-6-7-16(13-17)19-9-4-5-10-20(19)25/h4-15H,3H2,1-2H3,(H,26,27)",CCS(=O)(=O)c1ccc(OC)c(Nc2oc(cn2)c3cccc(c3)c4ccccc4F)c1,CHEMBL831719,Selectivity for polo-like kinase 1 by scintillation proximity assay; No data,Selectivity,,,,Not Determined,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1142709,"J. Med. Chem., 48, p. 1610 (2005)",15743202,Scientific Literature
1,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL935201,Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as ARE-luciferase activity at 0.1 uM,Activity,=,18,%,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1143116,"Bioorg. Med. Chem. Lett., 18, p. 2122 (2008)",18262787,Scientific Literature
1,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL935199,Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as SBE-luciferase activity at 0.1 uM,Activity,=,51,%,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1143116,"Bioorg. Med. Chem. Lett., 18, p. 2122 (2008)",18262787,Scientific Literature
1,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL935200,Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as p3TP-luciferase activity at 0.1 uM,Activity,=,75,%,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1143116,"Bioorg. Med. Chem. Lett., 18, p. 2122 (2008)",18262787,Scientific Literature
"19, page S12 table 1",CHEMBL405042,"InChI=1S/C16H15N3O3S/c1-10(15-13-4-2-3-5-14(13)19-16(15)20)18-11-6-8-12(9-7-11)23(17,21)22/h2-9,18H,1H3,(H,19,20)(H2,17,21,22)/b15-10-",C\C(=C/1\C(=O)Nc2ccccc12)\Nc3ccc(cc3)S(=O)(=O)N,CHEMBL405042,"InChI=1S/C16H15N3O3S/c1-10(15-13-4-2-3-5-14(13)19-16(15)20)18-11-6-8-12(9-7-11)23(17,21)22/h2-9,18H,1H3,(H,19,20)(H2,17,21,22)/b15-10-",C\C(=C/1\C(=O)Nc2ccccc12)\Nc3ccc(cc3)S(=O)(=O)N,CHEMBL952119,Inhibition of CDK1,IC50,=,2300,nM,,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1143196,"J. Med. Chem., 51, p. 1179 (2008)",18271520,Scientific Literature
"20, page S12 table 1",CHEMBL270054,"InChI=1S/C14H11ClN4O3S/c15-8-1-6-12-11(7-8)13(14(20)17-12)19-18-9-2-4-10(5-3-9)23(16,21)22/h1-7,18H,(H2,16,21,22)(H,17,19,20)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(Cl)cc23)cc1,CHEMBL270054,"InChI=1S/C14H11ClN4O3S/c15-8-1-6-12-11(7-8)13(14(20)17-12)19-18-9-2-4-10(5-3-9)23(16,21)22/h1-7,18H,(H2,16,21,22)(H,17,19,20)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(Cl)cc23)cc1,CHEMBL952119,Inhibition of CDK1,IC50,=,300,nM,,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1143196,"J. Med. Chem., 51, p. 1179 (2008)",18271520,Scientific Literature
"22, page S12 table 1",CHEMBL269827,"InChI=1S/C17H13N5O4S/c18-27(24,25)12-4-2-11(3-5-12)21-22-16-13-7-10(15-8-19-9-26-15)1-6-14(13)20-17(16)23/h1-9,21H,(H2,18,24,25)(H,20,22,23)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)c4ocnc4)cc1,CHEMBL269827,"InChI=1S/C17H13N5O4S/c18-27(24,25)12-4-2-11(3-5-12)21-22-16-13-7-10(15-8-19-9-26-15)1-6-14(13)20-17(16)23/h1-9,21H,(H2,18,24,25)(H,20,22,23)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)c4ocnc4)cc1,CHEMBL952119,Inhibition of CDK1,IC50,=,10,nM,,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1143196,"J. Med. Chem., 51, p. 1179 (2008)",18271520,Scientific Literature
"29, page S12 table 1",CHEMBL270544,"InChI=1S/C18H18N4O3S/c1-11(2)10-12-4-3-5-15-16(12)17(18(23)20-15)22-21-13-6-8-14(9-7-13)26(19,24)25/h3-10,21H,1-2H3,(H2,19,24,25)(H,20,22,23)",CC(=Cc1cccc2NC(=O)\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\c12)C,CHEMBL270544,"InChI=1S/C18H18N4O3S/c1-11(2)10-12-4-3-5-15-16(12)17(18(23)20-15)22-21-13-6-8-14(9-7-13)26(19,24)25/h3-10,21H,1-2H3,(H2,19,24,25)(H,20,22,23)",CC(=Cc1cccc2NC(=O)\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\c12)C,CHEMBL952119,Inhibition of CDK1,IC50,=,15,nM,,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1143196,"J. Med. Chem., 51, p. 1179 (2008)",18271520,Scientific Literature
"43, page S12 table 1",CHEMBL271843,"InChI=1S/C15H14N4O3S/c1-9-2-7-13-12(8-9)14(15(20)17-13)19-18-10-3-5-11(6-4-10)23(16,21)22/h2-8,18H,1H3,(H2,16,21,22)(H,17,19,20)",Cc1ccc2NC(=O)\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL271843,"InChI=1S/C15H14N4O3S/c1-9-2-7-13-12(8-9)14(15(20)17-13)19-18-10-3-5-11(6-4-10)23(16,21)22/h2-8,18H,1H3,(H2,16,21,22)(H,17,19,20)",Cc1ccc2NC(=O)\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL952119,Inhibition of CDK1,IC50,=,330,nM,,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1143196,"J. Med. Chem., 51, p. 1179 (2008)",18271520,Scientific Literature
"48, page S12 table 1",CHEMBL272414,"InChI=1S/C17H18N4O3S/c1-21(2)12-5-8-16-14(9-12)15(17(22)20-16)10-19-11-3-6-13(7-4-11)25(18,23)24/h3-10,19H,1-2H3,(H,20,22)(H2,18,23,24)/b15-10-",CN(C)c1ccc2NC(=O)\C(=C/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL272414,"InChI=1S/C17H18N4O3S/c1-21(2)12-5-8-16-14(9-12)15(17(22)20-16)10-19-11-3-6-13(7-4-11)25(18,23)24/h3-10,19H,1-2H3,(H,20,22)(H2,18,23,24)/b15-10-",CN(C)c1ccc2NC(=O)\C(=C/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL952119,Inhibition of CDK1,IC50,=,2800,nM,,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1143196,"J. Med. Chem., 51, p. 1179 (2008)",18271520,Scientific Literature
"54, page S12 table 1",CHEMBL269883,"InChI=1S/C20H21N3O5S/c1-12(2)11-28-20(25)13-3-8-18-16(9-13)17(19(24)23-18)10-22-14-4-6-15(7-5-14)29(21,26)27/h3-10,12,22H,11H2,1-2H3,(H,23,24)(H2,21,26,27)/b17-10-",CC(C)COC(=O)c1ccc2NC(=O)\C(=C/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL269883,"InChI=1S/C20H21N3O5S/c1-12(2)11-28-20(25)13-3-8-18-16(9-13)17(19(24)23-18)10-22-14-4-6-15(7-5-14)29(21,26)27/h3-10,12,22H,11H2,1-2H3,(H,23,24)(H2,21,26,27)/b17-10-",CC(C)COC(=O)c1ccc2NC(=O)\C(=C/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL952119,Inhibition of CDK1,IC50,=,19,nM,,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1143196,"J. Med. Chem., 51, p. 1179 (2008)",18271520,Scientific Literature
"58, page S12 table 1",CHEMBL272028,"InChI=1S/C20H19N7O4S/c21-32(30,31)15-4-2-13(3-5-15)26-27-18-16-9-12(1-6-17(16)25-20(18)29)19(28)23-8-7-14-10-22-11-24-14/h1-6,9-11,26H,7-8H2,(H,22,24)(H,23,28)(H2,21,30,31)(H,25,27,29)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)C(=O)NCCc4c[nH]cn4)cc1,CHEMBL272028,"InChI=1S/C20H19N7O4S/c21-32(30,31)15-4-2-13(3-5-15)26-27-18-16-9-12(1-6-17(16)25-20(18)29)19(28)23-8-7-14-10-22-11-24-14/h1-6,9-11,26H,7-8H2,(H,22,24)(H,23,28)(H2,21,30,31)(H,25,27,29)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)C(=O)NCCc4c[nH]cn4)cc1,CHEMBL952119,Inhibition of CDK1,IC50,=,60,nM,,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1143196,"J. Med. Chem., 51, p. 1179 (2008)",18271520,Scientific Literature
"59, page S12 table 1",CHEMBL272026,"InChI=1S/C21H21N7O4S/c22-33(31,32)16-5-3-15(4-6-16)26-27-19-17-12-14(2-7-18(17)25-21(19)30)20(29)24-8-1-10-28-11-9-23-13-28/h2-7,9,11-13,26H,1,8,10H2,(H,24,29)(H2,22,31,32)(H,25,27,30)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)C(=O)NCCCn4ccnc4)cc1,CHEMBL272026,"InChI=1S/C21H21N7O4S/c22-33(31,32)16-5-3-15(4-6-16)26-27-19-17-12-14(2-7-18(17)25-21(19)30)20(29)24-8-1-10-28-11-9-23-13-28/h2-7,9,11-13,26H,1,8,10H2,(H,24,29)(H2,22,31,32)(H,25,27,30)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)C(=O)NCCCn4ccnc4)cc1,CHEMBL952119,Inhibition of CDK1,IC50,=,230,nM,,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1143196,"J. Med. Chem., 51, p. 1179 (2008)",18271520,Scientific Literature
"60, page S12 table 1",CHEMBL272165,"InChI=1S/C21H18N6O4S/c22-32(30,31)16-4-2-15(3-5-16)26-27-19-17-11-14(1-6-18(17)25-21(19)29)20(28)24-12-13-7-9-23-10-8-13/h1-11,26H,12H2,(H,24,28)(H2,22,30,31)(H,25,27,29)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)C(=O)NCc4ccncc4)cc1,CHEMBL272165,"InChI=1S/C21H18N6O4S/c22-32(30,31)16-4-2-15(3-5-16)26-27-19-17-11-14(1-6-18(17)25-21(19)29)20(28)24-12-13-7-9-23-10-8-13/h1-11,26H,12H2,(H,24,28)(H2,22,30,31)(H,25,27,29)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)C(=O)NCc4ccncc4)cc1,CHEMBL952119,Inhibition of CDK1,IC50,=,74,nM,,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1143196,"J. Med. Chem., 51, p. 1179 (2008)",18271520,Scientific Literature
"62, page S12 table 1",CHEMBL410072,"InChI=1S/C20H23N5O5S/c1-20(2,11-26)10-22-18(27)12-3-8-16-15(9-12)17(19(28)23-16)25-24-13-4-6-14(7-5-13)31(21,29)30/h3-9,24,26H,10-11H2,1-2H3,(H,22,27)(H2,21,29,30)(H,23,25,28)",CC(C)(CO)CNC(=O)c1ccc2NC(=O)\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL410072,"InChI=1S/C20H23N5O5S/c1-20(2,11-26)10-22-18(27)12-3-8-16-15(9-12)17(19(28)23-16)25-24-13-4-6-14(7-5-13)31(21,29)30/h3-9,24,26H,10-11H2,1-2H3,(H,22,27)(H2,21,29,30)(H,23,25,28)",CC(C)(CO)CNC(=O)c1ccc2NC(=O)\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL952119,Inhibition of CDK1,IC50,=,60,nM,,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1143196,"J. Med. Chem., 51, p. 1179 (2008)",18271520,Scientific Literature
"66, page S12 table 1",CHEMBL271594,"InChI=1S/C17H18N4O3S/c1-10(2)11-3-8-14-15(9-11)19-17(22)16(14)21-20-12-4-6-13(7-5-12)25(18,23)24/h3-10,20H,1-2H3,(H2,18,23,24)(H,19,21,22)",CC(C)c1ccc2\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\C(=O)Nc2c1,CHEMBL271594,"InChI=1S/C17H18N4O3S/c1-10(2)11-3-8-14-15(9-11)19-17(22)16(14)21-20-12-4-6-13(7-5-12)25(18,23)24/h3-10,20H,1-2H3,(H2,18,23,24)(H,19,21,22)",CC(C)c1ccc2\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\C(=O)Nc2c1,CHEMBL952119,Inhibition of CDK1,IC50,=,790,nM,,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1143196,"J. Med. Chem., 51, p. 1179 (2008)",18271520,Scientific Literature
"80, page S13 table 1",CHEMBL271595,"InChI=1S/C16H12N4O3S2/c17-25(22,23)10-3-1-9(2-4-10)18-7-11-14-12(20-16(11)21)5-6-13-15(14)24-8-19-13/h1-8,18H,(H,20,21)(H2,17,22,23)/b11-7-",NS(=O)(=O)c1ccc(N\C=C\2/C(=O)Nc3ccc4ncsc4c23)cc1,CHEMBL271595,"InChI=1S/C16H12N4O3S2/c17-25(22,23)10-3-1-9(2-4-10)18-7-11-14-12(20-16(11)21)5-6-13-15(14)24-8-19-13/h1-8,18H,(H,20,21)(H2,17,22,23)/b11-7-",NS(=O)(=O)c1ccc(N\C=C\2/C(=O)Nc3ccc4ncsc4c23)cc1,CHEMBL952119,Inhibition of CDK1,IC50,=,29,nM,,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1143196,"J. Med. Chem., 51, p. 1179 (2008)",18271520,Scientific Literature
"81, page S13 table 1",CHEMBL409892,"InChI=1S/C17H13N5O3S/c18-26(24,25)11-5-3-10(4-6-11)21-22-16-15-12-2-1-9-19-13(12)7-8-14(15)20-17(16)23/h1-9,21H,(H2,18,24,25)(H,20,22,23)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc4ncccc4c23)cc1,CHEMBL409892,"InChI=1S/C17H13N5O3S/c18-26(24,25)11-5-3-10(4-6-11)21-22-16-15-12-2-1-9-19-13(12)7-8-14(15)20-17(16)23/h1-9,21H,(H2,18,24,25)(H,20,22,23)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc4ncccc4c23)cc1,CHEMBL952119,Inhibition of CDK1,IC50,=,12,nM,,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1143196,"J. Med. Chem., 51, p. 1179 (2008)",18271520,Scientific Literature
"19, page S12 table 1",CHEMBL405042,"InChI=1S/C16H15N3O3S/c1-10(15-13-4-2-3-5-14(13)19-16(15)20)18-11-6-8-12(9-7-11)23(17,21)22/h2-9,18H,1H3,(H,19,20)(H2,17,21,22)/b15-10-",C\C(=C/1\C(=O)Nc2ccccc12)\Nc3ccc(cc3)S(=O)(=O)N,CHEMBL405042,"InChI=1S/C16H15N3O3S/c1-10(15-13-4-2-3-5-14(13)19-16(15)20)18-11-6-8-12(9-7-11)23(17,21)22/h2-9,18H,1H3,(H,19,20)(H2,17,21,22)/b15-10-",C\C(=C/1\C(=O)Nc2ccccc12)\Nc3ccc(cc3)S(=O)(=O)N,CHEMBL952109,Inhibition of CDK2,IC50,=,360,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1143196,"J. Med. Chem., 51, p. 1179 (2008)",18271520,Scientific Literature
"20, page S12 table 1",CHEMBL270054,"InChI=1S/C14H11ClN4O3S/c15-8-1-6-12-11(7-8)13(14(20)17-12)19-18-9-2-4-10(5-3-9)23(16,21)22/h1-7,18H,(H2,16,21,22)(H,17,19,20)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(Cl)cc23)cc1,CHEMBL270054,"InChI=1S/C14H11ClN4O3S/c15-8-1-6-12-11(7-8)13(14(20)17-12)19-18-9-2-4-10(5-3-9)23(16,21)22/h1-7,18H,(H2,16,21,22)(H,17,19,20)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(Cl)cc23)cc1,CHEMBL952109,Inhibition of CDK2,IC50,=,43,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1143196,"J. Med. Chem., 51, p. 1179 (2008)",18271520,Scientific Literature
"22, page S12 table 1",CHEMBL269827,"InChI=1S/C17H13N5O4S/c18-27(24,25)12-4-2-11(3-5-12)21-22-16-13-7-10(15-8-19-9-26-15)1-6-14(13)20-17(16)23/h1-9,21H,(H2,18,24,25)(H,20,22,23)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)c4ocnc4)cc1,CHEMBL269827,"InChI=1S/C17H13N5O4S/c18-27(24,25)12-4-2-11(3-5-12)21-22-16-13-7-10(15-8-19-9-26-15)1-6-14(13)20-17(16)23/h1-9,21H,(H2,18,24,25)(H,20,22,23)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)c4ocnc4)cc1,CHEMBL952109,Inhibition of CDK2,IC50,=,2.3,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1143196,"J. Med. Chem., 51, p. 1179 (2008)",18271520,Scientific Literature
"29, page S12 table 1",CHEMBL270544,"InChI=1S/C18H18N4O3S/c1-11(2)10-12-4-3-5-15-16(12)17(18(23)20-15)22-21-13-6-8-14(9-7-13)26(19,24)25/h3-10,21H,1-2H3,(H2,19,24,25)(H,20,22,23)",CC(=Cc1cccc2NC(=O)\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\c12)C,CHEMBL270544,"InChI=1S/C18H18N4O3S/c1-11(2)10-12-4-3-5-15-16(12)17(18(23)20-15)22-21-13-6-8-14(9-7-13)26(19,24)25/h3-10,21H,1-2H3,(H2,19,24,25)(H,20,22,23)",CC(=Cc1cccc2NC(=O)\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\c12)C,CHEMBL952109,Inhibition of CDK2,IC50,=,1.5,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1143196,"J. Med. Chem., 51, p. 1179 (2008)",18271520,Scientific Literature
"43, page S12 table 1",CHEMBL271843,"InChI=1S/C15H14N4O3S/c1-9-2-7-13-12(8-9)14(15(20)17-13)19-18-10-3-5-11(6-4-10)23(16,21)22/h2-8,18H,1H3,(H2,16,21,22)(H,17,19,20)",Cc1ccc2NC(=O)\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL271843,"InChI=1S/C15H14N4O3S/c1-9-2-7-13-12(8-9)14(15(20)17-13)19-18-10-3-5-11(6-4-10)23(16,21)22/h2-8,18H,1H3,(H2,16,21,22)(H,17,19,20)",Cc1ccc2NC(=O)\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL952109,Inhibition of CDK2,IC50,=,46,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1143196,"J. Med. Chem., 51, p. 1179 (2008)",18271520,Scientific Literature
"48, page S12 table 1",CHEMBL272414,"InChI=1S/C17H18N4O3S/c1-21(2)12-5-8-16-14(9-12)15(17(22)20-16)10-19-11-3-6-13(7-4-11)25(18,23)24/h3-10,19H,1-2H3,(H,20,22)(H2,18,23,24)/b15-10-",CN(C)c1ccc2NC(=O)\C(=C/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL272414,"InChI=1S/C17H18N4O3S/c1-21(2)12-5-8-16-14(9-12)15(17(22)20-16)10-19-11-3-6-13(7-4-11)25(18,23)24/h3-10,19H,1-2H3,(H,20,22)(H2,18,23,24)/b15-10-",CN(C)c1ccc2NC(=O)\C(=C/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL952109,Inhibition of CDK2,IC50,=,310,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1143196,"J. Med. Chem., 51, p. 1179 (2008)",18271520,Scientific Literature
"54, page S12 table 1",CHEMBL269883,"InChI=1S/C20H21N3O5S/c1-12(2)11-28-20(25)13-3-8-18-16(9-13)17(19(24)23-18)10-22-14-4-6-15(7-5-14)29(21,26)27/h3-10,12,22H,11H2,1-2H3,(H,23,24)(H2,21,26,27)/b17-10-",CC(C)COC(=O)c1ccc2NC(=O)\C(=C/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL269883,"InChI=1S/C20H21N3O5S/c1-12(2)11-28-20(25)13-3-8-18-16(9-13)17(19(24)23-18)10-22-14-4-6-15(7-5-14)29(21,26)27/h3-10,12,22H,11H2,1-2H3,(H,23,24)(H2,21,26,27)/b17-10-",CC(C)COC(=O)c1ccc2NC(=O)\C(=C/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL952109,Inhibition of CDK2,IC50,=,3,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1143196,"J. Med. Chem., 51, p. 1179 (2008)",18271520,Scientific Literature
"58, page S12 table 1",CHEMBL272028,"InChI=1S/C20H19N7O4S/c21-32(30,31)15-4-2-13(3-5-15)26-27-18-16-9-12(1-6-17(16)25-20(18)29)19(28)23-8-7-14-10-22-11-24-14/h1-6,9-11,26H,7-8H2,(H,22,24)(H,23,28)(H2,21,30,31)(H,25,27,29)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)C(=O)NCCc4c[nH]cn4)cc1,CHEMBL272028,"InChI=1S/C20H19N7O4S/c21-32(30,31)15-4-2-13(3-5-15)26-27-18-16-9-12(1-6-17(16)25-20(18)29)19(28)23-8-7-14-10-22-11-24-14/h1-6,9-11,26H,7-8H2,(H,22,24)(H,23,28)(H2,21,30,31)(H,25,27,29)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)C(=O)NCCc4c[nH]cn4)cc1,CHEMBL952109,Inhibition of CDK2,IC50,=,12,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1143196,"J. Med. Chem., 51, p. 1179 (2008)",18271520,Scientific Literature
"59, page S12 table 1",CHEMBL272026,"InChI=1S/C21H21N7O4S/c22-33(31,32)16-5-3-15(4-6-16)26-27-19-17-12-14(2-7-18(17)25-21(19)30)20(29)24-8-1-10-28-11-9-23-13-28/h2-7,9,11-13,26H,1,8,10H2,(H,24,29)(H2,22,31,32)(H,25,27,30)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)C(=O)NCCCn4ccnc4)cc1,CHEMBL272026,"InChI=1S/C21H21N7O4S/c22-33(31,32)16-5-3-15(4-6-16)26-27-19-17-12-14(2-7-18(17)25-21(19)30)20(29)24-8-1-10-28-11-9-23-13-28/h2-7,9,11-13,26H,1,8,10H2,(H,24,29)(H2,22,31,32)(H,25,27,30)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)C(=O)NCCCn4ccnc4)cc1,CHEMBL952109,Inhibition of CDK2,IC50,=,25,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1143196,"J. Med. Chem., 51, p. 1179 (2008)",18271520,Scientific Literature
"60, page S12 table 1",CHEMBL272165,"InChI=1S/C21H18N6O4S/c22-32(30,31)16-4-2-15(3-5-16)26-27-19-17-11-14(1-6-18(17)25-21(19)29)20(28)24-12-13-7-9-23-10-8-13/h1-11,26H,12H2,(H,24,28)(H2,22,30,31)(H,25,27,29)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)C(=O)NCc4ccncc4)cc1,CHEMBL272165,"InChI=1S/C21H18N6O4S/c22-32(30,31)16-4-2-15(3-5-16)26-27-19-17-11-14(1-6-18(17)25-21(19)29)20(28)24-12-13-7-9-23-10-8-13/h1-11,26H,12H2,(H,24,28)(H2,22,30,31)(H,25,27,29)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(cc23)C(=O)NCc4ccncc4)cc1,CHEMBL952109,Inhibition of CDK2,IC50,=,8.9,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1143196,"J. Med. Chem., 51, p. 1179 (2008)",18271520,Scientific Literature
"62, page S12 table 1",CHEMBL410072,"InChI=1S/C20H23N5O5S/c1-20(2,11-26)10-22-18(27)12-3-8-16-15(9-12)17(19(28)23-16)25-24-13-4-6-14(7-5-13)31(21,29)30/h3-9,24,26H,10-11H2,1-2H3,(H,22,27)(H2,21,29,30)(H,23,25,28)",CC(C)(CO)CNC(=O)c1ccc2NC(=O)\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL410072,"InChI=1S/C20H23N5O5S/c1-20(2,11-26)10-22-18(27)12-3-8-16-15(9-12)17(19(28)23-16)25-24-13-4-6-14(7-5-13)31(21,29)30/h3-9,24,26H,10-11H2,1-2H3,(H,22,27)(H2,21,29,30)(H,23,25,28)",CC(C)(CO)CNC(=O)c1ccc2NC(=O)\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\c2c1,CHEMBL952109,Inhibition of CDK2,IC50,=,6.8,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1143196,"J. Med. Chem., 51, p. 1179 (2008)",18271520,Scientific Literature
"66, page S12 table 1",CHEMBL271594,"InChI=1S/C17H18N4O3S/c1-10(2)11-3-8-14-15(9-11)19-17(22)16(14)21-20-12-4-6-13(7-5-12)25(18,23)24/h3-10,20H,1-2H3,(H2,18,23,24)(H,19,21,22)",CC(C)c1ccc2\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\C(=O)Nc2c1,CHEMBL271594,"InChI=1S/C17H18N4O3S/c1-10(2)11-3-8-14-15(9-11)19-17(22)16(14)21-20-12-4-6-13(7-5-12)25(18,23)24/h3-10,20H,1-2H3,(H2,18,23,24)(H,19,21,22)",CC(C)c1ccc2\C(=N/Nc3ccc(cc3)S(=O)(=O)N)\C(=O)Nc2c1,CHEMBL952109,Inhibition of CDK2,IC50,=,75,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1143196,"J. Med. Chem., 51, p. 1179 (2008)",18271520,Scientific Literature
"80, page S13 table 1",CHEMBL271595,"InChI=1S/C16H12N4O3S2/c17-25(22,23)10-3-1-9(2-4-10)18-7-11-14-12(20-16(11)21)5-6-13-15(14)24-8-19-13/h1-8,18H,(H,20,21)(H2,17,22,23)/b11-7-",NS(=O)(=O)c1ccc(N\C=C\2/C(=O)Nc3ccc4ncsc4c23)cc1,CHEMBL271595,"InChI=1S/C16H12N4O3S2/c17-25(22,23)10-3-1-9(2-4-10)18-7-11-14-12(20-16(11)21)5-6-13-15(14)24-8-19-13/h1-8,18H,(H,20,21)(H2,17,22,23)/b11-7-",NS(=O)(=O)c1ccc(N\C=C\2/C(=O)Nc3ccc4ncsc4c23)cc1,CHEMBL952109,Inhibition of CDK2,IC50,=,2.8,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1143196,"J. Med. Chem., 51, p. 1179 (2008)",18271520,Scientific Literature
"81, page S13 table 1",CHEMBL409892,"InChI=1S/C17H13N5O3S/c18-26(24,25)11-5-3-10(4-6-11)21-22-16-15-12-2-1-9-19-13(12)7-8-14(15)20-17(16)23/h1-9,21H,(H2,18,24,25)(H,20,22,23)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc4ncccc4c23)cc1,CHEMBL409892,"InChI=1S/C17H13N5O3S/c18-26(24,25)11-5-3-10(4-6-11)21-22-16-15-12-2-1-9-19-13(12)7-8-14(15)20-17(16)23/h1-9,21H,(H2,18,24,25)(H,20,22,23)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc4ncccc4c23)cc1,CHEMBL952109,Inhibition of CDK2,IC50,=,1.6,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1143196,"J. Med. Chem., 51, p. 1179 (2008)",18271520,Scientific Literature
11,CHEMBL269985,"InChI=1S/C25H23N3O3/c1-16-4-7-21(25-28-27-17(2)31-25)14-23(16)19-8-10-20(11-9-19)24(29)26-15-18-5-12-22(30-3)13-6-18/h4-14H,15H2,1-3H3,(H,26,29)",COc1ccc(CNC(=O)c2ccc(cc2)c3cc(ccc3C)c4oc(C)nn4)cc1,CHEMBL269985,"InChI=1S/C25H23N3O3/c1-16-4-7-21(25-28-27-17(2)31-25)14-23(16)19-8-10-20(11-9-19)24(29)26-15-18-5-12-22(30-3)13-6-18/h4-14H,15H2,1-3H3,(H,26,29)",COc1ccc(CNC(=O)c2ccc(cc2)c3cc(ccc3C)c4oc(C)nn4)cc1,CHEMBL946927,Inhibition of p38alpha by fluorescence polarization assay,IC50,=,520,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1143258,"Bioorg. Med. Chem. Lett., 18, p. 324 (2008)",17981461,Scientific Literature
12,CHEMBL402108,"InChI=1S/C24H20ClN3O2/c1-15-3-6-20(24-28-27-16(2)30-24)13-22(15)18-7-9-19(10-8-18)23(29)26-14-17-4-11-21(25)12-5-17/h3-13H,14H2,1-2H3,(H,26,29)",Cc1oc(nn1)c2ccc(C)c(c2)c3ccc(cc3)C(=O)NCc4ccc(Cl)cc4,CHEMBL402108,"InChI=1S/C24H20ClN3O2/c1-15-3-6-20(24-28-27-16(2)30-24)13-22(15)18-7-9-19(10-8-18)23(29)26-14-17-4-11-21(25)12-5-17/h3-13H,14H2,1-2H3,(H,26,29)",Cc1oc(nn1)c2ccc(C)c(c2)c3ccc(cc3)C(=O)NCc4ccc(Cl)cc4,CHEMBL946927,Inhibition of p38alpha by fluorescence polarization assay,IC50,=,600,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1143258,"Bioorg. Med. Chem. Lett., 18, p. 324 (2008)",17981461,Scientific Literature
28,CHEMBL257113,"InChI=1S/C20H19N3O2/c1-13-22-23-20(25-13)18-4-2-3-17(11-18)15-7-9-16(10-8-15)19(24)21-12-14-5-6-14/h2-4,7-11,14H,5-6,12H2,1H3,(H,21,24)",Cc1oc(nn1)c2cccc(c2)c3ccc(cc3)C(=O)NCC4CC4,CHEMBL257113,"InChI=1S/C20H19N3O2/c1-13-22-23-20(25-13)18-4-2-3-17(11-18)15-7-9-16(10-8-15)19(24)21-12-14-5-6-14/h2-4,7-11,14H,5-6,12H2,1H3,(H,21,24)",Cc1oc(nn1)c2cccc(c2)c3ccc(cc3)C(=O)NCC4CC4,CHEMBL946927,Inhibition of p38alpha by fluorescence polarization assay,IC50,>,16000,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1143258,"Bioorg. Med. Chem. Lett., 18, p. 324 (2008)",17981461,Scientific Literature
3,CHEMBL270164,"InChI=1S/C24H18N4O2/c1-15-6-7-20(24-28-27-16(2)30-24)13-22(15)18-8-10-19(11-9-18)23(29)26-21-5-3-4-17(12-21)14-25/h3-13H,1-2H3,(H,26,29)",Cc1oc(nn1)c2ccc(C)c(c2)c3ccc(cc3)C(=O)Nc4cccc(c4)C#N,CHEMBL270164,"InChI=1S/C24H18N4O2/c1-15-6-7-20(24-28-27-16(2)30-24)13-22(15)18-8-10-19(11-9-18)23(29)26-21-5-3-4-17(12-21)14-25/h3-13H,1-2H3,(H,26,29)",Cc1oc(nn1)c2ccc(C)c(c2)c3ccc(cc3)C(=O)Nc4cccc(c4)C#N,CHEMBL946927,Inhibition of p38alpha by fluorescence polarization assay,IC50,=,1500,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1143258,"Bioorg. Med. Chem. Lett., 18, p. 324 (2008)",17981461,Scientific Literature
11,CHEMBL269985,"InChI=1S/C25H23N3O3/c1-16-4-7-21(25-28-27-17(2)31-25)14-23(16)19-8-10-20(11-9-19)24(29)26-15-18-5-12-22(30-3)13-6-18/h4-14H,15H2,1-3H3,(H,26,29)",COc1ccc(CNC(=O)c2ccc(cc2)c3cc(ccc3C)c4oc(C)nn4)cc1,CHEMBL269985,"InChI=1S/C25H23N3O3/c1-16-4-7-21(25-28-27-17(2)31-25)14-23(16)19-8-10-20(11-9-19)24(29)26-15-18-5-12-22(30-3)13-6-18/h4-14H,15H2,1-3H3,(H,26,29)",COc1ccc(CNC(=O)c2ccc(cc2)c3cc(ccc3C)c4oc(C)nn4)cc1,CHEMBL946927,Inhibition of p38alpha by fluorescence polarization assay,Ki,=,80,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1143258,"Bioorg. Med. Chem. Lett., 18, p. 324 (2008)",17981461,Scientific Literature
12,CHEMBL402108,"InChI=1S/C24H20ClN3O2/c1-15-3-6-20(24-28-27-16(2)30-24)13-22(15)18-7-9-19(10-8-18)23(29)26-14-17-4-11-21(25)12-5-17/h3-13H,14H2,1-2H3,(H,26,29)",Cc1oc(nn1)c2ccc(C)c(c2)c3ccc(cc3)C(=O)NCc4ccc(Cl)cc4,CHEMBL402108,"InChI=1S/C24H20ClN3O2/c1-15-3-6-20(24-28-27-16(2)30-24)13-22(15)18-7-9-19(10-8-18)23(29)26-14-17-4-11-21(25)12-5-17/h3-13H,14H2,1-2H3,(H,26,29)",Cc1oc(nn1)c2ccc(C)c(c2)c3ccc(cc3)C(=O)NCc4ccc(Cl)cc4,CHEMBL946927,Inhibition of p38alpha by fluorescence polarization assay,Ki,=,100,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1143258,"Bioorg. Med. Chem. Lett., 18, p. 324 (2008)",17981461,Scientific Literature
28,CHEMBL257113,"InChI=1S/C20H19N3O2/c1-13-22-23-20(25-13)18-4-2-3-17(11-18)15-7-9-16(10-8-15)19(24)21-12-14-5-6-14/h2-4,7-11,14H,5-6,12H2,1H3,(H,21,24)",Cc1oc(nn1)c2cccc(c2)c3ccc(cc3)C(=O)NCC4CC4,CHEMBL257113,"InChI=1S/C20H19N3O2/c1-13-22-23-20(25-13)18-4-2-3-17(11-18)15-7-9-16(10-8-15)19(24)21-12-14-5-6-14/h2-4,7-11,14H,5-6,12H2,1H3,(H,21,24)",Cc1oc(nn1)c2cccc(c2)c3ccc(cc3)C(=O)NCC4CC4,CHEMBL946927,Inhibition of p38alpha by fluorescence polarization assay,Ki,>,2500,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1143258,"Bioorg. Med. Chem. Lett., 18, p. 324 (2008)",17981461,Scientific Literature
3,CHEMBL270164,"InChI=1S/C24H18N4O2/c1-15-6-7-20(24-28-27-16(2)30-24)13-22(15)18-8-10-19(11-9-18)23(29)26-21-5-3-4-17(12-21)14-25/h3-13H,1-2H3,(H,26,29)",Cc1oc(nn1)c2ccc(C)c(c2)c3ccc(cc3)C(=O)Nc4cccc(c4)C#N,CHEMBL270164,"InChI=1S/C24H18N4O2/c1-15-6-7-20(24-28-27-16(2)30-24)13-22(15)18-8-10-19(11-9-18)23(29)26-21-5-3-4-17(12-21)14-25/h3-13H,1-2H3,(H,26,29)",Cc1oc(nn1)c2ccc(C)c(c2)c3ccc(cc3)C(=O)Nc4cccc(c4)C#N,CHEMBL946927,Inhibition of p38alpha by fluorescence polarization assay,Ki,=,240,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1143258,"Bioorg. Med. Chem. Lett., 18, p. 324 (2008)",17981461,Scientific Literature
2,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL941575,"AUC in mouse at 10 mg/kg, po",AUC,=,489,ng hr ml-1,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
2,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL941579,Antiproliferative activity against human A549 cells after 3 days by methylene blue stain technique,IC50,=,411,nM,,CHEMBL392,A549 (Lung carcinoma cells),Homo sapiens,,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
2,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL941580,Antiproliferative activity against human H460 cells after 3 days by methylene blue stain technique,IC50,=,380,nM,,CHEMBL612545,,,,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
2,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL941578,Antiproliferative activity against human HCT116 cells after 3 days by methylene blue stain technique,IC50,=,699,nM,,CHEMBL394,HCT-116 (Colon carcinoma cells),Homo sapiens,,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
21,CHEMBL480371,"InChI=1S/C20H13BrF3N3O2S/c21-13-4-2-1-3-11(13)9-29-16-8-17(30-18(16)19(25)28)27-10-26-14-7-12(20(22,23)24)5-6-15(14)27/h1-8,10H,9H2,(H2,25,28)",NC(=O)c1sc(cc1OCc2ccccc2Br)n3cnc4cc(ccc34)C(F)(F)F,CHEMBL480371,"InChI=1S/C20H13BrF3N3O2S/c21-13-4-2-1-3-11(13)9-29-16-8-17(30-18(16)19(25)28)27-10-26-14-7-12(20(22,23)24)5-6-15(14)27/h1-8,10H,9H2,(H2,25,28)",NC(=O)c1sc(cc1OCc2ccccc2Br)n3cnc4cc(ccc34)C(F)(F)F,CHEMBL941578,Antiproliferative activity against human HCT116 cells after 3 days by methylene blue stain technique,IC50,>,30000,nM,,CHEMBL394,HCT-116 (Colon carcinoma cells),Homo sapiens,,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
22,CHEMBL481510,"InChI=1S/C20H13BrF3N3O2S/c21-13-4-2-1-3-11(13)9-29-16-8-17(30-18(16)19(25)28)27-10-26-14-6-5-12(7-15(14)27)20(22,23)24/h1-8,10H,9H2,(H2,25,28)",NC(=O)c1sc(cc1OCc2ccccc2Br)n3cnc4ccc(cc34)C(F)(F)F,CHEMBL481510,"InChI=1S/C20H13BrF3N3O2S/c21-13-4-2-1-3-11(13)9-29-16-8-17(30-18(16)19(25)28)27-10-26-14-6-5-12(7-15(14)27)20(22,23)24/h1-8,10H,9H2,(H2,25,28)",NC(=O)c1sc(cc1OCc2ccccc2Br)n3cnc4ccc(cc34)C(F)(F)F,CHEMBL941578,Antiproliferative activity against human HCT116 cells after 3 days by methylene blue stain technique,IC50,=,3590,nM,,CHEMBL394,HCT-116 (Colon carcinoma cells),Homo sapiens,,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
29,CHEMBL514162,"InChI=1S/C21H18ClN3O4S/c1-27-16-7-14-15(8-17(16)28-2)25(11-24-14)19-9-18(20(30-19)21(23)26)29-10-12-5-3-4-6-13(12)22/h3-9,11H,10H2,1-2H3,(H2,23,26)",COc1cc2ncn(c3cc(OCc4ccccc4Cl)c(s3)C(=O)N)c2cc1OC,CHEMBL514162,"InChI=1S/C21H18ClN3O4S/c1-27-16-7-14-15(8-17(16)28-2)25(11-24-14)19-9-18(20(30-19)21(23)26)29-10-12-5-3-4-6-13(12)22/h3-9,11H,10H2,1-2H3,(H2,23,26)",COc1cc2ncn(c3cc(OCc4ccccc4Cl)c(s3)C(=O)N)c2cc1OC,CHEMBL941578,Antiproliferative activity against human HCT116 cells after 3 days by methylene blue stain technique,IC50,=,999,nM,,CHEMBL394,HCT-116 (Colon carcinoma cells),Homo sapiens,,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
40,CHEMBL473629,"InChI=1S/C22H21N3O4S/c1-27-17-10-15-16(11-18(17)28-2)25(13-24-15)20-12-19(21(30-20)22(23)26)29-9-8-14-6-4-3-5-7-14/h3-7,10-13H,8-9H2,1-2H3,(H2,23,26)",COc1cc2ncn(c3cc(OCCc4ccccc4)c(s3)C(=O)N)c2cc1OC,CHEMBL473629,"InChI=1S/C22H21N3O4S/c1-27-17-10-15-16(11-18(17)28-2)25(13-24-15)20-12-19(21(30-20)22(23)26)29-9-8-14-6-4-3-5-7-14/h3-7,10-13H,8-9H2,1-2H3,(H2,23,26)",COc1cc2ncn(c3cc(OCCc4ccccc4)c(s3)C(=O)N)c2cc1OC,CHEMBL941578,Antiproliferative activity against human HCT116 cells after 3 days by methylene blue stain technique,IC50,=,24100,nM,,CHEMBL394,HCT-116 (Colon carcinoma cells),Homo sapiens,,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
44,CHEMBL480382,"InChI=1S/C19H17N3O4S2/c1-24-14-6-12-13(7-15(14)25-2)22(10-21-12)17-8-16(18(28-17)19(20)23)26-9-11-4-3-5-27-11/h3-8,10H,9H2,1-2H3,(H2,20,23)",COc1cc2ncn(c3cc(OCc4cccs4)c(s3)C(=O)N)c2cc1OC,CHEMBL480382,"InChI=1S/C19H17N3O4S2/c1-24-14-6-12-13(7-15(14)25-2)22(10-21-12)17-8-16(18(28-17)19(20)23)26-9-11-4-3-5-27-11/h3-8,10H,9H2,1-2H3,(H2,20,23)",COc1cc2ncn(c3cc(OCc4cccs4)c(s3)C(=O)N)c2cc1OC,CHEMBL941578,Antiproliferative activity against human HCT116 cells after 3 days by methylene blue stain technique,IC50,=,1540,nM,,CHEMBL394,HCT-116 (Colon carcinoma cells),Homo sapiens,,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
2,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL941581,Antiproliferative activity against human HN5 cells after 3 days by methylene blue stain technique,IC50,=,678,nM,,CHEMBL614828,HN5 (Squamous cell carcinoma),Homo sapiens,,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
2,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL941582,Antiproliferative activity against human MCF7 cells after 3 days by methylene blue stain technique,IC50,=,558,nM,,CHEMBL387,MCF7 (Breast carcinoma cells),Homo sapiens,,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
2,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL942557,Antiproliferative activity against human NCI-N87 cells after 3 days by methylene blue stain technique,IC50,=,601,nM,,CHEMBL614197,NCI-N87,Homo sapiens,,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
2,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL942588,Antiproliferative activity against human PC3 cells after 3 days by methylene blue stain technique,IC50,=,6820,nM,,CHEMBL390,PC-3 (Prostate carcinoma cells),Homo sapiens,,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
2,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL942558,Antiproliferative activity against human RKO cells after 3 days by methylene blue stain technique,IC50,=,398,nM,,CHEMBL614879,RKO (Colon carcinoma),Homo sapiens,,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
2,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL941573,"Clearance in mouse at 6.7 mg/kg, iv",CL,=,47.4,mL.min-1.kg-1,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
2,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL941569,Inhibition of Aurora A,IC50,=,4800,nM,,CHEMBL4722,Serine/threonine-protein kinase Aurora-A,Homo sapiens,O14965,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
2,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL941570,Inhibition of EGFR,IC50,>,48000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
2,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL941577,Inhibition of GSK3,IC50,>,15000,nM,,CHEMBL612545,,,,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
2,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL941566,Inhibition of PDGFR1beta,IC50,=,160,nM,,CHEMBL1913,Platelet-derived growth factor receptor beta,Homo sapiens,P09619,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
11,CHEMBL516248,"InChI=1S/C20H17N3O3S/c1-25-14-6-4-5-13(9-14)11-26-17-10-18(27-19(17)20(21)24)23-12-22-15-7-2-3-8-16(15)23/h2-10,12H,11H2,1H3,(H2,21,24)",COc1cccc(COc2cc(sc2C(=O)N)n3cnc4ccccc34)c1,CHEMBL516248,"InChI=1S/C20H17N3O3S/c1-25-14-6-4-5-13(9-14)11-26-17-10-18(27-19(17)20(21)24)23-12-22-15-7-2-3-8-16(15)23/h2-10,12H,11H2,1H3,(H2,21,24)",COc1cccc(COc2cc(sc2C(=O)N)n3cnc4ccccc34)c1,CHEMBL941563,Inhibition of PLK1 expressed in baculovirus-infected Trichoplusia-ni cells by scintillation proximity assay,IC50,=,28,nM,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
17,CHEMBL518953,"InChI=1S/C19H14BrN3O2S/c20-13-6-2-1-5-12(13)10-25-16-9-17(26-18(16)19(21)24)23-11-22-14-7-3-4-8-15(14)23/h1-9,11H,10H2,(H2,21,24)",NC(=O)c1sc(cc1OCc2ccccc2Br)n3cnc4ccccc34,CHEMBL518953,"InChI=1S/C19H14BrN3O2S/c20-13-6-2-1-5-12(13)10-25-16-9-17(26-18(16)19(21)24)23-11-22-14-7-3-4-8-15(14)23/h1-9,11H,10H2,(H2,21,24)",NC(=O)c1sc(cc1OCc2ccccc2Br)n3cnc4ccccc34,CHEMBL941563,Inhibition of PLK1 expressed in baculovirus-infected Trichoplusia-ni cells by scintillation proximity assay,IC50,=,11,nM,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
2,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL941563,Inhibition of PLK1 expressed in baculovirus-infected Trichoplusia-ni cells by scintillation proximity assay,IC50,=,2,nM,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
21,CHEMBL480371,"InChI=1S/C20H13BrF3N3O2S/c21-13-4-2-1-3-11(13)9-29-16-8-17(30-18(16)19(25)28)27-10-26-14-7-12(20(22,23)24)5-6-15(14)27/h1-8,10H,9H2,(H2,25,28)",NC(=O)c1sc(cc1OCc2ccccc2Br)n3cnc4cc(ccc34)C(F)(F)F,CHEMBL480371,"InChI=1S/C20H13BrF3N3O2S/c21-13-4-2-1-3-11(13)9-29-16-8-17(30-18(16)19(25)28)27-10-26-14-7-12(20(22,23)24)5-6-15(14)27/h1-8,10H,9H2,(H2,25,28)",NC(=O)c1sc(cc1OCc2ccccc2Br)n3cnc4cc(ccc34)C(F)(F)F,CHEMBL941563,Inhibition of PLK1 expressed in baculovirus-infected Trichoplusia-ni cells by scintillation proximity assay,IC50,=,300,nM,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
22,CHEMBL481510,"InChI=1S/C20H13BrF3N3O2S/c21-13-4-2-1-3-11(13)9-29-16-8-17(30-18(16)19(25)28)27-10-26-14-6-5-12(7-15(14)27)20(22,23)24/h1-8,10H,9H2,(H2,25,28)",NC(=O)c1sc(cc1OCc2ccccc2Br)n3cnc4ccc(cc34)C(F)(F)F,CHEMBL481510,"InChI=1S/C20H13BrF3N3O2S/c21-13-4-2-1-3-11(13)9-29-16-8-17(30-18(16)19(25)28)27-10-26-14-6-5-12(7-15(14)27)20(22,23)24/h1-8,10H,9H2,(H2,25,28)",NC(=O)c1sc(cc1OCc2ccccc2Br)n3cnc4ccc(cc34)C(F)(F)F,CHEMBL941563,Inhibition of PLK1 expressed in baculovirus-infected Trichoplusia-ni cells by scintillation proximity assay,IC50,=,9,nM,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
29,CHEMBL514162,"InChI=1S/C21H18ClN3O4S/c1-27-16-7-14-15(8-17(16)28-2)25(11-24-14)19-9-18(20(30-19)21(23)26)29-10-12-5-3-4-6-13(12)22/h3-9,11H,10H2,1-2H3,(H2,23,26)",COc1cc2ncn(c3cc(OCc4ccccc4Cl)c(s3)C(=O)N)c2cc1OC,CHEMBL514162,"InChI=1S/C21H18ClN3O4S/c1-27-16-7-14-15(8-17(16)28-2)25(11-24-14)19-9-18(20(30-19)21(23)26)29-10-12-5-3-4-6-13(12)22/h3-9,11H,10H2,1-2H3,(H2,23,26)",COc1cc2ncn(c3cc(OCc4ccccc4Cl)c(s3)C(=O)N)c2cc1OC,CHEMBL941563,Inhibition of PLK1 expressed in baculovirus-infected Trichoplusia-ni cells by scintillation proximity assay,IC50,=,2,nM,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
40,CHEMBL473629,"InChI=1S/C22H21N3O4S/c1-27-17-10-15-16(11-18(17)28-2)25(13-24-15)20-12-19(21(30-20)22(23)26)29-9-8-14-6-4-3-5-7-14/h3-7,10-13H,8-9H2,1-2H3,(H2,23,26)",COc1cc2ncn(c3cc(OCCc4ccccc4)c(s3)C(=O)N)c2cc1OC,CHEMBL473629,"InChI=1S/C22H21N3O4S/c1-27-17-10-15-16(11-18(17)28-2)25(13-24-15)20-12-19(21(30-20)22(23)26)29-9-8-14-6-4-3-5-7-14/h3-7,10-13H,8-9H2,1-2H3,(H2,23,26)",COc1cc2ncn(c3cc(OCCc4ccccc4)c(s3)C(=O)N)c2cc1OC,CHEMBL941563,Inhibition of PLK1 expressed in baculovirus-infected Trichoplusia-ni cells by scintillation proximity assay,IC50,=,130,nM,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
44,CHEMBL480382,"InChI=1S/C19H17N3O4S2/c1-24-14-6-12-13(7-15(14)25-2)22(10-21-12)17-8-16(18(28-17)19(20)23)26-9-11-4-3-5-27-11/h3-8,10H,9H2,1-2H3,(H2,20,23)",COc1cc2ncn(c3cc(OCc4cccs4)c(s3)C(=O)N)c2cc1OC,CHEMBL480382,"InChI=1S/C19H17N3O4S2/c1-24-14-6-12-13(7-15(14)25-2)22(10-21-12)17-8-16(18(28-17)19(20)23)26-9-11-4-3-5-27-11/h3-8,10H,9H2,1-2H3,(H2,20,23)",COc1cc2ncn(c3cc(OCc4cccs4)c(s3)C(=O)N)c2cc1OC,CHEMBL941563,Inhibition of PLK1 expressed in baculovirus-infected Trichoplusia-ni cells by scintillation proximity assay,IC50,=,11,nM,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
51,CHEMBL473420,"InChI=1S/C23H19F3N2O5S/c1-30-17-8-15-16(9-18(17)31-2)28(12-27-15)20-10-19(21(34-20)22(29)32-3)33-11-13-6-4-5-7-14(13)23(24,25)26/h4-10,12H,11H2,1-3H3",COC(=O)c1sc(cc1OCc2ccccc2C(F)(F)F)n3cnc4cc(OC)c(OC)cc34,CHEMBL473420,"InChI=1S/C23H19F3N2O5S/c1-30-17-8-15-16(9-18(17)31-2)28(12-27-15)20-10-19(21(34-20)22(29)32-3)33-11-13-6-4-5-7-14(13)23(24,25)26/h4-10,12H,11H2,1-3H3",COC(=O)c1sc(cc1OCc2ccccc2C(F)(F)F)n3cnc4cc(OC)c(OC)cc34,CHEMBL941563,Inhibition of PLK1 expressed in baculovirus-infected Trichoplusia-ni cells by scintillation proximity assay,IC50,>,1000,nM,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
56,CHEMBL471789,"InChI=1S/C23H19F3N2O4S/c1-13(29)22-20(32-11-14-6-4-5-7-15(14)23(24,25)26)10-21(33-22)28-12-27-16-8-18(30-2)19(31-3)9-17(16)28/h4-10,12H,11H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)C)c2cc1OC,CHEMBL471789,"InChI=1S/C23H19F3N2O4S/c1-13(29)22-20(32-11-14-6-4-5-7-15(14)23(24,25)26)10-21(33-22)28-12-27-16-8-18(30-2)19(31-3)9-17(16)28/h4-10,12H,11H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)C)c2cc1OC,CHEMBL941563,Inhibition of PLK1 expressed in baculovirus-infected Trichoplusia-ni cells by scintillation proximity assay,IC50,=,85,nM,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
57,CHEMBL518968,"InChI=1S/C23H20F3N3O4S/c1-27-22(30)21-19(33-11-13-6-4-5-7-14(13)23(24,25)26)10-20(34-21)29-12-28-15-8-17(31-2)18(32-3)9-16(15)29/h4-10,12H,11H2,1-3H3,(H,27,30)",CNC(=O)c1sc(cc1OCc2ccccc2C(F)(F)F)n3cnc4cc(OC)c(OC)cc34,CHEMBL518968,"InChI=1S/C23H20F3N3O4S/c1-27-22(30)21-19(33-11-13-6-4-5-7-14(13)23(24,25)26)10-20(34-21)29-12-28-15-8-17(31-2)18(32-3)9-16(15)29/h4-10,12H,11H2,1-3H3,(H,27,30)",CNC(=O)c1sc(cc1OCc2ccccc2C(F)(F)F)n3cnc4cc(OC)c(OC)cc34,CHEMBL941563,Inhibition of PLK1 expressed in baculovirus-infected Trichoplusia-ni cells by scintillation proximity assay,IC50,>,1000,nM,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
58,CHEMBL482326,"InChI=1S/C24H22F3N3O4S/c1-29(2)23(31)22-20(34-12-14-7-5-6-8-15(14)24(25,26)27)11-21(35-22)30-13-28-16-9-18(32-3)19(33-4)10-17(16)30/h5-11,13H,12H2,1-4H3",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N(C)C)c2cc1OC,CHEMBL482326,"InChI=1S/C24H22F3N3O4S/c1-29(2)23(31)22-20(34-12-14-7-5-6-8-15(14)24(25,26)27)11-21(35-22)30-13-28-16-9-18(32-3)19(33-4)10-17(16)30/h5-11,13H,12H2,1-4H3",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N(C)C)c2cc1OC,CHEMBL941563,Inhibition of PLK1 expressed in baculovirus-infected Trichoplusia-ni cells by scintillation proximity assay,IC50,>,1000,nM,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
2,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL941564,Inhibition of PLK3,IC50,=,9,nM,,CHEMBL4897,Serine/threonine-protein kinase PLK3,Homo sapiens,Q9H4B4,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
2,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL941572,Inhibition of Src,IC50,>,30000,nM,,CHEMBL267,Tyrosine-protein kinase SRC,Homo sapiens,P12931,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
2,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL941567,Inhibition of VEGFR2,IC50,=,360,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
2,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL941565,Inhibition of VEGFR3,IC50,=,92,nM,,CHEMBL1955,Vascular endothelial growth factor receptor 3,Homo sapiens,P35916,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
2,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL941568,Inhibition of cFMS,IC50,=,620,nM,,CHEMBL1844,Macrophage colony stimulating factor  receptor ,Homo sapiens,P07333,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
2,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL941571,Inhibition of p38alpha,IC50,>,15000,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
2,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL941576,Oral bioavailability in mouse at 10 mg/kg,F,=,14,%,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
2,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL941574,"Volume of distribution at steady state in mouse at 6.7 mg/kg, iv",Vdss,=,1.5,L.kg-1,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1143265,"Bioorg. Med. Chem. Lett., 19, p. 1018 (2009)",19097784,Scientific Literature
30,CHEMBL514938,"InChI=1S/C23H15ClFN3O2S/c24-18-10-16(6-7-19(18)30-12-14-3-1-4-15(25)9-14)28-22-17-11-21(20-5-2-8-29-20)31-23(17)27-13-26-22/h1-11,13H,12H2,(H,26,27,28)",Fc1cccc(COc2ccc(Nc3ncnc4sc(cc34)c5occc5)cc2Cl)c1,CHEMBL514938,"InChI=1S/C23H15ClFN3O2S/c24-18-10-16(6-7-19(18)30-12-14-3-1-4-15(25)9-14)28-22-17-11-21(20-5-2-8-29-20)31-23(17)27-13-26-22/h1-11,13H,12H2,(H,26,27,28)",Fc1cccc(COc2ccc(Nc3ncnc4sc(cc34)c5occc5)cc2Cl)c1,CHEMBL990361,Antiproliferative activity against HFF after 72 hrs by CTG assay,IC50,>,30000,nM,,CHEMBL614071,HFF (Foreskin fibroblasts),Homo sapiens,,CHEMBL1143296,"Bioorg. Med. Chem. Lett., 19, p. 817 (2009)",19111461,Scientific Literature
33,CHEMBL506414,"InChI=1S/C23H15ClFN3OS2/c24-18-10-16(6-7-19(18)29-12-14-3-1-4-15(25)9-14)28-22-17-11-21(20-5-2-8-30-20)31-23(17)27-13-26-22/h1-11,13H,12H2,(H,26,27,28)",Fc1cccc(COc2ccc(Nc3ncnc4sc(cc34)c5cccs5)cc2Cl)c1,CHEMBL506414,"InChI=1S/C23H15ClFN3OS2/c24-18-10-16(6-7-19(18)29-12-14-3-1-4-15(25)9-14)28-22-17-11-21(20-5-2-8-30-20)31-23(17)27-13-26-22/h1-11,13H,12H2,(H,26,27,28)",Fc1cccc(COc2ccc(Nc3ncnc4sc(cc34)c5cccs5)cc2Cl)c1,CHEMBL990361,Antiproliferative activity against HFF after 72 hrs by CTG assay,IC50,=,9720,nM,,CHEMBL614071,HFF (Foreskin fibroblasts),Homo sapiens,,CHEMBL1143296,"Bioorg. Med. Chem. Lett., 19, p. 817 (2009)",19111461,Scientific Literature
26,CHEMBL473436,"InChI=1S/C23H16ClFN4OS/c24-17-10-16(6-7-20(17)30-12-14-3-1-4-15(25)9-14)29-23-22-19(27-13-28-23)11-21(31-22)18-5-2-8-26-18/h1-11,13,26H,12H2,(H,27,28,29)",Fc1cccc(COc2ccc(Nc3ncnc4cc(sc34)c5ccc[nH]5)cc2Cl)c1,CHEMBL473436,"InChI=1S/C23H16ClFN4OS/c24-17-10-16(6-7-20(17)30-12-14-3-1-4-15(25)9-14)29-23-22-19(27-13-28-23)11-21(31-22)18-5-2-8-26-18/h1-11,13,26H,12H2,(H,27,28,29)",Fc1cccc(COc2ccc(Nc3ncnc4cc(sc34)c5ccc[nH]5)cc2Cl)c1,CHEMBL990364,Antiproliferative activity against HFF after 72 hrs by MEB assay,IC50,=,2370,nM,,CHEMBL614071,HFF (Foreskin fibroblasts),Homo sapiens,,CHEMBL1143296,"Bioorg. Med. Chem. Lett., 19, p. 817 (2009)",19111461,Scientific Literature
30,CHEMBL514938,"InChI=1S/C23H15ClFN3O2S/c24-18-10-16(6-7-19(18)30-12-14-3-1-4-15(25)9-14)28-22-17-11-21(20-5-2-8-29-20)31-23(17)27-13-26-22/h1-11,13H,12H2,(H,26,27,28)",Fc1cccc(COc2ccc(Nc3ncnc4sc(cc34)c5occc5)cc2Cl)c1,CHEMBL514938,"InChI=1S/C23H15ClFN3O2S/c24-18-10-16(6-7-19(18)30-12-14-3-1-4-15(25)9-14)28-22-17-11-21(20-5-2-8-29-20)31-23(17)27-13-26-22/h1-11,13H,12H2,(H,26,27,28)",Fc1cccc(COc2ccc(Nc3ncnc4sc(cc34)c5occc5)cc2Cl)c1,CHEMBL990360,Antiproliferative activity against human BT474 cells expressing ErbB2 after 72 hrs by CTG assay,IC50,>,30000,nM,,CHEMBL612545,,,,CHEMBL1143296,"Bioorg. Med. Chem. Lett., 19, p. 817 (2009)",19111461,Scientific Literature
33,CHEMBL506414,"InChI=1S/C23H15ClFN3OS2/c24-18-10-16(6-7-19(18)29-12-14-3-1-4-15(25)9-14)28-22-17-11-21(20-5-2-8-30-20)31-23(17)27-13-26-22/h1-11,13H,12H2,(H,26,27,28)",Fc1cccc(COc2ccc(Nc3ncnc4sc(cc34)c5cccs5)cc2Cl)c1,CHEMBL506414,"InChI=1S/C23H15ClFN3OS2/c24-18-10-16(6-7-19(18)29-12-14-3-1-4-15(25)9-14)28-22-17-11-21(20-5-2-8-30-20)31-23(17)27-13-26-22/h1-11,13H,12H2,(H,26,27,28)",Fc1cccc(COc2ccc(Nc3ncnc4sc(cc34)c5cccs5)cc2Cl)c1,CHEMBL990360,Antiproliferative activity against human BT474 cells expressing ErbB2 after 72 hrs by CTG assay,IC50,=,3220,nM,,CHEMBL612545,,,,CHEMBL1143296,"Bioorg. Med. Chem. Lett., 19, p. 817 (2009)",19111461,Scientific Literature
26,CHEMBL473436,"InChI=1S/C23H16ClFN4OS/c24-17-10-16(6-7-20(17)30-12-14-3-1-4-15(25)9-14)29-23-22-19(27-13-28-23)11-21(31-22)18-5-2-8-26-18/h1-11,13,26H,12H2,(H,27,28,29)",Fc1cccc(COc2ccc(Nc3ncnc4cc(sc34)c5ccc[nH]5)cc2Cl)c1,CHEMBL473436,"InChI=1S/C23H16ClFN4OS/c24-17-10-16(6-7-20(17)30-12-14-3-1-4-15(25)9-14)29-23-22-19(27-13-28-23)11-21(31-22)18-5-2-8-26-18/h1-11,13,26H,12H2,(H,27,28,29)",Fc1cccc(COc2ccc(Nc3ncnc4cc(sc34)c5ccc[nH]5)cc2Cl)c1,CHEMBL990363,Antiproliferative activity against human BT474 cells expressing ErbB2 by MEB assay,IC50,=,540,nM,,CHEMBL612545,,,,CHEMBL1143296,"Bioorg. Med. Chem. Lett., 19, p. 817 (2009)",19111461,Scientific Literature
30,CHEMBL514938,"InChI=1S/C23H15ClFN3O2S/c24-18-10-16(6-7-19(18)30-12-14-3-1-4-15(25)9-14)28-22-17-11-21(20-5-2-8-29-20)31-23(17)27-13-26-22/h1-11,13H,12H2,(H,26,27,28)",Fc1cccc(COc2ccc(Nc3ncnc4sc(cc34)c5occc5)cc2Cl)c1,CHEMBL514938,"InChI=1S/C23H15ClFN3O2S/c24-18-10-16(6-7-19(18)30-12-14-3-1-4-15(25)9-14)28-22-17-11-21(20-5-2-8-29-20)31-23(17)27-13-26-22/h1-11,13H,12H2,(H,26,27,28)",Fc1cccc(COc2ccc(Nc3ncnc4sc(cc34)c5occc5)cc2Cl)c1,CHEMBL990359,Antiproliferative activity against human HN5 cells expressing EGFR after 72 hrs by CTG assay,IC50,>,30000,nM,,CHEMBL614828,HN5 (Squamous cell carcinoma),Homo sapiens,,CHEMBL1143296,"Bioorg. Med. Chem. Lett., 19, p. 817 (2009)",19111461,Scientific Literature
33,CHEMBL506414,"InChI=1S/C23H15ClFN3OS2/c24-18-10-16(6-7-19(18)29-12-14-3-1-4-15(25)9-14)28-22-17-11-21(20-5-2-8-30-20)31-23(17)27-13-26-22/h1-11,13H,12H2,(H,26,27,28)",Fc1cccc(COc2ccc(Nc3ncnc4sc(cc34)c5cccs5)cc2Cl)c1,CHEMBL506414,"InChI=1S/C23H15ClFN3OS2/c24-18-10-16(6-7-19(18)29-12-14-3-1-4-15(25)9-14)28-22-17-11-21(20-5-2-8-30-20)31-23(17)27-13-26-22/h1-11,13H,12H2,(H,26,27,28)",Fc1cccc(COc2ccc(Nc3ncnc4sc(cc34)c5cccs5)cc2Cl)c1,CHEMBL990359,Antiproliferative activity against human HN5 cells expressing EGFR after 72 hrs by CTG assay,IC50,=,10080,nM,,CHEMBL614828,HN5 (Squamous cell carcinoma),Homo sapiens,,CHEMBL1143296,"Bioorg. Med. Chem. Lett., 19, p. 817 (2009)",19111461,Scientific Literature
26,CHEMBL473436,"InChI=1S/C23H16ClFN4OS/c24-17-10-16(6-7-20(17)30-12-14-3-1-4-15(25)9-14)29-23-22-19(27-13-28-23)11-21(31-22)18-5-2-8-26-18/h1-11,13,26H,12H2,(H,27,28,29)",Fc1cccc(COc2ccc(Nc3ncnc4cc(sc34)c5ccc[nH]5)cc2Cl)c1,CHEMBL473436,"InChI=1S/C23H16ClFN4OS/c24-17-10-16(6-7-20(17)30-12-14-3-1-4-15(25)9-14)29-23-22-19(27-13-28-23)11-21(31-22)18-5-2-8-26-18/h1-11,13,26H,12H2,(H,27,28,29)",Fc1cccc(COc2ccc(Nc3ncnc4cc(sc34)c5ccc[nH]5)cc2Cl)c1,CHEMBL990362,Antiproliferative activity against human HN5 cells expressing EGFR by MEB assay,IC50,=,570,nM,,CHEMBL614828,HN5 (Squamous cell carcinoma),Homo sapiens,,CHEMBL1143296,"Bioorg. Med. Chem. Lett., 19, p. 817 (2009)",19111461,Scientific Literature
19,CHEMBL475761,"InChI=1S/C29H27ClFN5O2S/c1-35-9-11-36(12-10-35)16-22-6-8-26(38-22)27-15-24-28(39-27)29(33-18-32-24)34-21-5-7-25(23(30)14-21)37-17-19-3-2-4-20(31)13-19/h2-8,13-15,18H,9-12,16-17H2,1H3,(H,32,33,34)",CN1CCN(Cc2oc(cc2)c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)CC1,CHEMBL475761,"InChI=1S/C29H27ClFN5O2S/c1-35-9-11-36(12-10-35)16-22-6-8-26(38-22)27-15-24-28(39-27)29(33-18-32-24)34-21-5-7-25(23(30)14-21)37-17-19-3-2-4-20(31)13-19/h2-8,13-15,18H,9-12,16-17H2,1H3,(H,32,33,34)",CN1CCN(Cc2oc(cc2)c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)CC1,CHEMBL1028080,Inhibition of EGFR,IC50,=,5,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1143296,"Bioorg. Med. Chem. Lett., 19, p. 817 (2009)",19111461,Scientific Literature
26,CHEMBL473436,"InChI=1S/C23H16ClFN4OS/c24-17-10-16(6-7-20(17)30-12-14-3-1-4-15(25)9-14)29-23-22-19(27-13-28-23)11-21(31-22)18-5-2-8-26-18/h1-11,13,26H,12H2,(H,27,28,29)",Fc1cccc(COc2ccc(Nc3ncnc4cc(sc34)c5ccc[nH]5)cc2Cl)c1,CHEMBL473436,"InChI=1S/C23H16ClFN4OS/c24-17-10-16(6-7-20(17)30-12-14-3-1-4-15(25)9-14)29-23-22-19(27-13-28-23)11-21(31-22)18-5-2-8-26-18/h1-11,13,26H,12H2,(H,27,28,29)",Fc1cccc(COc2ccc(Nc3ncnc4cc(sc34)c5ccc[nH]5)cc2Cl)c1,CHEMBL1028080,Inhibition of EGFR,IC50,=,68,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1143296,"Bioorg. Med. Chem. Lett., 19, p. 817 (2009)",19111461,Scientific Literature
30,CHEMBL514938,"InChI=1S/C23H15ClFN3O2S/c24-18-10-16(6-7-19(18)30-12-14-3-1-4-15(25)9-14)28-22-17-11-21(20-5-2-8-29-20)31-23(17)27-13-26-22/h1-11,13H,12H2,(H,26,27,28)",Fc1cccc(COc2ccc(Nc3ncnc4sc(cc34)c5occc5)cc2Cl)c1,CHEMBL514938,"InChI=1S/C23H15ClFN3O2S/c24-18-10-16(6-7-19(18)30-12-14-3-1-4-15(25)9-14)28-22-17-11-21(20-5-2-8-29-20)31-23(17)27-13-26-22/h1-11,13H,12H2,(H,26,27,28)",Fc1cccc(COc2ccc(Nc3ncnc4sc(cc34)c5occc5)cc2Cl)c1,CHEMBL1028080,Inhibition of EGFR,IC50,=,15,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1143296,"Bioorg. Med. Chem. Lett., 19, p. 817 (2009)",19111461,Scientific Literature
33,CHEMBL506414,"InChI=1S/C23H15ClFN3OS2/c24-18-10-16(6-7-19(18)29-12-14-3-1-4-15(25)9-14)28-22-17-11-21(20-5-2-8-30-20)31-23(17)27-13-26-22/h1-11,13H,12H2,(H,26,27,28)",Fc1cccc(COc2ccc(Nc3ncnc4sc(cc34)c5cccs5)cc2Cl)c1,CHEMBL506414,"InChI=1S/C23H15ClFN3OS2/c24-18-10-16(6-7-19(18)29-12-14-3-1-4-15(25)9-14)28-22-17-11-21(20-5-2-8-30-20)31-23(17)27-13-26-22/h1-11,13H,12H2,(H,26,27,28)",Fc1cccc(COc2ccc(Nc3ncnc4sc(cc34)c5cccs5)cc2Cl)c1,CHEMBL1028080,Inhibition of EGFR,IC50,=,9,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1143296,"Bioorg. Med. Chem. Lett., 19, p. 817 (2009)",19111461,Scientific Literature
35,CHEMBL475599,"InChI=1S/C27H24ClFN4O3S3/c1-39(34,35)8-7-30-13-21-10-18(15-37-21)25-12-22-26(31-16-32-27(22)38-25)33-20-5-6-24(23(28)11-20)36-14-17-3-2-4-19(29)9-17/h2-6,9-12,15-16,30H,7-8,13-14H2,1H3,(H,31,32,33)",CS(=O)(=O)CCNCc1cc(cs1)c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2,CHEMBL475599,"InChI=1S/C27H24ClFN4O3S3/c1-39(34,35)8-7-30-13-21-10-18(15-37-21)25-12-22-26(31-16-32-27(22)38-25)33-20-5-6-24(23(28)11-20)36-14-17-3-2-4-19(29)9-17/h2-6,9-12,15-16,30H,7-8,13-14H2,1H3,(H,31,32,33)",CS(=O)(=O)CCNCc1cc(cs1)c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2,CHEMBL1028080,Inhibition of EGFR,IC50,=,304,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1143296,"Bioorg. Med. Chem. Lett., 19, p. 817 (2009)",19111461,Scientific Literature
19,CHEMBL475761,"InChI=1S/C29H27ClFN5O2S/c1-35-9-11-36(12-10-35)16-22-6-8-26(38-22)27-15-24-28(39-27)29(33-18-32-24)34-21-5-7-25(23(30)14-21)37-17-19-3-2-4-20(31)13-19/h2-8,13-15,18H,9-12,16-17H2,1H3,(H,32,33,34)",CN1CCN(Cc2oc(cc2)c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)CC1,CHEMBL475761,"InChI=1S/C29H27ClFN5O2S/c1-35-9-11-36(12-10-35)16-22-6-8-26(38-22)27-15-24-28(39-27)29(33-18-32-24)34-21-5-7-25(23(30)14-21)37-17-19-3-2-4-20(31)13-19/h2-8,13-15,18H,9-12,16-17H2,1H3,(H,32,33,34)",CN1CCN(Cc2oc(cc2)c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)CC1,CHEMBL991255,Inhibition of ErbB2,IC50,=,250,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1143296,"Bioorg. Med. Chem. Lett., 19, p. 817 (2009)",19111461,Scientific Literature
26,CHEMBL473436,"InChI=1S/C23H16ClFN4OS/c24-17-10-16(6-7-20(17)30-12-14-3-1-4-15(25)9-14)29-23-22-19(27-13-28-23)11-21(31-22)18-5-2-8-26-18/h1-11,13,26H,12H2,(H,27,28,29)",Fc1cccc(COc2ccc(Nc3ncnc4cc(sc34)c5ccc[nH]5)cc2Cl)c1,CHEMBL473436,"InChI=1S/C23H16ClFN4OS/c24-17-10-16(6-7-20(17)30-12-14-3-1-4-15(25)9-14)29-23-22-19(27-13-28-23)11-21(31-22)18-5-2-8-26-18/h1-11,13,26H,12H2,(H,27,28,29)",Fc1cccc(COc2ccc(Nc3ncnc4cc(sc34)c5ccc[nH]5)cc2Cl)c1,CHEMBL991255,Inhibition of ErbB2,IC50,=,121,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1143296,"Bioorg. Med. Chem. Lett., 19, p. 817 (2009)",19111461,Scientific Literature
30,CHEMBL514938,"InChI=1S/C23H15ClFN3O2S/c24-18-10-16(6-7-19(18)30-12-14-3-1-4-15(25)9-14)28-22-17-11-21(20-5-2-8-29-20)31-23(17)27-13-26-22/h1-11,13H,12H2,(H,26,27,28)",Fc1cccc(COc2ccc(Nc3ncnc4sc(cc34)c5occc5)cc2Cl)c1,CHEMBL514938,"InChI=1S/C23H15ClFN3O2S/c24-18-10-16(6-7-19(18)30-12-14-3-1-4-15(25)9-14)28-22-17-11-21(20-5-2-8-29-20)31-23(17)27-13-26-22/h1-11,13H,12H2,(H,26,27,28)",Fc1cccc(COc2ccc(Nc3ncnc4sc(cc34)c5occc5)cc2Cl)c1,CHEMBL991255,Inhibition of ErbB2,IC50,=,14,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1143296,"Bioorg. Med. Chem. Lett., 19, p. 817 (2009)",19111461,Scientific Literature
33,CHEMBL506414,"InChI=1S/C23H15ClFN3OS2/c24-18-10-16(6-7-19(18)29-12-14-3-1-4-15(25)9-14)28-22-17-11-21(20-5-2-8-30-20)31-23(17)27-13-26-22/h1-11,13H,12H2,(H,26,27,28)",Fc1cccc(COc2ccc(Nc3ncnc4sc(cc34)c5cccs5)cc2Cl)c1,CHEMBL506414,"InChI=1S/C23H15ClFN3OS2/c24-18-10-16(6-7-19(18)29-12-14-3-1-4-15(25)9-14)28-22-17-11-21(20-5-2-8-30-20)31-23(17)27-13-26-22/h1-11,13H,12H2,(H,26,27,28)",Fc1cccc(COc2ccc(Nc3ncnc4sc(cc34)c5cccs5)cc2Cl)c1,CHEMBL991255,Inhibition of ErbB2,IC50,=,43,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1143296,"Bioorg. Med. Chem. Lett., 19, p. 817 (2009)",19111461,Scientific Literature
35,CHEMBL475599,"InChI=1S/C27H24ClFN4O3S3/c1-39(34,35)8-7-30-13-21-10-18(15-37-21)25-12-22-26(31-16-32-27(22)38-25)33-20-5-6-24(23(28)11-20)36-14-17-3-2-4-19(29)9-17/h2-6,9-12,15-16,30H,7-8,13-14H2,1H3,(H,31,32,33)",CS(=O)(=O)CCNCc1cc(cs1)c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2,CHEMBL475599,"InChI=1S/C27H24ClFN4O3S3/c1-39(34,35)8-7-30-13-21-10-18(15-37-21)25-12-22-26(31-16-32-27(22)38-25)33-20-5-6-24(23(28)11-20)36-14-17-3-2-4-19(29)9-17/h2-6,9-12,15-16,30H,7-8,13-14H2,1H3,(H,31,32,33)",CS(=O)(=O)CCNCc1cc(cs1)c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2,CHEMBL991255,Inhibition of ErbB2,IC50,=,299,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1143296,"Bioorg. Med. Chem. Lett., 19, p. 817 (2009)",19111461,Scientific Literature
26,CHEMBL473436,"InChI=1S/C23H16ClFN4OS/c24-17-10-16(6-7-20(17)30-12-14-3-1-4-15(25)9-14)29-23-22-19(27-13-28-23)11-21(31-22)18-5-2-8-26-18/h1-11,13,26H,12H2,(H,27,28,29)",Fc1cccc(COc2ccc(Nc3ncnc4cc(sc34)c5ccc[nH]5)cc2Cl)c1,CHEMBL473436,"InChI=1S/C23H16ClFN4OS/c24-17-10-16(6-7-20(17)30-12-14-3-1-4-15(25)9-14)29-23-22-19(27-13-28-23)11-21(31-22)18-5-2-8-26-18/h1-11,13,26H,12H2,(H,27,28,29)",Fc1cccc(COc2ccc(Nc3ncnc4cc(sc34)c5ccc[nH]5)cc2Cl)c1,CHEMBL990365,Inhibition of ErbB2 intracellular autophosphorylation of ErbB2 in human BT474 cells by DELFIA assay,IC50,=,826,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1143296,"Bioorg. Med. Chem. Lett., 19, p. 817 (2009)",19111461,Scientific Literature
20,CHEMBL495771,"InChI=1S/C17H19N7O/c1-2-12(1)20-17-18-6-5-14(21-17)13-11-19-24-15(13)3-4-16(22-24)23-7-9-25-10-8-23/h3-6,11-12H,1-2,7-10H2,(H,18,20,21)",C1CN(CCO1)c2ccc3c(cnn3n2)c4ccnc(NC5CC5)n4,CHEMBL495771,"InChI=1S/C17H19N7O/c1-2-12(1)20-17-18-6-5-14(21-17)13-11-19-24-15(13)3-4-16(22-24)23-7-9-25-10-8-23/h3-6,11-12H,1-2,7-10H2,(H,18,20,21)",C1CN(CCO1)c2ccc3c(cnn3n2)c4ccnc(NC5CC5)n4,CHEMBL1002025,Dose normalized AUC in orally dosed mouse,AUC,>,1000,ng hr kg mg-1 ml-1,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1143431,"Bioorg. Med. Chem. Lett., 18, p. 5758 (2008)",18835709,Scientific Literature
20,CHEMBL495771,"InChI=1S/C17H19N7O/c1-2-12(1)20-17-18-6-5-14(21-17)13-11-19-24-15(13)3-4-16(22-24)23-7-9-25-10-8-23/h3-6,11-12H,1-2,7-10H2,(H,18,20,21)",C1CN(CCO1)c2ccc3c(cnn3n2)c4ccnc(NC5CC5)n4,CHEMBL495771,"InChI=1S/C17H19N7O/c1-2-12(1)20-17-18-6-5-14(21-17)13-11-19-24-15(13)3-4-16(22-24)23-7-9-25-10-8-23/h3-6,11-12H,1-2,7-10H2,(H,18,20,21)",C1CN(CCO1)c2ccc3c(cnn3n2)c4ccnc(NC5CC5)n4,CHEMBL1002018,Inhibition of CDK4 by radioactive glutathione plate-binding assay,IC50,=,400,nM,,CHEMBL331,Cyclin-dependent kinase 4,Homo sapiens,P11802,CHEMBL1143431,"Bioorg. Med. Chem. Lett., 18, p. 5758 (2008)",18835709,Scientific Literature
24,CHEMBL446024,"InChI=1S/C12H9F3N6/c13-12(14,15)7-17-11-16-5-3-9(20-11)8-6-19-21-10(8)2-1-4-18-21/h1-6H,7H2,(H,16,17,20)",FC(F)(F)CNc1nccc(n1)c2cnn3ncccc23,CHEMBL446024,"InChI=1S/C12H9F3N6/c13-12(14,15)7-17-11-16-5-3-9(20-11)8-6-19-21-10(8)2-1-4-18-21/h1-6H,7H2,(H,16,17,20)",FC(F)(F)CNc1nccc(n1)c2cnn3ncccc23,CHEMBL1002018,Inhibition of CDK4 by radioactive glutathione plate-binding assay,IC50,=,1000,nM,,CHEMBL331,Cyclin-dependent kinase 4,Homo sapiens,P11802,CHEMBL1143431,"Bioorg. Med. Chem. Lett., 18, p. 5758 (2008)",18835709,Scientific Literature
25,CHEMBL513330,"InChI=1S/C17H13ClN6/c18-13-5-3-12(4-6-13)10-20-17-19-9-7-15(23-17)14-11-22-24-16(14)2-1-8-21-24/h1-9,11H,10H2,(H,19,20,23)",Clc1ccc(CNc2nccc(n2)c3cnn4ncccc34)cc1,CHEMBL513330,"InChI=1S/C17H13ClN6/c18-13-5-3-12(4-6-13)10-20-17-19-9-7-15(23-17)14-11-22-24-16(14)2-1-8-21-24/h1-9,11H,10H2,(H,19,20,23)",Clc1ccc(CNc2nccc(n2)c3cnn4ncccc34)cc1,CHEMBL1002018,Inhibition of CDK4 by radioactive glutathione plate-binding assay,IC50,=,1000,nM,,CHEMBL331,Cyclin-dependent kinase 4,Homo sapiens,P11802,CHEMBL1143431,"Bioorg. Med. Chem. Lett., 18, p. 5758 (2008)",18835709,Scientific Literature
26,CHEMBL524901,"InChI=1S/C17H21N7O/c1-3-16-14(13-21-24(16)20-6-1)15-4-7-19-17(22-15)18-5-2-8-23-9-11-25-12-10-23/h1,3-4,6-7,13H,2,5,8-12H2,(H,18,19,22)",C(CNc1nccc(n1)c2cnn3ncccc23)CN4CCOCC4,CHEMBL524901,"InChI=1S/C17H21N7O/c1-3-16-14(13-21-24(16)20-6-1)15-4-7-19-17(22-15)18-5-2-8-23-9-11-25-12-10-23/h1,3-4,6-7,13H,2,5,8-12H2,(H,18,19,22)",C(CNc1nccc(n1)c2cnn3ncccc23)CN4CCOCC4,CHEMBL1002018,Inhibition of CDK4 by radioactive glutathione plate-binding assay,IC50,=,3200,nM,,CHEMBL331,Cyclin-dependent kinase 4,Homo sapiens,P11802,CHEMBL1143431,"Bioorg. Med. Chem. Lett., 18, p. 5758 (2008)",18835709,Scientific Literature
28,CHEMBL468963,"InChI=1S/C22H21F3N8/c1-31-9-11-32(12-10-31)20-5-4-15(13-17(20)22(23,24)25)29-21-26-8-6-18(30-21)16-14-28-33-19(16)3-2-7-27-33/h2-8,13-14H,9-12H2,1H3,(H,26,29,30)",CN1CCN(CC1)c2ccc(Nc3nccc(n3)c4cnn5ncccc45)cc2C(F)(F)F,CHEMBL468963,"InChI=1S/C22H21F3N8/c1-31-9-11-32(12-10-31)20-5-4-15(13-17(20)22(23,24)25)29-21-26-8-6-18(30-21)16-14-28-33-19(16)3-2-7-27-33/h2-8,13-14H,9-12H2,1H3,(H,26,29,30)",CN1CCN(CC1)c2ccc(Nc3nccc(n3)c4cnn5ncccc45)cc2C(F)(F)F,CHEMBL1002018,Inhibition of CDK4 by radioactive glutathione plate-binding assay,IC50,=,6,nM,,CHEMBL331,Cyclin-dependent kinase 4,Homo sapiens,P11802,CHEMBL1143431,"Bioorg. Med. Chem. Lett., 18, p. 5758 (2008)",18835709,Scientific Literature
33,CHEMBL495696,"InChI=1S/C17H11N7/c18-10-12-3-1-4-13(9-12)22-17-19-8-6-15(23-17)14-11-21-24-16(14)5-2-7-20-24/h1-9,11H,(H,19,22,23)",N#Cc1cccc(Nc2nccc(n2)c3cnn4ncccc34)c1,CHEMBL495696,"InChI=1S/C17H11N7/c18-10-12-3-1-4-13(9-12)22-17-19-8-6-15(23-17)14-11-21-24-16(14)5-2-7-20-24/h1-9,11H,(H,19,22,23)",N#Cc1cccc(Nc2nccc(n2)c3cnn4ncccc34)c1,CHEMBL1002018,Inhibition of CDK4 by radioactive glutathione plate-binding assay,IC50,=,4,nM,,CHEMBL331,Cyclin-dependent kinase 4,Homo sapiens,P11802,CHEMBL1143431,"Bioorg. Med. Chem. Lett., 18, p. 5758 (2008)",18835709,Scientific Literature
37,CHEMBL359963,"InChI=1S/C19H18N6/c1-13(2)14-5-7-15(8-6-14)23-19-20-11-9-17(24-19)16-12-22-25-18(16)4-3-10-21-25/h3-13H,1-2H3,(H,20,23,24)",CC(C)c1ccc(Nc2nccc(n2)c3cnn4ncccc34)cc1,CHEMBL359963,"InChI=1S/C19H18N6/c1-13(2)14-5-7-15(8-6-14)23-19-20-11-9-17(24-19)16-12-22-25-18(16)4-3-10-21-25/h3-13H,1-2H3,(H,20,23,24)",CC(C)c1ccc(Nc2nccc(n2)c3cnn4ncccc34)cc1,CHEMBL1002018,Inhibition of CDK4 by radioactive glutathione plate-binding assay,IC50,=,2000,nM,,CHEMBL331,Cyclin-dependent kinase 4,Homo sapiens,P11802,CHEMBL1143431,"Bioorg. Med. Chem. Lett., 18, p. 5758 (2008)",18835709,Scientific Literature
8,CHEMBL524057,"InChI=1S/C15H16N6/c1-2-11-14(13-4-3-8-17-21(13)20-11)12-7-9-16-15(19-12)18-10-5-6-10/h3-4,7-10H,2,5-6H2,1H3,(H,16,18,19)",CCc1nn2ncccc2c1c3ccnc(NC4CC4)n3,CHEMBL524057,"InChI=1S/C15H16N6/c1-2-11-14(13-4-3-8-17-21(13)20-11)12-7-9-16-15(19-12)18-10-5-6-10/h3-4,7-10H,2,5-6H2,1H3,(H,16,18,19)",CCc1nn2ncccc2c1c3ccnc(NC4CC4)n3,CHEMBL1002018,Inhibition of CDK4 by radioactive glutathione plate-binding assay,IC50,=,2000,nM,,CHEMBL331,Cyclin-dependent kinase 4,Homo sapiens,P11802,CHEMBL1143431,"Bioorg. Med. Chem. Lett., 18, p. 5758 (2008)",18835709,Scientific Literature
20,CHEMBL495771,"InChI=1S/C17H19N7O/c1-2-12(1)20-17-18-6-5-14(21-17)13-11-19-24-15(13)3-4-16(22-24)23-7-9-25-10-8-23/h3-6,11-12H,1-2,7-10H2,(H,18,20,21)",C1CN(CCO1)c2ccc3c(cnn3n2)c4ccnc(NC5CC5)n4,CHEMBL495771,"InChI=1S/C17H19N7O/c1-2-12(1)20-17-18-6-5-14(21-17)13-11-19-24-15(13)3-4-16(22-24)23-7-9-25-10-8-23/h3-6,11-12H,1-2,7-10H2,(H,18,20,21)",C1CN(CCO1)c2ccc3c(cnn3n2)c4ccnc(NC5CC5)n4,CHEMBL1002020,Inhibition of GSK3-beta by scintillation proximity assay,IC50,=,25000,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1143431,"Bioorg. Med. Chem. Lett., 18, p. 5758 (2008)",18835709,Scientific Literature
24,CHEMBL446024,"InChI=1S/C12H9F3N6/c13-12(14,15)7-17-11-16-5-3-9(20-11)8-6-19-21-10(8)2-1-4-18-21/h1-6H,7H2,(H,16,17,20)",FC(F)(F)CNc1nccc(n1)c2cnn3ncccc23,CHEMBL446024,"InChI=1S/C12H9F3N6/c13-12(14,15)7-17-11-16-5-3-9(20-11)8-6-19-21-10(8)2-1-4-18-21/h1-6H,7H2,(H,16,17,20)",FC(F)(F)CNc1nccc(n1)c2cnn3ncccc23,CHEMBL1002020,Inhibition of GSK3-beta by scintillation proximity assay,IC50,>,32000,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1143431,"Bioorg. Med. Chem. Lett., 18, p. 5758 (2008)",18835709,Scientific Literature
25,CHEMBL513330,"InChI=1S/C17H13ClN6/c18-13-5-3-12(4-6-13)10-20-17-19-9-7-15(23-17)14-11-22-24-16(14)2-1-8-21-24/h1-9,11H,10H2,(H,19,20,23)",Clc1ccc(CNc2nccc(n2)c3cnn4ncccc34)cc1,CHEMBL513330,"InChI=1S/C17H13ClN6/c18-13-5-3-12(4-6-13)10-20-17-19-9-7-15(23-17)14-11-22-24-16(14)2-1-8-21-24/h1-9,11H,10H2,(H,19,20,23)",Clc1ccc(CNc2nccc(n2)c3cnn4ncccc34)cc1,CHEMBL1002020,Inhibition of GSK3-beta by scintillation proximity assay,IC50,=,10000,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1143431,"Bioorg. Med. Chem. Lett., 18, p. 5758 (2008)",18835709,Scientific Literature
26,CHEMBL524901,"InChI=1S/C17H21N7O/c1-3-16-14(13-21-24(16)20-6-1)15-4-7-19-17(22-15)18-5-2-8-23-9-11-25-12-10-23/h1,3-4,6-7,13H,2,5,8-12H2,(H,18,19,22)",C(CNc1nccc(n1)c2cnn3ncccc23)CN4CCOCC4,CHEMBL524901,"InChI=1S/C17H21N7O/c1-3-16-14(13-21-24(16)20-6-1)15-4-7-19-17(22-15)18-5-2-8-23-9-11-25-12-10-23/h1,3-4,6-7,13H,2,5,8-12H2,(H,18,19,22)",C(CNc1nccc(n1)c2cnn3ncccc23)CN4CCOCC4,CHEMBL1002020,Inhibition of GSK3-beta by scintillation proximity assay,IC50,=,32000,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1143431,"Bioorg. Med. Chem. Lett., 18, p. 5758 (2008)",18835709,Scientific Literature
28,CHEMBL468963,"InChI=1S/C22H21F3N8/c1-31-9-11-32(12-10-31)20-5-4-15(13-17(20)22(23,24)25)29-21-26-8-6-18(30-21)16-14-28-33-19(16)3-2-7-27-33/h2-8,13-14H,9-12H2,1H3,(H,26,29,30)",CN1CCN(CC1)c2ccc(Nc3nccc(n3)c4cnn5ncccc45)cc2C(F)(F)F,CHEMBL468963,"InChI=1S/C22H21F3N8/c1-31-9-11-32(12-10-31)20-5-4-15(13-17(20)22(23,24)25)29-21-26-8-6-18(30-21)16-14-28-33-19(16)3-2-7-27-33/h2-8,13-14H,9-12H2,1H3,(H,26,29,30)",CN1CCN(CC1)c2ccc(Nc3nccc(n3)c4cnn5ncccc45)cc2C(F)(F)F,CHEMBL1002020,Inhibition of GSK3-beta by scintillation proximity assay,IC50,=,16,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1143431,"Bioorg. Med. Chem. Lett., 18, p. 5758 (2008)",18835709,Scientific Literature
33,CHEMBL495696,"InChI=1S/C17H11N7/c18-10-12-3-1-4-13(9-12)22-17-19-8-6-15(23-17)14-11-21-24-16(14)5-2-7-20-24/h1-9,11H,(H,19,22,23)",N#Cc1cccc(Nc2nccc(n2)c3cnn4ncccc34)c1,CHEMBL495696,"InChI=1S/C17H11N7/c18-10-12-3-1-4-13(9-12)22-17-19-8-6-15(23-17)14-11-21-24-16(14)5-2-7-20-24/h1-9,11H,(H,19,22,23)",N#Cc1cccc(Nc2nccc(n2)c3cnn4ncccc34)c1,CHEMBL1002020,Inhibition of GSK3-beta by scintillation proximity assay,IC50,=,10,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1143431,"Bioorg. Med. Chem. Lett., 18, p. 5758 (2008)",18835709,Scientific Literature
37,CHEMBL359963,"InChI=1S/C19H18N6/c1-13(2)14-5-7-15(8-6-14)23-19-20-11-9-17(24-19)16-12-22-25-18(16)4-3-10-21-25/h3-13H,1-2H3,(H,20,23,24)",CC(C)c1ccc(Nc2nccc(n2)c3cnn4ncccc34)cc1,CHEMBL359963,"InChI=1S/C19H18N6/c1-13(2)14-5-7-15(8-6-14)23-19-20-11-9-17(24-19)16-12-22-25-18(16)4-3-10-21-25/h3-13H,1-2H3,(H,20,23,24)",CC(C)c1ccc(Nc2nccc(n2)c3cnn4ncccc34)cc1,CHEMBL1002020,Inhibition of GSK3-beta by scintillation proximity assay,IC50,=,16,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1143431,"Bioorg. Med. Chem. Lett., 18, p. 5758 (2008)",18835709,Scientific Literature
8,CHEMBL524057,"InChI=1S/C15H16N6/c1-2-11-14(13-4-3-8-17-21(13)20-11)12-7-9-16-15(19-12)18-10-5-6-10/h3-4,7-10H,2,5-6H2,1H3,(H,16,18,19)",CCc1nn2ncccc2c1c3ccnc(NC4CC4)n3,CHEMBL524057,"InChI=1S/C15H16N6/c1-2-11-14(13-4-3-8-17-21(13)20-11)12-7-9-16-15(19-12)18-10-5-6-10/h3-4,7-10H,2,5-6H2,1H3,(H,16,18,19)",CCc1nn2ncccc2c1c3ccnc(NC4CC4)n3,CHEMBL1002019,Inhibition of VEGFR2 by HTRF assay,IC50,=,3200,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1143431,"Bioorg. Med. Chem. Lett., 18, p. 5758 (2008)",18835709,Scientific Literature
24,CHEMBL446024,"InChI=1S/C12H9F3N6/c13-12(14,15)7-17-11-16-5-3-9(20-11)8-6-19-21-10(8)2-1-4-18-21/h1-6H,7H2,(H,16,17,20)",FC(F)(F)CNc1nccc(n1)c2cnn3ncccc23,CHEMBL446024,"InChI=1S/C12H9F3N6/c13-12(14,15)7-17-11-16-5-3-9(20-11)8-6-19-21-10(8)2-1-4-18-21/h1-6H,7H2,(H,16,17,20)",FC(F)(F)CNc1nccc(n1)c2cnn3ncccc23,CHEMBL1002021,Inhibition of human CDK2 by HTRF assay,IC50,=,1000,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1143431,"Bioorg. Med. Chem. Lett., 18, p. 5758 (2008)",18835709,Scientific Literature
25,CHEMBL513330,"InChI=1S/C17H13ClN6/c18-13-5-3-12(4-6-13)10-20-17-19-9-7-15(23-17)14-11-22-24-16(14)2-1-8-21-24/h1-9,11H,10H2,(H,19,20,23)",Clc1ccc(CNc2nccc(n2)c3cnn4ncccc34)cc1,CHEMBL513330,"InChI=1S/C17H13ClN6/c18-13-5-3-12(4-6-13)10-20-17-19-9-7-15(23-17)14-11-22-24-16(14)2-1-8-21-24/h1-9,11H,10H2,(H,19,20,23)",Clc1ccc(CNc2nccc(n2)c3cnn4ncccc34)cc1,CHEMBL1002021,Inhibition of human CDK2 by HTRF assay,IC50,=,1000,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1143431,"Bioorg. Med. Chem. Lett., 18, p. 5758 (2008)",18835709,Scientific Literature
28,CHEMBL468963,"InChI=1S/C22H21F3N8/c1-31-9-11-32(12-10-31)20-5-4-15(13-17(20)22(23,24)25)29-21-26-8-6-18(30-21)16-14-28-33-19(16)3-2-7-27-33/h2-8,13-14H,9-12H2,1H3,(H,26,29,30)",CN1CCN(CC1)c2ccc(Nc3nccc(n3)c4cnn5ncccc45)cc2C(F)(F)F,CHEMBL468963,"InChI=1S/C22H21F3N8/c1-31-9-11-32(12-10-31)20-5-4-15(13-17(20)22(23,24)25)29-21-26-8-6-18(30-21)16-14-28-33-19(16)3-2-7-27-33/h2-8,13-14H,9-12H2,1H3,(H,26,29,30)",CN1CCN(CC1)c2ccc(Nc3nccc(n3)c4cnn5ncccc45)cc2C(F)(F)F,CHEMBL1002021,Inhibition of human CDK2 by HTRF assay,IC50,=,4,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1143431,"Bioorg. Med. Chem. Lett., 18, p. 5758 (2008)",18835709,Scientific Literature
33,CHEMBL495696,"InChI=1S/C17H11N7/c18-10-12-3-1-4-13(9-12)22-17-19-8-6-15(23-17)14-11-21-24-16(14)5-2-7-20-24/h1-9,11H,(H,19,22,23)",N#Cc1cccc(Nc2nccc(n2)c3cnn4ncccc34)c1,CHEMBL495696,"InChI=1S/C17H11N7/c18-10-12-3-1-4-13(9-12)22-17-19-8-6-15(23-17)14-11-21-24-16(14)5-2-7-20-24/h1-9,11H,(H,19,22,23)",N#Cc1cccc(Nc2nccc(n2)c3cnn4ncccc34)c1,CHEMBL1002021,Inhibition of human CDK2 by HTRF assay,IC50,=,2,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1143431,"Bioorg. Med. Chem. Lett., 18, p. 5758 (2008)",18835709,Scientific Literature
37,CHEMBL359963,"InChI=1S/C19H18N6/c1-13(2)14-5-7-15(8-6-14)23-19-20-11-9-17(24-19)16-12-22-25-18(16)4-3-10-21-25/h3-13H,1-2H3,(H,20,23,24)",CC(C)c1ccc(Nc2nccc(n2)c3cnn4ncccc34)cc1,CHEMBL359963,"InChI=1S/C19H18N6/c1-13(2)14-5-7-15(8-6-14)23-19-20-11-9-17(24-19)16-12-22-25-18(16)4-3-10-21-25/h3-13H,1-2H3,(H,20,23,24)",CC(C)c1ccc(Nc2nccc(n2)c3cnn4ncccc34)cc1,CHEMBL1002021,Inhibition of human CDK2 by HTRF assay,IC50,=,40,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1143431,"Bioorg. Med. Chem. Lett., 18, p. 5758 (2008)",18835709,Scientific Literature
15g,CHEMBL512076,"InChI=1S/C28H25ClFN5O3S/c1-2-31-28(36)38-21-11-19(32-14-21)6-8-22-13-24-26(39-22)27(34-16-33-24)35-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,32H,2,11,14-15H2,1H3,(H,31,36)(H,33,34,35)/t19-,21-/m1/s1",CCNC(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL512076,"InChI=1S/C28H25ClFN5O3S/c1-2-31-28(36)38-21-11-19(32-14-21)6-8-22-13-24-26(39-22)27(34-16-33-24)35-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,32H,2,11,14-15H2,1H3,(H,31,36)(H,33,34,35)/t19-,21-/m1/s1",CCNC(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL950401,Antiproliferative activity against human BT474 cells overexpressing ErbB2 after 3 days by methylene blue staining,IC50,=,30,nM,,CHEMBL612545,,,,CHEMBL1143444,"Bioorg. Med. Chem. Lett., 18, p. 5738 (2008)",18842405,Scientific Literature
15h,CHEMBL517123,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m1/s1",CN(C)C(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL517123,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m1/s1",CN(C)C(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL950401,Antiproliferative activity against human BT474 cells overexpressing ErbB2 after 3 days by methylene blue staining,IC50,=,30,nM,,CHEMBL612545,,,,CHEMBL1143444,"Bioorg. Med. Chem. Lett., 18, p. 5738 (2008)",18842405,Scientific Literature
15i,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL950401,Antiproliferative activity against human BT474 cells overexpressing ErbB2 after 3 days by methylene blue staining,IC50,=,30,nM,,CHEMBL612545,,,,CHEMBL1143444,"Bioorg. Med. Chem. Lett., 18, p. 5738 (2008)",18842405,Scientific Literature
15g,CHEMBL512076,"InChI=1S/C28H25ClFN5O3S/c1-2-31-28(36)38-21-11-19(32-14-21)6-8-22-13-24-26(39-22)27(34-16-33-24)35-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,32H,2,11,14-15H2,1H3,(H,31,36)(H,33,34,35)/t19-,21-/m1/s1",CCNC(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL512076,"InChI=1S/C28H25ClFN5O3S/c1-2-31-28(36)38-21-11-19(32-14-21)6-8-22-13-24-26(39-22)27(34-16-33-24)35-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,32H,2,11,14-15H2,1H3,(H,31,36)(H,33,34,35)/t19-,21-/m1/s1",CCNC(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL950400,Antiproliferative activity against human HN5 cells overexpressing EGFR after 3 days by methylene blue staining,IC50,=,95,nM,,CHEMBL614828,HN5 (Squamous cell carcinoma),Homo sapiens,,CHEMBL1143444,"Bioorg. Med. Chem. Lett., 18, p. 5738 (2008)",18842405,Scientific Literature
15h,CHEMBL517123,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m1/s1",CN(C)C(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL517123,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m1/s1",CN(C)C(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL950400,Antiproliferative activity against human HN5 cells overexpressing EGFR after 3 days by methylene blue staining,IC50,=,100,nM,,CHEMBL614828,HN5 (Squamous cell carcinoma),Homo sapiens,,CHEMBL1143444,"Bioorg. Med. Chem. Lett., 18, p. 5738 (2008)",18842405,Scientific Literature
15i,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL950400,Antiproliferative activity against human HN5 cells overexpressing EGFR after 3 days by methylene blue staining,IC50,=,160,nM,,CHEMBL614828,HN5 (Squamous cell carcinoma),Homo sapiens,,CHEMBL1143444,"Bioorg. Med. Chem. Lett., 18, p. 5738 (2008)",18842405,Scientific Literature
15g,CHEMBL512076,"InChI=1S/C28H25ClFN5O3S/c1-2-31-28(36)38-21-11-19(32-14-21)6-8-22-13-24-26(39-22)27(34-16-33-24)35-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,32H,2,11,14-15H2,1H3,(H,31,36)(H,33,34,35)/t19-,21-/m1/s1",CCNC(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL512076,"InChI=1S/C28H25ClFN5O3S/c1-2-31-28(36)38-21-11-19(32-14-21)6-8-22-13-24-26(39-22)27(34-16-33-24)35-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,32H,2,11,14-15H2,1H3,(H,31,36)(H,33,34,35)/t19-,21-/m1/s1",CCNC(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL950404,Antiproliferative activity against human foreskin fibroblast after 3 days by methylene blue staining,IC50,>,1000,nM,,CHEMBL612558,,,,CHEMBL1143444,"Bioorg. Med. Chem. Lett., 18, p. 5738 (2008)",18842405,Scientific Literature
15h,CHEMBL517123,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m1/s1",CN(C)C(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL517123,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m1/s1",CN(C)C(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL950404,Antiproliferative activity against human foreskin fibroblast after 3 days by methylene blue staining,IC50,>,1000,nM,,CHEMBL612558,,,,CHEMBL1143444,"Bioorg. Med. Chem. Lett., 18, p. 5738 (2008)",18842405,Scientific Literature
15i,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL950404,Antiproliferative activity against human foreskin fibroblast after 3 days by methylene blue staining,IC50,>,1000,nM,,CHEMBL612558,,,,CHEMBL1143444,"Bioorg. Med. Chem. Lett., 18, p. 5738 (2008)",18842405,Scientific Literature
15g,CHEMBL512076,"InChI=1S/C28H25ClFN5O3S/c1-2-31-28(36)38-21-11-19(32-14-21)6-8-22-13-24-26(39-22)27(34-16-33-24)35-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,32H,2,11,14-15H2,1H3,(H,31,36)(H,33,34,35)/t19-,21-/m1/s1",CCNC(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL512076,"InChI=1S/C28H25ClFN5O3S/c1-2-31-28(36)38-21-11-19(32-14-21)6-8-22-13-24-26(39-22)27(34-16-33-24)35-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,32H,2,11,14-15H2,1H3,(H,31,36)(H,33,34,35)/t19-,21-/m1/s1",CCNC(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL950403,Dose normalized AUC in po dosed mouse,AUC,=,93,ng hr kg mg-1 ml-1,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1143444,"Bioorg. Med. Chem. Lett., 18, p. 5738 (2008)",18842405,Scientific Literature
15g,CHEMBL512076,"InChI=1S/C28H25ClFN5O3S/c1-2-31-28(36)38-21-11-19(32-14-21)6-8-22-13-24-26(39-22)27(34-16-33-24)35-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,32H,2,11,14-15H2,1H3,(H,31,36)(H,33,34,35)/t19-,21-/m1/s1",CCNC(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL512076,"InChI=1S/C28H25ClFN5O3S/c1-2-31-28(36)38-21-11-19(32-14-21)6-8-22-13-24-26(39-22)27(34-16-33-24)35-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,32H,2,11,14-15H2,1H3,(H,31,36)(H,33,34,35)/t19-,21-/m1/s1",CCNC(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL950402,Induction of EGFR covalent modification after 3 hrs,Activity,=,24,%,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1143444,"Bioorg. Med. Chem. Lett., 18, p. 5738 (2008)",18842405,Scientific Literature
15h,CHEMBL517123,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m1/s1",CN(C)C(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL517123,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m1/s1",CN(C)C(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL950402,Induction of EGFR covalent modification after 3 hrs,Activity,=,11,%,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1143444,"Bioorg. Med. Chem. Lett., 18, p. 5738 (2008)",18842405,Scientific Literature
15i,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL950402,Induction of EGFR covalent modification after 3 hrs,Activity,=,5,%,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1143444,"Bioorg. Med. Chem. Lett., 18, p. 5738 (2008)",18842405,Scientific Literature
15g,CHEMBL512076,"InChI=1S/C28H25ClFN5O3S/c1-2-31-28(36)38-21-11-19(32-14-21)6-8-22-13-24-26(39-22)27(34-16-33-24)35-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,32H,2,11,14-15H2,1H3,(H,31,36)(H,33,34,35)/t19-,21-/m1/s1",CCNC(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL512076,"InChI=1S/C28H25ClFN5O3S/c1-2-31-28(36)38-21-11-19(32-14-21)6-8-22-13-24-26(39-22)27(34-16-33-24)35-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,32H,2,11,14-15H2,1H3,(H,31,36)(H,33,34,35)/t19-,21-/m1/s1",CCNC(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL995846,Inhibition of EGFR kinase,IC50,=,32,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1143444,"Bioorg. Med. Chem. Lett., 18, p. 5738 (2008)",18842405,Scientific Literature
15h,CHEMBL517123,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m1/s1",CN(C)C(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL517123,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m1/s1",CN(C)C(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL995846,Inhibition of EGFR kinase,IC50,=,28,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1143444,"Bioorg. Med. Chem. Lett., 18, p. 5738 (2008)",18842405,Scientific Literature
15i,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL995846,Inhibition of EGFR kinase,IC50,=,65,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1143444,"Bioorg. Med. Chem. Lett., 18, p. 5738 (2008)",18842405,Scientific Literature
15g,CHEMBL512076,"InChI=1S/C28H25ClFN5O3S/c1-2-31-28(36)38-21-11-19(32-14-21)6-8-22-13-24-26(39-22)27(34-16-33-24)35-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,32H,2,11,14-15H2,1H3,(H,31,36)(H,33,34,35)/t19-,21-/m1/s1",CCNC(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL512076,"InChI=1S/C28H25ClFN5O3S/c1-2-31-28(36)38-21-11-19(32-14-21)6-8-22-13-24-26(39-22)27(34-16-33-24)35-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,32H,2,11,14-15H2,1H3,(H,31,36)(H,33,34,35)/t19-,21-/m1/s1",CCNC(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL950399,Inhibition of ErbB2 kinase,IC50,=,43,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1143444,"Bioorg. Med. Chem. Lett., 18, p. 5738 (2008)",18842405,Scientific Literature
15h,CHEMBL517123,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m1/s1",CN(C)C(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL517123,"InChI=1S/C28H25ClFN5O3S/c1-35(2)28(36)38-21-11-19(31-14-21)6-8-22-13-24-26(39-22)27(33-16-32-24)34-20-7-9-25(23(29)12-20)37-15-17-4-3-5-18(30)10-17/h3-5,7,9-10,12-13,16,19,21,31H,11,14-15H2,1-2H3,(H,32,33,34)/t19-,21-/m1/s1",CN(C)C(=O)O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2,CHEMBL950399,Inhibition of ErbB2 kinase,IC50,=,68,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1143444,"Bioorg. Med. Chem. Lett., 18, p. 5738 (2008)",18842405,Scientific Literature
15i,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL950399,Inhibition of ErbB2 kinase,IC50,=,84,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1143444,"Bioorg. Med. Chem. Lett., 18, p. 5738 (2008)",18842405,Scientific Literature
7k,CHEMBL194911,"InChI=1S/C27H19F4N5O3/c1-38-18-9-4-15(5-10-18)23-21(22-24(32)33-13-34-25(22)39-23)14-2-7-17(8-3-14)35-26(37)36-20-12-16(27(29,30)31)6-11-19(20)28/h2-13H,1H3,(H2,32,33,34)(H2,35,36,37)",COc1ccc(cc1)c2oc3ncnc(N)c3c2c4ccc(NC(=O)Nc5cc(ccc5F)C(F)(F)F)cc4,CHEMBL194911,"InChI=1S/C27H19F4N5O3/c1-38-18-9-4-15(5-10-18)23-21(22-24(32)33-13-34-25(22)39-23)14-2-7-17(8-3-14)35-26(37)36-20-12-16(27(29,30)31)6-11-19(20)28/h2-13H,1H3,(H2,32,33,34)(H2,35,36,37)",COc1ccc(cc1)c2oc3ncnc(N)c3c2c4ccc(NC(=O)Nc5cc(ccc5F)C(F)(F)F)cc4,CHEMBL833951,Concentration required for growth inhibition of human umbilical vein endothelial cells stimulated by VEGF,IC50,=,45,nM,,CHEMBL613979,HUVEC (Umbilical vein endothelial cells),Homo sapiens,,CHEMBL1143549,"Bioorg. Med. Chem. Lett., 15, p. 2203 (2005)",15837294,Scientific Literature
7k,CHEMBL194911,"InChI=1S/C27H19F4N5O3/c1-38-18-9-4-15(5-10-18)23-21(22-24(32)33-13-34-25(22)39-23)14-2-7-17(8-3-14)35-26(37)36-20-12-16(27(29,30)31)6-11-19(20)28/h2-13H,1H3,(H2,32,33,34)(H2,35,36,37)",COc1ccc(cc1)c2oc3ncnc(N)c3c2c4ccc(NC(=O)Nc5cc(ccc5F)C(F)(F)F)cc4,CHEMBL194911,"InChI=1S/C27H19F4N5O3/c1-38-18-9-4-15(5-10-18)23-21(22-24(32)33-13-34-25(22)39-23)14-2-7-17(8-3-14)35-26(37)36-20-12-16(27(29,30)31)6-11-19(20)28/h2-13H,1H3,(H2,32,33,34)(H2,35,36,37)",COc1ccc(cc1)c2oc3ncnc(N)c3c2c4ccc(NC(=O)Nc5cc(ccc5F)C(F)(F)F)cc4,CHEMBL833924,Cytotoxic concentration against HFF cells was determined,IC50,=,790.0,nM,,CHEMBL614071,HFF (Foreskin fibroblasts),Homo sapiens,,CHEMBL1143549,"Bioorg. Med. Chem. Lett., 15, p. 2203 (2005)",15837294,Scientific Literature
10a,CHEMBL373073,"InChI=1S/C13H11N3O2/c1-17-9-4-2-8(3-5-9)11-6-10-12(14)15-7-16-13(10)18-11/h2-7H,1H3,(H2,14,15,16)",COc1ccc(cc1)c2oc3ncnc(N)c3c2,CHEMBL373073,"InChI=1S/C13H11N3O2/c1-17-9-4-2-8(3-5-9)11-6-10-12(14)15-7-16-13(10)18-11/h2-7H,1H3,(H2,14,15,16)",COc1ccc(cc1)c2oc3ncnc(N)c3c2,CHEMBL828663,Inhibitory concentration against human tyrosine protein kinase receptor TIE-2,IC50,>,20000,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1143549,"Bioorg. Med. Chem. Lett., 15, p. 2203 (2005)",15837294,Scientific Literature
5a,CHEMBL196022,"InChI=1S/C13H11N3O2/c1-17-9-4-2-8(3-5-9)10-6-18-13-11(10)12(14)15-7-16-13/h2-7H,1H3,(H2,14,15,16)",COc1ccc(cc1)c2coc3ncnc(N)c23,CHEMBL196022,"InChI=1S/C13H11N3O2/c1-17-9-4-2-8(3-5-9)10-6-18-13-11(10)12(14)15-7-16-13/h2-7H,1H3,(H2,14,15,16)",COc1ccc(cc1)c2coc3ncnc(N)c23,CHEMBL828663,Inhibitory concentration against human tyrosine protein kinase receptor TIE-2,IC50,>,20000,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1143549,"Bioorg. Med. Chem. Lett., 15, p. 2203 (2005)",15837294,Scientific Literature
7k,CHEMBL194911,"InChI=1S/C27H19F4N5O3/c1-38-18-9-4-15(5-10-18)23-21(22-24(32)33-13-34-25(22)39-23)14-2-7-17(8-3-14)35-26(37)36-20-12-16(27(29,30)31)6-11-19(20)28/h2-13H,1H3,(H2,32,33,34)(H2,35,36,37)",COc1ccc(cc1)c2oc3ncnc(N)c3c2c4ccc(NC(=O)Nc5cc(ccc5F)C(F)(F)F)cc4,CHEMBL194911,"InChI=1S/C27H19F4N5O3/c1-38-18-9-4-15(5-10-18)23-21(22-24(32)33-13-34-25(22)39-23)14-2-7-17(8-3-14)35-26(37)36-20-12-16(27(29,30)31)6-11-19(20)28/h2-13H,1H3,(H2,32,33,34)(H2,35,36,37)",COc1ccc(cc1)c2oc3ncnc(N)c3c2c4ccc(NC(=O)Nc5cc(ccc5F)C(F)(F)F)cc4,CHEMBL828663,Inhibitory concentration against human tyrosine protein kinase receptor TIE-2,IC50,=,2,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1143549,"Bioorg. Med. Chem. Lett., 15, p. 2203 (2005)",15837294,Scientific Literature
10a,CHEMBL373073,"InChI=1S/C13H11N3O2/c1-17-9-4-2-8(3-5-9)11-6-10-12(14)15-7-16-13(10)18-11/h2-7H,1H3,(H2,14,15,16)",COc1ccc(cc1)c2oc3ncnc(N)c3c2,CHEMBL373073,"InChI=1S/C13H11N3O2/c1-17-9-4-2-8(3-5-9)11-6-10-12(14)15-7-16-13(10)18-11/h2-7H,1H3,(H2,14,15,16)",COc1ccc(cc1)c2oc3ncnc(N)c3c2,CHEMBL829593,Inhibitory concentration against human vascular endothelial growth factor receptor 2,IC50,>,17000,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1143549,"Bioorg. Med. Chem. Lett., 15, p. 2203 (2005)",15837294,Scientific Literature
5a,CHEMBL196022,"InChI=1S/C13H11N3O2/c1-17-9-4-2-8(3-5-9)10-6-18-13-11(10)12(14)15-7-16-13/h2-7H,1H3,(H2,14,15,16)",COc1ccc(cc1)c2coc3ncnc(N)c23,CHEMBL196022,"InChI=1S/C13H11N3O2/c1-17-9-4-2-8(3-5-9)10-6-18-13-11(10)12(14)15-7-16-13/h2-7H,1H3,(H2,14,15,16)",COc1ccc(cc1)c2coc3ncnc(N)c23,CHEMBL829593,Inhibitory concentration against human vascular endothelial growth factor receptor 2,IC50,=,5500,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1143549,"Bioorg. Med. Chem. Lett., 15, p. 2203 (2005)",15837294,Scientific Literature
7k,CHEMBL194911,"InChI=1S/C27H19F4N5O3/c1-38-18-9-4-15(5-10-18)23-21(22-24(32)33-13-34-25(22)39-23)14-2-7-17(8-3-14)35-26(37)36-20-12-16(27(29,30)31)6-11-19(20)28/h2-13H,1H3,(H2,32,33,34)(H2,35,36,37)",COc1ccc(cc1)c2oc3ncnc(N)c3c2c4ccc(NC(=O)Nc5cc(ccc5F)C(F)(F)F)cc4,CHEMBL194911,"InChI=1S/C27H19F4N5O3/c1-38-18-9-4-15(5-10-18)23-21(22-24(32)33-13-34-25(22)39-23)14-2-7-17(8-3-14)35-26(37)36-20-12-16(27(29,30)31)6-11-19(20)28/h2-13H,1H3,(H2,32,33,34)(H2,35,36,37)",COc1ccc(cc1)c2oc3ncnc(N)c3c2c4ccc(NC(=O)Nc5cc(ccc5F)C(F)(F)F)cc4,CHEMBL829593,Inhibitory concentration against human vascular endothelial growth factor receptor 2,IC50,=,3,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1143549,"Bioorg. Med. Chem. Lett., 15, p. 2203 (2005)",15837294,Scientific Literature
11,CHEMBL374680,"InChI=1S/C21H18N6/c1-14-9-17(20-5-3-4-8-23-20)10-15(2)19(14)7-6-16-11-18(13-22-12-16)21-24-26-27-25-21/h3-13H,1-2H3,(H,24,25,26,27)/b7-6+",Cc1cc(cc(C)c1\C=C\c2cncc(c2)c3nn[nH]n3)c4ccccn4,CHEMBL374680,"InChI=1S/C21H18N6/c1-14-9-17(20-5-3-4-8-23-20)10-15(2)19(14)7-6-16-11-18(13-22-12-16)21-24-26-27-25-21/h3-13H,1-2H3,(H,24,25,26,27)/b7-6+",Cc1cc(cc(C)c1\C=C\c2cncc(c2)c3nn[nH]n3)c4ccccn4,CHEMBL951323,Inhibition of Raf1 kinase,IC50,=,100,nM,,CHEMBL1906,Serine/threonine-protein kinase RAF,Homo sapiens,P04049,CHEMBL1143922,"Bioorg. Med. Chem. Lett., 18, p. 2346 (2008)",18346893,Scientific Literature
13,CHEMBL218859,"InChI=1S/C17H18N2O/c1-12-5-4-6-13(2)16(12)8-7-14-9-15(11-19-10-14)17(20)18-3/h4-11H,1-3H3,(H,18,20)/b8-7+",CNC(=O)c1cncc(\C=C\c2c(C)cccc2C)c1,CHEMBL218859,"InChI=1S/C17H18N2O/c1-12-5-4-6-13(2)16(12)8-7-14-9-15(11-19-10-14)17(20)18-3/h4-11H,1-3H3,(H,18,20)/b8-7+",CNC(=O)c1cncc(\C=C\c2c(C)cccc2C)c1,CHEMBL951323,Inhibition of Raf1 kinase,IC50,=,250,nM,,CHEMBL1906,Serine/threonine-protein kinase RAF,Homo sapiens,P04049,CHEMBL1143922,"Bioorg. Med. Chem. Lett., 18, p. 2346 (2008)",18346893,Scientific Literature
27,CHEMBL218932,"InChI=1S/C19H21N3O3/c1-12-7-16(25-19(24)21-4)8-13(2)17(12)6-5-14-9-15(11-22-10-14)18(23)20-3/h5-11H,1-4H3,(H,20,23)(H,21,24)/b6-5+",CNC(=O)Oc1cc(C)c(\C=C\c2cncc(c2)C(=O)NC)c(C)c1,CHEMBL218932,"InChI=1S/C19H21N3O3/c1-12-7-16(25-19(24)21-4)8-13(2)17(12)6-5-14-9-15(11-22-10-14)18(23)20-3/h5-11H,1-4H3,(H,20,23)(H,21,24)/b6-5+",CNC(=O)Oc1cc(C)c(\C=C\c2cncc(c2)C(=O)NC)c(C)c1,CHEMBL951323,Inhibition of Raf1 kinase,IC50,=,10,nM,,CHEMBL1906,Serine/threonine-protein kinase RAF,Homo sapiens,P04049,CHEMBL1143922,"Bioorg. Med. Chem. Lett., 18, p. 2346 (2008)",18346893,Scientific Literature
28,CHEMBL304624,"InChI=1S/C20H15N3O/c24-17-8-4-7-16(13-17)19-18(14-9-11-21-12-10-14)22-20(23-19)15-5-2-1-3-6-15/h1-13,24H,(H,22,23)",Oc1cccc(c1)c2nc([nH]c2c3ccncc3)c4ccccc4,CHEMBL304624,"InChI=1S/C20H15N3O/c24-17-8-4-7-16(13-17)19-18(14-9-11-21-12-10-14)22-20(23-19)15-5-2-1-3-6-15/h1-13,24H,(H,22,23)",Oc1cccc(c1)c2nc([nH]c2c3ccncc3)c4ccccc4,CHEMBL951323,Inhibition of Raf1 kinase,IC50,=,23,nM,,CHEMBL1906,Serine/threonine-protein kinase RAF,Homo sapiens,P04049,CHEMBL1143922,"Bioorg. Med. Chem. Lett., 18, p. 2346 (2008)",18346893,Scientific Literature
32,CHEMBL218088,"InChI=1S/C16H16N2O2/c1-10-5-14(19)6-11(2)15(10)4-3-12-7-13(16(17)20)9-18-8-12/h3-9,19H,1-2H3,(H2,17,20)/b4-3+",Cc1cc(O)cc(C)c1\C=C\c2cncc(c2)C(=O)N,CHEMBL218088,"InChI=1S/C16H16N2O2/c1-10-5-14(19)6-11(2)15(10)4-3-12-7-13(16(17)20)9-18-8-12/h3-9,19H,1-2H3,(H2,17,20)/b4-3+",Cc1cc(O)cc(C)c1\C=C\c2cncc(c2)C(=O)N,CHEMBL951323,Inhibition of Raf1 kinase,IC50,=,158,nM,,CHEMBL1906,Serine/threonine-protein kinase RAF,Homo sapiens,P04049,CHEMBL1143922,"Bioorg. Med. Chem. Lett., 18, p. 2346 (2008)",18346893,Scientific Literature
33,CHEMBL263796,"InChI=1S/C15H12Cl2N2O/c1-18-15(20)11-7-10(8-19-9-11)5-6-12-13(16)3-2-4-14(12)17/h2-9H,1H3,(H,18,20)/b6-5+",CNC(=O)c1cncc(\C=C\c2c(Cl)cccc2Cl)c1,CHEMBL263796,"InChI=1S/C15H12Cl2N2O/c1-18-15(20)11-7-10(8-19-9-11)5-6-12-13(16)3-2-4-14(12)17/h2-9H,1H3,(H,18,20)/b6-5+",CNC(=O)c1cncc(\C=C\c2c(Cl)cccc2Cl)c1,CHEMBL951323,Inhibition of Raf1 kinase,IC50,=,251,nM,,CHEMBL1906,Serine/threonine-protein kinase RAF,Homo sapiens,P04049,CHEMBL1143922,"Bioorg. Med. Chem. Lett., 18, p. 2346 (2008)",18346893,Scientific Literature
9,CHEMBL1789963,"InChI=1S/C20H11Cl2NO4/c21-14-7-10(8-15(22)19(14)25)6-13-12-9-11(3-4-16(12)23-20(13)26)18(24)17-2-1-5-27-17/h1-9,25H,(H,23,26)",Oc1c(Cl)cc(C=C2C(=O)Nc3ccc(cc23)C(=O)c4occc4)cc1Cl,CHEMBL1789963,"InChI=1S/C20H11Cl2NO4/c21-14-7-10(8-15(22)19(14)25)6-13-12-9-11(3-4-16(12)23-20(13)26)18(24)17-2-1-5-27-17/h1-9,25H,(H,23,26)",Oc1c(Cl)cc(C=C2C(=O)Nc3ccc(cc23)C(=O)c4occc4)cc1Cl,CHEMBL951323,Inhibition of Raf1 kinase,IC50,=,46,nM,,CHEMBL1906,Serine/threonine-protein kinase RAF,Homo sapiens,P04049,CHEMBL1143922,"Bioorg. Med. Chem. Lett., 18, p. 2346 (2008)",18346893,Scientific Literature
SKF-86002,CHEMBL313417,"InChI=1S/C16H12FN3S/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14/h1-8H,9-10H2",Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL313417,"InChI=1S/C16H12FN3S/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14/h1-8H,9-10H2",Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL732624,In vitro inhibitory concentration against Mitogen-activated protein kinase p38 alpha,IC50,=,400,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1145138,"J. Med. Chem., 46, p. 4702 (2003)",14561090,Scientific Literature
11a,CHEMBL231013,"InChI=1S/C13H12N2O2/c1-17-12-3-2-10(8-11(12)13(14)16)9-4-6-15-7-5-9/h2-8H,1H3,(H2,14,16)",COc1ccc(cc1C(=O)N)c2ccncc2,CHEMBL231013,"InChI=1S/C13H12N2O2/c1-17-12-3-2-10(8-11(12)13(14)16)9-4-6-15-7-5-9/h2-8H,1H3,(H2,14,16)",COc1ccc(cc1C(=O)N)c2ccncc2,CHEMBL889184,Inhibition of human recombinant FLAG-IKKepsilon by TR-FRET assay,pIC50,,,,Not Determined,CHEMBL3529,Inhibitor of nuclear factor kappa B kinase epsilon subunit,Homo sapiens,Q14164,CHEMBL1145369,"Bioorg. Med. Chem. Lett., 17, p. 3972 (2007)",17502144,Scientific Literature
11c,CHEMBL268885,"InChI=1S/C20H17ClN2O4S/c1-27-19-17(13-4-8-16(9-5-13)28(23,25)26)10-14(11-18(19)20(22)24)12-2-6-15(21)7-3-12/h2-11H,1H3,(H2,22,24)(H2,23,25,26)",COc1c(cc(cc1c2ccc(cc2)S(=O)(=O)N)c3ccc(Cl)cc3)C(=O)N,CHEMBL268885,"InChI=1S/C20H17ClN2O4S/c1-27-19-17(13-4-8-16(9-5-13)28(23,25)26)10-14(11-18(19)20(22)24)12-2-6-15(21)7-3-12/h2-11H,1H3,(H2,22,24)(H2,23,25,26)",COc1c(cc(cc1c2ccc(cc2)S(=O)(=O)N)c3ccc(Cl)cc3)C(=O)N,CHEMBL889184,Inhibition of human recombinant FLAG-IKKepsilon by TR-FRET assay,pIC50,,,,Not Determined,CHEMBL3529,Inhibitor of nuclear factor kappa B kinase epsilon subunit,Homo sapiens,Q14164,CHEMBL1145369,"Bioorg. Med. Chem. Lett., 17, p. 3972 (2007)",17502144,Scientific Literature
4,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL889184,Inhibition of human recombinant FLAG-IKKepsilon by TR-FRET assay,pIC50,=,7.4,,,CHEMBL3529,Inhibitor of nuclear factor kappa B kinase epsilon subunit,Homo sapiens,Q14164,CHEMBL1145369,"Bioorg. Med. Chem. Lett., 17, p. 3972 (2007)",17502144,Scientific Literature
8b,CHEMBL230592,"InChI=1S/C24H24FN3O3S/c1-27-24(29)22-15-18(16-4-8-19(25)9-5-16)14-21(23(22)26)17-6-10-20(11-7-17)32(30,31)28-12-2-3-13-28/h4-11,14-15H,2-3,12-13,26H2,1H3,(H,27,29)",CNC(=O)c1cc(cc(c1N)c2ccc(cc2)S(=O)(=O)N3CCCC3)c4ccc(F)cc4,CHEMBL230592,"InChI=1S/C24H24FN3O3S/c1-27-24(29)22-15-18(16-4-8-19(25)9-5-16)14-21(23(22)26)17-6-10-20(11-7-17)32(30,31)28-12-2-3-13-28/h4-11,14-15H,2-3,12-13,26H2,1H3,(H,27,29)",CNC(=O)c1cc(cc(c1N)c2ccc(cc2)S(=O)(=O)N3CCCC3)c4ccc(F)cc4,CHEMBL889184,Inhibition of human recombinant FLAG-IKKepsilon by TR-FRET assay,pIC50,,,,Not Determined,CHEMBL3529,Inhibitor of nuclear factor kappa B kinase epsilon subunit,Homo sapiens,Q14164,CHEMBL1145369,"Bioorg. Med. Chem. Lett., 17, p. 3972 (2007)",17502144,Scientific Literature
8e,CHEMBL231623,"InChI=1S/C18H14FN3O/c19-14-3-1-11(2-4-14)13-9-15(12-5-7-22-8-6-12)17(20)16(10-13)18(21)23/h1-10H,20H2,(H2,21,23)",NC(=O)c1cc(cc(c1N)c2ccncc2)c3ccc(F)cc3,CHEMBL231623,"InChI=1S/C18H14FN3O/c19-14-3-1-11(2-4-14)13-9-15(12-5-7-22-8-6-12)17(20)16(10-13)18(21)23/h1-10H,20H2,(H2,21,23)",NC(=O)c1cc(cc(c1N)c2ccncc2)c3ccc(F)cc3,CHEMBL889184,Inhibition of human recombinant FLAG-IKKepsilon by TR-FRET assay,pIC50,<,4.8,,,CHEMBL3529,Inhibitor of nuclear factor kappa B kinase epsilon subunit,Homo sapiens,Q14164,CHEMBL1145369,"Bioorg. Med. Chem. Lett., 17, p. 3972 (2007)",17502144,Scientific Literature
8j,CHEMBL230597,"InChI=1S/C20H19N3O3S/c1-27(25,26)23-16-9-7-14(8-10-16)17-11-15(13-5-3-2-4-6-13)12-18(19(17)21)20(22)24/h2-12,23H,21H2,1H3,(H2,22,24)",CS(=O)(=O)Nc1ccc(cc1)c2cc(cc(C(=O)N)c2N)c3ccccc3,CHEMBL230597,"InChI=1S/C20H19N3O3S/c1-27(25,26)23-16-9-7-14(8-10-16)17-11-15(13-5-3-2-4-6-13)12-18(19(17)21)20(22)24/h2-12,23H,21H2,1H3,(H2,22,24)",CS(=O)(=O)Nc1ccc(cc1)c2cc(cc(C(=O)N)c2N)c3ccccc3,CHEMBL889184,Inhibition of human recombinant FLAG-IKKepsilon by TR-FRET assay,pIC50,<,4.8,,,CHEMBL3529,Inhibitor of nuclear factor kappa B kinase epsilon subunit,Homo sapiens,Q14164,CHEMBL1145369,"Bioorg. Med. Chem. Lett., 17, p. 3972 (2007)",17502144,Scientific Literature
8p,CHEMBL230911,"InChI=1S/C18H15N3O/c19-17-15(13-4-2-1-3-5-13)10-14(11-16(17)18(20)22)12-6-8-21-9-7-12/h1-11H,19H2,(H2,20,22)",NC(=O)c1cc(cc(c1N)c2ccccc2)c3ccncc3,CHEMBL230911,"InChI=1S/C18H15N3O/c19-17-15(13-4-2-1-3-5-13)10-14(11-16(17)18(20)22)12-6-8-21-9-7-12/h1-11H,19H2,(H2,20,22)",NC(=O)c1cc(cc(c1N)c2ccccc2)c3ccncc3,CHEMBL889184,Inhibition of human recombinant FLAG-IKKepsilon by TR-FRET assay,pIC50,=,5.4,,,CHEMBL3529,Inhibitor of nuclear factor kappa B kinase epsilon subunit,Homo sapiens,Q14164,CHEMBL1145369,"Bioorg. Med. Chem. Lett., 17, p. 3972 (2007)",17502144,Scientific Literature
11a,CHEMBL231013,"InChI=1S/C13H12N2O2/c1-17-12-3-2-10(8-11(12)13(14)16)9-4-6-15-7-5-9/h2-8H,1H3,(H2,14,16)",COc1ccc(cc1C(=O)N)c2ccncc2,CHEMBL231013,"InChI=1S/C13H12N2O2/c1-17-12-3-2-10(8-11(12)13(14)16)9-4-6-15-7-5-9/h2-8H,1H3,(H2,14,16)",COc1ccc(cc1C(=O)N)c2ccncc2,CHEMBL889182,Inhibition of human recombinant GST-IKKalpha by TR-FRET assay,pIC50,<,4.8,,,CHEMBL3476,Inhibitor of nuclear factor kappa B kinase alpha subunit,Homo sapiens,O15111,CHEMBL1145369,"Bioorg. Med. Chem. Lett., 17, p. 3972 (2007)",17502144,Scientific Literature
11c,CHEMBL268885,"InChI=1S/C20H17ClN2O4S/c1-27-19-17(13-4-8-16(9-5-13)28(23,25)26)10-14(11-18(19)20(22)24)12-2-6-15(21)7-3-12/h2-11H,1H3,(H2,22,24)(H2,23,25,26)",COc1c(cc(cc1c2ccc(cc2)S(=O)(=O)N)c3ccc(Cl)cc3)C(=O)N,CHEMBL268885,"InChI=1S/C20H17ClN2O4S/c1-27-19-17(13-4-8-16(9-5-13)28(23,25)26)10-14(11-18(19)20(22)24)12-2-6-15(21)7-3-12/h2-11H,1H3,(H2,22,24)(H2,23,25,26)",COc1c(cc(cc1c2ccc(cc2)S(=O)(=O)N)c3ccc(Cl)cc3)C(=O)N,CHEMBL889182,Inhibition of human recombinant GST-IKKalpha by TR-FRET assay,pIC50,<,4.8,,,CHEMBL3476,Inhibitor of nuclear factor kappa B kinase alpha subunit,Homo sapiens,O15111,CHEMBL1145369,"Bioorg. Med. Chem. Lett., 17, p. 3972 (2007)",17502144,Scientific Literature
4,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL889182,Inhibition of human recombinant GST-IKKalpha by TR-FRET assay,pIC50,<,4.8,,,CHEMBL3476,Inhibitor of nuclear factor kappa B kinase alpha subunit,Homo sapiens,O15111,CHEMBL1145369,"Bioorg. Med. Chem. Lett., 17, p. 3972 (2007)",17502144,Scientific Literature
8b,CHEMBL230592,"InChI=1S/C24H24FN3O3S/c1-27-24(29)22-15-18(16-4-8-19(25)9-5-16)14-21(23(22)26)17-6-10-20(11-7-17)32(30,31)28-12-2-3-13-28/h4-11,14-15H,2-3,12-13,26H2,1H3,(H,27,29)",CNC(=O)c1cc(cc(c1N)c2ccc(cc2)S(=O)(=O)N3CCCC3)c4ccc(F)cc4,CHEMBL230592,"InChI=1S/C24H24FN3O3S/c1-27-24(29)22-15-18(16-4-8-19(25)9-5-16)14-21(23(22)26)17-6-10-20(11-7-17)32(30,31)28-12-2-3-13-28/h4-11,14-15H,2-3,12-13,26H2,1H3,(H,27,29)",CNC(=O)c1cc(cc(c1N)c2ccc(cc2)S(=O)(=O)N3CCCC3)c4ccc(F)cc4,CHEMBL889182,Inhibition of human recombinant GST-IKKalpha by TR-FRET assay,pIC50,<,4.8,,,CHEMBL3476,Inhibitor of nuclear factor kappa B kinase alpha subunit,Homo sapiens,O15111,CHEMBL1145369,"Bioorg. Med. Chem. Lett., 17, p. 3972 (2007)",17502144,Scientific Literature
8e,CHEMBL231623,"InChI=1S/C18H14FN3O/c19-14-3-1-11(2-4-14)13-9-15(12-5-7-22-8-6-12)17(20)16(10-13)18(21)23/h1-10H,20H2,(H2,21,23)",NC(=O)c1cc(cc(c1N)c2ccncc2)c3ccc(F)cc3,CHEMBL231623,"InChI=1S/C18H14FN3O/c19-14-3-1-11(2-4-14)13-9-15(12-5-7-22-8-6-12)17(20)16(10-13)18(21)23/h1-10H,20H2,(H2,21,23)",NC(=O)c1cc(cc(c1N)c2ccncc2)c3ccc(F)cc3,CHEMBL889182,Inhibition of human recombinant GST-IKKalpha by TR-FRET assay,pIC50,=,5.3,,,CHEMBL3476,Inhibitor of nuclear factor kappa B kinase alpha subunit,Homo sapiens,O15111,CHEMBL1145369,"Bioorg. Med. Chem. Lett., 17, p. 3972 (2007)",17502144,Scientific Literature
8j,CHEMBL230597,"InChI=1S/C20H19N3O3S/c1-27(25,26)23-16-9-7-14(8-10-16)17-11-15(13-5-3-2-4-6-13)12-18(19(17)21)20(22)24/h2-12,23H,21H2,1H3,(H2,22,24)",CS(=O)(=O)Nc1ccc(cc1)c2cc(cc(C(=O)N)c2N)c3ccccc3,CHEMBL230597,"InChI=1S/C20H19N3O3S/c1-27(25,26)23-16-9-7-14(8-10-16)17-11-15(13-5-3-2-4-6-13)12-18(19(17)21)20(22)24/h2-12,23H,21H2,1H3,(H2,22,24)",CS(=O)(=O)Nc1ccc(cc1)c2cc(cc(C(=O)N)c2N)c3ccccc3,CHEMBL889182,Inhibition of human recombinant GST-IKKalpha by TR-FRET assay,pIC50,=,4.9,,,CHEMBL3476,Inhibitor of nuclear factor kappa B kinase alpha subunit,Homo sapiens,O15111,CHEMBL1145369,"Bioorg. Med. Chem. Lett., 17, p. 3972 (2007)",17502144,Scientific Literature
8p,CHEMBL230911,"InChI=1S/C18H15N3O/c19-17-15(13-4-2-1-3-5-13)10-14(11-16(17)18(20)22)12-6-8-21-9-7-12/h1-11H,19H2,(H2,20,22)",NC(=O)c1cc(cc(c1N)c2ccccc2)c3ccncc3,CHEMBL230911,"InChI=1S/C18H15N3O/c19-17-15(13-4-2-1-3-5-13)10-14(11-16(17)18(20)22)12-6-8-21-9-7-12/h1-11H,19H2,(H2,20,22)",NC(=O)c1cc(cc(c1N)c2ccccc2)c3ccncc3,CHEMBL889182,Inhibition of human recombinant GST-IKKalpha by TR-FRET assay,pIC50,=,5.5,,,CHEMBL3476,Inhibitor of nuclear factor kappa B kinase alpha subunit,Homo sapiens,O15111,CHEMBL1145369,"Bioorg. Med. Chem. Lett., 17, p. 3972 (2007)",17502144,Scientific Literature
11a,CHEMBL231013,"InChI=1S/C13H12N2O2/c1-17-12-3-2-10(8-11(12)13(14)16)9-4-6-15-7-5-9/h2-8H,1H3,(H2,14,16)",COc1ccc(cc1C(=O)N)c2ccncc2,CHEMBL231013,"InChI=1S/C13H12N2O2/c1-17-12-3-2-10(8-11(12)13(14)16)9-4-6-15-7-5-9/h2-8H,1H3,(H2,14,16)",COc1ccc(cc1C(=O)N)c2ccncc2,CHEMBL889183,Inhibition of human recombinant GST-IKKbeta by TR-FRET assay,pIC50,<,4.8,,,CHEMBL1991,Inhibitor of nuclear factor kappa B kinase beta subunit,Homo sapiens,O14920,CHEMBL1145369,"Bioorg. Med. Chem. Lett., 17, p. 3972 (2007)",17502144,Scientific Literature
11c,CHEMBL268885,"InChI=1S/C20H17ClN2O4S/c1-27-19-17(13-4-8-16(9-5-13)28(23,25)26)10-14(11-18(19)20(22)24)12-2-6-15(21)7-3-12/h2-11H,1H3,(H2,22,24)(H2,23,25,26)",COc1c(cc(cc1c2ccc(cc2)S(=O)(=O)N)c3ccc(Cl)cc3)C(=O)N,CHEMBL268885,"InChI=1S/C20H17ClN2O4S/c1-27-19-17(13-4-8-16(9-5-13)28(23,25)26)10-14(11-18(19)20(22)24)12-2-6-15(21)7-3-12/h2-11H,1H3,(H2,22,24)(H2,23,25,26)",COc1c(cc(cc1c2ccc(cc2)S(=O)(=O)N)c3ccc(Cl)cc3)C(=O)N,CHEMBL889183,Inhibition of human recombinant GST-IKKbeta by TR-FRET assay,pIC50,<,4.8,,,CHEMBL1991,Inhibitor of nuclear factor kappa B kinase beta subunit,Homo sapiens,O14920,CHEMBL1145369,"Bioorg. Med. Chem. Lett., 17, p. 3972 (2007)",17502144,Scientific Literature
4,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL889183,Inhibition of human recombinant GST-IKKbeta by TR-FRET assay,pIC50,<,4.8,,,CHEMBL1991,Inhibitor of nuclear factor kappa B kinase beta subunit,Homo sapiens,O14920,CHEMBL1145369,"Bioorg. Med. Chem. Lett., 17, p. 3972 (2007)",17502144,Scientific Literature
8b,CHEMBL230592,"InChI=1S/C24H24FN3O3S/c1-27-24(29)22-15-18(16-4-8-19(25)9-5-16)14-21(23(22)26)17-6-10-20(11-7-17)32(30,31)28-12-2-3-13-28/h4-11,14-15H,2-3,12-13,26H2,1H3,(H,27,29)",CNC(=O)c1cc(cc(c1N)c2ccc(cc2)S(=O)(=O)N3CCCC3)c4ccc(F)cc4,CHEMBL230592,"InChI=1S/C24H24FN3O3S/c1-27-24(29)22-15-18(16-4-8-19(25)9-5-16)14-21(23(22)26)17-6-10-20(11-7-17)32(30,31)28-12-2-3-13-28/h4-11,14-15H,2-3,12-13,26H2,1H3,(H,27,29)",CNC(=O)c1cc(cc(c1N)c2ccc(cc2)S(=O)(=O)N3CCCC3)c4ccc(F)cc4,CHEMBL889183,Inhibition of human recombinant GST-IKKbeta by TR-FRET assay,pIC50,<,4.8,,,CHEMBL1991,Inhibitor of nuclear factor kappa B kinase beta subunit,Homo sapiens,O14920,CHEMBL1145369,"Bioorg. Med. Chem. Lett., 17, p. 3972 (2007)",17502144,Scientific Literature
8e,CHEMBL231623,"InChI=1S/C18H14FN3O/c19-14-3-1-11(2-4-14)13-9-15(12-5-7-22-8-6-12)17(20)16(10-13)18(21)23/h1-10H,20H2,(H2,21,23)",NC(=O)c1cc(cc(c1N)c2ccncc2)c3ccc(F)cc3,CHEMBL231623,"InChI=1S/C18H14FN3O/c19-14-3-1-11(2-4-14)13-9-15(12-5-7-22-8-6-12)17(20)16(10-13)18(21)23/h1-10H,20H2,(H2,21,23)",NC(=O)c1cc(cc(c1N)c2ccncc2)c3ccc(F)cc3,CHEMBL889183,Inhibition of human recombinant GST-IKKbeta by TR-FRET assay,pIC50,=,5.8,,,CHEMBL1991,Inhibitor of nuclear factor kappa B kinase beta subunit,Homo sapiens,O14920,CHEMBL1145369,"Bioorg. Med. Chem. Lett., 17, p. 3972 (2007)",17502144,Scientific Literature
8j,CHEMBL230597,"InChI=1S/C20H19N3O3S/c1-27(25,26)23-16-9-7-14(8-10-16)17-11-15(13-5-3-2-4-6-13)12-18(19(17)21)20(22)24/h2-12,23H,21H2,1H3,(H2,22,24)",CS(=O)(=O)Nc1ccc(cc1)c2cc(cc(C(=O)N)c2N)c3ccccc3,CHEMBL230597,"InChI=1S/C20H19N3O3S/c1-27(25,26)23-16-9-7-14(8-10-16)17-11-15(13-5-3-2-4-6-13)12-18(19(17)21)20(22)24/h2-12,23H,21H2,1H3,(H2,22,24)",CS(=O)(=O)Nc1ccc(cc1)c2cc(cc(C(=O)N)c2N)c3ccccc3,CHEMBL889183,Inhibition of human recombinant GST-IKKbeta by TR-FRET assay,pIC50,=,5.8,,,CHEMBL1991,Inhibitor of nuclear factor kappa B kinase beta subunit,Homo sapiens,O14920,CHEMBL1145369,"Bioorg. Med. Chem. Lett., 17, p. 3972 (2007)",17502144,Scientific Literature
8p,CHEMBL230911,"InChI=1S/C18H15N3O/c19-17-15(13-4-2-1-3-5-13)10-14(11-16(17)18(20)22)12-6-8-21-9-7-12/h1-11H,19H2,(H2,20,22)",NC(=O)c1cc(cc(c1N)c2ccccc2)c3ccncc3,CHEMBL230911,"InChI=1S/C18H15N3O/c19-17-15(13-4-2-1-3-5-13)10-14(11-16(17)18(20)22)12-6-8-21-9-7-12/h1-11H,19H2,(H2,20,22)",NC(=O)c1cc(cc(c1N)c2ccccc2)c3ccncc3,CHEMBL889183,Inhibition of human recombinant GST-IKKbeta by TR-FRET assay,pIC50,=,5.4,,,CHEMBL1991,Inhibitor of nuclear factor kappa B kinase beta subunit,Homo sapiens,O14920,CHEMBL1145369,"Bioorg. Med. Chem. Lett., 17, p. 3972 (2007)",17502144,Scientific Literature
1,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL889563,Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as ARE-luciferase reporter activity at 0.1 uM relative to control,Activity,=,128,%,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1145400,"J. Med. Chem., 50, p. 3143 (2007)",17552507,Scientific Literature
1,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL889562,Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as SBE luciferase reporter activity at 0.1 uM relative to control,Activity,=,68,%,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1145400,"J. Med. Chem., 50, p. 3143 (2007)",17552507,Scientific Literature
1,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL889564,Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as p3TP-luciferase reporter activity at 0.05 uM relative to control,Activity,,,,Not Active,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1145400,"J. Med. Chem., 50, p. 3143 (2007)",17552507,Scientific Literature
1,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL889561,Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as p3TP-luciferase reporter activity at 0.1 uM relative to control,Activity,=,69,%,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1145400,"J. Med. Chem., 50, p. 3143 (2007)",17552507,Scientific Literature
1,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL889560,Inhibition of human recombinant ALK5 phosphorylation expressed in Sf9 cells,IC50,=,1542,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1145400,"J. Med. Chem., 50, p. 3143 (2007)",17552507,Scientific Literature
"K00591a, Diaminopyrimidine1",CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL939336,Inhibition of cFMS,IC50,=,30,nM,,CHEMBL1844,Macrophage colony stimulating factor  receptor ,Homo sapiens,P07333,CHEMBL1145498,"Proc. Natl. Acad. Sci. U.S.A., 104, p. 20523 (2007)",18077363,Scientific Literature
"K00569a, SB-220025",CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL936803,Inhibition of p38 MAP kinase,IC50,=,60,nM,,CHEMBL612545,,,,CHEMBL1145498,"Proc. Natl. Acad. Sci. U.S.A., 104, p. 20523 (2007)",18077363,Scientific Literature
"K00569a, SB-220025",CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL936810,Selectivity for p38 MAP kinase over EGFR,Selectivity ratio,>,1000,,,CHEMBL612545,,,,CHEMBL1145498,"Proc. Natl. Acad. Sci. U.S.A., 104, p. 20523 (2007)",18077363,Scientific Literature
"K00569a, SB-220025",CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL936807,Selectivity for p38 MAP kinase over ERK,Selectivity ratio,=,2000,,,CHEMBL612545,,,,CHEMBL1145498,"Proc. Natl. Acad. Sci. U.S.A., 104, p. 20523 (2007)",18077363,Scientific Literature
"K00569a, SB-220025",CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL936808,Selectivity for p38 MAP kinase over PKA,Selectivity ratio,=,500,,,CHEMBL612545,,,,CHEMBL1145498,"Proc. Natl. Acad. Sci. U.S.A., 104, p. 20523 (2007)",18077363,Scientific Literature
"K00569a, SB-220025",CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL936809,Selectivity for p38 MAP kinase over PKC,Selectivity ratio,=,50,,,CHEMBL612545,,,,CHEMBL1145498,"Proc. Natl. Acad. Sci. U.S.A., 104, p. 20523 (2007)",18077363,Scientific Literature
11f,CHEMBL205158,"InChI=1S/C25H25N5O2/c1-2-9-26-23(3-1)25-22(18-28-29-25)20-8-10-27-24(17-20)19-4-6-21(7-5-19)32-16-13-30-11-14-31-15-12-30/h1-10,17-18H,11-16H2,(H,28,29)",C(CN1CCOCC1)Oc2ccc(cc2)c3cc(ccn3)c4c[nH]nc4c5ccccn5,CHEMBL205158,"InChI=1S/C25H25N5O2/c1-2-9-26-23(3-1)25-22(18-28-29-25)20-8-10-27-24(17-20)19-4-6-21(7-5-19)32-16-13-30-11-14-31-15-12-30/h1-10,17-18H,11-16H2,(H,28,29)",C(CN1CCOCC1)Oc2ccc(cc2)c3cc(ccn3)c4c[nH]nc4c5ccccn5,CHEMBL860750,Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay,IC50,=,12,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1146081,"J. Med. Chem., 49, p. 2210 (2006)",16570917,Scientific Literature
11g,CHEMBL208437,"InChI=1S/C24H20N6O/c1-2-9-26-22(3-1)24-21(16-28-29-24)19-8-10-27-23(15-19)18-4-6-20(7-5-18)31-14-13-30-12-11-25-17-30/h1-12,15-17H,13-14H2,(H,28,29)",C(Cn1ccnc1)Oc2ccc(cc2)c3cc(ccn3)c4c[nH]nc4c5ccccn5,CHEMBL208437,"InChI=1S/C24H20N6O/c1-2-9-26-22(3-1)24-21(16-28-29-24)19-8-10-27-23(15-19)18-4-6-20(7-5-18)31-14-13-30-12-11-25-17-30/h1-12,15-17H,13-14H2,(H,28,29)",C(Cn1ccnc1)Oc2ccc(cc2)c3cc(ccn3)c4c[nH]nc4c5ccccn5,CHEMBL860750,Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay,IC50,=,30,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1146081,"J. Med. Chem., 49, p. 2210 (2006)",16570917,Scientific Literature
1j,CHEMBL202891,"InChI=1S/C20H16N4O/c1-25-16-7-5-14(6-8-16)19-12-15(9-11-22-19)17-13-23-24-20(17)18-4-2-3-10-21-18/h2-13H,1H3,(H,23,24)",COc1ccc(cc1)c2cc(ccn2)c3c[nH]nc3c4ccccn4,CHEMBL202891,"InChI=1S/C20H16N4O/c1-25-16-7-5-14(6-8-16)19-12-15(9-11-22-19)17-13-23-24-20(17)18-4-2-3-10-21-18/h2-13H,1H3,(H,23,24)",COc1ccc(cc1)c2cc(ccn2)c3c[nH]nc3c4ccccn4,CHEMBL860750,Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay,IC50,=,24,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1146081,"J. Med. Chem., 49, p. 2210 (2006)",16570917,Scientific Literature
1k,CHEMBL381948,"InChI=1S/C19H13FN4/c20-15-6-4-13(5-7-15)18-11-14(8-10-22-18)16-12-23-24-19(16)17-3-1-2-9-21-17/h1-12H,(H,23,24)",Fc1ccc(cc1)c2cc(ccn2)c3c[nH]nc3c4ccccn4,CHEMBL381948,"InChI=1S/C19H13FN4/c20-15-6-4-13(5-7-15)18-11-14(8-10-22-18)16-12-23-24-19(16)17-3-1-2-9-21-17/h1-12H,(H,23,24)",Fc1ccc(cc1)c2cc(ccn2)c3c[nH]nc3c4ccccn4,CHEMBL860750,Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay,IC50,=,48,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1146081,"J. Med. Chem., 49, p. 2210 (2006)",16570917,Scientific Literature
1l,CHEMBL206544,"InChI=1S/C22H20N4/c1-15(2)16-6-8-17(9-7-16)21-13-18(10-12-24-21)19-14-25-26-22(19)20-5-3-4-11-23-20/h3-15H,1-2H3,(H,25,26)",CC(C)c1ccc(cc1)c2cc(ccn2)c3c[nH]nc3c4ccccn4,CHEMBL206544,"InChI=1S/C22H20N4/c1-15(2)16-6-8-17(9-7-16)21-13-18(10-12-24-21)19-14-25-26-22(19)20-5-3-4-11-23-20/h3-15H,1-2H3,(H,25,26)",CC(C)c1ccc(cc1)c2cc(ccn2)c3c[nH]nc3c4ccccn4,CHEMBL860750,Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay,IC50,=,32,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1146081,"J. Med. Chem., 49, p. 2210 (2006)",16570917,Scientific Literature
11f,CHEMBL205158,"InChI=1S/C25H25N5O2/c1-2-9-26-23(3-1)25-22(18-28-29-25)20-8-10-27-24(17-20)19-4-6-21(7-5-19)32-16-13-30-11-14-31-15-12-30/h1-10,17-18H,11-16H2,(H,28,29)",C(CN1CCOCC1)Oc2ccc(cc2)c3cc(ccn3)c4c[nH]nc4c5ccccn5,CHEMBL205158,"InChI=1S/C25H25N5O2/c1-2-9-26-23(3-1)25-22(18-28-29-25)20-8-10-27-24(17-20)19-4-6-21(7-5-19)32-16-13-30-11-14-31-15-12-30/h1-10,17-18H,11-16H2,(H,28,29)",C(CN1CCOCC1)Oc2ccc(cc2)c3cc(ccn3)c4c[nH]nc4c5ccccn5,CHEMBL860754,Inhibition of TGF beta-induced transcription of firefly luciferase reporter gene in HepG2 cells,IC50,=,209,nM,,CHEMBL395,HepG2 (Hepatoblastoma cells),Homo sapiens,,CHEMBL1146081,"J. Med. Chem., 49, p. 2210 (2006)",16570917,Scientific Literature
11g,CHEMBL208437,"InChI=1S/C24H20N6O/c1-2-9-26-22(3-1)24-21(16-28-29-24)19-8-10-27-23(15-19)18-4-6-20(7-5-18)31-14-13-30-12-11-25-17-30/h1-12,15-17H,13-14H2,(H,28,29)",C(Cn1ccnc1)Oc2ccc(cc2)c3cc(ccn3)c4c[nH]nc4c5ccccn5,CHEMBL208437,"InChI=1S/C24H20N6O/c1-2-9-26-22(3-1)24-21(16-28-29-24)19-8-10-27-23(15-19)18-4-6-20(7-5-18)31-14-13-30-12-11-25-17-30/h1-12,15-17H,13-14H2,(H,28,29)",C(Cn1ccnc1)Oc2ccc(cc2)c3cc(ccn3)c4c[nH]nc4c5ccccn5,CHEMBL860754,Inhibition of TGF beta-induced transcription of firefly luciferase reporter gene in HepG2 cells,IC50,=,133,nM,,CHEMBL395,HepG2 (Hepatoblastoma cells),Homo sapiens,,CHEMBL1146081,"J. Med. Chem., 49, p. 2210 (2006)",16570917,Scientific Literature
1j,CHEMBL202891,"InChI=1S/C20H16N4O/c1-25-16-7-5-14(6-8-16)19-12-15(9-11-22-19)17-13-23-24-20(17)18-4-2-3-10-21-18/h2-13H,1H3,(H,23,24)",COc1ccc(cc1)c2cc(ccn2)c3c[nH]nc3c4ccccn4,CHEMBL202891,"InChI=1S/C20H16N4O/c1-25-16-7-5-14(6-8-16)19-12-15(9-11-22-19)17-13-23-24-20(17)18-4-2-3-10-21-18/h2-13H,1H3,(H,23,24)",COc1ccc(cc1)c2cc(ccn2)c3c[nH]nc3c4ccccn4,CHEMBL860754,Inhibition of TGF beta-induced transcription of firefly luciferase reporter gene in HepG2 cells,IC50,=,537,nM,,CHEMBL395,HepG2 (Hepatoblastoma cells),Homo sapiens,,CHEMBL1146081,"J. Med. Chem., 49, p. 2210 (2006)",16570917,Scientific Literature
12e,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL911353,Aqueous solubility of the compound,Solubility,=,60,uM,,CHEMBL612558,,,,CHEMBL1146152,"Bioorg. Med. Chem. Lett., 16, p. 6236 (2006)",16997559,Scientific Literature
12e,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL910218,Inhibition of Alk5,Log IC50,<,5.3,,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1146152,"Bioorg. Med. Chem. Lett., 16, p. 6236 (2006)",16997559,Scientific Literature
6,CHEMBL222419,"InChI=1S/C22H20ClN3O4S/c1-12(13-6-4-5-7-14(13)23)30-19-10-20(31-21(19)22(24)27)26-11-25-15-8-17(28-2)18(29-3)9-16(15)26/h4-12H,1-3H3,(H2,24,27)/t12-/m1/s1",COc1cc2ncn(c3cc(O[C@H](C)c4ccccc4Cl)c(s3)C(=O)N)c2cc1OC,CHEMBL222419,"InChI=1S/C22H20ClN3O4S/c1-12(13-6-4-5-7-14(13)23)30-19-10-20(31-21(19)22(24)27)26-11-25-15-8-17(28-2)18(29-3)9-16(15)26/h4-12H,1-3H3,(H2,24,27)/t12-/m1/s1",COc1cc2ncn(c3cc(O[C@H](C)c4ccccc4Cl)c(s3)C(=O)N)c2cc1OC,CHEMBL911350,Inhibition of CDK2,Log IC50,=,5.8,,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1146152,"Bioorg. Med. Chem. Lett., 16, p. 6236 (2006)",16997559,Scientific Literature
12e,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL911354,Inhibition of CYP1A2,Log IC50,<,4.3,,,CHEMBL3356,Cytochrome P450 1A2,Homo sapiens,P05177,CHEMBL1146152,"Bioorg. Med. Chem. Lett., 16, p. 6236 (2006)",16997559,Scientific Literature
12e,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL911356,Inhibition of CYP2C9,Log IC50,<,4.3,,,CHEMBL3397,Cytochrome P450 2C9,Homo sapiens,P11712,CHEMBL1146152,"Bioorg. Med. Chem. Lett., 16, p. 6236 (2006)",16997559,Scientific Literature
12e,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL911355,Inhibition of CYP2D6,Log IC50,<,4.3,,,CHEMBL289,Cytochrome P450 2D6,Homo sapiens,P10635,CHEMBL1146152,"Bioorg. Med. Chem. Lett., 16, p. 6236 (2006)",16997559,Scientific Literature
12e,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL911357,Inhibition of CYP3A4,Log IC50,<,4.3,,,CHEMBL340,Cytochrome P450 3A4,Homo sapiens,P08684,CHEMBL1146152,"Bioorg. Med. Chem. Lett., 16, p. 6236 (2006)",16997559,Scientific Literature
12e,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL910219,Inhibition of EGFR,Log IC50,<,5,,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1146152,"Bioorg. Med. Chem. Lett., 16, p. 6236 (2006)",16997559,Scientific Literature
12e,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL910220,Inhibition of ErB2,Log IC50,<,5,,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1146152,"Bioorg. Med. Chem. Lett., 16, p. 6236 (2006)",16997559,Scientific Literature
12e,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL911348,Inhibition of IKK-beta,Log IC50,<,4.8,,,CHEMBL1991,Inhibitor of nuclear factor kappa B kinase beta subunit,Homo sapiens,O14920,CHEMBL1146152,"Bioorg. Med. Chem. Lett., 16, p. 6236 (2006)",16997559,Scientific Literature
12e,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL910222,Inhibition of IKKalpha,Log IC50,<,4.8,,,CHEMBL3476,Inhibitor of nuclear factor kappa B kinase alpha subunit,Homo sapiens,O15111,CHEMBL1146152,"Bioorg. Med. Chem. Lett., 16, p. 6236 (2006)",16997559,Scientific Literature
12e,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL910223,Inhibition of JNK3,Log IC50,<,4.8,,,CHEMBL2637,c-Jun N-terminal kinase 3,Homo sapiens,P53779,CHEMBL1146152,"Bioorg. Med. Chem. Lett., 16, p. 6236 (2006)",16997559,Scientific Literature
12e,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL911349,Inhibition of PLK1,Log IC50,=,6.1,,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1146152,"Bioorg. Med. Chem. Lett., 16, p. 6236 (2006)",16997559,Scientific Literature
12e,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL911347,Inhibition of human recombinant IKKepsilon by TR-FRET assay,Log IC50,=,7.4,,,CHEMBL3529,Inhibitor of nuclear factor kappa B kinase epsilon subunit,Homo sapiens,Q14164,CHEMBL1146152,"Bioorg. Med. Chem. Lett., 16, p. 6236 (2006)",16997559,Scientific Literature
6,CHEMBL222419,"InChI=1S/C22H20ClN3O4S/c1-12(13-6-4-5-7-14(13)23)30-19-10-20(31-21(19)22(24)27)26-11-25-15-8-17(28-2)18(29-3)9-16(15)26/h4-12H,1-3H3,(H2,24,27)/t12-/m1/s1",COc1cc2ncn(c3cc(O[C@H](C)c4ccccc4Cl)c(s3)C(=O)N)c2cc1OC,CHEMBL222419,"InChI=1S/C22H20ClN3O4S/c1-12(13-6-4-5-7-14(13)23)30-19-10-20(31-21(19)22(24)27)26-11-25-15-8-17(28-2)18(29-3)9-16(15)26/h4-12H,1-3H3,(H2,24,27)/t12-/m1/s1",COc1cc2ncn(c3cc(O[C@H](C)c4ccccc4Cl)c(s3)C(=O)N)c2cc1OC,CHEMBL911347,Inhibition of human recombinant IKKepsilon by TR-FRET assay,Log IC50,=,4.7,,,CHEMBL3529,Inhibitor of nuclear factor kappa B kinase epsilon subunit,Homo sapiens,Q14164,CHEMBL1146152,"Bioorg. Med. Chem. Lett., 16, p. 6236 (2006)",16997559,Scientific Literature
12e,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL911351,Inhibition of p38alpha,pIC50,<,4.8,,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1146152,"Bioorg. Med. Chem. Lett., 16, p. 6236 (2006)",16997559,Scientific Literature
12e,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL373751,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4S(=O)(=O)C)c(C#N)s3)c2cc1OC,CHEMBL911352,Inhibition of p38beta,Log IC50,<,4.8,,,CHEMBL3961,MAP kinase p38 beta,Homo sapiens,Q15759,CHEMBL1146152,"Bioorg. Med. Chem. Lett., 16, p. 6236 (2006)",16997559,Scientific Literature
8b,CHEMBL517907,"InChI=1S/C23H26N4O3S/c1-3-18-7-6-8-19(15-18)27-23-21-16-20(9-10-22(21)25-17-26-23)30-13-5-4-11-24-12-14-31(2,28)29/h1,6-10,15-17,24H,4-5,11-14H2,2H3,(H,25,26,27)",CS(=O)(=O)CCNCCCCOc1ccc2ncnc(Nc3cccc(c3)C#C)c2c1,CHEMBL517907,"InChI=1S/C23H26N4O3S/c1-3-18-7-6-8-19(15-18)27-23-21-16-20(9-10-22(21)25-17-26-23)30-13-5-4-11-24-12-14-31(2,28)29/h1,6-10,15-17,24H,4-5,11-14H2,2H3,(H,25,26,27)",CS(=O)(=O)CCNCCCCOc1ccc2ncnc(Nc3cccc(c3)C#C)c2c1,CHEMBL682312,Inhibitory activity against ERBB2 receptor kinase,IC50,=,234,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1146682,"Bioorg. Med. Chem. Lett., 14, p. 111 (2004)",14684309,Scientific Literature
9a,CHEMBL15202,"InChI=1S/C22H19N3O2/c1-26-19-11-12-21-20(13-19)22(24-15-23-21)25-17-7-9-18(10-8-17)27-14-16-5-3-2-4-6-16/h2-13,15H,14H2,1H3,(H,23,24,25)",COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1,CHEMBL15202,"InChI=1S/C22H19N3O2/c1-26-19-11-12-21-20(13-19)22(24-15-23-21)25-17-7-9-18(10-8-17)27-14-16-5-3-2-4-6-16/h2-13,15H,14H2,1H3,(H,23,24,25)",COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1,CHEMBL682312,Inhibitory activity against ERBB2 receptor kinase,IC50,=,309,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1146682,"Bioorg. Med. Chem. Lett., 14, p. 111 (2004)",14684309,Scientific Literature
8b,CHEMBL517907,"InChI=1S/C23H26N4O3S/c1-3-18-7-6-8-19(15-18)27-23-21-16-20(9-10-22(21)25-17-26-23)30-13-5-4-11-24-12-14-31(2,28)29/h1,6-10,15-17,24H,4-5,11-14H2,2H3,(H,25,26,27)",CS(=O)(=O)CCNCCCCOc1ccc2ncnc(Nc3cccc(c3)C#C)c2c1,CHEMBL517907,"InChI=1S/C23H26N4O3S/c1-3-18-7-6-8-19(15-18)27-23-21-16-20(9-10-22(21)25-17-26-23)30-13-5-4-11-24-12-14-31(2,28)29/h1,6-10,15-17,24H,4-5,11-14H2,2H3,(H,25,26,27)",CS(=O)(=O)CCNCCCCOc1ccc2ncnc(Nc3cccc(c3)C#C)c2c1,CHEMBL674106,Inhibitory activity against epidermal growth factor receptor,IC50,=,11,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1146682,"Bioorg. Med. Chem. Lett., 14, p. 111 (2004)",14684309,Scientific Literature
9a,CHEMBL15202,"InChI=1S/C22H19N3O2/c1-26-19-11-12-21-20(13-19)22(24-15-23-21)25-17-7-9-18(10-8-17)27-14-16-5-3-2-4-6-16/h2-13,15H,14H2,1H3,(H,23,24,25)",COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1,CHEMBL15202,"InChI=1S/C22H19N3O2/c1-26-19-11-12-21-20(13-19)22(24-15-23-21)25-17-7-9-18(10-8-17)27-14-16-5-3-2-4-6-16/h2-13,15H,14H2,1H3,(H,23,24,25)",COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1,CHEMBL674106,Inhibitory activity against epidermal growth factor receptor,IC50,=,68,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1146682,"Bioorg. Med. Chem. Lett., 14, p. 111 (2004)",14684309,Scientific Literature
24,CHEMBL318728,"InChI=1S/C15H12N2O/c1-3-7-12(8-4-1)14-11-16-15(18-14)17-13-9-5-2-6-10-13/h1-11H,(H,16,17)",N(c1ccccc1)c2oc(cn2)c3ccccc3,CHEMBL318728,"InChI=1S/C15H12N2O/c1-3-7-12(8-4-1)14-11-16-15(18-14)17-13-9-5-2-6-10-13/h1-11H,(H,16,17)",N(c1ccccc1)c2oc(cn2)c3ccccc3,CHEMBL812621,Inhibitory activity towards vascular endothelial growth factor receptor 2,IC50,=,134,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1146769,"Bioorg. Med. Chem. Lett., 14, p. 2941 (2004)",15125964,Scientific Literature
8e,CHEMBL205798,"InChI=1S/C27H20ClFN4O2/c1-18(34)32-23-7-3-4-19(13-23)8-9-21-15-30-17-31-27(21)33-24-10-11-26(25(28)14-24)35-16-20-5-2-6-22(29)12-20/h2-7,10-15,17H,16H2,1H3,(H,32,34)(H,30,31,33)",CC(=O)Nc1cccc(c1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL205798,"InChI=1S/C27H20ClFN4O2/c1-18(34)32-23-7-3-4-19(13-23)8-9-21-15-30-17-31-27(21)33-24-10-11-26(25(28)14-24)35-16-20-5-2-6-22(29)12-20/h2-7,10-15,17H,16H2,1H3,(H,32,34)(H,30,31,33)",CC(=O)Nc1cccc(c1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL861553,Antiproliferative activity against human BT474 cell line,IC50,=,21600,nM,,CHEMBL614529,BT-474 (Breast ductal carcinoma cells),Homo sapiens,,CHEMBL1147004,"Bioorg. Med. Chem. Lett., 16, p. 2419 (2006)",16483772,Scientific Literature
8e,CHEMBL205798,"InChI=1S/C27H20ClFN4O2/c1-18(34)32-23-7-3-4-19(13-23)8-9-21-15-30-17-31-27(21)33-24-10-11-26(25(28)14-24)35-16-20-5-2-6-22(29)12-20/h2-7,10-15,17H,16H2,1H3,(H,32,34)(H,30,31,33)",CC(=O)Nc1cccc(c1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL205798,"InChI=1S/C27H20ClFN4O2/c1-18(34)32-23-7-3-4-19(13-23)8-9-21-15-30-17-31-27(21)33-24-10-11-26(25(28)14-24)35-16-20-5-2-6-22(29)12-20/h2-7,10-15,17H,16H2,1H3,(H,32,34)(H,30,31,33)",CC(=O)Nc1cccc(c1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL861554,Antiproliferative activity against human HFF cell line,IC50,>,30000,nM,,CHEMBL614071,HFF (Foreskin fibroblasts),Homo sapiens,,CHEMBL1147004,"Bioorg. Med. Chem. Lett., 16, p. 2419 (2006)",16483772,Scientific Literature
8e,CHEMBL205798,"InChI=1S/C27H20ClFN4O2/c1-18(34)32-23-7-3-4-19(13-23)8-9-21-15-30-17-31-27(21)33-24-10-11-26(25(28)14-24)35-16-20-5-2-6-22(29)12-20/h2-7,10-15,17H,16H2,1H3,(H,32,34)(H,30,31,33)",CC(=O)Nc1cccc(c1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL205798,"InChI=1S/C27H20ClFN4O2/c1-18(34)32-23-7-3-4-19(13-23)8-9-21-15-30-17-31-27(21)33-24-10-11-26(25(28)14-24)35-16-20-5-2-6-22(29)12-20/h2-7,10-15,17H,16H2,1H3,(H,32,34)(H,30,31,33)",CC(=O)Nc1cccc(c1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL861552,Antiproliferative activity against human HN5 cell line,IC50,=,13700,nM,,CHEMBL614828,HN5 (Squamous cell carcinoma),Homo sapiens,,CHEMBL1147004,"Bioorg. Med. Chem. Lett., 16, p. 2419 (2006)",16483772,Scientific Literature
8a,CHEMBL379093,"InChI=1S/C25H17ClFN3O/c26-23-14-22(11-12-24(23)31-16-19-7-4-8-21(27)13-19)30-25-20(15-28-17-29-25)10-9-18-5-2-1-3-6-18/h1-8,11-15,17H,16H2,(H,28,29,30)",Fc1cccc(COc2ccc(Nc3ncncc3C#Cc4ccccc4)cc2Cl)c1,CHEMBL379093,"InChI=1S/C25H17ClFN3O/c26-23-14-22(11-12-24(23)31-16-19-7-4-8-21(27)13-19)30-25-20(15-28-17-29-25)10-9-18-5-2-1-3-6-18/h1-8,11-15,17H,16H2,(H,28,29,30)",Fc1cccc(COc2ccc(Nc3ncncc3C#Cc4ccccc4)cc2Cl)c1,CHEMBL861550,Inhibition of EGFR,IC50,=,79,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1147004,"Bioorg. Med. Chem. Lett., 16, p. 2419 (2006)",16483772,Scientific Literature
8d,CHEMBL205966,"InChI=1S/C25H18ClFN4O/c26-23-13-22(10-11-24(23)32-15-18-2-1-3-20(27)12-18)31-25-19(14-29-16-30-25)7-4-17-5-8-21(28)9-6-17/h1-3,5-6,8-14,16H,15,28H2,(H,29,30,31)",Nc1ccc(cc1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL205966,"InChI=1S/C25H18ClFN4O/c26-23-13-22(10-11-24(23)32-15-18-2-1-3-20(27)12-18)31-25-19(14-29-16-30-25)7-4-17-5-8-21(28)9-6-17/h1-3,5-6,8-14,16H,15,28H2,(H,29,30,31)",Nc1ccc(cc1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL861550,Inhibition of EGFR,IC50,=,30,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1147004,"Bioorg. Med. Chem. Lett., 16, p. 2419 (2006)",16483772,Scientific Literature
8e,CHEMBL205798,"InChI=1S/C27H20ClFN4O2/c1-18(34)32-23-7-3-4-19(13-23)8-9-21-15-30-17-31-27(21)33-24-10-11-26(25(28)14-24)35-16-20-5-2-6-22(29)12-20/h2-7,10-15,17H,16H2,1H3,(H,32,34)(H,30,31,33)",CC(=O)Nc1cccc(c1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL205798,"InChI=1S/C27H20ClFN4O2/c1-18(34)32-23-7-3-4-19(13-23)8-9-21-15-30-17-31-27(21)33-24-10-11-26(25(28)14-24)35-16-20-5-2-6-22(29)12-20/h2-7,10-15,17H,16H2,1H3,(H,32,34)(H,30,31,33)",CC(=O)Nc1cccc(c1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL861550,Inhibition of EGFR,IC50,=,12,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1147004,"Bioorg. Med. Chem. Lett., 16, p. 2419 (2006)",16483772,Scientific Literature
8h,CHEMBL207410,"InChI=1S/C27H20ClFN4O2/c1-30-27(34)20-6-2-4-18(12-20)8-9-21-15-31-17-32-26(21)33-23-10-11-25(24(28)14-23)35-16-19-5-3-7-22(29)13-19/h2-7,10-15,17H,16H2,1H3,(H,30,34)(H,31,32,33)",CNC(=O)c1cccc(c1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL207410,"InChI=1S/C27H20ClFN4O2/c1-30-27(34)20-6-2-4-18(12-20)8-9-21-15-31-17-32-26(21)33-23-10-11-25(24(28)14-23)35-16-19-5-3-7-22(29)13-19/h2-7,10-15,17H,16H2,1H3,(H,30,34)(H,31,32,33)",CNC(=O)c1cccc(c1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL861550,Inhibition of EGFR,IC50,=,79,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1147004,"Bioorg. Med. Chem. Lett., 16, p. 2419 (2006)",16483772,Scientific Literature
8i,CHEMBL207247,"InChI=1S/C28H22ClFN4O2/c1-19(35)32-15-21-5-2-4-20(12-21)8-9-23-16-31-18-33-28(23)34-25-10-11-27(26(29)14-25)36-17-22-6-3-7-24(30)13-22/h2-7,10-14,16,18H,15,17H2,1H3,(H,32,35)(H,31,33,34)",CC(=O)NCc1cccc(c1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL207247,"InChI=1S/C28H22ClFN4O2/c1-19(35)32-15-21-5-2-4-20(12-21)8-9-23-16-31-18-33-28(23)34-25-10-11-27(26(29)14-25)36-17-22-6-3-7-24(30)13-22/h2-7,10-14,16,18H,15,17H2,1H3,(H,32,35)(H,31,33,34)",CC(=O)NCc1cccc(c1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL861550,Inhibition of EGFR,IC50,=,60,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1147004,"Bioorg. Med. Chem. Lett., 16, p. 2419 (2006)",16483772,Scientific Literature
8p,CHEMBL381604,"InChI=1S/C23H16ClFN6O/c24-20-11-19(6-7-21(20)32-13-15-2-1-3-17(25)10-15)30-22-16(12-27-14-29-22)4-5-18-8-9-28-23(26)31-18/h1-3,6-12,14H,13H2,(H2,26,28,31)(H,27,29,30)",Nc1nccc(n1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL381604,"InChI=1S/C23H16ClFN6O/c24-20-11-19(6-7-21(20)32-13-15-2-1-3-17(25)10-15)30-22-16(12-27-14-29-22)4-5-18-8-9-28-23(26)31-18/h1-3,6-12,14H,13H2,(H2,26,28,31)(H,27,29,30)",Nc1nccc(n1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL861550,Inhibition of EGFR,IC50,=,32,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1147004,"Bioorg. Med. Chem. Lett., 16, p. 2419 (2006)",16483772,Scientific Literature
8q,CHEMBL205765,"InChI=1S/C26H19ClFN5O2/c1-17(34)31-25-7-3-6-21(32-25)9-8-19-14-29-16-30-26(19)33-22-10-11-24(23(27)13-22)35-15-18-4-2-5-20(28)12-18/h2-7,10-14,16H,15H2,1H3,(H,29,30,33)(H,31,32,34)",CC(=O)Nc1cccc(n1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL205765,"InChI=1S/C26H19ClFN5O2/c1-17(34)31-25-7-3-6-21(32-25)9-8-19-14-29-16-30-26(19)33-22-10-11-24(23(27)13-22)35-15-18-4-2-5-20(28)12-18/h2-7,10-14,16H,15H2,1H3,(H,29,30,33)(H,31,32,34)",CC(=O)Nc1cccc(n1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL861550,Inhibition of EGFR,IC50,=,91,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1147004,"Bioorg. Med. Chem. Lett., 16, p. 2419 (2006)",16483772,Scientific Literature
8a,CHEMBL379093,"InChI=1S/C25H17ClFN3O/c26-23-14-22(11-12-24(23)31-16-19-7-4-8-21(27)13-19)30-25-20(15-28-17-29-25)10-9-18-5-2-1-3-6-18/h1-8,11-15,17H,16H2,(H,28,29,30)",Fc1cccc(COc2ccc(Nc3ncncc3C#Cc4ccccc4)cc2Cl)c1,CHEMBL379093,"InChI=1S/C25H17ClFN3O/c26-23-14-22(11-12-24(23)31-16-19-7-4-8-21(27)13-19)30-25-20(15-28-17-29-25)10-9-18-5-2-1-3-6-18/h1-8,11-15,17H,16H2,(H,28,29,30)",Fc1cccc(COc2ccc(Nc3ncncc3C#Cc4ccccc4)cc2Cl)c1,CHEMBL861551,Inhibition of ErbB2,IC50,=,780,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1147004,"Bioorg. Med. Chem. Lett., 16, p. 2419 (2006)",16483772,Scientific Literature
8d,CHEMBL205966,"InChI=1S/C25H18ClFN4O/c26-23-13-22(10-11-24(23)32-15-18-2-1-3-20(27)12-18)31-25-19(14-29-16-30-25)7-4-17-5-8-21(28)9-6-17/h1-3,5-6,8-14,16H,15,28H2,(H,29,30,31)",Nc1ccc(cc1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL205966,"InChI=1S/C25H18ClFN4O/c26-23-13-22(10-11-24(23)32-15-18-2-1-3-20(27)12-18)31-25-19(14-29-16-30-25)7-4-17-5-8-21(28)9-6-17/h1-3,5-6,8-14,16H,15,28H2,(H,29,30,31)",Nc1ccc(cc1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL861551,Inhibition of ErbB2,IC50,=,36,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1147004,"Bioorg. Med. Chem. Lett., 16, p. 2419 (2006)",16483772,Scientific Literature
8e,CHEMBL205798,"InChI=1S/C27H20ClFN4O2/c1-18(34)32-23-7-3-4-19(13-23)8-9-21-15-30-17-31-27(21)33-24-10-11-26(25(28)14-24)35-16-20-5-2-6-22(29)12-20/h2-7,10-15,17H,16H2,1H3,(H,32,34)(H,30,31,33)",CC(=O)Nc1cccc(c1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL205798,"InChI=1S/C27H20ClFN4O2/c1-18(34)32-23-7-3-4-19(13-23)8-9-21-15-30-17-31-27(21)33-24-10-11-26(25(28)14-24)35-16-20-5-2-6-22(29)12-20/h2-7,10-15,17H,16H2,1H3,(H,32,34)(H,30,31,33)",CC(=O)Nc1cccc(c1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL861551,Inhibition of ErbB2,IC50,=,13,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1147004,"Bioorg. Med. Chem. Lett., 16, p. 2419 (2006)",16483772,Scientific Literature
8h,CHEMBL207410,"InChI=1S/C27H20ClFN4O2/c1-30-27(34)20-6-2-4-18(12-20)8-9-21-15-31-17-32-26(21)33-23-10-11-25(24(28)14-23)35-16-19-5-3-7-22(29)13-19/h2-7,10-15,17H,16H2,1H3,(H,30,34)(H,31,32,33)",CNC(=O)c1cccc(c1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL207410,"InChI=1S/C27H20ClFN4O2/c1-30-27(34)20-6-2-4-18(12-20)8-9-21-15-31-17-32-26(21)33-23-10-11-25(24(28)14-23)35-16-19-5-3-7-22(29)13-19/h2-7,10-15,17H,16H2,1H3,(H,30,34)(H,31,32,33)",CNC(=O)c1cccc(c1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL861551,Inhibition of ErbB2,IC50,=,32,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1147004,"Bioorg. Med. Chem. Lett., 16, p. 2419 (2006)",16483772,Scientific Literature
8i,CHEMBL207247,"InChI=1S/C28H22ClFN4O2/c1-19(35)32-15-21-5-2-4-20(12-21)8-9-23-16-31-18-33-28(23)34-25-10-11-27(26(29)14-25)36-17-22-6-3-7-24(30)13-22/h2-7,10-14,16,18H,15,17H2,1H3,(H,32,35)(H,31,33,34)",CC(=O)NCc1cccc(c1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL207247,"InChI=1S/C28H22ClFN4O2/c1-19(35)32-15-21-5-2-4-20(12-21)8-9-23-16-31-18-33-28(23)34-25-10-11-27(26(29)14-25)36-17-22-6-3-7-24(30)13-22/h2-7,10-14,16,18H,15,17H2,1H3,(H,32,35)(H,31,33,34)",CC(=O)NCc1cccc(c1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL861551,Inhibition of ErbB2,IC50,=,52,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1147004,"Bioorg. Med. Chem. Lett., 16, p. 2419 (2006)",16483772,Scientific Literature
8p,CHEMBL381604,"InChI=1S/C23H16ClFN6O/c24-20-11-19(6-7-21(20)32-13-15-2-1-3-17(25)10-15)30-22-16(12-27-14-29-22)4-5-18-8-9-28-23(26)31-18/h1-3,6-12,14H,13H2,(H2,26,28,31)(H,27,29,30)",Nc1nccc(n1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL381604,"InChI=1S/C23H16ClFN6O/c24-20-11-19(6-7-21(20)32-13-15-2-1-3-17(25)10-15)30-22-16(12-27-14-29-22)4-5-18-8-9-28-23(26)31-18/h1-3,6-12,14H,13H2,(H2,26,28,31)(H,27,29,30)",Nc1nccc(n1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL861551,Inhibition of ErbB2,IC50,=,12,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1147004,"Bioorg. Med. Chem. Lett., 16, p. 2419 (2006)",16483772,Scientific Literature
8q,CHEMBL205765,"InChI=1S/C26H19ClFN5O2/c1-17(34)31-25-7-3-6-21(32-25)9-8-19-14-29-16-30-26(19)33-22-10-11-24(23(27)13-22)35-15-18-4-2-5-20(28)12-18/h2-7,10-14,16H,15H2,1H3,(H,29,30,33)(H,31,32,34)",CC(=O)Nc1cccc(n1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL205765,"InChI=1S/C26H19ClFN5O2/c1-17(34)31-25-7-3-6-21(32-25)9-8-19-14-29-16-30-26(19)33-22-10-11-24(23(27)13-22)35-15-18-4-2-5-20(28)12-18/h2-7,10-14,16H,15H2,1H3,(H,29,30,33)(H,31,32,34)",CC(=O)Nc1cccc(n1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL861551,Inhibition of ErbB2,IC50,=,59,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1147004,"Bioorg. Med. Chem. Lett., 16, p. 2419 (2006)",16483772,Scientific Literature
8e,CHEMBL205798,"InChI=1S/C27H20ClFN4O2/c1-18(34)32-23-7-3-4-19(13-23)8-9-21-15-30-17-31-27(21)33-24-10-11-26(25(28)14-24)35-16-20-5-2-6-22(29)12-20/h2-7,10-15,17H,16H2,1H3,(H,32,34)(H,30,31,33)",CC(=O)Nc1cccc(c1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL205798,"InChI=1S/C27H20ClFN4O2/c1-18(34)32-23-7-3-4-19(13-23)8-9-21-15-30-17-31-27(21)33-24-10-11-26(25(28)14-24)35-16-20-5-2-6-22(29)12-20/h2-7,10-15,17H,16H2,1H3,(H,32,34)(H,30,31,33)",CC(=O)Nc1cccc(c1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL861555,Permeability in PAMPA,permeability,<,3,nm s-1,,CHEMBL612558,,,,CHEMBL1147004,"Bioorg. Med. Chem. Lett., 16, p. 2419 (2006)",16483772,Scientific Literature
1,CHEMBL176857,"InChI=1S/C21H14Br2N2O3/c1-28-18-5-3-2-4-13(18)14-6-11(8-17(23)19(14)26)7-16-15-9-12(22)10-24-20(15)25-21(16)27/h2-10,26H,1H3,(H,24,25,27)/b16-7-",COc1ccccc1c2cc(\C=C\3/C(=O)Nc4ncc(Br)cc34)cc(Br)c2O,CHEMBL176857,"InChI=1S/C21H14Br2N2O3/c1-28-18-5-3-2-4-13(18)14-6-11(8-17(23)19(14)26)7-16-15-9-12(22)10-24-20(15)25-21(16)27/h2-10,26H,1H3,(H,24,25,27)/b16-7-",COc1ccccc1c2cc(\C=C\3/C(=O)Nc4ncc(Br)cc34)cc(Br)c2O,CHEMBL857421,Inhibition of c-Raf1 kinase,IC50,=,700,nM,,CHEMBL1906,Serine/threonine-protein kinase RAF,Homo sapiens,P04049,CHEMBL1147447,"Bioorg. Med. Chem. Lett., 14, p. 953 (2004)",15013000,Scientific Literature
5,CHEMBL175321,"InChI=1S/C17H13NO2/c19-11-6-8-12-10(9-11)5-7-13(12)16-14-3-1-2-4-15(14)18-17(16)20/h1-4,6,8-9,19H,5,7H2,(H,18,20)/b16-13-",Oc1ccc2\C(=C\3/C(=O)Nc4ccccc34)\CCc2c1,CHEMBL175321,"InChI=1S/C17H13NO2/c19-11-6-8-12-10(9-11)5-7-13(12)16-14-3-1-2-4-15(14)18-17(16)20/h1-4,6,8-9,19H,5,7H2,(H,18,20)/b16-13-",Oc1ccc2\C(=C\3/C(=O)Nc4ccccc34)\CCc2c1,CHEMBL857421,Inhibition of c-Raf1 kinase,IC50,>,10000,nM,,CHEMBL1906,Serine/threonine-protein kinase RAF,Homo sapiens,P04049,CHEMBL1147447,"Bioorg. Med. Chem. Lett., 14, p. 953 (2004)",15013000,Scientific Literature
6,CHEMBL1794058,"InChI=1S/C16H15N3O3S/c1-23(21,22)19-12-8-6-11(7-9-12)17-10-14-13-4-2-3-5-15(13)18-16(14)20/h2-10,17,19H,1H3,(H,18,20)/b14-10-",CS(=O)(=O)Nc1ccc(N\C=C\2/C(=O)Nc3ccccc23)cc1,CHEMBL1794058,"InChI=1S/C16H15N3O3S/c1-23(21,22)19-12-8-6-11(7-9-12)17-10-14-13-4-2-3-5-15(13)18-16(14)20/h2-10,17,19H,1H3,(H,18,20)/b14-10-",CS(=O)(=O)Nc1ccc(N\C=C\2/C(=O)Nc3ccccc23)cc1,CHEMBL857421,Inhibition of c-Raf1 kinase,IC50,>,10000,nM,,CHEMBL1906,Serine/threonine-protein kinase RAF,Homo sapiens,P04049,CHEMBL1147447,"Bioorg. Med. Chem. Lett., 14, p. 953 (2004)",15013000,Scientific Literature
7,CHEMBL1794057,"InChI=1S/C16H12N4O2/c21-15-11(10-3-1-2-4-12(10)18-15)8-17-9-5-6-13-14(7-9)20-16(22)19-13/h1-8,17H,(H,18,21)(H2,19,20,22)/b11-8-",O=C1Nc2ccc(N\C=C\3/C(=O)Nc4ccccc34)cc2N1,CHEMBL1794057,"InChI=1S/C16H12N4O2/c21-15-11(10-3-1-2-4-12(10)18-15)8-17-9-5-6-13-14(7-9)20-16(22)19-13/h1-8,17H,(H,18,21)(H2,19,20,22)/b11-8-",O=C1Nc2ccc(N\C=C\3/C(=O)Nc4ccccc34)cc2N1,CHEMBL857421,Inhibition of c-Raf1 kinase,IC50,>,10000,nM,,CHEMBL1906,Serine/threonine-protein kinase RAF,Homo sapiens,P04049,CHEMBL1147447,"Bioorg. Med. Chem. Lett., 14, p. 953 (2004)",15013000,Scientific Literature
8,CHEMBL1794059,"InChI=1S/C15H13N3O3S/c16-22(20,21)11-5-3-4-10(8-11)17-9-13-12-6-1-2-7-14(12)18-15(13)19/h1-9,17H,(H,18,19)(H2,16,20,21)/b13-9-",NS(=O)(=O)c1cccc(N\C=C\2/C(=O)Nc3ccccc23)c1,CHEMBL1794059,"InChI=1S/C15H13N3O3S/c16-22(20,21)11-5-3-4-10(8-11)17-9-13-12-6-1-2-7-14(12)18-15(13)19/h1-9,17H,(H,18,19)(H2,16,20,21)/b13-9-",NS(=O)(=O)c1cccc(N\C=C\2/C(=O)Nc3ccccc23)c1,CHEMBL857421,Inhibition of c-Raf1 kinase,IC50,>,10000,nM,,CHEMBL1906,Serine/threonine-protein kinase RAF,Homo sapiens,P04049,CHEMBL1147447,"Bioorg. Med. Chem. Lett., 14, p. 953 (2004)",15013000,Scientific Literature
9,CHEMBL1794056,"InChI=1S/C17H13N5O/c23-17-15(14-3-1-2-4-16(14)21-17)9-19-12-5-7-13(8-6-12)22-11-18-10-20-22/h1-11,19H,(H,21,23)/b15-9-",O=C1Nc2ccccc2/C/1=C/Nc3ccc(cc3)n4cncn4,CHEMBL1794056,"InChI=1S/C17H13N5O/c23-17-15(14-3-1-2-4-16(14)21-17)9-19-12-5-7-13(8-6-12)22-11-18-10-20-22/h1-11,19H,(H,21,23)/b15-9-",O=C1Nc2ccccc2/C/1=C/Nc3ccc(cc3)n4cncn4,CHEMBL857421,Inhibition of c-Raf1 kinase,IC50,>,10000,nM,,CHEMBL1906,Serine/threonine-protein kinase RAF,Homo sapiens,P04049,CHEMBL1147447,"Bioorg. Med. Chem. Lett., 14, p. 953 (2004)",15013000,Scientific Literature
1,CHEMBL176857,"InChI=1S/C21H14Br2N2O3/c1-28-18-5-3-2-4-13(18)14-6-11(8-17(23)19(14)26)7-16-15-9-12(22)10-24-20(15)25-21(16)27/h2-10,26H,1H3,(H,24,25,27)/b16-7-",COc1ccccc1c2cc(\C=C\3/C(=O)Nc4ncc(Br)cc34)cc(Br)c2O,CHEMBL176857,"InChI=1S/C21H14Br2N2O3/c1-28-18-5-3-2-4-13(18)14-6-11(8-17(23)19(14)26)7-16-15-9-12(22)10-24-20(15)25-21(16)27/h2-10,26H,1H3,(H,24,25,27)/b16-7-",COc1ccccc1c2cc(\C=C\3/C(=O)Nc4ncc(Br)cc34)cc(Br)c2O,CHEMBL818318,"Inhibition of receptor Tyrosine kinase A, TrkA (nerve growth factor receptor)",IC50,=,8,nM,,CHEMBL2815,Nerve growth factor receptor Trk-A,Homo sapiens,P04629,CHEMBL1147447,"Bioorg. Med. Chem. Lett., 14, p. 953 (2004)",15013000,Scientific Literature
5,CHEMBL175321,"InChI=1S/C17H13NO2/c19-11-6-8-12-10(9-11)5-7-13(12)16-14-3-1-2-4-15(14)18-17(16)20/h1-4,6,8-9,19H,5,7H2,(H,18,20)/b16-13-",Oc1ccc2\C(=C\3/C(=O)Nc4ccccc34)\CCc2c1,CHEMBL175321,"InChI=1S/C17H13NO2/c19-11-6-8-12-10(9-11)5-7-13(12)16-14-3-1-2-4-15(14)18-17(16)20/h1-4,6,8-9,19H,5,7H2,(H,18,20)/b16-13-",Oc1ccc2\C(=C\3/C(=O)Nc4ccccc34)\CCc2c1,CHEMBL818318,"Inhibition of receptor Tyrosine kinase A, TrkA (nerve growth factor receptor)",IC50,=,6,nM,,CHEMBL2815,Nerve growth factor receptor Trk-A,Homo sapiens,P04629,CHEMBL1147447,"Bioorg. Med. Chem. Lett., 14, p. 953 (2004)",15013000,Scientific Literature
6,CHEMBL1794058,"InChI=1S/C16H15N3O3S/c1-23(21,22)19-12-8-6-11(7-9-12)17-10-14-13-4-2-3-5-15(13)18-16(14)20/h2-10,17,19H,1H3,(H,18,20)/b14-10-",CS(=O)(=O)Nc1ccc(N\C=C\2/C(=O)Nc3ccccc23)cc1,CHEMBL1794058,"InChI=1S/C16H15N3O3S/c1-23(21,22)19-12-8-6-11(7-9-12)17-10-14-13-4-2-3-5-15(13)18-16(14)20/h2-10,17,19H,1H3,(H,18,20)/b14-10-",CS(=O)(=O)Nc1ccc(N\C=C\2/C(=O)Nc3ccccc23)cc1,CHEMBL818318,"Inhibition of receptor Tyrosine kinase A, TrkA (nerve growth factor receptor)",IC50,=,6,nM,,CHEMBL2815,Nerve growth factor receptor Trk-A,Homo sapiens,P04629,CHEMBL1147447,"Bioorg. Med. Chem. Lett., 14, p. 953 (2004)",15013000,Scientific Literature
7,CHEMBL1794057,"InChI=1S/C16H12N4O2/c21-15-11(10-3-1-2-4-12(10)18-15)8-17-9-5-6-13-14(7-9)20-16(22)19-13/h1-8,17H,(H,18,21)(H2,19,20,22)/b11-8-",O=C1Nc2ccc(N\C=C\3/C(=O)Nc4ccccc34)cc2N1,CHEMBL1794057,"InChI=1S/C16H12N4O2/c21-15-11(10-3-1-2-4-12(10)18-15)8-17-9-5-6-13-14(7-9)20-16(22)19-13/h1-8,17H,(H,18,21)(H2,19,20,22)/b11-8-",O=C1Nc2ccc(N\C=C\3/C(=O)Nc4ccccc34)cc2N1,CHEMBL818318,"Inhibition of receptor Tyrosine kinase A, TrkA (nerve growth factor receptor)",IC50,=,7.0,nM,,CHEMBL2815,Nerve growth factor receptor Trk-A,Homo sapiens,P04629,CHEMBL1147447,"Bioorg. Med. Chem. Lett., 14, p. 953 (2004)",15013000,Scientific Literature
8,CHEMBL1794059,"InChI=1S/C15H13N3O3S/c16-22(20,21)11-5-3-4-10(8-11)17-9-13-12-6-1-2-7-14(12)18-15(13)19/h1-9,17H,(H,18,19)(H2,16,20,21)/b13-9-",NS(=O)(=O)c1cccc(N\C=C\2/C(=O)Nc3ccccc23)c1,CHEMBL1794059,"InChI=1S/C15H13N3O3S/c16-22(20,21)11-5-3-4-10(8-11)17-9-13-12-6-1-2-7-14(12)18-15(13)19/h1-9,17H,(H,18,19)(H2,16,20,21)/b13-9-",NS(=O)(=O)c1cccc(N\C=C\2/C(=O)Nc3ccccc23)c1,CHEMBL818318,"Inhibition of receptor Tyrosine kinase A, TrkA (nerve growth factor receptor)",IC50,=,63,nM,,CHEMBL2815,Nerve growth factor receptor Trk-A,Homo sapiens,P04629,CHEMBL1147447,"Bioorg. Med. Chem. Lett., 14, p. 953 (2004)",15013000,Scientific Literature
9,CHEMBL1794056,"InChI=1S/C17H13N5O/c23-17-15(14-3-1-2-4-16(14)21-17)9-19-12-5-7-13(8-6-12)22-11-18-10-20-22/h1-11,19H,(H,21,23)/b15-9-",O=C1Nc2ccccc2/C/1=C/Nc3ccc(cc3)n4cncn4,CHEMBL1794056,"InChI=1S/C17H13N5O/c23-17-15(14-3-1-2-4-16(14)21-17)9-19-12-5-7-13(8-6-12)22-11-18-10-20-22/h1-11,19H,(H,21,23)/b15-9-",O=C1Nc2ccccc2/C/1=C/Nc3ccc(cc3)n4cncn4,CHEMBL818318,"Inhibition of receptor Tyrosine kinase A, TrkA (nerve growth factor receptor)",IC50,=,8,nM,,CHEMBL2815,Nerve growth factor receptor Trk-A,Homo sapiens,P04629,CHEMBL1147447,"Bioorg. Med. Chem. Lett., 14, p. 953 (2004)",15013000,Scientific Literature
1,CHEMBL1789961,"InChI=1S/C19H16N6O2/c1-27-17-9-13(7-8-16(17)26)10-22-24-18-15-11-23-25(19(15)21-12-20-18)14-5-3-2-4-6-14/h2-12,26H,1H3,(H,20,21,24)",COc1cc(C=NNc2ncnc3c2cnn3c4ccccc4)ccc1O,CHEMBL1789961,"InChI=1S/C19H16N6O2/c1-27-17-9-13(7-8-16(17)26)10-22-24-18-15-11-23-25(19(15)21-12-20-18)14-5-3-2-4-6-14/h2-12,26H,1H3,(H,20,21,24)",COc1cc(C=NNc2ncnc3c2cnn3c4ccccc4)ccc1O,CHEMBL684359,"Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration",pIC50,=,7,,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1147546,"Bioorg. Med. Chem. Lett., 14, p. 2121 (2004)",15080992,Scientific Literature
13,CHEMBL306865,"InChI=1S/C18H15N7O/c1-26-15-4-2-3-14(9-15)25-18-16(11-23-25)17(20-12-21-18)24-22-10-13-5-7-19-8-6-13/h2-12H,1H3,(H,20,21,24)/b22-10+",COc1cccc(c1)n2ncc3c(N\N=C\c4ccncc4)ncnc23,CHEMBL306865,"InChI=1S/C18H15N7O/c1-26-15-4-2-3-14(9-15)25-18-16(11-23-25)17(20-12-21-18)24-22-10-13-5-7-19-8-6-13/h2-12H,1H3,(H,20,21,24)/b22-10+",COc1cccc(c1)n2ncc3c(N\N=C\c4ccncc4)ncnc23,CHEMBL684359,"Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration",pIC50,=,8.2,,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1147546,"Bioorg. Med. Chem. Lett., 14, p. 2121 (2004)",15080992,Scientific Literature
17,CHEMBL67241,"InChI=1S/C20H20N8/c1-2-8-22-16-4-3-5-17(11-16)28-20-18(13-26-28)19(23-14-24-20)27-25-12-15-6-9-21-10-7-15/h3-7,9-14,22H,2,8H2,1H3,(H,23,24,27)/b25-12+",CCCNc1cccc(c1)n2ncc3c(N\N=C\c4ccncc4)ncnc23,CHEMBL67241,"InChI=1S/C20H20N8/c1-2-8-22-16-4-3-5-17(11-16)28-20-18(13-26-28)19(23-14-24-20)27-25-12-15-6-9-21-10-7-15/h3-7,9-14,22H,2,8H2,1H3,(H,23,24,27)/b25-12+",CCCNc1cccc(c1)n2ncc3c(N\N=C\c4ccncc4)ncnc23,CHEMBL684359,"Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration",pIC50,=,5.4,,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1147546,"Bioorg. Med. Chem. Lett., 14, p. 2121 (2004)",15080992,Scientific Literature
31,CHEMBL305477,"InChI=1S/C20H18N6O2/c1-27-16-7-3-5-14(9-16)11-23-25-19-18-12-24-26(20(18)22-13-21-19)15-6-4-8-17(10-15)28-2/h3-13H,1-2H3,(H,21,22,25)/b23-11+",COc1cccc(\C=N\Nc2ncnc3c2cnn3c4cccc(OC)c4)c1,CHEMBL305477,"InChI=1S/C20H18N6O2/c1-27-16-7-3-5-14(9-16)11-23-25-19-18-12-24-26(20(18)22-13-21-19)15-6-4-8-17(10-15)28-2/h3-13H,1-2H3,(H,21,22,25)/b23-11+",COc1cccc(\C=N\Nc2ncnc3c2cnn3c4cccc(OC)c4)c1,CHEMBL684359,"Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration",pIC50,=,7.6,,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1147546,"Bioorg. Med. Chem. Lett., 14, p. 2121 (2004)",15080992,Scientific Literature
34,CHEMBL69757,"InChI=1S/C19H15FN6O/c1-27-16-7-3-6-15(9-16)26-19-17(11-24-26)18(21-12-22-19)25-23-10-13-4-2-5-14(20)8-13/h2-12H,1H3,(H,21,22,25)/b23-10+",COc1cccc(c1)n2ncc3c(N\N=C\c4cccc(F)c4)ncnc23,CHEMBL69757,"InChI=1S/C19H15FN6O/c1-27-16-7-3-6-15(9-16)26-19-17(11-24-26)18(21-12-22-19)25-23-10-13-4-2-5-14(20)8-13/h2-12H,1H3,(H,21,22,25)/b23-10+",COc1cccc(c1)n2ncc3c(N\N=C\c4cccc(F)c4)ncnc23,CHEMBL684359,"Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration",pIC50,=,8.1,,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1147546,"Bioorg. Med. Chem. Lett., 14, p. 2121 (2004)",15080992,Scientific Literature
35,CHEMBL65884,"InChI=1S/C19H15FN6O/c1-27-16-4-2-3-15(9-16)26-19-17(11-24-26)18(21-12-22-19)25-23-10-13-5-7-14(20)8-6-13/h2-12H,1H3,(H,21,22,25)/b23-10+",COc1cccc(c1)n2ncc3c(N\N=C\c4ccc(F)cc4)ncnc23,CHEMBL65884,"InChI=1S/C19H15FN6O/c1-27-16-4-2-3-15(9-16)26-19-17(11-24-26)18(21-12-22-19)25-23-10-13-5-7-14(20)8-6-13/h2-12H,1H3,(H,21,22,25)/b23-10+",COc1cccc(c1)n2ncc3c(N\N=C\c4ccc(F)cc4)ncnc23,CHEMBL684359,"Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration",pIC50,=,8.1,,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1147546,"Bioorg. Med. Chem. Lett., 14, p. 2121 (2004)",15080992,Scientific Literature
40,CHEMBL66292,"InChI=1S/C20H18N6O3S/c1-29-16-5-3-4-15(10-16)26-20-18(12-24-26)19(21-13-22-20)25-23-11-14-6-8-17(9-7-14)30(2,27)28/h3-13H,1-2H3,(H,21,22,25)/b23-11+",COc1cccc(c1)n2ncc3c(N\N=C\c4ccc(cc4)S(=O)(=O)C)ncnc23,CHEMBL66292,"InChI=1S/C20H18N6O3S/c1-29-16-5-3-4-15(10-16)26-20-18(12-24-26)19(21-13-22-20)25-23-11-14-6-8-17(9-7-14)30(2,27)28/h3-13H,1-2H3,(H,21,22,25)/b23-11+",COc1cccc(c1)n2ncc3c(N\N=C\c4ccc(cc4)S(=O)(=O)C)ncnc23,CHEMBL684359,"Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration",pIC50,=,8.6,,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1147546,"Bioorg. Med. Chem. Lett., 14, p. 2121 (2004)",15080992,Scientific Literature
5,CHEMBL66004,"InChI=1S/C13H12N6O2/c1-21-11-4-8(2-3-10(11)20)5-16-18-12-9-6-17-19-13(9)15-7-14-12/h2-7,20H,1H3,(H2,14,15,17,18,19)/b16-5+",COc1cc(\C=N\Nc2ncnc3[nH]ncc23)ccc1O,CHEMBL66004,"InChI=1S/C13H12N6O2/c1-21-11-4-8(2-3-10(11)20)5-16-18-12-9-6-17-19-13(9)15-7-14-12/h2-7,20H,1H3,(H2,14,15,17,18,19)/b16-5+",COc1cc(\C=N\Nc2ncnc3[nH]ncc23)ccc1O,CHEMBL684359,"Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration",pIC50,=,5.5,,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1147546,"Bioorg. Med. Chem. Lett., 14, p. 2121 (2004)",15080992,Scientific Literature
51,CHEMBL303687,"InChI=1S/C20H18N6O/c1-14-6-8-15(9-7-14)11-23-25-19-18-12-24-26(20(18)22-13-21-19)16-4-3-5-17(10-16)27-2/h3-13H,1-2H3,(H,21,22,25)/b23-11+",COc1cccc(c1)n2ncc3c(N\N=C\c4ccc(C)cc4)ncnc23,CHEMBL303687,"InChI=1S/C20H18N6O/c1-14-6-8-15(9-7-14)11-23-25-19-18-12-24-26(20(18)22-13-21-19)16-4-3-5-17(10-16)27-2/h3-13H,1-2H3,(H,21,22,25)/b23-11+",COc1cccc(c1)n2ncc3c(N\N=C\c4ccc(C)cc4)ncnc23,CHEMBL684359,"Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration",pIC50,<,4.5,,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1147546,"Bioorg. Med. Chem. Lett., 14, p. 2121 (2004)",15080992,Scientific Literature
55,CHEMBL67374,"InChI=1S/C24H26N8O2/c1-31(2)12-11-25-24(33)18-9-7-17(8-10-18)14-28-30-22-21-15-29-32(23(21)27-16-26-22)19-5-4-6-20(13-19)34-3/h4-10,13-16H,11-12H2,1-3H3,(H,25,33)(H,26,27,30)/b28-14+",COc1cccc(c1)n2ncc3c(N\N=C\c4ccc(cc4)C(=O)NCCN(C)C)ncnc23,CHEMBL67374,"InChI=1S/C24H26N8O2/c1-31(2)12-11-25-24(33)18-9-7-17(8-10-18)14-28-30-22-21-15-29-32(23(21)27-16-26-22)19-5-4-6-20(13-19)34-3/h4-10,13-16H,11-12H2,1-3H3,(H,25,33)(H,26,27,30)/b28-14+",COc1cccc(c1)n2ncc3c(N\N=C\c4ccc(cc4)C(=O)NCCN(C)C)ncnc23,CHEMBL684359,"Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration",pIC50,=,7.8,,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1147546,"Bioorg. Med. Chem. Lett., 14, p. 2121 (2004)",15080992,Scientific Literature
6,CHEMBL63728,"InChI=1S/C16H18N6O2/c1-10(2)22-16-12(8-20-22)15(17-9-18-16)21-19-7-11-4-5-13(23)14(6-11)24-3/h4-10,23H,1-3H3,(H,17,18,21)/b19-7+",COc1cc(\C=N\Nc2ncnc3c2cnn3C(C)C)ccc1O,CHEMBL63728,"InChI=1S/C16H18N6O2/c1-10(2)22-16-12(8-20-22)15(17-9-18-16)21-19-7-11-4-5-13(23)14(6-11)24-3/h4-10,23H,1-3H3,(H,17,18,21)/b19-7+",COc1cc(\C=N\Nc2ncnc3c2cnn3C(C)C)ccc1O,CHEMBL684359,"Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration",pIC50,=,5.6,,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1147546,"Bioorg. Med. Chem. Lett., 14, p. 2121 (2004)",15080992,Scientific Literature
63,CHEMBL442363,"InChI=1S/C20H19N7O/c1-13(15-7-9-21-10-8-15)24-25-19-18-14(2)26-27(20(18)23-12-22-19)16-5-4-6-17(11-16)28-3/h4-12H,1-3H3,(H,22,23,25)/b24-13+",COc1cccc(c1)n2nc(C)c3c(N\N=C(/C)\c4ccncc4)ncnc23,CHEMBL442363,"InChI=1S/C20H19N7O/c1-13(15-7-9-21-10-8-15)24-25-19-18-14(2)26-27(20(18)23-12-22-19)16-5-4-6-17(11-16)28-3/h4-12H,1-3H3,(H,22,23,25)/b24-13+",COc1cccc(c1)n2nc(C)c3c(N\N=C(/C)\c4ccncc4)ncnc23,CHEMBL684359,"Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration",pIC50,=,5.2,,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1147546,"Bioorg. Med. Chem. Lett., 14, p. 2121 (2004)",15080992,Scientific Literature
7,CHEMBL1789962,"InChI=1S/C20H18N6O2/c1-28-18-9-15(7-8-17(18)27)10-23-25-19-16-11-24-26(20(16)22-13-21-19)12-14-5-3-2-4-6-14/h2-11,13,27H,12H2,1H3,(H,21,22,25)",COc1cc(C=NNc2ncnc3c2cnn3Cc4ccccc4)ccc1O,CHEMBL1789962,"InChI=1S/C20H18N6O2/c1-28-18-9-15(7-8-17(18)27)10-23-25-19-16-11-24-26(20(16)22-13-21-19)12-14-5-3-2-4-6-14/h2-11,13,27H,12H2,1H3,(H,21,22,25)",COc1cc(C=NNc2ncnc3c2cnn3Cc4ccccc4)ccc1O,CHEMBL684359,"Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration",pIC50,<,5,,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1147546,"Bioorg. Med. Chem. Lett., 14, p. 2121 (2004)",15080992,Scientific Literature
1A,CHEMBL306865,"InChI=1S/C18H15N7O/c1-26-15-4-2-3-14(9-15)25-18-16(11-23-25)17(20-12-21-18)24-22-10-13-5-7-19-8-6-13/h2-12H,1H3,(H,20,21,24)/b22-10+",COc1cccc(c1)n2ncc3c(N\N=C\c4ccncc4)ncnc23,CHEMBL306865,"InChI=1S/C18H15N7O/c1-26-15-4-2-3-14(9-15)25-18-16(11-23-25)17(20-12-21-18)24-22-10-13-5-7-19-8-6-13/h2-12H,1H3,(H,20,21,24)/b22-10+",COc1cccc(c1)n2ncc3c(N\N=C\c4ccncc4)ncnc23,CHEMBL713284,Cell permeation in MDCK cells,Cell permeation,=,127,nm s-1,,CHEMBL614068,MDCK (Kidney cells),Canis lupus familiaris,,CHEMBL1147547,"Bioorg. Med. Chem. Lett., 14, p. 2127 (2004)",15080993,Scientific Literature
1B,CHEMBL65884,"InChI=1S/C19H15FN6O/c1-27-16-4-2-3-15(9-16)26-19-17(11-24-26)18(21-12-22-19)25-23-10-13-5-7-14(20)8-6-13/h2-12H,1H3,(H,21,22,25)/b23-10+",COc1cccc(c1)n2ncc3c(N\N=C\c4ccc(F)cc4)ncnc23,CHEMBL65884,"InChI=1S/C19H15FN6O/c1-27-16-4-2-3-15(9-16)26-19-17(11-24-26)18(21-12-22-19)25-23-10-13-5-7-14(20)8-6-13/h2-12H,1H3,(H,21,22,25)/b23-10+",COc1cccc(c1)n2ncc3c(N\N=C\c4ccc(F)cc4)ncnc23,CHEMBL713284,Cell permeation in MDCK cells,Cell permeation,=,5,nm s-1,,CHEMBL614068,MDCK (Kidney cells),Canis lupus familiaris,,CHEMBL1147547,"Bioorg. Med. Chem. Lett., 14, p. 2127 (2004)",15080993,Scientific Literature
1C,CHEMBL67374,"InChI=1S/C24H26N8O2/c1-31(2)12-11-25-24(33)18-9-7-17(8-10-18)14-28-30-22-21-15-29-32(23(21)27-16-26-22)19-5-4-6-20(13-19)34-3/h4-10,13-16H,11-12H2,1-3H3,(H,25,33)(H,26,27,30)/b28-14+",COc1cccc(c1)n2ncc3c(N\N=C\c4ccc(cc4)C(=O)NCCN(C)C)ncnc23,CHEMBL67374,"InChI=1S/C24H26N8O2/c1-31(2)12-11-25-24(33)18-9-7-17(8-10-18)14-28-30-22-21-15-29-32(23(21)27-16-26-22)19-5-4-6-20(13-19)34-3/h4-10,13-16H,11-12H2,1-3H3,(H,25,33)(H,26,27,30)/b28-14+",COc1cccc(c1)n2ncc3c(N\N=C\c4ccc(cc4)C(=O)NCCN(C)C)ncnc23,CHEMBL713284,Cell permeation in MDCK cells,Cell permeation,=,15,nm s-1,,CHEMBL614068,MDCK (Kidney cells),Canis lupus familiaris,,CHEMBL1147547,"Bioorg. Med. Chem. Lett., 14, p. 2127 (2004)",15080993,Scientific Literature
1D,CHEMBL66292,"InChI=1S/C20H18N6O3S/c1-29-16-5-3-4-15(10-16)26-20-18(12-24-26)19(21-13-22-20)25-23-11-14-6-8-17(9-7-14)30(2,27)28/h3-13H,1-2H3,(H,21,22,25)/b23-11+",COc1cccc(c1)n2ncc3c(N\N=C\c4ccc(cc4)S(=O)(=O)C)ncnc23,CHEMBL66292,"InChI=1S/C20H18N6O3S/c1-29-16-5-3-4-15(10-16)26-20-18(12-24-26)19(21-13-22-20)25-23-11-14-6-8-17(9-7-14)30(2,27)28/h3-13H,1-2H3,(H,21,22,25)/b23-11+",COc1cccc(c1)n2ncc3c(N\N=C\c4ccc(cc4)S(=O)(=O)C)ncnc23,CHEMBL713284,Cell permeation in MDCK cells,Cell permeation,=,168,nm s-1,,CHEMBL614068,MDCK (Kidney cells),Canis lupus familiaris,,CHEMBL1147547,"Bioorg. Med. Chem. Lett., 14, p. 2127 (2004)",15080993,Scientific Literature
18,CHEMBL304624,"InChI=1S/C20H15N3O/c24-17-8-4-7-16(13-17)19-18(14-9-11-21-12-10-14)22-20(23-19)15-5-2-1-3-6-15/h1-13,24H,(H,22,23)",Oc1cccc(c1)c2nc([nH]c2c3ccncc3)c4ccccc4,CHEMBL304624,"InChI=1S/C20H15N3O/c24-17-8-4-7-16(13-17)19-18(14-9-11-21-12-10-14)22-20(23-19)15-5-2-1-3-6-15/h1-13,24H,(H,22,23)",Oc1cccc(c1)c2nc([nH]c2c3ccncc3)c4ccccc4,CHEMBL869914,Binding affinity at bRaf kinase in fluorescent ligand displacement assay,Kd,=,8,nM,,CHEMBL5145,Serine/threonine-protein kinase B-raf,Homo sapiens,P15056,CHEMBL1147772,"Bioorg. Med. Chem. Lett., 16, p. 378 (2006)",16260133,Scientific Literature
"33, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL869914,Binding affinity at bRaf kinase in fluorescent ligand displacement assay,Kd,=,0.3,nM,,CHEMBL5145,Serine/threonine-protein kinase B-raf,Homo sapiens,P15056,CHEMBL1147772,"Bioorg. Med. Chem. Lett., 16, p. 378 (2006)",16260133,Scientific Literature
7,CHEMBL200320,"InChI=1S/C21H17ClN4O/c22-17-6-5-16(11-18(17)27)20-19(14-7-9-24-10-8-14)25-21(26-20)15-3-1-13(12-23)2-4-15/h1-11,27H,12,23H2,(H,25,26)",NCc1ccc(cc1)c2nc(c3ccc(Cl)c(O)c3)c([nH]2)c4ccncc4,CHEMBL200320,"InChI=1S/C21H17ClN4O/c22-17-6-5-16(11-18(17)27)20-19(14-7-9-24-10-8-14)25-21(26-20)15-3-1-13(12-23)2-4-15/h1-11,27H,12,23H2,(H,25,26)",NCc1ccc(cc1)c2nc(c3ccc(Cl)c(O)c3)c([nH]2)c4ccncc4,CHEMBL869914,Binding affinity at bRaf kinase in fluorescent ligand displacement assay,Kd,=,5.3,nM,,CHEMBL5145,Serine/threonine-protein kinase B-raf,Homo sapiens,P15056,CHEMBL1147772,"Bioorg. Med. Chem. Lett., 16, p. 378 (2006)",16260133,Scientific Literature
7,CHEMBL200320,"InChI=1S/C21H17ClN4O/c22-17-6-5-16(11-18(17)27)20-19(14-7-9-24-10-8-14)25-21(26-20)15-3-1-13(12-23)2-4-15/h1-11,27H,12,23H2,(H,25,26)",NCc1ccc(cc1)c2nc(c3ccc(Cl)c(O)c3)c([nH]2)c4ccncc4,CHEMBL200320,"InChI=1S/C21H17ClN4O/c22-17-6-5-16(11-18(17)27)20-19(14-7-9-24-10-8-14)25-21(26-20)15-3-1-13(12-23)2-4-15/h1-11,27H,12,23H2,(H,25,26)",NCc1ccc(cc1)c2nc(c3ccc(Cl)c(O)c3)c([nH]2)c4ccncc4,CHEMBL869911,Inhibition bRaf kinase activity,IC50,=,8,nM,,CHEMBL5145,Serine/threonine-protein kinase B-raf,Homo sapiens,P15056,CHEMBL1147772,"Bioorg. Med. Chem. Lett., 16, p. 378 (2006)",16260133,Scientific Literature
"33, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL869919,Inhibition of CHK1 activity at 10 uM,Inhibition,=,9,%,,CHEMBL4630,Serine/threonine-protein kinase Chk1 ,Homo sapiens,O14757,CHEMBL1147772,"Bioorg. Med. Chem. Lett., 16, p. 378 (2006)",16260133,Scientific Literature
"33, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL865760,Inhibition of GSK3-beta activity at 10 uM,Inhibition,=,25,%,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1147772,"Bioorg. Med. Chem. Lett., 16, p. 378 (2006)",16260133,Scientific Literature
"33, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL865761,Inhibition of JNK1 activity at 10 uM,Inhibition,=,19,%,,CHEMBL2276,c-Jun N-terminal kinase 1,Homo sapiens,P45983,CHEMBL1147772,"Bioorg. Med. Chem. Lett., 16, p. 378 (2006)",16260133,Scientific Literature
"33, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL865762,Inhibition of Lck activity at 10 uM,Inhibition,=,39,%,,CHEMBL258,Tyrosine-protein kinase LCK,Homo sapiens,P06239,CHEMBL1147772,"Bioorg. Med. Chem. Lett., 16, p. 378 (2006)",16260133,Scientific Literature
"33, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL865763,Inhibition of MAPK2 activity at 10 uM,Inhibition,=,11,%,,CHEMBL4040,MAP kinase ERK2,Homo sapiens,P28482,CHEMBL1147772,"Bioorg. Med. Chem. Lett., 16, p. 378 (2006)",16260133,Scientific Literature
"33, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL865764,Inhibition of MAPKAPK2 activity at 10 uM,Inhibition,=,9,%,,CHEMBL2208,MAP kinase-activated protein kinase 2,Homo sapiens,P49137,CHEMBL1147772,"Bioorg. Med. Chem. Lett., 16, p. 378 (2006)",16260133,Scientific Literature
"33, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL865765,Inhibition of MEK1 activity at 10 uM,Inhibition,=,14,%,,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,Homo sapiens,Q02750,CHEMBL1147772,"Bioorg. Med. Chem. Lett., 16, p. 378 (2006)",16260133,Scientific Literature
"33, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL865766,Inhibition of MSK1 activity at 10 uM,Inhibition,=,38,%,,CHEMBL4237,Ribosomal protein S6 kinase alpha 5,Homo sapiens,O75582,CHEMBL1147772,"Bioorg. Med. Chem. Lett., 16, p. 378 (2006)",16260133,Scientific Literature
"33, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL865768,Inhibition of PKBalpha activity at 10 uM,Inhibition,=,8,%,,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,P31749,CHEMBL1147772,"Bioorg. Med. Chem. Lett., 16, p. 378 (2006)",16260133,Scientific Literature
"33, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL865775,Inhibition of PKCalpha activity at 10 uM,Inhibition,=,10,%,,CHEMBL299,Protein kinase C alpha ,Homo sapiens,P17252,CHEMBL1147772,"Bioorg. Med. Chem. Lett., 16, p. 378 (2006)",16260133,Scientific Literature
"33, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL865776,Inhibition of PRAK activity at 10 uM,Inhibition,=,18,%,,CHEMBL3094,MAP kinase-activated protein kinase 5,Homo sapiens,Q8IW41,CHEMBL1147772,"Bioorg. Med. Chem. Lett., 16, p. 378 (2006)",16260133,Scientific Literature
"33, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL865777,Inhibition of ROCK2 activity at 10 uM,Inhibition,=,26,%,,CHEMBL2973,Rho-associated protein kinase 2,Homo sapiens,O75116,CHEMBL1147772,"Bioorg. Med. Chem. Lett., 16, p. 378 (2006)",16260133,Scientific Literature
"33, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL865784,Inhibition of SGK activity at 10 uM,Inhibition,=,17,%,,CHEMBL2343,Serine/threonine-protein kinase Sgk1,Homo sapiens,O00141,CHEMBL1147772,"Bioorg. Med. Chem. Lett., 16, p. 378 (2006)",16260133,Scientific Literature
"33, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL865778,Inhibition of p38-alpha MAPK activity at 10 uM,Inhibition,=,46,%,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1147772,"Bioorg. Med. Chem. Lett., 16, p. 378 (2006)",16260133,Scientific Literature
"33, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL865779,Inhibition of p38-beta MAPK activity at 10 uM,Inhibition,=,9,%,,CHEMBL3961,MAP kinase p38 beta,Homo sapiens,Q15759,CHEMBL1147772,"Bioorg. Med. Chem. Lett., 16, p. 378 (2006)",16260133,Scientific Literature
"33, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL865781,Inhibition of p38-gamma MAPK activity at 10 uM,Inhibition,=,10,%,,CHEMBL4674,MAP kinase p38 gamma,Homo sapiens,P53778,CHEMBL1147772,"Bioorg. Med. Chem. Lett., 16, p. 378 (2006)",16260133,Scientific Literature
"33, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL865782,Inhibition of p38delta MAPK activity at 10 uM,Inhibition,=,10,%,,CHEMBL2939,MAP kinase p38 delta,Homo sapiens,O15264,CHEMBL1147772,"Bioorg. Med. Chem. Lett., 16, p. 378 (2006)",16260133,Scientific Literature
96,CHEMBL270054,"InChI=1S/C14H11ClN4O3S/c15-8-1-6-12-11(7-8)13(14(20)17-12)19-18-9-2-4-10(5-3-9)23(16,21)22/h1-7,18H,(H2,16,21,22)(H,17,19,20)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(Cl)cc23)cc1,CHEMBL270054,"InChI=1S/C14H11ClN4O3S/c15-8-1-6-12-11(7-8)13(14(20)17-12)19-18-9-2-4-10(5-3-9)23(16,21)22/h1-7,18H,(H2,16,21,22)(H,17,19,20)",NS(=O)(=O)c1ccc(N\N=C\2/C(=O)Nc3ccc(Cl)cc23)cc1,CHEMBL660781,Inhibition of Cyclin-Dependent Kinase 2,IC50,=,30,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1148343,"J. Med. Chem., 47, p. 3463 (2004)",15214773,Scientific Literature
15,CHEMBL243891,"InChI=1S/C22H19N5O4/c1-30-22(29)27-20-25-18-12-11-17(13-19(18)26-20)31-16-9-7-15(8-10-16)24-21(28)23-14-5-3-2-4-6-14/h2-13H,1H3,(H2,23,24,28)(H2,25,26,27,29)",COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1,CHEMBL243891,"InChI=1S/C22H19N5O4/c1-30-22(29)27-20-25-18-12-11-17(13-19(18)26-20)31-16-9-7-15(8-10-16)24-21(28)23-14-5-3-2-4-6-14/h2-13H,1H3,(H2,23,24,28)(H2,25,26,27,29)",COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1,CHEMBL895709,Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus,IC50,=,3200,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1148750,"J. Med. Chem., 50, p. 4453 (2007)",17676829,Scientific Literature
19,CHEMBL243907,"InChI=1S/C24H23N5O4/c1-3-15-5-4-6-17(13-15)26-23(30)25-16-7-9-18(10-8-16)33-19-11-12-20-21(14-19)28-22(27-20)29-24(31)32-2/h4-14H,3H2,1-2H3,(H2,25,26,30)(H2,27,28,29,31)",CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1,CHEMBL243907,"InChI=1S/C24H23N5O4/c1-3-15-5-4-6-17(13-15)26-23(30)25-16-7-9-18(10-8-16)33-19-11-12-20-21(14-19)28-22(27-20)29-24(31)32-2/h4-14H,3H2,1-2H3,(H2,25,26,30)(H2,27,28,29,31)",CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1,CHEMBL895709,Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus,IC50,=,18,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1148750,"J. Med. Chem., 50, p. 4453 (2007)",17676829,Scientific Literature
20,CHEMBL243908,"InChI=1S/C22H18BrN5O4/c1-31-22(30)28-20-26-18-10-9-17(12-19(18)27-20)32-16-7-5-14(6-8-16)24-21(29)25-15-4-2-3-13(23)11-15/h2-12H,1H3,(H2,24,25,29)(H2,26,27,28,30)",COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1,CHEMBL243908,"InChI=1S/C22H18BrN5O4/c1-31-22(30)28-20-26-18-10-9-17(12-19(18)27-20)32-16-7-5-14(6-8-16)24-21(29)25-15-4-2-3-13(23)11-15/h2-12H,1H3,(H2,24,25,29)(H2,26,27,28,30)",COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1,CHEMBL895709,Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus,IC50,=,13,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1148750,"J. Med. Chem., 50, p. 4453 (2007)",17676829,Scientific Literature
21,CHEMBL396283,"InChI=1S/C22H18ClN5O4/c1-31-22(30)28-20-26-18-10-9-17(12-19(18)27-20)32-16-7-5-14(6-8-16)24-21(29)25-15-4-2-3-13(23)11-15/h2-12H,1H3,(H2,24,25,29)(H2,26,27,28,30)",COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1,CHEMBL396283,"InChI=1S/C22H18ClN5O4/c1-31-22(30)28-20-26-18-10-9-17(12-19(18)27-20)32-16-7-5-14(6-8-16)24-21(29)25-15-4-2-3-13(23)11-15/h2-12H,1H3,(H2,24,25,29)(H2,26,27,28,30)",COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1,CHEMBL895709,Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus,IC50,=,40,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1148750,"J. Med. Chem., 50, p. 4453 (2007)",17676829,Scientific Literature
26,CHEMBL244097,"InChI=1S/C23H19N5O6/c1-33-23(32)28-21-26-18-10-9-17(12-19(18)27-21)34-16-7-5-14(6-8-16)24-22(31)25-15-4-2-3-13(11-15)20(29)30/h2-12H,1H3,(H,29,30)(H2,24,25,31)(H2,26,27,28,32)",COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(c4)C(=O)O)cc3)ccc2[nH]1,CHEMBL244097,"InChI=1S/C23H19N5O6/c1-33-23(32)28-21-26-18-10-9-17(12-19(18)27-21)34-16-7-5-14(6-8-16)24-22(31)25-15-4-2-3-13(11-15)20(29)30/h2-12H,1H3,(H,29,30)(H2,24,25,31)(H2,26,27,28,32)",COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(c4)C(=O)O)cc3)ccc2[nH]1,CHEMBL895709,Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus,IC50,>,10000,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1148750,"J. Med. Chem., 50, p. 4453 (2007)",17676829,Scientific Literature
30,CHEMBL244289,"InChI=1S/C23H17F4N5O4/c1-35-22(34)32-20-29-17-8-6-15(11-19(17)30-20)36-14-4-2-3-13(10-14)28-21(33)31-18-9-12(23(25,26)27)5-7-16(18)24/h2-11H,1H3,(H2,28,31,33)(H2,29,30,32,34)",COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)c3)ccc2[nH]1,CHEMBL244289,"InChI=1S/C23H17F4N5O4/c1-35-22(34)32-20-29-17-8-6-15(11-19(17)30-20)36-14-4-2-3-13(10-14)28-21(33)31-18-9-12(23(25,26)27)5-7-16(18)24/h2-11H,1H3,(H2,28,31,33)(H2,29,30,32,34)",COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)c3)ccc2[nH]1,CHEMBL895709,Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus,IC50,=,28,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1148750,"J. Med. Chem., 50, p. 4453 (2007)",17676829,Scientific Literature
34,CHEMBL243912,"InChI=1S/C23H17F4N5O3S/c1-35-22(34)32-20-29-17-9-7-15(11-19(17)30-20)36-14-5-3-13(4-6-14)28-21(33)31-18-10-12(23(25,26)27)2-8-16(18)24/h2-11H,1H3,(H2,28,31,33)(H2,29,30,32,34)",COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)cc2[nH]1,CHEMBL243912,"InChI=1S/C23H17F4N5O3S/c1-35-22(34)32-20-29-17-9-7-15(11-19(17)30-20)36-14-5-3-13(4-6-14)28-21(33)31-18-10-12(23(25,26)27)2-8-16(18)24/h2-11H,1H3,(H2,28,31,33)(H2,29,30,32,34)",COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)cc2[nH]1,CHEMBL895709,Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus,IC50,=,10,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1148750,"J. Med. Chem., 50, p. 4453 (2007)",17676829,Scientific Literature
36,CHEMBL244099,"InChI=1S/C23H17F4N5O5S/c1-37-22(34)32-20-29-17-9-7-15(11-19(17)30-20)38(35,36)14-5-3-13(4-6-14)28-21(33)31-18-10-12(23(25,26)27)2-8-16(18)24/h2-11H,1H3,(H2,28,31,33)(H2,29,30,32,34)",COC(=O)Nc1nc2ccc(cc2[nH]1)S(=O)(=O)c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3,CHEMBL244099,"InChI=1S/C23H17F4N5O5S/c1-37-22(34)32-20-29-17-9-7-15(11-19(17)30-20)38(35,36)14-5-3-13(4-6-14)28-21(33)31-18-10-12(23(25,26)27)2-8-16(18)24/h2-11H,1H3,(H2,28,31,33)(H2,29,30,32,34)",COC(=O)Nc1nc2ccc(cc2[nH]1)S(=O)(=O)c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3,CHEMBL895709,Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus,IC50,=,120,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1148750,"J. Med. Chem., 50, p. 4453 (2007)",17676829,Scientific Literature
40,CHEMBL244482,"InChI=1S/C23H16F4N4O4S/c1-34-22(33)31-21-30-17-9-7-15(11-19(17)36-21)35-14-5-3-13(4-6-14)28-20(32)29-18-10-12(23(25,26)27)2-8-16(18)24/h2-11H,1H3,(H2,28,29,32)(H,30,31,33)",COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)cc2s1,CHEMBL244482,"InChI=1S/C23H16F4N4O4S/c1-34-22(33)31-21-30-17-9-7-15(11-19(17)36-21)35-14-5-3-13(4-6-14)28-20(32)29-18-10-12(23(25,26)27)2-8-16(18)24/h2-11H,1H3,(H2,28,29,32)(H,30,31,33)",COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)cc2s1,CHEMBL895709,Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus,IC50,=,6.5,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1148750,"J. Med. Chem., 50, p. 4453 (2007)",17676829,Scientific Literature
47,CHEMBL243917,"InChI=1S/C28H19F4N5O3/c29-21-12-6-17(28(30,31)32)14-23(21)36-27(39)33-18-7-9-19(10-8-18)40-20-11-13-22-24(15-20)35-26(34-22)37-25(38)16-4-2-1-3-5-16/h1-15H,(H2,33,36,39)(H2,34,35,37,38)",Fc1ccc(cc1NC(=O)Nc2ccc(Oc3ccc4[nH]c(NC(=O)c5ccccc5)nc4c3)cc2)C(F)(F)F,CHEMBL243917,"InChI=1S/C28H19F4N5O3/c29-21-12-6-17(28(30,31)32)14-23(21)36-27(39)33-18-7-9-19(10-8-18)40-20-11-13-22-24(15-20)35-26(34-22)37-25(38)16-4-2-1-3-5-16/h1-15H,(H2,33,36,39)(H2,34,35,37,38)",Fc1ccc(cc1NC(=O)Nc2ccc(Oc3ccc4[nH]c(NC(=O)c5ccccc5)nc4c3)cc2)C(F)(F)F,CHEMBL895709,Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus,IC50,=,13,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1148750,"J. Med. Chem., 50, p. 4453 (2007)",17676829,Scientific Literature
49,CHEMBL244297,"InChI=1S/C26H17F4N5O4/c27-18-9-3-14(26(28,29)30)12-20(18)34-25(37)31-15-4-6-16(7-5-15)39-17-8-10-19-21(13-17)33-24(32-19)35-23(36)22-2-1-11-38-22/h1-13H,(H2,31,34,37)(H2,32,33,35,36)",Fc1ccc(cc1NC(=O)Nc2ccc(Oc3ccc4[nH]c(NC(=O)c5occc5)nc4c3)cc2)C(F)(F)F,CHEMBL244297,"InChI=1S/C26H17F4N5O4/c27-18-9-3-14(26(28,29)30)12-20(18)34-25(37)31-15-4-6-16(7-5-15)39-17-8-10-19-21(13-17)33-24(32-19)35-23(36)22-2-1-11-38-22/h1-13H,(H2,31,34,37)(H2,32,33,35,36)",Fc1ccc(cc1NC(=O)Nc2ccc(Oc3ccc4[nH]c(NC(=O)c5occc5)nc4c3)cc2)C(F)(F)F,CHEMBL895709,Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus,IC50,=,5.2,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1148750,"J. Med. Chem., 50, p. 4453 (2007)",17676829,Scientific Literature
15,CHEMBL243891,"InChI=1S/C22H19N5O4/c1-30-22(29)27-20-25-18-12-11-17(13-19(18)26-20)31-16-9-7-15(8-10-16)24-21(28)23-14-5-3-2-4-6-14/h2-13H,1H3,(H2,23,24,28)(H2,25,26,27,29)",COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1,CHEMBL243891,"InChI=1S/C22H19N5O4/c1-30-22(29)27-20-25-18-12-11-17(13-19(18)26-20)31-16-9-7-15(8-10-16)24-21(28)23-14-5-3-2-4-6-14/h2-13H,1H3,(H2,23,24,28)(H2,25,26,27,29)",COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1,CHEMBL895710,Inhibition of GST-tagged human recombinant VEGFR2 expressed in baculovirus,IC50,=,32,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1148750,"J. Med. Chem., 50, p. 4453 (2007)",17676829,Scientific Literature
19,CHEMBL243907,"InChI=1S/C24H23N5O4/c1-3-15-5-4-6-17(13-15)26-23(30)25-16-7-9-18(10-8-16)33-19-11-12-20-21(14-19)28-22(27-20)29-24(31)32-2/h4-14H,3H2,1-2H3,(H2,25,26,30)(H2,27,28,29,31)",CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1,CHEMBL243907,"InChI=1S/C24H23N5O4/c1-3-15-5-4-6-17(13-15)26-23(30)25-16-7-9-18(10-8-16)33-19-11-12-20-21(14-19)28-22(27-20)29-24(31)32-2/h4-14H,3H2,1-2H3,(H2,25,26,30)(H2,27,28,29,31)",CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1,CHEMBL895710,Inhibition of GST-tagged human recombinant VEGFR2 expressed in baculovirus,IC50,=,2.9,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1148750,"J. Med. Chem., 50, p. 4453 (2007)",17676829,Scientific Literature
20,CHEMBL243908,"InChI=1S/C22H18BrN5O4/c1-31-22(30)28-20-26-18-10-9-17(12-19(18)27-20)32-16-7-5-14(6-8-16)24-21(29)25-15-4-2-3-13(23)11-15/h2-12H,1H3,(H2,24,25,29)(H2,26,27,28,30)",COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1,CHEMBL243908,"InChI=1S/C22H18BrN5O4/c1-31-22(30)28-20-26-18-10-9-17(12-19(18)27-20)32-16-7-5-14(6-8-16)24-21(29)25-15-4-2-3-13(23)11-15/h2-12H,1H3,(H2,24,25,29)(H2,26,27,28,30)",COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1,CHEMBL895710,Inhibition of GST-tagged human recombinant VEGFR2 expressed in baculovirus,IC50,=,1.1,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1148750,"J. Med. Chem., 50, p. 4453 (2007)",17676829,Scientific Literature
21,CHEMBL396283,"InChI=1S/C22H18ClN5O4/c1-31-22(30)28-20-26-18-10-9-17(12-19(18)27-20)32-16-7-5-14(6-8-16)24-21(29)25-15-4-2-3-13(23)11-15/h2-12H,1H3,(H2,24,25,29)(H2,26,27,28,30)",COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1,CHEMBL396283,"InChI=1S/C22H18ClN5O4/c1-31-22(30)28-20-26-18-10-9-17(12-19(18)27-20)32-16-7-5-14(6-8-16)24-21(29)25-15-4-2-3-13(23)11-15/h2-12H,1H3,(H2,24,25,29)(H2,26,27,28,30)",COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1,CHEMBL895710,Inhibition of GST-tagged human recombinant VEGFR2 expressed in baculovirus,IC50,=,6.3,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1148750,"J. Med. Chem., 50, p. 4453 (2007)",17676829,Scientific Literature
26,CHEMBL244097,"InChI=1S/C23H19N5O6/c1-33-23(32)28-21-26-18-10-9-17(12-19(18)27-21)34-16-7-5-14(6-8-16)24-22(31)25-15-4-2-3-13(11-15)20(29)30/h2-12H,1H3,(H,29,30)(H2,24,25,31)(H2,26,27,28,32)",COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(c4)C(=O)O)cc3)ccc2[nH]1,CHEMBL244097,"InChI=1S/C23H19N5O6/c1-33-23(32)28-21-26-18-10-9-17(12-19(18)27-21)34-16-7-5-14(6-8-16)24-22(31)25-15-4-2-3-13(11-15)20(29)30/h2-12H,1H3,(H,29,30)(H2,24,25,31)(H2,26,27,28,32)",COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(c4)C(=O)O)cc3)ccc2[nH]1,CHEMBL895710,Inhibition of GST-tagged human recombinant VEGFR2 expressed in baculovirus,IC50,=,603,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1148750,"J. Med. Chem., 50, p. 4453 (2007)",17676829,Scientific Literature
30,CHEMBL244289,"InChI=1S/C23H17F4N5O4/c1-35-22(34)32-20-29-17-8-6-15(11-19(17)30-20)36-14-4-2-3-13(10-14)28-21(33)31-18-9-12(23(25,26)27)5-7-16(18)24/h2-11H,1H3,(H2,28,31,33)(H2,29,30,32,34)",COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)c3)ccc2[nH]1,CHEMBL244289,"InChI=1S/C23H17F4N5O4/c1-35-22(34)32-20-29-17-8-6-15(11-19(17)30-20)36-14-4-2-3-13(10-14)28-21(33)31-18-9-12(23(25,26)27)5-7-16(18)24/h2-11H,1H3,(H2,28,31,33)(H2,29,30,32,34)",COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)c3)ccc2[nH]1,CHEMBL895710,Inhibition of GST-tagged human recombinant VEGFR2 expressed in baculovirus,IC50,=,17,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1148750,"J. Med. Chem., 50, p. 4453 (2007)",17676829,Scientific Literature
34,CHEMBL243912,"InChI=1S/C23H17F4N5O3S/c1-35-22(34)32-20-29-17-9-7-15(11-19(17)30-20)36-14-5-3-13(4-6-14)28-21(33)31-18-10-12(23(25,26)27)2-8-16(18)24/h2-11H,1H3,(H2,28,31,33)(H2,29,30,32,34)",COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)cc2[nH]1,CHEMBL243912,"InChI=1S/C23H17F4N5O3S/c1-35-22(34)32-20-29-17-9-7-15(11-19(17)30-20)36-14-5-3-13(4-6-14)28-21(33)31-18-10-12(23(25,26)27)2-8-16(18)24/h2-11H,1H3,(H2,28,31,33)(H2,29,30,32,34)",COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)cc2[nH]1,CHEMBL895710,Inhibition of GST-tagged human recombinant VEGFR2 expressed in baculovirus,IC50,=,10,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1148750,"J. Med. Chem., 50, p. 4453 (2007)",17676829,Scientific Literature
36,CHEMBL244099,"InChI=1S/C23H17F4N5O5S/c1-37-22(34)32-20-29-17-9-7-15(11-19(17)30-20)38(35,36)14-5-3-13(4-6-14)28-21(33)31-18-10-12(23(25,26)27)2-8-16(18)24/h2-11H,1H3,(H2,28,31,33)(H2,29,30,32,34)",COC(=O)Nc1nc2ccc(cc2[nH]1)S(=O)(=O)c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3,CHEMBL244099,"InChI=1S/C23H17F4N5O5S/c1-37-22(34)32-20-29-17-9-7-15(11-19(17)30-20)38(35,36)14-5-3-13(4-6-14)28-21(33)31-18-10-12(23(25,26)27)2-8-16(18)24/h2-11H,1H3,(H2,28,31,33)(H2,29,30,32,34)",COC(=O)Nc1nc2ccc(cc2[nH]1)S(=O)(=O)c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3,CHEMBL895710,Inhibition of GST-tagged human recombinant VEGFR2 expressed in baculovirus,IC50,>,20000,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1148750,"J. Med. Chem., 50, p. 4453 (2007)",17676829,Scientific Literature
40,CHEMBL244482,"InChI=1S/C23H16F4N4O4S/c1-34-22(33)31-21-30-17-9-7-15(11-19(17)36-21)35-14-5-3-13(4-6-14)28-20(32)29-18-10-12(23(25,26)27)2-8-16(18)24/h2-11H,1H3,(H2,28,29,32)(H,30,31,33)",COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)cc2s1,CHEMBL244482,"InChI=1S/C23H16F4N4O4S/c1-34-22(33)31-21-30-17-9-7-15(11-19(17)36-21)35-14-5-3-13(4-6-14)28-20(32)29-18-10-12(23(25,26)27)2-8-16(18)24/h2-11H,1H3,(H2,28,29,32)(H,30,31,33)",COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)cc2s1,CHEMBL895710,Inhibition of GST-tagged human recombinant VEGFR2 expressed in baculovirus,IC50,=,2.1,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1148750,"J. Med. Chem., 50, p. 4453 (2007)",17676829,Scientific Literature
47,CHEMBL243917,"InChI=1S/C28H19F4N5O3/c29-21-12-6-17(28(30,31)32)14-23(21)36-27(39)33-18-7-9-19(10-8-18)40-20-11-13-22-24(15-20)35-26(34-22)37-25(38)16-4-2-1-3-5-16/h1-15H,(H2,33,36,39)(H2,34,35,37,38)",Fc1ccc(cc1NC(=O)Nc2ccc(Oc3ccc4[nH]c(NC(=O)c5ccccc5)nc4c3)cc2)C(F)(F)F,CHEMBL243917,"InChI=1S/C28H19F4N5O3/c29-21-12-6-17(28(30,31)32)14-23(21)36-27(39)33-18-7-9-19(10-8-18)40-20-11-13-22-24(15-20)35-26(34-22)37-25(38)16-4-2-1-3-5-16/h1-15H,(H2,33,36,39)(H2,34,35,37,38)",Fc1ccc(cc1NC(=O)Nc2ccc(Oc3ccc4[nH]c(NC(=O)c5ccccc5)nc4c3)cc2)C(F)(F)F,CHEMBL895710,Inhibition of GST-tagged human recombinant VEGFR2 expressed in baculovirus,IC50,=,42,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1148750,"J. Med. Chem., 50, p. 4453 (2007)",17676829,Scientific Literature
49,CHEMBL244297,"InChI=1S/C26H17F4N5O4/c27-18-9-3-14(26(28,29)30)12-20(18)34-25(37)31-15-4-6-16(7-5-15)39-17-8-10-19-21(13-17)33-24(32-19)35-23(36)22-2-1-11-38-22/h1-13H,(H2,31,34,37)(H2,32,33,35,36)",Fc1ccc(cc1NC(=O)Nc2ccc(Oc3ccc4[nH]c(NC(=O)c5occc5)nc4c3)cc2)C(F)(F)F,CHEMBL244297,"InChI=1S/C26H17F4N5O4/c27-18-9-3-14(26(28,29)30)12-20(18)34-25(37)31-15-4-6-16(7-5-15)39-17-8-10-19-21(13-17)33-24(32-19)35-23(36)22-2-1-11-38-22/h1-13H,(H2,31,34,37)(H2,32,33,35,36)",Fc1ccc(cc1NC(=O)Nc2ccc(Oc3ccc4[nH]c(NC(=O)c5occc5)nc4c3)cc2)C(F)(F)F,CHEMBL895710,Inhibition of GST-tagged human recombinant VEGFR2 expressed in baculovirus,IC50,=,5.1,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1148750,"J. Med. Chem., 50, p. 4453 (2007)",17676829,Scientific Literature
15,CHEMBL243891,"InChI=1S/C22H19N5O4/c1-30-22(29)27-20-25-18-12-11-17(13-19(18)26-20)31-16-9-7-15(8-10-16)24-21(28)23-14-5-3-2-4-6-14/h2-13H,1H3,(H2,23,24,28)(H2,25,26,27,29)",COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1,CHEMBL243891,"InChI=1S/C22H19N5O4/c1-30-22(29)27-20-25-18-12-11-17(13-19(18)26-20)31-16-9-7-15(8-10-16)24-21(28)23-14-5-3-2-4-6-14/h2-13H,1H3,(H2,23,24,28)(H2,25,26,27,29)",COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1,CHEMBL895711,Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA,IC50,,,,Not Determined,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1148750,"J. Med. Chem., 50, p. 4453 (2007)",17676829,Scientific Literature
19,CHEMBL243907,"InChI=1S/C24H23N5O4/c1-3-15-5-4-6-17(13-15)26-23(30)25-16-7-9-18(10-8-16)33-19-11-12-20-21(14-19)28-22(27-20)29-24(31)32-2/h4-14H,3H2,1-2H3,(H2,25,26,30)(H2,27,28,29,31)",CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1,CHEMBL243907,"InChI=1S/C24H23N5O4/c1-3-15-5-4-6-17(13-15)26-23(30)25-16-7-9-18(10-8-16)33-19-11-12-20-21(14-19)28-22(27-20)29-24(31)32-2/h4-14H,3H2,1-2H3,(H2,25,26,30)(H2,27,28,29,31)",CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1,CHEMBL895711,Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA,IC50,=,170,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1148750,"J. Med. Chem., 50, p. 4453 (2007)",17676829,Scientific Literature
20,CHEMBL243908,"InChI=1S/C22H18BrN5O4/c1-31-22(30)28-20-26-18-10-9-17(12-19(18)27-20)32-16-7-5-14(6-8-16)24-21(29)25-15-4-2-3-13(23)11-15/h2-12H,1H3,(H2,24,25,29)(H2,26,27,28,30)",COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1,CHEMBL243908,"InChI=1S/C22H18BrN5O4/c1-31-22(30)28-20-26-18-10-9-17(12-19(18)27-20)32-16-7-5-14(6-8-16)24-21(29)25-15-4-2-3-13(23)11-15/h2-12H,1H3,(H2,24,25,29)(H2,26,27,28,30)",COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1,CHEMBL895711,Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA,IC50,=,8,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1148750,"J. Med. Chem., 50, p. 4453 (2007)",17676829,Scientific Literature
21,CHEMBL396283,"InChI=1S/C22H18ClN5O4/c1-31-22(30)28-20-26-18-10-9-17(12-19(18)27-20)32-16-7-5-14(6-8-16)24-21(29)25-15-4-2-3-13(23)11-15/h2-12H,1H3,(H2,24,25,29)(H2,26,27,28,30)",COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1,CHEMBL396283,"InChI=1S/C22H18ClN5O4/c1-31-22(30)28-20-26-18-10-9-17(12-19(18)27-20)32-16-7-5-14(6-8-16)24-21(29)25-15-4-2-3-13(23)11-15/h2-12H,1H3,(H2,24,25,29)(H2,26,27,28,30)",COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1,CHEMBL895711,Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA,IC50,=,50,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1148750,"J. Med. Chem., 50, p. 4453 (2007)",17676829,Scientific Literature
26,CHEMBL244097,"InChI=1S/C23H19N5O6/c1-33-23(32)28-21-26-18-10-9-17(12-19(18)27-21)34-16-7-5-14(6-8-16)24-22(31)25-15-4-2-3-13(11-15)20(29)30/h2-12H,1H3,(H,29,30)(H2,24,25,31)(H2,26,27,28,32)",COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(c4)C(=O)O)cc3)ccc2[nH]1,CHEMBL244097,"InChI=1S/C23H19N5O6/c1-33-23(32)28-21-26-18-10-9-17(12-19(18)27-21)34-16-7-5-14(6-8-16)24-22(31)25-15-4-2-3-13(11-15)20(29)30/h2-12H,1H3,(H,29,30)(H2,24,25,31)(H2,26,27,28,32)",COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(c4)C(=O)O)cc3)ccc2[nH]1,CHEMBL895711,Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA,IC50,,,,Not Determined,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1148750,"J. Med. Chem., 50, p. 4453 (2007)",17676829,Scientific Literature
30,CHEMBL244289,"InChI=1S/C23H17F4N5O4/c1-35-22(34)32-20-29-17-8-6-15(11-19(17)30-20)36-14-4-2-3-13(10-14)28-21(33)31-18-9-12(23(25,26)27)5-7-16(18)24/h2-11H,1H3,(H2,28,31,33)(H2,29,30,32,34)",COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)c3)ccc2[nH]1,CHEMBL244289,"InChI=1S/C23H17F4N5O4/c1-35-22(34)32-20-29-17-8-6-15(11-19(17)30-20)36-14-4-2-3-13(10-14)28-21(33)31-18-9-12(23(25,26)27)5-7-16(18)24/h2-11H,1H3,(H2,28,31,33)(H2,29,30,32,34)",COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)c3)ccc2[nH]1,CHEMBL895711,Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA,IC50,=,81,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1148750,"J. Med. Chem., 50, p. 4453 (2007)",17676829,Scientific Literature
34,CHEMBL243912,"InChI=1S/C23H17F4N5O3S/c1-35-22(34)32-20-29-17-9-7-15(11-19(17)30-20)36-14-5-3-13(4-6-14)28-21(33)31-18-10-12(23(25,26)27)2-8-16(18)24/h2-11H,1H3,(H2,28,31,33)(H2,29,30,32,34)",COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)cc2[nH]1,CHEMBL243912,"InChI=1S/C23H17F4N5O3S/c1-35-22(34)32-20-29-17-9-7-15(11-19(17)30-20)36-14-5-3-13(4-6-14)28-21(33)31-18-10-12(23(25,26)27)2-8-16(18)24/h2-11H,1H3,(H2,28,31,33)(H2,29,30,32,34)",COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)cc2[nH]1,CHEMBL895711,Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA,IC50,=,76,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1148750,"J. Med. Chem., 50, p. 4453 (2007)",17676829,Scientific Literature
36,CHEMBL244099,"InChI=1S/C23H17F4N5O5S/c1-37-22(34)32-20-29-17-9-7-15(11-19(17)30-20)38(35,36)14-5-3-13(4-6-14)28-21(33)31-18-10-12(23(25,26)27)2-8-16(18)24/h2-11H,1H3,(H2,28,31,33)(H2,29,30,32,34)",COC(=O)Nc1nc2ccc(cc2[nH]1)S(=O)(=O)c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3,CHEMBL244099,"InChI=1S/C23H17F4N5O5S/c1-37-22(34)32-20-29-17-9-7-15(11-19(17)30-20)38(35,36)14-5-3-13(4-6-14)28-21(33)31-18-10-12(23(25,26)27)2-8-16(18)24/h2-11H,1H3,(H2,28,31,33)(H2,29,30,32,34)",COC(=O)Nc1nc2ccc(cc2[nH]1)S(=O)(=O)c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3,CHEMBL895711,Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA,IC50,=,160,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1148750,"J. Med. Chem., 50, p. 4453 (2007)",17676829,Scientific Literature
40,CHEMBL244482,"InChI=1S/C23H16F4N4O4S/c1-34-22(33)31-21-30-17-9-7-15(11-19(17)36-21)35-14-5-3-13(4-6-14)28-20(32)29-18-10-12(23(25,26)27)2-8-16(18)24/h2-11H,1H3,(H2,28,29,32)(H,30,31,33)",COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)cc2s1,CHEMBL244482,"InChI=1S/C23H16F4N4O4S/c1-34-22(33)31-21-30-17-9-7-15(11-19(17)36-21)35-14-5-3-13(4-6-14)28-20(32)29-18-10-12(23(25,26)27)2-8-16(18)24/h2-11H,1H3,(H2,28,29,32)(H,30,31,33)",COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)cc2s1,CHEMBL895711,Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA,IC50,=,7.2,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1148750,"J. Med. Chem., 50, p. 4453 (2007)",17676829,Scientific Literature
47,CHEMBL243917,"InChI=1S/C28H19F4N5O3/c29-21-12-6-17(28(30,31)32)14-23(21)36-27(39)33-18-7-9-19(10-8-18)40-20-11-13-22-24(15-20)35-26(34-22)37-25(38)16-4-2-1-3-5-16/h1-15H,(H2,33,36,39)(H2,34,35,37,38)",Fc1ccc(cc1NC(=O)Nc2ccc(Oc3ccc4[nH]c(NC(=O)c5ccccc5)nc4c3)cc2)C(F)(F)F,CHEMBL243917,"InChI=1S/C28H19F4N5O3/c29-21-12-6-17(28(30,31)32)14-23(21)36-27(39)33-18-7-9-19(10-8-18)40-20-11-13-22-24(15-20)35-26(34-22)37-25(38)16-4-2-1-3-5-16/h1-15H,(H2,33,36,39)(H2,34,35,37,38)",Fc1ccc(cc1NC(=O)Nc2ccc(Oc3ccc4[nH]c(NC(=O)c5ccccc5)nc4c3)cc2)C(F)(F)F,CHEMBL895711,Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA,IC50,=,120,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1148750,"J. Med. Chem., 50, p. 4453 (2007)",17676829,Scientific Literature
49,CHEMBL244297,"InChI=1S/C26H17F4N5O4/c27-18-9-3-14(26(28,29)30)12-20(18)34-25(37)31-15-4-6-16(7-5-15)39-17-8-10-19-21(13-17)33-24(32-19)35-23(36)22-2-1-11-38-22/h1-13H,(H2,31,34,37)(H2,32,33,35,36)",Fc1ccc(cc1NC(=O)Nc2ccc(Oc3ccc4[nH]c(NC(=O)c5occc5)nc4c3)cc2)C(F)(F)F,CHEMBL244297,"InChI=1S/C26H17F4N5O4/c27-18-9-3-14(26(28,29)30)12-20(18)34-25(37)31-15-4-6-16(7-5-15)39-17-8-10-19-21(13-17)33-24(32-19)35-23(36)22-2-1-11-38-22/h1-13H,(H2,31,34,37)(H2,32,33,35,36)",Fc1ccc(cc1NC(=O)Nc2ccc(Oc3ccc4[nH]c(NC(=O)c5occc5)nc4c3)cc2)C(F)(F)F,CHEMBL895711,Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA,IC50,=,6.2,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1148750,"J. Med. Chem., 50, p. 4453 (2007)",17676829,Scientific Literature
11a,CHEMBL232601,"InChI=1S/C23H19N3O2S/c24-13-19-18-9-4-12-26(22(28)15-10-11-15)23(18)29-21(19)25-20(27)17-8-3-6-14-5-1-2-7-16(14)17/h1-3,5-8,15H,4,9-12H2,(H,25,27)",O=C(Nc1sc2N(CCCc2c1C#N)C(=O)C3CC3)c4cccc5ccccc45,CHEMBL232601,"InChI=1S/C23H19N3O2S/c24-13-19-18-9-4-12-26(22(28)15-10-11-15)23(18)29-21(19)25-20(27)17-8-3-6-14-5-1-2-7-16(14)17/h1-3,5-8,15H,4,9-12H2,(H,25,27)",O=C(Nc1sc2N(CCCc2c1C#N)C(=O)C3CC3)c4cccc5ccccc45,CHEMBL897072,Inhibition of Alk5,pIC50,<,5,,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
5a,CHEMBL233001,"InChI=1S/C20H16N2OS/c21-12-17-15-9-3-4-11-18(15)24-20(17)22-19(23)16-10-5-7-13-6-1-2-8-14(13)16/h1-2,5-8,10H,3-4,9,11H2,(H,22,23)",O=C(Nc1sc2CCCCc2c1C#N)c3cccc4ccccc34,CHEMBL233001,"InChI=1S/C20H16N2OS/c21-12-17-15-9-3-4-11-18(15)24-20(17)22-19(23)16-10-5-7-13-6-1-2-8-14(13)16/h1-2,5-8,10H,3-4,9,11H2,(H,22,23)",O=C(Nc1sc2CCCCc2c1C#N)c3cccc4ccccc34,CHEMBL897072,Inhibition of Alk5,pIC50,<,5,,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
11a,CHEMBL232601,"InChI=1S/C23H19N3O2S/c24-13-19-18-9-4-12-26(22(28)15-10-11-15)23(18)29-21(19)25-20(27)17-8-3-6-14-5-1-2-7-16(14)17/h1-3,5-8,15H,4,9-12H2,(H,25,27)",O=C(Nc1sc2N(CCCc2c1C#N)C(=O)C3CC3)c4cccc5ccccc45,CHEMBL232601,"InChI=1S/C23H19N3O2S/c24-13-19-18-9-4-12-26(22(28)15-10-11-15)23(18)29-21(19)25-20(27)17-8-3-6-14-5-1-2-7-16(14)17/h1-3,5-8,15H,4,9-12H2,(H,25,27)",O=C(Nc1sc2N(CCCc2c1C#N)C(=O)C3CC3)c4cccc5ccccc45,CHEMBL897074,Inhibition of CDK2,pIC50,<,5,,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
5a,CHEMBL233001,"InChI=1S/C20H16N2OS/c21-12-17-15-9-3-4-11-18(15)24-20(17)22-19(23)16-10-5-7-13-6-1-2-8-14(13)16/h1-2,5-8,10H,3-4,9,11H2,(H,22,23)",O=C(Nc1sc2CCCCc2c1C#N)c3cccc4ccccc34,CHEMBL233001,"InChI=1S/C20H16N2OS/c21-12-17-15-9-3-4-11-18(15)24-20(17)22-19(23)16-10-5-7-13-6-1-2-8-14(13)16/h1-2,5-8,10H,3-4,9,11H2,(H,22,23)",O=C(Nc1sc2CCCCc2c1C#N)c3cccc4ccccc34,CHEMBL897074,Inhibition of CDK2,pIC50,<,5,,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
11a,CHEMBL232601,"InChI=1S/C23H19N3O2S/c24-13-19-18-9-4-12-26(22(28)15-10-11-15)23(18)29-21(19)25-20(27)17-8-3-6-14-5-1-2-7-16(14)17/h1-3,5-8,15H,4,9-12H2,(H,25,27)",O=C(Nc1sc2N(CCCc2c1C#N)C(=O)C3CC3)c4cccc5ccccc45,CHEMBL232601,"InChI=1S/C23H19N3O2S/c24-13-19-18-9-4-12-26(22(28)15-10-11-15)23(18)29-21(19)25-20(27)17-8-3-6-14-5-1-2-7-16(14)17/h1-3,5-8,15H,4,9-12H2,(H,25,27)",O=C(Nc1sc2N(CCCc2c1C#N)C(=O)C3CC3)c4cccc5ccccc45,CHEMBL897075,Inhibition of EGFR,pIC50,<,5,,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
5a,CHEMBL233001,"InChI=1S/C20H16N2OS/c21-12-17-15-9-3-4-11-18(15)24-20(17)22-19(23)16-10-5-7-13-6-1-2-8-14(13)16/h1-2,5-8,10H,3-4,9,11H2,(H,22,23)",O=C(Nc1sc2CCCCc2c1C#N)c3cccc4ccccc34,CHEMBL233001,"InChI=1S/C20H16N2OS/c21-12-17-15-9-3-4-11-18(15)24-20(17)22-19(23)16-10-5-7-13-6-1-2-8-14(13)16/h1-2,5-8,10H,3-4,9,11H2,(H,22,23)",O=C(Nc1sc2CCCCc2c1C#N)c3cccc4ccccc34,CHEMBL897075,Inhibition of EGFR,pIC50,<,5,,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
11a,CHEMBL232601,"InChI=1S/C23H19N3O2S/c24-13-19-18-9-4-12-26(22(28)15-10-11-15)23(18)29-21(19)25-20(27)17-8-3-6-14-5-1-2-7-16(14)17/h1-3,5-8,15H,4,9-12H2,(H,25,27)",O=C(Nc1sc2N(CCCc2c1C#N)C(=O)C3CC3)c4cccc5ccccc45,CHEMBL232601,"InChI=1S/C23H19N3O2S/c24-13-19-18-9-4-12-26(22(28)15-10-11-15)23(18)29-21(19)25-20(27)17-8-3-6-14-5-1-2-7-16(14)17/h1-3,5-8,15H,4,9-12H2,(H,25,27)",O=C(Nc1sc2N(CCCc2c1C#N)C(=O)C3CC3)c4cccc5ccccc45,CHEMBL897076,Inhibition of ErbB2,pIC50,<,5,,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
5a,CHEMBL233001,"InChI=1S/C20H16N2OS/c21-12-17-15-9-3-4-11-18(15)24-20(17)22-19(23)16-10-5-7-13-6-1-2-8-14(13)16/h1-2,5-8,10H,3-4,9,11H2,(H,22,23)",O=C(Nc1sc2CCCCc2c1C#N)c3cccc4ccccc34,CHEMBL233001,"InChI=1S/C20H16N2OS/c21-12-17-15-9-3-4-11-18(15)24-20(17)22-19(23)16-10-5-7-13-6-1-2-8-14(13)16/h1-2,5-8,10H,3-4,9,11H2,(H,22,23)",O=C(Nc1sc2CCCCc2c1C#N)c3cccc4ccccc34,CHEMBL897076,Inhibition of ErbB2,pIC50,<,5,,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
11a,CHEMBL232601,"InChI=1S/C23H19N3O2S/c24-13-19-18-9-4-12-26(22(28)15-10-11-15)23(18)29-21(19)25-20(27)17-8-3-6-14-5-1-2-7-16(14)17/h1-3,5-8,15H,4,9-12H2,(H,25,27)",O=C(Nc1sc2N(CCCc2c1C#N)C(=O)C3CC3)c4cccc5ccccc45,CHEMBL232601,"InChI=1S/C23H19N3O2S/c24-13-19-18-9-4-12-26(22(28)15-10-11-15)23(18)29-21(19)25-20(27)17-8-3-6-14-5-1-2-7-16(14)17/h1-3,5-8,15H,4,9-12H2,(H,25,27)",O=C(Nc1sc2N(CCCc2c1C#N)C(=O)C3CC3)c4cccc5ccccc45,CHEMBL897077,Inhibition of GSK3-beta,pIC50,<,5,,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
5a,CHEMBL233001,"InChI=1S/C20H16N2OS/c21-12-17-15-9-3-4-11-18(15)24-20(17)22-19(23)16-10-5-7-13-6-1-2-8-14(13)16/h1-2,5-8,10H,3-4,9,11H2,(H,22,23)",O=C(Nc1sc2CCCCc2c1C#N)c3cccc4ccccc34,CHEMBL233001,"InChI=1S/C20H16N2OS/c21-12-17-15-9-3-4-11-18(15)24-20(17)22-19(23)16-10-5-7-13-6-1-2-8-14(13)16/h1-2,5-8,10H,3-4,9,11H2,(H,22,23)",O=C(Nc1sc2CCCCc2c1C#N)c3cccc4ccccc34,CHEMBL897077,Inhibition of GSK3-beta,pIC50,<,5,,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
11a,CHEMBL232601,"InChI=1S/C23H19N3O2S/c24-13-19-18-9-4-12-26(22(28)15-10-11-15)23(18)29-21(19)25-20(27)17-8-3-6-14-5-1-2-7-16(14)17/h1-3,5-8,15H,4,9-12H2,(H,25,27)",O=C(Nc1sc2N(CCCc2c1C#N)C(=O)C3CC3)c4cccc5ccccc45,CHEMBL232601,"InChI=1S/C23H19N3O2S/c24-13-19-18-9-4-12-26(22(28)15-10-11-15)23(18)29-21(19)25-20(27)17-8-3-6-14-5-1-2-7-16(14)17/h1-3,5-8,15H,4,9-12H2,(H,25,27)",O=C(Nc1sc2N(CCCc2c1C#N)C(=O)C3CC3)c4cccc5ccccc45,CHEMBL897078,Inhibition of PLK1,pIC50,<,5,,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
5a,CHEMBL233001,"InChI=1S/C20H16N2OS/c21-12-17-15-9-3-4-11-18(15)24-20(17)22-19(23)16-10-5-7-13-6-1-2-8-14(13)16/h1-2,5-8,10H,3-4,9,11H2,(H,22,23)",O=C(Nc1sc2CCCCc2c1C#N)c3cccc4ccccc34,CHEMBL233001,"InChI=1S/C20H16N2OS/c21-12-17-15-9-3-4-11-18(15)24-20(17)22-19(23)16-10-5-7-13-6-1-2-8-14(13)16/h1-2,5-8,10H,3-4,9,11H2,(H,22,23)",O=C(Nc1sc2CCCCc2c1C#N)c3cccc4ccccc34,CHEMBL897078,Inhibition of PLK1,pIC50,<,5,,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
11a,CHEMBL232601,"InChI=1S/C23H19N3O2S/c24-13-19-18-9-4-12-26(22(28)15-10-11-15)23(18)29-21(19)25-20(27)17-8-3-6-14-5-1-2-7-16(14)17/h1-3,5-8,15H,4,9-12H2,(H,25,27)",O=C(Nc1sc2N(CCCc2c1C#N)C(=O)C3CC3)c4cccc5ccccc45,CHEMBL232601,"InChI=1S/C23H19N3O2S/c24-13-19-18-9-4-12-26(22(28)15-10-11-15)23(18)29-21(19)25-20(27)17-8-3-6-14-5-1-2-7-16(14)17/h1-3,5-8,15H,4,9-12H2,(H,25,27)",O=C(Nc1sc2N(CCCc2c1C#N)C(=O)C3CC3)c4cccc5ccccc45,CHEMBL897079,Inhibition of Src,pIC50,<,5,,,CHEMBL267,Tyrosine-protein kinase SRC,Homo sapiens,P12931,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
5a,CHEMBL233001,"InChI=1S/C20H16N2OS/c21-12-17-15-9-3-4-11-18(15)24-20(17)22-19(23)16-10-5-7-13-6-1-2-8-14(13)16/h1-2,5-8,10H,3-4,9,11H2,(H,22,23)",O=C(Nc1sc2CCCCc2c1C#N)c3cccc4ccccc34,CHEMBL233001,"InChI=1S/C20H16N2OS/c21-12-17-15-9-3-4-11-18(15)24-20(17)22-19(23)16-10-5-7-13-6-1-2-8-14(13)16/h1-2,5-8,10H,3-4,9,11H2,(H,22,23)",O=C(Nc1sc2CCCCc2c1C#N)c3cccc4ccccc34,CHEMBL897079,Inhibition of Src,pIC50,<,5,,,CHEMBL267,Tyrosine-protein kinase SRC,Homo sapiens,P12931,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
11a,CHEMBL232601,"InChI=1S/C23H19N3O2S/c24-13-19-18-9-4-12-26(22(28)15-10-11-15)23(18)29-21(19)25-20(27)17-8-3-6-14-5-1-2-7-16(14)17/h1-3,5-8,15H,4,9-12H2,(H,25,27)",O=C(Nc1sc2N(CCCc2c1C#N)C(=O)C3CC3)c4cccc5ccccc45,CHEMBL232601,"InChI=1S/C23H19N3O2S/c24-13-19-18-9-4-12-26(22(28)15-10-11-15)23(18)29-21(19)25-20(27)17-8-3-6-14-5-1-2-7-16(14)17/h1-3,5-8,15H,4,9-12H2,(H,25,27)",O=C(Nc1sc2N(CCCc2c1C#N)C(=O)C3CC3)c4cccc5ccccc45,CHEMBL897080,Inhibition of Tie2,pIC50,<,5,,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
5a,CHEMBL233001,"InChI=1S/C20H16N2OS/c21-12-17-15-9-3-4-11-18(15)24-20(17)22-19(23)16-10-5-7-13-6-1-2-8-14(13)16/h1-2,5-8,10H,3-4,9,11H2,(H,22,23)",O=C(Nc1sc2CCCCc2c1C#N)c3cccc4ccccc34,CHEMBL233001,"InChI=1S/C20H16N2OS/c21-12-17-15-9-3-4-11-18(15)24-20(17)22-19(23)16-10-5-7-13-6-1-2-8-14(13)16/h1-2,5-8,10H,3-4,9,11H2,(H,22,23)",O=C(Nc1sc2CCCCc2c1C#N)c3cccc4ccccc34,CHEMBL897080,Inhibition of Tie2,pIC50,<,5,,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
11a,CHEMBL232601,"InChI=1S/C23H19N3O2S/c24-13-19-18-9-4-12-26(22(28)15-10-11-15)23(18)29-21(19)25-20(27)17-8-3-6-14-5-1-2-7-16(14)17/h1-3,5-8,15H,4,9-12H2,(H,25,27)",O=C(Nc1sc2N(CCCc2c1C#N)C(=O)C3CC3)c4cccc5ccccc45,CHEMBL232601,"InChI=1S/C23H19N3O2S/c24-13-19-18-9-4-12-26(22(28)15-10-11-15)23(18)29-21(19)25-20(27)17-8-3-6-14-5-1-2-7-16(14)17/h1-3,5-8,15H,4,9-12H2,(H,25,27)",O=C(Nc1sc2N(CCCc2c1C#N)C(=O)C3CC3)c4cccc5ccccc45,CHEMBL897081,Inhibition of VegFr2,pIC50,<,5,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
5a,CHEMBL233001,"InChI=1S/C20H16N2OS/c21-12-17-15-9-3-4-11-18(15)24-20(17)22-19(23)16-10-5-7-13-6-1-2-8-14(13)16/h1-2,5-8,10H,3-4,9,11H2,(H,22,23)",O=C(Nc1sc2CCCCc2c1C#N)c3cccc4ccccc34,CHEMBL233001,"InChI=1S/C20H16N2OS/c21-12-17-15-9-3-4-11-18(15)24-20(17)22-19(23)16-10-5-7-13-6-1-2-8-14(13)16/h1-2,5-8,10H,3-4,9,11H2,(H,22,23)",O=C(Nc1sc2CCCCc2c1C#N)c3cccc4ccccc34,CHEMBL897081,Inhibition of VegFr2,pIC50,<,5,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
11a,CHEMBL232601,"InChI=1S/C23H19N3O2S/c24-13-19-18-9-4-12-26(22(28)15-10-11-15)23(18)29-21(19)25-20(27)17-8-3-6-14-5-1-2-7-16(14)17/h1-3,5-8,15H,4,9-12H2,(H,25,27)",O=C(Nc1sc2N(CCCc2c1C#N)C(=O)C3CC3)c4cccc5ccccc45,CHEMBL232601,"InChI=1S/C23H19N3O2S/c24-13-19-18-9-4-12-26(22(28)15-10-11-15)23(18)29-21(19)25-20(27)17-8-3-6-14-5-1-2-7-16(14)17/h1-3,5-8,15H,4,9-12H2,(H,25,27)",O=C(Nc1sc2N(CCCc2c1C#N)C(=O)C3CC3)c4cccc5ccccc45,CHEMBL897073,Inhibition of cFms,pIC50,<,5,,,CHEMBL1844,Macrophage colony stimulating factor  receptor ,Homo sapiens,P07333,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
5a,CHEMBL233001,"InChI=1S/C20H16N2OS/c21-12-17-15-9-3-4-11-18(15)24-20(17)22-19(23)16-10-5-7-13-6-1-2-8-14(13)16/h1-2,5-8,10H,3-4,9,11H2,(H,22,23)",O=C(Nc1sc2CCCCc2c1C#N)c3cccc4ccccc34,CHEMBL233001,"InChI=1S/C20H16N2OS/c21-12-17-15-9-3-4-11-18(15)24-20(17)22-19(23)16-10-5-7-13-6-1-2-8-14(13)16/h1-2,5-8,10H,3-4,9,11H2,(H,22,23)",O=C(Nc1sc2CCCCc2c1C#N)c3cccc4ccccc34,CHEMBL897073,Inhibition of cFms,pIC50,<,5,,,CHEMBL1844,Macrophage colony stimulating factor  receptor ,Homo sapiens,P07333,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
11a,CHEMBL232601,"InChI=1S/C23H19N3O2S/c24-13-19-18-9-4-12-26(22(28)15-10-11-15)23(18)29-21(19)25-20(27)17-8-3-6-14-5-1-2-7-16(14)17/h1-3,5-8,15H,4,9-12H2,(H,25,27)",O=C(Nc1sc2N(CCCc2c1C#N)C(=O)C3CC3)c4cccc5ccccc45,CHEMBL232601,"InChI=1S/C23H19N3O2S/c24-13-19-18-9-4-12-26(22(28)15-10-11-15)23(18)29-21(19)25-20(27)17-8-3-6-14-5-1-2-7-16(14)17/h1-3,5-8,15H,4,9-12H2,(H,25,27)",O=C(Nc1sc2N(CCCc2c1C#N)C(=O)C3CC3)c4cccc5ccccc45,CHEMBL897071,Inhibition of human JNK2alpha2,pIC50,=,6.5,,,CHEMBL4179,c-Jun N-terminal kinase 2,Homo sapiens,P45984,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
5a,CHEMBL233001,"InChI=1S/C20H16N2OS/c21-12-17-15-9-3-4-11-18(15)24-20(17)22-19(23)16-10-5-7-13-6-1-2-8-14(13)16/h1-2,5-8,10H,3-4,9,11H2,(H,22,23)",O=C(Nc1sc2CCCCc2c1C#N)c3cccc4ccccc34,CHEMBL233001,"InChI=1S/C20H16N2OS/c21-12-17-15-9-3-4-11-18(15)24-20(17)22-19(23)16-10-5-7-13-6-1-2-8-14(13)16/h1-2,5-8,10H,3-4,9,11H2,(H,22,23)",O=C(Nc1sc2CCCCc2c1C#N)c3cccc4ccccc34,CHEMBL897071,Inhibition of human JNK2alpha2,pIC50,=,6.5,,,CHEMBL4179,c-Jun N-terminal kinase 2,Homo sapiens,P45984,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
11a,CHEMBL232601,"InChI=1S/C23H19N3O2S/c24-13-19-18-9-4-12-26(22(28)15-10-11-15)23(18)29-21(19)25-20(27)17-8-3-6-14-5-1-2-7-16(14)17/h1-3,5-8,15H,4,9-12H2,(H,25,27)",O=C(Nc1sc2N(CCCc2c1C#N)C(=O)C3CC3)c4cccc5ccccc45,CHEMBL232601,"InChI=1S/C23H19N3O2S/c24-13-19-18-9-4-12-26(22(28)15-10-11-15)23(18)29-21(19)25-20(27)17-8-3-6-14-5-1-2-7-16(14)17/h1-3,5-8,15H,4,9-12H2,(H,25,27)",O=C(Nc1sc2N(CCCc2c1C#N)C(=O)C3CC3)c4cccc5ccccc45,CHEMBL897070,Inhibition of human recombinant full length ERK2,pIC50,<,5,,,CHEMBL4040,MAP kinase ERK2,Homo sapiens,P28482,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
11a,CHEMBL232601,"InChI=1S/C23H19N3O2S/c24-13-19-18-9-4-12-26(22(28)15-10-11-15)23(18)29-21(19)25-20(27)17-8-3-6-14-5-1-2-7-16(14)17/h1-3,5-8,15H,4,9-12H2,(H,25,27)",O=C(Nc1sc2N(CCCc2c1C#N)C(=O)C3CC3)c4cccc5ccccc45,CHEMBL232601,"InChI=1S/C23H19N3O2S/c24-13-19-18-9-4-12-26(22(28)15-10-11-15)23(18)29-21(19)25-20(27)17-8-3-6-14-5-1-2-7-16(14)17/h1-3,5-8,15H,4,9-12H2,(H,25,27)",O=C(Nc1sc2N(CCCc2c1C#N)C(=O)C3CC3)c4cccc5ccccc45,CHEMBL897067,Inhibition of human recombinant full length JNK1alpha1,pIC50,<,5,,,CHEMBL2276,c-Jun N-terminal kinase 1,Homo sapiens,P45983,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
5a,CHEMBL233001,"InChI=1S/C20H16N2OS/c21-12-17-15-9-3-4-11-18(15)24-20(17)22-19(23)16-10-5-7-13-6-1-2-8-14(13)16/h1-2,5-8,10H,3-4,9,11H2,(H,22,23)",O=C(Nc1sc2CCCCc2c1C#N)c3cccc4ccccc34,CHEMBL233001,"InChI=1S/C20H16N2OS/c21-12-17-15-9-3-4-11-18(15)24-20(17)22-19(23)16-10-5-7-13-6-1-2-8-14(13)16/h1-2,5-8,10H,3-4,9,11H2,(H,22,23)",O=C(Nc1sc2CCCCc2c1C#N)c3cccc4ccccc34,CHEMBL897067,Inhibition of human recombinant full length JNK1alpha1,pIC50,<,5,,,CHEMBL2276,c-Jun N-terminal kinase 1,Homo sapiens,P45983,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
5b,CHEMBL233002,"InChI=1S/C20H15FN2OS/c21-17-10-9-15(12-5-1-2-6-13(12)17)19(24)23-20-16(11-22)14-7-3-4-8-18(14)25-20/h1-2,5-6,9-10H,3-4,7-8H2,(H,23,24)",Fc1ccc(C(=O)Nc2sc3CCCCc3c2C#N)c4ccccc14,CHEMBL233002,"InChI=1S/C20H15FN2OS/c21-17-10-9-15(12-5-1-2-6-13(12)17)19(24)23-20-16(11-22)14-7-3-4-8-18(14)25-20/h1-2,5-6,9-10H,3-4,7-8H2,(H,23,24)",Fc1ccc(C(=O)Nc2sc3CCCCc3c2C#N)c4ccccc14,CHEMBL897067,Inhibition of human recombinant full length JNK1alpha1,pIC50,<,5,,,CHEMBL2276,c-Jun N-terminal kinase 1,Homo sapiens,P45983,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
5d,CHEMBL397570,"InChI=1S/C16H13FN2OS/c17-11-7-5-10(6-8-11)15(20)19-16-13(9-18)12-3-1-2-4-14(12)21-16/h5-8H,1-4H2,(H,19,20)",Fc1ccc(cc1)C(=O)Nc2sc3CCCCc3c2C#N,CHEMBL397570,"InChI=1S/C16H13FN2OS/c17-11-7-5-10(6-8-11)15(20)19-16-13(9-18)12-3-1-2-4-14(12)21-16/h5-8H,1-4H2,(H,19,20)",Fc1ccc(cc1)C(=O)Nc2sc3CCCCc3c2C#N,CHEMBL897067,Inhibition of human recombinant full length JNK1alpha1,pIC50,<,5,,,CHEMBL2276,c-Jun N-terminal kinase 1,Homo sapiens,P45983,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
5e,CHEMBL234838,"InChI=1S/C16H13FN2OS/c17-13-7-3-1-6-11(13)15(20)19-16-12(9-18)10-5-2-4-8-14(10)21-16/h1,3,6-7H,2,4-5,8H2,(H,19,20)",Fc1ccccc1C(=O)Nc2sc3CCCCc3c2C#N,CHEMBL234838,"InChI=1S/C16H13FN2OS/c17-13-7-3-1-6-11(13)15(20)19-16-12(9-18)10-5-2-4-8-14(10)21-16/h1,3,6-7H,2,4-5,8H2,(H,19,20)",Fc1ccccc1C(=O)Nc2sc3CCCCc3c2C#N,CHEMBL897067,Inhibition of human recombinant full length JNK1alpha1,pIC50,<,5,,,CHEMBL2276,c-Jun N-terminal kinase 1,Homo sapiens,P45983,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
5i,CHEMBL232405,"InChI=1S/C15H19N3O2S/c16-9-12-11-3-1-2-4-13(11)21-15(12)17-14(19)10-18-5-7-20-8-6-18/h1-8,10H2,(H,17,19)",O=C(CN1CCOCC1)Nc2sc3CCCCc3c2C#N,CHEMBL232405,"InChI=1S/C15H19N3O2S/c16-9-12-11-3-1-2-4-13(11)21-15(12)17-14(19)10-18-5-7-20-8-6-18/h1-8,10H2,(H,17,19)",O=C(CN1CCOCC1)Nc2sc3CCCCc3c2C#N,CHEMBL897067,Inhibition of human recombinant full length JNK1alpha1,pIC50,,,,Not Determined,CHEMBL2276,c-Jun N-terminal kinase 1,Homo sapiens,P45983,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
11a,CHEMBL232601,"InChI=1S/C23H19N3O2S/c24-13-19-18-9-4-12-26(22(28)15-10-11-15)23(18)29-21(19)25-20(27)17-8-3-6-14-5-1-2-7-16(14)17/h1-3,5-8,15H,4,9-12H2,(H,25,27)",O=C(Nc1sc2N(CCCc2c1C#N)C(=O)C3CC3)c4cccc5ccccc45,CHEMBL232601,"InChI=1S/C23H19N3O2S/c24-13-19-18-9-4-12-26(22(28)15-10-11-15)23(18)29-21(19)25-20(27)17-8-3-6-14-5-1-2-7-16(14)17/h1-3,5-8,15H,4,9-12H2,(H,25,27)",O=C(Nc1sc2N(CCCc2c1C#N)C(=O)C3CC3)c4cccc5ccccc45,CHEMBL897068,Inhibition of human truncated JNK3,pIC50,=,6.6,,,CHEMBL2637,c-Jun N-terminal kinase 3,Homo sapiens,P53779,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
5a,CHEMBL233001,"InChI=1S/C20H16N2OS/c21-12-17-15-9-3-4-11-18(15)24-20(17)22-19(23)16-10-5-7-13-6-1-2-8-14(13)16/h1-2,5-8,10H,3-4,9,11H2,(H,22,23)",O=C(Nc1sc2CCCCc2c1C#N)c3cccc4ccccc34,CHEMBL233001,"InChI=1S/C20H16N2OS/c21-12-17-15-9-3-4-11-18(15)24-20(17)22-19(23)16-10-5-7-13-6-1-2-8-14(13)16/h1-2,5-8,10H,3-4,9,11H2,(H,22,23)",O=C(Nc1sc2CCCCc2c1C#N)c3cccc4ccccc34,CHEMBL897068,Inhibition of human truncated JNK3,pIC50,=,6.7,,,CHEMBL2637,c-Jun N-terminal kinase 3,Homo sapiens,P53779,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
5b,CHEMBL233002,"InChI=1S/C20H15FN2OS/c21-17-10-9-15(12-5-1-2-6-13(12)17)19(24)23-20-16(11-22)14-7-3-4-8-18(14)25-20/h1-2,5-6,9-10H,3-4,7-8H2,(H,23,24)",Fc1ccc(C(=O)Nc2sc3CCCCc3c2C#N)c4ccccc14,CHEMBL233002,"InChI=1S/C20H15FN2OS/c21-17-10-9-15(12-5-1-2-6-13(12)17)19(24)23-20-16(11-22)14-7-3-4-8-18(14)25-20/h1-2,5-6,9-10H,3-4,7-8H2,(H,23,24)",Fc1ccc(C(=O)Nc2sc3CCCCc3c2C#N)c4ccccc14,CHEMBL897068,Inhibition of human truncated JNK3,pIC50,=,6,,,CHEMBL2637,c-Jun N-terminal kinase 3,Homo sapiens,P53779,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
5d,CHEMBL397570,"InChI=1S/C16H13FN2OS/c17-11-7-5-10(6-8-11)15(20)19-16-13(9-18)12-3-1-2-4-14(12)21-16/h5-8H,1-4H2,(H,19,20)",Fc1ccc(cc1)C(=O)Nc2sc3CCCCc3c2C#N,CHEMBL397570,"InChI=1S/C16H13FN2OS/c17-11-7-5-10(6-8-11)15(20)19-16-13(9-18)12-3-1-2-4-14(12)21-16/h5-8H,1-4H2,(H,19,20)",Fc1ccc(cc1)C(=O)Nc2sc3CCCCc3c2C#N,CHEMBL897068,Inhibition of human truncated JNK3,pIC50,=,5.5,,,CHEMBL2637,c-Jun N-terminal kinase 3,Homo sapiens,P53779,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
5e,CHEMBL234838,"InChI=1S/C16H13FN2OS/c17-13-7-3-1-6-11(13)15(20)19-16-12(9-18)10-5-2-4-8-14(10)21-16/h1,3,6-7H,2,4-5,8H2,(H,19,20)",Fc1ccccc1C(=O)Nc2sc3CCCCc3c2C#N,CHEMBL234838,"InChI=1S/C16H13FN2OS/c17-13-7-3-1-6-11(13)15(20)19-16-12(9-18)10-5-2-4-8-14(10)21-16/h1,3,6-7H,2,4-5,8H2,(H,19,20)",Fc1ccccc1C(=O)Nc2sc3CCCCc3c2C#N,CHEMBL897068,Inhibition of human truncated JNK3,pIC50,=,6.4,,,CHEMBL2637,c-Jun N-terminal kinase 3,Homo sapiens,P53779,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
5i,CHEMBL232405,"InChI=1S/C15H19N3O2S/c16-9-12-11-3-1-2-4-13(11)21-15(12)17-14(19)10-18-5-7-20-8-6-18/h1-8,10H2,(H,17,19)",O=C(CN1CCOCC1)Nc2sc3CCCCc3c2C#N,CHEMBL232405,"InChI=1S/C15H19N3O2S/c16-9-12-11-3-1-2-4-13(11)21-15(12)17-14(19)10-18-5-7-20-8-6-18/h1-8,10H2,(H,17,19)",O=C(CN1CCOCC1)Nc2sc3CCCCc3c2C#N,CHEMBL897068,Inhibition of human truncated JNK3,pIC50,<,4.8,,,CHEMBL2637,c-Jun N-terminal kinase 3,Homo sapiens,P53779,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
11a,CHEMBL232601,"InChI=1S/C23H19N3O2S/c24-13-19-18-9-4-12-26(22(28)15-10-11-15)23(18)29-21(19)25-20(27)17-8-3-6-14-5-1-2-7-16(14)17/h1-3,5-8,15H,4,9-12H2,(H,25,27)",O=C(Nc1sc2N(CCCc2c1C#N)C(=O)C3CC3)c4cccc5ccccc45,CHEMBL232601,"InChI=1S/C23H19N3O2S/c24-13-19-18-9-4-12-26(22(28)15-10-11-15)23(18)29-21(19)25-20(27)17-8-3-6-14-5-1-2-7-16(14)17/h1-3,5-8,15H,4,9-12H2,(H,25,27)",O=C(Nc1sc2N(CCCc2c1C#N)C(=O)C3CC3)c4cccc5ccccc45,CHEMBL897069,Inhibition of mitogen-activated protein kinase p38alpha,pIC50,<,4.8,,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
5a,CHEMBL233001,"InChI=1S/C20H16N2OS/c21-12-17-15-9-3-4-11-18(15)24-20(17)22-19(23)16-10-5-7-13-6-1-2-8-14(13)16/h1-2,5-8,10H,3-4,9,11H2,(H,22,23)",O=C(Nc1sc2CCCCc2c1C#N)c3cccc4ccccc34,CHEMBL233001,"InChI=1S/C20H16N2OS/c21-12-17-15-9-3-4-11-18(15)24-20(17)22-19(23)16-10-5-7-13-6-1-2-8-14(13)16/h1-2,5-8,10H,3-4,9,11H2,(H,22,23)",O=C(Nc1sc2CCCCc2c1C#N)c3cccc4ccccc34,CHEMBL897069,Inhibition of mitogen-activated protein kinase p38alpha,pIC50,<,4.8,,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
5b,CHEMBL233002,"InChI=1S/C20H15FN2OS/c21-17-10-9-15(12-5-1-2-6-13(12)17)19(24)23-20-16(11-22)14-7-3-4-8-18(14)25-20/h1-2,5-6,9-10H,3-4,7-8H2,(H,23,24)",Fc1ccc(C(=O)Nc2sc3CCCCc3c2C#N)c4ccccc14,CHEMBL233002,"InChI=1S/C20H15FN2OS/c21-17-10-9-15(12-5-1-2-6-13(12)17)19(24)23-20-16(11-22)14-7-3-4-8-18(14)25-20/h1-2,5-6,9-10H,3-4,7-8H2,(H,23,24)",Fc1ccc(C(=O)Nc2sc3CCCCc3c2C#N)c4ccccc14,CHEMBL897069,Inhibition of mitogen-activated protein kinase p38alpha,pIC50,<,4.8,,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
5d,CHEMBL397570,"InChI=1S/C16H13FN2OS/c17-11-7-5-10(6-8-11)15(20)19-16-13(9-18)12-3-1-2-4-14(12)21-16/h5-8H,1-4H2,(H,19,20)",Fc1ccc(cc1)C(=O)Nc2sc3CCCCc3c2C#N,CHEMBL397570,"InChI=1S/C16H13FN2OS/c17-11-7-5-10(6-8-11)15(20)19-16-13(9-18)12-3-1-2-4-14(12)21-16/h5-8H,1-4H2,(H,19,20)",Fc1ccc(cc1)C(=O)Nc2sc3CCCCc3c2C#N,CHEMBL897069,Inhibition of mitogen-activated protein kinase p38alpha,pIC50,<,4.8,,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
5e,CHEMBL234838,"InChI=1S/C16H13FN2OS/c17-13-7-3-1-6-11(13)15(20)19-16-12(9-18)10-5-2-4-8-14(10)21-16/h1,3,6-7H,2,4-5,8H2,(H,19,20)",Fc1ccccc1C(=O)Nc2sc3CCCCc3c2C#N,CHEMBL234838,"InChI=1S/C16H13FN2OS/c17-13-7-3-1-6-11(13)15(20)19-16-12(9-18)10-5-2-4-8-14(10)21-16/h1,3,6-7H,2,4-5,8H2,(H,19,20)",Fc1ccccc1C(=O)Nc2sc3CCCCc3c2C#N,CHEMBL897069,Inhibition of mitogen-activated protein kinase p38alpha,pIC50,<,4.8,,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
5i,CHEMBL232405,"InChI=1S/C15H19N3O2S/c16-9-12-11-3-1-2-4-13(11)21-15(12)17-14(19)10-18-5-7-20-8-6-18/h1-8,10H2,(H,17,19)",O=C(CN1CCOCC1)Nc2sc3CCCCc3c2C#N,CHEMBL232405,"InChI=1S/C15H19N3O2S/c16-9-12-11-3-1-2-4-13(11)21-15(12)17-14(19)10-18-5-7-20-8-6-18/h1-8,10H2,(H,17,19)",O=C(CN1CCOCC1)Nc2sc3CCCCc3c2C#N,CHEMBL897069,Inhibition of mitogen-activated protein kinase p38alpha,pIC50,<,4.8,,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1148840,"Bioorg. Med. Chem. Lett., 17, p. 1296 (2007)",17194588,Scientific Literature
10,CHEMBL215814,"InChI=1S/C30H26F4N4O4S/c1-43(39,40)12-11-35-16-23-7-10-27(42-23)20-5-8-26-24(14-20)29(37-18-36-26)38-22-6-9-28(25(15-22)30(32,33)34)41-17-19-3-2-4-21(31)13-19/h2-10,13-15,18,35H,11-12,16-17H2,1H3,(H,36,37,38)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(c4)C(F)(F)F)c3c2,CHEMBL215814,"InChI=1S/C30H26F4N4O4S/c1-43(39,40)12-11-35-16-23-7-10-27(42-23)20-5-8-26-24(14-20)29(37-18-36-26)38-22-6-9-28(25(15-22)30(32,33)34)41-17-19-3-2-4-21(31)13-19/h2-10,13-15,18,35H,11-12,16-17H2,1H3,(H,36,37,38)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(c4)C(F)(F)F)c3c2,CHEMBL910359,Inhibition of BT474 cell growth after 72 hrs,IC50,=,4490,nM,,CHEMBL614529,BT-474 (Breast ductal carcinoma cells),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
13,CHEMBL1794063,"InChI=1S/C34H28ClFN4O4S/c35-30-19-26(10-13-33(30)43-21-23-5-4-6-25(36)17-23)40-34-29-18-24(9-12-31(29)38-22-39-34)32-14-11-27(44-32)20-37-15-16-45(41,42)28-7-2-1-3-8-28/h1-14,17-19,22,37H,15-16,20-21H2,(H,38,39,40)",Fc1cccc(COc2ccc(Nc3ncnc4ccc(cc34)c5oc(CNCCS(=O)(=O)c6ccccc6)cc5)cc2Cl)c1,CHEMBL1794063,"InChI=1S/C34H28ClFN4O4S/c35-30-19-26(10-13-33(30)43-21-23-5-4-6-25(36)17-23)40-34-29-18-24(9-12-31(29)38-22-39-34)32-14-11-27(44-32)20-37-15-16-45(41,42)28-7-2-1-3-8-28/h1-14,17-19,22,37H,15-16,20-21H2,(H,38,39,40)",Fc1cccc(COc2ccc(Nc3ncnc4ccc(cc34)c5oc(CNCCS(=O)(=O)c6ccccc6)cc5)cc2Cl)c1,CHEMBL910359,Inhibition of BT474 cell growth after 72 hrs,IC50,=,1040,nM,,CHEMBL614529,BT-474 (Breast ductal carcinoma cells),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
2,CHEMBL213342,"InChI=1S/C29H28N4O4S/c1-38(34,35)16-15-30-18-25-12-14-28(37-25)22-7-13-27-26(17-22)29(32-20-31-27)33-23-8-10-24(11-9-23)36-19-21-5-3-2-4-6-21/h2-14,17,20,30H,15-16,18-19H2,1H3,(H,31,32,33)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2,CHEMBL213342,"InChI=1S/C29H28N4O4S/c1-38(34,35)16-15-30-18-25-12-14-28(37-25)22-7-13-27-26(17-22)29(32-20-31-27)33-23-8-10-24(11-9-23)36-19-21-5-3-2-4-6-21/h2-14,17,20,30H,15-16,18-19H2,1H3,(H,31,32,33)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2,CHEMBL910359,Inhibition of BT474 cell growth after 72 hrs,IC50,=,280,nM,,CHEMBL614529,BT-474 (Breast ductal carcinoma cells),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
20,CHEMBL212250,"InChI=1S/C34H27ClFN3O5S/c35-30-19-26(10-13-33(30)43-20-23-5-4-6-25(36)17-23)39-34-29-18-24(9-12-31(29)37-22-38-34)32-14-11-27(44-32)21-42-15-16-45(40,41)28-7-2-1-3-8-28/h1-14,17-19,22H,15-16,20-21H2,(H,37,38,39)",Fc1cccc(COc2ccc(Nc3ncnc4ccc(cc34)c5oc(COCCS(=O)(=O)c6ccccc6)cc5)cc2Cl)c1,CHEMBL212250,"InChI=1S/C34H27ClFN3O5S/c35-30-19-26(10-13-33(30)43-20-23-5-4-6-25(36)17-23)39-34-29-18-24(9-12-31(29)37-22-38-34)32-14-11-27(44-32)21-42-15-16-45(40,41)28-7-2-1-3-8-28/h1-14,17-19,22H,15-16,20-21H2,(H,37,38,39)",Fc1cccc(COc2ccc(Nc3ncnc4ccc(cc34)c5oc(COCCS(=O)(=O)c6ccccc6)cc5)cc2Cl)c1,CHEMBL910359,Inhibition of BT474 cell growth after 72 hrs,IC50,,,,Not Determined,CHEMBL614529,BT-474 (Breast ductal carcinoma cells),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
22,CHEMBL212251,"InChI=1S/C32H32ClFN4O4S/c1-3-13-38(14-15-43(2,39)40)19-26-9-12-30(42-26)23-7-10-29-27(17-23)32(36-21-35-29)37-25-8-11-31(28(33)18-25)41-20-22-5-4-6-24(34)16-22/h4-12,16-18,21H,3,13-15,19-20H2,1-2H3,(H,35,36,37)",CCCN(CCS(=O)(=O)C)Cc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2,CHEMBL212251,"InChI=1S/C32H32ClFN4O4S/c1-3-13-38(14-15-43(2,39)40)19-26-9-12-30(42-26)23-7-10-29-27(17-23)32(36-21-35-29)37-25-8-11-31(28(33)18-25)41-20-22-5-4-6-24(34)16-22/h4-12,16-18,21H,3,13-15,19-20H2,1-2H3,(H,35,36,37)",CCCN(CCS(=O)(=O)C)Cc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2,CHEMBL910359,Inhibition of BT474 cell growth after 72 hrs,IC50,=,250,nM,,CHEMBL614529,BT-474 (Breast ductal carcinoma cells),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
23,CHEMBL384407,"InChI=1S/C31H27ClFN5O4S/c1-43(39,40)14-13-38(12-11-34)18-25-7-10-29(42-25)22-5-8-28-26(16-22)31(36-20-35-28)37-24-6-9-30(27(32)17-24)41-19-21-3-2-4-23(33)15-21/h2-10,15-17,20H,12-14,18-19H2,1H3,(H,35,36,37)",CS(=O)(=O)CCN(CC#N)Cc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2,CHEMBL384407,"InChI=1S/C31H27ClFN5O4S/c1-43(39,40)14-13-38(12-11-34)18-25-7-10-29(42-25)22-5-8-28-26(16-22)31(36-20-35-28)37-24-6-9-30(27(32)17-24)41-19-21-3-2-4-23(33)15-21/h2-10,15-17,20H,12-14,18-19H2,1H3,(H,35,36,37)",CS(=O)(=O)CCN(CC#N)Cc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2,CHEMBL910359,Inhibition of BT474 cell growth after 72 hrs,IC50,=,67,nM,,CHEMBL614529,BT-474 (Breast ductal carcinoma cells),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
26,CHEMBL212954,"InChI=1S/C30H26ClFN4O3S/c31-26-16-23(5-8-29(26)38-18-20-2-1-3-22(32)14-20)35-30-25-15-21(4-7-27(25)33-19-34-30)28-9-6-24(39-28)17-36-10-12-40(37)13-11-36/h1-9,14-16,19H,10-13,17-18H2,(H,33,34,35)",Fc1cccc(COc2ccc(Nc3ncnc4ccc(cc34)c5oc(CN6CCS(=O)CC6)cc5)cc2Cl)c1,CHEMBL212954,"InChI=1S/C30H26ClFN4O3S/c31-26-16-23(5-8-29(26)38-18-20-2-1-3-22(32)14-20)35-30-25-15-21(4-7-27(25)33-19-34-30)28-9-6-24(39-28)17-36-10-12-40(37)13-11-36/h1-9,14-16,19H,10-13,17-18H2,(H,33,34,35)",Fc1cccc(COc2ccc(Nc3ncnc4ccc(cc34)c5oc(CN6CCS(=O)CC6)cc5)cc2Cl)c1,CHEMBL910359,Inhibition of BT474 cell growth after 72 hrs,IC50,=,100,nM,,CHEMBL614529,BT-474 (Breast ductal carcinoma cells),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
27,CHEMBL215716,"InChI=1S/C30H27FN4O3S/c31-26-17-23(7-10-29(26)37-19-21-4-2-1-3-5-21)34-30-25-16-22(6-9-27(25)32-20-33-30)28-11-8-24(38-28)18-35-12-14-39(36)15-13-35/h1-11,16-17,20H,12-15,18-19H2,(H,32,33,34)",Fc1cc(Nc2ncnc3ccc(cc23)c4oc(CN5CCS(=O)CC5)cc4)ccc1OCc6ccccc6,CHEMBL215716,"InChI=1S/C30H27FN4O3S/c31-26-17-23(7-10-29(26)37-19-21-4-2-1-3-5-21)34-30-25-16-22(6-9-27(25)32-20-33-30)28-11-8-24(38-28)18-35-12-14-39(36)15-13-35/h1-11,16-17,20H,12-15,18-19H2,(H,32,33,34)",Fc1cc(Nc2ncnc3ccc(cc23)c4oc(CN5CCS(=O)CC5)cc4)ccc1OCc6ccccc6,CHEMBL910359,Inhibition of BT474 cell growth after 72 hrs,IC50,=,1200,nM,,CHEMBL614529,BT-474 (Breast ductal carcinoma cells),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
28,CHEMBL212965,"InChI=1S/C30H27ClN4O3S/c31-26-17-23(7-10-29(26)37-19-21-4-2-1-3-5-21)34-30-25-16-22(6-9-27(25)32-20-33-30)28-11-8-24(38-28)18-35-12-14-39(36)15-13-35/h1-11,16-17,20H,12-15,18-19H2,(H,32,33,34)",Clc1cc(Nc2ncnc3ccc(cc23)c4oc(CN5CCS(=O)CC5)cc4)ccc1OCc6ccccc6,CHEMBL212965,"InChI=1S/C30H27ClN4O3S/c31-26-17-23(7-10-29(26)37-19-21-4-2-1-3-5-21)34-30-25-16-22(6-9-27(25)32-20-33-30)28-11-8-24(38-28)18-35-12-14-39(36)15-13-35/h1-11,16-17,20H,12-15,18-19H2,(H,32,33,34)",Clc1cc(Nc2ncnc3ccc(cc23)c4oc(CN5CCS(=O)CC5)cc4)ccc1OCc6ccccc6,CHEMBL910359,Inhibition of BT474 cell growth after 72 hrs,IC50,=,420,nM,,CHEMBL614529,BT-474 (Breast ductal carcinoma cells),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
5,CHEMBL214419,"InChI=1S/C30H27F3N4O4S/c1-42(38,39)14-13-34-17-25-10-12-28(41-25)21-5-11-27-26(16-21)29(36-19-35-27)37-23-6-8-24(9-7-23)40-18-20-3-2-4-22(15-20)30(31,32)33/h2-12,15-16,19,34H,13-14,17-18H2,1H3,(H,35,36,37)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(c5)C(F)(F)F)cc4)c3c2,CHEMBL214419,"InChI=1S/C30H27F3N4O4S/c1-42(38,39)14-13-34-17-25-10-12-28(41-25)21-5-11-27-26(16-21)29(36-19-35-27)37-23-6-8-24(9-7-23)40-18-20-3-2-4-22(15-20)30(31,32)33/h2-12,15-16,19,34H,13-14,17-18H2,1H3,(H,35,36,37)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(c5)C(F)(F)F)cc4)c3c2,CHEMBL910359,Inhibition of BT474 cell growth after 72 hrs,IC50,=,4200,nM,,CHEMBL614529,BT-474 (Breast ductal carcinoma cells),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
6,CHEMBL380247,"InChI=1S/C29H27ClN4O4S/c1-39(35,36)14-13-31-17-23-9-12-27(38-23)21-7-10-26-24(15-21)29(33-19-32-26)34-22-8-11-28(25(30)16-22)37-18-20-5-3-2-4-6-20/h2-12,15-16,19,31H,13-14,17-18H2,1H3,(H,32,33,34)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2,CHEMBL380247,"InChI=1S/C29H27ClN4O4S/c1-39(35,36)14-13-31-17-23-9-12-27(38-23)21-7-10-26-24(15-21)29(33-19-32-26)34-22-8-11-28(25(30)16-22)37-18-20-5-3-2-4-6-20/h2-12,15-16,19,31H,13-14,17-18H2,1H3,(H,32,33,34)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2,CHEMBL910359,Inhibition of BT474 cell growth after 72 hrs,IC50,=,250,nM,,CHEMBL614529,BT-474 (Breast ductal carcinoma cells),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
7,CHEMBL214689,"InChI=1S/C29H27BrN4O4S/c1-39(35,36)14-13-31-17-23-9-12-27(38-23)21-7-10-26-24(15-21)29(33-19-32-26)34-22-8-11-28(25(30)16-22)37-18-20-5-3-2-4-6-20/h2-12,15-16,19,31H,13-14,17-18H2,1H3,(H,32,33,34)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2,CHEMBL214689,"InChI=1S/C29H27BrN4O4S/c1-39(35,36)14-13-31-17-23-9-12-27(38-23)21-7-10-26-24(15-21)29(33-19-32-26)34-22-8-11-28(25(30)16-22)37-18-20-5-3-2-4-6-20/h2-12,15-16,19,31H,13-14,17-18H2,1H3,(H,32,33,34)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2,CHEMBL910359,Inhibition of BT474 cell growth after 72 hrs,IC50,=,270,nM,,CHEMBL614529,BT-474 (Breast ductal carcinoma cells),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
9,CHEMBL387207,"InChI=1S/C30H27F3N4O4S/c1-42(38,39)14-13-34-17-23-9-12-27(41-23)21-7-10-26-24(15-21)29(36-19-35-26)37-22-8-11-28(25(16-22)30(31,32)33)40-18-20-5-3-2-4-6-20/h2-12,15-16,19,34H,13-14,17-18H2,1H3,(H,35,36,37)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(c4)C(F)(F)F)c3c2,CHEMBL387207,"InChI=1S/C30H27F3N4O4S/c1-42(38,39)14-13-34-17-23-9-12-27(41-23)21-7-10-26-24(15-21)29(36-19-35-26)37-22-8-11-28(25(16-22)30(31,32)33)40-18-20-5-3-2-4-6-20/h2-12,15-16,19,34H,13-14,17-18H2,1H3,(H,35,36,37)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(c4)C(F)(F)F)c3c2,CHEMBL910359,Inhibition of BT474 cell growth after 72 hrs,IC50,=,10140,nM,,CHEMBL614529,BT-474 (Breast ductal carcinoma cells),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
10,CHEMBL215814,"InChI=1S/C30H26F4N4O4S/c1-43(39,40)12-11-35-16-23-7-10-27(42-23)20-5-8-26-24(14-20)29(37-18-36-26)38-22-6-9-28(25(15-22)30(32,33)34)41-17-19-3-2-4-21(31)13-19/h2-10,13-15,18,35H,11-12,16-17H2,1H3,(H,36,37,38)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(c4)C(F)(F)F)c3c2,CHEMBL215814,"InChI=1S/C30H26F4N4O4S/c1-43(39,40)12-11-35-16-23-7-10-27(42-23)20-5-8-26-24(14-20)29(37-18-36-26)38-22-6-9-28(25(15-22)30(32,33)34)41-17-19-3-2-4-21(31)13-19/h2-10,13-15,18,35H,11-12,16-17H2,1H3,(H,36,37,38)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(c4)C(F)(F)F)c3c2,CHEMBL910357,Inhibition of ErbB1,IC50,=,80,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
13,CHEMBL1794063,"InChI=1S/C34H28ClFN4O4S/c35-30-19-26(10-13-33(30)43-21-23-5-4-6-25(36)17-23)40-34-29-18-24(9-12-31(29)38-22-39-34)32-14-11-27(44-32)20-37-15-16-45(41,42)28-7-2-1-3-8-28/h1-14,17-19,22,37H,15-16,20-21H2,(H,38,39,40)",Fc1cccc(COc2ccc(Nc3ncnc4ccc(cc34)c5oc(CNCCS(=O)(=O)c6ccccc6)cc5)cc2Cl)c1,CHEMBL1794063,"InChI=1S/C34H28ClFN4O4S/c35-30-19-26(10-13-33(30)43-21-23-5-4-6-25(36)17-23)40-34-29-18-24(9-12-31(29)38-22-39-34)32-14-11-27(44-32)20-37-15-16-45(41,42)28-7-2-1-3-8-28/h1-14,17-19,22,37H,15-16,20-21H2,(H,38,39,40)",Fc1cccc(COc2ccc(Nc3ncnc4ccc(cc34)c5oc(CNCCS(=O)(=O)c6ccccc6)cc5)cc2Cl)c1,CHEMBL910357,Inhibition of ErbB1,IC50,=,19,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
2,CHEMBL213342,"InChI=1S/C29H28N4O4S/c1-38(34,35)16-15-30-18-25-12-14-28(37-25)22-7-13-27-26(17-22)29(32-20-31-27)33-23-8-10-24(11-9-23)36-19-21-5-3-2-4-6-21/h2-14,17,20,30H,15-16,18-19H2,1H3,(H,31,32,33)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2,CHEMBL213342,"InChI=1S/C29H28N4O4S/c1-38(34,35)16-15-30-18-25-12-14-28(37-25)22-7-13-27-26(17-22)29(32-20-31-27)33-23-8-10-24(11-9-23)36-19-21-5-3-2-4-6-21/h2-14,17,20,30H,15-16,18-19H2,1H3,(H,31,32,33)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2,CHEMBL910357,Inhibition of ErbB1,IC50,=,27,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
20,CHEMBL212250,"InChI=1S/C34H27ClFN3O5S/c35-30-19-26(10-13-33(30)43-20-23-5-4-6-25(36)17-23)39-34-29-18-24(9-12-31(29)37-22-38-34)32-14-11-27(44-32)21-42-15-16-45(40,41)28-7-2-1-3-8-28/h1-14,17-19,22H,15-16,20-21H2,(H,37,38,39)",Fc1cccc(COc2ccc(Nc3ncnc4ccc(cc34)c5oc(COCCS(=O)(=O)c6ccccc6)cc5)cc2Cl)c1,CHEMBL212250,"InChI=1S/C34H27ClFN3O5S/c35-30-19-26(10-13-33(30)43-20-23-5-4-6-25(36)17-23)39-34-29-18-24(9-12-31(29)37-22-38-34)32-14-11-27(44-32)21-42-15-16-45(40,41)28-7-2-1-3-8-28/h1-14,17-19,22H,15-16,20-21H2,(H,37,38,39)",Fc1cccc(COc2ccc(Nc3ncnc4ccc(cc34)c5oc(COCCS(=O)(=O)c6ccccc6)cc5)cc2Cl)c1,CHEMBL910357,Inhibition of ErbB1,IC50,=,25,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
22,CHEMBL212251,"InChI=1S/C32H32ClFN4O4S/c1-3-13-38(14-15-43(2,39)40)19-26-9-12-30(42-26)23-7-10-29-27(17-23)32(36-21-35-29)37-25-8-11-31(28(33)18-25)41-20-22-5-4-6-24(34)16-22/h4-12,16-18,21H,3,13-15,19-20H2,1-2H3,(H,35,36,37)",CCCN(CCS(=O)(=O)C)Cc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2,CHEMBL212251,"InChI=1S/C32H32ClFN4O4S/c1-3-13-38(14-15-43(2,39)40)19-26-9-12-30(42-26)23-7-10-29-27(17-23)32(36-21-35-29)37-25-8-11-31(28(33)18-25)41-20-22-5-4-6-24(34)16-22/h4-12,16-18,21H,3,13-15,19-20H2,1-2H3,(H,35,36,37)",CCCN(CCS(=O)(=O)C)Cc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2,CHEMBL910357,Inhibition of ErbB1,IC50,=,85,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
23,CHEMBL384407,"InChI=1S/C31H27ClFN5O4S/c1-43(39,40)14-13-38(12-11-34)18-25-7-10-29(42-25)22-5-8-28-26(16-22)31(36-20-35-28)37-24-6-9-30(27(32)17-24)41-19-21-3-2-4-23(33)15-21/h2-10,15-17,20H,12-14,18-19H2,1H3,(H,35,36,37)",CS(=O)(=O)CCN(CC#N)Cc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2,CHEMBL384407,"InChI=1S/C31H27ClFN5O4S/c1-43(39,40)14-13-38(12-11-34)18-25-7-10-29(42-25)22-5-8-28-26(16-22)31(36-20-35-28)37-24-6-9-30(27(32)17-24)41-19-21-3-2-4-23(33)15-21/h2-10,15-17,20H,12-14,18-19H2,1H3,(H,35,36,37)",CS(=O)(=O)CCN(CC#N)Cc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2,CHEMBL910357,Inhibition of ErbB1,IC50,=,27,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
26,CHEMBL212954,"InChI=1S/C30H26ClFN4O3S/c31-26-16-23(5-8-29(26)38-18-20-2-1-3-22(32)14-20)35-30-25-15-21(4-7-27(25)33-19-34-30)28-9-6-24(39-28)17-36-10-12-40(37)13-11-36/h1-9,14-16,19H,10-13,17-18H2,(H,33,34,35)",Fc1cccc(COc2ccc(Nc3ncnc4ccc(cc34)c5oc(CN6CCS(=O)CC6)cc5)cc2Cl)c1,CHEMBL212954,"InChI=1S/C30H26ClFN4O3S/c31-26-16-23(5-8-29(26)38-18-20-2-1-3-22(32)14-20)35-30-25-15-21(4-7-27(25)33-19-34-30)28-9-6-24(39-28)17-36-10-12-40(37)13-11-36/h1-9,14-16,19H,10-13,17-18H2,(H,33,34,35)",Fc1cccc(COc2ccc(Nc3ncnc4ccc(cc34)c5oc(CN6CCS(=O)CC6)cc5)cc2Cl)c1,CHEMBL910357,Inhibition of ErbB1,IC50,=,28,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
27,CHEMBL215716,"InChI=1S/C30H27FN4O3S/c31-26-17-23(7-10-29(26)37-19-21-4-2-1-3-5-21)34-30-25-16-22(6-9-27(25)32-20-33-30)28-11-8-24(38-28)18-35-12-14-39(36)15-13-35/h1-11,16-17,20H,12-15,18-19H2,(H,32,33,34)",Fc1cc(Nc2ncnc3ccc(cc23)c4oc(CN5CCS(=O)CC5)cc4)ccc1OCc6ccccc6,CHEMBL215716,"InChI=1S/C30H27FN4O3S/c31-26-17-23(7-10-29(26)37-19-21-4-2-1-3-5-21)34-30-25-16-22(6-9-27(25)32-20-33-30)28-11-8-24(38-28)18-35-12-14-39(36)15-13-35/h1-11,16-17,20H,12-15,18-19H2,(H,32,33,34)",Fc1cc(Nc2ncnc3ccc(cc23)c4oc(CN5CCS(=O)CC5)cc4)ccc1OCc6ccccc6,CHEMBL910357,Inhibition of ErbB1,IC50,=,16,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
28,CHEMBL212965,"InChI=1S/C30H27ClN4O3S/c31-26-17-23(7-10-29(26)37-19-21-4-2-1-3-5-21)34-30-25-16-22(6-9-27(25)32-20-33-30)28-11-8-24(38-28)18-35-12-14-39(36)15-13-35/h1-11,16-17,20H,12-15,18-19H2,(H,32,33,34)",Clc1cc(Nc2ncnc3ccc(cc23)c4oc(CN5CCS(=O)CC5)cc4)ccc1OCc6ccccc6,CHEMBL212965,"InChI=1S/C30H27ClN4O3S/c31-26-17-23(7-10-29(26)37-19-21-4-2-1-3-5-21)34-30-25-16-22(6-9-27(25)32-20-33-30)28-11-8-24(38-28)18-35-12-14-39(36)15-13-35/h1-11,16-17,20H,12-15,18-19H2,(H,32,33,34)",Clc1cc(Nc2ncnc3ccc(cc23)c4oc(CN5CCS(=O)CC5)cc4)ccc1OCc6ccccc6,CHEMBL910357,Inhibition of ErbB1,IC50,=,12,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
5,CHEMBL214419,"InChI=1S/C30H27F3N4O4S/c1-42(38,39)14-13-34-17-25-10-12-28(41-25)21-5-11-27-26(16-21)29(36-19-35-27)37-23-6-8-24(9-7-23)40-18-20-3-2-4-22(15-20)30(31,32)33/h2-12,15-16,19,34H,13-14,17-18H2,1H3,(H,35,36,37)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(c5)C(F)(F)F)cc4)c3c2,CHEMBL214419,"InChI=1S/C30H27F3N4O4S/c1-42(38,39)14-13-34-17-25-10-12-28(41-25)21-5-11-27-26(16-21)29(36-19-35-27)37-23-6-8-24(9-7-23)40-18-20-3-2-4-22(15-20)30(31,32)33/h2-12,15-16,19,34H,13-14,17-18H2,1H3,(H,35,36,37)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(c5)C(F)(F)F)cc4)c3c2,CHEMBL910357,Inhibition of ErbB1,IC50,=,91,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
6,CHEMBL380247,"InChI=1S/C29H27ClN4O4S/c1-39(35,36)14-13-31-17-23-9-12-27(38-23)21-7-10-26-24(15-21)29(33-19-32-26)34-22-8-11-28(25(30)16-22)37-18-20-5-3-2-4-6-20/h2-12,15-16,19,31H,13-14,17-18H2,1H3,(H,32,33,34)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2,CHEMBL380247,"InChI=1S/C29H27ClN4O4S/c1-39(35,36)14-13-31-17-23-9-12-27(38-23)21-7-10-26-24(15-21)29(33-19-32-26)34-22-8-11-28(25(30)16-22)37-18-20-5-3-2-4-6-20/h2-12,15-16,19,31H,13-14,17-18H2,1H3,(H,32,33,34)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2,CHEMBL910357,Inhibition of ErbB1,IC50,=,18,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
7,CHEMBL214689,"InChI=1S/C29H27BrN4O4S/c1-39(35,36)14-13-31-17-23-9-12-27(38-23)21-7-10-26-24(15-21)29(33-19-32-26)34-22-8-11-28(25(30)16-22)37-18-20-5-3-2-4-6-20/h2-12,15-16,19,31H,13-14,17-18H2,1H3,(H,32,33,34)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2,CHEMBL214689,"InChI=1S/C29H27BrN4O4S/c1-39(35,36)14-13-31-17-23-9-12-27(38-23)21-7-10-26-24(15-21)29(33-19-32-26)34-22-8-11-28(25(30)16-22)37-18-20-5-3-2-4-6-20/h2-12,15-16,19,31H,13-14,17-18H2,1H3,(H,32,33,34)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2,CHEMBL910357,Inhibition of ErbB1,IC50,=,25,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
9,CHEMBL387207,"InChI=1S/C30H27F3N4O4S/c1-42(38,39)14-13-34-17-23-9-12-27(41-23)21-7-10-26-24(15-21)29(36-19-35-26)37-22-8-11-28(25(16-22)30(31,32)33)40-18-20-5-3-2-4-6-20/h2-12,15-16,19,34H,13-14,17-18H2,1H3,(H,35,36,37)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(c4)C(F)(F)F)c3c2,CHEMBL387207,"InChI=1S/C30H27F3N4O4S/c1-42(38,39)14-13-34-17-23-9-12-27(41-23)21-7-10-26-24(15-21)29(36-19-35-26)37-22-8-11-28(25(16-22)30(31,32)33)40-18-20-5-3-2-4-6-20/h2-12,15-16,19,34H,13-14,17-18H2,1H3,(H,35,36,37)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(c4)C(F)(F)F)c3c2,CHEMBL910357,Inhibition of ErbB1,IC50,=,160,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
10,CHEMBL215814,"InChI=1S/C30H26F4N4O4S/c1-43(39,40)12-11-35-16-23-7-10-27(42-23)20-5-8-26-24(14-20)29(37-18-36-26)38-22-6-9-28(25(15-22)30(32,33)34)41-17-19-3-2-4-21(31)13-19/h2-10,13-15,18,35H,11-12,16-17H2,1H3,(H,36,37,38)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(c4)C(F)(F)F)c3c2,CHEMBL215814,"InChI=1S/C30H26F4N4O4S/c1-43(39,40)12-11-35-16-23-7-10-27(42-23)20-5-8-26-24(14-20)29(37-18-36-26)38-22-6-9-28(25(15-22)30(32,33)34)41-17-19-3-2-4-21(31)13-19/h2-10,13-15,18,35H,11-12,16-17H2,1H3,(H,36,37,38)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(c4)C(F)(F)F)c3c2,CHEMBL910356,Inhibition of ErbB2,IC50,=,220,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
13,CHEMBL1794063,"InChI=1S/C34H28ClFN4O4S/c35-30-19-26(10-13-33(30)43-21-23-5-4-6-25(36)17-23)40-34-29-18-24(9-12-31(29)38-22-39-34)32-14-11-27(44-32)20-37-15-16-45(41,42)28-7-2-1-3-8-28/h1-14,17-19,22,37H,15-16,20-21H2,(H,38,39,40)",Fc1cccc(COc2ccc(Nc3ncnc4ccc(cc34)c5oc(CNCCS(=O)(=O)c6ccccc6)cc5)cc2Cl)c1,CHEMBL1794063,"InChI=1S/C34H28ClFN4O4S/c35-30-19-26(10-13-33(30)43-21-23-5-4-6-25(36)17-23)40-34-29-18-24(9-12-31(29)38-22-39-34)32-14-11-27(44-32)20-37-15-16-45(41,42)28-7-2-1-3-8-28/h1-14,17-19,22,37H,15-16,20-21H2,(H,38,39,40)",Fc1cccc(COc2ccc(Nc3ncnc4ccc(cc34)c5oc(CNCCS(=O)(=O)c6ccccc6)cc5)cc2Cl)c1,CHEMBL910356,Inhibition of ErbB2,IC50,=,30,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
2,CHEMBL213342,"InChI=1S/C29H28N4O4S/c1-38(34,35)16-15-30-18-25-12-14-28(37-25)22-7-13-27-26(17-22)29(32-20-31-27)33-23-8-10-24(11-9-23)36-19-21-5-3-2-4-6-21/h2-14,17,20,30H,15-16,18-19H2,1H3,(H,31,32,33)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2,CHEMBL213342,"InChI=1S/C29H28N4O4S/c1-38(34,35)16-15-30-18-25-12-14-28(37-25)22-7-13-27-26(17-22)29(32-20-31-27)33-23-8-10-24(11-9-23)36-19-21-5-3-2-4-6-21/h2-14,17,20,30H,15-16,18-19H2,1H3,(H,31,32,33)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2,CHEMBL910356,Inhibition of ErbB2,IC50,=,26,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
20,CHEMBL212250,"InChI=1S/C34H27ClFN3O5S/c35-30-19-26(10-13-33(30)43-20-23-5-4-6-25(36)17-23)39-34-29-18-24(9-12-31(29)37-22-38-34)32-14-11-27(44-32)21-42-15-16-45(40,41)28-7-2-1-3-8-28/h1-14,17-19,22H,15-16,20-21H2,(H,37,38,39)",Fc1cccc(COc2ccc(Nc3ncnc4ccc(cc34)c5oc(COCCS(=O)(=O)c6ccccc6)cc5)cc2Cl)c1,CHEMBL212250,"InChI=1S/C34H27ClFN3O5S/c35-30-19-26(10-13-33(30)43-20-23-5-4-6-25(36)17-23)39-34-29-18-24(9-12-31(29)37-22-38-34)32-14-11-27(44-32)21-42-15-16-45(40,41)28-7-2-1-3-8-28/h1-14,17-19,22H,15-16,20-21H2,(H,37,38,39)",Fc1cccc(COc2ccc(Nc3ncnc4ccc(cc34)c5oc(COCCS(=O)(=O)c6ccccc6)cc5)cc2Cl)c1,CHEMBL910356,Inhibition of ErbB2,IC50,=,28,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
22,CHEMBL212251,"InChI=1S/C32H32ClFN4O4S/c1-3-13-38(14-15-43(2,39)40)19-26-9-12-30(42-26)23-7-10-29-27(17-23)32(36-21-35-29)37-25-8-11-31(28(33)18-25)41-20-22-5-4-6-24(34)16-22/h4-12,16-18,21H,3,13-15,19-20H2,1-2H3,(H,35,36,37)",CCCN(CCS(=O)(=O)C)Cc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2,CHEMBL212251,"InChI=1S/C32H32ClFN4O4S/c1-3-13-38(14-15-43(2,39)40)19-26-9-12-30(42-26)23-7-10-29-27(17-23)32(36-21-35-29)37-25-8-11-31(28(33)18-25)41-20-22-5-4-6-24(34)16-22/h4-12,16-18,21H,3,13-15,19-20H2,1-2H3,(H,35,36,37)",CCCN(CCS(=O)(=O)C)Cc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2,CHEMBL910356,Inhibition of ErbB2,IC50,=,20,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
23,CHEMBL384407,"InChI=1S/C31H27ClFN5O4S/c1-43(39,40)14-13-38(12-11-34)18-25-7-10-29(42-25)22-5-8-28-26(16-22)31(36-20-35-28)37-24-6-9-30(27(32)17-24)41-19-21-3-2-4-23(33)15-21/h2-10,15-17,20H,12-14,18-19H2,1H3,(H,35,36,37)",CS(=O)(=O)CCN(CC#N)Cc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2,CHEMBL384407,"InChI=1S/C31H27ClFN5O4S/c1-43(39,40)14-13-38(12-11-34)18-25-7-10-29(42-25)22-5-8-28-26(16-22)31(36-20-35-28)37-24-6-9-30(27(32)17-24)41-19-21-3-2-4-23(33)15-21/h2-10,15-17,20H,12-14,18-19H2,1H3,(H,35,36,37)",CS(=O)(=O)CCN(CC#N)Cc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2,CHEMBL910356,Inhibition of ErbB2,IC50,=,22,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
26,CHEMBL212954,"InChI=1S/C30H26ClFN4O3S/c31-26-16-23(5-8-29(26)38-18-20-2-1-3-22(32)14-20)35-30-25-15-21(4-7-27(25)33-19-34-30)28-9-6-24(39-28)17-36-10-12-40(37)13-11-36/h1-9,14-16,19H,10-13,17-18H2,(H,33,34,35)",Fc1cccc(COc2ccc(Nc3ncnc4ccc(cc34)c5oc(CN6CCS(=O)CC6)cc5)cc2Cl)c1,CHEMBL212954,"InChI=1S/C30H26ClFN4O3S/c31-26-16-23(5-8-29(26)38-18-20-2-1-3-22(32)14-20)35-30-25-15-21(4-7-27(25)33-19-34-30)28-9-6-24(39-28)17-36-10-12-40(37)13-11-36/h1-9,14-16,19H,10-13,17-18H2,(H,33,34,35)",Fc1cccc(COc2ccc(Nc3ncnc4ccc(cc34)c5oc(CN6CCS(=O)CC6)cc5)cc2Cl)c1,CHEMBL910356,Inhibition of ErbB2,IC50,=,18,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
27,CHEMBL215716,"InChI=1S/C30H27FN4O3S/c31-26-17-23(7-10-29(26)37-19-21-4-2-1-3-5-21)34-30-25-16-22(6-9-27(25)32-20-33-30)28-11-8-24(38-28)18-35-12-14-39(36)15-13-35/h1-11,16-17,20H,12-15,18-19H2,(H,32,33,34)",Fc1cc(Nc2ncnc3ccc(cc23)c4oc(CN5CCS(=O)CC5)cc4)ccc1OCc6ccccc6,CHEMBL215716,"InChI=1S/C30H27FN4O3S/c31-26-17-23(7-10-29(26)37-19-21-4-2-1-3-5-21)34-30-25-16-22(6-9-27(25)32-20-33-30)28-11-8-24(38-28)18-35-12-14-39(36)15-13-35/h1-11,16-17,20H,12-15,18-19H2,(H,32,33,34)",Fc1cc(Nc2ncnc3ccc(cc23)c4oc(CN5CCS(=O)CC5)cc4)ccc1OCc6ccccc6,CHEMBL910356,Inhibition of ErbB2,IC50,=,35,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
28,CHEMBL212965,"InChI=1S/C30H27ClN4O3S/c31-26-17-23(7-10-29(26)37-19-21-4-2-1-3-5-21)34-30-25-16-22(6-9-27(25)32-20-33-30)28-11-8-24(38-28)18-35-12-14-39(36)15-13-35/h1-11,16-17,20H,12-15,18-19H2,(H,32,33,34)",Clc1cc(Nc2ncnc3ccc(cc23)c4oc(CN5CCS(=O)CC5)cc4)ccc1OCc6ccccc6,CHEMBL212965,"InChI=1S/C30H27ClN4O3S/c31-26-17-23(7-10-29(26)37-19-21-4-2-1-3-5-21)34-30-25-16-22(6-9-27(25)32-20-33-30)28-11-8-24(38-28)18-35-12-14-39(36)15-13-35/h1-11,16-17,20H,12-15,18-19H2,(H,32,33,34)",Clc1cc(Nc2ncnc3ccc(cc23)c4oc(CN5CCS(=O)CC5)cc4)ccc1OCc6ccccc6,CHEMBL910356,Inhibition of ErbB2,IC50,=,23,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
5,CHEMBL214419,"InChI=1S/C30H27F3N4O4S/c1-42(38,39)14-13-34-17-25-10-12-28(41-25)21-5-11-27-26(16-21)29(36-19-35-27)37-23-6-8-24(9-7-23)40-18-20-3-2-4-22(15-20)30(31,32)33/h2-12,15-16,19,34H,13-14,17-18H2,1H3,(H,35,36,37)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(c5)C(F)(F)F)cc4)c3c2,CHEMBL214419,"InChI=1S/C30H27F3N4O4S/c1-42(38,39)14-13-34-17-25-10-12-28(41-25)21-5-11-27-26(16-21)29(36-19-35-27)37-23-6-8-24(9-7-23)40-18-20-3-2-4-22(15-20)30(31,32)33/h2-12,15-16,19,34H,13-14,17-18H2,1H3,(H,35,36,37)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(c5)C(F)(F)F)cc4)c3c2,CHEMBL910356,Inhibition of ErbB2,IC50,=,360,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
6,CHEMBL380247,"InChI=1S/C29H27ClN4O4S/c1-39(35,36)14-13-31-17-23-9-12-27(38-23)21-7-10-26-24(15-21)29(33-19-32-26)34-22-8-11-28(25(30)16-22)37-18-20-5-3-2-4-6-20/h2-12,15-16,19,31H,13-14,17-18H2,1H3,(H,32,33,34)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2,CHEMBL380247,"InChI=1S/C29H27ClN4O4S/c1-39(35,36)14-13-31-17-23-9-12-27(38-23)21-7-10-26-24(15-21)29(33-19-32-26)34-22-8-11-28(25(30)16-22)37-18-20-5-3-2-4-6-20/h2-12,15-16,19,31H,13-14,17-18H2,1H3,(H,32,33,34)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2,CHEMBL910356,Inhibition of ErbB2,IC50,=,22,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
7,CHEMBL214689,"InChI=1S/C29H27BrN4O4S/c1-39(35,36)14-13-31-17-23-9-12-27(38-23)21-7-10-26-24(15-21)29(33-19-32-26)34-22-8-11-28(25(30)16-22)37-18-20-5-3-2-4-6-20/h2-12,15-16,19,31H,13-14,17-18H2,1H3,(H,32,33,34)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2,CHEMBL214689,"InChI=1S/C29H27BrN4O4S/c1-39(35,36)14-13-31-17-23-9-12-27(38-23)21-7-10-26-24(15-21)29(33-19-32-26)34-22-8-11-28(25(30)16-22)37-18-20-5-3-2-4-6-20/h2-12,15-16,19,31H,13-14,17-18H2,1H3,(H,32,33,34)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2,CHEMBL910356,Inhibition of ErbB2,IC50,=,25,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
9,CHEMBL387207,"InChI=1S/C30H27F3N4O4S/c1-42(38,39)14-13-34-17-23-9-12-27(41-23)21-7-10-26-24(15-21)29(36-19-35-26)37-22-8-11-28(25(16-22)30(31,32)33)40-18-20-5-3-2-4-6-20/h2-12,15-16,19,34H,13-14,17-18H2,1H3,(H,35,36,37)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(c4)C(F)(F)F)c3c2,CHEMBL387207,"InChI=1S/C30H27F3N4O4S/c1-42(38,39)14-13-34-17-23-9-12-27(41-23)21-7-10-26-24(15-21)29(36-19-35-26)37-22-8-11-28(25(16-22)30(31,32)33)40-18-20-5-3-2-4-6-20/h2-12,15-16,19,34H,13-14,17-18H2,1H3,(H,35,36,37)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(c4)C(F)(F)F)c3c2,CHEMBL910356,Inhibition of ErbB2,IC50,=,200,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
23,CHEMBL384407,"InChI=1S/C31H27ClFN5O4S/c1-43(39,40)14-13-38(12-11-34)18-25-7-10-29(42-25)22-5-8-28-26(16-22)31(36-20-35-28)37-24-6-9-30(27(32)17-24)41-19-21-3-2-4-23(33)15-21/h2-10,15-17,20H,12-14,18-19H2,1H3,(H,35,36,37)",CS(=O)(=O)CCN(CC#N)Cc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2,CHEMBL384407,"InChI=1S/C31H27ClFN5O4S/c1-43(39,40)14-13-38(12-11-34)18-25-7-10-29(42-25)22-5-8-28-26(16-22)31(36-20-35-28)37-24-6-9-30(27(32)17-24)41-19-21-3-2-4-23(33)15-21/h2-10,15-17,20H,12-14,18-19H2,1H3,(H,35,36,37)",CS(=O)(=O)CCN(CC#N)Cc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2,CHEMBL912108,Inhibition of HFF cell growth,IC50,>,30000,nM,,CHEMBL614071,HFF (Foreskin fibroblasts),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
26,CHEMBL212954,"InChI=1S/C30H26ClFN4O3S/c31-26-16-23(5-8-29(26)38-18-20-2-1-3-22(32)14-20)35-30-25-15-21(4-7-27(25)33-19-34-30)28-9-6-24(39-28)17-36-10-12-40(37)13-11-36/h1-9,14-16,19H,10-13,17-18H2,(H,33,34,35)",Fc1cccc(COc2ccc(Nc3ncnc4ccc(cc34)c5oc(CN6CCS(=O)CC6)cc5)cc2Cl)c1,CHEMBL212954,"InChI=1S/C30H26ClFN4O3S/c31-26-16-23(5-8-29(26)38-18-20-2-1-3-22(32)14-20)35-30-25-15-21(4-7-27(25)33-19-34-30)28-9-6-24(39-28)17-36-10-12-40(37)13-11-36/h1-9,14-16,19H,10-13,17-18H2,(H,33,34,35)",Fc1cccc(COc2ccc(Nc3ncnc4ccc(cc34)c5oc(CN6CCS(=O)CC6)cc5)cc2Cl)c1,CHEMBL912108,Inhibition of HFF cell growth,IC50,=,8180,nM,,CHEMBL614071,HFF (Foreskin fibroblasts),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
10,CHEMBL215814,"InChI=1S/C30H26F4N4O4S/c1-43(39,40)12-11-35-16-23-7-10-27(42-23)20-5-8-26-24(14-20)29(37-18-36-26)38-22-6-9-28(25(15-22)30(32,33)34)41-17-19-3-2-4-21(31)13-19/h2-10,13-15,18,35H,11-12,16-17H2,1H3,(H,36,37,38)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(c4)C(F)(F)F)c3c2,CHEMBL215814,"InChI=1S/C30H26F4N4O4S/c1-43(39,40)12-11-35-16-23-7-10-27(42-23)20-5-8-26-24(14-20)29(37-18-36-26)38-22-6-9-28(25(15-22)30(32,33)34)41-17-19-3-2-4-21(31)13-19/h2-10,13-15,18,35H,11-12,16-17H2,1H3,(H,36,37,38)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(c4)C(F)(F)F)c3c2,CHEMBL910358,Inhibition of HN5 cell growth after 72 hrs,IC50,=,1940,nM,,CHEMBL614828,HN5 (Squamous cell carcinoma),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
13,CHEMBL1794063,"InChI=1S/C34H28ClFN4O4S/c35-30-19-26(10-13-33(30)43-21-23-5-4-6-25(36)17-23)40-34-29-18-24(9-12-31(29)38-22-39-34)32-14-11-27(44-32)20-37-15-16-45(41,42)28-7-2-1-3-8-28/h1-14,17-19,22,37H,15-16,20-21H2,(H,38,39,40)",Fc1cccc(COc2ccc(Nc3ncnc4ccc(cc34)c5oc(CNCCS(=O)(=O)c6ccccc6)cc5)cc2Cl)c1,CHEMBL1794063,"InChI=1S/C34H28ClFN4O4S/c35-30-19-26(10-13-33(30)43-21-23-5-4-6-25(36)17-23)40-34-29-18-24(9-12-31(29)38-22-39-34)32-14-11-27(44-32)20-37-15-16-45(41,42)28-7-2-1-3-8-28/h1-14,17-19,22,37H,15-16,20-21H2,(H,38,39,40)",Fc1cccc(COc2ccc(Nc3ncnc4ccc(cc34)c5oc(CNCCS(=O)(=O)c6ccccc6)cc5)cc2Cl)c1,CHEMBL910358,Inhibition of HN5 cell growth after 72 hrs,IC50,=,1070,nM,,CHEMBL614828,HN5 (Squamous cell carcinoma),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
2,CHEMBL213342,"InChI=1S/C29H28N4O4S/c1-38(34,35)16-15-30-18-25-12-14-28(37-25)22-7-13-27-26(17-22)29(32-20-31-27)33-23-8-10-24(11-9-23)36-19-21-5-3-2-4-6-21/h2-14,17,20,30H,15-16,18-19H2,1H3,(H,31,32,33)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2,CHEMBL213342,"InChI=1S/C29H28N4O4S/c1-38(34,35)16-15-30-18-25-12-14-28(37-25)22-7-13-27-26(17-22)29(32-20-31-27)33-23-8-10-24(11-9-23)36-19-21-5-3-2-4-6-21/h2-14,17,20,30H,15-16,18-19H2,1H3,(H,31,32,33)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2,CHEMBL910358,Inhibition of HN5 cell growth after 72 hrs,IC50,=,650,nM,,CHEMBL614828,HN5 (Squamous cell carcinoma),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
26,CHEMBL212954,"InChI=1S/C30H26ClFN4O3S/c31-26-16-23(5-8-29(26)38-18-20-2-1-3-22(32)14-20)35-30-25-15-21(4-7-27(25)33-19-34-30)28-9-6-24(39-28)17-36-10-12-40(37)13-11-36/h1-9,14-16,19H,10-13,17-18H2,(H,33,34,35)",Fc1cccc(COc2ccc(Nc3ncnc4ccc(cc34)c5oc(CN6CCS(=O)CC6)cc5)cc2Cl)c1,CHEMBL212954,"InChI=1S/C30H26ClFN4O3S/c31-26-16-23(5-8-29(26)38-18-20-2-1-3-22(32)14-20)35-30-25-15-21(4-7-27(25)33-19-34-30)28-9-6-24(39-28)17-36-10-12-40(37)13-11-36/h1-9,14-16,19H,10-13,17-18H2,(H,33,34,35)",Fc1cccc(COc2ccc(Nc3ncnc4ccc(cc34)c5oc(CN6CCS(=O)CC6)cc5)cc2Cl)c1,CHEMBL910358,Inhibition of HN5 cell growth after 72 hrs,IC50,=,60,nM,,CHEMBL614828,HN5 (Squamous cell carcinoma),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
27,CHEMBL215716,"InChI=1S/C30H27FN4O3S/c31-26-17-23(7-10-29(26)37-19-21-4-2-1-3-5-21)34-30-25-16-22(6-9-27(25)32-20-33-30)28-11-8-24(38-28)18-35-12-14-39(36)15-13-35/h1-11,16-17,20H,12-15,18-19H2,(H,32,33,34)",Fc1cc(Nc2ncnc3ccc(cc23)c4oc(CN5CCS(=O)CC5)cc4)ccc1OCc6ccccc6,CHEMBL215716,"InChI=1S/C30H27FN4O3S/c31-26-17-23(7-10-29(26)37-19-21-4-2-1-3-5-21)34-30-25-16-22(6-9-27(25)32-20-33-30)28-11-8-24(38-28)18-35-12-14-39(36)15-13-35/h1-11,16-17,20H,12-15,18-19H2,(H,32,33,34)",Fc1cc(Nc2ncnc3ccc(cc23)c4oc(CN5CCS(=O)CC5)cc4)ccc1OCc6ccccc6,CHEMBL910358,Inhibition of HN5 cell growth after 72 hrs,IC50,=,1000,nM,,CHEMBL614828,HN5 (Squamous cell carcinoma),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
28,CHEMBL212965,"InChI=1S/C30H27ClN4O3S/c31-26-17-23(7-10-29(26)37-19-21-4-2-1-3-5-21)34-30-25-16-22(6-9-27(25)32-20-33-30)28-11-8-24(38-28)18-35-12-14-39(36)15-13-35/h1-11,16-17,20H,12-15,18-19H2,(H,32,33,34)",Clc1cc(Nc2ncnc3ccc(cc23)c4oc(CN5CCS(=O)CC5)cc4)ccc1OCc6ccccc6,CHEMBL212965,"InChI=1S/C30H27ClN4O3S/c31-26-17-23(7-10-29(26)37-19-21-4-2-1-3-5-21)34-30-25-16-22(6-9-27(25)32-20-33-30)28-11-8-24(38-28)18-35-12-14-39(36)15-13-35/h1-11,16-17,20H,12-15,18-19H2,(H,32,33,34)",Clc1cc(Nc2ncnc3ccc(cc23)c4oc(CN5CCS(=O)CC5)cc4)ccc1OCc6ccccc6,CHEMBL910358,Inhibition of HN5 cell growth after 72 hrs,IC50,=,320,nM,,CHEMBL614828,HN5 (Squamous cell carcinoma),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
5,CHEMBL214419,"InChI=1S/C30H27F3N4O4S/c1-42(38,39)14-13-34-17-25-10-12-28(41-25)21-5-11-27-26(16-21)29(36-19-35-27)37-23-6-8-24(9-7-23)40-18-20-3-2-4-22(15-20)30(31,32)33/h2-12,15-16,19,34H,13-14,17-18H2,1H3,(H,35,36,37)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(c5)C(F)(F)F)cc4)c3c2,CHEMBL214419,"InChI=1S/C30H27F3N4O4S/c1-42(38,39)14-13-34-17-25-10-12-28(41-25)21-5-11-27-26(16-21)29(36-19-35-27)37-23-6-8-24(9-7-23)40-18-20-3-2-4-22(15-20)30(31,32)33/h2-12,15-16,19,34H,13-14,17-18H2,1H3,(H,35,36,37)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(c5)C(F)(F)F)cc4)c3c2,CHEMBL910358,Inhibition of HN5 cell growth after 72 hrs,IC50,=,6900,nM,,CHEMBL614828,HN5 (Squamous cell carcinoma),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
6,CHEMBL380247,"InChI=1S/C29H27ClN4O4S/c1-39(35,36)14-13-31-17-23-9-12-27(38-23)21-7-10-26-24(15-21)29(33-19-32-26)34-22-8-11-28(25(30)16-22)37-18-20-5-3-2-4-6-20/h2-12,15-16,19,31H,13-14,17-18H2,1H3,(H,32,33,34)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2,CHEMBL380247,"InChI=1S/C29H27ClN4O4S/c1-39(35,36)14-13-31-17-23-9-12-27(38-23)21-7-10-26-24(15-21)29(33-19-32-26)34-22-8-11-28(25(30)16-22)37-18-20-5-3-2-4-6-20/h2-12,15-16,19,31H,13-14,17-18H2,1H3,(H,32,33,34)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2,CHEMBL910358,Inhibition of HN5 cell growth after 72 hrs,IC50,=,250,nM,,CHEMBL614828,HN5 (Squamous cell carcinoma),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
7,CHEMBL214689,"InChI=1S/C29H27BrN4O4S/c1-39(35,36)14-13-31-17-23-9-12-27(38-23)21-7-10-26-24(15-21)29(33-19-32-26)34-22-8-11-28(25(30)16-22)37-18-20-5-3-2-4-6-20/h2-12,15-16,19,31H,13-14,17-18H2,1H3,(H,32,33,34)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2,CHEMBL214689,"InChI=1S/C29H27BrN4O4S/c1-39(35,36)14-13-31-17-23-9-12-27(38-23)21-7-10-26-24(15-21)29(33-19-32-26)34-22-8-11-28(25(30)16-22)37-18-20-5-3-2-4-6-20/h2-12,15-16,19,31H,13-14,17-18H2,1H3,(H,32,33,34)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2,CHEMBL910358,Inhibition of HN5 cell growth after 72 hrs,IC50,=,260,nM,,CHEMBL614828,HN5 (Squamous cell carcinoma),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
9,CHEMBL387207,"InChI=1S/C30H27F3N4O4S/c1-42(38,39)14-13-34-17-23-9-12-27(41-23)21-7-10-26-24(15-21)29(36-19-35-26)37-22-8-11-28(25(16-22)30(31,32)33)40-18-20-5-3-2-4-6-20/h2-12,15-16,19,34H,13-14,17-18H2,1H3,(H,35,36,37)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(c4)C(F)(F)F)c3c2,CHEMBL387207,"InChI=1S/C30H27F3N4O4S/c1-42(38,39)14-13-34-17-23-9-12-27(41-23)21-7-10-26-24(15-21)29(36-19-35-26)37-22-8-11-28(25(16-22)30(31,32)33)40-18-20-5-3-2-4-6-20/h2-12,15-16,19,34H,13-14,17-18H2,1H3,(H,35,36,37)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(c4)C(F)(F)F)c3c2,CHEMBL910358,Inhibition of HN5 cell growth after 72 hrs,IC50,=,5900,nM,,CHEMBL614828,HN5 (Squamous cell carcinoma),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
10,CHEMBL215814,"InChI=1S/C30H26F4N4O4S/c1-43(39,40)12-11-35-16-23-7-10-27(42-23)20-5-8-26-24(14-20)29(37-18-36-26)38-22-6-9-28(25(15-22)30(32,33)34)41-17-19-3-2-4-21(31)13-19/h2-10,13-15,18,35H,11-12,16-17H2,1H3,(H,36,37,38)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(c4)C(F)(F)F)c3c2,CHEMBL215814,"InChI=1S/C30H26F4N4O4S/c1-43(39,40)12-11-35-16-23-7-10-27(42-23)20-5-8-26-24(14-20)29(37-18-36-26)38-22-6-9-28(25(15-22)30(32,33)34)41-17-19-3-2-4-21(31)13-19/h2-10,13-15,18,35H,11-12,16-17H2,1H3,(H,36,37,38)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(c4)C(F)(F)F)c3c2,CHEMBL912107,Inhibition of N87 cell growth after 72 hrs,IC50,=,2890,nM,,CHEMBL612281,N87 (Gastric carcinoma cells),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
13,CHEMBL1794063,"InChI=1S/C34H28ClFN4O4S/c35-30-19-26(10-13-33(30)43-21-23-5-4-6-25(36)17-23)40-34-29-18-24(9-12-31(29)38-22-39-34)32-14-11-27(44-32)20-37-15-16-45(41,42)28-7-2-1-3-8-28/h1-14,17-19,22,37H,15-16,20-21H2,(H,38,39,40)",Fc1cccc(COc2ccc(Nc3ncnc4ccc(cc34)c5oc(CNCCS(=O)(=O)c6ccccc6)cc5)cc2Cl)c1,CHEMBL1794063,"InChI=1S/C34H28ClFN4O4S/c35-30-19-26(10-13-33(30)43-21-23-5-4-6-25(36)17-23)40-34-29-18-24(9-12-31(29)38-22-39-34)32-14-11-27(44-32)20-37-15-16-45(41,42)28-7-2-1-3-8-28/h1-14,17-19,22,37H,15-16,20-21H2,(H,38,39,40)",Fc1cccc(COc2ccc(Nc3ncnc4ccc(cc34)c5oc(CNCCS(=O)(=O)c6ccccc6)cc5)cc2Cl)c1,CHEMBL912107,Inhibition of N87 cell growth after 72 hrs,IC50,=,870,nM,,CHEMBL612281,N87 (Gastric carcinoma cells),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
2,CHEMBL213342,"InChI=1S/C29H28N4O4S/c1-38(34,35)16-15-30-18-25-12-14-28(37-25)22-7-13-27-26(17-22)29(32-20-31-27)33-23-8-10-24(11-9-23)36-19-21-5-3-2-4-6-21/h2-14,17,20,30H,15-16,18-19H2,1H3,(H,31,32,33)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2,CHEMBL213342,"InChI=1S/C29H28N4O4S/c1-38(34,35)16-15-30-18-25-12-14-28(37-25)22-7-13-27-26(17-22)29(32-20-31-27)33-23-8-10-24(11-9-23)36-19-21-5-3-2-4-6-21/h2-14,17,20,30H,15-16,18-19H2,1H3,(H,31,32,33)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2,CHEMBL912107,Inhibition of N87 cell growth after 72 hrs,IC50,=,870,nM,,CHEMBL612281,N87 (Gastric carcinoma cells),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
26,CHEMBL212954,"InChI=1S/C30H26ClFN4O3S/c31-26-16-23(5-8-29(26)38-18-20-2-1-3-22(32)14-20)35-30-25-15-21(4-7-27(25)33-19-34-30)28-9-6-24(39-28)17-36-10-12-40(37)13-11-36/h1-9,14-16,19H,10-13,17-18H2,(H,33,34,35)",Fc1cccc(COc2ccc(Nc3ncnc4ccc(cc34)c5oc(CN6CCS(=O)CC6)cc5)cc2Cl)c1,CHEMBL212954,"InChI=1S/C30H26ClFN4O3S/c31-26-16-23(5-8-29(26)38-18-20-2-1-3-22(32)14-20)35-30-25-15-21(4-7-27(25)33-19-34-30)28-9-6-24(39-28)17-36-10-12-40(37)13-11-36/h1-9,14-16,19H,10-13,17-18H2,(H,33,34,35)",Fc1cccc(COc2ccc(Nc3ncnc4ccc(cc34)c5oc(CN6CCS(=O)CC6)cc5)cc2Cl)c1,CHEMBL912107,Inhibition of N87 cell growth after 72 hrs,IC50,=,80,nM,,CHEMBL612281,N87 (Gastric carcinoma cells),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
27,CHEMBL215716,"InChI=1S/C30H27FN4O3S/c31-26-17-23(7-10-29(26)37-19-21-4-2-1-3-5-21)34-30-25-16-22(6-9-27(25)32-20-33-30)28-11-8-24(38-28)18-35-12-14-39(36)15-13-35/h1-11,16-17,20H,12-15,18-19H2,(H,32,33,34)",Fc1cc(Nc2ncnc3ccc(cc23)c4oc(CN5CCS(=O)CC5)cc4)ccc1OCc6ccccc6,CHEMBL215716,"InChI=1S/C30H27FN4O3S/c31-26-17-23(7-10-29(26)37-19-21-4-2-1-3-5-21)34-30-25-16-22(6-9-27(25)32-20-33-30)28-11-8-24(38-28)18-35-12-14-39(36)15-13-35/h1-11,16-17,20H,12-15,18-19H2,(H,32,33,34)",Fc1cc(Nc2ncnc3ccc(cc23)c4oc(CN5CCS(=O)CC5)cc4)ccc1OCc6ccccc6,CHEMBL912107,Inhibition of N87 cell growth after 72 hrs,IC50,=,1130,nM,,CHEMBL612281,N87 (Gastric carcinoma cells),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
28,CHEMBL212965,"InChI=1S/C30H27ClN4O3S/c31-26-17-23(7-10-29(26)37-19-21-4-2-1-3-5-21)34-30-25-16-22(6-9-27(25)32-20-33-30)28-11-8-24(38-28)18-35-12-14-39(36)15-13-35/h1-11,16-17,20H,12-15,18-19H2,(H,32,33,34)",Clc1cc(Nc2ncnc3ccc(cc23)c4oc(CN5CCS(=O)CC5)cc4)ccc1OCc6ccccc6,CHEMBL212965,"InChI=1S/C30H27ClN4O3S/c31-26-17-23(7-10-29(26)37-19-21-4-2-1-3-5-21)34-30-25-16-22(6-9-27(25)32-20-33-30)28-11-8-24(38-28)18-35-12-14-39(36)15-13-35/h1-11,16-17,20H,12-15,18-19H2,(H,32,33,34)",Clc1cc(Nc2ncnc3ccc(cc23)c4oc(CN5CCS(=O)CC5)cc4)ccc1OCc6ccccc6,CHEMBL912107,Inhibition of N87 cell growth after 72 hrs,IC50,=,460,nM,,CHEMBL612281,N87 (Gastric carcinoma cells),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
5,CHEMBL214419,"InChI=1S/C30H27F3N4O4S/c1-42(38,39)14-13-34-17-25-10-12-28(41-25)21-5-11-27-26(16-21)29(36-19-35-27)37-23-6-8-24(9-7-23)40-18-20-3-2-4-22(15-20)30(31,32)33/h2-12,15-16,19,34H,13-14,17-18H2,1H3,(H,35,36,37)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(c5)C(F)(F)F)cc4)c3c2,CHEMBL214419,"InChI=1S/C30H27F3N4O4S/c1-42(38,39)14-13-34-17-25-10-12-28(41-25)21-5-11-27-26(16-21)29(36-19-35-27)37-23-6-8-24(9-7-23)40-18-20-3-2-4-22(15-20)30(31,32)33/h2-12,15-16,19,34H,13-14,17-18H2,1H3,(H,35,36,37)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(c5)C(F)(F)F)cc4)c3c2,CHEMBL912107,Inhibition of N87 cell growth after 72 hrs,IC50,=,5200,nM,,CHEMBL612281,N87 (Gastric carcinoma cells),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
6,CHEMBL380247,"InChI=1S/C29H27ClN4O4S/c1-39(35,36)14-13-31-17-23-9-12-27(38-23)21-7-10-26-24(15-21)29(33-19-32-26)34-22-8-11-28(25(30)16-22)37-18-20-5-3-2-4-6-20/h2-12,15-16,19,31H,13-14,17-18H2,1H3,(H,32,33,34)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2,CHEMBL380247,"InChI=1S/C29H27ClN4O4S/c1-39(35,36)14-13-31-17-23-9-12-27(38-23)21-7-10-26-24(15-21)29(33-19-32-26)34-22-8-11-28(25(30)16-22)37-18-20-5-3-2-4-6-20/h2-12,15-16,19,31H,13-14,17-18H2,1H3,(H,32,33,34)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2,CHEMBL912107,Inhibition of N87 cell growth after 72 hrs,IC50,=,280,nM,,CHEMBL612281,N87 (Gastric carcinoma cells),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
7,CHEMBL214689,"InChI=1S/C29H27BrN4O4S/c1-39(35,36)14-13-31-17-23-9-12-27(38-23)21-7-10-26-24(15-21)29(33-19-32-26)34-22-8-11-28(25(30)16-22)37-18-20-5-3-2-4-6-20/h2-12,15-16,19,31H,13-14,17-18H2,1H3,(H,32,33,34)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2,CHEMBL214689,"InChI=1S/C29H27BrN4O4S/c1-39(35,36)14-13-31-17-23-9-12-27(38-23)21-7-10-26-24(15-21)29(33-19-32-26)34-22-8-11-28(25(30)16-22)37-18-20-5-3-2-4-6-20/h2-12,15-16,19,31H,13-14,17-18H2,1H3,(H,32,33,34)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2,CHEMBL912107,Inhibition of N87 cell growth after 72 hrs,IC50,=,370,nM,,CHEMBL612281,N87 (Gastric carcinoma cells),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
9,CHEMBL387207,"InChI=1S/C30H27F3N4O4S/c1-42(38,39)14-13-34-17-23-9-12-27(41-23)21-7-10-26-24(15-21)29(36-19-35-26)37-22-8-11-28(25(16-22)30(31,32)33)40-18-20-5-3-2-4-6-20/h2-12,15-16,19,34H,13-14,17-18H2,1H3,(H,35,36,37)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(c4)C(F)(F)F)c3c2,CHEMBL387207,"InChI=1S/C30H27F3N4O4S/c1-42(38,39)14-13-34-17-23-9-12-27(41-23)21-7-10-26-24(15-21)29(36-19-35-26)37-22-8-11-28(25(16-22)30(31,32)33)40-18-20-5-3-2-4-6-20/h2-12,15-16,19,34H,13-14,17-18H2,1H3,(H,35,36,37)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(c4)C(F)(F)F)c3c2,CHEMBL912107,Inhibition of N87 cell growth after 72 hrs,IC50,=,6500,nM,,CHEMBL612281,N87 (Gastric carcinoma cells),Homo sapiens,,CHEMBL1149340,"Bioorg. Med. Chem. Lett., 16, p. 4686 (2006)",16777410,Scientific Literature
10,CHEMBL399410,"InChI=1S/C27H23N3O2S/c1-30-26(22-5-4-21-17-23(32-2)9-6-20(21)16-22)25(18-12-14-28-15-13-18)29-27(30)19-7-10-24(11-8-19)33(3)31/h4-17H,1-3H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4)S(=O)C)n3C)c5ccncc5,CHEMBL399410,"InChI=1S/C27H23N3O2S/c1-30-26(22-5-4-21-17-23(32-2)9-6-20(21)16-22)25(18-12-14-28-15-13-18)29-27(30)19-7-10-24(11-8-19)33(3)31/h4-17H,1-3H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4)S(=O)C)n3C)c5ccncc5,CHEMBL897816,Inhibition of P38 kinase,IC50,=,16000,nM,,CHEMBL612545,,,,CHEMBL1149658,"Bioorg. Med. Chem. Lett., 17, p. 4756 (2007)",17618114,Scientific Literature
10,CHEMBL399410,"InChI=1S/C27H23N3O2S/c1-30-26(22-5-4-21-17-23(32-2)9-6-20(21)16-22)25(18-12-14-28-15-13-18)29-27(30)19-7-10-24(11-8-19)33(3)31/h4-17H,1-3H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4)S(=O)C)n3C)c5ccncc5,CHEMBL399410,"InChI=1S/C27H23N3O2S/c1-30-26(22-5-4-21-17-23(32-2)9-6-20(21)16-22)25(18-12-14-28-15-13-18)29-27(30)19-7-10-24(11-8-19)33(3)31/h4-17H,1-3H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4)S(=O)C)n3C)c5ccncc5,CHEMBL897815,Inhibition of Tie2 kinase by autophosphorylation assay,IC50,=,60,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1149658,"Bioorg. Med. Chem. Lett., 17, p. 4756 (2007)",17618114,Scientific Literature
10,CHEMBL399410,"InChI=1S/C27H23N3O2S/c1-30-26(22-5-4-21-17-23(32-2)9-6-20(21)16-22)25(18-12-14-28-15-13-18)29-27(30)19-7-10-24(11-8-19)33(3)31/h4-17H,1-3H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4)S(=O)C)n3C)c5ccncc5,CHEMBL399410,"InChI=1S/C27H23N3O2S/c1-30-26(22-5-4-21-17-23(32-2)9-6-20(21)16-22)25(18-12-14-28-15-13-18)29-27(30)19-7-10-24(11-8-19)33(3)31/h4-17H,1-3H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4)S(=O)C)n3C)c5ccncc5,CHEMBL897821,"Reduction in bFGF-induced angiogenesis in Matrigel mouse model at 25 mg/kg, ip bid",Activity,=,5,%,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1149658,"Bioorg. Med. Chem. Lett., 17, p. 4756 (2007)",17618114,Scientific Literature
10,CHEMBL399410,"InChI=1S/C27H23N3O2S/c1-30-26(22-5-4-21-17-23(32-2)9-6-20(21)16-22)25(18-12-14-28-15-13-18)29-27(30)19-7-10-24(11-8-19)33(3)31/h4-17H,1-3H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4)S(=O)C)n3C)c5ccncc5,CHEMBL399410,"InChI=1S/C27H23N3O2S/c1-30-26(22-5-4-21-17-23(32-2)9-6-20(21)16-22)25(18-12-14-28-15-13-18)29-27(30)19-7-10-24(11-8-19)33(3)31/h4-17H,1-3H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4)S(=O)C)n3C)c5ccncc5,CHEMBL897822,"Reduction in bFGF-induced angiogenesis in Matrigel mouse model at 50 mg/kg, ip bid",Activity,=,30,%,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1149658,"Bioorg. Med. Chem. Lett., 17, p. 4756 (2007)",17618114,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1037546,Binding constant for AAK1 kinase domain,Kd,>,10000,nM,,CHEMBL3830,Adaptor-associated kinase,Homo sapiens,Q2M2I8,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1037546,Binding constant for AAK1 kinase domain,Kd,>,10000,nM,,CHEMBL3830,Adaptor-associated kinase,Homo sapiens,Q2M2I8,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061129,Binding constant for ABL1 kinase domain,Kd,>,10000,nM,,CHEMBL1862,Tyrosine-protein kinase ABL,Homo sapiens,P00519,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061129,Binding constant for ABL1 kinase domain,Kd,>,10000,nM,,CHEMBL1862,Tyrosine-protein kinase ABL,Homo sapiens,P00519,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063789,Binding constant for ABL1(E255K) kinase domain,Kd,>,10000,nM,,CHEMBL1862,Tyrosine-protein kinase ABL,Homo sapiens,P00519,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063789,Binding constant for ABL1(E255K) kinase domain,Kd,>,10000,nM,,CHEMBL1862,Tyrosine-protein kinase ABL,Homo sapiens,P00519,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060174,Binding constant for ABL1(H396P) kinase domain,Kd,>,10000,nM,,CHEMBL1862,Tyrosine-protein kinase ABL,Homo sapiens,P00519,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060174,Binding constant for ABL1(H396P) kinase domain,Kd,>,10000,nM,,CHEMBL1862,Tyrosine-protein kinase ABL,Homo sapiens,P00519,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062829,Binding constant for ABL1(M351T) kinase domain,Kd,>,10000,nM,,CHEMBL1862,Tyrosine-protein kinase ABL,Homo sapiens,P00519,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062829,Binding constant for ABL1(M351T) kinase domain,Kd,>,10000,nM,,CHEMBL1862,Tyrosine-protein kinase ABL,Homo sapiens,P00519,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062830,Binding constant for ABL1(Q252H) kinase domain,Kd,>,10000,nM,,CHEMBL1862,Tyrosine-protein kinase ABL,Homo sapiens,P00519,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062830,Binding constant for ABL1(Q252H) kinase domain,Kd,>,10000,nM,,CHEMBL1862,Tyrosine-protein kinase ABL,Homo sapiens,P00519,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051277,Binding constant for ABL1(T315I) kinase domain,Kd,>,10000,nM,,CHEMBL1862,Tyrosine-protein kinase ABL,Homo sapiens,P00519,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051277,Binding constant for ABL1(T315I) kinase domain,Kd,>,10000,nM,,CHEMBL1862,Tyrosine-protein kinase ABL,Homo sapiens,P00519,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061130,Binding constant for ABL1(Y253F) kinase domain,Kd,>,10000,nM,,CHEMBL1862,Tyrosine-protein kinase ABL,Homo sapiens,P00519,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061130,Binding constant for ABL1(Y253F) kinase domain,Kd,>,10000,nM,,CHEMBL1862,Tyrosine-protein kinase ABL,Homo sapiens,P00519,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061131,Binding constant for ABL2 kinase domain,Kd,>,10000,nM,,CHEMBL4014,Tyrosine-protein kinase ABL2,Homo sapiens,P42684,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061131,Binding constant for ABL2 kinase domain,Kd,>,10000,nM,,CHEMBL4014,Tyrosine-protein kinase ABL2,Homo sapiens,P42684,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063697,Binding constant for ACVR1 kinase domain,Kd,>,10000,nM,,CHEMBL5903,Activin receptor type-1,Homo sapiens,Q04771,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063697,Binding constant for ACVR1 kinase domain,Kd,>,10000,nM,,CHEMBL5903,Activin receptor type-1,Homo sapiens,Q04771,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051278,Binding constant for ACVR1B kinase domain,Kd,>,10000,nM,,CHEMBL5310,Activin receptor type-1B,Homo sapiens,P36896,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051278,Binding constant for ACVR1B kinase domain,Kd,=,190,nM,,CHEMBL5310,Activin receptor type-1B,Homo sapiens,P36896,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060234,Binding constant for ACVR2A kinase domain,Kd,>,10000,nM,,CHEMBL5616,Activin receptor type-2A,Homo sapiens,P27037,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060234,Binding constant for ACVR2A kinase domain,Kd,>,10000,nM,,CHEMBL5616,Activin receptor type-2A,Homo sapiens,P27037,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1057608,Binding constant for ACVR2B kinase domain,Kd,>,10000,nM,,CHEMBL5466,Activin receptor type-2B,Homo sapiens,Q13705,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1057608,Binding constant for ACVR2B kinase domain,Kd,>,10000,nM,,CHEMBL5466,Activin receptor type-2B,Homo sapiens,Q13705,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063790,Binding constant for ACVRL1 kinase domain,Kd,>,10000,nM,,CHEMBL5311,Serine/threonine-protein kinase receptor R3,Homo sapiens,P37023,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063790,Binding constant for ACVRL1 kinase domain,Kd,>,10000,nM,,CHEMBL5311,Serine/threonine-protein kinase receptor R3,Homo sapiens,P37023,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062831,Binding constant for ADCK3 kinase domain,Kd,>,10000,nM,,CHEMBL5550,"Chaperone activity of bc1 complex-like, mitochondrial",Homo sapiens,Q8NI60,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062831,Binding constant for ADCK3 kinase domain,Kd,>,10000,nM,,CHEMBL5550,"Chaperone activity of bc1 complex-like, mitochondrial",Homo sapiens,Q8NI60,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051279,Binding constant for AKT1 kinase domain,Kd,>,10000,nM,,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,P31749,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051279,Binding constant for AKT1 kinase domain,Kd,>,10000,nM,,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,P31749,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062832,Binding constant for AKT2 kinase domain,Kd,>,10000,nM,,CHEMBL2431,Serine/threonine-protein kinase AKT2,Homo sapiens,P31751,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062832,Binding constant for AKT2 kinase domain,Kd,>,10000,nM,,CHEMBL2431,Serine/threonine-protein kinase AKT2,Homo sapiens,P31751,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051280,Binding constant for AKT3 kinase domain,Kd,>,10000,nM,,CHEMBL4816,Serine/threonine-protein kinase AKT3,Homo sapiens,Q9Y243,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051280,Binding constant for AKT3 kinase domain,Kd,>,10000,nM,,CHEMBL4816,Serine/threonine-protein kinase AKT3,Homo sapiens,Q9Y243,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1050837,Binding constant for ALK kinase domain,Kd,>,10000,nM,,CHEMBL4247,ALK tyrosine kinase receptor,Homo sapiens,Q9UM73,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1050837,Binding constant for ALK kinase domain,Kd,>,10000,nM,,CHEMBL4247,ALK tyrosine kinase receptor,Homo sapiens,Q9UM73,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060175,Binding constant for AMPK-alpha1 kinase domain,Kd,>,10000,nM,,CHEMBL4045,"AMP-activated protein kinase, alpha-1 subunit",Homo sapiens,Q13131,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060175,Binding constant for AMPK-alpha1 kinase domain,Kd,>,10000,nM,,CHEMBL4045,"AMP-activated protein kinase, alpha-1 subunit",Homo sapiens,Q13131,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060176,Binding constant for AMPK-alpha2 kinase domain,Kd,>,10000,nM,,CHEMBL2116,"AMP-activated protein kinase, alpha-2 subunit",Homo sapiens,P54646,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060176,Binding constant for AMPK-alpha2 kinase domain,Kd,>,10000,nM,,CHEMBL2116,"AMP-activated protein kinase, alpha-2 subunit",Homo sapiens,P54646,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060235,Binding constant for ANKK1 kinase domain,Kd,>,10000,nM,,CHEMBL5547,Ankyrin repeat and protein kinase domain-containing protein 1,Homo sapiens,Q8NFD2,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060235,Binding constant for ANKK1 kinase domain,Kd,>,10000,nM,,CHEMBL5547,Ankyrin repeat and protein kinase domain-containing protein 1,Homo sapiens,Q8NFD2,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060177,Binding constant for ARK5 kinase domain,Kd,>,10000,nM,,CHEMBL5784,NUAK family SNF1-like kinase 1,Homo sapiens,O60285,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060177,Binding constant for ARK5 kinase domain,Kd,>,10000,nM,,CHEMBL5784,NUAK family SNF1-like kinase 1,Homo sapiens,O60285,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062833,Binding constant for AURKA kinase domain,Kd,>,10000,nM,,CHEMBL4722,Serine/threonine-protein kinase Aurora-A,Homo sapiens,O14965,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062833,Binding constant for AURKA kinase domain,Kd,>,10000,nM,,CHEMBL4722,Serine/threonine-protein kinase Aurora-A,Homo sapiens,O14965,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062834,Binding constant for AURKB kinase domain,Kd,>,10000,nM,,CHEMBL2185,Serine/threonine-protein kinase Aurora-B,Homo sapiens,Q96GD4,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062834,Binding constant for AURKB kinase domain,Kd,>,10000,nM,,CHEMBL2185,Serine/threonine-protein kinase Aurora-B,Homo sapiens,Q96GD4,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060237,Binding constant for AXL kinase domain,Kd,>,10000,nM,,CHEMBL4895,Tyrosine-protein kinase receptor UFO,Homo sapiens,P30530,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060237,Binding constant for AXL kinase domain,Kd,>,10000,nM,,CHEMBL4895,Tyrosine-protein kinase receptor UFO,Homo sapiens,P30530,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063698,Binding constant for BIKE kinase domain,Kd,>,10000,nM,,CHEMBL4522,BMP-2-inducible protein kinase,Homo sapiens,Q9NSY1,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063698,Binding constant for BIKE kinase domain,Kd,>,10000,nM,,CHEMBL4522,BMP-2-inducible protein kinase,Homo sapiens,Q9NSY1,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063791,Binding constant for BLK kinase domain,Kd,>,10000,nM,,CHEMBL2250,Tyrosine-protein kinase BLK,Homo sapiens,P51451,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063791,Binding constant for BLK kinase domain,Kd,>,10000,nM,,CHEMBL2250,Tyrosine-protein kinase BLK,Homo sapiens,P51451,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063699,Binding constant for BMPR1A kinase domain,Kd,>,10000,nM,,CHEMBL5275,Bone morphogenetic protein receptor type-1A,Homo sapiens,P36894,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063699,Binding constant for BMPR1A kinase domain,Kd,>,10000,nM,,CHEMBL5275,Bone morphogenetic protein receptor type-1A,Homo sapiens,P36894,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061133,Binding constant for BMPR2 kinase domain,Kd,>,10000,nM,,CHEMBL5467,Bone morphogenetic protein receptor type-2,Homo sapiens,Q13873,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061133,Binding constant for BMPR2 kinase domain,Kd,>,10000,nM,,CHEMBL5467,Bone morphogenetic protein receptor type-2,Homo sapiens,Q13873,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051281,Binding constant for BRAF kinase domain,Kd,>,10000,nM,,CHEMBL5145,Serine/threonine-protein kinase B-raf,Homo sapiens,P15056,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051281,Binding constant for BRAF kinase domain,Kd,>,10000,nM,,CHEMBL5145,Serine/threonine-protein kinase B-raf,Homo sapiens,P15056,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051282,Binding constant for BRAF(V600E) kinase domain,Kd,>,10000,nM,,CHEMBL5145,Serine/threonine-protein kinase B-raf,Homo sapiens,P15056,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051282,Binding constant for BRAF(V600E) kinase domain,Kd,>,10000,nM,,CHEMBL5145,Serine/threonine-protein kinase B-raf,Homo sapiens,P15056,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061135,Binding constant for BRSK1 kinase domain,Kd,>,10000,nM,,CHEMBL5650,BR serine/threonine-protein kinase 1,Homo sapiens,Q8TDC3,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061135,Binding constant for BRSK1 kinase domain,Kd,>,10000,nM,,CHEMBL5650,BR serine/threonine-protein kinase 1,Homo sapiens,Q8TDC3,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1052133,Binding constant for CAMK1D kinase domain,Kd,>,10000,nM,,CHEMBL5073,CaM kinase I delta,Homo sapiens,Q8IU85,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1052133,Binding constant for CAMK1D kinase domain,Kd,>,10000,nM,,CHEMBL5073,CaM kinase I delta,Homo sapiens,Q8IU85,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060178,Binding constant for CAMK1G kinase domain,Kd,>,10000,nM,,CHEMBL5258,CaM kinase I gamma,Homo sapiens,Q96NX5,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060178,Binding constant for CAMK1G kinase domain,Kd,>,10000,nM,,CHEMBL5258,CaM kinase I gamma,Homo sapiens,Q96NX5,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062835,Binding constant for CAMK2A kinase domain,Kd,>,10000,nM,,CHEMBL4147,CaM kinase II alpha,Homo sapiens,Q9UQM7,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062835,Binding constant for CAMK2A kinase domain,Kd,>,10000,nM,,CHEMBL4147,CaM kinase II alpha,Homo sapiens,Q9UQM7,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060183,Binding constant for CAMK2B kinase domain,Kd,>,10000,nM,,CHEMBL4121,CaM kinase II beta,Homo sapiens,Q13554,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060183,Binding constant for CAMK2B kinase domain,Kd,>,10000,nM,,CHEMBL4121,CaM kinase II beta,Homo sapiens,Q13554,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063792,Binding constant for CAMK2D kinase domain,Kd,>,10000,nM,,CHEMBL2801,CaM kinase II delta,Homo sapiens,Q13557,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063792,Binding constant for CAMK2D kinase domain,Kd,>,10000,nM,,CHEMBL2801,CaM kinase II delta,Homo sapiens,Q13557,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061137,Binding constant for CAMK2G kinase domain,Kd,>,10000,nM,,CHEMBL3829,CaM kinase II gamma,Homo sapiens,Q13555,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061137,Binding constant for CAMK2G kinase domain,Kd,>,10000,nM,,CHEMBL3829,CaM kinase II gamma,Homo sapiens,Q13555,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060179,Binding constant for CAMK4 kinase domain,Kd,>,10000,nM,,CHEMBL2494,CaM kinase IV,Homo sapiens,Q16566,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060179,Binding constant for CAMK4 kinase domain,Kd,>,10000,nM,,CHEMBL2494,CaM kinase IV,Homo sapiens,Q16566,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062836,Binding constant for CAMKK1 kinase domain,Kd,>,10000,nM,,CHEMBL5256,CaM-kinase kinase alpha,Homo sapiens,Q8N5S9,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062836,Binding constant for CAMKK1 kinase domain,Kd,>,10000,nM,,CHEMBL5256,CaM-kinase kinase alpha,Homo sapiens,Q8N5S9,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063793,Binding constant for CAMKK2 kinase domain,Kd,>,10000,nM,,CHEMBL5284,CaM-kinase kinase beta,Homo sapiens,Q96RR4,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063793,Binding constant for CAMKK2 kinase domain,Kd,>,10000,nM,,CHEMBL5284,CaM-kinase kinase beta,Homo sapiens,Q96RR4,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060184,Binding constant for CDC2L1 kinase domain,Kd,>,10000,nM,,CHEMBL5808,PITSLRE serine/threonine-protein kinase CDC2L1,Homo sapiens,P21127,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060184,Binding constant for CDC2L1 kinase domain,Kd,>,10000,nM,,CHEMBL5808,PITSLRE serine/threonine-protein kinase CDC2L1,Homo sapiens,P21127,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063794,Binding constant for CDC2L2 kinase domain,Kd,>,10000,nM,,CHEMBL5416,PITSLRE serine/threonine-protein kinase CDC2L2,Homo sapiens,Q9UQ88,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063794,Binding constant for CDC2L2 kinase domain,Kd,>,10000,nM,,CHEMBL5416,PITSLRE serine/threonine-protein kinase CDC2L2,Homo sapiens,Q9UQ88,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062837,Binding constant for CDK11 kinase domain,Kd,>,10000,nM,,CHEMBL6002,Cell division cycle 2-like protein kinase 6,Homo sapiens,Q9BWU1,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062837,Binding constant for CDK11 kinase domain,Kd,>,10000,nM,,CHEMBL6002,Cell division cycle 2-like protein kinase 6,Homo sapiens,Q9BWU1,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051283,Binding constant for CDK8 kinase domain,Kd,>,10000,nM,,CHEMBL5719,Cell division protein kinase 8,Homo sapiens,P49336,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051283,Binding constant for CDK8 kinase domain,Kd,>,10000,nM,,CHEMBL5719,Cell division protein kinase 8,Homo sapiens,P49336,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060185,Binding constant for CHEK1 kinase domain,Kd,>,10000,nM,,CHEMBL4630,Serine/threonine-protein kinase Chk1 ,Homo sapiens,O14757,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060185,Binding constant for CHEK1 kinase domain,Kd,>,10000,nM,,CHEMBL4630,Serine/threonine-protein kinase Chk1 ,Homo sapiens,O14757,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062838,Binding constant for CIT kinase domain,Kd,>,10000,nM,,CHEMBL5579,Citron Rho-interacting kinase,Homo sapiens,O14578,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062838,Binding constant for CIT kinase domain,Kd,>,10000,nM,,CHEMBL5579,Citron Rho-interacting kinase,Homo sapiens,O14578,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061139,Binding constant for CLK2 kinase domain,Kd,>,10000,nM,,CHEMBL4225,Dual specificity protein kinase CLK2,Homo sapiens,P49760,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061139,Binding constant for CLK2 kinase domain,Kd,>,10000,nM,,CHEMBL4225,Dual specificity protein kinase CLK2,Homo sapiens,P49760,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061140,Binding constant for CLK4 kinase domain,Kd,>,10000,nM,,CHEMBL4203,Dual specificity protein kinase CLK4,Homo sapiens,Q9HAZ1,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061140,Binding constant for CLK4 kinase domain,Kd,>,10000,nM,,CHEMBL4203,Dual specificity protein kinase CLK4,Homo sapiens,Q9HAZ1,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063702,Binding constant for CSF1R kinase domain,Kd,=,1.6,nM,,CHEMBL1844,Macrophage colony stimulating factor  receptor ,Homo sapiens,P07333,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063702,Binding constant for CSF1R kinase domain,Kd,>,10000,nM,,CHEMBL1844,Macrophage colony stimulating factor  receptor ,Homo sapiens,P07333,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060186,Binding constant for CSNK1G1 kinase domain,Kd,>,10000,nM,,CHEMBL2426,Casein kinase I gamma 1,Homo sapiens,Q9HCP0,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060186,Binding constant for CSNK1G1 kinase domain,Kd,>,10000,nM,,CHEMBL2426,Casein kinase I gamma 1,Homo sapiens,Q9HCP0,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1044652,Binding constant for DAPK1 kinase domain,Kd,>,10000,nM,,CHEMBL2558,Death-associated protein kinase 1,Homo sapiens,P53355,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1044652,Binding constant for DAPK1 kinase domain,Kd,>,10000,nM,,CHEMBL2558,Death-associated protein kinase 1,Homo sapiens,P53355,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060187,Binding constant for DAPK3 kinase domain,Kd,>,10000,nM,,CHEMBL2468,Death-associated protein kinase 3,Homo sapiens,O43293,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060187,Binding constant for DAPK3 kinase domain,Kd,>,10000,nM,,CHEMBL2468,Death-associated protein kinase 3,Homo sapiens,O43293,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063705,Binding constant for DCAMKL1 kinase domain,Kd,>,10000,nM,,CHEMBL5683,Serine/threonine-protein kinase DCLK1,Homo sapiens,O15075,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063705,Binding constant for DCAMKL1 kinase domain,Kd,>,10000,nM,,CHEMBL5683,Serine/threonine-protein kinase DCLK1,Homo sapiens,O15075,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063795,Binding constant for DCAMKL2 kinase domain,Kd,>,10000,nM,,CHEMBL5519,Serine/threonine-protein kinase DCLK2,Homo sapiens,Q8N568,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063795,Binding constant for DCAMKL2 kinase domain,Kd,>,10000,nM,,CHEMBL5519,Serine/threonine-protein kinase DCLK2,Homo sapiens,Q8N568,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060188,Binding constant for DCAMKL3 kinase domain,Kd,>,10000,nM,,CHEMBL6123,Serine/threonine-protein kinase DCLK3,Homo sapiens,Q9C098,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060188,Binding constant for DCAMKL3 kinase domain,Kd,>,10000,nM,,CHEMBL6123,Serine/threonine-protein kinase DCLK3,Homo sapiens,Q9C098,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1050825,Binding constant for DDR1 kinase domain,Kd,>,10000,nM,,CHEMBL5319,Epithelial discoidin domain-containing receptor 1,Homo sapiens,Q08345,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1050825,Binding constant for DDR1 kinase domain,Kd,>,10000,nM,,CHEMBL5319,Epithelial discoidin domain-containing receptor 1,Homo sapiens,Q08345,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060180,Binding constant for DDR2 kinase domain,Kd,>,10000,nM,,CHEMBL5122,Discoidin domain-containing receptor 2,Homo sapiens,Q16832,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060180,Binding constant for DDR2 kinase domain,Kd,>,10000,nM,,CHEMBL5122,Discoidin domain-containing receptor 2,Homo sapiens,Q16832,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063706,Binding constant for DMPK kinase domain,Kd,>,10000,nM,,CHEMBL5320,Myotonin-protein kinase,Homo sapiens,Q09013,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063706,Binding constant for DMPK kinase domain,Kd,>,10000,nM,,CHEMBL5320,Myotonin-protein kinase,Homo sapiens,Q09013,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060242,Binding constant for DMPK2 kinase domain,Kd,>,10000,nM,,CHEMBL5615,Serine/threonine-protein kinase MRCK gamma,Homo sapiens,Q6DT37,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060242,Binding constant for DMPK2 kinase domain,Kd,>,10000,nM,,CHEMBL5615,Serine/threonine-protein kinase MRCK gamma,Homo sapiens,Q6DT37,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061142,Binding constant for DRAK1 kinase domain,Kd,>,10000,nM,,CHEMBL4525,Serine/threonine-protein kinase 17A,Homo sapiens,Q9UEE5,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061142,Binding constant for DRAK1 kinase domain,Kd,>,10000,nM,,CHEMBL4525,Serine/threonine-protein kinase 17A,Homo sapiens,Q9UEE5,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060182,Binding constant for EGFR kinase domain,Kd,>,10000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060182,Binding constant for EGFR kinase domain,Kd,>,10000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061143,Binding constant for EGFR(E746-A750del) kinase domain,Kd,>,10000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061143,Binding constant for EGFR(E746-A750del) kinase domain,Kd,>,10000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061068,Binding constant for EGFR(G719C) kinase domain,Kd,>,10000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061068,Binding constant for EGFR(G719C) kinase domain,Kd,>,10000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060190,Binding constant for EGFR(G719S) kinase domain,Kd,>,10000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060190,Binding constant for EGFR(G719S) kinase domain,Kd,>,10000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063796,"Binding constant for EGFR(L747-E749del, A750P) kinase domain",Kd,>,10000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063796,"Binding constant for EGFR(L747-E749del, A750P) kinase domain",Kd,>,10000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063797,"Binding constant for EGFR(L747-S752del, P753S) kinase domain",Kd,>,10000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063797,"Binding constant for EGFR(L747-S752del, P753S) kinase domain",Kd,>,10000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051285,"Binding constant for EGFR(L747-T751del,Sins) kinase domain",Kd,>,10000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051285,"Binding constant for EGFR(L747-T751del,Sins) kinase domain",Kd,>,10000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062839,Binding constant for EGFR(L858R) kinase domain,Kd,>,10000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062839,Binding constant for EGFR(L858R) kinase domain,Kd,>,10000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051286,Binding constant for EGFR(L861Q) kinase domain,Kd,>,10000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051286,Binding constant for EGFR(L861Q) kinase domain,Kd,>,10000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1050839,Binding constant for EGFR(S752-I759del) kinase domain,Kd,>,10000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1050839,Binding constant for EGFR(S752-I759del) kinase domain,Kd,>,10000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061144,Binding constant for EPHA1 kinase domain,Kd,>,10000,nM,,CHEMBL5810,Ephrin type-A receptor 1,Homo sapiens,P21709,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061144,Binding constant for EPHA1 kinase domain,Kd,>,10000,nM,,CHEMBL5810,Ephrin type-A receptor 1,Homo sapiens,P21709,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051287,Binding constant for EPHA2 kinase domain,Kd,>,10000,nM,,CHEMBL2068,Ephrin type-A receptor 2,Homo sapiens,P29317,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051287,Binding constant for EPHA2 kinase domain,Kd,>,10000,nM,,CHEMBL2068,Ephrin type-A receptor 2,Homo sapiens,P29317,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061145,Binding constant for EPHA3 kinase domain,Kd,>,10000,nM,,CHEMBL4954,Ephrin type-A receptor 3,Homo sapiens,P29320,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061145,Binding constant for EPHA3 kinase domain,Kd,>,10000,nM,,CHEMBL4954,Ephrin type-A receptor 3,Homo sapiens,P29320,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061895,Binding constant for EPHA4 kinase domain,Kd,>,10000,nM,,CHEMBL3988,Ephrin type-A receptor 4,Homo sapiens,P54764,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061895,Binding constant for EPHA4 kinase domain,Kd,>,10000,nM,,CHEMBL3988,Ephrin type-A receptor 4,Homo sapiens,P54764,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061069,Binding constant for EPHA5 kinase domain,Kd,>,10000,nM,,CHEMBL3987,Ephrin type-A receptor 5,Homo sapiens,P54756,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061069,Binding constant for EPHA5 kinase domain,Kd,>,10000,nM,,CHEMBL3987,Ephrin type-A receptor 5,Homo sapiens,P54756,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060244,Binding constant for EPHA6 kinase domain,Kd,>,10000,nM,,CHEMBL4526,Ephrin type-A receptor 6,Homo sapiens,Q9UF33,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060244,Binding constant for EPHA6 kinase domain,Kd,>,10000,nM,,CHEMBL4526,Ephrin type-A receptor 6,Homo sapiens,Q9UF33,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063707,Binding constant for EPHA7 kinase domain,Kd,>,10000,nM,,CHEMBL4602,Ephrin type-A receptor 7,Homo sapiens,Q15375,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063707,Binding constant for EPHA7 kinase domain,Kd,>,10000,nM,,CHEMBL4602,Ephrin type-A receptor 7,Homo sapiens,Q15375,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063708,Binding constant for EPHA8 kinase domain,Kd,>,10000,nM,,CHEMBL4134,Ephrin type-A receptor 8,Homo sapiens,P29322,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063708,Binding constant for EPHA8 kinase domain,Kd,>,10000,nM,,CHEMBL4134,Ephrin type-A receptor 8,Homo sapiens,P29322,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060191,Binding constant for EPHB1 kinase domain,Kd,>,10000,nM,,CHEMBL5072,Ephrin type-B receptor 1,Homo sapiens,P54762,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060191,Binding constant for EPHB1 kinase domain,Kd,>,10000,nM,,CHEMBL5072,Ephrin type-B receptor 1,Homo sapiens,P54762,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063709,Binding constant for EPHB2 kinase domain,Kd,>,10000,nM,,CHEMBL3290,Ephrin type-B receptor 2,Homo sapiens,P29323,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063709,Binding constant for EPHB2 kinase domain,Kd,>,10000,nM,,CHEMBL3290,Ephrin type-B receptor 2,Homo sapiens,P29323,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061070,Binding constant for EPHB3 kinase domain,Kd,>,10000,nM,,CHEMBL4901,Ephrin type-B receptor 3,Homo sapiens,P54753,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061070,Binding constant for EPHB3 kinase domain,Kd,>,10000,nM,,CHEMBL4901,Ephrin type-B receptor 3,Homo sapiens,P54753,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060192,Binding constant for EPHB4 kinase domain,Kd,>,10000,nM,,CHEMBL5147,Ephrin type-B receptor 4,Homo sapiens,P54760,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060192,Binding constant for EPHB4 kinase domain,Kd,>,10000,nM,,CHEMBL5147,Ephrin type-B receptor 4,Homo sapiens,P54760,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061896,Binding constant for ERBB2 kinase domain,Kd,>,10000,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061896,Binding constant for ERBB2 kinase domain,Kd,>,10000,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061897,Binding constant for ERBB4 kinase domain,Kd,>,10000,nM,,CHEMBL4139,Tubulin alpha-1 chain,Rattus norvegicus,P68370,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061897,Binding constant for ERBB4 kinase domain,Kd,>,10000,nM,,CHEMBL4139,Tubulin alpha-1 chain,Rattus norvegicus,P68370,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063710,Binding constant for ERK3 kinase domain,Kd,>,10000,nM,,CHEMBL5121,Mitogen-activated protein kinase 6,Homo sapiens,Q16659,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063710,Binding constant for ERK3 kinase domain,Kd,>,10000,nM,,CHEMBL5121,Mitogen-activated protein kinase 6,Homo sapiens,Q16659,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060245,Binding constant for ERK4 kinase domain,Kd,>,10000,nM,,CHEMBL5759,Mitogen-activated protein kinase 4,Homo sapiens,P31152,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060245,Binding constant for ERK4 kinase domain,Kd,>,10000,nM,,CHEMBL5759,Mitogen-activated protein kinase 4,Homo sapiens,P31152,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063799,Binding constant for ERK5 kinase domain,Kd,>,10000,nM,,CHEMBL5332,Mitogen-activated protein kinase 7,Homo sapiens,Q13164,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063799,Binding constant for ERK5 kinase domain,Kd,>,10000,nM,,CHEMBL5332,Mitogen-activated protein kinase 7,Homo sapiens,Q13164,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060193,Binding constant for ERK8 kinase domain,Kd,>,10000,nM,,CHEMBL5198,Mitogen-activated protein kinase 15,Homo sapiens,Q8TD08,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060193,Binding constant for ERK8 kinase domain,Kd,>,10000,nM,,CHEMBL5198,Mitogen-activated protein kinase 15,Homo sapiens,Q8TD08,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061071,Binding constant for FER kinase domain,Kd,>,10000,nM,,CHEMBL3982,Tyrosine-protein kinase FER,Homo sapiens,P16591,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061071,Binding constant for FER kinase domain,Kd,>,10000,nM,,CHEMBL3982,Tyrosine-protein kinase FER,Homo sapiens,P16591,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061072,Binding constant for FES kinase domain,Kd,>,10000,nM,,CHEMBL5455,Tyrosine-protein kinase FES,Homo sapiens,P07332,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061072,Binding constant for FES kinase domain,Kd,>,10000,nM,,CHEMBL5455,Tyrosine-protein kinase FES,Homo sapiens,P07332,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062840,Binding constant for FGFR1 kinase domain,Kd,>,10000,nM,,CHEMBL3650,Fibroblast growth factor receptor 1,Homo sapiens,P11362,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062840,Binding constant for FGFR1 kinase domain,Kd,>,10000,nM,,CHEMBL3650,Fibroblast growth factor receptor 1,Homo sapiens,P11362,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1048161,Binding constant for FGFR2 kinase domain,Kd,>,10000,nM,,CHEMBL4142,Fibroblast growth factor receptor 2,Homo sapiens,P21802,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1048161,Binding constant for FGFR2 kinase domain,Kd,>,10000,nM,,CHEMBL4142,Fibroblast growth factor receptor 2,Homo sapiens,P21802,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063711,Binding constant for FGFR3 kinase domain,Kd,>,10000,nM,,CHEMBL2742,Fibroblast growth factor receptor 3,Homo sapiens,P22607,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063711,Binding constant for FGFR3 kinase domain,Kd,>,10000,nM,,CHEMBL2742,Fibroblast growth factor receptor 3,Homo sapiens,P22607,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062841,Binding constant for FGFR3(G697C) kinase domain,Kd,>,10000,nM,,CHEMBL2742,Fibroblast growth factor receptor 3,Homo sapiens,P22607,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062841,Binding constant for FGFR3(G697C) kinase domain,Kd,>,10000,nM,,CHEMBL2742,Fibroblast growth factor receptor 3,Homo sapiens,P22607,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063800,Binding constant for FGFR4 kinase domain,Kd,>,10000,nM,,CHEMBL3973,Fibroblast growth factor receptor 4,Homo sapiens,P22455,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063800,Binding constant for FGFR4 kinase domain,Kd,>,10000,nM,,CHEMBL3973,Fibroblast growth factor receptor 4,Homo sapiens,P22455,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1050840,Binding constant for FGR kinase domain,Kd,>,10000,nM,,CHEMBL4454,Tyrosine-protein kinase FGR,Homo sapiens,P09769,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1050840,Binding constant for FGR kinase domain,Kd,>,10000,nM,,CHEMBL4454,Tyrosine-protein kinase FGR,Homo sapiens,P09769,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061174,Binding constant for FLT1 kinase domain,Kd,>,10000,nM,,CHEMBL1868,Vascular endothelial growth factor receptor 1,Homo sapiens,P17948,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061174,Binding constant for FLT1 kinase domain,Kd,>,10000,nM,,CHEMBL1868,Vascular endothelial growth factor receptor 1,Homo sapiens,P17948,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061898,Binding constant for FLT3 kinase domain,Kd,>,10000,nM,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,Homo sapiens,P36888,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061898,Binding constant for FLT3 kinase domain,Kd,>,10000,nM,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,Homo sapiens,P36888,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060194,Binding constant for FLT3(D835H) kinase domain,Kd,>,10000,nM,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,Homo sapiens,P36888,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060194,Binding constant for FLT3(D835H) kinase domain,Kd,>,10000,nM,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,Homo sapiens,P36888,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1050826,Binding constant for FLT3(D835Y) kinase domain,Kd,>,10000,nM,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,Homo sapiens,P36888,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1050826,Binding constant for FLT3(D835Y) kinase domain,Kd,>,10000,nM,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,Homo sapiens,P36888,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063729,Binding constant for FLT3(ITD) kinase domain,Kd,>,10000,nM,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,Homo sapiens,P36888,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063729,Binding constant for FLT3(ITD) kinase domain,Kd,>,10000,nM,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,Homo sapiens,P36888,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061073,Binding constant for FLT3(N841I) kinase domain,Kd,>,10000,nM,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,Homo sapiens,P36888,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061073,Binding constant for FLT3(N841I) kinase domain,Kd,>,10000,nM,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,Homo sapiens,P36888,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060246,Binding constant for FLT4 kinase domain,Kd,>,10000,nM,,CHEMBL1955,Vascular endothelial growth factor receptor 3,Homo sapiens,P35916,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060246,Binding constant for FLT4 kinase domain,Kd,>,10000,nM,,CHEMBL1955,Vascular endothelial growth factor receptor 3,Homo sapiens,P35916,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060247,Binding constant for FRK kinase domain,Kd,>,10000,nM,,CHEMBL4223,Tyrosine-protein kinase FRK,Homo sapiens,P42685,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060247,Binding constant for FRK kinase domain,Kd,>,10000,nM,,CHEMBL4223,Tyrosine-protein kinase FRK,Homo sapiens,P42685,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061899,Binding constant for FYN kinase domain,Kd,>,10000,nM,,CHEMBL1841,Tyrosine-protein kinase FYN,Homo sapiens,P06241,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061899,Binding constant for FYN kinase domain,Kd,>,10000,nM,,CHEMBL1841,Tyrosine-protein kinase FYN,Homo sapiens,P06241,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062777,Binding constant for GAK kinase domain,Kd,>,10000,nM,,CHEMBL4355,Serine/threonine-protein kinase GAK,Homo sapiens,O14976,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062777,Binding constant for GAK kinase domain,Kd,>,10000,nM,,CHEMBL4355,Serine/threonine-protein kinase GAK,Homo sapiens,O14976,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060248,"Binding constant for GCN2(Kin.Dom.2,S808G) kinase domain",Kd,>,10000,nM,,CHEMBL5358,Eukaryotic translation initiation factor 2-alpha kinase 4,Homo sapiens,Q9P2K8,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060248,"Binding constant for GCN2(Kin.Dom.2,S808G) kinase domain",Kd,>,10000,nM,,CHEMBL5358,Eukaryotic translation initiation factor 2-alpha kinase 4,Homo sapiens,Q9P2K8,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063730,Binding constant for HCK kinase domain,Kd,>,10000,nM,,CHEMBL3234,Tyrosine-protein kinase HCK ,Homo sapiens,P08631,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063730,Binding constant for HCK kinase domain,Kd,>,10000,nM,,CHEMBL3234,Tyrosine-protein kinase HCK ,Homo sapiens,P08631,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061075,Binding constant for IGF1R kinase domain,Kd,>,10000,nM,,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061075,Binding constant for IGF1R kinase domain,Kd,>,10000,nM,,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060195,Binding constant for INSR kinase domain,Kd,>,10000,nM,,CHEMBL1981,Insulin receptor,Homo sapiens,P06213,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060195,Binding constant for INSR kinase domain,Kd,>,10000,nM,,CHEMBL1981,Insulin receptor,Homo sapiens,P06213,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061175,Binding constant for INSRR kinase domain,Kd,>,10000,nM,,CHEMBL5483,Insulin receptor-related protein,Homo sapiens,P14616,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061175,Binding constant for INSRR kinase domain,Kd,>,10000,nM,,CHEMBL5483,Insulin receptor-related protein,Homo sapiens,P14616,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062842,Binding constant for IRAK3 kinase domain,Kd,>,10000,nM,,CHEMBL5081,Interleukin-1 receptor-associated kinase 3,Homo sapiens,Q9Y616,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062842,Binding constant for IRAK3 kinase domain,Kd,>,10000,nM,,CHEMBL5081,Interleukin-1 receptor-associated kinase 3,Homo sapiens,Q9Y616,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063712,Binding constant for ITK kinase domain,Kd,>,10000,nM,,CHEMBL2959,Tyrosine-protein kinase ITK/TSK ,Homo sapiens,Q08881,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063712,Binding constant for ITK kinase domain,Kd,>,10000,nM,,CHEMBL2959,Tyrosine-protein kinase ITK/TSK ,Homo sapiens,Q08881,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1057717,Binding constant for JAK1(Kin.Dom.1/JH2 - pseudokinase) kinase domain,Kd,>,10000,nM,,CHEMBL2835,Tyrosine-protein kinase JAK1 ,Homo sapiens,P23458,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1057717,Binding constant for JAK1(Kin.Dom.1/JH2 - pseudokinase) kinase domain,Kd,>,10000,nM,,CHEMBL2835,Tyrosine-protein kinase JAK1 ,Homo sapiens,P23458,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063801,Binding constant for JAK2(Kin.Dom.2/JH1 - catalytic) kinase domain,Kd,>,10000,nM,,CHEMBL2971,Tyrosine-protein kinase JAK2,Homo sapiens,O60674,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063801,Binding constant for JAK2(Kin.Dom.2/JH1 - catalytic) kinase domain,Kd,>,10000,nM,,CHEMBL2971,Tyrosine-protein kinase JAK2,Homo sapiens,O60674,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051335,Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain,Kd,>,10000,nM,,CHEMBL2148,Tyrosine-protein kinase JAK3,Homo sapiens,P52333,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051335,Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain,Kd,>,10000,nM,,CHEMBL2148,Tyrosine-protein kinase JAK3,Homo sapiens,P52333,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063713,Binding constant for JNK3 kinase domain,Kd,>,10000,nM,,CHEMBL2637,c-Jun N-terminal kinase 3,Homo sapiens,P53779,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063713,Binding constant for JNK3 kinase domain,Kd,>,10000,nM,,CHEMBL2637,c-Jun N-terminal kinase 3,Homo sapiens,P53779,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060197,Binding constant for KIT kinase domain,Kd,>,10000,nM,,CHEMBL1936,Stem cell growth factor receptor,Homo sapiens,P10721,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060197,Binding constant for KIT kinase domain,Kd,>,10000,nM,,CHEMBL1936,Stem cell growth factor receptor,Homo sapiens,P10721,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060198,Binding constant for KIT(D816V) kinase domain,Kd,>,10000,nM,,CHEMBL1936,Stem cell growth factor receptor,Homo sapiens,P10721,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060198,Binding constant for KIT(D816V) kinase domain,Kd,>,10000,nM,,CHEMBL1936,Stem cell growth factor receptor,Homo sapiens,P10721,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061077,Binding constant for KIT(V559D) kinase domain,Kd,>,10000,nM,,CHEMBL1936,Stem cell growth factor receptor,Homo sapiens,P10721,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061077,Binding constant for KIT(V559D) kinase domain,Kd,>,10000,nM,,CHEMBL1936,Stem cell growth factor receptor,Homo sapiens,P10721,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051336,"Binding constant for KIT(V559D,T670I) kinase domain",Kd,>,10000,nM,,CHEMBL1936,Stem cell growth factor receptor,Homo sapiens,P10721,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051336,"Binding constant for KIT(V559D,T670I) kinase domain",Kd,>,10000,nM,,CHEMBL1936,Stem cell growth factor receptor,Homo sapiens,P10721,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061901,"Binding constant for KIT(V559D,V654A) kinase domain",Kd,>,10000,nM,,CHEMBL1936,Stem cell growth factor receptor,Homo sapiens,P10721,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061901,"Binding constant for KIT(V559D,V654A) kinase domain",Kd,>,10000,nM,,CHEMBL1936,Stem cell growth factor receptor,Homo sapiens,P10721,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062843,Binding constant for LATS1 kinase domain,Kd,>,10000,nM,,CHEMBL6167,Serine/threonine-protein kinase LATS1,Homo sapiens,O95835,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062843,Binding constant for LATS1 kinase domain,Kd,>,10000,nM,,CHEMBL6167,Serine/threonine-protein kinase LATS1,Homo sapiens,O95835,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060249,Binding constant for LATS2 kinase domain,Kd,>,10000,nM,,CHEMBL5907,Serine/threonine-protein kinase LATS2,Homo sapiens,Q9NRM7,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060249,Binding constant for LATS2 kinase domain,Kd,>,10000,nM,,CHEMBL5907,Serine/threonine-protein kinase LATS2,Homo sapiens,Q9NRM7,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051337,Binding constant for LCK kinase domain,Kd,>,10000,nM,,CHEMBL258,Tyrosine-protein kinase LCK,Homo sapiens,P06239,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051337,Binding constant for LCK kinase domain,Kd,>,10000,nM,,CHEMBL258,Tyrosine-protein kinase LCK,Homo sapiens,P06239,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051338,Binding constant for LOK kinase domain,Kd,>,10000,nM,,CHEMBL3981,Serine/threonine-protein kinase 10,Homo sapiens,O94804,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051338,Binding constant for LOK kinase domain,Kd,>,10000,nM,,CHEMBL3981,Serine/threonine-protein kinase 10,Homo sapiens,O94804,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061078,Binding constant for LTK kinase domain,Kd,>,10000,nM,,CHEMBL5627,Leukocyte tyrosine kinase receptor,Homo sapiens,P29376,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061078,Binding constant for LTK kinase domain,Kd,>,10000,nM,,CHEMBL5627,Leukocyte tyrosine kinase receptor,Homo sapiens,P29376,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1037544,Binding constant for LYN kinase domain,Kd,>,10000,nM,,CHEMBL3905,Tyrosine-protein kinase Lyn ,Homo sapiens,P07948,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1037544,Binding constant for LYN kinase domain,Kd,>,10000,nM,,CHEMBL3905,Tyrosine-protein kinase Lyn ,Homo sapiens,P07948,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062844,Binding constant for MAP3K4 kinase domain,Kd,>,10000,nM,,CHEMBL4853,Mitogen-activated protein kinase kinase kinase 4,Homo sapiens,Q9Y6R4,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062844,Binding constant for MAP3K4 kinase domain,Kd,>,10000,nM,,CHEMBL4853,Mitogen-activated protein kinase kinase kinase 4,Homo sapiens,Q9Y6R4,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060199,Binding constant for MAP3K5 kinase domain,Kd,>,10000,nM,,CHEMBL5285,Mitogen-activated protein kinase kinase kinase 5,Homo sapiens,Q99683,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060199,Binding constant for MAP3K5 kinase domain,Kd,>,10000,nM,,CHEMBL5285,Mitogen-activated protein kinase kinase kinase 5,Homo sapiens,Q99683,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061176,Binding constant for MAP4K1 kinase domain,Kd,>,10000,nM,,CHEMBL5749,Mitogen-activated protein kinase kinase kinase kinase 1,Homo sapiens,Q92918,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061176,Binding constant for MAP4K1 kinase domain,Kd,>,10000,nM,,CHEMBL5749,Mitogen-activated protein kinase kinase kinase kinase 1,Homo sapiens,Q92918,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063715,Binding constant for MAP4K3 kinase domain,Kd,>,10000,nM,,CHEMBL5432,Mitogen-activated protein kinase kinase kinase kinase 3,Homo sapiens,Q8IVH8,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063715,Binding constant for MAP4K3 kinase domain,Kd,>,10000,nM,,CHEMBL5432,Mitogen-activated protein kinase kinase kinase kinase 3,Homo sapiens,Q8IVH8,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1037548,Binding constant for MAP4K4 kinase domain,Kd,>,10000,nM,,CHEMBL6166,Mitogen-activated protein kinase kinase kinase kinase 4,Homo sapiens,O95819,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1037548,Binding constant for MAP4K4 kinase domain,Kd,>,10000,nM,,CHEMBL6166,Mitogen-activated protein kinase kinase kinase kinase 4,Homo sapiens,O95819,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061903,Binding constant for MAP4K5 kinase domain,Kd,>,10000,nM,,CHEMBL4852,Mitogen-activated protein kinase kinase kinase kinase 5,Homo sapiens,Q9Y4K4,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061903,Binding constant for MAP4K5 kinase domain,Kd,>,10000,nM,,CHEMBL4852,Mitogen-activated protein kinase kinase kinase kinase 5,Homo sapiens,Q9Y4K4,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061090,Binding constant for MAPKAPK2 kinase domain,Kd,>,10000,nM,,CHEMBL2208,MAP kinase-activated protein kinase 2,Homo sapiens,P49137,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061090,Binding constant for MAPKAPK2 kinase domain,Kd,>,10000,nM,,CHEMBL2208,MAP kinase-activated protein kinase 2,Homo sapiens,P49137,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061904,Binding constant for MAPKAPK5 kinase domain,Kd,>,10000,nM,,CHEMBL3094,MAP kinase-activated protein kinase 5,Homo sapiens,Q8IW41,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061904,Binding constant for MAPKAPK5 kinase domain,Kd,>,10000,nM,,CHEMBL3094,MAP kinase-activated protein kinase 5,Homo sapiens,Q8IW41,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061905,Binding constant for MARK1 kinase domain,Kd,>,10000,nM,,CHEMBL5940,Serine/threonine-protein kinase MARK1,Homo sapiens,Q9P0L2,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061905,Binding constant for MARK1 kinase domain,Kd,>,10000,nM,,CHEMBL5940,Serine/threonine-protein kinase MARK1,Homo sapiens,Q9P0L2,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1049903,Binding constant for MARK2 kinase domain,Kd,>,10000,nM,,CHEMBL3831,MAP/microtubule affinity-regulating kinase 2,Homo sapiens,Q7KZI7,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1049903,Binding constant for MARK2 kinase domain,Kd,>,10000,nM,,CHEMBL3831,MAP/microtubule affinity-regulating kinase 2,Homo sapiens,Q7KZI7,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051302,Binding constant for MARK4 kinase domain,Kd,>,10000,nM,,CHEMBL5754,MAP/microtubule affinity-regulating kinase 4,Homo sapiens,Q96L34,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051302,Binding constant for MARK4 kinase domain,Kd,>,10000,nM,,CHEMBL5754,MAP/microtubule affinity-regulating kinase 4,Homo sapiens,Q96L34,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062778,Binding constant for MEK4 kinase domain,Kd,>,10000,nM,,CHEMBL2897,Dual specificity mitogen-activated protein kinase kinase 4,Homo sapiens,P45985,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062778,Binding constant for MEK4 kinase domain,Kd,>,10000,nM,,CHEMBL2897,Dual specificity mitogen-activated protein kinase kinase 4,Homo sapiens,P45985,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051289,Binding constant for MEK6 kinase domain,Kd,>,10000,nM,,CHEMBL2171,Dual specificity mitogen-activated protein kinase kinase 6,Homo sapiens,P52564,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051289,Binding constant for MEK6 kinase domain,Kd,>,10000,nM,,CHEMBL2171,Dual specificity mitogen-activated protein kinase kinase 6,Homo sapiens,P52564,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1037553,Binding constant for MERTK kinase domain,Kd,>,10000,nM,,CHEMBL5331,Proto-oncogene tyrosine-protein kinase MER,Homo sapiens,Q12866,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1037553,Binding constant for MERTK kinase domain,Kd,>,10000,nM,,CHEMBL5331,Proto-oncogene tyrosine-protein kinase MER,Homo sapiens,Q12866,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063731,Binding constant for MET kinase domain,Kd,>,10000,nM,,CHEMBL3717,Hepatocyte growth factor receptor,Homo sapiens,P08581,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063731,Binding constant for MET kinase domain,Kd,>,10000,nM,,CHEMBL3717,Hepatocyte growth factor receptor,Homo sapiens,P08581,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1050830,Binding constant for MKNK2 kinase domain,Kd,>,10000,nM,,CHEMBL4204,MAP kinase signal-integrating kinase 2,Homo sapiens,Q9HBH9,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1050830,Binding constant for MKNK2 kinase domain,Kd,>,10000,nM,,CHEMBL4204,MAP kinase signal-integrating kinase 2,Homo sapiens,Q9HBH9,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060200,Binding constant for MLCK kinase domain,Kd,>,10000,nM,,CHEMBL3062,"Myosin light chain kinase, smooth muscle",Gallus gallus,P11799,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060200,Binding constant for MLCK kinase domain,Kd,>,10000,nM,,CHEMBL3062,"Myosin light chain kinase, smooth muscle",Gallus gallus,P11799,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063716,Binding constant for MLK1 kinase domain,Kd,>,10000,nM,,CHEMBL2872,Mitogen-activated protein kinase kinase kinase 9,Homo sapiens,P80192,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063716,Binding constant for MLK1 kinase domain,Kd,>,10000,nM,,CHEMBL2872,Mitogen-activated protein kinase kinase kinase 9,Homo sapiens,P80192,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061177,Binding constant for MLK2 kinase domain,Kd,>,10000,nM,,CHEMBL2873,Mitogen-activated protein kinase kinase kinase 10,Homo sapiens,Q02779,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061177,Binding constant for MLK2 kinase domain,Kd,>,10000,nM,,CHEMBL2873,Mitogen-activated protein kinase kinase kinase 10,Homo sapiens,Q02779,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1050827,Binding constant for MLK3 kinase domain,Kd,>,10000,nM,,CHEMBL2708,Mitogen-activated protein kinase kinase kinase 11,Homo sapiens,Q16584,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1050827,Binding constant for MLK3 kinase domain,Kd,>,10000,nM,,CHEMBL2708,Mitogen-activated protein kinase kinase kinase 11,Homo sapiens,Q16584,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060251,Binding constant for MRCKA kinase domain,Kd,>,10000,nM,,CHEMBL4516,Serine/threonine-protein kinase MRCK-A,Homo sapiens,Q5VT25,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060251,Binding constant for MRCKA kinase domain,Kd,>,10000,nM,,CHEMBL4516,Serine/threonine-protein kinase MRCK-A,Homo sapiens,Q5VT25,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051290,Binding constant for MRCKB kinase domain,Kd,>,10000,nM,,CHEMBL5052,Serine/threonine-protein kinase MRCK beta,Homo sapiens,Q9Y5S2,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051290,Binding constant for MRCKB kinase domain,Kd,>,10000,nM,,CHEMBL5052,Serine/threonine-protein kinase MRCK beta,Homo sapiens,Q9Y5S2,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063805,Binding constant for MST2 kinase domain,Kd,>,10000,nM,,CHEMBL4708,Serine/threonine-protein kinase MST2,Homo sapiens,Q13188,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063805,Binding constant for MST2 kinase domain,Kd,>,10000,nM,,CHEMBL4708,Serine/threonine-protein kinase MST2,Homo sapiens,Q13188,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062845,Binding constant for MST3 kinase domain,Kd,>,10000,nM,,CHEMBL5082,Serine/threonine-protein kinase 24,Homo sapiens,Q9Y6E0,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062845,Binding constant for MST3 kinase domain,Kd,>,10000,nM,,CHEMBL5082,Serine/threonine-protein kinase 24,Homo sapiens,Q9Y6E0,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051339,Binding constant for MUSK kinase domain,Kd,>,10000,nM,,CHEMBL5684,"Muscle, skeletal receptor tyrosine protein kinase",Homo sapiens,O15146,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051339,Binding constant for MUSK kinase domain,Kd,>,10000,nM,,CHEMBL5684,"Muscle, skeletal receptor tyrosine protein kinase",Homo sapiens,O15146,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1050836,Binding constant for MYLK kinase domain,Kd,>,10000,nM,,CHEMBL2428,"Myosin light chain kinase, smooth muscle",Homo sapiens,Q15746,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1050836,Binding constant for MYLK kinase domain,Kd,>,10000,nM,,CHEMBL2428,"Myosin light chain kinase, smooth muscle",Homo sapiens,Q15746,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061160,Binding constant for MYLK2 kinase domain,Kd,>,10000,nM,,CHEMBL2777,myosin light chain kinase 2,Homo sapiens,Q9H1R3,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061160,Binding constant for MYLK2 kinase domain,Kd,>,10000,nM,,CHEMBL2777,myosin light chain kinase 2,Homo sapiens,Q9H1R3,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061080,Binding constant for MYO3A kinase domain,Kd,>,10000,nM,,CHEMBL5546,Myosin IIIA,Homo sapiens,Q8NEV4,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061080,Binding constant for MYO3A kinase domain,Kd,>,10000,nM,,CHEMBL5546,Myosin IIIA,Homo sapiens,Q8NEV4,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060259,Binding constant for MYO3B kinase domain,Kd,>,10000,nM,,CHEMBL5654,Myosin-IIIB,Homo sapiens,Q8WXR4,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060259,Binding constant for MYO3B kinase domain,Kd,>,10000,nM,,CHEMBL5654,Myosin-IIIB,Homo sapiens,Q8WXR4,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060252,Binding constant for NDR2 kinase domain,Kd,>,10000,nM,,CHEMBL4851,Serine/threonine-protein kinase 38-like,Homo sapiens,Q9Y2H1,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060252,Binding constant for NDR2 kinase domain,Kd,>,10000,nM,,CHEMBL4851,Serine/threonine-protein kinase 38-like,Homo sapiens,Q9Y2H1,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062846,Binding constant for NEK1 kinase domain,Kd,>,10000,nM,,CHEMBL5855,Serine/threonine-protein kinase Nek1,Homo sapiens,Q96PY6,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062846,Binding constant for NEK1 kinase domain,Kd,>,10000,nM,,CHEMBL5855,Serine/threonine-protein kinase Nek1,Homo sapiens,Q96PY6,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063807,Binding constant for NEK2 kinase domain,Kd,>,10000,nM,,CHEMBL3835,Serine/threonine-protein kinase NEK2,Homo sapiens,P51955,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063807,Binding constant for NEK2 kinase domain,Kd,>,10000,nM,,CHEMBL3835,Serine/threonine-protein kinase NEK2,Homo sapiens,P51955,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062847,Binding constant for NEK5 kinase domain,Kd,>,10000,nM,,CHEMBL5044,Serine/threonine-protein kinase Nek5,Homo sapiens,Q6P3R8,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062847,Binding constant for NEK5 kinase domain,Kd,>,10000,nM,,CHEMBL5044,Serine/threonine-protein kinase Nek5,Homo sapiens,Q6P3R8,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062858,Binding constant for NEK6 kinase domain,Kd,>,10000,nM,,CHEMBL4309,Serine/threonine-protein kinase NEK6,Homo sapiens,Q9HC98,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062858,Binding constant for NEK6 kinase domain,Kd,>,10000,nM,,CHEMBL4309,Serine/threonine-protein kinase NEK6,Homo sapiens,Q9HC98,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061081,Binding constant for NEK9 kinase domain,Kd,>,10000,nM,,CHEMBL5257,Serine/threonine-protein kinase NEK9,Homo sapiens,Q8TD19,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061081,Binding constant for NEK9 kinase domain,Kd,>,10000,nM,,CHEMBL5257,Serine/threonine-protein kinase NEK9,Homo sapiens,Q8TD19,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063737,Binding constant for PAK1 kinase domain,Kd,>,10000,nM,,CHEMBL4600,Serine/threonine-protein kinase PAK 1,Homo sapiens,Q13153,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063737,Binding constant for PAK1 kinase domain,Kd,>,10000,nM,,CHEMBL4600,Serine/threonine-protein kinase PAK 1,Homo sapiens,Q13153,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1050828,Binding constant for PAK2 kinase domain,Kd,>,10000,nM,,CHEMBL4487,Serine/threonine-protein kinase PAK 2,Homo sapiens,Q13177,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1050828,Binding constant for PAK2 kinase domain,Kd,>,10000,nM,,CHEMBL4487,Serine/threonine-protein kinase PAK 2,Homo sapiens,Q13177,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051307,Binding constant for PAK4 kinase domain,Kd,>,10000,nM,,CHEMBL4482,Serine/threonine-protein kinase PAK 4,Homo sapiens,O96013,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051307,Binding constant for PAK4 kinase domain,Kd,>,10000,nM,,CHEMBL4482,Serine/threonine-protein kinase PAK 4,Homo sapiens,O96013,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061921,Binding constant for PAK6 kinase domain,Kd,>,10000,nM,,CHEMBL4311,Serine/threonine-protein kinase PAK6,Homo sapiens,Q9NQU5,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061921,Binding constant for PAK6 kinase domain,Kd,>,10000,nM,,CHEMBL4311,Serine/threonine-protein kinase PAK6,Homo sapiens,Q9NQU5,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051348,Binding constant for PAK7/PAK5 kinase domain,Kd,>,10000,nM,,CHEMBL4524,Serine/threonine-protein kinase PAK7,Homo sapiens,Q9P286,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051348,Binding constant for PAK7/PAK5 kinase domain,Kd,>,10000,nM,,CHEMBL4524,Serine/threonine-protein kinase PAK7,Homo sapiens,Q9P286,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051303,Binding constant for PCTK1 kinase domain,Kd,>,10000,nM,,CHEMBL4597,Serine/threonine-protein kinase PCTAIRE-1,Homo sapiens,Q00536,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051303,Binding constant for PCTK1 kinase domain,Kd,>,10000,nM,,CHEMBL4597,Serine/threonine-protein kinase PCTAIRE-1,Homo sapiens,Q00536,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062783,Binding constant for PDGFRA kinase domain,Kd,>,10000,nM,,CHEMBL2007,Platelet-derived growth factor receptor alpha ,Homo sapiens,P16234,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062783,Binding constant for PDGFRA kinase domain,Kd,>,10000,nM,,CHEMBL2007,Platelet-derived growth factor receptor alpha ,Homo sapiens,P16234,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051304,Binding constant for PDGFRB kinase domain,Kd,>,10000,nM,,CHEMBL1913,Platelet-derived growth factor receptor beta,Homo sapiens,P09619,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051304,Binding constant for PDGFRB kinase domain,Kd,>,10000,nM,,CHEMBL1913,Platelet-derived growth factor receptor beta,Homo sapiens,P09619,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1037549,Binding constant for PHKG2 kinase domain,Kd,>,10000,nM,,CHEMBL2349,Phosphorylase kinase gamma subunit 2,Homo sapiens,P15735,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1037549,Binding constant for PHKG2 kinase domain,Kd,>,10000,nM,,CHEMBL2349,Phosphorylase kinase gamma subunit 2,Homo sapiens,P15735,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060260,Binding constant for PIK3CA kinase domain,Kd,>,10000,nM,,CHEMBL4005,PI3-kinase p110-alpha subunit,Homo sapiens,P42336,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060260,Binding constant for PIK3CA kinase domain,Kd,>,10000,nM,,CHEMBL4005,PI3-kinase p110-alpha subunit,Homo sapiens,P42336,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1050831,Binding constant for PIK3CA(E545K) kinase domain,Kd,>,10000,nM,,CHEMBL4005,PI3-kinase p110-alpha subunit,Homo sapiens,P42336,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1050831,Binding constant for PIK3CA(E545K) kinase domain,Kd,>,10000,nM,,CHEMBL4005,PI3-kinase p110-alpha subunit,Homo sapiens,P42336,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051308,Binding constant for PIM1 kinase domain,Kd,>,10000,nM,,CHEMBL2147,Serine/threonine-protein kinase PIM1 ,Homo sapiens,P11309,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051308,Binding constant for PIM1 kinase domain,Kd,>,10000,nM,,CHEMBL2147,Serine/threonine-protein kinase PIM1 ,Homo sapiens,P11309,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061184,Binding constant for PIM2 kinase domain,Kd,>,10000,nM,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,Q9P1W9,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061184,Binding constant for PIM2 kinase domain,Kd,>,10000,nM,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,Q9P1W9,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051340,Binding constant for PIM3 kinase domain,Kd,>,10000,nM,,CHEMBL5407,Serine/threonine-protein kinase PIM3,Homo sapiens,Q86V86,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051340,Binding constant for PIM3 kinase domain,Kd,>,10000,nM,,CHEMBL5407,Serine/threonine-protein kinase PIM3,Homo sapiens,Q86V86,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051309,Binding constant for PKAC-alpha kinase domain,Kd,>,10000,nM,,CHEMBL4101,cAMP-dependent protein kinase alpha-catalytic subunit,Homo sapiens,P17612,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051309,Binding constant for PKAC-alpha kinase domain,Kd,>,10000,nM,,CHEMBL4101,cAMP-dependent protein kinase alpha-catalytic subunit,Homo sapiens,P17612,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061154,Binding constant for PKMYT1 kinase domain,Kd,>,10000,nM,,CHEMBL3984,Tyrosine- and threonine-specific cdc2-inhibitory kinase,Homo sapiens,Q99640,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061154,Binding constant for PKMYT1 kinase domain,Kd,>,10000,nM,,CHEMBL3984,Tyrosine- and threonine-specific cdc2-inhibitory kinase,Homo sapiens,Q99640,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051253,Binding constant for PKN1 kinase domain,Kd,>,10000,nM,,CHEMBL3384,Protein kinase N1,Homo sapiens,Q16512,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051253,Binding constant for PKN1 kinase domain,Kd,>,10000,nM,,CHEMBL3384,Protein kinase N1,Homo sapiens,Q16512,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051310,Binding constant for PKN2 kinase domain,Kd,>,10000,nM,,CHEMBL3032,Protein kinase N2,Homo sapiens,Q16513,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051310,Binding constant for PKN2 kinase domain,Kd,>,10000,nM,,CHEMBL3032,Protein kinase N2,Homo sapiens,Q16513,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051311,Binding constant for PLK1 kinase domain,Kd,>,10000,nM,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051311,Binding constant for PLK1 kinase domain,Kd,>,10000,nM,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061092,Binding constant for PLK3 kinase domain,Kd,>,10000,nM,,CHEMBL4897,Serine/threonine-protein kinase PLK3,Homo sapiens,Q9H4B4,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061092,Binding constant for PLK3 kinase domain,Kd,>,10000,nM,,CHEMBL4897,Serine/threonine-protein kinase PLK3,Homo sapiens,Q9H4B4,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060341,Binding constant for PLK4 kinase domain,Kd,>,10000,nM,,CHEMBL3788,Serine/threonine-protein kinase PLK4,Homo sapiens,O00444,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060341,Binding constant for PLK4 kinase domain,Kd,>,10000,nM,,CHEMBL3788,Serine/threonine-protein kinase PLK4,Homo sapiens,O00444,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062865,Binding constant for PRKCD kinase domain,Kd,>,10000,nM,,CHEMBL2996,Protein kinase C delta,Homo sapiens,Q05655,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062865,Binding constant for PRKCD kinase domain,Kd,>,10000,nM,,CHEMBL2996,Protein kinase C delta,Homo sapiens,Q05655,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051254,Binding constant for PRKCE kinase domain,Kd,>,10000,nM,,CHEMBL3582,Protein kinase C epsilon,Homo sapiens,Q02156,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051254,Binding constant for PRKCE kinase domain,Kd,>,10000,nM,,CHEMBL3582,Protein kinase C epsilon,Homo sapiens,Q02156,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060261,Binding constant for PRKCH kinase domain,Kd,>,10000,nM,,CHEMBL3616,Protein kinase C eta,Homo sapiens,P24723,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060261,Binding constant for PRKCH kinase domain,Kd,>,10000,nM,,CHEMBL3616,Protein kinase C eta,Homo sapiens,P24723,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051255,Binding constant for PRKCQ kinase domain,Kd,>,10000,nM,,CHEMBL3920,Protein kinase C theta,Homo sapiens,Q04759,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051255,Binding constant for PRKCQ kinase domain,Kd,>,10000,nM,,CHEMBL3920,Protein kinase C theta,Homo sapiens,Q04759,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061155,Binding constant for PRKD1 kinase domain,Kd,>,10000,nM,,CHEMBL3863,Protein kinase C mu,Homo sapiens,Q15139,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061155,Binding constant for PRKD1 kinase domain,Kd,>,10000,nM,,CHEMBL3863,Protein kinase C mu,Homo sapiens,Q15139,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061156,Binding constant for PRKD2 kinase domain,Kd,>,10000,nM,,CHEMBL4900,Serine/threonine-protein kinase D2,Homo sapiens,Q9BZL6,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061156,Binding constant for PRKD2 kinase domain,Kd,>,10000,nM,,CHEMBL4900,Serine/threonine-protein kinase D2,Homo sapiens,Q9BZL6,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062866,Binding constant for PRKD3 kinase domain,Kd,>,10000,nM,,CHEMBL2595,Protein kinase C nu,Homo sapiens,O94806,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062866,Binding constant for PRKD3 kinase domain,Kd,>,10000,nM,,CHEMBL2595,Protein kinase C nu,Homo sapiens,O94806,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062859,Binding constant for PRKG1 kinase domain,Kd,>,10000,nM,,CHEMBL4273,cGMP-dependent protein kinase 1 beta,Homo sapiens,Q13976,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062859,Binding constant for PRKG1 kinase domain,Kd,>,10000,nM,,CHEMBL4273,cGMP-dependent protein kinase 1 beta,Homo sapiens,Q13976,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051256,Binding constant for PRKG2 kinase domain,Kd,>,10000,nM,,CHEMBL2896,cGMP-dependent protein kinase 2,Homo sapiens,Q13237,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051256,Binding constant for PRKG2 kinase domain,Kd,>,10000,nM,,CHEMBL2896,cGMP-dependent protein kinase 2,Homo sapiens,Q13237,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062867,Binding constant for PRKR kinase domain,Kd,>,10000,nM,,CHEMBL5785,"Interferon-induced, double-stranded RNA-activated protein kinase",Homo sapiens,P19525,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062867,Binding constant for PRKR kinase domain,Kd,>,10000,nM,,CHEMBL5785,"Interferon-induced, double-stranded RNA-activated protein kinase",Homo sapiens,P19525,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061093,Binding constant for PTK2 kinase domain,Kd,>,10000,nM,,CHEMBL2695,Focal adhesion kinase 1,Homo sapiens,Q05397,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061093,Binding constant for PTK2 kinase domain,Kd,>,10000,nM,,CHEMBL2695,Focal adhesion kinase 1,Homo sapiens,Q05397,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061159,Binding constant for PTK6 kinase domain,Kd,>,10000,nM,,CHEMBL4601,Tyrosine-protein kinase BRK,Homo sapiens,Q13882,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061159,Binding constant for PTK6 kinase domain,Kd,>,10000,nM,,CHEMBL4601,Tyrosine-protein kinase BRK,Homo sapiens,Q13882,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062868,Binding constant for RAF1 kinase domain,Kd,>,10000,nM,,CHEMBL1906,Serine/threonine-protein kinase RAF,Homo sapiens,P04049,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062868,Binding constant for RAF1 kinase domain,Kd,>,10000,nM,,CHEMBL1906,Serine/threonine-protein kinase RAF,Homo sapiens,P04049,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061179,Binding constant for RET kinase domain,Kd,>,10000,nM,,CHEMBL2041,Tyrosine-protein kinase receptor RET,Homo sapiens,P07949,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061179,Binding constant for RET kinase domain,Kd,>,10000,nM,,CHEMBL2041,Tyrosine-protein kinase receptor RET,Homo sapiens,P07949,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051257,Binding constant for RET(M918T) kinase domain,Kd,>,10000,nM,,CHEMBL2041,Tyrosine-protein kinase receptor RET,Homo sapiens,P07949,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051257,Binding constant for RET(M918T) kinase domain,Kd,>,10000,nM,,CHEMBL2041,Tyrosine-protein kinase receptor RET,Homo sapiens,P07949,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062869,Binding constant for RIPK1 kinase domain,Kd,>,10000,nM,,CHEMBL5464,Receptor-interacting serine/threonine-protein kinase 1,Homo sapiens,Q13546,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062869,Binding constant for RIPK1 kinase domain,Kd,>,10000,nM,,CHEMBL5464,Receptor-interacting serine/threonine-protein kinase 1,Homo sapiens,Q13546,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051312,Binding constant for RIPK2 kinase domain,Kd,>,10000,nM,,CHEMBL5014,Serine/threonine-protein kinase RIPK2,Homo sapiens,O43353,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051312,Binding constant for RIPK2 kinase domain,Kd,=,3400,nM,,CHEMBL5014,Serine/threonine-protein kinase RIPK2,Homo sapiens,O43353,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061925,Binding constant for ROS1 kinase domain,Kd,>,10000,nM,,CHEMBL5568,Proto-oncogene tyrosine-protein kinase ROS,Homo sapiens,P08922,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061925,Binding constant for ROS1 kinase domain,Kd,>,10000,nM,,CHEMBL5568,Proto-oncogene tyrosine-protein kinase ROS,Homo sapiens,P08922,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051351,Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain,Kd,>,10000,nM,,CHEMBL2553,Ribosomal protein S6 kinase alpha 1,Homo sapiens,Q15418,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051351,Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain,Kd,>,10000,nM,,CHEMBL2553,Ribosomal protein S6 kinase alpha 1,Homo sapiens,Q15418,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062785,Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain,Kd,>,10000,nM,,CHEMBL2553,Ribosomal protein S6 kinase alpha 1,Homo sapiens,Q15418,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062785,Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain,Kd,=,1300,nM,,CHEMBL2553,Ribosomal protein S6 kinase alpha 1,Homo sapiens,Q15418,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060342,Binding constant for RPS6KA2(Kin.Dom.1 - N-terminal) kinase domain,Kd,>,10000,nM,,CHEMBL3906,Ribosomal protein S6 kinase alpha 2,Homo sapiens,Q15349,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060342,Binding constant for RPS6KA2(Kin.Dom.1 - N-terminal) kinase domain,Kd,>,10000,nM,,CHEMBL3906,Ribosomal protein S6 kinase alpha 2,Homo sapiens,Q15349,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062786,Binding constant for RPS6KA2(Kin.Dom.2 - C-terminal) kinase domain,Kd,>,10000,nM,,CHEMBL3906,Ribosomal protein S6 kinase alpha 2,Homo sapiens,Q15349,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062786,Binding constant for RPS6KA2(Kin.Dom.2 - C-terminal) kinase domain,Kd,>,10000,nM,,CHEMBL3906,Ribosomal protein S6 kinase alpha 2,Homo sapiens,Q15349,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062870,Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain,Kd,>,10000,nM,,CHEMBL2345,Ribosomal protein S6 kinase alpha 3,Homo sapiens,P51812,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062870,Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain,Kd,>,10000,nM,,CHEMBL2345,Ribosomal protein S6 kinase alpha 3,Homo sapiens,P51812,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051259,Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain,Kd,>,10000,nM,,CHEMBL3125,Ribosomal protein S6 kinase alpha 4,Homo sapiens,O75676,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051259,Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain,Kd,>,10000,nM,,CHEMBL3125,Ribosomal protein S6 kinase alpha 4,Homo sapiens,O75676,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061185,Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain,Kd,>,10000,nM,,CHEMBL3125,Ribosomal protein S6 kinase alpha 4,Homo sapiens,O75676,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061185,Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain,Kd,>,10000,nM,,CHEMBL3125,Ribosomal protein S6 kinase alpha 4,Homo sapiens,O75676,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1037545,Binding constant for RPS6KA5(Kin.Dom.1 - C-terminal) kinase domain,Kd,>,10000,nM,,CHEMBL4237,Ribosomal protein S6 kinase alpha 5,Homo sapiens,O75582,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1037545,Binding constant for RPS6KA5(Kin.Dom.1 - C-terminal) kinase domain,Kd,>,10000,nM,,CHEMBL4237,Ribosomal protein S6 kinase alpha 5,Homo sapiens,O75582,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1056938,Binding constant for RPS6KA5(Kin.Dom.2 - N-terminal) kinase domain,Kd,>,10000,nM,,CHEMBL4237,Ribosomal protein S6 kinase alpha 5,Homo sapiens,O75582,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1056938,Binding constant for RPS6KA5(Kin.Dom.2 - N-terminal) kinase domain,Kd,>,10000,nM,,CHEMBL4237,Ribosomal protein S6 kinase alpha 5,Homo sapiens,O75582,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1039275,Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain,Kd,>,10000,nM,,CHEMBL4924,Ribosomal protein S6 kinase alpha 6,Homo sapiens,Q9UK32,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1039275,Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain,Kd,>,10000,nM,,CHEMBL4924,Ribosomal protein S6 kinase alpha 6,Homo sapiens,Q9UK32,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061926,Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain,Kd,>,10000,nM,,CHEMBL4924,Ribosomal protein S6 kinase alpha 6,Homo sapiens,Q9UK32,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061926,Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain,Kd,>,10000,nM,,CHEMBL4924,Ribosomal protein S6 kinase alpha 6,Homo sapiens,Q9UK32,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062787,Binding constant for SLK kinase domain,Kd,>,10000,nM,,CHEMBL4202,Serine/threonine-protein kinase 2,Homo sapiens,Q9H2G2,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062787,Binding constant for SLK kinase domain,Kd,>,10000,nM,,CHEMBL4202,Serine/threonine-protein kinase 2,Homo sapiens,Q9H2G2,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062871,Binding constant for SNARK kinase domain,Kd,>,10000,nM,,CHEMBL5698,NUAK family SNF1-like kinase 2,Homo sapiens,Q9H093,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062871,Binding constant for SNARK kinase domain,Kd,>,10000,nM,,CHEMBL5698,NUAK family SNF1-like kinase 2,Homo sapiens,Q9H093,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1050832,Binding constant for SNF1LK kinase domain,Kd,>,10000,nM,,CHEMBL6082,Serine/threonine-protein kinase SIK1,Homo sapiens,P57059,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1050832,Binding constant for SNF1LK kinase domain,Kd,>,10000,nM,,CHEMBL6082,Serine/threonine-protein kinase SIK1,Homo sapiens,P57059,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061927,Binding constant for SRC kinase domain,Kd,>,10000,nM,,CHEMBL267,Tyrosine-protein kinase SRC,Homo sapiens,P12931,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061927,Binding constant for SRC kinase domain,Kd,>,10000,nM,,CHEMBL267,Tyrosine-protein kinase SRC,Homo sapiens,P12931,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062872,Binding constant for SRMS kinase domain,Kd,>,10000,nM,,CHEMBL5703,Tyrosine-protein kinase Srms,Homo sapiens,Q9H3Y6,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062872,Binding constant for SRMS kinase domain,Kd,>,10000,nM,,CHEMBL5703,Tyrosine-protein kinase Srms,Homo sapiens,Q9H3Y6,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051353,Binding constant for STK16 kinase domain,Kd,>,10000,nM,,CHEMBL3938,Serine/threonine-protein kinase 16,Homo sapiens,O75716,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051353,Binding constant for STK16 kinase domain,Kd,>,10000,nM,,CHEMBL3938,Serine/threonine-protein kinase 16,Homo sapiens,O75716,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062873,Binding constant for STK36 kinase domain,Kd,>,10000,nM,,CHEMBL4312,Serine/threonine-protein kinase 36,Homo sapiens,Q9NRP7,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062873,Binding constant for STK36 kinase domain,Kd,>,10000,nM,,CHEMBL4312,Serine/threonine-protein kinase 36,Homo sapiens,Q9NRP7,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061186,Binding constant for SYK kinase domain,Kd,>,10000,nM,,CHEMBL2599,Tyrosine-protein kinase SYK,Homo sapiens,P43405,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061186,Binding constant for SYK kinase domain,Kd,>,10000,nM,,CHEMBL2599,Tyrosine-protein kinase SYK,Homo sapiens,P43405,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051352,Binding constant for SgK085 kinase domain,Kd,>,10000,nM,,CHEMBL5426,Myosin light chain kinase family member 4,Homo sapiens,Q86YV6,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051352,Binding constant for SgK085 kinase domain,Kd,>,10000,nM,,CHEMBL5426,Myosin light chain kinase family member 4,Homo sapiens,Q86YV6,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061929,Binding constant for TEC kinase domain,Kd,>,10000,nM,,CHEMBL4246,Tyrosine-protein kinase TEC,Homo sapiens,P42680,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061929,Binding constant for TEC kinase domain,Kd,>,10000,nM,,CHEMBL4246,Tyrosine-protein kinase TEC,Homo sapiens,P42680,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1037550,Binding constant for TESK1 kinase domain,Kd,>,10000,nM,,CHEMBL5604,Dual specificity testis-specific protein kinase 1,Homo sapiens,Q15569,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1037550,Binding constant for TESK1 kinase domain,Kd,>,10000,nM,,CHEMBL5604,Dual specificity testis-specific protein kinase 1,Homo sapiens,Q15569,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051314,Binding constant for TGFBR1 kinase domain,Kd,>,10000,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051314,Binding constant for TGFBR1 kinase domain,Kd,=,170,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051354,Binding constant for TGFBR2 kinase domain,Kd,>,10000,nM,,CHEMBL4267,TGF-beta receptor type II,Homo sapiens,P37173,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051354,Binding constant for TGFBR2 kinase domain,Kd,>,10000,nM,,CHEMBL4267,TGF-beta receptor type II,Homo sapiens,P37173,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061930,Binding constant for TIE1 kinase domain,Kd,>,10000,nM,,CHEMBL5274,Tyrosine-protein kinase receptor Tie-1,Homo sapiens,P35590,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061930,Binding constant for TIE1 kinase domain,Kd,>,10000,nM,,CHEMBL5274,Tyrosine-protein kinase receptor Tie-1,Homo sapiens,P35590,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051315,Binding constant for TIE2 kinase domain,Kd,>,10000,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051315,Binding constant for TIE2 kinase domain,Kd,>,10000,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061931,Binding constant for TLK1 kinase domain,Kd,>,10000,nM,,CHEMBL5388,Serine/threonine-protein kinase tousled-like 1,Homo sapiens,Q9UKI8,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061931,Binding constant for TLK1 kinase domain,Kd,>,10000,nM,,CHEMBL5388,Serine/threonine-protein kinase tousled-like 1,Homo sapiens,Q9UKI8,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061984,Binding constant for TLK2 kinase domain,Kd,>,10000,nM,,CHEMBL5404,Serine/threonine-protein kinase tousled-like 2,Homo sapiens,Q86UE8,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061984,Binding constant for TLK2 kinase domain,Kd,>,10000,nM,,CHEMBL5404,Serine/threonine-protein kinase tousled-like 2,Homo sapiens,Q86UE8,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062874,Binding constant for TNIK kinase domain,Kd,>,10000,nM,,CHEMBL4527,TRAF2- and NCK-interacting kinase,Homo sapiens,Q9UKE5,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062874,Binding constant for TNIK kinase domain,Kd,>,10000,nM,,CHEMBL4527,TRAF2- and NCK-interacting kinase,Homo sapiens,Q9UKE5,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051355,Binding constant for TNK2 kinase domain,Kd,>,10000,nM,,CHEMBL4599,Tyrosine kinase non-receptor protein 2,Homo sapiens,Q07912,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051355,Binding constant for TNK2 kinase domain,Kd,>,10000,nM,,CHEMBL4599,Tyrosine kinase non-receptor protein 2,Homo sapiens,Q07912,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061933,Binding constant for TRKA kinase domain,Kd,=,630,nM,,CHEMBL2815,Nerve growth factor receptor Trk-A,Homo sapiens,P04629,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061933,Binding constant for TRKA kinase domain,Kd,>,10000,nM,,CHEMBL2815,Nerve growth factor receptor Trk-A,Homo sapiens,P04629,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062875,Binding constant for TRKB kinase domain,Kd,=,36,nM,,CHEMBL4898,Neurotrophic tyrosine kinase receptor type 2,Homo sapiens,Q16620,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062875,Binding constant for TRKB kinase domain,Kd,>,10000,nM,,CHEMBL4898,Neurotrophic tyrosine kinase receptor type 2,Homo sapiens,Q16620,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1041998,Binding constant for TRKC kinase domain,Kd,=,120,nM,,CHEMBL5608,NT-3 growth factor receptor,Homo sapiens,Q16288,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1041998,Binding constant for TRKC kinase domain,Kd,>,10000,nM,,CHEMBL5608,NT-3 growth factor receptor,Homo sapiens,Q16288,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061934,Binding constant for TTK kinase domain,Kd,>,10000,nM,,CHEMBL3983,Dual specificity protein kinase TTK,Homo sapiens,P33981,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061934,Binding constant for TTK kinase domain,Kd,>,10000,nM,,CHEMBL3983,Dual specificity protein kinase TTK,Homo sapiens,P33981,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061187,Binding constant for TXK kinase domain,Kd,>,10000,nM,,CHEMBL4367,Tyrosine-protein kinase TXK,Homo sapiens,P42681,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061187,Binding constant for TXK kinase domain,Kd,>,10000,nM,,CHEMBL4367,Tyrosine-protein kinase TXK,Homo sapiens,P42681,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061188,Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain,Kd,>,10000,nM,,CHEMBL3553,Tyrosine-protein kinase TYK2 ,Homo sapiens,P29597,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061188,Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain,Kd,>,10000,nM,,CHEMBL3553,Tyrosine-protein kinase TYK2 ,Homo sapiens,P29597,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051260,Binding constant for TYRO3 kinase domain,Kd,>,10000,nM,,CHEMBL5314,Tyrosine-protein kinase receptor TYRO3,Homo sapiens,Q06418,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051260,Binding constant for TYRO3 kinase domain,Kd,>,10000,nM,,CHEMBL5314,Tyrosine-protein kinase receptor TYRO3,Homo sapiens,Q06418,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051261,Binding constant for VEGFR2 kinase domain,Kd,>,10000,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051261,Binding constant for VEGFR2 kinase domain,Kd,>,10000,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061935,Binding constant for WEE1 kinase domain,Kd,>,10000,nM,,CHEMBL5491,Serine/threonine-protein kinase WEE1,Homo sapiens,P30291,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061935,Binding constant for WEE1 kinase domain,Kd,>,10000,nM,,CHEMBL5491,Serine/threonine-protein kinase WEE1,Homo sapiens,P30291,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062789,Binding constant for YANK3 kinase domain,Kd,>,10000,nM,,CHEMBL5405,Serine/threonine-protein kinase 32C,Homo sapiens,Q86UX6,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062789,Binding constant for YANK3 kinase domain,Kd,>,10000,nM,,CHEMBL5405,Serine/threonine-protein kinase 32C,Homo sapiens,Q86UX6,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051262,Binding constant for YES kinase domain,Kd,>,10000,nM,,CHEMBL2073,Tyrosine-protein kinase YES,Homo sapiens,P07947,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051262,Binding constant for YES kinase domain,Kd,>,10000,nM,,CHEMBL2073,Tyrosine-protein kinase YES,Homo sapiens,P07947,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051263,Binding constant for YSK1 kinase domain,Kd,>,10000,nM,,CHEMBL5552,Serine/threonine-protein kinase 25,Homo sapiens,O00506,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051263,Binding constant for YSK1 kinase domain,Kd,>,10000,nM,,CHEMBL5552,Serine/threonine-protein kinase 25,Homo sapiens,O00506,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051317,Binding constant for ZAK kinase domain,Kd,>,10000,nM,,CHEMBL3886,Mixed lineage kinase 7,Homo sapiens,Q9NYL2,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051317,Binding constant for ZAK kinase domain,Kd,>,10000,nM,,CHEMBL3886,Mixed lineage kinase 7,Homo sapiens,Q9NYL2,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061189,Binding constant for ZAP70 kinase domain,Kd,>,10000,nM,,CHEMBL2803,Tyrosine-protein kinase ZAP-70 ,Homo sapiens,P43403,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061189,Binding constant for ZAP70 kinase domain,Kd,>,10000,nM,,CHEMBL2803,Tyrosine-protein kinase ZAP-70 ,Homo sapiens,P43403,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061132,Binding constant for full-length ADCK4,Kd,>,10000,nM,,CHEMBL5753,Uncharacterized aarF domain-containing protein kinase 4,Homo sapiens,Q96D53,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061132,Binding constant for full-length ADCK4,Kd,>,10000,nM,,CHEMBL5753,Uncharacterized aarF domain-containing protein kinase 4,Homo sapiens,Q96D53,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060236,Binding constant for full-length AURKC,Kd,>,10000,nM,,CHEMBL3935,Serine/threonine-protein kinase Aurora-C,Homo sapiens,Q9UQB9,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060236,Binding constant for full-length AURKC,Kd,>,10000,nM,,CHEMBL3935,Serine/threonine-protein kinase Aurora-C,Homo sapiens,Q9UQB9,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061134,Binding constant for full-length BMX,Kd,>,10000,nM,,CHEMBL3834,Tyrosine-protein kinase BMX,Homo sapiens,P51813,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061134,Binding constant for full-length BMX,Kd,>,10000,nM,,CHEMBL3834,Tyrosine-protein kinase BMX,Homo sapiens,P51813,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061136,Binding constant for full-length BRSK2,Kd,>,10000,nM,,CHEMBL4574,BR serine/threonine-protein kinase 2,Homo sapiens,Q8IWQ3,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061136,Binding constant for full-length BRSK2,Kd,>,10000,nM,,CHEMBL4574,BR serine/threonine-protein kinase 2,Homo sapiens,Q8IWQ3,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060238,Binding constant for full-length BTK,Kd,>,10000,nM,,CHEMBL5251,Tyrosine-protein kinase BTK,Homo sapiens,Q06187,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060238,Binding constant for full-length BTK,Kd,>,10000,nM,,CHEMBL5251,Tyrosine-protein kinase BTK,Homo sapiens,Q06187,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060239,Binding constant for full-length CAMK1,Kd,>,10000,nM,,CHEMBL2493,CaM kinase I alpha,Homo sapiens,Q14012,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060239,Binding constant for full-length CAMK1,Kd,>,10000,nM,,CHEMBL2493,CaM kinase I alpha,Homo sapiens,Q14012,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061138,Binding constant for full-length CDK2,Kd,>,10000,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061138,Binding constant for full-length CDK2,Kd,>,10000,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1043736,Binding constant for full-length CDK3,Kd,>,10000,nM,,CHEMBL4442,Cyclin-dependent kinase 3,Homo sapiens,Q00526,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1043736,Binding constant for full-length CDK3,Kd,>,10000,nM,,CHEMBL4442,Cyclin-dependent kinase 3,Homo sapiens,Q00526,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1037551,Binding constant for full-length CDK5,Kd,>,10000,nM,,CHEMBL4036,Cyclin-dependent kinase 5,Homo sapiens,Q00535,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1037551,Binding constant for full-length CDK5,Kd,>,10000,nM,,CHEMBL4036,Cyclin-dependent kinase 5,Homo sapiens,Q00535,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063700,Binding constant for full-length CDK7,Kd,>,10000,nM,,CHEMBL3055,Cyclin-dependent kinase 7,Homo sapiens,P50613,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063700,Binding constant for full-length CDK7,Kd,>,10000,nM,,CHEMBL3055,Cyclin-dependent kinase 7,Homo sapiens,P50613,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063701,Binding constant for full-length CDK9,Kd,>,10000,nM,,CHEMBL3116,Cyclin-dependent kinase 9,Homo sapiens,P50750,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063701,Binding constant for full-length CDK9,Kd,>,10000,nM,,CHEMBL3116,Cyclin-dependent kinase 9,Homo sapiens,P50750,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1050838,Binding constant for full-length CLK1,Kd,>,10000,nM,,CHEMBL4224,Dual specificty protein kinase CLK1,Homo sapiens,P49759,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1050838,Binding constant for full-length CLK1,Kd,>,10000,nM,,CHEMBL4224,Dual specificty protein kinase CLK1,Homo sapiens,P49759,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060240,Binding constant for full-length CLK3,Kd,>,10000,nM,,CHEMBL4226,Dual specificity protein kinase CLK3,Homo sapiens,P49761,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060240,Binding constant for full-length CLK3,Kd,>,10000,nM,,CHEMBL4226,Dual specificity protein kinase CLK3,Homo sapiens,P49761,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1037547,Binding constant for full-length CSK,Kd,>,10000,nM,,CHEMBL2634,Tyrosine-protein kinase CSK,Homo sapiens,P41240,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1037547,Binding constant for full-length CSK,Kd,>,10000,nM,,CHEMBL2634,Tyrosine-protein kinase CSK,Homo sapiens,P41240,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063703,Binding constant for full-length CSNK1A1L,Kd,>,10000,nM,,CHEMBL5520,Casein kinase I isoform alpha-like,Homo sapiens,Q8N752,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063703,Binding constant for full-length CSNK1A1L,Kd,=,5900,nM,,CHEMBL5520,Casein kinase I isoform alpha-like,Homo sapiens,Q8N752,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1050829,Binding constant for full-length CSNK1D,Kd,>,10000,nM,,CHEMBL2828,Casein kinase I delta,Homo sapiens,P48730,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1050829,Binding constant for full-length CSNK1D,Kd,=,170,nM,,CHEMBL2828,Casein kinase I delta,Homo sapiens,P48730,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1050834,Binding constant for full-length CSNK1E,Kd,>,10000,nM,,CHEMBL4937,Casein kinase I epsilon,Homo sapiens,P49674,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1050834,Binding constant for full-length CSNK1E,Kd,=,260,nM,,CHEMBL4937,Casein kinase I epsilon,Homo sapiens,P49674,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063704,Binding constant for full-length CSNK1G2,Kd,>,10000,nM,,CHEMBL2543,Casein kinase I gamma 2,Homo sapiens,P78368,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063704,Binding constant for full-length CSNK1G2,Kd,>,10000,nM,,CHEMBL2543,Casein kinase I gamma 2,Homo sapiens,P78368,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051284,Binding constant for full-length CSNK1G3,Kd,>,10000,nM,,CHEMBL5084,Casein kinase I isoform gamma-3,Homo sapiens,Q9Y6M4,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051284,Binding constant for full-length CSNK1G3,Kd,>,10000,nM,,CHEMBL5084,Casein kinase I isoform gamma-3,Homo sapiens,Q9Y6M4,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060241,Binding constant for full-length CSNK2A1,Kd,>,10000,nM,,CHEMBL3629,Casein kinase II alpha,Homo sapiens,P68400,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060241,Binding constant for full-length CSNK2A1,Kd,>,10000,nM,,CHEMBL3629,Casein kinase II alpha,Homo sapiens,P68400,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061141,Binding constant for full-length CSNK2A2,Kd,>,10000,nM,,CHEMBL4070,Casein kinase II alpha (prime),Homo sapiens,P19784,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061141,Binding constant for full-length CSNK2A2,Kd,>,10000,nM,,CHEMBL4070,Casein kinase II alpha (prime),Homo sapiens,P19784,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1053760,Binding constant for full-length DAPK2,Kd,>,10000,nM,,CHEMBL3123,Death-associated protein kinase 2,Homo sapiens,Q9UIK4,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1053760,Binding constant for full-length DAPK2,Kd,>,10000,nM,,CHEMBL3123,Death-associated protein kinase 2,Homo sapiens,Q9UIK4,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060181,Binding constant for full-length DLK,Kd,>,10000,nM,,CHEMBL2468,Death-associated protein kinase 3,Homo sapiens,O43293,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060181,Binding constant for full-length DLK,Kd,>,10000,nM,,CHEMBL2468,Death-associated protein kinase 3,Homo sapiens,O43293,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060189,Binding constant for full-length DRAK2,Kd,>,10000,nM,,CHEMBL3980,Serine/threonine-protein kinase 17B,Homo sapiens,O94768,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060189,Binding constant for full-length DRAK2,Kd,>,10000,nM,,CHEMBL3980,Serine/threonine-protein kinase 17B,Homo sapiens,O94768,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060243,Binding constant for full-length DYRK1B,Kd,>,10000,nM,,CHEMBL5543,Dual specificity tyrosine-phosphorylation-regulated kinase 1B,Homo sapiens,Q9Y463,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060243,Binding constant for full-length DYRK1B,Kd,>,10000,nM,,CHEMBL5543,Dual specificity tyrosine-phosphorylation-regulated kinase 1B,Homo sapiens,Q9Y463,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1037552,Binding constant for full-length ERK1,Kd,>,10000,nM,,CHEMBL3385,MAP kinase ERK1,Homo sapiens,P27361,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1037552,Binding constant for full-length ERK1,Kd,>,10000,nM,,CHEMBL3385,MAP kinase ERK1,Homo sapiens,P27361,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063798,Binding constant for full-length ERK2,Kd,>,10000,nM,,CHEMBL4040,MAP kinase ERK2,Homo sapiens,P28482,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063798,Binding constant for full-length ERK2,Kd,>,10000,nM,,CHEMBL4040,MAP kinase ERK2,Homo sapiens,P28482,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061900,Binding constant for full-length GSK3A,Kd,>,10000,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061900,Binding constant for full-length GSK3A,Kd,>,10000,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061074,Binding constant for full-length GSK3B,Kd,>,10000,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061074,Binding constant for full-length GSK3B,Kd,>,10000,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1050835,Binding constant for full-length IKK-epsilon,Kd,>,10000,nM,,CHEMBL3529,Inhibitor of nuclear factor kappa B kinase epsilon subunit,Homo sapiens,Q14164,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1050835,Binding constant for full-length IKK-epsilon,Kd,>,10000,nM,,CHEMBL3529,Inhibitor of nuclear factor kappa B kinase epsilon subunit,Homo sapiens,Q14164,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061076,Binding constant for full-length JNK1,Kd,>,10000,nM,,CHEMBL2276,c-Jun N-terminal kinase 1,Homo sapiens,P45983,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061076,Binding constant for full-length JNK1,Kd,>,10000,nM,,CHEMBL2276,c-Jun N-terminal kinase 1,Homo sapiens,P45983,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060196,Binding constant for full-length JNK2,Kd,>,10000,nM,,CHEMBL4179,c-Jun N-terminal kinase 2,Homo sapiens,P45984,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060196,Binding constant for full-length JNK2,Kd,>,10000,nM,,CHEMBL4179,c-Jun N-terminal kinase 2,Homo sapiens,P45984,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061902,Binding constant for full-length LIMK1,Kd,>,10000,nM,,CHEMBL3836,LIM domain kinase 1,Homo sapiens,P53667,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061902,Binding constant for full-length LIMK1,Kd,>,10000,nM,,CHEMBL3836,LIM domain kinase 1,Homo sapiens,P53667,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063714,Binding constant for full-length LIMK2,Kd,>,10000,nM,,CHEMBL5932,LIM domain kinase 2,Homo sapiens,P53671,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063714,Binding constant for full-length LIMK2,Kd,>,10000,nM,,CHEMBL5932,LIM domain kinase 2,Homo sapiens,P53671,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051288,Binding constant for full-length LKB1,Kd,>,10000,nM,,CHEMBL5606,Serine/threonine-protein kinase 11,Homo sapiens,Q15831,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051288,Binding constant for full-length LKB1,Kd,>,10000,nM,,CHEMBL5606,Serine/threonine-protein kinase 11,Homo sapiens,Q15831,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063802,Binding constant for full-length MARK3,Kd,>,10000,nM,,CHEMBL5600,Serine/threonine-protein kinase c-TAK1,Homo sapiens,P27448,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063802,Binding constant for full-length MARK3,Kd,>,10000,nM,,CHEMBL5600,Serine/threonine-protein kinase c-TAK1,Homo sapiens,P27448,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061906,Binding constant for full-length MEK1,Kd,>,10000,nM,,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,Homo sapiens,Q02750,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061906,Binding constant for full-length MEK1,Kd,>,10000,nM,,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,Homo sapiens,Q02750,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061079,Binding constant for full-length MEK2,Kd,>,10000,nM,,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,Homo sapiens,P36507,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061079,Binding constant for full-length MEK2,Kd,>,10000,nM,,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,Homo sapiens,P36507,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1060250,Binding constant for full-length MEK3,Kd,>,10000,nM,,CHEMBL2109,Dual specificity mitogen-activated protein kinase kinase 3,Homo sapiens,P46734,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1060250,Binding constant for full-length MEK3,Kd,>,10000,nM,,CHEMBL2109,Dual specificity mitogen-activated protein kinase kinase 3,Homo sapiens,P46734,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063803,Binding constant for full-length MELK,Kd,>,10000,nM,,CHEMBL4578,Maternal embryonic leucine zipper kinase,Homo sapiens,Q14680,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063803,Binding constant for full-length MELK,Kd,>,10000,nM,,CHEMBL4578,Maternal embryonic leucine zipper kinase,Homo sapiens,Q14680,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063804,Binding constant for full-length MKNK1,Kd,>,10000,nM,,CHEMBL4718,MAP kinase-interacting serine/threonine-protein kinase MNK1,Homo sapiens,Q9BUB5,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063804,Binding constant for full-length MKNK1,Kd,>,10000,nM,,CHEMBL4718,MAP kinase-interacting serine/threonine-protein kinase MNK1,Homo sapiens,Q9BUB5,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061178,Binding constant for full-length MST1,Kd,>,10000,nM,,CHEMBL4598,Serine/threonine-protein kinase MST1,Homo sapiens,Q13043,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061178,Binding constant for full-length MST1,Kd,>,10000,nM,,CHEMBL4598,Serine/threonine-protein kinase MST1,Homo sapiens,Q13043,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063806,Binding constant for full-length MST4,Kd,>,10000,nM,,CHEMBL5941,Serine/threonine-protein kinase MST4,Homo sapiens,Q9P289,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063806,Binding constant for full-length MST4,Kd,>,10000,nM,,CHEMBL5941,Serine/threonine-protein kinase MST4,Homo sapiens,Q9P289,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063808,Binding constant for full-length NEK7,Kd,>,10000,nM,,CHEMBL4849,Serine/threonine-protein kinase NEK7,Homo sapiens,Q8TDX7,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063808,Binding constant for full-length NEK7,Kd,>,10000,nM,,CHEMBL4849,Serine/threonine-protein kinase NEK7,Homo sapiens,Q8TDX7,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1063809,Binding constant for full-length NLK,Kd,>,10000,nM,,CHEMBL5364,Serine/threonine protein kinase NLK,Homo sapiens,Q9UBE8,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1063809,Binding constant for full-length NLK,Kd,>,10000,nM,,CHEMBL5364,Serine/threonine protein kinase NLK,Homo sapiens,Q9UBE8,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062779,Binding constant for full-length PAK3,Kd,>,10000,nM,,CHEMBL2999,Serine/threonine-protein kinase PAK 3,Homo sapiens,O75914,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062779,Binding constant for full-length PAK3,Kd,>,10000,nM,,CHEMBL2999,Serine/threonine-protein kinase PAK 3,Homo sapiens,O75914,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051349,Binding constant for full-length PCTK2,Kd,>,10000,nM,,CHEMBL5790,Serine/threonine-protein kinase PCTAIRE-2,Homo sapiens,Q00537,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051349,Binding constant for full-length PCTK2,Kd,>,10000,nM,,CHEMBL5790,Serine/threonine-protein kinase PCTAIRE-2,Homo sapiens,Q00537,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062782,Binding constant for full-length PCTK3,Kd,>,10000,nM,,CHEMBL5316,Serine/threonine-protein kinase PCTAIRE-3,Homo sapiens,Q07002,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062782,Binding constant for full-length PCTK3,Kd,>,10000,nM,,CHEMBL5316,Serine/threonine-protein kinase PCTAIRE-3,Homo sapiens,Q07002,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061922,Binding constant for full-length PDPK1,Kd,>,10000,nM,,CHEMBL2534,3-phosphoinositide dependent protein kinase-1,Homo sapiens,O15530,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061922,Binding constant for full-length PDPK1,Kd,>,10000,nM,,CHEMBL2534,3-phosphoinositide dependent protein kinase-1,Homo sapiens,O15530,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051350,Binding constant for full-length PFTK1,Kd,>,10000,nM,,CHEMBL6162,Serine/threonine-protein kinase PFTAIRE-1,Homo sapiens,O94921,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051350,Binding constant for full-length PFTK1,Kd,>,10000,nM,,CHEMBL6162,Serine/threonine-protein kinase PFTAIRE-1,Homo sapiens,O94921,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061153,Binding constant for full-length PHKG1,Kd,>,10000,nM,,CHEMBL4004,Phosphorylase kinase gamma subunit 1,Homo sapiens,Q16816,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061153,Binding constant for full-length PHKG1,Kd,>,10000,nM,,CHEMBL4004,Phosphorylase kinase gamma subunit 1,Homo sapiens,Q16816,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061923,Binding constant for full-length PIP5K1A,Kd,>,10000,nM,,CHEMBL5969,Phosphatidylinositol-4-phosphate 5-kinase type-1 alpha,Homo sapiens,Q99755,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061923,Binding constant for full-length PIP5K1A,Kd,>,10000,nM,,CHEMBL5969,Phosphatidylinositol-4-phosphate 5-kinase type-1 alpha,Homo sapiens,Q99755,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062784,Binding constant for full-length PIP5K2B,Kd,>,10000,nM,,CHEMBL5667,Phosphatidylinositol-5-phosphate 4-kinase type-2 beta,Homo sapiens,P78356,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062784,Binding constant for full-length PIP5K2B,Kd,>,10000,nM,,CHEMBL5667,Phosphatidylinositol-5-phosphate 4-kinase type-2 beta,Homo sapiens,P78356,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1039274,Binding constant for full-length PKAC-beta,Kd,>,10000,nM,,CHEMBL2918,cAMP-dependent protein kinase beta-1 catalytic subunit,Homo sapiens,P22694,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1039274,Binding constant for full-length PKAC-beta,Kd,>,10000,nM,,CHEMBL2918,cAMP-dependent protein kinase beta-1 catalytic subunit,Homo sapiens,P22694,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061157,Binding constant for full-length PRKX,Kd,>,10000,nM,,CHEMBL5818,Serine/threonine-protein kinase PRKX,Homo sapiens,P51817,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061157,Binding constant for full-length PRKX,Kd,>,10000,nM,,CHEMBL5818,Serine/threonine-protein kinase PRKX,Homo sapiens,P51817,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061158,Binding constant for full-length PTK2B,Kd,>,10000,nM,,CHEMBL5469,Protein tyrosine kinase 2 beta,Homo sapiens,Q14289,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061158,Binding constant for full-length PTK2B,Kd,>,10000,nM,,CHEMBL5469,Protein tyrosine kinase 2 beta,Homo sapiens,Q14289,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051258,Binding constant for full-length RIOK1,Kd,>,10000,nM,,CHEMBL5975,Serine/threonine-protein kinase RIO1,Homo sapiens,Q9BRS2,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051258,Binding constant for full-length RIOK1,Kd,>,10000,nM,,CHEMBL5975,Serine/threonine-protein kinase RIO1,Homo sapiens,Q9BRS2,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061924,Binding constant for full-length RIOK3,Kd,>,10000,nM,,CHEMBL5659,Serine/threonine-protein kinase RIO3,Homo sapiens,O14730,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061924,Binding constant for full-length RIOK3,Kd,>,10000,nM,,CHEMBL5659,Serine/threonine-protein kinase RIO3,Homo sapiens,O14730,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061982,Binding constant for full-length SNF1LK2,Kd,>,10000,nM,,CHEMBL5699,Serine/threonine-protein kinase SIK2,Homo sapiens,Q9H0K1,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061982,Binding constant for full-length SNF1LK2,Kd,>,10000,nM,,CHEMBL5699,Serine/threonine-protein kinase SIK2,Homo sapiens,Q9H0K1,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051313,Binding constant for full-length SRPK1,Kd,>,10000,nM,,CHEMBL4375,Serine/threonine-protein kinase SRPK1,Homo sapiens,Q96SB4,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051313,Binding constant for full-length SRPK1,Kd,>,10000,nM,,CHEMBL4375,Serine/threonine-protein kinase SRPK1,Homo sapiens,Q96SB4,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061928,Binding constant for full-length SRPK2,Kd,>,10000,nM,,CHEMBL5668,Serine/threonine-protein kinase SRPK2,Homo sapiens,P78362,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061928,Binding constant for full-length SRPK2,Kd,>,10000,nM,,CHEMBL5668,Serine/threonine-protein kinase SRPK2,Homo sapiens,P78362,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061983,Binding constant for full-length STK33,Kd,>,10000,nM,,CHEMBL6005,Serine/threonine-protein kinase 33,Homo sapiens,Q9BYT3,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061983,Binding constant for full-length STK33,Kd,>,10000,nM,,CHEMBL6005,Serine/threonine-protein kinase 33,Homo sapiens,Q9BYT3,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062788,Binding constant for full-length TNK1,Kd,>,10000,nM,,CHEMBL5334,Non-receptor tyrosine-protein kinase TNK1,Homo sapiens,Q13470,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062788,Binding constant for full-length TNK1,Kd,>,10000,nM,,CHEMBL5334,Non-receptor tyrosine-protein kinase TNK1,Homo sapiens,Q13470,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061932,Binding constant for full-length TNNI3K,Kd,>,10000,nM,,CHEMBL5260,Serine/threonine-protein kinase TNNI3K,Homo sapiens,Q59H18,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061932,Binding constant for full-length TNNI3K,Kd,>,10000,nM,,CHEMBL5260,Serine/threonine-protein kinase TNNI3K,Homo sapiens,Q59H18,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051316,Binding constant for full-length TSSK1,Kd,>,10000,nM,,CHEMBL6003,Testis-specific serine/threonine-protein kinase 1,Homo sapiens,Q9BXA7,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1051316,Binding constant for full-length TSSK1,Kd,>,10000,nM,,CHEMBL6003,Testis-specific serine/threonine-protein kinase 1,Homo sapiens,Q9BXA7,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061985,Binding constant for full-length YANK2,Kd,>,10000,nM,,CHEMBL5912,Serine/threonine-protein kinase 32B,Homo sapiens,Q9NY57,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061985,Binding constant for full-length YANK2,Kd,>,10000,nM,,CHEMBL5912,Serine/threonine-protein kinase 32B,Homo sapiens,Q9NY57,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061091,Binding constant for full-length p38-alpha,Kd,>,10000,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061091,Binding constant for full-length p38-alpha,Kd,>,10000,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1062864,Binding constant for full-length p38-beta,Kd,>,10000,nM,,CHEMBL3961,MAP kinase p38 beta,Homo sapiens,Q15759,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062864,Binding constant for full-length p38-beta,Kd,>,10000,nM,,CHEMBL3961,MAP kinase p38 beta,Homo sapiens,Q15759,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1061183,Binding constant for full-length p38-gamma,Kd,>,10000,nM,,CHEMBL4674,MAP kinase p38 gamma,Homo sapiens,P53778,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061183,Binding constant for full-length p38-gamma,Kd,>,10000,nM,,CHEMBL4674,MAP kinase p38 gamma,Homo sapiens,P53778,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1051265,Selectivity for CSF1R as proportion of 290 kinases in screen with similar potency; non-selective = 1 highly selective = 0,Selectivity,=,0,,,CHEMBL1844,Macrophage colony stimulating factor  receptor ,Homo sapiens,P07333,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1061989,Selectivity for TGFBR1 as proportion of 290 kinases in screen with similar potency; non-selective = 1 highly selective = 0,Selectivity,=,0.0104,,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1150977,"Nat. Biotechnol., 26, p. 127 (2008)",18183025,Scientific Literature
1,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL1001220,"AUC in Beagle dog at 1 mg/kg, iv",AUC,=,0.5,ug hr ml-1,,CHEMBL373,Canis familiaris,Canis lupus familiaris,,CHEMBL1152233,"Bioorg. Med. Chem. Lett., 18, p. 5428 (2008)",18818075,Scientific Literature
1,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL1001213,"AUC in Lewis rat at 5 mg/kg, iv",AUC,=,1.7,ug hr ml-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1152233,"Bioorg. Med. Chem. Lett., 18, p. 5428 (2008)",18818075,Scientific Literature
1,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL1001221,"Bioavailability in Beagle dog at 1 mg/kg, iv",F,=,18,%,,CHEMBL373,Canis familiaris,Canis lupus familiaris,,CHEMBL1152233,"Bioorg. Med. Chem. Lett., 18, p. 5428 (2008)",18818075,Scientific Literature
1,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL1001215,"Bioavailability in Lewis rat at 5 mg/kg, iv",F,=,50,%,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1152233,"Bioorg. Med. Chem. Lett., 18, p. 5428 (2008)",18818075,Scientific Literature
1,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL1001217,"Clearance in Beagle dog at 1 mg/kg, iv",CL,=,34,mL.min-1.kg-1,,CHEMBL373,Canis familiaris,Canis lupus familiaris,,CHEMBL1152233,"Bioorg. Med. Chem. Lett., 18, p. 5428 (2008)",18818075,Scientific Literature
1,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL1001207,"Clearance in Lewis rat at 5 mg/kg, iv",CL,=,49,mL.min-1.kg-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1152233,"Bioorg. Med. Chem. Lett., 18, p. 5428 (2008)",18818075,Scientific Literature
1,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL1001219,"Half life in Beagle dog at 1 mg/kg, iv",T1/2,=,1.9,hr,,CHEMBL373,Canis familiaris,Canis lupus familiaris,,CHEMBL1152233,"Bioorg. Med. Chem. Lett., 18, p. 5428 (2008)",18818075,Scientific Literature
1,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL1001211,"Half life in Lewis rat at 5 mg/kg, iv",T1/2,=,1.2,hr,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1152233,"Bioorg. Med. Chem. Lett., 18, p. 5428 (2008)",18818075,Scientific Literature
1,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL1001227,Inhibition of AKT3,IC50,>,10000,nM,,CHEMBL4816,Serine/threonine-protein kinase AKT3,Homo sapiens,Q9Y243,CHEMBL1152233,"Bioorg. Med. Chem. Lett., 18, p. 5428 (2008)",18818075,Scientific Literature
1,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL1001229,Inhibition of C-FMS,IC50,>,10000,nM,,CHEMBL1844,Macrophage colony stimulating factor  receptor ,Homo sapiens,P07333,CHEMBL1152233,"Bioorg. Med. Chem. Lett., 18, p. 5428 (2008)",18818075,Scientific Literature
1,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL1001228,Inhibition of CDK2/CyclinA,IC50,>,10000,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1152233,"Bioorg. Med. Chem. Lett., 18, p. 5428 (2008)",18818075,Scientific Literature
1,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL1001226,Inhibition of EGFR,IC50,=,6300,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1152233,"Bioorg. Med. Chem. Lett., 18, p. 5428 (2008)",18818075,Scientific Literature
1,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL1001230,Inhibition of ERBB2,IC50,>,10000,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1152233,"Bioorg. Med. Chem. Lett., 18, p. 5428 (2008)",18818075,Scientific Literature
1,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL1001231,Inhibition of ERBB4,IC50,>,10000,nM,,CHEMBL3009,Receptor protein-tyrosine kinase erbB-4,Homo sapiens,Q15303,CHEMBL1152233,"Bioorg. Med. Chem. Lett., 18, p. 5428 (2008)",18818075,Scientific Literature
1,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL1001225,Inhibition of ERK,IC50,=,5800,nM,,CHEMBL612545,,,,CHEMBL1152233,"Bioorg. Med. Chem. Lett., 18, p. 5428 (2008)",18818075,Scientific Literature
1,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL1001222,Inhibition of GSK3-beta,IC50,=,2200,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1152233,"Bioorg. Med. Chem. Lett., 18, p. 5428 (2008)",18818075,Scientific Literature
1,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL998555,Inhibition of GST-fused p38alpha expressed in Escherichia coli,IC50,=,120,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1152233,"Bioorg. Med. Chem. Lett., 18, p. 5428 (2008)",18818075,Scientific Literature
1,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL998553,"Inhibition of LPS-induced TNF production in mouse at 30 mg/kg, po",Inhibition,=,65,%,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1152233,"Bioorg. Med. Chem. Lett., 18, p. 5428 (2008)",18818075,Scientific Literature
1,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL998554,Inhibition of LPS-induced TNF release in human PBMC,IC50,=,300,nM,,CHEMBL613107,PBMC (Peripheral blood mononuclear cells),Homo sapiens,,CHEMBL1152233,"Bioorg. Med. Chem. Lett., 18, p. 5428 (2008)",18818075,Scientific Literature
1,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL1001224,Inhibition of MEK,IC50,=,5800,nM,,CHEMBL612545,,,,CHEMBL1152233,"Bioorg. Med. Chem. Lett., 18, p. 5428 (2008)",18818075,Scientific Literature
1,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL1001232,Inhibition of PDHK4,IC50,>,10000,nM,,CHEMBL4141,Pyruvate dehydrogenase kinase isoform 4,Homo sapiens,Q16654,CHEMBL1152233,"Bioorg. Med. Chem. Lett., 18, p. 5428 (2008)",18818075,Scientific Literature
1,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL1001233,Inhibition of TIE2,IC50,>,10000,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1152233,"Bioorg. Med. Chem. Lett., 18, p. 5428 (2008)",18818075,Scientific Literature
1,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL1001234,Inhibition of VEGFR2,IC50,>,10000,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1152233,"Bioorg. Med. Chem. Lett., 18, p. 5428 (2008)",18818075,Scientific Literature
1,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL1001223,Inhibition of c-Raf,IC50,=,5800,nM,,CHEMBL1906,Serine/threonine-protein kinase RAF,Homo sapiens,P04049,CHEMBL1152233,"Bioorg. Med. Chem. Lett., 18, p. 5428 (2008)",18818075,Scientific Literature
1,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL998557,Metabolic stability in dog liver S9 microsomal fraction assessed as parent compound turnover after 30 mins,Stability,=,81,%,,CHEMBL612558,,,,CHEMBL1152233,"Bioorg. Med. Chem. Lett., 18, p. 5428 (2008)",18818075,Scientific Literature
1,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL998556,Metabolic stability in rat liver S9 microsomal fraction assessed as parent compound turnover after 30 mins,Stability,=,27,%,,CHEMBL612558,,,,CHEMBL1152233,"Bioorg. Med. Chem. Lett., 18, p. 5428 (2008)",18818075,Scientific Literature
1,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL1001218,"Volume of distribution at steady state in Beagle dog at 1 mg/kg, iv",Vdss,=,3.8,L.kg-1,,CHEMBL373,Canis familiaris,Canis lupus familiaris,,CHEMBL1152233,"Bioorg. Med. Chem. Lett., 18, p. 5428 (2008)",18818075,Scientific Literature
1,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL485745,InChI=1S/C18H12FN3/c19-15-6-4-14(5-7-15)18-17(13-8-10-20-11-9-13)16-3-1-2-12-22(16)21-18/h1-12H,Fc1ccc(cc1)c2nn3ccccc3c2c4ccncc4,CHEMBL1001209,"Volume of distribution at steady state in Lewis rat at 5 mg/kg, iv",Vdss,=,3.2,L.kg-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1152233,"Bioorg. Med. Chem. Lett., 18, p. 5428 (2008)",18818075,Scientific Literature
SB-220025,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL939460,Inhibition of recombinant ERK2,IC50,=,19000,nM,,CHEMBL4040,MAP kinase ERK2,Homo sapiens,P28482,CHEMBL1152247,"Bioorg. Med. Chem. Lett., 18, p. 5372 (2008)",18835158,Scientific Literature
15e,CHEMBL520037,"InChI=1S/C22H20F3N5O3/c1-12-16-11-26-21(28-15-9-17(31-2)19(33-4)18(10-15)32-3)29-30(16)20(27-12)13-6-5-7-14(8-13)22(23,24)25/h5-11H,1-4H3,(H,28,29)",COc1cc(Nc2ncc3c(C)nc(c4cccc(c4)C(F)(F)F)n3n2)cc(OC)c1OC,CHEMBL520037,"InChI=1S/C22H20F3N5O3/c1-12-16-11-26-21(28-15-9-17(31-2)19(33-4)18(10-15)32-3)29-30(16)20(27-12)13-6-5-7-14(8-13)22(23,24)25/h5-11H,1-4H3,(H,28,29)",COc1cc(Nc2ncc3c(C)nc(c4cccc(c4)C(F)(F)F)n3n2)cc(OC)c1OC,CHEMBL942202,AUC in po dosed mouse,AUC,=,264,ng hr ml-1,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1152258,"Bioorg. Med. Chem. Lett., 18, p. 6214 (2008)",18929484,Scientific Literature
15e,CHEMBL520037,"InChI=1S/C22H20F3N5O3/c1-12-16-11-26-21(28-15-9-17(31-2)19(33-4)18(10-15)32-3)29-30(16)20(27-12)13-6-5-7-14(8-13)22(23,24)25/h5-11H,1-4H3,(H,28,29)",COc1cc(Nc2ncc3c(C)nc(c4cccc(c4)C(F)(F)F)n3n2)cc(OC)c1OC,CHEMBL520037,"InChI=1S/C22H20F3N5O3/c1-12-16-11-26-21(28-15-9-17(31-2)19(33-4)18(10-15)32-3)29-30(16)20(27-12)13-6-5-7-14(8-13)22(23,24)25/h5-11H,1-4H3,(H,28,29)",COc1cc(Nc2ncc3c(C)nc(c4cccc(c4)C(F)(F)F)n3n2)cc(OC)c1OC,CHEMBL942195,Antiproliferative activity against human H460 cells after 72 hrs,IC50,=,5400,nM,,CHEMBL612545,,,,CHEMBL1152258,"Bioorg. Med. Chem. Lett., 18, p. 6214 (2008)",18929484,Scientific Literature
15e,CHEMBL520037,"InChI=1S/C22H20F3N5O3/c1-12-16-11-26-21(28-15-9-17(31-2)19(33-4)18(10-15)32-3)29-30(16)20(27-12)13-6-5-7-14(8-13)22(23,24)25/h5-11H,1-4H3,(H,28,29)",COc1cc(Nc2ncc3c(C)nc(c4cccc(c4)C(F)(F)F)n3n2)cc(OC)c1OC,CHEMBL520037,"InChI=1S/C22H20F3N5O3/c1-12-16-11-26-21(28-15-9-17(31-2)19(33-4)18(10-15)32-3)29-30(16)20(27-12)13-6-5-7-14(8-13)22(23,24)25/h5-11H,1-4H3,(H,28,29)",COc1cc(Nc2ncc3c(C)nc(c4cccc(c4)C(F)(F)F)n3n2)cc(OC)c1OC,CHEMBL942194,Antiproliferative activity against human HCT116 cells after 72 hrs,IC50,=,3900,nM,,CHEMBL394,HCT-116 (Colon carcinoma cells),Homo sapiens,,CHEMBL1152258,"Bioorg. Med. Chem. Lett., 18, p. 6214 (2008)",18929484,Scientific Literature
15e,CHEMBL520037,"InChI=1S/C22H20F3N5O3/c1-12-16-11-26-21(28-15-9-17(31-2)19(33-4)18(10-15)32-3)29-30(16)20(27-12)13-6-5-7-14(8-13)22(23,24)25/h5-11H,1-4H3,(H,28,29)",COc1cc(Nc2ncc3c(C)nc(c4cccc(c4)C(F)(F)F)n3n2)cc(OC)c1OC,CHEMBL520037,"InChI=1S/C22H20F3N5O3/c1-12-16-11-26-21(28-15-9-17(31-2)19(33-4)18(10-15)32-3)29-30(16)20(27-12)13-6-5-7-14(8-13)22(23,24)25/h5-11H,1-4H3,(H,28,29)",COc1cc(Nc2ncc3c(C)nc(c4cccc(c4)C(F)(F)F)n3n2)cc(OC)c1OC,CHEMBL942196,Antiproliferative activity against human MCF7 cells after 72 hrs,IC50,=,4800,nM,,CHEMBL387,MCF7 (Breast carcinoma cells),Homo sapiens,,CHEMBL1152258,"Bioorg. Med. Chem. Lett., 18, p. 6214 (2008)",18929484,Scientific Literature
15e,CHEMBL520037,"InChI=1S/C22H20F3N5O3/c1-12-16-11-26-21(28-15-9-17(31-2)19(33-4)18(10-15)32-3)29-30(16)20(27-12)13-6-5-7-14(8-13)22(23,24)25/h5-11H,1-4H3,(H,28,29)",COc1cc(Nc2ncc3c(C)nc(c4cccc(c4)C(F)(F)F)n3n2)cc(OC)c1OC,CHEMBL520037,"InChI=1S/C22H20F3N5O3/c1-12-16-11-26-21(28-15-9-17(31-2)19(33-4)18(10-15)32-3)29-30(16)20(27-12)13-6-5-7-14(8-13)22(23,24)25/h5-11H,1-4H3,(H,28,29)",COc1cc(Nc2ncc3c(C)nc(c4cccc(c4)C(F)(F)F)n3n2)cc(OC)c1OC,CHEMBL942197,Antiproliferative activity against human PC3 cells after 72 hrs,IC50,=,7800,nM,,CHEMBL390,PC-3 (Prostate carcinoma cells),Homo sapiens,,CHEMBL1152258,"Bioorg. Med. Chem. Lett., 18, p. 6214 (2008)",18929484,Scientific Literature
15e,CHEMBL520037,"InChI=1S/C22H20F3N5O3/c1-12-16-11-26-21(28-15-9-17(31-2)19(33-4)18(10-15)32-3)29-30(16)20(27-12)13-6-5-7-14(8-13)22(23,24)25/h5-11H,1-4H3,(H,28,29)",COc1cc(Nc2ncc3c(C)nc(c4cccc(c4)C(F)(F)F)n3n2)cc(OC)c1OC,CHEMBL520037,"InChI=1S/C22H20F3N5O3/c1-12-16-11-26-21(28-15-9-17(31-2)19(33-4)18(10-15)32-3)29-30(16)20(27-12)13-6-5-7-14(8-13)22(23,24)25/h5-11H,1-4H3,(H,28,29)",COc1cc(Nc2ncc3c(C)nc(c4cccc(c4)C(F)(F)F)n3n2)cc(OC)c1OC,CHEMBL942193,Antiproliferative activity against human RKO cells after 72 hrs,IC50,=,3200,nM,,CHEMBL614879,RKO (Colon carcinoma),Homo sapiens,,CHEMBL1152258,"Bioorg. Med. Chem. Lett., 18, p. 6214 (2008)",18929484,Scientific Literature
15e,CHEMBL520037,"InChI=1S/C22H20F3N5O3/c1-12-16-11-26-21(28-15-9-17(31-2)19(33-4)18(10-15)32-3)29-30(16)20(27-12)13-6-5-7-14(8-13)22(23,24)25/h5-11H,1-4H3,(H,28,29)",COc1cc(Nc2ncc3c(C)nc(c4cccc(c4)C(F)(F)F)n3n2)cc(OC)c1OC,CHEMBL520037,"InChI=1S/C22H20F3N5O3/c1-12-16-11-26-21(28-15-9-17(31-2)19(33-4)18(10-15)32-3)29-30(16)20(27-12)13-6-5-7-14(8-13)22(23,24)25/h5-11H,1-4H3,(H,28,29)",COc1cc(Nc2ncc3c(C)nc(c4cccc(c4)C(F)(F)F)n3n2)cc(OC)c1OC,CHEMBL942199,"Clearance in mouse at 2.9 mg/kg, iv",CL,=,81,mL.min-1.kg-1,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1152258,"Bioorg. Med. Chem. Lett., 18, p. 6214 (2008)",18929484,Scientific Literature
10b,CHEMBL486124,"InChI=1S/C19H24N6O/c1-15-17-14-21-19(20-8-5-9-24-10-12-26-13-11-24)23-25(17)18(22-15)16-6-3-2-4-7-16/h2-4,6-7,14H,5,8-13H2,1H3,(H,20,23)",Cc1nc(c2ccccc2)n3nc(NCCCN4CCOCC4)ncc13,CHEMBL486124,"InChI=1S/C19H24N6O/c1-15-17-14-21-19(20-8-5-9-24-10-12-26-13-11-24)23-25(17)18(22-15)16-6-3-2-4-7-16/h2-4,6-7,14H,5,8-13H2,1H3,(H,20,23)",Cc1nc(c2ccccc2)n3nc(NCCCN4CCOCC4)ncc13,CHEMBL942191,Inhibition of PLK1 expressed in baculovirus infected Trichoplusia ni cells,IC50,>,10000,nM,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1152258,"Bioorg. Med. Chem. Lett., 18, p. 6214 (2008)",18929484,Scientific Literature
15e,CHEMBL520037,"InChI=1S/C22H20F3N5O3/c1-12-16-11-26-21(28-15-9-17(31-2)19(33-4)18(10-15)32-3)29-30(16)20(27-12)13-6-5-7-14(8-13)22(23,24)25/h5-11H,1-4H3,(H,28,29)",COc1cc(Nc2ncc3c(C)nc(c4cccc(c4)C(F)(F)F)n3n2)cc(OC)c1OC,CHEMBL520037,"InChI=1S/C22H20F3N5O3/c1-12-16-11-26-21(28-15-9-17(31-2)19(33-4)18(10-15)32-3)29-30(16)20(27-12)13-6-5-7-14(8-13)22(23,24)25/h5-11H,1-4H3,(H,28,29)",COc1cc(Nc2ncc3c(C)nc(c4cccc(c4)C(F)(F)F)n3n2)cc(OC)c1OC,CHEMBL942191,Inhibition of PLK1 expressed in baculovirus infected Trichoplusia ni cells,IC50,=,30,nM,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1152258,"Bioorg. Med. Chem. Lett., 18, p. 6214 (2008)",18929484,Scientific Literature
15h,CHEMBL519881,"InChI=1S/C27H25N5O4/c1-17-22-16-28-27(30-19-14-23(33-2)25(35-4)24(15-19)34-3)31-32(22)26(29-17)18-9-8-12-21(13-18)36-20-10-6-5-7-11-20/h5-16H,1-4H3,(H,30,31)",COc1cc(Nc2ncc3c(C)nc(c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC,CHEMBL519881,"InChI=1S/C27H25N5O4/c1-17-22-16-28-27(30-19-14-23(33-2)25(35-4)24(15-19)34-3)31-32(22)26(29-17)18-9-8-12-21(13-18)36-20-10-6-5-7-11-20/h5-16H,1-4H3,(H,30,31)",COc1cc(Nc2ncc3c(C)nc(c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC,CHEMBL942191,Inhibition of PLK1 expressed in baculovirus infected Trichoplusia ni cells,IC50,=,500,nM,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1152258,"Bioorg. Med. Chem. Lett., 18, p. 6214 (2008)",18929484,Scientific Literature
15e,CHEMBL520037,"InChI=1S/C22H20F3N5O3/c1-12-16-11-26-21(28-15-9-17(31-2)19(33-4)18(10-15)32-3)29-30(16)20(27-12)13-6-5-7-14(8-13)22(23,24)25/h5-11H,1-4H3,(H,28,29)",COc1cc(Nc2ncc3c(C)nc(c4cccc(c4)C(F)(F)F)n3n2)cc(OC)c1OC,CHEMBL520037,"InChI=1S/C22H20F3N5O3/c1-12-16-11-26-21(28-15-9-17(31-2)19(33-4)18(10-15)32-3)29-30(16)20(27-12)13-6-5-7-14(8-13)22(23,24)25/h5-11H,1-4H3,(H,28,29)",COc1cc(Nc2ncc3c(C)nc(c4cccc(c4)C(F)(F)F)n3n2)cc(OC)c1OC,CHEMBL942192,Inhibition of PLK3 expressed in baculovirus infected Trichoplusia ni cells,IC50,=,30,nM,,CHEMBL4897,Serine/threonine-protein kinase PLK3,Homo sapiens,Q9H4B4,CHEMBL1152258,"Bioorg. Med. Chem. Lett., 18, p. 6214 (2008)",18929484,Scientific Literature
15e,CHEMBL520037,"InChI=1S/C22H20F3N5O3/c1-12-16-11-26-21(28-15-9-17(31-2)19(33-4)18(10-15)32-3)29-30(16)20(27-12)13-6-5-7-14(8-13)22(23,24)25/h5-11H,1-4H3,(H,28,29)",COc1cc(Nc2ncc3c(C)nc(c4cccc(c4)C(F)(F)F)n3n2)cc(OC)c1OC,CHEMBL520037,"InChI=1S/C22H20F3N5O3/c1-12-16-11-26-21(28-15-9-17(31-2)19(33-4)18(10-15)32-3)29-30(16)20(27-12)13-6-5-7-14(8-13)22(23,24)25/h5-11H,1-4H3,(H,28,29)",COc1cc(Nc2ncc3c(C)nc(c4cccc(c4)C(F)(F)F)n3n2)cc(OC)c1OC,CHEMBL942203,Oral bioavailability in mouse,F,=,18,%,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1152258,"Bioorg. Med. Chem. Lett., 18, p. 6214 (2008)",18929484,Scientific Literature
15e,CHEMBL520037,"InChI=1S/C22H20F3N5O3/c1-12-16-11-26-21(28-15-9-17(31-2)19(33-4)18(10-15)32-3)29-30(16)20(27-12)13-6-5-7-14(8-13)22(23,24)25/h5-11H,1-4H3,(H,28,29)",COc1cc(Nc2ncc3c(C)nc(c4cccc(c4)C(F)(F)F)n3n2)cc(OC)c1OC,CHEMBL520037,"InChI=1S/C22H20F3N5O3/c1-12-16-11-26-21(28-15-9-17(31-2)19(33-4)18(10-15)32-3)29-30(16)20(27-12)13-6-5-7-14(8-13)22(23,24)25/h5-11H,1-4H3,(H,28,29)",COc1cc(Nc2ncc3c(C)nc(c4cccc(c4)C(F)(F)F)n3n2)cc(OC)c1OC,CHEMBL942201,"Volume of distribution at steady state in mouse at 2.9 mg/kg, iv",Vdss,=,2.3,L.kg-1,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1152258,"Bioorg. Med. Chem. Lett., 18, p. 6214 (2008)",18929484,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1070008,Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting,Ki,=,17,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1153122,"Bioorg. Med. Chem. Lett., 20, p. 326 (2010)",19914068,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1070009,Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay,IC50,=,250,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1153122,"Bioorg. Med. Chem. Lett., 20, p. 326 (2010)",19914068,Scientific Literature
15a,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL964939,Antiproliferative activity against human BT474 cells overexpressing ErbB2 after 3 days,IC50,=,90,nM,,CHEMBL612545,,,,CHEMBL1153281,"Bioorg. Med. Chem. Lett., 19, p. 1332 (2009)",19208477,Scientific Literature
15j,CHEMBL455434,"InChI=1S/C30H29N5O3S/c36-30(35-12-14-37-15-13-35)38-25-17-24(31-19-25)10-11-26-18-27-28(39-26)29(33-20-32-27)34-23-8-6-22(7-9-23)16-21-4-2-1-3-5-21/h1-9,18,20,24-25,31H,12-17,19H2,(H,32,33,34)/t24-,25-/m1/s1",O=C(O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)N6CCOCC6,CHEMBL455434,"InChI=1S/C30H29N5O3S/c36-30(35-12-14-37-15-13-35)38-25-17-24(31-19-25)10-11-26-18-27-28(39-26)29(33-20-32-27)34-23-8-6-22(7-9-23)16-21-4-2-1-3-5-21/h1-9,18,20,24-25,31H,12-17,19H2,(H,32,33,34)/t24-,25-/m1/s1",O=C(O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)N6CCOCC6,CHEMBL964939,Antiproliferative activity against human BT474 cells overexpressing ErbB2 after 3 days,IC50,=,70,nM,,CHEMBL612545,,,,CHEMBL1153281,"Bioorg. Med. Chem. Lett., 19, p. 1332 (2009)",19208477,Scientific Literature
15m,CHEMBL507821,"InChI=1S/C31H29N7O3S/c39-31(37-10-12-40-13-11-37)41-25-15-23(32-18-25)6-8-26-16-27-29(42-26)30(34-20-33-27)36-24-7-9-28-22(14-24)17-35-38(28)19-21-4-2-1-3-5-21/h1-5,7,9,14,16-17,20,23,25,32H,10-13,15,18-19H2,(H,33,34,36)/t23-,25-/m1/s1",O=C(O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc6ccccc6)c4)c3s2)N7CCOCC7,CHEMBL507821,"InChI=1S/C31H29N7O3S/c39-31(37-10-12-40-13-11-37)41-25-15-23(32-18-25)6-8-26-16-27-29(42-26)30(34-20-33-27)36-24-7-9-28-22(14-24)17-35-38(28)19-21-4-2-1-3-5-21/h1-5,7,9,14,16-17,20,23,25,32H,10-13,15,18-19H2,(H,33,34,36)/t23-,25-/m1/s1",O=C(O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc6ccccc6)c4)c3s2)N7CCOCC7,CHEMBL964939,Antiproliferative activity against human BT474 cells overexpressing ErbB2 after 3 days,IC50,=,20,nM,,CHEMBL612545,,,,CHEMBL1153281,"Bioorg. Med. Chem. Lett., 19, p. 1332 (2009)",19208477,Scientific Literature
15a,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL964938,Antiproliferative activity against human HN5 cells overexpressing EGFR after 3 days,IC50,=,260,nM,,CHEMBL614828,HN5 (Squamous cell carcinoma),Homo sapiens,,CHEMBL1153281,"Bioorg. Med. Chem. Lett., 19, p. 1332 (2009)",19208477,Scientific Literature
15j,CHEMBL455434,"InChI=1S/C30H29N5O3S/c36-30(35-12-14-37-15-13-35)38-25-17-24(31-19-25)10-11-26-18-27-28(39-26)29(33-20-32-27)34-23-8-6-22(7-9-23)16-21-4-2-1-3-5-21/h1-9,18,20,24-25,31H,12-17,19H2,(H,32,33,34)/t24-,25-/m1/s1",O=C(O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)N6CCOCC6,CHEMBL455434,"InChI=1S/C30H29N5O3S/c36-30(35-12-14-37-15-13-35)38-25-17-24(31-19-25)10-11-26-18-27-28(39-26)29(33-20-32-27)34-23-8-6-22(7-9-23)16-21-4-2-1-3-5-21/h1-9,18,20,24-25,31H,12-17,19H2,(H,32,33,34)/t24-,25-/m1/s1",O=C(O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)N6CCOCC6,CHEMBL964938,Antiproliferative activity against human HN5 cells overexpressing EGFR after 3 days,IC50,=,270,nM,,CHEMBL614828,HN5 (Squamous cell carcinoma),Homo sapiens,,CHEMBL1153281,"Bioorg. Med. Chem. Lett., 19, p. 1332 (2009)",19208477,Scientific Literature
15m,CHEMBL507821,"InChI=1S/C31H29N7O3S/c39-31(37-10-12-40-13-11-37)41-25-15-23(32-18-25)6-8-26-16-27-29(42-26)30(34-20-33-27)36-24-7-9-28-22(14-24)17-35-38(28)19-21-4-2-1-3-5-21/h1-5,7,9,14,16-17,20,23,25,32H,10-13,15,18-19H2,(H,33,34,36)/t23-,25-/m1/s1",O=C(O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc6ccccc6)c4)c3s2)N7CCOCC7,CHEMBL507821,"InChI=1S/C31H29N7O3S/c39-31(37-10-12-40-13-11-37)41-25-15-23(32-18-25)6-8-26-16-27-29(42-26)30(34-20-33-27)36-24-7-9-28-22(14-24)17-35-38(28)19-21-4-2-1-3-5-21/h1-5,7,9,14,16-17,20,23,25,32H,10-13,15,18-19H2,(H,33,34,36)/t23-,25-/m1/s1",O=C(O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc6ccccc6)c4)c3s2)N7CCOCC7,CHEMBL964938,Antiproliferative activity against human HN5 cells overexpressing EGFR after 3 days,IC50,=,70,nM,,CHEMBL614828,HN5 (Squamous cell carcinoma),Homo sapiens,,CHEMBL1153281,"Bioorg. Med. Chem. Lett., 19, p. 1332 (2009)",19208477,Scientific Literature
15a,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL964943,Cytotoxicity against HFF,IC50,>,1000,nM,,CHEMBL614071,HFF (Foreskin fibroblasts),Homo sapiens,,CHEMBL1153281,"Bioorg. Med. Chem. Lett., 19, p. 1332 (2009)",19208477,Scientific Literature
15j,CHEMBL455434,"InChI=1S/C30H29N5O3S/c36-30(35-12-14-37-15-13-35)38-25-17-24(31-19-25)10-11-26-18-27-28(39-26)29(33-20-32-27)34-23-8-6-22(7-9-23)16-21-4-2-1-3-5-21/h1-9,18,20,24-25,31H,12-17,19H2,(H,32,33,34)/t24-,25-/m1/s1",O=C(O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)N6CCOCC6,CHEMBL455434,"InChI=1S/C30H29N5O3S/c36-30(35-12-14-37-15-13-35)38-25-17-24(31-19-25)10-11-26-18-27-28(39-26)29(33-20-32-27)34-23-8-6-22(7-9-23)16-21-4-2-1-3-5-21/h1-9,18,20,24-25,31H,12-17,19H2,(H,32,33,34)/t24-,25-/m1/s1",O=C(O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)N6CCOCC6,CHEMBL964943,Cytotoxicity against HFF,IC50,>,1000,nM,,CHEMBL614071,HFF (Foreskin fibroblasts),Homo sapiens,,CHEMBL1153281,"Bioorg. Med. Chem. Lett., 19, p. 1332 (2009)",19208477,Scientific Literature
15m,CHEMBL507821,"InChI=1S/C31H29N7O3S/c39-31(37-10-12-40-13-11-37)41-25-15-23(32-18-25)6-8-26-16-27-29(42-26)30(34-20-33-27)36-24-7-9-28-22(14-24)17-35-38(28)19-21-4-2-1-3-5-21/h1-5,7,9,14,16-17,20,23,25,32H,10-13,15,18-19H2,(H,33,34,36)/t23-,25-/m1/s1",O=C(O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc6ccccc6)c4)c3s2)N7CCOCC7,CHEMBL507821,"InChI=1S/C31H29N7O3S/c39-31(37-10-12-40-13-11-37)41-25-15-23(32-18-25)6-8-26-16-27-29(42-26)30(34-20-33-27)36-24-7-9-28-22(14-24)17-35-38(28)19-21-4-2-1-3-5-21/h1-5,7,9,14,16-17,20,23,25,32H,10-13,15,18-19H2,(H,33,34,36)/t23-,25-/m1/s1",O=C(O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc6ccccc6)c4)c3s2)N7CCOCC7,CHEMBL964943,Cytotoxicity against HFF,IC50,>,1000,nM,,CHEMBL614071,HFF (Foreskin fibroblasts),Homo sapiens,,CHEMBL1153281,"Bioorg. Med. Chem. Lett., 19, p. 1332 (2009)",19208477,Scientific Literature
15a,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL964941,"Dose normalized AUC in mouse at 10 mg/kg, po after 6 hrs",AUC,=,91,ng hr ml-1 mg-1 kg-1,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1153281,"Bioorg. Med. Chem. Lett., 19, p. 1332 (2009)",19208477,Scientific Literature
15j,CHEMBL455434,"InChI=1S/C30H29N5O3S/c36-30(35-12-14-37-15-13-35)38-25-17-24(31-19-25)10-11-26-18-27-28(39-26)29(33-20-32-27)34-23-8-6-22(7-9-23)16-21-4-2-1-3-5-21/h1-9,18,20,24-25,31H,12-17,19H2,(H,32,33,34)/t24-,25-/m1/s1",O=C(O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)N6CCOCC6,CHEMBL455434,"InChI=1S/C30H29N5O3S/c36-30(35-12-14-37-15-13-35)38-25-17-24(31-19-25)10-11-26-18-27-28(39-26)29(33-20-32-27)34-23-8-6-22(7-9-23)16-21-4-2-1-3-5-21/h1-9,18,20,24-25,31H,12-17,19H2,(H,32,33,34)/t24-,25-/m1/s1",O=C(O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)N6CCOCC6,CHEMBL964941,"Dose normalized AUC in mouse at 10 mg/kg, po after 6 hrs",AUC,,,,Not Determined,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1153281,"Bioorg. Med. Chem. Lett., 19, p. 1332 (2009)",19208477,Scientific Literature
15m,CHEMBL507821,"InChI=1S/C31H29N7O3S/c39-31(37-10-12-40-13-11-37)41-25-15-23(32-18-25)6-8-26-16-27-29(42-26)30(34-20-33-27)36-24-7-9-28-22(14-24)17-35-38(28)19-21-4-2-1-3-5-21/h1-5,7,9,14,16-17,20,23,25,32H,10-13,15,18-19H2,(H,33,34,36)/t23-,25-/m1/s1",O=C(O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc6ccccc6)c4)c3s2)N7CCOCC7,CHEMBL507821,"InChI=1S/C31H29N7O3S/c39-31(37-10-12-40-13-11-37)41-25-15-23(32-18-25)6-8-26-16-27-29(42-26)30(34-20-33-27)36-24-7-9-28-22(14-24)17-35-38(28)19-21-4-2-1-3-5-21/h1-5,7,9,14,16-17,20,23,25,32H,10-13,15,18-19H2,(H,33,34,36)/t23-,25-/m1/s1",O=C(O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc6ccccc6)c4)c3s2)N7CCOCC7,CHEMBL964941,"Dose normalized AUC in mouse at 10 mg/kg, po after 6 hrs",AUC,=,98,ng hr ml-1 mg-1 kg-1,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1153281,"Bioorg. Med. Chem. Lett., 19, p. 1332 (2009)",19208477,Scientific Literature
15a,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL964937,Induction of EGFR covalent modification assessed as alkylation after 3 hrs by LC/MS mass spectroscopy,Activity,=,3,%,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1153281,"Bioorg. Med. Chem. Lett., 19, p. 1332 (2009)",19208477,Scientific Literature
15j,CHEMBL455434,"InChI=1S/C30H29N5O3S/c36-30(35-12-14-37-15-13-35)38-25-17-24(31-19-25)10-11-26-18-27-28(39-26)29(33-20-32-27)34-23-8-6-22(7-9-23)16-21-4-2-1-3-5-21/h1-9,18,20,24-25,31H,12-17,19H2,(H,32,33,34)/t24-,25-/m1/s1",O=C(O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)N6CCOCC6,CHEMBL455434,"InChI=1S/C30H29N5O3S/c36-30(35-12-14-37-15-13-35)38-25-17-24(31-19-25)10-11-26-18-27-28(39-26)29(33-20-32-27)34-23-8-6-22(7-9-23)16-21-4-2-1-3-5-21/h1-9,18,20,24-25,31H,12-17,19H2,(H,32,33,34)/t24-,25-/m1/s1",O=C(O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)N6CCOCC6,CHEMBL964937,Induction of EGFR covalent modification assessed as alkylation after 3 hrs by LC/MS mass spectroscopy,Activity,=,14,%,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1153281,"Bioorg. Med. Chem. Lett., 19, p. 1332 (2009)",19208477,Scientific Literature
15m,CHEMBL507821,"InChI=1S/C31H29N7O3S/c39-31(37-10-12-40-13-11-37)41-25-15-23(32-18-25)6-8-26-16-27-29(42-26)30(34-20-33-27)36-24-7-9-28-22(14-24)17-35-38(28)19-21-4-2-1-3-5-21/h1-5,7,9,14,16-17,20,23,25,32H,10-13,15,18-19H2,(H,33,34,36)/t23-,25-/m1/s1",O=C(O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc6ccccc6)c4)c3s2)N7CCOCC7,CHEMBL507821,"InChI=1S/C31H29N7O3S/c39-31(37-10-12-40-13-11-37)41-25-15-23(32-18-25)6-8-26-16-27-29(42-26)30(34-20-33-27)36-24-7-9-28-22(14-24)17-35-38(28)19-21-4-2-1-3-5-21/h1-5,7,9,14,16-17,20,23,25,32H,10-13,15,18-19H2,(H,33,34,36)/t23-,25-/m1/s1",O=C(O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc6ccccc6)c4)c3s2)N7CCOCC7,CHEMBL964937,Induction of EGFR covalent modification assessed as alkylation after 3 hrs by LC/MS mass spectroscopy,Activity,=,4,%,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1153281,"Bioorg. Med. Chem. Lett., 19, p. 1332 (2009)",19208477,Scientific Literature
15a,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL964194,Inhibition of EGFR by HTRF assay,IC50,=,80,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1153281,"Bioorg. Med. Chem. Lett., 19, p. 1332 (2009)",19208477,Scientific Literature
15j,CHEMBL455434,"InChI=1S/C30H29N5O3S/c36-30(35-12-14-37-15-13-35)38-25-17-24(31-19-25)10-11-26-18-27-28(39-26)29(33-20-32-27)34-23-8-6-22(7-9-23)16-21-4-2-1-3-5-21/h1-9,18,20,24-25,31H,12-17,19H2,(H,32,33,34)/t24-,25-/m1/s1",O=C(O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)N6CCOCC6,CHEMBL455434,"InChI=1S/C30H29N5O3S/c36-30(35-12-14-37-15-13-35)38-25-17-24(31-19-25)10-11-26-18-27-28(39-26)29(33-20-32-27)34-23-8-6-22(7-9-23)16-21-4-2-1-3-5-21/h1-9,18,20,24-25,31H,12-17,19H2,(H,32,33,34)/t24-,25-/m1/s1",O=C(O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)N6CCOCC6,CHEMBL964194,Inhibition of EGFR by HTRF assay,IC50,=,240,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1153281,"Bioorg. Med. Chem. Lett., 19, p. 1332 (2009)",19208477,Scientific Literature
15m,CHEMBL507821,"InChI=1S/C31H29N7O3S/c39-31(37-10-12-40-13-11-37)41-25-15-23(32-18-25)6-8-26-16-27-29(42-26)30(34-20-33-27)36-24-7-9-28-22(14-24)17-35-38(28)19-21-4-2-1-3-5-21/h1-5,7,9,14,16-17,20,23,25,32H,10-13,15,18-19H2,(H,33,34,36)/t23-,25-/m1/s1",O=C(O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc6ccccc6)c4)c3s2)N7CCOCC7,CHEMBL507821,"InChI=1S/C31H29N7O3S/c39-31(37-10-12-40-13-11-37)41-25-15-23(32-18-25)6-8-26-16-27-29(42-26)30(34-20-33-27)36-24-7-9-28-22(14-24)17-35-38(28)19-21-4-2-1-3-5-21/h1-5,7,9,14,16-17,20,23,25,32H,10-13,15,18-19H2,(H,33,34,36)/t23-,25-/m1/s1",O=C(O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc6ccccc6)c4)c3s2)N7CCOCC7,CHEMBL964194,Inhibition of EGFR by HTRF assay,IC50,=,80,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1153281,"Bioorg. Med. Chem. Lett., 19, p. 1332 (2009)",19208477,Scientific Literature
15a,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL964196,Inhibition of ErbB2 by HTRF assay,IC50,=,80,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1153281,"Bioorg. Med. Chem. Lett., 19, p. 1332 (2009)",19208477,Scientific Literature
15j,CHEMBL455434,"InChI=1S/C30H29N5O3S/c36-30(35-12-14-37-15-13-35)38-25-17-24(31-19-25)10-11-26-18-27-28(39-26)29(33-20-32-27)34-23-8-6-22(7-9-23)16-21-4-2-1-3-5-21/h1-9,18,20,24-25,31H,12-17,19H2,(H,32,33,34)/t24-,25-/m1/s1",O=C(O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)N6CCOCC6,CHEMBL455434,"InChI=1S/C30H29N5O3S/c36-30(35-12-14-37-15-13-35)38-25-17-24(31-19-25)10-11-26-18-27-28(39-26)29(33-20-32-27)34-23-8-6-22(7-9-23)16-21-4-2-1-3-5-21/h1-9,18,20,24-25,31H,12-17,19H2,(H,32,33,34)/t24-,25-/m1/s1",O=C(O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)N6CCOCC6,CHEMBL964196,Inhibition of ErbB2 by HTRF assay,IC50,=,60,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1153281,"Bioorg. Med. Chem. Lett., 19, p. 1332 (2009)",19208477,Scientific Literature
15m,CHEMBL507821,"InChI=1S/C31H29N7O3S/c39-31(37-10-12-40-13-11-37)41-25-15-23(32-18-25)6-8-26-16-27-29(42-26)30(34-20-33-27)36-24-7-9-28-22(14-24)17-35-38(28)19-21-4-2-1-3-5-21/h1-5,7,9,14,16-17,20,23,25,32H,10-13,15,18-19H2,(H,33,34,36)/t23-,25-/m1/s1",O=C(O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc6ccccc6)c4)c3s2)N7CCOCC7,CHEMBL507821,"InChI=1S/C31H29N7O3S/c39-31(37-10-12-40-13-11-37)41-25-15-23(32-18-25)6-8-26-16-27-29(42-26)30(34-20-33-27)36-24-7-9-28-22(14-24)17-35-38(28)19-21-4-2-1-3-5-21/h1-5,7,9,14,16-17,20,23,25,32H,10-13,15,18-19H2,(H,33,34,36)/t23-,25-/m1/s1",O=C(O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc6ccccc6)c4)c3s2)N7CCOCC7,CHEMBL964196,Inhibition of ErbB2 by HTRF assay,IC50,=,50,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1153281,"Bioorg. Med. Chem. Lett., 19, p. 1332 (2009)",19208477,Scientific Literature
15a,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL964942,Protein binding in rat plasma by HPLC,PPB,=,98,%,,CHEMBL613652,Plasma,Rattus norvegicus,,CHEMBL1153281,"Bioorg. Med. Chem. Lett., 19, p. 1332 (2009)",19208477,Scientific Literature
15j,CHEMBL455434,"InChI=1S/C30H29N5O3S/c36-30(35-12-14-37-15-13-35)38-25-17-24(31-19-25)10-11-26-18-27-28(39-26)29(33-20-32-27)34-23-8-6-22(7-9-23)16-21-4-2-1-3-5-21/h1-9,18,20,24-25,31H,12-17,19H2,(H,32,33,34)/t24-,25-/m1/s1",O=C(O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)N6CCOCC6,CHEMBL455434,"InChI=1S/C30H29N5O3S/c36-30(35-12-14-37-15-13-35)38-25-17-24(31-19-25)10-11-26-18-27-28(39-26)29(33-20-32-27)34-23-8-6-22(7-9-23)16-21-4-2-1-3-5-21/h1-9,18,20,24-25,31H,12-17,19H2,(H,32,33,34)/t24-,25-/m1/s1",O=C(O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)N6CCOCC6,CHEMBL964942,Protein binding in rat plasma by HPLC,PPB,=,96.4,%,,CHEMBL613652,Plasma,Rattus norvegicus,,CHEMBL1153281,"Bioorg. Med. Chem. Lett., 19, p. 1332 (2009)",19208477,Scientific Literature
15m,CHEMBL507821,"InChI=1S/C31H29N7O3S/c39-31(37-10-12-40-13-11-37)41-25-15-23(32-18-25)6-8-26-16-27-29(42-26)30(34-20-33-27)36-24-7-9-28-22(14-24)17-35-38(28)19-21-4-2-1-3-5-21/h1-5,7,9,14,16-17,20,23,25,32H,10-13,15,18-19H2,(H,33,34,36)/t23-,25-/m1/s1",O=C(O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc6ccccc6)c4)c3s2)N7CCOCC7,CHEMBL507821,"InChI=1S/C31H29N7O3S/c39-31(37-10-12-40-13-11-37)41-25-15-23(32-18-25)6-8-26-16-27-29(42-26)30(34-20-33-27)36-24-7-9-28-22(14-24)17-35-38(28)19-21-4-2-1-3-5-21/h1-5,7,9,14,16-17,20,23,25,32H,10-13,15,18-19H2,(H,33,34,36)/t23-,25-/m1/s1",O=C(O[C@H]1CN[C@@H](C1)C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc6ccccc6)c4)c3s2)N7CCOCC7,CHEMBL964942,Protein binding in rat plasma by HPLC,PPB,=,97.3,%,,CHEMBL613652,Plasma,Rattus norvegicus,,CHEMBL1153281,"Bioorg. Med. Chem. Lett., 19, p. 1332 (2009)",19208477,Scientific Literature
15a,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL507329,"InChI=1S/C30H27ClFN5O4S/c31-25-14-22(5-7-27(25)40-17-19-2-1-3-20(32)12-19)36-29-28-26(34-18-35-29)15-24(42-28)6-4-21-13-23(16-33-21)41-30(38)37-8-10-39-11-9-37/h1-3,5,7,12,14-15,18,21,23,33H,8-11,13,16-17H2,(H,34,35,36)/t21-,23-/m1/s1",Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@H](CN5)OC(=O)N6CCOCC6)sc34)cc2Cl)c1,CHEMBL964940,Ratio of IC50 for human HN5 cells to IC50 for hman BT474 cells,Ratio IC50,=,3,,,CHEMBL612545,,,,CHEMBL1153281,"Bioorg. Med. Chem. Lett., 19, p. 1332 (2009)",19208477,Scientific Literature
25,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL960993,Antiproliferative activity against human A549 cells after 72 hrs by luminescence-based cell viability assay,IC50,=,11,nM,,CHEMBL392,A549 (Lung carcinoma cells),Homo sapiens,,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
25,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL960991,Antiproliferative activity against human COLO205 cells after 72 hrs by luminescence-based cell viability assay,IC50,=,5,nM,,CHEMBL614561,COLO 205 (Colon adenocarcinoma cells),Homo sapiens,,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
16,CHEMBL493326,"InChI=1S/C21H18ClN3O3S/c1-12(14-5-3-4-6-15(14)22)28-18-10-19(29-20(18)21(23)26)25-11-24-16-8-7-13(27-2)9-17(16)25/h3-12H,1-2H3,(H2,23,26)/t12-/m1/s1",COc1ccc2ncn(c3cc(O[C@H](C)c4ccccc4Cl)c(s3)C(=O)N)c2c1,CHEMBL493326,"InChI=1S/C21H18ClN3O3S/c1-12(14-5-3-4-6-15(14)22)28-18-10-19(29-20(18)21(23)26)25-11-24-16-8-7-13(27-2)9-17(16)25/h3-12H,1-2H3,(H2,23,26)/t12-/m1/s1",COc1ccc2ncn(c3cc(O[C@H](C)c4ccccc4Cl)c(s3)C(=O)N)c2c1,CHEMBL960988,Antiproliferative activity against human HCT116 cells after 72 hrs by luminescence-based cell viability assay,IC50,=,321,nM,,CHEMBL394,HCT-116 (Colon carcinoma cells),Homo sapiens,,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
17,CHEMBL522709,"InChI=1S/C22H18F3N3O3S/c1-12(14-5-3-4-6-15(14)22(23,24)25)31-18-10-19(32-20(18)21(26)29)28-11-27-16-8-7-13(30-2)9-17(16)28/h3-12H,1-2H3,(H2,26,29)/t12-/m1/s1",COc1ccc2ncn(c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(s3)C(=O)N)c2c1,CHEMBL522709,"InChI=1S/C22H18F3N3O3S/c1-12(14-5-3-4-6-15(14)22(23,24)25)31-18-10-19(32-20(18)21(26)29)28-11-27-16-8-7-13(30-2)9-17(16)28/h3-12H,1-2H3,(H2,26,29)/t12-/m1/s1",COc1ccc2ncn(c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(s3)C(=O)N)c2c1,CHEMBL960988,Antiproliferative activity against human HCT116 cells after 72 hrs by luminescence-based cell viability assay,IC50,=,476,nM,,CHEMBL394,HCT-116 (Colon carcinoma cells),Homo sapiens,,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
18,CHEMBL1794067,"InChI=1S/C23H22ClN3O5S/c1-13(16-4-2-3-5-17(16)24)32-20-9-21(33-22(20)23(25)30)27-12-26-18-7-6-15(8-19(18)27)31-11-14(29)10-28/h2-9,12-14,28-29H,10-11H2,1H3,(H2,25,30)/t13-,14+/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC[C@@H](O)CO)cc23)c4ccccc4Cl,CHEMBL1794067,"InChI=1S/C23H22ClN3O5S/c1-13(16-4-2-3-5-17(16)24)32-20-9-21(33-22(20)23(25)30)27-12-26-18-7-6-15(8-19(18)27)31-11-14(29)10-28/h2-9,12-14,28-29H,10-11H2,1H3,(H2,25,30)/t13-,14+/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC[C@@H](O)CO)cc23)c4ccccc4Cl,CHEMBL960988,Antiproliferative activity against human HCT116 cells after 72 hrs by luminescence-based cell viability assay,IC50,=,73,nM,,CHEMBL394,HCT-116 (Colon carcinoma cells),Homo sapiens,,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
2,CHEMBL514162,"InChI=1S/C21H18ClN3O4S/c1-27-16-7-14-15(8-17(16)28-2)25(11-24-14)19-9-18(20(30-19)21(23)26)29-10-12-5-3-4-6-13(12)22/h3-9,11H,10H2,1-2H3,(H2,23,26)",COc1cc2ncn(c3cc(OCc4ccccc4Cl)c(s3)C(=O)N)c2cc1OC,CHEMBL514162,"InChI=1S/C21H18ClN3O4S/c1-27-16-7-14-15(8-17(16)28-2)25(11-24-14)19-9-18(20(30-19)21(23)26)29-10-12-5-3-4-6-13(12)22/h3-9,11H,10H2,1-2H3,(H2,23,26)",COc1cc2ncn(c3cc(OCc4ccccc4Cl)c(s3)C(=O)N)c2cc1OC,CHEMBL960988,Antiproliferative activity against human HCT116 cells after 72 hrs by luminescence-based cell viability assay,IC50,=,1140,nM,,CHEMBL394,HCT-116 (Colon carcinoma cells),Homo sapiens,,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
21,CHEMBL1794068,"InChI=1S/C28H29F3N4O3S/c1-17(20-5-3-4-6-21(20)28(29,30)31)38-24-14-25(39-26(24)27(32)36)35-16-33-22-8-7-19(13-23(22)35)37-15-18-9-11-34(2)12-10-18/h3-8,13-14,16-18H,9-12,15H2,1-2H3,(H2,32,36)/t17-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OCC4CCN(C)CC4)cc23)c5ccccc5C(F)(F)F,CHEMBL1794068,"InChI=1S/C28H29F3N4O3S/c1-17(20-5-3-4-6-21(20)28(29,30)31)38-24-14-25(39-26(24)27(32)36)35-16-33-22-8-7-19(13-23(22)35)37-15-18-9-11-34(2)12-10-18/h3-8,13-14,16-18H,9-12,15H2,1-2H3,(H2,32,36)/t17-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OCC4CCN(C)CC4)cc23)c5ccccc5C(F)(F)F,CHEMBL960988,Antiproliferative activity against human HCT116 cells after 72 hrs by luminescence-based cell viability assay,IC50,=,30,nM,,CHEMBL394,HCT-116 (Colon carcinoma cells),Homo sapiens,,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
22,CHEMBL1794069,"InChI=1S/C27H29ClN4O3S/c1-17(20-5-3-4-6-21(20)28)35-24-14-25(36-26(24)27(29)33)32-16-30-22-8-7-19(13-23(22)32)34-15-18-9-11-31(2)12-10-18/h3-8,13-14,16-18H,9-12,15H2,1-2H3,(H2,29,33)/t17-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OCC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL1794069,"InChI=1S/C27H29ClN4O3S/c1-17(20-5-3-4-6-21(20)28)35-24-14-25(36-26(24)27(29)33)32-16-30-22-8-7-19(13-23(22)32)34-15-18-9-11-31(2)12-10-18/h3-8,13-14,16-18H,9-12,15H2,1-2H3,(H2,29,33)/t17-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OCC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL960988,Antiproliferative activity against human HCT116 cells after 72 hrs by luminescence-based cell viability assay,IC50,=,34,nM,,CHEMBL394,HCT-116 (Colon carcinoma cells),Homo sapiens,,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
25,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL960988,Antiproliferative activity against human HCT116 cells after 72 hrs by luminescence-based cell viability assay,IC50,=,11,nM,,CHEMBL394,HCT-116 (Colon carcinoma cells),Homo sapiens,,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
3,CHEMBL222419,"InChI=1S/C22H20ClN3O4S/c1-12(13-6-4-5-7-14(13)23)30-19-10-20(31-21(19)22(24)27)26-11-25-15-8-17(28-2)18(29-3)9-16(15)26/h4-12H,1-3H3,(H2,24,27)/t12-/m1/s1",COc1cc2ncn(c3cc(O[C@H](C)c4ccccc4Cl)c(s3)C(=O)N)c2cc1OC,CHEMBL222419,"InChI=1S/C22H20ClN3O4S/c1-12(13-6-4-5-7-14(13)23)30-19-10-20(31-21(19)22(24)27)26-11-25-15-8-17(28-2)18(29-3)9-16(15)26/h4-12H,1-3H3,(H2,24,27)/t12-/m1/s1",COc1cc2ncn(c3cc(O[C@H](C)c4ccccc4Cl)c(s3)C(=O)N)c2cc1OC,CHEMBL960988,Antiproliferative activity against human HCT116 cells after 72 hrs by luminescence-based cell viability assay,IC50,=,25,nM,,CHEMBL394,HCT-116 (Colon carcinoma cells),Homo sapiens,,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
4,CHEMBL521806,"InChI=1S/C22H20ClN3O4S/c1-12(13-6-4-5-7-14(13)23)30-19-10-20(31-21(19)22(24)27)26-11-25-15-8-17(28-2)18(29-3)9-16(15)26/h4-12H,1-3H3,(H2,24,27)/t12-/m0/s1",COc1cc2ncn(c3cc(O[C@@H](C)c4ccccc4Cl)c(s3)C(=O)N)c2cc1OC,CHEMBL521806,"InChI=1S/C22H20ClN3O4S/c1-12(13-6-4-5-7-14(13)23)30-19-10-20(31-21(19)22(24)27)26-11-25-15-8-17(28-2)18(29-3)9-16(15)26/h4-12H,1-3H3,(H2,24,27)/t12-/m0/s1",COc1cc2ncn(c3cc(O[C@@H](C)c4ccccc4Cl)c(s3)C(=O)N)c2cc1OC,CHEMBL960988,Antiproliferative activity against human HCT116 cells after 72 hrs by luminescence-based cell viability assay,IC50,=,994,nM,,CHEMBL394,HCT-116 (Colon carcinoma cells),Homo sapiens,,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
25,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL960992,Antiproliferative activity against human HT-29 cells after 72 hrs by luminescence-based cell viability assay,IC50,=,3,nM,,CHEMBL384,HT-29 (Colon adenocarcinoma cells),Homo sapiens,,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
25,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL960864,Antiproliferative activity against human MX1 cells after 72 hrs by luminescence-based cell viability assay,IC50,=,9,nM,,CHEMBL613704,MX1 (Breast carcinoma cells),Homo sapiens,,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
25,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL960865,Antiproliferative activity against human SKOV3 cells after 72 hrs by luminescence-based cell viability assay,IC50,=,11,nM,,CHEMBL614925,SK-OV-3 (Ovarian carcinoma cells),Homo sapiens,,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
1,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL960987,Inhibition of full length human PLK3 expressed in baculovirus-infected Trichoplusia ni cells by scintillation proximity assay,IC50,=,9,nM,,CHEMBL4897,Serine/threonine-protein kinase PLK3,Homo sapiens,Q9H4B4,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
16,CHEMBL493326,"InChI=1S/C21H18ClN3O3S/c1-12(14-5-3-4-6-15(14)22)28-18-10-19(29-20(18)21(23)26)25-11-24-16-8-7-13(27-2)9-17(16)25/h3-12H,1-2H3,(H2,23,26)/t12-/m1/s1",COc1ccc2ncn(c3cc(O[C@H](C)c4ccccc4Cl)c(s3)C(=O)N)c2c1,CHEMBL493326,"InChI=1S/C21H18ClN3O3S/c1-12(14-5-3-4-6-15(14)22)28-18-10-19(29-20(18)21(23)26)25-11-24-16-8-7-13(27-2)9-17(16)25/h3-12H,1-2H3,(H2,23,26)/t12-/m1/s1",COc1ccc2ncn(c3cc(O[C@H](C)c4ccccc4Cl)c(s3)C(=O)N)c2c1,CHEMBL960987,Inhibition of full length human PLK3 expressed in baculovirus-infected Trichoplusia ni cells by scintillation proximity assay,IC50,=,35,nM,,CHEMBL4897,Serine/threonine-protein kinase PLK3,Homo sapiens,Q9H4B4,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
17,CHEMBL522709,"InChI=1S/C22H18F3N3O3S/c1-12(14-5-3-4-6-15(14)22(23,24)25)31-18-10-19(32-20(18)21(26)29)28-11-27-16-8-7-13(30-2)9-17(16)28/h3-12H,1-2H3,(H2,26,29)/t12-/m1/s1",COc1ccc2ncn(c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(s3)C(=O)N)c2c1,CHEMBL522709,"InChI=1S/C22H18F3N3O3S/c1-12(14-5-3-4-6-15(14)22(23,24)25)31-18-10-19(32-20(18)21(26)29)28-11-27-16-8-7-13(30-2)9-17(16)28/h3-12H,1-2H3,(H2,26,29)/t12-/m1/s1",COc1ccc2ncn(c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(s3)C(=O)N)c2c1,CHEMBL960987,Inhibition of full length human PLK3 expressed in baculovirus-infected Trichoplusia ni cells by scintillation proximity assay,IC50,=,41,nM,,CHEMBL4897,Serine/threonine-protein kinase PLK3,Homo sapiens,Q9H4B4,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
18,CHEMBL1794067,"InChI=1S/C23H22ClN3O5S/c1-13(16-4-2-3-5-17(16)24)32-20-9-21(33-22(20)23(25)30)27-12-26-18-7-6-15(8-19(18)27)31-11-14(29)10-28/h2-9,12-14,28-29H,10-11H2,1H3,(H2,25,30)/t13-,14+/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC[C@@H](O)CO)cc23)c4ccccc4Cl,CHEMBL1794067,"InChI=1S/C23H22ClN3O5S/c1-13(16-4-2-3-5-17(16)24)32-20-9-21(33-22(20)23(25)30)27-12-26-18-7-6-15(8-19(18)27)31-11-14(29)10-28/h2-9,12-14,28-29H,10-11H2,1H3,(H2,25,30)/t13-,14+/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC[C@@H](O)CO)cc23)c4ccccc4Cl,CHEMBL960987,Inhibition of full length human PLK3 expressed in baculovirus-infected Trichoplusia ni cells by scintillation proximity assay,IC50,=,61,nM,,CHEMBL4897,Serine/threonine-protein kinase PLK3,Homo sapiens,Q9H4B4,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
2,CHEMBL514162,"InChI=1S/C21H18ClN3O4S/c1-27-16-7-14-15(8-17(16)28-2)25(11-24-14)19-9-18(20(30-19)21(23)26)29-10-12-5-3-4-6-13(12)22/h3-9,11H,10H2,1-2H3,(H2,23,26)",COc1cc2ncn(c3cc(OCc4ccccc4Cl)c(s3)C(=O)N)c2cc1OC,CHEMBL514162,"InChI=1S/C21H18ClN3O4S/c1-27-16-7-14-15(8-17(16)28-2)25(11-24-14)19-9-18(20(30-19)21(23)26)29-10-12-5-3-4-6-13(12)22/h3-9,11H,10H2,1-2H3,(H2,23,26)",COc1cc2ncn(c3cc(OCc4ccccc4Cl)c(s3)C(=O)N)c2cc1OC,CHEMBL960987,Inhibition of full length human PLK3 expressed in baculovirus-infected Trichoplusia ni cells by scintillation proximity assay,IC50,=,9,nM,,CHEMBL4897,Serine/threonine-protein kinase PLK3,Homo sapiens,Q9H4B4,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
21,CHEMBL1794068,"InChI=1S/C28H29F3N4O3S/c1-17(20-5-3-4-6-21(20)28(29,30)31)38-24-14-25(39-26(24)27(32)36)35-16-33-22-8-7-19(13-23(22)35)37-15-18-9-11-34(2)12-10-18/h3-8,13-14,16-18H,9-12,15H2,1-2H3,(H2,32,36)/t17-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OCC4CCN(C)CC4)cc23)c5ccccc5C(F)(F)F,CHEMBL1794068,"InChI=1S/C28H29F3N4O3S/c1-17(20-5-3-4-6-21(20)28(29,30)31)38-24-14-25(39-26(24)27(32)36)35-16-33-22-8-7-19(13-23(22)35)37-15-18-9-11-34(2)12-10-18/h3-8,13-14,16-18H,9-12,15H2,1-2H3,(H2,32,36)/t17-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OCC4CCN(C)CC4)cc23)c5ccccc5C(F)(F)F,CHEMBL960987,Inhibition of full length human PLK3 expressed in baculovirus-infected Trichoplusia ni cells by scintillation proximity assay,IC50,=,550,nM,,CHEMBL4897,Serine/threonine-protein kinase PLK3,Homo sapiens,Q9H4B4,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
22,CHEMBL1794069,"InChI=1S/C27H29ClN4O3S/c1-17(20-5-3-4-6-21(20)28)35-24-14-25(36-26(24)27(29)33)32-16-30-22-8-7-19(13-23(22)32)34-15-18-9-11-31(2)12-10-18/h3-8,13-14,16-18H,9-12,15H2,1-2H3,(H2,29,33)/t17-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OCC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL1794069,"InChI=1S/C27H29ClN4O3S/c1-17(20-5-3-4-6-21(20)28)35-24-14-25(36-26(24)27(29)33)32-16-30-22-8-7-19(13-23(22)32)34-15-18-9-11-31(2)12-10-18/h3-8,13-14,16-18H,9-12,15H2,1-2H3,(H2,29,33)/t17-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OCC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL960987,Inhibition of full length human PLK3 expressed in baculovirus-infected Trichoplusia ni cells by scintillation proximity assay,IC50,=,1100,nM,,CHEMBL4897,Serine/threonine-protein kinase PLK3,Homo sapiens,Q9H4B4,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
25,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL960987,Inhibition of full length human PLK3 expressed in baculovirus-infected Trichoplusia ni cells by scintillation proximity assay,IC50,=,630,nM,,CHEMBL4897,Serine/threonine-protein kinase PLK3,Homo sapiens,Q9H4B4,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
3,CHEMBL222419,"InChI=1S/C22H20ClN3O4S/c1-12(13-6-4-5-7-14(13)23)30-19-10-20(31-21(19)22(24)27)26-11-25-15-8-17(28-2)18(29-3)9-16(15)26/h4-12H,1-3H3,(H2,24,27)/t12-/m1/s1",COc1cc2ncn(c3cc(O[C@H](C)c4ccccc4Cl)c(s3)C(=O)N)c2cc1OC,CHEMBL222419,"InChI=1S/C22H20ClN3O4S/c1-12(13-6-4-5-7-14(13)23)30-19-10-20(31-21(19)22(24)27)26-11-25-15-8-17(28-2)18(29-3)9-16(15)26/h4-12H,1-3H3,(H2,24,27)/t12-/m1/s1",COc1cc2ncn(c3cc(O[C@H](C)c4ccccc4Cl)c(s3)C(=O)N)c2cc1OC,CHEMBL960987,Inhibition of full length human PLK3 expressed in baculovirus-infected Trichoplusia ni cells by scintillation proximity assay,IC50,=,6,nM,,CHEMBL4897,Serine/threonine-protein kinase PLK3,Homo sapiens,Q9H4B4,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
4,CHEMBL521806,"InChI=1S/C22H20ClN3O4S/c1-12(13-6-4-5-7-14(13)23)30-19-10-20(31-21(19)22(24)27)26-11-25-15-8-17(28-2)18(29-3)9-16(15)26/h4-12H,1-3H3,(H2,24,27)/t12-/m0/s1",COc1cc2ncn(c3cc(O[C@@H](C)c4ccccc4Cl)c(s3)C(=O)N)c2cc1OC,CHEMBL521806,"InChI=1S/C22H20ClN3O4S/c1-12(13-6-4-5-7-14(13)23)30-19-10-20(31-21(19)22(24)27)26-11-25-15-8-17(28-2)18(29-3)9-16(15)26/h4-12H,1-3H3,(H2,24,27)/t12-/m0/s1",COc1cc2ncn(c3cc(O[C@@H](C)c4ccccc4Cl)c(s3)C(=O)N)c2cc1OC,CHEMBL960987,Inhibition of full length human PLK3 expressed in baculovirus-infected Trichoplusia ni cells by scintillation proximity assay,IC50,=,44,nM,,CHEMBL4897,Serine/threonine-protein kinase PLK3,Homo sapiens,Q9H4B4,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
25,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL960866,Inhibition of human Nek2,IC50,=,21,nM,,CHEMBL3835,Serine/threonine-protein kinase NEK2,Homo sapiens,P51955,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
25,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL960872,Inhibition of human Nuak1,IC50,=,2000,nM,,CHEMBL5784,NUAK family SNF1-like kinase 1,Homo sapiens,O60285,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
25,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL960867,Inhibition of human PDGFR1beta,IC50,=,420,nM,,CHEMBL1913,Platelet-derived growth factor receptor beta,Homo sapiens,P09619,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
25,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL960870,Inhibition of human PI3Kdelta,IC50,=,440,nM,,CHEMBL3130,PI3-kinase p110-delta subunit,Homo sapiens,O00329,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
25,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL960868,Inhibition of human PIM1,IC50,=,310,nM,,CHEMBL2147,Serine/threonine-protein kinase PIM1 ,Homo sapiens,P11309,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
1,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL960986,Inhibition of human PLK1 kinase domain expressed in baculovirus-infected Trichoplusia ni cells by scintillation proximity assay,IC50,=,2,nM,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
16,CHEMBL493326,"InChI=1S/C21H18ClN3O3S/c1-12(14-5-3-4-6-15(14)22)28-18-10-19(29-20(18)21(23)26)25-11-24-16-8-7-13(27-2)9-17(16)25/h3-12H,1-2H3,(H2,23,26)/t12-/m1/s1",COc1ccc2ncn(c3cc(O[C@H](C)c4ccccc4Cl)c(s3)C(=O)N)c2c1,CHEMBL493326,"InChI=1S/C21H18ClN3O3S/c1-12(14-5-3-4-6-15(14)22)28-18-10-19(29-20(18)21(23)26)25-11-24-16-8-7-13(27-2)9-17(16)25/h3-12H,1-2H3,(H2,23,26)/t12-/m1/s1",COc1ccc2ncn(c3cc(O[C@H](C)c4ccccc4Cl)c(s3)C(=O)N)c2c1,CHEMBL960986,Inhibition of human PLK1 kinase domain expressed in baculovirus-infected Trichoplusia ni cells by scintillation proximity assay,IC50,=,1,nM,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
17,CHEMBL522709,"InChI=1S/C22H18F3N3O3S/c1-12(14-5-3-4-6-15(14)22(23,24)25)31-18-10-19(32-20(18)21(26)29)28-11-27-16-8-7-13(30-2)9-17(16)28/h3-12H,1-2H3,(H2,26,29)/t12-/m1/s1",COc1ccc2ncn(c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(s3)C(=O)N)c2c1,CHEMBL522709,"InChI=1S/C22H18F3N3O3S/c1-12(14-5-3-4-6-15(14)22(23,24)25)31-18-10-19(32-20(18)21(26)29)28-11-27-16-8-7-13(30-2)9-17(16)28/h3-12H,1-2H3,(H2,26,29)/t12-/m1/s1",COc1ccc2ncn(c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(s3)C(=O)N)c2c1,CHEMBL960986,Inhibition of human PLK1 kinase domain expressed in baculovirus-infected Trichoplusia ni cells by scintillation proximity assay,IC50,=,3,nM,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
18,CHEMBL1794067,"InChI=1S/C23H22ClN3O5S/c1-13(16-4-2-3-5-17(16)24)32-20-9-21(33-22(20)23(25)30)27-12-26-18-7-6-15(8-19(18)27)31-11-14(29)10-28/h2-9,12-14,28-29H,10-11H2,1H3,(H2,25,30)/t13-,14+/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC[C@@H](O)CO)cc23)c4ccccc4Cl,CHEMBL1794067,"InChI=1S/C23H22ClN3O5S/c1-13(16-4-2-3-5-17(16)24)32-20-9-21(33-22(20)23(25)30)27-12-26-18-7-6-15(8-19(18)27)31-11-14(29)10-28/h2-9,12-14,28-29H,10-11H2,1H3,(H2,25,30)/t13-,14+/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC[C@@H](O)CO)cc23)c4ccccc4Cl,CHEMBL960986,Inhibition of human PLK1 kinase domain expressed in baculovirus-infected Trichoplusia ni cells by scintillation proximity assay,IC50,=,1,nM,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
2,CHEMBL514162,"InChI=1S/C21H18ClN3O4S/c1-27-16-7-14-15(8-17(16)28-2)25(11-24-14)19-9-18(20(30-19)21(23)26)29-10-12-5-3-4-6-13(12)22/h3-9,11H,10H2,1-2H3,(H2,23,26)",COc1cc2ncn(c3cc(OCc4ccccc4Cl)c(s3)C(=O)N)c2cc1OC,CHEMBL514162,"InChI=1S/C21H18ClN3O4S/c1-27-16-7-14-15(8-17(16)28-2)25(11-24-14)19-9-18(20(30-19)21(23)26)29-10-12-5-3-4-6-13(12)22/h3-9,11H,10H2,1-2H3,(H2,23,26)",COc1cc2ncn(c3cc(OCc4ccccc4Cl)c(s3)C(=O)N)c2cc1OC,CHEMBL960986,Inhibition of human PLK1 kinase domain expressed in baculovirus-infected Trichoplusia ni cells by scintillation proximity assay,IC50,=,2,nM,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
21,CHEMBL1794068,"InChI=1S/C28H29F3N4O3S/c1-17(20-5-3-4-6-21(20)28(29,30)31)38-24-14-25(39-26(24)27(32)36)35-16-33-22-8-7-19(13-23(22)35)37-15-18-9-11-34(2)12-10-18/h3-8,13-14,16-18H,9-12,15H2,1-2H3,(H2,32,36)/t17-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OCC4CCN(C)CC4)cc23)c5ccccc5C(F)(F)F,CHEMBL1794068,"InChI=1S/C28H29F3N4O3S/c1-17(20-5-3-4-6-21(20)28(29,30)31)38-24-14-25(39-26(24)27(32)36)35-16-33-22-8-7-19(13-23(22)35)37-15-18-9-11-34(2)12-10-18/h3-8,13-14,16-18H,9-12,15H2,1-2H3,(H2,32,36)/t17-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OCC4CCN(C)CC4)cc23)c5ccccc5C(F)(F)F,CHEMBL960986,Inhibition of human PLK1 kinase domain expressed in baculovirus-infected Trichoplusia ni cells by scintillation proximity assay,IC50,=,7,nM,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
22,CHEMBL1794069,"InChI=1S/C27H29ClN4O3S/c1-17(20-5-3-4-6-21(20)28)35-24-14-25(36-26(24)27(29)33)32-16-30-22-8-7-19(13-23(22)32)34-15-18-9-11-31(2)12-10-18/h3-8,13-14,16-18H,9-12,15H2,1-2H3,(H2,29,33)/t17-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OCC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL1794069,"InChI=1S/C27H29ClN4O3S/c1-17(20-5-3-4-6-21(20)28)35-24-14-25(36-26(24)27(29)33)32-16-30-22-8-7-19(13-23(22)32)34-15-18-9-11-31(2)12-10-18/h3-8,13-14,16-18H,9-12,15H2,1-2H3,(H2,29,33)/t17-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OCC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL960986,Inhibition of human PLK1 kinase domain expressed in baculovirus-infected Trichoplusia ni cells by scintillation proximity assay,IC50,=,6,nM,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
25,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL960986,Inhibition of human PLK1 kinase domain expressed in baculovirus-infected Trichoplusia ni cells by scintillation proximity assay,IC50,=,2,nM,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
3,CHEMBL222419,"InChI=1S/C22H20ClN3O4S/c1-12(13-6-4-5-7-14(13)23)30-19-10-20(31-21(19)22(24)27)26-11-25-15-8-17(28-2)18(29-3)9-16(15)26/h4-12H,1-3H3,(H2,24,27)/t12-/m1/s1",COc1cc2ncn(c3cc(O[C@H](C)c4ccccc4Cl)c(s3)C(=O)N)c2cc1OC,CHEMBL222419,"InChI=1S/C22H20ClN3O4S/c1-12(13-6-4-5-7-14(13)23)30-19-10-20(31-21(19)22(24)27)26-11-25-15-8-17(28-2)18(29-3)9-16(15)26/h4-12H,1-3H3,(H2,24,27)/t12-/m1/s1",COc1cc2ncn(c3cc(O[C@H](C)c4ccccc4Cl)c(s3)C(=O)N)c2cc1OC,CHEMBL960986,Inhibition of human PLK1 kinase domain expressed in baculovirus-infected Trichoplusia ni cells by scintillation proximity assay,IC50,=,0.8,nM,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
4,CHEMBL521806,"InChI=1S/C22H20ClN3O4S/c1-12(13-6-4-5-7-14(13)23)30-19-10-20(31-21(19)22(24)27)26-11-25-15-8-17(28-2)18(29-3)9-16(15)26/h4-12H,1-3H3,(H2,24,27)/t12-/m0/s1",COc1cc2ncn(c3cc(O[C@@H](C)c4ccccc4Cl)c(s3)C(=O)N)c2cc1OC,CHEMBL521806,"InChI=1S/C22H20ClN3O4S/c1-12(13-6-4-5-7-14(13)23)30-19-10-20(31-21(19)22(24)27)26-11-25-15-8-17(28-2)18(29-3)9-16(15)26/h4-12H,1-3H3,(H2,24,27)/t12-/m0/s1",COc1cc2ncn(c3cc(O[C@@H](C)c4ccccc4Cl)c(s3)C(=O)N)c2cc1OC,CHEMBL960986,Inhibition of human PLK1 kinase domain expressed in baculovirus-infected Trichoplusia ni cells by scintillation proximity assay,IC50,=,30,nM,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
25,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL960871,Inhibition of human VEGFR2,IC50,=,1200,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
16,CHEMBL493326,"InChI=1S/C21H18ClN3O3S/c1-12(14-5-3-4-6-15(14)22)28-18-10-19(29-20(18)21(23)26)25-11-24-16-8-7-13(27-2)9-17(16)25/h3-12H,1-2H3,(H2,23,26)/t12-/m1/s1",COc1ccc2ncn(c3cc(O[C@H](C)c4ccccc4Cl)c(s3)C(=O)N)c2c1,CHEMBL493326,"InChI=1S/C21H18ClN3O3S/c1-12(14-5-3-4-6-15(14)22)28-18-10-19(29-20(18)21(23)26)25-11-24-16-8-7-13(27-2)9-17(16)25/h3-12H,1-2H3,(H2,23,26)/t12-/m1/s1",COc1ccc2ncn(c3cc(O[C@H](C)c4ccccc4Cl)c(s3)C(=O)N)c2c1,CHEMBL960990,Protein binding in human plasma at 2000 ng/mL after 6 hrs by equilibrium dialysis method,PPB,=,99.5,%,,CHEMBL613424,Plasma,Homo sapiens,,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
17,CHEMBL522709,"InChI=1S/C22H18F3N3O3S/c1-12(14-5-3-4-6-15(14)22(23,24)25)31-18-10-19(32-20(18)21(26)29)28-11-27-16-8-7-13(30-2)9-17(16)28/h3-12H,1-2H3,(H2,26,29)/t12-/m1/s1",COc1ccc2ncn(c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(s3)C(=O)N)c2c1,CHEMBL522709,"InChI=1S/C22H18F3N3O3S/c1-12(14-5-3-4-6-15(14)22(23,24)25)31-18-10-19(32-20(18)21(26)29)28-11-27-16-8-7-13(30-2)9-17(16)28/h3-12H,1-2H3,(H2,26,29)/t12-/m1/s1",COc1ccc2ncn(c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(s3)C(=O)N)c2c1,CHEMBL960990,Protein binding in human plasma at 2000 ng/mL after 6 hrs by equilibrium dialysis method,PPB,=,99.5,%,,CHEMBL613424,Plasma,Homo sapiens,,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
21,CHEMBL1794068,"InChI=1S/C28H29F3N4O3S/c1-17(20-5-3-4-6-21(20)28(29,30)31)38-24-14-25(39-26(24)27(32)36)35-16-33-22-8-7-19(13-23(22)35)37-15-18-9-11-34(2)12-10-18/h3-8,13-14,16-18H,9-12,15H2,1-2H3,(H2,32,36)/t17-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OCC4CCN(C)CC4)cc23)c5ccccc5C(F)(F)F,CHEMBL1794068,"InChI=1S/C28H29F3N4O3S/c1-17(20-5-3-4-6-21(20)28(29,30)31)38-24-14-25(39-26(24)27(32)36)35-16-33-22-8-7-19(13-23(22)35)37-15-18-9-11-34(2)12-10-18/h3-8,13-14,16-18H,9-12,15H2,1-2H3,(H2,32,36)/t17-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OCC4CCN(C)CC4)cc23)c5ccccc5C(F)(F)F,CHEMBL960990,Protein binding in human plasma at 2000 ng/mL after 6 hrs by equilibrium dialysis method,PPB,=,97.7,%,,CHEMBL613424,Plasma,Homo sapiens,,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
22,CHEMBL1794069,"InChI=1S/C27H29ClN4O3S/c1-17(20-5-3-4-6-21(20)28)35-24-14-25(36-26(24)27(29)33)32-16-30-22-8-7-19(13-23(22)32)34-15-18-9-11-31(2)12-10-18/h3-8,13-14,16-18H,9-12,15H2,1-2H3,(H2,29,33)/t17-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OCC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL1794069,"InChI=1S/C27H29ClN4O3S/c1-17(20-5-3-4-6-21(20)28)35-24-14-25(36-26(24)27(29)33)32-16-30-22-8-7-19(13-23(22)32)34-15-18-9-11-31(2)12-10-18/h3-8,13-14,16-18H,9-12,15H2,1-2H3,(H2,29,33)/t17-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OCC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL960990,Protein binding in human plasma at 2000 ng/mL after 6 hrs by equilibrium dialysis method,PPB,=,97.9,%,,CHEMBL613424,Plasma,Homo sapiens,,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
25,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL960990,Protein binding in human plasma at 2000 ng/mL after 6 hrs by equilibrium dialysis method,PPB,=,91.5,%,,CHEMBL613424,Plasma,Homo sapiens,,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
25,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL961682,Selectivity ratio of IC50 for human Nek2 to IC50 for human PLK1,Fold change,>,100,,,CHEMBL612545,,,,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
25,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL961688,Selectivity ratio of IC50 for human Nuak1 to IC50 for human PLK1,Fold change,>,100,,,CHEMBL612545,,,,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
25,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL961683,Selectivity ratio of IC50 for human PDGFR1beta to IC50 for human PLK1,Fold change,>,100,,,CHEMBL612545,,,,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
25,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL961686,Selectivity ratio of IC50 for human PI3Kdelta to IC50 for human PLK1,Fold change,>,100,,,CHEMBL612545,,,,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
25,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL961685,Selectivity ratio of IC50 for human PI3Kgamma to IC50 for human PLK1,Fold change,>,100,,,CHEMBL612545,,,,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
25,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL961684,Selectivity ratio of IC50 for human PIM1 to IC50 for human PLK1,Fold change,>,100,,,CHEMBL612545,,,,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
25,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL960873,Selectivity ratio of IC50 for human PLK3 to IC50 for human PLK1,Fold change,>,100,,,CHEMBL612545,,,,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
25,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL961687,Selectivity ratio of IC50 for human VEGFR2 to IC50 for human PLK1,Fold change,>,100,,,CHEMBL612545,,,,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
16,CHEMBL493326,"InChI=1S/C21H18ClN3O3S/c1-12(14-5-3-4-6-15(14)22)28-18-10-19(29-20(18)21(23)26)25-11-24-16-8-7-13(27-2)9-17(16)25/h3-12H,1-2H3,(H2,23,26)/t12-/m1/s1",COc1ccc2ncn(c3cc(O[C@H](C)c4ccccc4Cl)c(s3)C(=O)N)c2c1,CHEMBL493326,"InChI=1S/C21H18ClN3O3S/c1-12(14-5-3-4-6-15(14)22)28-18-10-19(29-20(18)21(23)26)25-11-24-16-8-7-13(27-2)9-17(16)25/h3-12H,1-2H3,(H2,23,26)/t12-/m1/s1",COc1ccc2ncn(c3cc(O[C@H](C)c4ccccc4Cl)c(s3)C(=O)N)c2c1,CHEMBL960989,Solubility in 0.05 M phosphate buffer at 200 uM at pH 7.4 after 15 mins by HPLC,Solubility,=,3,uM,,CHEMBL612545,,,,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
17,CHEMBL522709,"InChI=1S/C22H18F3N3O3S/c1-12(14-5-3-4-6-15(14)22(23,24)25)31-18-10-19(32-20(18)21(26)29)28-11-27-16-8-7-13(30-2)9-17(16)28/h3-12H,1-2H3,(H2,26,29)/t12-/m1/s1",COc1ccc2ncn(c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(s3)C(=O)N)c2c1,CHEMBL522709,"InChI=1S/C22H18F3N3O3S/c1-12(14-5-3-4-6-15(14)22(23,24)25)31-18-10-19(32-20(18)21(26)29)28-11-27-16-8-7-13(30-2)9-17(16)28/h3-12H,1-2H3,(H2,26,29)/t12-/m1/s1",COc1ccc2ncn(c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(s3)C(=O)N)c2c1,CHEMBL960989,Solubility in 0.05 M phosphate buffer at 200 uM at pH 7.4 after 15 mins by HPLC,Solubility,=,1,uM,,CHEMBL612545,,,,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
18,CHEMBL1794067,"InChI=1S/C23H22ClN3O5S/c1-13(16-4-2-3-5-17(16)24)32-20-9-21(33-22(20)23(25)30)27-12-26-18-7-6-15(8-19(18)27)31-11-14(29)10-28/h2-9,12-14,28-29H,10-11H2,1H3,(H2,25,30)/t13-,14+/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC[C@@H](O)CO)cc23)c4ccccc4Cl,CHEMBL1794067,"InChI=1S/C23H22ClN3O5S/c1-13(16-4-2-3-5-17(16)24)32-20-9-21(33-22(20)23(25)30)27-12-26-18-7-6-15(8-19(18)27)31-11-14(29)10-28/h2-9,12-14,28-29H,10-11H2,1H3,(H2,25,30)/t13-,14+/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC[C@@H](O)CO)cc23)c4ccccc4Cl,CHEMBL960989,Solubility in 0.05 M phosphate buffer at 200 uM at pH 7.4 after 15 mins by HPLC,Solubility,=,15,uM,,CHEMBL612545,,,,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
21,CHEMBL1794068,"InChI=1S/C28H29F3N4O3S/c1-17(20-5-3-4-6-21(20)28(29,30)31)38-24-14-25(39-26(24)27(32)36)35-16-33-22-8-7-19(13-23(22)35)37-15-18-9-11-34(2)12-10-18/h3-8,13-14,16-18H,9-12,15H2,1-2H3,(H2,32,36)/t17-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OCC4CCN(C)CC4)cc23)c5ccccc5C(F)(F)F,CHEMBL1794068,"InChI=1S/C28H29F3N4O3S/c1-17(20-5-3-4-6-21(20)28(29,30)31)38-24-14-25(39-26(24)27(32)36)35-16-33-22-8-7-19(13-23(22)35)37-15-18-9-11-34(2)12-10-18/h3-8,13-14,16-18H,9-12,15H2,1-2H3,(H2,32,36)/t17-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OCC4CCN(C)CC4)cc23)c5ccccc5C(F)(F)F,CHEMBL960989,Solubility in 0.05 M phosphate buffer at 200 uM at pH 7.4 after 15 mins by HPLC,Solubility,=,109,uM,,CHEMBL612545,,,,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
22,CHEMBL1794069,"InChI=1S/C27H29ClN4O3S/c1-17(20-5-3-4-6-21(20)28)35-24-14-25(36-26(24)27(29)33)32-16-30-22-8-7-19(13-23(22)32)34-15-18-9-11-31(2)12-10-18/h3-8,13-14,16-18H,9-12,15H2,1-2H3,(H2,29,33)/t17-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OCC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL1794069,"InChI=1S/C27H29ClN4O3S/c1-17(20-5-3-4-6-21(20)28)35-24-14-25(36-26(24)27(29)33)32-16-30-22-8-7-19(13-23(22)32)34-15-18-9-11-31(2)12-10-18/h3-8,13-14,16-18H,9-12,15H2,1-2H3,(H2,29,33)/t17-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OCC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL960989,Solubility in 0.05 M phosphate buffer at 200 uM at pH 7.4 after 15 mins by HPLC,Solubility,>=,172,uM,,CHEMBL612545,,,,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
25,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL1794070,"InChI=1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(OC4CCN(C)CC4)cc23)c5ccccc5Cl,CHEMBL960989,Solubility in 0.05 M phosphate buffer at 200 uM at pH 7.4 after 15 mins by HPLC,Solubility,>=,190,uM,,CHEMBL612545,,,,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
3,CHEMBL222419,"InChI=1S/C22H20ClN3O4S/c1-12(13-6-4-5-7-14(13)23)30-19-10-20(31-21(19)22(24)27)26-11-25-15-8-17(28-2)18(29-3)9-16(15)26/h4-12H,1-3H3,(H2,24,27)/t12-/m1/s1",COc1cc2ncn(c3cc(O[C@H](C)c4ccccc4Cl)c(s3)C(=O)N)c2cc1OC,CHEMBL222419,"InChI=1S/C22H20ClN3O4S/c1-12(13-6-4-5-7-14(13)23)30-19-10-20(31-21(19)22(24)27)26-11-25-15-8-17(28-2)18(29-3)9-16(15)26/h4-12H,1-3H3,(H2,24,27)/t12-/m1/s1",COc1cc2ncn(c3cc(O[C@H](C)c4ccccc4Cl)c(s3)C(=O)N)c2cc1OC,CHEMBL960989,Solubility in 0.05 M phosphate buffer at 200 uM at pH 7.4 after 15 mins by HPLC,Solubility,=,2,uM,,CHEMBL612545,,,,CHEMBL1153318,"Bioorg. Med. Chem. Lett., 19, p. 1694 (2009)",19237286,Scientific Literature
10,CHEMBL365286,"InChI=1S/C11H11N5O/c1-2-16-8-6-4-3-5-7(8)13-11(16)9-10(12)15-17-14-9/h3-6H,2H2,1H3,(H2,12,15)",CCn1c(nc2ccccc12)c3nonc3N,CHEMBL365286,"InChI=1S/C11H11N5O/c1-2-16-8-6-4-3-5-7(8)13-11(16)9-10(12)15-17-14-9/h3-6H,2H2,1H3,(H2,12,15)",CCn1c(nc2ccccc12)c3nonc3N,CHEMBL1104158,Inhibition of GSK3-beta assessed as decrease in NADH absorbance at 340 nm in the presence of,Ki,=,700,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1153801,"Bioorg. Med. Chem. Lett., 19, p. 5191 (2009)",19632115,Scientific Literature
10,CHEMBL365286,"InChI=1S/C11H11N5O/c1-2-16-8-6-4-3-5-7(8)13-11(16)9-10(12)15-17-14-9/h3-6H,2H2,1H3,(H2,12,15)",CCn1c(nc2ccccc12)c3nonc3N,CHEMBL365286,"InChI=1S/C11H11N5O/c1-2-16-8-6-4-3-5-7(8)13-11(16)9-10(12)15-17-14-9/h3-6H,2H2,1H3,(H2,12,15)",CCn1c(nc2ccccc12)c3nonc3N,CHEMBL1104157,Inhibition of PKAalpha assessed as decrease in NADH absorbance at 340 nm in the presence of,Ki,=,960,nM,,CHEMBL4101,cAMP-dependent protein kinase alpha-catalytic subunit,Homo sapiens,P17612,CHEMBL1153801,"Bioorg. Med. Chem. Lett., 19, p. 5191 (2009)",19632115,Scientific Literature
10,CHEMBL365286,"InChI=1S/C11H11N5O/c1-2-16-8-6-4-3-5-7(8)13-11(16)9-10(12)15-17-14-9/h3-6H,2H2,1H3,(H2,12,15)",CCn1c(nc2ccccc12)c3nonc3N,CHEMBL365286,"InChI=1S/C11H11N5O/c1-2-16-8-6-4-3-5-7(8)13-11(16)9-10(12)15-17-14-9/h3-6H,2H2,1H3,(H2,12,15)",CCn1c(nc2ccccc12)c3nonc3N,CHEMBL1104159,Inhibition of ROCK1 assessed as decrease in NADH absorbance at 340 nm in the presence of,Ki,=,330,nM,,CHEMBL3231,Rho-associated protein kinase 1 ,Homo sapiens,Q13464,CHEMBL1153801,"Bioorg. Med. Chem. Lett., 19, p. 5191 (2009)",19632115,Scientific Literature
10,CHEMBL365286,"InChI=1S/C11H11N5O/c1-2-16-8-6-4-3-5-7(8)13-11(16)9-10(12)15-17-14-9/h3-6H,2H2,1H3,(H2,12,15)",CCn1c(nc2ccccc12)c3nonc3N,CHEMBL365286,"InChI=1S/C11H11N5O/c1-2-16-8-6-4-3-5-7(8)13-11(16)9-10(12)15-17-14-9/h3-6H,2H2,1H3,(H2,12,15)",CCn1c(nc2ccccc12)c3nonc3N,CHEMBL1104156,Inhibition of p70S6K assessed as decrease in NADH absorbance at 340 nm in the presence of,Ki,=,50,nM,,CHEMBL4501,Ribosomal protein S6 kinase 1,Homo sapiens,P23443,CHEMBL1153801,"Bioorg. Med. Chem. Lett., 19, p. 5191 (2009)",19632115,Scientific Literature
1,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL963230,Inhibition of human ALK5 activity in human HaCaT cells assessed as ARE-luciferase reporter activity at 0.5 uM,Activity,=,76,%,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1153849,"Eur. J. Med. Chem., 44, p. 568 (2009)",18467006,Scientific Literature
1,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL963229,Inhibition of human ALK5 activity in human HaCaT cells assessed as p3TP-luciferase reporter activity at 0.5 uM,Activity,=,25,%,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1153849,"Eur. J. Med. Chem., 44, p. 568 (2009)",18467006,Scientific Literature
1,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL963233,Inhibition of p38alpha MAP kinase at 10 uM,Activity,=,49,%,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1153849,"Eur. J. Med. Chem., 44, p. 568 (2009)",18467006,Scientific Literature
1,CHEMBL513897,"InChI=1S/C28H31N7O/c1-3-14-35-15-6-7-20(17-35)19-10-11-23(18(2)16-19)32-28-33-26-22(12-13-30-26)27(34-28)31-24-9-5-4-8-21(24)25(29)36/h4-5,7-13,16H,3,6,14-15,17H2,1-2H3,(H2,29,36)(H3,30,31,32,33,34)",CCCN1CCC=C(C1)c2ccc(Nc3nc(Nc4ccccc4C(=O)N)c5cc[nH]c5n3)c(C)c2,CHEMBL513897,"InChI=1S/C28H31N7O/c1-3-14-35-15-6-7-20(17-35)19-10-11-23(18(2)16-19)32-28-33-26-22(12-13-30-26)27(34-28)31-24-9-5-4-8-21(24)25(29)36/h4-5,7-13,16H,3,6,14-15,17H2,1-2H3,(H2,29,36)(H3,30,31,32,33,34)",CCCN1CCC=C(C1)c2ccc(Nc3nc(Nc4ccccc4C(=O)N)c5cc[nH]c5n3)c(C)c2,CHEMBL955914,Inhibition of ALK,IC50,=,1,nM,,CHEMBL4247,ALK tyrosine kinase receptor,Homo sapiens,Q9UM73,CHEMBL1153895,"Bioorg. Med. Chem. Lett., 19, p. 469 (2009)",19056263,Scientific Literature
(+/-)-8,CHEMBL477069,"InChI=1S/C28H32FN7O2/c1-3-12-36-13-4-5-18(16-36)17-6-9-22(24(14-17)38-2)33-28-34-26-21(10-11-31-26)27(35-28)32-23-15-19(29)7-8-20(23)25(30)37/h6-11,14-15,18H,3-5,12-13,16H2,1-2H3,(H2,30,37)(H3,31,32,33,34,35)",CCCN1CCCC(C1)c2ccc(Nc3nc(Nc4cc(F)ccc4C(=O)N)c5cc[nH]c5n3)c(OC)c2,CHEMBL477069,"InChI=1S/C28H32FN7O2/c1-3-12-36-13-4-5-18(16-36)17-6-9-22(24(14-17)38-2)33-28-34-26-21(10-11-31-26)27(35-28)32-23-15-19(29)7-8-20(23)25(30)37/h6-11,14-15,18H,3-5,12-13,16H2,1-2H3,(H2,30,37)(H3,31,32,33,34,35)",CCCN1CCCC(C1)c2ccc(Nc3nc(Nc4cc(F)ccc4C(=O)N)c5cc[nH]c5n3)c(OC)c2,CHEMBL955911,Inhibition of GST-tagged human IGF1R expressed in Sf9 cells by Wallac Victor fluorometer,IC50,=,0.4,nM,,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1153895,"Bioorg. Med. Chem. Lett., 19, p. 469 (2009)",19056263,Scientific Literature
1,CHEMBL513897,"InChI=1S/C28H31N7O/c1-3-14-35-15-6-7-20(17-35)19-10-11-23(18(2)16-19)32-28-33-26-22(12-13-30-26)27(34-28)31-24-9-5-4-8-21(24)25(29)36/h4-5,7-13,16H,3,6,14-15,17H2,1-2H3,(H2,29,36)(H3,30,31,32,33,34)",CCCN1CCC=C(C1)c2ccc(Nc3nc(Nc4ccccc4C(=O)N)c5cc[nH]c5n3)c(C)c2,CHEMBL513897,"InChI=1S/C28H31N7O/c1-3-14-35-15-6-7-20(17-35)19-10-11-23(18(2)16-19)32-28-33-26-22(12-13-30-26)27(34-28)31-24-9-5-4-8-21(24)25(29)36/h4-5,7-13,16H,3,6,14-15,17H2,1-2H3,(H2,29,36)(H3,30,31,32,33,34)",CCCN1CCC=C(C1)c2ccc(Nc3nc(Nc4ccccc4C(=O)N)c5cc[nH]c5n3)c(C)c2,CHEMBL955911,Inhibition of GST-tagged human IGF1R expressed in Sf9 cells by Wallac Victor fluorometer,IC50,=,5,nM,,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1153895,"Bioorg. Med. Chem. Lett., 19, p. 469 (2009)",19056263,Scientific Literature
25,CHEMBL458865,"InChI=1S/C27H31FN8O2/c1-16(2)35-10-12-36(13-11-35)18-5-7-22(23(15-18)38-3)32-27-33-25-19(8-9-30-25)26(34-27)31-21-6-4-17(28)14-20(21)24(29)37/h4-9,14-16H,10-13H2,1-3H3,(H2,29,37)(H3,30,31,32,33,34)",COc1cc(ccc1Nc2nc(Nc3ccc(F)cc3C(=O)N)c4cc[nH]c4n2)N5CCN(CC5)C(C)C,CHEMBL458865,"InChI=1S/C27H31FN8O2/c1-16(2)35-10-12-36(13-11-35)18-5-7-22(23(15-18)38-3)32-27-33-25-19(8-9-30-25)26(34-27)31-21-6-4-17(28)14-20(21)24(29)37/h4-9,14-16H,10-13H2,1-3H3,(H2,29,37)(H3,30,31,32,33,34)",COc1cc(ccc1Nc2nc(Nc3ccc(F)cc3C(=O)N)c4cc[nH]c4n2)N5CCN(CC5)C(C)C,CHEMBL955911,Inhibition of GST-tagged human IGF1R expressed in Sf9 cells by Wallac Victor fluorometer,IC50,=,0.8,nM,,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1153895,"Bioorg. Med. Chem. Lett., 19, p. 469 (2009)",19056263,Scientific Literature
32,CHEMBL450071,"InChI=1S/C30H37FN8O4/c1-18(2)38-10-12-39(13-11-38)20-5-7-25(26(15-20)43-3)35-30-36-27-22(8-9-32-27)28(37-30)34-24-6-4-19(31)14-23(24)29(42)33-16-21(41)17-40/h4-9,14-15,18,21,40-41H,10-13,16-17H2,1-3H3,(H,33,42)(H3,32,34,35,36,37)/t21-/m1/s1",COc1cc(ccc1Nc2nc(Nc3ccc(F)cc3C(=O)NC[C@@H](O)CO)c4cc[nH]c4n2)N5CCN(CC5)C(C)C,CHEMBL450071,"InChI=1S/C30H37FN8O4/c1-18(2)38-10-12-39(13-11-38)20-5-7-25(26(15-20)43-3)35-30-36-27-22(8-9-32-27)28(37-30)34-24-6-4-19(31)14-23(24)29(42)33-16-21(41)17-40/h4-9,14-15,18,21,40-41H,10-13,16-17H2,1-3H3,(H,33,42)(H3,32,34,35,36,37)/t21-/m1/s1",COc1cc(ccc1Nc2nc(Nc3ccc(F)cc3C(=O)NC[C@@H](O)CO)c4cc[nH]c4n2)N5CCN(CC5)C(C)C,CHEMBL955911,Inhibition of GST-tagged human IGF1R expressed in Sf9 cells by Wallac Victor fluorometer,IC50,=,16,nM,,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1153895,"Bioorg. Med. Chem. Lett., 19, p. 469 (2009)",19056263,Scientific Literature
9,CHEMBL476259,"InChI=1S/C28H32FN7O2/c1-3-12-36-13-9-17(10-14-36)18-4-7-22(24(15-18)38-2)33-28-34-26-21(8-11-31-26)27(35-28)32-23-16-19(29)5-6-20(23)25(30)37/h4-8,11,15-17H,3,9-10,12-14H2,1-2H3,(H2,30,37)(H3,31,32,33,34,35)",CCCN1CCC(CC1)c2ccc(Nc3nc(Nc4cc(F)ccc4C(=O)N)c5cc[nH]c5n3)c(OC)c2,CHEMBL476259,"InChI=1S/C28H32FN7O2/c1-3-12-36-13-9-17(10-14-36)18-4-7-22(24(15-18)38-2)33-28-34-26-21(8-11-31-26)27(35-28)32-23-16-19(29)5-6-20(23)25(30)37/h4-8,11,15-17H,3,9-10,12-14H2,1-2H3,(H2,30,37)(H3,31,32,33,34,35)",CCCN1CCC(CC1)c2ccc(Nc3nc(Nc4cc(F)ccc4C(=O)N)c5cc[nH]c5n3)c(OC)c2,CHEMBL955911,Inhibition of GST-tagged human IGF1R expressed in Sf9 cells by Wallac Victor fluorometer,IC50,=,0.3,nM,,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1153895,"Bioorg. Med. Chem. Lett., 19, p. 469 (2009)",19056263,Scientific Literature
1,CHEMBL513897,"InChI=1S/C28H31N7O/c1-3-14-35-15-6-7-20(17-35)19-10-11-23(18(2)16-19)32-28-33-26-22(12-13-30-26)27(34-28)31-24-9-5-4-8-21(24)25(29)36/h4-5,7-13,16H,3,6,14-15,17H2,1-2H3,(H2,29,36)(H3,30,31,32,33,34)",CCCN1CCC=C(C1)c2ccc(Nc3nc(Nc4ccccc4C(=O)N)c5cc[nH]c5n3)c(C)c2,CHEMBL513897,"InChI=1S/C28H31N7O/c1-3-14-35-15-6-7-20(17-35)19-10-11-23(18(2)16-19)32-28-33-26-22(12-13-30-26)27(34-28)31-24-9-5-4-8-21(24)25(29)36/h4-5,7-13,16H,3,6,14-15,17H2,1-2H3,(H2,29,36)(H3,30,31,32,33,34)",CCCN1CCC=C(C1)c2ccc(Nc3nc(Nc4ccccc4C(=O)N)c5cc[nH]c5n3)c(C)c2,CHEMBL955913,Inhibition of JNK1,IC50,=,12,nM,,CHEMBL2276,c-Jun N-terminal kinase 1,Homo sapiens,P45983,CHEMBL1153895,"Bioorg. Med. Chem. Lett., 19, p. 469 (2009)",19056263,Scientific Literature
(+/-)-8,CHEMBL477069,"InChI=1S/C28H32FN7O2/c1-3-12-36-13-4-5-18(16-36)17-6-9-22(24(14-17)38-2)33-28-34-26-21(10-11-31-26)27(35-28)32-23-15-19(29)7-8-20(23)25(30)37/h6-11,14-15,18H,3-5,12-13,16H2,1-2H3,(H2,30,37)(H3,31,32,33,34,35)",CCCN1CCCC(C1)c2ccc(Nc3nc(Nc4cc(F)ccc4C(=O)N)c5cc[nH]c5n3)c(OC)c2,CHEMBL477069,"InChI=1S/C28H32FN7O2/c1-3-12-36-13-4-5-18(16-36)17-6-9-22(24(14-17)38-2)33-28-34-26-21(10-11-31-26)27(35-28)32-23-15-19(29)7-8-20(23)25(30)37/h6-11,14-15,18H,3-5,12-13,16H2,1-2H3,(H2,30,37)(H3,31,32,33,34,35)",CCCN1CCCC(C1)c2ccc(Nc3nc(Nc4cc(F)ccc4C(=O)N)c5cc[nH]c5n3)c(OC)c2,CHEMBL955912,Inhibition of human IGF1R phosphorylation expressed in HEK293 cells by DELFIA,IC50,=,60,nM,,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1153895,"Bioorg. Med. Chem. Lett., 19, p. 469 (2009)",19056263,Scientific Literature
25,CHEMBL458865,"InChI=1S/C27H31FN8O2/c1-16(2)35-10-12-36(13-11-35)18-5-7-22(23(15-18)38-3)32-27-33-25-19(8-9-30-25)26(34-27)31-21-6-4-17(28)14-20(21)24(29)37/h4-9,14-16H,10-13H2,1-3H3,(H2,29,37)(H3,30,31,32,33,34)",COc1cc(ccc1Nc2nc(Nc3ccc(F)cc3C(=O)N)c4cc[nH]c4n2)N5CCN(CC5)C(C)C,CHEMBL458865,"InChI=1S/C27H31FN8O2/c1-16(2)35-10-12-36(13-11-35)18-5-7-22(23(15-18)38-3)32-27-33-25-19(8-9-30-25)26(34-27)31-21-6-4-17(28)14-20(21)24(29)37/h4-9,14-16H,10-13H2,1-3H3,(H2,29,37)(H3,30,31,32,33,34)",COc1cc(ccc1Nc2nc(Nc3ccc(F)cc3C(=O)N)c4cc[nH]c4n2)N5CCN(CC5)C(C)C,CHEMBL955912,Inhibition of human IGF1R phosphorylation expressed in HEK293 cells by DELFIA,IC50,=,60,nM,,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1153895,"Bioorg. Med. Chem. Lett., 19, p. 469 (2009)",19056263,Scientific Literature
32,CHEMBL450071,"InChI=1S/C30H37FN8O4/c1-18(2)38-10-12-39(13-11-38)20-5-7-25(26(15-20)43-3)35-30-36-27-22(8-9-32-27)28(37-30)34-24-6-4-19(31)14-23(24)29(42)33-16-21(41)17-40/h4-9,14-15,18,21,40-41H,10-13,16-17H2,1-3H3,(H,33,42)(H3,32,34,35,36,37)/t21-/m1/s1",COc1cc(ccc1Nc2nc(Nc3ccc(F)cc3C(=O)NC[C@@H](O)CO)c4cc[nH]c4n2)N5CCN(CC5)C(C)C,CHEMBL450071,"InChI=1S/C30H37FN8O4/c1-18(2)38-10-12-39(13-11-38)20-5-7-25(26(15-20)43-3)35-30-36-27-22(8-9-32-27)28(37-30)34-24-6-4-19(31)14-23(24)29(42)33-16-21(41)17-40/h4-9,14-15,18,21,40-41H,10-13,16-17H2,1-3H3,(H,33,42)(H3,32,34,35,36,37)/t21-/m1/s1",COc1cc(ccc1Nc2nc(Nc3ccc(F)cc3C(=O)NC[C@@H](O)CO)c4cc[nH]c4n2)N5CCN(CC5)C(C)C,CHEMBL955912,Inhibition of human IGF1R phosphorylation expressed in HEK293 cells by DELFIA,IC50,=,5600,nM,,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1153895,"Bioorg. Med. Chem. Lett., 19, p. 469 (2009)",19056263,Scientific Literature
9,CHEMBL476259,"InChI=1S/C28H32FN7O2/c1-3-12-36-13-9-17(10-14-36)18-4-7-22(24(15-18)38-2)33-28-34-26-21(8-11-31-26)27(35-28)32-23-16-19(29)5-6-20(23)25(30)37/h4-8,11,15-17H,3,9-10,12-14H2,1-2H3,(H2,30,37)(H3,31,32,33,34,35)",CCCN1CCC(CC1)c2ccc(Nc3nc(Nc4cc(F)ccc4C(=O)N)c5cc[nH]c5n3)c(OC)c2,CHEMBL476259,"InChI=1S/C28H32FN7O2/c1-3-12-36-13-9-17(10-14-36)18-4-7-22(24(15-18)38-2)33-28-34-26-21(8-11-31-26)27(35-28)32-23-16-19(29)5-6-20(23)25(30)37/h4-8,11,15-17H,3,9-10,12-14H2,1-2H3,(H2,30,37)(H3,31,32,33,34,35)",CCCN1CCC(CC1)c2ccc(Nc3nc(Nc4cc(F)ccc4C(=O)N)c5cc[nH]c5n3)c(OC)c2,CHEMBL955912,Inhibition of human IGF1R phosphorylation expressed in HEK293 cells by DELFIA,IC50,=,47,nM,,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1153895,"Bioorg. Med. Chem. Lett., 19, p. 469 (2009)",19056263,Scientific Literature
1,CHEMBL513897,"InChI=1S/C28H31N7O/c1-3-14-35-15-6-7-20(17-35)19-10-11-23(18(2)16-19)32-28-33-26-22(12-13-30-26)27(34-28)31-24-9-5-4-8-21(24)25(29)36/h4-5,7-13,16H,3,6,14-15,17H2,1-2H3,(H2,29,36)(H3,30,31,32,33,34)",CCCN1CCC=C(C1)c2ccc(Nc3nc(Nc4ccccc4C(=O)N)c5cc[nH]c5n3)c(C)c2,CHEMBL513897,"InChI=1S/C28H31N7O/c1-3-14-35-15-6-7-20(17-35)19-10-11-23(18(2)16-19)32-28-33-26-22(12-13-30-26)27(34-28)31-24-9-5-4-8-21(24)25(29)36/h4-5,7-13,16H,3,6,14-15,17H2,1-2H3,(H2,29,36)(H3,30,31,32,33,34)",CCCN1CCC=C(C1)c2ccc(Nc3nc(Nc4ccccc4C(=O)N)c5cc[nH]c5n3)c(C)c2,CHEMBL955915,Inhibition of human IR,IC50,=,6.3,nM,,CHEMBL1981,Insulin receptor,Homo sapiens,P06213,CHEMBL1153895,"Bioorg. Med. Chem. Lett., 19, p. 469 (2009)",19056263,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062749,Cytotoxicity against human embryo lung fibrosis cells at 30 uM by MTT assay,Activity,=,55,%,,CHEMBL612545,,,,CHEMBL1154039,"Bioorg. Med. Chem. Lett., 19, p. 4868 (2009)",19616940,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062750,Inhibition of ALK4 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 0.1 uM after 3 hrs,Inhibition,=,25.7,%,,CHEMBL5310,Activin receptor type-1B,Homo sapiens,P36896,CHEMBL1154039,"Bioorg. Med. Chem. Lett., 19, p. 4868 (2009)",19616940,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062751,Inhibition of ALK4 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 1 uM after 3 hrs,Inhibition,=,69.4,%,,CHEMBL5310,Activin receptor type-1B,Homo sapiens,P36896,CHEMBL1154039,"Bioorg. Med. Chem. Lett., 19, p. 4868 (2009)",19616940,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062747,Inhibition of ALK5 assessed as inhibition of immobilized Smad3 phosphorylation,IC50,=,94,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1154039,"Bioorg. Med. Chem. Lett., 19, p. 4868 (2009)",19616940,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062748,Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 0.1 uM,Inhibition,=,24.2,%,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1154039,"Bioorg. Med. Chem. Lett., 19, p. 4868 (2009)",19616940,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062752,Inhibition of ALK5 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 0.1 uM after 3 hrs,Inhibition,=,14.6,%,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1154039,"Bioorg. Med. Chem. Lett., 19, p. 4868 (2009)",19616940,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062753,Inhibition of ALK5 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 1 uM after 3 hrs,Inhibition,=,75.1,%,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1154039,"Bioorg. Med. Chem. Lett., 19, p. 4868 (2009)",19616940,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1062754,Inhibition of ALK7 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 0.1 uM after 3 hrs,Inhibition,=,8.9,%,,CHEMBL5642,Activin receptor type-1C,Homo sapiens,Q8NER5,CHEMBL1154039,"Bioorg. Med. Chem. Lett., 19, p. 4868 (2009)",19616940,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1056764,Inhibition of ALK7 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 1 uM after 3 hrs,Inhibition,=,54,%,,CHEMBL5642,Activin receptor type-1C,Homo sapiens,Q8NER5,CHEMBL1154039,"Bioorg. Med. Chem. Lett., 19, p. 4868 (2009)",19616940,Scientific Literature
11,CHEMBL511765,"InChI=1S/C25H27FN8O3/c1-13-10-19(37-4)18(11-17(13)29-20(35)12-34(2)3)31-25-32-23-14(8-9-28-23)24(33-25)30-16-7-5-6-15(26)21(16)22(27)36/h5-11H,12H2,1-4H3,(H2,27,36)(H,29,35)(H3,28,30,31,32,33)",COc1cc(C)c(NC(=O)CN(C)C)cc1Nc2nc(Nc3cccc(F)c3C(=O)N)c4cc[nH]c4n2,CHEMBL511765,"InChI=1S/C25H27FN8O3/c1-13-10-19(37-4)18(11-17(13)29-20(35)12-34(2)3)31-25-32-23-14(8-9-28-23)24(33-25)30-16-7-5-6-15(26)21(16)22(27)36/h5-11H,12H2,1-4H3,(H2,27,36)(H,29,35)(H3,28,30,31,32,33)",COc1cc(C)c(NC(=O)CN(C)C)cc1Nc2nc(Nc3cccc(F)c3C(=O)N)c4cc[nH]c4n2,CHEMBL1033173,Inhibition of His-tagged JNK1,IC50,=,1995,nM,,CHEMBL2276,c-Jun N-terminal kinase 1,Homo sapiens,P45983,CHEMBL1154536,"Bioorg. Med. Chem. Lett., 19, p. 360 (2009)",19071018,Scientific Literature
13,CHEMBL467581,"InChI=1S/C26H29FN8O3/c1-14-11-20(38-5)18(12-19(14)35(4)21(36)13-34(2)3)31-26-32-24-15(9-10-29-24)25(33-26)30-17-8-6-7-16(27)22(17)23(28)37/h6-12H,13H2,1-5H3,(H2,28,37)(H3,29,30,31,32,33)",COc1cc(C)c(cc1Nc2nc(Nc3cccc(F)c3C(=O)N)c4cc[nH]c4n2)N(C)C(=O)CN(C)C,CHEMBL467581,"InChI=1S/C26H29FN8O3/c1-14-11-20(38-5)18(12-19(14)35(4)21(36)13-34(2)3)31-26-32-24-15(9-10-29-24)25(33-26)30-17-8-6-7-16(27)22(17)23(28)37/h6-12H,13H2,1-5H3,(H2,28,37)(H3,29,30,31,32,33)",COc1cc(C)c(cc1Nc2nc(Nc3cccc(F)c3C(=O)N)c4cc[nH]c4n2)N(C)C(=O)CN(C)C,CHEMBL1033173,Inhibition of His-tagged JNK1,IC50,=,10000,nM,,CHEMBL2276,c-Jun N-terminal kinase 1,Homo sapiens,P45983,CHEMBL1154536,"Bioorg. Med. Chem. Lett., 19, p. 360 (2009)",19071018,Scientific Literature
31,CHEMBL505915,"InChI=1S/C31H36FN9O3/c1-18(2)40-13-11-39(12-14-40)17-26(42)41-10-8-19-15-25(44-3)23(16-24(19)41)36-31-37-29-20(7-9-34-29)30(38-31)35-22-6-4-5-21(32)27(22)28(33)43/h4-7,9,15-16,18H,8,10-14,17H2,1-3H3,(H2,33,43)(H3,34,35,36,37,38)",COc1cc2CCN(C(=O)CN3CCN(CC3)C(C)C)c2cc1Nc4nc(Nc5cccc(F)c5C(=O)N)c6cc[nH]c6n4,CHEMBL505915,"InChI=1S/C31H36FN9O3/c1-18(2)40-13-11-39(12-14-40)17-26(42)41-10-8-19-15-25(44-3)23(16-24(19)41)36-31-37-29-20(7-9-34-29)30(38-31)35-22-6-4-5-21(32)27(22)28(33)43/h4-7,9,15-16,18H,8,10-14,17H2,1-3H3,(H2,33,43)(H3,34,35,36,37,38)",COc1cc2CCN(C(=O)CN3CCN(CC3)C(C)C)c2cc1Nc4nc(Nc5cccc(F)c5C(=O)N)c6cc[nH]c6n4,CHEMBL1033173,Inhibition of His-tagged JNK1,IC50,=,1585,nM,,CHEMBL2276,c-Jun N-terminal kinase 1,Homo sapiens,P45983,CHEMBL1154536,"Bioorg. Med. Chem. Lett., 19, p. 360 (2009)",19071018,Scientific Literature
9,CHEMBL517171,"InChI=1S/C28H31ClFN7O3/c1-3-11-37-12-8-16(9-13-37)40-22-15-21(23(39-2)14-18(22)29)34-28-35-26-17(7-10-32-26)27(36-28)33-20-6-4-5-19(30)24(20)25(31)38/h4-7,10,14-16H,3,8-9,11-13H2,1-2H3,(H2,31,38)(H3,32,33,34,35,36)",CCCN1CCC(CC1)Oc2cc(Nc3nc(Nc4cccc(F)c4C(=O)N)c5cc[nH]c5n3)c(OC)cc2Cl,CHEMBL517171,"InChI=1S/C28H31ClFN7O3/c1-3-11-37-12-8-16(9-13-37)40-22-15-21(23(39-2)14-18(22)29)34-28-35-26-17(7-10-32-26)27(36-28)33-20-6-4-5-19(30)24(20)25(31)38/h4-7,10,14-16H,3,8-9,11-13H2,1-2H3,(H2,31,38)(H3,32,33,34,35,36)",CCCN1CCC(CC1)Oc2cc(Nc3nc(Nc4cccc(F)c4C(=O)N)c5cc[nH]c5n3)c(OC)cc2Cl,CHEMBL1033173,Inhibition of His-tagged JNK1,IC50,=,3981,nM,,CHEMBL2276,c-Jun N-terminal kinase 1,Homo sapiens,P45983,CHEMBL1154536,"Bioorg. Med. Chem. Lett., 19, p. 360 (2009)",19071018,Scientific Literature
11,CHEMBL511765,"InChI=1S/C25H27FN8O3/c1-13-10-19(37-4)18(11-17(13)29-20(35)12-34(2)3)31-25-32-23-14(8-9-28-23)24(33-25)30-16-7-5-6-15(26)21(16)22(27)36/h5-11H,12H2,1-4H3,(H2,27,36)(H,29,35)(H3,28,30,31,32,33)",COc1cc(C)c(NC(=O)CN(C)C)cc1Nc2nc(Nc3cccc(F)c3C(=O)N)c4cc[nH]c4n2,CHEMBL511765,"InChI=1S/C25H27FN8O3/c1-13-10-19(37-4)18(11-17(13)29-20(35)12-34(2)3)31-25-32-23-14(8-9-28-23)24(33-25)30-16-7-5-6-15(26)21(16)22(27)36/h5-11H,12H2,1-4H3,(H2,27,36)(H,29,35)(H3,28,30,31,32,33)",COc1cc(C)c(NC(=O)CN(C)C)cc1Nc2nc(Nc3cccc(F)c3C(=O)N)c4cc[nH]c4n2,CHEMBL1033172,Inhibition of IGF-1R,IC50,=,0.5,nM,,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1154536,"Bioorg. Med. Chem. Lett., 19, p. 360 (2009)",19071018,Scientific Literature
13,CHEMBL467581,"InChI=1S/C26H29FN8O3/c1-14-11-20(38-5)18(12-19(14)35(4)21(36)13-34(2)3)31-26-32-24-15(9-10-29-24)25(33-26)30-17-8-6-7-16(27)22(17)23(28)37/h6-12H,13H2,1-5H3,(H2,28,37)(H3,29,30,31,32,33)",COc1cc(C)c(cc1Nc2nc(Nc3cccc(F)c3C(=O)N)c4cc[nH]c4n2)N(C)C(=O)CN(C)C,CHEMBL467581,"InChI=1S/C26H29FN8O3/c1-14-11-20(38-5)18(12-19(14)35(4)21(36)13-34(2)3)31-26-32-24-15(9-10-29-24)25(33-26)30-17-8-6-7-16(27)22(17)23(28)37/h6-12H,13H2,1-5H3,(H2,28,37)(H3,29,30,31,32,33)",COc1cc(C)c(cc1Nc2nc(Nc3cccc(F)c3C(=O)N)c4cc[nH]c4n2)N(C)C(=O)CN(C)C,CHEMBL1033172,Inhibition of IGF-1R,IC50,=,63,nM,,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1154536,"Bioorg. Med. Chem. Lett., 19, p. 360 (2009)",19071018,Scientific Literature
31,CHEMBL505915,"InChI=1S/C31H36FN9O3/c1-18(2)40-13-11-39(12-14-40)17-26(42)41-10-8-19-15-25(44-3)23(16-24(19)41)36-31-37-29-20(7-9-34-29)30(38-31)35-22-6-4-5-21(32)27(22)28(33)43/h4-7,9,15-16,18H,8,10-14,17H2,1-3H3,(H2,33,43)(H3,34,35,36,37,38)",COc1cc2CCN(C(=O)CN3CCN(CC3)C(C)C)c2cc1Nc4nc(Nc5cccc(F)c5C(=O)N)c6cc[nH]c6n4,CHEMBL505915,"InChI=1S/C31H36FN9O3/c1-18(2)40-13-11-39(12-14-40)17-26(42)41-10-8-19-15-25(44-3)23(16-24(19)41)36-31-37-29-20(7-9-34-29)30(38-31)35-22-6-4-5-21(32)27(22)28(33)43/h4-7,9,15-16,18H,8,10-14,17H2,1-3H3,(H2,33,43)(H3,34,35,36,37,38)",COc1cc2CCN(C(=O)CN3CCN(CC3)C(C)C)c2cc1Nc4nc(Nc5cccc(F)c5C(=O)N)c6cc[nH]c6n4,CHEMBL1033172,Inhibition of IGF-1R,IC50,=,32,nM,,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1154536,"Bioorg. Med. Chem. Lett., 19, p. 360 (2009)",19071018,Scientific Literature
9,CHEMBL517171,"InChI=1S/C28H31ClFN7O3/c1-3-11-37-12-8-16(9-13-37)40-22-15-21(23(39-2)14-18(22)29)34-28-35-26-17(7-10-32-26)27(36-28)33-20-6-4-5-19(30)24(20)25(31)38/h4-7,10,14-16H,3,8-9,11-13H2,1-2H3,(H2,31,38)(H3,32,33,34,35,36)",CCCN1CCC(CC1)Oc2cc(Nc3nc(Nc4cccc(F)c4C(=O)N)c5cc[nH]c5n3)c(OC)cc2Cl,CHEMBL517171,"InChI=1S/C28H31ClFN7O3/c1-3-11-37-12-8-16(9-13-37)40-22-15-21(23(39-2)14-18(22)29)34-28-35-26-17(7-10-32-26)27(36-28)33-20-6-4-5-19(30)24(20)25(31)38/h4-7,10,14-16H,3,8-9,11-13H2,1-2H3,(H2,31,38)(H3,32,33,34,35,36)",CCCN1CCC(CC1)Oc2cc(Nc3nc(Nc4cccc(F)c4C(=O)N)c5cc[nH]c5n3)c(OC)cc2Cl,CHEMBL1033172,Inhibition of IGF-1R,IC50,=,25,nM,,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1154536,"Bioorg. Med. Chem. Lett., 19, p. 360 (2009)",19071018,Scientific Literature
11,CHEMBL511765,"InChI=1S/C25H27FN8O3/c1-13-10-19(37-4)18(11-17(13)29-20(35)12-34(2)3)31-25-32-23-14(8-9-28-23)24(33-25)30-16-7-5-6-15(26)21(16)22(27)36/h5-11H,12H2,1-4H3,(H2,27,36)(H,29,35)(H3,28,30,31,32,33)",COc1cc(C)c(NC(=O)CN(C)C)cc1Nc2nc(Nc3cccc(F)c3C(=O)N)c4cc[nH]c4n2,CHEMBL511765,"InChI=1S/C25H27FN8O3/c1-13-10-19(37-4)18(11-17(13)29-20(35)12-34(2)3)31-25-32-23-14(8-9-28-23)24(33-25)30-16-7-5-6-15(26)21(16)22(27)36/h5-11H,12H2,1-4H3,(H2,27,36)(H,29,35)(H3,28,30,31,32,33)",COc1cc(C)c(NC(=O)CN(C)C)cc1Nc2nc(Nc3cccc(F)c3C(=O)N)c4cc[nH]c4n2,CHEMBL1033175,Inhibition of phospho IGFR1 by cellular assay,IC50,=,38,nM,,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1154536,"Bioorg. Med. Chem. Lett., 19, p. 360 (2009)",19071018,Scientific Literature
13,CHEMBL467581,"InChI=1S/C26H29FN8O3/c1-14-11-20(38-5)18(12-19(14)35(4)21(36)13-34(2)3)31-26-32-24-15(9-10-29-24)25(33-26)30-17-8-6-7-16(27)22(17)23(28)37/h6-12H,13H2,1-5H3,(H2,28,37)(H3,29,30,31,32,33)",COc1cc(C)c(cc1Nc2nc(Nc3cccc(F)c3C(=O)N)c4cc[nH]c4n2)N(C)C(=O)CN(C)C,CHEMBL467581,"InChI=1S/C26H29FN8O3/c1-14-11-20(38-5)18(12-19(14)35(4)21(36)13-34(2)3)31-26-32-24-15(9-10-29-24)25(33-26)30-17-8-6-7-16(27)22(17)23(28)37/h6-12H,13H2,1-5H3,(H2,28,37)(H3,29,30,31,32,33)",COc1cc(C)c(cc1Nc2nc(Nc3cccc(F)c3C(=O)N)c4cc[nH]c4n2)N(C)C(=O)CN(C)C,CHEMBL1033175,Inhibition of phospho IGFR1 by cellular assay,IC50,=,1728,nM,,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1154536,"Bioorg. Med. Chem. Lett., 19, p. 360 (2009)",19071018,Scientific Literature
31,CHEMBL505915,"InChI=1S/C31H36FN9O3/c1-18(2)40-13-11-39(12-14-40)17-26(42)41-10-8-19-15-25(44-3)23(16-24(19)41)36-31-37-29-20(7-9-34-29)30(38-31)35-22-6-4-5-21(32)27(22)28(33)43/h4-7,9,15-16,18H,8,10-14,17H2,1-3H3,(H2,33,43)(H3,34,35,36,37,38)",COc1cc2CCN(C(=O)CN3CCN(CC3)C(C)C)c2cc1Nc4nc(Nc5cccc(F)c5C(=O)N)c6cc[nH]c6n4,CHEMBL505915,"InChI=1S/C31H36FN9O3/c1-18(2)40-13-11-39(12-14-40)17-26(42)41-10-8-19-15-25(44-3)23(16-24(19)41)36-31-37-29-20(7-9-34-29)30(38-31)35-22-6-4-5-21(32)27(22)28(33)43/h4-7,9,15-16,18H,8,10-14,17H2,1-3H3,(H2,33,43)(H3,34,35,36,37,38)",COc1cc2CCN(C(=O)CN3CCN(CC3)C(C)C)c2cc1Nc4nc(Nc5cccc(F)c5C(=O)N)c6cc[nH]c6n4,CHEMBL1033175,Inhibition of phospho IGFR1 by cellular assay,IC50,=,376,nM,,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1154536,"Bioorg. Med. Chem. Lett., 19, p. 360 (2009)",19071018,Scientific Literature
9,CHEMBL517171,"InChI=1S/C28H31ClFN7O3/c1-3-11-37-12-8-16(9-13-37)40-22-15-21(23(39-2)14-18(22)29)34-28-35-26-17(7-10-32-26)27(36-28)33-20-6-4-5-19(30)24(20)25(31)38/h4-7,10,14-16H,3,8-9,11-13H2,1-2H3,(H2,31,38)(H3,32,33,34,35,36)",CCCN1CCC(CC1)Oc2cc(Nc3nc(Nc4cccc(F)c4C(=O)N)c5cc[nH]c5n3)c(OC)cc2Cl,CHEMBL517171,"InChI=1S/C28H31ClFN7O3/c1-3-11-37-12-8-16(9-13-37)40-22-15-21(23(39-2)14-18(22)29)34-28-35-26-17(7-10-32-26)27(36-28)33-20-6-4-5-19(30)24(20)25(31)38/h4-7,10,14-16H,3,8-9,11-13H2,1-2H3,(H2,31,38)(H3,32,33,34,35,36)",CCCN1CCC(CC1)Oc2cc(Nc3nc(Nc4cccc(F)c4C(=O)N)c5cc[nH]c5n3)c(OC)cc2Cl,CHEMBL1033175,Inhibition of phospho IGFR1 by cellular assay,IC50,=,5366,nM,,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1154536,"Bioorg. Med. Chem. Lett., 19, p. 360 (2009)",19071018,Scientific Literature
3,CHEMBL514261,"InChI=1S/C27H30FN7O3/c1-16(2)34-11-13-35(14-12-34)17-7-8-20(22(15-17)38-3)31-27-32-24-18(9-10-29-24)25(33-27)30-21-6-4-5-19(28)23(21)26(36)37/h4-10,15-16H,11-14H2,1-3H3,(H,36,37)(H3,29,30,31,32,33)",COc1cc(ccc1Nc2nc(Nc3cccc(F)c3C(=O)O)c4cc[nH]c4n2)N5CCN(CC5)C(C)C,CHEMBL514261,"InChI=1S/C27H30FN7O3/c1-16(2)34-11-13-35(14-12-34)17-7-8-20(22(15-17)38-3)31-27-32-24-18(9-10-29-24)25(33-27)30-21-6-4-5-19(28)23(21)26(36)37/h4-10,15-16H,11-14H2,1-3H3,(H,36,37)(H3,29,30,31,32,33)",COc1cc(ccc1Nc2nc(Nc3cccc(F)c3C(=O)O)c4cc[nH]c4n2)N5CCN(CC5)C(C)C,CHEMBL1025720,"Bioavailability in rat at 9.8 mg/kg, po",F,=,0,%,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1154545,"Bioorg. Med. Chem. Lett., 19, p. 373 (2009)",19081716,Scientific Literature
27,CHEMBL456252,"InChI=1S/C25H28N8O3S/c1-32(2)13-20(34)33-9-4-5-14-11-19(36-3)17(12-18(14)33)29-25-30-23-15(6-8-27-23)24(31-25)28-16-7-10-37-21(16)22(26)35/h6-8,10-12H,4-5,9,13H2,1-3H3,(H2,26,35)(H3,27,28,29,30,31)",COc1cc2CCCN(C(=O)CN(C)C)c2cc1Nc3nc(Nc4ccsc4C(=O)N)c5cc[nH]c5n3,CHEMBL456252,"InChI=1S/C25H28N8O3S/c1-32(2)13-20(34)33-9-4-5-14-11-19(36-3)17(12-18(14)33)29-25-30-23-15(6-8-27-23)24(31-25)28-16-7-10-37-21(16)22(26)35/h6-8,10-12H,4-5,9,13H2,1-3H3,(H2,26,35)(H3,27,28,29,30,31)",COc1cc2CCCN(C(=O)CN(C)C)c2cc1Nc3nc(Nc4ccsc4C(=O)N)c5cc[nH]c5n3,CHEMBL1025721,Chemical stability assessed as half life in 0.1 N HCl by LC-MS,T1/2,=,830,hr,,CHEMBL612545,,,,CHEMBL1154545,"Bioorg. Med. Chem. Lett., 19, p. 373 (2009)",19081716,Scientific Literature
28,CHEMBL463931,"InChI=1S/C27H32N8O3S/c1-27(2)8-10-35(21(36)14-34(3)4)19-13-18(20(38-5)12-16(19)27)31-26-32-24-15(6-9-29-24)25(33-26)30-17-7-11-39-22(17)23(28)37/h6-7,9,11-13H,8,10,14H2,1-5H3,(H2,28,37)(H3,29,30,31,32,33)",COc1cc2c(cc1Nc3nc(Nc4ccsc4C(=O)N)c5cc[nH]c5n3)N(CCC2(C)C)C(=O)CN(C)C,CHEMBL463931,"InChI=1S/C27H32N8O3S/c1-27(2)8-10-35(21(36)14-34(3)4)19-13-18(20(38-5)12-16(19)27)31-26-32-24-15(6-9-29-24)25(33-26)30-17-7-11-39-22(17)23(28)37/h6-7,9,11-13H,8,10,14H2,1-5H3,(H2,28,37)(H3,29,30,31,32,33)",COc1cc2c(cc1Nc3nc(Nc4ccsc4C(=O)N)c5cc[nH]c5n3)N(CCC2(C)C)C(=O)CN(C)C,CHEMBL1025721,Chemical stability assessed as half life in 0.1 N HCl by LC-MS,T1/2,=,720,hr,,CHEMBL612545,,,,CHEMBL1154545,"Bioorg. Med. Chem. Lett., 19, p. 373 (2009)",19081716,Scientific Literature
33,CHEMBL458415,"InChI=1S/C27H29N7O2/c1-32(2)16-24(35)33-12-10-18-14-23(36-3)20(15-22(18)33)29-27-30-25-19(8-11-28-25)26(31-27)34-13-9-17-6-4-5-7-21(17)34/h4-8,11,14-15H,9-10,12-13,16H2,1-3H3,(H2,28,29,30,31)",COc1cc2CCN(C(=O)CN(C)C)c2cc1Nc3nc(N4CCc5ccccc45)c6cc[nH]c6n3,CHEMBL458415,"InChI=1S/C27H29N7O2/c1-32(2)16-24(35)33-12-10-18-14-23(36-3)20(15-22(18)33)29-27-30-25-19(8-11-28-25)26(31-27)34-13-9-17-6-4-5-7-21(17)34/h4-8,11,14-15H,9-10,12-13,16H2,1-3H3,(H2,28,29,30,31)",COc1cc2CCN(C(=O)CN(C)C)c2cc1Nc3nc(N4CCc5ccccc45)c6cc[nH]c6n3,CHEMBL1025721,Chemical stability assessed as half life in 0.1 N HCl by LC-MS,T1/2,>,1000,hr,,CHEMBL612545,,,,CHEMBL1154545,"Bioorg. Med. Chem. Lett., 19, p. 373 (2009)",19081716,Scientific Literature
4,CHEMBL458865,"InChI=1S/C27H31FN8O2/c1-16(2)35-10-12-36(13-11-35)18-5-7-22(23(15-18)38-3)32-27-33-25-19(8-9-30-25)26(34-27)31-21-6-4-17(28)14-20(21)24(29)37/h4-9,14-16H,10-13H2,1-3H3,(H2,29,37)(H3,30,31,32,33,34)",COc1cc(ccc1Nc2nc(Nc3ccc(F)cc3C(=O)N)c4cc[nH]c4n2)N5CCN(CC5)C(C)C,CHEMBL458865,"InChI=1S/C27H31FN8O2/c1-16(2)35-10-12-36(13-11-35)18-5-7-22(23(15-18)38-3)32-27-33-25-19(8-9-30-25)26(34-27)31-21-6-4-17(28)14-20(21)24(29)37/h4-9,14-16H,10-13H2,1-3H3,(H2,29,37)(H3,30,31,32,33,34)",COc1cc(ccc1Nc2nc(Nc3ccc(F)cc3C(=O)N)c4cc[nH]c4n2)N5CCN(CC5)C(C)C,CHEMBL1025721,Chemical stability assessed as half life in 0.1 N HCl by LC-MS,T1/2,=,2,hr,,CHEMBL612545,,,,CHEMBL1154545,"Bioorg. Med. Chem. Lett., 19, p. 373 (2009)",19081716,Scientific Literature
3,CHEMBL514261,"InChI=1S/C27H30FN7O3/c1-16(2)34-11-13-35(14-12-34)17-7-8-20(22(15-17)38-3)31-27-32-24-18(9-10-29-24)25(33-27)30-21-6-4-5-19(28)23(21)26(36)37/h4-10,15-16H,11-14H2,1-3H3,(H,36,37)(H3,29,30,31,32,33)",COc1cc(ccc1Nc2nc(Nc3cccc(F)c3C(=O)O)c4cc[nH]c4n2)N5CCN(CC5)C(C)C,CHEMBL514261,"InChI=1S/C27H30FN7O3/c1-16(2)34-11-13-35(14-12-34)17-7-8-20(22(15-17)38-3)31-27-32-24-18(9-10-29-24)25(33-27)30-21-6-4-5-19(28)23(21)26(36)37/h4-10,15-16H,11-14H2,1-3H3,(H,36,37)(H3,29,30,31,32,33)",COc1cc(ccc1Nc2nc(Nc3cccc(F)c3C(=O)O)c4cc[nH]c4n2)N5CCN(CC5)C(C)C,CHEMBL1025718,"Clearance in rat at 2.2 mg/kg, iv or 9.8 mg/kg, po",CL,>,200,mL.min-1.kg-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1154545,"Bioorg. Med. Chem. Lett., 19, p. 373 (2009)",19081716,Scientific Literature
3,CHEMBL514261,"InChI=1S/C27H30FN7O3/c1-16(2)34-11-13-35(14-12-34)17-7-8-20(22(15-17)38-3)31-27-32-24-18(9-10-29-24)25(33-27)30-21-6-4-5-19(28)23(21)26(36)37/h4-10,15-16H,11-14H2,1-3H3,(H,36,37)(H3,29,30,31,32,33)",COc1cc(ccc1Nc2nc(Nc3cccc(F)c3C(=O)O)c4cc[nH]c4n2)N5CCN(CC5)C(C)C,CHEMBL514261,"InChI=1S/C27H30FN7O3/c1-16(2)34-11-13-35(14-12-34)17-7-8-20(22(15-17)38-3)31-27-32-24-18(9-10-29-24)25(33-27)30-21-6-4-5-19(28)23(21)26(36)37/h4-10,15-16H,11-14H2,1-3H3,(H,36,37)(H3,29,30,31,32,33)",COc1cc(ccc1Nc2nc(Nc3cccc(F)c3C(=O)O)c4cc[nH]c4n2)N5CCN(CC5)C(C)C,CHEMBL1025719,"Dose normalized AUC in rat at 9.8 mg/kg, po",AUC,=,0,ng hr ml-1 mg-1 kg-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1154545,"Bioorg. Med. Chem. Lett., 19, p. 373 (2009)",19081716,Scientific Literature
14,CHEMBL458438,"InChI=1S/C29H32N8O/c1-19(2)36-14-16-37(17-15-36)20-9-10-25(26(18-20)38-3)33-29-34-27-22(11-13-31-27)28(35-29)32-24-8-4-7-23-21(24)6-5-12-30-23/h4-13,18-19H,14-17H2,1-3H3,(H3,31,32,33,34,35)",COc1cc(ccc1Nc2nc(Nc3cccc4ncccc34)c5cc[nH]c5n2)N6CCN(CC6)C(C)C,CHEMBL458438,"InChI=1S/C29H32N8O/c1-19(2)36-14-16-37(17-15-36)20-9-10-25(26(18-20)38-3)33-29-34-27-22(11-13-31-27)28(35-29)32-24-8-4-7-23-21(24)6-5-12-30-23/h4-13,18-19H,14-17H2,1-3H3,(H3,31,32,33,34,35)",COc1cc(ccc1Nc2nc(Nc3cccc4ncccc34)c5cc[nH]c5n2)N6CCN(CC6)C(C)C,CHEMBL1025722,Inhibition of IGF1R,IC50,=,250,nM,,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1154545,"Bioorg. Med. Chem. Lett., 19, p. 373 (2009)",19081716,Scientific Literature
27,CHEMBL456252,"InChI=1S/C25H28N8O3S/c1-32(2)13-20(34)33-9-4-5-14-11-19(36-3)17(12-18(14)33)29-25-30-23-15(6-8-27-23)24(31-25)28-16-7-10-37-21(16)22(26)35/h6-8,10-12H,4-5,9,13H2,1-3H3,(H2,26,35)(H3,27,28,29,30,31)",COc1cc2CCCN(C(=O)CN(C)C)c2cc1Nc3nc(Nc4ccsc4C(=O)N)c5cc[nH]c5n3,CHEMBL456252,"InChI=1S/C25H28N8O3S/c1-32(2)13-20(34)33-9-4-5-14-11-19(36-3)17(12-18(14)33)29-25-30-23-15(6-8-27-23)24(31-25)28-16-7-10-37-21(16)22(26)35/h6-8,10-12H,4-5,9,13H2,1-3H3,(H2,26,35)(H3,27,28,29,30,31)",COc1cc2CCCN(C(=O)CN(C)C)c2cc1Nc3nc(Nc4ccsc4C(=O)N)c5cc[nH]c5n3,CHEMBL1025722,Inhibition of IGF1R,IC50,<,0.2,nM,,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1154545,"Bioorg. Med. Chem. Lett., 19, p. 373 (2009)",19081716,Scientific Literature
28,CHEMBL463931,"InChI=1S/C27H32N8O3S/c1-27(2)8-10-35(21(36)14-34(3)4)19-13-18(20(38-5)12-16(19)27)31-26-32-24-15(6-9-29-24)25(33-26)30-17-7-11-39-22(17)23(28)37/h6-7,9,11-13H,8,10,14H2,1-5H3,(H2,28,37)(H3,29,30,31,32,33)",COc1cc2c(cc1Nc3nc(Nc4ccsc4C(=O)N)c5cc[nH]c5n3)N(CCC2(C)C)C(=O)CN(C)C,CHEMBL463931,"InChI=1S/C27H32N8O3S/c1-27(2)8-10-35(21(36)14-34(3)4)19-13-18(20(38-5)12-16(19)27)31-26-32-24-15(6-9-29-24)25(33-26)30-17-7-11-39-22(17)23(28)37/h6-7,9,11-13H,8,10,14H2,1-5H3,(H2,28,37)(H3,29,30,31,32,33)",COc1cc2c(cc1Nc3nc(Nc4ccsc4C(=O)N)c5cc[nH]c5n3)N(CCC2(C)C)C(=O)CN(C)C,CHEMBL1025722,Inhibition of IGF1R,IC50,=,0.2,nM,,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1154545,"Bioorg. Med. Chem. Lett., 19, p. 373 (2009)",19081716,Scientific Literature
33,CHEMBL458415,"InChI=1S/C27H29N7O2/c1-32(2)16-24(35)33-12-10-18-14-23(36-3)20(15-22(18)33)29-27-30-25-19(8-11-28-25)26(31-27)34-13-9-17-6-4-5-7-21(17)34/h4-8,11,14-15H,9-10,12-13,16H2,1-3H3,(H2,28,29,30,31)",COc1cc2CCN(C(=O)CN(C)C)c2cc1Nc3nc(N4CCc5ccccc45)c6cc[nH]c6n3,CHEMBL458415,"InChI=1S/C27H29N7O2/c1-32(2)16-24(35)33-12-10-18-14-23(36-3)20(15-22(18)33)29-27-30-25-19(8-11-28-25)26(31-27)34-13-9-17-6-4-5-7-21(17)34/h4-8,11,14-15H,9-10,12-13,16H2,1-3H3,(H2,28,29,30,31)",COc1cc2CCN(C(=O)CN(C)C)c2cc1Nc3nc(N4CCc5ccccc45)c6cc[nH]c6n3,CHEMBL1025722,Inhibition of IGF1R,IC50,=,0.8,nM,,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1154545,"Bioorg. Med. Chem. Lett., 19, p. 373 (2009)",19081716,Scientific Literature
4,CHEMBL458865,"InChI=1S/C27H31FN8O2/c1-16(2)35-10-12-36(13-11-35)18-5-7-22(23(15-18)38-3)32-27-33-25-19(8-9-30-25)26(34-27)31-21-6-4-17(28)14-20(21)24(29)37/h4-9,14-16H,10-13H2,1-3H3,(H2,29,37)(H3,30,31,32,33,34)",COc1cc(ccc1Nc2nc(Nc3ccc(F)cc3C(=O)N)c4cc[nH]c4n2)N5CCN(CC5)C(C)C,CHEMBL458865,"InChI=1S/C27H31FN8O2/c1-16(2)35-10-12-36(13-11-35)18-5-7-22(23(15-18)38-3)32-27-33-25-19(8-9-30-25)26(34-27)31-21-6-4-17(28)14-20(21)24(29)37/h4-9,14-16H,10-13H2,1-3H3,(H2,29,37)(H3,30,31,32,33,34)",COc1cc(ccc1Nc2nc(Nc3ccc(F)cc3C(=O)N)c4cc[nH]c4n2)N5CCN(CC5)C(C)C,CHEMBL1025722,Inhibition of IGF1R,IC50,=,0.9,nM,,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1154545,"Bioorg. Med. Chem. Lett., 19, p. 373 (2009)",19081716,Scientific Literature
14,CHEMBL458438,"InChI=1S/C29H32N8O/c1-19(2)36-14-16-37(17-15-36)20-9-10-25(26(18-20)38-3)33-29-34-27-22(11-13-31-27)28(35-29)32-24-8-4-7-23-21(24)6-5-12-30-23/h4-13,18-19H,14-17H2,1-3H3,(H3,31,32,33,34,35)",COc1cc(ccc1Nc2nc(Nc3cccc4ncccc34)c5cc[nH]c5n2)N6CCN(CC6)C(C)C,CHEMBL458438,"InChI=1S/C29H32N8O/c1-19(2)36-14-16-37(17-15-36)20-9-10-25(26(18-20)38-3)33-29-34-27-22(11-13-31-27)28(35-29)32-24-8-4-7-23-21(24)6-5-12-30-23/h4-13,18-19H,14-17H2,1-3H3,(H3,31,32,33,34,35)",COc1cc(ccc1Nc2nc(Nc3cccc4ncccc34)c5cc[nH]c5n2)N6CCN(CC6)C(C)C,CHEMBL1025723,Inhibition of IGF1R phosphorylation by cellular assay,IC50,=,2534,nM,,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1154545,"Bioorg. Med. Chem. Lett., 19, p. 373 (2009)",19081716,Scientific Literature
27,CHEMBL456252,"InChI=1S/C25H28N8O3S/c1-32(2)13-20(34)33-9-4-5-14-11-19(36-3)17(12-18(14)33)29-25-30-23-15(6-8-27-23)24(31-25)28-16-7-10-37-21(16)22(26)35/h6-8,10-12H,4-5,9,13H2,1-3H3,(H2,26,35)(H3,27,28,29,30,31)",COc1cc2CCCN(C(=O)CN(C)C)c2cc1Nc3nc(Nc4ccsc4C(=O)N)c5cc[nH]c5n3,CHEMBL456252,"InChI=1S/C25H28N8O3S/c1-32(2)13-20(34)33-9-4-5-14-11-19(36-3)17(12-18(14)33)29-25-30-23-15(6-8-27-23)24(31-25)28-16-7-10-37-21(16)22(26)35/h6-8,10-12H,4-5,9,13H2,1-3H3,(H2,26,35)(H3,27,28,29,30,31)",COc1cc2CCCN(C(=O)CN(C)C)c2cc1Nc3nc(Nc4ccsc4C(=O)N)c5cc[nH]c5n3,CHEMBL1025723,Inhibition of IGF1R phosphorylation by cellular assay,IC50,=,6,nM,,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1154545,"Bioorg. Med. Chem. Lett., 19, p. 373 (2009)",19081716,Scientific Literature
28,CHEMBL463931,"InChI=1S/C27H32N8O3S/c1-27(2)8-10-35(21(36)14-34(3)4)19-13-18(20(38-5)12-16(19)27)31-26-32-24-15(6-9-29-24)25(33-26)30-17-7-11-39-22(17)23(28)37/h6-7,9,11-13H,8,10,14H2,1-5H3,(H2,28,37)(H3,29,30,31,32,33)",COc1cc2c(cc1Nc3nc(Nc4ccsc4C(=O)N)c5cc[nH]c5n3)N(CCC2(C)C)C(=O)CN(C)C,CHEMBL463931,"InChI=1S/C27H32N8O3S/c1-27(2)8-10-35(21(36)14-34(3)4)19-13-18(20(38-5)12-16(19)27)31-26-32-24-15(6-9-29-24)25(33-26)30-17-7-11-39-22(17)23(28)37/h6-7,9,11-13H,8,10,14H2,1-5H3,(H2,28,37)(H3,29,30,31,32,33)",COc1cc2c(cc1Nc3nc(Nc4ccsc4C(=O)N)c5cc[nH]c5n3)N(CCC2(C)C)C(=O)CN(C)C,CHEMBL1025723,Inhibition of IGF1R phosphorylation by cellular assay,IC50,<,2,nM,,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1154545,"Bioorg. Med. Chem. Lett., 19, p. 373 (2009)",19081716,Scientific Literature
33,CHEMBL458415,"InChI=1S/C27H29N7O2/c1-32(2)16-24(35)33-12-10-18-14-23(36-3)20(15-22(18)33)29-27-30-25-19(8-11-28-25)26(31-27)34-13-9-17-6-4-5-7-21(17)34/h4-8,11,14-15H,9-10,12-13,16H2,1-3H3,(H2,28,29,30,31)",COc1cc2CCN(C(=O)CN(C)C)c2cc1Nc3nc(N4CCc5ccccc45)c6cc[nH]c6n3,CHEMBL458415,"InChI=1S/C27H29N7O2/c1-32(2)16-24(35)33-12-10-18-14-23(36-3)20(15-22(18)33)29-27-30-25-19(8-11-28-25)26(31-27)34-13-9-17-6-4-5-7-21(17)34/h4-8,11,14-15H,9-10,12-13,16H2,1-3H3,(H2,28,29,30,31)",COc1cc2CCN(C(=O)CN(C)C)c2cc1Nc3nc(N4CCc5ccccc45)c6cc[nH]c6n3,CHEMBL1025723,Inhibition of IGF1R phosphorylation by cellular assay,IC50,=,160,nM,,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1154545,"Bioorg. Med. Chem. Lett., 19, p. 373 (2009)",19081716,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL987398,Antitrypanosomal activity against Trypanosoma cruzi Y in mouse cardiomyocytes assessed as induction of parasite apoptosis at 10 uM after 72 hrs postinfection by TUNEL method,Activity,=,47.9,%,,CHEMBL368,Trypanosoma cruzi,Trypanosoma cruzi,,CHEMBL1155165,"Antimicrob. Agents Chemother., 51, p. 2905 (2007)",17526757,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL987399,Antitrypanosomal activity against Trypanosoma cruzi Y in mouse cardiomyocytes assessed as induction of parasite apoptosis at 10 uM after 96 hrs postinfection by TUNEL method,Activity,=,26.5,%,,CHEMBL368,Trypanosoma cruzi,Trypanosoma cruzi,,CHEMBL1155165,"Antimicrob. Agents Chemother., 51, p. 2905 (2007)",17526757,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL987395,Antitrypanosomal activity against Trypanosoma cruzi Y in mouse cardiomyocytes assessed as inhibition of trypomastigote release at 10 uM after 96 hrs,Activity,,,,Active,CHEMBL368,Trypanosoma cruzi,Trypanosoma cruzi,,CHEMBL1155165,"Antimicrob. Agents Chemother., 51, p. 2905 (2007)",17526757,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL987391,Antitrypanosomal activity against Trypanosoma cruzi Y in mouse cardiomyocytes assessed as number of intracellular parasites per infected cell at 10 uM after 24 hrs postinfection by Giemsa staining,Activity,=,1.4,,,CHEMBL368,Trypanosoma cruzi,Trypanosoma cruzi,,CHEMBL1155165,"Antimicrob. Agents Chemother., 51, p. 2905 (2007)",17526757,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL987392,Antitrypanosomal activity against Trypanosoma cruzi Y in mouse cardiomyocytes assessed as number of intracellular parasites per infected cell at 10 uM after 48 hrs postinfection by Giemsa staining,Activity,=,4.4,,,CHEMBL368,Trypanosoma cruzi,Trypanosoma cruzi,,CHEMBL1155165,"Antimicrob. Agents Chemother., 51, p. 2905 (2007)",17526757,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL987393,Antitrypanosomal activity against Trypanosoma cruzi Y in mouse cardiomyocytes assessed as number of intracellular parasites per infected cell at 10 uM after 72 hrs postinfection by Giemsa staining,Activity,=,38,,,CHEMBL368,Trypanosoma cruzi,Trypanosoma cruzi,,CHEMBL1155165,"Antimicrob. Agents Chemother., 51, p. 2905 (2007)",17526757,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL987394,Antitrypanosomal activity against Trypanosoma cruzi Y in mouse cardiomyocytes assessed as number of intracellular parasites per infected cell at 10 uM after 96 hrs postinfection by Giemsa staining,Activity,=,58,,,CHEMBL368,Trypanosoma cruzi,Trypanosoma cruzi,,CHEMBL1155165,"Antimicrob. Agents Chemother., 51, p. 2905 (2007)",17526757,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL987397,Antitrypanosomal activity against Trypanosoma cruzi Y in mouse cardiomyocytes assessed as number of nontrypomastigote release at 10 uM after 96 hrs,Activity,=,53,,,CHEMBL368,Trypanosoma cruzi,Trypanosoma cruzi,,CHEMBL1155165,"Antimicrob. Agents Chemother., 51, p. 2905 (2007)",17526757,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL987396,Antitrypanosomal activity against Trypanosoma cruzi Y in mouse cardiomyocytes assessed as number of trypomastigote release at 10 uM after 96 hrs,Activity,=,19,,,CHEMBL368,Trypanosoma cruzi,Trypanosoma cruzi,,CHEMBL1155165,"Antimicrob. Agents Chemother., 51, p. 2905 (2007)",17526757,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL987390,Antitrypanosomal activity against Trypanosoma cruzi Y in mouse cardiomyocytes assessed as reduction of intracellular amastigotes at 10 uM by Giemsa staining,Activity,,,,Active,CHEMBL368,Trypanosoma cruzi,Trypanosoma cruzi,,CHEMBL1155165,"Antimicrob. Agents Chemother., 51, p. 2905 (2007)",17526757,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL987387,Antitrypanosomal activity against Trypanosoma cruzi trypomastigotes assessed as effect on parasite morphology at 10 uM,Activity,,,,Active,CHEMBL368,Trypanosoma cruzi,Trypanosoma cruzi,,CHEMBL1155165,"Antimicrob. Agents Chemother., 51, p. 2905 (2007)",17526757,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL987388,Antitrypanosomal activity against Trypanosoma cruzi trypomastigotes assessed as parasite motility at 10 uM,Activity,,,,Active,CHEMBL368,Trypanosoma cruzi,Trypanosoma cruzi,,CHEMBL1155165,"Antimicrob. Agents Chemother., 51, p. 2905 (2007)",17526757,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL987389,Antitrypanosomal activity against Trypanosoma cruzi trypomastigotes assessed as parasite viability at 10 uM by trypan blue exclusion method,Activity,,,,Active,CHEMBL368,Trypanosoma cruzi,Trypanosoma cruzi,,CHEMBL1155165,"Antimicrob. Agents Chemother., 51, p. 2905 (2007)",17526757,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL990890,Inhibition of TGF-beta-1-induced Smad2 phosphorylation in mouse embryo cardiomyocytes at 10 uM by immunoblot,Activity,,,,Active,CHEMBL612545,,,,CHEMBL1155165,"Antimicrob. Agents Chemother., 51, p. 2905 (2007)",17526757,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL990887,Inhibition of TGFbeta signaling in mink C32 cells at 10 uM by luciferase based assay,Activity,,,,Active,CHEMBL1075401,C32,Homo sapiens,,CHEMBL1155165,"Antimicrob. Agents Chemother., 51, p. 2905 (2007)",17526757,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL990891,Inhibition of Trypanosoma cruzi Dm28C infection-induced Smad2 phosphorylation in mouse embryo cardiomyocytes at 10 uM by immunoblot,Activity,,,,Active,CHEMBL368,Trypanosoma cruzi,Trypanosoma cruzi,,CHEMBL1155165,"Antimicrob. Agents Chemother., 51, p. 2905 (2007)",17526757,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL990888,Inhibition of Trypanosoma cruzi Y infection-induced TGFbeta signaling in mink C32 cells at 10 uM by luciferase based assay,Activity,,,,Active,CHEMBL368,Trypanosoma cruzi,Trypanosoma cruzi,,CHEMBL1155165,"Antimicrob. Agents Chemother., 51, p. 2905 (2007)",17526757,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL990892,Inhibition of invasion of Trypanosoma cruzi Dm28C in mouse embryo cardiomyocytes assessed as pathogen infection at 10 uM for 1 hr measured at 4 hrs postinfection,Activity,,,,Active,CHEMBL368,Trypanosoma cruzi,Trypanosoma cruzi,,CHEMBL1155165,"Antimicrob. Agents Chemother., 51, p. 2905 (2007)",17526757,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL990894,Inhibition of invasion of Trypanosoma cruzi Dm28C in mouse embryo cardiomyocytes at 10 uM for 1 hr measured at 4 hrs postinfection relative to control,Inhibition,=,2.8,%,,CHEMBL368,Trypanosoma cruzi,Trypanosoma cruzi,,CHEMBL1155165,"Antimicrob. Agents Chemother., 51, p. 2905 (2007)",17526757,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL990889,Inhibition of invasion of Trypanosoma cruzi Y in mouse embryo cardiomyocytes assessed as pathogen infection at 10 uM for 1 hr measured at 4 hrs postinfection,Activity,,,,Active,CHEMBL368,Trypanosoma cruzi,Trypanosoma cruzi,,CHEMBL1155165,"Antimicrob. Agents Chemother., 51, p. 2905 (2007)",17526757,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL990893,Inhibition of invasion of Trypanosoma cruzi Y in mouse embryo cardiomyocytes at 10 uM for 1 hr measured at 4 hrs postinfection relative to control,Inhibition,=,39,%,,CHEMBL368,Trypanosoma cruzi,Trypanosoma cruzi,,CHEMBL1155165,"Antimicrob. Agents Chemother., 51, p. 2905 (2007)",17526757,Scientific Literature
1,CHEMBL185238,"InChI=1S/C17H13N5/c1-11-4-2-5-16(20-11)17-12(10-19-22-17)13-7-8-14-15(21-13)6-3-9-18-14/h2-10H,1H3,(H,19,22)",Cc1cccc(n1)c2n[nH]cc2c3ccc4ncccc4n3,CHEMBL185238,"InChI=1S/C17H13N5/c1-11-4-2-5-16(20-11)17-12(10-19-22-17)13-7-8-14-15(21-13)6-3-9-18-14/h2-10H,1H3,(H,19,22)",Cc1cccc(n1)c2n[nH]cc2c3ccc4ncccc4n3,CHEMBL1048115,Inhibition of TGFR1,IC50,=,4,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1155322,"Eur. J. Med. Chem., 44, p. 4259 (2009)",19640613,Scientific Literature
11,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1048115,Inhibition of TGFR1,IC50,=,94,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1155322,"Eur. J. Med. Chem., 44, p. 4259 (2009)",19640613,Scientific Literature
15,CHEMBL268889,"InChI=1S/C18H15N3O2/c1-2-8-19-13(4-1)17-18(21-9-3-5-16(21)20-17)12-6-7-14-15(10-12)23-11-22-14/h1-2,4,6-8,10H,3,5,9,11H2",C1Cc2nc(c3ccccn3)c(c4ccc5OCOc5c4)n2C1,CHEMBL268889,"InChI=1S/C18H15N3O2/c1-2-8-19-13(4-1)17-18(21-9-3-5-16(21)20-17)12-6-7-14-15(10-12)23-11-22-14/h1-2,4,6-8,10H,3,5,9,11H2",C1Cc2nc(c3ccccn3)c(c4ccc5OCOc5c4)n2C1,CHEMBL1048115,Inhibition of TGFR1,IC50,=,460,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1155322,"Eur. J. Med. Chem., 44, p. 4259 (2009)",19640613,Scientific Literature
22,CHEMBL361237,"InChI=1S/C17H11FN4S/c18-11-5-3-10(4-6-11)15-16(23-17(19)22-15)14-8-7-12-13(21-14)2-1-9-20-12/h1-9H,(H2,19,22)",Nc1nc(c2ccc(F)cc2)c(s1)c3ccc4ncccc4n3,CHEMBL361237,"InChI=1S/C17H11FN4S/c18-11-5-3-10(4-6-11)15-16(23-17(19)22-15)14-8-7-12-13(21-14)2-1-9-20-12/h1-9H,(H2,19,22)",Nc1nc(c2ccc(F)cc2)c(s1)c3ccc4ncccc4n3,CHEMBL1048115,Inhibition of TGFR1,IC50,=,11,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1155322,"Eur. J. Med. Chem., 44, p. 4259 (2009)",19640613,Scientific Literature
26,CHEMBL181361,"InChI=1S/C16H11N5S/c17-16-21-14(12-4-1-2-8-19-12)15(22-16)13-7-6-10-11(20-13)5-3-9-18-10/h1-9H,(H2,17,21)",Nc1nc(c2ccccn2)c(s1)c3ccc4ncccc4n3,CHEMBL181361,"InChI=1S/C16H11N5S/c17-16-21-14(12-4-1-2-8-19-12)15(22-16)13-7-6-10-11(20-13)5-3-9-18-10/h1-9H,(H2,17,21)",Nc1nc(c2ccccn2)c(s1)c3ccc4ncccc4n3,CHEMBL1048115,Inhibition of TGFR1,IC50,=,20,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1155322,"Eur. J. Med. Chem., 44, p. 4259 (2009)",19640613,Scientific Literature
33,CHEMBL208437,"InChI=1S/C24H20N6O/c1-2-9-26-22(3-1)24-21(16-28-29-24)19-8-10-27-23(15-19)18-4-6-20(7-5-18)31-14-13-30-12-11-25-17-30/h1-12,15-17H,13-14H2,(H,28,29)",C(Cn1ccnc1)Oc2ccc(cc2)c3cc(ccn3)c4c[nH]nc4c5ccccn5,CHEMBL208437,"InChI=1S/C24H20N6O/c1-2-9-26-22(3-1)24-21(16-28-29-24)19-8-10-27-23(15-19)18-4-6-20(7-5-18)31-14-13-30-12-11-25-17-30/h1-12,15-17H,13-14H2,(H,28,29)",C(Cn1ccnc1)Oc2ccc(cc2)c3cc(ccn3)c4c[nH]nc4c5ccccn5,CHEMBL1048115,Inhibition of TGFR1,IC50,=,30,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1155322,"Eur. J. Med. Chem., 44, p. 4259 (2009)",19640613,Scientific Literature
4,CHEMBL365663,"InChI=1S/C17H11ClN4S/c18-11-4-1-3-10(9-11)15-16(23-17(19)22-15)14-7-6-12-13(21-14)5-2-8-20-12/h1-9H,(H2,19,22)",Nc1nc(c2cccc(Cl)c2)c(s1)c3ccc4ncccc4n3,CHEMBL365663,"InChI=1S/C17H11ClN4S/c18-11-4-1-3-10(9-11)15-16(23-17(19)22-15)14-7-6-12-13(21-14)5-2-8-20-12/h1-9H,(H2,19,22)",Nc1nc(c2cccc(Cl)c2)c(s1)c3ccc4ncccc4n3,CHEMBL1048115,Inhibition of TGFR1,IC50,=,13,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1155322,"Eur. J. Med. Chem., 44, p. 4259 (2009)",19640613,Scientific Literature
47,CHEMBL381948,"InChI=1S/C19H13FN4/c20-15-6-4-13(5-7-15)18-11-14(8-10-22-18)16-12-23-24-19(16)17-3-1-2-9-21-17/h1-12H,(H,23,24)",Fc1ccc(cc1)c2cc(ccn2)c3c[nH]nc3c4ccccn4,CHEMBL381948,"InChI=1S/C19H13FN4/c20-15-6-4-13(5-7-15)18-11-14(8-10-22-18)16-12-23-24-19(16)17-3-1-2-9-21-17/h1-12H,(H,23,24)",Fc1ccc(cc1)c2cc(ccn2)c3c[nH]nc3c4ccccn4,CHEMBL1048115,Inhibition of TGFR1,IC50,=,48,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1155322,"Eur. J. Med. Chem., 44, p. 4259 (2009)",19640613,Scientific Literature
81,CHEMBL267228,"InChI=1S/C22H17N3O3/c26-12-14-4-6-15(7-5-14)22-24-20(21(25-22)17-3-1-2-10-23-17)16-8-9-18-19(11-16)28-13-27-18/h1-11,26H,12-13H2,(H,24,25)",OCc1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL267228,"InChI=1S/C22H17N3O3/c26-12-14-4-6-15(7-5-14)22-24-20(21(25-22)17-3-1-2-10-23-17)16-8-9-18-19(11-16)28-13-27-18/h1-11,26H,12-13H2,(H,24,25)",OCc1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1048115,Inhibition of TGFR1,IC50,=,260,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1155322,"Eur. J. Med. Chem., 44, p. 4259 (2009)",19640613,Scientific Literature
22,CHEMBL267228,"InChI=1S/C22H17N3O3/c26-12-14-4-6-15(7-5-14)22-24-20(21(25-22)17-3-1-2-10-23-17)16-8-9-18-19(11-16)28-13-27-18/h1-11,26H,12-13H2,(H,24,25)",OCc1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL267228,"InChI=1S/C22H17N3O3/c26-12-14-4-6-15(7-5-14)22-24-20(21(25-22)17-3-1-2-10-23-17)16-8-9-18-19(11-16)28-13-27-18/h1-11,26H,12-13H2,(H,24,25)",OCc1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1107780,Antagonistic activity at TGFBR1,IC50,=,260,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1155424,"Bioorg. Med. Chem. Lett., 20, p. 1918 (2010)",20176484,Scientific Literature
23,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1107780,Antagonistic activity at TGFBR1,IC50,=,94,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1155424,"Bioorg. Med. Chem. Lett., 20, p. 1918 (2010)",20176484,Scientific Literature
22,CHEMBL267228,"InChI=1S/C22H17N3O3/c26-12-14-4-6-15(7-5-14)22-24-20(21(25-22)17-3-1-2-10-23-17)16-8-9-18-19(11-16)28-13-27-18/h1-11,26H,12-13H2,(H,24,25)",OCc1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL267228,"InChI=1S/C22H17N3O3/c26-12-14-4-6-15(7-5-14)22-24-20(21(25-22)17-3-1-2-10-23-17)16-8-9-18-19(11-16)28-13-27-18/h1-11,26H,12-13H2,(H,24,25)",OCc1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1107780,Antagonistic activity at TGFBR1,Log Ki,=,-0.585,,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1155424,"Bioorg. Med. Chem. Lett., 20, p. 1918 (2010)",20176484,Scientific Literature
23,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1107780,Antagonistic activity at TGFBR1,Log Ki,=,-1.027,,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1155424,"Bioorg. Med. Chem. Lett., 20, p. 1918 (2010)",20176484,Scientific Literature
8,CHEMBL476351,"InChI=1S/C28H30N4O3/c1-19-2-9-24(31-28(34)23-10-11-29-26(16-23)32-12-14-35-15-13-32)17-25(19)21-5-7-22(8-6-21)27(33)30-18-20-3-4-20/h2,5-11,16-17,20H,3-4,12-15,18H2,1H3,(H,30,33)(H,31,34)",Cc1ccc(NC(=O)c2ccnc(c2)N3CCOCC3)cc1c4ccc(cc4)C(=O)NCC5CC5,CHEMBL476351,"InChI=1S/C28H30N4O3/c1-19-2-9-24(31-28(34)23-10-11-29-26(16-23)32-12-14-35-15-13-32)17-25(19)21-5-7-22(8-6-21)27(33)30-18-20-3-4-20/h2,5-11,16-17,20H,3-4,12-15,18H2,1H3,(H,30,33)(H,31,34)",Cc1ccc(NC(=O)c2ccnc(c2)N3CCOCC3)cc1c4ccc(cc4)C(=O)NCC5CC5,CHEMBL989969,Binding affinity to human unphosphorylated p38alpha by surface plasmon resonance,Activity,,,,Active,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1155813,"Bioorg. Med. Chem. Lett., 18, p. 4433 (2008)",18602262,Scientific Literature
1,CHEMBL270164,"InChI=1S/C24H18N4O2/c1-15-6-7-20(24-28-27-16(2)30-24)13-22(15)18-8-10-19(11-9-18)23(29)26-21-5-3-4-17(12-21)14-25/h3-13H,1-2H3,(H,26,29)",Cc1oc(nn1)c2ccc(C)c(c2)c3ccc(cc3)C(=O)Nc4cccc(c4)C#N,CHEMBL270164,"InChI=1S/C24H18N4O2/c1-15-6-7-20(24-28-27-16(2)30-24)13-22(15)18-8-10-19(11-9-18)23(29)26-21-5-3-4-17(12-21)14-25/h3-13H,1-2H3,(H,26,29)",Cc1oc(nn1)c2ccc(C)c(c2)c3ccc(cc3)C(=O)Nc4cccc(c4)C#N,CHEMBL987298,Displacement of rhodamine-green labeled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human p38alpha by fluorescence polarization,Ki,=,240,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1155813,"Bioorg. Med. Chem. Lett., 18, p. 4433 (2008)",18602262,Scientific Literature
16,CHEMBL477583,"InChI=1S/C23H22N2O3/c1-15-2-9-20(25-23(27)19-10-11-28-14-19)12-21(15)17-5-7-18(8-6-17)22(26)24-13-16-3-4-16/h2,5-12,14,16H,3-4,13H2,1H3,(H,24,26)(H,25,27)",Cc1ccc(NC(=O)c2cocc2)cc1c3ccc(cc3)C(=O)NCC4CC4,CHEMBL477583,"InChI=1S/C23H22N2O3/c1-15-2-9-20(25-23(27)19-10-11-28-14-19)12-21(15)17-5-7-18(8-6-17)22(26)24-13-16-3-4-16/h2,5-12,14,16H,3-4,13H2,1H3,(H,24,26)(H,25,27)",Cc1ccc(NC(=O)c2cocc2)cc1c3ccc(cc3)C(=O)NCC4CC4,CHEMBL987298,Displacement of rhodamine-green labeled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human p38alpha by fluorescence polarization,Ki,=,15,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1155813,"Bioorg. Med. Chem. Lett., 18, p. 4433 (2008)",18602262,Scientific Literature
6,CHEMBL477182,"InChI=1S/C28H30N4O2/c1-19-4-11-24(31-28(34)23-12-13-29-26(16-23)32-14-2-3-15-32)17-25(19)21-7-9-22(10-8-21)27(33)30-18-20-5-6-20/h4,7-13,16-17,20H,2-3,5-6,14-15,18H2,1H3,(H,30,33)(H,31,34)",Cc1ccc(NC(=O)c2ccnc(c2)N3CCCC3)cc1c4ccc(cc4)C(=O)NCC5CC5,CHEMBL477182,"InChI=1S/C28H30N4O2/c1-19-4-11-24(31-28(34)23-12-13-29-26(16-23)32-14-2-3-15-32)17-25(19)21-7-9-22(10-8-21)27(33)30-18-20-5-6-20/h4,7-13,16-17,20H,2-3,5-6,14-15,18H2,1H3,(H,30,33)(H,31,34)",Cc1ccc(NC(=O)c2ccnc(c2)N3CCCC3)cc1c4ccc(cc4)C(=O)NCC5CC5,CHEMBL987298,Displacement of rhodamine-green labeled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human p38alpha by fluorescence polarization,Ki,=,1.9,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1155813,"Bioorg. Med. Chem. Lett., 18, p. 4433 (2008)",18602262,Scientific Literature
8,CHEMBL476351,"InChI=1S/C28H30N4O3/c1-19-2-9-24(31-28(34)23-10-11-29-26(16-23)32-12-14-35-15-13-32)17-25(19)21-5-7-22(8-6-21)27(33)30-18-20-3-4-20/h2,5-11,16-17,20H,3-4,12-15,18H2,1H3,(H,30,33)(H,31,34)",Cc1ccc(NC(=O)c2ccnc(c2)N3CCOCC3)cc1c4ccc(cc4)C(=O)NCC5CC5,CHEMBL476351,"InChI=1S/C28H30N4O3/c1-19-2-9-24(31-28(34)23-10-11-29-26(16-23)32-12-14-35-15-13-32)17-25(19)21-5-7-22(8-6-21)27(33)30-18-20-3-4-20/h2,5-11,16-17,20H,3-4,12-15,18H2,1H3,(H,30,33)(H,31,34)",Cc1ccc(NC(=O)c2ccnc(c2)N3CCOCC3)cc1c4ccc(cc4)C(=O)NCC5CC5,CHEMBL987298,Displacement of rhodamine-green labeled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human p38alpha by fluorescence polarization,Ki,=,4.4,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1155813,"Bioorg. Med. Chem. Lett., 18, p. 4433 (2008)",18602262,Scientific Literature
16,CHEMBL477583,"InChI=1S/C23H22N2O3/c1-15-2-9-20(25-23(27)19-10-11-28-14-19)12-21(15)17-5-7-18(8-6-17)22(26)24-13-16-3-4-16/h2,5-12,14,16H,3-4,13H2,1H3,(H,24,26)(H,25,27)",Cc1ccc(NC(=O)c2cocc2)cc1c3ccc(cc3)C(=O)NCC4CC4,CHEMBL477583,"InChI=1S/C23H22N2O3/c1-15-2-9-20(25-23(27)19-10-11-28-14-19)12-21(15)17-5-7-18(8-6-17)22(26)24-13-16-3-4-16/h2,5-12,14,16H,3-4,13H2,1H3,(H,24,26)(H,25,27)",Cc1ccc(NC(=O)c2cocc2)cc1c3ccc(cc3)C(=O)NCC4CC4,CHEMBL987300,Inhibition of HSP27 phosphorylation in IL-1-alpha-stimulated HLF cells,IC50,=,88,nM,,CHEMBL5976,Heat shock protein beta-1,Homo sapiens,P04792,CHEMBL1155813,"Bioorg. Med. Chem. Lett., 18, p. 4433 (2008)",18602262,Scientific Literature
8,CHEMBL476351,"InChI=1S/C28H30N4O3/c1-19-2-9-24(31-28(34)23-10-11-29-26(16-23)32-12-14-35-15-13-32)17-25(19)21-5-7-22(8-6-21)27(33)30-18-20-3-4-20/h2,5-11,16-17,20H,3-4,12-15,18H2,1H3,(H,30,33)(H,31,34)",Cc1ccc(NC(=O)c2ccnc(c2)N3CCOCC3)cc1c4ccc(cc4)C(=O)NCC5CC5,CHEMBL476351,"InChI=1S/C28H30N4O3/c1-19-2-9-24(31-28(34)23-10-11-29-26(16-23)32-12-14-35-15-13-32)17-25(19)21-5-7-22(8-6-21)27(33)30-18-20-3-4-20/h2,5-11,16-17,20H,3-4,12-15,18H2,1H3,(H,30,33)(H,31,34)",Cc1ccc(NC(=O)c2ccnc(c2)N3CCOCC3)cc1c4ccc(cc4)C(=O)NCC5CC5,CHEMBL987300,Inhibition of HSP27 phosphorylation in IL-1-alpha-stimulated HLF cells,IC50,=,27,nM,,CHEMBL5976,Heat shock protein beta-1,Homo sapiens,P04792,CHEMBL1155813,"Bioorg. Med. Chem. Lett., 18, p. 4433 (2008)",18602262,Scientific Literature
16,CHEMBL477583,"InChI=1S/C23H22N2O3/c1-15-2-9-20(25-23(27)19-10-11-28-14-19)12-21(15)17-5-7-18(8-6-17)22(26)24-13-16-3-4-16/h2,5-12,14,16H,3-4,13H2,1H3,(H,24,26)(H,25,27)",Cc1ccc(NC(=O)c2cocc2)cc1c3ccc(cc3)C(=O)NCC4CC4,CHEMBL477583,"InChI=1S/C23H22N2O3/c1-15-2-9-20(25-23(27)19-10-11-28-14-19)12-21(15)17-5-7-18(8-6-17)22(26)24-13-16-3-4-16/h2,5-12,14,16H,3-4,13H2,1H3,(H,24,26)(H,25,27)",Cc1ccc(NC(=O)c2cocc2)cc1c3ccc(cc3)C(=O)NCC4CC4,CHEMBL987303,Inhibition of LPS-stimulated TNFalpha release in human PBMC by ELISA,IC50,=,650,nM,,CHEMBL613107,PBMC (Peripheral blood mononuclear cells),Homo sapiens,,CHEMBL1155813,"Bioorg. Med. Chem. Lett., 18, p. 4433 (2008)",18602262,Scientific Literature
8,CHEMBL476351,"InChI=1S/C28H30N4O3/c1-19-2-9-24(31-28(34)23-10-11-29-26(16-23)32-12-14-35-15-13-32)17-25(19)21-5-7-22(8-6-21)27(33)30-18-20-3-4-20/h2,5-11,16-17,20H,3-4,12-15,18H2,1H3,(H,30,33)(H,31,34)",Cc1ccc(NC(=O)c2ccnc(c2)N3CCOCC3)cc1c4ccc(cc4)C(=O)NCC5CC5,CHEMBL476351,"InChI=1S/C28H30N4O3/c1-19-2-9-24(31-28(34)23-10-11-29-26(16-23)32-12-14-35-15-13-32)17-25(19)21-5-7-22(8-6-21)27(33)30-18-20-3-4-20/h2,5-11,16-17,20H,3-4,12-15,18H2,1H3,(H,30,33)(H,31,34)",Cc1ccc(NC(=O)c2ccnc(c2)N3CCOCC3)cc1c4ccc(cc4)C(=O)NCC5CC5,CHEMBL987303,Inhibition of LPS-stimulated TNFalpha release in human PBMC by ELISA,IC50,=,270,nM,,CHEMBL613107,PBMC (Peripheral blood mononuclear cells),Homo sapiens,,CHEMBL1155813,"Bioorg. Med. Chem. Lett., 18, p. 4433 (2008)",18602262,Scientific Literature
16,CHEMBL477583,"InChI=1S/C23H22N2O3/c1-15-2-9-20(25-23(27)19-10-11-28-14-19)12-21(15)17-5-7-18(8-6-17)22(26)24-13-16-3-4-16/h2,5-12,14,16H,3-4,13H2,1H3,(H,24,26)(H,25,27)",Cc1ccc(NC(=O)c2cocc2)cc1c3ccc(cc3)C(=O)NCC4CC4,CHEMBL477583,"InChI=1S/C23H22N2O3/c1-15-2-9-20(25-23(27)19-10-11-28-14-19)12-21(15)17-5-7-18(8-6-17)22(26)24-13-16-3-4-16/h2,5-12,14,16H,3-4,13H2,1H3,(H,24,26)(H,25,27)",Cc1ccc(NC(=O)c2cocc2)cc1c3ccc(cc3)C(=O)NCC4CC4,CHEMBL987299,Inhibition of human recombinant p38alpha-mediated ATF2 phosphorylation by TR-FRET assay,Ki,=,6,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1155813,"Bioorg. Med. Chem. Lett., 18, p. 4433 (2008)",18602262,Scientific Literature
8,CHEMBL476351,"InChI=1S/C28H30N4O3/c1-19-2-9-24(31-28(34)23-10-11-29-26(16-23)32-12-14-35-15-13-32)17-25(19)21-5-7-22(8-6-21)27(33)30-18-20-3-4-20/h2,5-11,16-17,20H,3-4,12-15,18H2,1H3,(H,30,33)(H,31,34)",Cc1ccc(NC(=O)c2ccnc(c2)N3CCOCC3)cc1c4ccc(cc4)C(=O)NCC5CC5,CHEMBL476351,"InChI=1S/C28H30N4O3/c1-19-2-9-24(31-28(34)23-10-11-29-26(16-23)32-12-14-35-15-13-32)17-25(19)21-5-7-22(8-6-21)27(33)30-18-20-3-4-20/h2,5-11,16-17,20H,3-4,12-15,18H2,1H3,(H,30,33)(H,31,34)",Cc1ccc(NC(=O)c2ccnc(c2)N3CCOCC3)cc1c4ccc(cc4)C(=O)NCC5CC5,CHEMBL987299,Inhibition of human recombinant p38alpha-mediated ATF2 phosphorylation by TR-FRET assay,Ki,=,6,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1155813,"Bioorg. Med. Chem. Lett., 18, p. 4433 (2008)",18602262,Scientific Literature
16,CHEMBL477583,"InChI=1S/C23H22N2O3/c1-15-2-9-20(25-23(27)19-10-11-28-14-19)12-21(15)17-5-7-18(8-6-17)22(26)24-13-16-3-4-16/h2,5-12,14,16H,3-4,13H2,1H3,(H,24,26)(H,25,27)",Cc1ccc(NC(=O)c2cocc2)cc1c3ccc(cc3)C(=O)NCC4CC4,CHEMBL477583,"InChI=1S/C23H22N2O3/c1-15-2-9-20(25-23(27)19-10-11-28-14-19)12-21(15)17-5-7-18(8-6-17)22(26)24-13-16-3-4-16/h2,5-12,14,16H,3-4,13H2,1H3,(H,24,26)(H,25,27)",Cc1ccc(NC(=O)c2cocc2)cc1c3ccc(cc3)C(=O)NCC4CC4,CHEMBL987301,Inhibition of p38alpha phosphorylation in IL-1-alpha-stimulated HLF cells,IC50,=,16,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1155813,"Bioorg. Med. Chem. Lett., 18, p. 4433 (2008)",18602262,Scientific Literature
8,CHEMBL476351,"InChI=1S/C28H30N4O3/c1-19-2-9-24(31-28(34)23-10-11-29-26(16-23)32-12-14-35-15-13-32)17-25(19)21-5-7-22(8-6-21)27(33)30-18-20-3-4-20/h2,5-11,16-17,20H,3-4,12-15,18H2,1H3,(H,30,33)(H,31,34)",Cc1ccc(NC(=O)c2ccnc(c2)N3CCOCC3)cc1c4ccc(cc4)C(=O)NCC5CC5,CHEMBL476351,"InChI=1S/C28H30N4O3/c1-19-2-9-24(31-28(34)23-10-11-29-26(16-23)32-12-14-35-15-13-32)17-25(19)21-5-7-22(8-6-21)27(33)30-18-20-3-4-20/h2,5-11,16-17,20H,3-4,12-15,18H2,1H3,(H,30,33)(H,31,34)",Cc1ccc(NC(=O)c2ccnc(c2)N3CCOCC3)cc1c4ccc(cc4)C(=O)NCC5CC5,CHEMBL987301,Inhibition of p38alpha phosphorylation in IL-1-alpha-stimulated HLF cells,IC50,=,6,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1155813,"Bioorg. Med. Chem. Lett., 18, p. 4433 (2008)",18602262,Scientific Literature
16,CHEMBL477583,"InChI=1S/C23H22N2O3/c1-15-2-9-20(25-23(27)19-10-11-28-14-19)12-21(15)17-5-7-18(8-6-17)22(26)24-13-16-3-4-16/h2,5-12,14,16H,3-4,13H2,1H3,(H,24,26)(H,25,27)",Cc1ccc(NC(=O)c2cocc2)cc1c3ccc(cc3)C(=O)NCC4CC4,CHEMBL477583,"InChI=1S/C23H22N2O3/c1-15-2-9-20(25-23(27)19-10-11-28-14-19)12-21(15)17-5-7-18(8-6-17)22(26)24-13-16-3-4-16/h2,5-12,14,16H,3-4,13H2,1H3,(H,24,26)(H,25,27)",Cc1ccc(NC(=O)c2cocc2)cc1c3ccc(cc3)C(=O)NCC4CC4,CHEMBL987302,Ratio of IC50 for HSP27 phosphorylation to IC50 for p38alpha phosphorylation in IL-1-alpha-stimulated HLF cells,Ratio IC50,=,5.5,,,CHEMBL612545,,,,CHEMBL1155813,"Bioorg. Med. Chem. Lett., 18, p. 4433 (2008)",18602262,Scientific Literature
8,CHEMBL476351,"InChI=1S/C28H30N4O3/c1-19-2-9-24(31-28(34)23-10-11-29-26(16-23)32-12-14-35-15-13-32)17-25(19)21-5-7-22(8-6-21)27(33)30-18-20-3-4-20/h2,5-11,16-17,20H,3-4,12-15,18H2,1H3,(H,30,33)(H,31,34)",Cc1ccc(NC(=O)c2ccnc(c2)N3CCOCC3)cc1c4ccc(cc4)C(=O)NCC5CC5,CHEMBL476351,"InChI=1S/C28H30N4O3/c1-19-2-9-24(31-28(34)23-10-11-29-26(16-23)32-12-14-35-15-13-32)17-25(19)21-5-7-22(8-6-21)27(33)30-18-20-3-4-20/h2,5-11,16-17,20H,3-4,12-15,18H2,1H3,(H,30,33)(H,31,34)",Cc1ccc(NC(=O)c2ccnc(c2)N3CCOCC3)cc1c4ccc(cc4)C(=O)NCC5CC5,CHEMBL987302,Ratio of IC50 for HSP27 phosphorylation to IC50 for p38alpha phosphorylation in IL-1-alpha-stimulated HLF cells,Ratio IC50,=,4.5,,,CHEMBL612545,,,,CHEMBL1155813,"Bioorg. Med. Chem. Lett., 18, p. 4433 (2008)",18602262,Scientific Literature
16,CHEMBL477583,"InChI=1S/C23H22N2O3/c1-15-2-9-20(25-23(27)19-10-11-28-14-19)12-21(15)17-5-7-18(8-6-17)22(26)24-13-16-3-4-16/h2,5-12,14,16H,3-4,13H2,1H3,(H,24,26)(H,25,27)",Cc1ccc(NC(=O)c2cocc2)cc1c3ccc(cc3)C(=O)NCC4CC4,CHEMBL477583,"InChI=1S/C23H22N2O3/c1-15-2-9-20(25-23(27)19-10-11-28-14-19)12-21(15)17-5-7-18(8-6-17)22(26)24-13-16-3-4-16/h2,5-12,14,16H,3-4,13H2,1H3,(H,24,26)(H,25,27)",Cc1ccc(NC(=O)c2cocc2)cc1c3ccc(cc3)C(=O)NCC4CC4,CHEMBL989968,Ratio of IC50 for LPS-stimulated TNFalpha release in human PBMC to Ki for human p38alpha,Ratio,=,43,,,CHEMBL612545,,,,CHEMBL1155813,"Bioorg. Med. Chem. Lett., 18, p. 4433 (2008)",18602262,Scientific Literature
8,CHEMBL476351,"InChI=1S/C28H30N4O3/c1-19-2-9-24(31-28(34)23-10-11-29-26(16-23)32-12-14-35-15-13-32)17-25(19)21-5-7-22(8-6-21)27(33)30-18-20-3-4-20/h2,5-11,16-17,20H,3-4,12-15,18H2,1H3,(H,30,33)(H,31,34)",Cc1ccc(NC(=O)c2ccnc(c2)N3CCOCC3)cc1c4ccc(cc4)C(=O)NCC5CC5,CHEMBL476351,"InChI=1S/C28H30N4O3/c1-19-2-9-24(31-28(34)23-10-11-29-26(16-23)32-12-14-35-15-13-32)17-25(19)21-5-7-22(8-6-21)27(33)30-18-20-3-4-20/h2,5-11,16-17,20H,3-4,12-15,18H2,1H3,(H,30,33)(H,31,34)",Cc1ccc(NC(=O)c2ccnc(c2)N3CCOCC3)cc1c4ccc(cc4)C(=O)NCC5CC5,CHEMBL989968,Ratio of IC50 for LPS-stimulated TNFalpha release in human PBMC to Ki for human p38alpha,Ratio,=,61,,,CHEMBL612545,,,,CHEMBL1155813,"Bioorg. Med. Chem. Lett., 18, p. 4433 (2008)",18602262,Scientific Literature
10,CHEMBL517507,"InChI=1S/C23H26N2O2/c1-15-5-8-19(23(27)25-20-3-2-4-20)13-21(15)17-9-11-18(12-10-17)22(26)24-14-16-6-7-16/h5,8-13,16,20H,2-4,6-7,14H2,1H3,(H,24,26)(H,25,27)",Cc1ccc(cc1c2ccc(cc2)C(=O)NCC3CC3)C(=O)NC4CCC4,CHEMBL517507,"InChI=1S/C23H26N2O2/c1-15-5-8-19(23(27)25-20-3-2-4-20)13-21(15)17-9-11-18(12-10-17)22(26)24-14-16-6-7-16/h5,8-13,16,20H,2-4,6-7,14H2,1H3,(H,24,26)(H,25,27)",Cc1ccc(cc1c2ccc(cc2)C(=O)NCC3CC3)C(=O)NC4CCC4,CHEMBL983811,Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay,IC50,=,850,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1155838,"Bioorg. Med. Chem. Lett., 18, p. 4428 (2008)",18614366,Scientific Literature
15,CHEMBL517666,"InChI=1S/C21H24N2O2/c1-3-20(24)23-18-11-4-14(2)19(12-18)16-7-9-17(10-8-16)21(25)22-13-15-5-6-15/h4,7-12,15H,3,5-6,13H2,1-2H3,(H,22,25)(H,23,24)",CCC(=O)Nc1ccc(C)c(c1)c2ccc(cc2)C(=O)NCC3CC3,CHEMBL517666,"InChI=1S/C21H24N2O2/c1-3-20(24)23-18-11-4-14(2)19(12-18)16-7-9-17(10-8-16)21(25)22-13-15-5-6-15/h4,7-12,15H,3,5-6,13H2,1-2H3,(H,22,25)(H,23,24)",CCC(=O)Nc1ccc(C)c(c1)c2ccc(cc2)C(=O)NCC3CC3,CHEMBL983811,Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay,IC50,=,1100,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1155838,"Bioorg. Med. Chem. Lett., 18, p. 4428 (2008)",18614366,Scientific Literature
19,CHEMBL516908,"InChI=1S/C23H26N2O2/c1-15-2-11-20(25-22(26)12-16-3-4-16)13-21(15)18-7-9-19(10-8-18)23(27)24-14-17-5-6-17/h2,7-11,13,16-17H,3-6,12,14H2,1H3,(H,24,27)(H,25,26)",Cc1ccc(NC(=O)CC2CC2)cc1c3ccc(cc3)C(=O)NCC4CC4,CHEMBL516908,"InChI=1S/C23H26N2O2/c1-15-2-11-20(25-22(26)12-16-3-4-16)13-21(15)18-7-9-19(10-8-18)23(27)24-14-17-5-6-17/h2,7-11,13,16-17H,3-6,12,14H2,1H3,(H,24,27)(H,25,26)",Cc1ccc(NC(=O)CC2CC2)cc1c3ccc(cc3)C(=O)NCC4CC4,CHEMBL983811,Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay,IC50,=,450,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1155838,"Bioorg. Med. Chem. Lett., 18, p. 4428 (2008)",18614366,Scientific Literature
25,CHEMBL477583,"InChI=1S/C23H22N2O3/c1-15-2-9-20(25-23(27)19-10-11-28-14-19)12-21(15)17-5-7-18(8-6-17)22(26)24-13-16-3-4-16/h2,5-12,14,16H,3-4,13H2,1H3,(H,24,26)(H,25,27)",Cc1ccc(NC(=O)c2cocc2)cc1c3ccc(cc3)C(=O)NCC4CC4,CHEMBL477583,"InChI=1S/C23H22N2O3/c1-15-2-9-20(25-23(27)19-10-11-28-14-19)12-21(15)17-5-7-18(8-6-17)22(26)24-13-16-3-4-16/h2,5-12,14,16H,3-4,13H2,1H3,(H,24,26)(H,25,27)",Cc1ccc(NC(=O)c2cocc2)cc1c3ccc(cc3)C(=O)NCC4CC4,CHEMBL983811,Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay,IC50,=,96,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1155838,"Bioorg. Med. Chem. Lett., 18, p. 4428 (2008)",18614366,Scientific Literature
38,CHEMBL479038,"InChI=1S/C21H22N2O2/c24-20(22-13-14-4-5-14)16-8-6-15(7-9-16)17-2-1-3-18(12-17)21(25)23-19-10-11-19/h1-3,6-9,12,14,19H,4-5,10-11,13H2,(H,22,24)(H,23,25)",O=C(NCC1CC1)c2ccc(cc2)c3cccc(c3)C(=O)NC4CC4,CHEMBL479038,"InChI=1S/C21H22N2O2/c24-20(22-13-14-4-5-14)16-8-6-15(7-9-16)17-2-1-3-18(12-17)21(25)23-19-10-11-19/h1-3,6-9,12,14,19H,4-5,10-11,13H2,(H,22,24)(H,23,25)",O=C(NCC1CC1)c2ccc(cc2)c3cccc(c3)C(=O)NC4CC4,CHEMBL983811,Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay,IC50,>,16000,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1155838,"Bioorg. Med. Chem. Lett., 18, p. 4428 (2008)",18614366,Scientific Literature
8,CHEMBL477978,"InChI=1S/C25H30N2O2/c1-17-7-10-21(25(29)27-22-5-3-2-4-6-22)15-23(17)19-11-13-20(14-12-19)24(28)26-16-18-8-9-18/h7,10-15,18,22H,2-6,8-9,16H2,1H3,(H,26,28)(H,27,29)",Cc1ccc(cc1c2ccc(cc2)C(=O)NCC3CC3)C(=O)NC4CCCCC4,CHEMBL477978,"InChI=1S/C25H30N2O2/c1-17-7-10-21(25(29)27-22-5-3-2-4-6-22)15-23(17)19-11-13-20(14-12-19)24(28)26-16-18-8-9-18/h7,10-15,18,22H,2-6,8-9,16H2,1H3,(H,26,28)(H,27,29)",Cc1ccc(cc1c2ccc(cc2)C(=O)NCC3CC3)C(=O)NC4CCCCC4,CHEMBL983811,Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay,IC50,=,8800,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1155838,"Bioorg. Med. Chem. Lett., 18, p. 4428 (2008)",18614366,Scientific Literature
9,CHEMBL477979,"InChI=1S/C22H26N2O2/c1-14(2)24-22(26)19-7-4-15(3)20(12-19)17-8-10-18(11-9-17)21(25)23-13-16-5-6-16/h4,7-12,14,16H,5-6,13H2,1-3H3,(H,23,25)(H,24,26)",CC(C)NC(=O)c1ccc(C)c(c1)c2ccc(cc2)C(=O)NCC3CC3,CHEMBL477979,"InChI=1S/C22H26N2O2/c1-14(2)24-22(26)19-7-4-15(3)20(12-19)17-8-10-18(11-9-17)21(25)23-13-16-5-6-16/h4,7-12,14,16H,5-6,13H2,1-3H3,(H,23,25)(H,24,26)",CC(C)NC(=O)c1ccc(C)c(c1)c2ccc(cc2)C(=O)NCC3CC3,CHEMBL983811,Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay,IC50,=,2500,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1155838,"Bioorg. Med. Chem. Lett., 18, p. 4428 (2008)",18614366,Scientific Literature
10,CHEMBL517507,"InChI=1S/C23H26N2O2/c1-15-5-8-19(23(27)25-20-3-2-4-20)13-21(15)17-9-11-18(12-10-17)22(26)24-14-16-6-7-16/h5,8-13,16,20H,2-4,6-7,14H2,1H3,(H,24,26)(H,25,27)",Cc1ccc(cc1c2ccc(cc2)C(=O)NCC3CC3)C(=O)NC4CCC4,CHEMBL517507,"InChI=1S/C23H26N2O2/c1-15-5-8-19(23(27)25-20-3-2-4-20)13-21(15)17-9-11-18(12-10-17)22(26)24-14-16-6-7-16/h5,8-13,16,20H,2-4,6-7,14H2,1H3,(H,24,26)(H,25,27)",Cc1ccc(cc1c2ccc(cc2)C(=O)NCC3CC3)C(=O)NC4CCC4,CHEMBL983811,Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay,Ki,=,130,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1155838,"Bioorg. Med. Chem. Lett., 18, p. 4428 (2008)",18614366,Scientific Literature
15,CHEMBL517666,"InChI=1S/C21H24N2O2/c1-3-20(24)23-18-11-4-14(2)19(12-18)16-7-9-17(10-8-16)21(25)22-13-15-5-6-15/h4,7-12,15H,3,5-6,13H2,1-2H3,(H,22,25)(H,23,24)",CCC(=O)Nc1ccc(C)c(c1)c2ccc(cc2)C(=O)NCC3CC3,CHEMBL517666,"InChI=1S/C21H24N2O2/c1-3-20(24)23-18-11-4-14(2)19(12-18)16-7-9-17(10-8-16)21(25)22-13-15-5-6-15/h4,7-12,15H,3,5-6,13H2,1-2H3,(H,22,25)(H,23,24)",CCC(=O)Nc1ccc(C)c(c1)c2ccc(cc2)C(=O)NCC3CC3,CHEMBL983811,Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay,Ki,=,170,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1155838,"Bioorg. Med. Chem. Lett., 18, p. 4428 (2008)",18614366,Scientific Literature
19,CHEMBL516908,"InChI=1S/C23H26N2O2/c1-15-2-11-20(25-22(26)12-16-3-4-16)13-21(15)18-7-9-19(10-8-18)23(27)24-14-17-5-6-17/h2,7-11,13,16-17H,3-6,12,14H2,1H3,(H,24,27)(H,25,26)",Cc1ccc(NC(=O)CC2CC2)cc1c3ccc(cc3)C(=O)NCC4CC4,CHEMBL516908,"InChI=1S/C23H26N2O2/c1-15-2-11-20(25-22(26)12-16-3-4-16)13-21(15)18-7-9-19(10-8-18)23(27)24-14-17-5-6-17/h2,7-11,13,16-17H,3-6,12,14H2,1H3,(H,24,27)(H,25,26)",Cc1ccc(NC(=O)CC2CC2)cc1c3ccc(cc3)C(=O)NCC4CC4,CHEMBL983811,Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay,Ki,=,70,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1155838,"Bioorg. Med. Chem. Lett., 18, p. 4428 (2008)",18614366,Scientific Literature
25,CHEMBL477583,"InChI=1S/C23H22N2O3/c1-15-2-9-20(25-23(27)19-10-11-28-14-19)12-21(15)17-5-7-18(8-6-17)22(26)24-13-16-3-4-16/h2,5-12,14,16H,3-4,13H2,1H3,(H,24,26)(H,25,27)",Cc1ccc(NC(=O)c2cocc2)cc1c3ccc(cc3)C(=O)NCC4CC4,CHEMBL477583,"InChI=1S/C23H22N2O3/c1-15-2-9-20(25-23(27)19-10-11-28-14-19)12-21(15)17-5-7-18(8-6-17)22(26)24-13-16-3-4-16/h2,5-12,14,16H,3-4,13H2,1H3,(H,24,26)(H,25,27)",Cc1ccc(NC(=O)c2cocc2)cc1c3ccc(cc3)C(=O)NCC4CC4,CHEMBL983811,Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay,Ki,=,15,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1155838,"Bioorg. Med. Chem. Lett., 18, p. 4428 (2008)",18614366,Scientific Literature
38,CHEMBL479038,"InChI=1S/C21H22N2O2/c24-20(22-13-14-4-5-14)16-8-6-15(7-9-16)17-2-1-3-18(12-17)21(25)23-19-10-11-19/h1-3,6-9,12,14,19H,4-5,10-11,13H2,(H,22,24)(H,23,25)",O=C(NCC1CC1)c2ccc(cc2)c3cccc(c3)C(=O)NC4CC4,CHEMBL479038,"InChI=1S/C21H22N2O2/c24-20(22-13-14-4-5-14)16-8-6-15(7-9-16)17-2-1-3-18(12-17)21(25)23-19-10-11-19/h1-3,6-9,12,14,19H,4-5,10-11,13H2,(H,22,24)(H,23,25)",O=C(NCC1CC1)c2ccc(cc2)c3cccc(c3)C(=O)NC4CC4,CHEMBL983811,Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay,Ki,>,2500,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1155838,"Bioorg. Med. Chem. Lett., 18, p. 4428 (2008)",18614366,Scientific Literature
8,CHEMBL477978,"InChI=1S/C25H30N2O2/c1-17-7-10-21(25(29)27-22-5-3-2-4-6-22)15-23(17)19-11-13-20(14-12-19)24(28)26-16-18-8-9-18/h7,10-15,18,22H,2-6,8-9,16H2,1H3,(H,26,28)(H,27,29)",Cc1ccc(cc1c2ccc(cc2)C(=O)NCC3CC3)C(=O)NC4CCCCC4,CHEMBL477978,"InChI=1S/C25H30N2O2/c1-17-7-10-21(25(29)27-22-5-3-2-4-6-22)15-23(17)19-11-13-20(14-12-19)24(28)26-16-18-8-9-18/h7,10-15,18,22H,2-6,8-9,16H2,1H3,(H,26,28)(H,27,29)",Cc1ccc(cc1c2ccc(cc2)C(=O)NCC3CC3)C(=O)NC4CCCCC4,CHEMBL983811,Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay,Ki,=,1400,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1155838,"Bioorg. Med. Chem. Lett., 18, p. 4428 (2008)",18614366,Scientific Literature
9,CHEMBL477979,"InChI=1S/C22H26N2O2/c1-14(2)24-22(26)19-7-4-15(3)20(12-19)17-8-10-18(11-9-17)21(25)23-13-16-5-6-16/h4,7-12,14,16H,5-6,13H2,1-3H3,(H,23,25)(H,24,26)",CC(C)NC(=O)c1ccc(C)c(c1)c2ccc(cc2)C(=O)NCC3CC3,CHEMBL477979,"InChI=1S/C22H26N2O2/c1-14(2)24-22(26)19-7-4-15(3)20(12-19)17-8-10-18(11-9-17)21(25)23-13-16-5-6-16/h4,7-12,14,16H,5-6,13H2,1-3H3,(H,23,25)(H,24,26)",CC(C)NC(=O)c1ccc(C)c(c1)c2ccc(cc2)C(=O)NCC3CC3,CHEMBL983811,Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay,Ki,=,400,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1155838,"Bioorg. Med. Chem. Lett., 18, p. 4428 (2008)",18614366,Scientific Literature
11a,CHEMBL475932,"InChI=1S/C22H24N6O3S/c1-5-32(29,30)16-7-9-20(31-4)19(13-16)24-22-23-11-10-21(25-22)28(3)15-6-8-17-14(2)26-27-18(17)12-15/h6-13H,5H2,1-4H3,(H,26,27)(H,23,24,25)",CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(n2)N(C)c3ccc4c(C)n[nH]c4c3)c1,CHEMBL475932,"InChI=1S/C22H24N6O3S/c1-5-32(29,30)16-7-9-20(31-4)19(13-16)24-22-23-11-10-21(25-22)28(3)15-6-8-17-14(2)26-27-18(17)12-15/h6-13H,5H2,1-4H3,(H,26,27)(H,23,24,25)",CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(n2)N(C)c3ccc4c(C)n[nH]c4c3)c1,CHEMBL981075,Clearance in rat at 10 mg/kg,CL,=,10,mL.min-1.kg-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1155848,"J. Med. Chem., 51, p. 4632 (2008)",18620382,Scientific Literature
5a,CHEMBL479079,"InChI=1S/C21H22N6O3/c1-12-15-6-5-13(9-16(15)27-26-12)23-19-7-8-22-21(25-19)24-14-10-17(28-2)20(30-4)18(11-14)29-3/h5-11H,1-4H3,(H,26,27)(H2,22,23,24,25)",COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC,CHEMBL479079,"InChI=1S/C21H22N6O3/c1-12-15-6-5-13(9-16(15)27-26-12)23-19-7-8-22-21(25-19)24-14-10-17(28-2)20(30-4)18(11-14)29-3/h5-11H,1-4H3,(H,26,27)(H2,22,23,24,25)",COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC,CHEMBL981075,Clearance in rat at 10 mg/kg,CL,=,16,mL.min-1.kg-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1155848,"J. Med. Chem., 51, p. 4632 (2008)",18620382,Scientific Literature
5a,CHEMBL479079,"InChI=1S/C21H22N6O3/c1-12-15-6-5-13(9-16(15)27-26-12)23-19-7-8-22-21(25-19)24-14-10-17(28-2)20(30-4)18(11-14)29-3/h5-11H,1-4H3,(H,26,27)(H2,22,23,24,25)",COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC,CHEMBL479079,"InChI=1S/C21H22N6O3/c1-12-15-6-5-13(9-16(15)27-26-12)23-19-7-8-22-21(25-19)24-14-10-17(28-2)20(30-4)18(11-14)29-3/h5-11H,1-4H3,(H,26,27)(H2,22,23,24,25)",COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC,CHEMBL981074,Inhibition of VEGF-induced HUVEC proliferation,IC50,=,180,nM,,CHEMBL613979,HUVEC (Umbilical vein endothelial cells),Homo sapiens,,CHEMBL1155848,"J. Med. Chem., 51, p. 4632 (2008)",18620382,Scientific Literature
12b,CHEMBL1794073,"InChI=1S/C20H21N7O2S.ClH/c1-13-17-8-7-15(12-18(17)27(3)25-13)26(2)19-9-10-22-20(24-19)23-14-5-4-6-16(11-14)30(21,28)29;/h4-12H,1-3H3,(H2,21,28,29)(H,22,23,24);1H",Cl.CN(c1ccc2c(C)nn(C)c2c1)c3ccnc(Nc4cccc(c4)S(=O)(=O)N)n3,CHEMBL476571,"InChI=1S/C20H21N7O2S/c1-13-17-8-7-15(12-18(17)27(3)25-13)26(2)19-9-10-22-20(24-19)23-14-5-4-6-16(11-14)30(21,28)29/h4-12H,1-3H3,(H2,21,28,29)(H,22,23,24)",CN(c1ccc2c(C)nn(C)c2c1)c3ccnc(Nc4cccc(c4)S(=O)(=O)N)n3,CHEMBL983780,Inhibition of VEGF-induced HUVEC proliferation by BrdU incorporation method after 72 hrs,IC50,=,1400,nM,,CHEMBL613979,HUVEC (Umbilical vein endothelial cells),Homo sapiens,,CHEMBL1155848,"J. Med. Chem., 51, p. 4632 (2008)",18620382,Scientific Literature
12c,CHEMBL1794074,"InChI=1S/C20H21N7O2S.2ClH/c1-13-17-8-7-15(12-18(17)25-27(13)3)26(2)19-9-10-22-20(24-19)23-14-5-4-6-16(11-14)30(21,28)29;;/h4-12H,1-3H3,(H2,21,28,29)(H,22,23,24);2*1H",Cl.Cl.CN(c1ccc2c(C)n(C)nc2c1)c3ccnc(Nc4cccc(c4)S(=O)(=O)N)n3,CHEMBL514838,"InChI=1S/C20H21N7O2S/c1-13-17-8-7-15(12-18(17)25-27(13)3)26(2)19-9-10-22-20(24-19)23-14-5-4-6-16(11-14)30(21,28)29/h4-12H,1-3H3,(H2,21,28,29)(H,22,23,24)",CN(c1ccc2c(C)n(C)nc2c1)c3ccnc(Nc4cccc(c4)S(=O)(=O)N)n3,CHEMBL983780,Inhibition of VEGF-induced HUVEC proliferation by BrdU incorporation method after 72 hrs,IC50,=,23,nM,,CHEMBL613979,HUVEC (Umbilical vein endothelial cells),Homo sapiens,,CHEMBL1155848,"J. Med. Chem., 51, p. 4632 (2008)",18620382,Scientific Literature
5a,CHEMBL479079,"InChI=1S/C21H22N6O3/c1-12-15-6-5-13(9-16(15)27-26-12)23-19-7-8-22-21(25-19)24-14-10-17(28-2)20(30-4)18(11-14)29-3/h5-11H,1-4H3,(H,26,27)(H2,22,23,24,25)",COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC,CHEMBL479079,"InChI=1S/C21H22N6O3/c1-12-15-6-5-13(9-16(15)27-26-12)23-19-7-8-22-21(25-19)24-14-10-17(28-2)20(30-4)18(11-14)29-3/h5-11H,1-4H3,(H,26,27)(H2,22,23,24,25)",COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC,CHEMBL981071,Inhibition of VEGFR2,IC50,=,6.3,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1155848,"J. Med. Chem., 51, p. 4632 (2008)",18620382,Scientific Literature
12b,CHEMBL1794073,"InChI=1S/C20H21N7O2S.ClH/c1-13-17-8-7-15(12-18(17)27(3)25-13)26(2)19-9-10-22-20(24-19)23-14-5-4-6-16(11-14)30(21,28)29;/h4-12H,1-3H3,(H2,21,28,29)(H,22,23,24);1H",Cl.CN(c1ccc2c(C)nn(C)c2c1)c3ccnc(Nc4cccc(c4)S(=O)(=O)N)n3,CHEMBL476571,"InChI=1S/C20H21N7O2S/c1-13-17-8-7-15(12-18(17)27(3)25-13)26(2)19-9-10-22-20(24-19)23-14-5-4-6-16(11-14)30(21,28)29/h4-12H,1-3H3,(H2,21,28,29)(H,22,23,24)",CN(c1ccc2c(C)nn(C)c2c1)c3ccnc(Nc4cccc(c4)S(=O)(=O)N)n3,CHEMBL983779,Inhibition of human VEGFR2-mediated proliferation of HUVEC,IC50,=,36,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1155848,"J. Med. Chem., 51, p. 4632 (2008)",18620382,Scientific Literature
12c,CHEMBL1794074,"InChI=1S/C20H21N7O2S.2ClH/c1-13-17-8-7-15(12-18(17)25-27(13)3)26(2)19-9-10-22-20(24-19)23-14-5-4-6-16(11-14)30(21,28)29;;/h4-12H,1-3H3,(H2,21,28,29)(H,22,23,24);2*1H",Cl.Cl.CN(c1ccc2c(C)n(C)nc2c1)c3ccnc(Nc4cccc(c4)S(=O)(=O)N)n3,CHEMBL514838,"InChI=1S/C20H21N7O2S/c1-13-17-8-7-15(12-18(17)25-27(13)3)26(2)19-9-10-22-20(24-19)23-14-5-4-6-16(11-14)30(21,28)29/h4-12H,1-3H3,(H2,21,28,29)(H,22,23,24)",CN(c1ccc2c(C)n(C)nc2c1)c3ccnc(Nc4cccc(c4)S(=O)(=O)N)n3,CHEMBL983779,Inhibition of human VEGFR2-mediated proliferation of HUVEC,IC50,=,5.6,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1155848,"J. Med. Chem., 51, p. 4632 (2008)",18620382,Scientific Literature
12b,CHEMBL1794073,"InChI=1S/C20H21N7O2S.ClH/c1-13-17-8-7-15(12-18(17)27(3)25-13)26(2)19-9-10-22-20(24-19)23-14-5-4-6-16(11-14)30(21,28)29;/h4-12H,1-3H3,(H2,21,28,29)(H,22,23,24);1H",Cl.CN(c1ccc2c(C)nn(C)c2c1)c3ccnc(Nc4cccc(c4)S(=O)(=O)N)n3,CHEMBL476571,"InChI=1S/C20H21N7O2S/c1-13-17-8-7-15(12-18(17)27(3)25-13)26(2)19-9-10-22-20(24-19)23-14-5-4-6-16(11-14)30(21,28)29/h4-12H,1-3H3,(H2,21,28,29)(H,22,23,24)",CN(c1ccc2c(C)nn(C)c2c1)c3ccnc(Nc4cccc(c4)S(=O)(=O)N)n3,CHEMBL983782,Inhibition of human recombinant CYP2C19,IC50,=,9300,nM,,CHEMBL3622,Cytochrome P450 2C19,Homo sapiens,P33261,CHEMBL1155848,"J. Med. Chem., 51, p. 4632 (2008)",18620382,Scientific Literature
12c,CHEMBL1794074,"InChI=1S/C20H21N7O2S.2ClH/c1-13-17-8-7-15(12-18(17)25-27(13)3)26(2)19-9-10-22-20(24-19)23-14-5-4-6-16(11-14)30(21,28)29;;/h4-12H,1-3H3,(H2,21,28,29)(H,22,23,24);2*1H",Cl.Cl.CN(c1ccc2c(C)n(C)nc2c1)c3ccnc(Nc4cccc(c4)S(=O)(=O)N)n3,CHEMBL514838,"InChI=1S/C20H21N7O2S/c1-13-17-8-7-15(12-18(17)25-27(13)3)26(2)19-9-10-22-20(24-19)23-14-5-4-6-16(11-14)30(21,28)29/h4-12H,1-3H3,(H2,21,28,29)(H,22,23,24)",CN(c1ccc2c(C)n(C)nc2c1)c3ccnc(Nc4cccc(c4)S(=O)(=O)N)n3,CHEMBL983782,Inhibition of human recombinant CYP2C19,IC50,=,20000,nM,,CHEMBL3622,Cytochrome P450 2C19,Homo sapiens,P33261,CHEMBL1155848,"J. Med. Chem., 51, p. 4632 (2008)",18620382,Scientific Literature
12b,CHEMBL1794073,"InChI=1S/C20H21N7O2S.ClH/c1-13-17-8-7-15(12-18(17)27(3)25-13)26(2)19-9-10-22-20(24-19)23-14-5-4-6-16(11-14)30(21,28)29;/h4-12H,1-3H3,(H2,21,28,29)(H,22,23,24);1H",Cl.CN(c1ccc2c(C)nn(C)c2c1)c3ccnc(Nc4cccc(c4)S(=O)(=O)N)n3,CHEMBL476571,"InChI=1S/C20H21N7O2S/c1-13-17-8-7-15(12-18(17)27(3)25-13)26(2)19-9-10-22-20(24-19)23-14-5-4-6-16(11-14)30(21,28)29/h4-12H,1-3H3,(H2,21,28,29)(H,22,23,24)",CN(c1ccc2c(C)nn(C)c2c1)c3ccnc(Nc4cccc(c4)S(=O)(=O)N)n3,CHEMBL983781,Inhibition of human recombinant CYP2C9,IC50,=,1000,nM,,CHEMBL3397,Cytochrome P450 2C9,Homo sapiens,P11712,CHEMBL1155848,"J. Med. Chem., 51, p. 4632 (2008)",18620382,Scientific Literature
12c,CHEMBL1794074,"InChI=1S/C20H21N7O2S.2ClH/c1-13-17-8-7-15(12-18(17)25-27(13)3)26(2)19-9-10-22-20(24-19)23-14-5-4-6-16(11-14)30(21,28)29;;/h4-12H,1-3H3,(H2,21,28,29)(H,22,23,24);2*1H",Cl.Cl.CN(c1ccc2c(C)n(C)nc2c1)c3ccnc(Nc4cccc(c4)S(=O)(=O)N)n3,CHEMBL514838,"InChI=1S/C20H21N7O2S/c1-13-17-8-7-15(12-18(17)25-27(13)3)26(2)19-9-10-22-20(24-19)23-14-5-4-6-16(11-14)30(21,28)29/h4-12H,1-3H3,(H2,21,28,29)(H,22,23,24)",CN(c1ccc2c(C)n(C)nc2c1)c3ccnc(Nc4cccc(c4)S(=O)(=O)N)n3,CHEMBL983781,Inhibition of human recombinant CYP2C9,IC50,=,1400,nM,,CHEMBL3397,Cytochrome P450 2C9,Homo sapiens,P11712,CHEMBL1155848,"J. Med. Chem., 51, p. 4632 (2008)",18620382,Scientific Literature
12b,CHEMBL1794073,"InChI=1S/C20H21N7O2S.ClH/c1-13-17-8-7-15(12-18(17)27(3)25-13)26(2)19-9-10-22-20(24-19)23-14-5-4-6-16(11-14)30(21,28)29;/h4-12H,1-3H3,(H2,21,28,29)(H,22,23,24);1H",Cl.CN(c1ccc2c(C)nn(C)c2c1)c3ccnc(Nc4cccc(c4)S(=O)(=O)N)n3,CHEMBL476571,"InChI=1S/C20H21N7O2S/c1-13-17-8-7-15(12-18(17)27(3)25-13)26(2)19-9-10-22-20(24-19)23-14-5-4-6-16(11-14)30(21,28)29/h4-12H,1-3H3,(H2,21,28,29)(H,22,23,24)",CN(c1ccc2c(C)nn(C)c2c1)c3ccnc(Nc4cccc(c4)S(=O)(=O)N)n3,CHEMBL983783,Inhibition of human recombinant CYP2D6,IC50,=,6300,nM,,CHEMBL289,Cytochrome P450 2D6,Homo sapiens,P10635,CHEMBL1155848,"J. Med. Chem., 51, p. 4632 (2008)",18620382,Scientific Literature
12c,CHEMBL1794074,"InChI=1S/C20H21N7O2S.2ClH/c1-13-17-8-7-15(12-18(17)25-27(13)3)26(2)19-9-10-22-20(24-19)23-14-5-4-6-16(11-14)30(21,28)29;;/h4-12H,1-3H3,(H2,21,28,29)(H,22,23,24);2*1H",Cl.Cl.CN(c1ccc2c(C)n(C)nc2c1)c3ccnc(Nc4cccc(c4)S(=O)(=O)N)n3,CHEMBL514838,"InChI=1S/C20H21N7O2S/c1-13-17-8-7-15(12-18(17)25-27(13)3)26(2)19-9-10-22-20(24-19)23-14-5-4-6-16(11-14)30(21,28)29/h4-12H,1-3H3,(H2,21,28,29)(H,22,23,24)",CN(c1ccc2c(C)n(C)nc2c1)c3ccnc(Nc4cccc(c4)S(=O)(=O)N)n3,CHEMBL983783,Inhibition of human recombinant CYP2D6,IC50,=,16000,nM,,CHEMBL289,Cytochrome P450 2D6,Homo sapiens,P10635,CHEMBL1155848,"J. Med. Chem., 51, p. 4632 (2008)",18620382,Scientific Literature
12b,CHEMBL1794073,"InChI=1S/C20H21N7O2S.ClH/c1-13-17-8-7-15(12-18(17)27(3)25-13)26(2)19-9-10-22-20(24-19)23-14-5-4-6-16(11-14)30(21,28)29;/h4-12H,1-3H3,(H2,21,28,29)(H,22,23,24);1H",Cl.CN(c1ccc2c(C)nn(C)c2c1)c3ccnc(Nc4cccc(c4)S(=O)(=O)N)n3,CHEMBL476571,"InChI=1S/C20H21N7O2S/c1-13-17-8-7-15(12-18(17)27(3)25-13)26(2)19-9-10-22-20(24-19)23-14-5-4-6-16(11-14)30(21,28)29/h4-12H,1-3H3,(H2,21,28,29)(H,22,23,24)",CN(c1ccc2c(C)nn(C)c2c1)c3ccnc(Nc4cccc(c4)S(=O)(=O)N)n3,CHEMBL983778,Inhibition of human recombinant CYP3A4 using 7-benzyloxyquinoline substrate,IC50,=,1700,nM,,CHEMBL340,Cytochrome P450 3A4,Homo sapiens,P08684,CHEMBL1155848,"J. Med. Chem., 51, p. 4632 (2008)",18620382,Scientific Literature
12c,CHEMBL1794074,"InChI=1S/C20H21N7O2S.2ClH/c1-13-17-8-7-15(12-18(17)25-27(13)3)26(2)19-9-10-22-20(24-19)23-14-5-4-6-16(11-14)30(21,28)29;;/h4-12H,1-3H3,(H2,21,28,29)(H,22,23,24);2*1H",Cl.Cl.CN(c1ccc2c(C)n(C)nc2c1)c3ccnc(Nc4cccc(c4)S(=O)(=O)N)n3,CHEMBL514838,"InChI=1S/C20H21N7O2S/c1-13-17-8-7-15(12-18(17)25-27(13)3)26(2)19-9-10-22-20(24-19)23-14-5-4-6-16(11-14)30(21,28)29/h4-12H,1-3H3,(H2,21,28,29)(H,22,23,24)",CN(c1ccc2c(C)n(C)nc2c1)c3ccnc(Nc4cccc(c4)S(=O)(=O)N)n3,CHEMBL983778,Inhibition of human recombinant CYP3A4 using 7-benzyloxyquinoline substrate,IC50,=,31000,nM,,CHEMBL340,Cytochrome P450 3A4,Homo sapiens,P08684,CHEMBL1155848,"J. Med. Chem., 51, p. 4632 (2008)",18620382,Scientific Literature
12b,CHEMBL1794073,"InChI=1S/C20H21N7O2S.ClH/c1-13-17-8-7-15(12-18(17)27(3)25-13)26(2)19-9-10-22-20(24-19)23-14-5-4-6-16(11-14)30(21,28)29;/h4-12H,1-3H3,(H2,21,28,29)(H,22,23,24);1H",Cl.CN(c1ccc2c(C)nn(C)c2c1)c3ccnc(Nc4cccc(c4)S(=O)(=O)N)n3,CHEMBL476571,"InChI=1S/C20H21N7O2S/c1-13-17-8-7-15(12-18(17)27(3)25-13)26(2)19-9-10-22-20(24-19)23-14-5-4-6-16(11-14)30(21,28)29/h4-12H,1-3H3,(H2,21,28,29)(H,22,23,24)",CN(c1ccc2c(C)nn(C)c2c1)c3ccnc(Nc4cccc(c4)S(=O)(=O)N)n3,CHEMBL983784,Inhibition of human recombinant CYP3A4 using diethoxyfluorescein substrate,IC50,=,13000,nM,,CHEMBL340,Cytochrome P450 3A4,Homo sapiens,P08684,CHEMBL1155848,"J. Med. Chem., 51, p. 4632 (2008)",18620382,Scientific Literature
12c,CHEMBL1794074,"InChI=1S/C20H21N7O2S.2ClH/c1-13-17-8-7-15(12-18(17)25-27(13)3)26(2)19-9-10-22-20(24-19)23-14-5-4-6-16(11-14)30(21,28)29;;/h4-12H,1-3H3,(H2,21,28,29)(H,22,23,24);2*1H",Cl.Cl.CN(c1ccc2c(C)n(C)nc2c1)c3ccnc(Nc4cccc(c4)S(=O)(=O)N)n3,CHEMBL514838,"InChI=1S/C20H21N7O2S/c1-13-17-8-7-15(12-18(17)25-27(13)3)26(2)19-9-10-22-20(24-19)23-14-5-4-6-16(11-14)30(21,28)29/h4-12H,1-3H3,(H2,21,28,29)(H,22,23,24)",CN(c1ccc2c(C)n(C)nc2c1)c3ccnc(Nc4cccc(c4)S(=O)(=O)N)n3,CHEMBL983784,Inhibition of human recombinant CYP3A4 using diethoxyfluorescein substrate,IC50,=,16000,nM,,CHEMBL340,Cytochrome P450 3A4,Homo sapiens,P08684,CHEMBL1155848,"J. Med. Chem., 51, p. 4632 (2008)",18620382,Scientific Literature
2,CHEMBL478442,"InChI=1S/C17H17N3O3/c1-10-4-5-11(6-14(10)21)20-17-12-7-15(22-2)16(23-3)8-13(12)18-9-19-17/h4-9,21H,1-3H3,(H,18,19,20)",COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC,CHEMBL478442,"InChI=1S/C17H17N3O3/c1-10-4-5-11(6-14(10)21)20-17-12-7-15(22-2)16(23-3)8-13(12)18-9-19-17/h4-9,21H,1-3H3,(H,18,19,20)",COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC,CHEMBL981072,Inhibition of human recombinant VEGFR2,IC50,=,0.6,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1155848,"J. Med. Chem., 51, p. 4632 (2008)",18620382,Scientific Literature
11a,CHEMBL475932,"InChI=1S/C22H24N6O3S/c1-5-32(29,30)16-7-9-20(31-4)19(13-16)24-22-23-11-10-21(25-22)28(3)15-6-8-17-14(2)26-27-18(17)12-15/h6-13H,5H2,1-4H3,(H,26,27)(H,23,24,25)",CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(n2)N(C)c3ccc4c(C)n[nH]c4c3)c1,CHEMBL475932,"InChI=1S/C22H24N6O3S/c1-5-32(29,30)16-7-9-20(31-4)19(13-16)24-22-23-11-10-21(25-22)28(3)15-6-8-17-14(2)26-27-18(17)12-15/h6-13H,5H2,1-4H3,(H,26,27)(H,23,24,25)",CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(n2)N(C)c3ccc4c(C)n[nH]c4c3)c1,CHEMBL981076,Oral bioavailability in rat at 10 mg/kg,F,=,65,%,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1155848,"J. Med. Chem., 51, p. 4632 (2008)",18620382,Scientific Literature
5a,CHEMBL479079,"InChI=1S/C21H22N6O3/c1-12-15-6-5-13(9-16(15)27-26-12)23-19-7-8-22-21(25-19)24-14-10-17(28-2)20(30-4)18(11-14)29-3/h5-11H,1-4H3,(H,26,27)(H2,22,23,24,25)",COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC,CHEMBL479079,"InChI=1S/C21H22N6O3/c1-12-15-6-5-13(9-16(15)27-26-12)23-19-7-8-22-21(25-19)24-14-10-17(28-2)20(30-4)18(11-14)29-3/h5-11H,1-4H3,(H,26,27)(H2,22,23,24,25)",COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC,CHEMBL981076,Oral bioavailability in rat at 10 mg/kg,F,=,85,%,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1155848,"J. Med. Chem., 51, p. 4632 (2008)",18620382,Scientific Literature
"1, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL984678,Binding affinity to B-Raf by fluorescene ligand binding assay,Kd,=,0.3,nM,,CHEMBL5145,Serine/threonine-protein kinase B-raf,Homo sapiens,P15056,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
10,CHEMBL1794072,"InChI=1S/C28H27N3O3.ClH/c1-31(2)15-16-33-23-7-3-19(4-8-23)27-18-25(28(34-27)20-11-13-29-14-12-20)22-5-9-24-21(17-22)6-10-26(24)30-32;/h3-5,7-9,11-14,17-18,32H,6,10,15-16H2,1-2H3;1H",Cl.CN(C)CCOc1ccc(cc1)c2oc(c3ccncc3)c(c2)c4ccc5C(=NO)CCc5c4,CHEMBL1852436,"InChI=1S/C28H27N3O3/c1-31(2)15-16-33-23-7-3-19(4-8-23)27-18-25(28(34-27)20-11-13-29-14-12-20)22-5-9-24-21(17-22)6-10-26(24)30-32/h3-5,7-9,11-14,17-18,32H,6,10,15-16H2,1-2H3",CN(C)CCOc1ccc(cc1)c2oc(c3ccncc3)c(c2)c4ccc5C(=NO)CCc5c4,CHEMBL984678,Binding affinity to B-Raf by fluorescene ligand binding assay,Kd,=,0.5,nM,,CHEMBL5145,Serine/threonine-protein kinase B-raf,Homo sapiens,P15056,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
5,CHEMBL1794071,"InChI=1S/C22H23N5O.ClH/c28-27-19-4-2-16-13-17(1-3-18(16)19)21-20(14-5-9-23-10-6-14)25-22(26-21)15-7-11-24-12-8-15;/h1,3,5-6,9-10,13,15,24,28H,2,4,7-8,11-12H2,(H,25,26);1H",Cl.ON=C1CCc2cc(ccc12)c3nc([nH]c3c4ccncc4)C5CCNCC5,CHEMBL1851806,"InChI=1S/C22H23N5O/c28-27-19-4-2-16-13-17(1-3-18(16)19)21-20(14-5-9-23-10-6-14)25-22(26-21)15-7-11-24-12-8-15/h1,3,5-6,9-10,13,15,24,28H,2,4,7-8,11-12H2,(H,25,26)",ON=C1CCc2cc(ccc12)c3[nH]c(nc3c4ccncc4)C5CCNCC5,CHEMBL984678,Binding affinity to B-Raf by fluorescene ligand binding assay,Kd,=,1.7,nM,,CHEMBL5145,Serine/threonine-protein kinase B-raf,Homo sapiens,P15056,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
"1, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL984683,Blood clearance in rat,CL,=,45,mL.min-1.kg-1,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
"1, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL984679,Inhibition of B-Raf-mediated ERK phosphorylation in rat PC12 cells at 1 uM pretreated for 60 mins prior to nerve growth factor stimulation,Inhibition,=,99,%,,CHEMBL612545,,,,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
10,CHEMBL1794072,"InChI=1S/C28H27N3O3.ClH/c1-31(2)15-16-33-23-7-3-19(4-8-23)27-18-25(28(34-27)20-11-13-29-14-12-20)22-5-9-24-21(17-22)6-10-26(24)30-32;/h3-5,7-9,11-14,17-18,32H,6,10,15-16H2,1-2H3;1H",Cl.CN(C)CCOc1ccc(cc1)c2oc(c3ccncc3)c(c2)c4ccc5C(=NO)CCc5c4,CHEMBL1852436,"InChI=1S/C28H27N3O3/c1-31(2)15-16-33-23-7-3-19(4-8-23)27-18-25(28(34-27)20-11-13-29-14-12-20)22-5-9-24-21(17-22)6-10-26(24)30-32/h3-5,7-9,11-14,17-18,32H,6,10,15-16H2,1-2H3",CN(C)CCOc1ccc(cc1)c2oc(c3ccncc3)c(c2)c4ccc5C(=NO)CCc5c4,CHEMBL984679,Inhibition of B-Raf-mediated ERK phosphorylation in rat PC12 cells at 1 uM pretreated for 60 mins prior to nerve growth factor stimulation,Inhibition,=,75,%,,CHEMBL612545,,,,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
5,CHEMBL1794071,"InChI=1S/C22H23N5O.ClH/c28-27-19-4-2-16-13-17(1-3-18(16)19)21-20(14-5-9-23-10-6-14)25-22(26-21)15-7-11-24-12-8-15;/h1,3,5-6,9-10,13,15,24,28H,2,4,7-8,11-12H2,(H,25,26);1H",Cl.ON=C1CCc2cc(ccc12)c3nc([nH]c3c4ccncc4)C5CCNCC5,CHEMBL1851806,"InChI=1S/C22H23N5O/c28-27-19-4-2-16-13-17(1-3-18(16)19)21-20(14-5-9-23-10-6-14)25-22(26-21)15-7-11-24-12-8-15/h1,3,5-6,9-10,13,15,24,28H,2,4,7-8,11-12H2,(H,25,26)",ON=C1CCc2cc(ccc12)c3[nH]c(nc3c4ccncc4)C5CCNCC5,CHEMBL984679,Inhibition of B-Raf-mediated ERK phosphorylation in rat PC12 cells at 1 uM pretreated for 60 mins prior to nerve growth factor stimulation,Inhibition,=,36,%,,CHEMBL612545,,,,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
"1, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL984680,Inhibition of B-Raf-mediated ERK phosphorylation in rat PC12 cells at 3 uM pretreated for 60 mins prior to nerve growth factor stimulation,Inhibition,=,101,%,,CHEMBL612545,,,,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
10,CHEMBL1794072,"InChI=1S/C28H27N3O3.ClH/c1-31(2)15-16-33-23-7-3-19(4-8-23)27-18-25(28(34-27)20-11-13-29-14-12-20)22-5-9-24-21(17-22)6-10-26(24)30-32;/h3-5,7-9,11-14,17-18,32H,6,10,15-16H2,1-2H3;1H",Cl.CN(C)CCOc1ccc(cc1)c2oc(c3ccncc3)c(c2)c4ccc5C(=NO)CCc5c4,CHEMBL1852436,"InChI=1S/C28H27N3O3/c1-31(2)15-16-33-23-7-3-19(4-8-23)27-18-25(28(34-27)20-11-13-29-14-12-20)22-5-9-24-21(17-22)6-10-26(24)30-32/h3-5,7-9,11-14,17-18,32H,6,10,15-16H2,1-2H3",CN(C)CCOc1ccc(cc1)c2oc(c3ccncc3)c(c2)c4ccc5C(=NO)CCc5c4,CHEMBL984680,Inhibition of B-Raf-mediated ERK phosphorylation in rat PC12 cells at 3 uM pretreated for 60 mins prior to nerve growth factor stimulation,Inhibition,=,87,%,,CHEMBL612545,,,,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
5,CHEMBL1794071,"InChI=1S/C22H23N5O.ClH/c28-27-19-4-2-16-13-17(1-3-18(16)19)21-20(14-5-9-23-10-6-14)25-22(26-21)15-7-11-24-12-8-15;/h1,3,5-6,9-10,13,15,24,28H,2,4,7-8,11-12H2,(H,25,26);1H",Cl.ON=C1CCc2cc(ccc12)c3nc([nH]c3c4ccncc4)C5CCNCC5,CHEMBL1851806,"InChI=1S/C22H23N5O/c28-27-19-4-2-16-13-17(1-3-18(16)19)21-20(14-5-9-23-10-6-14)25-22(26-21)15-7-11-24-12-8-15/h1,3,5-6,9-10,13,15,24,28H,2,4,7-8,11-12H2,(H,25,26)",ON=C1CCc2cc(ccc12)c3[nH]c(nc3c4ccncc4)C5CCNCC5,CHEMBL984680,Inhibition of B-Raf-mediated ERK phosphorylation in rat PC12 cells at 3 uM pretreated for 60 mins prior to nerve growth factor stimulation,Inhibition,=,59,%,,CHEMBL612545,,,,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
"1, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL984695,Inhibition of bovine heart PKA,Inhibition,=,-2,%,,CHEMBL612545,,,,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
"1, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL984705,"Inhibition of cold water stress-induced hippocampal ERK phosphorylation in rat administered at 3 or 10 mg/kg, iv bolus 5 mins prior to cold water swim by western blotting",Activity,,,,Active,CHEMBL612545,,,,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
"1, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL984677,Inhibition of human Chk1 expressed in Escherichia coli at 10 uM,Inhibition,=,9,%,,CHEMBL2527,Serine/threonine-protein kinase Chk2,Homo sapiens,O96017,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
"1, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL984686,Inhibition of human Ck2 expressed in insect Sf9 cells at 10 uM,Inhibition,=,8,%,,CHEMBL612545,,,,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
"1, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL984687,Inhibition of human GSK3-beta expressed in insect Sf21 cells at 10 uM,Inhibition,=,25,%,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
"1, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL984676,Inhibition of human JNK1alpha1 expressed in insect Sf21 cells at 10 uM,Inhibition,=,19,%,,CHEMBL2276,c-Jun N-terminal kinase 1,Homo sapiens,P45983,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
"1, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL984688,Inhibition of human Lck expressed in insect Sf9 cells at 10 uM,Inhibition,=,39,%,,CHEMBL258,Tyrosine-protein kinase LCK,Homo sapiens,P06239,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
"1, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL984689,Inhibition of human MAPK2 at 10 uM,Inhibition,=,11,%,,CHEMBL4040,MAP kinase ERK2,Homo sapiens,P28482,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
"1, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL984690,Inhibition of human MAPKAPK2 expressed in Escherichia coli at 10 uM,Inhibition,=,9,%,,CHEMBL2208,MAP kinase-activated protein kinase 2,Homo sapiens,P49137,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
"1, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL984691,Inhibition of human MEK1 at 10 uM,Inhibition,=,14,%,,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,Homo sapiens,Q02750,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
"1, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL984692,Inhibition of human MSK1 expressed in insect Sf9 cells at 10 uM,Inhibition,=,38,%,,CHEMBL4237,Ribosomal protein S6 kinase alpha 5,Homo sapiens,O75582,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
"1, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL984696,Inhibition of human PKBalpha expressed in insect Sf9 cells at 10 uM,Inhibition,=,8,%,,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,P31749,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
"1, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL984697,Inhibition of human PKCalpha at 10 uM,Inhibition,=,10,%,,CHEMBL299,Protein kinase C alpha ,Homo sapiens,P17252,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
"1, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL984698,Inhibition of human PRAK expressed in insect Sf9 cells at 10 uM,Inhibition,=,18,%,,CHEMBL3094,MAP kinase-activated protein kinase 5,Homo sapiens,Q8IW41,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
"1, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL984704,Inhibition of human SGK at 10 uM,Inhibition,=,17,%,,CHEMBL2343,Serine/threonine-protein kinase Sgk1,Homo sapiens,O00141,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
"1, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL984702,Inhibition of human p38-gamma at 10 uM,Inhibition,=,10,%,,CHEMBL4674,MAP kinase p38 gamma,Homo sapiens,P53778,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
"1, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL984700,Inhibition of human p38alpha at 10 uM,Inhibition,=,46,%,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
"1, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL984701,Inhibition of human p38beta at 10 uM,Inhibition,=,9,%,,CHEMBL3961,MAP kinase p38 beta,Homo sapiens,Q15759,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
"1, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL984703,Inhibition of human p38delta at 10 uM,Inhibition,=,10,%,,CHEMBL2939,MAP kinase p38 delta,Homo sapiens,O15264,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
"1, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL984693,Inhibition of human p70S6K at 10 uM,Inhibition,=,13,%,,CHEMBL4501,Ribosomal protein S6 kinase 1,Homo sapiens,P23443,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
"1, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL984694,Inhibition of rabbit skeletal muscle phosphorylase kinase,Inhibition,=,3,%,,CHEMBL612545,,,,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
"1, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL984699,Inhibition of rat ROCK2 expressed in insect Sf9 cells at 10 uM,Inhibition,=,26,%,,CHEMBL5490,Rho-associated protein kinase 2,Rattus norvegicus,Q62868,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
"1, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL984685,Inhibition of rat liver AMPK at 10 uM,Inhibition,=,14,%,,CHEMBL4637,"AMP-activated protein kinase, alpha-2 subunit",Rattus norvegicus,Q09137,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
"1, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL984682,Neuroprotective activity against oxygen and glucose deprivation-induced cell death in rat hippocampal slices,Activity,,,,Active,CHEMBL613631,Hippocampus,Rattus norvegicus,,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
"1, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL984684,"Ratio of drug level in brain to blood in rat at 1 and 3 mg/kg/h, iv infused to steady-state for 6 to 16 hrs",Ratio,=,0.14,,,CHEMBL612558,,,,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
10,CHEMBL1794072,"InChI=1S/C28H27N3O3.ClH/c1-31(2)15-16-33-23-7-3-19(4-8-23)27-18-25(28(34-27)20-11-13-29-14-12-20)22-5-9-24-21(17-22)6-10-26(24)30-32;/h3-5,7-9,11-14,17-18,32H,6,10,15-16H2,1-2H3;1H",Cl.CN(C)CCOc1ccc(cc1)c2oc(c3ccncc3)c(c2)c4ccc5C(=NO)CCc5c4,CHEMBL1852436,"InChI=1S/C28H27N3O3/c1-31(2)15-16-33-23-7-3-19(4-8-23)27-18-25(28(34-27)20-11-13-29-14-12-20)22-5-9-24-21(17-22)6-10-26(24)30-32/h3-5,7-9,11-14,17-18,32H,6,10,15-16H2,1-2H3",CN(C)CCOc1ccc(cc1)c2oc(c3ccncc3)c(c2)c4ccc5C(=NO)CCc5c4,CHEMBL984684,"Ratio of drug level in brain to blood in rat at 1 and 3 mg/kg/h, iv infused to steady-state for 6 to 16 hrs",Ratio,=,1.33,,,CHEMBL612558,,,,CHEMBL1155855,"Bioorg. Med. Chem. Lett., 18, p. 4373 (2008)",18621524,Scientific Literature
3,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL967076,Inhibition of GSK3,IC50,=,0.8,nM,,CHEMBL612545,,,,CHEMBL1155871,"Bioorg. Med. Chem., 16, p. 7167 (2008)",18625560,Scientific Literature
6e,CHEMBL505187,"InChI=1S/C32H28N6O2/c1-2-38-20-29(27-15-17-33-31-28(27)16-18-34-31)30(37-38)23-9-6-10-25(19-23)36-32(39)35-24-11-13-26(14-12-24)40-21-22-7-4-3-5-8-22/h3-20H,2,21H2,1H3,(H,33,34)(H2,35,36,39)",CCn1cc(c2ccnc3[nH]ccc23)c(n1)c4cccc(NC(=O)Nc5ccc(OCc6ccccc6)cc5)c4,CHEMBL505187,"InChI=1S/C32H28N6O2/c1-2-38-20-29(27-15-17-33-31-28(27)16-18-34-31)30(37-38)23-9-6-10-25(19-23)36-32(39)35-24-11-13-26(14-12-24)40-21-22-7-4-3-5-8-22/h3-20H,2,21H2,1H3,(H,33,34)(H2,35,36,39)",CCn1cc(c2ccnc3[nH]ccc23)c(n1)c4cccc(NC(=O)Nc5ccc(OCc6ccccc6)cc5)c4,CHEMBL971750,Inhibition of B-Raf by fluorescence anisotropy binding assay,IC50,=,110,nM,,CHEMBL5145,Serine/threonine-protein kinase B-raf,Homo sapiens,P15056,CHEMBL1156556,"Bioorg. Med. Chem. Lett., 18, p. 4610 (2008)",18662874,Scientific Literature
47,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL997786,Inhibition of CDK2,IC50,=,5,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1156672,"Eur. J. Med. Chem., 43, p. 949 (2008)",17707953,Scientific Literature
60,CHEMBL405021,"InChI=1S/C17H15N3O/c21-17(12-6-7-12)18-16-14-9-8-13(10-15(14)19-20-16)11-4-2-1-3-5-11/h1-5,8-10,12H,6-7H2,(H2,18,19,20,21)",O=C(Nc1n[nH]c2cc(ccc12)c3ccccc3)C4CC4,CHEMBL405021,"InChI=1S/C17H15N3O/c21-17(12-6-7-12)18-16-14-9-8-13(10-15(14)19-20-16)11-4-2-1-3-5-11/h1-5,8-10,12H,6-7H2,(H2,18,19,20,21)",O=C(Nc1n[nH]c2cc(ccc12)c3ccccc3)C4CC4,CHEMBL997786,Inhibition of CDK2,IC50,>,1000,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1156672,"Eur. J. Med. Chem., 43, p. 949 (2008)",17707953,Scientific Literature
63,CHEMBL407113,"InChI=1S/C17H16N4O3S/c18-25(23,24)13-3-1-2-11(8-13)12-6-7-14-15(9-12)20-21-16(14)19-17(22)10-4-5-10/h1-3,6-10H,4-5H2,(H2,18,23,24)(H2,19,20,21,22)",NS(=O)(=O)c1cccc(c1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL407113,"InChI=1S/C17H16N4O3S/c18-25(23,24)13-3-1-2-11(8-13)12-6-7-14-15(9-12)20-21-16(14)19-17(22)10-4-5-10/h1-3,6-10H,4-5H2,(H2,18,23,24)(H2,19,20,21,22)",NS(=O)(=O)c1cccc(c1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL997786,Inhibition of CDK2,IC50,>,1000,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1156672,"Eur. J. Med. Chem., 43, p. 949 (2008)",17707953,Scientific Literature
72,CHEMBL101804,"InChI=1S/C14H12N4O2/c19-14(8-3-4-8)16-13-9-5-6-10(11-2-1-7-20-11)15-12(9)17-18-13/h1-2,5-8H,3-4H2,(H2,15,16,17,18,19)",O=C(Nc1n[nH]c2nc(ccc12)c3occc3)C4CC4,CHEMBL101804,"InChI=1S/C14H12N4O2/c19-14(8-3-4-8)16-13-9-5-6-10(11-2-1-7-20-11)15-12(9)17-18-13/h1-2,5-8H,3-4H2,(H2,15,16,17,18,19)",O=C(Nc1n[nH]c2nc(ccc12)c3occc3)C4CC4,CHEMBL997786,Inhibition of CDK2,IC50,>,1000,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1156672,"Eur. J. Med. Chem., 43, p. 949 (2008)",17707953,Scientific Literature
73,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL997786,Inhibition of CDK2,IC50,>,1000,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1156672,"Eur. J. Med. Chem., 43, p. 949 (2008)",17707953,Scientific Literature
76,CHEMBL101747,"InChI=1S/C19H22BrN5OS/c1-2-25-7-5-12(6-8-25)10-16(26)21-18-13-11-14(20)17(15-4-3-9-27-15)22-19(13)24-23-18/h3-4,9,11-12H,2,5-8,10H2,1H3,(H2,21,22,23,24,26)",CCN1CCC(CC(=O)Nc2n[nH]c3nc(c(Br)cc23)c4cccs4)CC1,CHEMBL101747,"InChI=1S/C19H22BrN5OS/c1-2-25-7-5-12(6-8-25)10-16(26)21-18-13-11-14(20)17(15-4-3-9-27-15)22-19(13)24-23-18/h3-4,9,11-12H,2,5-8,10H2,1H3,(H2,21,22,23,24,26)",CCN1CCC(CC(=O)Nc2n[nH]c3nc(c(Br)cc23)c4cccs4)CC1,CHEMBL997786,Inhibition of CDK2,IC50,>,1000,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1156672,"Eur. J. Med. Chem., 43, p. 949 (2008)",17707953,Scientific Literature
32,CHEMBL406125,"InChI=1S/C18H20N6O/c1-24-9-7-13(8-10-24)18(25)19-16-14-11-15(12-5-3-2-4-6-12)20-22-17(14)23-21-16/h2-6,11,13H,7-10H2,1H3,(H2,19,21,22,23,25)",CN1CCC(CC1)C(=O)Nc2n[nH]c3nnc(cc23)c4ccccc4,CHEMBL406125,"InChI=1S/C18H20N6O/c1-24-9-7-13(8-10-24)18(25)19-16-14-11-15(12-5-3-2-4-6-12)20-22-17(14)23-21-16/h2-6,11,13H,7-10H2,1H3,(H2,19,21,22,23,25)",CN1CCC(CC1)C(=O)Nc2n[nH]c3nnc(cc23)c4ccccc4,CHEMBL997785,Inhibition of GSK3,IC50,=,9,nM,,CHEMBL612545,,,,CHEMBL1156672,"Eur. J. Med. Chem., 43, p. 949 (2008)",17707953,Scientific Literature
35,CHEMBL35785,"InChI=1S/C14H12N6O/c21-14(8-3-4-8)16-12-10-6-11(9-2-1-5-15-7-9)17-19-13(10)20-18-12/h1-2,5-8H,3-4H2,(H2,16,18,19,20,21)",O=C(Nc1n[nH]c2nnc(cc12)c3cccnc3)C4CC4,CHEMBL35785,"InChI=1S/C14H12N6O/c21-14(8-3-4-8)16-12-10-6-11(9-2-1-5-15-7-9)17-19-13(10)20-18-12/h1-2,5-8H,3-4H2,(H2,16,18,19,20,21)",O=C(Nc1n[nH]c2nnc(cc12)c3cccnc3)C4CC4,CHEMBL997785,Inhibition of GSK3,IC50,=,0.08,nM,,CHEMBL612545,,,,CHEMBL1156672,"Eur. J. Med. Chem., 43, p. 949 (2008)",17707953,Scientific Literature
37,CHEMBL39300,"InChI=1S/C19H20F2N6O/c1-2-27-8-6-11(7-9-27)19(28)22-17-13-10-15(23-25-18(13)26-24-17)12-4-3-5-14(20)16(12)21/h3-5,10-11H,2,6-9H2,1H3,(H2,22,24,25,26,28)",CCN1CCC(CC1)C(=O)Nc2n[nH]c3nnc(cc23)c4cccc(F)c4F,CHEMBL39300,"InChI=1S/C19H20F2N6O/c1-2-27-8-6-11(7-9-27)19(28)22-17-13-10-15(23-25-18(13)26-24-17)12-4-3-5-14(20)16(12)21/h3-5,10-11H,2,6-9H2,1H3,(H2,22,24,25,26,28)",CCN1CCC(CC1)C(=O)Nc2n[nH]c3nnc(cc23)c4cccc(F)c4F,CHEMBL997785,Inhibition of GSK3,IC50,=,0.95,nM,,CHEMBL612545,,,,CHEMBL1156672,"Eur. J. Med. Chem., 43, p. 949 (2008)",17707953,Scientific Literature
38,CHEMBL38425,"InChI=1S/C20H22F2N6O/c1-2-28-8-6-12(7-9-28)10-17(29)23-19-14-11-16(24-26-20(14)27-25-19)13-4-3-5-15(21)18(13)22/h3-5,11-12H,2,6-10H2,1H3,(H2,23,25,26,27,29)",CCN1CCC(CC(=O)Nc2n[nH]c3nnc(cc23)c4cccc(F)c4F)CC1,CHEMBL38425,"InChI=1S/C20H22F2N6O/c1-2-28-8-6-12(7-9-28)10-17(29)23-19-14-11-16(24-26-20(14)27-25-19)13-4-3-5-15(21)18(13)22/h3-5,11-12H,2,6-10H2,1H3,(H2,23,25,26,27,29)",CCN1CCC(CC(=O)Nc2n[nH]c3nnc(cc23)c4cccc(F)c4F)CC1,CHEMBL997785,Inhibition of GSK3,IC50,=,0.19,nM,,CHEMBL612545,,,,CHEMBL1156672,"Eur. J. Med. Chem., 43, p. 949 (2008)",17707953,Scientific Literature
47,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL997785,Inhibition of GSK3,IC50,=,0.8,nM,,CHEMBL612545,,,,CHEMBL1156672,"Eur. J. Med. Chem., 43, p. 949 (2008)",17707953,Scientific Literature
57,CHEMBL261129,"InChI=1S/C19H20BrN5O2/c1-25-8-6-12(7-9-25)19(27)22-18-14-10-15(20)16(21-17(14)23-24-18)11-2-4-13(26)5-3-11/h2-5,10,12,26H,6-9H2,1H3,(H2,21,22,23,24,27)",CN1CCC(CC1)C(=O)Nc2n[nH]c3nc(c(Br)cc23)c4ccc(O)cc4,CHEMBL261129,"InChI=1S/C19H20BrN5O2/c1-25-8-6-12(7-9-25)19(27)22-18-14-10-15(20)16(21-17(14)23-24-18)11-2-4-13(26)5-3-11/h2-5,10,12,26H,6-9H2,1H3,(H2,21,22,23,24,27)",CN1CCC(CC1)C(=O)Nc2n[nH]c3nc(c(Br)cc23)c4ccc(O)cc4,CHEMBL997785,Inhibition of GSK3,IC50,=,1,nM,,CHEMBL612545,,,,CHEMBL1156672,"Eur. J. Med. Chem., 43, p. 949 (2008)",17707953,Scientific Literature
60,CHEMBL405021,"InChI=1S/C17H15N3O/c21-17(12-6-7-12)18-16-14-9-8-13(10-15(14)19-20-16)11-4-2-1-3-5-11/h1-5,8-10,12H,6-7H2,(H2,18,19,20,21)",O=C(Nc1n[nH]c2cc(ccc12)c3ccccc3)C4CC4,CHEMBL405021,"InChI=1S/C17H15N3O/c21-17(12-6-7-12)18-16-14-9-8-13(10-15(14)19-20-16)11-4-2-1-3-5-11/h1-5,8-10,12H,6-7H2,(H2,18,19,20,21)",O=C(Nc1n[nH]c2cc(ccc12)c3ccccc3)C4CC4,CHEMBL997785,Inhibition of GSK3,IC50,=,498,nM,,CHEMBL612545,,,,CHEMBL1156672,"Eur. J. Med. Chem., 43, p. 949 (2008)",17707953,Scientific Literature
63,CHEMBL407113,"InChI=1S/C17H16N4O3S/c18-25(23,24)13-3-1-2-11(8-13)12-6-7-14-15(9-12)20-21-16(14)19-17(22)10-4-5-10/h1-3,6-10H,4-5H2,(H2,18,23,24)(H2,19,20,21,22)",NS(=O)(=O)c1cccc(c1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL407113,"InChI=1S/C17H16N4O3S/c18-25(23,24)13-3-1-2-11(8-13)12-6-7-14-15(9-12)20-21-16(14)19-17(22)10-4-5-10/h1-3,6-10H,4-5H2,(H2,18,23,24)(H2,19,20,21,22)",NS(=O)(=O)c1cccc(c1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL997785,Inhibition of GSK3,IC50,=,481,nM,,CHEMBL612545,,,,CHEMBL1156672,"Eur. J. Med. Chem., 43, p. 949 (2008)",17707953,Scientific Literature
72,CHEMBL101804,"InChI=1S/C14H12N4O2/c19-14(8-3-4-8)16-13-9-5-6-10(11-2-1-7-20-11)15-12(9)17-18-13/h1-2,5-8H,3-4H2,(H2,15,16,17,18,19)",O=C(Nc1n[nH]c2nc(ccc12)c3occc3)C4CC4,CHEMBL101804,"InChI=1S/C14H12N4O2/c19-14(8-3-4-8)16-13-9-5-6-10(11-2-1-7-20-11)15-12(9)17-18-13/h1-2,5-8H,3-4H2,(H2,15,16,17,18,19)",O=C(Nc1n[nH]c2nc(ccc12)c3occc3)C4CC4,CHEMBL997785,Inhibition of GSK3,IC50,=,141,nM,,CHEMBL612545,,,,CHEMBL1156672,"Eur. J. Med. Chem., 43, p. 949 (2008)",17707953,Scientific Literature
73,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL997785,Inhibition of GSK3,IC50,=,7,nM,,CHEMBL612545,,,,CHEMBL1156672,"Eur. J. Med. Chem., 43, p. 949 (2008)",17707953,Scientific Literature
76,CHEMBL101747,"InChI=1S/C19H22BrN5OS/c1-2-25-7-5-12(6-8-25)10-16(26)21-18-13-11-14(20)17(15-4-3-9-27-15)22-19(13)24-23-18/h3-4,9,11-12H,2,5-8,10H2,1H3,(H2,21,22,23,24,26)",CCN1CCC(CC(=O)Nc2n[nH]c3nc(c(Br)cc23)c4cccs4)CC1,CHEMBL101747,"InChI=1S/C19H22BrN5OS/c1-2-25-7-5-12(6-8-25)10-16(26)21-18-13-11-14(20)17(15-4-3-9-27-15)22-19(13)24-23-18/h3-4,9,11-12H,2,5-8,10H2,1H3,(H2,21,22,23,24,26)",CCN1CCC(CC(=O)Nc2n[nH]c3nc(c(Br)cc23)c4cccs4)CC1,CHEMBL997785,Inhibition of GSK3,IC50,=,18,nM,,CHEMBL612545,,,,CHEMBL1156672,"Eur. J. Med. Chem., 43, p. 949 (2008)",17707953,Scientific Literature
32,CHEMBL406125,"InChI=1S/C18H20N6O/c1-24-9-7-13(8-10-24)18(25)19-16-14-11-15(12-5-3-2-4-6-12)20-22-17(14)23-21-16/h2-6,11,13H,7-10H2,1H3,(H2,19,21,22,23,25)",CN1CCC(CC1)C(=O)Nc2n[nH]c3nnc(cc23)c4ccccc4,CHEMBL406125,"InChI=1S/C18H20N6O/c1-24-9-7-13(8-10-24)18(25)19-16-14-11-15(12-5-3-2-4-6-12)20-22-17(14)23-21-16/h2-6,11,13H,7-10H2,1H3,(H2,19,21,22,23,25)",CN1CCC(CC1)C(=O)Nc2n[nH]c3nnc(cc23)c4ccccc4,CHEMBL997785,Inhibition of GSK3,pIC50,=,8.05,,,CHEMBL612545,,,,CHEMBL1156672,"Eur. J. Med. Chem., 43, p. 949 (2008)",17707953,Scientific Literature
35,CHEMBL35785,"InChI=1S/C14H12N6O/c21-14(8-3-4-8)16-12-10-6-11(9-2-1-5-15-7-9)17-19-13(10)20-18-12/h1-2,5-8H,3-4H2,(H2,16,18,19,20,21)",O=C(Nc1n[nH]c2nnc(cc12)c3cccnc3)C4CC4,CHEMBL35785,"InChI=1S/C14H12N6O/c21-14(8-3-4-8)16-12-10-6-11(9-2-1-5-15-7-9)17-19-13(10)20-18-12/h1-2,5-8H,3-4H2,(H2,16,18,19,20,21)",O=C(Nc1n[nH]c2nnc(cc12)c3cccnc3)C4CC4,CHEMBL997785,Inhibition of GSK3,pIC50,=,10.1,,,CHEMBL612545,,,,CHEMBL1156672,"Eur. J. Med. Chem., 43, p. 949 (2008)",17707953,Scientific Literature
37,CHEMBL39300,"InChI=1S/C19H20F2N6O/c1-2-27-8-6-11(7-9-27)19(28)22-17-13-10-15(23-25-18(13)26-24-17)12-4-3-5-14(20)16(12)21/h3-5,10-11H,2,6-9H2,1H3,(H2,22,24,25,26,28)",CCN1CCC(CC1)C(=O)Nc2n[nH]c3nnc(cc23)c4cccc(F)c4F,CHEMBL39300,"InChI=1S/C19H20F2N6O/c1-2-27-8-6-11(7-9-27)19(28)22-17-13-10-15(23-25-18(13)26-24-17)12-4-3-5-14(20)16(12)21/h3-5,10-11H,2,6-9H2,1H3,(H2,22,24,25,26,28)",CCN1CCC(CC1)C(=O)Nc2n[nH]c3nnc(cc23)c4cccc(F)c4F,CHEMBL997785,Inhibition of GSK3,pIC50,=,9.02,,,CHEMBL612545,,,,CHEMBL1156672,"Eur. J. Med. Chem., 43, p. 949 (2008)",17707953,Scientific Literature
38,CHEMBL38425,"InChI=1S/C20H22F2N6O/c1-2-28-8-6-12(7-9-28)10-17(29)23-19-14-11-16(24-26-20(14)27-25-19)13-4-3-5-15(21)18(13)22/h3-5,11-12H,2,6-10H2,1H3,(H2,23,25,26,27,29)",CCN1CCC(CC(=O)Nc2n[nH]c3nnc(cc23)c4cccc(F)c4F)CC1,CHEMBL38425,"InChI=1S/C20H22F2N6O/c1-2-28-8-6-12(7-9-28)10-17(29)23-19-14-11-16(24-26-20(14)27-25-19)13-4-3-5-15(21)18(13)22/h3-5,11-12H,2,6-10H2,1H3,(H2,23,25,26,27,29)",CCN1CCC(CC(=O)Nc2n[nH]c3nnc(cc23)c4cccc(F)c4F)CC1,CHEMBL997785,Inhibition of GSK3,pIC50,=,9.72,,,CHEMBL612545,,,,CHEMBL1156672,"Eur. J. Med. Chem., 43, p. 949 (2008)",17707953,Scientific Literature
47,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL997785,Inhibition of GSK3,pIC50,=,9.09,,,CHEMBL612545,,,,CHEMBL1156672,"Eur. J. Med. Chem., 43, p. 949 (2008)",17707953,Scientific Literature
57,CHEMBL261129,"InChI=1S/C19H20BrN5O2/c1-25-8-6-12(7-9-25)19(27)22-18-14-10-15(20)16(21-17(14)23-24-18)11-2-4-13(26)5-3-11/h2-5,10,12,26H,6-9H2,1H3,(H2,21,22,23,24,27)",CN1CCC(CC1)C(=O)Nc2n[nH]c3nc(c(Br)cc23)c4ccc(O)cc4,CHEMBL261129,"InChI=1S/C19H20BrN5O2/c1-25-8-6-12(7-9-25)19(27)22-18-14-10-15(20)16(21-17(14)23-24-18)11-2-4-13(26)5-3-11/h2-5,10,12,26H,6-9H2,1H3,(H2,21,22,23,24,27)",CN1CCC(CC1)C(=O)Nc2n[nH]c3nc(c(Br)cc23)c4ccc(O)cc4,CHEMBL997785,Inhibition of GSK3,pIC50,=,9,,,CHEMBL612545,,,,CHEMBL1156672,"Eur. J. Med. Chem., 43, p. 949 (2008)",17707953,Scientific Literature
60,CHEMBL405021,"InChI=1S/C17H15N3O/c21-17(12-6-7-12)18-16-14-9-8-13(10-15(14)19-20-16)11-4-2-1-3-5-11/h1-5,8-10,12H,6-7H2,(H2,18,19,20,21)",O=C(Nc1n[nH]c2cc(ccc12)c3ccccc3)C4CC4,CHEMBL405021,"InChI=1S/C17H15N3O/c21-17(12-6-7-12)18-16-14-9-8-13(10-15(14)19-20-16)11-4-2-1-3-5-11/h1-5,8-10,12H,6-7H2,(H2,18,19,20,21)",O=C(Nc1n[nH]c2cc(ccc12)c3ccccc3)C4CC4,CHEMBL997785,Inhibition of GSK3,pIC50,=,6.3,,,CHEMBL612545,,,,CHEMBL1156672,"Eur. J. Med. Chem., 43, p. 949 (2008)",17707953,Scientific Literature
63,CHEMBL407113,"InChI=1S/C17H16N4O3S/c18-25(23,24)13-3-1-2-11(8-13)12-6-7-14-15(9-12)20-21-16(14)19-17(22)10-4-5-10/h1-3,6-10H,4-5H2,(H2,18,23,24)(H2,19,20,21,22)",NS(=O)(=O)c1cccc(c1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL407113,"InChI=1S/C17H16N4O3S/c18-25(23,24)13-3-1-2-11(8-13)12-6-7-14-15(9-12)20-21-16(14)19-17(22)10-4-5-10/h1-3,6-10H,4-5H2,(H2,18,23,24)(H2,19,20,21,22)",NS(=O)(=O)c1cccc(c1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL997785,Inhibition of GSK3,pIC50,=,6.32,,,CHEMBL612545,,,,CHEMBL1156672,"Eur. J. Med. Chem., 43, p. 949 (2008)",17707953,Scientific Literature
72,CHEMBL101804,"InChI=1S/C14H12N4O2/c19-14(8-3-4-8)16-13-9-5-6-10(11-2-1-7-20-11)15-12(9)17-18-13/h1-2,5-8H,3-4H2,(H2,15,16,17,18,19)",O=C(Nc1n[nH]c2nc(ccc12)c3occc3)C4CC4,CHEMBL101804,"InChI=1S/C14H12N4O2/c19-14(8-3-4-8)16-13-9-5-6-10(11-2-1-7-20-11)15-12(9)17-18-13/h1-2,5-8H,3-4H2,(H2,15,16,17,18,19)",O=C(Nc1n[nH]c2nc(ccc12)c3occc3)C4CC4,CHEMBL997785,Inhibition of GSK3,pIC50,=,6.85,,,CHEMBL612545,,,,CHEMBL1156672,"Eur. J. Med. Chem., 43, p. 949 (2008)",17707953,Scientific Literature
73,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL997785,Inhibition of GSK3,pIC50,=,8.15,,,CHEMBL612545,,,,CHEMBL1156672,"Eur. J. Med. Chem., 43, p. 949 (2008)",17707953,Scientific Literature
76,CHEMBL101747,"InChI=1S/C19H22BrN5OS/c1-2-25-7-5-12(6-8-25)10-16(26)21-18-13-11-14(20)17(15-4-3-9-27-15)22-19(13)24-23-18/h3-4,9,11-12H,2,5-8,10H2,1H3,(H2,21,22,23,24,26)",CCN1CCC(CC(=O)Nc2n[nH]c3nc(c(Br)cc23)c4cccs4)CC1,CHEMBL101747,"InChI=1S/C19H22BrN5OS/c1-2-25-7-5-12(6-8-25)10-16(26)21-18-13-11-14(20)17(15-4-3-9-27-15)22-19(13)24-23-18/h3-4,9,11-12H,2,5-8,10H2,1H3,(H2,21,22,23,24,26)",CCN1CCC(CC(=O)Nc2n[nH]c3nc(c(Br)cc23)c4cccs4)CC1,CHEMBL997785,Inhibition of GSK3,pIC50,=,7.74,,,CHEMBL612545,,,,CHEMBL1156672,"Eur. J. Med. Chem., 43, p. 949 (2008)",17707953,Scientific Literature
"28, SKF-86002",CHEMBL313417,"InChI=1S/C16H12FN3S/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14/h1-8H,9-10H2",Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL313417,"InChI=1S/C16H12FN3S/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14/h1-8H,9-10H2",Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL1050681,"Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of p38alpha expressed in Escherichia coli BL21(DE3) cells by enzyme fragment complementation assay",IC50,=,820,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1156773,"J. Med. Chem., 53, p. 357 (2010)",19928858,Scientific Literature
"28, SKF-86002",CHEMBL313417,"InChI=1S/C16H12FN3S/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14/h1-8H,9-10H2",Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL313417,"InChI=1S/C16H12FN3S/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14/h1-8H,9-10H2",Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL1050682,Inhibition of p38alpha active form expressed in Escherichia coli BL21(DE3) cells by HTRF assay,IC50,=,110,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1156773,"J. Med. Chem., 53, p. 357 (2010)",19928858,Scientific Literature
19,CHEMBL1096290,"InChI=1S/C20H25N7O2/c1-4-27-15-11-13(12-26-9-5-6-10-26)22-14(7-8-20(2,3)28)16(15)23-19(27)17-18(21)25-29-24-17/h11,28H,4-6,9-10,12H2,1-3H3,(H2,21,25)",CCn1c(nc2c(nc(CN3CCCC3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1096290,"InChI=1S/C20H25N7O2/c1-4-27-15-11-13(12-26-9-5-6-10-26)22-14(7-8-20(2,3)28)16(15)23-19(27)17-18(21)25-29-24-17/h11,28H,4-6,9-10,12H2,1-3H3,(H2,21,25)",CCn1c(nc2c(nc(CN3CCCC3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1109956,Antiproliferative activity against human BT474 cells,IC50,=,1250,nM,,CHEMBL612545,,,,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
23,CHEMBL1098943,"InChI=1S/C18H23N7O3/c1-5-25-12-10-13(27-9-8-20-4)21-11(6-7-18(2,3)26)14(12)22-17(25)15-16(19)24-28-23-15/h10,20,26H,5,8-9H2,1-4H3,(H2,19,24)",CCn1c(nc2c(nc(OCCNC)cc12)C#CC(C)(C)O)c3nonc3N,CHEMBL1098943,"InChI=1S/C18H23N7O3/c1-5-25-12-10-13(27-9-8-20-4)21-11(6-7-18(2,3)26)14(12)22-17(25)15-16(19)24-28-23-15/h10,20,26H,5,8-9H2,1-4H3,(H2,19,24)",CCn1c(nc2c(nc(OCCNC)cc12)C#CC(C)(C)O)c3nonc3N,CHEMBL1109956,Antiproliferative activity against human BT474 cells,IC50,=,3190,nM,,CHEMBL612545,,,,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
26,CHEMBL1096634,"InChI=1S/C23H25N7O3/c1-4-30-17-12-18(32-13-15(24)14-8-6-5-7-9-14)26-16(10-11-23(2,3)31)19(17)27-22(30)20-21(25)29-33-28-20/h5-9,12,15,31H,4,13,24H2,1-3H3,(H2,25,29)/t15-/m0/s1",CCn1c(nc2c(nc(OC[C@H](N)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1096634,"InChI=1S/C23H25N7O3/c1-4-30-17-12-18(32-13-15(24)14-8-6-5-7-9-14)26-16(10-11-23(2,3)31)19(17)27-22(30)20-21(25)29-33-28-20/h5-9,12,15,31H,4,13,24H2,1-3H3,(H2,25,29)/t15-/m0/s1",CCn1c(nc2c(nc(OC[C@H](N)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1109956,Antiproliferative activity against human BT474 cells,IC50,=,2100,nM,,CHEMBL612545,,,,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
27,CHEMBL1096626,"InChI=1S/C23H25N7O3/c1-4-30-17-12-18(32-13-15(24)14-8-6-5-7-9-14)26-16(10-11-23(2,3)31)19(17)27-22(30)20-21(25)29-33-28-20/h5-9,12,15,31H,4,13,24H2,1-3H3,(H2,25,29)/t15-/m1/s1",CCn1c(nc2c(nc(OC[C@@H](N)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1096626,"InChI=1S/C23H25N7O3/c1-4-30-17-12-18(32-13-15(24)14-8-6-5-7-9-14)26-16(10-11-23(2,3)31)19(17)27-22(30)20-21(25)29-33-28-20/h5-9,12,15,31H,4,13,24H2,1-3H3,(H2,25,29)/t15-/m1/s1",CCn1c(nc2c(nc(OC[C@@H](N)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1109956,Antiproliferative activity against human BT474 cells,IC50,=,3440,nM,,CHEMBL612545,,,,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
30,CHEMBL1099276,"InChI=1S/C23H25N7O3/c1-4-30-16-12-18(32-17(13-24)14-8-6-5-7-9-14)26-15(10-11-23(2,3)31)19(16)27-22(30)20-21(25)29-33-28-20/h5-9,12,17,31H,4,13,24H2,1-3H3,(H2,25,29)/t17-/m0/s1",CCn1c(nc2c(nc(O[C@@H](CN)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1099276,"InChI=1S/C23H25N7O3/c1-4-30-16-12-18(32-17(13-24)14-8-6-5-7-9-14)26-15(10-11-23(2,3)31)19(16)27-22(30)20-21(25)29-33-28-20/h5-9,12,17,31H,4,13,24H2,1-3H3,(H2,25,29)/t17-/m0/s1",CCn1c(nc2c(nc(O[C@@H](CN)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1109956,Antiproliferative activity against human BT474 cells,IC50,=,35,nM,,CHEMBL612545,,,,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
19,CHEMBL1096290,"InChI=1S/C20H25N7O2/c1-4-27-15-11-13(12-26-9-5-6-10-26)22-14(7-8-20(2,3)28)16(15)23-19(27)17-18(21)25-29-24-17/h11,28H,4-6,9-10,12H2,1-3H3,(H2,21,25)",CCn1c(nc2c(nc(CN3CCCC3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1096290,"InChI=1S/C20H25N7O2/c1-4-27-15-11-13(12-26-9-5-6-10-26)22-14(7-8-20(2,3)28)16(15)23-19(27)17-18(21)25-29-24-17/h11,28H,4-6,9-10,12H2,1-3H3,(H2,21,25)",CCn1c(nc2c(nc(CN3CCCC3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1109958,Antiproliferative activity against human HFF cells,IC50,=,30000,nM,,CHEMBL614071,HFF (Foreskin fibroblasts),Homo sapiens,,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
23,CHEMBL1098943,"InChI=1S/C18H23N7O3/c1-5-25-12-10-13(27-9-8-20-4)21-11(6-7-18(2,3)26)14(12)22-17(25)15-16(19)24-28-23-15/h10,20,26H,5,8-9H2,1-4H3,(H2,19,24)",CCn1c(nc2c(nc(OCCNC)cc12)C#CC(C)(C)O)c3nonc3N,CHEMBL1098943,"InChI=1S/C18H23N7O3/c1-5-25-12-10-13(27-9-8-20-4)21-11(6-7-18(2,3)26)14(12)22-17(25)15-16(19)24-28-23-15/h10,20,26H,5,8-9H2,1-4H3,(H2,19,24)",CCn1c(nc2c(nc(OCCNC)cc12)C#CC(C)(C)O)c3nonc3N,CHEMBL1109958,Antiproliferative activity against human HFF cells,IC50,=,17000,nM,,CHEMBL614071,HFF (Foreskin fibroblasts),Homo sapiens,,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
26,CHEMBL1096634,"InChI=1S/C23H25N7O3/c1-4-30-17-12-18(32-13-15(24)14-8-6-5-7-9-14)26-16(10-11-23(2,3)31)19(17)27-22(30)20-21(25)29-33-28-20/h5-9,12,15,31H,4,13,24H2,1-3H3,(H2,25,29)/t15-/m0/s1",CCn1c(nc2c(nc(OC[C@H](N)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1096634,"InChI=1S/C23H25N7O3/c1-4-30-17-12-18(32-13-15(24)14-8-6-5-7-9-14)26-16(10-11-23(2,3)31)19(17)27-22(30)20-21(25)29-33-28-20/h5-9,12,15,31H,4,13,24H2,1-3H3,(H2,25,29)/t15-/m0/s1",CCn1c(nc2c(nc(OC[C@H](N)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1109958,Antiproliferative activity against human HFF cells,IC50,=,5000,nM,,CHEMBL614071,HFF (Foreskin fibroblasts),Homo sapiens,,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
27,CHEMBL1096626,"InChI=1S/C23H25N7O3/c1-4-30-17-12-18(32-13-15(24)14-8-6-5-7-9-14)26-16(10-11-23(2,3)31)19(17)27-22(30)20-21(25)29-33-28-20/h5-9,12,15,31H,4,13,24H2,1-3H3,(H2,25,29)/t15-/m1/s1",CCn1c(nc2c(nc(OC[C@@H](N)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1096626,"InChI=1S/C23H25N7O3/c1-4-30-17-12-18(32-13-15(24)14-8-6-5-7-9-14)26-16(10-11-23(2,3)31)19(17)27-22(30)20-21(25)29-33-28-20/h5-9,12,15,31H,4,13,24H2,1-3H3,(H2,25,29)/t15-/m1/s1",CCn1c(nc2c(nc(OC[C@@H](N)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1109958,Antiproliferative activity against human HFF cells,IC50,=,20000,nM,,CHEMBL614071,HFF (Foreskin fibroblasts),Homo sapiens,,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
30,CHEMBL1099276,"InChI=1S/C23H25N7O3/c1-4-30-16-12-18(32-17(13-24)14-8-6-5-7-9-14)26-15(10-11-23(2,3)31)19(16)27-22(30)20-21(25)29-33-28-20/h5-9,12,17,31H,4,13,24H2,1-3H3,(H2,25,29)/t17-/m0/s1",CCn1c(nc2c(nc(O[C@@H](CN)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1099276,"InChI=1S/C23H25N7O3/c1-4-30-16-12-18(32-17(13-24)14-8-6-5-7-9-14)26-15(10-11-23(2,3)31)19(16)27-22(30)20-21(25)29-33-28-20/h5-9,12,17,31H,4,13,24H2,1-3H3,(H2,25,29)/t17-/m0/s1",CCn1c(nc2c(nc(O[C@@H](CN)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1109958,Antiproliferative activity against human HFF cells,IC50,=,519,nM,,CHEMBL614071,HFF (Foreskin fibroblasts),Homo sapiens,,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
19,CHEMBL1096290,"InChI=1S/C20H25N7O2/c1-4-27-15-11-13(12-26-9-5-6-10-26)22-14(7-8-20(2,3)28)16(15)23-19(27)17-18(21)25-29-24-17/h11,28H,4-6,9-10,12H2,1-3H3,(H2,21,25)",CCn1c(nc2c(nc(CN3CCCC3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1096290,"InChI=1S/C20H25N7O2/c1-4-27-15-11-13(12-26-9-5-6-10-26)22-14(7-8-20(2,3)28)16(15)23-19(27)17-18(21)25-29-24-17/h11,28H,4-6,9-10,12H2,1-3H3,(H2,21,25)",CCn1c(nc2c(nc(CN3CCCC3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1109957,Antiproliferative activity against human LNCAP cells,IC50,=,313,nM,,CHEMBL612518,LNCaP (Prostate carcinoma),Homo sapiens,,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
23,CHEMBL1098943,"InChI=1S/C18H23N7O3/c1-5-25-12-10-13(27-9-8-20-4)21-11(6-7-18(2,3)26)14(12)22-17(25)15-16(19)24-28-23-15/h10,20,26H,5,8-9H2,1-4H3,(H2,19,24)",CCn1c(nc2c(nc(OCCNC)cc12)C#CC(C)(C)O)c3nonc3N,CHEMBL1098943,"InChI=1S/C18H23N7O3/c1-5-25-12-10-13(27-9-8-20-4)21-11(6-7-18(2,3)26)14(12)22-17(25)15-16(19)24-28-23-15/h10,20,26H,5,8-9H2,1-4H3,(H2,19,24)",CCn1c(nc2c(nc(OCCNC)cc12)C#CC(C)(C)O)c3nonc3N,CHEMBL1109957,Antiproliferative activity against human LNCAP cells,IC50,=,896,nM,,CHEMBL612518,LNCaP (Prostate carcinoma),Homo sapiens,,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
26,CHEMBL1096634,"InChI=1S/C23H25N7O3/c1-4-30-17-12-18(32-13-15(24)14-8-6-5-7-9-14)26-16(10-11-23(2,3)31)19(17)27-22(30)20-21(25)29-33-28-20/h5-9,12,15,31H,4,13,24H2,1-3H3,(H2,25,29)/t15-/m0/s1",CCn1c(nc2c(nc(OC[C@H](N)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1096634,"InChI=1S/C23H25N7O3/c1-4-30-17-12-18(32-13-15(24)14-8-6-5-7-9-14)26-16(10-11-23(2,3)31)19(17)27-22(30)20-21(25)29-33-28-20/h5-9,12,15,31H,4,13,24H2,1-3H3,(H2,25,29)/t15-/m0/s1",CCn1c(nc2c(nc(OC[C@H](N)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1109957,Antiproliferative activity against human LNCAP cells,IC50,=,124,nM,,CHEMBL612518,LNCaP (Prostate carcinoma),Homo sapiens,,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
27,CHEMBL1096626,"InChI=1S/C23H25N7O3/c1-4-30-17-12-18(32-13-15(24)14-8-6-5-7-9-14)26-16(10-11-23(2,3)31)19(17)27-22(30)20-21(25)29-33-28-20/h5-9,12,15,31H,4,13,24H2,1-3H3,(H2,25,29)/t15-/m1/s1",CCn1c(nc2c(nc(OC[C@@H](N)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1096626,"InChI=1S/C23H25N7O3/c1-4-30-17-12-18(32-13-15(24)14-8-6-5-7-9-14)26-16(10-11-23(2,3)31)19(17)27-22(30)20-21(25)29-33-28-20/h5-9,12,15,31H,4,13,24H2,1-3H3,(H2,25,29)/t15-/m1/s1",CCn1c(nc2c(nc(OC[C@@H](N)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1109957,Antiproliferative activity against human LNCAP cells,IC50,=,176,nM,,CHEMBL612518,LNCaP (Prostate carcinoma),Homo sapiens,,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
30,CHEMBL1099276,"InChI=1S/C23H25N7O3/c1-4-30-16-12-18(32-17(13-24)14-8-6-5-7-9-14)26-15(10-11-23(2,3)31)19(16)27-22(30)20-21(25)29-33-28-20/h5-9,12,17,31H,4,13,24H2,1-3H3,(H2,25,29)/t17-/m0/s1",CCn1c(nc2c(nc(O[C@@H](CN)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1099276,"InChI=1S/C23H25N7O3/c1-4-30-16-12-18(32-17(13-24)14-8-6-5-7-9-14)26-15(10-11-23(2,3)31)19(16)27-22(30)20-21(25)29-33-28-20/h5-9,12,17,31H,4,13,24H2,1-3H3,(H2,25,29)/t17-/m0/s1",CCn1c(nc2c(nc(O[C@@H](CN)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1109957,Antiproliferative activity against human LNCAP cells,IC50,=,27,nM,,CHEMBL612518,LNCaP (Prostate carcinoma),Homo sapiens,,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
19,CHEMBL1096290,"InChI=1S/C20H25N7O2/c1-4-27-15-11-13(12-26-9-5-6-10-26)22-14(7-8-20(2,3)28)16(15)23-19(27)17-18(21)25-29-24-17/h11,28H,4-6,9-10,12H2,1-3H3,(H2,21,25)",CCn1c(nc2c(nc(CN3CCCC3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1096290,"InChI=1S/C20H25N7O2/c1-4-27-15-11-13(12-26-9-5-6-10-26)22-14(7-8-20(2,3)28)16(15)23-19(27)17-18(21)25-29-24-17/h11,28H,4-6,9-10,12H2,1-3H3,(H2,21,25)",CCn1c(nc2c(nc(CN3CCCC3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1109952,Inhibition of AKT,IC50,=,6,nM,,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,P31749,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
23,CHEMBL1098943,"InChI=1S/C18H23N7O3/c1-5-25-12-10-13(27-9-8-20-4)21-11(6-7-18(2,3)26)14(12)22-17(25)15-16(19)24-28-23-15/h10,20,26H,5,8-9H2,1-4H3,(H2,19,24)",CCn1c(nc2c(nc(OCCNC)cc12)C#CC(C)(C)O)c3nonc3N,CHEMBL1098943,"InChI=1S/C18H23N7O3/c1-5-25-12-10-13(27-9-8-20-4)21-11(6-7-18(2,3)26)14(12)22-17(25)15-16(19)24-28-23-15/h10,20,26H,5,8-9H2,1-4H3,(H2,19,24)",CCn1c(nc2c(nc(OCCNC)cc12)C#CC(C)(C)O)c3nonc3N,CHEMBL1109952,Inhibition of AKT,IC50,=,12,nM,,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,P31749,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
26,CHEMBL1096634,"InChI=1S/C23H25N7O3/c1-4-30-17-12-18(32-13-15(24)14-8-6-5-7-9-14)26-16(10-11-23(2,3)31)19(17)27-22(30)20-21(25)29-33-28-20/h5-9,12,15,31H,4,13,24H2,1-3H3,(H2,25,29)/t15-/m0/s1",CCn1c(nc2c(nc(OC[C@H](N)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1096634,"InChI=1S/C23H25N7O3/c1-4-30-17-12-18(32-13-15(24)14-8-6-5-7-9-14)26-16(10-11-23(2,3)31)19(17)27-22(30)20-21(25)29-33-28-20/h5-9,12,15,31H,4,13,24H2,1-3H3,(H2,25,29)/t15-/m0/s1",CCn1c(nc2c(nc(OC[C@H](N)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1109952,Inhibition of AKT,IC50,=,3,nM,,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,P31749,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
27,CHEMBL1096626,"InChI=1S/C23H25N7O3/c1-4-30-17-12-18(32-13-15(24)14-8-6-5-7-9-14)26-16(10-11-23(2,3)31)19(17)27-22(30)20-21(25)29-33-28-20/h5-9,12,15,31H,4,13,24H2,1-3H3,(H2,25,29)/t15-/m1/s1",CCn1c(nc2c(nc(OC[C@@H](N)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1096626,"InChI=1S/C23H25N7O3/c1-4-30-17-12-18(32-13-15(24)14-8-6-5-7-9-14)26-16(10-11-23(2,3)31)19(17)27-22(30)20-21(25)29-33-28-20/h5-9,12,15,31H,4,13,24H2,1-3H3,(H2,25,29)/t15-/m1/s1",CCn1c(nc2c(nc(OC[C@@H](N)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1109952,Inhibition of AKT,IC50,=,5,nM,,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,P31749,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
30,CHEMBL1099276,"InChI=1S/C23H25N7O3/c1-4-30-16-12-18(32-17(13-24)14-8-6-5-7-9-14)26-15(10-11-23(2,3)31)19(16)27-22(30)20-21(25)29-33-28-20/h5-9,12,17,31H,4,13,24H2,1-3H3,(H2,25,29)/t17-/m0/s1",CCn1c(nc2c(nc(O[C@@H](CN)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1099276,"InChI=1S/C23H25N7O3/c1-4-30-16-12-18(32-17(13-24)14-8-6-5-7-9-14)26-15(10-11-23(2,3)31)19(16)27-22(30)20-21(25)29-33-28-20/h5-9,12,17,31H,4,13,24H2,1-3H3,(H2,25,29)/t17-/m0/s1",CCn1c(nc2c(nc(O[C@@H](CN)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1109952,Inhibition of AKT,IC50,=,1,nM,,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,P31749,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
30,CHEMBL1099276,"InChI=1S/C23H25N7O3/c1-4-30-16-12-18(32-17(13-24)14-8-6-5-7-9-14)26-15(10-11-23(2,3)31)19(16)27-22(30)20-21(25)29-33-28-20/h5-9,12,17,31H,4,13,24H2,1-3H3,(H2,25,29)/t17-/m0/s1",CCn1c(nc2c(nc(O[C@@H](CN)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1099276,"InChI=1S/C23H25N7O3/c1-4-30-16-12-18(32-17(13-24)14-8-6-5-7-9-14)26-15(10-11-23(2,3)31)19(16)27-22(30)20-21(25)29-33-28-20/h5-9,12,17,31H,4,13,24H2,1-3H3,(H2,25,29)/t17-/m0/s1",CCn1c(nc2c(nc(O[C@@H](CN)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1109952,Inhibition of AKT,Ki,=,0.4,nM,,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,P31749,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
19,CHEMBL1096290,"InChI=1S/C20H25N7O2/c1-4-27-15-11-13(12-26-9-5-6-10-26)22-14(7-8-20(2,3)28)16(15)23-19(27)17-18(21)25-29-24-17/h11,28H,4-6,9-10,12H2,1-3H3,(H2,21,25)",CCn1c(nc2c(nc(CN3CCCC3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1096290,"InChI=1S/C20H25N7O2/c1-4-27-15-11-13(12-26-9-5-6-10-26)22-14(7-8-20(2,3)28)16(15)23-19(27)17-18(21)25-29-24-17/h11,28H,4-6,9-10,12H2,1-3H3,(H2,21,25)",CCn1c(nc2c(nc(CN3CCCC3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1109953,Inhibition of AKT2,IC50,=,200,nM,,CHEMBL2431,Serine/threonine-protein kinase AKT2,Homo sapiens,P31751,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
23,CHEMBL1098943,"InChI=1S/C18H23N7O3/c1-5-25-12-10-13(27-9-8-20-4)21-11(6-7-18(2,3)26)14(12)22-17(25)15-16(19)24-28-23-15/h10,20,26H,5,8-9H2,1-4H3,(H2,19,24)",CCn1c(nc2c(nc(OCCNC)cc12)C#CC(C)(C)O)c3nonc3N,CHEMBL1098943,"InChI=1S/C18H23N7O3/c1-5-25-12-10-13(27-9-8-20-4)21-11(6-7-18(2,3)26)14(12)22-17(25)15-16(19)24-28-23-15/h10,20,26H,5,8-9H2,1-4H3,(H2,19,24)",CCn1c(nc2c(nc(OCCNC)cc12)C#CC(C)(C)O)c3nonc3N,CHEMBL1109953,Inhibition of AKT2,IC50,=,79,nM,,CHEMBL2431,Serine/threonine-protein kinase AKT2,Homo sapiens,P31751,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
26,CHEMBL1096634,"InChI=1S/C23H25N7O3/c1-4-30-17-12-18(32-13-15(24)14-8-6-5-7-9-14)26-16(10-11-23(2,3)31)19(17)27-22(30)20-21(25)29-33-28-20/h5-9,12,15,31H,4,13,24H2,1-3H3,(H2,25,29)/t15-/m0/s1",CCn1c(nc2c(nc(OC[C@H](N)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1096634,"InChI=1S/C23H25N7O3/c1-4-30-17-12-18(32-13-15(24)14-8-6-5-7-9-14)26-16(10-11-23(2,3)31)19(17)27-22(30)20-21(25)29-33-28-20/h5-9,12,15,31H,4,13,24H2,1-3H3,(H2,25,29)/t15-/m0/s1",CCn1c(nc2c(nc(OC[C@H](N)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1109953,Inhibition of AKT2,IC50,=,20,nM,,CHEMBL2431,Serine/threonine-protein kinase AKT2,Homo sapiens,P31751,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
27,CHEMBL1096626,"InChI=1S/C23H25N7O3/c1-4-30-17-12-18(32-13-15(24)14-8-6-5-7-9-14)26-16(10-11-23(2,3)31)19(17)27-22(30)20-21(25)29-33-28-20/h5-9,12,15,31H,4,13,24H2,1-3H3,(H2,25,29)/t15-/m1/s1",CCn1c(nc2c(nc(OC[C@@H](N)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1096626,"InChI=1S/C23H25N7O3/c1-4-30-17-12-18(32-13-15(24)14-8-6-5-7-9-14)26-16(10-11-23(2,3)31)19(17)27-22(30)20-21(25)29-33-28-20/h5-9,12,15,31H,4,13,24H2,1-3H3,(H2,25,29)/t15-/m1/s1",CCn1c(nc2c(nc(OC[C@@H](N)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1109953,Inhibition of AKT2,IC50,=,20,nM,,CHEMBL2431,Serine/threonine-protein kinase AKT2,Homo sapiens,P31751,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
30,CHEMBL1099276,"InChI=1S/C23H25N7O3/c1-4-30-16-12-18(32-17(13-24)14-8-6-5-7-9-14)26-15(10-11-23(2,3)31)19(16)27-22(30)20-21(25)29-33-28-20/h5-9,12,17,31H,4,13,24H2,1-3H3,(H2,25,29)/t17-/m0/s1",CCn1c(nc2c(nc(O[C@@H](CN)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1099276,"InChI=1S/C23H25N7O3/c1-4-30-16-12-18(32-17(13-24)14-8-6-5-7-9-14)26-15(10-11-23(2,3)31)19(16)27-22(30)20-21(25)29-33-28-20/h5-9,12,17,31H,4,13,24H2,1-3H3,(H2,25,29)/t17-/m0/s1",CCn1c(nc2c(nc(O[C@@H](CN)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1109953,Inhibition of AKT2,IC50,=,25,nM,,CHEMBL2431,Serine/threonine-protein kinase AKT2,Homo sapiens,P31751,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
30,CHEMBL1099276,"InChI=1S/C23H25N7O3/c1-4-30-16-12-18(32-17(13-24)14-8-6-5-7-9-14)26-15(10-11-23(2,3)31)19(16)27-22(30)20-21(25)29-33-28-20/h5-9,12,17,31H,4,13,24H2,1-3H3,(H2,25,29)/t17-/m0/s1",CCn1c(nc2c(nc(O[C@@H](CN)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1099276,"InChI=1S/C23H25N7O3/c1-4-30-16-12-18(32-17(13-24)14-8-6-5-7-9-14)26-15(10-11-23(2,3)31)19(16)27-22(30)20-21(25)29-33-28-20/h5-9,12,17,31H,4,13,24H2,1-3H3,(H2,25,29)/t17-/m0/s1",CCn1c(nc2c(nc(O[C@@H](CN)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1109953,Inhibition of AKT2,Ki,=,5,nM,,CHEMBL2431,Serine/threonine-protein kinase AKT2,Homo sapiens,P31751,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
19,CHEMBL1096290,"InChI=1S/C20H25N7O2/c1-4-27-15-11-13(12-26-9-5-6-10-26)22-14(7-8-20(2,3)28)16(15)23-19(27)17-18(21)25-29-24-17/h11,28H,4-6,9-10,12H2,1-3H3,(H2,21,25)",CCn1c(nc2c(nc(CN3CCCC3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1096290,"InChI=1S/C20H25N7O2/c1-4-27-15-11-13(12-26-9-5-6-10-26)22-14(7-8-20(2,3)28)16(15)23-19(27)17-18(21)25-29-24-17/h11,28H,4-6,9-10,12H2,1-3H3,(H2,21,25)",CCn1c(nc2c(nc(CN3CCCC3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1109954,Inhibition of AKT3,IC50,=,22,nM,,CHEMBL4816,Serine/threonine-protein kinase AKT3,Homo sapiens,Q9Y243,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
23,CHEMBL1098943,"InChI=1S/C18H23N7O3/c1-5-25-12-10-13(27-9-8-20-4)21-11(6-7-18(2,3)26)14(12)22-17(25)15-16(19)24-28-23-15/h10,20,26H,5,8-9H2,1-4H3,(H2,19,24)",CCn1c(nc2c(nc(OCCNC)cc12)C#CC(C)(C)O)c3nonc3N,CHEMBL1098943,"InChI=1S/C18H23N7O3/c1-5-25-12-10-13(27-9-8-20-4)21-11(6-7-18(2,3)26)14(12)22-17(25)15-16(19)24-28-23-15/h10,20,26H,5,8-9H2,1-4H3,(H2,19,24)",CCn1c(nc2c(nc(OCCNC)cc12)C#CC(C)(C)O)c3nonc3N,CHEMBL1109954,Inhibition of AKT3,IC50,,,,Not Determined,CHEMBL4816,Serine/threonine-protein kinase AKT3,Homo sapiens,Q9Y243,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
26,CHEMBL1096634,"InChI=1S/C23H25N7O3/c1-4-30-17-12-18(32-13-15(24)14-8-6-5-7-9-14)26-16(10-11-23(2,3)31)19(17)27-22(30)20-21(25)29-33-28-20/h5-9,12,15,31H,4,13,24H2,1-3H3,(H2,25,29)/t15-/m0/s1",CCn1c(nc2c(nc(OC[C@H](N)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1096634,"InChI=1S/C23H25N7O3/c1-4-30-17-12-18(32-13-15(24)14-8-6-5-7-9-14)26-16(10-11-23(2,3)31)19(17)27-22(30)20-21(25)29-33-28-20/h5-9,12,15,31H,4,13,24H2,1-3H3,(H2,25,29)/t15-/m0/s1",CCn1c(nc2c(nc(OC[C@H](N)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1109954,Inhibition of AKT3,IC50,=,17,nM,,CHEMBL4816,Serine/threonine-protein kinase AKT3,Homo sapiens,Q9Y243,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
27,CHEMBL1096626,"InChI=1S/C23H25N7O3/c1-4-30-17-12-18(32-13-15(24)14-8-6-5-7-9-14)26-16(10-11-23(2,3)31)19(17)27-22(30)20-21(25)29-33-28-20/h5-9,12,15,31H,4,13,24H2,1-3H3,(H2,25,29)/t15-/m1/s1",CCn1c(nc2c(nc(OC[C@@H](N)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1096626,"InChI=1S/C23H25N7O3/c1-4-30-17-12-18(32-13-15(24)14-8-6-5-7-9-14)26-16(10-11-23(2,3)31)19(17)27-22(30)20-21(25)29-33-28-20/h5-9,12,15,31H,4,13,24H2,1-3H3,(H2,25,29)/t15-/m1/s1",CCn1c(nc2c(nc(OC[C@@H](N)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1109954,Inhibition of AKT3,IC50,=,49,nM,,CHEMBL4816,Serine/threonine-protein kinase AKT3,Homo sapiens,Q9Y243,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
30,CHEMBL1099276,"InChI=1S/C23H25N7O3/c1-4-30-16-12-18(32-17(13-24)14-8-6-5-7-9-14)26-15(10-11-23(2,3)31)19(16)27-22(30)20-21(25)29-33-28-20/h5-9,12,17,31H,4,13,24H2,1-3H3,(H2,25,29)/t17-/m0/s1",CCn1c(nc2c(nc(O[C@@H](CN)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1099276,"InChI=1S/C23H25N7O3/c1-4-30-16-12-18(32-17(13-24)14-8-6-5-7-9-14)26-15(10-11-23(2,3)31)19(16)27-22(30)20-21(25)29-33-28-20/h5-9,12,17,31H,4,13,24H2,1-3H3,(H2,25,29)/t17-/m0/s1",CCn1c(nc2c(nc(O[C@@H](CN)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1109954,Inhibition of AKT3,IC50,=,1,nM,,CHEMBL4816,Serine/threonine-protein kinase AKT3,Homo sapiens,Q9Y243,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
19,CHEMBL1096290,"InChI=1S/C20H25N7O2/c1-4-27-15-11-13(12-26-9-5-6-10-26)22-14(7-8-20(2,3)28)16(15)23-19(27)17-18(21)25-29-24-17/h11,28H,4-6,9-10,12H2,1-3H3,(H2,21,25)",CCn1c(nc2c(nc(CN3CCCC3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1096290,"InChI=1S/C20H25N7O2/c1-4-27-15-11-13(12-26-9-5-6-10-26)22-14(7-8-20(2,3)28)16(15)23-19(27)17-18(21)25-29-24-17/h11,28H,4-6,9-10,12H2,1-3H3,(H2,21,25)",CCn1c(nc2c(nc(CN3CCCC3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1109955,Inhibition of GSK3-beta phosphorylation in human BT474 cells,IC50,=,2700,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
23,CHEMBL1098943,"InChI=1S/C18H23N7O3/c1-5-25-12-10-13(27-9-8-20-4)21-11(6-7-18(2,3)26)14(12)22-17(25)15-16(19)24-28-23-15/h10,20,26H,5,8-9H2,1-4H3,(H2,19,24)",CCn1c(nc2c(nc(OCCNC)cc12)C#CC(C)(C)O)c3nonc3N,CHEMBL1098943,"InChI=1S/C18H23N7O3/c1-5-25-12-10-13(27-9-8-20-4)21-11(6-7-18(2,3)26)14(12)22-17(25)15-16(19)24-28-23-15/h10,20,26H,5,8-9H2,1-4H3,(H2,19,24)",CCn1c(nc2c(nc(OCCNC)cc12)C#CC(C)(C)O)c3nonc3N,CHEMBL1109955,Inhibition of GSK3-beta phosphorylation in human BT474 cells,IC50,=,2600,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
26,CHEMBL1096634,"InChI=1S/C23H25N7O3/c1-4-30-17-12-18(32-13-15(24)14-8-6-5-7-9-14)26-16(10-11-23(2,3)31)19(17)27-22(30)20-21(25)29-33-28-20/h5-9,12,15,31H,4,13,24H2,1-3H3,(H2,25,29)/t15-/m0/s1",CCn1c(nc2c(nc(OC[C@H](N)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1096634,"InChI=1S/C23H25N7O3/c1-4-30-17-12-18(32-13-15(24)14-8-6-5-7-9-14)26-16(10-11-23(2,3)31)19(17)27-22(30)20-21(25)29-33-28-20/h5-9,12,15,31H,4,13,24H2,1-3H3,(H2,25,29)/t15-/m0/s1",CCn1c(nc2c(nc(OC[C@H](N)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1109955,Inhibition of GSK3-beta phosphorylation in human BT474 cells,IC50,=,1110,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
27,CHEMBL1096626,"InChI=1S/C23H25N7O3/c1-4-30-17-12-18(32-13-15(24)14-8-6-5-7-9-14)26-16(10-11-23(2,3)31)19(17)27-22(30)20-21(25)29-33-28-20/h5-9,12,15,31H,4,13,24H2,1-3H3,(H2,25,29)/t15-/m1/s1",CCn1c(nc2c(nc(OC[C@@H](N)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1096626,"InChI=1S/C23H25N7O3/c1-4-30-17-12-18(32-13-15(24)14-8-6-5-7-9-14)26-16(10-11-23(2,3)31)19(17)27-22(30)20-21(25)29-33-28-20/h5-9,12,15,31H,4,13,24H2,1-3H3,(H2,25,29)/t15-/m1/s1",CCn1c(nc2c(nc(OC[C@@H](N)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1109955,Inhibition of GSK3-beta phosphorylation in human BT474 cells,IC50,=,1040,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
30,CHEMBL1099276,"InChI=1S/C23H25N7O3/c1-4-30-16-12-18(32-17(13-24)14-8-6-5-7-9-14)26-15(10-11-23(2,3)31)19(16)27-22(30)20-21(25)29-33-28-20/h5-9,12,17,31H,4,13,24H2,1-3H3,(H2,25,29)/t17-/m0/s1",CCn1c(nc2c(nc(O[C@@H](CN)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1099276,"InChI=1S/C23H25N7O3/c1-4-30-16-12-18(32-17(13-24)14-8-6-5-7-9-14)26-15(10-11-23(2,3)31)19(16)27-22(30)20-21(25)29-33-28-20/h5-9,12,17,31H,4,13,24H2,1-3H3,(H2,25,29)/t17-/m0/s1",CCn1c(nc2c(nc(O[C@@H](CN)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1109955,Inhibition of GSK3-beta phosphorylation in human BT474 cells,IC50,=,40,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
30,CHEMBL1099276,"InChI=1S/C23H25N7O3/c1-4-30-16-12-18(32-17(13-24)14-8-6-5-7-9-14)26-15(10-11-23(2,3)31)19(16)27-22(30)20-21(25)29-33-28-20/h5-9,12,17,31H,4,13,24H2,1-3H3,(H2,25,29)/t17-/m0/s1",CCn1c(nc2c(nc(O[C@@H](CN)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1099276,"InChI=1S/C23H25N7O3/c1-4-30-16-12-18(32-17(13-24)14-8-6-5-7-9-14)26-15(10-11-23(2,3)31)19(16)27-22(30)20-21(25)29-33-28-20/h5-9,12,17,31H,4,13,24H2,1-3H3,(H2,25,29)/t17-/m0/s1",CCn1c(nc2c(nc(O[C@@H](CN)c3ccccc3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1109959,Inhibition of GSK3B phosphorylation in human BT474 cells xenogragfted in ip dosed mouse,Inhibition,,,,Dose-dependent effect,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1157000,"Bioorg. Med. Chem. Lett., 19, p. 1508 (2009)",19179070,Scientific Literature
TCMDC-137304,CHEMBL531804,"InChI=1S/C23H21N7/c1-30(2)22-12-17-20(13-24-22)25-14-26-23(17)27-16-8-9-18-19(11-16)29-21(28-18)10-15-6-4-3-5-7-15/h3-9,11-14H,10H2,1-2H3,(H,28,29)(H,25,26,27)",CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1,CHEMBL531804,"InChI=1S/C23H21N7/c1-30(2)22-12-17-20(13-24-22)25-14-26-23(17)27-16-8-9-18-19(11-16)29-21(28-18)10-15-6-4-3-5-7-15/h3-9,11-14H,10H2,1-2H3,(H,28,29)(H,25,26,27)",CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1,CHEMBL1054505,"TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested",IFI,=,0.79,%,,CHEMBL612545,,,,CHEMBL1157539,"Nature, 465, p. 305 (2010)",20485427,GSK Malaria Screening
TCMDC-138201,CHEMBL581096,"InChI=1S/C21H17N3O.ClH/c1-14-5-7-16(25)13-20(14)24-19-9-11-23-21-12-15(6-8-17(19)21)18-4-2-3-10-22-18;/h2-13,25H,1H3,(H,23,24);1H",Cl.Cc1ccc(O)cc1Nc2ccnc3cc(ccc23)c4ccccn4,CHEMBL395358,"InChI=1S/C21H17N3O/c1-14-5-7-16(25)13-20(14)24-19-9-11-23-21-12-15(6-8-17(19)21)18-4-2-3-10-22-18/h2-13,25H,1H3,(H,23,24)",Cc1ccc(O)cc1Nc2ccnc3cc(ccc23)c4ccccn4,CHEMBL1054505,"TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested",IFI,=,3.57,%,,CHEMBL612545,,,,CHEMBL1157539,"Nature, 465, p. 305 (2010)",20485427,GSK Malaria Screening
TCMDC-138467,CHEMBL529066,"InChI=1S/C29H27ClN4O4S.ClH/c1-39(35,36)14-13-31-17-23-9-12-27(38-23)21-7-10-26-24(15-21)29(33-19-32-26)34-22-8-11-28(25(30)16-22)37-18-20-5-3-2-4-6-20;/h2-12,15-16,19,31H,13-14,17-18H2,1H3,(H,32,33,34);1H",Cl.CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2,CHEMBL380247,"InChI=1S/C29H27ClN4O4S/c1-39(35,36)14-13-31-17-23-9-12-27(38-23)21-7-10-26-24(15-21)29(33-19-32-26)34-22-8-11-28(25(30)16-22)37-18-20-5-3-2-4-6-20/h2-12,15-16,19,31H,13-14,17-18H2,1H3,(H,32,33,34)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2,CHEMBL1054505,"TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested",IFI,=,3.47,%,,CHEMBL612545,,,,CHEMBL1157539,"Nature, 465, p. 305 (2010)",20485427,GSK Malaria Screening
TCMDC-138687,CHEMBL468963,"InChI=1S/C22H21F3N8/c1-31-9-11-32(12-10-31)20-5-4-15(13-17(20)22(23,24)25)29-21-26-8-6-18(30-21)16-14-28-33-19(16)3-2-7-27-33/h2-8,13-14H,9-12H2,1H3,(H,26,29,30)",CN1CCN(CC1)c2ccc(Nc3nccc(n3)c4cnn5ncccc45)cc2C(F)(F)F,CHEMBL468963,"InChI=1S/C22H21F3N8/c1-31-9-11-32(12-10-31)20-5-4-15(13-17(20)22(23,24)25)29-21-26-8-6-18(30-21)16-14-28-33-19(16)3-2-7-27-33/h2-8,13-14H,9-12H2,1H3,(H,26,29,30)",CN1CCN(CC1)c2ccc(Nc3nccc(n3)c4cnn5ncccc45)cc2C(F)(F)F,CHEMBL1054505,"TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested",IFI,=,13.85,%,,CHEMBL612545,,,,CHEMBL1157539,"Nature, 465, p. 305 (2010)",20485427,GSK Malaria Screening
TCMDC-141371,CHEMBL588025,"InChI=1S/C20H13F4N5O2.ClH/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18;/h1-9H,(H2,25,26,27)(H2,28,29,30);1H",Cl.Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL1054505,"TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested",IFI,=,7.25,%,,CHEMBL612545,,,,CHEMBL1157539,"Nature, 465, p. 305 (2010)",20485427,GSK Malaria Screening
TCMDC-137304,CHEMBL531804,"InChI=1S/C23H21N7/c1-30(2)22-12-17-20(13-24-22)25-14-26-23(17)27-16-8-9-18-19(11-16)29-21(28-18)10-15-6-4-3-5-7-15/h3-9,11-14H,10H2,1-2H3,(H,28,29)(H,25,26,27)",CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1,CHEMBL531804,"InChI=1S/C23H21N7/c1-30(2)22-12-17-20(13-24-22)25-14-26-23(17)27-16-8-9-18-19(11-16)29-21(28-18)10-15-6-4-3-5-7-15/h3-9,11-14H,10H2,1-2H3,(H,28,29)(H,25,26,27)",CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1,CHEMBL1054502,"TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM",Inhibition,=,0,%,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,,CHEMBL1157539,"Nature, 465, p. 305 (2010)",20485427,GSK Malaria Screening
TCMDC-138201,CHEMBL581096,"InChI=1S/C21H17N3O.ClH/c1-14-5-7-16(25)13-20(14)24-19-9-11-23-21-12-15(6-8-17(19)21)18-4-2-3-10-22-18;/h2-13,25H,1H3,(H,23,24);1H",Cl.Cc1ccc(O)cc1Nc2ccnc3cc(ccc23)c4ccccn4,CHEMBL395358,"InChI=1S/C21H17N3O/c1-14-5-7-16(25)13-20(14)24-19-9-11-23-21-12-15(6-8-17(19)21)18-4-2-3-10-22-18/h2-13,25H,1H3,(H,23,24)",Cc1ccc(O)cc1Nc2ccnc3cc(ccc23)c4ccccn4,CHEMBL1054502,"TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM",Inhibition,=,0,%,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,,CHEMBL1157539,"Nature, 465, p. 305 (2010)",20485427,GSK Malaria Screening
TCMDC-138467,CHEMBL529066,"InChI=1S/C29H27ClN4O4S.ClH/c1-39(35,36)14-13-31-17-23-9-12-27(38-23)21-7-10-26-24(15-21)29(33-19-32-26)34-22-8-11-28(25(30)16-22)37-18-20-5-3-2-4-6-20;/h2-12,15-16,19,31H,13-14,17-18H2,1H3,(H,32,33,34);1H",Cl.CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2,CHEMBL380247,"InChI=1S/C29H27ClN4O4S/c1-39(35,36)14-13-31-17-23-9-12-27(38-23)21-7-10-26-24(15-21)29(33-19-32-26)34-22-8-11-28(25(30)16-22)37-18-20-5-3-2-4-6-20/h2-12,15-16,19,31H,13-14,17-18H2,1H3,(H,32,33,34)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2,CHEMBL1054502,"TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM",Inhibition,=,0,%,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,,CHEMBL1157539,"Nature, 465, p. 305 (2010)",20485427,GSK Malaria Screening
TCMDC-138687,CHEMBL468963,"InChI=1S/C22H21F3N8/c1-31-9-11-32(12-10-31)20-5-4-15(13-17(20)22(23,24)25)29-21-26-8-6-18(30-21)16-14-28-33-19(16)3-2-7-27-33/h2-8,13-14H,9-12H2,1H3,(H,26,29,30)",CN1CCN(CC1)c2ccc(Nc3nccc(n3)c4cnn5ncccc45)cc2C(F)(F)F,CHEMBL468963,"InChI=1S/C22H21F3N8/c1-31-9-11-32(12-10-31)20-5-4-15(13-17(20)22(23,24)25)29-21-26-8-6-18(30-21)16-14-28-33-19(16)3-2-7-27-33/h2-8,13-14H,9-12H2,1H3,(H,26,29,30)",CN1CCN(CC1)c2ccc(Nc3nccc(n3)c4cnn5ncccc45)cc2C(F)(F)F,CHEMBL1054502,"TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM",Inhibition,=,0,%,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,,CHEMBL1157539,"Nature, 465, p. 305 (2010)",20485427,GSK Malaria Screening
TCMDC-141371,CHEMBL588025,"InChI=1S/C20H13F4N5O2.ClH/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18;/h1-9H,(H2,25,26,27)(H2,28,29,30);1H",Cl.Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL1054502,"TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM",Inhibition,=,0,%,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,,CHEMBL1157539,"Nature, 465, p. 305 (2010)",20485427,GSK Malaria Screening
TCMDC-137304,CHEMBL531804,"InChI=1S/C23H21N7/c1-30(2)22-12-17-20(13-24-22)25-14-26-23(17)27-16-8-9-18-19(11-16)29-21(28-18)10-15-6-4-3-5-7-15/h3-9,11-14H,10H2,1-2H3,(H,28,29)(H,25,26,27)",CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1,CHEMBL531804,"InChI=1S/C23H21N7/c1-30(2)22-12-17-20(13-24-22)25-14-26-23(17)27-16-8-9-18-19(11-16)29-21(28-18)10-15-6-4-3-5-7-15/h3-9,11-14H,10H2,1-2H3,(H,28,29)(H,25,26,27)",CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1,CHEMBL1054503,"TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.",XC50,=,1143.63,nM,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,,CHEMBL1157539,"Nature, 465, p. 305 (2010)",20485427,GSK Malaria Screening
TCMDC-138201,CHEMBL581096,"InChI=1S/C21H17N3O.ClH/c1-14-5-7-16(25)13-20(14)24-19-9-11-23-21-12-15(6-8-17(19)21)18-4-2-3-10-22-18;/h2-13,25H,1H3,(H,23,24);1H",Cl.Cc1ccc(O)cc1Nc2ccnc3cc(ccc23)c4ccccn4,CHEMBL395358,"InChI=1S/C21H17N3O/c1-14-5-7-16(25)13-20(14)24-19-9-11-23-21-12-15(6-8-17(19)21)18-4-2-3-10-22-18/h2-13,25H,1H3,(H,23,24)",Cc1ccc(O)cc1Nc2ccnc3cc(ccc23)c4ccccn4,CHEMBL1054503,"TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.",XC50,=,761.45,nM,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,,CHEMBL1157539,"Nature, 465, p. 305 (2010)",20485427,GSK Malaria Screening
TCMDC-138467,CHEMBL529066,"InChI=1S/C29H27ClN4O4S.ClH/c1-39(35,36)14-13-31-17-23-9-12-27(38-23)21-7-10-26-24(15-21)29(33-19-32-26)34-22-8-11-28(25(30)16-22)37-18-20-5-3-2-4-6-20;/h2-12,15-16,19,31H,13-14,17-18H2,1H3,(H,32,33,34);1H",Cl.CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2,CHEMBL380247,"InChI=1S/C29H27ClN4O4S/c1-39(35,36)14-13-31-17-23-9-12-27(38-23)21-7-10-26-24(15-21)29(33-19-32-26)34-22-8-11-28(25(30)16-22)37-18-20-5-3-2-4-6-20/h2-12,15-16,19,31H,13-14,17-18H2,1H3,(H,32,33,34)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2,CHEMBL1054503,"TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.",XC50,=,556.86,nM,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,,CHEMBL1157539,"Nature, 465, p. 305 (2010)",20485427,GSK Malaria Screening
TCMDC-138687,CHEMBL468963,"InChI=1S/C22H21F3N8/c1-31-9-11-32(12-10-31)20-5-4-15(13-17(20)22(23,24)25)29-21-26-8-6-18(30-21)16-14-28-33-19(16)3-2-7-27-33/h2-8,13-14H,9-12H2,1H3,(H,26,29,30)",CN1CCN(CC1)c2ccc(Nc3nccc(n3)c4cnn5ncccc45)cc2C(F)(F)F,CHEMBL468963,"InChI=1S/C22H21F3N8/c1-31-9-11-32(12-10-31)20-5-4-15(13-17(20)22(23,24)25)29-21-26-8-6-18(30-21)16-14-28-33-19(16)3-2-7-27-33/h2-8,13-14H,9-12H2,1H3,(H,26,29,30)",CN1CCN(CC1)c2ccc(Nc3nccc(n3)c4cnn5ncccc45)cc2C(F)(F)F,CHEMBL1054503,"TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.",XC50,=,1070.12,nM,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,,CHEMBL1157539,"Nature, 465, p. 305 (2010)",20485427,GSK Malaria Screening
TCMDC-141371,CHEMBL588025,"InChI=1S/C20H13F4N5O2.ClH/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18;/h1-9H,(H2,25,26,27)(H2,28,29,30);1H",Cl.Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL1054503,"TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.",XC50,=,1716.4,nM,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,,CHEMBL1157539,"Nature, 465, p. 305 (2010)",20485427,GSK Malaria Screening
TCMDC-137304,CHEMBL531804,"InChI=1S/C23H21N7/c1-30(2)22-12-17-20(13-24-22)25-14-26-23(17)27-16-8-9-18-19(11-16)29-21(28-18)10-15-6-4-3-5-7-15/h3-9,11-14H,10H2,1-2H3,(H,28,29)(H,25,26,27)",CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1,CHEMBL531804,"InChI=1S/C23H21N7/c1-30(2)22-12-17-20(13-24-22)25-14-26-23(17)27-16-8-9-18-19(11-16)29-21(28-18)10-15-6-4-3-5-7-15/h3-9,11-14H,10H2,1-2H3,(H,28,29)(H,25,26,27)",CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1,CHEMBL1054500,"TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM",Inhibition,=,85,%,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,,CHEMBL1157539,"Nature, 465, p. 305 (2010)",20485427,GSK Malaria Screening
TCMDC-138201,CHEMBL581096,"InChI=1S/C21H17N3O.ClH/c1-14-5-7-16(25)13-20(14)24-19-9-11-23-21-12-15(6-8-17(19)21)18-4-2-3-10-22-18;/h2-13,25H,1H3,(H,23,24);1H",Cl.Cc1ccc(O)cc1Nc2ccnc3cc(ccc23)c4ccccn4,CHEMBL395358,"InChI=1S/C21H17N3O/c1-14-5-7-16(25)13-20(14)24-19-9-11-23-21-12-15(6-8-17(19)21)18-4-2-3-10-22-18/h2-13,25H,1H3,(H,23,24)",Cc1ccc(O)cc1Nc2ccnc3cc(ccc23)c4ccccn4,CHEMBL1054500,"TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM",Inhibition,=,97,%,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,,CHEMBL1157539,"Nature, 465, p. 305 (2010)",20485427,GSK Malaria Screening
TCMDC-138467,CHEMBL529066,"InChI=1S/C29H27ClN4O4S.ClH/c1-39(35,36)14-13-31-17-23-9-12-27(38-23)21-7-10-26-24(15-21)29(33-19-32-26)34-22-8-11-28(25(30)16-22)37-18-20-5-3-2-4-6-20;/h2-12,15-16,19,31H,13-14,17-18H2,1H3,(H,32,33,34);1H",Cl.CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2,CHEMBL380247,"InChI=1S/C29H27ClN4O4S/c1-39(35,36)14-13-31-17-23-9-12-27(38-23)21-7-10-26-24(15-21)29(33-19-32-26)34-22-8-11-28(25(30)16-22)37-18-20-5-3-2-4-6-20/h2-12,15-16,19,31H,13-14,17-18H2,1H3,(H,32,33,34)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2,CHEMBL1054500,"TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM",Inhibition,=,100,%,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,,CHEMBL1157539,"Nature, 465, p. 305 (2010)",20485427,GSK Malaria Screening
TCMDC-138687,CHEMBL468963,"InChI=1S/C22H21F3N8/c1-31-9-11-32(12-10-31)20-5-4-15(13-17(20)22(23,24)25)29-21-26-8-6-18(30-21)16-14-28-33-19(16)3-2-7-27-33/h2-8,13-14H,9-12H2,1H3,(H,26,29,30)",CN1CCN(CC1)c2ccc(Nc3nccc(n3)c4cnn5ncccc45)cc2C(F)(F)F,CHEMBL468963,"InChI=1S/C22H21F3N8/c1-31-9-11-32(12-10-31)20-5-4-15(13-17(20)22(23,24)25)29-21-26-8-6-18(30-21)16-14-28-33-19(16)3-2-7-27-33/h2-8,13-14H,9-12H2,1H3,(H,26,29,30)",CN1CCN(CC1)c2ccc(Nc3nccc(n3)c4cnn5ncccc45)cc2C(F)(F)F,CHEMBL1054500,"TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM",Inhibition,=,95,%,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,,CHEMBL1157539,"Nature, 465, p. 305 (2010)",20485427,GSK Malaria Screening
TCMDC-141371,CHEMBL588025,"InChI=1S/C20H13F4N5O2.ClH/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18;/h1-9H,(H2,25,26,27)(H2,28,29,30);1H",Cl.Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL1054500,"TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM",Inhibition,=,99,%,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,,CHEMBL1157539,"Nature, 465, p. 305 (2010)",20485427,GSK Malaria Screening
TCMDC-137304,CHEMBL531804,"InChI=1S/C23H21N7/c1-30(2)22-12-17-20(13-24-22)25-14-26-23(17)27-16-8-9-18-19(11-16)29-21(28-18)10-15-6-4-3-5-7-15/h3-9,11-14H,10H2,1-2H3,(H,28,29)(H,25,26,27)",CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1,CHEMBL531804,"InChI=1S/C23H21N7/c1-30(2)22-12-17-20(13-24-22)25-14-26-23(17)27-16-8-9-18-19(11-16)29-21(28-18)10-15-6-4-3-5-7-15/h3-9,11-14H,10H2,1-2H3,(H,28,29)(H,25,26,27)",CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1,CHEMBL1054501,"TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM",Inhibition,=,29,%,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,,CHEMBL1157539,"Nature, 465, p. 305 (2010)",20485427,GSK Malaria Screening
TCMDC-138201,CHEMBL581096,"InChI=1S/C21H17N3O.ClH/c1-14-5-7-16(25)13-20(14)24-19-9-11-23-21-12-15(6-8-17(19)21)18-4-2-3-10-22-18;/h2-13,25H,1H3,(H,23,24);1H",Cl.Cc1ccc(O)cc1Nc2ccnc3cc(ccc23)c4ccccn4,CHEMBL395358,"InChI=1S/C21H17N3O/c1-14-5-7-16(25)13-20(14)24-19-9-11-23-21-12-15(6-8-17(19)21)18-4-2-3-10-22-18/h2-13,25H,1H3,(H,23,24)",Cc1ccc(O)cc1Nc2ccnc3cc(ccc23)c4ccccn4,CHEMBL1054501,"TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM",Inhibition,=,98,%,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,,CHEMBL1157539,"Nature, 465, p. 305 (2010)",20485427,GSK Malaria Screening
TCMDC-138467,CHEMBL529066,"InChI=1S/C29H27ClN4O4S.ClH/c1-39(35,36)14-13-31-17-23-9-12-27(38-23)21-7-10-26-24(15-21)29(33-19-32-26)34-22-8-11-28(25(30)16-22)37-18-20-5-3-2-4-6-20;/h2-12,15-16,19,31H,13-14,17-18H2,1H3,(H,32,33,34);1H",Cl.CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2,CHEMBL380247,"InChI=1S/C29H27ClN4O4S/c1-39(35,36)14-13-31-17-23-9-12-27(38-23)21-7-10-26-24(15-21)29(33-19-32-26)34-22-8-11-28(25(30)16-22)37-18-20-5-3-2-4-6-20/h2-12,15-16,19,31H,13-14,17-18H2,1H3,(H,32,33,34)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2,CHEMBL1054501,"TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM",Inhibition,=,76,%,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,,CHEMBL1157539,"Nature, 465, p. 305 (2010)",20485427,GSK Malaria Screening
TCMDC-138687,CHEMBL468963,"InChI=1S/C22H21F3N8/c1-31-9-11-32(12-10-31)20-5-4-15(13-17(20)22(23,24)25)29-21-26-8-6-18(30-21)16-14-28-33-19(16)3-2-7-27-33/h2-8,13-14H,9-12H2,1H3,(H,26,29,30)",CN1CCN(CC1)c2ccc(Nc3nccc(n3)c4cnn5ncccc45)cc2C(F)(F)F,CHEMBL468963,"InChI=1S/C22H21F3N8/c1-31-9-11-32(12-10-31)20-5-4-15(13-17(20)22(23,24)25)29-21-26-8-6-18(30-21)16-14-28-33-19(16)3-2-7-27-33/h2-8,13-14H,9-12H2,1H3,(H,26,29,30)",CN1CCN(CC1)c2ccc(Nc3nccc(n3)c4cnn5ncccc45)cc2C(F)(F)F,CHEMBL1054501,"TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM",Inhibition,=,94,%,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,,CHEMBL1157539,"Nature, 465, p. 305 (2010)",20485427,GSK Malaria Screening
TCMDC-141371,CHEMBL588025,"InChI=1S/C20H13F4N5O2.ClH/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18;/h1-9H,(H2,25,26,27)(H2,28,29,30);1H",Cl.Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL1054501,"TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM",Inhibition,=,99,%,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,,CHEMBL1157539,"Nature, 465, p. 305 (2010)",20485427,GSK Malaria Screening
TCMDC-137304,CHEMBL531804,"InChI=1S/C23H21N7/c1-30(2)22-12-17-20(13-24-22)25-14-26-23(17)27-16-8-9-18-19(11-16)29-21(28-18)10-15-6-4-3-5-7-15/h3-9,11-14H,10H2,1-2H3,(H,28,29)(H,25,26,27)",CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1,CHEMBL531804,"InChI=1S/C23H21N7/c1-30(2)22-12-17-20(13-24-22)25-14-26-23(17)27-16-8-9-18-19(11-16)29-21(28-18)10-15-6-4-3-5-7-15/h3-9,11-14H,10H2,1-2H3,(H,28,29)(H,25,26,27)",CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1,CHEMBL1054504,TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.,Inhibition,=,11,%,,CHEMBL395,HepG2 (Hepatoblastoma cells),Homo sapiens,,CHEMBL1157539,"Nature, 465, p. 305 (2010)",20485427,GSK Malaria Screening
TCMDC-138201,CHEMBL581096,"InChI=1S/C21H17N3O.ClH/c1-14-5-7-16(25)13-20(14)24-19-9-11-23-21-12-15(6-8-17(19)21)18-4-2-3-10-22-18;/h2-13,25H,1H3,(H,23,24);1H",Cl.Cc1ccc(O)cc1Nc2ccnc3cc(ccc23)c4ccccn4,CHEMBL395358,"InChI=1S/C21H17N3O/c1-14-5-7-16(25)13-20(14)24-19-9-11-23-21-12-15(6-8-17(19)21)18-4-2-3-10-22-18/h2-13,25H,1H3,(H,23,24)",Cc1ccc(O)cc1Nc2ccnc3cc(ccc23)c4ccccn4,CHEMBL1054504,TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.,Inhibition,=,6,%,,CHEMBL395,HepG2 (Hepatoblastoma cells),Homo sapiens,,CHEMBL1157539,"Nature, 465, p. 305 (2010)",20485427,GSK Malaria Screening
TCMDC-138467,CHEMBL529066,"InChI=1S/C29H27ClN4O4S.ClH/c1-39(35,36)14-13-31-17-23-9-12-27(38-23)21-7-10-26-24(15-21)29(33-19-32-26)34-22-8-11-28(25(30)16-22)37-18-20-5-3-2-4-6-20;/h2-12,15-16,19,31H,13-14,17-18H2,1H3,(H,32,33,34);1H",Cl.CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2,CHEMBL380247,"InChI=1S/C29H27ClN4O4S/c1-39(35,36)14-13-31-17-23-9-12-27(38-23)21-7-10-26-24(15-21)29(33-19-32-26)34-22-8-11-28(25(30)16-22)37-18-20-5-3-2-4-6-20/h2-12,15-16,19,31H,13-14,17-18H2,1H3,(H,32,33,34)",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2,CHEMBL1054504,TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.,Inhibition,=,4,%,,CHEMBL395,HepG2 (Hepatoblastoma cells),Homo sapiens,,CHEMBL1157539,"Nature, 465, p. 305 (2010)",20485427,GSK Malaria Screening
TCMDC-138687,CHEMBL468963,"InChI=1S/C22H21F3N8/c1-31-9-11-32(12-10-31)20-5-4-15(13-17(20)22(23,24)25)29-21-26-8-6-18(30-21)16-14-28-33-19(16)3-2-7-27-33/h2-8,13-14H,9-12H2,1H3,(H,26,29,30)",CN1CCN(CC1)c2ccc(Nc3nccc(n3)c4cnn5ncccc45)cc2C(F)(F)F,CHEMBL468963,"InChI=1S/C22H21F3N8/c1-31-9-11-32(12-10-31)20-5-4-15(13-17(20)22(23,24)25)29-21-26-8-6-18(30-21)16-14-28-33-19(16)3-2-7-27-33/h2-8,13-14H,9-12H2,1H3,(H,26,29,30)",CN1CCN(CC1)c2ccc(Nc3nccc(n3)c4cnn5ncccc45)cc2C(F)(F)F,CHEMBL1054504,TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.,Inhibition,=,77,%,,CHEMBL395,HepG2 (Hepatoblastoma cells),Homo sapiens,,CHEMBL1157539,"Nature, 465, p. 305 (2010)",20485427,GSK Malaria Screening
TCMDC-141371,CHEMBL588025,"InChI=1S/C20H13F4N5O2.ClH/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18;/h1-9H,(H2,25,26,27)(H2,28,29,30);1H",Cl.Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL1054504,TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.,Inhibition,=,57,%,,CHEMBL395,HepG2 (Hepatoblastoma cells),Homo sapiens,,CHEMBL1157539,"Nature, 465, p. 305 (2010)",20485427,GSK Malaria Screening
SB-220025,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1067575,Inhibition of human MAPK p38alpha,IC50,=,19,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1157644,"Bioorg. Med. Chem., 18, p. 2204 (2010)",20188577,Scientific Literature
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1613772,"PubChem BioAssay. Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay: c-Raf Inhibition.   (Class of assay: confirmatory) [Related pubchem assays: 1454 , 995 ]",Potency,=,28.1838,uM,Inconclusive,CHEMBL1906,Serine/threonine-protein kinase RAF,Homo sapiens,P04049,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614438,"PubChem BioAssay. Confirmation Concentration-Response Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF.   (Class of assay: confirmatory) [Related pubchem assays: 1454 , 995 ]",Potency,=,2.8184,uM,Active,CHEMBL4040,MAP kinase ERK2,Homo sapiens,P28482,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1613859,"PubChem BioAssay. Counterscreen for APE1 Inhibitors: Fluorescent Dye Displacement Validation Assay.   (Class of assay: confirmatory) [Related pubchem assays: 1705 , 1708 ]",Potency,=,31.6228,uM,Not Active,CHEMBL612545,,,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614433,"PubChem BioAssay. Counterscreen for APE1 Inhibitors: qHTS Validation Assay for Inhibitors of Endonuclease IV.   (Class of assay: confirmatory) [Related pubchem assays: 1705 , 1707 ]",Potency,=,19.9526,uM,Inconclusive,CHEMBL1293285,Endonuclease 4,Escherichia coli K-12,P0A6C1,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11114151,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1614502,"PubChem BioAssay. Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillization by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau.  (Class of assay: confirmatory) [Related pubchem assays: 596 ]",Potency,=,22.3872,uM,Inconclusive,CHEMBL1293224,Microtubule-associated protein tau,Homo sapiens,P10636,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID26752223,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1614502,"PubChem BioAssay. Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillization by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau.  (Class of assay: confirmatory) [Related pubchem assays: 596 ]",Potency,=,15.8489,uM,Inconclusive,CHEMBL1293224,Microtubule-associated protein tau,Homo sapiens,P10636,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614502,"PubChem BioAssay. Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillization by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau.  (Class of assay: confirmatory) [Related pubchem assays: 596 ]",Potency,=,7.0795,uM,Active,CHEMBL1293224,Microtubule-associated protein tau,Homo sapiens,P10636,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11111220,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1741322,PubChem BioAssay. Cytochrome panel assay with activity outcomes. (Class of assay: other)   Panel member name: p450-cyp1a2 Compounds with AC50 equal or less than 10 uM are considered active,AC50,=,7.943282347,uM,Active,CHEMBL3356,Cytochrome P450 1A2,Homo sapiens,P05177,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11114151,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1741322,PubChem BioAssay. Cytochrome panel assay with activity outcomes. (Class of assay: other)   Panel member name: p450-cyp1a2 Compounds with AC50 equal or less than 10 uM are considered active,AC50,=,15.84893192,uM,inconclusive,CHEMBL3356,Cytochrome P450 1A2,Homo sapiens,P05177,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11111220,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1741323,PubChem BioAssay. Cytochrome panel assay with activity outcomes. (Class of assay: other)   Panel member name: p450-cyp2c19 Compounds with AC50 equal or less than 10 uM are considered active,AC50,=,25.11886432,uM,inconclusive,CHEMBL3622,Cytochrome P450 2C19,Homo sapiens,P33261,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11114151,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1741323,PubChem BioAssay. Cytochrome panel assay with activity outcomes. (Class of assay: other)   Panel member name: p450-cyp2c19 Compounds with AC50 equal or less than 10 uM are considered active,AC50,=,2.511886432,uM,Active,CHEMBL3622,Cytochrome P450 2C19,Homo sapiens,P33261,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11111220,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1741325,PubChem BioAssay. Cytochrome panel assay with activity outcomes. (Class of assay: other)   Panel member name: p450-cyp2c9 Compounds with AC50 equal or less than 10 uM are considered active,AC50,=,12.58925412,uM,Active,CHEMBL3397,Cytochrome P450 2C9,Homo sapiens,P11712,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11114151,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1741325,PubChem BioAssay. Cytochrome panel assay with activity outcomes. (Class of assay: other)   Panel member name: p450-cyp2c9 Compounds with AC50 equal or less than 10 uM are considered active,AC50,,,,inactive,CHEMBL3397,Cytochrome P450 2C9,Homo sapiens,P11712,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11111220,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1741321,PubChem BioAssay. Cytochrome panel assay with activity outcomes. (Class of assay: other)   Panel member name: p450-cyp2d6 Compounds with AC50 equal or less than 10 uM are considered active,AC50,=,31.6227766,uM,inconclusive,CHEMBL289,Cytochrome P450 2D6,Homo sapiens,P10635,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11114151,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1741321,PubChem BioAssay. Cytochrome panel assay with activity outcomes. (Class of assay: other)   Panel member name: p450-cyp2d6 Compounds with AC50 equal or less than 10 uM are considered active,AC50,=,12.58925412,uM,Active,CHEMBL289,Cytochrome P450 2D6,Homo sapiens,P10635,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11111220,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1741324,PubChem BioAssay. Cytochrome panel assay with activity outcomes. (Class of assay: other)   Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active,AC50,=,5.011872336,uM,Active,CHEMBL340,Cytochrome P450 3A4,Homo sapiens,P08684,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11114151,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1741324,PubChem BioAssay. Cytochrome panel assay with activity outcomes. (Class of assay: other)   Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active,AC50,=,10,uM,Active,CHEMBL340,Cytochrome P450 3A4,Homo sapiens,P08684,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID90341621,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1613805,PubChem BioAssay. Cytometry Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF cells.   (Class of assay: confirmatory) ,Potency,=,26.1216,uM,Inconclusive,CHEMBL2842,FK506 binding protein 12,Homo sapiens,P42345,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11114151,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1794467,PubChem BioAssay. Inhibitors of USP1/UAF1: Pilot qHTS.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504878],Potency,,56.2341,uM,inconclusive,CHEMBL1795087,Ubiquitin carboxyl-terminal hydrolase 1,Homo sapiens,O94782,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID90341621,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1794467,PubChem BioAssay. Inhibitors of USP1/UAF1: Pilot qHTS.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504878],Potency,,31.6228,uM,inconclusive,CHEMBL1795087,Ubiquitin carboxyl-terminal hydrolase 1,Homo sapiens,O94782,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963785,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ABL1,-Log Ki,<,6.2,none,inactive,CHEMBL1862,Tyrosine-protein kinase ABL,Homo sapiens,P00519,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963785,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ABL1,-Log Ki,<,6.2,none,inactive,CHEMBL1862,Tyrosine-protein kinase ABL,Homo sapiens,P00519,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963785,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ABL1,-Log Ki,<,5.4,none,inactive,CHEMBL1862,Tyrosine-protein kinase ABL,Homo sapiens,P00519,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963785,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ABL1,-Log Ki,<,6.2,none,inactive,CHEMBL1862,Tyrosine-protein kinase ABL,Homo sapiens,P00519,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963777,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ACK1,-Log Ki,<,5.4,none,inactive,CHEMBL4599,Tyrosine kinase non-receptor protein 2,Homo sapiens,Q07912,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963777,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ACK1,-Log Ki,<,5.4,none,inactive,CHEMBL4599,Tyrosine kinase non-receptor protein 2,Homo sapiens,Q07912,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963721,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ACVR1,-Log Ki,<,5.4,none,inactive,CHEMBL5903,Activin receptor type-1,Homo sapiens,Q04771,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963721,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ACVR1,-Log Ki,<,5.4,none,inactive,CHEMBL5903,Activin receptor type-1,Homo sapiens,Q04771,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963809,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: AKT1,-Log Ki,<,5.1,none,inactive,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,P31749,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963809,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: AKT1,-Log Ki,<,5.1,none,inactive,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,P31749,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963809,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: AKT1,-Log Ki,=,6.3,none,active,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,P31749,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963739,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: AKT2,-Log Ki,<,5.1,none,inactive,CHEMBL2431,Serine/threonine-protein kinase AKT2,Homo sapiens,P31751,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963739,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: AKT2,-Log Ki,<,5.1,none,inactive,CHEMBL2431,Serine/threonine-protein kinase AKT2,Homo sapiens,P31751,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963739,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: AKT2,-Log Ki,<,5.1,none,inactive,CHEMBL2431,Serine/threonine-protein kinase AKT2,Homo sapiens,P31751,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963739,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: AKT2,-Log Ki,=,6.2,none,active,CHEMBL2431,Serine/threonine-protein kinase AKT2,Homo sapiens,P31751,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963699,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: AKT3,-Log Ki,<,5,none,inactive,CHEMBL4816,Serine/threonine-protein kinase AKT3,Homo sapiens,Q9Y243,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963699,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: AKT3,-Log Ki,<,5,none,inactive,CHEMBL4816,Serine/threonine-protein kinase AKT3,Homo sapiens,Q9Y243,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963699,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: AKT3,-Log Ki,<,5,none,inactive,CHEMBL4816,Serine/threonine-protein kinase AKT3,Homo sapiens,Q9Y243,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963699,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: AKT3,-Log Ki,=,5.7,none,active,CHEMBL4816,Serine/threonine-protein kinase AKT3,Homo sapiens,Q9Y243,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963704,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ALK,-Log Ki,=,6.1,none,active,CHEMBL4247,ALK tyrosine kinase receptor,Homo sapiens,Q9UM73,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963704,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ALK,-Log Ki,<,5.9,none,inactive,CHEMBL4247,ALK tyrosine kinase receptor,Homo sapiens,Q9UM73,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963704,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ALK,-Log Ki,<,5.2,none,inactive,CHEMBL4247,ALK tyrosine kinase receptor,Homo sapiens,Q9UM73,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963704,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ALK,-Log Ki,<,5.2,none,inactive,CHEMBL4247,ALK tyrosine kinase receptor,Homo sapiens,Q9UM73,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963704,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ALK,-Log Ki,<,5.9,none,inactive,CHEMBL4247,ALK tyrosine kinase receptor,Homo sapiens,Q9UM73,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1964114,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: AXL,-Log Ki,<,5.7,none,inactive,CHEMBL4895,Tyrosine-protein kinase receptor UFO,Homo sapiens,P30530,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1964114,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: AXL,-Log Ki,=,6.6,none,active,CHEMBL4895,Tyrosine-protein kinase receptor UFO,Homo sapiens,P30530,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963752,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: BLK,-Log Ki,=,6.4,none,active,CHEMBL2250,Tyrosine-protein kinase BLK,Homo sapiens,P51451,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963752,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: BLK,-Log Ki,<,5.8,none,inactive,CHEMBL2250,Tyrosine-protein kinase BLK,Homo sapiens,P51451,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963752,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: BLK,-Log Ki,<,5.8,none,inactive,CHEMBL2250,Tyrosine-protein kinase BLK,Homo sapiens,P51451,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963752,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: BLK,-Log Ki,<,5.8,none,inactive,CHEMBL2250,Tyrosine-protein kinase BLK,Homo sapiens,P51451,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963733,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: BTK,-Log Ki,<,5.2,none,inactive,CHEMBL5251,Tyrosine-protein kinase BTK,Homo sapiens,Q06187,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963733,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: BTK,-Log Ki,<,5.2,none,inactive,CHEMBL5251,Tyrosine-protein kinase BTK,Homo sapiens,Q06187,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963733,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: BTK,-Log Ki,<,5.9,none,inactive,CHEMBL5251,Tyrosine-protein kinase BTK,Homo sapiens,Q06187,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963816,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CAMK1,-Log Ki,<,5.5,none,inactive,CHEMBL2493,CaM kinase I alpha,Homo sapiens,Q14012,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963816,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CAMK1,-Log Ki,<,5.5,none,inactive,CHEMBL2493,CaM kinase I alpha,Homo sapiens,Q14012,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963816,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CAMK1,-Log Ki,<,5.1,none,inactive,CHEMBL2493,CaM kinase I alpha,Homo sapiens,Q14012,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963816,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CAMK1,-Log Ki,<,5.3,none,inactive,CHEMBL2493,CaM kinase I alpha,Homo sapiens,Q14012,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963811,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CAMK1D,-Log Ki,<,5.6,none,inactive,CHEMBL5073,CaM kinase I delta,Homo sapiens,Q8IU85,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963811,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CAMK1D,-Log Ki,<,5.6,none,inactive,CHEMBL5073,CaM kinase I delta,Homo sapiens,Q8IU85,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1964111,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CAMK2A,-Log Ki,<,5.1,none,inactive,CHEMBL4147,CaM kinase II alpha,Homo sapiens,Q9UQM7,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1964111,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CAMK2A,-Log Ki,<,5.1,none,inactive,CHEMBL4147,CaM kinase II alpha,Homo sapiens,Q9UQM7,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963787,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CAMK2B,-Log Ki,<,5.1,none,inactive,CHEMBL4121,CaM kinase II beta,Homo sapiens,Q13554,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963787,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CAMK2B,-Log Ki,<,5.1,none,inactive,CHEMBL4121,CaM kinase II beta,Homo sapiens,Q13554,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963787,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CAMK2B,-Log Ki,=,5.1,none,active,CHEMBL4121,CaM kinase II beta,Homo sapiens,Q13554,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963738,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CAMK2D,-Log Ki,=,5.4,none,active,CHEMBL2801,CaM kinase II delta,Homo sapiens,Q13557,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963738,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CAMK2D,-Log Ki,<,5.2,none,inactive,CHEMBL2801,CaM kinase II delta,Homo sapiens,Q13557,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963738,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CAMK2D,-Log Ki,<,5.2,none,inactive,CHEMBL2801,CaM kinase II delta,Homo sapiens,Q13557,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963710,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CAMK2G,-Log Ki,=,5.4,none,active,CHEMBL3829,CaM kinase II gamma,Homo sapiens,Q13555,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963710,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CAMK2G,-Log Ki,<,5.2,none,inactive,CHEMBL3829,CaM kinase II gamma,Homo sapiens,Q13555,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963710,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CAMK2G,-Log Ki,<,5.2,none,inactive,CHEMBL3829,CaM kinase II gamma,Homo sapiens,Q13555,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963819,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CDC2,-Log Ki,=,5.2,none,active,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963819,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CDC2,-Log Ki,<,5.1,none,inactive,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963819,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CDC2,-Log Ki,<,5.1,none,inactive,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963819,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CDC2,-Log Ki,<,5.1,none,inactive,CHEMBL308,Cyclin-dependent kinase 1,Homo sapiens,P06493,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963813,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CDC2L6,-Log Ki,<,4,none,inactive,CHEMBL6002,Cell division cycle 2-like protein kinase 6,Homo sapiens,Q9BWU1,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1964102,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CDC42BPA,-Log Ki,<,5,none,inactive,CHEMBL4516,Serine/threonine-protein kinase MRCK-A,Homo sapiens,Q5VT25,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1964102,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CDC42BPA,-Log Ki,<,5,none,inactive,CHEMBL4516,Serine/threonine-protein kinase MRCK-A,Homo sapiens,Q5VT25,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1964102,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CDC42BPA,-Log Ki,<,5,none,inactive,CHEMBL4516,Serine/threonine-protein kinase MRCK-A,Homo sapiens,Q5VT25,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1964102,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CDC42BPA,-Log Ki,=,6.8,none,active,CHEMBL4516,Serine/threonine-protein kinase MRCK-A,Homo sapiens,Q5VT25,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963731,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CDC7,-Log Ki,<,5.9,none,inactive,CHEMBL5443,Cell division cycle 7-related protein kinase,Homo sapiens,O00311,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963731,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CDC7,-Log Ki,<,5.9,none,inactive,CHEMBL5443,Cell division cycle 7-related protein kinase,Homo sapiens,O00311,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963731,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CDC7,-Log Ki,<,5.9,none,inactive,CHEMBL5443,Cell division cycle 7-related protein kinase,Homo sapiens,O00311,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963731,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CDC7,-Log Ki,=,7.1,none,active,CHEMBL5443,Cell division cycle 7-related protein kinase,Homo sapiens,O00311,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963723,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CDK2,-Log Ki,=,5.1,none,active,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963723,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CDK2,-Log Ki,<,5.1,none,inactive,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963723,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CDK2,-Log Ki,<,5.1,none,inactive,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963723,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CDK2,-Log Ki,=,6.1,none,active,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963790,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CDK5,-Log Ki,=,5,none,active,CHEMBL4036,Cyclin-dependent kinase 5,Homo sapiens,Q00535,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963790,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CDK5,-Log Ki,<,5,none,inactive,CHEMBL4036,Cyclin-dependent kinase 5,Homo sapiens,Q00535,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963790,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CDK5,-Log Ki,<,5,none,inactive,CHEMBL4036,Cyclin-dependent kinase 5,Homo sapiens,Q00535,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963790,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CDK5,-Log Ki,<,5.5,none,inactive,CHEMBL4036,Cyclin-dependent kinase 5,Homo sapiens,Q00535,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963790,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CDK5,-Log Ki,<,5,none,inactive,CHEMBL4036,Cyclin-dependent kinase 5,Homo sapiens,Q00535,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963825,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CDK7,-Log Ki,<,5.4,none,inactive,CHEMBL3055,Cyclin-dependent kinase 7,Homo sapiens,P50613,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963825,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CDK7,-Log Ki,<,5.4,none,inactive,CHEMBL3055,Cyclin-dependent kinase 7,Homo sapiens,P50613,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963824,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CDK8,-Log Ki,<,5.4,none,inactive,CHEMBL5719,Cell division protein kinase 8,Homo sapiens,P49336,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963824,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CDK8,-Log Ki,<,5.4,none,inactive,CHEMBL5719,Cell division protein kinase 8,Homo sapiens,P49336,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963831,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CDK9,-Log Ki,<,5.8,none,inactive,CHEMBL3116,Cyclin-dependent kinase 9,Homo sapiens,P50750,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963831,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CDK9,-Log Ki,<,5.8,none,inactive,CHEMBL3116,Cyclin-dependent kinase 9,Homo sapiens,P50750,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963782,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CHEK1,-Log Ki,<,5.1,none,inactive,CHEMBL4630,Serine/threonine-protein kinase Chk1 ,Homo sapiens,O14757,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963782,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CHEK1,-Log Ki,<,5.1,none,inactive,CHEMBL4630,Serine/threonine-protein kinase Chk1 ,Homo sapiens,O14757,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963782,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CHEK1,-Log Ki,<,5.1,none,inactive,CHEMBL4630,Serine/threonine-protein kinase Chk1 ,Homo sapiens,O14757,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963720,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CHEK2,-Log Ki,=,6.2,none,active,CHEMBL2527,Serine/threonine-protein kinase Chk2,Homo sapiens,O96017,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963720,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CHEK2,-Log Ki,<,5.3,none,inactive,CHEMBL2527,Serine/threonine-protein kinase Chk2,Homo sapiens,O96017,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963720,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CHEK2,-Log Ki,<,5.3,none,inactive,CHEMBL2527,Serine/threonine-protein kinase Chk2,Homo sapiens,O96017,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963720,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CHEK2,-Log Ki,<,5.8,none,inactive,CHEMBL2527,Serine/threonine-protein kinase Chk2,Homo sapiens,O96017,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963776,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CHUK,-Log Ki,<,5.4,none,inactive,CHEMBL3476,Inhibitor of nuclear factor kappa B kinase alpha subunit,Homo sapiens,O15111,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963776,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CHUK,-Log Ki,<,5.4,none,inactive,CHEMBL3476,Inhibitor of nuclear factor kappa B kinase alpha subunit,Homo sapiens,O15111,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963691,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CLK2,-Log Ki,=,6.4,none,active,CHEMBL4225,Dual specificity protein kinase CLK2,Homo sapiens,P49760,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963691,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CLK2,-Log Ki,=,5.9,none,active,CHEMBL4225,Dual specificity protein kinase CLK2,Homo sapiens,P49760,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963691,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CLK2,-Log Ki,<,5.4,none,inactive,CHEMBL4225,Dual specificity protein kinase CLK2,Homo sapiens,P49760,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963691,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CLK2,-Log Ki,<,5.1,none,inactive,CHEMBL4225,Dual specificity protein kinase CLK2,Homo sapiens,P49760,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963691,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CLK2,-Log Ki,<,5.4,none,inactive,CHEMBL4225,Dual specificity protein kinase CLK2,Homo sapiens,P49760,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963691,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CLK2,-Log Ki,<,5.1,none,inactive,CHEMBL4225,Dual specificity protein kinase CLK2,Homo sapiens,P49760,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963837,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CLK4,-Log Ki,=,6.8,none,active,CHEMBL4203,Dual specificity protein kinase CLK4,Homo sapiens,Q9HAZ1,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963837,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CLK4,-Log Ki,=,6,none,active,CHEMBL4203,Dual specificity protein kinase CLK4,Homo sapiens,Q9HAZ1,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963837,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CLK4,-Log Ki,<,5.6,none,inactive,CHEMBL4203,Dual specificity protein kinase CLK4,Homo sapiens,Q9HAZ1,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963837,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CLK4,-Log Ki,=,6.4,none,active,CHEMBL4203,Dual specificity protein kinase CLK4,Homo sapiens,Q9HAZ1,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963837,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CLK4,-Log Ki,<,5.6,none,inactive,CHEMBL4203,Dual specificity protein kinase CLK4,Homo sapiens,Q9HAZ1,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963837,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CLK4,-Log Ki,=,6.2,none,active,CHEMBL4203,Dual specificity protein kinase CLK4,Homo sapiens,Q9HAZ1,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1964104,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CSF1R,-Log Ki,<,5.6,none,inactive,CHEMBL1844,Macrophage colony stimulating factor  receptor ,Homo sapiens,P07333,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1964104,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CSF1R,-Log Ki,<,5.6,none,inactive,CHEMBL1844,Macrophage colony stimulating factor  receptor ,Homo sapiens,P07333,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1964104,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CSF1R,-Log Ki,<,5.6,none,inactive,CHEMBL1844,Macrophage colony stimulating factor  receptor ,Homo sapiens,P07333,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1964104,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CSF1R,-Log Ki,=,6.3,none,active,CHEMBL1844,Macrophage colony stimulating factor  receptor ,Homo sapiens,P07333,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1964104,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CSF1R,-Log Ki,=,7.4,none,active,CHEMBL1844,Macrophage colony stimulating factor  receptor ,Homo sapiens,P07333,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1964104,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CSF1R,-Log Ki,<,5.6,none,inactive,CHEMBL1844,Macrophage colony stimulating factor  receptor ,Homo sapiens,P07333,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963741,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CSNK1A1,-Log Ki,=,5.8,none,active,CHEMBL2793,Casein kinase I alpha,Homo sapiens,P48729,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963741,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CSNK1A1,-Log Ki,=,7.9,none,active,CHEMBL2793,Casein kinase I alpha,Homo sapiens,P48729,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963741,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CSNK1A1,-Log Ki,=,7,none,active,CHEMBL2793,Casein kinase I alpha,Homo sapiens,P48729,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963741,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CSNK1A1,-Log Ki,<,5.2,none,inactive,CHEMBL2793,Casein kinase I alpha,Homo sapiens,P48729,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963741,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CSNK1A1,-Log Ki,<,5.4,none,inactive,CHEMBL2793,Casein kinase I alpha,Homo sapiens,P48729,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963741,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CSNK1A1,-Log Ki,<,5.2,none,inactive,CHEMBL2793,Casein kinase I alpha,Homo sapiens,P48729,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963783,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CSNK1D,-Log Ki,=,6.9,none,active,CHEMBL2828,Casein kinase I delta,Homo sapiens,P48730,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963783,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CSNK1D,-Log Ki,=,7.9,none,active,CHEMBL2828,Casein kinase I delta,Homo sapiens,P48730,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963783,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CSNK1D,-Log Ki,<,5.1,none,inactive,CHEMBL2828,Casein kinase I delta,Homo sapiens,P48730,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963783,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CSNK1D,-Log Ki,<,5.1,none,inactive,CHEMBL2828,Casein kinase I delta,Homo sapiens,P48730,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963743,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CSNK1G1,-Log Ki,<,5.2,none,inactive,CHEMBL2426,Casein kinase I gamma 1,Homo sapiens,Q9HCP0,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963743,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CSNK1G1,-Log Ki,<,5.2,none,inactive,CHEMBL2426,Casein kinase I gamma 1,Homo sapiens,Q9HCP0,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963743,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CSNK1G1,-Log Ki,<,5.2,none,inactive,CHEMBL2426,Casein kinase I gamma 1,Homo sapiens,Q9HCP0,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963686,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CSNK1G2,-Log Ki,<,5.1,none,inactive,CHEMBL2543,Casein kinase I gamma 2,Homo sapiens,P78368,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963686,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CSNK1G2,-Log Ki,=,5.5,none,active,CHEMBL2543,Casein kinase I gamma 2,Homo sapiens,P78368,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963686,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CSNK1G2,-Log Ki,<,5.1,none,inactive,CHEMBL2543,Casein kinase I gamma 2,Homo sapiens,P78368,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963686,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CSNK1G2,-Log Ki,<,5.1,none,inactive,CHEMBL2543,Casein kinase I gamma 2,Homo sapiens,P78368,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1964116,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CSNK1G3,-Log Ki,<,5.2,none,inactive,CHEMBL5084,Casein kinase I isoform gamma-3,Homo sapiens,Q9Y6M4,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1964116,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CSNK1G3,-Log Ki,<,5.2,none,inactive,CHEMBL5084,Casein kinase I isoform gamma-3,Homo sapiens,Q9Y6M4,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963735,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CSNK2A1,-Log Ki,=,5.9,none,active,CHEMBL3629,Casein kinase II alpha,Homo sapiens,P68400,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963735,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CSNK2A1,-Log Ki,=,6.1,none,active,CHEMBL3629,Casein kinase II alpha,Homo sapiens,P68400,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963735,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: CSNK2A1,-Log Ki,<,5.2,none,inactive,CHEMBL3629,Casein kinase II alpha,Homo sapiens,P68400,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963719,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: DAPK3,-Log Ki,<,5.9,none,inactive,CHEMBL2468,Death-associated protein kinase 3,Homo sapiens,O43293,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963719,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: DAPK3,-Log Ki,<,5.9,none,inactive,CHEMBL2468,Death-associated protein kinase 3,Homo sapiens,O43293,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963719,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: DAPK3,-Log Ki,<,5.3,none,inactive,CHEMBL2468,Death-associated protein kinase 3,Homo sapiens,O43293,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963719,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: DAPK3,-Log Ki,<,5.9,none,inactive,CHEMBL2468,Death-associated protein kinase 3,Homo sapiens,O43293,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963719,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: DAPK3,-Log Ki,<,5.3,none,inactive,CHEMBL2468,Death-associated protein kinase 3,Homo sapiens,O43293,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963719,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: DAPK3,-Log Ki,=,6.3,none,active,CHEMBL2468,Death-associated protein kinase 3,Homo sapiens,O43293,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963822,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: DCAMKL1,-Log Ki,<,5,none,inactive,CHEMBL5683,Serine/threonine-protein kinase DCLK1,Homo sapiens,O15075,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963822,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: DCAMKL1,-Log Ki,<,5,none,inactive,CHEMBL5683,Serine/threonine-protein kinase DCLK1,Homo sapiens,O15075,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963822,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: DCAMKL1,-Log Ki,<,5,none,inactive,CHEMBL5683,Serine/threonine-protein kinase DCLK1,Homo sapiens,O15075,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963822,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: DCAMKL1,-Log Ki,<,5,none,inactive,CHEMBL5683,Serine/threonine-protein kinase DCLK1,Homo sapiens,O15075,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1964107,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: DYRK1A,-Log Ki,=,5.6,none,active,CHEMBL2292,Dual-specificity tyrosine-phosphorylation regulated kinase 1A,Homo sapiens,Q13627,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1964107,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: DYRK1A,-Log Ki,<,5.2,none,inactive,CHEMBL2292,Dual-specificity tyrosine-phosphorylation regulated kinase 1A,Homo sapiens,Q13627,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1964107,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: DYRK1A,-Log Ki,<,5.7,none,inactive,CHEMBL2292,Dual-specificity tyrosine-phosphorylation regulated kinase 1A,Homo sapiens,Q13627,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1964107,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: DYRK1A,-Log Ki,=,5.3,none,active,CHEMBL2292,Dual-specificity tyrosine-phosphorylation regulated kinase 1A,Homo sapiens,Q13627,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1964107,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: DYRK1A,-Log Ki,<,5.7,none,inactive,CHEMBL2292,Dual-specificity tyrosine-phosphorylation regulated kinase 1A,Homo sapiens,Q13627,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1964107,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: DYRK1A,-Log Ki,<,5.2,none,inactive,CHEMBL2292,Dual-specificity tyrosine-phosphorylation regulated kinase 1A,Homo sapiens,Q13627,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963799,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: DYRK1B,-Log Ki,<,5.6,none,inactive,CHEMBL5543,Dual specificity tyrosine-phosphorylation-regulated kinase 1B,Homo sapiens,Q9Y463,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963799,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: DYRK1B,-Log Ki,<,5.6,none,inactive,CHEMBL5543,Dual specificity tyrosine-phosphorylation-regulated kinase 1B,Homo sapiens,Q9Y463,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963773,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: DYRK3,-Log Ki,=,5.7,none,active,CHEMBL4575,Dual-specificity tyrosine-phosphorylation regulated kinase 3,Homo sapiens,O43781,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963773,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: DYRK3,-Log Ki,<,5.2,none,inactive,CHEMBL4575,Dual-specificity tyrosine-phosphorylation regulated kinase 3,Homo sapiens,O43781,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963797,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: DYRK4,-Log Ki,<,5.1,none,inactive,CHEMBL1075115,Dual specificity tyrosine-phosphorylation-regulated kinase 4,Homo sapiens,Q9NR20,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963797,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: DYRK4,-Log Ki,<,5.1,none,inactive,CHEMBL1075115,Dual specificity tyrosine-phosphorylation-regulated kinase 4,Homo sapiens,Q9NR20,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963711,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: EEF2K,-Log Ki,<,5.4,none,inactive,CHEMBL5026,Serine/threonine-protein kinase EEF2K,Homo sapiens,O00418,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963711,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: EEF2K,-Log Ki,<,5.4,none,inactive,CHEMBL5026,Serine/threonine-protein kinase EEF2K,Homo sapiens,O00418,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963766,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: EGFR,-Log Ki,<,5.7,none,inactive,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963766,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: EGFR,-Log Ki,<,5.9,none,inactive,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963766,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: EGFR,-Log Ki,=,6.6,none,active,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963766,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: EGFR,-Log Ki,<,5.7,none,inactive,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963791,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: EPHA2,-Log Ki,<,5.5,none,inactive,CHEMBL2068,Ephrin type-A receptor 2,Homo sapiens,P29317,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963791,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: EPHA2,-Log Ki,<,5.1,none,inactive,CHEMBL2068,Ephrin type-A receptor 2,Homo sapiens,P29317,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963791,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: EPHA2,-Log Ki,<,5.5,none,inactive,CHEMBL2068,Ephrin type-A receptor 2,Homo sapiens,P29317,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963791,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: EPHA2,-Log Ki,<,5.5,none,inactive,CHEMBL2068,Ephrin type-A receptor 2,Homo sapiens,P29317,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963780,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ERBB2,-Log Ki,<,5.8,none,inactive,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963780,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ERBB2,-Log Ki,<,5.8,none,inactive,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963780,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ERBB2,-Log Ki,=,6,none,active,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963780,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ERBB2,-Log Ki,<,5.8,none,inactive,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963833,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ERBB4,-Log Ki,<,5.4,none,inactive,CHEMBL3009,Receptor protein-tyrosine kinase erbB-4,Homo sapiens,Q15303,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963833,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ERBB4,-Log Ki,=,5.6,none,active,CHEMBL3009,Receptor protein-tyrosine kinase erbB-4,Homo sapiens,Q15303,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963833,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ERBB4,-Log Ki,<,5.4,none,inactive,CHEMBL3009,Receptor protein-tyrosine kinase erbB-4,Homo sapiens,Q15303,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963833,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ERBB4,-Log Ki,<,5.4,none,inactive,CHEMBL3009,Receptor protein-tyrosine kinase erbB-4,Homo sapiens,Q15303,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963815,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FER,-Log Ki,=,5.9,none,active,CHEMBL3982,Tyrosine-protein kinase FER,Homo sapiens,P16591,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963815,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FER,-Log Ki,<,5.8,none,inactive,CHEMBL3982,Tyrosine-protein kinase FER,Homo sapiens,P16591,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963758,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FES,-Log Ki,<,5.7,none,inactive,CHEMBL5455,Tyrosine-protein kinase FES,Homo sapiens,P07332,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963758,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FES,-Log Ki,<,5.7,none,inactive,CHEMBL5455,Tyrosine-protein kinase FES,Homo sapiens,P07332,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963740,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FGFR1,-Log Ki,=,5.3,none,active,CHEMBL3650,Fibroblast growth factor receptor 1,Homo sapiens,P11362,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963740,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FGFR1,-Log Ki,<,5.3,none,inactive,CHEMBL3650,Fibroblast growth factor receptor 1,Homo sapiens,P11362,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963740,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FGFR1,-Log Ki,<,5.4,none,inactive,CHEMBL3650,Fibroblast growth factor receptor 1,Homo sapiens,P11362,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963740,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FGFR1,-Log Ki,=,5.4,none,active,CHEMBL3650,Fibroblast growth factor receptor 1,Homo sapiens,P11362,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963740,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FGFR1,-Log Ki,<,5.4,none,inactive,CHEMBL3650,Fibroblast growth factor receptor 1,Homo sapiens,P11362,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963740,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FGFR1,-Log Ki,<,5.3,none,inactive,CHEMBL3650,Fibroblast growth factor receptor 1,Homo sapiens,P11362,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963828,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FGFR3,-Log Ki,<,5.7,none,inactive,CHEMBL2742,Fibroblast growth factor receptor 3,Homo sapiens,P22607,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963828,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FGFR3,-Log Ki,<,5.7,none,inactive,CHEMBL2742,Fibroblast growth factor receptor 3,Homo sapiens,P22607,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963828,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FGFR3,-Log Ki,<,5.7,none,inactive,CHEMBL2742,Fibroblast growth factor receptor 3,Homo sapiens,P22607,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963826,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FLT1,-Log Ki,<,6.4,none,inactive,CHEMBL1868,Vascular endothelial growth factor receptor 1,Homo sapiens,P17948,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963826,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FLT1,-Log Ki,<,5.4,none,inactive,CHEMBL1868,Vascular endothelial growth factor receptor 1,Homo sapiens,P17948,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963826,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FLT1,-Log Ki,=,6.9,none,active,CHEMBL1868,Vascular endothelial growth factor receptor 1,Homo sapiens,P17948,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963826,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FLT1,-Log Ki,<,5.4,none,inactive,CHEMBL1868,Vascular endothelial growth factor receptor 1,Homo sapiens,P17948,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963826,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FLT1,-Log Ki,<,6.4,none,inactive,CHEMBL1868,Vascular endothelial growth factor receptor 1,Homo sapiens,P17948,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963779,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FLT3,-Log Ki,<,5.6,none,inactive,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,Homo sapiens,P36888,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963779,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FLT3,-Log Ki,<,5.5,none,inactive,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,Homo sapiens,P36888,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963779,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FLT3,-Log Ki,=,7.3,none,active,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,Homo sapiens,P36888,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963779,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FLT3,-Log Ki,<,5.5,none,inactive,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,Homo sapiens,P36888,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963779,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FLT3,-Log Ki,=,5.8,none,active,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,Homo sapiens,P36888,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963812,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FLT4,-Log Ki,=,6.4,none,active,CHEMBL1955,Vascular endothelial growth factor receptor 3,Homo sapiens,P35916,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963812,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FLT4,-Log Ki,=,5.2,none,active,CHEMBL1955,Vascular endothelial growth factor receptor 3,Homo sapiens,P35916,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963812,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FLT4,-Log Ki,=,7,none,active,CHEMBL1955,Vascular endothelial growth factor receptor 3,Homo sapiens,P35916,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963812,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FLT4,-Log Ki,=,5.5,none,active,CHEMBL1955,Vascular endothelial growth factor receptor 3,Homo sapiens,P35916,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1964118,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FRK,-Log Ki,=,6.1,none,active,CHEMBL4223,Tyrosine-protein kinase FRK,Homo sapiens,P42685,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1964118,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FRK,-Log Ki,<,5.6,none,inactive,CHEMBL4223,Tyrosine-protein kinase FRK,Homo sapiens,P42685,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963817,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FYN,-Log Ki,<,6.1,none,inactive,CHEMBL1841,Tyrosine-protein kinase FYN,Homo sapiens,P06241,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963817,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FYN,-Log Ki,<,6.1,none,inactive,CHEMBL1841,Tyrosine-protein kinase FYN,Homo sapiens,P06241,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963817,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FYN,-Log Ki,<,5.2,none,inactive,CHEMBL1841,Tyrosine-protein kinase FYN,Homo sapiens,P06241,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963817,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FYN,-Log Ki,<,6.1,none,inactive,CHEMBL1841,Tyrosine-protein kinase FYN,Homo sapiens,P06241,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963817,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FYN,-Log Ki,<,5.2,none,inactive,CHEMBL1841,Tyrosine-protein kinase FYN,Homo sapiens,P06241,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963817,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: FYN,-Log Ki,<,6.1,none,inactive,CHEMBL1841,Tyrosine-protein kinase FYN,Homo sapiens,P06241,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963789,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: GPRK5,-Log Ki,<,5.4,none,inactive,CHEMBL5678,G protein-coupled receptor kinase 5,Homo sapiens,P34947,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963789,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: GPRK5,-Log Ki,<,5.4,none,inactive,CHEMBL5678,G protein-coupled receptor kinase 5,Homo sapiens,P34947,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963771,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: GSK3A,-Log Ki,<,5.1,none,inactive,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963771,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: GSK3A,-Log Ki,=,5.6,none,active,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963771,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: GSK3A,-Log Ki,<,5.4,none,inactive,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963771,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: GSK3A,-Log Ki,<,5.1,none,inactive,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963771,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: GSK3A,-Log Ki,<,5.4,none,inactive,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963771,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: GSK3A,-Log Ki,=,7.3,none,active,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963830,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: GSK3B,-Log Ki,=,5.7,none,active,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963830,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: GSK3B,-Log Ki,<,5.2,none,inactive,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963830,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: GSK3B,-Log Ki,<,5.4,none,inactive,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963830,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: GSK3B,-Log Ki,=,5.7,none,active,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963830,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: GSK3B,-Log Ki,<,5.4,none,inactive,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963830,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: GSK3B,-Log Ki,=,7.2,none,active,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963754,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: HIPK2,-Log Ki,=,5.6,none,active,CHEMBL4576,Homeodomain-interacting protein kinase 2,Homo sapiens,Q9H2X6,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963754,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: HIPK2,-Log Ki,<,5.5,none,inactive,CHEMBL4576,Homeodomain-interacting protein kinase 2,Homo sapiens,Q9H2X6,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963754,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: HIPK2,-Log Ki,<,5.5,none,inactive,CHEMBL4576,Homeodomain-interacting protein kinase 2,Homo sapiens,Q9H2X6,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963754,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: HIPK2,-Log Ki,=,6.1,none,active,CHEMBL4576,Homeodomain-interacting protein kinase 2,Homo sapiens,Q9H2X6,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963818,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: HIPK4,-Log Ki,=,5.6,none,active,CHEMBL1075167,Homeodomain-interacting protein kinase 4,Homo sapiens,Q8NE63,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963818,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: HIPK4,-Log Ki,<,5.1,none,inactive,CHEMBL1075167,Homeodomain-interacting protein kinase 4,Homo sapiens,Q8NE63,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963818,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: HIPK4,-Log Ki,<,5.1,none,inactive,CHEMBL1075167,Homeodomain-interacting protein kinase 4,Homo sapiens,Q8NE63,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963818,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: HIPK4,-Log Ki,=,5.3,none,active,CHEMBL1075167,Homeodomain-interacting protein kinase 4,Homo sapiens,Q8NE63,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963792,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: IGF1R,-Log Ki,=,5.9,none,active,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963792,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: IGF1R,-Log Ki,<,5.9,none,inactive,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963792,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: IGF1R,-Log Ki,<,5.6,none,inactive,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963792,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: IGF1R,-Log Ki,<,6,none,inactive,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963792,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: IGF1R,-Log Ki,<,5.6,none,inactive,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963792,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: IGF1R,-Log Ki,<,5.7,none,inactive,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1964112,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: IKBKB,-Log Ki,<,5.5,none,inactive,CHEMBL1991,Inhibitor of nuclear factor kappa B kinase beta subunit,Homo sapiens,O14920,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1964112,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: IKBKB,-Log Ki,<,5.5,none,inactive,CHEMBL1991,Inhibitor of nuclear factor kappa B kinase beta subunit,Homo sapiens,O14920,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1964108,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: IKBKE,-Log Ki,<,5.5,none,inactive,CHEMBL3529,Inhibitor of nuclear factor kappa B kinase epsilon subunit,Homo sapiens,Q14164,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1964108,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: IKBKE,-Log Ki,<,5.5,none,inactive,CHEMBL3529,Inhibitor of nuclear factor kappa B kinase epsilon subunit,Homo sapiens,Q14164,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963759,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: INSR,-Log Ki,=,5.6,none,active,CHEMBL1981,Insulin receptor,Homo sapiens,P06213,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963759,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: INSR,-Log Ki,<,5.3,none,inactive,CHEMBL1981,Insulin receptor,Homo sapiens,P06213,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963759,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: INSR,-Log Ki,<,5.3,none,inactive,CHEMBL1981,Insulin receptor,Homo sapiens,P06213,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963759,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: INSR,-Log Ki,<,5.3,none,inactive,CHEMBL1981,Insulin receptor,Homo sapiens,P06213,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963802,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: IRAK1,-Log Ki,=,5.8,none,active,CHEMBL3357,Interleukin-1 receptor-associated kinase 1 ,Homo sapiens,P51617,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963802,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: IRAK1,-Log Ki,=,5.2,none,active,CHEMBL3357,Interleukin-1 receptor-associated kinase 1 ,Homo sapiens,P51617,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963802,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: IRAK1,-Log Ki,<,5.1,none,inactive,CHEMBL3357,Interleukin-1 receptor-associated kinase 1 ,Homo sapiens,P51617,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963802,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: IRAK1,-Log Ki,<,5.1,none,inactive,CHEMBL3357,Interleukin-1 receptor-associated kinase 1 ,Homo sapiens,P51617,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963808,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: IRAK4,-Log Ki,=,6.8,none,active,CHEMBL3778,Interleukin-1 receptor-associated kinase 4,Homo sapiens,Q9NWZ3,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963808,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: IRAK4,-Log Ki,<,5,none,inactive,CHEMBL3778,Interleukin-1 receptor-associated kinase 4,Homo sapiens,Q9NWZ3,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963808,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: IRAK4,-Log Ki,<,5,none,inactive,CHEMBL3778,Interleukin-1 receptor-associated kinase 4,Homo sapiens,Q9NWZ3,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963808,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: IRAK4,-Log Ki,<,5,none,inactive,CHEMBL3778,Interleukin-1 receptor-associated kinase 4,Homo sapiens,Q9NWZ3,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963747,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ITK,-Log Ki,=,6.7,none,active,CHEMBL2959,Tyrosine-protein kinase ITK/TSK ,Homo sapiens,Q08881,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963747,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ITK,-Log Ki,<,5.8,none,inactive,CHEMBL2959,Tyrosine-protein kinase ITK/TSK ,Homo sapiens,Q08881,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963747,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ITK,-Log Ki,=,6,none,active,CHEMBL2959,Tyrosine-protein kinase ITK/TSK ,Homo sapiens,Q08881,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963747,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ITK,-Log Ki,<,5.8,none,inactive,CHEMBL2959,Tyrosine-protein kinase ITK/TSK ,Homo sapiens,Q08881,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963693,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: JAK2,-Log Ki,<,5.8,none,inactive,CHEMBL2971,Tyrosine-protein kinase JAK2,Homo sapiens,O60674,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963693,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: JAK2,-Log Ki,<,5.8,none,inactive,CHEMBL2971,Tyrosine-protein kinase JAK2,Homo sapiens,O60674,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963693,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: JAK2,-Log Ki,<,5.6,none,inactive,CHEMBL2971,Tyrosine-protein kinase JAK2,Homo sapiens,O60674,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963693,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: JAK2,-Log Ki,=,5.9,none,active,CHEMBL2971,Tyrosine-protein kinase JAK2,Homo sapiens,O60674,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963693,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: JAK2,-Log Ki,<,5.6,none,inactive,CHEMBL2971,Tyrosine-protein kinase JAK2,Homo sapiens,O60674,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963693,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: JAK2,-Log Ki,<,5.8,none,inactive,CHEMBL2971,Tyrosine-protein kinase JAK2,Homo sapiens,O60674,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963742,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: JAK3,-Log Ki,<,5.8,none,inactive,CHEMBL2148,Tyrosine-protein kinase JAK3,Homo sapiens,P52333,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963742,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: JAK3,-Log Ki,<,5.8,none,inactive,CHEMBL2148,Tyrosine-protein kinase JAK3,Homo sapiens,P52333,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963742,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: JAK3,-Log Ki,<,5.3,none,inactive,CHEMBL2148,Tyrosine-protein kinase JAK3,Homo sapiens,P52333,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963742,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: JAK3,-Log Ki,=,6.7,none,active,CHEMBL2148,Tyrosine-protein kinase JAK3,Homo sapiens,P52333,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963742,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: JAK3,-Log Ki,<,5.3,none,inactive,CHEMBL2148,Tyrosine-protein kinase JAK3,Homo sapiens,P52333,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963742,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: JAK3,-Log Ki,<,5.8,none,inactive,CHEMBL2148,Tyrosine-protein kinase JAK3,Homo sapiens,P52333,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963788,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: KDR,-Log Ki,=,6.6,none,active,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963788,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: KDR,-Log Ki,=,5.3,none,active,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963788,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: KDR,-Log Ki,<,5.6,none,inactive,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963788,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: KDR,-Log Ki,=,6.6,none,active,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963788,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: KDR,-Log Ki,<,5.6,none,inactive,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963788,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: KDR,-Log Ki,<,5.1,none,inactive,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1964105,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: KIAA1811,-Log Ki,=,5.3,none,active,CHEMBL5650,BR serine/threonine-protein kinase 1,Homo sapiens,Q8TDC3,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1964105,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: KIAA1811,-Log Ki,<,5,none,inactive,CHEMBL5650,BR serine/threonine-protein kinase 1,Homo sapiens,Q8TDC3,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1964105,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: KIAA1811,-Log Ki,=,6.6,none,active,CHEMBL5650,BR serine/threonine-protein kinase 1,Homo sapiens,Q8TDC3,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1964105,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: KIAA1811,-Log Ki,<,5,none,inactive,CHEMBL5650,BR serine/threonine-protein kinase 1,Homo sapiens,Q8TDC3,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963734,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: KIT,-Log Ki,<,5.9,none,inactive,CHEMBL1936,Stem cell growth factor receptor,Homo sapiens,P10721,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963734,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: KIT,-Log Ki,<,5.9,none,inactive,CHEMBL1936,Stem cell growth factor receptor,Homo sapiens,P10721,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963734,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: KIT,-Log Ki,<,5.2,none,inactive,CHEMBL1936,Stem cell growth factor receptor,Homo sapiens,P10721,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963734,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: KIT,-Log Ki,=,6.9,none,active,CHEMBL1936,Stem cell growth factor receptor,Homo sapiens,P10721,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963734,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: KIT,-Log Ki,<,5.9,none,inactive,CHEMBL1936,Stem cell growth factor receptor,Homo sapiens,P10721,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963718,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: LCK,-Log Ki,=,6.4,none,active,CHEMBL258,Tyrosine-protein kinase LCK,Homo sapiens,P06239,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963718,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: LCK,-Log Ki,=,6.9,none,active,CHEMBL258,Tyrosine-protein kinase LCK,Homo sapiens,P06239,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963718,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: LCK,-Log Ki,<,5.2,none,inactive,CHEMBL258,Tyrosine-protein kinase LCK,Homo sapiens,P06239,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963718,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: LCK,-Log Ki,=,5.7,none,active,CHEMBL258,Tyrosine-protein kinase LCK,Homo sapiens,P06239,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963718,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: LCK,-Log Ki,<,5.2,none,inactive,CHEMBL258,Tyrosine-protein kinase LCK,Homo sapiens,P06239,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963718,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: LCK,-Log Ki,=,5.6,none,active,CHEMBL258,Tyrosine-protein kinase LCK,Homo sapiens,P06239,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963749,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: LIMK1,-Log Ki,=,6.1,none,active,CHEMBL3836,LIM domain kinase 1,Homo sapiens,P53667,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963749,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: LIMK1,-Log Ki,=,5.1,none,active,CHEMBL3836,LIM domain kinase 1,Homo sapiens,P53667,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963806,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: LRRK2,-Log Ki,<,5.6,none,inactive,CHEMBL1075104,Leucine-rich repeat serine/threonine-protein kinase 2,Homo sapiens,Q5S007,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963806,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: LRRK2,-Log Ki,<,5.6,none,inactive,CHEMBL1075104,Leucine-rich repeat serine/threonine-protein kinase 2,Homo sapiens,Q5S007,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1964115,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: LTK,-Log Ki,<,5.6,none,inactive,CHEMBL5627,Leukocyte tyrosine kinase receptor,Homo sapiens,P29376,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1964115,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: LTK,-Log Ki,<,5.6,none,inactive,CHEMBL5627,Leukocyte tyrosine kinase receptor,Homo sapiens,P29376,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963745,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: LYN,-Log Ki,=,7.8,none,active,CHEMBL3905,Tyrosine-protein kinase Lyn ,Homo sapiens,P07948,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963745,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: LYN,-Log Ki,=,6.5,none,active,CHEMBL3905,Tyrosine-protein kinase Lyn ,Homo sapiens,P07948,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963745,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: LYN,-Log Ki,<,5.8,none,inactive,CHEMBL3905,Tyrosine-protein kinase Lyn ,Homo sapiens,P07948,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963745,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: LYN,-Log Ki,<,5.8,none,inactive,CHEMBL3905,Tyrosine-protein kinase Lyn ,Homo sapiens,P07948,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963692,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAP2K1,-Log Ki,<,5.5,none,inactive,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,Homo sapiens,Q02750,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963692,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAP2K1,-Log Ki,<,5.5,none,inactive,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,Homo sapiens,Q02750,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1964106,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAP2K2,-Log Ki,<,5.4,none,inactive,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,Homo sapiens,P36507,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1964106,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAP2K2,-Log Ki,<,5.4,none,inactive,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,Homo sapiens,P36507,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963772,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAP4K2,-Log Ki,=,6.3,none,active,CHEMBL5330,Mitogen-activated protein kinase kinase kinase kinase 2,Homo sapiens,Q12851,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963772,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAP4K2,-Log Ki,<,5.2,none,inactive,CHEMBL5330,Mitogen-activated protein kinase kinase kinase kinase 2,Homo sapiens,Q12851,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963772,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAP4K2,-Log Ki,<,5.2,none,inactive,CHEMBL5330,Mitogen-activated protein kinase kinase kinase kinase 2,Homo sapiens,Q12851,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963772,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAP4K2,-Log Ki,<,5.6,none,inactive,CHEMBL5330,Mitogen-activated protein kinase kinase kinase kinase 2,Homo sapiens,Q12851,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963772,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAP4K2,-Log Ki,<,5.2,none,inactive,CHEMBL5330,Mitogen-activated protein kinase kinase kinase kinase 2,Homo sapiens,Q12851,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1964101,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAP4K4,-Log Ki,=,6.5,none,active,CHEMBL6166,Mitogen-activated protein kinase kinase kinase kinase 4,Homo sapiens,O95819,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1964101,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAP4K4,-Log Ki,=,6.1,none,active,CHEMBL6166,Mitogen-activated protein kinase kinase kinase kinase 4,Homo sapiens,O95819,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1964101,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAP4K4,-Log Ki,<,5.3,none,inactive,CHEMBL6166,Mitogen-activated protein kinase kinase kinase kinase 4,Homo sapiens,O95819,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1964101,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAP4K4,-Log Ki,=,6.6,none,active,CHEMBL6166,Mitogen-activated protein kinase kinase kinase kinase 4,Homo sapiens,O95819,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1964101,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAP4K4,-Log Ki,<,5.3,none,inactive,CHEMBL6166,Mitogen-activated protein kinase kinase kinase kinase 4,Homo sapiens,O95819,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1964101,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAP4K4,-Log Ki,<,5,none,inactive,CHEMBL6166,Mitogen-activated protein kinase kinase kinase kinase 4,Homo sapiens,O95819,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963810,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAP4K5,-Log Ki,=,6.7,none,active,CHEMBL4852,Mitogen-activated protein kinase kinase kinase kinase 5,Homo sapiens,Q9Y4K4,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963810,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAP4K5,-Log Ki,=,6.3,none,active,CHEMBL4852,Mitogen-activated protein kinase kinase kinase kinase 5,Homo sapiens,Q9Y4K4,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963810,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAP4K5,-Log Ki,=,6.7,none,active,CHEMBL4852,Mitogen-activated protein kinase kinase kinase kinase 5,Homo sapiens,Q9Y4K4,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963810,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAP4K5,-Log Ki,=,5.8,none,active,CHEMBL4852,Mitogen-activated protein kinase kinase kinase kinase 5,Homo sapiens,Q9Y4K4,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963794,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPK1,-Log Ki,<,5.1,none,inactive,CHEMBL4040,MAP kinase ERK2,Homo sapiens,P28482,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963794,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPK1,-Log Ki,=,5.5,none,active,CHEMBL4040,MAP kinase ERK2,Homo sapiens,P28482,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963794,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPK1,-Log Ki,<,5.1,none,inactive,CHEMBL4040,MAP kinase ERK2,Homo sapiens,P28482,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963794,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPK1,-Log Ki,<,5.1,none,inactive,CHEMBL4040,MAP kinase ERK2,Homo sapiens,P28482,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1964109,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPK10,-Log Ki,<,5.5,none,inactive,CHEMBL2637,c-Jun N-terminal kinase 3,Homo sapiens,P53779,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963836,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPK12,-Log Ki,<,5.2,none,inactive,CHEMBL4674,MAP kinase p38 gamma,Homo sapiens,P53778,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963836,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPK12,-Log Ki,<,5.2,none,inactive,CHEMBL4674,MAP kinase p38 gamma,Homo sapiens,P53778,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963836,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPK12,-Log Ki,<,5.2,none,inactive,CHEMBL4674,MAP kinase p38 gamma,Homo sapiens,P53778,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963836,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPK12,-Log Ki,<,5.2,none,inactive,CHEMBL4674,MAP kinase p38 gamma,Homo sapiens,P53778,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963761,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPK13,-Log Ki,<,5.1,none,inactive,CHEMBL2939,MAP kinase p38 delta,Homo sapiens,O15264,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963761,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPK13,-Log Ki,<,5.1,none,inactive,CHEMBL2939,MAP kinase p38 delta,Homo sapiens,O15264,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963761,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPK13,-Log Ki,<,5.1,none,inactive,CHEMBL2939,MAP kinase p38 delta,Homo sapiens,O15264,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963761,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPK13,-Log Ki,<,5.1,none,inactive,CHEMBL2939,MAP kinase p38 delta,Homo sapiens,O15264,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1964117,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPK14,-Log Ki,<,5.4,none,inactive,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1964117,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPK14,-Log Ki,<,5.4,none,inactive,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963725,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPK8,-Log Ki,<,5.5,none,inactive,CHEMBL2276,c-Jun N-terminal kinase 1,Homo sapiens,P45983,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963725,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPK8,-Log Ki,<,5.5,none,inactive,CHEMBL2276,c-Jun N-terminal kinase 1,Homo sapiens,P45983,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963725,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPK8,-Log Ki,<,5.3,none,inactive,CHEMBL2276,c-Jun N-terminal kinase 1,Homo sapiens,P45983,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963725,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPK8,-Log Ki,<,5.5,none,inactive,CHEMBL2276,c-Jun N-terminal kinase 1,Homo sapiens,P45983,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963725,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPK8,-Log Ki,<,5.3,none,inactive,CHEMBL2276,c-Jun N-terminal kinase 1,Homo sapiens,P45983,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963725,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPK8,-Log Ki,<,5.5,none,inactive,CHEMBL2276,c-Jun N-terminal kinase 1,Homo sapiens,P45983,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963746,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPK9,-Log Ki,=,5.9,none,active,CHEMBL4179,c-Jun N-terminal kinase 2,Homo sapiens,P45984,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963746,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPK9,-Log Ki,=,5.6,none,active,CHEMBL4179,c-Jun N-terminal kinase 2,Homo sapiens,P45984,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963746,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPK9,-Log Ki,<,5.4,none,inactive,CHEMBL4179,c-Jun N-terminal kinase 2,Homo sapiens,P45984,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963746,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPK9,-Log Ki,<,5.4,none,inactive,CHEMBL4179,c-Jun N-terminal kinase 2,Homo sapiens,P45984,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963746,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPK9,-Log Ki,<,5.4,none,inactive,CHEMBL4179,c-Jun N-terminal kinase 2,Homo sapiens,P45984,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963746,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPK9,-Log Ki,<,5.4,none,inactive,CHEMBL4179,c-Jun N-terminal kinase 2,Homo sapiens,P45984,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963729,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPKAPK2,-Log Ki,<,5.1,none,inactive,CHEMBL2208,MAP kinase-activated protein kinase 2,Homo sapiens,P49137,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963729,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPKAPK2,-Log Ki,<,5.1,none,inactive,CHEMBL2208,MAP kinase-activated protein kinase 2,Homo sapiens,P49137,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963729,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPKAPK2,-Log Ki,<,5.1,none,inactive,CHEMBL2208,MAP kinase-activated protein kinase 2,Homo sapiens,P49137,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963729,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPKAPK2,-Log Ki,<,5.1,none,inactive,CHEMBL2208,MAP kinase-activated protein kinase 2,Homo sapiens,P49137,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963781,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPKAPK3,-Log Ki,<,5,none,inactive,CHEMBL4670,MAP kinase-activated protein kinase 3,Homo sapiens,Q16644,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963781,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPKAPK3,-Log Ki,<,5,none,inactive,CHEMBL4670,MAP kinase-activated protein kinase 3,Homo sapiens,Q16644,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963781,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPKAPK3,-Log Ki,<,5,none,inactive,CHEMBL4670,MAP kinase-activated protein kinase 3,Homo sapiens,Q16644,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963781,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPKAPK3,-Log Ki,<,5,none,inactive,CHEMBL4670,MAP kinase-activated protein kinase 3,Homo sapiens,Q16644,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963728,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPKAPK5,-Log Ki,<,5.8,none,inactive,CHEMBL3094,MAP kinase-activated protein kinase 5,Homo sapiens,Q8IW41,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963728,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPKAPK5,-Log Ki,<,5.8,none,inactive,CHEMBL3094,MAP kinase-activated protein kinase 5,Homo sapiens,Q8IW41,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963728,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPKAPK5,-Log Ki,=,7.2,none,active,CHEMBL3094,MAP kinase-activated protein kinase 5,Homo sapiens,Q8IW41,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963728,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MAPKAPK5,-Log Ki,<,5.8,none,inactive,CHEMBL3094,MAP kinase-activated protein kinase 5,Homo sapiens,Q8IW41,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963834,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MARK2,-Log Ki,=,5.8,none,active,CHEMBL3831,MAP/microtubule affinity-regulating kinase 2,Homo sapiens,Q7KZI7,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963834,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MARK2,-Log Ki,<,5.1,none,inactive,CHEMBL3831,MAP/microtubule affinity-regulating kinase 2,Homo sapiens,Q7KZI7,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963834,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MARK2,-Log Ki,<,5.1,none,inactive,CHEMBL3831,MAP/microtubule affinity-regulating kinase 2,Homo sapiens,Q7KZI7,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963834,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MARK2,-Log Ki,=,5.9,none,active,CHEMBL3831,MAP/microtubule affinity-regulating kinase 2,Homo sapiens,Q7KZI7,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963756,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MARK3,-Log Ki,=,5.9,none,active,CHEMBL5600,Serine/threonine-protein kinase c-TAK1,Homo sapiens,P27448,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963756,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MARK3,-Log Ki,<,5.2,none,inactive,CHEMBL5600,Serine/threonine-protein kinase c-TAK1,Homo sapiens,P27448,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963756,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MARK3,-Log Ki,<,5.3,none,inactive,CHEMBL5600,Serine/threonine-protein kinase c-TAK1,Homo sapiens,P27448,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963756,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MARK3,-Log Ki,<,5.2,none,inactive,CHEMBL5600,Serine/threonine-protein kinase c-TAK1,Homo sapiens,P27448,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963756,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MARK3,-Log Ki,=,5.8,none,active,CHEMBL5600,Serine/threonine-protein kinase c-TAK1,Homo sapiens,P27448,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963689,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MATK,-Log Ki,<,5.7,none,inactive,CHEMBL4175,Tyrosine-protein kinase CTK,Homo sapiens,P42679,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963689,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MATK,-Log Ki,<,5.7,none,inactive,CHEMBL4175,Tyrosine-protein kinase CTK,Homo sapiens,P42679,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963804,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MELK,-Log Ki,<,5.8,none,inactive,CHEMBL4578,Maternal embryonic leucine zipper kinase,Homo sapiens,Q14680,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963804,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MELK,-Log Ki,=,6.1,none,active,CHEMBL4578,Maternal embryonic leucine zipper kinase,Homo sapiens,Q14680,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963804,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MELK,-Log Ki,=,6.8,none,active,CHEMBL4578,Maternal embryonic leucine zipper kinase,Homo sapiens,Q14680,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963804,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MELK,-Log Ki,<,5.8,none,inactive,CHEMBL4578,Maternal embryonic leucine zipper kinase,Homo sapiens,Q14680,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963775,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MET,-Log Ki,<,5.5,none,inactive,CHEMBL3717,Hepatocyte growth factor receptor,Homo sapiens,P08581,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963775,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MET,-Log Ki,<,5.6,none,inactive,CHEMBL3717,Hepatocyte growth factor receptor,Homo sapiens,P08581,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963775,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MET,-Log Ki,<,5.5,none,inactive,CHEMBL3717,Hepatocyte growth factor receptor,Homo sapiens,P08581,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963775,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MET,-Log Ki,<,5.6,none,inactive,CHEMBL3717,Hepatocyte growth factor receptor,Homo sapiens,P08581,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963775,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MET,-Log Ki,<,5.5,none,inactive,CHEMBL3717,Hepatocyte growth factor receptor,Homo sapiens,P08581,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963795,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MINK,-Log Ki,=,6.1,none,active,CHEMBL5518,Misshapen-like kinase 1,Homo sapiens,Q8N4C8,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963795,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MINK,-Log Ki,=,5.9,none,active,CHEMBL5518,Misshapen-like kinase 1,Homo sapiens,Q8N4C8,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963795,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MINK,-Log Ki,<,5.1,none,inactive,CHEMBL5518,Misshapen-like kinase 1,Homo sapiens,Q8N4C8,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963786,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MKNK2,-Log Ki,<,5,none,inactive,CHEMBL4204,MAP kinase signal-integrating kinase 2,Homo sapiens,Q9HBH9,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963786,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MKNK2,-Log Ki,<,5,none,inactive,CHEMBL4204,MAP kinase signal-integrating kinase 2,Homo sapiens,Q9HBH9,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963786,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MKNK2,-Log Ki,=,6.2,none,active,CHEMBL4204,MAP kinase signal-integrating kinase 2,Homo sapiens,Q9HBH9,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1964103,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MST1R,-Log Ki,<,5.4,none,inactive,CHEMBL2689,Macrophage-stimulating protein receptor,Homo sapiens,Q04912,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1964103,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: MST1R,-Log Ki,<,5.4,none,inactive,CHEMBL2689,Macrophage-stimulating protein receptor,Homo sapiens,Q04912,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963823,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: NEK2,-Log Ki,=,5.3,none,active,CHEMBL3835,Serine/threonine-protein kinase NEK2,Homo sapiens,P51955,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963823,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: NEK2,-Log Ki,<,5,none,inactive,CHEMBL3835,Serine/threonine-protein kinase NEK2,Homo sapiens,P51955,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963823,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: NEK2,-Log Ki,=,6.3,none,active,CHEMBL3835,Serine/threonine-protein kinase NEK2,Homo sapiens,P51955,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963823,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: NEK2,-Log Ki,<,5,none,inactive,CHEMBL3835,Serine/threonine-protein kinase NEK2,Homo sapiens,P51955,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963796,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: NEK4,-Log Ki,=,5.2,none,active,CHEMBL5819,Serine/threonine-protein kinase Nek4,Homo sapiens,P51957,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963796,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: NEK4,-Log Ki,<,5.2,none,inactive,CHEMBL5819,Serine/threonine-protein kinase Nek4,Homo sapiens,P51957,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963796,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: NEK4,-Log Ki,<,5.2,none,inactive,CHEMBL5819,Serine/threonine-protein kinase Nek4,Homo sapiens,P51957,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963796,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: NEK4,-Log Ki,<,5.2,none,inactive,CHEMBL5819,Serine/threonine-protein kinase Nek4,Homo sapiens,P51957,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963757,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: NTRK1,-Log Ki,=,6.5,none,active,CHEMBL2815,Nerve growth factor receptor Trk-A,Homo sapiens,P04629,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963757,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: NTRK1,-Log Ki,<,5.6,none,inactive,CHEMBL2815,Nerve growth factor receptor Trk-A,Homo sapiens,P04629,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963757,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: NTRK1,-Log Ki,<,5.5,none,inactive,CHEMBL2815,Nerve growth factor receptor Trk-A,Homo sapiens,P04629,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963757,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: NTRK1,-Log Ki,=,6.4,none,active,CHEMBL2815,Nerve growth factor receptor Trk-A,Homo sapiens,P04629,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963757,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: NTRK1,-Log Ki,=,5.8,none,active,CHEMBL2815,Nerve growth factor receptor Trk-A,Homo sapiens,P04629,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963757,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: NTRK1,-Log Ki,<,5.6,none,inactive,CHEMBL2815,Nerve growth factor receptor Trk-A,Homo sapiens,P04629,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963832,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: NTRK2,-Log Ki,=,6.1,none,active,CHEMBL4898,Neurotrophic tyrosine kinase receptor type 2,Homo sapiens,Q16620,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963832,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: NTRK2,-Log Ki,<,5.3,none,inactive,CHEMBL4898,Neurotrophic tyrosine kinase receptor type 2,Homo sapiens,Q16620,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963832,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: NTRK2,-Log Ki,<,5.4,none,inactive,CHEMBL4898,Neurotrophic tyrosine kinase receptor type 2,Homo sapiens,Q16620,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963832,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: NTRK2,-Log Ki,<,5.3,none,inactive,CHEMBL4898,Neurotrophic tyrosine kinase receptor type 2,Homo sapiens,Q16620,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963832,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: NTRK2,-Log Ki,=,6.8,none,active,CHEMBL4898,Neurotrophic tyrosine kinase receptor type 2,Homo sapiens,Q16620,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963832,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: NTRK2,-Log Ki,<,5.3,none,inactive,CHEMBL4898,Neurotrophic tyrosine kinase receptor type 2,Homo sapiens,Q16620,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963688,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: NTRK3,-Log Ki,=,7.6,none,active,CHEMBL5608,NT-3 growth factor receptor,Homo sapiens,Q16288,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963688,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: NTRK3,-Log Ki,<,5.5,none,inactive,CHEMBL5608,NT-3 growth factor receptor,Homo sapiens,Q16288,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963688,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: NTRK3,-Log Ki,=,6.5,none,active,CHEMBL5608,NT-3 growth factor receptor,Homo sapiens,Q16288,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963688,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: NTRK3,-Log Ki,<,5.9,none,inactive,CHEMBL5608,NT-3 growth factor receptor,Homo sapiens,Q16288,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963737,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PAK1,-Log Ki,<,5,none,inactive,CHEMBL4600,Serine/threonine-protein kinase PAK 1,Homo sapiens,Q13153,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963737,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PAK1,-Log Ki,<,5,none,inactive,CHEMBL4600,Serine/threonine-protein kinase PAK 1,Homo sapiens,Q13153,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963737,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PAK1,-Log Ki,<,5,none,inactive,CHEMBL4600,Serine/threonine-protein kinase PAK 1,Homo sapiens,Q13153,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963737,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PAK1,-Log Ki,<,5,none,inactive,CHEMBL4600,Serine/threonine-protein kinase PAK 1,Homo sapiens,Q13153,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963736,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PAK4,-Log Ki,<,5.3,none,inactive,CHEMBL4482,Serine/threonine-protein kinase PAK 4,Homo sapiens,O96013,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963736,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PAK4,-Log Ki,<,5.3,none,inactive,CHEMBL4482,Serine/threonine-protein kinase PAK 4,Homo sapiens,O96013,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963736,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PAK4,-Log Ki,<,5.3,none,inactive,CHEMBL4482,Serine/threonine-protein kinase PAK 4,Homo sapiens,O96013,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963736,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PAK4,-Log Ki,<,5.3,none,inactive,CHEMBL4482,Serine/threonine-protein kinase PAK 4,Homo sapiens,O96013,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963736,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PAK4,-Log Ki,<,5.3,none,inactive,CHEMBL4482,Serine/threonine-protein kinase PAK 4,Homo sapiens,O96013,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963736,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PAK4,-Log Ki,<,5.3,none,inactive,CHEMBL4482,Serine/threonine-protein kinase PAK 4,Homo sapiens,O96013,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963700,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PASK,-Log Ki,<,5.8,none,inactive,CHEMBL6054,PAS domain-containing serine/threonine-protein kinase,Homo sapiens,Q96RG2,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963805,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PDGFRA,-Log Ki,<,5.6,none,inactive,CHEMBL2007,Platelet-derived growth factor receptor alpha ,Homo sapiens,P16234,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963805,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PDGFRA,-Log Ki,<,5.6,none,inactive,CHEMBL2007,Platelet-derived growth factor receptor alpha ,Homo sapiens,P16234,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963778,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PDGFRB,-Log Ki,<,5.7,none,inactive,CHEMBL1913,Platelet-derived growth factor receptor beta,Homo sapiens,P09619,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963821,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PDPK1,-Log Ki,<,5.4,none,inactive,CHEMBL2534,3-phosphoinositide dependent protein kinase-1,Homo sapiens,O15530,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963821,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PDPK1,-Log Ki,<,5.4,none,inactive,CHEMBL2534,3-phosphoinositide dependent protein kinase-1,Homo sapiens,O15530,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963821,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PDPK1,-Log Ki,<,5.4,none,inactive,CHEMBL2534,3-phosphoinositide dependent protein kinase-1,Homo sapiens,O15530,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963821,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PDPK1,-Log Ki,<,5.4,none,inactive,CHEMBL2534,3-phosphoinositide dependent protein kinase-1,Homo sapiens,O15530,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963696,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PHKG2,-Log Ki,=,5.6,none,active,CHEMBL2349,Phosphorylase kinase gamma subunit 2,Homo sapiens,P15735,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963696,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PHKG2,-Log Ki,<,5.3,none,inactive,CHEMBL2349,Phosphorylase kinase gamma subunit 2,Homo sapiens,P15735,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963696,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PHKG2,-Log Ki,<,5.3,none,inactive,CHEMBL2349,Phosphorylase kinase gamma subunit 2,Homo sapiens,P15735,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963696,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PHKG2,-Log Ki,<,5.3,none,inactive,CHEMBL2349,Phosphorylase kinase gamma subunit 2,Homo sapiens,P15735,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963726,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PIM1,-Log Ki,=,6.2,none,active,CHEMBL2147,Serine/threonine-protein kinase PIM1 ,Homo sapiens,P11309,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963726,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PIM1,-Log Ki,=,6,none,active,CHEMBL2147,Serine/threonine-protein kinase PIM1 ,Homo sapiens,P11309,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963726,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PIM1,-Log Ki,<,5.2,none,inactive,CHEMBL2147,Serine/threonine-protein kinase PIM1 ,Homo sapiens,P11309,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963726,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PIM1,-Log Ki,<,5,none,inactive,CHEMBL2147,Serine/threonine-protein kinase PIM1 ,Homo sapiens,P11309,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963726,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PIM1,-Log Ki,<,5.2,none,inactive,CHEMBL2147,Serine/threonine-protein kinase PIM1 ,Homo sapiens,P11309,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963726,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PIM1,-Log Ki,=,6.5,none,active,CHEMBL2147,Serine/threonine-protein kinase PIM1 ,Homo sapiens,P11309,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963820,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PIM2,-Log Ki,<,5.8,none,inactive,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,Q9P1W9,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963820,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PIM2,-Log Ki,<,5.8,none,inactive,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,Q9P1W9,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963820,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PIM2,-Log Ki,<,5.8,none,inactive,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,Q9P1W9,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963820,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PIM2,-Log Ki,<,5.8,none,inactive,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,Q9P1W9,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963764,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PIM3,-Log Ki,=,5.6,none,active,CHEMBL5407,Serine/threonine-protein kinase PIM3,Homo sapiens,Q86V86,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963764,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PIM3,-Log Ki,=,5.8,none,active,CHEMBL5407,Serine/threonine-protein kinase PIM3,Homo sapiens,Q86V86,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963748,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PKN2,-Log Ki,=,5.6,none,active,CHEMBL3032,Protein kinase N2,Homo sapiens,Q16513,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963748,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PKN2,-Log Ki,<,5.1,none,inactive,CHEMBL3032,Protein kinase N2,Homo sapiens,Q16513,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963748,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PKN2,-Log Ki,<,5.1,none,inactive,CHEMBL3032,Protein kinase N2,Homo sapiens,Q16513,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963748,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PKN2,-Log Ki,=,7.6,none,active,CHEMBL3032,Protein kinase N2,Homo sapiens,Q16513,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963829,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PLK1,-Log Ki,<,5.1,none,inactive,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963829,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PLK1,-Log Ki,<,5.1,none,inactive,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963829,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PLK1,-Log Ki,=,7.9,none,active,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963829,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PLK1,-Log Ki,<,5.1,none,inactive,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963697,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PLK3,-Log Ki,<,5.1,none,inactive,CHEMBL4897,Serine/threonine-protein kinase PLK3,Homo sapiens,Q9H4B4,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963697,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PLK3,-Log Ki,<,5.1,none,inactive,CHEMBL4897,Serine/threonine-protein kinase PLK3,Homo sapiens,Q9H4B4,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963697,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PLK3,-Log Ki,=,8.1,none,active,CHEMBL4897,Serine/threonine-protein kinase PLK3,Homo sapiens,Q9H4B4,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963697,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PLK3,-Log Ki,<,5.1,none,inactive,CHEMBL4897,Serine/threonine-protein kinase PLK3,Homo sapiens,Q9H4B4,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963705,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PLK4,-Log Ki,<,5.4,none,inactive,CHEMBL3788,Serine/threonine-protein kinase PLK4,Homo sapiens,O00444,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963705,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PLK4,-Log Ki,=,6.7,none,active,CHEMBL3788,Serine/threonine-protein kinase PLK4,Homo sapiens,O00444,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963705,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PLK4,-Log Ki,=,6.5,none,active,CHEMBL3788,Serine/threonine-protein kinase PLK4,Homo sapiens,O00444,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963701,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKAA1,-Log Ki,=,5.8,none,active,CHEMBL4045,"AMP-activated protein kinase, alpha-1 subunit",Homo sapiens,Q13131,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963701,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKAA1,-Log Ki,<,5.2,none,inactive,CHEMBL4045,"AMP-activated protein kinase, alpha-1 subunit",Homo sapiens,Q13131,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963701,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKAA1,-Log Ki,<,5.5,none,inactive,CHEMBL4045,"AMP-activated protein kinase, alpha-1 subunit",Homo sapiens,Q13131,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963701,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKAA1,-Log Ki,<,5.3,none,inactive,CHEMBL4045,"AMP-activated protein kinase, alpha-1 subunit",Homo sapiens,Q13131,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963701,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKAA1,-Log Ki,<,5.5,none,inactive,CHEMBL4045,"AMP-activated protein kinase, alpha-1 subunit",Homo sapiens,Q13131,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963701,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKAA1,-Log Ki,<,5.8,none,inactive,CHEMBL4045,"AMP-activated protein kinase, alpha-1 subunit",Homo sapiens,Q13131,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963835,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKACA,-Log Ki,<,5.1,none,inactive,CHEMBL4101,cAMP-dependent protein kinase alpha-catalytic subunit,Homo sapiens,P17612,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963835,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKACA,-Log Ki,=,5.8,none,active,CHEMBL4101,cAMP-dependent protein kinase alpha-catalytic subunit,Homo sapiens,P17612,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963835,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKACA,-Log Ki,<,5.9,none,inactive,CHEMBL4101,cAMP-dependent protein kinase alpha-catalytic subunit,Homo sapiens,P17612,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963835,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKACA,-Log Ki,<,5.1,none,inactive,CHEMBL4101,cAMP-dependent protein kinase alpha-catalytic subunit,Homo sapiens,P17612,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963835,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKACA,-Log Ki,<,5.9,none,inactive,CHEMBL4101,cAMP-dependent protein kinase alpha-catalytic subunit,Homo sapiens,P17612,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963835,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKACA,-Log Ki,=,7.5,none,active,CHEMBL4101,cAMP-dependent protein kinase alpha-catalytic subunit,Homo sapiens,P17612,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963703,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKCD,-Log Ki,<,5.1,none,inactive,CHEMBL2996,Protein kinase C delta,Homo sapiens,Q05655,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963703,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKCD,-Log Ki,<,5.1,none,inactive,CHEMBL2996,Protein kinase C delta,Homo sapiens,Q05655,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963703,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKCD,-Log Ki,=,8.3,none,active,CHEMBL2996,Protein kinase C delta,Homo sapiens,Q05655,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963767,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKCG,-Log Ki,<,5.1,none,inactive,CHEMBL2938,Protein kinase C gamma,Homo sapiens,P05129,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963767,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKCG,-Log Ki,=,5.2,none,active,CHEMBL2938,Protein kinase C gamma,Homo sapiens,P05129,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963767,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKCG,-Log Ki,<,5.1,none,inactive,CHEMBL2938,Protein kinase C gamma,Homo sapiens,P05129,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963767,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKCG,-Log Ki,=,6.6,none,active,CHEMBL2938,Protein kinase C gamma,Homo sapiens,P05129,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963798,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKCI,-Log Ki,<,5.3,none,inactive,CHEMBL2598,Protein kinase C iota,Homo sapiens,P41743,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963798,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKCI,-Log Ki,=,7.5,none,active,CHEMBL2598,Protein kinase C iota,Homo sapiens,P41743,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963715,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKCN,-Log Ki,=,5.8,none,active,CHEMBL2595,Protein kinase C nu,Homo sapiens,O94806,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963715,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKCN,-Log Ki,=,6.6,none,active,CHEMBL2595,Protein kinase C nu,Homo sapiens,O94806,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963715,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKCN,-Log Ki,=,5.4,none,active,CHEMBL2595,Protein kinase C nu,Homo sapiens,O94806,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963715,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKCN,-Log Ki,<,5,none,inactive,CHEMBL2595,Protein kinase C nu,Homo sapiens,O94806,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963715,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKCN,-Log Ki,<,5.4,none,inactive,CHEMBL2595,Protein kinase C nu,Homo sapiens,O94806,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963715,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKCN,-Log Ki,=,5.6,none,active,CHEMBL2595,Protein kinase C nu,Homo sapiens,O94806,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963687,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKCQ,-Log Ki,<,5.6,none,inactive,CHEMBL3920,Protein kinase C theta,Homo sapiens,Q04759,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963687,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKCQ,-Log Ki,<,5.6,none,inactive,CHEMBL3920,Protein kinase C theta,Homo sapiens,Q04759,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963694,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKCZ,-Log Ki,<,5.1,none,inactive,CHEMBL3438,Protein kinase C zeta,Homo sapiens,Q05513,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963694,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKCZ,-Log Ki,<,5.1,none,inactive,CHEMBL3438,Protein kinase C zeta,Homo sapiens,Q05513,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963694,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKCZ,-Log Ki,<,5.1,none,inactive,CHEMBL3438,Protein kinase C zeta,Homo sapiens,Q05513,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963694,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKCZ,-Log Ki,=,7.6,none,active,CHEMBL3438,Protein kinase C zeta,Homo sapiens,Q05513,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963707,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKD2,-Log Ki,=,5.3,none,active,CHEMBL4900,Serine/threonine-protein kinase D2,Homo sapiens,Q9BZL6,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963707,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKD2,-Log Ki,=,5.9,none,active,CHEMBL4900,Serine/threonine-protein kinase D2,Homo sapiens,Q9BZL6,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963707,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKD2,-Log Ki,<,5,none,inactive,CHEMBL4900,Serine/threonine-protein kinase D2,Homo sapiens,Q9BZL6,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963707,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKD2,-Log Ki,=,5.7,none,active,CHEMBL4900,Serine/threonine-protein kinase D2,Homo sapiens,Q9BZL6,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963695,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKG1,-Log Ki,<,5.7,none,inactive,CHEMBL4273,cGMP-dependent protein kinase 1 beta,Homo sapiens,Q13976,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963695,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKG1,-Log Ki,<,5.7,none,inactive,CHEMBL4273,cGMP-dependent protein kinase 1 beta,Homo sapiens,Q13976,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963695,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKG1,-Log Ki,=,6.5,none,active,CHEMBL4273,cGMP-dependent protein kinase 1 beta,Homo sapiens,Q13976,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963695,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKG1,-Log Ki,=,6.8,none,active,CHEMBL4273,cGMP-dependent protein kinase 1 beta,Homo sapiens,Q13976,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963702,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKG2,-Log Ki,<,5.8,none,inactive,CHEMBL2896,cGMP-dependent protein kinase 2,Homo sapiens,Q13237,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963702,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKG2,-Log Ki,<,5.8,none,inactive,CHEMBL2896,cGMP-dependent protein kinase 2,Homo sapiens,Q13237,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963702,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKG2,-Log Ki,<,5.8,none,inactive,CHEMBL2896,cGMP-dependent protein kinase 2,Homo sapiens,Q13237,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963702,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKG2,-Log Ki,=,7.4,none,active,CHEMBL2896,cGMP-dependent protein kinase 2,Homo sapiens,Q13237,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963800,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKX,-Log Ki,<,5.8,none,inactive,CHEMBL5818,Serine/threonine-protein kinase PRKX,Homo sapiens,P51817,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963800,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKX,-Log Ki,<,5.8,none,inactive,CHEMBL5818,Serine/threonine-protein kinase PRKX,Homo sapiens,P51817,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963800,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKX,-Log Ki,<,5.5,none,inactive,CHEMBL5818,Serine/threonine-protein kinase PRKX,Homo sapiens,P51817,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963800,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKX,-Log Ki,=,6,none,active,CHEMBL5818,Serine/threonine-protein kinase PRKX,Homo sapiens,P51817,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963800,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKX,-Log Ki,<,5.5,none,inactive,CHEMBL5818,Serine/threonine-protein kinase PRKX,Homo sapiens,P51817,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963800,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PRKX,-Log Ki,=,7.3,none,active,CHEMBL5818,Serine/threonine-protein kinase PRKX,Homo sapiens,P51817,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963801,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PTK2,-Log Ki,<,5.8,none,inactive,CHEMBL2695,Focal adhesion kinase 1,Homo sapiens,Q05397,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963801,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PTK2,-Log Ki,<,5.2,none,inactive,CHEMBL2695,Focal adhesion kinase 1,Homo sapiens,Q05397,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963801,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PTK2,-Log Ki,=,6.3,none,active,CHEMBL2695,Focal adhesion kinase 1,Homo sapiens,Q05397,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963801,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PTK2,-Log Ki,<,5.2,none,inactive,CHEMBL2695,Focal adhesion kinase 1,Homo sapiens,Q05397,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963760,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PTK2B,-Log Ki,<,5.8,none,inactive,CHEMBL5469,Protein tyrosine kinase 2 beta,Homo sapiens,Q14289,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963760,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PTK2B,-Log Ki,=,6.8,none,active,CHEMBL5469,Protein tyrosine kinase 2 beta,Homo sapiens,Q14289,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963803,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: PTK6,-Log Ki,<,5.6,none,inactive,CHEMBL4601,Tyrosine-protein kinase BRK,Homo sapiens,Q13882,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963706,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: RET,-Log Ki,=,7.3,none,active,CHEMBL2041,Tyrosine-protein kinase receptor RET,Homo sapiens,P07949,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963706,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: RET,-Log Ki,=,5.9,none,active,CHEMBL2041,Tyrosine-protein kinase receptor RET,Homo sapiens,P07949,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963706,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: RET,-Log Ki,<,5.5,none,inactive,CHEMBL2041,Tyrosine-protein kinase receptor RET,Homo sapiens,P07949,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963706,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: RET,-Log Ki,<,5.5,none,inactive,CHEMBL2041,Tyrosine-protein kinase receptor RET,Homo sapiens,P07949,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963706,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: RET,-Log Ki,<,5.9,none,inactive,CHEMBL2041,Tyrosine-protein kinase receptor RET,Homo sapiens,P07949,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963814,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ROCK1,-Log Ki,=,5.9,none,active,CHEMBL3231,Rho-associated protein kinase 1 ,Homo sapiens,Q13464,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963814,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ROCK1,-Log Ki,<,5,none,inactive,CHEMBL3231,Rho-associated protein kinase 1 ,Homo sapiens,Q13464,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963814,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ROCK1,-Log Ki,<,5.4,none,inactive,CHEMBL3231,Rho-associated protein kinase 1 ,Homo sapiens,Q13464,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963814,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ROCK1,-Log Ki,<,5,none,inactive,CHEMBL3231,Rho-associated protein kinase 1 ,Homo sapiens,Q13464,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963814,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ROCK1,-Log Ki,<,5.4,none,inactive,CHEMBL3231,Rho-associated protein kinase 1 ,Homo sapiens,Q13464,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963722,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ROCK2,-Log Ki,=,5.8,none,active,CHEMBL2973,Rho-associated protein kinase 2,Homo sapiens,O75116,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963722,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ROCK2,-Log Ki,<,5.1,none,inactive,CHEMBL2973,Rho-associated protein kinase 2,Homo sapiens,O75116,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963722,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ROCK2,-Log Ki,<,5.4,none,inactive,CHEMBL2973,Rho-associated protein kinase 2,Homo sapiens,O75116,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963722,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ROCK2,-Log Ki,<,5.1,none,inactive,CHEMBL2973,Rho-associated protein kinase 2,Homo sapiens,O75116,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963751,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ROS1,-Log Ki,<,5.7,none,inactive,CHEMBL5568,Proto-oncogene tyrosine-protein kinase ROS,Homo sapiens,P08922,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963751,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ROS1,-Log Ki,<,5.7,none,inactive,CHEMBL5568,Proto-oncogene tyrosine-protein kinase ROS,Homo sapiens,P08922,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963690,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: RPS6KA3,-Log Ki,=,5.5,none,active,CHEMBL2345,Ribosomal protein S6 kinase alpha 3,Homo sapiens,P51812,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963690,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: RPS6KA3,-Log Ki,<,5.1,none,inactive,CHEMBL2345,Ribosomal protein S6 kinase alpha 3,Homo sapiens,P51812,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963690,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: RPS6KA3,-Log Ki,<,5.4,none,inactive,CHEMBL2345,Ribosomal protein S6 kinase alpha 3,Homo sapiens,P51812,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963690,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: RPS6KA3,-Log Ki,=,5.1,none,active,CHEMBL2345,Ribosomal protein S6 kinase alpha 3,Homo sapiens,P51812,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963690,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: RPS6KA3,-Log Ki,<,5.4,none,inactive,CHEMBL2345,Ribosomal protein S6 kinase alpha 3,Homo sapiens,P51812,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963690,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: RPS6KA3,-Log Ki,=,7.4,none,active,CHEMBL2345,Ribosomal protein S6 kinase alpha 3,Homo sapiens,P51812,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963744,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: RPS6KA5,-Log Ki,<,5.7,none,inactive,CHEMBL4237,Ribosomal protein S6 kinase alpha 5,Homo sapiens,O75582,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963744,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: RPS6KA5,-Log Ki,<,5.7,none,inactive,CHEMBL4237,Ribosomal protein S6 kinase alpha 5,Homo sapiens,O75582,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963744,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: RPS6KA5,-Log Ki,=,6.6,none,active,CHEMBL4237,Ribosomal protein S6 kinase alpha 5,Homo sapiens,O75582,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963744,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: RPS6KA5,-Log Ki,=,7.2,none,active,CHEMBL4237,Ribosomal protein S6 kinase alpha 5,Homo sapiens,O75582,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963708,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: RPS6KB1,-Log Ki,=,5.6,none,active,CHEMBL4501,Ribosomal protein S6 kinase 1,Homo sapiens,P23443,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963708,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: RPS6KB1,-Log Ki,<,5.2,none,inactive,CHEMBL4501,Ribosomal protein S6 kinase 1,Homo sapiens,P23443,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963708,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: RPS6KB1,-Log Ki,<,5.2,none,inactive,CHEMBL4501,Ribosomal protein S6 kinase 1,Homo sapiens,P23443,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963708,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: RPS6KB1,-Log Ki,=,8.5,none,active,CHEMBL4501,Ribosomal protein S6 kinase 1,Homo sapiens,P23443,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963793,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: SGK,-Log Ki,=,5.6,none,active,CHEMBL5794,Serine/threonine-protein kinase Sgk2,Homo sapiens,Q9HBY8,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963793,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: SGK,-Log Ki,=,5.2,none,active,CHEMBL5794,Serine/threonine-protein kinase Sgk2,Homo sapiens,Q9HBY8,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963793,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: SGK,-Log Ki,<,5,none,inactive,CHEMBL5794,Serine/threonine-protein kinase Sgk2,Homo sapiens,Q9HBY8,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963793,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: SGK,-Log Ki,=,6.7,none,active,CHEMBL5794,Serine/threonine-protein kinase Sgk2,Homo sapiens,Q9HBY8,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963827,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: SLK,-Log Ki,=,6,none,active,CHEMBL4202,Serine/threonine-protein kinase 2,Homo sapiens,Q9H2G2,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963827,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: SLK,-Log Ki,<,5,none,inactive,CHEMBL4202,Serine/threonine-protein kinase 2,Homo sapiens,Q9H2G2,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963827,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: SLK,-Log Ki,=,7.9,none,active,CHEMBL4202,Serine/threonine-protein kinase 2,Homo sapiens,Q9H2G2,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963827,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: SLK,-Log Ki,=,5.8,none,active,CHEMBL4202,Serine/threonine-protein kinase 2,Homo sapiens,Q9H2G2,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963768,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: SRC,-Log Ki,=,6.3,none,active,CHEMBL267,Tyrosine-protein kinase SRC,Homo sapiens,P12931,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963768,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: SRC,-Log Ki,<,5.3,none,inactive,CHEMBL267,Tyrosine-protein kinase SRC,Homo sapiens,P12931,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963768,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: SRC,-Log Ki,=,5.3,none,active,CHEMBL267,Tyrosine-protein kinase SRC,Homo sapiens,P12931,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963768,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: SRC,-Log Ki,<,5.7,none,inactive,CHEMBL267,Tyrosine-protein kinase SRC,Homo sapiens,P12931,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963770,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: SRMS,-Log Ki,<,5.8,none,inactive,CHEMBL5703,Tyrosine-protein kinase Srms,Homo sapiens,Q9H3Y6,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963770,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: SRMS,-Log Ki,<,5.8,none,inactive,CHEMBL5703,Tyrosine-protein kinase Srms,Homo sapiens,Q9H3Y6,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963724,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: SRPK1,-Log Ki,<,5.1,none,inactive,CHEMBL4375,Serine/threonine-protein kinase SRPK1,Homo sapiens,Q96SB4,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963724,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: SRPK1,-Log Ki,<,5.1,none,inactive,CHEMBL4375,Serine/threonine-protein kinase SRPK1,Homo sapiens,Q96SB4,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963724,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: SRPK1,-Log Ki,<,5.1,none,inactive,CHEMBL4375,Serine/threonine-protein kinase SRPK1,Homo sapiens,Q96SB4,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963724,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: SRPK1,-Log Ki,=,5.1,none,active,CHEMBL4375,Serine/threonine-protein kinase SRPK1,Homo sapiens,Q96SB4,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963807,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: STK12,-Log Ki,=,6.9,none,active,CHEMBL2185,Serine/threonine-protein kinase Aurora-B,Homo sapiens,Q96GD4,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963807,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: STK12,-Log Ki,<,5.2,none,inactive,CHEMBL2185,Serine/threonine-protein kinase Aurora-B,Homo sapiens,Q96GD4,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963807,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: STK12,-Log Ki,<,5.2,none,inactive,CHEMBL2185,Serine/threonine-protein kinase Aurora-B,Homo sapiens,Q96GD4,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963807,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: STK12,-Log Ki,<,5.4,none,inactive,CHEMBL2185,Serine/threonine-protein kinase Aurora-B,Homo sapiens,Q96GD4,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963807,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: STK12,-Log Ki,=,6.1,none,active,CHEMBL2185,Serine/threonine-protein kinase Aurora-B,Homo sapiens,Q96GD4,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963717,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: STK17A,-Log Ki,=,6.9,none,active,CHEMBL4525,Serine/threonine-protein kinase 17A,Homo sapiens,Q9UEE5,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963717,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: STK17A,-Log Ki,=,6.8,none,active,CHEMBL4525,Serine/threonine-protein kinase 17A,Homo sapiens,Q9UEE5,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963716,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: STK22B,-Log Ki,<,5.8,none,inactive,CHEMBL6014,Testis-specific serine/threonine-protein kinase 2,Homo sapiens,Q96PF2,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963716,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: STK22B,-Log Ki,<,5.8,none,inactive,CHEMBL6014,Testis-specific serine/threonine-protein kinase 2,Homo sapiens,Q96PF2,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963716,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: STK22B,-Log Ki,=,7.2,none,active,CHEMBL6014,Testis-specific serine/threonine-protein kinase 2,Homo sapiens,Q96PF2,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963716,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: STK22B,-Log Ki,<,5.8,none,inactive,CHEMBL6014,Testis-specific serine/threonine-protein kinase 2,Homo sapiens,Q96PF2,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963753,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: STK22D,-Log Ki,<,5.8,none,inactive,CHEMBL6003,Testis-specific serine/threonine-protein kinase 1,Homo sapiens,Q9BXA7,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963753,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: STK22D,-Log Ki,<,5.8,none,inactive,CHEMBL6003,Testis-specific serine/threonine-protein kinase 1,Homo sapiens,Q9BXA7,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963753,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: STK22D,-Log Ki,=,6.7,none,active,CHEMBL6003,Testis-specific serine/threonine-protein kinase 1,Homo sapiens,Q9BXA7,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963753,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: STK22D,-Log Ki,=,7.3,none,active,CHEMBL6003,Testis-specific serine/threonine-protein kinase 1,Homo sapiens,Q9BXA7,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1964119,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: STK3,-Log Ki,=,6.5,none,active,CHEMBL4708,Serine/threonine-protein kinase MST2,Homo sapiens,Q13188,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1964119,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: STK3,-Log Ki,=,5.5,none,active,CHEMBL4708,Serine/threonine-protein kinase MST2,Homo sapiens,Q13188,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1964119,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: STK3,-Log Ki,=,6.7,none,active,CHEMBL4708,Serine/threonine-protein kinase MST2,Homo sapiens,Q13188,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1964119,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: STK3,-Log Ki,<,5.1,none,inactive,CHEMBL4708,Serine/threonine-protein kinase MST2,Homo sapiens,Q13188,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963727,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: STK6,-Log Ki,=,6.6,none,active,CHEMBL4722,Serine/threonine-protein kinase Aurora-A,Homo sapiens,O14965,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963727,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: STK6,-Log Ki,<,5.7,none,inactive,CHEMBL4722,Serine/threonine-protein kinase Aurora-A,Homo sapiens,O14965,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963727,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: STK6,-Log Ki,<,5.8,none,inactive,CHEMBL4722,Serine/threonine-protein kinase Aurora-A,Homo sapiens,O14965,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963727,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: STK6,-Log Ki,<,5.4,none,inactive,CHEMBL4722,Serine/threonine-protein kinase Aurora-A,Homo sapiens,O14965,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963727,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: STK6,-Log Ki,<,5.8,none,inactive,CHEMBL4722,Serine/threonine-protein kinase Aurora-A,Homo sapiens,O14965,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963727,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: STK6,-Log Ki,=,6.3,none,active,CHEMBL4722,Serine/threonine-protein kinase Aurora-A,Homo sapiens,O14965,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963712,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: SYK,-Log Ki,=,6.3,none,active,CHEMBL2599,Tyrosine-protein kinase SYK,Homo sapiens,P43405,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963712,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: SYK,-Log Ki,<,5.8,none,inactive,CHEMBL2599,Tyrosine-protein kinase SYK,Homo sapiens,P43405,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963750,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: TAO1,-Log Ki,<,5,none,inactive,CHEMBL5261,Serine/threonine-protein kinase TAO1,Homo sapiens,Q7L7X3,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963750,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: TAO1,-Log Ki,<,5,none,inactive,CHEMBL5261,Serine/threonine-protein kinase TAO1,Homo sapiens,Q7L7X3,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963750,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: TAO1,-Log Ki,<,5.6,none,inactive,CHEMBL5261,Serine/threonine-protein kinase TAO1,Homo sapiens,Q7L7X3,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963750,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: TAO1,-Log Ki,<,5,none,inactive,CHEMBL5261,Serine/threonine-protein kinase TAO1,Homo sapiens,Q7L7X3,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963750,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: TAO1,-Log Ki,<,5.2,none,inactive,CHEMBL5261,Serine/threonine-protein kinase TAO1,Homo sapiens,Q7L7X3,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963750,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: TAO1,-Log Ki,<,5,none,inactive,CHEMBL5261,Serine/threonine-protein kinase TAO1,Homo sapiens,Q7L7X3,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963698,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: TBK1,-Log Ki,<,5.5,none,inactive,CHEMBL5408,Serine/threonine-protein kinase TBK1,Homo sapiens,Q9UHD2,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963698,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: TBK1,-Log Ki,<,5.5,none,inactive,CHEMBL5408,Serine/threonine-protein kinase TBK1,Homo sapiens,Q9UHD2,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1964100,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: TOPK,-Log Ki,<,5,none,inactive,CHEMBL4896,PDZ-binding kinase,Homo sapiens,Q96KB5,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1964100,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: TOPK,-Log Ki,<,5,none,inactive,CHEMBL4896,PDZ-binding kinase,Homo sapiens,Q96KB5,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1964100,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: TOPK,-Log Ki,<,5,none,inactive,CHEMBL4896,PDZ-binding kinase,Homo sapiens,Q96KB5,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1964100,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: TOPK,-Log Ki,<,5,none,inactive,CHEMBL4896,PDZ-binding kinase,Homo sapiens,Q96KB5,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963765,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: TYK2,-Log Ki,<,5.7,none,inactive,CHEMBL3553,Tyrosine-protein kinase TYK2 ,Homo sapiens,P29597,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963765,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: TYK2,-Log Ki,<,5.7,none,inactive,CHEMBL3553,Tyrosine-protein kinase TYK2 ,Homo sapiens,P29597,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963765,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: TYK2,-Log Ki,<,5.7,none,inactive,CHEMBL3553,Tyrosine-protein kinase TYK2 ,Homo sapiens,P29597,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963765,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: TYK2,-Log Ki,<,5.7,none,inactive,CHEMBL3553,Tyrosine-protein kinase TYK2 ,Homo sapiens,P29597,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963714,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: TYRO3,-Log Ki,<,5.7,none,inactive,CHEMBL5314,Tyrosine-protein kinase receptor TYRO3,Homo sapiens,Q06418,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905411,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1963714,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: TYRO3,-Log Ki,<,5.5,none,inactive,CHEMBL5314,Tyrosine-protein kinase receptor TYRO3,Homo sapiens,Q06418,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905623,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1963714,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: TYRO3,-Log Ki,<,5.5,none,inactive,CHEMBL5314,Tyrosine-protein kinase receptor TYRO3,Homo sapiens,Q06418,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963714,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: TYRO3,-Log Ki,<,5.7,none,inactive,CHEMBL5314,Tyrosine-protein kinase receptor TYRO3,Homo sapiens,Q06418,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905238,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963763,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ZAK,-Log Ki,=,5.2,none,active,CHEMBL3886,Mixed lineage kinase 7,Homo sapiens,Q9NYL2,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905253,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1963763,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ZAK,-Log Ki,<,5.1,none,inactive,CHEMBL3886,Mixed lineage kinase 7,Homo sapiens,Q9NYL2,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905429,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1963763,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ZAK,-Log Ki,<,5.1,none,inactive,CHEMBL3886,Mixed lineage kinase 7,Homo sapiens,Q9NYL2,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID103905674,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1963763,PubChem BioAssay. Navigating the Kinome. (Class of assay: other)   Panel member name: ZAK,-Log Ki,<,5.1,none,inactive,CHEMBL3886,Mixed lineage kinase 7,Homo sapiens,Q9NYL2,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID90341621,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1737980,"PubChem BioAssay. Nrf2 qHTS screen for inhibitors: Validation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493163, AID504444, AID504648]",Potency,,11.5821,uM,inconclusive,CHEMBL1075094,Nuclear factor erythroid 2-related factor 2,Homo sapiens,Q16236,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID85231062,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614045,"PubChem BioAssay. Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488774]",Potency,,4.6535,uM,Active,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID85231062,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614221,"PubChem BioAssay. Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774]",Potency,,7.3753,uM,Active,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614362,PubChem BioAssay. Validation screen for inhibitors of Lassa infection.   (Class of assay: confirmatory) ,Potency,=,11.2202,uM,Inconclusive,CHEMBL612545,,,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1613941,PubChem BioAssay. Validation screen for small molecules that induce DNA re-replication in MCF 10A normal breast cells.   (Class of assay: confirmatory) ,Potency,=,3.1623,uM,Active,CHEMBL1293278,Geminin,Homo sapiens,O75496,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID85231062,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1738636,"PubChem BioAssay. Validation screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463097, AID463113, AID493165, AID493166, AID504806, AID504809]",Potency,,29.0929,uM,inconclusive,CHEMBL1293278,Geminin,Homo sapiens,O75496,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID90341621,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1737868,"PubChem BioAssay. Validation screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493143, AID504466]",Potency,,29.081,uM,inactive,CHEMBL1741209,ATPase family AAA domain-containing protein 5,Homo sapiens,Q96QE3,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID90341621,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1738675,"PubChem BioAssay. Validation screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493125, AID504467]",Potency,,25.9185,uM,inconclusive,CHEMBL1741209,ATPase family AAA domain-containing protein 5,Homo sapiens,Q96QE3,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11111220,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614108,PubChem BioAssay. qHTS Assay for Activators of Cytochrome P450 3A4.   (Class of assay: confirmatory) [Related pubchem assays: 410 ],Potency,=,5.0119,uM,Not Active,CHEMBL340,Cytochrome P450 3A4,Homo sapiens,P08684,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11114151,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1614108,PubChem BioAssay. qHTS Assay for Activators of Cytochrome P450 3A4.   (Class of assay: confirmatory) [Related pubchem assays: 410 ],Potency,=,10,uM,Not Active,CHEMBL340,Cytochrome P450 3A4,Homo sapiens,P08684,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID26753187,CHEMBL1594610,"InChI=1S/C16H12FN3S.2ClH/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14;;/h1-8H,9-10H2;2*1H",Cl.Cl.Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL313417,"InChI=1S/C16H12FN3S/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14/h1-8H,9-10H2",Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL1614108,PubChem BioAssay. qHTS Assay for Activators of Cytochrome P450 3A4.   (Class of assay: confirmatory) [Related pubchem assays: 410 ],Potency,=,15.8489,uM,Not Active,CHEMBL340,Cytochrome P450 3A4,Homo sapiens,P08684,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11111220,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1613997,PubChem BioAssay. qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Kinetic Measurement of Intracellular Calcium Response.   (Class of assay: confirmatory) ,Potency,=,31.6228,uM,Inconclusive,CHEMBL276,Muscarinic acetylcholine receptor M1,Rattus norvegicus,P08482,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11111220,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1613991,PubChem BioAssay. qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Measurement of IP-One Response.   (Class of assay: confirmatory) ,Potency,=,11.2202,uM,Active,CHEMBL276,Muscarinic acetylcholine receptor M1,Rattus norvegicus,P08482,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614052,PubChem BioAssay. qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction.   (Class of assay: confirmatory) ,Potency,=,10,uM,Inconclusive,CHEMBL5162,Neuropeptide S receptor,Homo sapiens,Q6W5P4,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11114151,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1613797,PubChem BioAssay. qHTS Assay for Anthrax Lethal Toxin Internalization.   (Class of assay: confirmatory) ,Potency,=,15.8489,uM,Inconclusive,CHEMBL4372,Anthrax lethal factor,Bacillus anthracis,P15917,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID26753187,CHEMBL1594610,"InChI=1S/C16H12FN3S.2ClH/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14;;/h1-8H,9-10H2;2*1H",Cl.Cl.Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL313417,"InChI=1S/C16H12FN3S/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14/h1-8H,9-10H2",Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL1613797,PubChem BioAssay. qHTS Assay for Anthrax Lethal Toxin Internalization.   (Class of assay: confirmatory) ,Potency,=,15.8489,uM,Inconclusive,CHEMBL4372,Anthrax lethal factor,Bacillus anthracis,P15917,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1613970,PubChem BioAssay. qHTS Assay for Compounds that Induce Erasure of Genomic Imprints.   (Class of assay: confirmatory) ,Potency,=,10,uM,Not Active,CHEMBL612545,,,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID26753187,CHEMBL1594610,"InChI=1S/C16H12FN3S.2ClH/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14;;/h1-8H,9-10H2;2*1H",Cl.Cl.Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL313417,"InChI=1S/C16H12FN3S/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14/h1-8H,9-10H2",Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL1613842,PubChem BioAssay. qHTS Assay for Enhancers of SMN2 Splice Variant Expression.   (Class of assay: confirmatory) ,Potency,=,11.2202,uM,Not Active,CHEMBL1293232,Survival motor neuron protein,Homo sapiens,Q16637,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1613842,PubChem BioAssay. qHTS Assay for Enhancers of SMN2 Splice Variant Expression.   (Class of assay: confirmatory) ,Potency,=,14.1254,uM,Not Active,CHEMBL1293232,Survival motor neuron protein,Homo sapiens,Q16637,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11111220,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614456,PubChem BioAssay. qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway.   (Class of assay: confirmatory) [Related pubchem assays: 915 ],Potency,=,0.7943,uM,Inconclusive,CHEMBL4261,Hypoxia-inducible factor 1 alpha,Homo sapiens,Q16665,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11111220,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1613823,PubChem BioAssay. qHTS Assay for Identification of Small Molecule Agonists for NFkB Signaling Pathway.   (Class of assay: confirmatory) [Related pubchem assays: 895 ],Potency,=,7.9433,uM,Inconclusive,CHEMBL3251,Nuclear factor NF-kappa-B p105 subunit,Homo sapiens,P19838,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11111220,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614086,PubChem BioAssay. qHTS Assay for Identification of Small Molecule Agonists for Thrombopoietin (TPO) Signaling Pathway.   (Class of assay: confirmatory) [Related pubchem assays: 918 ],Potency,=,10,uM,Inconclusive,CHEMBL1293256,Thrombopoietin,Homo sapiens,P40225,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11111220,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1613803,PubChem BioAssay. qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway.   (Class of assay: confirmatory) [Related pubchem assays: 914 ],Potency,=,0.7943,uM,Inconclusive,CHEMBL4261,Hypoxia-inducible factor 1 alpha,Homo sapiens,Q16665,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11111220,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614274,PubChem BioAssay. qHTS Assay for Identification of Small Molecule Antagonists for NFkB Signaling Pathway.   (Class of assay: confirmatory) ,Potency,=,7.9433,uM,Inconclusive,CHEMBL3251,Nuclear factor NF-kappa-B p105 subunit,Homo sapiens,P19838,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11111220,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614034,PubChem BioAssay. qHTS Assay for Identification of Small Molecule Antagonists for Thrombopoietin (TPO) Signaling Pathway.   (Class of assay: confirmatory) [Related pubchem assays: 917 ],Potency,=,10,uM,Inconclusive,CHEMBL1293256,Thrombopoietin,Homo sapiens,P40225,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID26752223,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1614234,PubChem BioAssay. qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium.   (Class of assay: confirmatory) [Related pubchem assays: 901 ],Potency,=,2.5119,uM,Active,CHEMBL1293238,Inositol monophosphatase 1,Rattus norvegicus,P97697,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614234,PubChem BioAssay. qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium.   (Class of assay: confirmatory) [Related pubchem assays: 901 ],Potency,=,11.2202,uM,Not Active,CHEMBL1293238,Inositol monophosphatase 1,Rattus norvegicus,P97697,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11111220,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1613777,PubChem BioAssay. qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19.   (Class of assay: confirmatory) [Related pubchem assays: 410 ],Potency,=,25.1189,uM,Inconclusive,CHEMBL3622,Cytochrome P450 2C19,Homo sapiens,P33261,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11114151,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1613777,PubChem BioAssay. qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19.   (Class of assay: confirmatory) [Related pubchem assays: 410 ],Potency,=,2.5119,uM,Active,CHEMBL3622,Cytochrome P450 2C19,Homo sapiens,P33261,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11111220,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614027,"PubChem BioAssay. qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C9.   (Class of assay: confirmatory) [Related pubchem assays: 885 , 884 , 410 ]",Potency,=,12.5893,uM,Active,CHEMBL3397,Cytochrome P450 2C9,Homo sapiens,P11712,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11111220,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614110,PubChem BioAssay. qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6.   (Class of assay: confirmatory) [Related pubchem assays: 410 ],Potency,=,31.6228,uM,Inconclusive,CHEMBL289,Cytochrome P450 2D6,Homo sapiens,P10635,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11114151,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1614110,PubChem BioAssay. qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6.   (Class of assay: confirmatory) [Related pubchem assays: 410 ],Potency,=,12.5893,uM,Active,CHEMBL289,Cytochrome P450 2D6,Homo sapiens,P10635,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11111220,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1613886,PubChem BioAssay. qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4.   (Class of assay: confirmatory) [Related pubchem assays: 410 ],Potency,=,5.0119,uM,Active,CHEMBL340,Cytochrome P450 3A4,Homo sapiens,P08684,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11114151,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1613886,PubChem BioAssay. qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4.   (Class of assay: confirmatory) [Related pubchem assays: 410 ],Potency,=,10,uM,Active,CHEMBL340,Cytochrome P450 3A4,Homo sapiens,P08684,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID26753187,CHEMBL1594610,"InChI=1S/C16H12FN3S.2ClH/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14;;/h1-8H,9-10H2;2*1H",Cl.Cl.Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL313417,"InChI=1S/C16H12FN3S/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14/h1-8H,9-10H2",Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL1613886,PubChem BioAssay. qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4.   (Class of assay: confirmatory) [Related pubchem assays: 410 ],Potency,=,15.8489,uM,Active,CHEMBL340,Cytochrome P450 3A4,Homo sapiens,P08684,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11114151,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1613914,PubChem BioAssay. qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E).   (Class of assay: confirmatory) ,Potency,=,19.9526,uM,Inconclusive,CHEMBL1293226,Lysine-specific demethylase 4D-like,Homo sapiens,B2RXH2,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID26753187,CHEMBL1594610,"InChI=1S/C16H12FN3S.2ClH/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14;;/h1-8H,9-10H2;2*1H",Cl.Cl.Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL313417,"InChI=1S/C16H12FN3S/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14/h1-8H,9-10H2",Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL1613914,PubChem BioAssay. qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E).   (Class of assay: confirmatory) ,Potency,=,31.6228,uM,Inconclusive,CHEMBL1293226,Lysine-specific demethylase 4D-like,Homo sapiens,B2RXH2,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11111220,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614240,PubChem BioAssay. qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase).   (Class of assay: confirmatory) ,Potency,=,25.1189,uM,Inconclusive,CHEMBL2903,Arachidonate 15-lipoxygenase,Homo sapiens,P16050,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID26753187,CHEMBL1594610,"InChI=1S/C16H12FN3S.2ClH/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14;;/h1-8H,9-10H2;2*1H",Cl.Cl.Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL313417,"InChI=1S/C16H12FN3S/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14/h1-8H,9-10H2",Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL1614240,PubChem BioAssay. qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase).   (Class of assay: confirmatory) ,Potency,=,0.5012,uM,Inconclusive,CHEMBL2903,Arachidonate 15-lipoxygenase,Homo sapiens,P16050,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11114151,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1613800,"PubChem BioAssay. qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2).   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2312, AID2537, AID2702]",Potency,,1.2589,uM,inactive,CHEMBL2457,"Arachidonate 15-lipoxygenase, type II",Homo sapiens,O15296,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID26753187,CHEMBL1594610,"InChI=1S/C16H12FN3S.2ClH/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14;;/h1-8H,9-10H2;2*1H",Cl.Cl.Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL313417,"InChI=1S/C16H12FN3S/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14/h1-8H,9-10H2",Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL1613800,"PubChem BioAssay. qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2).   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2312, AID2537, AID2702]",Potency,,10,uM,inconclusive,CHEMBL2457,"Arachidonate 15-lipoxygenase, type II",Homo sapiens,O15296,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11114151,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1614458,PubChem BioAssay. qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1).   (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],Potency,=,31.6228,uM,Inconclusive,CHEMBL3577,Aldehyde dehydrogenase 1A1,Homo sapiens,P00352,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID26752223,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1614458,PubChem BioAssay. qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1).   (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],Potency,=,23.7558,uM,Inconclusive,CHEMBL3577,Aldehyde dehydrogenase 1A1,Homo sapiens,P00352,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614458,PubChem BioAssay. qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1).   (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],Potency,=,35.4813,uM,Inconclusive,CHEMBL3577,Aldehyde dehydrogenase 1A1,Homo sapiens,P00352,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID29217555,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1614174,PubChem BioAssay. qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase).   (Class of assay: confirmatory) ,Potency,=,19.9526,uM,Inconclusive,CHEMBL1293248,4'-phosphopantetheinyl transferase ffp,Bacillus subtilis,Q9F4F7,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614067,"PubChem BioAssay. qHTS Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM).   (Class of assay: confirmatory) [Related pubchem assays: 593 (Fluorescein region spectral profiling screen), 2386 (Probe Development Summary for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 594 (Rhodamine region spectral profiling screen), 2364 (qHTS Validation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM))]",Potency,=,1.122,uM,Inconclusive,CHEMBL1293237,Bloom syndrome protein,Homo sapiens,P54132,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11114151,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1614501,PubChem BioAssay. qHTS Assay for Inhibitors of Firefly Luciferase.   (Class of assay: confirmatory) [Related pubchem assays: 2309 (Probe Summary for Inhibitors and Stabilizers of Firefly Luciferase)],Potency,=,7.9433,uM,Active,CHEMBL5567,Luciferin 4-monooxygenase,Photinus pyralis,P08659,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID29217658,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1614275,"PubChem BioAssay. qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia.   (Class of assay: confirmatory) [Related pubchem assays: 2472 , 2464 ]",Potency,=,15.8114,uM,Inconclusive,CHEMBL1293234,"Putative fructose-1,6-bisphosphate aldolase",Giardia intestinalis,O97447,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID26752223,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1738606,PubChem BioAssay. qHTS Assay for Inhibitors of GCN5L2.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504398],Potency,,25.1189,uM,inconclusive,CHEMBL5501,Histone acetyltransferase GCN5,Homo sapiens,Q92830,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11114151,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1614038,"PubChem BioAssay. qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase).   (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))]",Potency,=,35.4813,uM,Inconclusive,CHEMBL1293255,15-hydroxyprostaglandin dehydrogenase [NAD+],Homo sapiens,P15428,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID26753187,CHEMBL1594610,"InChI=1S/C16H12FN3S.2ClH/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14;;/h1-8H,9-10H2;2*1H",Cl.Cl.Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL313417,"InChI=1S/C16H12FN3S/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14/h1-8H,9-10H2",Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL1614038,"PubChem BioAssay. qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase).   (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))]",Potency,=,31.6228,uM,Inconclusive,CHEMBL1293255,15-hydroxyprostaglandin dehydrogenase [NAD+],Homo sapiens,P15428,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614038,"PubChem BioAssay. qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase).   (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))]",Potency,=,12.5893,uM,Active,CHEMBL1293255,15-hydroxyprostaglandin dehydrogenase [NAD+],Homo sapiens,P15428,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11114151,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1613910,"PubChem BioAssay. qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4.   (Class of assay: confirmatory) ",Potency,=,31.6228,uM,Active,CHEMBL4159,Endoplasmic reticulum-associated amyloid beta-peptide-binding protein,Homo sapiens,Q99714,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID26753187,CHEMBL1594610,"InChI=1S/C16H12FN3S.2ClH/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14;;/h1-8H,9-10H2;2*1H",Cl.Cl.Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL313417,"InChI=1S/C16H12FN3S/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14/h1-8H,9-10H2",Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL1613910,"PubChem BioAssay. qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4.   (Class of assay: confirmatory) ",Potency,=,19.9526,uM,Inconclusive,CHEMBL4159,Endoplasmic reticulum-associated amyloid beta-peptide-binding protein,Homo sapiens,Q99714,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1738442,PubChem BioAssay. qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],Potency,,0.0355,uM,inactive,CHEMBL6032,"Histone-lysine N-methyltransferase, H3 lysine-9 specific 3",Homo sapiens,Q96KQ7,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID90341621,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1738442,PubChem BioAssay. qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],Potency,,1.122,uM,inconclusive,CHEMBL6032,"Histone-lysine N-methyltransferase, H3 lysine-9 specific 3",Homo sapiens,Q96KQ7,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614166,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,Potency,=,12.5893,uM,Inconclusive,CHEMBL1293317,Muscleblind-like protein 1,Homo sapiens,Q9NR56,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11114151,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1614364,PubChem BioAssay. qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1).   (Class of assay: confirmatory) ,Potency,=,14.1254,uM,Not Active,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,Homo sapiens,Q9NUW8,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID26752223,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1614364,PubChem BioAssay. qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1).   (Class of assay: confirmatory) ,Potency,=,17.7828,uM,Not Active,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,Homo sapiens,Q9NUW8,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID26753187,CHEMBL1594610,"InChI=1S/C16H12FN3S.2ClH/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14;;/h1-8H,9-10H2;2*1H",Cl.Cl.Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL313417,"InChI=1S/C16H12FN3S/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14/h1-8H,9-10H2",Fc1ccc(cc1)c2nc3SCCn3c2c4ccncc4,CHEMBL1614364,PubChem BioAssay. qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1).   (Class of assay: confirmatory) ,Potency,=,10,uM,Not Active,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,Homo sapiens,Q9NUW8,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID29215044,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1614364,PubChem BioAssay. qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1).   (Class of assay: confirmatory) ,Potency,=,56.2341,uM,Not Active,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,Homo sapiens,Q9NUW8,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614364,PubChem BioAssay. qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1).   (Class of assay: confirmatory) ,Potency,=,44.6684,uM,Not Active,CHEMBL1075138,Tyrosyl-DNA phosphodiesterase 1,Homo sapiens,Q9NUW8,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11111220,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1613808,PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay.   (Class of assay: confirmatory) ,Potency,=,15.8489,uM,Inconclusive,CHEMBL4040,MAP kinase ERK2,Homo sapiens,P28482,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11114151,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1613808,PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay.   (Class of assay: confirmatory) ,Potency,=,39.8107,uM,Inconclusive,CHEMBL4040,MAP kinase ERK2,Homo sapiens,P28482,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614521,PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF.   (Class of assay: confirmatory) [Related pubchem assays: 995 ],Potency,=,2.8184,uM,Active,CHEMBL4040,MAP kinase ERK2,Homo sapiens,P28482,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID29217555,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1614211,"PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) [Related pubchem assays: 1705 (qHTS Validation Assay for Inhibitors of the Human Apurinic/apyrimidinic  Endonuclease 1 (APE1)), 2324 (Probe Development Summary of Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1)), 1707 (Counterscreen for APE1 Inhibitors: Fluorescent Dye Displacement Validation Assay), 1708 (Counterscreen for APE1 Inhibitors: qHTS Validation Assay for Inhibitors of Endonuclease IV)]",Potency,=,28.1838,uM,Inconclusive,CHEMBL5619,DNA-(apurinic or apyrimidinic site) lyase,Homo sapiens,P27695,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614211,"PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) [Related pubchem assays: 1705 (qHTS Validation Assay for Inhibitors of the Human Apurinic/apyrimidinic  Endonuclease 1 (APE1)), 2324 (Probe Development Summary of Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1)), 1707 (Counterscreen for APE1 Inhibitors: Fluorescent Dye Displacement Validation Assay), 1708 (Counterscreen for APE1 Inhibitors: qHTS Validation Assay for Inhibitors of Endonuclease IV)]",Potency,=,17.7828,uM,Inconclusive,CHEMBL5619,DNA-(apurinic or apyrimidinic site) lyase,Homo sapiens,P27695,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11114151,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1614019,PubChem BioAssay. qHTS Assay for Lipid Storage Modulators.   (Class of assay: confirmatory) ,Potency,=,0.1122,uM,Inconclusive,CHEMBL612545,,,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614019,PubChem BioAssay. qHTS Assay for Lipid Storage Modulators.   (Class of assay: confirmatory) ,Potency,=,19.9526,uM,Inconclusive,CHEMBL612545,,,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID85231062,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614171,PubChem BioAssay. qHTS Assay for Modulators of Human Peripheral Myelin Protein 22 (PMP22) Expression/Activity.   (Class of assay: confirmatory) ,Potency,=,33.8078,uM,Inconclusive,CHEMBL1293298,Peripheral myelin protein 22,Homo sapiens,Q01453,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614544,PubChem BioAssay. qHTS Assay for Modulators of Lamin A Splicing.   (Class of assay: confirmatory) ,Potency,=,0.0045,uM,Inconclusive,CHEMBL1293235,Prelamin-A/C,Homo sapiens,P02545,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1613769,"PubChem BioAssay. qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent).   (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))]",Potency,=,39.8107,uM,Inconclusive,CHEMBL3563,Cruzipain,Trypanosoma cruzi,P25779,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID90341621,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1613838,PubChem BioAssay. qHTS Assay for Rab9 Promoter Activators.   (Class of assay: confirmatory) ,Potency,=,58.0479,uM,Not Active,CHEMBL1293294,Ras-related protein Rab-9A,Homo sapiens,P51151,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID90341621,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614414,PubChem BioAssay. qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion.   (Class of assay: confirmatory) ,Potency,=,18.3564,uM,Active,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID90341621,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1794486,PubChem BioAssay. qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1)..   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813],Potency,,11.9173,uM,inconclusive,CHEMBL5027,Flap endonuclease 1,Homo sapiens,P39748,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11111220,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1613992,PubChem BioAssay. qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature.   (Class of assay: confirmatory) ,Potency,=,1.5849,uM,Not Active,CHEMBL4096,Cellular tumor antigen p53,Homo sapiens,P04637,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11111220,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1613995,PubChem BioAssay. qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature.   (Class of assay: confirmatory) [Related pubchem assays: 902 ],Potency,=,31.6228,uM,Not Active,CHEMBL4096,Cellular tumor antigen p53,Homo sapiens,P04637,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614291,PubChem BioAssay. qHTS Validation Assay for Identification of Novel General Anesthetics.   (Class of assay: confirmatory) ,Potency,=,28.1838,uM,Not Active,CHEMBL1293254,Ferritin light chain,Equus caballus,P02791,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID85231062,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1738402,PubChem BioAssay. qHTS Validation Assay for Inhibitors for MPP8 Chromodomain Interactions with Methylated Histone Tails.   (Class of assay: confirmatory) ,Potency,,39.8107,uM,inconclusive,CHEMBL1741210,M-phase phosphoprotein 8,Homo sapiens,Q99549,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614522,"PubChem BioAssay. qHTS Validation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM).   (Class of assay: confirmatory) [Related pubchem assays: 593 (Fluorescein region spectral profiling screen), 594 (Rhodamine region spectral profiling screen)]",Potency,=,1.122,uM,Inconclusive,CHEMBL1293237,Bloom syndrome protein,Homo sapiens,P54132,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID90341621,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1738610,PubChem BioAssay. qHTS Validation Assay for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],Potency,,39.8107,uM,inconclusive,CHEMBL1741193,Chromobox protein homolog 1,Homo sapiens,P83916,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614283,"PubChem BioAssay. qHTS Validation Assay for Inhibitors of the Human Apurinic/apyrimidinic  Endonuclease 1 (APE1).   (Class of assay: confirmatory) [Related pubchem assays: 1707 , 1708 ]",Potency,=,28.1838,uM,Inconclusive,CHEMBL5619,DNA-(apurinic or apyrimidinic site) lyase,Homo sapiens,P27695,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID90341621,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1613922,PubChem BioAssay. qHTS Validation Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).   (Class of assay: confirmatory) ,Potency,,11.9173,uM,inconclusive,CHEMBL5027,Flap endonuclease 1,Homo sapiens,P39748,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID90341621,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614015,PubChem BioAssay. qHTS Validation Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493014],Potency,,29.0929,uM,inconclusive,CHEMBL612545,,,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID90341621,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614279,"PubChem BioAssay. qHTS Validation Assay to Find Inhibitors of T. brucei phosphofructokinase.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488768, AID492961]",Potency,,37.933,uM,inconclusive,CHEMBL5686,6-phospho-1-fructokinase,Trypanosoma brucei,O15648,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID29217555,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1963893,PubChem BioAssay. qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS.   (Class of assay: confirmatory) ,Potency,,11.2202,uM,inconclusive,CHEMBL1781865,78 kDa glucose-regulated protein,Homo sapiens,P11021,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID90341621,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1794380,"PubChem BioAssay. qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588378, AID588380]",Potency,,39.8107,uM,inconclusive,CHEMBL612545,,,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID90341621,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1794367,"PubChem BioAssay. qHTS for Inhibitors of ATXN expression: Validation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588349, AID588380]",Potency,,39.8107,uM,inconclusive,CHEMBL1795085,Ataxin-2,Homo sapiens,Q99700,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1794569,PubChem BioAssay. qHTS for Inhibitors of Polymerase Eta.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636],Potency,,28.1838,uM,inconclusive,CHEMBL5542,DNA polymerase eta,Homo sapiens,Q9Y253,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID29217555,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1794536,PubChem BioAssay. qHTS for Inhibitors of Polymerase Kappa.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588638],Potency,,29.9349,uM,inconclusive,CHEMBL5365,DNA polymerase kappa,Homo sapiens,Q9UBT6,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID90341621,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1794536,PubChem BioAssay. qHTS for Inhibitors of Polymerase Kappa.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588638],Potency,,33.5875,uM,inconclusive,CHEMBL5365,DNA polymerase kappa,Homo sapiens,Q9UBT6,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614421,"PubChem BioAssay. qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding.   (Class of assay: confirmatory) [Related pubchem assays: 596 ]",Potency,=,7.9433,uM,Inconclusive,CHEMBL1293224,Microtubule-associated protein tau,Homo sapiens,P10636,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349745,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,35.3383,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349749,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,6.2841,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349772,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL274064,"InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)",Nc1nccc(n1)c2c(ncn2C3CCNCC3)c4ccc(F)cc4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.0089,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349794,CHEMBL399410,"InChI=1S/C27H23N3O2S/c1-30-26(22-5-4-21-17-23(32-2)9-6-20(21)16-22)25(18-12-14-28-15-13-18)29-27(30)19-7-10-24(11-8-19)33(3)31/h4-17H,1-3H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4)S(=O)C)n3C)c5ccncc5,CHEMBL399410,"InChI=1S/C27H23N3O2S/c1-30-26(22-5-4-21-17-23(32-2)9-6-20(21)16-22)25(18-12-14-28-15-13-18)29-27(30)19-7-10-24(11-8-19)33(3)31/h4-17H,1-3H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4)S(=O)C)n3C)c5ccncc5,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,15.785,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349795,CHEMBL524901,"InChI=1S/C17H21N7O/c1-3-16-14(13-21-24(16)20-6-1)15-4-7-19-17(22-15)18-5-2-8-23-9-11-25-12-10-23/h1,3-4,6-7,13H,2,5,8-12H2,(H,18,19,22)",C(CNc1nccc(n1)c2cnn3ncccc23)CN4CCOCC4,CHEMBL524901,"InChI=1S/C17H21N7O/c1-3-16-14(13-21-24(16)20-6-1)15-4-7-19-17(22-15)18-5-2-8-23-9-11-25-12-10-23/h1,3-4,6-7,13H,2,5,8-12H2,(H,18,19,22)",C(CNc1nccc(n1)c2cnn3ncccc23)CN4CCOCC4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,4.9917,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349797,CHEMBL250322,"InChI=1S/C18H17N5O2/c1-11-5-6-14(10-15(11)24)21-16-7-8-20-18(23-16)22-13-4-2-3-12(9-13)17(19)25/h2-10,24H,1H3,(H2,19,25)(H2,20,21,22,23)",Cc1ccc(Nc2ccnc(Nc3cccc(c3)C(=O)N)n2)cc1O,CHEMBL250322,"InChI=1S/C18H17N5O2/c1-11-5-6-14(10-15(11)24)21-16-7-8-20-18(23-16)22-13-4-2-3-12(9-13)17(19)25/h2-10,24H,1H3,(H2,19,25)(H2,20,21,22,23)",Cc1ccc(Nc2ccnc(Nc3cccc(c3)C(=O)N)n2)cc1O,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,39.6502,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349798,CHEMBL207410,"InChI=1S/C27H20ClFN4O2/c1-30-27(34)20-6-2-4-18(12-20)8-9-21-15-31-17-32-26(21)33-23-10-11-25(24(28)14-23)35-16-19-5-3-7-22(29)13-19/h2-7,10-15,17H,16H2,1H3,(H,30,34)(H,31,32,33)",CNC(=O)c1cccc(c1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL207410,"InChI=1S/C27H20ClFN4O2/c1-30-27(34)20-6-2-4-18(12-20)8-9-21-15-31-17-32-26(21)33-23-10-11-25(24(28)14-23)35-16-19-5-3-7-22(29)13-19/h2-7,10-15,17H,16H2,1H3,(H,30,34)(H,31,32,33)",CNC(=O)c1cccc(c1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.7911,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349799,CHEMBL486124,"InChI=1S/C19H24N6O/c1-15-17-14-21-19(20-8-5-9-24-10-12-26-13-11-24)23-25(17)18(22-15)16-6-3-2-4-7-16/h2-4,6-7,14H,5,8-13H2,1H3,(H,20,23)",Cc1nc(c2ccccc2)n3nc(NCCCN4CCOCC4)ncc13,CHEMBL486124,"InChI=1S/C19H24N6O/c1-15-17-14-21-19(20-8-5-9-24-10-12-26-13-11-24)23-25(17)18(22-15)16-6-3-2-4-7-16/h2-4,6-7,14H,5,8-13H2,1H3,(H,20,23)",Cc1nc(c2ccccc2)n3nc(NCCCN4CCOCC4)ncc13,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.0044,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349800,CHEMBL192413,"InChI=1S/C16H11N3O/c17-10-12-5-4-8-14(9-12)19-16-18-11-15(20-16)13-6-2-1-3-7-13/h1-9,11H,(H,18,19)",N#Cc1cccc(Nc2oc(cn2)c3ccccc3)c1,CHEMBL192413,"InChI=1S/C16H11N3O/c17-10-12-5-4-8-14(9-12)19-16-18-11-15(20-16)13-6-2-1-3-7-13/h1-9,11H,(H,18,19)",N#Cc1cccc(Nc2oc(cn2)c3ccccc3)c1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.315,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349801,CHEMBL346551,"InChI=1S/C16H12N2O2/c19-15-13(11-7-3-1-4-8-11)14(16(20)18-15)17-12-9-5-2-6-10-12/h1-10H,(H2,17,18,19,20)",O=C1NC(=O)C(=C1Nc2ccccc2)c3ccccc3,CHEMBL346551,"InChI=1S/C16H12N2O2/c19-15-13(11-7-3-1-4-8-11)14(16(20)18-15)17-12-9-5-2-6-10-12/h1-10H,(H2,17,18,19,20)",O=C1NC(=O)C(=C1Nc2ccccc2)c3ccccc3,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,3.965,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349806,CHEMBL1885746,"InChI=1S/C21H15FN6/c22-15-4-2-14(3-5-15)20-19(18-8-1-13(11-23)12-28(18)27-20)17-9-10-24-21(26-17)25-16-6-7-16/h1-5,8-10,12,16H,6-7H2,(H,24,25,26)",Fc1ccc(cc1)c2nn3cc(ccc3c2c4ccnc(NC5CC5)n4)C#N,CHEMBL1885746,"InChI=1S/C21H15FN6/c22-15-4-2-14(3-5-15)20-19(18-8-1-13(11-23)12-28(18)27-20)17-9-10-24-21(26-17)25-16-6-7-16/h1-5,8-10,12,16H,6-7H2,(H,24,25,26)",Fc1ccc(cc1)c2nn3cc(ccc3c2c4ccnc(NC5CC5)n4)C#N,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,3.5338,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349807,CHEMBL14112,"InChI=1S/C21H23FN4O/c22-19-4-2-17(3-5-19)20-21(18-6-8-23-9-7-18)26(16-24-20)11-1-10-25-12-14-27-15-13-25/h2-9,16H,1,10-15H2",Fc1ccc(cc1)c2ncn(CCCN3CCOCC3)c2c4ccncc4,CHEMBL14112,"InChI=1S/C21H23FN4O/c22-19-4-2-17(3-5-19)20-21(18-6-8-23-9-7-18)26(16-24-20)11-1-10-25-12-14-27-15-13-25/h2-9,16H,1,10-15H2",Fc1ccc(cc1)c2ncn(CCCN3CCOCC3)c2c4ccncc4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.0031,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349810,CHEMBL419903,"InChI=1S/C17H14FN3O/c18-13-6-3-10(4-7-13)12-5-8-14-15(9-12)20-21-16(14)19-17(22)11-1-2-11/h3-9,11H,1-2H2,(H2,19,20,21,22)",Fc1ccc(cc1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL419903,"InChI=1S/C17H14FN3O/c18-13-6-3-10(4-7-13)12-5-8-14-15(9-12)20-21-16(14)19-17(22)11-1-2-11/h3-9,11H,1-2H2,(H2,19,20,21,22)",Fc1ccc(cc1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,15.785,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349812,CHEMBL243917,"InChI=1S/C28H19F4N5O3/c29-21-12-6-17(28(30,31)32)14-23(21)36-27(39)33-18-7-9-19(10-8-18)40-20-11-13-22-24(15-20)35-26(34-22)37-25(38)16-4-2-1-3-5-16/h1-15H,(H2,33,36,39)(H2,34,35,37,38)",Fc1ccc(cc1NC(=O)Nc2ccc(Oc3ccc4[nH]c(NC(=O)c5ccccc5)nc4c3)cc2)C(F)(F)F,CHEMBL243917,"InChI=1S/C28H19F4N5O3/c29-21-12-6-17(28(30,31)32)14-23(21)36-27(39)33-18-7-9-19(10-8-18)40-20-11-13-22-24(15-20)35-26(34-22)37-25(38)16-4-2-1-3-5-16/h1-15H,(H2,33,36,39)(H2,34,35,37,38)",Fc1ccc(cc1NC(=O)Nc2ccc(Oc3ccc4[nH]c(NC(=O)c5ccccc5)nc4c3)cc2)C(F)(F)F,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,6.2841,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349816,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL260417,"InChI=1S/C16H13BrN4O2/c17-12-7-11-14(18-13(12)8-3-5-10(22)6-4-8)20-21-15(11)19-16(23)9-1-2-9/h3-7,9,22H,1-2H2,(H2,18,19,20,21,23)",Oc1ccc(cc1)c2nc3[nH]nc(NC(=O)C4CC4)c3cc2Br,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,12.5385,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349817,CHEMBL194117,"InChI=1S/C21H16N2O2/c1-3-7-16(8-4-1)20-15-22-21(25-20)23-17-11-13-19(14-12-17)24-18-9-5-2-6-10-18/h1-15H,(H,22,23)",N(c1ccc(Oc2ccccc2)cc1)c3oc(cn3)c4ccccc4,CHEMBL194117,"InChI=1S/C21H16N2O2/c1-3-7-16(8-4-1)20-15-22-21(25-20)23-17-11-13-19(14-12-17)24-18-9-5-2-6-10-18/h1-15H,(H,22,23)",N(c1ccc(Oc2ccccc2)cc1)c3oc(cn3)c4ccccc4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.2502,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349821,CHEMBL396283,"InChI=1S/C22H18ClN5O4/c1-31-22(30)28-20-26-18-10-9-17(12-19(18)27-20)32-16-7-5-14(6-8-16)24-21(29)25-15-4-2-3-13(23)11-15/h2-12H,1H3,(H2,24,25,29)(H2,26,27,28,30)",COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1,CHEMBL396283,"InChI=1S/C22H18ClN5O4/c1-31-22(30)28-20-26-18-10-9-17(12-19(18)27-20)32-16-7-5-14(6-8-16)24-21(29)25-15-4-2-3-13(23)11-15/h2-12H,1H3,(H2,24,25,29)(H2,26,27,28,30)",COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,6.2841,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349825,CHEMBL244097,"InChI=1S/C23H19N5O6/c1-33-23(32)28-21-26-18-10-9-17(12-19(18)27-21)34-16-7-5-14(6-8-16)24-22(31)25-15-4-2-3-13(11-15)20(29)30/h2-12H,1H3,(H,29,30)(H2,24,25,31)(H2,26,27,28,32)",COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(c4)C(=O)O)cc3)ccc2[nH]1,CHEMBL244097,"InChI=1S/C23H19N5O6/c1-33-23(32)28-21-26-18-10-9-17(12-19(18)27-21)34-16-7-5-14(6-8-16)24-22(31)25-15-4-2-3-13(11-15)20(29)30/h2-12H,1H3,(H,29,30)(H2,24,25,31)(H2,26,27,28,32)",COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(c4)C(=O)O)cc3)ccc2[nH]1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,3.965,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349826,CHEMBL400388,"InChI=1S/C17H14FN5O/c18-12-4-2-6-14(10-12)21-15-7-8-20-17(23-15)22-13-5-1-3-11(9-13)16(19)24/h1-10H,(H2,19,24)(H2,20,21,22,23)",NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1,CHEMBL400388,"InChI=1S/C17H14FN5O/c18-12-4-2-6-14(10-12)21-15-7-8-20-17(23-15)22-13-5-1-3-11(9-13)16(19)24/h1-10H,(H2,19,24)(H2,20,21,22,23)",NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,2.5018,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349827,CHEMBL243891,"InChI=1S/C22H19N5O4/c1-30-22(29)27-20-25-18-12-11-17(13-19(18)26-20)31-16-9-7-15(8-10-16)24-21(28)23-14-5-3-2-4-6-14/h2-13H,1H3,(H2,23,24,28)(H2,25,26,27,29)",COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1,CHEMBL243891,"InChI=1S/C22H19N5O4/c1-30-22(29)27-20-25-18-12-11-17(13-19(18)26-20)31-16-9-7-15(8-10-16)24-21(28)23-14-5-3-2-4-6-14/h2-13H,1H3,(H2,23,24,28)(H2,25,26,27,29)",COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,3.1495,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349828,CHEMBL402108,"InChI=1S/C24H20ClN3O2/c1-15-3-6-20(24-28-27-16(2)30-24)13-22(15)18-7-9-19(10-8-18)23(29)26-14-17-4-11-21(25)12-5-17/h3-13H,14H2,1-2H3,(H,26,29)",Cc1oc(nn1)c2ccc(C)c(c2)c3ccc(cc3)C(=O)NCc4ccc(Cl)cc4,CHEMBL402108,"InChI=1S/C24H20ClN3O2/c1-15-3-6-20(24-28-27-16(2)30-24)13-22(15)18-7-9-19(10-8-18)23(29)26-14-17-4-11-21(25)12-5-17/h3-13H,14H2,1-2H3,(H,26,29)",Cc1oc(nn1)c2ccc(C)c(c2)c3ccc(cc3)C(=O)NCc4ccc(Cl)cc4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.6284,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349829,CHEMBL481510,"InChI=1S/C20H13BrF3N3O2S/c21-13-4-2-1-3-11(13)9-29-16-8-17(30-18(16)19(25)28)27-10-26-14-6-5-12(7-15(14)27)20(22,23)24/h1-8,10H,9H2,(H2,25,28)",NC(=O)c1sc(cc1OCc2ccccc2Br)n3cnc4ccc(cc34)C(F)(F)F,CHEMBL481510,"InChI=1S/C20H13BrF3N3O2S/c21-13-4-2-1-3-11(13)9-29-16-8-17(30-18(16)19(25)28)27-10-26-14-6-5-12(7-15(14)27)20(22,23)24/h1-8,10H,9H2,(H2,25,28)",NC(=O)c1sc(cc1OCc2ccccc2Br)n3cnc4ccc(cc34)C(F)(F)F,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,6.2841,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349830,CHEMBL218720,"InChI=1S/C22H19F3N4O2/c1-11-16-9-15(7-8-18(16)29-28-11)27-21(31)20-12(2)26-19(30)10-17(20)13-3-5-14(6-4-13)22(23,24)25/h3-9,17H,10H2,1-2H3,(H,26,30)(H,27,31)(H,28,29)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3ccc4[nH]nc(C)c4c3,CHEMBL218720,"InChI=1S/C22H19F3N4O2/c1-11-16-9-15(7-8-18(16)29-28-11)27-21(31)20-12(2)26-19(30)10-17(20)13-3-5-14(6-4-13)22(23,24)25/h3-9,17H,10H2,1-2H3,(H,26,30)(H,27,31)(H,28,29)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3ccc4[nH]nc(C)c4c3,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.1117,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349832,CHEMBL215993,"InChI=1S/C25H19N3O2/c1-2-5-18(6-3-1)16-30-21-11-9-20(10-12-21)28-25-22-15-19(24-7-4-14-29-24)8-13-23(22)26-17-27-25/h1-15,17H,16H2,(H,26,27,28)",C(Oc1ccc(Nc2ncnc3ccc(cc23)c4occc4)cc1)c5ccccc5,CHEMBL215993,"InChI=1S/C25H19N3O2/c1-2-5-18(6-3-1)16-30-21-11-9-20(10-12-21)28-25-22-15-19(24-7-4-14-29-24)8-13-23(22)26-17-27-25/h1-15,17H,16H2,(H,26,27,28)",C(Oc1ccc(Nc2ncnc3ccc(cc23)c4occc4)cc1)c5ccccc5,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,31.4952,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349833,CHEMBL160333,"InChI=1S/C16H10Cl2N2O3/c17-9-3-1-2-8(6-9)13-14(16(23)20-15(13)22)19-10-4-5-12(21)11(18)7-10/h1-7,21H,(H2,19,20,22,23)",Oc1ccc(NC2=C(C(=O)NC2=O)c3cccc(Cl)c3)cc1Cl,CHEMBL160333,"InChI=1S/C16H10Cl2N2O3/c17-9-3-1-2-8(6-9)13-14(16(23)20-15(13)22)19-10-4-5-12(21)11(18)7-10/h1-7,21H,(H2,19,20,22,23)",Oc1ccc(NC2=C(C(=O)NC2=O)c3cccc(Cl)c3)cc1Cl,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,25.0176,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349834,CHEMBL233002,"InChI=1S/C20H15FN2OS/c21-17-10-9-15(12-5-1-2-6-13(12)17)19(24)23-20-16(11-22)14-7-3-4-8-18(14)25-20/h1-2,5-6,9-10H,3-4,7-8H2,(H,23,24)",Fc1ccc(C(=O)Nc2sc3CCCCc3c2C#N)c4ccccc14,CHEMBL233002,"InChI=1S/C20H15FN2OS/c21-17-10-9-15(12-5-1-2-6-13(12)17)19(24)23-20-16(11-22)14-7-3-4-8-18(14)25-20/h1-2,5-6,9-10H,3-4,7-8H2,(H,23,24)",Fc1ccc(C(=O)Nc2sc3CCCCc3c2C#N)c4ccccc14,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.7911,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349835,CHEMBL268889,"InChI=1S/C18H15N3O2/c1-2-8-19-13(4-1)17-18(21-9-3-5-16(21)20-17)12-6-7-14-15(10-12)23-11-22-14/h1-2,4,6-8,10H,3,5,9,11H2",C1Cc2nc(c3ccccn3)c(c4ccc5OCOc5c4)n2C1,CHEMBL268889,"InChI=1S/C18H15N3O2/c1-2-8-19-13(4-1)17-18(21-9-3-5-16(21)20-17)12-6-7-14-15(10-12)23-11-22-14/h1-2,4,6-8,10H,3,5,9,11H2",C1Cc2nc(c3ccccn3)c(c4ccc5OCOc5c4)n2C1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,9.9597,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349837,CHEMBL304624,"InChI=1S/C20H15N3O/c24-17-8-4-7-16(13-17)19-18(14-9-11-21-12-10-14)22-20(23-19)15-5-2-1-3-6-15/h1-13,24H,(H,22,23)",Oc1cccc(c1)c2nc([nH]c2c3ccncc3)c4ccccc4,CHEMBL304624,"InChI=1S/C20H15N3O/c24-17-8-4-7-16(13-17)19-18(14-9-11-21-12-10-14)22-20(23-19)15-5-2-1-3-6-15/h1-13,24H,(H,22,23)",Oc1cccc(c1)c2nc([nH]c2c3ccncc3)c4ccccc4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,31.4952,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349842,CHEMBL427058,"InChI=1S/C21H16ClF3N4O2/c1-10-18(20(31)28-14-6-12-9-26-29-19(12)16(22)7-14)15(8-17(30)27-10)11-2-4-13(5-3-11)21(23,24)25/h2-7,9,15H,8H2,1H3,(H,26,29)(H,27,30)(H,28,31)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3cc(Cl)c4[nH]ncc4c3,CHEMBL427058,"InChI=1S/C21H16ClF3N4O2/c1-10-18(20(31)28-14-6-12-9-26-29-19(12)16(22)7-14)15(8-17(30)27-10)11-2-4-13(5-3-11)21(23,24)25/h2-7,9,15H,8H2,1H3,(H,26,29)(H,27,30)(H,28,31)",CC1=C(C(CC(=O)N1)c2ccc(cc2)C(F)(F)F)C(=O)Nc3cc(Cl)c4[nH]ncc4c3,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.4449,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349843,CHEMBL1888586,"InChI=1S/C19H20FN5O/c20-13-3-1-12(2-4-13)17-18(16-9-10-22-19(21)24-16)25(11-23-17)14-5-7-15(26)8-6-14/h1-4,9-11,14-15,26H,5-8H2,(H2,21,22,24)",Nc1nccc(n1)c2c(ncn2C3CCC(O)CC3)c4ccc(F)cc4,CHEMBL1888586,"InChI=1S/C19H20FN5O/c20-13-3-1-12(2-4-13)17-18(16-9-10-22-19(21)24-16)25(11-23-17)14-5-7-15(26)8-6-14/h1-4,9-11,14-15,26H,5-8H2,(H2,21,22,24)",Nc1nccc(n1)c2c(ncn2C3CCC(O)CC3)c4ccc(F)cc4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,22.2969,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349844,CHEMBL160937,"InChI=1S/C16H11ClN2O3/c17-12-7-2-1-6-11(12)13-14(16(22)19-15(13)21)18-9-4-3-5-10(20)8-9/h1-8,20H,(H2,18,19,21,22)",Oc1cccc(NC2=C(C(=O)NC2=O)c3ccccc3Cl)c1,CHEMBL160937,"InChI=1S/C16H11ClN2O3/c17-12-7-2-1-6-11(12)13-14(16(22)19-15(13)21)18-9-4-3-5-10(20)8-9/h1-8,20H,(H2,18,19,21,22)",Oc1cccc(NC2=C(C(=O)NC2=O)c3ccccc3Cl)c1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,12.5385,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349846,CHEMBL480371,"InChI=1S/C20H13BrF3N3O2S/c21-13-4-2-1-3-11(13)9-29-16-8-17(30-18(16)19(25)28)27-10-26-14-7-12(20(22,23)24)5-6-15(14)27/h1-8,10H,9H2,(H2,25,28)",NC(=O)c1sc(cc1OCc2ccccc2Br)n3cnc4cc(ccc34)C(F)(F)F,CHEMBL480371,"InChI=1S/C20H13BrF3N3O2S/c21-13-4-2-1-3-11(13)9-29-16-8-17(30-18(16)19(25)28)27-10-26-14-7-12(20(22,23)24)5-6-15(14)27/h1-8,10H,9H2,(H2,25,28)",NC(=O)c1sc(cc1OCc2ccccc2Br)n3cnc4cc(ccc34)C(F)(F)F,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,31.4952,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349849,CHEMBL215716,"InChI=1S/C30H27FN4O3S/c31-26-17-23(7-10-29(26)37-19-21-4-2-1-3-5-21)34-30-25-16-22(6-9-27(25)32-20-33-30)28-11-8-24(38-28)18-35-12-14-39(36)15-13-35/h1-11,16-17,20H,12-15,18-19H2,(H,32,33,34)",Fc1cc(Nc2ncnc3ccc(cc23)c4oc(CN5CCS(=O)CC5)cc4)ccc1OCc6ccccc6,CHEMBL215716,"InChI=1S/C30H27FN4O3S/c31-26-17-23(7-10-29(26)37-19-21-4-2-1-3-5-21)34-30-25-16-22(6-9-27(25)32-20-33-30)28-11-8-24(38-28)18-35-12-14-39(36)15-13-35/h1-11,16-17,20H,12-15,18-19H2,(H,32,33,34)",Fc1cc(Nc2ncnc3ccc(cc23)c4oc(CN5CCS(=O)CC5)cc4)ccc1OCc6ccccc6,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,35.3383,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349850,CHEMBL261440,"InChI=1S/C17H13F2N3O/c18-11-4-6-14(19)13(8-11)10-3-5-12-15(7-10)21-22-16(12)20-17(23)9-1-2-9/h3-9H,1-2H2,(H2,20,21,22,23)",Fc1ccc(F)c(c1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL261440,"InChI=1S/C17H13F2N3O/c18-11-4-6-14(19)13(8-11)10-3-5-12-15(7-10)21-22-16(12)20-17(23)9-1-2-9/h3-9H,1-2H2,(H2,20,21,22,23)",Fc1ccc(F)c(c1)c2ccc3c(NC(=O)C4CC4)n[nH]c3c2,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,25.0176,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349851,CHEMBL95502,"InChI=1S/C22H27FN6/c1-21(2)11-16(12-22(3,4)28-21)29-13-26-18(14-5-7-15(23)8-6-14)19(29)17-9-10-25-20(24)27-17/h5-10,13,16,28H,11-12H2,1-4H3,(H2,24,25,27)",CC1(C)CC(CC(C)(C)N1)n2cnc(c3ccc(F)cc3)c2c4ccnc(N)n4,CHEMBL95502,"InChI=1S/C22H27FN6/c1-21(2)11-16(12-22(3,4)28-21)29-13-26-18(14-5-7-15(23)8-6-14)19(29)17-9-10-25-20(24)27-17/h5-10,13,16,28H,11-12H2,1-4H3,(H2,24,25,27)",CC1(C)CC(CC(C)(C)N1)n2cnc(c3ccc(F)cc3)c2c4ccnc(N)n4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.0199,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349852,CHEMBL157258,"InChI=1S/C16H9Cl3N2O3/c17-9-4-2-1-3-8(9)12-13(16(24)21-15(12)23)20-7-5-10(18)14(22)11(19)6-7/h1-6,22H,(H2,20,21,23,24)",Oc1c(Cl)cc(NC2=C(C(=O)NC2=O)c3ccccc3Cl)cc1Cl,CHEMBL157258,"InChI=1S/C16H9Cl3N2O3/c17-9-4-2-1-3-8(9)12-13(16(24)21-15(12)23)20-7-5-10(18)14(22)11(19)6-7/h1-6,22H,(H2,20,21,23,24)",Oc1c(Cl)cc(NC2=C(C(=O)NC2=O)c3ccccc3Cl)cc1Cl,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,31.4952,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349853,CHEMBL359963,"InChI=1S/C19H18N6/c1-13(2)14-5-7-15(8-6-14)23-19-20-11-9-17(24-19)16-12-22-25-18(16)4-3-10-21-25/h3-13H,1-2H3,(H,20,23,24)",CC(C)c1ccc(Nc2nccc(n2)c3cnn4ncccc34)cc1,CHEMBL359963,"InChI=1S/C19H18N6/c1-13(2)14-5-7-15(8-6-14)23-19-20-11-9-17(24-19)16-12-22-25-18(16)4-3-10-21-25/h3-13H,1-2H3,(H,20,23,24)",CC(C)c1ccc(Nc2nccc(n2)c3cnn4ncccc34)cc1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,11.1749,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349854,CHEMBL243907,"InChI=1S/C24H23N5O4/c1-3-15-5-4-6-17(13-15)26-23(30)25-16-7-9-18(10-8-16)33-19-11-12-20-21(14-19)28-22(27-20)29-24(31)32-2/h4-14H,3H2,1-2H3,(H2,25,26,30)(H2,27,28,29,31)",CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1,CHEMBL243907,"InChI=1S/C24H23N5O4/c1-3-15-5-4-6-17(13-15)26-23(30)25-16-7-9-18(10-8-16)33-19-11-12-20-21(14-19)28-22(27-20)29-24(31)32-2/h4-14H,3H2,1-2H3,(H2,25,26,30)(H2,27,28,29,31)",CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,12.5385,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349856,CHEMBL270164,"InChI=1S/C24H18N4O2/c1-15-6-7-20(24-28-27-16(2)30-24)13-22(15)18-8-10-19(11-9-18)23(29)26-21-5-3-4-17(12-21)14-25/h3-13H,1-2H3,(H,26,29)",Cc1oc(nn1)c2ccc(C)c(c2)c3ccc(cc3)C(=O)Nc4cccc(c4)C#N,CHEMBL270164,"InChI=1S/C24H18N4O2/c1-15-6-7-20(24-28-27-16(2)30-24)13-22(15)18-8-10-19(11-9-18)23(29)26-21-5-3-4-17(12-21)14-25/h3-13H,1-2H3,(H,26,29)",Cc1oc(nn1)c2ccc(C)c(c2)c3ccc(cc3)C(=O)Nc4cccc(c4)C#N,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,19.8722,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349857,CHEMBL237571,"InChI=1S/C28H25N3O3S/c1-18-15-24(35(4,32)33)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(34-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)(=O)C)n3C)c5ccncc5,CHEMBL237571,"InChI=1S/C28H25N3O3S/c1-18-15-24(35(4,32)33)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(34-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)(=O)C)n3C)c5ccncc5,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,7.9112,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349858,CHEMBL266707,"InChI=1S/C16H12FN3S/c17-13-3-1-12(2-4-13)15-14(11-5-7-18-8-6-11)19-16-20(15)9-10-21-16/h1-8H,9-10H2",Fc1ccc(cc1)c2c(nc3SCCn23)c4ccncc4,CHEMBL266707,"InChI=1S/C16H12FN3S/c17-13-3-1-12(2-4-13)15-14(11-5-7-18-8-6-11)19-16-20(15)9-10-21-16/h1-8H,9-10H2",Fc1ccc(cc1)c2c(nc3SCCn23)c4ccncc4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,1.4068,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349861,CHEMBL1896047,"InChI=1S/C23H22F4N6/c1-32(2)13-3-11-28-22-29-12-10-18(30-22)20-19-9-6-16(23(25,26)27)14-33(19)31-21(20)15-4-7-17(24)8-5-15/h4-10,12,14H,3,11,13H2,1-2H3,(H,28,29,30)",CN(C)CCCNc1nccc(n1)c2c(nn3cc(ccc23)C(F)(F)F)c4ccc(F)cc4,CHEMBL1896047,"InChI=1S/C23H22F4N6/c1-32(2)13-3-11-28-22-29-12-10-18(30-22)20-19-9-6-16(23(25,26)27)14-33(19)31-21(20)15-4-7-17(24)8-5-15/h4-10,12,14H,3,11,13H2,1-2H3,(H,28,29,30)",CN(C)CCCNc1nccc(n1)c2c(nn3cc(ccc23)C(F)(F)F)c4ccc(F)cc4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,22.2969,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349863,CHEMBL39300,"InChI=1S/C19H20F2N6O/c1-2-27-8-6-11(7-9-27)19(28)22-17-13-10-15(23-25-18(13)26-24-17)12-4-3-5-14(20)16(12)21/h3-5,10-11H,2,6-9H2,1H3,(H2,22,24,25,26,28)",CCN1CCC(CC1)C(=O)Nc2n[nH]c3nnc(cc23)c4cccc(F)c4F,CHEMBL39300,"InChI=1S/C19H20F2N6O/c1-2-27-8-6-11(7-9-27)19(28)22-17-13-10-15(23-25-18(13)26-24-17)12-4-3-5-14(20)16(12)21/h3-5,10-11H,2,6-9H2,1H3,(H2,22,24,25,26,28)",CCN1CCC(CC1)C(=O)Nc2n[nH]c3nnc(cc23)c4cccc(F)c4F,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,9.9597,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349865,CHEMBL517507,"InChI=1S/C23H26N2O2/c1-15-5-8-19(23(27)25-20-3-2-4-20)13-21(15)17-9-11-18(12-10-17)22(26)24-14-16-6-7-16/h5,8-13,16,20H,2-4,6-7,14H2,1H3,(H,24,26)(H,25,27)",Cc1ccc(cc1c2ccc(cc2)C(=O)NCC3CC3)C(=O)NC4CCC4,CHEMBL517507,"InChI=1S/C23H26N2O2/c1-15-5-8-19(23(27)25-20-3-2-4-20)13-21(15)17-9-11-18(12-10-17)22(26)24-14-16-6-7-16/h5,8-13,16,20H,2-4,6-7,14H2,1H3,(H,24,26)(H,25,27)",Cc1ccc(cc1c2ccc(cc2)C(=O)NCC3CC3)C(=O)NC4CCC4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,11.1749,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349871,CHEMBL15202,"InChI=1S/C22H19N3O2/c1-26-19-11-12-21-20(13-19)22(24-15-23-21)25-17-7-9-18(10-8-17)27-14-16-5-3-2-4-6-16/h2-13,15H,14H2,1H3,(H,23,24,25)",COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1,CHEMBL15202,"InChI=1S/C22H19N3O2/c1-26-19-11-12-21-20(13-19)22(24-15-23-21)25-17-7-9-18(10-8-17)27-14-16-5-3-2-4-6-16/h2-13,15H,14H2,1H3,(H,23,24,25)",COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,28.0702,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349874,CHEMBL1851668,"InChI=1S/C20H12Br2N2O2/c21-16-7-11(8-17(22)19(16)25)6-15-14-9-12(13-2-1-5-23-10-13)3-4-18(14)24-20(15)26/h1-10,25H,(H,24,26)",Oc1c(Br)cc(C=C2C(=O)Nc3ccc(cc23)c4cccnc4)cc1Br,CHEMBL1851668,"InChI=1S/C20H12Br2N2O2/c21-16-7-11(8-17(22)19(16)25)6-15-14-9-12(13-2-1-5-23-10-13)3-4-18(14)24-20(15)26/h1-10,25H,(H,24,26)",Oc1c(Br)cc(C=C2C(=O)Nc3ccc(cc23)c4cccnc4)cc1Br,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,12.5385,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349876,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,25.0176,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349877,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL247228,"InChI=1S/C20H13F4N5O2/c21-14-6-3-11(20(22,23)24)7-15(14)29-19(30)28-12-4-1-10(2-5-12)13-8-31-18-16(13)17(25)26-9-27-18/h1-9H,(H2,25,26,27)(H2,28,29,30)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)c12,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,15.785,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349884,CHEMBL373073,"InChI=1S/C13H11N3O2/c1-17-9-4-2-8(3-5-9)11-6-10-12(14)15-7-16-13(10)18-11/h2-7H,1H3,(H2,14,15,16)",COc1ccc(cc1)c2oc3ncnc(N)c3c2,CHEMBL373073,"InChI=1S/C13H11N3O2/c1-17-9-4-2-8(3-5-9)11-6-10-12(14)15-7-16-13(10)18-11/h2-7H,1H3,(H2,14,15,16)",COc1ccc(cc1)c2oc3ncnc(N)c3c2,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,7.0509,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349885,CHEMBL95207,"InChI=1S/C19H21FN6/c1-25-10-7-15(8-11-25)26-12-23-17(13-2-4-14(20)5-3-13)18(26)16-6-9-22-19(21)24-16/h2-6,9,12,15H,7-8,10-11H2,1H3,(H2,21,22,24)",CN1CCC(CC1)n2cnc(c3ccc(F)cc3)c2c4ccnc(N)n4,CHEMBL95207,"InChI=1S/C19H21FN6/c1-25-10-7-15(8-11-25)26-12-23-17(13-2-4-14(20)5-3-13)18(26)16-6-9-22-19(21)24-16/h2-6,9,12,15H,7-8,10-11H2,1H3,(H2,21,22,24)",CN1CCC(CC1)n2cnc(c3ccc(F)cc3)c2c4ccnc(N)n4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,31.4952,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349886,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,19.8722,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349887,CHEMBL208437,"InChI=1S/C24H20N6O/c1-2-9-26-22(3-1)24-21(16-28-29-24)19-8-10-27-23(15-19)18-4-6-20(7-5-18)31-14-13-30-12-11-25-17-30/h1-12,15-17H,13-14H2,(H,28,29)",C(Cn1ccnc1)Oc2ccc(cc2)c3cc(ccn3)c4c[nH]nc4c5ccccn5,CHEMBL208437,"InChI=1S/C24H20N6O/c1-2-9-26-22(3-1)24-21(16-28-29-24)19-8-10-27-23(15-19)18-4-6-20(7-5-18)31-14-13-30-12-11-25-17-30/h1-12,15-17H,13-14H2,(H,28,29)",C(Cn1ccnc1)Oc2ccc(cc2)c3cc(ccn3)c4c[nH]nc4c5ccccn5,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,31.4952,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349889,CHEMBL185939,"InChI=1S/C25H17F3N6O2/c26-25(27,28)16-5-3-15(4-6-16)23-22(19-2-1-10-30-34(19)33-23)18-9-11-29-24(32-18)31-17-7-8-20-21(14-17)36-13-12-35-20/h1-11,14H,12-13H2,(H,29,31,32)",FC(F)(F)c1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccc6OCCOc6c5)n4,CHEMBL185939,"InChI=1S/C25H17F3N6O2/c26-25(27,28)16-5-3-15(4-6-16)23-22(19-2-1-10-30-34(19)33-23)18-9-11-29-24(32-18)31-17-7-8-20-21(14-17)36-13-12-35-20/h1-11,14H,12-13H2,(H,29,31,32)",FC(F)(F)c1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccc6OCCOc6c5)n4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,15.785,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349890,CHEMBL1789961,"InChI=1S/C19H16N6O2/c1-27-17-9-13(7-8-16(17)26)10-22-24-18-15-11-23-25(19(15)21-12-20-18)14-5-3-2-4-6-14/h2-12,26H,1H3,(H,20,21,24)",COc1cc(C=NNc2ncnc3c2cnn3c4ccccc4)ccc1O,CHEMBL1789961,"InChI=1S/C19H16N6O2/c1-27-17-9-13(7-8-16(17)26)10-22-24-18-15-11-23-25(19(15)21-12-20-18)14-5-3-2-4-6-14/h2-12,26H,1H3,(H,20,21,24)",COc1cc(C=NNc2ncnc3c2cnn3c4ccccc4)ccc1O,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,15.785,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349891,CHEMBL1852436,"InChI=1S/C28H27N3O3/c1-31(2)15-16-33-23-7-3-19(4-8-23)27-18-25(28(34-27)20-11-13-29-14-12-20)22-5-9-24-21(17-22)6-10-26(24)30-32/h3-5,7-9,11-14,17-18,32H,6,10,15-16H2,1-2H3",CN(C)CCOc1ccc(cc1)c2oc(c3ccncc3)c(c2)c4ccc5C(=NO)CCc5c4,CHEMBL1852436,"InChI=1S/C28H27N3O3/c1-31(2)15-16-33-23-7-3-19(4-8-23)27-18-25(28(34-27)20-11-13-29-14-12-20)22-5-9-24-21(17-22)6-10-26(24)30-32/h3-5,7-9,11-14,17-18,32H,6,10,15-16H2,1-2H3",CN(C)CCOc1ccc(cc1)c2oc(c3ccncc3)c(c2)c4ccc5C(=NO)CCc5c4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,25.0176,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349892,CHEMBL1880739,"InChI=1S/C15H8Br2INO2/c16-11-4-7(5-12(17)14(11)20)3-10-9-6-8(18)1-2-13(9)19-15(10)21/h1-6,20H,(H,19,21)",Oc1c(Br)cc(C=C2C(=O)Nc3ccc(I)cc23)cc1Br,CHEMBL1880739,"InChI=1S/C15H8Br2INO2/c16-11-4-7(5-12(17)14(11)20)3-10-9-6-8(18)1-2-13(9)19-15(10)21/h1-6,20H,(H,19,21)",Oc1c(Br)cc(C=C2C(=O)Nc3ccc(I)cc23)cc1Br,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.0028,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349893,CHEMBL365072,"InChI=1S/C12H14N6O/c1-3-7-9-8(5-6-14-7)18(4-2)12(15-9)10-11(13)17-19-16-10/h5-6H,3-4H2,1-2H3,(H2,13,17)",CCc1nccc2c1nc(c3nonc3N)n2CC,CHEMBL365072,"InChI=1S/C12H14N6O/c1-3-7-9-8(5-6-14-7)18(4-2)12(15-9)10-11(13)17-19-16-10/h5-6H,3-4H2,1-2H3,(H2,13,17)",CCc1nccc2c1nc(c3nonc3N)n2CC,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,25.0176,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349894,CHEMBL188048,"InChI=1S/C9H8N6O/c1-15-6-2-3-11-4-5(6)12-9(15)7-8(10)14-16-13-7/h2-4H,1H3,(H2,10,14)",Cn1c(nc2cnccc12)c3nonc3N,CHEMBL188048,"InChI=1S/C9H8N6O/c1-15-6-2-3-11-4-5(6)12-9(15)7-8(10)14-16-13-7/h2-4H,1H3,(H2,10,14)",Cn1c(nc2cnccc12)c3nonc3N,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,15.785,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349896,CHEMBL427159,"InChI=1S/C23H16F2N6O/c1-32-16-7-4-14(5-8-16)22-21(20-3-2-11-27-31(20)30-22)19-10-12-26-23(29-19)28-15-6-9-17(24)18(25)13-15/h2-13H,1H3,(H,26,28,29)",COc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccc(F)c(F)c5)n4,CHEMBL427159,"InChI=1S/C23H16F2N6O/c1-32-16-7-4-14(5-8-16)22-21(20-3-2-11-27-31(20)30-22)19-10-12-26-23(29-19)28-15-6-9-17(24)18(25)13-15/h2-13H,1H3,(H,26,28,29)",COc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccc(F)c(F)c5)n4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,25.0176,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349897,CHEMBL365248,"InChI=1S/C18H13F3N6O2/c1-28-16-6-5-15-13(10-23-27(15)26-16)14-7-8-22-17(25-14)24-11-3-2-4-12(9-11)29-18(19,20)21/h2-10H,1H3,(H,22,24,25)",COc1ccc2c(cnn2n1)c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3,CHEMBL365248,"InChI=1S/C18H13F3N6O2/c1-28-16-6-5-15-13(10-23-27(15)26-16)14-7-8-22-17(25-14)24-11-3-2-4-12(9-11)29-18(19,20)21/h2-10H,1H3,(H,22,24,25)",COc1ccc2c(cnn2n1)c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,1.9872,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349898,CHEMBL188426,"InChI=1S/C20H17F3N6O2/c1-3-31-18-5-4-17-15(11-25-29(17)28-18)16-6-7-24-19(27-16)26-13-8-12(20(21,22)23)9-14(10-13)30-2/h4-11H,3H2,1-2H3,(H,24,26,27)",CCOc1ccc2c(cnn2n1)c3ccnc(Nc4cc(OC)cc(c4)C(F)(F)F)n3,CHEMBL188426,"InChI=1S/C20H17F3N6O2/c1-3-31-18-5-4-17-15(11-25-29(17)28-18)16-6-7-24-19(27-16)26-13-8-12(20(21,22)23)9-14(10-13)30-2/h4-11H,3H2,1-2H3,(H,24,26,27)",CCOc1ccc2c(cnn2n1)c3ccnc(Nc4cc(OC)cc(c4)C(F)(F)F)n3,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,12.5385,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349899,CHEMBL513330,"InChI=1S/C17H13ClN6/c18-13-5-3-12(4-6-13)10-20-17-19-9-7-15(23-17)14-11-22-24-16(14)2-1-8-21-24/h1-9,11H,10H2,(H,19,20,23)",Clc1ccc(CNc2nccc(n2)c3cnn4ncccc34)cc1,CHEMBL513330,"InChI=1S/C17H13ClN6/c18-13-5-3-12(4-6-13)10-20-17-19-9-7-15(23-17)14-11-22-24-16(14)2-1-8-21-24/h1-9,11H,10H2,(H,19,20,23)",Clc1ccc(CNc2nccc(n2)c3cnn4ncccc34)cc1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,1.9872,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349900,CHEMBL477979,"InChI=1S/C22H26N2O2/c1-14(2)24-22(26)19-7-4-15(3)20(12-19)17-8-10-18(11-9-17)21(25)23-13-16-5-6-16/h4,7-12,14,16H,5-6,13H2,1-3H3,(H,23,25)(H,24,26)",CC(C)NC(=O)c1ccc(C)c(c1)c2ccc(cc2)C(=O)NCC3CC3,CHEMBL477979,"InChI=1S/C22H26N2O2/c1-14(2)24-22(26)19-7-4-15(3)20(12-19)17-8-10-18(11-9-17)21(25)23-13-16-5-6-16/h4,7-12,14,16H,5-6,13H2,1-3H3,(H,23,25)(H,24,26)",CC(C)NC(=O)c1ccc(C)c(c1)c2ccc(cc2)C(=O)NCC3CC3,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,15.785,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349901,CHEMBL318892,"InChI=1S/C25H25FN6/c1-31-15-12-21(13-16-31)32-17-28-23(18-7-9-19(26)10-8-18)24(32)22-11-14-27-25(30-22)29-20-5-3-2-4-6-20/h2-11,14,17,21H,12-13,15-16H2,1H3,(H,27,29,30)",CN1CCC(CC1)n2cnc(c3ccc(F)cc3)c2c4ccnc(Nc5ccccc5)n4,CHEMBL318892,"InChI=1S/C25H25FN6/c1-31-15-12-21(13-16-31)32-17-28-23(18-7-9-19(26)10-8-18)24(32)22-11-14-27-25(30-22)29-20-5-3-2-4-6-20/h2-11,14,17,21H,12-13,15-16H2,1H3,(H,27,29,30)",CN1CCC(CC1)n2cnc(c3ccc(F)cc3)c2c4ccnc(Nc5ccccc5)n4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,15.785,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349905,CHEMBL269985,"InChI=1S/C25H23N3O3/c1-16-4-7-21(25-28-27-17(2)31-25)14-23(16)19-8-10-20(11-9-19)24(29)26-15-18-5-12-22(30-3)13-6-18/h4-14H,15H2,1-3H3,(H,26,29)",COc1ccc(CNC(=O)c2ccc(cc2)c3cc(ccc3C)c4oc(C)nn4)cc1,CHEMBL269985,"InChI=1S/C25H23N3O3/c1-16-4-7-21(25-28-27-17(2)31-25)14-23(16)19-8-10-20(11-9-19)24(29)26-15-18-5-12-22(30-3)13-6-18/h4-14H,15H2,1-3H3,(H,26,29)",COc1ccc(CNC(=O)c2ccc(cc2)c3cc(ccc3C)c4oc(C)nn4)cc1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,12.5385,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349907,CHEMBL234838,"InChI=1S/C16H13FN2OS/c17-13-7-3-1-6-11(13)15(20)19-16-12(9-18)10-5-2-4-8-14(10)21-16/h1,3,6-7H,2,4-5,8H2,(H,19,20)",Fc1ccccc1C(=O)Nc2sc3CCCCc3c2C#N,CHEMBL234838,"InChI=1S/C16H13FN2OS/c17-13-7-3-1-6-11(13)15(20)19-16-12(9-18)10-5-2-4-8-14(10)21-16/h1,3,6-7H,2,4-5,8H2,(H,19,20)",Fc1ccccc1C(=O)Nc2sc3CCCCc3c2C#N,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,1.5785,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349908,CHEMBL1794052,"InChI=1S/C17H11Br2NO4/c1-24-17(23)9-2-3-14-10(7-9)11(16(22)20-14)4-8-5-12(18)15(21)13(19)6-8/h2-7,21H,1H3,(H,20,22)",COC(=O)c1ccc2NC(=O)C(=Cc3cc(Br)c(O)c(Br)c3)c2c1,CHEMBL1794052,"InChI=1S/C17H11Br2NO4/c1-24-17(23)9-2-3-14-10(7-9)11(16(22)20-14)4-8-5-12(18)15(21)13(19)6-8/h2-7,21H,1H3,(H,20,22)",COC(=O)c1ccc2NC(=O)C(=Cc3cc(Br)c(O)c(Br)c3)c2c1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,14.0684,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349910,CHEMBL220465,"InChI=1S/C25H24N8O3/c1-4-33-20-13-21(27-14-19(20)29-24(33)22-23(26)31-36-30-22)35-18-7-5-6-16(12-18)28-25(34)15-8-10-17(11-9-15)32(2)3/h5-14H,4H2,1-3H3,(H2,26,31)(H,28,34)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(cc4)N(C)C)c3)cc12)c5nonc5N,CHEMBL220465,"InChI=1S/C25H24N8O3/c1-4-33-20-13-21(27-14-19(20)29-24(33)22-23(26)31-36-30-22)35-18-7-5-6-16(12-18)28-25(34)15-8-10-17(11-9-15)32(2)3/h5-14H,4H2,1-3H3,(H2,26,31)(H,28,34)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(cc4)N(C)C)c3)cc12)c5nonc5N,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.0705,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349911,CHEMBL207247,"InChI=1S/C28H22ClFN4O2/c1-19(35)32-15-21-5-2-4-20(12-21)8-9-23-16-31-18-33-28(23)34-25-10-11-27(26(29)14-25)36-17-22-6-3-7-24(30)13-22/h2-7,10-14,16,18H,15,17H2,1H3,(H,32,35)(H,31,33,34)",CC(=O)NCc1cccc(c1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL207247,"InChI=1S/C28H22ClFN4O2/c1-19(35)32-15-21-5-2-4-20(12-21)8-9-23-16-31-18-33-28(23)34-25-10-11-27(26(29)14-25)36-17-22-6-3-7-24(30)13-22/h2-7,10-14,16,18H,15,17H2,1H3,(H,32,35)(H,31,33,34)",CC(=O)NCc1cccc(c1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,31.4952,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349912,CHEMBL330422,"InChI=1S/C21H25FN6O/c1-27-11-7-17(8-12-27)28-14-25-19(15-2-4-16(22)5-3-15)20(28)18-6-9-23-21(26-18)24-10-13-29/h2-6,9,14,17,29H,7-8,10-13H2,1H3,(H,23,24,26)",CN1CCC(CC1)n2cnc(c3ccc(F)cc3)c2c4ccnc(NCCO)n4,CHEMBL330422,"InChI=1S/C21H25FN6O/c1-27-11-7-17(8-12-27)28-14-25-19(15-2-4-16(22)5-3-15)20(28)18-6-9-23-21(26-18)24-10-13-29/h2-6,9,14,17,29H,7-8,10-13H2,1H3,(H,23,24,26)",CN1CCC(CC1)n2cnc(c3ccc(F)cc3)c2c4ccnc(NCCO)n4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.4449,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349913,CHEMBL32464,"InChI=1S/C22H17N5/c1-2-6-15(7-3-1)12-21-26-19-11-10-16(13-20(19)27-21)25-22-17-8-4-5-9-18(17)23-14-24-22/h1-11,13-14H,12H2,(H,26,27)(H,23,24,25)",C(c1ccccc1)c2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2,CHEMBL32464,"InChI=1S/C22H17N5/c1-2-6-15(7-3-1)12-21-26-19-11-10-16(13-20(19)27-21)25-22-17-8-4-5-9-18(17)23-14-24-22/h1-11,13-14H,12H2,(H,26,27)(H,23,24,25)",C(c1ccccc1)c2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,25.0176,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349914,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL237570,"InChI=1S/C28H25N3O2S/c1-18-15-24(34(4)32)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(33-3)8-7-20(21)16-22/h5-17H,1-4H3",COc1ccc2cc(ccc2c1)c3c(nc(c4ccc(cc4C)S(=O)C)n3C)c5ccncc5,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.3965,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349916,CHEMBL189415,"InChI=1S/C23H15F3N6/c24-23(25,26)16-7-4-8-17(13-16)29-22-27-12-11-20(30-22)18-14-28-32-21(18)10-9-19(31-32)15-5-2-1-3-6-15/h1-14H,(H,27,29,30)",FC(F)(F)c1cccc(Nc2nccc(n2)c3cnn4nc(ccc34)c5ccccc5)c1,CHEMBL189415,"InChI=1S/C23H15F3N6/c24-23(25,26)16-7-4-8-17(13-16)29-22-27-12-11-20(30-22)18-14-28-32-21(18)10-9-19(31-32)15-5-2-1-3-6-15/h1-14H,(H,27,29,30)",FC(F)(F)c1cccc(Nc2nccc(n2)c3cnn4nc(ccc34)c5ccccc5)c1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,19.8722,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349917,CHEMBL473436,"InChI=1S/C23H16ClFN4OS/c24-17-10-16(6-7-20(17)30-12-14-3-1-4-15(25)9-14)29-23-22-19(27-13-28-23)11-21(31-22)18-5-2-8-26-18/h1-11,13,26H,12H2,(H,27,28,29)",Fc1cccc(COc2ccc(Nc3ncnc4cc(sc34)c5ccc[nH]5)cc2Cl)c1,CHEMBL473436,"InChI=1S/C23H16ClFN4OS/c24-17-10-16(6-7-20(17)30-12-14-3-1-4-15(25)9-14)29-23-22-19(27-13-28-23)11-21(31-22)18-5-2-8-26-18/h1-11,13,26H,12H2,(H,27,28,29)",Fc1cccc(COc2ccc(Nc3ncnc4cc(sc34)c5ccc[nH]5)cc2Cl)c1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,5.6007,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349920,CHEMBL480382,"InChI=1S/C19H17N3O4S2/c1-24-14-6-12-13(7-15(14)25-2)22(10-21-12)17-8-16(18(28-17)19(20)23)26-9-11-4-3-5-27-11/h3-8,10H,9H2,1-2H3,(H2,20,23)",COc1cc2ncn(c3cc(OCc4cccs4)c(s3)C(=O)N)c2cc1OC,CHEMBL480382,"InChI=1S/C19H17N3O4S2/c1-24-14-6-12-13(7-15(14)25-2)22(10-21-12)17-8-16(18(28-17)19(20)23)26-9-11-4-3-5-27-11/h3-8,10H,9H2,1-2H3,(H2,20,23)",COc1cc2ncn(c3cc(OCc4cccs4)c(s3)C(=O)N)c2cc1OC,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,1.9872,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349921,CHEMBL374453,"InChI=1S/C20H16Cl2N4O2/c1-10-19(20(28)25-13-3-5-17-12(6-13)9-23-26-17)14(8-18(27)24-10)11-2-4-15(21)16(22)7-11/h2-7,9,14H,8H2,1H3,(H,23,26)(H,24,27)(H,25,28)",CC1=C(C(CC(=O)N1)c2ccc(Cl)c(Cl)c2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL374453,"InChI=1S/C20H16Cl2N4O2/c1-10-19(20(28)25-13-3-5-17-12(6-13)9-23-26-17)14(8-18(27)24-10)11-2-4-15(21)16(22)7-11/h2-7,9,14H,8H2,1H3,(H,23,26)(H,24,27)(H,25,28)",CC1=C(C(CC(=O)N1)c2ccc(Cl)c(Cl)c2)C(=O)Nc3ccc4[nH]ncc4c3,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,12.5385,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349924,CHEMBL360561,"InChI=1S/C17H16N2O3/c1-20-14-9-8-13(10-15(14)21-2)19-17-18-11-16(22-17)12-6-4-3-5-7-12/h3-11H,1-2H3,(H,18,19)",COc1ccc(Nc2oc(cn2)c3ccccc3)cc1OC,CHEMBL360561,"InChI=1S/C17H16N2O3/c1-20-14-9-8-13(10-15(14)21-2)19-17-18-11-16(22-17)12-6-4-3-5-7-12/h3-11H,1-2H3,(H,18,19)",COc1ccc(Nc2oc(cn2)c3ccccc3)cc1OC,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,22.2969,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349926,CHEMBL187985,"InChI=1S/C14H17N7O/c1-2-21-9-5-6-16-13(20-7-3-4-8-20)10(9)17-14(21)11-12(15)19-22-18-11/h5-6H,2-4,7-8H2,1H3,(H2,15,19)",CCn1c(nc2c(nccc12)N3CCCC3)c4nonc4N,CHEMBL187985,"InChI=1S/C14H17N7O/c1-2-21-9-5-6-16-13(20-7-3-4-8-20)10(9)17-14(21)11-12(15)19-22-18-11/h5-6H,2-4,7-8H2,1H3,(H2,15,19)",CCn1c(nc2c(nccc12)N3CCCC3)c4nonc4N,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,19.8722,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349927,CHEMBL379093,"InChI=1S/C25H17ClFN3O/c26-23-14-22(11-12-24(23)31-16-19-7-4-8-21(27)13-19)30-25-20(15-28-17-29-25)10-9-18-5-2-1-3-6-18/h1-8,11-15,17H,16H2,(H,28,29,30)",Fc1cccc(COc2ccc(Nc3ncncc3C#Cc4ccccc4)cc2Cl)c1,CHEMBL379093,"InChI=1S/C25H17ClFN3O/c26-23-14-22(11-12-24(23)31-16-19-7-4-8-21(27)13-19)30-25-20(15-28-17-29-25)10-9-18-5-2-1-3-6-18/h1-8,11-15,17H,16H2,(H,28,29,30)",Fc1cccc(COc2ccc(Nc3ncncc3C#Cc4ccccc4)cc2Cl)c1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.0141,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349929,CHEMBL101747,"InChI=1S/C19H22BrN5OS/c1-2-25-7-5-12(6-8-25)10-16(26)21-18-13-11-14(20)17(15-4-3-9-27-15)22-19(13)24-23-18/h3-4,9,11-12H,2,5-8,10H2,1H3,(H2,21,22,23,24,26)",CCN1CCC(CC(=O)Nc2n[nH]c3nc(c(Br)cc23)c4cccs4)CC1,CHEMBL101747,"InChI=1S/C19H22BrN5OS/c1-2-25-7-5-12(6-8-25)10-16(26)21-18-13-11-14(20)17(15-4-3-9-27-15)22-19(13)24-23-18/h3-4,9,11-12H,2,5-8,10H2,1H3,(H2,21,22,23,24,26)",CCN1CCC(CC(=O)Nc2n[nH]c3nc(c(Br)cc23)c4cccs4)CC1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,35.3383,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349930,CHEMBL183993,"InChI=1S/C19H15F3N6O/c1-2-29-17-7-6-16-14(11-24-28(16)27-17)15-8-9-23-18(26-15)25-13-5-3-4-12(10-13)19(20,21)22/h3-11H,2H2,1H3,(H,23,25,26)",CCOc1ccc2c(cnn2n1)c3ccnc(Nc4cccc(c4)C(F)(F)F)n3,CHEMBL183993,"InChI=1S/C19H15F3N6O/c1-2-29-17-7-6-16-14(11-24-28(16)27-17)15-8-9-23-18(26-15)25-13-5-3-4-12(10-13)19(20,21)22/h3-11H,2H2,1H3,(H,23,25,26)",CCOc1ccc2c(cnn2n1)c3ccnc(Nc4cccc(c4)C(F)(F)F)n3,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,31.4952,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349931,CHEMBL243908,"InChI=1S/C22H18BrN5O4/c1-31-22(30)28-20-26-18-10-9-17(12-19(18)27-20)32-16-7-5-14(6-8-16)24-21(29)25-15-4-2-3-13(23)11-15/h2-12H,1H3,(H2,24,25,29)(H2,26,27,28,30)",COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1,CHEMBL243908,"InChI=1S/C22H18BrN5O4/c1-31-22(30)28-20-26-18-10-9-17(12-19(18)27-20)32-16-7-5-14(6-8-16)24-21(29)25-15-4-2-3-13(23)11-15/h2-12H,1H3,(H2,24,25,29)(H2,26,27,28,30)",COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,17.7111,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349934,CHEMBL395358,"InChI=1S/C21H17N3O/c1-14-5-7-16(25)13-20(14)24-19-9-11-23-21-12-15(6-8-17(19)21)18-4-2-3-10-22-18/h2-13,25H,1H3,(H,23,24)",Cc1ccc(O)cc1Nc2ccnc3cc(ccc23)c4ccccn4,CHEMBL395358,"InChI=1S/C21H17N3O/c1-14-5-7-16(25)13-20(14)24-19-9-11-23-21-12-15(6-8-17(19)21)18-4-2-3-10-22-18/h2-13,25H,1H3,(H,23,24)",Cc1ccc(O)cc1Nc2ccnc3cc(ccc23)c4ccccn4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,25.0176,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349935,CHEMBL188240,"InChI=1S/C12H14N6O2/c1-3-18-7-5-6-14-12(19-4-2)8(7)15-11(18)9-10(13)17-20-16-9/h5-6H,3-4H2,1-2H3,(H2,13,17)",CCOc1nccc2c1nc(c3nonc3N)n2CC,CHEMBL188240,"InChI=1S/C12H14N6O2/c1-3-18-7-5-6-14-12(19-4-2)8(7)15-11(18)9-10(13)17-20-16-9/h5-6H,3-4H2,1-2H3,(H2,13,17)",CCOc1nccc2c1nc(c3nonc3N)n2CC,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,4.9917,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349936,CHEMBL101804,"InChI=1S/C14H12N4O2/c19-14(8-3-4-8)16-13-9-5-6-10(11-2-1-7-20-11)15-12(9)17-18-13/h1-2,5-8H,3-4H2,(H2,15,16,17,18,19)",O=C(Nc1n[nH]c2nc(ccc12)c3occc3)C4CC4,CHEMBL101804,"InChI=1S/C14H12N4O2/c19-14(8-3-4-8)16-13-9-5-6-10(11-2-1-7-20-11)15-12(9)17-18-13/h1-2,5-8H,3-4H2,(H2,15,16,17,18,19)",O=C(Nc1n[nH]c2nc(ccc12)c3occc3)C4CC4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.0791,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349937,CHEMBL495902,"InChI=1S/C18H17N3O/c1-11-2-3-13(18(22)20-15-5-6-15)9-16(11)12-4-7-17-14(8-12)10-19-21-17/h2-4,7-10,15H,5-6H2,1H3,(H,19,21)(H,20,22)",Cc1ccc(cc1c2ccc3[nH]ncc3c2)C(=O)NC4CC4,CHEMBL495902,"InChI=1S/C18H17N3O/c1-11-2-3-13(18(22)20-15-5-6-15)9-16(11)12-4-7-17-14(8-12)10-19-21-17/h2-4,7-10,15H,5-6H2,1H3,(H,19,21)(H,20,22)",Cc1ccc(cc1c2ccc3[nH]ncc3c2)C(=O)NC4CC4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,8.8766,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349939,CHEMBL359999,"InChI=1S/C18H16N6O2/c1-25-13-8-12(9-14(10-13)26-2)22-18-19-7-5-16(23-18)15-11-21-24-17(15)4-3-6-20-24/h3-11H,1-2H3,(H,19,22,23)",COc1cc(Nc2nccc(n2)c3cnn4ncccc34)cc(OC)c1,CHEMBL359999,"InChI=1S/C18H16N6O2/c1-25-13-8-12(9-14(10-13)26-2)22-18-19-7-5-16(23-18)15-11-21-24-17(15)4-3-6-20-24/h3-11H,1-2H3,(H,19,22,23)",COc1cc(Nc2nccc(n2)c3cnn4ncccc34)cc(OC)c1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,2.5018,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349940,CHEMBL206544,"InChI=1S/C22H20N4/c1-15(2)16-6-8-17(9-7-16)21-13-18(10-12-24-21)19-14-25-26-22(19)20-5-3-4-11-23-20/h3-15H,1-2H3,(H,25,26)",CC(C)c1ccc(cc1)c2cc(ccn2)c3c[nH]nc3c4ccccn4,CHEMBL206544,"InChI=1S/C22H20N4/c1-15(2)16-6-8-17(9-7-16)21-13-18(10-12-24-21)19-14-25-26-22(19)20-5-3-4-11-23-20/h3-15H,1-2H3,(H,25,26)",CC(C)c1ccc(cc1)c2cc(ccn2)c3c[nH]nc3c4ccccn4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,3.1495,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349942,CHEMBL202891,"InChI=1S/C20H16N4O/c1-25-16-7-5-14(6-8-16)19-12-15(9-11-22-19)17-13-23-24-20(17)18-4-2-3-10-21-18/h2-13H,1H3,(H,23,24)",COc1ccc(cc1)c2cc(ccn2)c3c[nH]nc3c4ccccn4,CHEMBL202891,"InChI=1S/C20H16N4O/c1-25-16-7-5-14(6-8-16)19-12-15(9-11-22-19)17-13-23-24-20(17)18-4-2-3-10-21-18/h2-13H,1H3,(H,23,24)",COc1ccc(cc1)c2cc(ccn2)c3c[nH]nc3c4ccccn4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,4.4488,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349943,CHEMBL181361,"InChI=1S/C16H11N5S/c17-16-21-14(12-4-1-2-8-19-12)15(22-16)13-7-6-10-11(20-13)5-3-9-18-10/h1-9H,(H2,17,21)",Nc1nc(c2ccccn2)c(s1)c3ccc4ncccc4n3,CHEMBL181361,"InChI=1S/C16H11N5S/c17-16-21-14(12-4-1-2-8-19-12)15(22-16)13-7-6-10-11(20-13)5-3-9-18-10/h1-9H,(H2,17,21)",Nc1nc(c2ccccn2)c(s1)c3ccc4ncccc4n3,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,14.0684,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349945,CHEMBL476351,"InChI=1S/C28H30N4O3/c1-19-2-9-24(31-28(34)23-10-11-29-26(16-23)32-12-14-35-15-13-32)17-25(19)21-5-7-22(8-6-21)27(33)30-18-20-3-4-20/h2,5-11,16-17,20H,3-4,12-15,18H2,1H3,(H,30,33)(H,31,34)",Cc1ccc(NC(=O)c2ccnc(c2)N3CCOCC3)cc1c4ccc(cc4)C(=O)NCC5CC5,CHEMBL476351,"InChI=1S/C28H30N4O3/c1-19-2-9-24(31-28(34)23-10-11-29-26(16-23)32-12-14-35-15-13-32)17-25(19)21-5-7-22(8-6-21)27(33)30-18-20-3-4-20/h2,5-11,16-17,20H,3-4,12-15,18H2,1H3,(H,30,33)(H,31,34)",Cc1ccc(NC(=O)c2ccnc(c2)N3CCOCC3)cc1c4ccc(cc4)C(=O)NCC5CC5,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,4.4488,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349947,CHEMBL397570,"InChI=1S/C16H13FN2OS/c17-11-7-5-10(6-8-11)15(20)19-16-13(9-18)12-3-1-2-4-14(12)21-16/h5-8H,1-4H2,(H,19,20)",Fc1ccc(cc1)C(=O)Nc2sc3CCCCc3c2C#N,CHEMBL397570,"InChI=1S/C16H13FN2OS/c17-11-7-5-10(6-8-11)15(20)19-16-13(9-18)12-3-1-2-4-14(12)21-16/h5-8H,1-4H2,(H,19,20)",Fc1ccc(cc1)C(=O)Nc2sc3CCCCc3c2C#N,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.315,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349950,CHEMBL505915,"InChI=1S/C31H36FN9O3/c1-18(2)40-13-11-39(12-14-40)17-26(42)41-10-8-19-15-25(44-3)23(16-24(19)41)36-31-37-29-20(7-9-34-29)30(38-31)35-22-6-4-5-21(32)27(22)28(33)43/h4-7,9,15-16,18H,8,10-14,17H2,1-3H3,(H2,33,43)(H3,34,35,36,37,38)",COc1cc2CCN(C(=O)CN3CCN(CC3)C(C)C)c2cc1Nc4nc(Nc5cccc(F)c5C(=O)N)c6cc[nH]c6n4,CHEMBL505915,"InChI=1S/C31H36FN9O3/c1-18(2)40-13-11-39(12-14-40)17-26(42)41-10-8-19-15-25(44-3)23(16-24(19)41)36-31-37-29-20(7-9-34-29)30(38-31)35-22-6-4-5-21(32)27(22)28(33)43/h4-7,9,15-16,18H,8,10-14,17H2,1-3H3,(H2,33,43)(H3,34,35,36,37,38)",COc1cc2CCN(C(=O)CN3CCN(CC3)C(C)C)c2cc1Nc4nc(Nc5cccc(F)c5C(=O)N)c6cc[nH]c6n4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,22.2969,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349951,CHEMBL468963,"InChI=1S/C22H21F3N8/c1-31-9-11-32(12-10-31)20-5-4-15(13-17(20)22(23,24)25)29-21-26-8-6-18(30-21)16-14-28-33-19(16)3-2-7-27-33/h2-8,13-14H,9-12H2,1H3,(H,26,29,30)",CN1CCN(CC1)c2ccc(Nc3nccc(n3)c4cnn5ncccc45)cc2C(F)(F)F,CHEMBL468963,"InChI=1S/C22H21F3N8/c1-31-9-11-32(12-10-31)20-5-4-15(13-17(20)22(23,24)25)29-21-26-8-6-18(30-21)16-14-28-33-19(16)3-2-7-27-33/h2-8,13-14H,9-12H2,1H3,(H,26,29,30)",CN1CCN(CC1)c2ccc(Nc3nccc(n3)c4cnn5ncccc45)cc2C(F)(F)F,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,3.1495,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349952,CHEMBL244482,"InChI=1S/C23H16F4N4O4S/c1-34-22(33)31-21-30-17-9-7-15(11-19(17)36-21)35-14-5-3-13(4-6-14)28-20(32)29-18-10-12(23(25,26)27)2-8-16(18)24/h2-11H,1H3,(H2,28,29,32)(H,30,31,33)",COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)cc2s1,CHEMBL244482,"InChI=1S/C23H16F4N4O4S/c1-34-22(33)31-21-30-17-9-7-15(11-19(17)36-21)35-14-5-3-13(4-6-14)28-20(32)29-18-10-12(23(25,26)27)2-8-16(18)24/h2-11H,1H3,(H2,28,29,32)(H,30,31,33)",COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)cc2s1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,9.9597,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349954,CHEMBL257113,"InChI=1S/C20H19N3O2/c1-13-22-23-20(25-13)18-4-2-3-17(11-18)15-7-9-16(10-8-15)19(24)21-12-14-5-6-14/h2-4,7-11,14H,5-6,12H2,1H3,(H,21,24)",Cc1oc(nn1)c2cccc(c2)c3ccc(cc3)C(=O)NCC4CC4,CHEMBL257113,"InChI=1S/C20H19N3O2/c1-13-22-23-20(25-13)18-4-2-3-17(11-18)15-7-9-16(10-8-15)19(24)21-12-14-5-6-14/h2-4,7-11,14H,5-6,12H2,1H3,(H,21,24)",Cc1oc(nn1)c2cccc(c2)c3ccc(cc3)C(=O)NCC4CC4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,25.0176,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349955,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,3.1495,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349957,CHEMBL471789,"InChI=1S/C23H19F3N2O4S/c1-13(29)22-20(32-11-14-6-4-5-7-15(14)23(24,25)26)10-21(33-22)28-12-27-16-8-18(30-2)19(31-3)9-17(16)28/h4-10,12H,11H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)C)c2cc1OC,CHEMBL471789,"InChI=1S/C23H19F3N2O4S/c1-13(29)22-20(32-11-14-6-4-5-7-15(14)23(24,25)26)10-21(33-22)28-12-27-16-8-18(30-2)19(31-3)9-17(16)28/h4-10,12H,11H2,1-3H3",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)C)c2cc1OC,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,25.0176,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349958,CHEMBL185238,"InChI=1S/C17H13N5/c1-11-4-2-5-16(20-11)17-12(10-19-22-17)13-7-8-14-15(21-13)6-3-9-18-14/h2-10H,1H3,(H,19,22)",Cc1cccc(n1)c2n[nH]cc2c3ccc4ncccc4n3,CHEMBL185238,"InChI=1S/C17H13N5/c1-11-4-2-5-16(20-11)17-12(10-19-22-17)13-7-8-14-15(21-13)6-3-9-18-14/h2-10H,1H3,(H,19,22)",Cc1cccc(n1)c2n[nH]cc2c3ccc4ncccc4n3,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.6284,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349961,CHEMBL194911,"InChI=1S/C27H19F4N5O3/c1-38-18-9-4-15(5-10-18)23-21(22-24(32)33-13-34-25(22)39-23)14-2-7-17(8-3-14)35-26(37)36-20-12-16(27(29,30)31)6-11-19(20)28/h2-13H,1H3,(H2,32,33,34)(H2,35,36,37)",COc1ccc(cc1)c2oc3ncnc(N)c3c2c4ccc(NC(=O)Nc5cc(ccc5F)C(F)(F)F)cc4,CHEMBL194911,"InChI=1S/C27H19F4N5O3/c1-38-18-9-4-15(5-10-18)23-21(22-24(32)33-13-34-25(22)39-23)14-2-7-17(8-3-14)35-26(37)36-20-12-16(27(29,30)31)6-11-19(20)28/h2-13H,1H3,(H2,32,33,34)(H2,35,36,37)",COc1ccc(cc1)c2oc3ncnc(N)c3c2c4ccc(NC(=O)Nc5cc(ccc5F)C(F)(F)F)cc4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,11.1749,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349962,CHEMBL517171,"InChI=1S/C28H31ClFN7O3/c1-3-11-37-12-8-16(9-13-37)40-22-15-21(23(39-2)14-18(22)29)34-28-35-26-17(7-10-32-26)27(36-28)33-20-6-4-5-19(30)24(20)25(31)38/h4-7,10,14-16H,3,8-9,11-13H2,1-2H3,(H2,31,38)(H3,32,33,34,35,36)",CCCN1CCC(CC1)Oc2cc(Nc3nc(Nc4cccc(F)c4C(=O)N)c5cc[nH]c5n3)c(OC)cc2Cl,CHEMBL517171,"InChI=1S/C28H31ClFN7O3/c1-3-11-37-12-8-16(9-13-37)40-22-15-21(23(39-2)14-18(22)29)34-28-35-26-17(7-10-32-26)27(36-28)33-20-6-4-5-19(30)24(20)25(31)38/h4-7,10,14-16H,3,8-9,11-13H2,1-2H3,(H2,31,38)(H3,32,33,34,35,36)",CCCN1CCC(CC1)Oc2cc(Nc3nc(Nc4cccc(F)c4C(=O)N)c5cc[nH]c5n3)c(OC)cc2Cl,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,12.5385,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349963,CHEMBL458865,"InChI=1S/C27H31FN8O2/c1-16(2)35-10-12-36(13-11-35)18-5-7-22(23(15-18)38-3)32-27-33-25-19(8-9-30-25)26(34-27)31-21-6-4-17(28)14-20(21)24(29)37/h4-9,14-16H,10-13H2,1-3H3,(H2,29,37)(H3,30,31,32,33,34)",COc1cc(ccc1Nc2nc(Nc3ccc(F)cc3C(=O)N)c4cc[nH]c4n2)N5CCN(CC5)C(C)C,CHEMBL458865,"InChI=1S/C27H31FN8O2/c1-16(2)35-10-12-36(13-11-35)18-5-7-22(23(15-18)38-3)32-27-33-25-19(8-9-30-25)26(34-27)31-21-6-4-17(28)14-20(21)24(29)37/h4-9,14-16H,10-13H2,1-3H3,(H2,29,37)(H3,30,31,32,33,34)",COc1cc(ccc1Nc2nc(Nc3ccc(F)cc3C(=O)N)c4cc[nH]c4n2)N5CCN(CC5)C(C)C,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,25.0176,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349964,CHEMBL244289,"InChI=1S/C23H17F4N5O4/c1-35-22(34)32-20-29-17-8-6-15(11-19(17)30-20)36-14-4-2-3-13(10-14)28-21(33)31-18-9-12(23(25,26)27)5-7-16(18)24/h2-11H,1H3,(H2,28,31,33)(H2,29,30,32,34)",COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)c3)ccc2[nH]1,CHEMBL244289,"InChI=1S/C23H17F4N5O4/c1-35-22(34)32-20-29-17-8-6-15(11-19(17)30-20)36-14-4-2-3-13(10-14)28-21(33)31-18-9-12(23(25,26)27)5-7-16(18)24/h2-11H,1H3,(H2,28,31,33)(H2,29,30,32,34)",COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)c3)ccc2[nH]1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,11.1749,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349965,CHEMBL458438,"InChI=1S/C29H32N8O/c1-19(2)36-14-16-37(17-15-36)20-9-10-25(26(18-20)38-3)33-29-34-27-22(11-13-31-27)28(35-29)32-24-8-4-7-23-21(24)6-5-12-30-23/h4-13,18-19H,14-17H2,1-3H3,(H3,31,32,33,34,35)",COc1cc(ccc1Nc2nc(Nc3cccc4ncccc34)c5cc[nH]c5n2)N6CCN(CC6)C(C)C,CHEMBL458438,"InChI=1S/C29H32N8O/c1-19(2)36-14-16-37(17-15-36)20-9-10-25(26(18-20)38-3)33-29-34-27-22(11-13-31-27)28(35-29)32-24-8-4-7-23-21(24)6-5-12-30-23/h4-13,18-19H,14-17H2,1-3H3,(H3,31,32,33,34,35)",COc1cc(ccc1Nc2nc(Nc3cccc4ncccc34)c5cc[nH]c5n2)N6CCN(CC6)C(C)C,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,19.8722,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349969,CHEMBL1888322,"InChI=1S/C29H31F4N7O2/c1-39-13-15-40(16-14-39)12-2-11-34-27-36-24-10-8-22(18-26(24)37-27)42-21-6-4-20(5-7-21)35-28(41)38-25-17-19(29(31,32)33)3-9-23(25)30/h3-10,17-18H,2,11-16H2,1H3,(H2,34,36,37)(H2,35,38,41)",CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(ccc5F)C(F)(F)F)cc4)cc3[nH]2)CC1,CHEMBL1888322,"InChI=1S/C29H31F4N7O2/c1-39-13-15-40(16-14-39)12-2-11-34-27-36-24-10-8-22(18-26(24)37-27)42-21-6-4-20(5-7-21)35-28(41)38-25-17-19(29(31,32)33)3-9-23(25)30/h3-10,17-18H,2,11-16H2,1H3,(H2,34,36,37)(H2,35,38,41)",CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(ccc5F)C(F)(F)F)cc4)cc3[nH]2)CC1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,4.4488,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349970,CHEMBL516248,"InChI=1S/C20H17N3O3S/c1-25-14-6-4-5-13(9-14)11-26-17-10-18(27-19(17)20(21)24)23-12-22-15-7-2-3-8-16(15)23/h2-10,12H,11H2,1H3,(H2,21,24)",COc1cccc(COc2cc(sc2C(=O)N)n3cnc4ccccc34)c1,CHEMBL516248,"InChI=1S/C20H17N3O3S/c1-25-14-6-4-5-13(9-14)11-26-17-10-18(27-19(17)20(21)24)23-12-22-15-7-2-3-8-16(15)23/h2-10,12H,11H2,1H3,(H2,21,24)",COc1cccc(COc2cc(sc2C(=O)N)n3cnc4ccccc34)c1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,4.9917,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349971,CHEMBL518968,"InChI=1S/C23H20F3N3O4S/c1-27-22(30)21-19(33-11-13-6-4-5-7-14(13)23(24,25)26)10-20(34-21)29-12-28-15-8-17(31-2)18(32-3)9-16(15)29/h4-10,12H,11H2,1-3H3,(H,27,30)",CNC(=O)c1sc(cc1OCc2ccccc2C(F)(F)F)n3cnc4cc(OC)c(OC)cc34,CHEMBL518968,"InChI=1S/C23H20F3N3O4S/c1-27-22(30)21-19(33-11-13-6-4-5-7-14(13)23(24,25)26)10-20(34-21)29-12-28-15-8-17(31-2)18(32-3)9-16(15)29/h4-10,12H,11H2,1-3H3,(H,27,30)",CNC(=O)c1sc(cc1OCc2ccccc2C(F)(F)F)n3cnc4cc(OC)c(OC)cc34,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,31.4952,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349973,CHEMBL473420,"InChI=1S/C23H19F3N2O5S/c1-30-17-8-15-16(9-18(17)31-2)28(12-27-15)20-10-19(21(34-20)22(29)32-3)33-11-13-6-4-5-7-14(13)23(24,25)26/h4-10,12H,11H2,1-3H3",COC(=O)c1sc(cc1OCc2ccccc2C(F)(F)F)n3cnc4cc(OC)c(OC)cc34,CHEMBL473420,"InChI=1S/C23H19F3N2O5S/c1-30-17-8-15-16(9-18(17)31-2)28(12-27-15)20-10-19(21(34-20)22(29)32-3)33-11-13-6-4-5-7-14(13)23(24,25)26/h4-10,12H,11H2,1-3H3",COC(=O)c1sc(cc1OCc2ccccc2C(F)(F)F)n3cnc4cc(OC)c(OC)cc34,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,7.9112,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349975,CHEMBL381604,"InChI=1S/C23H16ClFN6O/c24-20-11-19(6-7-21(20)32-13-15-2-1-3-17(25)10-15)30-22-16(12-27-14-29-22)4-5-18-8-9-28-23(26)31-18/h1-3,6-12,14H,13H2,(H2,26,28,31)(H,27,29,30)",Nc1nccc(n1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL381604,"InChI=1S/C23H16ClFN6O/c24-20-11-19(6-7-21(20)32-13-15-2-1-3-17(25)10-15)30-22-16(12-27-14-29-22)4-5-18-8-9-28-23(26)31-18/h1-3,6-12,14H,13H2,(H2,26,28,31)(H,27,29,30)",Nc1nccc(n1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,17.7111,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349976,CHEMBL520037,"InChI=1S/C22H20F3N5O3/c1-12-16-11-26-21(28-15-9-17(31-2)19(33-4)18(10-15)32-3)29-30(16)20(27-12)13-6-5-7-14(8-13)22(23,24)25/h5-11H,1-4H3,(H,28,29)",COc1cc(Nc2ncc3c(C)nc(c4cccc(c4)C(F)(F)F)n3n2)cc(OC)c1OC,CHEMBL520037,"InChI=1S/C22H20F3N5O3/c1-12-16-11-26-21(28-15-9-17(31-2)19(33-4)18(10-15)32-3)29-30(16)20(27-12)13-6-5-7-14(8-13)22(23,24)25/h5-11H,1-4H3,(H,28,29)",COc1cc(Nc2ncc3c(C)nc(c4cccc(c4)C(F)(F)F)n3n2)cc(OC)c1OC,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,9.9597,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349979,CHEMBL1098943,"InChI=1S/C18H23N7O3/c1-5-25-12-10-13(27-9-8-20-4)21-11(6-7-18(2,3)26)14(12)22-17(25)15-16(19)24-28-23-15/h10,20,26H,5,8-9H2,1-4H3,(H2,19,24)",CCn1c(nc2c(nc(OCCNC)cc12)C#CC(C)(C)O)c3nonc3N,CHEMBL1098943,"InChI=1S/C18H23N7O3/c1-5-25-12-10-13(27-9-8-20-4)21-11(6-7-18(2,3)26)14(12)22-17(25)15-16(19)24-28-23-15/h10,20,26H,5,8-9H2,1-4H3,(H2,19,24)",CCn1c(nc2c(nc(OCCNC)cc12)C#CC(C)(C)O)c3nonc3N,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,1.9872,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349980,CHEMBL1096290,"InChI=1S/C20H25N7O2/c1-4-27-15-11-13(12-26-9-5-6-10-26)22-14(7-8-20(2,3)28)16(15)23-19(27)17-18(21)25-29-24-17/h11,28H,4-6,9-10,12H2,1-3H3,(H2,21,25)",CCn1c(nc2c(nc(CN3CCCC3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1096290,"InChI=1S/C20H25N7O2/c1-4-27-15-11-13(12-26-9-5-6-10-26)22-14(7-8-20(2,3)28)16(15)23-19(27)17-18(21)25-29-24-17/h11,28H,4-6,9-10,12H2,1-3H3,(H2,21,25)",CCn1c(nc2c(nc(CN3CCCC3)cc12)C#CC(C)(C)O)c4nonc4N,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,31.4952,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349982,CHEMBL232601,"InChI=1S/C23H19N3O2S/c24-13-19-18-9-4-12-26(22(28)15-10-11-15)23(18)29-21(19)25-20(27)17-8-3-6-14-5-1-2-7-16(14)17/h1-3,5-8,15H,4,9-12H2,(H,25,27)",O=C(Nc1sc2N(CCCc2c1C#N)C(=O)C3CC3)c4cccc5ccccc45,CHEMBL232601,"InChI=1S/C23H19N3O2S/c24-13-19-18-9-4-12-26(22(28)15-10-11-15)23(18)29-21(19)25-20(27)17-8-3-6-14-5-1-2-7-16(14)17/h1-3,5-8,15H,4,9-12H2,(H,25,27)",O=C(Nc1sc2N(CCCc2c1C#N)C(=O)C3CC3)c4cccc5ccccc45,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,4.9917,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349984,CHEMBL361894,"InChI=1S/C18H14N6O2/c1-2-15-13(11-21-24(15)20-6-1)14-5-7-19-18(23-14)22-12-3-4-16-17(10-12)26-9-8-25-16/h1-7,10-11H,8-9H2,(H,19,22,23)",C1COc2cc(Nc3nccc(n3)c4cnn5ncccc45)ccc2O1,CHEMBL361894,"InChI=1S/C18H14N6O2/c1-2-15-13(11-21-24(15)20-6-1)14-5-7-19-18(23-14)22-12-3-4-16-17(10-12)26-9-8-25-16/h1-7,10-11H,8-9H2,(H,19,22,23)",C1COc2cc(Nc3nccc(n3)c4cnn5ncccc45)ccc2O1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,2.5018,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349985,CHEMBL479079,"InChI=1S/C21H22N6O3/c1-12-15-6-5-13(9-16(15)27-26-12)23-19-7-8-22-21(25-19)24-14-10-17(28-2)20(30-4)18(11-14)29-3/h5-11H,1-4H3,(H,26,27)(H2,22,23,24,25)",COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC,CHEMBL479079,"InChI=1S/C21H22N6O3/c1-12-15-6-5-13(9-16(15)27-26-12)23-19-7-8-22-21(25-19)24-14-10-17(28-2)20(30-4)18(11-14)29-3/h5-11H,1-4H3,(H,26,27)(H2,22,23,24,25)",COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,25.0176,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349986,CHEMBL505187,"InChI=1S/C32H28N6O2/c1-2-38-20-29(27-15-17-33-31-28(27)16-18-34-31)30(37-38)23-9-6-10-25(19-23)36-32(39)35-24-11-13-26(14-12-24)40-21-22-7-4-3-5-8-22/h3-20H,2,21H2,1H3,(H,33,34)(H2,35,36,39)",CCn1cc(c2ccnc3[nH]ccc23)c(n1)c4cccc(NC(=O)Nc5ccc(OCc6ccccc6)cc5)c4,CHEMBL505187,"InChI=1S/C32H28N6O2/c1-2-38-20-29(27-15-17-33-31-28(27)16-18-34-31)30(37-38)23-9-6-10-25(19-23)36-32(39)35-24-11-13-26(14-12-24)40-21-22-7-4-3-5-8-22/h3-20H,2,21H2,1H3,(H,33,34)(H2,35,36,39)",CCn1cc(c2ccnc3[nH]ccc23)c(n1)c4cccc(NC(=O)Nc5ccc(OCc6ccccc6)cc5)c4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,31.4952,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349994,CHEMBL476259,"InChI=1S/C28H32FN7O2/c1-3-12-36-13-9-17(10-14-36)18-4-7-22(24(15-18)38-2)33-28-34-26-21(8-11-31-26)27(35-28)32-23-16-19(29)5-6-20(23)25(30)37/h4-8,11,15-17H,3,9-10,12-14H2,1-2H3,(H2,30,37)(H3,31,32,33,34,35)",CCCN1CCC(CC1)c2ccc(Nc3nc(Nc4cc(F)ccc4C(=O)N)c5cc[nH]c5n3)c(OC)c2,CHEMBL476259,"InChI=1S/C28H32FN7O2/c1-3-12-36-13-9-17(10-14-36)18-4-7-22(24(15-18)38-2)33-28-34-26-21(8-11-31-26)27(35-28)32-23-16-19(29)5-6-20(23)25(30)37/h4-8,11,15-17H,3,9-10,12-14H2,1-2H3,(H2,30,37)(H3,31,32,33,34,35)",CCCN1CCC(CC1)c2ccc(Nc3nc(Nc4cc(F)ccc4C(=O)N)c5cc[nH]c5n3)c(OC)c2,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,25.0176,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349996,CHEMBL495696,"InChI=1S/C17H11N7/c18-10-12-3-1-4-13(9-12)22-17-19-8-6-15(23-17)14-11-21-24-16(14)5-2-7-20-24/h1-9,11H,(H,19,22,23)",N#Cc1cccc(Nc2nccc(n2)c3cnn4ncccc34)c1,CHEMBL495696,"InChI=1S/C17H11N7/c18-10-12-3-1-4-13(9-12)22-17-19-8-6-15(23-17)14-11-21-24-16(14)5-2-7-20-24/h1-9,11H,(H,19,22,23)",N#Cc1cccc(Nc2nccc(n2)c3cnn4ncccc34)c1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.0628,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349997,CHEMBL396107,"InChI=1S/C21H13F6N5O2/c22-20(23,24)11-5-12(21(25,26)27)7-14(6-11)32-19(33)31-13-3-1-10(2-4-13)15-8-34-18-16(15)17(28)29-9-30-18/h1-9H,(H2,28,29,30)(H2,31,32,33)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(cc(c4)C(F)(F)F)C(F)(F)F)cc3)c12,CHEMBL396107,"InChI=1S/C21H13F6N5O2/c22-20(23,24)11-5-12(21(25,26)27)7-14(6-11)32-19(33)31-13-3-1-10(2-4-13)15-8-34-18-16(15)17(28)29-9-30-18/h1-9H,(H2,28,29,30)(H2,31,32,33)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cc(cc(c4)C(F)(F)F)C(F)(F)F)cc3)c12,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,19.8722,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349998,CHEMBL205798,"InChI=1S/C27H20ClFN4O2/c1-18(34)32-23-7-3-4-19(13-23)8-9-21-15-30-17-31-27(21)33-24-10-11-26(25(28)14-24)35-16-20-5-2-6-22(29)12-20/h2-7,10-15,17H,16H2,1H3,(H,32,34)(H,30,31,33)",CC(=O)Nc1cccc(c1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL205798,"InChI=1S/C27H20ClFN4O2/c1-18(34)32-23-7-3-4-19(13-23)8-9-21-15-30-17-31-27(21)33-24-10-11-26(25(28)14-24)35-16-20-5-2-6-22(29)12-20/h2-7,10-15,17H,16H2,1H3,(H,32,34)(H,30,31,33)",CC(=O)Nc1cccc(c1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,15.785,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350002,CHEMBL477182,"InChI=1S/C28H30N4O2/c1-19-4-11-24(31-28(34)23-12-13-29-26(16-23)32-14-2-3-15-32)17-25(19)21-7-9-22(10-8-21)27(33)30-18-20-5-6-20/h4,7-13,16-17,20H,2-3,5-6,14-15,18H2,1H3,(H,30,33)(H,31,34)",Cc1ccc(NC(=O)c2ccnc(c2)N3CCCC3)cc1c4ccc(cc4)C(=O)NCC5CC5,CHEMBL477182,"InChI=1S/C28H30N4O2/c1-19-4-11-24(31-28(34)23-12-13-29-26(16-23)32-14-2-3-15-32)17-25(19)21-7-9-22(10-8-21)27(33)30-18-20-5-6-20/h4,7-13,16-17,20H,2-3,5-6,14-15,18H2,1H3,(H,30,33)(H,31,34)",Cc1ccc(NC(=O)c2ccnc(c2)N3CCCC3)cc1c4ccc(cc4)C(=O)NCC5CC5,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,28.0702,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350003,CHEMBL477069,"InChI=1S/C28H32FN7O2/c1-3-12-36-13-4-5-18(16-36)17-6-9-22(24(14-17)38-2)33-28-34-26-21(10-11-31-26)27(35-28)32-23-15-19(29)7-8-20(23)25(30)37/h6-11,14-15,18H,3-5,12-13,16H2,1-2H3,(H2,30,37)(H3,31,32,33,34,35)",CCCN1CCCC(C1)c2ccc(Nc3nc(Nc4cc(F)ccc4C(=O)N)c5cc[nH]c5n3)c(OC)c2,CHEMBL477069,"InChI=1S/C28H32FN7O2/c1-3-12-36-13-4-5-18(16-36)17-6-9-22(24(14-17)38-2)33-28-34-26-21(10-11-31-26)27(35-28)32-23-15-19(29)7-8-20(23)25(30)37/h6-11,14-15,18H,3-5,12-13,16H2,1-2H3,(H2,30,37)(H3,31,32,33,34,35)",CCCN1CCCC(C1)c2ccc(Nc3nc(Nc4cc(F)ccc4C(=O)N)c5cc[nH]c5n3)c(OC)c2,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,14.0684,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350004,CHEMBL521658,"InChI=1S/C21H27N7O3/c1-4-28-18-15(30-12-13-6-9-23-10-7-13)11-24-14(5-8-21(2,3)29)16(18)25-20(28)17-19(22)27-31-26-17/h11,13,23,29H,4,6-7,9-10,12H2,1-3H3,(H2,22,27)",CCn1c(nc2c(ncc(OCC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N,CHEMBL521658,"InChI=1S/C21H27N7O3/c1-4-28-18-15(30-12-13-6-9-23-10-7-13)11-24-14(5-8-21(2,3)29)16(18)25-20(28)17-19(22)27-31-26-17/h11,13,23,29H,4,6-7,9-10,12H2,1-3H3,(H2,22,27)",CCn1c(nc2c(ncc(OCC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,3.965,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350005,CHEMBL494280,"InChI=1S/C16H20N8O2/c1-2-24-14-11(25-8-4-7-18)9-20-10(5-3-6-17)12(14)21-16(24)13-15(19)23-26-22-13/h9H,2,4,6-8,17-18H2,1H3,(H2,19,23)",CCn1c(nc2c(ncc(OCCCN)c12)C#CCN)c3nonc3N,CHEMBL494280,"InChI=1S/C16H20N8O2/c1-2-24-14-11(25-8-4-7-18)9-20-10(5-3-6-17)12(14)21-16(24)13-15(19)23-26-22-13/h9H,2,4,6-8,17-18H2,1H3,(H2,19,23)",CCn1c(nc2c(ncc(OCCCN)c12)C#CCN)c3nonc3N,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.7911,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350006,CHEMBL522857,"InChI=1S/C20H25N7O3/c1-4-27-17-14(29-12-6-9-22-10-7-12)11-23-13(5-8-20(2,3)28)15(17)24-19(27)16-18(21)26-30-25-16/h11-12,22,28H,4,6-7,9-10H2,1-3H3,(H2,21,26)",CCn1c(nc2c(ncc(OC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N,CHEMBL522857,"InChI=1S/C20H25N7O3/c1-4-27-17-14(29-12-6-9-22-10-7-12)11-23-13(5-8-20(2,3)28)15(17)24-19(27)16-18(21)26-30-25-16/h11-12,22,28H,4,6-7,9-10H2,1-3H3,(H2,21,26)",CCn1c(nc2c(ncc(OC3CCNCC3)c12)C#CC(C)(C)O)c4nonc4N,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.005,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350007,CHEMBL1882194,"InChI=1S/C21H23N7/c1-3-27(4-2)15-16-7-9-17(10-8-16)25-21-22-13-11-19(26-21)18-14-24-28-20(18)6-5-12-23-28/h5-14H,3-4,15H2,1-2H3,(H,22,25,26)",CCN(CC)Cc1ccc(Nc2nccc(n2)c3cnn4ncccc34)cc1,CHEMBL1882194,"InChI=1S/C21H23N7/c1-3-27(4-2)15-16-7-9-17(10-8-16)25-21-22-13-11-19(26-21)18-14-24-28-20(18)6-5-12-23-28/h5-14H,3-4,15H2,1-2H3,(H,22,25,26)",CCN(CC)Cc1ccc(Nc2nccc(n2)c3cnn4ncccc34)cc1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.0397,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350010,CHEMBL426800,"InChI=1S/C11H10FN5O/c1-2-17-8-5-6(12)3-4-7(8)14-11(17)9-10(13)16-18-15-9/h3-5H,2H2,1H3,(H2,13,16)",CCn1c(nc2ccc(F)cc12)c3nonc3N,CHEMBL426800,"InChI=1S/C11H10FN5O/c1-2-17-8-5-6(12)3-4-7(8)14-11(17)9-10(13)16-18-15-9/h3-5H,2H2,1H3,(H2,13,16)",CCn1c(nc2ccc(F)cc12)c3nonc3N,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,6.2841,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350011,CHEMBL479038,"InChI=1S/C21H22N2O2/c24-20(22-13-14-4-5-14)16-8-6-15(7-9-16)17-2-1-3-18(12-17)21(25)23-19-10-11-19/h1-3,6-9,12,14,19H,4-5,10-11,13H2,(H,22,24)(H,23,25)",O=C(NCC1CC1)c2ccc(cc2)c3cccc(c3)C(=O)NC4CC4,CHEMBL479038,"InChI=1S/C21H22N2O2/c24-20(22-13-14-4-5-14)16-8-6-15(7-9-16)17-2-1-3-18(12-17)21(25)23-19-10-11-19/h1-3,6-9,12,14,19H,4-5,10-11,13H2,(H,22,24)(H,23,25)",O=C(NCC1CC1)c2ccc(cc2)c3cccc(c3)C(=O)NC4CC4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,5.6007,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350012,CHEMBL477978,"InChI=1S/C25H30N2O2/c1-17-7-10-21(25(29)27-22-5-3-2-4-6-22)15-23(17)19-11-13-20(14-12-19)24(28)26-16-18-8-9-18/h7,10-15,18,22H,2-6,8-9,16H2,1H3,(H,26,28)(H,27,29)",Cc1ccc(cc1c2ccc(cc2)C(=O)NCC3CC3)C(=O)NC4CCCCC4,CHEMBL477978,"InChI=1S/C25H30N2O2/c1-17-7-10-21(25(29)27-22-5-3-2-4-6-22)15-23(17)19-11-13-20(14-12-19)24(28)26-16-18-8-9-18/h7,10-15,18,22H,2-6,8-9,16H2,1H3,(H,26,28)(H,27,29)",Cc1ccc(cc1c2ccc(cc2)C(=O)NCC3CC3)C(=O)NC4CCCCC4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,1.4068,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350013,CHEMBL188247,"InChI=1S/C26H19F3N6O2/c1-15-2-8-20-23(24(34-35(20)33-15)16-3-5-17(6-4-16)26(27,28)29)19-10-11-30-25(32-19)31-18-7-9-21-22(14-18)37-13-12-36-21/h2-11,14H,12-13H2,1H3,(H,30,31,32)",Cc1ccc2c(c3ccnc(Nc4ccc5OCCOc5c4)n3)c(nn2n1)c6ccc(cc6)C(F)(F)F,CHEMBL188247,"InChI=1S/C26H19F3N6O2/c1-15-2-8-20-23(24(34-35(20)33-15)16-3-5-17(6-4-16)26(27,28)29)19-10-11-30-25(32-19)31-18-7-9-21-22(14-18)37-13-12-36-21/h2-11,14H,12-13H2,1H3,(H,30,31,32)",Cc1ccc2c(c3ccnc(Nc4ccc5OCCOc5c4)n3)c(nn2n1)c6ccc(cc6)C(F)(F)F,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,28.0702,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350014,CHEMBL446024,"InChI=1S/C12H9F3N6/c13-12(14,15)7-17-11-16-5-3-9(20-11)8-6-19-21-10(8)2-1-4-18-21/h1-6H,7H2,(H,16,17,20)",FC(F)(F)CNc1nccc(n1)c2cnn3ncccc23,CHEMBL446024,"InChI=1S/C12H9F3N6/c13-12(14,15)7-17-11-16-5-3-9(20-11)8-6-19-21-10(8)2-1-4-18-21/h1-6H,7H2,(H,16,17,20)",FC(F)(F)CNc1nccc(n1)c2cnn3ncccc23,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,31.4952,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350019,CHEMBL205765,"InChI=1S/C26H19ClFN5O2/c1-17(34)31-25-7-3-6-21(32-25)9-8-19-14-29-16-30-26(19)33-22-10-11-24(23(27)13-22)35-15-18-4-2-5-20(28)12-18/h2-7,10-14,16H,15H2,1H3,(H,29,30,33)(H,31,32,34)",CC(=O)Nc1cccc(n1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL205765,"InChI=1S/C26H19ClFN5O2/c1-17(34)31-25-7-3-6-21(32-25)9-8-19-14-29-16-30-26(19)33-22-10-11-24(23(27)13-22)35-15-18-4-2-5-20(28)12-18/h2-7,10-14,16H,15H2,1H3,(H,29,30,33)(H,31,32,34)",CC(=O)Nc1cccc(n1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,35.3383,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350020,CHEMBL428877,"InChI=1S/C26H26FN5O/c1-2-18-3-9-22(10-4-18)33-26-29-16-13-23(31-26)25-24(19-5-7-20(27)8-6-19)30-17-32(25)21-11-14-28-15-12-21/h3-10,13,16-17,21,28H,2,11-12,14-15H2,1H3",CCc1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL428877,"InChI=1S/C26H26FN5O/c1-2-18-3-9-22(10-4-18)33-26-29-16-13-23(31-26)25-24(19-5-7-20(27)8-6-19)30-17-32(25)21-11-14-28-15-12-21/h3-10,13,16-17,21,28H,2,11-12,14-15H2,1H3",CCc1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,11.1749,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350023,CHEMBL261129,"InChI=1S/C19H20BrN5O2/c1-25-8-6-12(7-9-25)19(27)22-18-14-10-15(20)16(21-17(14)23-24-18)11-2-4-13(26)5-3-11/h2-5,10,12,26H,6-9H2,1H3,(H2,21,22,23,24,27)",CN1CCC(CC1)C(=O)Nc2n[nH]c3nc(c(Br)cc23)c4ccc(O)cc4,CHEMBL261129,"InChI=1S/C19H20BrN5O2/c1-25-8-6-12(7-9-25)19(27)22-18-14-10-15(20)16(21-17(14)23-24-18)11-2-4-13(26)5-3-11/h2-5,10,12,26H,6-9H2,1H3,(H2,21,22,23,24,27)",CN1CCC(CC1)C(=O)Nc2n[nH]c3nc(c(Br)cc23)c4ccc(O)cc4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,12.5385,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350024,CHEMBL261129,"InChI=1S/C19H20BrN5O2/c1-25-8-6-12(7-9-25)19(27)22-18-14-10-15(20)16(21-17(14)23-24-18)11-2-4-13(26)5-3-11/h2-5,10,12,26H,6-9H2,1H3,(H2,21,22,23,24,27)",CN1CCC(CC1)C(=O)Nc2n[nH]c3nc(c(Br)cc23)c4ccc(O)cc4,CHEMBL261129,"InChI=1S/C19H20BrN5O2/c1-25-8-6-12(7-9-25)19(27)22-18-14-10-15(20)16(21-17(14)23-24-18)11-2-4-13(26)5-3-11/h2-5,10,12,26H,6-9H2,1H3,(H2,21,22,23,24,27)",CN1CCC(CC1)C(=O)Nc2n[nH]c3nc(c(Br)cc23)c4ccc(O)cc4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,19.8722,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350028,CHEMBL352222,"InChI=1S/C16H9Cl2N3O5/c17-10-5-8(6-11(18)14(10)22)19-13-12(15(23)20-16(13)24)7-2-1-3-9(4-7)21(25)26/h1-6,22H,(H2,19,20,23,24)",Oc1c(Cl)cc(NC2=C(C(=O)NC2=O)c3cccc(c3)N(=O)=O)cc1Cl,CHEMBL352222,"InChI=1S/C16H9Cl2N3O5/c17-10-5-8(6-11(18)14(10)22)19-13-12(15(23)20-16(13)24)7-2-1-3-9(4-7)21(25)26/h1-6,22H,(H2,19,20,23,24)",Oc1c(Cl)cc(NC2=C(C(=O)NC2=O)c3cccc(c3)N(=O)=O)cc1Cl,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.0141,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350029,CHEMBL477583,"InChI=1S/C23H22N2O3/c1-15-2-9-20(25-23(27)19-10-11-28-14-19)12-21(15)17-5-7-18(8-6-17)22(26)24-13-16-3-4-16/h2,5-12,14,16H,3-4,13H2,1H3,(H,24,26)(H,25,27)",Cc1ccc(NC(=O)c2cocc2)cc1c3ccc(cc3)C(=O)NCC4CC4,CHEMBL477583,"InChI=1S/C23H22N2O3/c1-15-2-9-20(25-23(27)19-10-11-28-14-19)12-21(15)17-5-7-18(8-6-17)22(26)24-13-16-3-4-16/h2,5-12,14,16H,3-4,13H2,1H3,(H,24,26)(H,25,27)",Cc1ccc(NC(=O)c2cocc2)cc1c3ccc(cc3)C(=O)NCC4CC4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,3.1495,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350036,CHEMBL434729,"InChI=1S/C24H17F3N6/c1-15-10-11-20-21(22(32-33(20)31-15)16-6-3-2-4-7-16)19-12-13-28-23(30-19)29-18-9-5-8-17(14-18)24(25,26)27/h2-14H,1H3,(H,28,29,30)",Cc1ccc2c(c3ccnc(Nc4cccc(c4)C(F)(F)F)n3)c(nn2n1)c5ccccc5,CHEMBL434729,"InChI=1S/C24H17F3N6/c1-15-10-11-20-21(22(32-33(20)31-15)16-6-3-2-4-7-16)19-12-13-28-23(30-19)29-18-9-5-8-17(14-18)24(25,26)27/h2-14H,1H3,(H,28,29,30)",Cc1ccc2c(c3ccnc(Nc4cccc(c4)C(F)(F)F)n3)c(nn2n1)c5ccccc5,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,14.0684,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350037,CHEMBL1789962,"InChI=1S/C20H18N6O2/c1-28-18-9-15(7-8-17(18)27)10-23-25-19-16-11-24-26(20(16)22-13-21-19)12-14-5-3-2-4-6-14/h2-11,13,27H,12H2,1H3,(H,21,22,25)",COc1cc(C=NNc2ncnc3c2cnn3Cc4ccccc4)ccc1O,CHEMBL1789962,"InChI=1S/C20H18N6O2/c1-28-18-9-15(7-8-17(18)27)10-23-25-19-16-11-24-26(20(16)22-13-21-19)12-14-5-3-2-4-6-14/h2-11,13,27H,12H2,1H3,(H,21,22,25)",COc1cc(C=NNc2ncnc3c2cnn3Cc4ccccc4)ccc1O,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,7.9112,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350042,CHEMBL519881,"InChI=1S/C27H25N5O4/c1-17-22-16-28-27(30-19-14-23(33-2)25(35-4)24(15-19)34-3)31-32(22)26(29-17)18-9-8-12-21(13-18)36-20-10-6-5-7-11-20/h5-16H,1-4H3,(H,30,31)",COc1cc(Nc2ncc3c(C)nc(c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC,CHEMBL519881,"InChI=1S/C27H25N5O4/c1-17-22-16-28-27(30-19-14-23(33-2)25(35-4)24(15-19)34-3)31-32(22)26(29-17)18-9-8-12-21(13-18)36-20-10-6-5-7-11-20/h5-16H,1-4H3,(H,30,31)",COc1cc(Nc2ncc3c(C)nc(c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,3.1495,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350043,CHEMBL38425,"InChI=1S/C20H22F2N6O/c1-2-28-8-6-12(7-9-28)10-17(29)23-19-14-11-16(24-26-20(14)27-25-19)13-4-3-5-15(21)18(13)22/h3-5,11-12H,2,6-10H2,1H3,(H2,23,25,26,27,29)",CCN1CCC(CC(=O)Nc2n[nH]c3nnc(cc23)c4cccc(F)c4F)CC1,CHEMBL38425,"InChI=1S/C20H22F2N6O/c1-2-28-8-6-12(7-9-28)10-17(29)23-19-14-11-16(24-26-20(14)27-25-19)13-4-3-5-15(21)18(13)22/h3-5,11-12H,2,6-10H2,1H3,(H2,23,25,26,27,29)",CCN1CCC(CC(=O)Nc2n[nH]c3nnc(cc23)c4cccc(F)c4F)CC1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.0281,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350044,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1516890,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)",Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,4.9917,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350045,CHEMBL188268,"InChI=1S/C15H13N7O/c16-7-9-1-3-10(4-2-9)22-12-5-6-18-8-11(12)19-15(22)13-14(17)21-23-20-13/h1-6,8H,7,16H2,(H2,17,21)",NCc1ccc(cc1)n2c(nc3cnccc23)c4nonc4N,CHEMBL188268,"InChI=1S/C15H13N7O/c16-7-9-1-3-10(4-2-9)22-12-5-6-18-8-11(12)19-15(22)13-14(17)21-23-20-13/h1-6,8H,7,16H2,(H2,17,21)",NCc1ccc(cc1)n2c(nc3cnccc23)c4nonc4N,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,12.5385,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350046,CHEMBL405021,"InChI=1S/C17H15N3O/c21-17(12-6-7-12)18-16-14-9-8-13(10-15(14)19-20-16)11-4-2-1-3-5-11/h1-5,8-10,12H,6-7H2,(H2,18,19,20,21)",O=C(Nc1n[nH]c2cc(ccc12)c3ccccc3)C4CC4,CHEMBL405021,"InChI=1S/C17H15N3O/c21-17(12-6-7-12)18-16-14-9-8-13(10-15(14)19-20-16)11-4-2-1-3-5-11/h1-5,8-10,12H,6-7H2,(H2,18,19,20,21)",O=C(Nc1n[nH]c2cc(ccc12)c3ccccc3)C4CC4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.8877,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350051,CHEMBL318728,"InChI=1S/C15H12N2O/c1-3-7-12(8-4-1)14-11-16-15(18-14)17-13-9-5-2-6-10-13/h1-11H,(H,16,17)",N(c1ccccc1)c2oc(cn2)c3ccccc3,CHEMBL318728,"InChI=1S/C15H12N2O/c1-3-7-12(8-4-1)14-11-16-15(18-14)17-13-9-5-2-6-10-13/h1-11H,(H,16,17)",N(c1ccccc1)c2oc(cn2)c3ccccc3,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,4.9917,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350052,CHEMBL188794,"InChI=1S/C24H16ClF3N6O/c1-35-16-7-4-14(5-8-16)22-21(20-3-2-11-30-34(20)33-22)19-10-12-29-23(32-19)31-15-6-9-18(25)17(13-15)24(26,27)28/h2-13H,1H3,(H,29,31,32)",COc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccc(Cl)c(c5)C(F)(F)F)n4,CHEMBL188794,"InChI=1S/C24H16ClF3N6O/c1-35-16-7-4-14(5-8-16)22-21(20-3-2-11-30-34(20)33-22)19-10-12-29-23(32-19)31-15-6-9-18(25)17(13-15)24(26,27)28/h2-13H,1H3,(H,29,31,32)",COc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccc(Cl)c(c5)C(F)(F)F)n4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,22.2969,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350053,CHEMBL406125,"InChI=1S/C18H20N6O/c1-24-9-7-13(8-10-24)18(25)19-16-14-11-15(12-5-3-2-4-6-12)20-22-17(14)23-21-16/h2-6,11,13H,7-10H2,1H3,(H2,19,21,22,23,25)",CN1CCC(CC1)C(=O)Nc2n[nH]c3nnc(cc23)c4ccccc4,CHEMBL406125,"InChI=1S/C18H20N6O/c1-24-9-7-13(8-10-24)18(25)19-16-14-11-15(12-5-3-2-4-6-12)20-22-17(14)23-21-16/h2-6,11,13H,7-10H2,1H3,(H2,19,21,22,23,25)",CN1CCC(CC1)C(=O)Nc2n[nH]c3nnc(cc23)c4ccccc4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.3965,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350055,CHEMBL1789963,"InChI=1S/C20H11Cl2NO4/c21-14-7-10(8-15(22)19(14)25)6-13-12-9-11(3-4-16(12)23-20(13)26)18(24)17-2-1-5-27-17/h1-9,25H,(H,23,26)",Oc1c(Cl)cc(C=C2C(=O)Nc3ccc(cc23)C(=O)c4occc4)cc1Cl,CHEMBL1789963,"InChI=1S/C20H11Cl2NO4/c21-14-7-10(8-15(22)19(14)25)6-13-12-9-11(3-4-16(12)23-20(13)26)18(24)17-2-1-5-27-17/h1-9,25H,(H,23,26)",Oc1c(Cl)cc(C=C2C(=O)Nc3ccc(cc23)C(=O)c4occc4)cc1Cl,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,3.1495,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350056,CHEMBL189459,"InChI=1S/C23H17FN6/c1-15-7-12-20-21(22(29-30(20)28-15)16-8-10-17(24)11-9-16)19-13-14-25-23(27-19)26-18-5-3-2-4-6-18/h2-14H,1H3,(H,25,26,27)",Cc1ccc2c(c3ccnc(Nc4ccccc4)n3)c(nn2n1)c5ccc(F)cc5,CHEMBL189459,"InChI=1S/C23H17FN6/c1-15-7-12-20-21(22(29-30(20)28-15)16-8-10-17(24)11-9-16)19-13-14-25-23(27-19)26-18-5-3-2-4-6-18/h2-14H,1H3,(H,25,26,27)",Cc1ccc2c(c3ccnc(Nc4ccccc4)n3)c(nn2n1)c5ccc(F)cc5,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,25.0176,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350057,CHEMBL188257,"InChI=1S/C25H20N6O3/c1-32-18-7-4-16(5-8-18)24-23(20-3-2-11-27-31(20)30-24)19-10-12-26-25(29-19)28-17-6-9-21-22(15-17)34-14-13-33-21/h2-12,15H,13-14H2,1H3,(H,26,28,29)",COc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccc6OCCOc6c5)n4,CHEMBL188257,"InChI=1S/C25H20N6O3/c1-32-18-7-4-16(5-8-18)24-23(20-3-2-11-27-31(20)30-24)19-10-12-26-25(29-19)28-17-6-9-21-22(15-17)34-14-13-33-21/h2-12,15H,13-14H2,1H3,(H,26,28,29)",COc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccc6OCCOc6c5)n4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,15.785,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350058,CHEMBL186213,"InChI=1S/C24H17F3N6O/c1-34-18-9-7-15(8-10-18)22-21(20-6-3-12-29-33(20)32-22)19-11-13-28-23(31-19)30-17-5-2-4-16(14-17)24(25,26)27/h2-14H,1H3,(H,28,30,31)",COc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5cccc(c5)C(F)(F)F)n4,CHEMBL186213,"InChI=1S/C24H17F3N6O/c1-34-18-9-7-15(8-10-18)22-21(20-6-3-12-29-33(20)32-22)19-11-13-28-23(31-19)30-17-5-2-4-16(14-17)24(25,26)27/h2-14H,1H3,(H,28,30,31)",COc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5cccc(c5)C(F)(F)F)n4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,25.0176,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350059,CHEMBL362155,"InChI=1S/C25H17F3N6O2/c26-25(27,28)16-4-1-3-15(13-16)23-22(19-5-2-9-30-34(19)33-23)18-8-10-29-24(32-18)31-17-6-7-20-21(14-17)36-12-11-35-20/h1-10,13-14H,11-12H2,(H,29,31,32)",FC(F)(F)c1cccc(c1)c2nn3ncccc3c2c4ccnc(Nc5ccc6OCCOc6c5)n4,CHEMBL362155,"InChI=1S/C25H17F3N6O2/c26-25(27,28)16-4-1-3-15(13-16)23-22(19-5-2-9-30-34(19)33-23)18-8-10-29-24(32-18)31-17-6-7-20-21(14-17)36-12-11-35-20/h1-10,13-14H,11-12H2,(H,29,31,32)",FC(F)(F)c1cccc(c1)c2nn3ncccc3c2c4ccnc(Nc5ccc6OCCOc6c5)n4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,31.4952,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350060,CHEMBL365297,"InChI=1S/C24H17FN6O2/c25-16-5-3-15(4-6-16)23-22(19-2-1-10-27-31(19)30-23)18-9-11-26-24(29-18)28-17-7-8-20-21(14-17)33-13-12-32-20/h1-11,14H,12-13H2,(H,26,28,29)",Fc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccc6OCCOc6c5)n4,CHEMBL365297,"InChI=1S/C24H17FN6O2/c25-16-5-3-15(4-6-16)23-22(19-2-1-10-27-31(19)30-23)18-9-11-26-24(29-18)28-17-7-8-20-21(14-17)33-13-12-32-20/h1-11,14H,12-13H2,(H,26,28,29)",Fc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccc6OCCOc6c5)n4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,7.9112,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350061,CHEMBL230911,"InChI=1S/C18H15N3O/c19-17-15(13-4-2-1-3-5-13)10-14(11-16(17)18(20)22)12-6-8-21-9-7-12/h1-11H,19H2,(H2,20,22)",NC(=O)c1cc(cc(c1N)c2ccccc2)c3ccncc3,CHEMBL230911,"InChI=1S/C18H15N3O/c19-17-15(13-4-2-1-3-5-13)10-14(11-16(17)18(20)22)12-6-8-21-9-7-12/h1-11H,19H2,(H2,20,22)",NC(=O)c1cc(cc(c1N)c2ccccc2)c3ccncc3,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,31.4952,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350062,CHEMBL485598,"InChI=1S/C25H18F4N6O/c1-13-21(24(36)33-18-7-8-19-16(10-18)12-31-35-19)22(14-2-5-17(26)6-3-14)34-23(32-13)15-4-9-20(30-11-15)25(27,28)29/h2-12,22H,1H3,(H,31,35)(H,32,34)(H,33,36)",CC1=C(C(N=C(N1)c2ccc(nc2)C(F)(F)F)c3ccc(F)cc3)C(=O)Nc4ccc5[nH]ncc5c4,CHEMBL485598,"InChI=1S/C25H18F4N6O/c1-13-21(24(36)33-18-7-8-19-16(10-18)12-31-35-19)22(14-2-5-17(26)6-3-14)34-23(32-13)15-4-9-20(30-11-15)25(27,28)29/h2-12,22H,1H3,(H,31,35)(H,32,34)(H,33,36)",CC1=C(C(N=C(N1)c2ccc(nc2)C(F)(F)F)c3ccc(F)cc3)C(=O)Nc4ccc5[nH]ncc5c4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,35.3383,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350066,CHEMBL408732,"InChI=1S/C17H16N4O2/c1-23-12-6-4-10(5-7-12)14-9-8-13-15(18-14)20-21-16(13)19-17(22)11-2-3-11/h4-9,11H,2-3H2,1H3,(H2,18,19,20,21,22)",COc1ccc(cc1)c2ccc3c(NC(=O)C4CC4)n[nH]c3n2,CHEMBL408732,"InChI=1S/C17H16N4O2/c1-23-12-6-4-10(5-7-12)14-9-8-13-15(18-14)20-21-16(13)19-17(22)11-2-3-11/h4-9,11H,2-3H2,1H3,(H2,18,19,20,21,22)",COc1ccc(cc1)c2ccc3c(NC(=O)C4CC4)n[nH]c3n2,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,9.9597,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350067,CHEMBL478442,"InChI=1S/C17H17N3O3/c1-10-4-5-11(6-14(10)21)20-17-12-7-15(22-2)16(23-3)8-13(12)18-9-19-17/h4-9,21H,1-3H3,(H,18,19,20)",COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC,CHEMBL478442,"InChI=1S/C17H17N3O3/c1-10-4-5-11(6-14(10)21)20-17-12-7-15(22-2)16(23-3)8-13(12)18-9-19-17/h4-9,21H,1-3H3,(H,18,19,20)",COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,19.8722,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350069,CHEMBL495771,"InChI=1S/C17H19N7O/c1-2-12(1)20-17-18-6-5-14(21-17)13-11-19-24-15(13)3-4-16(22-24)23-7-9-25-10-8-23/h3-6,11-12H,1-2,7-10H2,(H,18,20,21)",C1CN(CCO1)c2ccc3c(cnn3n2)c4ccnc(NC5CC5)n4,CHEMBL495771,"InChI=1S/C17H19N7O/c1-2-12(1)20-17-18-6-5-14(21-17)13-11-19-24-15(13)3-4-16(22-24)23-7-9-25-10-8-23/h3-6,11-12H,1-2,7-10H2,(H,18,20,21)",C1CN(CCO1)c2ccc3c(cnn3n2)c4ccnc(NC5CC5)n4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,1.5785,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350073,CHEMBL531804,"InChI=1S/C23H21N7/c1-30(2)22-12-17-20(13-24-22)25-14-26-23(17)27-16-8-9-18-19(11-16)29-21(28-18)10-15-6-4-3-5-7-15/h3-9,11-14H,10H2,1-2H3,(H,28,29)(H,25,26,27)",CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1,CHEMBL531804,"InChI=1S/C23H21N7/c1-30(2)22-12-17-20(13-24-22)25-14-26-23(17)27-16-8-9-18-19(11-16)29-21(28-18)10-15-6-4-3-5-7-15/h3-9,11-14H,10H2,1-2H3,(H,28,29)(H,25,26,27)",CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,8.8766,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350074,CHEMBL189148,"InChI=1S/C22H15ClN6/c23-16-10-8-15(9-11-16)21-20(19-7-4-13-25-29(19)28-21)18-12-14-24-22(27-18)26-17-5-2-1-3-6-17/h1-14H,(H,24,26,27)",Clc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccccc5)n4,CHEMBL189148,"InChI=1S/C22H15ClN6/c23-16-10-8-15(9-11-16)21-20(19-7-4-13-25-29(19)28-21)18-12-14-24-22(27-18)26-17-5-2-1-3-6-17/h1-14H,(H,24,26,27)",Clc1ccc(cc1)c2nn3ncccc3c2c4ccnc(Nc5ccccc5)n4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,22.2969,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350075,CHEMBL516908,"InChI=1S/C23H26N2O2/c1-15-2-11-20(25-22(26)12-16-3-4-16)13-21(15)18-7-9-19(10-8-18)23(27)24-14-17-5-6-17/h2,7-11,13,16-17H,3-6,12,14H2,1H3,(H,24,27)(H,25,26)",Cc1ccc(NC(=O)CC2CC2)cc1c3ccc(cc3)C(=O)NCC4CC4,CHEMBL516908,"InChI=1S/C23H26N2O2/c1-15-2-11-20(25-22(26)12-16-3-4-16)13-21(15)18-7-9-19(10-8-18)23(27)24-14-17-5-6-17/h2,7-11,13,16-17H,3-6,12,14H2,1H3,(H,24,27)(H,25,26)",Cc1ccc(NC(=O)CC2CC2)cc1c3ccc(cc3)C(=O)NCC4CC4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,3.965,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350077,CHEMBL524057,"InChI=1S/C15H16N6/c1-2-11-14(13-4-3-8-17-21(13)20-11)12-7-9-16-15(19-12)18-10-5-6-10/h3-4,7-10H,2,5-6H2,1H3,(H,16,18,19)",CCc1nn2ncccc2c1c3ccnc(NC4CC4)n3,CHEMBL524057,"InChI=1S/C15H16N6/c1-2-11-14(13-4-3-8-17-21(13)20-11)12-7-9-16-15(19-12)18-10-5-6-10/h3-4,7-10H,2,5-6H2,1H3,(H,16,18,19)",CCc1nn2ncccc2c1c3ccnc(NC4CC4)n3,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,1.1175,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350082,CHEMBL212965,"InChI=1S/C30H27ClN4O3S/c31-26-17-23(7-10-29(26)37-19-21-4-2-1-3-5-21)34-30-25-16-22(6-9-27(25)32-20-33-30)28-11-8-24(38-28)18-35-12-14-39(36)15-13-35/h1-11,16-17,20H,12-15,18-19H2,(H,32,33,34)",Clc1cc(Nc2ncnc3ccc(cc23)c4oc(CN5CCS(=O)CC5)cc4)ccc1OCc6ccccc6,CHEMBL212965,"InChI=1S/C30H27ClN4O3S/c31-26-17-23(7-10-29(26)37-19-21-4-2-1-3-5-21)34-30-25-16-22(6-9-27(25)32-20-33-30)28-11-8-24(38-28)18-35-12-14-39(36)15-13-35/h1-11,16-17,20H,12-15,18-19H2,(H,32,33,34)",Clc1cc(Nc2ncnc3ccc(cc23)c4oc(CN5CCS(=O)CC5)cc4)ccc1OCc6ccccc6,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,1.9872,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350083,CHEMBL14233,"InChI=1S/C25H22FN5O3/c26-18-5-1-16(2-6-18)22-23(31(15-29-22)19-9-12-27-13-10-19)21-11-14-28-25(30-21)34-20-7-3-17(4-8-20)24(32)33/h1-8,11,14-15,19,27H,9-10,12-13H2,(H,32,33)",OC(=O)c1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL14233,"InChI=1S/C25H22FN5O3/c26-18-5-1-16(2-6-18)22-23(31(15-29-22)19-9-12-27-13-10-19)21-11-14-28-25(30-21)34-20-7-3-17(4-8-20)24(32)33/h1-8,11,14-15,19,27H,9-10,12-13H2,(H,32,33)",OC(=O)c1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.6284,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350087,CHEMBL13972,"InChI=1S/C25H21FN6O/c26-19-5-3-18(4-6-19)23-24(32(16-30-23)20-9-12-28-13-10-20)22-11-14-29-25(31-22)33-21-7-1-17(15-27)2-8-21/h1-8,11,14,16,20,28H,9-10,12-13H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc(cc5)C#N)n4,CHEMBL13972,"InChI=1S/C25H21FN6O/c26-19-5-3-18(4-6-19)23-24(32(16-30-23)20-9-12-28-13-10-20)22-11-14-29-25(31-22)33-21-7-1-17(15-27)2-8-21/h1-8,11,14,16,20,28H,9-10,12-13H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc(cc5)C#N)n4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,14.0684,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350088,CHEMBL275200,"InChI=1S/C28H30FN5O/c1-28(2,3)20-6-10-23(11-7-20)35-27-31-17-14-24(33-27)26-25(19-4-8-21(29)9-5-19)32-18-34(26)22-12-15-30-16-13-22/h4-11,14,17-18,22,30H,12-13,15-16H2,1-3H3",CC(C)(C)c1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL275200,"InChI=1S/C28H30FN5O/c1-28(2,3)20-6-10-23(11-7-20)35-27-31-17-14-24(33-27)26-25(19-4-8-21(29)9-5-19)32-18-34(26)22-12-15-30-16-13-22/h4-11,14,17-18,22,30H,12-13,15-16H2,1-3H3",CC(C)(C)c1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,6.2841,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350092,CHEMBL176553,"InChI=1S/C17H16N2O3/c1-20-14-8-13(9-15(10-14)21-2)19-17-18-11-16(22-17)12-6-4-3-5-7-12/h3-11H,1-2H3,(H,18,19)",COc1cc(Nc2oc(cn2)c3ccccc3)cc(OC)c1,CHEMBL176553,"InChI=1S/C17H16N2O3/c1-20-14-8-13(9-15(10-14)21-2)19-17-18-11-16(22-17)12-6-4-3-5-7-12/h3-11H,1-2H3,(H,18,19)",COc1cc(Nc2oc(cn2)c3ccccc3)cc(OC)c1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,31.4952,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350094,CHEMBL194027,"InChI=1S/C16H14N2O2/c1-19-14-10-6-5-9-13(14)18-16-17-11-15(20-16)12-7-3-2-4-8-12/h2-11H,1H3,(H,17,18)",COc1ccccc1Nc2oc(cn2)c3ccccc3,CHEMBL194027,"InChI=1S/C16H14N2O2/c1-19-14-10-6-5-9-13(14)18-16-17-11-15(20-16)12-7-3-2-4-8-12/h2-11H,1H3,(H,17,18)",COc1ccccc1Nc2oc(cn2)c3ccccc3,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,1.2538,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350095,CHEMBL417804,"InChI=1S/C25H24FN5O2/c1-32-21-4-2-3-5-22(21)33-25-28-15-12-20(30-25)24-23(17-6-8-18(26)9-7-17)29-16-31(24)19-10-13-27-14-11-19/h2-9,12,15-16,19,27H,10-11,13-14H2,1H3",COc1ccccc1Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5,CHEMBL417804,"InChI=1S/C25H24FN5O2/c1-32-21-4-2-3-5-22(21)33-25-28-15-12-20(30-25)24-23(17-6-8-18(26)9-7-17)29-16-31(24)19-10-13-27-14-11-19/h2-9,12,15-16,19,27H,10-11,13-14H2,1H3",COc1ccccc1Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,25.0176,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350096,CHEMBL275168,"InChI=1S/C24H21ClFN5O/c25-17-3-7-20(8-4-17)32-24-28-14-11-21(30-24)23-22(16-1-5-18(26)6-2-16)29-15-31(23)19-9-12-27-13-10-19/h1-8,11,14-15,19,27H,9-10,12-13H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc(Cl)cc5)n4,CHEMBL275168,"InChI=1S/C24H21ClFN5O/c25-17-3-7-20(8-4-17)32-24-28-14-11-21(30-24)23-22(16-1-5-18(26)6-2-16)29-15-31(23)19-9-12-27-13-10-19/h1-8,11,14-15,19,27H,9-10,12-13H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc(Cl)cc5)n4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,17.7111,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350097,CHEMBL275724,"InChI=1S/C25H23FN6O2/c26-18-5-1-16(2-6-18)22-23(32(15-30-22)19-9-12-28-13-10-19)21-11-14-29-25(31-21)34-20-7-3-17(4-8-20)24(27)33/h1-8,11,14-15,19,28H,9-10,12-13H2,(H2,27,33)",NC(=O)c1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL275724,"InChI=1S/C25H23FN6O2/c26-18-5-1-16(2-6-18)22-23(32(15-30-22)19-9-12-28-13-10-19)21-11-14-29-25(31-21)34-20-7-3-17(4-8-20)24(27)33/h1-8,11,14-15,19,28H,9-10,12-13H2,(H2,27,33)",NC(=O)c1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,12.5385,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350098,CHEMBL14014,"InChI=1S/C24H21F2N5O/c25-17-6-4-16(5-7-17)22-23(31(15-29-22)19-8-11-27-12-9-19)21-10-13-28-24(30-21)32-20-3-1-2-18(26)14-20/h1-7,10,13-15,19,27H,8-9,11-12H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5cccc(F)c5)n4,CHEMBL14014,"InChI=1S/C24H21F2N5O/c25-17-6-4-16(5-7-17)22-23(31(15-29-22)19-8-11-27-12-9-19)21-10-13-28-24(30-21)32-20-3-1-2-18(26)14-20/h1-7,10,13-15,19,27H,8-9,11-12H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5cccc(F)c5)n4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,6.2841,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350099,CHEMBL506414,"InChI=1S/C23H15ClFN3OS2/c24-18-10-16(6-7-19(18)29-12-14-3-1-4-15(25)9-14)28-22-17-11-21(20-5-2-8-30-20)31-23(17)27-13-26-22/h1-11,13H,12H2,(H,26,27,28)",Fc1cccc(COc2ccc(Nc3ncnc4sc(cc34)c5cccs5)cc2Cl)c1,CHEMBL506414,"InChI=1S/C23H15ClFN3OS2/c24-18-10-16(6-7-19(18)29-12-14-3-1-4-15(25)9-14)28-22-17-11-21(20-5-2-8-30-20)31-23(17)27-13-26-22/h1-11,13H,12H2,(H,26,27,28)",Fc1cccc(COc2ccc(Nc3ncnc4sc(cc34)c5cccs5)cc2Cl)c1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,15.785,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350100,CHEMBL273611,"InChI=1S/C25H22FN5O3/c26-17-3-1-16(2-4-17)23-24(31(14-29-23)18-7-10-27-11-8-18)20-9-12-28-25(30-20)34-19-5-6-21-22(13-19)33-15-32-21/h1-6,9,12-14,18,27H,7-8,10-11,15H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc6OCOc6c5)n4,CHEMBL273611,"InChI=1S/C25H22FN5O3/c26-17-3-1-16(2-4-17)23-24(31(14-29-23)18-7-10-27-11-8-18)20-9-12-28-25(30-20)34-19-5-6-21-22(13-19)33-15-32-21/h1-6,9,12-14,18,27H,7-8,10-11,15H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc6OCOc6c5)n4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,12.5385,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350102,CHEMBL14212,"InChI=1S/C26H26FN5O/c1-17-4-3-5-23(18(17)2)33-26-29-15-12-22(31-26)25-24(19-6-8-20(27)9-7-19)30-16-32(25)21-10-13-28-14-11-21/h3-9,12,15-16,21,28H,10-11,13-14H2,1-2H3",Cc1cccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)c1C,CHEMBL14212,"InChI=1S/C26H26FN5O/c1-17-4-3-5-23(18(17)2)33-26-29-15-12-22(31-26)25-24(19-6-8-20(27)9-7-19)30-16-32(25)21-10-13-28-14-11-21/h3-9,12,15-16,21,28H,10-11,13-14H2,1-2H3",Cc1cccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)c1C,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,14.0684,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350103,CHEMBL475761,"InChI=1S/C29H27ClFN5O2S/c1-35-9-11-36(12-10-35)16-22-6-8-26(38-22)27-15-24-28(39-27)29(33-18-32-24)34-21-5-7-25(23(30)14-21)37-17-19-3-2-4-20(31)13-19/h2-8,13-15,18H,9-12,16-17H2,1H3,(H,32,33,34)",CN1CCN(Cc2oc(cc2)c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)CC1,CHEMBL475761,"InChI=1S/C29H27ClFN5O2S/c1-35-9-11-36(12-10-35)16-22-6-8-26(38-22)27-15-24-28(39-27)29(33-18-32-24)34-21-5-7-25(23(30)14-21)37-17-19-3-2-4-20(31)13-19/h2-8,13-15,18H,9-12,16-17H2,1H3,(H,32,33,34)",CN1CCN(Cc2oc(cc2)c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)CC1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,19.8722,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350104,CHEMBL13868,"InChI=1S/C30H26FN5O2/c31-22-8-6-21(7-9-22)28-29(36(20-34-28)23-14-17-32-18-15-23)27-16-19-33-30(35-27)38-26-12-10-25(11-13-26)37-24-4-2-1-3-5-24/h1-13,16,19-20,23,32H,14-15,17-18H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc(Oc6ccccc6)cc5)n4,CHEMBL13868,"InChI=1S/C30H26FN5O2/c31-22-8-6-21(7-9-22)28-29(36(20-34-28)23-14-17-32-18-15-23)27-16-19-33-30(35-27)38-26-12-10-25(11-13-26)37-24-4-2-1-3-5-24/h1-13,16,19-20,23,32H,14-15,17-18H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc(Oc6ccccc6)cc5)n4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,12.5385,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350105,CHEMBL231013,"InChI=1S/C13H12N2O2/c1-17-12-3-2-10(8-11(12)13(14)16)9-4-6-15-7-5-9/h2-8H,1H3,(H2,14,16)",COc1ccc(cc1C(=O)N)c2ccncc2,CHEMBL231013,"InChI=1S/C13H12N2O2/c1-17-12-3-2-10(8-11(12)13(14)16)9-4-6-15-7-5-9/h2-8H,1H3,(H2,14,16)",COc1ccc(cc1C(=O)N)c2ccncc2,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,7.9112,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350110,CHEMBL275666,"InChI=1S/C25H21F4N5O/c26-18-6-4-16(5-7-18)22-23(34(15-32-22)19-8-11-30-12-9-19)21-10-13-31-24(33-21)35-20-3-1-2-17(14-20)25(27,28)29/h1-7,10,13-15,19,30H,8-9,11-12H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5cccc(c5)C(F)(F)F)n4,CHEMBL275666,"InChI=1S/C25H21F4N5O/c26-18-6-4-16(5-7-18)22-23(34(15-32-22)19-8-11-30-12-9-19)21-10-13-31-24(33-21)35-20-3-1-2-17(14-20)25(27,28)29/h1-7,10,13-15,19,30H,8-9,11-12H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5cccc(c5)C(F)(F)F)n4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,12.5385,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350111,CHEMBL212954,"InChI=1S/C30H26ClFN4O3S/c31-26-16-23(5-8-29(26)38-18-20-2-1-3-22(32)14-20)35-30-25-15-21(4-7-27(25)33-19-34-30)28-9-6-24(39-28)17-36-10-12-40(37)13-11-36/h1-9,14-16,19H,10-13,17-18H2,(H,33,34,35)",Fc1cccc(COc2ccc(Nc3ncnc4ccc(cc34)c5oc(CN6CCS(=O)CC6)cc5)cc2Cl)c1,CHEMBL212954,"InChI=1S/C30H26ClFN4O3S/c31-26-16-23(5-8-29(26)38-18-20-2-1-3-22(32)14-20)35-30-25-15-21(4-7-27(25)33-19-34-30)28-9-6-24(39-28)17-36-10-12-40(37)13-11-36/h1-9,14-16,19H,10-13,17-18H2,(H,33,34,35)",Fc1cccc(COc2ccc(Nc3ncnc4ccc(cc34)c5oc(CN6CCS(=O)CC6)cc5)cc2Cl)c1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,11.1749,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350112,CHEMBL1785003,"InChI=1S/C27H27FN6O2/c28-20-8-5-19(6-9-20)25-26(34(17-32-25)21-11-14-30-15-12-21)22-13-16-31-27(33-22)36-23-4-2-1-3-18(23)7-10-24(29)35/h1-6,8-9,13,16-17,21,30H,7,10-12,14-15H2,(H2,29,35)",NC(=O)CCc1ccccc1Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5,CHEMBL1785003,"InChI=1S/C27H27FN6O2/c28-20-8-5-19(6-9-20)25-26(34(17-32-25)21-11-14-30-15-12-21)22-13-16-31-27(33-22)36-23-4-2-1-3-18(23)7-10-24(29)35/h1-6,8-9,13,16-17,21,30H,7,10-12,14-15H2,(H2,29,35)",NC(=O)CCc1ccccc1Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.7911,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350114,CHEMBL443563,"InChI=1S/C18H18N2O4/c1-21-14-9-13(10-15(22-2)17(14)23-3)20-18-19-11-16(24-18)12-7-5-4-6-8-12/h4-11H,1-3H3,(H,19,20)",COc1cc(Nc2oc(cn2)c3ccccc3)cc(OC)c1OC,CHEMBL443563,"InChI=1S/C18H18N2O4/c1-21-14-9-13(10-15(22-2)17(14)23-3)20-18-19-11-16(24-18)12-7-5-4-6-8-12/h4-11H,1-3H3,(H,19,20)",COc1cc(Nc2oc(cn2)c3ccccc3)cc(OC)c1OC,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,2.5018,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350117,CHEMBL1785004,"InChI=1S/C24H20F3N5O/c25-16-3-1-15(2-4-16)22-23(32(14-30-22)17-7-10-28-11-8-17)21-9-12-29-24(31-21)33-18-5-6-19(26)20(27)13-18/h1-6,9,12-14,17,28H,7-8,10-11H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc(F)c(F)c5)n4,CHEMBL1785004,"InChI=1S/C24H20F3N5O/c25-16-3-1-15(2-4-16)22-23(32(14-30-22)17-7-10-28-11-8-17)21-9-12-29-24(31-21)33-18-5-6-19(26)20(27)13-18/h1-6,9,12-14,17,28H,7-8,10-11H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc(F)c(F)c5)n4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,22.2969,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350118,CHEMBL275798,"InChI=1S/C24H22FN5O/c25-18-8-6-17(7-9-18)22-23(30(16-28-22)19-10-13-26-14-11-19)21-12-15-27-24(29-21)31-20-4-2-1-3-5-20/h1-9,12,15-16,19,26H,10-11,13-14H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccccc5)n4,CHEMBL275798,"InChI=1S/C24H22FN5O/c25-18-8-6-17(7-9-18)22-23(30(16-28-22)19-10-13-26-14-11-19)21-12-15-27-24(29-21)31-20-4-2-1-3-5-20/h1-9,12,15-16,19,26H,10-11,13-14H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccccc5)n4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,6.2841,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350119,CHEMBL269450,"InChI=1S/C24H21F2N5O/c25-17-3-1-16(2-4-17)22-23(31(15-29-22)19-9-12-27-13-10-19)21-11-14-28-24(30-21)32-20-7-5-18(26)6-8-20/h1-8,11,14-15,19,27H,9-10,12-13H2",Fc1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL269450,"InChI=1S/C24H21F2N5O/c25-17-3-1-16(2-4-17)22-23(31(15-29-22)19-9-12-27-13-10-19)21-11-14-28-24(30-21)32-20-7-5-18(26)6-8-20/h1-8,11,14-15,19,27H,9-10,12-13H2",Fc1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,19.8722,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350122,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL514499,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",COc1cc2ncn(c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(=O)N)c2cc1OC,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.2502,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350128,CHEMBL514162,"InChI=1S/C21H18ClN3O4S/c1-27-16-7-14-15(8-17(16)28-2)25(11-24-14)19-9-18(20(30-19)21(23)26)29-10-12-5-3-4-6-13(12)22/h3-9,11H,10H2,1-2H3,(H2,23,26)",COc1cc2ncn(c3cc(OCc4ccccc4Cl)c(s3)C(=O)N)c2cc1OC,CHEMBL514162,"InChI=1S/C21H18ClN3O4S/c1-27-16-7-14-15(8-17(16)28-2)25(11-24-14)19-9-18(20(30-19)21(23)26)29-10-12-5-3-4-6-13(12)22/h3-9,11H,10H2,1-2H3,(H2,23,26)",COc1cc2ncn(c3cc(OCc4ccccc4Cl)c(s3)C(=O)N)c2cc1OC,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.6284,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350130,CHEMBL185962,"InChI=1S/C11H10N6O/c12-10-9(15-18-16-10)11-14-7-5-13-4-3-8(7)17(11)6-1-2-6/h3-6H,1-2H2,(H2,12,16)",Nc1nonc1c2nc3cnccc3n2C4CC4,CHEMBL185962,"InChI=1S/C11H10N6O/c12-10-9(15-18-16-10)11-14-7-5-13-4-3-8(7)17(11)6-1-2-6/h3-6H,1-2H2,(H2,12,16)",Nc1nonc1c2nc3cnccc3n2C4CC4,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,25.0176,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350131,CHEMBL473629,"InChI=1S/C22H21N3O4S/c1-27-17-10-15-16(11-18(17)28-2)25(13-24-15)20-12-19(21(30-20)22(23)26)29-9-8-14-6-4-3-5-7-14/h3-7,10-13H,8-9H2,1-2H3,(H2,23,26)",COc1cc2ncn(c3cc(OCCc4ccccc4)c(s3)C(=O)N)c2cc1OC,CHEMBL473629,"InChI=1S/C22H21N3O4S/c1-27-17-10-15-16(11-18(17)28-2)25(13-24-15)20-12-19(21(30-20)22(23)26)29-9-8-14-6-4-3-5-7-14/h3-7,10-13H,8-9H2,1-2H3,(H2,23,26)",COc1cc2ncn(c3cc(OCCc4ccccc4)c(s3)C(=O)N)c2cc1OC,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,17.7111,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350132,CHEMBL233001,"InChI=1S/C20H16N2OS/c21-12-17-15-9-3-4-11-18(15)24-20(17)22-19(23)16-10-5-7-13-6-1-2-8-14(13)16/h1-2,5-8,10H,3-4,9,11H2,(H,22,23)",O=C(Nc1sc2CCCCc2c1C#N)c3cccc4ccccc34,CHEMBL233001,"InChI=1S/C20H16N2OS/c21-12-17-15-9-3-4-11-18(15)24-20(17)22-19(23)16-10-5-7-13-6-1-2-8-14(13)16/h1-2,5-8,10H,3-4,9,11H2,(H,22,23)",O=C(Nc1sc2CCCCc2c1C#N)c3cccc4ccccc34,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.1987,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350134,CHEMBL187081,"InChI=1S/C17H14N6O/c1-24-13-5-2-4-12(10-13)21-17-18-9-7-15(22-17)14-11-20-23-16(14)6-3-8-19-23/h2-11H,1H3,(H,18,21,22)",COc1cccc(Nc2nccc(n2)c3cnn4ncccc34)c1,CHEMBL187081,"InChI=1S/C17H14N6O/c1-24-13-5-2-4-12(10-13)21-17-18-9-7-15(22-17)14-11-20-23-16(14)6-3-8-19-23/h2-11H,1H3,(H,18,21,22)",COc1cccc(Nc2nccc(n2)c3cnn4ncccc34)c1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.5601,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350135,CHEMBL243912,"InChI=1S/C23H17F4N5O3S/c1-35-22(34)32-20-29-17-9-7-15(11-19(17)30-20)36-14-5-3-13(4-6-14)28-21(33)31-18-10-12(23(25,26)27)2-8-16(18)24/h2-11H,1H3,(H2,28,31,33)(H2,29,30,32,34)",COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)cc2[nH]1,CHEMBL243912,"InChI=1S/C23H17F4N5O3S/c1-35-22(34)32-20-29-17-9-7-15(11-19(17)30-20)36-14-5-3-13(4-6-14)28-21(33)31-18-10-12(23(25,26)27)2-8-16(18)24/h2-11H,1H3,(H2,28,31,33)(H2,29,30,32,34)",COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(ccc4F)C(F)(F)F)cc3)cc2[nH]1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,4.9917,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350137,CHEMBL192417,"InChI=1S/C16H14N2O/c1-12-6-5-9-14(10-12)18-16-17-11-15(19-16)13-7-3-2-4-8-13/h2-11H,1H3,(H,17,18)",Cc1cccc(Nc2oc(cn2)c3ccccc3)c1,CHEMBL192417,"InChI=1S/C16H14N2O/c1-12-6-5-9-14(10-12)18-16-17-11-15(19-16)13-7-3-2-4-8-13/h2-11H,1H3,(H,17,18)",Cc1cccc(Nc2oc(cn2)c3ccccc3)c1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,25.0176,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350138,CHEMBL518953,"InChI=1S/C19H14BrN3O2S/c20-13-6-2-1-5-12(13)10-25-16-9-17(26-18(16)19(21)24)23-11-22-14-7-3-4-8-15(14)23/h1-9,11H,10H2,(H2,21,24)",NC(=O)c1sc(cc1OCc2ccccc2Br)n3cnc4ccccc34,CHEMBL518953,"InChI=1S/C19H14BrN3O2S/c20-13-6-2-1-5-12(13)10-25-16-9-17(26-18(16)19(21)24)23-11-22-14-7-3-4-8-15(14)23/h1-9,11H,10H2,(H2,21,24)",NC(=O)c1sc(cc1OCc2ccccc2Br)n3cnc4ccccc34,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,8.8766,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350139,CHEMBL244297,"InChI=1S/C26H17F4N5O4/c27-18-9-3-14(26(28,29)30)12-20(18)34-25(37)31-15-4-6-16(7-5-15)39-17-8-10-19-21(13-17)33-24(32-19)35-23(36)22-2-1-11-38-22/h1-13H,(H2,31,34,37)(H2,32,33,35,36)",Fc1ccc(cc1NC(=O)Nc2ccc(Oc3ccc4[nH]c(NC(=O)c5occc5)nc4c3)cc2)C(F)(F)F,CHEMBL244297,"InChI=1S/C26H17F4N5O4/c27-18-9-3-14(26(28,29)30)12-20(18)34-25(37)31-15-4-6-16(7-5-15)39-17-8-10-19-21(13-17)33-24(32-19)35-23(36)22-2-1-11-38-22/h1-13H,(H2,31,34,37)(H2,32,33,35,36)",Fc1ccc(cc1NC(=O)Nc2ccc(Oc3ccc4[nH]c(NC(=O)c5occc5)nc4c3)cc2)C(F)(F)F,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,7.9112,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350142,CHEMBL1895450,"InChI=1S/C27H31N9O3/c1-28-26(38)23-18(8-5-10-29-23)31-25-17-9-11-30-24(17)33-27(34-25)32-19-14-20-16(13-21(19)39-4)7-6-12-36(20)22(37)15-35(2)3/h5,8-11,13-14H,6-7,12,15H2,1-4H3,(H,28,38)(H3,30,31,32,33,34)",CNC(=O)c1ncccc1Nc2nc(Nc3cc4N(CCCc4cc3OC)C(=O)CN(C)C)nc5[nH]ccc25,CHEMBL1895450,"InChI=1S/C27H31N9O3/c1-28-26(38)23-18(8-5-10-29-23)31-25-17-9-11-30-24(17)33-27(34-25)32-19-14-20-16(13-21(19)39-4)7-6-12-36(20)22(37)15-35(2)3/h5,8-11,13-14H,6-7,12,15H2,1-4H3,(H,28,38)(H3,30,31,32,33,34)",CNC(=O)c1ncccc1Nc2nc(Nc3cc4N(CCCc4cc3OC)C(=O)CN(C)C)nc5[nH]ccc25,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,3.965,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350144,CHEMBL463931,"InChI=1S/C27H32N8O3S/c1-27(2)8-10-35(21(36)14-34(3)4)19-13-18(20(38-5)12-16(19)27)31-26-32-24-15(6-9-29-24)25(33-26)30-17-7-11-39-22(17)23(28)37/h6-7,9,11-13H,8,10,14H2,1-5H3,(H2,28,37)(H3,29,30,31,32,33)",COc1cc2c(cc1Nc3nc(Nc4ccsc4C(=O)N)c5cc[nH]c5n3)N(CCC2(C)C)C(=O)CN(C)C,CHEMBL463931,"InChI=1S/C27H32N8O3S/c1-27(2)8-10-35(21(36)14-34(3)4)19-13-18(20(38-5)12-16(19)27)31-26-32-24-15(6-9-29-24)25(33-26)30-17-7-11-39-22(17)23(28)37/h6-7,9,11-13H,8,10,14H2,1-5H3,(H2,28,37)(H3,29,30,31,32,33)",COc1cc2c(cc1Nc3nc(Nc4ccsc4C(=O)N)c5cc[nH]c5n3)N(CCC2(C)C)C(=O)CN(C)C,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.4992,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350146,CHEMBL511765,"InChI=1S/C25H27FN8O3/c1-13-10-19(37-4)18(11-17(13)29-20(35)12-34(2)3)31-25-32-23-14(8-9-28-23)24(33-25)30-16-7-5-6-15(26)21(16)22(27)36/h5-11H,12H2,1-4H3,(H2,27,36)(H,29,35)(H3,28,30,31,32,33)",COc1cc(C)c(NC(=O)CN(C)C)cc1Nc2nc(Nc3cccc(F)c3C(=O)N)c4cc[nH]c4n2,CHEMBL511765,"InChI=1S/C25H27FN8O3/c1-13-10-19(37-4)18(11-17(13)29-20(35)12-34(2)3)31-25-32-23-14(8-9-28-23)24(33-25)30-16-7-5-6-15(26)21(16)22(27)36/h5-11H,12H2,1-4H3,(H2,27,36)(H,29,35)(H3,28,30,31,32,33)",COc1cc(C)c(NC(=O)CN(C)C)cc1Nc2nc(Nc3cccc(F)c3C(=O)N)c4cc[nH]c4n2,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,2.5018,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350147,CHEMBL205966,"InChI=1S/C25H18ClFN4O/c26-23-13-22(10-11-24(23)32-15-18-2-1-3-20(27)12-18)31-25-19(14-29-16-30-25)7-4-17-5-8-21(28)9-6-17/h1-3,5-6,8-14,16H,15,28H2,(H,29,30,31)",Nc1ccc(cc1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL205966,"InChI=1S/C25H18ClFN4O/c26-23-13-22(10-11-24(23)32-15-18-2-1-3-20(27)12-18)31-25-19(14-29-16-30-25)7-4-17-5-8-21(28)9-6-17/h1-3,5-6,8-14,16H,15,28H2,(H,29,30,31)",Nc1ccc(cc1)C#Cc2cncnc2Nc3ccc(OCc4cccc(F)c4)c(Cl)c3,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,3.1495,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350148,CHEMBL467581,"InChI=1S/C26H29FN8O3/c1-14-11-20(38-5)18(12-19(14)35(4)21(36)13-34(2)3)31-26-32-24-15(9-10-29-24)25(33-26)30-17-8-6-7-16(27)22(17)23(28)37/h6-12H,13H2,1-5H3,(H2,28,37)(H3,29,30,31,32,33)",COc1cc(C)c(cc1Nc2nc(Nc3cccc(F)c3C(=O)N)c4cc[nH]c4n2)N(C)C(=O)CN(C)C,CHEMBL467581,"InChI=1S/C26H29FN8O3/c1-14-11-20(38-5)18(12-19(14)35(4)21(36)13-34(2)3)31-26-32-24-15(9-10-29-24)25(33-26)30-17-8-6-7-16(27)22(17)23(28)37/h6-12H,13H2,1-5H3,(H2,28,37)(H3,29,30,31,32,33)",COc1cc(C)c(cc1Nc2nc(Nc3cccc(F)c3C(=O)N)c4cc[nH]c4n2)N(C)C(=O)CN(C)C,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,25.0176,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350149,CHEMBL458415,"InChI=1S/C27H29N7O2/c1-32(2)16-24(35)33-12-10-18-14-23(36-3)20(15-22(18)33)29-27-30-25-19(8-11-28-25)26(31-27)34-13-9-17-6-4-5-7-21(17)34/h4-8,11,14-15H,9-10,12-13,16H2,1-3H3,(H2,28,29,30,31)",COc1cc2CCN(C(=O)CN(C)C)c2cc1Nc3nc(N4CCc5ccccc45)c6cc[nH]c6n3,CHEMBL458415,"InChI=1S/C27H29N7O2/c1-32(2)16-24(35)33-12-10-18-14-23(36-3)20(15-22(18)33)29-27-30-25-19(8-11-28-25)26(31-27)34-13-9-17-6-4-5-7-21(17)34/h4-8,11,14-15H,9-10,12-13,16H2,1-3H3,(H2,28,29,30,31)",COc1cc2CCN(C(=O)CN(C)C)c2cc1Nc3nc(N4CCc5ccccc45)c6cc[nH]c6n3,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,31.4952,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350150,CHEMBL456252,"InChI=1S/C25H28N8O3S/c1-32(2)13-20(34)33-9-4-5-14-11-19(36-3)17(12-18(14)33)29-25-30-23-15(6-8-27-23)24(31-25)28-16-7-10-37-21(16)22(26)35/h6-8,10-12H,4-5,9,13H2,1-3H3,(H2,26,35)(H3,27,28,29,30,31)",COc1cc2CCCN(C(=O)CN(C)C)c2cc1Nc3nc(Nc4ccsc4C(=O)N)c5cc[nH]c5n3,CHEMBL456252,"InChI=1S/C25H28N8O3S/c1-32(2)13-20(34)33-9-4-5-14-11-19(36-3)17(12-18(14)33)29-25-30-23-15(6-8-27-23)24(31-25)28-16-7-10-37-21(16)22(26)35/h6-8,10-12H,4-5,9,13H2,1-3H3,(H2,26,35)(H3,27,28,29,30,31)",COc1cc2CCCN(C(=O)CN(C)C)c2cc1Nc3nc(Nc4ccsc4C(=O)N)c5cc[nH]c5n3,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.0705,uM,active,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350151,CHEMBL273564,"InChI=1S/C20H14F3N5O2/c21-20(22,23)12-2-1-3-14(8-12)28-19(29)27-13-6-4-11(5-7-13)15-9-30-18-16(15)17(24)25-10-26-18/h1-10H,(H2,24,25,26)(H2,27,28,29)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cccc(c4)C(F)(F)F)cc3)c12,CHEMBL273564,"InChI=1S/C20H14F3N5O2/c21-20(22,23)12-2-1-3-14(8-12)28-19(29)27-13-6-4-11(5-7-13)15-9-30-18-16(15)17(24)25-10-26-18/h1-10H,(H2,24,25,26)(H2,27,28,29)",Nc1ncnc2occ(c3ccc(NC(=O)Nc4cccc(c4)C(F)(F)F)cc3)c12,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,9.9597,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124350152,CHEMBL506153,"InChI=1S/C14H18N8O2/c1-3-22-11-8(14(23)18-5-4-16-2)6-17-7-9(11)19-13(22)10-12(15)21-24-20-10/h6-7,16H,3-5H2,1-2H3,(H2,15,21)(H,18,23)",CCn1c(nc2cncc(C(=O)NCCNC)c12)c3nonc3N,CHEMBL506153,"InChI=1S/C14H18N8O2/c1-3-22-11-8(14(23)18-5-4-16-2)6-17-7-9(11)19-13(22)10-12(15)21-24-20-10/h6-7,16H,3-5H2,1-2H3,(H2,15,21)(H,18,23)",CCn1c(nc2cncc(C(=O)NCCNC)c12)c3nonc3N,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,12.5385,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,11.2202,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID90341621,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1794308,"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",Potency,,0.231,uM,inconclusive,CHEMBL614818,HEK293 (Embryonic kidney fibroblasts),Homo sapiens,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1613900,"PubChem BioAssay. qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 3D7. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]",Potency,=,3.5481,uM,Active,CHEMBL612545,,,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614198,PubChem BioAssay. qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 7G8. (Class of assay: confirmatory) ,Potency,=,5.0119,uM,Active,CHEMBL612545,,,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614207,"PubChem BioAssay. qHTS for differential inhibitors of proliferation of Plasmodium falciparum line D10. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]",Potency,=,10,uM,Active,CHEMBL612545,,,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614537,"PubChem BioAssay. qHTS for differential inhibitors of proliferation of Plasmodium falciparum line Dd2. (Class of assay: confirmatory) [Related PubChem assays: 1876 (Assay for Plasmodium falciparum line 7D3), 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]",Potency,=,11.2202,uM,Active,CHEMBL612545,,,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614114,PubChem BioAssay. qHTS for differential inhibitors of proliferation of Plasmodium falciparum line GB4. (Class of assay: confirmatory) ,Potency,=,3.1623,uM,Active,CHEMBL612545,,,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1614142,"PubChem BioAssay. qHTS for differential inhibitors of proliferation of Plasmodium falciparum line HB3. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 3D7), 1828 (Summary assay)]",Potency,=,4.4668,uM,Active,CHEMBL612545,,,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1613767,"PubChem BioAssay. qHTS for differential inhibitors of proliferation of Plasmodium falciparum line W2. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 7D3), 1828 (Summary assay)]",Potency,=,3.5481,uM,Active,CHEMBL612545,,,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID11111220,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1794375,"PubChem BioAssay. qHTS for inhibitors of binding or entry into cells for Marburg Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",Potency,,20.5878,uM,inconclusive,CHEMBL612545,,,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID124349745,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1794375,"PubChem BioAssay. qHTS for inhibitors of binding or entry into cells for Marburg Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",Potency,,20.5878,uM,inconclusive,CHEMBL612545,,,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106291,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1794375,"PubChem BioAssay. qHTS for inhibitors of binding or entry into cells for Marburg Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",Potency,,8.9125,uM,active,CHEMBL612545,,,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID50106292,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1794375,"PubChem BioAssay. qHTS for inhibitors of binding or entry into cells for Marburg Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",Potency,,20.5878,uM,inconclusive,CHEMBL612545,,,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID85231062,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1794375,"PubChem BioAssay. qHTS for inhibitors of binding or entry into cells for Marburg Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",Potency,,20.5878,uM,inconclusive,CHEMBL612545,,,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
SID90341621,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1794375,"PubChem BioAssay. qHTS for inhibitors of binding or entry into cells for Marburg Virus.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",Potency,,20.5878,uM,inconclusive,CHEMBL612545,,,,CHEMBL1201862,PubChem BioAssay data set,,PubChem BioAssays
1A,CHEMBL306865,"InChI=1S/C18H15N7O/c1-26-15-4-2-3-14(9-15)25-18-16(11-23-25)17(20-12-21-18)24-22-10-13-5-7-19-8-6-13/h2-12H,1H3,(H,20,21,24)/b22-10+",COc1cccc(c1)n2ncc3c(N\N=C\c4ccncc4)ncnc23,CHEMBL306865,"InChI=1S/C18H15N7O/c1-26-15-4-2-3-14(9-15)25-18-16(11-23-25)17(20-12-21-18)24-22-10-13-5-7-19-8-6-13/h2-12H,1H3,(H,20,21,24)/b22-10+",COc1cccc(c1)n2ncc3c(N\N=C\c4ccncc4)ncnc23,CHEMBL1249829,Inhibition of GSK3-beta,IC50,=,16,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1240296,"Trends Pharmacol. Sci., 25, p. 471 (2004)",15559249,Scientific Literature
I5,CHEMBL156987,"InChI=1S/C17H10Cl2N2O4/c18-9-3-1-2-8(6-9)13-14(16(23)21-15(13)22)20-10-4-5-12(19)11(7-10)17(24)25/h1-7H,(H,24,25)(H2,20,21,22,23)",OC(=O)c1cc(NC2=C(C(=O)NC2=O)c3cccc(Cl)c3)ccc1Cl,CHEMBL156987,"InChI=1S/C17H10Cl2N2O4/c18-9-3-1-2-8(6-9)13-14(16(23)21-15(13)22)20-10-4-5-12(19)11(7-10)17(24)25/h1-7H,(H,24,25)(H2,20,21,22,23)",OC(=O)c1cc(NC2=C(C(=O)NC2=O)c3cccc(Cl)c3)ccc1Cl,CHEMBL1249829,Inhibition of GSK3-beta,IC50,=,160,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1240296,"Trends Pharmacol. Sci., 25, p. 471 (2004)",15559249,Scientific Literature
34,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL408564,"InChI=1S/C14H11BrN4O2/c15-9-6-8-12(16-11(9)10-2-1-5-21-10)18-19-13(8)17-14(20)7-3-4-7/h1-2,5-7H,3-4H2,(H2,16,17,18,19,20)",Brc1cc2c(NC(=O)C3CC3)n[nH]c2nc1c4occc4,CHEMBL1249828,Inhibition of GSK3alpha,IC50,=,7,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1240296,"Trends Pharmacol. Sci., 25, p. 471 (2004)",15559249,Scientific Literature
I5,CHEMBL156987,"InChI=1S/C17H10Cl2N2O4/c18-9-3-1-2-8(6-9)13-14(16(23)21-15(13)22)20-10-4-5-12(19)11(7-10)17(24)25/h1-7H,(H,24,25)(H2,20,21,22,23)",OC(=O)c1cc(NC2=C(C(=O)NC2=O)c3cccc(Cl)c3)ccc1Cl,CHEMBL156987,"InChI=1S/C17H10Cl2N2O4/c18-9-3-1-2-8(6-9)13-14(16(23)21-15(13)22)20-10-4-5-12(19)11(7-10)17(24)25/h1-7H,(H,24,25)(H2,20,21,22,23)",OC(=O)c1cc(NC2=C(C(=O)NC2=O)c3cccc(Cl)c3)ccc1Cl,CHEMBL1249828,Inhibition of GSK3alpha,IC50,=,76,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1240296,"Trends Pharmacol. Sci., 25, p. 471 (2004)",15559249,Scientific Literature
66,CHEMBL196022,"InChI=1S/C13H11N3O2/c1-17-9-4-2-8(3-5-9)10-6-18-13-11(10)12(14)15-7-16-13/h2-7H,1H3,(H2,14,15,16)",COc1ccc(cc1)c2coc3ncnc(N)c23,CHEMBL196022,"InChI=1S/C13H11N3O2/c1-17-9-4-2-8(3-5-9)10-6-18-13-11(10)12(14)15-7-16-13/h2-7H,1H3,(H2,14,15,16)",COc1ccc(cc1)c2coc3ncnc(N)c23,CHEMBL1243603,Inhibition of KDR,pIC50,=,5.26,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1240323,"J. Mol. Graph. Model., 26, p. 236 (2007)",17293140,Scientific Literature
69,CHEMBL194911,"InChI=1S/C27H19F4N5O3/c1-38-18-9-4-15(5-10-18)23-21(22-24(32)33-13-34-25(22)39-23)14-2-7-17(8-3-14)35-26(37)36-20-12-16(27(29,30)31)6-11-19(20)28/h2-13H,1H3,(H2,32,33,34)(H2,35,36,37)",COc1ccc(cc1)c2oc3ncnc(N)c3c2c4ccc(NC(=O)Nc5cc(ccc5F)C(F)(F)F)cc4,CHEMBL194911,"InChI=1S/C27H19F4N5O3/c1-38-18-9-4-15(5-10-18)23-21(22-24(32)33-13-34-25(22)39-23)14-2-7-17(8-3-14)35-26(37)36-20-12-16(27(29,30)31)6-11-19(20)28/h2-13H,1H3,(H2,32,33,34)(H2,35,36,37)",COc1ccc(cc1)c2oc3ncnc(N)c3c2c4ccc(NC(=O)Nc5cc(ccc5F)C(F)(F)F)cc4,CHEMBL1243603,Inhibition of KDR,pIC50,=,8.52,,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1240323,"J. Mol. Graph. Model., 26, p. 236 (2007)",17293140,Scientific Literature
69,CHEMBL194911,"InChI=1S/C27H19F4N5O3/c1-38-18-9-4-15(5-10-18)23-21(22-24(32)33-13-34-25(22)39-23)14-2-7-17(8-3-14)35-26(37)36-20-12-16(27(29,30)31)6-11-19(20)28/h2-13H,1H3,(H2,32,33,34)(H2,35,36,37)",COc1ccc(cc1)c2oc3ncnc(N)c3c2c4ccc(NC(=O)Nc5cc(ccc5F)C(F)(F)F)cc4,CHEMBL194911,"InChI=1S/C27H19F4N5O3/c1-38-18-9-4-15(5-10-18)23-21(22-24(32)33-13-34-25(22)39-23)14-2-7-17(8-3-14)35-26(37)36-20-12-16(27(29,30)31)6-11-19(20)28/h2-13H,1H3,(H2,32,33,34)(H2,35,36,37)",COc1ccc(cc1)c2oc3ncnc(N)c3c2c4ccc(NC(=O)Nc5cc(ccc5F)C(F)(F)F)cc4,CHEMBL1243605,Inhibition of Tie2,pIC50,=,8.7,,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1240323,"J. Mol. Graph. Model., 26, p. 236 (2007)",17293140,Scientific Literature
GW-2974,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL30432,"InChI=1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28)",CN(C)c1cc2c(Nc3ccc4c(cnn4Cc5ccccc5)c3)ncnc2cn1,CHEMBL1266185,Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay,Inhibition,,,,Not Active,CHEMBL612545,,,,CHEMBL1255231,"Nat. Chem. Biol., 3, p. 268 (2007)",17417631,Scientific Literature
"1a, SB-431542",CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1272395,Inhibition of TGFbeta receptor,IC50,=,125,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1268952,"J. Med. Chem., 53, p. 7287 (2010)",20919678,Scientific Literature
"1a, SB-431542",CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1272394,Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA,EC50,=,172,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1268952,"J. Med. Chem., 53, p. 7287 (2010)",20919678,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1787527,Binding affinity to human KIT D816V mutant incubated for 1 hr by kinase binding assay,Kd,>,10000,nM,,CHEMBL612545,,,,CHEMBL1782045,"Eur. J. Med. Chem., 46, p. 2043 (2011)",21429632,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1787527,Binding affinity to human KIT D816V mutant incubated for 1 hr by kinase binding assay,Kd,>,10000,nM,,CHEMBL612545,,,,CHEMBL1782045,"Eur. J. Med. Chem., 46, p. 2043 (2011)",21429632,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1787525,Binding affinity to human KIT incubated for 1 hr by kinase binding assay,Kd,>,10000,nM,,CHEMBL1936,Stem cell growth factor receptor,Homo sapiens,P10721,CHEMBL1782045,"Eur. J. Med. Chem., 46, p. 2043 (2011)",21429632,Scientific Literature
SB-431542,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL440084,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",NC(=O)c1ccc(cc1)c2nc(c3ccccn3)c([nH]2)c4ccc5OCOc5c4,CHEMBL1787525,Binding affinity to human KIT incubated for 1 hr by kinase binding assay,Kd,>,10000,nM,,CHEMBL1936,Stem cell growth factor receptor,Homo sapiens,P10721,CHEMBL1782045,"Eur. J. Med. Chem., 46, p. 2043 (2011)",21429632,Scientific Literature
12,CHEMBL273611,"InChI=1S/C25H22FN5O3/c26-17-3-1-16(2-4-17)23-24(31(14-29-23)18-7-10-27-11-8-18)20-9-12-28-25(30-20)34-19-5-6-21-22(13-19)33-15-32-21/h1-6,9,12-14,18,27H,7-8,10-11,15H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc6OCOc6c5)n4,CHEMBL273611,"InChI=1S/C25H22FN5O3/c26-17-3-1-16(2-4-17)23-24(31(14-29-23)18-7-10-27-11-8-18)20-9-12-28-25(30-20)34-19-5-6-21-22(13-19)33-15-32-21/h1-6,9,12-14,18,27H,7-8,10-11,15H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc6OCOc6c5)n4,CHEMBL1785239,Inhibition of p38alpha,IC50,=,23,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
13,CHEMBL417804,"InChI=1S/C25H24FN5O2/c1-32-21-4-2-3-5-22(21)33-25-28-15-12-20(30-25)24-23(17-6-8-18(26)9-7-17)29-16-31(24)19-10-13-27-14-11-19/h2-9,12,15-16,19,27H,10-11,13-14H2,1H3",COc1ccccc1Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5,CHEMBL417804,"InChI=1S/C25H24FN5O2/c1-32-21-4-2-3-5-22(21)33-25-28-15-12-20(30-25)24-23(17-6-8-18(26)9-7-17)29-16-31(24)19-10-13-27-14-11-19/h2-9,12,15-16,19,27H,10-11,13-14H2,1H3",COc1ccccc1Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5,CHEMBL1785239,Inhibition of p38alpha,IC50,=,25,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
20,CHEMBL275200,"InChI=1S/C28H30FN5O/c1-28(2,3)20-6-10-23(11-7-20)35-27-31-17-14-24(33-27)26-25(19-4-8-21(29)9-5-19)32-18-34(26)22-12-15-30-16-13-22/h4-11,14,17-18,22,30H,12-13,15-16H2,1-3H3",CC(C)(C)c1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL275200,"InChI=1S/C28H30FN5O/c1-28(2,3)20-6-10-23(11-7-20)35-27-31-17-14-24(33-27)26-25(19-4-8-21(29)9-5-19)32-18-34(26)22-12-15-30-16-13-22/h4-11,14,17-18,22,30H,12-13,15-16H2,1-3H3",CC(C)(C)c1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL1785239,Inhibition of p38alpha,IC50,=,79,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
21,CHEMBL14233,"InChI=1S/C25H22FN5O3/c26-18-5-1-16(2-6-18)22-23(31(15-29-22)19-9-12-27-13-10-19)21-11-14-28-25(30-21)34-20-7-3-17(4-8-20)24(32)33/h1-8,11,14-15,19,27H,9-10,12-13H2,(H,32,33)",OC(=O)c1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL14233,"InChI=1S/C25H22FN5O3/c26-18-5-1-16(2-6-18)22-23(31(15-29-22)19-9-12-27-13-10-19)21-11-14-28-25(30-21)34-20-7-3-17(4-8-20)24(32)33/h1-8,11,14-15,19,27H,9-10,12-13H2,(H,32,33)",OC(=O)c1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL1785239,Inhibition of p38alpha,IC50,=,82,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
23,CHEMBL275724,"InChI=1S/C25H23FN6O2/c26-18-5-1-16(2-6-18)22-23(32(15-30-22)19-9-12-28-13-10-19)21-11-14-29-25(31-21)34-20-7-3-17(4-8-20)24(27)33/h1-8,11,14-15,19,28H,9-10,12-13H2,(H2,27,33)",NC(=O)c1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL275724,"InChI=1S/C25H23FN6O2/c26-18-5-1-16(2-6-18)22-23(32(15-30-22)19-9-12-28-13-10-19)21-11-14-29-25(31-21)34-20-7-3-17(4-8-20)24(27)33/h1-8,11,14-15,19,28H,9-10,12-13H2,(H2,27,33)",NC(=O)c1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL1785239,Inhibition of p38alpha,IC50,=,89.7,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
24,CHEMBL14014,"InChI=1S/C24H21F2N5O/c25-17-6-4-16(5-7-17)22-23(31(15-29-22)19-8-11-27-12-9-19)21-10-13-28-24(30-21)32-20-3-1-2-18(26)14-20/h1-7,10,13-15,19,27H,8-9,11-12H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5cccc(F)c5)n4,CHEMBL14014,"InChI=1S/C24H21F2N5O/c25-17-6-4-16(5-7-17)22-23(31(15-29-22)19-8-11-27-12-9-19)21-10-13-28-24(30-21)32-20-3-1-2-18(26)14-20/h1-7,10,13-15,19,27H,8-9,11-12H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5cccc(F)c5)n4,CHEMBL1785239,Inhibition of p38alpha,IC50,=,95,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
25,CHEMBL275168,"InChI=1S/C24H21ClFN5O/c25-17-3-7-20(8-4-17)32-24-28-14-11-21(30-24)23-22(16-1-5-18(26)6-2-16)29-15-31(23)19-9-12-27-13-10-19/h1-8,11,14-15,19,27H,9-10,12-13H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc(Cl)cc5)n4,CHEMBL275168,"InChI=1S/C24H21ClFN5O/c25-17-3-7-20(8-4-17)32-24-28-14-11-21(30-24)23-22(16-1-5-18(26)6-2-16)29-15-31(23)19-9-12-27-13-10-19/h1-8,11,14-15,19,27H,9-10,12-13H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc(Cl)cc5)n4,CHEMBL1785239,Inhibition of p38alpha,IC50,=,114,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
27,CHEMBL13868,"InChI=1S/C30H26FN5O2/c31-22-8-6-21(7-9-22)28-29(36(20-34-28)23-14-17-32-18-15-23)27-16-19-33-30(35-27)38-26-12-10-25(11-13-26)37-24-4-2-1-3-5-24/h1-13,16,19-20,23,32H,14-15,17-18H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc(Oc6ccccc6)cc5)n4,CHEMBL13868,"InChI=1S/C30H26FN5O2/c31-22-8-6-21(7-9-22)28-29(36(20-34-28)23-14-17-32-18-15-23)27-16-19-33-30(35-27)38-26-12-10-25(11-13-26)37-24-4-2-1-3-5-24/h1-13,16,19-20,23,32H,14-15,17-18H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc(Oc6ccccc6)cc5)n4,CHEMBL1785239,Inhibition of p38alpha,IC50,=,130,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
28,CHEMBL275666,"InChI=1S/C25H21F4N5O/c26-18-6-4-16(5-7-18)22-23(34(15-32-22)19-8-11-30-12-9-19)21-10-13-31-24(33-21)35-20-3-1-2-17(14-20)25(27,28)29/h1-7,10,13-15,19,30H,8-9,11-12H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5cccc(c5)C(F)(F)F)n4,CHEMBL275666,"InChI=1S/C25H21F4N5O/c26-18-6-4-16(5-7-18)22-23(34(15-32-22)19-8-11-30-12-9-19)21-10-13-31-24(33-21)35-20-3-1-2-17(14-20)25(27,28)29/h1-7,10,13-15,19,30H,8-9,11-12H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5cccc(c5)C(F)(F)F)n4,CHEMBL1785239,Inhibition of p38alpha,IC50,=,132,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
29,CHEMBL1785002,"InChI=1S/C26H25FN6O2/c27-19-7-5-17(6-8-19)24-25(33(16-31-24)20-9-12-29-13-10-20)21-11-14-30-26(32-21)35-22-4-2-1-3-18(22)15-23(28)34/h1-8,11,14,16,20,29H,9-10,12-13,15H2,(H2,28,34)",NC(=O)Cc1ccccc1Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5,CHEMBL1785002,"InChI=1S/C26H25FN6O2/c27-19-7-5-17(6-8-19)24-25(33(16-31-24)20-9-12-29-13-10-20)21-11-14-30-26(32-21)35-22-4-2-1-3-18(22)15-23(28)34/h1-8,11,14,16,20,29H,9-10,12-13,15H2,(H2,28,34)",NC(=O)Cc1ccccc1Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5,CHEMBL1785239,Inhibition of p38alpha,IC50,=,134,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
3,CHEMBL428877,"InChI=1S/C26H26FN5O/c1-2-18-3-9-22(10-4-18)33-26-29-16-13-23(31-26)25-24(19-5-7-20(27)8-6-19)30-17-32(25)21-11-14-28-15-12-21/h3-10,13,16-17,21,28H,2,11-12,14-15H2,1H3",CCc1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL428877,"InChI=1S/C26H26FN5O/c1-2-18-3-9-22(10-4-18)33-26-29-16-13-23(31-26)25-24(19-5-7-20(27)8-6-19)30-17-32(25)21-11-14-28-15-12-21/h3-10,13,16-17,21,28H,2,11-12,14-15H2,1H3",CCc1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL1785239,Inhibition of p38alpha,IC50,=,7.4,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
30,CHEMBL1785003,"InChI=1S/C27H27FN6O2/c28-20-8-5-19(6-9-20)25-26(34(17-32-25)21-11-14-30-15-12-21)22-13-16-31-27(33-22)36-23-4-2-1-3-18(23)7-10-24(29)35/h1-6,8-9,13,16-17,21,30H,7,10-12,14-15H2,(H2,29,35)",NC(=O)CCc1ccccc1Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5,CHEMBL1785003,"InChI=1S/C27H27FN6O2/c28-20-8-5-19(6-9-20)25-26(34(17-32-25)21-11-14-30-15-12-21)22-13-16-31-27(33-22)36-23-4-2-1-3-18(23)7-10-24(29)35/h1-6,8-9,13,16-17,21,30H,7,10-12,14-15H2,(H2,29,35)",NC(=O)CCc1ccccc1Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5,CHEMBL1785239,Inhibition of p38alpha,IC50,=,151,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
33,CHEMBL13972,"InChI=1S/C25H21FN6O/c26-19-5-3-18(4-6-19)23-24(32(16-30-23)20-9-12-28-13-10-20)22-11-14-29-25(31-22)33-21-7-1-17(15-27)2-8-21/h1-8,11,14,16,20,28H,9-10,12-13H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc(cc5)C#N)n4,CHEMBL13972,"InChI=1S/C25H21FN6O/c26-19-5-3-18(4-6-19)23-24(32(16-30-23)20-9-12-28-13-10-20)22-11-14-29-25(31-22)33-21-7-1-17(15-27)2-8-21/h1-8,11,14,16,20,28H,9-10,12-13H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc(cc5)C#N)n4,CHEMBL1785239,Inhibition of p38alpha,IC50,=,177,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
35,CHEMBL1785004,"InChI=1S/C24H20F3N5O/c25-16-3-1-15(2-4-16)22-23(32(14-30-22)17-7-10-28-11-8-17)21-9-12-29-24(31-21)33-18-5-6-19(26)20(27)13-18/h1-6,9,12-14,17,28H,7-8,10-11H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc(F)c(F)c5)n4,CHEMBL1785004,"InChI=1S/C24H20F3N5O/c25-16-3-1-15(2-4-16)22-23(32(14-30-22)17-7-10-28-11-8-17)21-9-12-29-24(31-21)33-18-5-6-19(26)20(27)13-18/h1-6,9,12-14,17,28H,7-8,10-11H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc(F)c(F)c5)n4,CHEMBL1785239,Inhibition of p38alpha,IC50,=,209,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
37,CHEMBL269450,"InChI=1S/C24H21F2N5O/c25-17-3-1-16(2-4-17)22-23(31(15-29-22)19-9-12-27-13-10-19)21-11-14-28-24(30-21)32-20-7-5-18(26)6-8-20/h1-8,11,14-15,19,27H,9-10,12-13H2",Fc1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL269450,"InChI=1S/C24H21F2N5O/c25-17-3-1-16(2-4-17)22-23(31(15-29-22)19-9-12-27-13-10-19)21-11-14-28-24(30-21)32-20-7-5-18(26)6-8-20/h1-8,11,14-15,19,27H,9-10,12-13H2",Fc1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL1785239,Inhibition of p38alpha,IC50,=,300,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
43,CHEMBL418348,"InChI=1S/C25H24FN5O3S/c1-35(32,33)21-8-6-20(7-9-21)34-25-28-15-12-22(30-25)24-23(17-2-4-18(26)5-3-17)29-16-31(24)19-10-13-27-14-11-19/h2-9,12,15-16,19,27H,10-11,13-14H2,1H3",CS(=O)(=O)c1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL418348,"InChI=1S/C25H24FN5O3S/c1-35(32,33)21-8-6-20(7-9-21)34-25-28-15-12-22(30-25)24-23(17-2-4-18(26)5-3-17)29-16-31(24)19-10-13-27-14-11-19/h2-9,12,15-16,19,27H,10-11,13-14H2,1H3",CS(=O)(=O)c1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL1785239,Inhibition of p38alpha,IC50,=,650,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
44,CHEMBL275798,"InChI=1S/C24H22FN5O/c25-18-8-6-17(7-9-18)22-23(30(16-28-22)19-10-13-26-14-11-19)21-12-15-27-24(29-21)31-20-4-2-1-3-5-20/h1-9,12,15-16,19,26H,10-11,13-14H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccccc5)n4,CHEMBL275798,"InChI=1S/C24H22FN5O/c25-18-8-6-17(7-9-18)22-23(30(16-28-22)19-10-13-26-14-11-19)21-12-15-27-24(29-21)31-20-4-2-1-3-5-20/h1-9,12,15-16,19,26H,10-11,13-14H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccccc5)n4,CHEMBL1785239,Inhibition of p38alpha,IC50,=,19.2,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
8,CHEMBL14212,"InChI=1S/C26H26FN5O/c1-17-4-3-5-23(18(17)2)33-26-29-15-12-22(31-26)25-24(19-6-8-20(27)9-7-19)30-16-32(25)21-10-13-28-14-11-21/h3-9,12,15-16,21,28H,10-11,13-14H2,1-2H3",Cc1cccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)c1C,CHEMBL14212,"InChI=1S/C26H26FN5O/c1-17-4-3-5-23(18(17)2)33-26-29-15-12-22(31-26)25-24(19-6-8-20(27)9-7-19)30-16-32(25)21-10-13-28-14-11-21/h3-9,12,15-16,21,28H,10-11,13-14H2,1-2H3",Cc1cccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)c1C,CHEMBL1785239,Inhibition of p38alpha,IC50,=,15.2,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
12,CHEMBL273611,"InChI=1S/C25H22FN5O3/c26-17-3-1-16(2-4-17)23-24(31(14-29-23)18-7-10-27-11-8-18)20-9-12-28-25(30-20)34-19-5-6-21-22(13-19)33-15-32-21/h1-6,9,12-14,18,27H,7-8,10-11,15H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc6OCOc6c5)n4,CHEMBL273611,"InChI=1S/C25H22FN5O3/c26-17-3-1-16(2-4-17)23-24(31(14-29-23)18-7-10-27-11-8-18)20-9-12-28-25(30-20)34-19-5-6-21-22(13-19)33-15-32-21/h1-6,9,12-14,18,27H,7-8,10-11,15H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc6OCOc6c5)n4,CHEMBL1785239,Inhibition of p38alpha,pIC50,=,7.64,,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
13,CHEMBL417804,"InChI=1S/C25H24FN5O2/c1-32-21-4-2-3-5-22(21)33-25-28-15-12-20(30-25)24-23(17-6-8-18(26)9-7-17)29-16-31(24)19-10-13-27-14-11-19/h2-9,12,15-16,19,27H,10-11,13-14H2,1H3",COc1ccccc1Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5,CHEMBL417804,"InChI=1S/C25H24FN5O2/c1-32-21-4-2-3-5-22(21)33-25-28-15-12-20(30-25)24-23(17-6-8-18(26)9-7-17)29-16-31(24)19-10-13-27-14-11-19/h2-9,12,15-16,19,27H,10-11,13-14H2,1H3",COc1ccccc1Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5,CHEMBL1785239,Inhibition of p38alpha,pIC50,=,7.6,,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
20,CHEMBL275200,"InChI=1S/C28H30FN5O/c1-28(2,3)20-6-10-23(11-7-20)35-27-31-17-14-24(33-27)26-25(19-4-8-21(29)9-5-19)32-18-34(26)22-12-15-30-16-13-22/h4-11,14,17-18,22,30H,12-13,15-16H2,1-3H3",CC(C)(C)c1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL275200,"InChI=1S/C28H30FN5O/c1-28(2,3)20-6-10-23(11-7-20)35-27-31-17-14-24(33-27)26-25(19-4-8-21(29)9-5-19)32-18-34(26)22-12-15-30-16-13-22/h4-11,14,17-18,22,30H,12-13,15-16H2,1-3H3",CC(C)(C)c1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL1785239,Inhibition of p38alpha,pIC50,=,7.1,,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
21,CHEMBL14233,"InChI=1S/C25H22FN5O3/c26-18-5-1-16(2-6-18)22-23(31(15-29-22)19-9-12-27-13-10-19)21-11-14-28-25(30-21)34-20-7-3-17(4-8-20)24(32)33/h1-8,11,14-15,19,27H,9-10,12-13H2,(H,32,33)",OC(=O)c1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL14233,"InChI=1S/C25H22FN5O3/c26-18-5-1-16(2-6-18)22-23(31(15-29-22)19-9-12-27-13-10-19)21-11-14-28-25(30-21)34-20-7-3-17(4-8-20)24(32)33/h1-8,11,14-15,19,27H,9-10,12-13H2,(H,32,33)",OC(=O)c1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL1785239,Inhibition of p38alpha,pIC50,=,7.09,,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
23,CHEMBL275724,"InChI=1S/C25H23FN6O2/c26-18-5-1-16(2-6-18)22-23(32(15-30-22)19-9-12-28-13-10-19)21-11-14-29-25(31-21)34-20-7-3-17(4-8-20)24(27)33/h1-8,11,14-15,19,28H,9-10,12-13H2,(H2,27,33)",NC(=O)c1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL275724,"InChI=1S/C25H23FN6O2/c26-18-5-1-16(2-6-18)22-23(32(15-30-22)19-9-12-28-13-10-19)21-11-14-29-25(31-21)34-20-7-3-17(4-8-20)24(27)33/h1-8,11,14-15,19,28H,9-10,12-13H2,(H2,27,33)",NC(=O)c1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL1785239,Inhibition of p38alpha,pIC50,=,7.05,,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
24,CHEMBL14014,"InChI=1S/C24H21F2N5O/c25-17-6-4-16(5-7-17)22-23(31(15-29-22)19-8-11-27-12-9-19)21-10-13-28-24(30-21)32-20-3-1-2-18(26)14-20/h1-7,10,13-15,19,27H,8-9,11-12H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5cccc(F)c5)n4,CHEMBL14014,"InChI=1S/C24H21F2N5O/c25-17-6-4-16(5-7-17)22-23(31(15-29-22)19-8-11-27-12-9-19)21-10-13-28-24(30-21)32-20-3-1-2-18(26)14-20/h1-7,10,13-15,19,27H,8-9,11-12H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5cccc(F)c5)n4,CHEMBL1785239,Inhibition of p38alpha,pIC50,=,7.02,,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
25,CHEMBL275168,"InChI=1S/C24H21ClFN5O/c25-17-3-7-20(8-4-17)32-24-28-14-11-21(30-24)23-22(16-1-5-18(26)6-2-16)29-15-31(23)19-9-12-27-13-10-19/h1-8,11,14-15,19,27H,9-10,12-13H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc(Cl)cc5)n4,CHEMBL275168,"InChI=1S/C24H21ClFN5O/c25-17-3-7-20(8-4-17)32-24-28-14-11-21(30-24)23-22(16-1-5-18(26)6-2-16)29-15-31(23)19-9-12-27-13-10-19/h1-8,11,14-15,19,27H,9-10,12-13H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc(Cl)cc5)n4,CHEMBL1785239,Inhibition of p38alpha,pIC50,=,6.94,,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
27,CHEMBL13868,"InChI=1S/C30H26FN5O2/c31-22-8-6-21(7-9-22)28-29(36(20-34-28)23-14-17-32-18-15-23)27-16-19-33-30(35-27)38-26-12-10-25(11-13-26)37-24-4-2-1-3-5-24/h1-13,16,19-20,23,32H,14-15,17-18H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc(Oc6ccccc6)cc5)n4,CHEMBL13868,"InChI=1S/C30H26FN5O2/c31-22-8-6-21(7-9-22)28-29(36(20-34-28)23-14-17-32-18-15-23)27-16-19-33-30(35-27)38-26-12-10-25(11-13-26)37-24-4-2-1-3-5-24/h1-13,16,19-20,23,32H,14-15,17-18H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc(Oc6ccccc6)cc5)n4,CHEMBL1785239,Inhibition of p38alpha,pIC50,=,6.89,,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
28,CHEMBL275666,"InChI=1S/C25H21F4N5O/c26-18-6-4-16(5-7-18)22-23(34(15-32-22)19-8-11-30-12-9-19)21-10-13-31-24(33-21)35-20-3-1-2-17(14-20)25(27,28)29/h1-7,10,13-15,19,30H,8-9,11-12H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5cccc(c5)C(F)(F)F)n4,CHEMBL275666,"InChI=1S/C25H21F4N5O/c26-18-6-4-16(5-7-18)22-23(34(15-32-22)19-8-11-30-12-9-19)21-10-13-31-24(33-21)35-20-3-1-2-17(14-20)25(27,28)29/h1-7,10,13-15,19,30H,8-9,11-12H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5cccc(c5)C(F)(F)F)n4,CHEMBL1785239,Inhibition of p38alpha,pIC50,=,6.88,,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
29,CHEMBL1785002,"InChI=1S/C26H25FN6O2/c27-19-7-5-17(6-8-19)24-25(33(16-31-24)20-9-12-29-13-10-20)21-11-14-30-26(32-21)35-22-4-2-1-3-18(22)15-23(28)34/h1-8,11,14,16,20,29H,9-10,12-13,15H2,(H2,28,34)",NC(=O)Cc1ccccc1Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5,CHEMBL1785002,"InChI=1S/C26H25FN6O2/c27-19-7-5-17(6-8-19)24-25(33(16-31-24)20-9-12-29-13-10-20)21-11-14-30-26(32-21)35-22-4-2-1-3-18(22)15-23(28)34/h1-8,11,14,16,20,29H,9-10,12-13,15H2,(H2,28,34)",NC(=O)Cc1ccccc1Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5,CHEMBL1785239,Inhibition of p38alpha,pIC50,=,6.87,,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
3,CHEMBL428877,"InChI=1S/C26H26FN5O/c1-2-18-3-9-22(10-4-18)33-26-29-16-13-23(31-26)25-24(19-5-7-20(27)8-6-19)30-17-32(25)21-11-14-28-15-12-21/h3-10,13,16-17,21,28H,2,11-12,14-15H2,1H3",CCc1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL428877,"InChI=1S/C26H26FN5O/c1-2-18-3-9-22(10-4-18)33-26-29-16-13-23(31-26)25-24(19-5-7-20(27)8-6-19)30-17-32(25)21-11-14-28-15-12-21/h3-10,13,16-17,21,28H,2,11-12,14-15H2,1H3",CCc1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL1785239,Inhibition of p38alpha,pIC50,=,8.13,,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
30,CHEMBL1785003,"InChI=1S/C27H27FN6O2/c28-20-8-5-19(6-9-20)25-26(34(17-32-25)21-11-14-30-15-12-21)22-13-16-31-27(33-22)36-23-4-2-1-3-18(23)7-10-24(29)35/h1-6,8-9,13,16-17,21,30H,7,10-12,14-15H2,(H2,29,35)",NC(=O)CCc1ccccc1Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5,CHEMBL1785003,"InChI=1S/C27H27FN6O2/c28-20-8-5-19(6-9-20)25-26(34(17-32-25)21-11-14-30-15-12-21)22-13-16-31-27(33-22)36-23-4-2-1-3-18(23)7-10-24(29)35/h1-6,8-9,13,16-17,21,30H,7,10-12,14-15H2,(H2,29,35)",NC(=O)CCc1ccccc1Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5,CHEMBL1785239,Inhibition of p38alpha,pIC50,=,6.82,,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
33,CHEMBL13972,"InChI=1S/C25H21FN6O/c26-19-5-3-18(4-6-19)23-24(32(16-30-23)20-9-12-28-13-10-20)22-11-14-29-25(31-22)33-21-7-1-17(15-27)2-8-21/h1-8,11,14,16,20,28H,9-10,12-13H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc(cc5)C#N)n4,CHEMBL13972,"InChI=1S/C25H21FN6O/c26-19-5-3-18(4-6-19)23-24(32(16-30-23)20-9-12-28-13-10-20)22-11-14-29-25(31-22)33-21-7-1-17(15-27)2-8-21/h1-8,11,14,16,20,28H,9-10,12-13H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc(cc5)C#N)n4,CHEMBL1785239,Inhibition of p38alpha,pIC50,=,6.75,,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
35,CHEMBL1785004,"InChI=1S/C24H20F3N5O/c25-16-3-1-15(2-4-16)22-23(32(14-30-22)17-7-10-28-11-8-17)21-9-12-29-24(31-21)33-18-5-6-19(26)20(27)13-18/h1-6,9,12-14,17,28H,7-8,10-11H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc(F)c(F)c5)n4,CHEMBL1785004,"InChI=1S/C24H20F3N5O/c25-16-3-1-15(2-4-16)22-23(32(14-30-22)17-7-10-28-11-8-17)21-9-12-29-24(31-21)33-18-5-6-19(26)20(27)13-18/h1-6,9,12-14,17,28H,7-8,10-11H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccc(F)c(F)c5)n4,CHEMBL1785239,Inhibition of p38alpha,pIC50,=,6.68,,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
37,CHEMBL269450,"InChI=1S/C24H21F2N5O/c25-17-3-1-16(2-4-17)22-23(31(15-29-22)19-9-12-27-13-10-19)21-11-14-28-24(30-21)32-20-7-5-18(26)6-8-20/h1-8,11,14-15,19,27H,9-10,12-13H2",Fc1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL269450,"InChI=1S/C24H21F2N5O/c25-17-3-1-16(2-4-17)22-23(31(15-29-22)19-9-12-27-13-10-19)21-11-14-28-24(30-21)32-20-7-5-18(26)6-8-20/h1-8,11,14-15,19,27H,9-10,12-13H2",Fc1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL1785239,Inhibition of p38alpha,pIC50,=,6.52,,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
43,CHEMBL418348,"InChI=1S/C25H24FN5O3S/c1-35(32,33)21-8-6-20(7-9-21)34-25-28-15-12-22(30-25)24-23(17-2-4-18(26)5-3-17)29-16-31(24)19-10-13-27-14-11-19/h2-9,12,15-16,19,27H,10-11,13-14H2,1H3",CS(=O)(=O)c1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL418348,"InChI=1S/C25H24FN5O3S/c1-35(32,33)21-8-6-20(7-9-21)34-25-28-15-12-22(30-25)24-23(17-2-4-18(26)5-3-17)29-16-31(24)19-10-13-27-14-11-19/h2-9,12,15-16,19,27H,10-11,13-14H2,1H3",CS(=O)(=O)c1ccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)cc1,CHEMBL1785239,Inhibition of p38alpha,pIC50,=,6.19,,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
44,CHEMBL275798,"InChI=1S/C24H22FN5O/c25-18-8-6-17(7-9-18)22-23(30(16-28-22)19-10-13-26-14-11-19)21-12-15-27-24(29-21)31-20-4-2-1-3-5-20/h1-9,12,15-16,19,26H,10-11,13-14H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccccc5)n4,CHEMBL275798,"InChI=1S/C24H22FN5O/c25-18-8-6-17(7-9-18)22-23(30(16-28-22)19-10-13-26-14-11-19)21-12-15-27-24(29-21)31-20-4-2-1-3-5-20/h1-9,12,15-16,19,26H,10-11,13-14H2",Fc1ccc(cc1)c2ncn(C3CCNCC3)c2c4ccnc(Oc5ccccc5)n4,CHEMBL1785239,Inhibition of p38alpha,pIC50,=,7.72,,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
8,CHEMBL14212,"InChI=1S/C26H26FN5O/c1-17-4-3-5-23(18(17)2)33-26-29-15-12-22(31-26)25-24(19-6-8-20(27)9-7-19)30-16-32(25)21-10-13-28-14-11-21/h3-9,12,15-16,21,28H,10-11,13-14H2,1-2H3",Cc1cccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)c1C,CHEMBL14212,"InChI=1S/C26H26FN5O/c1-17-4-3-5-23(18(17)2)33-26-29-15-12-22(31-26)25-24(19-6-8-20(27)9-7-19)30-16-32(25)21-10-13-28-14-11-21/h3-9,12,15-16,21,28H,10-11,13-14H2,1-2H3",Cc1cccc(Oc2nccc(n2)c3c(ncn3C4CCNCC4)c5ccc(F)cc5)c1C,CHEMBL1785239,Inhibition of p38alpha,pIC50,=,7.82,,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1782054,"Eur. J. Med. Chem., 43, p. 830 (2008)",17706839,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908786,Binding constant for AAK1 kinase domain,Kd,>,10000,nM,,CHEMBL3830,Adaptor-associated kinase,Homo sapiens,Q2M2I8,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908675,Binding constant for ABL1(E255K)-phosphorylated kinase domain,Kd,>,10000,nM,,CHEMBL1862,Tyrosine-protein kinase ABL,Homo sapiens,P00519,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908676,Binding constant for ABL1(F317I)-nonphosphorylated kinase domain,Kd,>,10000,nM,,CHEMBL1862,Tyrosine-protein kinase ABL,Homo sapiens,P00519,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908677,Binding constant for ABL1(F317I)-phosphorylated kinase domain,Kd,>,10000,nM,,CHEMBL1862,Tyrosine-protein kinase ABL,Homo sapiens,P00519,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908678,Binding constant for ABL1(F317L)-nonphosphorylated kinase domain,Kd,>,10000,nM,,CHEMBL1862,Tyrosine-protein kinase ABL,Homo sapiens,P00519,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908679,Binding constant for ABL1(F317L)-phosphorylated kinase domain,Kd,>,10000,nM,,CHEMBL1862,Tyrosine-protein kinase ABL,Homo sapiens,P00519,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908680,Binding constant for ABL1(H396P)-nonphosphorylated kinase domain,Kd,>,10000,nM,,CHEMBL1862,Tyrosine-protein kinase ABL,Homo sapiens,P00519,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908681,Binding constant for ABL1(H396P)-phosphorylated kinase domain,Kd,>,10000,nM,,CHEMBL1862,Tyrosine-protein kinase ABL,Homo sapiens,P00519,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908682,Binding constant for ABL1(M351T)-phosphorylated kinase domain,Kd,>,10000,nM,,CHEMBL1862,Tyrosine-protein kinase ABL,Homo sapiens,P00519,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908683,Binding constant for ABL1(Q252H)-nonphosphorylated kinase domain,Kd,>,10000,nM,,CHEMBL1862,Tyrosine-protein kinase ABL,Homo sapiens,P00519,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908684,Binding constant for ABL1(Q252H)-phosphorylated kinase domain,Kd,>,10000,nM,,CHEMBL1862,Tyrosine-protein kinase ABL,Homo sapiens,P00519,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908685,Binding constant for ABL1(T315I)-nonphosphorylated kinase domain,Kd,>,10000,nM,,CHEMBL1862,Tyrosine-protein kinase ABL,Homo sapiens,P00519,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908686,Binding constant for ABL1(T315I)-phosphorylated kinase domain,Kd,>,10000,nM,,CHEMBL1862,Tyrosine-protein kinase ABL,Homo sapiens,P00519,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908687,Binding constant for ABL1(Y253F)-phosphorylated kinase domain,Kd,>,10000,nM,,CHEMBL1862,Tyrosine-protein kinase ABL,Homo sapiens,P00519,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908688,Binding constant for ABL1-nonphosphorylated kinase domain,Kd,>,10000,nM,,CHEMBL1862,Tyrosine-protein kinase ABL,Homo sapiens,P00519,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908689,Binding constant for ABL1-phosphorylated kinase domain,Kd,>,10000,nM,,CHEMBL1862,Tyrosine-protein kinase ABL,Homo sapiens,P00519,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908690,Binding constant for ABL2 kinase domain,Kd,>,10000,nM,,CHEMBL4014,Tyrosine-protein kinase ABL2,Homo sapiens,P42684,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908516,Binding constant for ACVR1 kinase domain,Kd,>,10000,nM,,CHEMBL5903,Activin receptor type-1,Homo sapiens,Q04771,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908640,Binding constant for ACVR1B kinase domain,Kd,>,10000,nM,,CHEMBL5310,Activin receptor type-1B,Homo sapiens,P36896,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908535,Binding constant for ACVR2A kinase domain,Kd,>,10000,nM,,CHEMBL5616,Activin receptor type-2A,Homo sapiens,P27037,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908517,Binding constant for ACVR2B kinase domain,Kd,>,10000,nM,,CHEMBL5466,Activin receptor type-2B,Homo sapiens,Q13705,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908475,Binding constant for ACVRL1 kinase domain,Kd,>,10000,nM,,CHEMBL5311,Serine/threonine-protein kinase receptor R3,Homo sapiens,P37023,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908813,Binding constant for ADCK3 kinase domain,Kd,>,10000,nM,,CHEMBL5550,"Chaperone activity of bc1 complex-like, mitochondrial",Homo sapiens,Q8NI60,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908832,Binding constant for ADCK4 kinase domain,Kd,>,10000,nM,,CHEMBL5753,Uncharacterized aarF domain-containing protein kinase 4,Homo sapiens,Q96D53,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908691,Binding constant for AKT1 kinase domain,Kd,>,10000,nM,,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,P31749,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908536,Binding constant for AKT2 kinase domain,Kd,>,10000,nM,,CHEMBL2431,Serine/threonine-protein kinase AKT2,Homo sapiens,P31751,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908716,Binding constant for AKT3 kinase domain,Kd,>,10000,nM,,CHEMBL4816,Serine/threonine-protein kinase AKT3,Homo sapiens,Q9Y243,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908641,Binding constant for ALK kinase domain,Kd,>,10000,nM,,CHEMBL4247,ALK tyrosine kinase receptor,Homo sapiens,Q9UM73,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908470,Binding constant for AMPK-alpha1 kinase domain,Kd,>,10000,nM,,CHEMBL4045,"AMP-activated protein kinase, alpha-1 subunit",Homo sapiens,Q13131,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908744,Binding constant for AMPK-alpha2 kinase domain,Kd,>,10000,nM,,CHEMBL2116,"AMP-activated protein kinase, alpha-2 subunit",Homo sapiens,P54646,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908432,Binding constant for ANKK1 kinase domain,Kd,>,10000,nM,,CHEMBL5547,Ankyrin repeat and protein kinase domain-containing protein 1,Homo sapiens,Q8NFD2,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908785,Binding constant for ARK5 kinase domain,Kd,>,10000,nM,,CHEMBL5784,NUAK family SNF1-like kinase 1,Homo sapiens,O60285,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908725,Binding constant for ASK1 kinase domain,Kd,>,10000,nM,,CHEMBL5285,Mitogen-activated protein kinase kinase kinase 5,Homo sapiens,Q99683,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908659,Binding constant for ASK2 kinase domain,Kd,>,10000,nM,,CHEMBL1163123,Mitogen-activated protein kinase kinase kinase 6,Homo sapiens,O95382,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908616,Binding constant for AURKA kinase domain,Kd,>,10000,nM,,CHEMBL4722,Serine/threonine-protein kinase Aurora-A,Homo sapiens,O14965,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908469,Binding constant for AURKB kinase domain,Kd,>,10000,nM,,CHEMBL2185,Serine/threonine-protein kinase Aurora-B,Homo sapiens,Q96GD4,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908466,Binding constant for AURKC kinase domain,Kd,>,10000,nM,,CHEMBL3935,Serine/threonine-protein kinase Aurora-C,Homo sapiens,Q9UQB9,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908537,Binding constant for AXL kinase domain,Kd,>,10000,nM,,CHEMBL4895,Tyrosine-protein kinase receptor UFO,Homo sapiens,P30530,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908806,Binding constant for BIKE kinase domain,Kd,>,10000,nM,,CHEMBL4522,BMP-2-inducible protein kinase,Homo sapiens,Q9NSY1,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908538,Binding constant for BLK kinase domain,Kd,>,10000,nM,,CHEMBL2250,Tyrosine-protein kinase BLK,Homo sapiens,P51451,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908642,Binding constant for BMPR1A kinase domain,Kd,>,10000,nM,,CHEMBL5275,Bone morphogenetic protein receptor type-1A,Homo sapiens,P36894,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908522,Binding constant for BMPR1B kinase domain,Kd,>,10000,nM,,CHEMBL5476,Bone morphogenetic protein receptor type-1B,Homo sapiens,O00238,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908523,Binding constant for BMPR2 kinase domain,Kd,>,10000,nM,,CHEMBL5467,Bone morphogenetic protein receptor type-2,Homo sapiens,Q13873,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908539,Binding constant for BMX kinase domain,Kd,>,10000,nM,,CHEMBL3834,Tyrosine-protein kinase BMX,Homo sapiens,P51813,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908643,Binding constant for BRAF kinase domain,Kd,>,10000,nM,,CHEMBL5145,Serine/threonine-protein kinase B-raf,Homo sapiens,P15056,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908644,Binding constant for BRAF(V600E) kinase domain,Kd,>,10000,nM,,CHEMBL5145,Serine/threonine-protein kinase B-raf,Homo sapiens,P15056,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908726,Binding constant for BRK kinase domain,Kd,>,10000,nM,,CHEMBL4601,Tyrosine-protein kinase BRK,Homo sapiens,Q13882,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908399,Binding constant for BRSK1 kinase domain,Kd,>,10000,nM,,CHEMBL5650,BR serine/threonine-protein kinase 1,Homo sapiens,Q8TDC3,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908626,Binding constant for BRSK2 kinase domain,Kd,>,10000,nM,,CHEMBL4574,BR serine/threonine-protein kinase 2,Homo sapiens,Q8IWQ3,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908476,Binding constant for BTK kinase domain,Kd,>,10000,nM,,CHEMBL5251,Tyrosine-protein kinase BTK,Homo sapiens,Q06187,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908619,Binding constant for CAMK1 kinase domain,Kd,>,10000,nM,,CHEMBL2493,CaM kinase I alpha,Homo sapiens,Q14012,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908815,Binding constant for CAMK1D kinase domain,Kd,>,10000,nM,,CHEMBL5073,CaM kinase I delta,Homo sapiens,Q8IU85,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908816,Binding constant for CAMK1G kinase domain,Kd,>,10000,nM,,CHEMBL5258,CaM kinase I gamma,Homo sapiens,Q96NX5,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908427,Binding constant for CAMK2A kinase domain,Kd,>,10000,nM,,CHEMBL4147,CaM kinase II alpha,Homo sapiens,Q9UQM7,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908524,Binding constant for CAMK2B kinase domain,Kd,>,10000,nM,,CHEMBL4121,CaM kinase II beta,Homo sapiens,Q13554,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908467,Binding constant for CAMK2D kinase domain,Kd,>,10000,nM,,CHEMBL2801,CaM kinase II delta,Homo sapiens,Q13557,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908428,Binding constant for CAMK2G kinase domain,Kd,>,10000,nM,,CHEMBL3829,CaM kinase II gamma,Homo sapiens,Q13555,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908540,Binding constant for CAMK4 kinase domain,Kd,>,10000,nM,,CHEMBL2494,CaM kinase IV,Homo sapiens,Q16566,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908840,Binding constant for CAMKK1 kinase domain,Kd,>,10000,nM,,CHEMBL5256,CaM-kinase kinase alpha,Homo sapiens,Q8N5S9,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908757,Binding constant for CAMKK2 kinase domain,Kd,>,10000,nM,,CHEMBL5284,CaM-kinase kinase beta,Homo sapiens,Q96RR4,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908446,Binding constant for CASK kinase domain,Kd,>,10000,nM,,CHEMBL1908381,Peripheral plasma membrane protein CASK,Homo sapiens,O14936,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908405,Binding constant for CDC2L1 kinase domain,Kd,>,10000,nM,,CHEMBL5808,PITSLRE serine/threonine-protein kinase CDC2L1,Homo sapiens,P21127,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908830,Binding constant for CDC2L2 kinase domain,Kd,>,10000,nM,,CHEMBL5416,PITSLRE serine/threonine-protein kinase CDC2L2,Homo sapiens,Q9UQ88,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908458,Binding constant for CDC2L5 kinase domain,Kd,>,10000,nM,,CHEMBL1795192,Cyclin-dependent kinase 13,Homo sapiens,Q14004,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908791,Binding constant for CDK11 kinase domain,Kd,>,10000,nM,,CHEMBL6002,Cell division cycle 2-like protein kinase 6,Homo sapiens,Q9BWU1,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908541,Binding constant for CDK2 kinase domain,Kd,>,10000,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908525,Binding constant for CDK3 kinase domain,Kd,>,10000,nM,,CHEMBL4442,Cyclin-dependent kinase 3,Homo sapiens,Q00526,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908477,Binding constant for CDK4-cyclinD1 kinase domain,Kd,>,10000,nM,,CHEMBL331,Cyclin-dependent kinase 4,Homo sapiens,P11802,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908478,Binding constant for CDK4-cyclinD3 kinase domain,Kd,>,10000,nM,,CHEMBL331,Cyclin-dependent kinase 4,Homo sapiens,P11802,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908667,Binding constant for CDK5 kinase domain,Kd,>,10000,nM,,CHEMBL4036,Cyclin-dependent kinase 5,Homo sapiens,Q00535,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908542,Binding constant for CDK7 kinase domain,Kd,>,10000,nM,,CHEMBL3055,Cyclin-dependent kinase 7,Homo sapiens,P50613,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908526,Binding constant for CDK8 kinase domain,Kd,>,10000,nM,,CHEMBL5719,Cell division protein kinase 8,Homo sapiens,P49336,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908527,Binding constant for CDK9 kinase domain,Kd,>,10000,nM,,CHEMBL3116,Cyclin-dependent kinase 9,Homo sapiens,P50750,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908638,Binding constant for CDKL1 kinase domain,Kd,>,10000,nM,,CHEMBL5789,Cyclin-dependent kinase-like 1,Homo sapiens,Q00532,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908625,Binding constant for CDKL2 kinase domain,Kd,>,10000,nM,,CHEMBL5728,Cyclin-dependent kinase-like 2,Homo sapiens,Q92772,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908519,Binding constant for CDKL3 kinase domain,Kd,>,10000,nM,,CHEMBL1163117,Cyclin-dependent kinase-like 3,Homo sapiens,Q8IVW4,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908602,Binding constant for CDKL5 kinase domain,Kd,>,10000,nM,,CHEMBL1163112,Cyclin-dependent kinase-like 5,Homo sapiens,O76039,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908528,Binding constant for CHEK1 kinase domain,Kd,>,10000,nM,,CHEMBL4630,Serine/threonine-protein kinase Chk1 ,Homo sapiens,O14757,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908500,Binding constant for CHEK2 kinase domain,Kd,>,10000,nM,,CHEMBL2527,Serine/threonine-protein kinase Chk2,Homo sapiens,O96017,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908762,Binding constant for CIT kinase domain,Kd,>,10000,nM,,CHEMBL5579,Citron Rho-interacting kinase,Homo sapiens,O14578,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908461,Binding constant for CLK1 kinase domain,Kd,>,10000,nM,,CHEMBL4224,Dual specificty protein kinase CLK1,Homo sapiens,P49759,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908629,Binding constant for CLK2 kinase domain,Kd,>,10000,nM,,CHEMBL4225,Dual specificity protein kinase CLK2,Homo sapiens,P49760,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908628,Binding constant for CLK3 kinase domain,Kd,>,10000,nM,,CHEMBL4226,Dual specificity protein kinase CLK3,Homo sapiens,P49761,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908822,Binding constant for CLK4 kinase domain,Kd,>,10000,nM,,CHEMBL4203,Dual specificity protein kinase CLK4,Homo sapiens,Q9HAZ1,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908692,Binding constant for CSF1R kinase domain,Kd,=,2.2,nM,,CHEMBL1844,Macrophage colony stimulating factor  receptor ,Homo sapiens,P07333,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908645,Binding constant for CSK kinase domain,Kd,>,10000,nM,,CHEMBL2634,Tyrosine-protein kinase CSK,Homo sapiens,P41240,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908543,Binding constant for CSNK1A1 kinase domain,Kd,>,10000,nM,,CHEMBL2793,Casein kinase I alpha,Homo sapiens,P48729,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908420,Binding constant for CSNK1A1L kinase domain,Kd,>,10000,nM,,CHEMBL5520,Casein kinase I isoform alpha-like,Homo sapiens,Q8N752,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908413,Binding constant for CSNK1D kinase domain,Kd,>,10000,nM,,CHEMBL2828,Casein kinase I delta,Homo sapiens,P48730,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908544,Binding constant for CSNK1E kinase domain,Kd,>,10000,nM,,CHEMBL4937,Casein kinase I epsilon,Homo sapiens,P49674,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908825,Binding constant for CSNK1G1 kinase domain,Kd,>,10000,nM,,CHEMBL2426,Casein kinase I gamma 1,Homo sapiens,Q9HCP0,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908530,Binding constant for CSNK1G2 kinase domain,Kd,>,10000,nM,,CHEMBL2543,Casein kinase I gamma 2,Homo sapiens,P78368,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908646,Binding constant for CSNK1G3 kinase domain,Kd,>,10000,nM,,CHEMBL5084,Casein kinase I isoform gamma-3,Homo sapiens,Q9Y6M4,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908545,Binding constant for CSNK2A1 kinase domain,Kd,>,10000,nM,,CHEMBL3629,Casein kinase II alpha,Homo sapiens,P68400,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908546,Binding constant for CSNK2A2 kinase domain,Kd,>,10000,nM,,CHEMBL4070,Casein kinase II alpha (prime),Homo sapiens,P19784,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908561,Binding constant for CTK kinase domain,Kd,>,10000,nM,,CHEMBL4175,Tyrosine-protein kinase CTK,Homo sapiens,P42679,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908668,Binding constant for DAPK1 kinase domain,Kd,>,10000,nM,,CHEMBL2558,Death-associated protein kinase 1,Homo sapiens,P53355,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908774,Binding constant for DAPK2 kinase domain,Kd,>,10000,nM,,CHEMBL3123,Death-associated protein kinase 2,Homo sapiens,Q9UIK4,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908531,Binding constant for DAPK3 kinase domain,Kd,>,10000,nM,,CHEMBL2468,Death-associated protein kinase 3,Homo sapiens,O43293,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908663,Binding constant for DCAMKL1 kinase domain,Kd,>,10000,nM,,CHEMBL5683,Serine/threonine-protein kinase DCLK1,Homo sapiens,O15075,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908511,Binding constant for DCAMKL2 kinase domain,Kd,>,10000,nM,,CHEMBL5519,Serine/threonine-protein kinase DCLK2,Homo sapiens,Q8N568,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908404,Binding constant for DCAMKL3 kinase domain,Kd,>,10000,nM,,CHEMBL6123,Serine/threonine-protein kinase DCLK3,Homo sapiens,Q9C098,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908547,Binding constant for DDR1 kinase domain,Kd,>,10000,nM,,CHEMBL5319,Epithelial discoidin domain-containing receptor 1,Homo sapiens,Q08345,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908474,Binding constant for DDR2 kinase domain,Kd,>,10000,nM,,CHEMBL5122,Discoidin domain-containing receptor 2,Homo sapiens,Q16832,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908459,Binding constant for DLK kinase domain,Kd,>,10000,nM,,CHEMBL1908389,Mitogen-activated protein kinase kinase kinase 12,Homo sapiens,Q12852,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908647,Binding constant for DMPK kinase domain,Kd,>,10000,nM,,CHEMBL5320,Myotonin-protein kinase,Homo sapiens,Q09013,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908804,Binding constant for DMPK2 kinase domain,Kd,>,10000,nM,,CHEMBL5615,Serine/threonine-protein kinase MRCK gamma,Homo sapiens,Q6DT37,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908665,Binding constant for DRAK1 kinase domain,Kd,>,10000,nM,,CHEMBL4525,Serine/threonine-protein kinase 17A,Homo sapiens,Q9UEE5,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908639,Binding constant for DRAK2 kinase domain,Kd,>,10000,nM,,CHEMBL3980,Serine/threonine-protein kinase 17B,Homo sapiens,O94768,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908409,Binding constant for DYRK1A kinase domain,Kd,>,10000,nM,,CHEMBL2292,Dual-specificity tyrosine-phosphorylation regulated kinase 1A,Homo sapiens,Q13627,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908661,Binding constant for DYRK1B kinase domain,Kd,>,10000,nM,,CHEMBL5543,Dual specificity tyrosine-phosphorylation-regulated kinase 1B,Homo sapiens,Q9Y463,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908615,Binding constant for DYRK2 kinase domain,Kd,>,10000,nM,,CHEMBL4376,Dual-specificity tyrosine-phosphorylation regulated kinase 2,Homo sapiens,Q92630,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908693,Binding constant for EGFR kinase domain,Kd,>,10000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908694,Binding constant for EGFR(E746-A750del) kinase domain,Kd,>,10000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908695,Binding constant for EGFR(G719C) kinase domain,Kd,>,10000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908696,Binding constant for EGFR(G719S) kinase domain,Kd,>,10000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908697,"Binding constant for EGFR(L747-E749del, A750P) kinase domain",Kd,>,10000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908698,"Binding constant for EGFR(L747-S752del, P753S) kinase domain",Kd,>,10000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908699,"Binding constant for EGFR(L747-T751del,Sins) kinase domain",Kd,>,10000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908700,Binding constant for EGFR(L858R) kinase domain,Kd,>,10000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908701,"Binding constant for EGFR(L858R,T790M) kinase domain",Kd,>,10000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908702,Binding constant for EGFR(L861Q) kinase domain,Kd,>,10000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908703,Binding constant for EGFR(S752-I759del) kinase domain,Kd,>,10000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908704,Binding constant for EGFR(T790M) kinase domain,Kd,>,10000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908777,Binding constant for EIF2AK1 kinase domain,Kd,>,10000,nM,,CHEMBL6029,Eukaryotic translation initiation factor 2-alpha kinase 1,Homo sapiens,Q9BQI3,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908705,Binding constant for EPHA1 kinase domain,Kd,>,10000,nM,,CHEMBL5810,Ephrin type-A receptor 1,Homo sapiens,P21709,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908648,Binding constant for EPHA2 kinase domain,Kd,>,10000,nM,,CHEMBL2068,Ephrin type-A receptor 2,Homo sapiens,P29317,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908706,Binding constant for EPHA3 kinase domain,Kd,>,10000,nM,,CHEMBL4954,Ephrin type-A receptor 3,Homo sapiens,P29320,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908649,Binding constant for EPHA4 kinase domain,Kd,>,10000,nM,,CHEMBL3988,Ephrin type-A receptor 4,Homo sapiens,P54764,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908434,Binding constant for EPHA5 kinase domain,Kd,>,10000,nM,,CHEMBL3987,Ephrin type-A receptor 5,Homo sapiens,P54756,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908445,Binding constant for EPHA6 kinase domain,Kd,>,10000,nM,,CHEMBL4526,Ephrin type-A receptor 6,Homo sapiens,Q9UF33,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908650,Binding constant for EPHA7 kinase domain,Kd,>,10000,nM,,CHEMBL4602,Ephrin type-A receptor 7,Homo sapiens,Q15375,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908817,Binding constant for EPHA8 kinase domain,Kd,>,10000,nM,,CHEMBL4134,Ephrin type-A receptor 8,Homo sapiens,P29322,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908651,Binding constant for EPHB1 kinase domain,Kd,>,10000,nM,,CHEMBL5072,Ephrin type-B receptor 1,Homo sapiens,P54762,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908802,Binding constant for EPHB2 kinase domain,Kd,>,10000,nM,,CHEMBL3290,Ephrin type-B receptor 2,Homo sapiens,P29323,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908652,Binding constant for EPHB3 kinase domain,Kd,>,10000,nM,,CHEMBL4901,Ephrin type-B receptor 3,Homo sapiens,P54753,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908653,Binding constant for EPHB4 kinase domain,Kd,>,10000,nM,,CHEMBL5147,Ephrin type-B receptor 4,Homo sapiens,P54760,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908654,Binding constant for EPHB6 kinase domain,Kd,>,10000,nM,,CHEMBL5836,Ephrin type-B receptor 6,Homo sapiens,O15197,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908501,Binding constant for ERBB2 kinase domain,Kd,>,10000,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908548,Binding constant for ERBB3 kinase domain,Kd,>,10000,nM,,CHEMBL5838,Receptor tyrosine-protein kinase erbB-3,Homo sapiens,P21860,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908512,Binding constant for ERBB4 kinase domain,Kd,>,10000,nM,,CHEMBL3009,Receptor protein-tyrosine kinase erbB-4,Homo sapiens,Q15303,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908582,Binding constant for ERK1 kinase domain,Kd,>,10000,nM,,CHEMBL3385,MAP kinase ERK1,Homo sapiens,P27361,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908410,Binding constant for ERK2 kinase domain,Kd,>,10000,nM,,CHEMBL4040,MAP kinase ERK2,Homo sapiens,P28482,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908584,Binding constant for ERK3 kinase domain,Kd,>,10000,nM,,CHEMBL5121,Mitogen-activated protein kinase 6,Homo sapiens,Q16659,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908583,Binding constant for ERK4 kinase domain,Kd,>,10000,nM,,CHEMBL5759,Mitogen-activated protein kinase 4,Homo sapiens,P31152,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908585,Binding constant for ERK5 kinase domain,Kd,>,10000,nM,,CHEMBL5332,Mitogen-activated protein kinase 7,Homo sapiens,Q13164,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908412,Binding constant for ERK8 kinase domain,Kd,>,10000,nM,,CHEMBL5198,Mitogen-activated protein kinase 15,Homo sapiens,Q8TD08,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908532,Binding constant for ERN1 kinase domain,Kd,>,10000,nM,,CHEMBL1163101,Serine/threonine-protein kinase/endoribonuclease IRE1,Homo sapiens,O75460,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908426,Binding constant for FAK kinase domain,Kd,>,10000,nM,,CHEMBL2695,Focal adhesion kinase 1,Homo sapiens,Q05397,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908707,Binding constant for FER kinase domain,Kd,>,10000,nM,,CHEMBL3982,Tyrosine-protein kinase FER,Homo sapiens,P16591,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908549,Binding constant for FES kinase domain,Kd,>,10000,nM,,CHEMBL5455,Tyrosine-protein kinase FES,Homo sapiens,P07332,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908829,Binding constant for FGFR1 kinase domain,Kd,>,10000,nM,,CHEMBL3650,Fibroblast growth factor receptor 1,Homo sapiens,P11362,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908828,Binding constant for FGFR2 kinase domain,Kd,>,10000,nM,,CHEMBL4142,Fibroblast growth factor receptor 2,Homo sapiens,P21802,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908479,Binding constant for FGFR3 kinase domain,Kd,>,10000,nM,,CHEMBL2742,Fibroblast growth factor receptor 3,Homo sapiens,P22607,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908480,Binding constant for FGFR3(G697C) kinase domain,Kd,>,10000,nM,,CHEMBL2742,Fibroblast growth factor receptor 3,Homo sapiens,P22607,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908827,Binding constant for FGFR4 kinase domain,Kd,>,10000,nM,,CHEMBL3973,Fibroblast growth factor receptor 4,Homo sapiens,P22455,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908708,Binding constant for FGR kinase domain,Kd,>,10000,nM,,CHEMBL4454,Tyrosine-protein kinase FGR,Homo sapiens,P09769,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908550,Binding constant for FLT1 kinase domain,Kd,>,10000,nM,,CHEMBL1868,Vascular endothelial growth factor receptor 1,Homo sapiens,P17948,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908631,Binding constant for FLT3 kinase domain,Kd,>,10000,nM,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,Homo sapiens,P36888,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908632,Binding constant for FLT3(D835H) kinase domain,Kd,>,10000,nM,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,Homo sapiens,P36888,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908633,Binding constant for FLT3(D835Y) kinase domain,Kd,>,10000,nM,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,Homo sapiens,P36888,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908634,Binding constant for FLT3(ITD) kinase domain,Kd,>,10000,nM,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,Homo sapiens,P36888,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908635,Binding constant for FLT3(K663Q) kinase domain,Kd,>,10000,nM,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,Homo sapiens,P36888,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908636,Binding constant for FLT3(N841I) kinase domain,Kd,>,10000,nM,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,Homo sapiens,P36888,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908637,Binding constant for FLT3(R834Q) kinase domain,Kd,>,10000,nM,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,Homo sapiens,P36888,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908551,Binding constant for FLT4 kinase domain,Kd,>,10000,nM,,CHEMBL1955,Vascular endothelial growth factor receptor 3,Homo sapiens,P35916,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908552,Binding constant for FRK kinase domain,Kd,>,10000,nM,,CHEMBL4223,Tyrosine-protein kinase FRK,Homo sapiens,P42685,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908424,Binding constant for FYN kinase domain,Kd,>,10000,nM,,CHEMBL1841,Tyrosine-protein kinase FYN,Homo sapiens,P06241,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908709,Binding constant for GAK kinase domain,Kd,>,10000,nM,,CHEMBL4355,Serine/threonine-protein kinase GAK,Homo sapiens,O14976,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908507,"Binding constant for GCN2(Kin.Dom.2,S808G) kinase domain",Kd,>,10000,nM,,CHEMBL5358,Eukaryotic translation initiation factor 2-alpha kinase 4,Homo sapiens,Q9P2K8,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908595,Binding constant for GRK1 kinase domain,Kd,>,10000,nM,,CHEMBL5607,Rhodopsin kinase,Homo sapiens,Q15835,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908436,Binding constant for GRK4 kinase domain,Kd,>,10000,nM,,CHEMBL5861,G protein-coupled receptor kinase 4,Homo sapiens,P32298,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908416,Binding constant for GRK7 kinase domain,Kd,>,10000,nM,,CHEMBL1075133,G protein-coupled receptor kinase 7,Homo sapiens,Q8WTQ7,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908811,Binding constant for GSK3A kinase domain,Kd,>,10000,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908553,Binding constant for GSK3B kinase domain,Kd,>,10000,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908554,Binding constant for HCK kinase domain,Kd,>,10000,nM,,CHEMBL3234,Tyrosine-protein kinase HCK ,Homo sapiens,P08631,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908423,Binding constant for HIPK1 kinase domain,Kd,>,10000,nM,,CHEMBL5427,Homeodomain-interacting protein kinase 1,Homo sapiens,Q86Z02,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908826,Binding constant for HIPK2 kinase domain,Kd,>,10000,nM,,CHEMBL4576,Homeodomain-interacting protein kinase 2,Homo sapiens,Q9H2X6,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908720,Binding constant for HIPK3 kinase domain,Kd,>,10000,nM,,CHEMBL4577,Homeodomain-interacting protein kinase 3,Homo sapiens,Q9H422,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908417,Binding constant for HIPK4 kinase domain,Kd,>,10000,nM,,CHEMBL1075167,Homeodomain-interacting protein kinase 4,Homo sapiens,Q8NE63,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908513,Binding constant for HPK1 kinase domain,Kd,>,10000,nM,,CHEMBL5749,Mitogen-activated protein kinase kinase kinase kinase 1,Homo sapiens,Q92918,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908781,Binding constant for HUNK kinase domain,Kd,>,10000,nM,,CHEMBL1795165,Hormonally up-regulated neu tumor-associated kinase,Homo sapiens,P57058,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908787,Binding constant for ICK kinase domain,Kd,>,10000,nM,,CHEMBL1163126,Serine/threonine-protein kinase ICK,Homo sapiens,Q9UPZ9,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908497,Binding constant for IGF1R kinase domain,Kd,>,10000,nM,,CHEMBL1957,Insulin-like growth factor I receptor,Homo sapiens,P08069,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908529,Binding constant for IKK-alpha kinase domain,Kd,>,10000,nM,,CHEMBL3476,Inhibitor of nuclear factor kappa B kinase alpha subunit,Homo sapiens,O15111,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908533,Binding constant for IKK-beta kinase domain,Kd,>,10000,nM,,CHEMBL1991,Inhibitor of nuclear factor kappa B kinase beta subunit,Homo sapiens,O14920,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908771,Binding constant for IKK-epsilon kinase domain,Kd,>,10000,nM,,CHEMBL3529,Inhibitor of nuclear factor kappa B kinase epsilon subunit,Homo sapiens,Q14164,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908481,Binding constant for INSR kinase domain,Kd,>,10000,nM,,CHEMBL1981,Insulin receptor,Homo sapiens,P06213,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908772,Binding constant for INSRR kinase domain,Kd,>,10000,nM,,CHEMBL5483,Insulin receptor-related protein,Homo sapiens,P14616,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908534,Binding constant for IRAK1 kinase domain,Kd,>,10000,nM,,CHEMBL3357,Interleukin-1 receptor-associated kinase 1 ,Homo sapiens,P51617,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908763,Binding constant for IRAK3 kinase domain,Kd,>,10000,nM,,CHEMBL5081,Interleukin-1 receptor-associated kinase 3,Homo sapiens,Q9Y616,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908795,Binding constant for IRAK4 kinase domain,Kd,>,10000,nM,,CHEMBL3778,Interleukin-1 receptor-associated kinase 4,Homo sapiens,Q9NWZ3,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908717,Binding constant for ITK kinase domain,Kd,>,10000,nM,,CHEMBL2959,Tyrosine-protein kinase ITK/TSK ,Homo sapiens,Q08881,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908556,Binding constant for JAK1(JH1domain-catalytic) kinase domain,Kd,>,10000,nM,,CHEMBL2835,Tyrosine-protein kinase JAK1 ,Homo sapiens,P23458,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908555,Binding constant for JAK1(JH2domain-pseudokinase) kinase domain,Kd,>,10000,nM,,CHEMBL2835,Tyrosine-protein kinase JAK1 ,Homo sapiens,P23458,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908670,Binding constant for JAK2(JH1domain-catalytic) kinase domain,Kd,>,10000,nM,,CHEMBL2971,Tyrosine-protein kinase JAK2,Homo sapiens,O60674,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908482,Binding constant for JAK3(JH1domain-catalytic) kinase domain,Kd,>,10000,nM,,CHEMBL2148,Tyrosine-protein kinase JAK3,Homo sapiens,P52333,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908586,Binding constant for JNK1 kinase domain,Kd,>,10000,nM,,CHEMBL2276,c-Jun N-terminal kinase 1,Homo sapiens,P45983,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908414,Binding constant for JNK2 kinase domain,Kd,>,10000,nM,,CHEMBL4179,c-Jun N-terminal kinase 2,Homo sapiens,P45984,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908588,Binding constant for JNK3 kinase domain,Kd,>,10000,nM,,CHEMBL2637,c-Jun N-terminal kinase 3,Homo sapiens,P53779,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908483,Binding constant for KIT kinase domain,Kd,>,10000,nM,,CHEMBL1936,Stem cell growth factor receptor,Homo sapiens,P10721,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908484,Binding constant for KIT(A829P) kinase domain,Kd,>,10000,nM,,CHEMBL1936,Stem cell growth factor receptor,Homo sapiens,P10721,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908485,Binding constant for KIT(D816H) kinase domain,Kd,>,10000,nM,,CHEMBL1936,Stem cell growth factor receptor,Homo sapiens,P10721,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908486,Binding constant for KIT(D816V) kinase domain,Kd,>,10000,nM,,CHEMBL1936,Stem cell growth factor receptor,Homo sapiens,P10721,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908487,Binding constant for KIT(L576P) kinase domain,Kd,>,10000,nM,,CHEMBL1936,Stem cell growth factor receptor,Homo sapiens,P10721,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908488,Binding constant for KIT(V559D) kinase domain,Kd,>,10000,nM,,CHEMBL1936,Stem cell growth factor receptor,Homo sapiens,P10721,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908489,"Binding constant for KIT(V559D,T670I) kinase domain",Kd,>,10000,nM,,CHEMBL1936,Stem cell growth factor receptor,Homo sapiens,P10721,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908490,"Binding constant for KIT(V559D,V654A) kinase domain",Kd,>,10000,nM,,CHEMBL1936,Stem cell growth factor receptor,Homo sapiens,P10721,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908660,Binding constant for LATS1 kinase domain,Kd,>,10000,nM,,CHEMBL6167,Serine/threonine-protein kinase LATS1,Homo sapiens,O95835,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908780,Binding constant for LATS2 kinase domain,Kd,>,10000,nM,,CHEMBL5907,Serine/threonine-protein kinase LATS2,Homo sapiens,Q9NRM7,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908710,Binding constant for LCK kinase domain,Kd,>,10000,nM,,CHEMBL258,Tyrosine-protein kinase LCK,Homo sapiens,P06239,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908558,Binding constant for LIMK1 kinase domain,Kd,>,10000,nM,,CHEMBL3836,LIM domain kinase 1,Homo sapiens,P53667,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908718,Binding constant for LIMK2 kinase domain,Kd,>,10000,nM,,CHEMBL5932,LIM domain kinase 2,Homo sapiens,P53671,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908495,Binding constant for LKB1 kinase domain,Kd,>,10000,nM,,CHEMBL5606,Serine/threonine-protein kinase 11,Homo sapiens,Q15831,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908727,Binding constant for LOK kinase domain,Kd,>,10000,nM,,CHEMBL3981,Serine/threonine-protein kinase 10,Homo sapiens,O94804,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908437,Binding constant for LRRK2 kinase domain,Kd,>,10000,nM,,CHEMBL1075104,Leucine-rich repeat serine/threonine-protein kinase 2,Homo sapiens,Q5S007,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908438,Binding constant for LRRK2(G2019S) kinase domain,Kd,>,10000,nM,,CHEMBL1075104,Leucine-rich repeat serine/threonine-protein kinase 2,Homo sapiens,Q5S007,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908440,Binding constant for LTK kinase domain,Kd,>,10000,nM,,CHEMBL5627,Leukocyte tyrosine kinase receptor,Homo sapiens,P29376,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908559,Binding constant for LYN kinase domain,Kd,>,10000,nM,,CHEMBL3905,Tyrosine-protein kinase Lyn ,Homo sapiens,P07948,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908662,Binding constant for LZK kinase domain,Kd,>,10000,nM,,CHEMBL1163124,Mitogen-activated protein kinase kinase kinase 13,Homo sapiens,O43283,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908722,Binding constant for MAK kinase domain,Kd,>,10000,nM,,CHEMBL1163106,Serine/threonine-protein kinase MAK,Homo sapiens,P20794,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908723,Binding constant for MAP3K1 kinase domain,Kd,>,10000,nM,,CHEMBL3956,Mitogen-activated protein kinase kinase kinase 1,Homo sapiens,Q13233,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908498,Binding constant for MAP3K15 kinase domain,Kd,>,10000,nM,,CHEMBL1163127,Mitogen-activated protein kinase kinase kinase 15,Homo sapiens,Q6ZN16,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908759,Binding constant for MAP3K2 kinase domain,Kd,>,10000,nM,,CHEMBL5914,Mitogen-activated protein kinase kinase kinase 2,Homo sapiens,Q9Y2U5,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908562,Binding constant for MAP3K3 kinase domain,Kd,>,10000,nM,,CHEMBL5970,Mitogen-activated protein kinase kinase kinase 3,Homo sapiens,Q99759,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908724,Binding constant for MAP3K4 kinase domain,Kd,>,10000,nM,,CHEMBL4853,Mitogen-activated protein kinase kinase kinase 4,Homo sapiens,Q9Y6R4,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908656,Binding constant for MAP4K2 kinase domain,Kd,>,10000,nM,,CHEMBL5330,Mitogen-activated protein kinase kinase kinase kinase 2,Homo sapiens,Q12851,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908618,Binding constant for MAP4K3 kinase domain,Kd,>,10000,nM,,CHEMBL5432,Mitogen-activated protein kinase kinase kinase kinase 3,Homo sapiens,Q8IVH8,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908453,Binding constant for MAP4K4 kinase domain,Kd,>,10000,nM,,CHEMBL6166,Mitogen-activated protein kinase kinase kinase kinase 4,Homo sapiens,O95819,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908758,Binding constant for MAP4K5 kinase domain,Kd,>,10000,nM,,CHEMBL4852,Mitogen-activated protein kinase kinase kinase kinase 5,Homo sapiens,Q9Y4K4,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908400,Binding constant for MAPKAPK2 kinase domain,Kd,>,10000,nM,,CHEMBL2208,MAP kinase-activated protein kinase 2,Homo sapiens,P49137,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908620,Binding constant for MAPKAPK5 kinase domain,Kd,>,10000,nM,,CHEMBL3094,MAP kinase-activated protein kinase 5,Homo sapiens,Q8IW41,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908810,Binding constant for MARK1 kinase domain,Kd,>,10000,nM,,CHEMBL5940,Serine/threonine-protein kinase MARK1,Homo sapiens,Q9P0L2,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908803,Binding constant for MARK2 kinase domain,Kd,>,10000,nM,,CHEMBL3831,MAP/microtubule affinity-regulating kinase 2,Homo sapiens,Q7KZI7,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908560,Binding constant for MARK3 kinase domain,Kd,>,10000,nM,,CHEMBL5600,Serine/threonine-protein kinase c-TAK1,Homo sapiens,P27448,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908837,Binding constant for MARK4 kinase domain,Kd,>,10000,nM,,CHEMBL5754,MAP/microtubule affinity-regulating kinase 4,Homo sapiens,Q96L34,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908788,Binding constant for MAST1 kinase domain,Kd,>,10000,nM,,CHEMBL1163128,Microtubule-associated serine/threonine-protein kinase 1,Homo sapiens,Q9Y2H9,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908590,Binding constant for MEK1 kinase domain,Kd,>,10000,nM,,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,Homo sapiens,Q02750,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908834,Binding constant for MEK2 kinase domain,Kd,>,10000,nM,,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,Homo sapiens,P36507,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908591,Binding constant for MEK3 kinase domain,Kd,>,10000,nM,,CHEMBL2109,Dual specificity mitogen-activated protein kinase kinase 3,Homo sapiens,P46734,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908599,Binding constant for MEK4 kinase domain,Kd,>,10000,nM,,CHEMBL2897,Dual specificity mitogen-activated protein kinase kinase 4,Homo sapiens,P45985,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908418,Binding constant for MEK5 kinase domain,Kd,>,10000,nM,,CHEMBL4948,Dual specificity mitogen-activated protein kinase kinase 5,Homo sapiens,Q13163,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908592,Binding constant for MEK6 kinase domain,Kd,>,10000,nM,,CHEMBL2171,Dual specificity mitogen-activated protein kinase kinase 6,Homo sapiens,P52564,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908784,Binding constant for MELK kinase domain,Kd,>,10000,nM,,CHEMBL4578,Maternal embryonic leucine zipper kinase,Homo sapiens,Q14680,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908464,Binding constant for MERTK kinase domain,Kd,>,10000,nM,,CHEMBL5331,Proto-oncogene tyrosine-protein kinase MER,Homo sapiens,Q12866,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908491,Binding constant for MET kinase domain,Kd,>,10000,nM,,CHEMBL3717,Hepatocyte growth factor receptor,Homo sapiens,P08581,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908492,Binding constant for MET(M1250T) kinase domain,Kd,>,10000,nM,,CHEMBL3717,Hepatocyte growth factor receptor,Homo sapiens,P08581,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908493,Binding constant for MET(Y1235D) kinase domain,Kd,>,10000,nM,,CHEMBL3717,Hepatocyte growth factor receptor,Homo sapiens,P08581,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908510,Binding constant for MINK kinase domain,Kd,>,10000,nM,,CHEMBL5518,Misshapen-like kinase 1,Homo sapiens,Q8N4C8,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908419,Binding constant for MKK7 kinase domain,Kd,>,10000,nM,,CHEMBL3530,Dual specificity mitogen-activated protein kinase kinase 7,Homo sapiens,O14733,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908520,Binding constant for MKNK1 kinase domain,Kd,>,10000,nM,,CHEMBL4718,MAP kinase-interacting serine/threonine-protein kinase MNK1,Homo sapiens,Q9BUB5,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908805,Binding constant for MKNK2 kinase domain,Kd,>,10000,nM,,CHEMBL4204,MAP kinase signal-integrating kinase 2,Homo sapiens,Q9HBH9,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908435,Binding constant for MLCK kinase domain,Kd,>,10000,nM,,CHEMBL4627,Myosin light chain kinase,Homo sapiens,Q32MK0,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908403,Binding constant for MLK1 kinase domain,Kd,>,10000,nM,,CHEMBL2872,Mitogen-activated protein kinase kinase kinase 9,Homo sapiens,P80192,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908564,Binding constant for MLK2 kinase domain,Kd,>,10000,nM,,CHEMBL2873,Mitogen-activated protein kinase kinase kinase 10,Homo sapiens,Q02779,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908563,Binding constant for MLK3 kinase domain,Kd,>,10000,nM,,CHEMBL2708,Mitogen-activated protein kinase kinase kinase 11,Homo sapiens,Q16584,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908617,Binding constant for MRCKA kinase domain,Kd,>,10000,nM,,CHEMBL4516,Serine/threonine-protein kinase MRCK-A,Homo sapiens,Q5VT25,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908728,Binding constant for MRCKB kinase domain,Kd,>,10000,nM,,CHEMBL5052,Serine/threonine-protein kinase MRCK beta,Homo sapiens,Q9Y5S2,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908752,Binding constant for MST1 kinase domain,Kd,>,10000,nM,,CHEMBL4598,Serine/threonine-protein kinase MST1,Homo sapiens,Q13043,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908565,Binding constant for MST1R kinase domain,Kd,>,10000,nM,,CHEMBL2689,Macrophage-stimulating protein receptor,Homo sapiens,Q04912,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908751,Binding constant for MST2 kinase domain,Kd,>,10000,nM,,CHEMBL4708,Serine/threonine-protein kinase MST2,Homo sapiens,Q13188,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908614,Binding constant for MST3 kinase domain,Kd,>,10000,nM,,CHEMBL5082,Serine/threonine-protein kinase 24,Homo sapiens,Q9Y6E0,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908800,Binding constant for MST4 kinase domain,Kd,>,10000,nM,,CHEMBL5941,Serine/threonine-protein kinase MST4,Homo sapiens,Q9P289,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908669,Binding constant for MTOR kinase domain,Kd,>,10000,nM,,CHEMBL2842,FK506 binding protein 12,Homo sapiens,P42345,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908719,Binding constant for MUSK kinase domain,Kd,>,10000,nM,,CHEMBL5684,"Muscle, skeletal receptor tyrosine protein kinase",Homo sapiens,O15146,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908406,Binding constant for MYLK kinase domain,Kd,>,10000,nM,,CHEMBL2428,"Myosin light chain kinase, smooth muscle",Homo sapiens,Q15746,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908402,Binding constant for MYLK2 kinase domain,Kd,>,10000,nM,,CHEMBL2777,myosin light chain kinase 2,Homo sapiens,Q9H1R3,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908506,Binding constant for MYLK4 kinase domain,Kd,>,10000,nM,,CHEMBL5426,Myosin light chain kinase family member 4,Homo sapiens,Q86YV6,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908801,Binding constant for MYO3A kinase domain,Kd,>,10000,nM,,CHEMBL5546,Myosin IIIA,Homo sapiens,Q8NEV4,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908514,Binding constant for MYO3B kinase domain,Kd,>,10000,nM,,CHEMBL5654,Myosin-IIIB,Homo sapiens,Q8WXR4,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908764,Binding constant for NDR1 kinase domain,Kd,>,10000,nM,,CHEMBL1075155,Serine/threonine-protein kinase 38,Homo sapiens,Q15208,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908789,Binding constant for NDR2 kinase domain,Kd,>,10000,nM,,CHEMBL4851,Serine/threonine-protein kinase 38-like,Homo sapiens,Q9Y2H1,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908765,Binding constant for NEK1 kinase domain,Kd,>,10000,nM,,CHEMBL5855,Serine/threonine-protein kinase Nek1,Homo sapiens,Q96PY6,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908422,Binding constant for NEK11 kinase domain,Kd,>,10000,nM,,CHEMBL5638,Serine/threonine-protein kinase Nek11,Homo sapiens,Q8NG66,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908566,Binding constant for NEK2 kinase domain,Kd,>,10000,nM,,CHEMBL3835,Serine/threonine-protein kinase NEK2,Homo sapiens,P51955,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908567,Binding constant for NEK3 kinase domain,Kd,>,10000,nM,,CHEMBL5679,Serine/threonine-protein kinase Nek3,Homo sapiens,P51956,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908601,Binding constant for NEK4 kinase domain,Kd,>,10000,nM,,CHEMBL5819,Serine/threonine-protein kinase Nek4,Homo sapiens,P51957,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908439,Binding constant for NEK5 kinase domain,Kd,>,10000,nM,,CHEMBL5044,Serine/threonine-protein kinase Nek5,Homo sapiens,Q6P3R8,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908776,Binding constant for NEK6 kinase domain,Kd,>,10000,nM,,CHEMBL4309,Serine/threonine-protein kinase NEK6,Homo sapiens,Q9HC98,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908451,Binding constant for NEK7 kinase domain,Kd,>,10000,nM,,CHEMBL4849,Serine/threonine-protein kinase NEK7,Homo sapiens,Q8TDX7,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908401,Binding constant for NEK9 kinase domain,Kd,>,10000,nM,,CHEMBL5257,Serine/threonine-protein kinase NEK9,Homo sapiens,Q8TD19,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908425,Binding constant for NIM1 kinase domain,Kd,>,10000,nM,,CHEMBL3542,Serine/threonine-protein kinase NIM1,Homo sapiens,Q8IY84,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908797,Binding constant for NLK kinase domain,Kd,>,10000,nM,,CHEMBL5364,Serine/threonine protein kinase NLK,Homo sapiens,Q9UBE8,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908674,Binding constant for OSR1 kinase domain,Kd,>,10000,nM,,CHEMBL1163104,Serine/threonine-protein kinase OSR1,Homo sapiens,O95747,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908568,Binding constant for PAK1 kinase domain,Kd,>,10000,nM,,CHEMBL4600,Serine/threonine-protein kinase PAK 1,Homo sapiens,Q13153,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908569,Binding constant for PAK2 kinase domain,Kd,>,10000,nM,,CHEMBL4487,Serine/threonine-protein kinase PAK 2,Homo sapiens,Q13177,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908570,Binding constant for PAK3 kinase domain,Kd,>,10000,nM,,CHEMBL2999,Serine/threonine-protein kinase PAK 3,Homo sapiens,O75914,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908508,Binding constant for PAK4 kinase domain,Kd,>,10000,nM,,CHEMBL4482,Serine/threonine-protein kinase PAK 4,Homo sapiens,O96013,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908812,Binding constant for PAK6 kinase domain,Kd,>,10000,nM,,CHEMBL4311,Serine/threonine-protein kinase PAK6,Homo sapiens,Q9NQU5,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908814,Binding constant for PAK7 kinase domain,Kd,>,10000,nM,,CHEMBL4524,Serine/threonine-protein kinase PAK7,Homo sapiens,Q9P286,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908730,Binding constant for PCTK1 kinase domain,Kd,>,10000,nM,,CHEMBL4597,Serine/threonine-protein kinase PCTAIRE-1,Homo sapiens,Q00536,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908473,Binding constant for PCTK2 kinase domain,Kd,>,10000,nM,,CHEMBL5790,Serine/threonine-protein kinase PCTAIRE-2,Homo sapiens,Q00537,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908571,Binding constant for PCTK3 kinase domain,Kd,>,10000,nM,,CHEMBL5316,Serine/threonine-protein kinase PCTAIRE-3,Homo sapiens,Q07002,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908731,Binding constant for PDGFRA kinase domain,Kd,>,10000,nM,,CHEMBL2007,Platelet-derived growth factor receptor alpha ,Homo sapiens,P16234,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908572,Binding constant for PDGFRB kinase domain,Kd,>,10000,nM,,CHEMBL1913,Platelet-derived growth factor receptor beta,Homo sapiens,P09619,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908573,Binding constant for PDPK1 kinase domain,Kd,>,10000,nM,,CHEMBL2534,3-phosphoinositide dependent protein kinase-1,Homo sapiens,O15530,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908456,Binding constant for PFCDPK1(P.falciparum) kinase domain,Kd,>,10000,nM,,CHEMBL1908387,Calcium-dependent protein kinase 1,Plasmodium falciparum (isolate 3D7),P62344,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908457,Binding constant for PFPK5(P.falciparum) kinase domain,Kd,>,10000,nM,,CHEMBL1908388,Cell division control protein 2 homolog,Plasmodium falciparum (isolate 3D7),P61075,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908415,Binding constant for PFTAIRE2 kinase domain,Kd,>,10000,nM,,CHEMBL5856,Serine/threonine-protein kinase PFTAIRE-2,Homo sapiens,Q96Q40,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908767,Binding constant for PFTK1 kinase domain,Kd,>,10000,nM,,CHEMBL6162,Serine/threonine-protein kinase PFTAIRE-1,Homo sapiens,O94921,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908732,Binding constant for PHKG1 kinase domain,Kd,>,10000,nM,,CHEMBL4004,Phosphorylase kinase gamma subunit 1,Homo sapiens,Q16816,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908494,Binding constant for PHKG2 kinase domain,Kd,>,10000,nM,,CHEMBL2349,Phosphorylase kinase gamma subunit 2,Homo sapiens,P15735,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908574,Binding constant for PIK3C2B kinase domain,Kd,>,10000,nM,,CHEMBL5554,Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing beta polypeptide,Homo sapiens,O00750,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908655,Binding constant for PIK3C2G kinase domain,Kd,>,10000,nM,,CHEMBL1163120,Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing subunit gamma,Homo sapiens,O75747,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908733,Binding constant for PIK3CA kinase domain,Kd,>,10000,nM,,CHEMBL4005,PI3-kinase p110-alpha subunit,Homo sapiens,P42336,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908734,Binding constant for PIK3CA(C420R) kinase domain,Kd,>,10000,nM,,CHEMBL4005,PI3-kinase p110-alpha subunit,Homo sapiens,P42336,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908735,Binding constant for PIK3CA(E542K) kinase domain,Kd,>,10000,nM,,CHEMBL4005,PI3-kinase p110-alpha subunit,Homo sapiens,P42336,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908736,Binding constant for PIK3CA(E545A) kinase domain,Kd,>,10000,nM,,CHEMBL4005,PI3-kinase p110-alpha subunit,Homo sapiens,P42336,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908737,Binding constant for PIK3CA(E545K) kinase domain,Kd,>,10000,nM,,CHEMBL4005,PI3-kinase p110-alpha subunit,Homo sapiens,P42336,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908738,Binding constant for PIK3CA(H1047L) kinase domain,Kd,>,10000,nM,,CHEMBL4005,PI3-kinase p110-alpha subunit,Homo sapiens,P42336,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908739,Binding constant for PIK3CA(H1047Y) kinase domain,Kd,>,10000,nM,,CHEMBL4005,PI3-kinase p110-alpha subunit,Homo sapiens,P42336,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908740,Binding constant for PIK3CA(I800L) kinase domain,Kd,>,10000,nM,,CHEMBL4005,PI3-kinase p110-alpha subunit,Homo sapiens,P42336,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908741,Binding constant for PIK3CA(M1043I) kinase domain,Kd,>,10000,nM,,CHEMBL4005,PI3-kinase p110-alpha subunit,Homo sapiens,P42336,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908742,Binding constant for PIK3CA(Q546K) kinase domain,Kd,>,10000,nM,,CHEMBL4005,PI3-kinase p110-alpha subunit,Homo sapiens,P42336,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908743,Binding constant for PIK3CB kinase domain,Kd,>,10000,nM,,CHEMBL3145,PI3-kinase p110-beta subunit,Homo sapiens,P42338,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908671,Binding constant for PIK3CD kinase domain,Kd,>,10000,nM,,CHEMBL3130,PI3-kinase p110-delta subunit,Homo sapiens,O00329,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908576,Binding constant for PIK3CG kinase domain,Kd,>,10000,nM,,CHEMBL3267,PI3-kinase p110-gamma subunit,Homo sapiens,P48736,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908577,Binding constant for PIK4CB kinase domain,Kd,>,10000,nM,,CHEMBL3268,PI4-kinase beta subunit,Homo sapiens,Q9UBF8,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908575,Binding constant for PIM1 kinase domain,Kd,>,10000,nM,,CHEMBL2147,Serine/threonine-protein kinase PIM1 ,Homo sapiens,P11309,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908761,Binding constant for PIM2 kinase domain,Kd,>,10000,nM,,CHEMBL4523,Serine/threonine-protein kinase PIM2,Homo sapiens,Q9P1W9,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908499,Binding constant for PIM3 kinase domain,Kd,>,10000,nM,,CHEMBL5407,Serine/threonine-protein kinase PIM3,Homo sapiens,Q86V86,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908521,Binding constant for PIP5K1A kinase domain,Kd,>,10000,nM,,CHEMBL5969,Phosphatidylinositol-4-phosphate 5-kinase type-1 alpha,Homo sapiens,Q99755,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908448,Binding constant for PIP5K1C kinase domain,Kd,>,10000,nM,,CHEMBL1908383,Phosphatidylinositol-4-phosphate 5-kinase type-1 gamma,Homo sapiens,O60331,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908612,Binding constant for PIP5K2B kinase domain,Kd,>,10000,nM,,CHEMBL5667,Phosphatidylinositol-5-phosphate 4-kinase type-2 beta,Homo sapiens,P78356,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908831,Binding constant for PIP5K2C kinase domain,Kd,>,10000,nM,,CHEMBL1770034,Phosphatidylinositol-5-phosphate 4-kinase type-2 gamma,Homo sapiens,Q8TBX8,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908578,Binding constant for PKAC-alpha kinase domain,Kd,>,10000,nM,,CHEMBL4101,cAMP-dependent protein kinase alpha-catalytic subunit,Homo sapiens,P17612,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908579,Binding constant for PKAC-beta kinase domain,Kd,>,10000,nM,,CHEMBL2918,cAMP-dependent protein kinase beta-1 catalytic subunit,Homo sapiens,P22694,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908454,Binding constant for PKMYT1 kinase domain,Kd,>,10000,nM,,CHEMBL3984,Tyrosine- and threonine-specific cdc2-inhibitory kinase,Homo sapiens,Q99640,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908442,Binding constant for PKN1 kinase domain,Kd,>,10000,nM,,CHEMBL3384,Protein kinase N1,Homo sapiens,Q16512,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908747,Binding constant for PKN2 kinase domain,Kd,>,10000,nM,,CHEMBL3032,Protein kinase N2,Homo sapiens,Q16513,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908450,Binding constant for PKNB(M.tuberculosis) kinase domain,Kd,>,10000,nM,,CHEMBL1908385,Serine/threonine-protein kinase pknB,Mycobacterium tuberculosis,P0A5S4,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908672,Binding constant for PLK1 kinase domain,Kd,>,10000,nM,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908760,Binding constant for PLK2 kinase domain,Kd,>,10000,nM,,CHEMBL5938,Serine/threonine-protein kinase PLK2,Homo sapiens,Q9NYY3,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908630,Binding constant for PLK3 kinase domain,Kd,>,10000,nM,,CHEMBL4897,Serine/threonine-protein kinase PLK3,Homo sapiens,Q9H4B4,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908773,Binding constant for PLK4 kinase domain,Kd,>,10000,nM,,CHEMBL3788,Serine/threonine-protein kinase PLK4,Homo sapiens,O00444,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908745,Binding constant for PRKCD kinase domain,Kd,>,10000,nM,,CHEMBL2996,Protein kinase C delta,Homo sapiens,Q05655,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908711,Binding constant for PRKCE kinase domain,Kd,>,10000,nM,,CHEMBL3582,Protein kinase C epsilon,Homo sapiens,Q02156,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908746,Binding constant for PRKCH kinase domain,Kd,>,10000,nM,,CHEMBL3616,Protein kinase C eta,Homo sapiens,P24723,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908580,Binding constant for PRKCI kinase domain,Kd,>,10000,nM,,CHEMBL2598,Protein kinase C iota,Homo sapiens,P41743,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908748,Binding constant for PRKCQ kinase domain,Kd,>,10000,nM,,CHEMBL3920,Protein kinase C theta,Homo sapiens,Q04759,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908581,Binding constant for PRKD1 kinase domain,Kd,>,10000,nM,,CHEMBL3863,Protein kinase C mu,Homo sapiens,Q15139,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908799,Binding constant for PRKD2 kinase domain,Kd,>,10000,nM,,CHEMBL4900,Serine/threonine-protein kinase D2,Homo sapiens,Q9BZL6,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908721,Binding constant for PRKD3 kinase domain,Kd,>,10000,nM,,CHEMBL2595,Protein kinase C nu,Homo sapiens,O94806,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908749,Binding constant for PRKG1 kinase domain,Kd,>,10000,nM,,CHEMBL4273,cGMP-dependent protein kinase 1 beta,Homo sapiens,Q13976,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908750,Binding constant for PRKG2 kinase domain,Kd,>,10000,nM,,CHEMBL2896,cGMP-dependent protein kinase 2,Homo sapiens,Q13237,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908593,Binding constant for PRKR kinase domain,Kd,>,10000,nM,,CHEMBL5785,"Interferon-induced, double-stranded RNA-activated protein kinase",Homo sapiens,P19525,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908673,Binding constant for PRKX kinase domain,Kd,>,10000,nM,,CHEMBL5818,Serine/threonine-protein kinase PRKX,Homo sapiens,P51817,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908447,Binding constant for PRP4 kinase domain,Kd,>,10000,nM,,CHEMBL1908382,Serine/threonine-protein kinase PRP4 homolog,Homo sapiens,Q13523,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908429,Binding constant for PYK2 kinase domain,Kd,>,10000,nM,,CHEMBL5469,Protein tyrosine kinase 2 beta,Homo sapiens,Q14289,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908471,Binding constant for QSK kinase domain,Kd,>,10000,nM,,CHEMBL6149,Serine/threonine-protein kinase SIK3,Homo sapiens,Q9Y2K2,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908594,Binding constant for RAF1 kinase domain,Kd,>,10000,nM,,CHEMBL1906,Serine/threonine-protein kinase RAF,Homo sapiens,P04049,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908818,Binding constant for RET kinase domain,Kd,>,10000,nM,,CHEMBL2041,Tyrosine-protein kinase receptor RET,Homo sapiens,P07949,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908819,Binding constant for RET(M918T) kinase domain,Kd,>,10000,nM,,CHEMBL2041,Tyrosine-protein kinase receptor RET,Homo sapiens,P07949,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908820,Binding constant for RET(V804L) kinase domain,Kd,>,10000,nM,,CHEMBL2041,Tyrosine-protein kinase receptor RET,Homo sapiens,P07949,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908821,Binding constant for RET(V804M) kinase domain,Kd,>,10000,nM,,CHEMBL2041,Tyrosine-protein kinase receptor RET,Homo sapiens,P07949,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908838,Binding constant for RIOK1 kinase domain,Kd,>,10000,nM,,CHEMBL5975,Serine/threonine-protein kinase RIO1,Homo sapiens,Q9BRS2,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908808,Binding constant for RIOK2 kinase domain,Kd,>,10000,nM,,CHEMBL6000,Serine/threonine-protein kinase RIO2,Homo sapiens,Q9BVS4,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908623,Binding constant for RIOK3 kinase domain,Kd,>,10000,nM,,CHEMBL5659,Serine/threonine-protein kinase RIO3,Homo sapiens,O14730,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908621,Binding constant for RIPK1 kinase domain,Kd,>,10000,nM,,CHEMBL5464,Receptor-interacting serine/threonine-protein kinase 1,Homo sapiens,Q13546,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908622,Binding constant for RIPK2 kinase domain,Kd,>,10000,nM,,CHEMBL5014,Serine/threonine-protein kinase RIPK2,Homo sapiens,O43353,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908460,Binding constant for RIPK4 kinase domain,Kd,>,10000,nM,,CHEMBL6083,Receptor-interacting serine/threonine-protein kinase 4,Homo sapiens,P57078,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908455,Binding constant for RIPK5 kinase domain,Kd,>,10000,nM,,CHEMBL1908386,Dual serine/threonine and tyrosine protein kinase,Homo sapiens,Q6XUX3,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908712,Binding constant for ROCK1 kinase domain,Kd,>,10000,nM,,CHEMBL3231,Rho-associated protein kinase 1 ,Homo sapiens,Q13464,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908666,Binding constant for ROCK2 kinase domain,Kd,>,10000,nM,,CHEMBL2973,Rho-associated protein kinase 2,Homo sapiens,O75116,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908596,Binding constant for ROS1 kinase domain,Kd,>,10000,nM,,CHEMBL5568,Proto-oncogene tyrosine-protein kinase ROS,Homo sapiens,P08922,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908503,Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain,Kd,>,10000,nM,,CHEMBL3125,Ribosomal protein S6 kinase alpha 4,Homo sapiens,O75676,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908624,Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain,Kd,>,10000,nM,,CHEMBL3125,Ribosomal protein S6 kinase alpha 4,Homo sapiens,O75676,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908433,Binding constant for RPS6KA5(Kin.Dom.1-N-terminal) kinase domain,Kd,>,10000,nM,,CHEMBL4237,Ribosomal protein S6 kinase alpha 5,Homo sapiens,O75582,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908664,Binding constant for RPS6KA5(Kin.Dom.2-C-terminal) kinase domain,Kd,>,10000,nM,,CHEMBL4237,Ribosomal protein S6 kinase alpha 5,Homo sapiens,O75582,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908597,Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain,Kd,>,10000,nM,,CHEMBL2553,Ribosomal protein S6 kinase alpha 1,Homo sapiens,Q15418,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908598,Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain,Kd,>,10000,nM,,CHEMBL2553,Ribosomal protein S6 kinase alpha 1,Homo sapiens,Q15418,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908657,Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain,Kd,>,10000,nM,,CHEMBL2345,Ribosomal protein S6 kinase alpha 3,Homo sapiens,P51812,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908824,Binding constant for RSK3(Kin.Dom.1-N-terminal) kinase domain,Kd,>,10000,nM,,CHEMBL3906,Ribosomal protein S6 kinase alpha 2,Homo sapiens,Q15349,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908502,Binding constant for RSK3(Kin.Dom.2-C-terminal) kinase domain,Kd,>,10000,nM,,CHEMBL3906,Ribosomal protein S6 kinase alpha 2,Homo sapiens,Q15349,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908778,Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain,Kd,>,10000,nM,,CHEMBL4924,Ribosomal protein S6 kinase alpha 6,Homo sapiens,Q9UK32,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908779,Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain,Kd,>,10000,nM,,CHEMBL4924,Ribosomal protein S6 kinase alpha 6,Homo sapiens,Q9UK32,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908603,Binding constant for S6K1 kinase domain,Kd,>,10000,nM,,CHEMBL4501,Ribosomal protein S6 kinase 1,Homo sapiens,P23443,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908509,Binding constant for SBK1 kinase domain,Kd,>,10000,nM,,CHEMBL1163129,Serine/threonine-protein kinase SBK1,Homo sapiens,Q52WX2,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908770,Binding constant for SGK3 kinase domain,Kd,>,10000,nM,,CHEMBL6186,Serine/threonine-protein kinase Sgk3,Homo sapiens,Q96BR1,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908430,Binding constant for SIK kinase domain,Kd,>,10000,nM,,CHEMBL6082,Serine/threonine-protein kinase SIK1,Homo sapiens,P57059,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908792,Binding constant for SIK2 kinase domain,Kd,>,10000,nM,,CHEMBL5699,Serine/threonine-protein kinase SIK2,Homo sapiens,Q9H0K1,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908783,Binding constant for SLK kinase domain,Kd,>,10000,nM,,CHEMBL4202,Serine/threonine-protein kinase 2,Homo sapiens,Q9H2G2,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908836,Binding constant for SNARK kinase domain,Kd,>,10000,nM,,CHEMBL5698,NUAK family SNF1-like kinase 2,Homo sapiens,Q9H093,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908449,Binding constant for SNRK kinase domain,Kd,>,10000,nM,,CHEMBL1908384,SNF-related serine/threonine-protein kinase,Homo sapiens,Q9NRH2,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908713,Binding constant for SRC kinase domain,Kd,>,10000,nM,,CHEMBL267,Tyrosine-protein kinase SRC,Homo sapiens,P12931,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908407,Binding constant for SRMS kinase domain,Kd,>,10000,nM,,CHEMBL5703,Tyrosine-protein kinase Srms,Homo sapiens,Q9H3Y6,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908600,Binding constant for SRPK1 kinase domain,Kd,>,10000,nM,,CHEMBL4375,Serine/threonine-protein kinase SRPK1,Homo sapiens,Q96SB4,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908465,Binding constant for SRPK2 kinase domain,Kd,>,10000,nM,,CHEMBL5668,Serine/threonine-protein kinase SRPK2,Homo sapiens,P78362,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908775,Binding constant for SRPK3 kinase domain,Kd,>,10000,nM,,CHEMBL5415,Serine/threonine-protein kinase SRPK3,Homo sapiens,Q9UPE1,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908472,Binding constant for STK16 kinase domain,Kd,>,10000,nM,,CHEMBL3938,Serine/threonine-protein kinase 16,Homo sapiens,O75716,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908835,Binding constant for STK33 kinase domain,Kd,>,10000,nM,,CHEMBL6005,Serine/threonine-protein kinase 33,Homo sapiens,Q9BYT3,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908408,Binding constant for STK35 kinase domain,Kd,>,10000,nM,,CHEMBL5651,Serine/threonine-protein kinase 35,Homo sapiens,Q8TDR2,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908793,Binding constant for STK36 kinase domain,Kd,>,10000,nM,,CHEMBL4312,Serine/threonine-protein kinase 36,Homo sapiens,Q9NRP7,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908768,Binding constant for STK39 kinase domain,Kd,>,10000,nM,,CHEMBL1163108,STE20/SPS1-related proline-alanine-rich protein kinase,Homo sapiens,Q9UEW8,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908604,Binding constant for SYK kinase domain,Kd,>,10000,nM,,CHEMBL2599,Tyrosine-protein kinase SYK,Homo sapiens,P43405,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908444,Binding constant for SgK110 kinase domain,Kd,>,10000,nM,,CHEMBL5116,Putative uncharacterized serine/threonine-protein kinase SgK110,Homo sapiens,P0C264,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908421,Binding constant for TAK1 kinase domain,Kd,>,10000,nM,,CHEMBL5776,Mitogen-activated protein kinase kinase kinase 7,Homo sapiens,O43318,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908823,Binding constant for TAOK1 kinase domain,Kd,>,10000,nM,,CHEMBL5261,Serine/threonine-protein kinase TAO1,Homo sapiens,Q7L7X3,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908796,Binding constant for TAOK2 kinase domain,Kd,>,10000,nM,,CHEMBL1075195,Serine/threonine-protein kinase TAO2,Homo sapiens,Q9UL54,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908798,Binding constant for TAOK3 kinase domain,Kd,>,10000,nM,,CHEMBL5701,Serine/threonine-protein kinase TAO3,Homo sapiens,Q9H2K8,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908769,Binding constant for TBK1 kinase domain,Kd,>,10000,nM,,CHEMBL5408,Serine/threonine-protein kinase TBK1,Homo sapiens,Q9UHD2,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908605,Binding constant for TEC kinase domain,Kd,>,10000,nM,,CHEMBL4246,Tyrosine-protein kinase TEC,Homo sapiens,P42680,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908753,Binding constant for TESK1 kinase domain,Kd,>,10000,nM,,CHEMBL5604,Dual specificity testis-specific protein kinase 1,Homo sapiens,Q15569,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908658,Binding constant for TGFBR1 kinase domain,Kd,>,10000,nM,,CHEMBL4439,TGF-beta receptor type I,Homo sapiens,P36897,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908606,Binding constant for TGFBR2 kinase domain,Kd,>,10000,nM,,CHEMBL4267,TGF-beta receptor type II,Homo sapiens,P37173,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908714,Binding constant for TIE1 kinase domain,Kd,>,10000,nM,,CHEMBL5274,Tyrosine-protein kinase receptor Tie-1,Homo sapiens,P35590,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908496,Binding constant for TIE2 kinase domain,Kd,>,10000,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908766,Binding constant for TLK1 kinase domain,Kd,>,10000,nM,,CHEMBL5388,Serine/threonine-protein kinase tousled-like 1,Homo sapiens,Q9UKI8,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908468,Binding constant for TLK2 kinase domain,Kd,>,10000,nM,,CHEMBL5404,Serine/threonine-protein kinase tousled-like 2,Homo sapiens,Q86UE8,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908790,Binding constant for TNIK kinase domain,Kd,>,10000,nM,,CHEMBL4527,TRAF2- and NCK-interacting kinase,Homo sapiens,Q9UKE5,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908627,Binding constant for TNK1 kinase domain,Kd,>,10000,nM,,CHEMBL5334,Non-receptor tyrosine-protein kinase TNK1,Homo sapiens,Q13470,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908504,Binding constant for TNK2 kinase domain,Kd,>,10000,nM,,CHEMBL4599,Tyrosine kinase non-receptor protein 2,Homo sapiens,Q07912,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908794,Binding constant for TNNI3K kinase domain,Kd,>,10000,nM,,CHEMBL5260,Serine/threonine-protein kinase TNNI3K,Homo sapiens,Q59H18,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908505,Binding constant for TRKA kinase domain,Kd,=,630,nM,,CHEMBL2815,Nerve growth factor receptor Trk-A,Homo sapiens,P04629,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908729,Binding constant for TRKB kinase domain,Kd,=,36,nM,,CHEMBL4898,Neurotrophic tyrosine kinase receptor type 2,Homo sapiens,Q16620,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908462,Binding constant for TRKC kinase domain,Kd,=,120,nM,,CHEMBL5608,NT-3 growth factor receptor,Homo sapiens,Q16288,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908807,Binding constant for TRPM6 kinase domain,Kd,>,10000,nM,,CHEMBL1628470,Transient receptor potential cation channel subfamily M member 6,Homo sapiens,Q9BX84,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908839,Binding constant for TSSK1B kinase domain,Kd,>,10000,nM,,CHEMBL6003,Testis-specific serine/threonine-protein kinase 1,Homo sapiens,Q9BXA7,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908607,Binding constant for TTK kinase domain,Kd,>,10000,nM,,CHEMBL3983,Dual specificity protein kinase TTK,Homo sapiens,P33981,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908608,Binding constant for TXK kinase domain,Kd,>,10000,nM,,CHEMBL4367,Tyrosine-protein kinase TXK,Homo sapiens,P42681,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908609,Binding constant for TYK2(JH1domain-catalytic) kinase domain,Kd,>,10000,nM,,CHEMBL3553,Tyrosine-protein kinase TYK2 ,Homo sapiens,P29597,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908610,Binding constant for TYK2(JH2domain-pseudokinase) kinase domain,Kd,>,10000,nM,,CHEMBL3553,Tyrosine-protein kinase TYK2 ,Homo sapiens,P29597,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908754,Binding constant for TYRO3 kinase domain,Kd,>,10000,nM,,CHEMBL5314,Tyrosine-protein kinase receptor TYRO3,Homo sapiens,Q06418,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908613,Binding constant for ULK1 kinase domain,Kd,>,10000,nM,,CHEMBL6006,Serine/threonine-protein kinase ULK1,Homo sapiens,O75385,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908782,Binding constant for ULK2 kinase domain,Kd,>,10000,nM,,CHEMBL5435,Serine/threonine-protein kinase ULK2,Homo sapiens,Q8IYT8,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908515,Binding constant for ULK3 kinase domain,Kd,>,10000,nM,,CHEMBL5047,Serine/threonine-protein kinase ULK3,Homo sapiens,Q6PHR2,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908557,Binding constant for VEGFR2 kinase domain,Kd,>,10000,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908755,Binding constant for VRK2 kinase domain,Kd,>,10000,nM,,CHEMBL1649059,Serine/threonine-protein kinase VRK2,Homo sapiens,Q86Y07,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908611,Binding constant for WEE1 kinase domain,Kd,>,10000,nM,,CHEMBL5491,Serine/threonine-protein kinase WEE1,Homo sapiens,P30291,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908443,Binding constant for WEE2 kinase domain,Kd,>,10000,nM,,CHEMBL5095,Wee1-like protein kinase 2,Homo sapiens,P0C1S8,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908518,Binding constant for YANK1 kinase domain,Kd,>,10000,nM,,CHEMBL6150,Serine/threonine-protein kinase 32A,Homo sapiens,Q8WU08,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908809,Binding constant for YANK2 kinase domain,Kd,>,10000,nM,,CHEMBL5912,Serine/threonine-protein kinase 32B,Homo sapiens,Q9NY57,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908431,Binding constant for YANK3 kinase domain,Kd,>,10000,nM,,CHEMBL5405,Serine/threonine-protein kinase 32C,Homo sapiens,Q86UX6,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908715,Binding constant for YES kinase domain,Kd,>,10000,nM,,CHEMBL2073,Tyrosine-protein kinase YES,Homo sapiens,P07947,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908756,Binding constant for YSK1 kinase domain,Kd,>,10000,nM,,CHEMBL5552,Serine/threonine-protein kinase 25,Homo sapiens,O00506,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908833,Binding constant for YSK4 kinase domain,Kd,>,10000,nM,,CHEMBL6191,SPS1/STE20-related protein kinase YSK4,Homo sapiens,Q56UN5,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908452,Binding constant for ZAK kinase domain,Kd,>,10000,nM,,CHEMBL3886,Mixed lineage kinase 7,Homo sapiens,Q9NYL2,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908441,Binding constant for ZAP70 kinase domain,Kd,>,10000,nM,,CHEMBL2803,Tyrosine-protein kinase ZAP-70 ,Homo sapiens,P43403,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908411,Binding constant for p38-alpha kinase domain,Kd,>,10000,nM,,CHEMBL260,MAP kinase p38 alpha,Homo sapiens,Q16539,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908587,Binding constant for p38-beta kinase domain,Kd,>,10000,nM,,CHEMBL3961,MAP kinase p38 beta,Homo sapiens,Q15759,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908589,Binding constant for p38-delta kinase domain,Kd,>,10000,nM,,CHEMBL2939,MAP kinase p38 delta,Homo sapiens,O15264,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
GW-2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908463,Binding constant for p38-gamma kinase domain,Kd,>,10000,nM,,CHEMBL4674,MAP kinase p38 gamma,Homo sapiens,P53778,CHEMBL1908390,"Nat. Biotechnol., 29, p. 1046 (2011)",22037378,Scientific Literature
"6, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL1948284,Growth inhibition of human HCT116 cells expressing wild-type B-Raf and K-Ras2 G13D mutant after 72 hrs by WST-1 assay,EC50,=,1100,nM,,CHEMBL394,HCT-116 (Colon carcinoma cells),Homo sapiens,,CHEMBL1944549,"Bioorg. Med. Chem. Lett., 22, p. 789 (2012)",22222036,Scientific Literature
"6, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL1948285,Growth inhibition of human SK-MEL-2 cells expressing wild-type B-Raf and N-Ras2 Q61R mutant after 72 hrs by WST-1 assay,EC50,=,1100,nM,,CHEMBL614917,SK-MEL-2 (Melanoma cells),Homo sapiens,,CHEMBL1944549,"Bioorg. Med. Chem. Lett., 22, p. 789 (2012)",22222036,Scientific Literature
"6, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL1948276,Inhibition of B-Raf V600E mutant-mediated Erk phosphorylation in human A549 cells after 60 mins by Western blot analysis,EC50,=,28,nM,,CHEMBL612545,,,,CHEMBL1944549,"Bioorg. Med. Chem. Lett., 22, p. 789 (2012)",22222036,Scientific Literature
"6, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL1948277,Inhibition of B-Raf V600E mutant-mediated Erk phosphorylation in human Colo205 cells after 60 mins by Western blot analysis,EC50,=,28,nM,,CHEMBL612545,,,,CHEMBL1944549,"Bioorg. Med. Chem. Lett., 22, p. 789 (2012)",22222036,Scientific Literature
"6, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL1948278,Inhibition of B-Raf V600E mutant-mediated Erk phosphorylation in human HT-29 cells after 60 mins by Western blot analysis,EC50,=,28,nM,,CHEMBL612545,,,,CHEMBL1944549,"Bioorg. Med. Chem. Lett., 22, p. 789 (2012)",22222036,Scientific Literature
"6, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL1948279,Inhibition of B-Raf V600E mutant-mediated Erk phosphorylation in human MALME3M cells after 60 mins by Western blot analysis,EC50,=,28,nM,,CHEMBL612545,,,,CHEMBL1944549,"Bioorg. Med. Chem. Lett., 22, p. 789 (2012)",22222036,Scientific Literature
"6, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL1948280,Inhibition of B-Raf V600E mutant-mediated Erk phosphorylation in human SKMEL28 cells after 60 mins by Western blot analysis,EC50,=,28,nM,,CHEMBL612545,,,,CHEMBL1944549,"Bioorg. Med. Chem. Lett., 22, p. 789 (2012)",22222036,Scientific Literature
"6, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL1948273,Inhibition of B-Raf-mediated Erk phosphorylation in human HFF cells after 60 mins by Western blot analysis,EC50,=,1100,nM,,CHEMBL5145,Serine/threonine-protein kinase B-raf,Homo sapiens,P15056,CHEMBL1944549,"Bioorg. Med. Chem. Lett., 22, p. 789 (2012)",22222036,Scientific Literature
"6, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL1948274,Inhibition of B-Raf-mediated Erk phosphorylation in human HMEC cells after 60 mins by Western blot analysis,EC50,=,1100,nM,,CHEMBL5145,Serine/threonine-protein kinase B-raf,Homo sapiens,P15056,CHEMBL1944549,"Bioorg. Med. Chem. Lett., 22, p. 789 (2012)",22222036,Scientific Literature
"6, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL1948275,Inhibition of B-Raf-mediated Erk phosphorylation in human PREC cells after 60 mins by Western blot analysis,EC50,=,1100,nM,,CHEMBL5145,Serine/threonine-protein kinase B-raf,Homo sapiens,P15056,CHEMBL1944549,"Bioorg. Med. Chem. Lett., 22, p. 789 (2012)",22222036,Scientific Literature
"6, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL1948272,Inhibition of N-terminus His-6 tagged human B-Raf expressed in baculovirus infected insect Sf9 cells,Ki,=,0.16,nM,,CHEMBL5145,Serine/threonine-protein kinase B-raf,Homo sapiens,P15056,CHEMBL1944549,"Bioorg. Med. Chem. Lett., 22, p. 789 (2012)",22222036,Scientific Literature
"6, SB-590885",CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL477989,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24+",CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4,CHEMBL1947622,Selectivity ratio of IC50 for human C-Raf to IC50 for B-Raf V600E mutant,Ratio IC50,=,11,,,CHEMBL612545,,,,CHEMBL1944549,"Bioorg. Med. Chem. Lett., 22, p. 789 (2012)",22222036,Scientific Literature
14d,CHEMBL1896047,"InChI=1S/C23H22F4N6/c1-32(2)13-3-11-28-22-29-12-10-18(30-22)20-19-9-6-16(23(25,26)27)14-33(19)31-21(20)15-4-7-17(24)8-5-15/h4-10,12,14H,3,11,13H2,1-2H3,(H,28,29,30)",CN(C)CCCNc1nccc(n1)c2c(nn3cc(ccc23)C(F)(F)F)c4ccc(F)cc4,CHEMBL1896047,"InChI=1S/C23H22F4N6/c1-32(2)13-3-11-28-22-29-12-10-18(30-22)20-19-9-6-16(23(25,26)27)14-33(19)31-21(20)15-4-7-17(24)8-5-15/h4-10,12,14H,3,11,13H2,1-2H3,(H,28,29,30)",CN(C)CCCNc1nccc(n1)c2c(nn3cc(ccc23)C(F)(F)F)c4ccc(F)cc4,CHEMBL1953468,Inhibition of p38 kinase,IC50,=,630,nM,,CHEMBL612545,,,,CHEMBL1949665,"Org Lett, 7, p. 4753 (2005)",16209527,Scientific Literature
14h,CHEMBL1909402,"InChI=1S/C18H11F4N5/c19-12-4-1-10(2-5-12)16-15(13-7-8-24-17(23)25-13)14-6-3-11(18(20,21)22)9-27(14)26-16/h1-9H,(H2,23,24,25)",Nc1nccc(n1)c2c(nn3cc(ccc23)C(F)(F)F)c4ccc(F)cc4,CHEMBL1909402,"InChI=1S/C18H11F4N5/c19-12-4-1-10(2-5-12)16-15(13-7-8-24-17(23)25-13)14-6-3-11(18(20,21)22)9-27(14)26-16/h1-9H,(H2,23,24,25)",Nc1nccc(n1)c2c(nn3cc(ccc23)C(F)(F)F)c4ccc(F)cc4,CHEMBL1953468,Inhibition of p38 kinase,IC50,=,200,nM,,CHEMBL612545,,,,CHEMBL1949665,"Org Lett, 7, p. 4753 (2005)",16209527,Scientific Literature
14o,CHEMBL1952232,"InChI=1S/C21H17F4N5O/c22-15-5-2-13(3-6-15)19-18(16-8-10-27-20(28-16)26-9-1-11-31)17-7-4-14(21(23,24)25)12-30(17)29-19/h2-8,10,12,31H,1,9,11H2,(H,26,27,28)",OCCCNc1nccc(n1)c2c(nn3cc(ccc23)C(F)(F)F)c4ccc(F)cc4,CHEMBL1952232,"InChI=1S/C21H17F4N5O/c22-15-5-2-13(3-6-15)19-18(16-8-10-27-20(28-16)26-9-1-11-31)17-7-4-14(21(23,24)25)12-30(17)29-19/h2-8,10,12,31H,1,9,11H2,(H,26,27,28)",OCCCNc1nccc(n1)c2c(nn3cc(ccc23)C(F)(F)F)c4ccc(F)cc4,CHEMBL1953468,Inhibition of p38 kinase,IC50,=,60,nM,,CHEMBL612545,,,,CHEMBL1949665,"Org Lett, 7, p. 4753 (2005)",16209527,Scientific Literature
14t,CHEMBL1885746,"InChI=1S/C21H15FN6/c22-15-4-2-14(3-5-15)20-19(18-8-1-13(11-23)12-28(18)27-20)17-9-10-24-21(26-17)25-16-6-7-16/h1-5,8-10,12,16H,6-7H2,(H,24,25,26)",Fc1ccc(cc1)c2nn3cc(ccc3c2c4ccnc(NC5CC5)n4)C#N,CHEMBL1885746,"InChI=1S/C21H15FN6/c22-15-4-2-14(3-5-15)20-19(18-8-1-13(11-23)12-28(18)27-20)17-9-10-24-21(26-17)25-16-6-7-16/h1-5,8-10,12,16H,6-7H2,(H,24,25,26)",Fc1ccc(cc1)c2nn3cc(ccc3c2c4ccnc(NC5CC5)n4)C#N,CHEMBL1953468,Inhibition of p38 kinase,IC50,=,30,nM,,CHEMBL612545,,,,CHEMBL1949665,"Org Lett, 7, p. 4753 (2005)",16209527,Scientific Literature
14v,CHEMBL1909404,"InChI=1S/C21H19FN6O2/c22-15-5-2-13(3-6-15)19-18(16-8-10-25-21(26-16)24-9-1-11-29)17-7-4-14(20(23)30)12-28(17)27-19/h2-8,10,12,29H,1,9,11H2,(H2,23,30)(H,24,25,26)",NC(=O)c1ccc2c(c3ccnc(NCCCO)n3)c(nn2c1)c4ccc(F)cc4,CHEMBL1909404,"InChI=1S/C21H19FN6O2/c22-15-5-2-13(3-6-15)19-18(16-8-10-25-21(26-16)24-9-1-11-29)17-7-4-14(20(23)30)12-28(17)27-19/h2-8,10,12,29H,1,9,11H2,(H2,23,30)(H,24,25,26)",NC(=O)c1ccc2c(c3ccnc(NCCCO)n3)c(nn2c1)c4ccc(F)cc4,CHEMBL1953468,Inhibition of p38 kinase,IC50,=,10,nM,,CHEMBL612545,,,,CHEMBL1949665,"Org Lett, 7, p. 4753 (2005)",16209527,Scientific Literature
SB-7720770-B,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1959025,"Antihypertensive activity in normotensive Sprague-Dawley rat assessed as reduction of blood pressure at 1 mg/kg, po after 2 hrs",Activity,=,12,mmHg,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
GSK269962A,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1960786,Antihypertensive activity in po dosed spontaneously hypertensive rat assessed as reduction of blood pressure,Activity,,,,Dose-dependent effect,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
SB-7720770-B,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1960786,Antihypertensive activity in po dosed spontaneously hypertensive rat assessed as reduction of blood pressure,Activity,,,,Dose-dependent effect,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
SB-7720770-B,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1959022,"Antihypertensive activity in rat assessed as reduction of DOCA salt-induced blood pressure at 1 mg/kg, po after 2 hrs",Activity,=,60,mmHg,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
GSK269962A,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1959020,"Antihypertensive activity in spontaneously hypertensive rat assessed as reduction of blood pressure at 0.3 to 3 mg/kg, po after 2 hrs",Activity,,,,Dose-dependent effect,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
SB-7720770-B,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1959020,"Antihypertensive activity in spontaneously hypertensive rat assessed as reduction of blood pressure at 0.3 to 3 mg/kg, po after 2 hrs",Activity,,,,Dose-dependent effect,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
SB-7720770-B,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1959023,"Antihypertensive activity in spontaneously hypertensive rat assessed as reduction of blood pressure at 1 mg/kg, po after 2 hrs",Activity,=,40,mmHg,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
GSK269962A,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1958894,Antiinflammatory activity in human THP1 cells assessed as inhibition of LPS-induced IL-6 production treated 30 mins before LPS stimulation measured after 18 hrs by ELISA,Inhibition,,,,Dose-dependent effect,CHEMBL614245,THP-1 (Acute monocytic leukemia cells),Homo sapiens,,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
SB-7720770-B,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1958894,Antiinflammatory activity in human THP1 cells assessed as inhibition of LPS-induced IL-6 production treated 30 mins before LPS stimulation measured after 18 hrs by ELISA,Inhibition,,,,Dose-dependent effect,CHEMBL614245,THP-1 (Acute monocytic leukemia cells),Homo sapiens,,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
GSK269962A,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1958893,Antiinflammatory activity in human THP1 cells assessed as inhibition of LPS-induced TNFalpha production treated 30 mins before LPS stimulation measured after 18 hrs by ELISA,Inhibition,,,,Dose-dependent effect,CHEMBL614245,THP-1 (Acute monocytic leukemia cells),Homo sapiens,,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
SB-7720770-B,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1958893,Antiinflammatory activity in human THP1 cells assessed as inhibition of LPS-induced TNFalpha production treated 30 mins before LPS stimulation measured after 18 hrs by ELISA,Inhibition,,,,Dose-dependent effect,CHEMBL614245,THP-1 (Acute monocytic leukemia cells),Homo sapiens,,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
SB-7720770-B,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1959024,"Cardiovascular activity in DOCA salt treated rat assessed as increase in heart rate at 1 mg/kg, po",Activity,,,,Toxic,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
GSK269962A,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1959021,"Cardiovascular activity in spontaneously hypertensive rat assessed as increase in heart rate at 0.3 to 3 mg/kg, po",Activity,,,,Dose-dependent effect,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
SB-7720770-B,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1959021,"Cardiovascular activity in spontaneously hypertensive rat assessed as increase in heart rate at 0.3 to 3 mg/kg, po",Activity,,,,Dose-dependent effect,CHEMBL376,Rattus norvegicus,Rattus norvegicus,,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
GSK269962A,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1960791,Inhibition of AKT1,IC50,=,955,nM,,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,P31749,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
SB-7720770-B,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1960791,Inhibition of AKT1,IC50,=,324,nM,,CHEMBL4282,Serine/threonine-protein kinase AKT,Homo sapiens,P31749,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
GSK269962A,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1960792,Inhibition of AKT2,IC50,=,1350,nM,,CHEMBL2431,Serine/threonine-protein kinase AKT2,Homo sapiens,P31751,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
SB-7720770-B,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1960792,Inhibition of AKT2,IC50,=,1950,nM,,CHEMBL2431,Serine/threonine-protein kinase AKT2,Homo sapiens,P31751,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
GSK269962A,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1960793,Inhibition of AKT3,IC50,=,1510,nM,,CHEMBL4816,Serine/threonine-protein kinase AKT3,Homo sapiens,Q9Y243,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
SB-7720770-B,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1960793,Inhibition of AKT3,IC50,=,1290,nM,,CHEMBL4816,Serine/threonine-protein kinase AKT3,Homo sapiens,Q9Y243,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
GSK269962A,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1960794,Inhibition of CDK2,IC50,=,3500,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
SB-7720770-B,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1960794,Inhibition of CDK2,IC50,=,7000,nM,,CHEMBL301,Cyclin-dependent kinase 2,Homo sapiens,P24941,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
GSK269962A,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1960795,Inhibition of GSK3alpha,IC50,=,1260,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
SB-7720770-B,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1960795,Inhibition of GSK3alpha,IC50,=,9100,nM,,CHEMBL2850,Glycogen synthase kinase-3 alpha,Homo sapiens,P49840,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
GSK269962A,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1960796,Inhibition of IKK2,IC50,>,10000,nM,,CHEMBL1991,Inhibitor of nuclear factor kappa B kinase beta subunit,Homo sapiens,O14920,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
SB-7720770-B,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1960796,Inhibition of IKK2,IC50,>,10000,nM,,CHEMBL1991,Inhibitor of nuclear factor kappa B kinase beta subunit,Homo sapiens,O14920,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
GSK269962A,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1958879,Inhibition of JNK3,IC50,>,10000,nM,,CHEMBL2637,c-Jun N-terminal kinase 3,Homo sapiens,P53779,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
SB-7720770-B,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1958879,Inhibition of JNK3,IC50,>,10000,nM,,CHEMBL2637,c-Jun N-terminal kinase 3,Homo sapiens,P53779,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
GSK269962A,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1960790,Inhibition of MSK1,IC50,=,49,nM,,CHEMBL4237,Ribosomal protein S6 kinase alpha 5,Homo sapiens,O75582,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
SB-7720770-B,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1960790,Inhibition of MSK1,IC50,=,14,nM,,CHEMBL4237,Ribosomal protein S6 kinase alpha 5,Homo sapiens,O75582,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
GSK269962A,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1958880,Inhibition of PLK,IC50,>,10000,nM,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
SB-7720770-B,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1958880,Inhibition of PLK,IC50,>,10000,nM,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
GSK269962A,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1960789,Inhibition of RSK1,IC50,=,132,nM,,CHEMBL2553,Ribosomal protein S6 kinase alpha 1,Homo sapiens,Q15418,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
SB-7720770-B,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1960789,Inhibition of RSK1,IC50,=,35,nM,,CHEMBL2553,Ribosomal protein S6 kinase alpha 1,Homo sapiens,Q15418,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
GSK269962A,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1958891,Inhibition of angiotensin-2-induced actin stress fiber formation in human primary aortic smooth muscle cells at 1 uM treated 30 mins before angiotensin-2 stimulation measured after 2 hrs using rhodamine phalloidin staining by confocal microscopic analysis,Inhibition,,,,Active,CHEMBL612545,,,,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
SB-7720770-B,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1958891,Inhibition of angiotensin-2-induced actin stress fiber formation in human primary aortic smooth muscle cells at 1 uM treated 30 mins before angiotensin-2 stimulation measured after 2 hrs using rhodamine phalloidin staining by confocal microscopic analysis,Inhibition,,,,Active,CHEMBL612545,,,,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
GSK269962A,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1960788,Inhibition of human ROCK2,IC50,=,4,nM,,CHEMBL2973,Rho-associated protein kinase 2,Homo sapiens,O75116,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
SB-7720770-B,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1960788,Inhibition of human ROCK2,IC50,=,6,nM,,CHEMBL2973,Rho-associated protein kinase 2,Homo sapiens,O75116,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
GSK269962A,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1960787,Inhibition of human recombinant N-terminal his-tagged ROCK1 (3-543) expressed in baculovirus infected Sf9 cells using Biotin-Ahx-AKRRLSSLRA-CONH2 substrate and [gamma-33P]ATP after 90 mins by scintillation proximity assay,IC50,=,1.6,nM,,CHEMBL3231,Rho-associated protein kinase 1 ,Homo sapiens,Q13464,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
SB-7720770-B,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1960787,Inhibition of human recombinant N-terminal his-tagged ROCK1 (3-543) expressed in baculovirus infected Sf9 cells using Biotin-Ahx-AKRRLSSLRA-CONH2 substrate and [gamma-33P]ATP after 90 mins by scintillation proximity assay,IC50,=,5.6,nM,,CHEMBL3231,Rho-associated protein kinase 1 ,Homo sapiens,Q13464,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
GSK269962A,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1958883,Selectivity ratio of IC50 for AKT1 to IC50 for human recombinant N-terminal his-tagged ROCK1 (3-543),Ratio IC50,>,30,,,CHEMBL612545,,,,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
GSK269962A,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1958884,Selectivity ratio of IC50 for AKT2 to IC50 for human recombinant N-terminal his-tagged ROCK1 (3-543),Ratio IC50,>,30,,,CHEMBL612545,,,,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
GSK269962A,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1958885,Selectivity ratio of IC50 for AKT3 to IC50 for human recombinant N-terminal his-tagged ROCK1 (3-543),Ratio IC50,>,30,,,CHEMBL612545,,,,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
GSK269962A,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1958886,Selectivity ratio of IC50 for CDK2 to IC50 for human recombinant N-terminal his-tagged ROCK1 (3-543),Ratio IC50,>,30,,,CHEMBL612545,,,,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
GSK269962A,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1958887,Selectivity ratio of IC50 for GSK3alpha to IC50 for human recombinant N-terminal his-tagged ROCK1 (3-543),Ratio IC50,>,30,,,CHEMBL612545,,,,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
GSK269962A,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1958888,Selectivity ratio of IC50 for IKK2 to IC50 for human recombinant N-terminal his-tagged ROCK1 (3-543),Ratio IC50,>,30,,,CHEMBL612545,,,,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
GSK269962A,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1958889,Selectivity ratio of IC50 for JNK3 to IC50 for human recombinant N-terminal his-tagged ROCK1 (3-543),Ratio IC50,>,30,,,CHEMBL612545,,,,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
GSK269962A,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1958882,Selectivity ratio of IC50 for MSK1 to IC50 for human recombinant N-terminal his-tagged ROCK1 (3-543),Ratio IC50,>,30,,,CHEMBL612545,,,,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
GSK269962A,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1958890,Selectivity ratio of IC50 for PLK to IC50 for human recombinant N-terminal his-tagged ROCK1 (3-543),Ratio IC50,>,30,,,CHEMBL612545,,,,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
GSK269962A,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1958881,Selectivity ratio of IC50 for RSK1 to IC50 for human recombinant N-terminal his-tagged ROCK1 (3-543),Ratio IC50,>,30,,,CHEMBL612545,,,,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
GSK269962A,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1959018,Vasodilatory activity in Sprague-Dawley rat aorta assessed as reversal of KCl/phenylephrine-induced muscle contraction,Activity,,,,Dose-dependent effect,CHEMBL613606,Aorta,Rattus norvegicus,,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
SB-7720770-B,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1959018,Vasodilatory activity in Sprague-Dawley rat aorta assessed as reversal of KCl/phenylephrine-induced muscle contraction,Activity,,,,Dose-dependent effect,CHEMBL613606,Aorta,Rattus norvegicus,,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
GSK269962A,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1959018,Vasodilatory activity in Sprague-Dawley rat aorta assessed as reversal of KCl/phenylephrine-induced muscle contraction,IC50,=,35,nM,,CHEMBL613606,Aorta,Rattus norvegicus,,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
SB-7720770-B,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1959018,Vasodilatory activity in Sprague-Dawley rat aorta assessed as reversal of KCl/phenylephrine-induced muscle contraction,IC50,=,39,nM,,CHEMBL613606,Aorta,Rattus norvegicus,,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
GSK269962A,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL220241,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",CCn1c(nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc12)c6nonc6N,CHEMBL1959019,Vasodilatory activity in Sprague-Dawley rat aorta assessed as reversal of KCl/phenylephrine-induced muscle contraction measured after drug washout,Activity,,,,Not Active,CHEMBL613606,Aorta,Rattus norvegicus,,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
SB-7720770-B,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1956071,"InChI=1S/C15H18N8O2/c1-2-23-12-9(15(24)22-4-3-8(16)7-22)5-18-6-10(12)19-14(23)11-13(17)21-25-20-11/h5-6,8H,2-4,7,16H2,1H3,(H2,17,21)/t8-/m0/s1",CCn1c(nc2cncc(C(=O)N3CC[C@H](N)C3)c12)c4nonc4N,CHEMBL1959019,Vasodilatory activity in Sprague-Dawley rat aorta assessed as reversal of KCl/phenylephrine-induced muscle contraction measured after drug washout,Activity,,,,Not Active,CHEMBL613606,Aorta,Rattus norvegicus,,CHEMBL1955726,"J Pharmacol Exp Ther, 320, p. 89 (2007)",17018693,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1960106,"Antitumor activity in mouse M-NFS-60 cells allografted in CD-1 nude mouse assessed as inhibition of tumor cell growth in peritoneal cavity at 80 mg/kg, po BID starting 1 hr before challenge for 4 days measured after 4 days",GI,,,,Active,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1960107,Antitumor activity in mouse M-NFS-60 cells allografted in po dosed CD-1 nude mouse assessed as inhibition of tumor cell growth in peritoneal cavity compound starting 1 hr before challenge twice a day for 4 days measured after 4 days,GI,,,,Dose-dependent effect,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1960087,"Cmax in mouse at 20 mg/kg, po",Cmax,=,1.4,uM,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1960093,"Cmax in mouse at 20 mg/kg, po",Cmax,=,0.05,uM,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1960088,"Cmax in mouse at 80 mg/kg, po",Cmax,=,5.6,uM,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1960094,"Cmax in mouse at 80 mg/kg, po",Cmax,=,0.4,uM,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959942,Effect on LPS-induced IL-6 production in CSF-1-stimulated human macrophages at 0.03906 to 20 uM preincubated for 30 mins before LPS stimulation measured after 20 hrs by ELISA,Activity,,,,Not Active,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959936,Effect on LPS-induced IL-6 production in human PBMC at 0.03906 to 20 uM preincubated for 30 mins before LPS stimulation measured after 20 hrs by ELISA,Activity,,,,Not Active,CHEMBL613107,PBMC (Peripheral blood mononuclear cells),Homo sapiens,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959939,Effect on LPS-induced IL-6 production in human monocytes at 0.03906 to 20 uM preincubated for 30 mins before LPS stimulation measured after 20 hrs by ELISA,Activity,,,,Not Active,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959945,Effect on LPS-induced IL-6 production in mouse intraperitoneal macrophages pretreated with CSF-1 at 0.03906 to 20 uM compound incubated for 30 mins before LPS stimulation measured after 20 hrs by ELISA,Activity,,,,Not Active,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959943,Effect on LPS-induced PGE2 production in CSF-1-stimulated human macrophages at 0.03906 to 20 uM preincubated for 30 mins before LPS stimulation measured after 20 hrs by ELISA,Activity,,,,Not Active,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959937,Effect on LPS-induced PGE2 production in human PBMC at 0.03906 to 20 uM preincubated for 30 mins before LPS stimulation measured after 20 hrs by ELISA,Activity,,,,Not Active,CHEMBL613107,PBMC (Peripheral blood mononuclear cells),Homo sapiens,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959940,Effect on LPS-induced PGE2 production in human monocytes at 0.03906 to 20 uM preincubated for 30 mins before LPS stimulation measured after 20 hrs by ELISA,Activity,,,,Not Active,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959941,Effect on LPS-induced TNF production in CSF-1-stimulated human macrophages at 0.03906 to 20 uM preincubated for 30 mins before LPS stimulation measured after 20 hrs by ELISA,Activity,,,,Not Active,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959935,Effect on LPS-induced TNF production in human PBMC at 0.03906 to 20 uM preincubated for 30 mins before LPS stimulation measured after 20 hrs by ELISA,Activity,,,,Not Active,CHEMBL613107,PBMC (Peripheral blood mononuclear cells),Homo sapiens,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959938,Effect on LPS-induced TNF production in human monocytes at 0.03906 to 20 uM preincubated for 30 mins before LPS stimulation measured after 20 hrs by ELISA,Activity,,,,Not Active,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959944,Effect on LPS-induced TNF production in mouse intraperitoneal macrophages pretreated with CSF-1 at 0.03906 to 20 uM compound incubated for 30 mins before LPS stimulation measured after 20 hrs by ELISA,Activity,,,,Not Active,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959488,Growth inhibition of CSF-1-stimulated freshly isolated human monocytes after 3 days by spectrophotometry,IC50,=,470,nM,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959486,Growth inhibition of CSF1-stimulated mouse M-NFS-60 cells after 3 days by spectrophotometry,IC50,=,330,nM,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959931,Growth inhibition of CSF1-stimulated mouse M-NFS-60 cells at 0.7 uM after 3 days by spectrophotometry,GI,,,,Active,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959490,Growth inhibition of VEGF-stimulated HUVEC after 3 days by spectrophotometry,IC50,=,12000,nM,,CHEMBL613979,HUVEC (Umbilical vein endothelial cells),Homo sapiens,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959491,Growth inhibition of bFGF-stimulated HUVEC after 3 days by spectrophotometry,IC50,>,10000,nM,,CHEMBL613979,HUVEC (Umbilical vein endothelial cells),Homo sapiens,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959489,Growth inhibition of serum-stimulated HFF after 3 days by spectrophotometry,IC50,>,30000,nM,,CHEMBL614071,HFF (Foreskin fibroblasts),Homo sapiens,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959493,Growth inhibition of serum-stimulated human A549 cells after 3 days by spectrophotometry,IC50,>,30000,nM,,CHEMBL392,A549 (Lung carcinoma cells),Homo sapiens,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959494,Growth inhibition of serum-stimulated human BT474 cells after 3 days by spectrophotometry,IC50,=,21000,nM,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959929,Growth inhibition of serum-stimulated human HN5 cells after 3 days by spectrophotometry,IC50,=,29000,nM,,CHEMBL614828,HN5 (Squamous cell carcinoma),Homo sapiens,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959492,Growth inhibition of serum-stimulated human MDA231 cells after 3 days by spectrophotometry,IC50,>,30000,nM,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959930,Growth inhibition of serum-stimulated human NCI-N87 cells after 3 days by spectrophotometry,IC50,>,30000,nM,,CHEMBL614197,NCI-N87,Homo sapiens,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959487,Growth inhibition of serum-stimulated mouse NSO cells after 3 days by spectrophotometry,IC50,=,13500,nM,,CHEMBL615003,NSO (Myeloma cells),Mus musculus,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1960105,"Increase in LPS-stimulated IL-6 production in mouse at 40 mg/kg, po administered 0.5 hr before LPS challenge measured 1.5 hr after LPS challenge",Activity,,,,Active,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959932,Inhibition of CSF-1-stimulated growth of freshly isolated human monocytes at 1 uM preincubated for 30 mins before inducer addition measured after 5 days by WST-1 method,GI,=,100,%,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959933,Inhibition of GMCSF-stimulated growth of freshly isolated human monocytes at 1 uM preincubated for 30 mins before inducer addition measured after 5 days by WST-1 method,GI,=,80,%,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1960101,"Inhibition of LPS-stimulated IL-6 production in CSF-1 primed mouse at 40 mg/kg, po administered 0.5 hr before LPS challenge post CSF-1 priming measured 1.5 hr after LPS challenge",Inhibition,=,-6,%,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1960102,"Inhibition of LPS-stimulated IL-6 production in CSF-1 primed mouse at 40 mg/kg, po administered 4.5 hr before LPS challenge and CSF-1 priming measured 1.5 hr after LPS challenge",Inhibition,=,49,%,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1960099,"Inhibition of LPS-stimulated IL-6 production in mouse at 40 mg/kg, po administered 0.5 hr before LPS challenge measured 1.5 hr after LPS challenge",Inhibition,=,20,%,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1960100,"Inhibition of LPS-stimulated IL-6 production in mouse at 40 mg/kg, po administered 4.5 hr before LPS challenge measured 1.5 hr after LPS challenge",Inhibition,=,-28,%,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1960103,"Inhibition of LPS-stimulated TNF production in CSF-1 primed mouse at 20 to 80 mg/kg, po administered 4.5 hr before LPS challenge and CSF-1 priming measured 1.5 hr after LPS challenge",Inhibition,,,,Active,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1960097,"Inhibition of LPS-stimulated TNF production in CSF-1 primed mouse at 40 mg/kg, po administered 0.5 hr before LPS challenge post CSF-1 priming measured 1.5 hr after LPS challenge",Inhibition,=,63,%,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1960098,"Inhibition of LPS-stimulated TNF production in CSF-1 primed mouse at 40 mg/kg, po administered 4.5 hr before LPS challenge and CSF-1 priming measured 1.5 hr after LPS challenge",Inhibition,=,58,%,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1960104,"Inhibition of LPS-stimulated TNF production in mouse at 20 to 80 mg/kg, po administered 4.5 hr before LPS challenge and measured 1.5 hr after LPS challenge",Inhibition,,,,Active,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1960095,"Inhibition of LPS-stimulated TNF production in mouse at 40 mg/kg, po administered 0.5 hr before LPS challenge measured 1.5 hr after LPS challenge",Inhibition,=,68,%,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1960096,"Inhibition of LPS-stimulated TNF production in mouse at 40 mg/kg, po administered 4.5 hr before LPS challenge measured 1.5 hr after LPS challenge",Inhibition,=,42,%,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959934,Inhibition of LPS-stimulated growth of freshly isolated human monocytes at 1 uM preincubated for 30 mins before inducer addition measured after 5 days by WST-1 method,GI,=,50,%,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959958,Inhibition of PTH-induced Wistar rat calvarial bone degradation assessed as reduction in DPPD level in media at 0.1 uM after 48 hrs,Inhibition,=,80,%,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959959,Inhibition of PTH-induced Wistar rat calvarial bone degradation assessed as reduction in DPPD level in media at 1 to 100 uM after 48 hrs,Inhibition,,,,Active,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1960085,Inhibition of PTH-induced Wistar rat fetal long bone degradation assessed as labeled 45Ca release in to media at 0.1 to 0.3 uM after 48 hrs by liquid scintillation spectrometry,Inhibition,=,30,%,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1960086,Inhibition of PTH-induced Wistar rat fetal long bone degradation assessed as labeled 45Ca release in to media at 1 to 10 uM after 48 hrs by liquid scintillation spectrometry,Inhibition,,,,Active,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959332,Inhibition of human FLT3 catalytic domain after by scintillation counting,IC50,>,13000,nM,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,Homo sapiens,P36888,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959342,Inhibition of human GST-tagged PKA using biotin-(6-amino caproic acid)-LRRASLGKKK-amide as substrate after 70 mins by scintillation proximity assay,IC50,>,10000,nM,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959343,Inhibition of human GST-tagged PLK1 using biotin-amino hexanoic acid-SFNDTLDFD-NH2 as substrate after 15 mins by scintillation proximity assay,IC50,>,24000,nM,,CHEMBL3024,Serine/threonine-protein kinase PLK1,Homo sapiens,P53350,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959348,Inhibition of human GST-tagged Tie2 using biotin-(6-amino caproic acid)-LEARLVAYEGWVAGKKK-NH2 after 2 hrs by homogenous time-resolved fluorescence method,IC50,>,20000,nM,,CHEMBL4128,Tyrosine-protein kinase TIE-2,Homo sapiens,Q02763,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959349,Inhibition of human GST-tagged VEGFR2 catalytic domain using biotin-aminohexyl-EEEEYFELVAKKKK-NH2 as substrate after 40 mins by homogenous time-resolved fluorescence method,IC50,>,20000,nM,,CHEMBL279,Vascular endothelial growth factor receptor 2,Homo sapiens,P35968,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959327,Inhibition of human GST-tagged c-SRC autophosphorylation using biotin-(6-amino caproic acid)-AAAQQIYGQ-NH2 as substrate after 40 mins by homogenous time-resolved fluorescence method,IC50,>,16000,nM,,CHEMBL267,Tyrosine-protein kinase SRC,Homo sapiens,P12931,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959339,Inhibition of human GST-tagged p38 MAPK using biotin-IPTSPITTTYFFFRRR-amide as substrate after 60 mins by scintillation proximity assay,IC50,>,16000,nM,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959328,Inhibition of human His-tagged EGFR using biotin-amino hexanoic acid-RAHEEIYHFFFAKKK-NH2 as substrate after 15 mins by scintillation proximity assay,IC50,>,24000,nM,,CHEMBL203,Epidermal growth factor receptor erbB1,Homo sapiens,P00533,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959329,Inhibition of human His-tagged ERBB2 using biotin-amino hexanoic acid-RAHEEIYHFFFAKKK-NH2 as substrate after 15 mins by scintillation proximity assay,IC50,>,24000,nM,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,Homo sapiens,P04626,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959330,Inhibition of human His-tagged ERBB4 using biotin-amino hexanoic acid-RAHEEIYHFFFAKKK-NH2 as substrate after 15 mins by scintillation proximity assay,IC50,>,24000,nM,,CHEMBL3009,Receptor protein-tyrosine kinase erbB-4,Homo sapiens,Q15303,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959333,Inhibition of human His-tagged GSK-3b using biotin-6-amino caproic acid-AAAKRREILSRRPS(PO3)YR-amide as substrate after 19 mins by NXT scintillation counting,IC50,>,32000,nM,,CHEMBL262,Glycogen synthase kinase-3 beta,Homo sapiens,P49841,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959338,Inhibition of human His-tagged MK2 using K(biotin)KLNRTLSVA as substrate after 2 hrs by scintillation counting,IC50,>,10000,nM,,CHEMBL2208,MAP kinase-activated protein kinase 2,Homo sapiens,P49137,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959341,Inhibition of human His-tagged PDHK4 using biotin-YHGHSMSDPGVSYRRR-amide as substrate after 20 mins by scintillation proximity assay,IC50,>,28000,nM,,CHEMBL4141,Pyruvate dehydrogenase kinase isoform 4,Homo sapiens,Q16654,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959346,Inhibition of human His-tagged PKCz using biotin-(amino hexanoic acid)-FKLKRKGSFKKFA-CONH2 as substrate after 40 mins by scintillation proximity assay,IC50,>,24000,nM,,CHEMBL3438,Protein kinase C zeta,Homo sapiens,Q05513,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959334,Inhibition of human ITK,IC50,>,16000,nM,,CHEMBL2959,Tyrosine-protein kinase ITK/TSK ,Homo sapiens,Q08881,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959335,Inhibition of human JAK2 catalytic domain after by scintillation counting,IC50,>,13000,nM,,CHEMBL2971,Tyrosine-protein kinase JAK2,Homo sapiens,O60674,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959336,Inhibition of human JNK3,IC50,>,16000,nM,,CHEMBL2637,c-Jun N-terminal kinase 3,Homo sapiens,P53779,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959340,Inhibition of human PDGFR-1b,IC50,>,10000,nM,,CHEMBL1913,Platelet-derived growth factor receptor beta,Homo sapiens,P09619,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959344,Inhibition of human PKCa catalytic domain after by scintillation counting,IC50,>,13000,nM,,CHEMBL299,Protein kinase C alpha ,Homo sapiens,P17252,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959345,Inhibition of human PKCb1 catalytic domain after by scintillation counting,IC50,>,13000,nM,,CHEMBL3045,Protein kinase C beta,Homo sapiens,P05771,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959347,Inhibition of human SYK,IC50,>,16000,nM,,CHEMBL2599,Tyrosine-protein kinase SYK,Homo sapiens,P43405,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959326,Inhibition of human cKIT catalytic domain after by scintillation counting,IC50,>,13000,nM,,CHEMBL1936,Stem cell growth factor receptor,Homo sapiens,P10721,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959946,Inhibition of human osteoclast attachment to plastic surface assessed cells per cm2 of plastic at 1 uM after 3 days by immunocytochemistry (Rvb = 9723 +/- 1380 cells/cm2 of plastic),Activity,=,2984,/cm2,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959954,Inhibition of human osteoclast attachment to plastic surface assessed cells per cm2 of plastic at 10 uM after 3 days by immunocytochemistry (Rvb = 9723 +/- 1380 cells/cm2 of plastic),Activity,=,2728,/cm2,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959950,Inhibition of human osteoclast attachment to plastic surface assessed cells per cm2 of plastic at 3 uM after 3 days by immunocytochemistry (Rvb = 9723 +/- 1380 cells/cm2 of plastic),Activity,=,3369,/cm2,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959950,Inhibition of human osteoclast attachment to plastic surface assessed cells per cm2 of plastic at 3 uM after 3 days by immunocytochemistry (Rvb = 9723 +/- 1380 cells/cm2 of plastic),Activity,=,3369,/cm2,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959948,Inhibition of human osteoclast degradation of bone assessed as bone slice resorbed at 1 uM after 3 days by immunocytochemistry (Rvb = 26.6 +/- 4.7 %),Inhibition,=,3.3,%,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959956,Inhibition of human osteoclast degradation of bone assessed as bone slice resorbed at 10 uM after 3 days by immunocytochemistry (Rvb = 26.6 +/- 4.7 %),Inhibition,=,1.2,%,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959952,Inhibition of human osteoclast degradation of bone assessed as bone slice resorbed at 3 uM after 3 days by immunocytochemistry (Rvb = 26.6 +/- 4.7 %),Inhibition,=,1.5,%,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959947,Inhibition of human osteoclast degradation of bone assessed as reduction in 23C6(+) cells with more than 3 nuclei per cm2 of bone at 1 uM after 3 days by immunocytochemistry (Rvb = 854 +/- 122 cells/cm2 of bone),Activity,=,244,/cm2,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959955,Inhibition of human osteoclast degradation of bone assessed as reduction in 23C6(+) cells with more than 3 nuclei per cm2 of bone at 10 uM after 3 days by immunocytochemistry (Rvb = 854 +/- 122 cells/cm2 of bone),Activity,=,34,/cm2,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959951,Inhibition of human osteoclast degradation of bone assessed as reduction in 23C6(+) cells with more than 3 nuclei per cm2 of bone at 3 uM after 3 days by immunocytochemistry (Rvb = 854 +/- 122 cells/cm2 of bone),Activity,=,120,/cm2,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959949,Inhibition of human osteoclast degradation of bone assessed as reduction in actin ring formation per cm2 of bone at 1 uM after 3 days by immunocytochemistry (Rvb = 1546 +/- 232 /cm2 of bone),Activity,=,479,/cm2,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959957,Inhibition of human osteoclast degradation of bone assessed as reduction in actin ring formation per cm2 of bone at 10 uM after 3 days by immunocytochemistry (Rvb = 1546 +/- 232 /cm2 of bone),Activity,=,0,/cm2,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959953,Inhibition of human osteoclast degradation of bone assessed as reduction in actin ring formation per cm2 of bone at 3 uM after 3 days by immunocytochemistry (Rvb = 1546 +/- 232 /cm2 of bone),Activity,=,148,/cm2,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959337,Inhibition of mouse LCK,IC50,>,10000,nM,,CHEMBL2480,Tyrosine-protein kinase LCK,Mus musculus,P06240,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959325,Inhibition of recombinant human GST-tagged CDK4 catalytic domain after 30 mins by liquid scintillation counting,IC50,>,19000,nM,,CHEMBL331,Cyclin-dependent kinase 4,Homo sapiens,P11802,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959323,Inhibition of recombinant human GST-tagged CFMS kinase catalytic domain using biotin-EAIYAPFAKKK-NH2 as substrate after 40 mins by NXT scintillation counting,IC50,=,30,nM,,CHEMBL1844,Macrophage colony stimulating factor  receptor ,Homo sapiens,P07333,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959331,Inhibition of recombinant human GST-tagged ERK2 after 60 mins by fluorescence polarization assay,IC50,>,10000,nM,,CHEMBL4040,MAP kinase ERK2,Homo sapiens,P28482,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959324,Inhibition of recombinant human His-tagged B-RAF after 60 mins by fluorescence polarization assay,IC50,>,4800,nM,,CHEMBL5145,Serine/threonine-protein kinase B-raf,Homo sapiens,P15056,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1958804,"Inhibition of thioglycolate-induced macrophage influx into peritoneal cavity in mouse at 20 mg/kg, po BID administered 7 days before and 4 days after thioglycolate challenge",Inhibition,=,8,%,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1960109,"Inhibition of thioglycolate-induced macrophage influx into peritoneal cavity in mouse at 20 mg/kg, po BID starting 1 hr before thioglycolate challenge for 4 days",Inhibition,=,17,%,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1958806,"Inhibition of thioglycolate-induced macrophage influx into peritoneal cavity in mouse at 20 to 80 mg/kg, po BID",Inhibition,,,,tde,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1958805,"Inhibition of thioglycolate-induced macrophage influx into peritoneal cavity in mouse at 80 mg/kg, po BID administered 7 days before and 4 days after thioglycolate challenge",Inhibition,=,45,%,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1958803,"Inhibition of thioglycolate-induced macrophage influx into peritoneal cavity in mouse at 80 mg/kg, po BID starting 1 hr before thioglycolate challenge for 4 days",Inhibition,=,25,%,,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1960089,Protein binding in cell-culture media with 10% fetal calf serum at 3 uM,PB,=,24,%,,CHEMBL613440,Serum,Bos taurus,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1960092,Protein binding in cell-culture media with human plasma at 3 uM,PB,=,98,%,,CHEMBL613424,Plasma,Homo sapiens,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1960090,Protein binding in cell-culture media with mouse plasma at 3 uM,PB,=,93,%,,CHEMBL613589,Plasma,Mus musculus,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1960091,Protein binding in cell-culture media with rat plasma at 3 uM,PB,=,95,%,,CHEMBL613652,Plasma,Rattus norvegicus,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959358,Selectivity ratio of IC50 for human FLT3 to IC50 for recombinant human GST-tagged CFMS kinase,Ratio IC50,=,150,,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959351,Selectivity ratio of IC50 for human GST-tagged CDK4 to IC50 for recombinant human GST-tagged CFMS kinase,Ratio IC50,=,150,,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959478,Selectivity ratio of IC50 for human GST-tagged PKA to IC50 for recombinant human GST-tagged CFMS kinase,Ratio IC50,=,150,,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959479,Selectivity ratio of IC50 for human GST-tagged PLK1 to IC50 for recombinant human GST-tagged CFMS kinase,Ratio IC50,=,150,,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959484,Selectivity ratio of IC50 for human GST-tagged Tie2 to IC50 for recombinant human GST-tagged CFMS kinase,Ratio IC50,=,150,,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959485,Selectivity ratio of IC50 for human GST-tagged VEGFR2 to IC50 for recombinant human GST-tagged CFMS kinase,Ratio IC50,=,150,,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959353,Selectivity ratio of IC50 for human GST-tagged c-SRC to IC50 for recombinant human GST-tagged CFMS kinase,Ratio IC50,=,150,,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959365,Selectivity ratio of IC50 for human GST-tagged p38 MAPK to IC50 for recombinant human GST-tagged CFMS kinase,Ratio IC50,=,150,,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959350,Selectivity ratio of IC50 for human His-tagged B-RAF to IC50 for recombinant human GST-tagged CFMS kinase,Ratio IC50,=,150,,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959354,Selectivity ratio of IC50 for human His-tagged EGFR to IC50 for recombinant human GST-tagged CFMS kinase,Ratio IC50,=,150,,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959355,Selectivity ratio of IC50 for human His-tagged ERBB2 to IC50 for recombinant human GST-tagged CFMS kinase,Ratio IC50,=,150,,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959356,Selectivity ratio of IC50 for human His-tagged ERBB4 to IC50 for recombinant human GST-tagged CFMS kinase,Ratio IC50,=,150,,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959359,Selectivity ratio of IC50 for human His-tagged GSK-3b to IC50 for recombinant human GST-tagged CFMS kinase,Ratio IC50,=,150,,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959364,Selectivity ratio of IC50 for human His-tagged MK2 to IC50 for recombinant human GST-tagged CFMS kinase,Ratio IC50,=,150,,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959477,Selectivity ratio of IC50 for human His-tagged PDHK4 to IC50 for recombinant human GST-tagged CFMS kinase,Ratio IC50,=,150,,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959482,Selectivity ratio of IC50 for human His-tagged PKCz to IC50 for recombinant human GST-tagged CFMS kinase,Ratio IC50,=,150,,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959360,Selectivity ratio of IC50 for human ITK to IC50 for recombinant human GST-tagged CFMS kinase,Ratio IC50,=,150,,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959361,Selectivity ratio of IC50 for human JAK2 to IC50 for recombinant human GST-tagged CFMS kinase,Ratio IC50,=,150,,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959362,Selectivity ratio of IC50 for human JNK3 to IC50 for recombinant human GST-tagged CFMS kinase,Ratio IC50,=,150,,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959366,Selectivity ratio of IC50 for human PDGFR-1b to IC50 for recombinant human GST-tagged CFMS kinase,Ratio IC50,=,150,,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959480,Selectivity ratio of IC50 for human PKCa to IC50 for recombinant human GST-tagged CFMS kinase,Ratio IC50,=,150,,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959481,Selectivity ratio of IC50 for human PKCb1 to IC50 for recombinant human GST-tagged CFMS kinase,Ratio IC50,=,150,,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959483,Selectivity ratio of IC50 for human SYK to IC50 for recombinant human GST-tagged CFMS kinase,Ratio IC50,=,150,,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959352,Selectivity ratio of IC50 for human cKIT catalytic domain to IC50 for recombinant human GST-tagged CFMS kinase,Ratio IC50,=,150,,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959363,Selectivity ratio of IC50 for mouse LCK to IC50 for recombinant human GST-tagged CFMS kinase,Ratio IC50,=,150,,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1959357,Selectivity ratio of IC50 for recombinant human GST-tagged ERK2 to IC50 for recombinant human GST-tagged CFMS kinase,Ratio IC50,=,150,,,CHEMBL612545,,,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
GW2580,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL261849,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1960108,"Toxicity in mouse M-NFS-60 cells allografted CD-1 nude mouse assessed as effect on body weight at 20 to 80 mg/kg, po BID starting 1 hr before challenge for 4 days",Activity,,,,Non-toxic,CHEMBL375,Mus musculus,Mus musculus,,CHEMBL1955811,"Proc. Natl. Acad. Sci. U.S.A., 102, p. 16078 (2005)",16249345,Scientific Literature
3744W,CHEMBL1956068,"InChI=1S/C22H15N3O4/c1-28-9-3-5-13-11(7-9)15-17-18(22(27)25-21(17)26)16-12-8-10(29-2)4-6-14(12)24-20(16)19(15)23-13/h3-8,23-24H,1-2H3,(H,25,26,27)",COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c6C(=O)NC(=O)c6c3c2c1,CHEMBL1956068,"InChI=1S/C22H15N3O4/c1-28-9-3-5-13-11(7-9)15-17-18(22(27)25-21(17)26)16-12-8-10(29-2)4-6-14(12)24-20(16)19(15)23-13/h3-8,23-24H,1-2H3,(H,25,26,27)",COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c6C(=O)NC(=O)c6c3c2c1,CHEMBL1959230,Inhibition of PDGF-dependent PDGFR autophosphorylation in rat A10 cells,IC50,=,15,nM,,CHEMBL612545,,,,CHEMBL1955835,"Cell Signal, 11, p. 95 (1999)",10048786,Scientific Literature
3744W,CHEMBL1956068,"InChI=1S/C22H15N3O4/c1-28-9-3-5-13-11(7-9)15-17-18(22(27)25-21(17)26)16-12-8-10(29-2)4-6-14(12)24-20(16)19(15)23-13/h3-8,23-24H,1-2H3,(H,25,26,27)",COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c6C(=O)NC(=O)c6c3c2c1,CHEMBL1956068,"InChI=1S/C22H15N3O4/c1-28-9-3-5-13-11(7-9)15-17-18(22(27)25-21(17)26)16-12-8-10(29-2)4-6-14(12)24-20(16)19(15)23-13/h3-8,23-24H,1-2H3,(H,25,26,27)",COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c6C(=O)NC(=O)c6c3c2c1,CHEMBL1959231,Inhibition of PDGF-dependent PDGFR-mediated cell proliferation in rat A10 cells,IC50,=,10,nM,,CHEMBL612545,,,,CHEMBL1955835,"Cell Signal, 11, p. 95 (1999)",10048786,Scientific Literature
3744W,CHEMBL1956068,"InChI=1S/C22H15N3O4/c1-28-9-3-5-13-11(7-9)15-17-18(22(27)25-21(17)26)16-12-8-10(29-2)4-6-14(12)24-20(16)19(15)23-13/h3-8,23-24H,1-2H3,(H,25,26,27)",COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c6C(=O)NC(=O)c6c3c2c1,CHEMBL1956068,"InChI=1S/C22H15N3O4/c1-28-9-3-5-13-11(7-9)15-17-18(22(27)25-21(17)26)16-12-8-10(29-2)4-6-14(12)24-20(16)19(15)23-13/h3-8,23-24H,1-2H3,(H,25,26,27)",COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c6C(=O)NC(=O)c6c3c2c1,CHEMBL1959232,Inhibition of recombinant cytoplasmic domain of PDGFRbeta autophosphorylation expressed in baculovirus infected Sf21 insect cells using [gamma-33P]ATP by SDS-PAGE based scintillation counting,IC50,=,1800,nM,,CHEMBL1913,Platelet-derived growth factor receptor beta,Homo sapiens,P09619,CHEMBL1955835,"Cell Signal, 11, p. 95 (1999)",10048786,Scientific Literature
3744W,CHEMBL1956068,"InChI=1S/C22H15N3O4/c1-28-9-3-5-13-11(7-9)15-17-18(22(27)25-21(17)26)16-12-8-10(29-2)4-6-14(12)24-20(16)19(15)23-13/h3-8,23-24H,1-2H3,(H,25,26,27)",COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c6C(=O)NC(=O)c6c3c2c1,CHEMBL1956068,"InChI=1S/C22H15N3O4/c1-28-9-3-5-13-11(7-9)15-17-18(22(27)25-21(17)26)16-12-8-10(29-2)4-6-14(12)24-20(16)19(15)23-13/h3-8,23-24H,1-2H3,(H,25,26,27)",COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c6C(=O)NC(=O)c6c3c2c1,CHEMBL1959232,Inhibition of recombinant cytoplasmic domain of PDGFRbeta autophosphorylation expressed in baculovirus infected Sf21 insect cells using [gamma-33P]ATP by SDS-PAGE based scintillation counting,Inhibition,,,,Dose-dependent effect,CHEMBL1913,Platelet-derived growth factor receptor beta,Homo sapiens,P09619,CHEMBL1955835,"Cell Signal, 11, p. 95 (1999)",10048786,Scientific Literature
3744W,CHEMBL1956068,"InChI=1S/C22H15N3O4/c1-28-9-3-5-13-11(7-9)15-17-18(22(27)25-21(17)26)16-12-8-10(29-2)4-6-14(12)24-20(16)19(15)23-13/h3-8,23-24H,1-2H3,(H,25,26,27)",COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c6C(=O)NC(=O)c6c3c2c1,CHEMBL1956068,"InChI=1S/C22H15N3O4/c1-28-9-3-5-13-11(7-9)15-17-18(22(27)25-21(17)26)16-12-8-10(29-2)4-6-14(12)24-20(16)19(15)23-13/h3-8,23-24H,1-2H3,(H,25,26,27)",COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c6C(=O)NC(=O)c6c3c2c1,CHEMBL1959322,Inhibition of recombinant cytoplasmic domain of PDGFRbeta expressed in baculovirus infected Sf21 insect cells assessed as tyrosine phosphorylation treated 30 hrs after infection measured after 48 hrs of post infection by Western blotting,IC50,=,2000,nM,,CHEMBL1913,Platelet-derived growth factor receptor beta,Homo sapiens,P09619,CHEMBL1955835,"Cell Signal, 11, p. 95 (1999)",10048786,Scientific Literature
3744W,CHEMBL1956068,"InChI=1S/C22H15N3O4/c1-28-9-3-5-13-11(7-9)15-17-18(22(27)25-21(17)26)16-12-8-10(29-2)4-6-14(12)24-20(16)19(15)23-13/h3-8,23-24H,1-2H3,(H,25,26,27)",COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c6C(=O)NC(=O)c6c3c2c1,CHEMBL1956068,"InChI=1S/C22H15N3O4/c1-28-9-3-5-13-11(7-9)15-17-18(22(27)25-21(17)26)16-12-8-10(29-2)4-6-14(12)24-20(16)19(15)23-13/h3-8,23-24H,1-2H3,(H,25,26,27)",COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c6C(=O)NC(=O)c6c3c2c1,CHEMBL1959322,Inhibition of recombinant cytoplasmic domain of PDGFRbeta expressed in baculovirus infected Sf21 insect cells assessed as tyrosine phosphorylation treated 30 hrs after infection measured after 48 hrs of post infection by Western blotting,Inhibition,,,,Dose-dependent effect,CHEMBL1913,Platelet-derived growth factor receptor beta,Homo sapiens,P09619,CHEMBL1955835,"Cell Signal, 11, p. 95 (1999)",10048786,Scientific Literature
3744W,CHEMBL1956068,"InChI=1S/C22H15N3O4/c1-28-9-3-5-13-11(7-9)15-17-18(22(27)25-21(17)26)16-12-8-10(29-2)4-6-14(12)24-20(16)19(15)23-13/h3-8,23-24H,1-2H3,(H,25,26,27)",COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c6C(=O)NC(=O)c6c3c2c1,CHEMBL1956068,"InChI=1S/C22H15N3O4/c1-28-9-3-5-13-11(7-9)15-17-18(22(27)25-21(17)26)16-12-8-10(29-2)4-6-14(12)24-20(16)19(15)23-13/h3-8,23-24H,1-2H3,(H,25,26,27)",COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c6C(=O)NC(=O)c6c3c2c1,CHEMBL1959321,"Inhibition of recombinant cytoplasmic domain of PDGFRbeta expressed in baculovirus infected Sf21 insect cells using 10 fold less poly(Glu4,Tyr1) and [gamma-33P]ATP at 100 uM by SDS-PAGE based scintillation counting",Inhibition,,,,Not Active,CHEMBL1913,Platelet-derived growth factor receptor beta,Homo sapiens,P09619,CHEMBL1955835,"Cell Signal, 11, p. 95 (1999)",10048786,Scientific Literature
3744W,CHEMBL1956068,"InChI=1S/C22H15N3O4/c1-28-9-3-5-13-11(7-9)15-17-18(22(27)25-21(17)26)16-12-8-10(29-2)4-6-14(12)24-20(16)19(15)23-13/h3-8,23-24H,1-2H3,(H,25,26,27)",COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c6C(=O)NC(=O)c6c3c2c1,CHEMBL1956068,"InChI=1S/C22H15N3O4/c1-28-9-3-5-13-11(7-9)15-17-18(22(27)25-21(17)26)16-12-8-10(29-2)4-6-14(12)24-20(16)19(15)23-13/h3-8,23-24H,1-2H3,(H,25,26,27)",COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c6C(=O)NC(=O)c6c3c2c1,CHEMBL1959320,"Inhibition of recombinant cytoplasmic domain of PDGFRbeta expressed in baculovirus infected Sf21 insect cells using poly(Glu4,Tyr1) and [gamma-33P]ATP at 100 uM by SDS-PAGE based scintillation counting",Inhibition,,,,Not Active,CHEMBL1913,Platelet-derived growth factor receptor beta,Homo sapiens,P09619,CHEMBL1955835,"Cell Signal, 11, p. 95 (1999)",10048786,Scientific Literature
